PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bigi, A; Beltrami, E; Trinei, M; Stendardo, M; Pelicci, PG; Giorgio, M				Bigi, A.; Beltrami, E.; Trinei, M.; Stendardo, M.; Pelicci, P. G.; Giorgio, M.			Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis	ONCOGENE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; MANGANESE SUPEROXIDE-DISMUTASE; BREAST-CANCER; CELL-DEATH; K-RAS; ONCOGENIC RAS; LUNG-CANCER; IN-VIVO; P53; CYCLOSPORINE	Mitochondrial alterations induced by oncogenes are known to be crucial for tumorigenesis. Ras oncogene leads to proliferative signals through a Raf-1/MEK/ERK kinase cascade, whose components have been found to be also associated with mitochondria. The mitochondrial pepdidyl-prolyl isomerase cyclophilin D (CypD) is an important regulator of the mitochondrial permeability transition and a key player in mitochondria physiology; however, its role in cancer is still unclear. Using cellular and in vivo mouse models, we demonstrated that CypD protein upregulation induced by oncogenic Ras through the Raf-1/MEK/ERK pathway has a deterministic role in tumor progression. In fact, targeting CypD gene expression clearly affected RasV12-induced transformation, as showed by in vitro data on murine NIH3T3 and human MCF10A mammary epithelial cells. In addition, studies in xenograft and K-Ras lung cancer mouse models demonstrated that genetic deletion or pharmacological suppression of CypD efficiently prevented Ras-dependent tumor formation. Furthermore, Erbb2-mediated breast tumorigenesis was similarly prevented by targeting CypD. From a mechanistic point of view, CypD expression was associated with a reduced induction of p21(WAF1/CIP1) and p53 functions, unraveling an antagonistic function of CypD on p21-p53-mediated growth suppression. CypD activity is p53 dependent. Interestingly, a physical association between p53 and CypD was detected in mitochondria of MCF10A cells; furthermore, both in vitro and in vivo studies proved that CypD inhibitor-based treatment was able to efficiently impair this interaction, leading to a tumor formation reduction. All together, these findings indicate that the countering effect of CypD on the p53-p21 pathway participates in oncogene-dependent transformation.	[Bigi, A.; Beltrami, E.; Trinei, M.; Stendardo, M.; Pelicci, P. G.; Giorgio, M.] European Inst Oncol, Dept Expt Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO)	Giorgio, M (corresponding author), European Inst Oncol, Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	marco.giorgio@ieo.eu	Pelicci, Pier Giuseppe/AAL-6572-2020; Giorgio, Marco/I-9425-2012; beltrami, elena/AAE-9937-2021	Giorgio, Marco/0000-0002-5842-6042; 	Italian Association for Cancer Research (AIRC); Fondazione Umberto Veronesi (FUV)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi (FUV)(Fondazione Umberto Veronesi)	This work was supported by the Italian Association for Cancer Research (AIRC) and the Fondazione Umberto Veronesi (FUV) grants awarded to MG. We thank Michael Forte and Paolo Bernardi for helpful discussion and for providing CypDKO mice, Mariano Barbacid for K-Ras/RERT mice, Jacob Tropmair for MEK-1 mutants and Novartis (Basel-Switzerland) for Deb025.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Beltrami E, 2013, AGING CELL, V12, P177, DOI 10.1111/acel.12036; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chen G, 2009, ANTIOXID REDOX SIGN, V11, P1083, DOI [10.1089/ars.2008.2321, 10.1089/ARS.2008.2321]; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Galluzzi L, 2011, ANTIOXID REDOX SIGN, V15, P1691, DOI 10.1089/ars.2010.3504; Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hogan B, 1994, MANIPULATING MOUSE E; Holley AK, 2010, ANN NY ACAD SCI, V1201, P72, DOI 10.1111/j.1749-6632.2010.05612.x; Holley AK, 2009, FUTURE ONCOL, V5, P117, DOI 10.2217/14796694.5.1.117; Hursting SD, 2002, MOL CARCINOGEN, V33, P16, DOI 10.1002/mc.10020; Jiang K, 2012, INT J MOL MED, V30, P302, DOI 10.3892/ijmm.2012.989; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kumar P, 2001, BIOCHEM BIOPH RES CO, V284, P219, DOI 10.1006/bbrc.2001.4952; Li B, 2012, BBA-BIOENERGETICS, V1817, P1628, DOI 10.1016/j.bbabio.2012.05.011; Longo Valter D, 2004, Sci Aging Knowledge Environ, V2004, ppe36, DOI 10.1126/sageke.2004.39.pe36; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Marcu R, 2012, BIOELECTROCHEMISTRY, V85, P21, DOI 10.1016/j.bioelechem.2011.11.005; Masuo T, 2009, CANCER LETT, V285, P66, DOI 10.1016/j.canlet.2009.05.001; Murphy ME, 2004, CELL CYCLE, V3, P836; Neuzil J, 2012, CELL RES, V22, P285, DOI 10.1038/cr.2011.160; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Rapino S, 2015, ELECTROCHIM ACTA, V179, P65, DOI 10.1016/j.electacta.2015.04.053; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schubert A, 2004, CANCER RES, V64, P85, DOI 10.1158/0008-5472.CAN-03-0476; Senturk S, 2014, P NATL ACAD SCI USA, V111, pE3287, DOI 10.1073/pnas.1321640111; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsumura H, 2006, ONCOGENE, V25, P7673, DOI 10.1038/sj.onc.1209749; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zhao LP, 2013, NEUROCHEM RES, V38, P705, DOI 10.1007/s11064-013-0968-5; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493; Zupanska A, 2005, NEUROCHEM INT, V47, P430, DOI 10.1016/j.neuint.2005.05.010	54	18	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5132	5143		10.1038/onc.2016.42	http://dx.doi.org/10.1038/onc.2016.42			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	26973251				2022-12-26	WOS:000384433000005
J	Lisewski, U; Koehncke, C; Wilck, N; Buschmeyer, B; Pieske, B; Roepke, TK				Lisewski, Ulrike; Koehncke, Clemens; Wilck, Nicola; Buschmeyer, Bastian; Pieske, Burkert; Roepke, Torsten K.			Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3(-/-) mice	FASEB JOURNAL			English	Article						arrhythmia; Kv channel; trafficking; KCNE; aldosteronism	EMERGING ROLE; CHANNELS; DELETION; EXPRESSION; LOCALIZATION; DISRUPTION; MUTATIONS; COMPONENT; MEMBRANE; RECEPTOR	Hyperaldosteronism is associated with an increased prevalence of atrial fibrillation (AF). Mutations in KCNE3 have been associated with AF, and Kcne3(-/-) mice exhibit hyperaldosteronism. In this study, we used recently developed Kcne3(-/-) mice to study atrial electrophysiology with respect to development of aldosterone-dependent AF. In invasive electrophysiology studies, Kcne3(-/-) mice displayed a reduced atrial effective refractory period (AERP) and inducible episodes of paroxysmal AF. The cellular arrhythmogenic correlate for AF pre-disposition was a significant increase in atrial Kv currents generated by the micromolar 4-aminopyridine-sensitive Kv current encoded by Kv1.5. Electrophysiological alterations in Kcne3(-/-) mice were aldosterone dependent and were associated with increased Rab4, -5, and -9-dependent recycling of Kv1.5 channels to the Z-disc/T-tubulus region and lateral membrane via activation of the Akt/AS160 pathway. Treatment with spironolactone inhibited Akt/AS160 phosphorylation, reduced Rab-dependent Kv1.5 recycling, normalized AERP and atrial Kv currents to the wild-type level, and reduced arrhythmia induction in Kcne3(-/-) mice. Kcne3 deletion in mice predisposes to AF by a heretofore unrecognized mechanism-namely, increased aldosterone-dependent Kv1.5 recycling via Rab GTPases. The findings uncover detailed molecular mechanisms underpinning a channelopathy-linked form of AF and emphasize the inevitability of considering extracardiac mechanisms in genetic arrhythmia syndromes.	[Lisewski, Ulrike; Koehncke, Clemens; Wilck, Nicola; Buschmeyer, Bastian; Roepke, Torsten K.] Expt & Clin Res Ctr, Berlin, Germany; [Koehncke, Clemens; Pieske, Burkert] Univ Med Berlin, Dept Cardiol, Campus Virchow, Berlin, Germany; [Roepke, Torsten K.] Univ Med Berlin, Dept Cardiol & Angiol, Campus Mitte, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Roepke, TK (corresponding author), Charite Univ Med Berlin, Dept Cardiol & Angiol, Campus Mitte,Charitepl 1, D-10117 Berlin, Germany.	torsten-kai.roepke@charite.de	Pieske, Burkert/M-8089-2016	Pieske, Burkert/0000-0002-6466-5306; Wilck, Nicola/0000-0003-3189-5364	Deutsche Forschungsgemeinschaft; Friede Springer Herzstiftung; Fritz-Thyssen-Stiftung; ECRC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friede Springer Herzstiftung; Fritz-Thyssen-Stiftung; ECRC	The authors thank Prof. Thomas J. Jentsch (Max Delbruck Center for Molecular Medicine, Berlin, Germany) for providing Kcne3 knockout mice, Helmut Kraus for graphic support, and Astrid Schiche, Carolin Gartner, and Nora Lange [Experimental and Clinical Research Center (ECRC)] for excellent technical expertise. This work was supported by the Deutsche Forschungsgemeinschaft, Friede Springer Herzstiftung, Fritz-Thyssen-Stiftung and intramural funding from ECRC. The authors declare no conflicts of interest.	Balse E, 2012, PHYSIOL REV, V92, P1317, DOI 10.1152/physrev.00041.2011; Balse E, 2009, P NATL ACAD SCI USA, V106, P14681, DOI 10.1073/pnas.0902809106; Boycott HE, 2013, P NATL ACAD SCI USA, V110, pE3955, DOI 10.1073/pnas.1309896110; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Darbar D, 2008, HEART RHYTHM, V5, P483, DOI 10.1016/j.hrthm.2007.09.002; Eldstrom J, 2006, FEBS LETT, V580, P6039, DOI 10.1016/j.febslet.2006.09.069; Frohlich H, 2011, PFLUG ARCH EUR J PHY, V461, P45, DOI 10.1007/s00424-010-0890-5; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Kohncke C, 2013, JOVE-J VIS EXP, DOI 10.3791/50145; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; Lundby A., 2008, CELL PHYSIOL BIOCHEM, V21; Ma KJ, 2007, CHINESE MED J-PEKING, V120, P150, DOI 10.1097/00029330-200701020-00017; Maruoka ND, 2000, FEBS LETT, V473, P188, DOI 10.1016/S0014-5793(00)01521-0; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Mongue-Din H, 2007, PFLUG ARCH EUR J PHY, V454, P165, DOI 10.1007/s00424-006-0197-8; Nagoshi T, 2012, HORM METAB RES, V44, P931, DOI 10.1055/s-0032-1316343; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Olesen MS, 2014, EUR J HUM GENET, V22, P297, DOI 10.1038/ejhg.2013.139; Olesen MS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-24; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Ravn LS, 2005, AM J CARDIOL, V96, P405, DOI 10.1016/j.amjcard.2005.03.086; Reil JC, 2012, EUR HEART J, V33, P2098, DOI 10.1093/eurheartj/ehr266; Roepke TK, 2006, VASC PHARMACOL, V44, P90, DOI 10.1016/j.vph.2005.07.013; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Somanna NK, 2015, CELL SIGNAL, V27, P1928, DOI 10.1016/j.cellsig.2015.07.001; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; VanWagoner DR, 1997, CIRC RES, V80, P772; Westphal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073490; Williams RS, 2011, CLIN CARDIOL, V34, P415, DOI 10.1002/clc.20914; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570; Zhang DF, 2005, CHINESE MED J-PEKING, V118, P1735	45	7	7	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2476	2489		10.1096/fj.201600317R	http://dx.doi.org/10.1096/fj.201600317R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	26985008				2022-12-26	WOS:000379249500004
J	Lenz, JD; Stohl, EA; Robertson, RM; Hackett, KT; Fisher, K; Xiong, K; Lee, M; Hesek, D; Mobashery, S; Seifert, HS; Davies, C; Dillard, JP				Lenz, Jonathan D.; Stohl, Elizabeth A.; Robertson, Rosanna M.; Hackett, Kathleen T.; Fisher, Kathryn; Xiong, Kalia; Lee, Mijoon; Hesek, Dusan; Mobashery, Shahriar; Seifert, H. Steven; Davies, Christopher; Dillard, Joseph P.			Amidase Activity of AmiC Controls Cell Separation and Stem Peptide Release and Is Enhanced by NlpD in Neisseria gonorrhoeae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; L-ALANINE AMIDASE; FALLOPIAN-TUBE MUCOSA; ESCHERICHIA-COLI; SOLUBLE PEPTIDOGLYCAN; MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL PEPTIDOGLYCAN; PSEUDOMONAS-AERUGINOSA; LYTIC TRANSGLYCOSYLASE; NOSTOC-PUNCTIFORME	The human-restricted pathogen Neisseria gonorrhoeae encodes a single N-acetylmuramyl-L-alanine amidase involved in cell separation (AmiC), as compared with three largely redundant cell separation amidases found in Escherichia coli (AmiA, AmiB, and AmiC). Deletion of amiC from N. gonorrhoeae results in severely impaired cell separation and altered peptidoglycan (PG) fragment release, but little else is known about how AmiC functions in gonococci. Here, we demonstrated that gonococcal AmiC can act on macromolecular PG to liberate cross-linked and non-cross-linked peptides indicative of amidase activity, and we provided the first evidence that a cell separation amidase can utilize a small synthetic PG fragment as substrate (GlcNAc-MurNAc(pentapeptide)-GlcNAc-MurNAc (pentapeptide)). An investigation of two residues in the active site of AmiC revealed that Glu-229 is critical for both normal cell separation and the release of PG fragments by gonococci during growth. In contrast, Gln-316 has an autoinhibitory role, and its mutation to lysine resulted in an AmiC with increased enzymatic activity on macromolecular PG and on the synthetic PG derivative. Curiously, the same Q316K mutation that increased AmiC activity also resulted in cell separation and PG fragment release defects, indicating that activation state is not the only factor determining normal AmiC activity. In addition to displaying high basal activity on PG, gonococcal AmiC can utilize metal ions other than the zinc cofactor typically used by cell separation amidases, potentially protecting its ability to function in zinc-limiting environments. Thus gonococcal AmiC has distinct differences from related enzymes, and these studies revealed parameters for how AmiC functions in cell separation and PG fragment release.	[Lenz, Jonathan D.; Hackett, Kathleen T.; Fisher, Kathryn; Xiong, Kalia; Dillard, Joseph P.] Univ Wisconsin, Dept Med Microbiol & Immunol, 1550 Linden Dr,4157 Microbial Sci Bldg, Madison, WI 53706 USA; [Stohl, Elizabeth A.; Seifert, H. Steven] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Robertson, Rosanna M.; Davies, Christopher] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Lee, Mijoon; Hesek, Dusan; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46556 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine; Medical University of South Carolina; University of Notre Dame	Dillard, JP (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, 1550 Linden Dr,4157 Microbial Sci Bldg, Madison, WI 53706 USA.	jpdillard@wisc.edu	Lee, Mijoon/AFK-1543-2022	Lee, Mijoon/0000-0001-7432-0427; Fisher, Kathryn/0000-0003-2260-8634; Lenz, Jonathan/0000-0002-2637-9720	National Institutes of Health [R01 AI097157, R21 AI099539, T32 AI055397, F32 AI115911, R37 AI033493, R01 AI044239, R01 GM066861, R01 AI090348, R01 GM061629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI114821, R37AI033493, R01AI090348, R01AI044239, F32AI115911, T32AI055397, R01AI097157, R21AI099539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861, R01GM061629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI097157 and R21 AI099539 (to J.P. D.), T32 AI055397 and F32 AI115911 (to J. D. L.), R37 AI033493 and R01 AI044239 (to E. A. S. and H. S. S.), R01 GM066861 (to C. D.), and R01 AI090348 and R01 GM061629 (to S. M.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barbee LA, 2014, CURR OPIN INFECT DIS, V27, P282, DOI [10.1097/QCO.0000000000000058, 10.1097/QCO.0000000000000059]; BARBOUR AG, 1981, ANTIMICROB AGENTS CH, V19, P316, DOI 10.1128/AAC.19.2.316; Berendt S, 2012, J BACTERIOL, V194, P5218, DOI 10.1128/JB.00912-12; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Buttner FM, 2016, FEBS J, V283, P1336, DOI 10.1111/febs.13673; Carrasco-Lopez C, 2011, J BIOL CHEM, V286, P31714, DOI 10.1074/jbc.M111.264366; CDC, 2013, ANTIBIOTIC RESISTANC; Cloud KA, 2004, J BACTERIOL, V186, P7811, DOI 10.1128/JB.186.22.7811-7814.2004; Cloud KA, 2002, INFECT IMMUN, V70, P2752, DOI 10.1128/IAI.70.6.2752-2757.2002; Cloud-Hansen KA, 2008, J BACTERIOL, V190, P5989, DOI 10.1128/JB.00506-08; Craig M, 2013, MOL MICROBIOL, V89, P887, DOI 10.1111/mmi.12318; den Blaauwen T, 2014, BIOORG CHEM, V55, P27, DOI 10.1016/j.bioorg.2014.03.007; Dillard J. P., 2011, CURR PROTOC MICROBIO, V23; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Firczuk M, 2007, FEMS MICROBIOL REV, V31, P676, DOI 10.1111/j.1574-6976.2007.00084.x; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Garcia DL, 2006, J BACTERIOL, V188, P7211, DOI 10.1128/JB.00724-06; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GOLDMAN W E, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P187; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; GREGG CR, 1981, J INFECT DIS, V143, P432, DOI 10.1093/infdis/143.3.432; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; HEBELER BH, 1976, J BACTERIOL, V126, P1186, DOI 10.1128/JB.126.3.1186-1193.1976; HEBELER BH, 1976, J BACTERIOL, V126, P1180, DOI 10.1128/JB.126.3.1180-1185.1976; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; JENSEN SE, 1976, J BACTERIOL, V127, P319, DOI 10.1128/JB.127.1.319-326.1976; Jimenez Garcia Daniel, 2007, THESIS; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kumar A, 2013, ACTA CRYSTALLOGR D, V69, P2543, DOI 10.1107/S0907444913026371; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Lee M, 2013, J AM CHEM SOC, V135, P12604, DOI 10.1021/ja407445x; Lee M, 2010, CHEMBIOCHEM, V11, P2525, DOI 10.1002/cbic.201000626; Lehner J, 2011, MOL MICROBIOL, V79, P1655, DOI 10.1111/j.1365-2958.2011.07554.x; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Martinez-Caballero S, 2013, J AM CHEM SOC, V135, P10318, DOI 10.1021/ja405464b; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Mavrogiorgos N, 2014, INNATE IMMUN-LONDON, V20, P377, DOI 10.1177/1753425913493453; Mehr IJ, 2000, GENETICS, V154, P523; MELLY MA, 1984, J INFECT DIS, V149, P378, DOI 10.1093/infdis/149.3.378; Moll A, 2014, J BACTERIOL, V196, P3937, DOI 10.1128/JB.02094-14; MORSE SA, 1974, P SOC EXP BIOL MED, V145, P1418; Peters NT, 2013, MOL MICROBIOL, V89, P690, DOI 10.1111/mmi.12304; Peters NT, 2011, J BACTERIOL, V193, P4973, DOI 10.1128/JB.00316-11; Prigozhin DM, 2013, J BIOL CHEM, V288, P31549, DOI 10.1074/jbc.M113.510792; Priyadarshini R, 2006, J BACTERIOL, V188, P5345, DOI 10.1128/JB.00476-06; Ramsey ME, 2012, APPL ENVIRON MICROB, V78, P3068, DOI 10.1128/AEM.07871-11; Rocaboy M, 2013, MOL MICROBIOL, V90, P267, DOI 10.1111/mmi.12361; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; ROSENTHAL RS, 1979, INFECT IMMUN, V24, P869, DOI 10.1128/IAI.24.3.869-878.1979; ROSENTHAL RS, 1980, INFECT IMMUN, V28, P867; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Shida T, 2001, J BIOL CHEM, V276, P28140, DOI 10.1074/jbc.M103903200; SINHA RK, 1980, INFECT IMMUN, V29, P914; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Stohl EA, 2016, J BACTERIOL, V198, P615, DOI 10.1128/JB.00540-15; Stohl EA, 2012, J BIOL CHEM, V287, P11222, DOI 10.1074/jbc.M111.338830; Uehara T, 2007, J BACTERIOL, V189, P5634, DOI 10.1128/JB.00446-07; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Veyrier FJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005338; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Woodhams KL, 2013, INFECT IMMUN, V81, P3490, DOI 10.1128/IAI.00279-13; Yang DC, 2012, MOL MICROBIOL, V85, P768, DOI 10.1111/j.1365-2958.2012.08138.x	66	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10916	10933		10.1074/jbc.M116.715573	http://dx.doi.org/10.1074/jbc.M116.715573			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26984407	hybrid, Green Published			2022-12-26	WOS:000377042600041
J	El Kishawi, RR; Soo, KL; Abed, YA; Muda, WAMW				El Kishawi, Rima Rafiq; Soo, Kah Leng; Abed, Yehia Awad; Muda, Wan Abdul Manan Wan			Prevalence and Associated Factors for Dual Form of Malnutrition in Mother-Child Pairs at the Same Household in the Gaza Strip-Palestine	PLOS ONE			English	Article							NUTRITION TRANSITION; UNDERWEIGHT; OVERWEIGHT; BURDEN	Background In many developing countries nutritional, and epidemiological transitions are emerging into continuing undernutrition and escalating overnutrition, giving rise to the double burden of the malnutrition phenomenon. Objectives This study aims to determine the prevalence of the dual form of malnutrition (overweight mother/underweight child) in the same household and its associated factors in the Gaza Strip. Methods A total of 357 mother-child pairs from the same households were surveyed from three different geographical locations in the Gaza Strip, namely, El Remal urban area, Jabalia refugee camp, and Al Qarara rural area. The height and weight of mothers aged 18-50 years were measured, and their body mass index (BMI) was computed. The mothers were categorized according to the criterion of the World Health Organization (WHO) for BMI as overweight if they have a BMI >= 25 kg/m(2). Anthropometric indices were measured for children aged two to five years to classify the underweight children Z-score <-1. Results The results showed the prevalence of the dual form of malnutrition in the Gaza Strip was 15.7%, and its associated factors were child's birth order (ORadj, 1.50, 95% CL, 1.22, 1.82; p = < 0.001), father's educational (low or medium) levels (ORadj, 3.19, 95% CL, 1.07, 9.5; p = 0. 036), or (ORadj, 3.4, 95% CL, 1.12, 10.37; p = 0. 031), high scores of mothers' nutrition knowledge (ORadj, 1.23, 95% CL, 1.01, 1.52; p = 0. 048), and low monthly income (ORadj, 0.28, 95% CL, 0.09, 0.88; p = 0. 030). Conclusions The results from this study showed the dual form of malnutrition in the same household was prevalent in the Gaza Strip. This is a public health issue that must be understood and addressed and policy makers must implement an appropriate nutrition action plan to control dual form of malnutrition based on the underlying specific risk factors in the study population. In addition, interventions are needed to help individuals to translate their nutrition knowledge into healthy dietary behaviors.	[El Kishawi, Rima Rafiq; Soo, Kah Leng; Muda, Wan Abdul Manan Wan] Univ Sains Malaysia, Sch Hlth Sci, Program Nutr, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia; [Abed, Yehia Awad] Al Quds Univ, Sch Publ Hlth, Gaza City, Gaza Strip, Israel	Universiti Sains Malaysia	El Kishawi, RR (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Program Nutr, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	rimaa2_us@yahoo.com	Muda, Wan A Manan A Wan/H-5475-2016	Muda, Wan A Manan A Wan/0000-0003-4241-3869				Al-Majdalawi J., 2008, THESIS AL QUDS U; Angeles-Agdeppa I, 2003, ASIA PAC J CLIN NUTR, V12, P438; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; Doak C, 2002, PUBLIC HEALTH NUTR, V5, P215, DOI 10.1079/PHN2001296; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Doak CM, 2000, J NUTR, V130, P2965, DOI 10.1093/jn/130.12.2965; Garrett James L., 2005, Food and Nutrition Bulletin, V26, P209; Grijalva-Eternod CS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001320; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; Ihab AN, 2013, INT J PREVENTIVE MED, V4, P690; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Khor GL, 2003, ASIA PAC J CLIN NUTR, V12, P427; Massad S, 2012, LANCET, V380, pS5; Mikki N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-485; Mostafa Kamal S M, 2011, Malays J Nutr, V17, P105; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Radi SM, 2013, E MEDITERR HEALTH J, V19, P234, DOI 10.26719/2013.19.3.234; Rayhan MI, 2006, PAK J NUTR, V5, P558, DOI [DOI 10.3923/PJN.2006.558.562, 10.3923/pjn.2006.558.562]; Roemling C, 2012, DUAL BURDEN HOUSEHOL; Saibul N, 2009, ASIA PAC J CLIN NUTR, V18, P412; Singh GCP, 2009, ASIA-PAC J PUBLIC HE, V21, P144, DOI 10.1177/1010539509332063; Vega-Franco L, 1999, SALUD PUBLICA MEXICO, V41, P328; W.H.O, 1983, MEAS CHANG NUTR STAT; WHO, 2000, OB PREV MAN GLOB EP; World Food Program, 2013, STAT PAL SOC FOOD SE; World Health Organization, 2007, P CONCL CONS M WASH	31	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151494	10.1371/journal.pone.0151494	http://dx.doi.org/10.1371/journal.pone.0151494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990551	Green Submitted, gold, Green Published			2022-12-26	WOS:000372582800067
J	Chang, CJ; Lee, CC; Chan, YT; Trudeau, DL; Wu, MH; Tsai, CH; Yu, SM; Ho, THD; Wang, AHJ; Hsiao, CD; Arnold, FH; Chao, YC				Chang, Chia-Jung; Lee, Cheng-Chung; Chan, Yueh-Te; Trudeau, Devin L.; Wu, Mei-Huey; Tsai, Chih-Hsuan; Yu, Su-May; Ho, Tuan-Hua David; Wang, Andrew H. -J.; Hsiao, Chwan-Deng; Arnold, Frances H.; Chao, Yu-Chan			Exploring the Mechanism Responsible for Cellulase Thermostability by Structure-Guided Recombination	PLOS ONE			English	Article							ISOLATED BACILLUS-SUBTILIS; ELEVATED-TEMPERATURES; SEQUENCE ELEMENTS; PLANT BIOMASS; HYDROLYSIS; ENZYMES; ACID; EXPRESSION; STABILITY; PROTEINS	Cellulases from Bacillus and Geobacillus bacteria are potentially useful in the biofuel and animal feed industries. One of the unique characteristics of these enzymes is that they are usually quite thermostable. We previously identified a cellulase, GsCelA, from thermophilic Geobacillus sp. 70PC53, which is much more thermostable than its Bacillus homolog, BsCel5A. Thus, these two cellulases provide a pair of structures ideal for investigating the mechanism regarding how these cellulases can retain activity at high temperature. In the present study, we applied the SCHEMA non-contiguous recombination algorithm as a novel tool, which assigns protein sequences into blocks for domain swapping in a way that lessens structural disruption, to generate a set of chimeric proteins derived from the recombination of GsCelA and BsCel5A. Analyzing the activity and thermostability of this designed library set, which requires only a limited number of chimeras by SCHEMA calculations, revealed that one of the blocks may contribute to the higher thermostability of GsCelA. When tested against swollen Avicel, the highly thermostable chimeric cellulase C10 containing this block showed significantly higher activity (22%-43%) and higher thermostability compared to the parental enzymes. With further structural determinations and mutagenesis analyses, a 310 helix was identified as being responsible for the improved thermostability of this block. Furthermore, in the presence of ionic calcium and crown ether (CR), the chimeric C10 was found to retain 40% residual activity even after heat treatment at 90 degrees C. Combining crystal structure determinations and structure-guided SCHEMA recombination, we have determined the mechanism responsible for the high thermostability of GsCelA, and generated a novel recombinant enzyme with significantly higher activity.	[Chang, Chia-Jung; Tsai, Chih-Hsuan; Yu, Su-May; Hsiao, Chwan-Deng; Chao, Yu-Chan] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lee, Cheng-Chung; Chan, Yueh-Te; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lee, Cheng-Chung; Chan, Yueh-Te; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Trudeau, Devin L.; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Wu, Mei-Huey] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan; [Wu, Mei-Huey; Ho, Tuan-Hua David] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Yu, Su-May; Ho, Tuan-Hua David; Chao, Yu-Chan] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chang, Chia-Jung] Reber Genet Co Ltd, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; California Institute of Technology; National Cheng Kung University; Academia Sinica - Taiwan; National Chung Hsing University	Chao, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.; Chao, YC (corresponding author), Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan.	mbycchao@imb.sinica.edu.tw	Chao, Yu-Chan/ABF-6571-2021; Hsiao, Chwan-Deng/AAZ-8869-2021; Yu, Su-May/ABB-6950-2021	Chao, Yu-Chan/0000-0002-9528-8806; Hsiao, Chwan-Deng/0000-0002-7012-1532; Yu, Su-May/0000-0001-8744-9246; Arnold, Frances H./0000-0002-4027-364X	Ministry of Science and Technology [MOST105-2321-B-001-024, MOST104-2811-B-001-112]; Academia Sinica, Taiwan, ROC [5202402020-4006]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica, Taiwan, ROC(Academia Sinica - Taiwan)	This work was supported by grants MOST105-2321-B-001-024 and MOST104-2811-B-001-112 from Ministry of Science and Technology, and 5202402020-4006 from Academia Sinica, Taiwan, ROC.	Abdel-Banat BMA, 2010, APPL MICROBIOL BIOT, V85, P861, DOI 10.1007/s00253-009-2248-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Heinzelman P, 2013, METHOD ENZYMOL, V523, P351, DOI 10.1016/B978-0-12-394292-0.00016-3; Heinzelman P, 2009, J BIOL CHEM, V284, P26229, DOI 10.1074/jbc.C109.034058; Karypis G, 2000, VLSI DES, V11, P285, DOI 10.1155/2000/19436; Karypis G, 1999, IEEE T VLSI SYST, V7, P69, DOI 10.1109/92.748202; Komor RS, 2012, PROTEIN ENG DES SEL, V25, P827, DOI 10.1093/protein/gzs058; Lee CC, 2014, ANGEW CHEM INT EDIT, V53, P13054, DOI 10.1002/anie.201405664; Li W, 2008, MOL BIOTECHNOL, V40, P195, DOI 10.1007/s12033-008-9079-y; Meng F, 2014, LETT APPL MICROBIOL, V59, P306, DOI 10.1111/lam.12276; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng IS, 2009, EXTREMOPHILES, V13, P425, DOI 10.1007/s00792-009-0228-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rastogi G, 2010, BIORESOURCE TECHNOL, V101, P8798, DOI 10.1016/j.biortech.2010.06.001; Romero PA, 2012, ACS SYNTH BIOL, V1, P221, DOI 10.1021/sb300014t; Santos CR, 2012, BIOCHEM J, V441, P95, DOI 10.1042/BJ20110869; Sengupta S, 2000, APPL MICROBIOL BIOT, V53, P732, DOI 10.1007/s002530000327; Smith MA, 2013, ACS SYNTH BIOL, V2, P690, DOI 10.1021/sb400010m; Smith MA, 2013, PROTEIN SCI, V22, P231, DOI 10.1002/pro.2202; Smith MA, 2012, FEBS J, V279, P4453, DOI 10.1111/febs.12032; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Taylor MP, 2009, TRENDS BIOTECHNOL, V27, P398, DOI 10.1016/j.tibtech.2009.03.006; Trudeau DL, 2014, BIOTECHNOL BIOENG, V111, P2390, DOI 10.1002/bit.25308; Trudeau DL, 2013, CURR OPIN CHEM BIOL, V17, P902, DOI 10.1016/j.cbpa.2013.10.007; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Wu I, 2013, BIOTECHNOL BIOENG, V110, P1874, DOI 10.1002/bit.24864; Yang DL, 2010, MOL BIOL REP, V37, P1923, DOI 10.1007/s11033-009-9635-y; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zambare VP, 2011, EXTREMOPHILES, V15, P611, DOI 10.1007/s00792-011-0391-2; Zhang XZ, 2011, METAB ENG, V13, P364, DOI 10.1016/j.ymben.2011.04.003; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c	34	35	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0147485	10.1371/journal.pone.0147485	http://dx.doi.org/10.1371/journal.pone.0147485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986867	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000372580300010
J	Eipper, S; Steiner, R; Lesner, A; Sienczyk, M; Palesch, D; Halatsch, ME; Zaczynska, E; Heim, C; Hartmann, MD; Zimecki, M; Wirtz, CR; Burster, T				Eipper, Steffen; Steiner, Robin; Lesner, Adam; Sienczyk, Marcin; Palesch, David; Halatsch, Marc-Eric; Zaczynska, Ewa; Heim, Christopher; Hartmann, Marcus D.; Zimecki, Michal; Wirtz, Christian Rainer; Burster, Timo			Lactoferrin Is an Allosteric Enhancer of the Proteolytic Activity of Cathepsin G	PLOS ONE			English	Article							NEUTROPHIL ELASTASE; SERINE PROTEASES; ACTIVATION; PROTEIN; INHIBITION; INCLUDES; GRANULES	Protease-mediated degradation of proteins is critical in a plethora of physiological processes. Neutrophils secrete serine proteases including cathepsin G (CatG), neutrophile elastase (NE), and proteinase 3 (PR3) together with lactoferrin (LF) as a first cellular immune response against pathogens. Here, we demonstrate that LF increases the catalytic activity of CatG at physiological concentration, with its highest enhancing capacity under acidic (pH 5.0) conditions, and broadens the substrate selectivity of CatG. On a functional level, the enzymatic activity of CatG was increased in the presence of LF in granulocyte-derived supernatant. Furthermore, LF enhanced CatG-induced activation of platelets as determined by cell surface expression of CD62P. Consequently, LF-mediated enhancement of CatG activity might promote innate immunity during acute inflammation.	[Eipper, Steffen; Steiner, Robin; Halatsch, Marc-Eric; Wirtz, Christian Rainer; Burster, Timo] Univ Ulm, Med Ctr, Dept Neurosurg, D-89069 Ulm, Germany; [Lesner, Adam] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Sienczyk, Marcin] Wroclaw Univ Technol, Fac Chem, PL-50370 Wroclaw, Poland; [Palesch, David] Univ Ulm, Med Ctr, Inst Mol Virol, D-89069 Ulm, Germany; [Zaczynska, Ewa; Zimecki, Michal] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Heim, Christopher; Hartmann, Marcus D.] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany	Ulm University; Fahrenheit Universities; University of Gdansk; Wroclaw University of Science & Technology; Ulm University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Max Planck Society	Burster, T (corresponding author), Univ Ulm, Med Ctr, Dept Neurosurg, D-89069 Ulm, Germany.	timo.burster@uni-ulm.de	Halatsch, Marc-Eric/B-7807-2008; Hartmann, Marcus/L-8759-2019; Lesner, Adam/M-2732-2019	Hartmann, Marcus/0000-0001-6937-5677; Lesner, Adam/0000-0001-8335-3431; Zimecki, Michal/0000-0002-6206-8006; Wirtz, Christian Rainer/0000-0001-8358-1813; Zaczynska, Ewa/0000-0003-0174-3677; Burster, Timo/0000-0002-9596-6558; Nilson, Robin/0000-0002-2528-9547	DAAD [91506408]; Deutsche Diabetes Stiftung "Das zuckerkranke Kind" (DDS) [226/06/13]; Humboldt grant [DPK-422-1658/2013]	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Diabetes Stiftung "Das zuckerkranke Kind" (DDS); Humboldt grant	This work was supported by DAAD 91506408, Deutsche Diabetes Stiftung "Das zuckerkranke Kind" (DDS) 226/06/13, and Humboldt DPK-422-1658/2013 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcella A, 2015, J NEUROSURG, P1; Arciniega-Martinez IM, 2015, MODULATORY EFFECTS O; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; BROZNA JP, 1977, J CLIN INVEST, V60, P1280, DOI 10.1172/JCI108887; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; Burster T, 2004, J IMMUNOL, V172, P5495, DOI 10.4049/jimmunol.172.9.5495; El Ouriaghli F, 2003, BLOOD, V101, P1752, DOI 10.1182/blood-2002-06-1734; ERMOLIEFF J, 1994, J BIOL CHEM, V269, P29502; GALLIN JI, 1984, CLIN RES, V32, P320; Ganz T, 2002, J CLIN INVEST, V109, P693, DOI 10.1172/JCI200215218; Grzywa R, 2014, CHEMBIOCHEM, V15, P2605, DOI 10.1002/cbic.201402360; Guillen C, 1998, ANN RHEUM DIS, V57, P309, DOI 10.1136/ard.57.5.309; He SH, 2003, BIOCHEM PHARMACOL, V65, P1007, DOI 10.1016/S0006-2952(02)01651-9; HECK LW, 1990, AM J PATHOL, V136, P1267; Hendrixson DR, 2003, MOL MICROBIOL, V47, P607, DOI 10.1046/j.1365-2958.2003.03327.x; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kruzel Marian L, 2007, Postepy Hig Med Dosw (Online), V61, P261; Kruzel ML, 2013, J BIOTECHNOL, V168, P666, DOI 10.1016/j.jbiotec.2013.09.011; Kruzel ML, 2013, J BIOTECHNOLOGY; Ledoux D, 2003, FEBS LETT, V537, P23, DOI 10.1016/S0014-5793(03)00064-4; Lopez-boado YS, 2004, J IMMUNOL, V172, P509, DOI 10.4049/jimmunol.172.1.509; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Menkin V, 1956, BIOCH MECH INFLAMMAT, P66; Miyata J, 2007, RHEUMATOL INT, V27, P375, DOI 10.1007/s00296-006-0210-8; ODEBERG H, 1975, J CLIN INVEST, V56, P1118, DOI 10.1172/JCI108186; Palesch D, 2011, ACTA BIOCHIM POL, V58, P39; Reich M, 2009, MOL IMMUNOL, V46, P2994, DOI 10.1016/j.molimm.2009.06.017; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; SCUDERI P, 1991, CELL IMMUNOL, V135, P299, DOI 10.1016/0008-8749(91)90275-G; Sedor J, 2007, PEDIATR RES, V61, P26, DOI 10.1203/01.pdr.0000250043.90468.c2; SELAK MA, 1988, BIOCHEM J, V251, P293, DOI 10.1042/bj2510293; Shafer WM, 1996, INFECT IMMUN, V64, P4842, DOI 10.1128/IAI.64.11.4842-4845.1996; Siqueiros-Cendon T, 2014, ACTA PHARMACOL SIN, V35, P557, DOI 10.1038/aps.2013.200; STOCKLEY RA, 1983, CLIN SCI, V64, P119, DOI 10.1042/cs0640119; van Velzen JF, 2012, THROMB RES, V130, P92, DOI 10.1016/j.thromres.2012.02.041; Wang J, 2014, BBA-MOL BASIS DIS, V1842, P2174, DOI 10.1016/j.bbadis.2014.07.026; Wilson TJ, 2009, MOL CANCER RES, V7, P1224, DOI 10.1158/1541-7786.MCR-09-0028; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361; Zimecki M, 2012, POSTEP HIG MED DOSW, V66, P16, DOI 10.5604/17322693.975145; Zou F, 2012, ANAL BIOCHEM, V421, P667, DOI 10.1016/j.ab.2011.11.016; Zou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022815	43	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151509	10.1371/journal.pone.0151509	http://dx.doi.org/10.1371/journal.pone.0151509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986619	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300080
J	Li, R; Chen, LZ; Zhao, SP; Huang, XS				Li, Rong; Chen, Lu-zhu; Zhao, Shui-ping; Huang, Xian-sheng			Inflammation Activation Contributes to Adipokine Imbalance in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; ATHEROSCLEROSIS; ADIPONECTIN	Inflammation can be activated as a defensive response by the attack of acute coronary syndrome (ACS) for ischemic tissue injury. The aim of the present study was to investigate the impact of ACS-activated inflammation on adipokine imbalance and the effects of statins on the crosstalk between inflammation and adipokine imbalance during ACS. In this study, 586 subjects were categorized into: (1) control group; (2) SA (stable angina) group; and (3) ACS group. Circulating levels of hs-CRP, adiponectin and resistin were measured by ELISA. Furthermore, forty C57BL/6 mice were randomized into: sham, AMI, low-statin (atorvastatin, 2 mg/kg/day) and high-statin (atorvastatin, 20 mg/kg/day) group. After 3 weeks, AMI models were established by surgical coronary artery ligation. Circulating levels and adipose expressions of adiponectin and resistin were assessed in animals. Besides, we investigate the effects of atorvastatin on ox-LDL-induced adipokine imbalance in vitro. As a result, we found that ACS patients had higher hs-CRP and resistin levels and lower adiponectin levels. Our correlation analysis demonstrated hs-CRP concentrations were positively correlated with resistin but negatively with adiponectin levels in humans. Our animal findings indicated higher circulating hs-CRP and resistin levels and lower adiponectin levels in AMI mice. Atorvastatin pre-treatment dose-dependently decreased hs-CRP and resistin levels but increased adiponectin levels in mice. The consistent findings were observed about the adipose expressions of resistin and adiponectin in mice. In study in vitro, ox-LDL increased cellular resistin expressions and otherwise for adiponectin expressions, which dose-dependently reversed by the addition of atorvastatin. Therefore, our study indicates that the ACS attack activates inflammation leading to adipokine imbalance that can be ameliorated by anti-inflammation of atorvastatin.	[Li, Rong] Cent S Univ, Xiangya Hosp 2, Dept Stomatol, Changsha, Hunan, Peoples R China; [Chen, Lu-zhu; Zhao, Shui-ping; Huang, Xian-sheng] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Huang, XS (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China.	initialhxs@163.com			National Natural Science Foundation of China [81000121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant No. 81000121.	Abdelmeguid AE, 1996, CIRCULATION, V94, P1528, DOI 10.1161/01.CIR.94.7.1528; Alam SR, 2015, HEART, V101, P1639, DOI 10.1136/heartjnl-2015-307745; Brunetti ND, 2014, ATHEROSCLEROSIS, V236, P456, DOI 10.1016/j.atherosclerosis.2014.07.037; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Ellis SG, 2009, J AM COLL CARDIOL, V54, P566, DOI 10.1016/j.jacc.2009.04.070; Kim BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137366; Kinlay S, 2003, CIRCULATION, V108, P1560, DOI 10.1161/01.CIR.0000091404.09558.AF; Kiyan Y, 2014, J MOL CELL CARDIOL, V66, P72, DOI 10.1016/j.yjmcc.2013.11.005; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Levitsky S, 2006, CIRCULATION, V114, pI339, DOI 10.1161/CIRCULATIONAHA.105.001685; MAGER A, 1991, CHEST, V99, P386, DOI 10.1378/chest.99.2.386; Margaritis M, 2013, CIRCULATION, V127, P2209, DOI 10.1161/CIRCULATIONAHA.112.001133; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Patti G, 2011, CIRCULATION, V123, P1622, DOI 10.1161/CIRCULATIONAHA.110.002451; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Wu ZH, 2009, PHARMACOLOGY, V84, P282, DOI 10.1159/000242999; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075535	22	6	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151916	10.1371/journal.pone.0151916	http://dx.doi.org/10.1371/journal.pone.0151916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986475	Green Submitted, gold, Green Published			2022-12-26	WOS:000372580300151
J	Zhao, W; Huang, XD; Zhang, LX; Yang, XJ; Wang, LH; Chen, YS; Wang, JH; Wu, GL				Zhao, Wei; Huang, XuDong; Zhang, LiXia; Yang, XinJun; Wang, Lihui; Chen, YunShuang; Wang, JingHua; Wu, GuangLi			Penehyclidine Hydrochloride Pretreatment Ameliorates Rhabdomyolysis-Induced AKI by Activating the Nrf2/HO-1 Pathway and Alleviating Endoplasmic Reticulum Stress in Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; UNFOLDED PROTEIN RESPONSE; HEME OXYGENASE-1; OXIDATIVE STRESS; CELL-DEATH; INDUCED APOPTOSIS; GENE-EXPRESSION; RENAL-FAILURE; KIDNEY INJURY; ER-STRESS	Acute kidney injury (AKI) is one of the most severe complications of rhabdomyolysis (RM). The underlying mechanisms and potential preventions need to be investigated. Penehyclidine hydrochloride (PHC) was reported to ameliorate renal ischemia-reperfusion injury, but the effect of PHC on RM-reduced AKI is unknown. In this study, we established a rat model of RM-induced AKI using an intramuscular glycerol injection in the hind limbs. Rats were pretreated with PHC before the glycerol injection, and the heme oxygenase-1 (HO-1) inhibitor ZnPP was introduced to evaluate the effect of HO-1 on RM-induced AKI. PHC pretreatment ameliorated the pathological renal injury and renal dysfunction, and decreased the renal apoptosis rate in RM-induced AKI. PHC significantly up-regulated HO-1 expression, increased HO-1 enzymatic activity and decreased the accumulation of myoglobin in renal tissues. This effect was partly inhibited by ZnPP. PHC pretreatment also effectively up-regulated nuclear factor erythroid 2-related factor 2 (Nrf2) and down-regulated glucose regulated protein 78 (GRP78) and caspase-12 at both the gene and protein levels. These results suggest that the protective effects of PHC pretreatment on RM-induced AKI occur at least in part through activating the Nrf2/HO-1 pathway and alleviating endoplasmic reticulum stress (ERS) in rat renal tissues.	[Zhao, Wei] Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, Beijing 100853, Peoples R China; [Zhao, Wei; Huang, XuDong; Zhang, LiXia; Yang, XinJun; Wang, Lihui; Chen, YunShuang; Wang, JingHua; Wu, GuangLi] Bethune Int Peace Hosp, Dept Nephrol, Shijiazhuang, Hebei Province, Peoples R China	Chinese People's Liberation Army General Hospital	Wu, GL (corresponding author), Bethune Int Peace Hosp, Dept Nephrol, Shijiazhuang, Hebei Province, Peoples R China.	wugl@medmail.com.cn			Application Basic Research Project of Hebei Province [13967702D]; Fund of Chinese PLA 12th Five-Year Plan for Medical Sciences [BWS11J058, CWS12J061]; Youth Cultivation Project of Chinese PLA for Medical Sciences [13QNP013]	Application Basic Research Project of Hebei Province; Fund of Chinese PLA 12th Five-Year Plan for Medical Sciences; Youth Cultivation Project of Chinese PLA for Medical Sciences	This study was supported by the grants from the Application Basic Research Project of Hebei Province (13967702D), the Fund of Chinese PLA 12th Five-Year Plan for Medical Sciences (BWS11J058, CWS12J061) and the Youth Cultivation Project of Chinese PLA for Medical Sciences (13QNP013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2009, AM J PHYSIOL-RENAL, V297, pF1137, DOI 10.1152/ajprenal.90449.2008; Agarwal Anupam, 2013, Trans Am Clin Climatol Assoc, V124, P111; BETTER OS, 1990, NEPHRON, V55, P97, DOI 10.1159/000185934; Chatzizisis YS, 2008, EUR J INTERN MED, V19, P568, DOI 10.1016/j.ejim.2007.06.037; Cui J, 2013, CHINESE MED J-PEKING, V126, P4764, DOI 10.3760/cma.j.issn.0366-6999.20130230; Gaut JR, 1993, CURR OPIN CELL BIOL, V5, P589, DOI 10.1016/0955-0674(93)90127-C; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Holt S, 2000, EXP NEPHROL, V8, P72; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; Jin QH, 2004, CELL MOL LIFE SCI, V61, P1816, DOI 10.1007/s00018-004-4143-7; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Knochel James P., 1993, Current Opinion in Rheumatology, V5, P725; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lee YS, 2006, APOPTOSIS, V11, P1091, DOI 10.1007/s10495-006-7110-y; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nath KA, 2013, KIDNEY INT, V84, P3, DOI 10.1038/ki.2013.88; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Plotnikov EY, 2009, BBA-MOL BASIS DIS, V1792, P796, DOI 10.1016/j.bbadis.2009.06.005; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tang WX, 2013, ARTIF ORGANS, V37, P390, DOI 10.1111/j.1525-1594.2012.01574.x; Vanholder R, 2000, J AM SOC NEPHROL, V11, P1553, DOI 10.1681/ASN.V1181553; Wang J, 2013, ANAESTHESIA, V68, P136, DOI 10.1111/anae.12092; Wang YA, 2005, LIFE SCI, V78, P210, DOI 10.1016/j.lfs.2005.04.071; Wang YP, 2014, J SURG RES, V186, P390, DOI 10.1016/j.jss.2013.07.041; Wang Z, 2014, KIDNEY INT, V86, P338, DOI 10.1038/ki.2014.65; Wu GL, 2012, INT J SPORTS MED, V33, P1, DOI 10.1055/s-0031-1284397; Wu XJ, 2012, INJURY, V43, P232, DOI 10.1016/j.injury.2011.10.009; Yang CW, 2003, FASEB J, V17, P1754, DOI 10.1096/fj.02-1191fje; Yin XL, 2011, AM J CHINESE MED, V39, P853, DOI 10.1142/S0192415X11009251; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; ZAGER RA, 1991, J AM SOC NEPHROL, V2, P848; Zhang Xue-mei, 2015, Sichuan Da Xue Xue Bao Yi Xue Ban, V46, P22; Zhao W, 2013, CHIN J INTEGR TRADIT, V14, P17, DOI [10.3969/j.issn.1009-587X.2013.01.006, DOI 10.3969/J.ISSN.1009-587X.2013.01.006]; [赵维 Zhao Wei], 2013, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V33, P366; Zhou JH, 2012, THER APHER DIAL, V16, P272, DOI 10.1111/j.1744-9987.2011.01057.x	45	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151158	10.1371/journal.pone.0151158	http://dx.doi.org/10.1371/journal.pone.0151158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987113	gold, Green Published			2022-12-26	WOS:000372580300049
J	Aodah, A; Pavlik, A; Karlage, K; Myrdal, PB				Aodah, Alhassan; Pavlik, Aaron; Karlage, Kelly; Myrdal, Paul B.			Preformulation Studies on Piperlongumine	PLOS ONE			English	Article							CANCER-CELLS; ANOIKIS RESISTANCE; STAT3	Piperlongumine is a natural alkaloid extracted from piper plants which has been used traditionally for the treatment of certain diseases. This compound shows interesting in vitro pharmacological activity such as selective anticancer activity and higher cytotoxicity than methotrexate, cyclophosphamide and adriamycin on breast, colon, and osteosarcoma cancers, respectively. However, the physicochemical properties for this compound have not been well characterized. In this research, preformulation studies for piperlongumine have been performed to determine factors which influence solubility and stability which, in turn, can be used to assist future formulation development. The solubility of piperlongumine in water was found to be approximately 26 mu g/ml. Using 10% polysorbate 80 as a surfactant resulted in a 27 fold increase in solubility. Cosolvents and cyclodextrins afforded concentrations of 1 mg/ml and higher. The pH degradation rate profile for piperlongumine at various temperatures shows significant instability of the drug at pH values >= 7 and 3, and maximum stability around pH 4. It was estimated that it would take approximately 17 weeks for piperlongumine to degrade by 10% at 25 degrees C, pH 4. Additionally, piperlongumine showed marked photo-degradation upon exposure to an ultraviolet light source, especially in aqueous media.	[Aodah, Alhassan; Pavlik, Aaron; Karlage, Kelly; Myrdal, Paul B.] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA	University of Arizona	Aodah, A (corresponding author), Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA.	aaodah@email.arizona.edu						Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Amidon GL, 1979, CHEM STABILITY PHARM, P97; BANERJEE T, 1986, CAN J CHEM, V64, P876, DOI 10.1139/v86-145; Bezerra DP, 2013, EUR J PHARM SCI, V48, P453, DOI 10.1016/j.ejps.2012.12.003; CHATTERJEE A, 1967, TETRAHEDRON, V23, P1769, DOI 10.1016/S0040-4020(01)82575-8; Dhillon H, 2014, TOXICOL REP, V1, P309, DOI 10.1016/j.toxrep.2014.05.011; Fofaria NM, 2016, INT J PHARMACEUT, V498, P12, DOI 10.1016/j.ijpharm.2015.11.045; Fofaria NM, 2015, CARCINOGENESIS, V36, P142, DOI 10.1093/carcin/bgu233; Fofaria NM, 2014, ONCOTARGET, V5, P7051, DOI 10.18632/oncotarget.2251; Fofaria NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094298; Kumar S, 2011, J ACUPUNCT MERIDIAN, V4, P134, DOI 10.1016/S2005-2901(11)60020-4; Lee S.W., 2009, [No title captured], Patent No. [WO20090312373, 20090312373, WO 20090312373]; Li JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09987; MISHRA SS, 1964, J PHARM SCI, V53, P1423, DOI 10.1002/jps.2600531138; Naika R, 2010, PHARMACOPHORE, V1, P141; Niu MS, 2015, CHEM-BIOL INTERACT, V237, P66, DOI 10.1016/j.cbi.2015.05.016; Patel K, 2015, J PHARM SCI-US, V104, P4417, DOI 10.1002/jps.24637; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Roh JL, 2014, ONCOTARGET, V5, P9227, DOI 10.18632/oncotarget.2402; SCHEINER JM, 1981, AM J HOSP PHARM, V38, P1911, DOI 10.1093/ajhp/38.12.1911; Son DJ, 2012, BIOCHEM BIOPH RES CO, V427, P349, DOI 10.1016/j.bbrc.2012.09.061	21	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151707	10.1371/journal.pone.0151707	http://dx.doi.org/10.1371/journal.pone.0151707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982320	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900115
J	Cuevas, RP; Pede, VO; McKinley, J; Velarde, O; Demont, M				Cuevas, Rosa Paula; Pede, Valerien O.; McKinley, Justin; Velarde, Orlee; Demont, Matty			Rice Grain Quality and Consumer Preferences: A Case Study of Two Rural Towns in the Philippines	PLOS ONE			English	Article							APPARENT AMYLOSE CONTENT; HEDONIC PRICE MODEL; MILLED-RICE; GELATINIZATION TEMPERATURE; STARCH; MARKET; AMYLOPECTIN; COOKING; FARMERS; LIPIDS	Hedonic pricing analysis is conducted to determine the implicit values of various attributes in the market value of a good. In this study, hedonic pricing analysis was applied to measure the contribution of grain quality search and experience attributes to the price of rice in two rural towns in the Philippines. Rice samples from respondents underwent quantitative routine assessments of grain quality. In particular, gelatinization temperature and chalkiness, two parameters that are normally assessed through visual scores, were evaluated by purely quantitative means (differential scanning calorimetry and by digital image analysis). Results indicate that rice consumed by respondents had mainly similar physical and chemical grain quality attributes. The respondents' revealed preferences were typical of what has been previously reported for Filipino rice consumers. Hedonic regression analyses showed that grain quality characteristics that affected price varied by income class. Some of the traits or socioeconomic factors that affected price were percent broken grains, gel consistency, and household per capita rice consumption. There is an income effect on rice price and the characteristics that affect price vary between income classes.	[Cuevas, Rosa Paula] Int Rice Res Inst, Grain Qual & Nutr Ctr, DAPO 7777, Manila, Philippines; [Pede, Valerien O.; McKinley, Justin; Velarde, Orlee; Demont, Matty] Int Rice Res Inst, Social Sci Div, DAPO 7777, Manila, Philippines; [Velarde, Orlee] Asian Dev Bank, 6 ADB Ave, Mandaluyong City 1550, Metro Manila, Philippines	CGIAR; International Rice Research Institute (IRRI); Asian Development Bank	McKinley, J (corresponding author), Int Rice Res Inst, Social Sci Div, DAPO 7777, Manila, Philippines.	j.mckinley@irri.org	Cuevas, Rosa Paula/D-3886-2017; Demont, Matty/C-7284-2013; McKinley, Justin/AAU-1130-2020	Cuevas, Rosa Paula/0000-0001-9624-7873; Demont, Matty/0000-0001-9086-5654; McKinley, Justin/0000-0003-3637-2597	Global Rice Science Partnership (GRiSP)	Global Rice Science Partnership (GRiSP)	The cost of data collection and grain quality analysis were covered through funds available from the Global Rice Science Partnership (GRiSP). More information about GRiSP is available at: http://www.grisp.net/main/summary. The funder provided support in the form of salaries for authors [VP, OV, RC] as well as the costs of grain quality tests, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Although one author [OV] is currently affiliated with a multilateral development finance institution, his contributions to this study were carried out while employed by the International Rice Research Institute and his current affiliation with the Asian Development Bank in no way influences the study.	Abansi C. L., 1990, Transactions of the National Academy of Science and Technology, V12, P235; Abansi C.L., 1992, CONSUMER DEMAND RICE; Adair C. R., 1966, RICE BREEDING TESTIN, P19; American Association of Cereal Chemists, 2000, APPR METH AM ASS CER; ANTONIO A A, 1974, Philippine Agriculturist, V58, P17; Ashida K, 2009, CEREAL CHEM, V86, P225, DOI 10.1094/CCHEM-86-2-0225; Bartell KH, 2003, FINE FILIPINO FOOD A; BASON ML, 1993, CEREAL CHEM, V70, P269; Bautista R. C., 2010, BR WELLS RICE RES ST, V581, P220; BRORSEN BW, 1984, AM J AGR ECON, V66, P156, DOI 10.2307/1241032; CAGAMPANG GB, 1973, J SCI FOOD AGR, V24, P1589, DOI 10.1002/jsfa.2740241214; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Calpe C, 2003, 20 SESS INT RIC COMM; Carew R, 2004, CAN J PLANT SCI, V84, P764; Champagne ET, 2010, RICE, V3, P270, DOI 10.1007/s12284-010-9057-4; Champagne ET, 1999, CEREAL CHEM, V76, P764, DOI 10.1094/CCHEM.1999.76.5.764; Chen MH, 2008, J CEREAL SCI, V47, P536, DOI 10.1016/j.jcs.2007.06.013; Chen YR, 2002, COMPUT ELECTRON AGR, V36, P173, DOI 10.1016/S0168-1699(02)00100-X; Codex Alimentarius Commission, 1995, COD STAND RIC; Combris P, 1997, ECON J, V107, P390, DOI 10.1111/j.0013-0133.1997.165.x; Council of the European Eunion, 2003, OFFICIAL J EUROPEAN, V270, P96; Cruz N. Dela, 2000, P15; Cuevas RP, 2010, FUNCT PLANT BIOL, V37, P439, DOI 10.1071/FP09258; Cuevas RP, 2012, GENETIC DIVERSITY IN PLANTS, P285; Dalton TJ, 2004, AGR ECON-BLACKWELL, V31, P149, DOI 10.1016/j.agecon.2004.09.003; Deaton AS., 2008, ECON POLIT WEEKLY, DOI [DOI 10.2139/SSRN.1135253, 10.2139/ssrn.1135253]; DELMUNDO AM, 1981, J TEXTURE STUD, V12, P107; Delwiche SR, 1996, CEREAL CHEM, V73, P257; Demont M, 2012, FOOD QUAL PREFER, V23, P63, DOI 10.1016/j.foodqual.2011.07.005; Deodhar SY, 2004, J INT FOOD AGRIBUS M, V16, P43, DOI 10.1300/J047v16n01_04; Fitzgerald MA, 2003, J AGR FOOD CHEM, V51, P2295, DOI 10.1021/jf020574i; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Fitzgerald MA, 2009, CEREAL CHEM, V86, P492, DOI 10.1094/CCHEM-86-5-0492; Graham R., 2002, PROPOSAL IRRI ESTABL; HAMAKER BR, 1993, CEREAL CHEM, V70, P377; Hulten C.R., 2003, EC POLICY REV, V9, P5; Ikehashi H., 1979, WORKSH CHEM ASP RIC, P223; IRRI, 2006, BREED GRAIN QUAL; ISO, 2007, 664712007 ISO; ISO, 2007, 664722007 ISO; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; Jensen RT, 2008, AM ECON REV, V98, P1553, DOI 10.1257/aer.98.4.1553; Juliano B.O., 1993, GRAIN QUALITY EVALUA; Juliano B.O., 1965, FOOD TECHNOL, V19, P116; Juliano BO, 2009, PHILIPP AGRIC SCI, V92, P106; Juliano BO, 2001, CEREAL FOOD WORLD, V46, P531; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Juliano BO, 1992, CONSUMER DEMAND RICE, P77; JULIANO BVO, 1981, J TEXTURE STUD, V12, P17, DOI 10.1111/j.1745-4603.1981.tb00533.x; KAOSAARD M, 1991, RICE GRAIN MARKETING AND QUALITY ISSUES, P23; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; KUMAR I, 1987, CROP SCI, V27, P1167, DOI 10.2135/cropsci1987.0011183X002700060016x; Laborte AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136562; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lantican FA., 2013, ESTIMATING DEMAND EL; Liang XM, 2002, CEREAL CHEM, V79, P812, DOI 10.1094/CCHEM.2002.79.6.812; LITTLE RR, 1958, CEREAL CHEM, V35, P111; Lusk JL, 2008, EXPT AUCTIONS; Lyman NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072157; MANINGAT CC, 1980, STARKE, V32, P76, DOI 10.1002/star.19800320303; Martin M, 2002, J CEREAL SCI, V36, P285, DOI 10.1006/jcrs.2001.0465; McGrance SJ, 1998, STARCH-STARKE, V50, P158, DOI 10.1002/(SICI)1521-379X(199804)50:4<158::AID-STAR158>3.0.CO;2-7; Minten B, 2013, WORLD DEV, V42, P100, DOI 10.1016/j.worlddev.2012.06.015; MORRISON WR, 1987, J CEREAL SCI, V5, P35, DOI 10.1016/S0733-5210(87)80007-3; Nakamura Y, 2002, STARCH-STARKE, V54, P117, DOI [10.1002/1521-379X(200204)54:3/4<117::AID-STAR117>3.0.CO;2-2, 10.1002/1521-379X(200204)54:3/4&lt;117::AID-STAR117&gt;3.0.CO;2-2]; Nerlove M, 1995, EUR ECON REV, V39, P1697, DOI 10.1016/0014-2921(95)00013-5; NORMAND FL, 1989, CEREAL CHEM, V66, P317; NSO, 2012, 2012 FAM INC EXP SUR; PAGASA, 2011, CLIM CHANG SCEN PHIL; PEREZ CM, 1978, STARKE, V30, P424, DOI 10.1002/star.19780301206; Rachmat R., 2006, Indonesian Journal of Agricultural Science, V7, P27; Reuss R, 2003, STORED GRAINS AUSTR; Rickman J. F., 2002, JIRCAS International Symposium Series, P94; Roferos LT, 2006, PHILIPP AGRIC SCI, V89, P58; Rutsaert P, 2013, REALIZING AFRICA'S RICE PROMISE, P294, DOI 10.1079/9781845938123.0294; Semple RL, 1992, RAS86189 REGNET NAPH, P526; SHAH CH, 1983, ECON DEV CULT CHANGE, V32, P121, DOI 10.1086/451374; Singh N, 2003, FOOD CHEM, V82, P433, DOI 10.1016/S0308-8146(03)00007-4; SLADE L, 1988, CARBOHYD POLYM, V8, P183, DOI 10.1016/0144-8617(88)90002-1; Spiller K, 2012, APPETITE, V59, P100, DOI 10.1016/j.appet.2012.04.007; STANLEY LR, 1991, REV ECON STAT, V73, P537, DOI 10.2307/2109582; Suwannaporn P, 2008, J FOOD PROD MARK, V14, P33, DOI 10.1080/10454440801986348; TASHIRO T, 1991, AUST J AGR RES, V42, P485, DOI 10.1071/AR9910485; Tomlins K, 2007, J SCI FOOD AGR, V87, P1564, DOI 10.1002/jsfa.2889; UNNEVEHR LJ, 1986, AM J AGR ECON, V68, P634, DOI 10.2307/1241547; Vilaplana F, 2012, CARBOHYD POLYM, V88, P103, DOI 10.1016/j.carbpol.2011.11.072; Wang ZG, 2009, J FAC AGR KYUSHU U, V54, P541; Yoshioka Y, 2007, CROP SCI, V47, P2113, DOI 10.2135/cropsci2006.10.0631sc; Zhao XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066218	89	55	58	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150345	10.1371/journal.pone.0150345	http://dx.doi.org/10.1371/journal.pone.0150345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982587	Green Published, gold			2022-12-26	WOS:000372574900037
J	Martinez-Alcantara, B; Martinez-Cuenca, MR; Fernandez, C; Legaz, F; Quinones, A				Martinez-Alcantara, Belen; Martinez-Cuenca, Mary-Rus; Fernandez, Carlos; Legaz, Francisco; Quinones, Ana			Production of N-15-Labelled Liquid Organic Fertilisers Based on Manure and Crop Residue for Use in Fertigation Studies	PLOS ONE			English	Article							NITROGEN; N-15; FECES; AVAILABILITY; SYSTEMS; URINE; SOILS	Large quantities of crop residue and animal manure from agricultural and livestock activities are annually produced worldwide. With proper management, these residues are potentially valuable sources of plant nutrients, mainly N. Recycling such subproducts in sustainably-based agricultural systems can minimise the use of mineral fertilisers, and hence reduce the potential risk of surface and groundwater pollution. Therefore, the purpose of this study was to obtain (small scale) two liquid labelled-organic fertilisers, an animal-and a vegetal-based organic (AO and VO, respectively) fertiliser, to be used as organic N sources in subsequent fertigation studies. Forage maize (Zea mays L.) grown under N-15-labelled fertiliser supply was used as raw material for VO fertiliser production, and also as N-15-labelled sheep feed to obtain N-15-labelled manure. The labelled faeces fraction was used as raw material for the AO fertiliser. The VO fertiliser was obtained after an acidic and an enzyme-driven hydrolysis. The AO fertiliser was obtained after acidic hydrolysis. The VO liquid fertiliser presented an N concentration of 330 mg mu L-1, 85% of total N was organic, while ammonium and nitrate N accounted for 55% and 45% of the mineral nitrogen fraction, respectively. This fertiliser also exhibited high K, Ca and S concentrations and notable values for the remaining macro-and micronutrients. The AO liquid fertiliser had a similar total N concentration (496 mg mu L-1, 82% of total N in an organic form) to that of VO, but its mineral N fraction significantly differed, which came in a predominantly (95%) ammonia form. It also had a high content of N, P, K and other macronutrients, and sufficient Fe, Zn, Mn, Cu and B levels, which suggests its suitability as a potential fertiliser. The percentage of N-15 enrichment in both VO and AO liquid fertilisers exceeded 2% N-15 atom excess, which enabled their use in subsequent assays run to assess nitrogen uptake efficiency.	[Martinez-Alcantara, Belen; Martinez-Cuenca, Mary-Rus; Legaz, Francisco; Quinones, Ana] Inst Valenciano Invest Agr, Dept Citriculture & Vegetable Prod, E-46113 Moncada, Valencia, Spain; [Fernandez, Carlos] Valencian Polytech Univ, Inst Anim Sci & Technol, Valencia, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA)	Quinones, A (corresponding author), Inst Valenciano Invest Agr, Dept Citriculture & Vegetable Prod, E-46113 Moncada, Valencia, Spain.	quinones_ana@gva.es	Fernández, Carlos Javier/I-4027-2015; Quinones, Ana/E-6229-2014; MARTINEZ ALCANTARA, BELEN/AGF-5074-2022; Martinez-Cuenca, Mary-Rus/K-7710-2015	Fernández, Carlos Javier/0000-0002-0368-0158; Quinones, Ana/0000-0002-6096-734X; MARTINEZ ALCANTARA, BELEN/0000-0002-7816-4115; Martinez-Cuenca, Mary-Rus/0000-0002-9017-2951	National Institute of Research and Agrarian and Food Technology [RTA2008-00071-00-00]; European Regional Development Funds	National Institute of Research and Agrarian and Food Technology; European Regional Development Funds(European Commission)	This work was funded by the National Institute of Research and Agrarian and Food Technology (RTA2008-00071-00-00) and the European Regional Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosshard C, 2011, NUTR CYCL AGROECOSYS, V90, P355, DOI 10.1007/s10705-011-9437-1; BREMNER JM, 1996, METHODS SOIL ANAL, V3, P1085; Capulin-Grande J., 2001, Agrociencia (Montecillo), V35, P287; Chantigny MH, 2004, CAN J SOIL SCI, V84, P43, DOI 10.4141/S03-012; Crohn DM, 2006, J ENVIRON QUAL, V35, P658, DOI 10.2134/jeq2005.0132; CROOK EM, 1946, BIOCHEM J, V40, P197, DOI 10.1042/bj0400197; CROUCH IJ, 1993, PLANT GROWTH REGUL, V13, P21, DOI 10.1007/BF00207588; EUROSTAT, 2011, EUR COMM AGR STAT; FAO, 2010, AN PROD HLTH DIV; Flowers RH, 1993, SOIL BIOL BIOCHEM, V15, P193; Gibson L., 2011, BIOMASS MAGAZINE, P701; Govere S, 2011, INT J MODERN ENG RES, V1, P196; Haq Z, 2006, APPL BIOCHEM BIOTECH, V129, P3, DOI 10.1385/ABAB:129:1:3; HE DY, 1994, SOIL SCI, V158, P65, DOI 10.1097/00010694-199407000-00008; IAEA, 1983, GUID US NITR 15 RAD; Jackson-Smith D, 1997, PROGR AGR TECHNOL ST; JENSEN ES, 1994, SOIL BIOL BIOCHEM, V26, P465, DOI 10.1016/0038-0717(94)90178-3; KIRCHMANN H, 1990, J SOIL SCI, V41, P379, DOI 10.1111/j.1365-2389.1990.tb00073.x; Laberge G, 2006, SOIL BIOL BIOCHEM, V38, P1998, DOI 10.1016/j.soilbio.2005.11.023; Langmeier M, 2002, AGRONOMIE, V22, P789, DOI 10.1051/agro:2002044; MARM, 2010, AGR REP; MASON VC, 1979, Z TIERPHYSIOL TIERER, V41, P121; Nolan JV., 1975, P 4 INT S RUM PHYS S, P416; NOWAK P, 1997, WASTE UTILIZATION EF, P1; Powell JM, 2004, AGRON J, V96, P433, DOI 10.2134/agronj2004.0433; Powell JM, 1999, AGRON J, V91, P814, DOI 10.2134/agronj1999.915814x; Powlson D. S., 1993, Nitrogen isotope techniques., P209; RAIGON MD, 1992, ANALUSIS, V20, P483; Sorensen P, 2005, SOIL SCI SOC AM J, V69, P1639, DOI 10.2136/sssaj2004.0364; SORENSEN P, 1994, PLANT SOIL, V162, P31, DOI 10.1007/BF01416087; Sorensen P, 1998, BIOL FERT SOILS, V28, P56, DOI 10.1007/s003740050463; Thirumaran G., 2009, AM EURASIAN J AGRON, V2, P57; Thomsen IK, 1997, PLANT SOIL, V197, P233, DOI 10.1023/A:1004224615075; Tuttobene R, 2009, AGRON SUSTAIN DEV, V29, P557, DOI 10.1051/agro/2009014; Vasanthkumar HHA., 2006, JEEVAMRUT SLURRY PRE, P4; Yacob O, 1980, PLANT SOIL, V57, P237	36	5	6	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150851	10.1371/journal.pone.0150851	http://dx.doi.org/10.1371/journal.pone.0150851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982183	Green Submitted, gold, Green Published			2022-12-26	WOS:000372574900054
J	Rajagopalan, V; Zhang, YH; Ojamaa, K; Chen, YF; Pingitore, A; Pol, CJ; Saunders, D; Balasubramanian, K; Towner, RA; Gerdes, AM				Rajagopalan, Viswanathan; Zhang, Youhua; Ojamaa, Kaie; Chen, Yue-feng; Pingitore, Alessandro; Pol, Christine J.; Saunders, Debra; Balasubramanian, Krithika; Towner, Rheal A.; Gerdes, A. Martin			Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects	PLOS ONE			English	Article							ATRIAL-FIBRILLATION INDUCIBILITY; CONGESTIVE-HEART-FAILURE; THYROID-HORMONE ACTION; L-THYROXINE TREATMENT; MYOCARDIAL-INFARCTION; SUBCLINICAL HYPOTHYROIDISM; DILATED CARDIOMYOPATHY; REPLACEMENT THERAPY; RATS; TRIIODOTHYRONINE	Background A large body of evidence suggests that thyroid hormones (THs) are beneficial for the treatment of cardiovascular disorders. We have shown that 3 days of triiodo-L-thyronine (T3) treatment in myocardial infarction (MI) rats increased left ventricular (LV) contractility and decreased myocyte apoptosis. However, no clinically translatable protocol is established for T3 treatment of ischemic heart disease. We hypothesized that low-dose oral T3 will offer safe therapeutic benefits in MI. Methods and Results Adult female rats underwent left coronary artery ligation or sham surgeries. T3 (similar to 6 mu g/kg/day) was available in drinking water ad libitum immediately following MI and continuing for 2 month(s) (mo). Compared to vehicle-treated MI, the oral T3-treated MI group at 2 mo had markedly improved anesthetized Magnetic Resonance Imaging-based LV ejection fraction and volumes without significant negative changes in heart rate, serum TH levels or heart weight, indicating safe therapy. Remarkably, T3 decreased the incidence of inducible atrial tachyarrhythmias by 88% and improved remodeling. These were accompanied by restoration of gene expression involving several key pathways including thyroid, ion channels, fibrosis, sympathetic, mitochondria and autophagy. Conclusions Low-dose oral T3 dramatically improved post-MI cardiac performance, decreased atrial arrhythmias and cardiac remodeling, and reversed many adverse changes in gene expression with no observable negative effects. This study also provides a safe and effective treatment/monitoring protocol that should readily translate to humans.	[Rajagopalan, Viswanathan; Zhang, Youhua; Chen, Yue-feng; Pol, Christine J.; Gerdes, A. Martin] New York Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY 11568 USA; [Ojamaa, Kaie] Feinstein Inst Med Res, Manhasset, NY USA; [Pingitore, Alessandro] CNR Clin Physiol Inst, Pisa, Italy; [Saunders, Debra; Balasubramanian, Krithika; Towner, Rheal A.] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA	New York Institute Technology; Northwell Health; Oklahoma Medical Research Foundation	Rajagopalan, V; Gerdes, AM (corresponding author), New York Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY 11568 USA.	vrajagop@nyit.edu; agerdes@nyit.edu	Pingitore, Alessandro/K-1843-2018	Pingitore, Alessandro/0000-0002-4049-184X; Chen, Yuefeng/0000-0002-5925-2291; Towner, Rheal/0000-0001-7368-8983	National Heart, Lung, And Blood Institute of the National Institutes of Health, Bethesda, MD [R01HL103671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103671] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute of the National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health, Bethesda, MD, under Award Number R01HL103671 (AMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Cerillo AG, 2014, ANN THORAC SURG, V97, P2089, DOI 10.1016/j.athoracsur.2014.01.049; Chen YF, 2008, J MOL CELL CARDIOL, V44, P180, DOI 10.1016/j.yjmcc.2007.09.009; Chen YF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-40; Chen Yue-Feng, 2011, Cardiovasc Pathol, V20, pe189, DOI 10.1016/j.carpath.2010.09.007; Davis PJ, 2002, THYROID, V12, P459, DOI 10.1089/105072502760143827; Dias P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000287; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Files MD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000680; Gerdes AM, 2015, AM J PHYSIOL-HEART C, V308, pH1, DOI 10.1152/ajpheart.00704.2014; Goldman S, 2009, CIRCULATION, V119, P3093, DOI 10.1161/CIRCULATIONAHA.108.834424; Hamilton MA, 1998, AM J CARDIOL, V81, P443, DOI 10.1016/S0002-9149(97)00950-8; Henderson KK, 2009, CIRC-HEART FAIL, V2, P243, DOI 10.1161/CIRCHEARTFAILURE.108.810747; Iervasi G, 2003, CIRCULATION, V107, P708, DOI 10.1161/01.CIR.0000048124.64204.3F; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010; Kenessey A, 2006, J BIOL CHEM, V281, P20666, DOI 10.1074/jbc.M512671200; Khalife WI, 2005, AM J PHYSIOL-HEART C, V289, pH2409, DOI 10.1152/ajpheart.00483.2005; Kishi T, 2015, J CARDIOL, V66, P201, DOI 10.1016/j.jjcc.2015.05.001; Klemperer JD, 1996, ANN THORAC SURG, V61, P1323, DOI 10.1016/0003-4975(96)00102-6; Kobayashi S, 2015, BBA-MOL BASIS DIS, V1852, P252, DOI 10.1016/j.bbadis.2014.05.020; Lesmana R, 2016, ENDOCRINOLOGY, V157, P23, DOI 10.1210/en.2015-1632; Liu YH, 2008, AM J PHYSIOL-HEART C, V294, pH2137, DOI 10.1152/ajpheart.01379.2007; Moruzzi P, 1996, AM J MED, V101, P461, DOI 10.1016/S0002-9343(96)00281-1; Olivares EL, 2007, ENDOCRINOLOGY, V148, P4786, DOI 10.1210/en.2007-0043; Pantos C, 2008, BASIC RES CARDIOL, V103, P308, DOI 10.1007/s00395-008-0697-0; PFEFFER MA, 1985, CIRCULATION, V72, P406, DOI 10.1161/01.CIR.72.2.406; Pingitore A, 2008, J CLIN ENDOCR METAB, V93, P1351, DOI 10.1210/jc.2007-2210; Pingitore A, 2012, ANN MED, V44, P745, DOI 10.3109/07853890.2011.573501; Pol CJ, 2011, ENDOCRINOLOGY, V152, P669, DOI 10.1210/en.2010-0431; Rajagopalan Viswanathan, 2015, Curr Heart Fail Rep, V12, P141, DOI 10.1007/s11897-014-0246-0; Sara JD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002225; Sato Y, 2005, CIRC RES, V97, P550, DOI 10.1161/01.RES.0000181431.04290.bd; Savinova OV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025054; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Suffredini S, 2012, BRIT J PHARMACOL, V165, P1457, DOI 10.1111/j.1476-5381.2011.01627.x; Tseng FY, 2012, J AM COLL CARDIOL, V60, P730, DOI 10.1016/j.jacc.2012.03.047; Wassen FWJS, 2002, ENDOCRINOLOGY, V143, P2812, DOI 10.1210/en.143.7.2812; Weltman NY, 2015, AM J PHYSIOL-HEART C, V309, pH1059, DOI 10.1152/ajpheart.00431.2015; Weltman NY, 2014, MOL MED, V20, P302, DOI 10.2119/molmed.2013.00040; Weltman NY, 2013, ENDOCRINOLOGY, V154, P2542, DOI 10.1210/en.2012-2087; YOUNG WF, 1984, CLIN PHARMACOL THER, V36, P781, DOI 10.1038/clpt.1984.257; Yu XC, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-6; Zhang YH, 2014, J CARD FAIL, V20, P1012, DOI 10.1016/j.cardfail.2014.10.003; Zhang YH, 2013, CIRC-ARRHYTHMIA ELEC, V6, P952, DOI 10.1161/CIRCEP.113.000502; Zucker IH, 2014, CLIN SCI, V126, P695, DOI 10.1042/CS20130294	46	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151413	10.1371/journal.pone.0151413	http://dx.doi.org/10.1371/journal.pone.0151413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981865	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900082
J	Reintjes, R; Das, E; Klemm, C; Richardus, JH; Kessler, V; Ahmad, A				Reintjes, Ralf; Das, Enny; Klemm, Celine; Richardus, Jan Hendrik; Kessler, Verena; Ahmad, Amena			"Pandemic Public Health Paradox": Time Series Analysis of the 2009/10 Influenza A / H1N1 Epidemiology, Media Attention, Risk Perception and Public Reactions in 5 European Countries	PLOS ONE			English	Article							NEWS COVERAGE; OUTBREAK; UNCERTAINTY; NEWSPAPERS	In 2009, influenza A H1N1 caused the first pandemic of the 21st century. Although a vaccine against this influenza subtype was offered before or at the onset of the second epidemic wave that caused most of the fatal cases in Europe, vaccination rates for that season were lower than expected. We propose that the contradiction between high risk of infection and low use of available prevention measures represents a pandemic public health paradox. This research aims for a better understanding of this paradox by exploring the time-dependent interplay among changing influenza epidemiology, media attention, pandemic control measures, risk perception and public health behavior among five European countries (Czech Republic, Denmark, Germany, Spain and the UK). Findings suggest that asynchronicity between media curves and epidemiological curves may potentially explain the pandemic public health paradox; media attention for influenza A H1N1 in Europe declined long before the epidemic reached its peak, and public risk perceptions and behaviors may have followed media logic, rather than epidemiological logic.	[Reintjes, Ralf; Kessler, Verena; Ahmad, Amena] Hamburg Univ Appl Sci, Hamburg, Germany; [Das, Enny] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Klemm, Celine] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands; [Reintjes, Ralf] Univ Tampere, FIN-33101 Tampere, Finland	Hochschule Angewandte Wissenschaft Hamburg; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Reintjes, R (corresponding author), Hamburg Univ Appl Sci, Hamburg, Germany.; Reintjes, R (corresponding author), Univ Tampere, FIN-33101 Tampere, Finland.	Ralf.Reintjes@haw-hamburg.de	Richardus, Jan Hendrik/AAE-1278-2021	Richardus, Jan Hendrik/0000-0003-0564-6313; Klemm, Celine/0000-0001-9178-3669	European Union Seventh Framework Programme (FP7) [278763]	European Union Seventh Framework Programme (FP7)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 278763.	Andersen PH, 2009, EPI NEWS, P27; Bundesministerium fur Gesundheit, 2009, INF BUND ZUM START I; Chang CC, 2012, HEALTH COMMUN, V27, P111, DOI 10.1080/10410236.2011.569004; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Department of Health, 2009, H1N1 SWIN FLU VACC P; Duncan B, 2009, EUROSURVEILLANCE, V14, P15; European Centre for Disease Prevention and Control, 2009, SIT REP INF NOV FLU; European Centre for Disease Prevention and Control, 2010, EUR 2009 INFL PAND T; Fenichel EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058249; FISCHHOFF B, 1985, ISSUES SCI TECHNOL, V2, P83; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Fogarty AS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-181; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goodall C, 2012, J HEALTH COMMUN, V17, P338, DOI 10.1080/10810730.2011.626499; Health Protection Agency, EP REP PAND H1N1 200; Hilton S, 1988, FLASH BUR 287 EUR IN, V8, P177; Hilton S, 1997, J COMMUN, V12, P319; Hilton S, 2011, J EPIDEMIOL COMMUN H, V65, P941, DOI 10.1136/jech.2010.119875; Hine D., 2010, 2009 INFLUENZA PANDE; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Kitzinger J, 1997, EUR J COMMUN, V12, P319, DOI 10.1177/0267323197012003002; Klemm C., 2014, J RISK RES; Klemm C, 2014, ICA C SEATTL US; McCombs ME, 1974, ASS ED JOURN SAN DIE; Mereckiene J, 2012, EUROSURVEILLANCE, V17, P18; Ministerio de Sanidad Politica Social e Igualdad, 2010, AN ACT MAT VAC ANT D; Ministerio de Sanidad y Politica Social, 2009, SWIN FLU VACC 2009; Ministerstvo zdravotnictvi ER, 2009, PRO CESTOVATELE 21 5; Ministerstvo zdravotnictvi ER, 2009, LEK TAM AKT UD PRO Z; Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863; National Board of Health, 2009, AENDR STRAT HANDT IN; National Board of Health, 2009, BEST TID TIL INFL H1; Rachul CM, 2011, CAN J PUBLIC HEALTH, V102, P200, DOI 10.1007/BF03404896; Robert Koch-Institut, 2010, EPIDEMIOL B, P191; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Peralta PS, 2010, REV ESP SALUD PUBLIC, V84, P529, DOI 10.1590/s1135-57272010000500007; Sethi MP R, 2010, PANDEMIC H1N1 SWINE; Sierra Moros J, 2010, REV ESP SALUD PUBLIC, V84, P463; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; The Gallup Organization, 2010, FLASH EUR 287 EUR IN; Vasterman PLM, 2013, EUR J COMMUN, V28, P436, DOI 10.1177/0267323113486235; Walter D, 2011, VACCINE, V29, P4008, DOI 10.1016/j.vaccine.2011.03.069; World Health Organization, 2009, PAND H1N1 2009 UPD 6; World Health Organization, 2009, CHANG REP REQ PAND H; Yu N., 2011, INT PUBLIC HLTH J, V3, P63	46	51	52	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151258	10.1371/journal.pone.0151258	http://dx.doi.org/10.1371/journal.pone.0151258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982071	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900073
J	Ramos, GD; Bernardi, L; Lauxen, I; Sant'Ana, M; Horwitz, AR; Lamers, ML				Ramos, Grasieli de Oliveira; Bernardi, Lisiane; Lauxen, Isabel; Sant'Ana Filho, Manoel; Horwitz, Alan Rick; Lamers, Marcelo Lazzaron			Fibronectin Modulates Cell Adhesion and Signaling to Promote Single Cell Migration of Highly Invasive Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; COLLECTIVE INVASION; RHO-GTPASES; INTEGRIN; CANCER; ACTIVATION; PLASTICITY; CADHERIN; MICROENVIRONMENT; METASTASIS	Cell migration is regulated by adhesion to the extracellular matrix (ECM) through integrins and activation of small RhoGTPases, such as RhoA and Rac1, resulting in changes to actomyosin organization. During invasion, epithelial-derived tumor cells switch from laminin-enriched basal membrane to collagen and fibronectin-enriched connective tissue. How this switch affects the tumor migration is still unclear. We tested the hypothesis that ECM dictates the invasiveness of Oral Squamous Cell Carcinoma (OSCC). We analyzed the migratory properties of two OSCC lines, a low invasive cell line with high e-cadherin levels (L-inv/HE-cad) or a highly invasive cell line with low e-cadherin levels (H-inv/LE-cad), plated on different ECM components. Compared to laminin, fibronectin induced non-directional collective migration and decreased RhoA activity in L-inv/HE-cad OSCC. For H-inv/LE-cad OSCC, fibronectin increased Rac1 activity and induced smaller adhesions, resulting in a fast single cell migration in both 2D and 3D environments. Consistent with these observations, human OSCC biopsies exhibited similar changes in cell-ECM adhesion distribution at the invasive front of the tumor, where cells encounter fibronectin. Our results indicate that ECM composition might induce a switch from collective to single cell migration according to tumor invasiveness due to changes in cell-ECM adhesion and the resulting signaling pathways that alter actomyosin organization.	[Ramos, Grasieli de Oliveira; Bernardi, Lisiane; Lauxen, Isabel; Sant'Ana Filho, Manoel; Lamers, Marcelo Lazzaron] Univ Fed Rio Grande do Sul, Sch Dent, Basic Res Ctr, Porto Alegre, RS, Brazil; [Ramos, Grasieli de Oliveira; Sant'Ana Filho, Manoel; Lamers, Marcelo Lazzaron] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Horwitz, Alan Rick] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA; [Lamers, Marcelo Lazzaron] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; University of Virginia; Universidade Federal do Rio Grande do Sul	Lamers, ML (corresponding author), Univ Fed Rio Grande do Sul, Sch Dent, Basic Res Ctr, Porto Alegre, RS, Brazil.; Lamers, ML (corresponding author), Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.; Lamers, ML (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil.	marcelo.lamers@ufrgs.br	de Oliveira Ramos, Grasieli/I-3268-2014; LAMERS, MARCELO/A-5291-2013	de Oliveira Ramos, Grasieli/0000-0003-1305-8060; LAMERS, MARCELO/0000-0001-5296-5662	Coordenacao de Pessoal de Nivel Superior (CAPES, Brazil) [9748-13-0, 202188/2014-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [479527/2012-1, 443699/2014-3]; National Institutes of Health (NIH) [GM23244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023244, R01GM023244] Funding Source: NIH RePORTER	Coordenacao de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Coordenacao de Pessoal de Nivel Superior (CAPES, Brazil, #9748-13-0, #202188/2014-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, #479527/2012-1, #443699/2014-3) and National Institutes of Health (NIH, GM23244). FIPE/HCPA - Fundo de Incentivo a Pesquisa e Eventos / Hospital de Clinicas de Porto Alegre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L, 2005, WHO CLASSIFICATION T, P283; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brockbank EC, 2005, BRIT J CANCER, V92, P102, DOI 10.1038/sj.bjc.6602255; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Chen LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040202; Chen QK, 2013, DIFFERENTIATION, V86, P126, DOI 10.1016/j.diff.2013.03.003; Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; HARADA T, 1994, VIRCHOWS ARCH, V424, P257; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Hodgson L., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1411s46, DOI 10.1002/0471143030.CB1411S46]; Huang WC, 2014, CANCER RES, V74, P751, DOI 10.1158/0008-5472.CAN-13-1297; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Kamarajan P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-330; Kosmehl H, 1999, BRIT J CANCER, V81, P1071, DOI 10.1038/sj.bjc.6690809; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518; Nagata M, 2003, INT J CANCER, V106, P683, DOI 10.1002/ijc.11283; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Serres E, 2014, ONCOGENE, V33, P3451, DOI 10.1038/onc.2013.305; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Thiery JP, 2010, B CANCER, V97, P1285, DOI 10.1684/bdc.2010.1206; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; von Schlippe M, 2000, J CELL SCI, V113, P425; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yao XS, 2013, INT J CANCER, V133, P2925, DOI 10.1002/ijc.28312; Yap LF, 2009, ONCOGENE, V28, P2524, DOI 10.1038/onc.2009.105	50	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151338	10.1371/journal.pone.0151338	http://dx.doi.org/10.1371/journal.pone.0151338			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978651	Green Published, gold			2022-12-26	WOS:000372572800062
J	Young, AMH; Donnelly, J; Czosnyka, M; Jalloh, I; Liu, XY; Aries, MJ; Fernandes, HM; Garnett, MR; Smielewski, P; Hutchinson, PJ; Agrawal, S				Young, Adam M. H.; Donnelly, Joseph; Czosnyka, Marek; Jalloh, Ibrahim; Liu, Xiuyun; Aries, Marcel J.; Fernandes, Helen M.; Garnett, Matthew R.; Smielewski, Peter; Hutchinson, Peter J.; Agrawal, Shruti			Continuous Multimodality Monitoring in Children after Traumatic Brain Injury-Preliminary Experience	PLOS ONE			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; BLOOD-FLOW; REACTIVITY	Introduction Multimodality monitoring is regularly employed in adult traumatic brain injury (TBI) patients where it provides physiologic and therapeutic insight into this heterogeneous condition. Pediatric studies are less frequent. Methods An analysis of data collected prospectively from 12 pediatric TBI patients admitted to Addenbrooke's Hospital, Pediatric Intensive Care Unit (PICU) between August 2012 and December 2014 was performed. Patients' intracranial pressure (ICP), mean arterial pressure (MAP), and cerebral perfusion pressure (CPP) were monitored continuously using brain monitoring software ICM+(R)) Pressure reactivity index (PRx) and 'Optimal CPP' (CPPopt) were calculated. Patient outcome was dichotomized into survivors and non-survivors. Results At 6 months 8/12 (66%) of the cohort survived the TBI. The median (+/- IQR) ICP was significantly lower in survivors 13.1 +/- 3.2 mm Hg compared to non-survivors 21.6 +/- 42.9 mm Hg (p = 0.003). The median time spent with ICP over 20 mm Hg was lower in survivors (9.7+ 9.8% vs 60.5 + 67.4% in non-survivors; p = 0.003). Although there was no evidence that CPP was different between survival groups, the time spent with a CPP close (within 10 mm Hg) to the optimal CPP was significantly longer in survivors (90.7 +/- 12.6%) compared with non-survivors (70.6 +/- 21.8%; p = 0.02). PRx provided significant outcome separation with median PRx in survivors being 0.02 +/- 0.19 compared to 0.39 +/- 0.62 in non-survivors (p = 0.02). Conclusion Our observations provide evidence that multi-modality monitoring may be useful in pediatric TBI with ICP, deviation of CPP from CPPopt, and PRx correlating with patient outcome.	[Young, Adam M. H.; Donnelly, Joseph; Czosnyka, Marek; Jalloh, Ibrahim; Liu, Xiuyun; Aries, Marcel J.; Fernandes, Helen M.; Garnett, Matthew R.; Smielewski, Peter; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Acad Neurosurg, Cambridge CB2 2QQ, England; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Dept Pediat Intens Care, Cambridge CB2 2QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Aries, Marcel J.] Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, NL-9700 AB Groningen, Netherlands	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Warsaw University of Technology; University of Groningen	Young, AMH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Acad Neurosurg, Cambridge CB2 2QQ, England.	ay276@cam.ac.uk	Donnelly, Joseph/E-9235-2018; Aries, Marcel/HFF-8727-2022; Liu, Xiuyun/V-4427-2017; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Liu, Xiuyun/0000-0001-9540-4865; Donnelly, Joseph/0000-0002-6502-8069; Smielewski, Peter/0000-0001-5096-3938	Medical Research Council (MRC) [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge; Peter J Hutchinson NIHR Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; NIHR Cambridge BRC; Woolf Fisher Scholarship; MRC [G0601025] Funding Source: UKRI; Medical Research Council [G0601025] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-013, ACF-2014-14-005, 12/35/57] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge; Peter J Hutchinson NIHR Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; NIHR Cambridge BRC; Woolf Fisher Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors gratefully acknowledge financial support as follows: Research support: the Medical Research Council (MRC, Grant Nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: Peter J Hutchinson NIHR Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and NIHR Cambridge BRC. Joseph Donnelly is supported by a Woolf Fisher Scholarship. MC-NIHR BRC. PS and MC have a financial interest in a part of the licensing fee for ICM+, a software licensed by Cambridge Enterprise Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carlson JN, 2015, PEDIAT CRIT CARE MED; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; GUILLAUME J, 1951, REV NEUROL, V84, P131; Haubrich C, 2015, MED ENG PHYS, V37, P175, DOI 10.1016/j.medengphy.2014.11.009; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lang E W, 1995, New Horiz, V3, P400; Langlois JA, 2004, TRAUMATIC BRAIN INJU; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MRC CRASH Trial Collaborators, 2008, BMJ-BRIT MED J, P336; Nordstrom C-H, 2013, CRIT CARE MED, V41, pe3; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Paulson O. B., 1990, BRAIN METAB REV, V2, P161; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roux P Le, 2015, NEUROCRIT CARE; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165	24	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0148817	10.1371/journal.pone.0148817	http://dx.doi.org/10.1371/journal.pone.0148817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978532	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800013
J	Aftab, Z; Robert, T; Wieber, PB				Aftab, Zohaib; Robert, Thomas; Wieber, Pierre-Brice			Balance Recovery Prediction with Multiple Strategies for Standing Humans	PLOS ONE			English	Article							STEP LENGTH; RESPONSES; PERTURBATIONS; OPTIMIZATION; INTEGRATION; MOVEMENTS; STANCE; MODEL; BODY; COST	Human balance recovery from external disturbances is a complex process, and simulating it remains an open challenge. In particular, there still is a need for a comprehensive numerical tool capable of predicting the outcome of a balance perturbation, including in particular the three elementary recovery strategies: ankle, hip and stepping with variable step duration. In order to fill this gap we further developed a previously proposed multiple step balance recovery prediction tool to include the use of the hip strategy and variable step duration. Simulated recovery reactions are compared against observations from different experimental situations from the literature. Reasonable accuracy in terms of step positions and durations were obtained for these different situations using a single set of controller parameters. Moreover, variations in the use of the hip strategy and the step duration between situations were consistent with biomechanical observations. Such a model could be useful to better understand the balance recovery mechanisms, and could also be used to identify potentially hazardous situations.	[Aftab, Zohaib] Univ Cent Punjab, Fac Engn, Lahore, Pakistan; [Robert, Thomas] Univ Lyon, F-69007 Lyon, France; [Robert, Thomas] IFSTTAR, TS2, LBMC, UMR T9406, F-69500 Bron, France; [Robert, Thomas] Univ Lyon 1, LBMC UMR T9406, F-69008 Lyon, France; [Wieber, Pierre-Brice] Univ Grenoble Alpes, LJK Lab Jean Kuntzmann, INRIA Grenoble Rhone Alpes, BIPOP Team, F-38334 Montbonnot St Martin, France	University of Central Punjab; Universite Gustave-Eiffel; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Robert, T (corresponding author), Univ Lyon, F-69007 Lyon, France.; Robert, T (corresponding author), IFSTTAR, TS2, LBMC, UMR T9406, F-69500 Bron, France.; Robert, T (corresponding author), Univ Lyon 1, LBMC UMR T9406, F-69008 Lyon, France.	thomas.robert@ifsttar.fr	Robert, Thomas/I-3465-2012	Robert, Thomas/0000-0002-6502-7082; Aftab, Zohaib/0000-0002-3480-1645	la Region Rhone-Alpes	la Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	Zohaib Aftab held a doctoral fellowship from la Region Rhone-Alpes.	Aftab Z, 2012, SIMULATION DYNAMIQUE; Aftab Z, 2012, P 12 IEEE RAS INT C; Aftab Z, 2012, J BIOMECH, V45, P2804, DOI 10.1016/j.jbiomech.2012.08.038; Atkeson CG, 2007, IEEE-RAS INT C HUMAN, P57, DOI 10.1109/ICHR.2007.4813849; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Chaffin D., 2006, OCCUPATIONAL BIOMECH, V2nd; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cyr MA, 2009, GAIT POSTURE, V29, P628, DOI 10.1016/j.gaitpost.2009.01.011; deGraaf B, 1997, HUM FACTORS, V39, P111, DOI 10.1518/001872097778940614; Diedam H, 2009, P 9 IEEE RAS INT C H; DO MC, 1982, J BIOMECH, V15, P933, DOI 10.1016/0021-9290(82)90011-2; Doke J, 2007, J EXP BIOL, V210, P2390, DOI 10.1242/jeb.02782; Guihard M, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2587, DOI 10.1109/IRDS.2002.1041660; Heinrich S, 2010, OSTEOPOROSIS INT, V21, P891, DOI 10.1007/s00198-009-1100-1; Herdt A, 2010, ADV ROBOTICS, V24, P719, DOI 10.1163/016918610X493552; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hsiao-Wecksler ET, 2007, CLIN BIOMECH, V22, P574, DOI 10.1016/j.clinbiomech.2007.01.013; King GW, 2005, GAIT POSTURE, V22, P219, DOI 10.1016/j.gaitpost.2004.09.008; Koolen T, 2012, INT J ROBOT RES, V31, P1094, DOI 10.1177/0278364912452673; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; MAKI BE, 1994, INT CONGR SER, V1070, P437; McIlroy WE, 1996, J GERONTOL A-BIOL, V51, pM289, DOI 10.1093/gerona/51A.6.M289; Mille ML, 2003, J NEUROPHYSIOL, V90, P666, DOI 10.1152/jn.00974.2002; Moglo K., 2005, ISB 20 C ASB 29 ANN; Owings TM, 2001, CLIN BIOMECH, V16, P813, DOI 10.1016/S0268-0033(01)00077-8; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Park S, 2004, EXP BRAIN RES, V154, P417, DOI 10.1007/s00221-003-1674-3; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pratt J, 2006, IEEE-RAS INT C HUMAN, P200, DOI 10.1109/ichr.2006.321385; Robert T, 2006, ANAL BIOMECANIQUE MA; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Stephens B, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P4026; Thelen DG, 1997, J GERONTOL A-BIOL, V52, pM8, DOI 10.1093/gerona/52A.1.M8; Tisserand R, 2014, NEUROPHYSIOL CLIN, V44, P133, DOI [10.1016/j.neucli.2013.10.076, DOI 10.1016/J.NEUCLI.2013.10.076]; Vallee P, 2015, COMPUT METHOD BIOMEC, V18, P2074, DOI 10.1080/10255842.2015.1069613; van der Kooij H, 1999, BIOL CYBERN, V80, P299, DOI 10.1007/s004220050527; Wight DL, 2008, J COMPUT NONLIN DYN, V3, DOI 10.1115/1.2815334; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Wu M, 2007, J BIOMECH, V40, P1559, DOI 10.1016/j.jbiomech.2006.07.019; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237	42	12	12	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151166	10.1371/journal.pone.0151166	http://dx.doi.org/10.1371/journal.pone.0151166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974820	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600053
J	Herrmann, KH; Kramer, M; Reichenbach, JR				Herrmann, Karl-Heinz; Kraemer, Martin; Reichenbach, Juergen R.			Time Efficient 3D Radial UTE Sampling with Fully Automatic Delay Compensation on a Clinical 3T MR Scanner	PLOS ONE			English	Article							ULTRASHORT ECHO-TIME; COMPRESSED SENSING RECONSTRUCTION; MAGNETIC-RESONANCE ANGIOGRAPHY; SYSTEM DELAYS; EDDY CURRENTS; SENSITIVITY; CONTRAST; BONE; PULSES	This work's aim was to minimize the acquisition time of a radial 3D ultra-short echo-time (UTE) sequence and to provide fully automated, gradient delay compensated, and therefore artifact free, reconstruction. The radial 3D UTE sequence (echo time 60 mu s) was implemented as single echo acquisition with center-out readouts and improved time efficient spoiling on a clinical 3T scanner without hardware modifications. To assess the sequence parameter dependent gradient delays each acquisition contained a quick calibration scan and utilized the phase of the readouts to detect the actual k-space center. This calibration scan does not require any user interaction. To evaluate the robustness of this automatic delay estimation phantom experiments were performed and 19 in vivo imaging data of the head, tibial cortical bone, feet and lung were acquired from 6 volunteers. As clinical application of this fast 3D UTE acquisition single breath-hold lung imaging is demonstrated. The proposed sequence allowed very short repetition times (TR similar to 1ms), thus reducing total acquisition time. The proposed, fully automated k-phase based gradient delay calibration resulted in accurate delay estimations (difference to manually determined optimal delay -0.13 +/- 0.45 mu s) and allowed unsupervised reconstruction of high quality images for both phantom and in vivo data. The employed fast spoiling scheme efficiently suppressed artifacts caused by incorrectly refocused echoes. The sequence proved to be quite insensitive to motion, flow and susceptibility artifacts and provides oversampling protection against aliasing foldovers in all directions. Due to the short TR, acquisition times are attractive for a wide range of clinical applications. For short T2* mapping this sequence provides free choice of the second TE, usually within less scan time as a comparable dual echo UTE sequence.	[Herrmann, Karl-Heinz; Kraemer, Martin; Reichenbach, Juergen R.] Univ Jena, Jena Univ Hosp, Inst Diagnost & Intervent Radiol, Med Phys Grp, Jena, Germany	Friedrich Schiller University of Jena	Herrmann, KH (corresponding author), Univ Jena, Jena Univ Hosp, Inst Diagnost & Intervent Radiol, Med Phys Grp, Jena, Germany.	karl-heinz.herrmann@med.uni-jena.de	Reichenbach, Jürgen R./B-4333-2011; Krämer, Martin/AAE-7632-2020	Reichenbach, Jürgen R./0000-0002-2640-0630; Krämer, Martin/0000-0002-0173-9830; Herrmann, Karl-Heinz/0000-0003-0757-3525	interdisciplinary Center of Clinical Research (IZKF); University Hospital Jena; Friedrich-Schiller-University Jena; Dissertation Fellowship by the Carl Zeiss Foundation	interdisciplinary Center of Clinical Research (IZKF); University Hospital Jena; Friedrich-Schiller-University Jena; Dissertation Fellowship by the Carl Zeiss Foundation	MK was supported by the interdisciplinary Center of Clinical Research (IZKF), University Hospital Jena, Friedrich-Schiller-University Jena (http://www.izkf.uniklinikum-jena.de/Startseite.html) and by a Dissertation Fellowship by the Carl Zeiss Foundation (http://carl-zeiss-stiftung.de/21-0-Aktuelle-Programme.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, MED PHYS, V40, DOI 10.1118/1.4792672; Anumula S, 2006, MAGN RESON MED, V56, P946, DOI 10.1002/mrm.21050; Atkinson IC, 2009, MAGN RESON MED, V62, P532, DOI 10.1002/mrm.22016; Beatty P.J., 2009, P 17 ANN M ISMRM HAW, P2824; Bracher AK, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120321; Bracher AK, 2011, MAGN RESON MED, V66, P538, DOI 10.1002/mrm.22828; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Carl M, 2011, MAGN RESON MED, V65, P531, DOI 10.1002/mrm.22623; Chan CF, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-17; Chandarana H, 2013, INVEST RADIOL, V48, P10, DOI 10.1097/RLI.0b013e318271869c; Du J, 2013, NMR BIOMED, V26, P489, DOI 10.1002/nbm.2906; Du J, 2011, MAGN RESON IMAGING, V29, P470, DOI 10.1016/j.mri.2010.11.003; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Grodzki DM, 2012, MAGN RESON MED, V67, P510, DOI 10.1002/mrm.23017; Gurney PT, 2006, MAGN RESON MED, V55, P575, DOI 10.1002/mrm.20796; Josan S, 2009, MAGN RESON MED, V61, P1083, DOI 10.1002/mrm.21879; Keil B, 2013, J MAGN RESON, V229, P75, DOI 10.1016/j.jmr.2013.02.001; Kramer M, 2015, MAGN RESON IMAGING, V33, P491, DOI 10.1016/j.mri.2015.01.005; Krug R, 2011, J MAGN RESON IMAGING, V34, P691, DOI 10.1002/jmri.22648; Larkman DJ, 2007, PHYS MED BIOL, V52, pR15, DOI 10.1088/0031-9155/52/7/R01; Larkman DJ, 2006, MAGN RESON MED, V55, P153, DOI 10.1002/mrm.20752; Lee GR, 2013, MAGN RESON MED, V69, P346, DOI 10.1002/mrm.24256; Lee YH, 2012, P INT SOC MAG RESON, V20, P3290; Li C, 2012, MAGN RESON MED, V68, P680, DOI 10.1002/mrm.23267; Lin W, 2009, MAGN RESON MED, V62, P1185, DOI 10.1002/mrm.22089; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Nam S, 2014, J MAGN RESON IMAGING, V39, P179, DOI 10.1002/jmri.24098; Nam S, 2013, MAGN RESON MED, V69, P91, DOI 10.1002/mrm.24234; Peters DC, 2003, MAGNET RESON MED, V50, P1, DOI 10.1002/mrm.10501; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Qian YX, 2008, MAGN RESON MED, V60, P135, DOI 10.1002/mrm.21620; Rad HS, 2011, NMR BIOMED, V24, P855, DOI 10.1002/nbm.1631; Rahmer J, 2006, MAGN RESON MED, V55, P1075, DOI 10.1002/mrm.20868; Rapacchi S, 2014, MAGN RESON MED, V71, P1771, DOI 10.1002/mrm.24842; Rilling G, 2013, MAGN RESON MED, V70, P392, DOI 10.1002/mrm.24471; Robison RK, 2010, MAGN RESON MED, V63, P1683, DOI 10.1002/mrm.22327; Robson MD, 2006, NMR BIOMED, V19, P765, DOI 10.1002/nbm.1100; Robson MD, 2004, CLIN RADIOL, V59, P727, DOI 10.1016/j.crad.2003.11.021; Robson MD, 2003, J COMPUT ASSIST TOMO, V27, P825, DOI 10.1097/00004728-200311000-00001; Schweser F, 2014, P INT SOC MAG RESON, V22, P3133; Waldman A, 2003, NEURORADIOLOGY, V45, P887, DOI 10.1007/s00234-003-1076-z; Wang HF, 2009, IEEE ENG MED BIO, P2672, DOI 10.1109/IEMBS.2009.5334086; Weiger M, 2013, MAGN RESON MED, V70, P328, DOI 10.1002/mrm.24816; Weiger M, 2012, NMR BIOMED, V25, P1144, DOI 10.1002/nbm.2783; Zwart NR, 2012, MAGN RESON MED, V67, P701, DOI 10.1002/mrm.23041	46	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150371	10.1371/journal.pone.0150371	http://dx.doi.org/10.1371/journal.pone.0150371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975051	Green Submitted, gold, Green Published			2022-12-26	WOS:000372570600023
J	Janghra, N; Morgan, JE; Sewry, CA; Wilson, FX; Davies, KE; Muntoni, F; Tinsley, J				Janghra, Narinder; Morgan, Jennifer E.; Sewry, Caroline A.; Wilson, Francis X.; Davies, Kay E.; Muntoni, Francesco; Tinsley, Jonathon			Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXPRESSION PATTERNS; A-UTROPHIN; B-UTROPHIN; MDX MICE; DEFICIENCY; SARCOLEMMA; PATHOLOGY; SEVERITY; THERAPY	Duchenne muscular dystrophy is a severe and currently incurable progressive neuromuscular condition, caused by mutations in the DMD gene that result in the inability to produce dystrophin. Lack of dystrophin leads to loss of muscle fibres and a reduction in muscle mass and function. There is evidence from dystrophin-deficient mouse models that increasing levels of utrophin at the muscle fibre sarcolemma by genetic or pharmacological means significantly reduces the muscular dystrophy pathology. In order to determine the efficacy of utrophin modulators in clinical trials, it is necessary to accurately measure utrophin levels and other biomarkers on a fibre by fibre basis within a biopsy section. Our aim was to develop robust and reproducible staining and imaging protocols to quantify sarcolemmal utrophin levels, sarcolemmal dystrophin complex members and numbers of regenerating fibres within a biopsy section. We quantified sarcolemmal utrophin in mature and regenerating fibres and the percentage of regenerating muscle fibres, in muscle biopsies from Duchenne, the milder Becker muscular dystrophy and controls. Fluorescent immunostaining followed by image analysis was performed to quantify utrophin intensity and beta-dystrogylcan and gamma-sarcoglycan intensity at the sarcolemma. Antibodies to fetal and developmental myosins were used to identify regenerating muscle fibres allowing the accurate calculation of percentage regeneration fibres in the biopsy. Our results indicate that muscle biopsies from Becker muscular dystrophy patients have fewer numbers of regenerating fibres and reduced utrophin intensity compared to muscle biopsies from Duchenne muscular dystrophy patients. Of particular interest, we show for the first time that the percentage of regenerating muscle fibres within the muscle biopsy correlate with the clinical severity of Becker and Duchenne muscular dystrophy patients from whom the biopsy was taken. The ongoing development of these tools to quantify sarcolemmal utrophin and muscle regeneration in muscle biopsies will be invaluable for assessing utrophin modulator activity in future clinical trials.	[Janghra, Narinder; Morgan, Jennifer E.; Sewry, Caroline A.; Muntoni, Francesco] UCL Inst Child Hlth, Dev Neurosci Programme, Dubowitz Neuromuscular Ctr, Mol Neurosci Sect, 30 Guilford St, London WC1N 1EH, England; [Wilson, Francis X.; Tinsley, Jonathon] Summit Therapeut Plc, 85b Pk Dr,Milton Pk, Abingdon OX14 4RY, Oxon, England; [Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 3PT, England	University of London; University College London; University of Oxford	Morgan, JE (corresponding author), UCL Inst Child Hlth, Dev Neurosci Programme, Dubowitz Neuromuscular Ctr, Mol Neurosci Sect, 30 Guilford St, London WC1N 1EH, England.	jennifer.morgan@ucl.ac.uk			Summit Therapeutics and Joining Jack; Great Ormond Street Hospital Children's Charity; GOSH Biomedical Research Centre; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; Medical Research Council; Biomedical Research Centre at GOSH; Summit Therapeutics; Medical Research Council [MC_UU_12021/2, MR/N010698/1] Funding Source: researchfish; Muscular Dystrophy UK [RA3/3073] Funding Source: researchfish; MRC [MC_UU_12021/2, MR/N010698/1] Funding Source: UKRI	Summit Therapeutics and Joining Jack; Great Ormond Street Hospital Children's Charity; GOSH Biomedical Research Centre; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Centre at GOSH; Summit Therapeutics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Muscular Dystrophy UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Summit Therapeutics and Joining Jack ( grant awarded to FM and JEM). JEM is supported by Great Ormond Street Hospital Children's Charity and FM is funded from the GOSH Biomedical Research Centre. This work was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. We gratefully acknowledge the support of the Medical Research Council and of the Biomedical Research Centre at GOSH for their support of the Centre for Neuromuscular Diseases Biobank. JT and FXW are employees of the sponsor (Summit Therapeutics). They were involved in the study design, data analysis, decision to publish, reviewing of the manuscript.	Anthony K, 2011, BRAIN, V134, P3544, DOI 10.1093/brain/awr291; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; Arechavala-Gomeza V, 2010, NEUROPATH APPL NEURO, V36, P265, DOI 10.1111/j.1365-2990.2009.01056.x; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; Belanto JJ, 2014, P NATL ACAD SCI USA, V111, P5723, DOI 10.1073/pnas.1323842111; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; Cirak S, 2011, LANCET; Cirak S, 2012, MOL THER, V20, P462, DOI 10.1038/mt.2011.248; CLERK A, 1993, HISTOCHEM J, V25, P554; Deconinck N, 1998, NEUROMUSCULAR DISORD, V8, P362, DOI 10.1016/S0960-8966(98)00048-0; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Gross JG, 1999, MUSCLE NERVE, V22, P174, DOI 10.1002/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S; Guiraud S, 2015, HUM MOL GENET, V24, P4212, DOI 10.1093/hmg/ddv154; HELLIWELL TR, 1992, NEUROMUSCULAR DISORD, V2, P177, DOI 10.1016/0960-8966(92)90004-P; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Johnson EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043515; Kleopa KA, 2006, HUM MOL GENET, V15, P1623, DOI 10.1093/hmg/ddl083; Koo T, 2013, HUM GENE THER, V24, P479, DOI 10.1089/hum.2012.234; Krag TO, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-31; Li DJ, 2010, J CELL SCI, V123, P2007, DOI 10.1242/jcs.064808; Lin S, 1998, J NEUROPATH EXP NEUR, V57, P780, DOI 10.1097/00005072-199808000-00007; MATSUMURA K, 1993, J CLIN INVEST, V92, P866, DOI 10.1172/JCI116661; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mercuri E, 2013, CURR OPIN PEDIATR, V25, P701, DOI 10.1097/MOP.0b013e328365ace5; MIZUNO Y, 1994, MUSCLE NERVE, V17, P206, DOI 10.1002/mus.880170212; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; Ricotti V, 2015, J NEUROL NEUROSURG P; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; SCOTT OM, 1982, MUSCLE NERVE, V5, P291, DOI 10.1002/mus.880050405; Sewry CA, 2005, NEUROMUSCULAR DISORD, V15, P779, DOI 10.1016/j.nmd.2005.08.002; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Tachi Nobutada, 1993, Acta Paediatrica Japonica (Overseas Edition), V35, P409; Taylor J, 1997, NEUROPATH APPL NEURO, V23, P399; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley J, 2015, J CLIN PHARM; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Torelli S, 2004, NEUROPATH APPL NEURO, V30, P540, DOI 10.1111/j.1365-2990.2004.00561.x; VAINZOF M, 1995, AM J MED GENET, V58, P305, DOI 10.1002/ajmg.1320580403; Vainzof M, 2016, NEUROMUSCUL DISORD; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; Wang ZJ, 2007, MOL THER, V15, P1160, DOI 10.1038/sj.mt.6300161; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; WILSON LA, 1994, NEUROPATH APPL NEURO, V20, P359, DOI 10.1111/j.1365-2990.1994.tb00981.x; Yoshimura M, 2004, MOL THER, V10, P821, DOI 10.1016/j.ymthe.2004.07.025	47	22	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150818	10.1371/journal.pone.0150818	http://dx.doi.org/10.1371/journal.pone.0150818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974331	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600033
J	Lee, CA; Yeh, KS				Lee, Chien-An; Yeh, Kuang-Sheng			The Non-Fimbriate Phenotype Is Predominant among Salmonella enterica Serovar Choleraesuis from Swine and Those Non-Fimbriate Strains Possess Distinct Amino Acid Variations in FimH	PLOS ONE			English	Article							ESCHERICHIA-COLI; TYPE-1 FIMBRIAE; ADHESIVE PROPERTIES; GENOME SEQUENCE; TYPHIMURIUM; EXPRESSION; MUTATIONS; GENES; COLONIZATION; CONSTRUCTION	Although most Salmonella serovars are able to infect a range of animal hosts, some have acquired the ability to cause systemic infections of specific hosts. For example, Salmonella enterica serovar Choleraesuis is primarily associated with systemic infection in swine. Adherence to host epithelial cells is considered a prerequisite for initial infection, and fimbrial appendages on the outer membrane of the bacteria are implicated in this process. Although type 1 fimbriae encoded by the fim gene cluster are commonly found in Salmonella serovars, it is not known whether S. Choleraesuis produces this fimbrial type and if and how fimbriae are involved in pathogenesis. In the present study, we demonstrated that only four out of 120 S. Choleraesuis isolates from pigs with salmonellosis produced type 1 fimbriae as assayed by the yeast agglutination test and electron microscopy. One of the 116 non-type 1 fimbria-producing isolates was transformed with plasmids carrying different fim genes from S. Typhimurium LB5010, a type 1 fimbria-producing strain. Our results indicate that non-type 1 fimbria-producing S. Choleraesuis required only an intact fimH to regain the ability to produce fimbrial appendages. Sequence comparison revealed six amino acid variations between the FimH of the non-type 1 fimbria-producing S. Choleraesuis isolates and those of the type 1 fimbria-producing S. Choleraesuis isolates. S. Choleraesuis that produced type 1 fimbriae contained FimH with an amino acid sequence identical to that of S. Typhimurium LB5010. Site-directed mutagenesis leading to the replacement of the non-conserved residues revealed that a change from glycine to valine at position of 63 (G63V) resulted in a non-type 1 fimbria-producing S. Choleraesuis being able to express type 1 fimbriae on its outer membrane. It is possible that this particular amino acid change prevents this polypeptide from proper interaction with other Fim subunits required for assembly of an intact type 1 fimbrial shaft in S. Choleraesuis; however, it remains to be determined if and how the absence of type 1 fimbriae production is related to the systemic infection of the swine host by S. Choleraesuis.	[Lee, Chien-An; Yeh, Kuang-Sheng] Natl Taiwan Univ, Dept Vet Med, Sch Vet Med, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Yeh, Kuang-Sheng] Natl Taiwan Univ, Vet Hosp, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Yeh, KS (corresponding author), Natl Taiwan Univ, Dept Vet Med, Sch Vet Med, Coll Bioresources & Agr, Taipei 10764, Taiwan.; Yeh, KS (corresponding author), Natl Taiwan Univ, Vet Hosp, Taipei 10764, Taiwan.	ksyeh@ntu.edu.tw	Yeh, Kuang-Sheng/J-7715-2013		Ministry of Science and Technology, Taiwan, R.O.C. [MOST 103-2313-B-002-044]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by Ministry of Science and Technology, Taiwan, R.O.C. under the contract number MOST 103-2313-B-002-044.	Althouse C, 2003, INFECT IMMUN, V71, P6446, DOI 10.1128/IAI.71.11.6446-6452.2003; Anderson RC, 1998, RES VET SCI, V64, P261, DOI 10.1016/S0034-5288(98)90136-9; BULLAS LR, 1983, J BACTERIOL, V156, P471, DOI 10.1128/JB.156.1.471-474.1983; Chattopadhyay S, 2013, MOL BIOL EVOL, V30, P1465, DOI 10.1093/molbev/mst048; Chattopadhyay S, 2012, J BACTERIOL, V194, P5002, DOI 10.1128/JB.00552-12; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Chiu TH, 2005, J FOOD PROTECT, V68, P1575, DOI 10.4315/0362-028X-68.8.1575; Clegg S., 1994, FIMBRIAE ADHESION GE, P105; CLSI, 2011, M10021 CLSI; DUGUID JP, 1976, J MED MICROBIOL, V9, P459, DOI 10.1099/00222615-9-4-459; DUGUID JP, 1957, J PATHOL BACTERIOL, V74, P397, DOI 10.1002/path.1700740218; DUGUID JP, 1966, J PATHOL BACTERIOL, V92, P107, DOI 10.1002/path.1700920113; Dwyer BE, 2011, MICROBIOL-SGM, V157, P3162, DOI 10.1099/mic.0.051425-0; Foley S L, 2008, J Anim Sci, V86, pE173; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Guo AZ, 2009, MICROBIOL-SGM, V155, P1623, DOI 10.1099/mic.0.026286-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hancox LS, 1997, FEMS IMMUNOL MED MIC, V19, P289, DOI 10.1016/S0928-8244(97)00095-3; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Kisiela D, 2005, INFECT IMMUN, V73, P6187, DOI 10.1128/IAI.73.9.6187-6190.2005; Kisiela DI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002733; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Kuzminska-Bajor M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00276; Kuzminska-Bajor M, 2012, VET MICROBIOL, V158, P205, DOI 10.1016/j.vetmic.2012.01.029; Lillington J, 2015, BBA-GEN SUBJECTS, V1850, P554, DOI 10.1016/j.bbagen.2014.07.009; LOCKMAN HA, 1992, INFECT IMMUN, V60, P491, DOI 10.1128/IAI.60.2.491-496.1992; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McFarland KA, 2008, J BACTERIOL, V190, P602, DOI 10.1128/JB.01388-07; OLD DC, 1968, J GEN MICROBIOL, V51, P1; Pires AFA, 2014, PREV VET MED, V116, P120, DOI 10.1016/j.prevetmed.2014.06.009; RUSSELL PW, 1992, J BACTERIOL, V174, P5923, DOI 10.1128/jb.174.18.5923-5935.1992; Schmidt JW, 2012, APPL ENVIRON MICROB, V78, P2716, DOI 10.1128/AEM.07015-11; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; SWENSON DL, 1991, MICROB PATHOGENESIS, V10, P487, DOI 10.1016/0882-4010(91)90115-Q; SWENSON DL, 1994, MOL GEN GENET, V244, P216, DOI 10.1007/BF00283525; Thankavel K, 1999, J BIOL CHEM, V274, P5797, DOI 10.1074/jbc.274.9.5797; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Tinker JK, 2000, INFECT IMMUN, V68, P3305, DOI 10.1128/IAI.68.6.3305-3313.2000; Tinker JK, 2001, J BACTERIOL, V183, P435, DOI 10.1128/JB.183.2.435-442.2001; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Wang KC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-111; YEH KS, 1995, J BACTERIOL, V177, P6861, DOI 10.1128/jb.177.23.6861-6865.1995; Yue M, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00419; Zeiner SA, 2012, INFECT IMMUN, V80, P3289, DOI 10.1128/IAI.00331-12	49	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151126	10.1371/journal.pone.0151126	http://dx.doi.org/10.1371/journal.pone.0151126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974320	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600049
J	Brown, JM; Poirot, E; Hess, KL; Brown, S; Vertucci, M; Hezareh, M				Brown, Joelle M.; Poirot, Eugenie; Hess, Kristen L.; Brown, Stephen; Vertucci, Michele; Hezareh, Marjan			Motivations for Intravaginal Product Use among a Cohort of Women in Los Angeles	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; VAGINAL PRACTICES; HIV ACQUISITION; RISK; PREVALENCE; INFECTION	Objective Intravaginal practices-including behaviors such as intravaginal cleansing and insertion of products-have been linked to a number of adverse reproductive health outcomes, including increased risk for bacterial vaginosis, sexually transmitted infections, and HIV. Currently, little is known about the motivations for intravaginal practices among women in the United States. The objective of this study was to identify and describe motivations for intravaginal washing and intravaginal insertion of products among women of differing ages and racial/ethnic groups. Methods Between 2008 and 2010, we enrolled a convenience sample of sexually active women aged 18-65 years living in Los Angeles recruited through community education and out-reach activities in HIV/AIDS service organizations, women's health clinics, community-based organizations, and HIV testing sites. At the enrollment visit, women completed a self-administered, computer-assisted questionnaire covering demographics, sexual behaviors, intravaginal practices, and motivations for intravaginal practices over the past month and past year. Results We enrolled 141 women; 34% of participants were Caucasian, 40% African American, and 26% Latina. Peri-sexual intravaginal washing was common in all groups, whether to clean up after sex (70%) or to prepare for sex (54%). African American women were more likely to report learning to wash intravaginally from their mothers compared to Latina or Caucasian women (70% vs. 49%, P = 0.04). Sixty-one percent of African American women reported using a douching device over the past year compared to 41% of Latina and 40% of Caucasian women (p = 0.02). Younger women were more likely to report that their male partners wanted them to wash intravaginally than older women (77% vs. 24%, P<0.01), and more likely to report the removal of odors as a motive than older women (65% vs. 40%, P = 0.04). The most commonly used intravaginal products included sexual lubricants, petroleum jelly, body lotions, oils, and wet wipes. Use of these products varied by race, and motives given included increasing lubrication, preparing for sex, smelling good, and preventing sexually transmitted infections. Conclusion Women's intravaginal practices and motivations for these practices differ across race and age. Motivations for use also vary by type of intravaginal product used. Given that some intravaginal practices have been shown to be harmful, interventions, programs and counseling messages to encourage less harmful practices are needed, and should consider underlying motivations that influence women's vaginal practices. Practitioners may use these results to better support women in achieving vaginal health.	[Brown, Joelle M.; Poirot, Eugenie] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Brown, Joelle M.; Hess, Kristen L.; Vertucci, Michele] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Brown, Stephen; Vertucci, Michele; Hezareh, Marjan] AIDS Res Alliance Amer, Los Angeles, CA USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Brown, JM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Brown, JM (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA.	Joelle.Brown@ucsf.edu			California HIV/AIDS Research Program [CR07-LA-582, CR07-ARA-581]; UCLA AIDS Institute [CH05-LA608]; NIH/NIMH [K01 MH100994]; UCSF-CTSI [KL2 TR000143]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH100994] Funding Source: NIH RePORTER	California HIV/AIDS Research Program; UCLA AIDS Institute; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCSF-CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the California HIV/AIDS Research Program (CR07-LA-582; CR07-ARA-581), and the UCLA AIDS Institute (CH05-LA608). JMB received funding from NIH/NIMH grant number K01 MH100994 and support from UCSF-CTSI grant number KL2 TR000143. The study results are solely the responsibility of the authors and do not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide ML, 2013, J ASSOC NURSE AIDS C, V24, P219, DOI 10.1016/j.jana.2012.08.009; American Sexual Health Association, 2014, VAG BACT VAG TRICH; Angeles Mount Saint Mary's University Los, 2015, REP STAT WOM GIRLS C; Annang L, 2006, SEX TRANSM DIS, V33, P215, DOI 10.1097/01.olq.0000205046.11916.c5; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Brown JM, 2013, OBSTET GYNECOL, V121, P773, DOI 10.1097/AOG.0b013e31828786f8; Chandra Anjani, 2005, Vital Health Stat 23, P1; Funkhouser E, 2002, J WOMEN HEALTH GEN-B, V11, P29, DOI 10.1089/152460902753473435; Funkhouser E, 2002, J AM COLL HEALTH, V50, P177, DOI 10.1080/07448480209596024; Gazmararian J A, 2001, Matern Child Health J, V5, P153, DOI 10.1023/A:1011391700314; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hilber AM, 2007, SEX TRANSM INFECT, V83, P505, DOI 10.1136/sti.2007.028597; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hilber AM, 2010, SOC SCI MED, V70, P392, DOI 10.1016/j.socscimed.2009.10.023; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Hutchinson KB, 2007, SEX TRANSM DIS, V34, P671, DOI 10.1097/01.olq.0000258435.34879.da; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Pavlova S I, 2000, Infect Dis Obstet Gynecol, V8, P99, DOI 10.1155/S1064744900000090; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Trabert B, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.085; van de Wijgert JHHM, 2000, J ACQ IMMUN DEF SYND, V24, P62	24	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151378	10.1371/journal.pone.0151378	http://dx.doi.org/10.1371/journal.pone.0151378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967165	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200049
J	Majeed, A; Piah, AM; Yahya, ZR				Majeed, Abdul; Piah, Abd Rahni Mt; Yahya, Zainor Ridzuan			Surface Reconstruction from Parallel Curves with Application to Parietal Bone Fracture Reconstruction	PLOS ONE			English	Article							CRANIOFACIAL RECONSTRUCTION; ALGORITHM	Maxillofacial trauma are common, secondary to road traffic accident, sports injury, falls and require sophisticated radiological imaging to precisely diagnose. A direct surgical reconstruction is complex and require clinical expertise. Bio-modelling helps in reconstructing surface model from 2D contours. In this manuscript we have constructed the 3D surface using 2D Computerized Tomography (CT) scan contours. The fracture part of the cranial vault are reconstructed using GC1 rational cubic Ball curve with three free parameters, later the 2D contours are flipped into 3D with equidistant z component. The constructed surface is represented by contours blending interpolant. At the end of this manuscript a case report of parietal bone fracture is also illustrated by employing this method with a Graphical User Interface (GUI) illustration.	[Majeed, Abdul] Univ Educ, Div Sci & Technol, Town Ship Lahore, Pakistan; [Piah, Abd Rahni Mt] Univ Sains Malaysia, Sch Math Sci, George Town 11800, Malaysia; [Yahya, Zainor Ridzuan] Univ Malaysia Perlis, Inst Engn Math, Pauh Putra Campus, Pauh 02600, Perlis, Malaysia	Universiti Sains Malaysia; Universiti Malaysia Perlis	Majeed, A (corresponding author), Univ Educ, Div Sci & Technol, Town Ship Lahore, Pakistan.	abdulmajeed@ue.edu.pk	Yahya, Zainor/GNH-4483-2022		Ministry of Education of Malaysia; Universiti Sains Malaysia [203/PMATHS/6711365]	Ministry of Education of Malaysia; Universiti Sains Malaysia(Universiti Sains Malaysia)	The authors would like to extend their gratitude to the Ministry of Education of Malaysia and Universiti Sains Malaysia for supporting this work under its Fundamental Research Grant Scheme (FRGS), Account No. 203/PMATHS/6711365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre F, 2008, VIPIMAGE; Ball A. A., 1974, Computer Aided Design, V6, P243, DOI 10.1016/0010-4485(74)90009-8; Bhatt A.D., 2008, COMPUT AIDED DES APP, V5, P194; Butland J, 1980, P COMPUTER GRAPHICS, P409; Cavalcanti MGP, 2014, DENTOMAXILLOFACIAL R; FANG Z., 2005, THESIS DREXEL U; Goodman TNT, 1992, P 5 ASEE INT C ECGDG; Kou XY, 2007, COMPUT AIDED DESIGN, V39, P284, DOI 10.1016/j.cad.2006.12.007; Lian Q, 2006, COMPUT AIDED DESIGN, V38, P507, DOI 10.1016/j.cad.2005.12.001; Ma Z, 2013, MED ENG PHYS, V35, P1819, DOI 10.1016/j.medengphy.2013.05.002; Ma Z, 2012, INT J NUMER METH BIO, V28, P714, DOI 10.1002/cnm.2463; Ma Z, 2010, COMPUT METHOD BIOMEC, V13, P235, DOI 10.1080/10255840903131878; Ma Z, 2009, IMAGAPP 2009: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON COMPUTER IMAGING THEORY AND APPLICATIONS, P135; Magnenat TN, 2000, IEEE T INF TECHNOL B, V4, P137, DOI [10.1109/4233.845206, DOI 10.1109/4233.845206]; Majeed A., 2014, APPL MATH SCI, V8, P3683, DOI DOI 10.12988/AMS.2014.43201; Majeed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122854; Min Kj, 2003, MED IMAGE COMPUTING, P99; Moura DC, 2011, MED ENG PHYS, V33, P924, DOI 10.1016/j.medengphy.2011.03.007; Moura DC, 2009, LECT NOTES COMPUTER; Muller A, 2003, J CRANIOFAC SURG, V14, P899; Park H, 2007, COMPUT AIDED DESIGN, V39, P439, DOI 10.1016/j.cad.2006.12.006; Piah ARM, 2011, SAINS MALAYS, V40, P1173; Pimenta S, 2006, RECONSTRUCTION 3D MO, V1; SAID HB, 1989, ACM T GRAPHIC, V8, P360, DOI 10.1145/77269.77275; Sarfraz M, 2006, COMPUT IMAGING VIS, V32, P528; Sauret V., 2002, IMAGING, V14, P464, DOI [10.1259/img.14.6.140464, DOI 10.1259/IMG.14.6.140464]; Vandermeulen D, 2006, FORENSIC SCI INT, V159, pS164, DOI 10.1016/j.forsciint.2006.02.036; Winslow BD, 2010, BIOMATERIALS, V31, P9373, DOI 10.1016/j.biomaterials.2010.07.078; Wu T, 2006, LECT NOTES COMPUT SC, V4190, P9; Wuyang S., 2010, IM VIS COMP NZ IVCNZ, P1; Yoshimoto F, 2003, COMPUT AIDED DESIGN, V35, P751, DOI 10.1016/S0010-4485(03)00006-X	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149921	10.1371/journal.pone.0149921	http://dx.doi.org/10.1371/journal.pone.0149921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967643	gold, Green Published, Green Submitted			2022-12-26	WOS:000371989200007
J	Yamaguchi, S; Aoyama, T; Ito, A; Nagai, M; Iijima, H; Tajino, J; Zhang, XK; Kiyan, W; Kuroki, H				Yamaguchi, Shoki; Aoyama, Tomoki; Ito, Akira; Nagai, Momoko; Iijima, Hirotaka; Tajino, Junichi; Zhang, Xiangkai; Kiyan, Wataru; Kuroki, Hiroshi			The Effect of Exercise on the Early Stages of Mesenchymal Stromal Cell-Induced Cartilage Repair in a Rat Osteochondral Defect Model	PLOS ONE			English	Article							CONTINUOUS PASSIVE MOTION; ARTICULAR-CARTILAGE; STEM-CELLS; RABBIT; OSTEOARTHRITIS; ADHESION; KNEE; TRANSPLANTATION; PERIOSTEAL; ARTHRITIS	The repair of articular cartilage is challenging owing to the restriction in the ability of articular cartilage to repair itself. Therefore, cell supplementation therapy is possible cartilage repair method. However, few studies have verified the efficacy and safety of cell supplementation therapy. The current study assessed the effect of exercise on early the phase of cartilage repair following cell supplementation utilizing mesenchymal stromal cell (MSC) intra-articular injection. An osteochondral defect was created on the femoral grooves bilaterally of Wistar rats. Mesenchymal stromal cells that were obtained from male Wistar rats were cultured in monolayer. After 4 weeks, MSCs were injected into the right knee joint and the rats were randomized into an exercise or no-exercise intervention group. The femurs were divided as follows: C group (no exercise without MSC injection); E group (exercise without MSC injection); M group (no exercise with MSC injection); and ME group (exercise with MSC injection). At 2, 4, and 8 weeks after the injection, the femurs were sectioned and histologically graded using the Wakitani cartilage repair scoring system. At 2 weeks after the injection, the total histological scores of the M and ME groups improved significantly compared with those of the C group. Four weeks after the injection, the scores of both the M and ME groups improved significantly. Additionally, the scores in the ME group showed a significant improvement compared to those in the M group. The improvement in the scores of the E, M, and ME groups at 8 weeks were not significantly different. The findings indicate that exercise may enhance cartilage repair after an MSC intra-articular injection. This study highlights the importance of exercise following cell transplantation therapy.	[Yamaguchi, Shoki; Iijima, Hirotaka; Tajino, Junichi; Zhang, Xiangkai; Kiyan, Wataru; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Motor Funct Anal, Kyoto, Japan; [Yamaguchi, Shoki; Ito, Akira; Iijima, Hirotaka] Japan Soc Promot Sci, Tokyo, Japan; [Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Dev & Rehabil Motor Funct, Kyoto, Japan; [Ito, Akira] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Nagai, Momoko] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University; Kyoto University; Kyoto University	Kuroki, H (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Motor Funct Anal, Kyoto, Japan.	kuroki.hiroshi.6s@kyoto-u.ac.jp	Iijima, Hirotaka/AAV-9480-2020; Ito, Akira/AAA-4872-2021	Ito, Akira/0000-0002-9645-9777	JSPS KAKENHI [25242055, 25560258];  [26-7304]; Grants-in-Aid for Scientific Research [14J07304] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A Grant-in-Aid for JSPS Research Fellows (number 26-7304), a JSPS KAKENHI Grant-in-Aid for Scientific Research (A) (number 25242055) and JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research (number 25560258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Beckett J, 2012, J ORTHOP RES, V30, P1604, DOI 10.1002/jor.22124; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chan EF, 2012, CARTILAGE, V3, P255, DOI 10.1177/1947603511435272; Clarke HD, 2003, J ARTHROPLASTY, V18, P10, DOI 10.1054/arth.2003.50101; Davis AM, 2013, OSTEOARTHR CARTILAGE, V21, P1414, DOI 10.1016/j.joca.2013.08.013; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Galois L, 2004, OSTEOARTHR CARTILAGE, V12, P779, DOI 10.1016/j.joca.2004.06.008; Gelse K, 2003, ARTHRITIS RHEUM-US, V48, P430, DOI 10.1002/art.10759; Giannini S, 2004, FOOT ANKLE INT, V25, P168, DOI 10.1177/107110070402500311; Gobbi A, 2006, ARTHROSCOPY, V22, P1085, DOI 10.1016/j.arthro.2006.05.016; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Hung BP, 2013, J BIOMED MATER RES A, V101, P3592, DOI 10.1002/jbm.a.34647; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; KREDER HJ, 1994, CLIN ORTHOP RELAT R, P288; Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2; McMahon LA, 2008, REGEN MED, V3, P743, DOI 10.2217/17460751.3.5.743; Nam HY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4309; Nam J, 2011, ARTHRITIS RHEUM-US, V63, P1613, DOI 10.1002/art.30311; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Nishimori M, 2006, J BONE JOINT SURG BR, V88B, P1236, DOI 10.1302/0301-620X.88B9.17810; ODRISCOLL SW, 1984, J BONE JOINT SURG AM, V66A, P1248, DOI 10.2106/00004623-198466080-00014; Orth P, 2012, OSTEOARTHR CARTILAGE, V20, P1161, DOI 10.1016/j.joca.2012.06.008; Peeters CMM, 2013, OSTEOARTHR CARTILAGE, V21, P1465, DOI 10.1016/j.joca.2013.06.025; Ragetly GR, 2010, J MATER SCI-MATER M, V21, P2479, DOI 10.1007/s10856-010-4096-3; RITSILA VA, 1994, CLIN ORTHOP RELAT R, P259; Song JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090858; Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033; Stoddart MJ, 2015, ADV DRUG DELIVER REV, V84, P135, DOI 10.1016/j.addr.2014.08.007; Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x; van Buul GM, 2012, OSTEOARTHR CARTILAGE, V20, P1186, DOI 10.1016/j.joca.2012.06.003; Vijayan S, 2010, INDIAN J ORTHOP, V44, P238, DOI 10.4103/0019-5413.65136; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061; Wondrasch B, 2009, AM J SPORT MED, V37, p88S, DOI 10.1177/0363546509351272; Yamaguchi S, 2013, J ORTHOP RES, V31, P1026, DOI 10.1002/jor.22332	38	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151580	10.1371/journal.pone.0151580	http://dx.doi.org/10.1371/journal.pone.0151580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968036	gold, Green Published			2022-12-26	WOS:000371989200065
J	Auvynet, C; de Chanville, CB; Hermand, P; Dorgham, K; Piesse, C; Pouchy, C; Carlier, L; Poupel, L; Barthelemy, S; Felouzis, V; Lacombe, C; Sagan, S; Salomon, B; Deterre, P; Sennlaub, F; Combadiere, C				Auvynet, Constance; de Chanville, Camille Baudesson; Hermand, Patricia; Dorgham, Karim; Piesse, Christophe; Pouchy, Charlotte; Carlier, Ludovic; Poupel, Lucie; Barthelemy, Sandrine; Felouzis, Virginie; Lacombe, Claire; Sagan, Sandrine; Salomon, Benoit; Deterre, Philippe; Sennlaub, Florian; Combadiere, Christophe			ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration	FASEB JOURNAL			English	Article						chemokine receptor; allosteric inhibitor; inflammation; functional selectivity	MONOCYTE CHEMOATTRACTANT PROTEIN-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR CCR2; RHEUMATOID-ARTHRITIS; CCR2(-/-) MICE; BONE-MARROW; ANTAGONIST; BINDING; LIGAND; RECRUITMENT	CC chemokine receptor type 2 (CCR2) is a key molecule in inflammatory diseases and is an obvious drug target for the treatment of inflammation. A number of nonpeptidic, competitive CCR2 antagonists have been developed, but none has yet been approved for clinical use. Our aim was to identify a short peptide that showed allosteric antagonism against human and mouse CCR2. On the basis of sequence analysis and 3-dimensional modeling, we identified an original 7-d-amino acid peptidic CCR2 inhibitor that we have called extracellular loop 1 inverso (ECL1i), d(LGTFLKC). In vitro, ECL1i selectively and potently inhibits CC chemokine ligand type 2 (CCL2)-triggered chemotaxis (IC50, 2 mu M) but no other conventional CCL2-associated events. We used the classic competitive CCR2 antagonist, BMS22 {2-[(isopropylaminocarbonyl)amino]-N-[2-[[cis-2-[[4-(methylthio)benzoyl]amino]cyclohexyl]amino]-2-oxoethyl]-5-(trifluoromethyl)benzamide}, as positive control and inhibited CCL2-dependent chemotaxis with an IC50 of 18 nM. As negative control, we used a peptide with the same composition as ECL1i, but in a different sequence, d(FKLTLCG). In vivo, ECL1i (4 mg/kg) interfered with CCR2-positive cell recruitment and attenuated disease progression in experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. This study establishes ECL1i as the first allosteric inhibitor of CCR2 with functional selectivity. ECL1i is a promising new agent in therapeutic development, and it may, by its selective effect, increase our understanding of CCR2 signaling pathways and functions.Auvynet, C., Baudesson de Chanville, C., Hermand, P., Dorgham, K., Piesse, C., Pouchy, C., Carlier, L., Poupel, L., Barthelemy, S., Felouzis, V., Lacombe, C., Sagan, S., Salomon, B., Deterre, P., Sennlaub, F., Combadiere, C. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.	[Auvynet, Constance; de Chanville, Camille Baudesson; Hermand, Patricia; Dorgham, Karim; Pouchy, Charlotte; Poupel, Lucie; Barthelemy, Sandrine; Felouzis, Virginie; Salomon, Benoit; Deterre, Philippe; Combadiere, Christophe] Univ Paris 06, Sorbonne Univ, Unite Mixte Rech Sci UMRS 1135,U1135, INSERM,CNRS,Equipe Rech Labellisee ERL 8255,Ctr I, Paris, France; [Piesse, Christophe] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine IBPS 3631, CNRS,Serv Synth Peptid, Paris, France; [Carlier, Ludovic; Lacombe, Claire; Sagan, Sandrine] Univ Paris 06, Sorbonne Univ, CNRS, UMR 7203,Lab Biomol, Paris, France; [Lacombe, Claire] Univ Rech Paris Sci & Lettres, Ecole Normale Super, Dept Chim, Paris, France; [Lacombe, Claire] Univ Paris Est Creteil Val de Marne, Fac Sci & Technol, Creteil, France; [Sennlaub, Florian] Univ Paris 06, Sorbonne Univ, Inst Vis, UMRS 968,INSERM,U968, Paris, France; [Sennlaub, Florian] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM, DHOS, Ctr Invest Clin 503, Paris, France; [Auvynet, Constance] Univ Paris Saclay, Univ Paris 11, INSERM, Inflammat Chemokines & Immunopathol UMR996, Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Combadiere, C (corresponding author), Ctr Immunol & Malad Infect CIMI Paris, 91 Blvd Hop, F-75013 Paris, France.	christophe.combadiere@upmc.fr	Dorgham, karim/A-2241-2016; s, s/HIK-1178-2022; s, s/HHD-0404-2022; Deterre, Philippe/O-8984-2017; S, SAGAN/I-8132-2013; Salomon, Benoit/AAP-5209-2021; Sennlaub, Florian/F-2756-2017; SAGAN, Sandrine/AAA-8537-2022; Combadiere, Christophe/I-5639-2013; QI, DANDAN/GVR-9324-2022; s, s/GYR-2278-2022; Salomon, Benoit L/M-2421-2017	Dorgham, karim/0000-0001-9539-3203; Deterre, Philippe/0000-0001-9303-0791; S, SAGAN/0000-0003-0083-4411; Salomon, Benoit/0000-0001-9673-5578; Sennlaub, Florian/0000-0003-4412-1341; Combadiere, Christophe/0000-0002-1755-4531; Salomon, Benoit L/0000-0001-9673-5578; HERMAND, Patricia/0000-0003-0628-9733; Poupel, Lucie/0000-0001-7015-8450; LACOMBE, Claire/0000-0001-9428-8145; Carlier, Ludovic/0000-0002-9036-6561	INSERM; Universite Pierre et Marie Curie; European Community [FP7-Health-2009 ENDOSTEM 241440]; Agence National de la Recherche Programme Emergence [ANR-EMMA-050]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie; European Community(European Commission); Agence National de la Recherche Programme Emergence(French National Research Agency (ANR))	The authors thank Sylvain Chemtob and Christiane Quiniou (Centre Hospitalier Universitaire Sainte Justine, Montreal, QC, Canada) for peptide design suggestions, and Yenkel Grinberg, Elodie Guyon, and Chahrazade El Amri for helpful discussions and technical assistance. This work was supported by grants from INSERM, the Universite Pierre et Marie Curie, the European Community's Seventh Framework Project FP7-Health-2009 ENDOSTEM 241440, and the Agence National de la Recherche Programme Emergence 2012 (ANR-EMMA-050).	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bayley JP, 2003, TISSUE ANTIGENS, V62, P170, DOI 10.1034/j.1399-0039.2003.00073.x; Blease K, 2000, J IMMUNOL, V165, P2603, DOI 10.4049/jimmunol.165.5.2603; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brini E, 2009, J NEUROIMMUNOL, V209, P33, DOI 10.1016/j.jneuroim.2009.01.022; Buntinx M, 2008, J PHARMACOL EXP THER, V327, P1, DOI 10.1124/jpet.108.140723; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Gavrilin MA, 2005, BIOCHEM BIOPH RES CO, V327, P533, DOI 10.1016/j.bbrc.2004.12.037; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goupil E, 2010, J BIOL CHEM, V285, P25624, DOI 10.1074/jbc.M110.115196; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Kenakin T, 2007, J RECEPT SIG TRANSD, V27, P247, DOI 10.1080/10799890701509000; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Khurana S, 2005, J VIROL, V79, P6791, DOI 10.1128/JVI.79.11.6791-6800.2005; Lacombe C, 2015, J MED CHEM, V58, P1089, DOI 10.1021/jm501018q; Loffet A, 2002, J PEPT SCI, V8, P1, DOI 10.1002/psc.366; McDonnell JM, 1996, NAT STRUCT BIOL, V3, P419, DOI 10.1038/nsb0596-419; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Monteclaro FS, 1997, J BIOL CHEM, V272, P23186, DOI 10.1074/jbc.272.37.23186; MYERS SJ, 1995, J BIOL CHEM, V270, P5786, DOI 10.1074/jbc.270.11.5786; Peri KG, 2002, SEMIN PERINATOL, V26, P389, DOI 10.1053/sper.2002.37307; Quiniou C, 2008, J IMMUNOL, V180, P6977, DOI 10.4049/jimmunol.180.10.6977; Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126; Rihakova L, 2009, AM J PHYSIOL-REG I, V297, pR1009, DOI 10.1152/ajpregu.90766.2008; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Waubant E, 2007, REV NEUROL-FRANCE, V163, P688, DOI 10.1016/S0035-3787(07)90481-6; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	52	20	20	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2370	2381		10.1096/fj.201500116	http://dx.doi.org/10.1096/fj.201500116			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26979087				2022-12-26	WOS:000376878300026
J	Katoh, Y; Terada, M; Nishijima, Y; Takei, R; Nozaki, S; Hamada, H; Nakayama, K				Katoh, Yohei; Terada, Masaya; Nishijima, Yuya; Takei, Ryota; Nozaki, Shohei; Hamada, Hiroshi; Nakayama, Kazuhisa			Overall Architecture of the Intraflagellar Transport (IFT)-B Complex Containing Cluap1/IFT38 as an Essential Component of the IFT-B Peripheral Subcomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cilia; intracellular trafficking; primary cilium; protein assembly; Cluap1; IFT-B complex; VIP assay	KINESIN-II; CILIOGENESIS; PROTEINS; CILIA; CHLAMYDOMONAS; CORE; FLAGELLA; LINKS; MAINTENANCE; PARTICLE	Intraflagellar transport (IFT) is essential for assembly and maintenance of cilia and flagella as well as ciliary motility and signaling. IFT is mediated by multisubunit complexes, including IFT-A, IFT-B, and the BBSome, in concert with kinesin and dynein motors. Under high salt conditions, purified IFT-B complex dissociates into a core subcomplex composed of at least nine subunits and at least five peripherally associated proteins. Using the visible immunoprecipitation assay, which we recently developed as a convenient protein-protein interaction assay, we determined the overall architecture of the IFT-B complex, which can be divided into core and peripheral subcomplexes composed of 10 and 6 subunits, respectively. In particular, we identified TTC26/IFT56 and Cluap1/IFT38, neither of which was included with certainty in previous models of the IFT-B complex, as integral components of the core and peripheral subcomplexes, respectively. Consistent with this, a ciliogenesis defect of Cluap1-deficient mouse embryonic fibroblasts was rescued by exogenous expression of wild-type Cluap1 but not by mutant Cluap1 lacking the binding ability to other IFT-B components. The detailed interaction map as well as comparison of subcellular localization of IFT-B components between wild-type and Cluap1-deficient cells provides insights into the functional relevance of the architecture of the IFT-B complex.	[Katoh, Yohei; Terada, Masaya; Nishijima, Yuya; Takei, Ryota; Nozaki, Shohei; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Hamada, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Hamada, Hiroshi] RIKEN, Ctr Dev Biol, Chuou Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Osaka University; RIKEN	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Hamada, Hiroshi/N-6374-2015; Nakayama, Kazuhisa/ABF-2924-2020; Katoh, Yohei/AAA-3378-2020	Hamada, Hiroshi/0000-0002-7196-5948; Katoh, Yohei/0000-0003-1649-4917; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science, and Technology, Japan [25113514, 15H01211]; Japan Society for Promotion of Science [22390013, 15H04370, 25860044, 15K07929]; Uehara Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15H04370, 16J03865, 15K14456] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas "Cilia and Centrosome" from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Grants 25113514 and 15H01211 to K. N.); Japan Society for Promotion of Science Grants 22390013 and 15H04370 (to K. N.) and 25860044 and 15K07929 (to Y. K.); and grants from the Uehara Memorial Foundation (to K. N.) and from the Takeda Science Foundation (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; Botilde Y, 2013, DEV BIOL, V381, P203, DOI 10.1016/j.ydbio.2013.05.024; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Ishikawa H, 2014, ELIFE, V3, DOI 10.7554/eLife.01566; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Katoh Y, 2015, J CELL SCI, V128, P2351, DOI 10.1242/jcs.168740; Lee CJ, 2014, INVEST OPHTH VIS SCI, V55, P4585, DOI 10.1167/iovs.14-14888; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Pasek Raymond C, 2012, Cilia, V1, P20, DOI 10.1186/2046-2530-1-20; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Richey EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043118; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schou KB, 2014, BIOINFORMATICS, V30, P899, DOI 10.1093/bioinformatics/btt661; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Swiderski RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004689; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Taschner M, 2011, J BIOL CHEM, V286, P26344, DOI 10.1074/jbc.M111.254920; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Yang N, 2015, DEVELOPMENT, V142, P2194, DOI 10.1242/dev.115261	39	75	79	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					10962	10975		10.1074/jbc.M116.713883	http://dx.doi.org/10.1074/jbc.M116.713883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26980730	Green Published, hybrid			2022-12-26	WOS:000377042100002
J	Mandal, S; Mahapa, A; Biswas, A; Jana, B; Polley, S; Sau, K; Sau, S				Mandal, Sukhendu; Mahapa, Avisek; Biswas, Anindya; Jana, Biswanath; Polley, Soumitra; Sau, Keya; Sau, Subrata			A Surfactant-Induced Functional Modulation of a Global Virulence Regulator from Staphylococcus aureus	PLOS ONE			English	Article							METHICILLIN-RESISTANT; TRITON X-100; CRYSTAL-STRUCTURE; GENE-REGULATION; IN-VITRO; SARA; PROTEIN; DETERMINANTS; OXACILLIN; BINDING	Triton X-100 (TX-100), a useful non-ionic surfactant, reduced the methicillin resistance in Staphylococcus aureus significantly. Many S. aureus proteins were expressed in the presence of TX-100. SarA, one of the TX-100-induced proteins, acts as a global virulence regulator in S. aureus. To understand the effects of TX-100 on the structure, and function of SarA, a recombinant S. aureus SarA (rSarA) and its derivative (C9W) have been investigated in the presence of varying concentrations of this surfactant using various probes. Our data have revealed that both rSarA and C9W bind to the cognate DNA with nearly similar affinity in the absence of TX-100. Interestingly, their DNA binding activities have been significantly increased in the presence of pre-micellar concentration of TX-100. The increase of TX-100 concentrations to micellar or post-micellar concentration did not greatly enhance their activities further. TX-100 molecules have altered the secondary and tertiary structures of both proteins to some extents. Size of the rSarA-TX-100 complex appears to be intermediate to those of rSarA and TX-100. Additional analyses show a relatively moderate interaction between C9W and TX-100. Binding of TX-100 to C9W has, however, occurred by a cooperative pathway particularly at micellar and higher concentrations of this surfactant. Taken together, TX-100-induced structural alteration of rSarA and C9W might be responsible for their increased DNA binding activity. As TX-100 has stabilized the somewhat weaker SarA-DNA complex effectively, it could be used to study its structure in the future.	[Mandal, Sukhendu; Biswas, Anindya; Jana, Biswanath; Polley, Soumitra; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, W Bengal, India; [Mahapa, Avisek; Sau, Keya] Haldia Inst Technol, Dept Biotechnol, Haldia, W Bengal, India	Department of Science & Technology (India); Bose Institute; Haldia Institute of Technology	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, W Bengal, India.; Sau, K (corresponding author), Haldia Inst Technol, Dept Biotechnol, Haldia, W Bengal, India.	keya_sau@yahoo.co.in; subratasau@yahoo.co.in	Mandal, Sukhendu/AAX-6423-2021; jana, biswanath/AAC-7540-2022	Mandal, Sukhendu/0000-0002-7752-0982; Polley, Soumitra/0000-0002-6337-7935; Biswas, Anindya/0000-0003-1645-2856; Jana, Biswanath/0000-0002-6464-7570	Council of Scientific and Industrial Research (India) [37 (1529)/12/EMR-II]; Board of Research in Nuclear Sciences / Department of Atomic Energy (India) [2013/37B/25/BRNS]	Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Board of Research in Nuclear Sciences / Department of Atomic Energy (India)(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	SM, AM and SP received Senior Research Fellowships from the Council of Scientific and Industrial Research (India). AB and BJ received Senior Research Fellowships from the Board of Research in Nuclear Sciences / Department of Atomic Energy (India). SS and KS received financial assistance for the work from the Board of Research in Nuclear Sciences / Department of Atomic Energy (India) (2013/37B/25/BRNS) and from the Council of Scientific and Industrial Research (India) [37 (1529)/12/EMR-II], respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya R, 2013, FUTURE MICROBIOL, V8, P1339, DOI 10.2217/fmb.13.92; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Ballal A, 2010, J BACTERIOL, V192, P336, DOI 10.1128/JB.01202-09; Ballal A, 2009, J BACTERIOL, V191, P3301, DOI 10.1128/JB.01496-08; Bandhu A, 2010, BIOCHEMISTRY-US, V49, P4235, DOI 10.1021/bi9020956; Biswas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095012; Biswas H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103579; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Ruiz CC, 2007, BIOMACROMOLECULES, V8, P2497, DOI 10.1021/bm0704121; Ruiz CC, 2011, J COLLOID INTERF SCI, V361, P178, DOI 10.1016/j.jcis.2011.05.019; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Cordwell SJ, 2002, MICROBIOL-SGM, V148, P2765, DOI 10.1099/00221287-148-9-2765; Creighton T.E., 1997, PROTEIN STRUCTURE PR; Cue D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00038; De S, 2005, J COLLOID INTERF SCI, V285, P562, DOI 10.1016/j.jcis.2004.12.022; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; DIMROTH P, 1990, J BIOL CHEM, V265, P7221; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fujimoto DF, 2009, MOL MICROBIOL, V74, P1445, DOI 10.1111/j.1365-2958.2009.06942.x; Fujimoto DF, 1998, J BACTERIOL, V180, P3724, DOI 10.1128/JB.180.14.3724-3726.1998; Ganguly T, 2009, FEBS J, V276, P1975, DOI 10.1111/j.1742-4658.2009.06924.x; Gooi HC, 2013, J MICROBIOL BIOTECHN, V23, P1554, DOI 10.4014/jmb.1306.06073; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Grover N, 2014, ENZYME MICROB TECH, V63, P1, DOI 10.1016/j.enzmictec.2014.04.018; HOLTJE JV, 1975, J BACTERIOL, V124, P1023, DOI 10.1128/JB.124.2.1023-1027.1975; Jana B, 2012, BIOCHEMISTRY-US, V51, P1223, DOI 10.1021/bi2015037; Juntachai W, 2011, MICROBIOL-SGM, V157, P3492, DOI 10.1099/mic.0.054528-0; Karbarz MJ, 2009, J BIOL CHEM, V284, P414, DOI 10.1074/jbc.M808390200; KOMATSUZAWA H, 1995, FEMS MICROBIOL LETT, V134, P209, DOI 10.1016/0378-1097(95)00406-X; KOMATSUZAWA H, 1994, J ANTIMICROB CHEMOTH, V34, P885, DOI 10.1093/jac/34.6.885; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li RG, 2003, J BACTERIOL, V185, P4219, DOI 10.1128/JB.185.14.4219-4225.2003; Linke D, 2009, METHOD ENZYMOL, V463, P603, DOI 10.1016/S0076-6879(09)63034-2; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu YF, 2006, P NATL ACAD SCI USA, V103, P2392, DOI 10.1073/pnas.0510439103; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; Mahapa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122168; Manna AC, 2007, MICROBIOL-SGM, V153, P1538, DOI 10.1099/mic.0.2006/004309-0; Morrison JM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00026; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; RAYCHAUDHURI D, 1985, J BACTERIOL, V164, P1337, DOI 10.1128/JB.164.3.1337-1349.1985; Rechtin TM, 1999, MOL MICROBIOL, V33, P307, DOI 10.1046/j.1365-2958.1999.01474.x; Sambrook J., 2001, MOL CLONING LAB MANU; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Singh SK, 2006, J PHYS CHEM B, V110, P9728, DOI 10.1021/jp0608426; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Suzuki J, 1997, FEMS MICROBIOL LETT, V153, P327, DOI 10.1016/S0378-1097(97)00269-3; Tatkiewicz W, 2015, METHODS MOL BIOL, V1258, P387, DOI 10.1007/978-1-4939-2205-5_22; Weng LY, 2012, GENE, V496, P79, DOI 10.1016/j.gene.2012.01.044; Zalucki YM, 2012, MBIO, V3, DOI 10.1128/mBio.00446-12; Zhu YW, 2014, ACTA CRYSTALLOGR D, V70, P2467, DOI 10.1107/S1399004714015326; Ziebandt AK, 2001, PROTEOMICS, V1, P480, DOI 10.1002/1615-9861(200104)1:4<480::AID-PROT480>3.0.CO;2-O	58	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151426	10.1371/journal.pone.0151426	http://dx.doi.org/10.1371/journal.pone.0151426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989900	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800062
J	Bulat, T; Smidak, R; Sialana, FJ; Jung, G; Rattei, T; Bilban, M; Sattmann, H; Lubec, G; Aradska, J				Bulat, Tanja; Smidak, Roman; Sialana, Fernando J.; Jung, Gangsoo; Rattei, Thomas; Bilban, Martin; Sattmann, Helmut; Lubec, Gert; Aradska, Jana			Transcriptomic and Proteomic Analysis of Arion vulgaris-Proteins for Probably Successful Survival Strategies?	PLOS ONE			English	Article							MASS-SPECTROMETRIC ANALYSIS; ACID-BINDING LECTIN; C1Q-DOMAIN-CONTAINING PROTEIN; MOQUIN-TANDON; LAND SLUG; ANNOTATION; CLONING; GENES; SNAIL; IDENTIFICATION	The Spanish slug, Arion vulgaris, is considered one of the hundred most invasive species in Central Europe. The immense and very successful adaptation and spreading of A. vulgaris suggest that it developed highly effective mechanisms to deal with infections and natural predators. Current transcriptomic and proteomic studies on gastropods have been restricted mainly to marine and freshwater gastropods. No transcriptomic or proteomic study on A. vulgaris has been carried out so far, and in the current study, the first transcriptomic database from adult specimen of A. vulgaris is reported. To facilitate and enable proteomics in this non-model organism, a mRNA-derived protein database was constructed for protein identification. A gel-based proteomic approach was used to obtain the first generation of a comprehensive slug mantle proteome. A total of 2128 proteins were unambiguously identified; 48 proteins represent novel proteins with no significant homology in NCBI non-redundant database. Combined transcriptomic and proteomic analysis revealed an extensive repertoire of novel proteins with a role in innate immunity including many associated pattern recognition, effector proteins and cytokine-like proteins. The number and diversity in gene families encoding lectins point to a complex defense system, probably as a result of adaptation to a pathogen-rich environment. These results are providing a fundamental and important resource for subsequent studies on molluscs as well as for putative antimicrobial compounds for drug discovery and biomedical applications.	[Bulat, Tanja; Smidak, Roman; Sialana, Fernando J.; Jung, Gangsoo; Aradska, Jana] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Rattei, Thomas] Univ Vienna, Dept Microbiol & Ecosyst Sci, Div Computat Syst Biol, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Dept Lab Med & Core Facil Genom, Vienna, Austria; [Sattmann, Helmut] Museum Nat Hist Vienna, Zool Dept 3, Vienna, Austria; [Lubec, Gert] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria	Medical University of Vienna; University of Vienna; Medical University of Vienna; University of Vienna	Aradska, J (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.; Lubec, G (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria.	gert.lubec@univie.ac.at; jana.aradska@gmail.com	Rattei, Thomas/F-1366-2011; Sialana, Fernando J./J-1303-2018	Rattei, Thomas/0000-0002-0592-7791; Sialana, Fernando J./0000-0001-9083-1657; Bilban, Martin/0000-0001-7043-7142; Lubec, Jana/0000-0003-0657-7647; Bennett, Keiryn L./0000-0001-9356-7708; Bulat, Tanja/0000-0001-7427-5611; Lubec, Gert/0000-0002-6333-9461				Ahmed KEAM, 2010, AMINO ACIDS, V38, P1043, DOI 10.1007/s00726-009-0312-1; Allam B, 2014, FISH SHELLFISH IMMUN, V41, P2, DOI 10.1016/j.fsi.2014.05.022; Amin Shorash, 2014, BMC Research Notes, V7, P488, DOI 10.1186/1756-0500-7-488; Bae N, 2012, ELECTROPHORESIS, V33, P1787, DOI 10.1002/elps.201100569; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Chen WQ, 2014, AMINO ACIDS, V46, P995, DOI 10.1007/s00726-013-1657-z; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Gerlach D, 2004, FEMS IMMUNOL MED MIC, V40, P215, DOI 10.1016/S0928-8244(03)00367-5; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Gismervik K, 2015, J APPL MICROBIOL, V118, P809, DOI 10.1111/jam.12750; Gismervik K, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0065-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hatteland Bjorn A., 2013, Fauna Norvegica, V32, P13, DOI 10.5324/fn.v31i0.1473; He XC, 2011, FISH SHELLFISH IMMUN, V31, P1247, DOI 10.1016/j.fsi.2011.08.021; Huang Y, 2014, DEV COMP IMMUNOL, V46, P255, DOI 10.1016/j.dci.2014.04.015; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kang SU, 2011, PROTEOMICS, V11, P2171, DOI 10.1002/pmic.201000374; Kong PF, 2010, DEV COMP IMMUNOL, V34, P837, DOI 10.1016/j.dci.2010.03.006; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kozlowski Jan, 2007, Journal of Plant Protection Research, V47, P219; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Patel Z, 2014, PARASITOL RES, V113, P4363, DOI 10.1007/s00436-014-4111-6; Pfenninger M, 2014, EVOL APPL, V7, P702, DOI 10.1111/eva.12177; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Schroeder FC, 1999, P NATL ACAD SCI USA, V96, P13620, DOI 10.1073/pnas.96.24.13620; Dreon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063782; Stalder GL, 2014, SCI TOTAL ENVIRON, V479, P11, DOI 10.1016/j.scitotenv.2014.01.103; Sun J, 2012, MOL ECOL RESOUR, V12, P1133, DOI 10.1111/1755-0998.12014; Sun J, 2012, J PROTEOME RES, V11, P4240, DOI 10.1021/pr3003613; Tahtouh M, 2009, MOL IMMUNOL, V46, P523, DOI 10.1016/j.molimm.2008.07.026; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Xu T, 2012, FISH SHELLFISH IMMUN, V32, P1106, DOI 10.1016/j.fsi.2012.03.012; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024; Yuasa HJ, 1998, COMP BIOCHEM PHYS B, V119, P479, DOI 10.1016/S0305-0491(98)00008-X; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003; Zhang Q, 2014, DEV COMP IMMUNOL, V46, P356, DOI 10.1016/j.dci.2014.05.009	45	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150614	10.1371/journal.pone.0150614	http://dx.doi.org/10.1371/journal.pone.0150614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986963	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300023
J	Gonzalez, E; Diez, JJ; Bajo, MA; del Peso, G; Grande, C; Rodriguez, O; Diaz-Almiron, M; Iglesias, P; Selgas, R				Gonzalez, Elena; Diez, Juan J.; Auxiliadora Bajo, M.; del Peso, Gloria; Grande, Cristina; Rodriguez, Olaia; Diaz-Almiron, Mariana; Iglesias, Pedro; Selgas, Rafael			Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; RENAL-FUNCTION; GLUCOSE; DYSFUNCTION	Background Human fibroblast growth factor 21 (FGF-21) is an endocrine liver hormone that stimulates adipocyte glucose uptake independently of insulin, suppresses hepatic glucose production and is involved in the regulation of body fat. Peritoneal dialysis (PD) patients suffer potential interference with FGF-21 status with as yet unknown repercussions. Objectives The aim of this study was to define the natural history of FGF-21 in PD patients, to analyze its relationship with glucose homeostasis parameters and to study the influence of residual renal function and peritoneal functional parameters on FGF-21 levels and their variation over time. Methods We studied 48 patients with uremia undergoing PD. Plasma samples were routinely obtained from each patient at baseline and at 1, 2 and 3 years after starting PD therapy. Results Plasma FGF-21 levels substantially increased over the first year and were maintained at high levels during the remainder of the study period (253 pg/ml (59; 685) at baseline; 582 pg/ml (60.5-949) at first year and 647 pg/ml (120.5-1116.6) at third year) (p<0.01). We found a positive correlation between time on dialysis and FGF-21 levels (p<0.001), and also, those patients with residual renal function (RRF) had significantly lower levels of FGF-21 than those without RRF (rho-0.484, p<0.05). Lastly, there was also a significant association between FGF-21 levels and peritoneal protein losses (PPL), independent of the time on dialysis (rho 0.410, p<0.05). Conclusion Our study shows that FGF-21 plasma levels in incident PD patients significantly increase during the first 3 years. This increment is dependent on or is associated with RRF and PPL (higher levels in patients with lower RRF and higher PPL). FGF-21 might be an important endocrine agent in PD patients and could act as hormonal signaling to maintain glucose homeostasis and prevent potential insulin resistance. These preliminary results suggest that FGF-21 might play a protective role as against the development of insulin resistance over time in patients undergoing a continuous glucose load.	[Gonzalez, Elena; Auxiliadora Bajo, M.; del Peso, Gloria; Selgas, Rafael] La Paz Univ Hosp, REDinREN, FRIAT IRSIN, Dept Nephrol,IdiPAZ, Madrid, Spain; [Diez, Juan J.; Grande, Cristina; Iglesias, Pedro] Univ Hosp Ramon Y Cajal, Dept Endocrinol, Madrid, Spain; [Rodriguez, Olaia] La Paz Univ Hosp, REDinREN, FRIAT IRSIN, Dept Biochem,IdiPAZ, Madrid, Spain; [Diaz-Almiron, Mariana] La Paz Univ Hosp, REDinREN, FRIAT IRSIN, Biostat Sect,IdiPAZ, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Hospital Universitario La Paz	Iglesias, P (corresponding author), Univ Hosp Ramon Y Cajal, Dept Endocrinol, Madrid, Spain.	piglo65@gmail.com	Iglesias, Pedro/AAC-1016-2020; González, Elena/A-2635-2017; Diez, Juan J./W-1803-2017; Bajo, Maria A/ABF-6991-2020; Iglesias, P/AAU-1011-2020	Iglesias, Pedro/0000-0003-0126-1985; González, Elena/0000-0003-2003-4737; Diez, Juan J./0000-0002-2017-0694; Bajo, Maria A/0000-0001-7364-557X; Iglesias, P/0000-0003-0126-1985	Rio Hortega Grant Program from the ISCIII; Extramural Grant Program from Baxter; Health Research Fund [FIS-12/00241]; REDinREN program from the ISCIII-FEDER Funds, IRSIN-FRIAT	Rio Hortega Grant Program from the ISCIII; Extramural Grant Program from Baxter; Health Research Fund(Instituto de Salud Carlos III); REDinREN program from the ISCIII-FEDER Funds, IRSIN-FRIAT	This study was partially funded with the Rio Hortega Grant Program from the ISCIII, the Extramural Grant Program from Baxter, Health Research Fund FIS-12/00241 and the REDinREN program from the ISCIII-FEDER Funds, IRSIN-FRIAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crasto C, 2012, J AM GERIATR SOC, V60, P792, DOI 10.1111/j.1532-5415.2011.03879.x; Cuevas-Ramos D, 2012, CURR OPIN PEDIATR, V24, P523, DOI 10.1097/MOP.0b013e3283557d22; Han SH, 2012, PERITON DIALYSIS INT, V32, P149, DOI 10.3747/pdi.2010.00111; Han SH, 2010, METABOLISM, V59, P1656, DOI 10.1016/j.metabol.2010.03.018; Hindricks J, 2014, CLIN ENDOCRINOL, V80, P918, DOI 10.1111/cen.12380; Holmes CJ, 2000, PERITON DIALYSIS INT, V20, pS37; Iglesias P, 2012, EUR J ENDOCRINOL, V167, P301, DOI 10.1530/EJE-12-0357; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kralisch S, 2011, CURR OPIN CLIN NUTR, V14, P354, DOI 10.1097/MCO.0b013e328346a326; Krediet RT, 2013, CLIN KIDNEY J, V6, P568, DOI 10.1093/ckj/sft122; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ohta Hiroya, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P302; Olauson H, 2013, CURR OPIN NEPHROL HY, V22, P397, DOI 10.1097/MNH.0b013e32836213ee; Sanchez-Villanueva R, 2013, NEFROLOGIA, V33, P85, DOI 10.3265/Nefrologia.pre2012.Nov.11430; SELGAS R, 1994, AM J KIDNEY DIS, V23, P64, DOI 10.1016/S0272-6386(12)80814-6; Selgas R, PERIT DIAL INT, V25, P68; Semba RD, 2012, J CLIN ENDOCR METAB, V97, P1375, DOI 10.1210/jc.2011-2823; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; Ulu SM, 2014, INT UROL NEPHROL, V46, P2409, DOI 10.1007/s11255-014-0753-7; Wu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030337	21	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151698	10.1371/journal.pone.0151698	http://dx.doi.org/10.1371/journal.pone.0151698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986485	Green Submitted, gold, Green Published			2022-12-26	WOS:000372580300115
J	Jaiteh, M; Taly, A; Henin, J				Jaiteh, Mariama; Taly, Antoine; Henin, Jerome			Evolution of Pentameric Ligand-Gated Ion Channels: Pro-Loop Receptors	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; X-RAY-STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTOR; GLYCINE RECEPTOR; CROSS-LINKING; GENOME; BINDING; DYNAMICS; GABA(A); SUBUNIT	Pentameric ligand-gated ion channels (pLGICs) are ubiquitous neurotransmitter receptors in Bilateria, with a small number of known prokaryotic homologues. Here we describe a new inventory and phylogenetic analysis of pLGIC genes across all kingdoms of life. Our main finding is a set of pLGIC genes in unicellular eukaryotes, some of which are metazoan-like Cys-loop receptors, and others devoid of Cys-loop cysteines, like their prokaryotic relatives. A number of such "Cys-less" receptors also appears in invertebrate metazoans. Together, those findings draw a new distribution of pLGICs in eukaryotes. A broader distribution of prokaryotic channels also emerges, including a major new archaeal taxon, Thaumarchaeota. More generally, pLGICs now appear nearly ubiquitous in major taxonomic groups except multicellular plants and fungi. However, pLGICs are sparsely present in unicellular taxa, suggesting a high rate of gene loss and a non-essential character, contrasting with their essential role as synaptic receptors of the bilaterian nervous system. Multiple alignments of these highly divergent sequences reveal a small number of conserved residues clustered at the interface between the extracellular and transmembrane domains. Only the "Cys-loop" proline is absolutely conserved, suggesting the more fitting name "Pro loop" for that motif, and "Pro-loop receptors" for the superfamily. The infered molecular phylogeny shows a Cys-loop and a Cys-less clade in eukaryotes, both containing metazoans and unicellular members. This suggests new hypotheses on the evolutionary history of the superfamily, such as a possible origin of the Cys-loop cysteines in an ancient unicellular eukaryote. Deeper phylogenetic relationships remain uncertain, particularly around the split between bacteria, archaea, and eukaryotes.	[Henin, Jerome] CNRS, Lab Biochim Theor, Inst Biol Physicochim, Paris, France; Univ Paris Diderot, Paris, France; [Jaiteh, Mariama] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Uppsala, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Swedish University of Agricultural Sciences	Henin, J (corresponding author), CNRS, Lab Biochim Theor, Inst Biol Physicochim, Paris, France.	henin@ibpc.fr	Hénin, Jérôme/AAX-5604-2020; Taly, Antoine/B-3339-2008; Hénin, Jérôme/A-7080-2008	Taly, Antoine/0000-0001-5109-0091; Hénin, Jérôme/0000-0003-2540-4098; Jaiteh, Mariama/0000-0002-9229-5314	Agence Nationale de la Recherche grant PentaGate; French Agence Nationale de la Recherche (Project PentaGate)	Agence Nationale de la Recherche grant PentaGate(French National Research Agency (ANR)); French Agence Nationale de la Recherche (Project PentaGate)(French National Research Agency (ANR))	Agence Nationale de la Recherche grant PentaGate (http://www.agence-nationale-recherche.fr/?Projet=ANR-13-BSV8-0020) benefitted all three authors by funding missions for AT and JH and a stipend for MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Drs. Alessandra Carbone (Universite Pierre et Marie Curie), Celine Brochier-Armanet (Universite Claude Bernard), Grace Brannigan (Rutgers University), and Pierre-Jean Corringer and Francis Biville (Institut Pasteur) for fruitful discussions. This work was supported by a grant from the French Agence Nationale de la Recherche (Project PentaGate).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Avila-Poveda OH, 2014, TISSUE CELL, V46, P379, DOI 10.1016/j.tice.2014.07.001; Bailly X, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00498; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Baussand J, 2008, EVOL BIOINFORM, V4, P255; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Cadugan DJ, 2007, BIOPHYS J, V93, P859, DOI 10.1529/biophysj.107.105171; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; COCKCROFT VB, 1990, MOL NEUROBIOL, V4, P129, DOI 10.1007/BF02780338; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Dent JA, 2010, ADV EXP MED BIOL, V683, P11; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Dufour V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003586; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Fairclough SR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r15; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kehoe J, 2009, J MOL EVOL, V69, P125, DOI 10.1007/s00239-009-9256-z; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liebeskind BJ, 2015, P NATL ACAD SCI USA, V112, pE846, DOI 10.1073/pnas.1501195112; Lobo IA, 2004, J NEUROCHEM, V90, P962, DOI 10.1111/j.1471-4159.2004.02561.x; Lynagh T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08558; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mnatsakanyan N, 2015, BIOCHEMISTRY-US, V54, P2670, DOI 10.1021/acs.biochem.5b00203; Mnatsakanyan N, 2013, J NEUROCHEM, V125, P843, DOI 10.1111/jnc.12260; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Purohit P, 2015, J PHYSIOL-LONDON, V593, P2851, DOI 10.1113/JP270223; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rendon G, 2011, CHANNELS, V5, P325, DOI 10.4161/chan.5.4.16822; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Scott S, 2015, J BIOL CHEM, V290, P5621, DOI 10.1074/jbc.M114.616573; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Tan G, 2015, SYST BIOL, V64, P778, DOI 10.1093/sysbio/syv033; Tasneem A, 2005, GENOME BIOL, V6; Tillman T, 2013, BIOCHEM J, V449, P61, DOI 10.1042/BJ20121072; Vernot B, 2007, Comput Syst Bioinformatics Conf, V6, P441, DOI 10.1142/9781860948732_0044; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yates DM, 2004, EXP PARASITOL, V108, P182, DOI 10.1016/j.exppara.2004.08.003; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	82	53	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151934	10.1371/journal.pone.0151934	http://dx.doi.org/10.1371/journal.pone.0151934			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986966	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300155
J	Jones, LD; Jackson, JW; Maggirwar, SB				Jones, Letitia D.; Jackson, Joseph W.; Maggirwar, Sanjay B.			Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CENTRAL-NERVOUS-SYSTEM; POTENT ANTIRETROVIRAL THERAPY; BOWEL-DISEASE PATIENTS; SOLUBLE CD40 LIGAND; ENDOTHELIAL-CELLS; NEUROCOGNITIVE DISORDERS; SODIUM FLUORESCEIN; THROMBOCYTOPENIC PURPURA; CLAUDIN-5 EXPRESSION	The number of HIV-1 positive individuals developing some form of HIV-associated neurocognitive disorder (HAND) is increasing. In these individuals, the integrity of the blood-brain barrier (BBB) is compromised due to an increase in exposure to pro-inflammatory mediators, viral proteins, and virus released from infected cells. It has been shown that soluble CD40L (sCD40L) is released upon platelet activation and is an important mediator of the pathogenesis of HAND but the underlying mechanisms are unclear, emphasizing the need of an effective animal model. Here, we have utilized a novel animal model in which wild-type (WT) mice were infected with EcoHIV; a derivative of HIV-1 that contains a substitution of envelope protein gp120 with that of gp80 derived from murine leukemia virus-1 (MuLV-1). As early as two-weeks post-infection, EcoHIV led to increased permeability of the BBB associated with decreased expression of tight junction protein claudin-5, in CD40L and platelet activation-dependent manner. Treatment with an antiplatelet drug, eptifibatide, in EcoHIV-infected mice normalized BBB function, sCD40L release and platelet activity, thus implicating platelet activation and platelet-derived CD40L in virally induced BBB dysfunction. Our results also validate and underscore the importance of EcoHIV infection mouse model as a tool to explore therapeutic targets for HAND.	[Jones, Letitia D.; Jackson, Joseph W.; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Maggirwar, SB (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Sanjay_Maggirwar@urmc.rochester.edu		Jackson, Joseph/0000-0002-3826-2749; Jones, Letitia/0000-0002-1889-5629	National Institutes of Health, USA [4F31NS086256-03, R01 NS054578, R01 HL128155, R01 NS066801, T32 AI049815]; University of Rochester Center for AIDS (CFAR) research grant [P30 AI078498]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815, P30AI078498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS086256, R01NS066801, R01NS054578] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for AIDS (CFAR) research grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health, USA (4F31NS086256-03 to LDJ; R01 NS054578, R01 HL128155 and R01 NS066801 to SBM; T32 AI049815 to JWJ). It was also supported in part by the University of Rochester Center for AIDS (CFAR) research grant (P30 AI078498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afessa B, 1998, CHEST, V113, P1225, DOI 10.1378/chest.113.5.1225; Ahmad R, 2006, AIDS, V20, P1907, DOI 10.1097/01.aids.0000244217.46445.45; Alcantara S, 2009, JAIDS-J ACQ IMM DEF, V51, P374, DOI 10.1097/QAI.0b013e3181a9cbcf; Amasheh S, 2009, ANN NY ACAD SCI, V1165, P211, DOI 10.1111/j.1749-6632.2009.04439.x; Andras IE, 2011, METHODS MOL BIOL, V762, P355, DOI 10.1007/978-1-61779-185-7_26; Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Avraham HK, 2004, J IMMUNOL, V173, P6228, DOI 10.4049/jimmunol.173.10.6228; BETTAIEB A, 1992, BLOOD, V80, P162; BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Chandler AB, 2010, THROMB RES, V125, P44, DOI 10.1016/j.thromres.2009.04.017; Chen CQ, 2015, CURR DRUG TARGETS, V16, P219, DOI 10.2174/1389450116666150113122229; Chen JF, 2012, HEMATOLOGY, V17, P283, DOI 10.1179/1607845412Y.0000000014; Cioni C, 2002, NEUROSCI LETT, V330, P299, DOI 10.1016/S0304-3940(02)00814-5; Corrales-Medina VF, 2010, JAIDS-J ACQ IMM DEF, V54, P217, DOI 10.1097/QAI.0b013e3181c8f4c9; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Danese S, 2003, GUT, V52, P1435, DOI 10.1136/gut.52.10.1435; Danese S, 2003, GASTROENTEROLOGY, V124, P1249, DOI 10.1016/S0016-5085(03)00289-0; Dang Q, 2012, J VIROL, V86, P13795, DOI 10.1128/JVI.02174-12; Dash PK, 2011, J NEUROSCI, V31, P3148, DOI 10.1523/JNEUROSCI.5473-10.2011; Davidson DC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-144; Davidson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051793; Denton PW, 2011, AIDS REV, V13, P135; DIEHL LJ, 1995, J VIROL, V69, P2328, DOI 10.1128/JVI.69.4.2328-2332.1995; Dominguez V, 1998, J ACQ IMMUN DEF SYND, V17, P385, DOI 10.1097/00042560-199804150-00001; Dow SW, 1999, J VIROL, V73, P6852, DOI 10.1128/JVI.73.8.6852-6861.1999; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Elzey BD, 2005, CELL IMMUNOL, V238, P1, DOI 10.1016/j.cellimm.2005.12.005; Elzey BD, 2005, J LEUKOCYTE BIOL, V78, P80, DOI 10.1189/jlb.1104669; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Flaujac C, 2010, CELL MOL LIFE SCI, V67, P545, DOI 10.1007/s00018-009-0209-x; Fletcher NF, 2011, VET J, V188, P260, DOI 10.1016/j.tvjl.2010.03.022; Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb; Gibellini D, 2007, J CELL PHYSIOL, V210, P315, DOI 10.1002/jcp.20815; Gorantla S, 2010, AM J PATHOL, V177, P2938, DOI 10.2353/ajpath.2010.100536; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Hadas E, 2013, DIS MODEL MECH, V6, P1292, DOI 10.1242/dmm.012617; He XL, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0247-2; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hill M, 2005, CURR HIV RES, V3, P73, DOI 10.2174/1570162052772942; HOFFMAN HJ, 1961, NEUROLOGY, V11, P1081, DOI 10.1212/WNL.11.12.1081; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178; Idzko M, 2015, J ALLERGY CLIN IMMUN, V135, P1416, DOI 10.1016/j.jaci.2015.04.028; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Inwald DP, 2003, CIRC RES, V92, P1041, DOI 10.1161/01.RES.0000070111.98158.6C; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jantzie LL, 2006, NEUROCHEM INT, V49, P717, DOI 10.1016/j.neuint.2006.06.010; Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003459; Ju SM, 2009, EXP MOL MED, V41, P86, DOI 10.3858/emm.2009.41.2.011; Kanmogne GD, 2002, J NEUROPATH EXP NEUR, V61, P992, DOI 10.1093/jnen/61.11.992; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Kelschenbach JL, 2012, J NEUROIMMUNE PHARM, V7, P380, DOI 10.1007/s11481-011-9316-1; Kiebala M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130061; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; KORNGOLD R, 1978, J EXP MED, V148, P1687; Langer HF, 2013, THROMB HAEMOSTASIS, V110, P888, DOI 10.1160/TH13-02-0096; Letendre Scott, 2011, Top Antivir Med, V19, P137; Li H, 2014, AM J RESP CRIT CARE, V190, P85, DOI 10.1164/rccm.201106-1151OC; Luabeya MK, 2000, NEUROPATH APPL NEURO, V26, P454, DOI 10.1046/j.1365-2990.2000.00275.x; Maclean AG, 2005, J MED PRIMATOL, V34, P237, DOI 10.1111/j.1600-0684.2005.00121.x; MALMGREN LT, 1980, J COMP NEUROL, V191, P103, DOI 10.1002/cne.901910106; Marks KM, 2009, JAIDS-J ACQ IMM DEF, V52, P595, DOI 10.1097/QAI.0b013e3181b79aff; Matter K, 2003, J CELL BIOL, V161, P459, DOI 10.1083/jcb.200304039; Mercier E, 2013, BMJ-BRIT MED J, P346; Milush JM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00236; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; Mourao MPG, 2007, PLATELETS, V18, P605, DOI 10.1080/09537100701426604; Muller KAL, 2015, THROMB HAEMOSTASIS, V114, P498, DOI 10.1160/TH14-11-0947; Muscarella LA, 2014, J NEUROPATH EXP NEUR, V73, P50, DOI [10.1097/NEN.0000000000000026, 10.1097/NEN.0000000000000024]; Nair Madhavan, 2015, J Alcohol Drug Depend, V3, P182; Pate KAM, 2013, J INFECT DIS, V208, P874, DOI 10.1093/infdis/jit278; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Ramirez SH, 2010, J NEUROSCI, V30, P9454, DOI 10.1523/JNEUROSCI.5796-09.2010; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Rausch DM, 1999, J LEUKOCYTE BIOL, V65, P466, DOI 10.1002/jlb.65.4.466; Ryan G, 2003, J VIROL, V77, P7477, DOI 10.1128/JVI.77.13.7477-7485.2003; Saini M, 2007, VACCINE, V25, P8660, DOI 10.1016/j.vaccine.2007.10.019; Satchell CS, 2010, AIDS, V24, P649, DOI 10.1097/QAD.0b013e328336098c; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schwartzkopff F, 2009, INNATE IMMUN-LONDON, V15, P368, DOI 10.1177/1753425909106171; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sindberg GM, 2015, J NEUROIMMUNE PHARM, V10, P74, DOI 10.1007/s11481-014-9574-9; Singh MV, 2012, J VIROL METHODS, V181, P170, DOI 10.1016/j.jviromet.2012.02.005; Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009; Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Tcheng JE, 2001, AM J CARDIOL, V88, P1097, DOI 10.1016/S0002-9149(01)02041-0; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; UNAIDS, 2012, GLOBAL REPORT UNAIDS; van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400; Vigorito M, 2015, BRAIN BEHAV IMMUN, V48, P336, DOI 10.1016/j.bbi.2015.02.020; Le VB, 2015, AM J RESP CRIT CARE, V191, P804, DOI 10.1164/rccm.201406-1031OC; Wang HW, 2008, J VIROL, V82, P7591, DOI 10.1128/JVI.00768-08; Wang J, 2011, J THROMB HAEMOST, V9, P562, DOI 10.1111/j.1538-7836.2010.04168.x; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Westmoreland SV, 1998, J NEUROVIROL, V4, P260, DOI 10.3109/13550289809114527; Wiley CA, 1999, AIDS, V13, P2055, DOI 10.1097/00002030-199910220-00007; Williams DW, 2014, CURR HIV RES, V12, P85, DOI 10.2174/1570162X12666140526114526; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Williams R, 2008, J NEUROVIROL, V14, P292, DOI 10.1080/13550280802074539; Wiwanitkit V, 2008, BLOOD COAGUL FIBRIN, V19, P739, DOI 10.1097/MBC.0b013e32830b14cb; World Health Organization, 2014, GLOB SUMM HIV AIDS E; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003	116	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151702	10.1371/journal.pone.0151702	http://dx.doi.org/10.1371/journal.pone.0151702			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986758	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300117
J	Kobayashi, T; Nishijima, T; Teruya, K; Aoki, T; Kikuchi, Y; Oka, S; Gatanaga, H				Kobayashi, Tetsuro; Nishijima, Takeshi; Teruya, Katsuji; Aoki, Takahiro; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy Era	PLOS ONE			English	Article							AVIUM COMPLEX INFECTION; DISEASE; SURVIVAL; COHORT; AIDS	Background Little information is available on the mortality and risk factors associated with death in disseminated non-tuberculous mycobacterial infection (dNTM) in HIV-infected patients in the ART-era. Methods In a single-center study, HIV-infected dNTM with positive NTM culture from sterile sites between 2000 and 2013 were analysed. The clinical characteristics at commencement of anti-mycobacterial treatment (baseline) were compared between those who survived and died. Results Twenty-four patients were analyzed. [The median CD4 27/mu L (range 2-185)]. Mycobacterium avium and M. intracellulare accounted for 20 (83%) and 3 (13%) of isolated NTM. NTM bacteremia was diagnosed in 15 (63%) patients. Seven (29%) patients died, and NTM bacteremia was significantly associated with mortality (p = 0.022). The baseline CD4 count was significantly lower in the non-survivors than the survivors (median 7/mu L versus 49, p = 0.034). Concomitant AIDS-defining diseases or malignancies were not associated with mortality. Immune-reconstitution syndrome (IRS) occurred to 19 (79%) patients (8 paradoxical and 11 unmasking), and prognosis tended to be better in unmasking-IRS than the other patients (n = 13) (p = 0.078). Patients with paradoxical-IRS had marginally lower CD4 count and higher frequency of bacteremia than those with unmasking-IRS (p = 0.051, and 0.059). Treatment with systemic corticosteroids was applied in 63% and 55% of patients with paradoxical and unmasking-IRS, respectively. Conclusion dNTM in HIV-infected patients resulted in high mortality even in the ART-era. NTM bacteremia and low CD4 count were risk factors for death, whereas patients presented with unmasking-IRS had marginally better prognosis. IRS occurred in 79% of the patients, suggesting difficulty in the management of dNTM.	[Kobayashi, Tetsuro; Nishijima, Takeshi; Teruya, Katsuji; Aoki, Takahiro; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Nishijima, T (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	tnishiji@acc.ncgm.go.jp	Kobayashi, Tetsuro/GZG-7054-2022		Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001, H24-AIDS-003]	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant-in Aids for AIDS Research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001; H24-AIDS-003). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; Chou CH, 2011, SCAND J INFECT DIS, V43, P8, DOI 10.3109/00365548.2010.519345; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; HORSBURGH CR, 1991, AM REV RESPIR DIS, V144, P557, DOI 10.1164/ajrccm/144.3_Pt_1.557; HORSBURGH CR, 1994, J INFECT DIS, V170, P573, DOI 10.1093/infdis/170.3.573; Karakousis PC, 2004, LANCET INFECT DIS, V4, P557, DOI 10.1016/S1473-3099(04)01130-2; Laupland KB, 2009, CRIT CARE MED, V37, pS273, DOI 10.1097/CCM.0b013e3181aa6117; LEWIS AG, 1960, ANN INTERN MED, V53, P273, DOI 10.7326/0003-4819-53-2-273; Miguez-Burbano MJ, 2006, INT J INFECT DIS, V10, P47, DOI 10.1016/j.ijid.2004.11.005; Moore RD, 1996, ANN INTERN MED, V124, P633, DOI 10.7326/0003-4819-124-7-199604010-00003; NIGHTINGALE SD, 1992, J INFECT DIS, V165, P1082, DOI 10.1093/infdis/165.6.1082; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Phillips P, 2005, CLIN INFECT DIS, V41, P1483, DOI 10.1086/497269; Ristola MA, 1999, J INFECTION, V39, P61, DOI 10.1016/S0163-4453(99)90104-4; Rossi M, 2001, SWISS MED WKLY, V131, P471; SHAPIRO AL, 1991, OTOLARYNG HEAD NECK, V105, P419, DOI 10.1177/019459989110500312; SLAP GB, 1984, JAMA-J AM MED ASSOC, V252, P1321, DOI 10.1001/jama.252.10.1321; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143	19	21	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151682	10.1371/journal.pone.0151682	http://dx.doi.org/10.1371/journal.pone.0151682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985832	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300111
J	Kole, C; Berdugo, N; Da Silva, C; Ait-Ali, N; Millet-Puel, G; Pagan, D; Blond, F; Poidevin, L; Ripp, R; Fontaine, V; Wincker, P; Zack, DJ; Sahel, JA; Poch, O; Leveillard, T				Kole, Christo; Berdugo, Naomi; Da Silva, Corinne; Ait-Ali, Najate; Millet-Puel, Geraldine; Pagan, Delphine; Blond, Frederic; Poidevin, Laetitia; Ripp, Raymond; Fontaine, Valerie; Wincker, Patrick; Zack, Donald J.; Sahel, Jose-Alain; Poch, Olivier; Leveillard, Thierry			Identification of an Alternative Splicing Product of the Otx2 Gene Expressed in the Neural Retina and Retinal Pigmented Epithelial Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MESSENGER-RNA; PHOTORECEPTOR DEVELOPMENT; MESENCHYMAL TRANSITION; TYROSINASE GENE; CONE SURVIVAL; SEQUENCE; CONSTRUCTION; DEGENERATION; MUTATIONS	To investigate the complexity of alternative splicing in the retina, we sequenced and analyzed a total of 115,706 clones from normalized cDNA libraries from mouse neural retina (66,217) and rat retinal pigmented epithelium (49,489). Based upon clustering the cDNAs and mapping them with their respective genomes, the estimated numbers of genes were 9,134 for the mouse neural retina and 12,050 for the rat retinal pigmented epithelium libraries. This unique collection of retinal of messenger RNAs is maintained and accessible through a web-base server to the whole community of retinal biologists for further functional characterization. The analysis revealed 3,248 and 3,202 alternative splice events for mouse neural retina and rat retinal pigmented epithelium, respectively. We focused on transcription factors involved in vision. Among the six candidates suitable for functional analysis, we selected Otx2S, a novel variant of the Otx2 gene with a deletion within the homeodomain sequence. Otx2S is expressed in both the neural retina and retinal pigmented epithelium, and encodes a protein that is targeted to the nucleus. OTX2S exerts transdominant activity on the tyrosinase promoter when tested in the physiological environment of primary RPE cells. By overexpressing OTX2S in primary RPE cells using an adeno associated viral vector, we identified 10 genes whose expression is positively regulated by OTX2S. We find that OTX2S is able to bind to the chromatin at the promoter of the retinal dehydrogenase 10 (RDH10) gene.	[Kole, Christo; Berdugo, Naomi; Ait-Ali, Najate; Millet-Puel, Geraldine; Pagan, Delphine; Blond, Frederic; Fontaine, Valerie; Sahel, Jose-Alain; Leveillard, Thierry] INSERM, U968, F-75012 Paris, France; [Kole, Christo; Berdugo, Naomi; Ait-Ali, Najate; Millet-Puel, Geraldine; Pagan, Delphine; Blond, Frederic; Fontaine, Valerie; Sahel, Jose-Alain; Leveillard, Thierry] Univ Paris 06, Sorbonne Univ, Inst Vis, UMR S 968, F-75012 Paris, France; [Kole, Christo; Berdugo, Naomi; Ait-Ali, Najate; Millet-Puel, Geraldine; Pagan, Delphine; Blond, Frederic; Fontaine, Valerie; Sahel, Jose-Alain; Leveillard, Thierry] CNRS, UMR 7210, F-75012 Paris, France; [Da Silva, Corinne; Wincker, Patrick] CEA, Ctr Natl Sequencage, GENOSCOPE, Inst Genom, 2 Rue Gaston Cremieux,CP5706, F-91057 Evry, France; [Poidevin, Laetitia; Poch, Olivier] Univ Strasbourg, CNRS, Fac Med, ICube UMR 7357,LBGI, 4 Rue Kirschleger, F-67085 Strasbourg, France; [Ripp, Raymond] Univ Strasbourg, CNRS, IGBMC UMR7104, 1 Rue Laurent Fries BP10142, F-67404 Illkirch Graffenstaden, France; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Wilmer Inst, Baltimore, MD 21287 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University	Leveillard, T (corresponding author), INSERM, U968, F-75012 Paris, France.; Leveillard, T (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Vis, UMR S 968, F-75012 Paris, France.; Leveillard, T (corresponding author), CNRS, UMR 7210, F-75012 Paris, France.	thierry.leveillard@inserm.fr	Léveillard, Thierry/AAR-1804-2020; Sahel, Jose-Alain/F-3172-2017; Kole, Christo/ABE-5654-2020	Léveillard, Thierry/0000-0001-5692-8770; Sahel, Jose-Alain/0000-0002-4831-1153; Kole, Christo/0000-0003-4695-3723; Puel, Geraldine/0000-0003-2387-538X; DA SILVA, Corinne/0000-0002-7618-7831; Blond, Frederic/0000-0002-2314-0570; Berdugo, Naomi/0000-0002-5460-573X; Najate, AIT-ALI/0000-0002-7626-8746	Inserm; Universite Pierre et Marie Curie; Universite de Strasbourg; Labex Lifesenses; Foundation Voir and Entendre; Fondation pour la recherche medicale; NATIONAL EYE INSTITUTE [P30EY001765] Funding Source: NIH RePORTER	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie; Universite de Strasbourg; Labex Lifesenses; Foundation Voir and Entendre; Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Inserm, Universite Pierre et Marie Curie, Universite de Strasbourg, Labex Lifesenses, the Foundation Voir and Entendre and the Fondation pour la recherche medicale.	Agoston Z, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-10; Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Alfano G, 2011, DEVELOPMENT, V138, P261, DOI 10.1242/dev.051037; Aurnhammer C, 2011, HUMAN GENE; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Beby F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011673; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Booij J, 2010, PLOS ONE, V5; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Cao H, 2011, PLOS ONE, V6; CARRIERE C, 1993, MOL CELL BIOL, V13, P7257, DOI 10.1128/MCB.13.12.7257; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chow L, 1998, MECH DEVELOP, V77, P149, DOI 10.1016/S0925-4773(98)00135-X; Comitato A, 2007, HUM MOL GENET, V16, P1699, DOI 10.1093/hmg/ddm118; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Courtois V, 2003, J NEUROCHEM, V84, P840, DOI 10.1046/j.1471-4159.2003.01583.x; Dalkara D, 2009, MOL THER, V17, P2096, DOI 10.1038/mt.2009.181; Delyfer MN, 2013, JOVE-J VIS EXP, DOI 10.3791/50375; Delyfer MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028791; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hao H, 2012, PLOS GENETICS, V8; Henderson RH, 2009, MOL VIS, V15, P2442; Hertel KJ, 2014, SPLICEOSOMAI PREMRNA; Hewitt FC, 2009, J VIROL, V83, P3919, DOI 10.1128/JVI.02466-08; Housset M, 2013, J NEUROSCI, V33, P9890, DOI 10.1523/JNEUROSCI.1099-13.2013; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Kanadia RN, 2008, DEVELOPMENT, V135, P3923, DOI 10.1242/dev.024620; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; Liu MM, 2013, CLIN GENET, V84, P142, DOI 10.1111/cge.12181; Lopez AJ, 1995, DEV BIOL, V172, P396, DOI 10.1006/dbio.1995.8050; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; Mordes D, 2006, MOL VIS, V12, P1259; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nandrot E, 2000, NEUROBIOL DIS, V7, P586, DOI 10.1006/nbdi.2000.0328; Nandrot E, 2006, AM J PHYSIOL-CELL PH, V290, P62; Nandrot EF, 2012, BIOL CELL, V104, P326, DOI 10.1111/boc.201100076; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Ohara O, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e22; Ou JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059247; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; Reichman S, 2010, HUM MOL GENET, V19, P250, DOI 10.1093/hmg/ddp484; Reinisalo M, 2012, MOL VIS, V18, P38; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Smith TPL, 2001, GENOME RES, V11, P626, DOI 10.1101/gr.170101; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Thill G, 2006, GENOME RES, V16, P776, DOI 10.1101/gr.5063306; Vithana EN, 2003, INVEST OPHTH VIS SCI, V44, P4204, DOI 10.1167/iovs.03-0253; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yuan LY, 2005, J NEUROSCI, V25, P748, DOI 10.1523/JNEUROSCI.2399-04.2005	64	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150758	10.1371/journal.pone.0150758	http://dx.doi.org/10.1371/journal.pone.0150758			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985665	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300026
J	Ma, WL; Lin, M; Ding, H; Lin, GR; Zhang, ZZ				Ma, Weilie; Lin, Margarita; Ding, Hang; Lin, Guorong; Zhang, Zhizhen			beta-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; A-I; LIPID EFFLUX; TANGIER-DISEASE; BINDING; ABCA1; RECEPTOR; CELLS; PROTEINS	Objective HDL and its apolipoproteins protect against atherosclerotic disease partly by removing excess cholesterol from macrophage foam cells. But the underlying mechanisms of cholesterol clearance are still not well defined. We investigated roles of vesicle trafficking of coatomer beta-COP in delivering cholesterol to the cell surface during apoA-1 and apoE-mediated lipid efflux from fibroblasts and THP-1 macrophages. Methods shRNA knockout, confocal and electron microscopy and biochemical analysis were used to investigate the roles of beta-COP in apolipoprotein-mediated cholesterol efflux in fibroblasts and THP-1 macrophages. Results We showed that beta-COP knockdown by lentiviral shRNA resulted in reduced apoA-1-mediated cholesterol efflux, while increased cholesterol accumulation and formation of larger vesicles were observed in THP-1 macrophages by laser scanning confocal microscopy. Immunogold electron microscopy showed that beta-COP appeared on the membrane protrusion complexes and colocalized with apoA-1 or apoE during cholesterol efflux. This was associated with releasing heterogeneous sizes of small particles into the culture media of THP-1 macrophage. Western blotting also showed that apoA-1 promotes beta-COP translocation to the cell membrane and secretion into culture media, in which a total of 17 proteins were identified by proteomics. Moreover, beta-COP exclusively associated with human plasma HDL fractions. Conclusion ApoA-1 and apoE promoted transport vesicles consisting of beta-COP and other candidate proteins to exocytose cholesterol, forming the protrusion complexes on cell surface, which were then released from the cell membrane as small particles to media.	[Ma, Weilie; Lin, Margarita; Ding, Hang; Lin, Guorong; Zhang, Zhizhen] Guangdong Med Univ, Dept Biochem & Mol Biol, Key Lab Med Mol Diagnost Guangdong Prov, Dongguan 523808, Guangdong, Peoples R China	Guangdong Medical University	Lin, GR; Zhang, ZZ (corresponding author), Guangdong Med Univ, Dept Biochem & Mol Biol, Key Lab Med Mol Diagnost Guangdong Prov, Dongguan 523808, Guangdong, Peoples R China.	glin@omegacoffee.com; zzzhang@gdmc.edu.cn	ZHANG, ZHIZHEN/GYA-3230-2022		National Natural Science Foundation of China [81170267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grant (81170267) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielicki JK, 1999, J LIPID RES, V40, P85; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chao WT, 2005, BIOCHEM BIOPH RES CO, V332, P743, DOI 10.1016/j.bbrc.2005.05.019; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Engel T, 2004, FEBS LETT, V566, P241, DOI 10.1016/j.febslet.2004.04.048; Enrich C, 2011, BBA-MOL CELL RES, V1813, P935, DOI 10.1016/j.bbamcr.2010.09.015; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HARDING C, 1984, EUR J CELL BIOL, V35, P256; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; HERSCOVITZ H, 1992, J LIPID RES, V33, P791; Innis-Whitehouse W, 1998, J LIPID RES, V39, P679; Ito J, 2014, J LIPIDS, V2014, DOI 10.1155/2014/530720; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lin GR, 2000, ATHEROSCLEROSIS, V149, P359, DOI 10.1016/S0021-9150(99)00503-1; Lin GR, 2002, BIOCHEM BIOPH RES CO, V291, P727, DOI 10.1006/bbrc.2002.6505; Lin SS, 2013, ARTERIOSCL THROM VAS, V33, pE31, DOI 10.1161/ATVBAHA.112.300720; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Ma WL, 2015, ATHEROSCLEROSIS, V239, P566, DOI 10.1016/j.atherosclerosis.2015.02.034; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mendez AJ, 1996, J LIPID RES, V37, P2510; MENDEZ AJ, 1995, J BIOL CHEM, V270, P5891, DOI 10.1074/jbc.270.11.5891; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; ORAM JF, 1983, J CLIN INVEST, V72, P1611, DOI 10.1172/JCI111120; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PFEFFER SR, 1983, J CELL BIOL, V97, P40, DOI 10.1083/jcb.97.1.40; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reboul E, 2013, BIOCHIMIE, V95, P957, DOI 10.1016/j.biochi.2012.11.009; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Takashima K, 2011, CELL STRUCT FUNCT, V36, P223, DOI 10.1247/csf.11035; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Weinert S, 2013, CARDIOVASC RES, V97, P544, DOI 10.1093/cvr/cvs367; WU YQ, 1988, ENDOCRINOLOGY, V123, P1879, DOI 10.1210/endo-123-4-1879; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zech T, 2012, CELL ADHES MIGR, V6, P476, DOI 10.4161/cam.21373; Zhang HT, 2013, J BIOL CHEM, V288, P20966, DOI 10.1074/jbc.M113.484535	48	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151767	10.1371/journal.pone.0151767	http://dx.doi.org/10.1371/journal.pone.0151767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986486	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300127
J	Zhou, YY; Shi, LJ; Cui, XL; Wang, SH; Luo, XR				Zhou, Yuanyue; Shi, Lijuan; Cui, Xilong; Wang, Suhong; Luo, Xuerong			Functional Connectivity of the Caudal Anterior Cingulate Cortex Is Decreased in Autism	PLOS ONE			English	Article							RESTING-STATE NETWORK; SPECTRUM DISORDERS; ABNORMALITIES; CHILDREN; ADULTS; ADOLESCENTS; ACTIVATION; ACCUMBENS; BEHAVIOR; REGIONS	The anterior cingulate cortex (ACC) is frequently reported to have functionally distinct subregions that play key roles in different intrinsic networks. However, the contribution of the ACC, which is connected to several cortical areas and the limbic system, to autism is not clearly understood, although it may be involved in dysfunctions across several distinct but related functional domains. By comparing resting-state fMRI data from persons with autism and healthy controls, we sought to identify the abnormalities in the functional connectivity (FC) of ACC sub-regions in autism. The analyses found autism-related reductions in FC between the left caudal ACC and the right rolandic operculum, insula, postcentral gyrus, superior temporal gyrus, and the middle temporal gyrus. The FC (z-scores) between the left caudal ACC and the right insula was negatively correlated with the Stereotyped Behaviors and Restricted Interests scores of the autism group. These findings suggest that the caudal ACC is recruited selectively in the pathomechanism of autism.	[Zhou, Yuanyue; Shi, Lijuan; Cui, Xilong; Luo, Xuerong] Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Zhou, Yuanyue] Hangzhou Seventh Peoples Hosp, Dept Child Psychiat, Hangzhou 310013, Zhejiang, Peoples R China; [Wang, Suhong] Soochow Univ, Affiliated Hosp 3, Dept Neurosci, Changzhou 213003, Peoples R China	Central South University; Soochow University - China	Luo, XR (corresponding author), Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	luoxr@vip.sina.com	Cui, Xilong/HHM-6692-2022		Major State Basic Research Development Program of China (973 Program) [2012CB517901]; Special Health Industry Research of China [201302002]; National Sci-tech Support Plan of China	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Special Health Industry Research of China; National Sci-tech Support Plan of China	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program, no. 2012CB517901), the Special Health Industry Research of China (Research on technology and standards of autism diagnose and control, no. 201302002), the National Sci-tech Support Plan of China (Epidemiological investigation on child and adolescent mental disorders in China).	Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 1996, BRAIN RES REV, V22, P229; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Blakemore SJ, 2006, BRAIN COGNITION, V61, P5, DOI 10.1016/j.bandc.2005.12.013; Bos DJ, 2014, NEUROIMAGE-CLIN, V4, P820, DOI 10.1016/j.nicl.2014.05.007; Cascio CJ, 2014, J CHILD PSYCHOL PSYC, V55, P162, DOI 10.1111/jcpp.12147; Cascio CJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-9; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; Crane L, 2009, AUTISM, V13, P215, DOI 10.1177/1362361309103794; Crone EA, 2006, J NEUROSCI, V26, P11239, DOI 10.1523/JNEUROSCI.2165-06.2006; Delmonte S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00430; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; GAZNICK N, 2013, NICOTINE, V16, P445; Gillberg C, 1996, DEV MED CHILD NEUROL, V38, P191; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, V3rd; Gotham K, 2008, J AM ACAD CHILD PSY, V47, P642, DOI 10.1097/CHI.0b013e31816bffb7; Habas C, 2010, NEURORADIOLOGY, V52, P47, DOI 10.1007/s00234-009-0572-1; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; Lin HY, 2015, J INT NEUROPSYCH SOC, V21, P271, DOI 10.1017/S135561771500020X; Liss M, 2006, AUTISM, V10, P155, DOI 10.1177/1362361306062021; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; RIMLAND B, 1995, J AUTISM DEV DISORD, V25, P61, DOI 10.1007/BF02178168; Shi LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122280; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; Tyszka JM, 2014, CEREB CORTEX, V24, P1894, DOI 10.1093/cercor/bht040; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang DW, 2014, HUM BRAIN MAPP, V35, P2573, DOI 10.1002/hbm.22350; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Wing J. K., 1966, EARLY CHILDHOOD AUTI, P3; Xue G, 2010, NEUROIMAGE, V50, P709, DOI 10.1016/j.neuroimage.2009.12.097; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	52	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151879	10.1371/journal.pone.0151879	http://dx.doi.org/10.1371/journal.pone.0151879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985666	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300146
J	Shen, MQ; Shi, HF				Shen, Minqian; Shi, Haifei			Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; CYTOKINE SIGNALING-3 EXPRESSION; PROTEIN-KINASE PATHWAY; OVARIAN-CANCER CELLS; HEPATITIS-C VIRUS; PROSTATE-CANCER; BREAST-CANCER; SUSTAINED ACTIVATION; UP-REGULATION; LIVER-CANCER	Obesity is a significant risk factor for certain cancers, including hepatocellular carcinoma (HCC). Leptin, a hormone secreted by white adipose tissue, precipitates HCC development. Epidemiology data show that men have a much higher incidence of HCC than women, suggesting that estrogens and its receptors may inhibit HCC development and progression. Whether estrogens antagonize oncogenic action of leptin is uncertain. To investigate potential inhibitory effects of estrogens on leptin-induced HCC development, HCC cell line HepG2 cells were treated with leptin in combination with 17 beta-estradiol (E2), estrogen receptor-alpha (ER-alpha) selective agonist PPT, ER-beta selective agonist DPN, or G protein-coupled ER (GPER) selective agonist G-1. Cell number, proliferation, and apoptosis were determined, and leptin-and estrogen-related intracellular signaling pathways were analyzed. HepG2 cells expressed a low level of ER-beta mRNA, and leptin treatment increased ER-beta expression. E2 suppressed leptin-induced HepG2 cell proliferation and promoted cell apoptosis in a dose-dependent manner. Additionally E2 reversed leptin-induced STAT3 and leptin-suppressed SOCS3, which was mainly achieved by activation of ER-beta. E2 also enhanced ERK via activating ER-alpha and GPER and activated p38/MAPK via activating ER beta. To conclude, E2 and its receptors antagonize the oncogenic actions of leptin in HepG2 cells by inhibiting cell proliferation and stimulating cell apoptosis, which was associated with reversing leptin-induced changes in SOCS3/STAT3 and increasing p38/MAPK by activating ER-beta, and increasing ERK by activating ER-alpha and GPER. Identifying roles of different estrogen receptors would provide comprehensive understanding of estrogenic mechanisms in HCC development and shed light on potential treatment for HCC patients.	[Shen, Minqian; Shi, Haifei] Miami Univ, Dept Biol Cell Mol & Struct Biol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Shi, HF (corresponding author), Miami Univ, Dept Biol Cell Mol & Struct Biol, Oxford, OH 45056 USA.	shih@miamioh.edu	Shen, Minqian/M-2713-2016	Migliaccio, Antimo/0000-0002-4197-2055	Sigma Xi [G2012161930, G20141015719335]; National Institutes of Health [R15 DK090823]; Madalene and George Shetler Diabetes Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK090823] Funding Source: NIH RePORTER	Sigma Xi; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Madalene and George Shetler Diabetes Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by Sigma Xi (G2012161930 and G20141015719335 to M. S.), National Institutes of Health (R15 DK090823 to H. S.) and Madalene and George Shetler Diabetes Research Award to H. S.	Acharya KD, 2012, DEV NEUROBIOL, V72, P1433, DOI 10.1002/dneu.22004; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Alexia C, 2004, BIOCHEM PHARMACOL, V68, P1003, DOI 10.1016/j.bcp.2004.05.029; Altiok N, 2011, ONCOL LETT, V2, P1281, DOI 10.3892/ol.2011.385; Anbalagan M., 2015, MOL CELL ENDOCRINOL; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Canfield S, 2005, J IMMUNOL, V174, P2494, DOI 10.4049/jimmunol.174.5.2494; Chan KKL, 2008, OBSTET GYNECOL, V111, P144, DOI 10.1097/01.AOG.0000296715.07705.e9; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Chu R, 2014, CANCER-AM CANCER SOC, V120, P142, DOI 10.1002/cncr.28383; Ciucci A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101623; CLEMENTI M, 1987, FEBS LETT, V221, P11, DOI 10.1016/0014-5793(87)80343-5; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Dondi D, 2010, ENDOCR-RELAT CANCER, V17, P731, DOI 10.1677/ERC-10-0032; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fazeli M, 2006, J IMMUNOL METHODS, V312, P190, DOI 10.1016/j.jim.2006.03.011; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Hayashida K, 2010, MICROBIOL IMMUNOL, V54, P684, DOI 10.1111/j.1348-0421.2010.00268.x; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; Ho Shuk-Mei, 2003, Reprod Biol Endocrinol, V1, P73, DOI 10.1186/1477-7827-1-73; Hsu IW, 2014, ONCOTARGET, V5, P7917, DOI 10.18632/oncotarget.1421; Ignatov T, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-51; Jammart B, 2013, J VIROL, V87, P5065, DOI 10.1128/JVI.01405-12; Jin J, 2013, MOL CELL BIOCHEM, V381, P267, DOI 10.1007/s11010-013-1710-y; Khan FZ, 2015, WORLD J HEPATOL, V7, P2155, DOI 10.4254/wjh.v7.i18.2155; Komyod W, 2007, MOL CANCER RES, V5, P271, DOI 10.1158/1541-7786.MCR-06-0274; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee J, 2002, BIOCHEM BIOPH RES CO, V298, P765, DOI 10.1016/S0006-291X(02)02562-7; Li SP, 2003, CANCER RES, V63, P3473; Li XP, 2006, MOL CANCER THER, V5, P1290, DOI 10.1158/1535-7163.MCT-05-0348; Liang X, 2013, HORM METAB RES, V45, P423, DOI 10.1055/s-0033-1333751; Lin SJ, 2003, J IMMUNOL, V171, P4708, DOI 10.4049/jimmunol.171.9.4708; Lin T, 2008, TOXICOLOGY, V247, P145, DOI 10.1016/j.tox.2008.02.017; Liu W, 2015, MOL CARCINOG, V14; Liu WH, 2009, J CELL PHYSIOL, V219, P642, DOI 10.1002/jcp.21713; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Marino M, 2014, WORLD J GASTRO ONCOL, V6, P67, DOI 10.4251/wjgo.v6.i3.67; Matsuda Y, 2003, CLIN CANCER RES, V9, P3389; Matsuda Y, 2006, MED MOL MORPHOL, V39, P169, DOI 10.1007/s00795-006-0339-2; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Miceli V, 2011, OMICS, V15, P313, DOI 10.1089/omi.2010.0108; Motylewska E, 2009, CANCER LETT, V276, P68, DOI 10.1016/j.canlet.2008.10.050; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Njei B, 2015, HEPATOLOGY, V61, P191, DOI 10.1002/hep.27388; Otvos L, 2011, BIOPOLYMERS, V96, P117, DOI 10.1002/bip.21377; Persson I, 2000, J STEROID BIOCHEM, V74, P357, DOI 10.1016/S0960-0760(00)00113-8; PORTER LE, 1987, GASTROENTEROLOGY, V92, P735, DOI 10.1016/0016-5085(87)90026-6; Prieto LM, 2008, HORM METAB RES, V40, P311, DOI 10.1055/s-2008-1073141; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shimizu I, 1998, GUT, V42, P112, DOI 10.1136/gut.42.1.112; Signoretti S, 2001, AM J PATHOL, V159, P13, DOI 10.1016/S0002-9440(10)61666-5; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Teng Y, 2015, J BIOL CHEM, V290, P15799, DOI 10.1074/jbc.M115.641167; Teng Y, 2014, MOL CELL ENDOCRINOL, V392, P23, DOI 10.1016/j.mce.2014.05.007; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tong YX, 2015, BIOCHEM BIOPH RES CO, V456, P86, DOI 10.1016/j.bbrc.2014.11.038; VANBEURD.WM, 1974, BIOCHEMISTRY-US, V140, P495, DOI 10.1042/bj1400495; Vanni E, 2014, CLIN LIVER DIS, V18, P191, DOI 10.1016/j.cld.2013.09.001; VanSaun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073054; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wang C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.397; Wang CJ, 2014, MOL MED REP, V10, P3125, DOI 10.3892/mmr.2014.2595; Wei Q, 2015, LAB INVEST; Wei RC, 2011, HUM GENE THER, V22, P1109, DOI 10.1089/hum.2010.219; Wieser V, 2012, DIGEST DIS, V30, P508, DOI 10.1159/000341702; Wu WY, 2014, J INVEST SURG, V27, P197, DOI 10.3109/08941939.2013.873098; Xiong Y, 2014, MOL MED REP, V10, P1649, DOI 10.3892/mmr.2014.2373; Xu ZZ, 2012, CELL SIGNAL, V24, P1658, DOI 10.1016/j.cellsig.2012.04.015; Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307; Yuan JM, 2004, CANCER, V101, P1009, DOI 10.1002/cncr.20427; Zhang Q, 2015, CELL BIOCHEM FUNCT, V33, P134, DOI 10.1002/cbf.3097; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhao LY, 2013, CELL MOL BIOL NOIS S, V59	86	31	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151455	10.1371/journal.pone.0151455	http://dx.doi.org/10.1371/journal.pone.0151455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982332	Green Submitted, gold, Green Published			2022-12-26	WOS:000372574900085
J	Antwi-Agyei, P; Peasey, A; Biran, A; Bruce, J; Ensink, J				Antwi-Agyei, Prince; Peasey, Anne; Biran, Adam; Bruce, Jane; Ensink, Jeroen			Risk Perceptions of Wastewater Use for Urban Agriculture in Accra, Ghana	PLOS ONE			English	Article							BEHAVIOR-CHANGE; FOOD SAFETY; IRRIGATION; HYGIENE	Poor food hygiene is a significant risk to public health globally, but especially in low and middle-income countries where access to sanitation, and general hygiene remain poor. Food hygiene becomes even more pertinent when untreated, or poorly treated wastewater is used in agriculture. In such circumstances the WHO recommends the adoption of a multiple-barrier approach that prescribes health protective measures at different entry points along the food chain. This study sought to assess the knowledge and awareness of wastewater use for crop production, its related health risks, and adoption of health protective measures by farmers, market salespersons and consumers using questionnaires and focus group discussions. In the period from September 2012 to August 2013, 490 respondents were interviewed during two cropping seasons. The study found that awareness of the source of irrigation water was low among consumers and street food vendors, though higher among market vendors. In contrast, health risk awareness was generally high among salespersons and consumers, but low among farmers. The study found that consumers did not prioritize health indicators when buying produce from vendors but were motivated to buy produce, or prepared food based on taste, friendship, cost, convenience and freshness of produce. Similarly, farmers' awareness of health risk did not influence their adoption of safer farm practices. The study recommends the promotion of interventions that would result in more direct benefits to both producers and vendors, together with hygiene education and enforcement of food safety byelaws in order to influence behaviour change, and increase the uptake of the multiple-barrier approach.	[Antwi-Agyei, Prince; Biran, Adam; Ensink, Jeroen] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Environm Hlth Grp, Keppel St, London WC1E 7HT, England; [Peasey, Anne] UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England; [Bruce, Jane] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Antwi-Agyei, P (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Environm Hlth Grp, Keppel St, London WC1E 7HT, England.	Princekaagyei@gmail.com		Antwi-Agyei, Prince/0000-0001-6940-2428; Peasey, Anne/0000-0001-7434-2079	Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium through the Department for International Development (DFID); Emory University	Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium through the Department for International Development (DFID); Emory University	The study was funded by the Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium (http://www.shareresearch.org/) through the Department for International Development (DFID). PAA received this funding for this study as part of his PhD scholarship. Fieldwork for this study was also partly supported by the Emory University led SANIPATH project in Accra, Ghana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah M., 2011, INTERNET J FOOD SAFE, V13, P191; AMA, 2007, MED TERM DEV PLAN 20; Amoah P, 2008, THESIS K NKRUMAH U S; Amponsah O, 2015, RESOUR CONSERV RECY, V97, P1, DOI 10.1016/j.resconrec.2015.01.009; Andreasen AlanR., 1995, MARKETING SOCIAL CHA; Antwi-Agyei P, FARM FORK R IN PRESS; Antwi-Agyei P, FAECAL EXPO IN PRESS; Antwi-Agyei P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142346; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; BREWER MS, 1994, J FOOD SAFETY, V14, P63, DOI 10.1111/j.1745-4565.1994.tb00584.x; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; Drechsel P, 2013, MOTIVATING BEHAV CHA; Drechsel P., 2002, URBAN AGR MAGAZINE, V8, P7; Drechsel P., 2006, INFORMAL IRRIGATION; Ensink J, 2006, THESIS LONDON SCH HY; Ensink J. H. J., 2004, Water Policy, V6, P197; Ensink JHJ, 2007, TROP MED INT HEALTH, V12, P2, DOI 10.1111/j.1365-3156.2007.01935.x; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Fung J., 2011, International Journal of Food Safety, Nutrition and Public Health, V4, P152, DOI 10.1504/IJFSNPH.2011.044544; Kar K, 2008, HDB COMMUNITY LED TO; Karg H, 2011, WATER INT, V36, P476, DOI 10.1080/02508060.2011.594684; Keraita B, 2008, THESIS U COPENHAGEN; Keraita B, 2008, J RISK RES, V11, P1047, DOI 10.1080/13669870802380825; Marks D. F., 2004, RES METHODS CLIN HLT; Mertens F, 2015, ECOL SOC, V20, DOI 10.5751/ES-07483-200318; Mertens F, 2012, SOC SCI MED, V75, P643, DOI 10.1016/j.socscimed.2011.10.016; Mutengu S, 2007, PHYS CHEM EARTH, V32, P1195, DOI 10.1016/j.pce.2007.07.019; Ndunda E. N., 2013, African Journal of Agricultural Research, V8, P119; Obuobie E, 2006, IRRIGATED URBAN VEGE; Peasey A., 2002, CRITICAL REV E UNPUB; Pruss-Ustun A., 2006, WORLD HEALTH; Pruss-Ustun A, 2014, TROPICAL MED INT HLT; Qadir M, 2010, AGR WATER MANAGE, V97, P561, DOI 10.1016/j.agwat.2008.11.004; Rheinlander T, 2008, J URBAN HEALTH, V85, P952, DOI 10.1007/s11524-008-9318-3; Scott BE, 2007, HEALTH POLICY PLANN, V22, P216, DOI 10.1093/heapol/czm014; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2006, FOOD SAF RISK ANAL G; World Health Organization, 2006, GUID SAF US WAST EXC, V2	39	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150603	10.1371/journal.pone.0150603	http://dx.doi.org/10.1371/journal.pone.0150603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978778	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000372572800031
J	Ciraci, C; Janczy, JR; Jain, N; Haasken, S; Silva, CPE; Benjamim, CF; Sadler, JJ; Olivier, AK; Iwakura, Y; Shayakhmetov, DM; Sutterwala, FS; Cassel, SL				Ciraci, Ceren; Janczy, John R.; Jain, Nidhi; Haasken, Stefanie; Pecli e Silva, Cyntia; Benjamim, Claudia F.; Sadler, Jeffrey J.; Olivier, Alicia K.; Iwakura, Yoichiro; Shayakhmetov, Dmitry M.; Sutterwala, Fayyaz S.; Cassel, Suzanne L.			Immune Complexes Indirectly Suppress the Generation of Th17 Responses In Vivo	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD4(+) T-CELLS; MICE DEFICIENT; AIRWAY INFLAMMATION; NLRP3 INFLAMMASOME; ADAPTIVE IMMUNITY; DENDRITIC CELLS; RECEPTOR; MACROPHAGES; CASPASE-1	The precise context in which the innate immune system is activated plays a pivotal role in the subsequent instruction of CD4(+) T helper (Th) cell responses. Th1 responses are downregulated when antigen is encountered in the presence of antigen-IgG immune complexes. To assess if Th17 responses to antigen are subject to similar influences in the presence of immune complexes we utilized an inflammatory airway disease model in which immunization of mice with Complete Freund's Adjuvant (CFA) and ovalbumin (Ova) induces a powerful Ova-specific Th1 and Th17 response. Here we show that modification of that immunization with CFA to include IgG-Ova immune complexes results in the suppression of CFA-induced Th17 responses and a concurrent enhancement of Ova-specific Th2 responses. Furthermore, we show the mechanism by which these immune complexes suppress Th17 responses is through the enhancement of IL-10 production. In addition, the generation of Th17 responses following immunization with CFA and Ova were dependent on IL-1 alpha but independent of NLRP3 inflammasome activation. Together these data represent a novel mechanism by which the generation of Th17 responses is regulated.	[Ciraci, Ceren; Janczy, John R.; Jain, Nidhi; Haasken, Stefanie; Pecli e Silva, Cyntia; Sadler, Jeffrey J.; Sutterwala, Fayyaz S.; Cassel, Suzanne L.] Univ Iowa, Carver Coll Med, Inflammat Program, Iowa City, IA USA; [Ciraci, Ceren] Istanbul Tech Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Janczy, John R.; Sutterwala, Fayyaz S.; Cassel, Suzanne L.] Univ Iowa, Carver Coll Med, Grad Program Immunol, Iowa City, IA USA; [Olivier, Alicia K.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA USA; [Sutterwala, Fayyaz S.; Cassel, Suzanne L.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Pecli e Silva, Cyntia; Benjamim, Claudia F.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Yamasaki 2669, Noda, Chiba 2780022, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Shayakhmetov, Dmitry M.] Emory Univ, Dept Med, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Sutterwala, Fayyaz S.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; Istanbul Technical University; University of Iowa; University of Iowa; University of Iowa; Universidade Federal do Rio de Janeiro; Tokyo University of Science; Japan Science & Technology Agency (JST); Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Cassel, SL (corresponding author), Univ Iowa, Carver Coll Med, Inflammat Program, Iowa City, IA USA.; Cassel, SL (corresponding author), Univ Iowa, Carver Coll Med, Grad Program Immunol, Iowa City, IA USA.; Cassel, SL (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA.	suzanne-cassel@uiowa.edu	Benjamim, Claudia/T-5090-2019; Sutterwala, Fayyaz/AAH-5859-2021; Iwakura, Yoichiro/E-5457-2011; ciraci, ceren/ABA-7687-2020; Cassel, Suzanne/AAI-3947-2021	Benjamim, Claudia/0000-0001-6247-9596; Iwakura, Yoichiro/0000-0002-9934-5775; ciraci, ceren/0000-0003-2162-0930; Cassel, Suzanne/0000-0003-2492-1923; Pecli, Cyntia/0000-0003-0129-3514; jain, nidhi/0000-0001-6723-4029	National Institutes of Health [R01 AI104706, T32 AI007485, T32 AI007511]; Asthma and Allergy Foundation of America fellowship; American Lung Association/The American Academy of Allergy; Asthma & Immunology Foundation Allergic Respiratory Disease Award; Bolsista da CAPES Scholarship [2790-14-9]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104706, T32AI007485, R01AI107960, R01AI065429, T32AI007511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asthma and Allergy Foundation of America fellowship; American Lung Association/The American Academy of Allergy; Asthma & Immunology Foundation Allergic Respiratory Disease Award; Bolsista da CAPES Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R01 AI104706 (S.L.C.), T32 AI007485 (J.R.J.), and T32 AI007511 (S.H.); an Asthma and Allergy Foundation of America fellowship (S.L.C.); an American Lung Association/The American Academy of Allergy, Asthma & Immunology Foundation Allergic Respiratory Disease Award (S.L.C.); and a Bolsista da CAPES Scholarship, 2790-14-9 (C.P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CF, 2004, J IMMUNOL, V173, P955, DOI 10.4049/jimmunol.173.2.955; Bandukwala HS, 2007, J EXP MED, V204, P1875, DOI 10.1084/jem.20061134; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciraci C, 2012, MICROBES INFECT, V14, P1263, DOI 10.1016/j.micinf.2012.07.007; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labow M, 1997, J IMMUNOL, V159, P2452; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Sutterwala FS, 1999, J LEUKOCYTE BIOL, V65, P543, DOI 10.1002/jlb.65.5.543; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032	31	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151252	10.1371/journal.pone.0151252	http://dx.doi.org/10.1371/journal.pone.0151252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978520	gold, Green Submitted, Green Published			2022-12-26	WOS:000372572800053
J	Weiss, M; Prochazka, J; Schlaghamersky, J; Cizek, L				Weiss, Matthias; Prochazka, Jiri; Schlaghamersky, Jiri; Cizek, Lukas			Fine-Scale Vertical Stratification and Guild Composition of Saproxylic Beetles in Lowland and Montane Forests: Similar Patterns despite Low Faunal Overlap	PLOS ONE			English	Article							COLEOPTERA CARABIDAE; ELEVATIONAL GRADIENT; ALTITUDINAL GRADIENT; IPS-TYPOGRAPHUS; NATIONAL-PARK; COMMUNITY; DIVERSITY; ASSEMBLAGES; MANAGEMENT; TURNOVER	Objective The finer scale patterns of arthropod vertical stratification in forests are rarely studied and poorly understood. Further, there are no studies investigating whether and how altitude affects arthropod vertical stratification in temperate forests. We therefore investigated the fine-scale vertical stratification of diversity and guild structure of saproxylic beetles in temperate lowland and montane forests and compared the resulting patterns between the two habitats. Methods The beetles were sampled with flight intercept traps arranged into vertical transects (sampling heights 0.4, 1.2, 7, 14, and 21 m). A triplet of such transects was installed in each of the five sites in the lowland and in the mountains; 75 traps were used in each forest type. Results 381 species were collected in the lowlands and 236 species in the mountains. Only 105 species (21%) were found at both habitats; in the montane forest as well as in the lowlands, the species richness peaked at 1.2 m, and the change in assemblage composition was most rapid near the ground. The assemblages clearly differed between the understorey (0.4 m, 1.2 m) and the canopy (7 m, 14 m, 21 m) and between the two sampling heights within the understorey, but less within the canopy. The stratification was better pronounced in the lowland, where canopy assemblages were richer than those near the forest floor (0.4 m). In the mountains the samples from 14 and 21 m were more species poor than those from the lower heights. The guild structure was similar in both habitats. Conclusions The main patterns of vertical stratification and guild composition were strikingly similar between the montane and the lowland forest despite the low overlap of their faunas. The assemblages of saproxylic beetles were most stratified near ground. The comparisons of species richness between canopy and understorey may thus give contrasting results depending on the exact sampling height in the understorey.	[Weiss, Matthias; Cizek, Lukas] Acad Sci Czech Republ, Inst Entomol, Biol Ctr CAS, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic; [Weiss, Matthias; Cizek, Lukas] Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Prochazka, Jiri; Schlaghamersky, Jiri] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Masaryk University Brno	Weiss, M (corresponding author), Acad Sci Czech Republ, Inst Entomol, Biol Ctr CAS, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.; Weiss, M (corresponding author), Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	mattweiss@t-online.de	Procházka, Jiří/AAC-9290-2019; Cizek, Lukas/G-7905-2014; Weiss, Matthias/R-6659-2018; Cizek, Lukas/K-7111-2015	Procházka, Jiří/0000-0002-8016-1992; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Weiss, Matthias/0000-0001-9095-0779	Grant Agency of the Czech Academy of Sciences [KJB600960705]; Grant Agency of the University of South Bohemia [04-168/2013/P]; Czech Science Foundation [P504/12/1952]; Ministry of Education, Youth and Sports of the Czech Republic [MSM 0021622416]; Biodiversity of Forest Ecosystems (European Social Fund) [CZ.1.07/2.3.00/20.0064]; state budget of the Czech Republic	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of the University of South Bohemia; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Biodiversity of Forest Ecosystems (European Social Fund); state budget of the Czech Republic	This work was supported by the Grant Agency of the Czech Academy of Sciences (grant No. KJB600960705) (https://www.muni.cz/research/avcr), Grant Agency of the University of South Bohemia (04-168/2013/P), Czech Science Foundation (grant No. P504/12/1952) (http://www.gacr.cz/), Ministry of Education, Youth and Sports of the Czech Republic (Research Plan MSM 0021622416) (http://www.msmt.cz/?lang=2), Biodiversity of Forest Ecosystems (European Social Fund) (grant No. CZ.1.07/2.3.00/20.0064) (http://ec.europa.eu/esf/home.jsp), and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bail JG, 2008, CANOPY ARTHROPOD RES, P327; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P4; Basset Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144110; Bouget C, 2013, BIODIVERS CONSERV, V22, P2111, DOI 10.1007/s10531-013-0531-3; Bouget C, 2011, FOREST ECOL MANAG, V261, P211, DOI 10.1016/j.foreco.2010.10.007; CHAO A, 1984, SCAND J STAT, V11, P265; Chen Y. C., 1995, J CHINESE STAT ASS, V33, P373; Colwell RK, 2013, ESTIMATES STAT ESTIM; Davies ALV, 1999, J BIOGEOGR, V26, P1039, DOI 10.1046/j.1365-2699.1999.00335.x; Duelli P, 2002, ACTA ZOOL ACAD SCI H, V48, P75; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Escobar F, 2007, ECOGRAPHY, V30, P193, DOI [10.1111/j.2007.0906-7590.04818.x, 10.1111/j.0906-7590.2007.04818.x]; Farka J., 2005, CERVENY SEZNAM OHROZ; Floren A, 2014, FOREST ECOL MANAG, V323, P57, DOI 10.1016/j.foreco.2014.03.028; Floren Andreas, 2008, P13; Frazer G.W., 1999, GAP LIGHT ANAL GLA V, P36; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; Gomez-Hernandez M, 2012, BIODIVERS CONSERV, V21, P2247, DOI 10.1007/s10531-011-0180-3; Gossner MM, 2009, EUR J ENTOMOL, V106, P241, DOI 10.14411/eje.2009.032; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hirao T, 2009, ECOL RES, V24, P263, DOI 10.1007/s11284-008-0502-4; Hjalten J, 2007, BASIC APPL ECOL, V8, P364, DOI 10.1016/j.baae.2006.08.003; Horak Jakub, 2009, Klapalekiana, V45, P191; Hulcr J, 2008, ENVIRON ENTOMOL, V37, P1461, DOI 10.1603/0046-225X-37.6.1461; Janik D, 2013, J VEG SCI, V24, P1141, DOI 10.1111/jvs.12018; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jung JK, 2012, J ASIA-PAC ENTOMOL, V15, P487, DOI 10.1016/j.aspen.2012.05.007; Leschen RAB, 2010, HDB ZOOLOGY; Maguire DY, 2014, ENVIRON ENTOMOL, V43, P9, DOI 10.1603/EN13056; Martikainen Petri, 2001, Ecological Bulletins, V49, P205; Meng H, 2013, APPL MICROBIOL BIOT, V97, P2219, DOI 10.1007/s00253-012-4063-7; Miklin J, 2014, J NAT CONSERV, V22, P35, DOI 10.1016/j.jnc.2013.08.002; Muller J, 2008, BIODIVERS CONSERV, V17, P2979, DOI 10.1007/s10531-008-9409-1; Muller J, 2015, ECOGRAPHY, V38, P499, DOI 10.1111/ecog.00908; Parmain G, 2015, B ENTOMOL RES, V105, P101, DOI 10.1017/S0007485314000741; Prochazka J, 2015, MIT SCH GES ENT, V88, P62; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Roberts DW., 2012, LABDSV ORDINATION MU; Robertson HG, 2002, BIODIVERS CONSERV, V11, P1637, DOI 10.1023/A:1016883901065; ROZKOSNY R., 1995, SCI NATUR U MASARYKI, V93, P209; Schlaghamersky Jiri, 2000, Folia Facultatis Scientiarum Naturalium Universitatis Masarykianae Brunensis Biologia, V103, P1; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Schroeder B, 2009, CAN ENTOMOL, V141, P515, DOI 10.4039/n09-022; Sebek P, 2012, ECOL INDIC, V20, P304, DOI 10.1016/j.ecolind.2012.02.033; Seibold S, 2015, CONSERV BIOL, V29, P382, DOI 10.1111/cobi.12427; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Sipos J, 2013, AGR FOREST ENTOMOL, V15, P255, DOI 10.1111/afe.12012; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Stokland JN, 2005, EUR FOREST INST PROC, P207; Su JC, 2001, ENVIRON ENTOMOL, V30, P400, DOI 10.1603/0046-225X-30.2.400; Tanabe S, 2002, ECOL ENTOMOL, V27, P720, DOI 10.1046/j.1365-2311.2002.00469.x; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tykarski P, 2006, FOREST ECOL MANAG, V225, P146, DOI 10.1016/j.foreco.2005.12.034; Ulyshen MD, 2011, FOREST ECOL MANAG, V261, P1479, DOI 10.1016/j.foreco.2011.01.033; Ulyshen MD, 2009, FOREST ECOL MANAG, V257, P653, DOI 10.1016/j.foreco.2008.09.047; Vance CC, 2003, ENVIRON ENTOMOL, V32, P1066, DOI 10.1603/0046-225X-32.5.1066; Vavra JC, 2013, PRIRODA SLEZSKA; Vodka S, 2013, FOREST ECOL MANAG, V304, P33, DOI 10.1016/j.foreco.2013.04.007; VRSKA T., 2006, DYNAMIKA VYVOJE PRAL; Vrska T, 2009, FOREST ECOL MANAG, V258, P347, DOI 10.1016/j.foreco.2009.03.007; Wermelinger B, 2007, J APPL ENTOMOL, V131, P104, DOI 10.1111/j.1439-0418.2006.01128.x; Wermelinger B, 2004, FOREST ECOL MANAG, V202, P67, DOI 10.1016/j.foreco.2004.07.018; Wu J, 2013, FOREST ECOL MANAG, V292, P29, DOI 10.1016/j.foreco.2012.12.004; Yu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069177; Zou Y, 2014, INSECT CONSERV DIVER, V7, P161, DOI 10.1111/icad.12039	70	25	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149506	10.1371/journal.pone.0149506	http://dx.doi.org/10.1371/journal.pone.0149506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978783	gold, Green Published			2022-12-26	WOS:000372572800015
J	Suparji, NS; Chan, G; Sapili, H; Arshad, NM; In, LLA; Awang, K; Nagoor, NH				Suparji, Noor Shahirah; Chan, Gomathi; Sapili, Hani; Arshad, Norhafiza M.; In, Lionel L. A.; Awang, Khalijah; Nagoor, Noor Hasima			Geranylated 4-Phenylcoumarins Exhibit Anticancer Effects against Human Prostate Cancer Cells through Caspase-Independent Mechanism	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; COUMARIN DERIVATIVES; NEURONAL DEATH; CYTOCHROME-C; APOPTOSIS; AUTOPHAGY; CALPAIN; LINES; AGENTS; SUBSTANCES	Geranylated 4-phenylcoumarins, DMDP-1 & -2 isolated from Mesua elegans were investigated for anticancer potential against human prostate cancer cells. Treatment with DMDP-1 & -2 resulted in cell death in a time and dose dependent manner in an MTT assay on all cancer cell lines tested with the exception of lung adenocarcinoma cells. DMDP-1 showed highest cytotoxic efficacy in PC-3 cells while DMDP-2 was most potent in DU 145 cells. Flow cytometry indicated that both coumarins were successful to induce programmed cell death after 24 h treatment. Elucidation on the mode-of-action via protein arrays and western blotting demonstrated death induced without any significant expressions of caspases, Bcl-2 family proteins and cleaved PARP, thus suggesting the involvement of caspase-independent pathways. In identifying autophagy, analysis of GFP-LC3 showed increased punctate in PC-3 cells pre-treated with CQ and treated with DMDP-1. In these cells decreased expression of autophagosome protein, p62 and cathepsin B further confirmed autophagy. In contrary, the DU 145 cells pre-treated with CQ and treated with DMDP-2 has reduced GFP-LC3 punctate although the number of cells with obvious GFP-LC3 puncta was significantly increased in the inhibitor-treated cells. The increase level of p62 suggested leakage of cathepsin B into the cytosol to trigger potential downstream death mediators. This correlated with increased expression of cathepsin B and reduced expression after treatment with its inhibitor, CA074. Also auto-degradation of calpain-2 upon treatment with DMDP-1 & -2 and its inhibitor alone, calpeptin compared with the combination treatment, further confirmed involvement of calpain-2 in PC-3 and DU 145 cells. Treatment with DMDP-1 & -2 also showed up-regulation of total and phosphorylated p53 levels in a time dependent manner. Hence, DMDP-1 & -2 showed ability to activate multiple death pathways involving autophagy, lysosomal and endoplasmic reticulum death proteins which could potentially be manipulated to develop anti-cancer therapy in apoptosis resistant cells.	[Suparji, Noor Shahirah; Sapili, Hani; Arshad, Norhafiza M.; In, Lionel L. A.; Nagoor, Noor Hasima] Univ Malaya, Fac Sci, Inst Biol Sci Genet & Mol Biol, Kuala Lumpur, Malaysia; [Chan, Gomathi; Awang, Khalijah] Univ Malaya, Fac Sci, Dept Chem, Ctr Nat Prod Res & Drug Discovery CENAR, Kuala Lumpur, Malaysia; [In, Lionel L. A.] UCSI Univ, Fac Sci Appl, Dept Biotechnol, Kuala Lumpur, Malaysia; [Arshad, Norhafiza M.; Nagoor, Noor Hasima] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; UCSI University; Universiti Malaya	Nagoor, NH (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci Genet & Mol Biol, Kuala Lumpur, Malaysia.; Nagoor, NH (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia.	hasima@um.edu.my	AWANG, KHALIJAH/B-8781-2010; IN, LIONEL/AAI-9847-2020; PITCHAI, NOOR HASIMA A K NAGOOR/B-9270-2010; In, Lionel/D-1338-2013; ARSHAD, NORHAFIZA MOHD/N-7615-2018	AWANG, KHALIJAH/0000-0001-5971-6570; IN, LIONEL/0000-0001-7182-112X; In, Lionel/0000-0001-7182-112X; ARSHAD, NORHAFIZA MOHD/0000-0003-1522-3373	University of Malaya Postgraduate Research Grant [PV043-2011A]; University Malaya Research Program [RP001-2012A]	University of Malaya Postgraduate Research Grant; University Malaya Research Program	This study was supported by the University of Malaya Postgraduate Research Grant (PV043-2011A) and University Malaya Research Program (RP001-2012A).	Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Aki T, 2012, CELL BIOL TOXICOL, V28, P125, DOI 10.1007/s10565-012-9212-3; Awaad AS, 2012, PHYTOTHER RES, V26, P452, DOI 10.1002/ptr.3690; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Chan G, 2012, EVID-BASED COMPL ALT, V2012, P18; Chen Y, 2012, EUR J MED CHEM, V49, P74, DOI 10.1016/j.ejmech.2011.12.025; Chi S, 1999, ONCOGENE, V18; Cromb Jones, 1987, J CHEM SOC PERK T, V1, P317; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawaii S, 2001, ANTICANCER RES, V21, P917; Khan KM, 2004, J ENZYM INHIB MED CH, V19, P373, DOI 10.1080/14756360409162453; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kostovo, 2005, CURR MED CHEM, V5, P29; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Linder S, 2005, DRUG RESIST UPDATE, V8, P199, DOI 10.1016/j.drup.2005.06.004; Lopez-Gonzalez JS, 2004, LUNG CANCER-J IASLC, V43, P275, DOI 10.1016/j.lungcan.2003.09.005; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakajima E, 2011, INVEST OPHTH VIS SCI, V52, P7059, DOI 10.1167/iovs.11-7497; Tung NH, 2013, BIOORG MED CHEM LETT, V23, P158, DOI 10.1016/j.bmcl.2012.10.127; OHKUMA S, 1981, J CELL BIOL, V90, P656, DOI 10.1083/jcb.90.3.656; Racoma IO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072882; Roberts Lewis R., 1999, Cell Biochemistry and Biophysics, V30, P71, DOI 10.1007/BF02737885; Rodriguez-Muela N, 2015, CELL DEATH DIFFER, V22, P476, DOI 10.1038/cdd.2014.203; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Verotta L, 2004, PHYTOCHEMISTRY, V65, P2867, DOI 10.1016/j.phytochem.2004.07.001; Wang L, 2006, RECENT PROGR CALOPHY, P325; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yang H, 2008, CURR PROTEIN PEPT SC, V9, P227, DOI 10.2174/138920308784533998; Yu DL, 2003, MED RES REV, V23, P322, DOI 10.1002/med.10034	43	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151472	10.1371/journal.pone.0151472	http://dx.doi.org/10.1371/journal.pone.0151472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974436	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600082
J	Wang, Z; Iida, A; Miyake, N; Nishiguchi, KM; Fujita, K; Nakazawa, T; Alswaid, A; Albalwi, MA; Kim, OH; Cho, TJ; Lim, GY; Isidor, B; David, A; Rustad, CF; Merckoll, E; Westvik, J; Stattin, EL; Grigelioniene, G; Kou, I; Nakajima, M; Ohashi, H; Smithson, S; Matsumoto, N; Nishimura, G; Ikegawa, S				Wang, Zheng; Iida, Aritoshi; Miyake, Noriko; Nishiguchi, Koji M.; Fujita, Kosuke; Nakazawa, Toru; Alswaid, Abdulrahman; Albalwi, Mohammed A.; Kim, Ok-Hwa; Cho, Tae-Joon; Lim, Gye-Yeon; Isidor, Bertrand; David, Albert; Rustad, Cecilie F.; Merckoll, Else; Westvik, Jostein; Stattin, Eva-Lena; Grigelioniene, Giedre; Kou, Ikuyo; Nakajima, Masahiro; Ohashi, Hirohumi; Smithson, Sarah; Matsumoto, Naomichi; Nishimura, Gen; Ikegawa, Shiro			Axial Spondylometaphyseal Dysplasia Is Caused by C21orf2 Mutations	PLOS ONE			English	Article							MESSENGER-RNA; CELL-LINE; I-TASSER; GENE; CLASSIFICATION; PREDICTION; FRAMEWORK; NOSOLOGY; SERVER; ATDC5	Axial spondylometaphyseal dysplasia (axial SMD) is an autosomal recessive disease characterized by dysplasia of axial skeleton and retinal dystrophy. We conducted whole exome sequencing and identified C21orf2 (chromosome 21 open reading frame 2) as a disease gene for axial SMD. C21orf2 mutations have been recently found to cause isolated retinal degeneration and Jeune syndrome. We found a total of five biallelic C21orf2 mutations in six families out of nine: three missense and two splicing mutations in patients with various ethnic backgrounds. The pathogenic effects of the splicing (splice-site and branch-point) mutations were confirmed on RNA level, which showed complex patterns of abnormal splicing. C21orf2 mutations presented with a wide range of skeletal phenotypes, including cupped and flared anterior ends of ribs, lacy ilia and metaphyseal dysplasia of proximal femora. Analysis of patients without C21orf2 mutation indicated genetic heterogeneity of axial SMD. Functional data in chondrocyte suggest C21orf2 is implicated in cartilage differentiation. C21orf2 protein was localized to the connecting cilium of the cone and rod photoreceptors, confirming its significance in retinal function. Our study indicates that axial SMD is a member of a unique group of ciliopathy affecting skeleton and retina.	[Wang, Zheng; Iida, Aritoshi; Kou, Ikuyo; Nakajima, Masahiro; Ikegawa, Shiro] RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Wang, Zheng] Chinese Acad Med Sci, Inst Basic Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China; [Wang, Zheng] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Wang, Zheng] Peking Union Med Coll, Beijing 100005, Peoples R China; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 9808574, Japan; [Fujita, Kosuke; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 9808574, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Opthalmol, Sendai, Miyagi 9808574, Japan; [Alswaid, Abdulrahman] King Abdulaziz Med City Natl Guard Hlth Affairs, Dept Pediat, Riyadh 22490, Saudi Arabia; [Albalwi, Mohammed A.] King Abdulaziz Med City Natl Guard Hlth Affairs, Dept Pathol & Lab Med, Riyadh 22490, Saudi Arabia; [Kim, Ok-Hwa] Woorisoa Childrens Hosp, Dept Radiol, Seoul 08291, South Korea; [Cho, Tae-Joon] Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Seoul 03080, South Korea; [Lim, Gye-Yeon] Catholic Univ, St Marys Hosp, Dept Radiol, Seoul 07345, South Korea; [Isidor, Bertrand; David, Albert] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Isidor, Bertrand; David, Albert] INSERM, UMR S 957, F-44093 Nantes, France; [Rustad, Cecilie F.] Oslo Univ Hosp, Clin Genet Sect, Dept Med Genet, N-0424 Oslo, Norway; [Merckoll, Else; Westvik, Jostein] Oslo Univ Hosp, Dept Radiol, N-0424 Oslo, Norway; [Stattin, Eva-Lena] Umea Univ, Dept Med Biosci Med & Clin Genet, S-90187 Umea, Sweden; [Grigelioniene, Giedre] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Grigelioniene, Giedre] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Ohashi, Hirohumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama 3398551, Japan; [Smithson, Sarah] St Michaels Hosp, Dept Clin Genet, Bristol BS2 8EG, Avon, England; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Fuchu, Tokyo 1838561, Japan	RIKEN; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Yokohama City University; Tohoku University; Tohoku University; Tohoku University; Seoul National University (SNU); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oslo; University of Oslo; Umea University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Saitama Children's Medical Center; Tokyo Metropolitan Children's Medical Center	Ikegawa, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Grigelioniene, Giedre/AAH-8408-2020; Grigelioniene, Giedre/N-6599-2013; Ikegawa, Shiro/N-6895-2015; Isidor, Bertrand/AAJ-3456-2021; Iida, Aritoshi/CAA-1373-2022	Grigelioniene, Giedre/0000-0001-9601-3137; Grigelioniene, Giedre/0000-0001-9601-3137; Ikegawa, Shiro/0000-0003-0316-2147; Isidor, Bertrand/0000-0001-6480-126X; Iida, Aritoshi/0000-0001-7538-1651; Rustad, Cecilie Fremstad/0000-0001-7903-9087; Al Balwi, Mohammed/0000-0003-2910-0390; Cho, Tae-Joon/0000-0001-8514-377X	Japan Agency For Medical Research and Development [M15319]; KAKENHI [26893018, 25293235]; Takeda Science Foundation; Japan Agency For Medical Research and Development (AMED) [M15319]	Japan Agency For Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Agency For Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was funded by No. M15319, Japan Agency For Medical Research and Development, http://www.amed.go.jp/en/, to SI; No. 26893018, KAKENHI Grants-in-Aid for Scientific Research, Research Activity Start-up, https://www.jsps.go.jp/english/e-grants, to KMN; No. 25293235, KAKENHI Grant-in-Aid for Scientific Research (B), https://www.jsps.go.jp/english/e-grants/grants01.html, to N. Miyake; Takeda Science Foundation, http://www.takeda-sci.or.jp/index.html, to ZW, N. Miyake, N. Matsumoto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank N. Atsumi for English revision. This study is supported and by KAKENHI Grants-in-Aid for Scientific Research, Research Activity Start-up (K. M. N., No. 26893018), KAKENHI Grant-in-Aid for Scientific Research (B) (N. Mi., No. 25293235), Takeda Science Foundation (Z. W., N. Mi., N. Ma.), and research grants from Japan Agency For Medical Research and Development (AMED) (S.I. N. Ma, No. M15319).	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ARIKAWA K, 1993, INVEST OPHTH VIS SCI, V34, P2145; Baujat G, 2013, J MED GENET, V50, P91, DOI 10.1136/jmedgenet-2012-101282; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Ehara S, 1997, EUR J PEDIATR, V156, P627, DOI 10.1007/s004310050679; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Isidor B, 2010, AM J MED GENET A, V152A, P1550, DOI 10.1002/ajmg.a.33397; Khan AO, 2015, C21ORF2 IS MUTATED R, P1725, DOI [10.1136/bjophthalmol-2015-307277, DOI 10.1136/BJOPHTHALMOL-2015-307277]; Krohn K, 1997, BIOCHEM BIOPH RES CO, V238, P806, DOI 10.1006/bbrc.1997.7352; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lyamichev Victor, 2003, Methods Mol Biol, V212, P229; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyake N, 2016, CLIN GENET, V89, P115, DOI 10.1111/cge.12586; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nakajima J, 2015, CLIN GENET, V87, P356, DOI 10.1111/cge.12394; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; Nishiguchi KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7006; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Scott HS, 1998, GENOMICS, V47, P64, DOI 10.1006/geno.1997.5066; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Suzuki S, 2011, AM J MED GENET A, V155A, P2521, DOI 10.1002/ajmg.a.34192; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Zhai ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064786; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150555	10.1371/journal.pone.0150555	http://dx.doi.org/10.1371/journal.pone.0150555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974433	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600026
J	Yang, SS; Fresnedo-Ramirez, J; Sun, Q; Manns, DC; Sacks, GL; Mansfield, AK; Luby, JJ; Londo, JP; Reisch, BI; Cadle-Davidson, LE; Fennell, AY				Yang, Shanshan; Fresnedo-Ramirez, Jonathan; Sun, Qi; Manns, David C.; Sacks, Gavin L.; Mansfield, Anna Katharine; Luby, James J.; Londo, Jason P.; Reisch, Bruce I.; Cadle-Davidson, Lance E.; Fennell, Anne Y.			Next Generation Mapping of Enological Traits in an F-2 Interspecific Grapevine Hybrid Family	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; DENSITY GENETIC-MAP; VITIS-VINIFERA; ENVIRONMENTAL COVARIABLES; AGRONOMIC TRAITS; MALIC-ACID; LOCI; WINE; CONSTRUCTION; SEGREGATION	In winegrapes (Vitis spp.), fruit quality traits such as berry color, total soluble solids content (SS), malic acid content (MA), and yeast assimilable nitrogen (YAN) affect fermentation or wine quality, and are important traits in selecting new hybrid winegrape cultivars. Given the high genetic diversity and heterozygosity of Vitis species and their tendency to exhibit inbreeding depression, linkage map construction and quantitative trait locus (QTL) mapping has relied on F-1 families with the use of simple sequence repeat (SSR) and other markers. This study presents the construction of a genetic map by single nucleotide polymorphisms identified through genotyping-by-sequencing (GBS) technology in an F-2 mapping family of 424 progeny derived from a cross between the wild species V. riparia Michx. and the interspecific hybrid winegrape cultivar, 'Seyval'. The resulting map has 1449 markers spanning 2424 cM in genetic length across 19 linkage groups, covering 95% of the genome with an average distance between markers of 1.67 cM. Compared to an SSR map previously developed for this F-2 family, these results represent an improved map covering a greater portion of the genome with higher marker density. The accuracy of the map was validated using the well-studied trait berry color. QTL affecting YAN, MA and SS related traits were detected. A joint MA and SS QTL spans a region with candidate genes involved in the malate metabolism pathway. We present an analytical pipeline for calling intercross GBS markers and a high-density linkage map for a large F-2 family of the highly heterozygous Vitis genus. This study serves as a model for further genetic investigations of the molecular basis of additional unique characters of North American hybrid wine cultivars and to enhance the breeding process by marker-assisted selection. The GBS protocols for identifying intercross markers developed in this study can be adapted for other heterozygous species.	[Yang, Shanshan; Reisch, Bruce I.] Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Geneva, NY USA; [Fresnedo-Ramirez, Jonathan; Sun, Qi] Cornell Univ, Inst Biotechnol, Bioinformat Facil, Rhodes Hall, Ithaca, NY USA; [Manns, David C.; Mansfield, Anna Katharine] Cornell Univ, Dept Food Sci, NYSAES, Geneva, NY USA; [Sacks, Gavin L.] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Luby, James J.] Univ Minnesota, Dept Hort Sci, St Paul, MN USA; [Londo, Jason P.; Cadle-Davidson, Lance E.] ARS, USDA, Grape Genet Res Unit, Geneva, NY USA; [Fennell, Anne Y.] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA; [Fennell, Anne Y.] BioSNTR, Brookings, SD USA	Cornell University; Cornell University; Cornell University; Cornell University; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); South Dakota State University	Fennell, AY (corresponding author), S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA.; Fennell, AY (corresponding author), BioSNTR, Brookings, SD USA.	Anne.Fennell@sdstate.edu	Sacks, Gavin L/B-2686-2009; Yang, Shanshan/G-9513-2018; Fresnedo-Ramírez, Jonathan/C-2811-2011	Fresnedo-Ramírez, Jonathan/0000-0003-1985-2513; Londo, Jason/0000-0003-0535-4820; Sacks, Gavin/0000-0002-1403-0505	United States Department of Agriculture, National Institute of Food and Agriculture Specialty Crops Research Initiative Award [2011-51181-30635]; ARS [ARS-0425016] Funding Source: Federal RePORTER	United States Department of Agriculture, National Institute of Food and Agriculture Specialty Crops Research Initiative Award; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the United States Department of Agriculture, National Institute of Food and Agriculture Specialty Crops Research Initiative Award No. 2011-51181-30635, BIR, LCD, AYF, GLS, JJL, AKM. This fund supported JFR and DCM. This work was also supported by the National Science Foundation Award No. IIA1355423, South Dakota Research Innovation Center and a gift from J. Lohr Vineyards & Wines to AYF. SY was supported by a grant from the National Grape and Wine Initiative to BIR. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the NSF, USDA or other funding entities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; [Anonymous], 2014, R LANG ENV STAT COMP; Azuma A, 2008, THEOR APPL GENET, V117, P1009, DOI 10.1007/s00122-008-0840-1; Banerjee S, 2008, GENETICS, V179, P2275, DOI 10.1534/genetics.108.088427; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Bell SJ, 2005, AUST J GRAPE WINE R, V11, P242, DOI 10.1111/j.1755-0238.2005.tb00028.x; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Boulton R. B., 1999, PRINCIPLES PRACTICES, P65; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brice C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-495; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cardoso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046021; Castellari M, 2000, J LIQ CHROMATOGR R T, V23, P2047, DOI 10.1081/JLC-100100472; Chen J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0428-2; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Di Gaspero G, 2010, AUST J GRAPE WINE R, V16, P122, DOI 10.1111/j.1755-0238.2009.00072.x; Doligez A, 2006, THEOR APPL GENET, V113, P369, DOI 10.1007/s00122-006-0295-1; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fennell A, 2005, ACTA HORTIC, P533, DOI 10.17660/ActaHortic.2005.689.66; Fennell AY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00834; Garris A, 2009, J AM SOC HORTIC SCI, V134, P261, DOI 10.21273/JASHS.134.2.261; Glaser A.I., 2014, GUIDE GENSTAT RELEAS; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GRATTAPAGLIA D, 1995, THEOR APPL GENET, V90, P933, DOI 10.1007/BF00222906; HUANG Z, 1989, AM J ENOL VITICULT, V40, P135; Jackson D., 2001, CLIMATE MONOGRAPHS C; Jackson R. S., 2014, WINE SCI PRINCIPLES; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; JIANG CJ, 1995, GENETICS, V140, P1111; Kanellis AK, 1993, BIOCH FRUIT RIPENING, P189, DOI DOI 10.1007/978-94-011-1584-1_6; Khan SA, 2013, TREE GENET GENOMES, V9, P475, DOI 10.1007/s11295-012-0571-y; KLIEWER W. M., 1967, AMER J ENOL VITICULT, V18, P87; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Lynch M., 1998, GENETICS ANAL QUANTI; Mahanil S, 2012, THEOR APPL GENET, V124, P23, DOI 10.1007/s00122-011-1684-7; Malosetti M, 2004, EUPHYTICA, V137, P139, DOI 10.1023/B:EUPH.0000040511.46388.ef; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Myles S, 2013, TRENDS GENET, V29, P190, DOI 10.1016/j.tig.2013.01.006; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Neto EC, 2013, QTLHOT INFERENCE QTL; Neto EC, 2013, GENETICS, V193, P1003, DOI 10.1534/genetics.112.147124; Nisbet MA, 2014, AM J ENOL VITICULT, V65, P325, DOI 10.5344/ajev.2014.13130; Plomion C, 1996, GENET SEL EVOL, V28, P223, DOI 10.1051/gse:19960302; Reisch BI, 2012, HANDB PLANT BREED, V8, P225, DOI 10.1007/978-1-4419-0763-9_7; Sacks GL, 2013, 15 AUSTR WIN IND TEC; Salmaso M, 2008, THEOR APPL GENET, V116, P1129, DOI 10.1007/s00122-008-0741-3; Sawler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080791; Song SR, 2014, EUPHYTICA, V195, P259, DOI 10.1007/s10681-013-0994-z; Sreekantan L, 2010, PLANT MOL BIOL, V73, P191, DOI 10.1007/s11103-010-9611-x; Staub JE, 1996, HORTSCIENCE, V31, P729, DOI 10.21273/HORTSCI.31.5.729; Stewart A. C., 2013, THESIS PURDUE U; Sun Q, 2011, J AGR FOOD CHEM, V59, P10657, DOI 10.1021/jf2026204; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Sweetman C, 2009, PHYTOCHEMISTRY, V70, P1329, DOI 10.1016/j.phytochem.2009.08.006; Ugliano M, 2011, J IND MICROBIOL BIOT, V38, P423, DOI 10.1007/s10295-010-0786-6; Ugliano Maurizio, 2009, P313, DOI 10.1007/978-0-387-74118-5_14; Van Ooijen J, 2006, JOINMAP 4 SOFTWARE C; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; VanOoijen JW, 2013, GENETIC MAPPING IN EXPERIMENTAL POPULATIONS, P1, DOI 10.1017/CBO9781139003889; Viana AP, 2013, GENET MOL RES, V12, P951, DOI 10.4238/2013.April.2.11; Volschenk H., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P123; VSN International, 2014, GENSTAT WIND; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wu RL, 2002, THEOR POPUL BIOL, V61, P349, DOI 10.1006/tpbi.2002.1577; Xu CW, 2005, GENETICS, V169, P1045, DOI 10.1534/genetics.103.019406; Yang RQ, 2008, GENETICA, V132, P323, DOI 10.1007/s10709-007-9175-0; Yang RQ, 2010, GENETICA, V138, P853, DOI 10.1007/s10709-010-9468-6; Young PR, 2010, WOODHEAD PUBL FOOD S, P316, DOI 10.1533/9781845699284.3.316; Zhu WS, 2009, J KOREAN STAT SOC, V38, P1, DOI 10.1016/j.jkss.2008.10.006	75	26	27	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149560	10.1371/journal.pone.0149560	http://dx.doi.org/10.1371/journal.pone.0149560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974672	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600012
J	Heinrich, A; Haarmann, H; Zahradnik, S; Frenzel, K; Schreiber, F; Klassert, TE; Heyl, KA; Endres, AS; Schmidtke, M; Hofmann, J; Slevogt, H				Heinrich, Annina; Haarmann, Helge; Zahradnik, Sabrina; Frenzel, Katrin; Schreiber, Frauke; Klassert, Tilman E.; Heyl, Kerstin A.; Endres, Anne-Sophie; Schmidtke, Michaela; Hofmann, Joerg; Slevogt, Hortense			Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells	FASEB JOURNAL			English	Article						bacterial colonization; viral infection; lung cancer; COPD; tumor suppressor	TOLL-LIKE RECEPTOR-3; INFLAMMATORY RESPONSE; RHINOVIRAL INFECTION; VIRAL-INFECTION; EXPRESSION; ASTHMA; DEFICIENT; BACTERIAL; DISEASE; COPD	Chronic obstructive pulmonary disease (COPD) is complicated by infectious exacerbations with acute worsening of respiratory symptoms. Coinfections of bacterial and viral pathogens are associated with more severe exacerbations. Moraxella catarrhalis is one of the most frequent lower respiratory tract pathogens detected in COPD. We therefore studied the impact of M. catarrhalis on the antiviral innate immune response that is mediated via TLR3 and p53. Molecular interactions between M. catarrhalis and normal human bronchial epithelial (NHBE) cells as well as Beas-2B cells were studied using flow cytometry, quantitative PCR analysis, chromatin immunoprecipitation, RNA interference, and ELISA. M. catarrhalis induces a significant down-regulation of TLR3 in human bronchial epithelial cells. In M. catarrhalis-infected cells, expression of p53 was decreased. We detected a reduced binding of p53 to the tlr3 promoter, resulting in reduced TLR3 gene transcription. M. catarrhalis diminished the TLR3-dependent secretion of IFN-, IFN-, and chemokine (C-X-C motif) ligand 8. In addition in M. catarrhalis infected cells, expression of rhinovirus type 1A RNA was increased compared with uninfected cells. M. catarrhalis reduces antiviral defense functions of bronchial epithelial cells, which may increase susceptibility to viral infections.Heinrich, A., Haarmann, H., Zahradnik, S., Frenzel, K., Schreiber, F., Klassert, T. E., Heyl, K. A., Endres, A.-S., Schmidtke, M., Hofmann, J., Slevogt, H. Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells.	[Heinrich, Annina; Schreiber, Frauke; Klassert, Tilman E.; Heyl, Kerstin A.; Slevogt, Hortense] Jena Univ Hosp, Sch Med, Sept Res Ctr, Jena, Germany; [Schmidtke, Michaela] Jena Univ Hosp, Sch Med, Dept Virol & Antiviral Therapy, Jena, Germany; [Haarmann, Helge] Univ Med Ctr Gottingen, Clin Cardiol & Pneumol, Gottingen, Germany; [Zahradnik, Sabrina] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Frenzel, Katrin; Hofmann, Joerg] Charite, Inst Med Virol, D-13353 Berlin, Germany; [Endres, Anne-Sophie] Evangel Geriatriezentum Berlin, Berlin, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Slevogt, H (corresponding author), Univ Hosp Jena, ZIK Sept, Host Sept, Albert Einstein Str 10, D-07745 Jena, Germany.	hortense.slevogt@med.uni-jena.de		Heyl, Kerstin/0000-0001-9659-2300; Hofmann, Joerg/0000-0003-3966-515X	German Respiratory Society; Federal Ministry for Education and Science [BMBF 03Z2JN22]	German Respiratory Society; Federal Ministry for Education and Science	This study was supported by the German Respiratory Society and by the Federal Ministry for Education and Science (BMBF 03Z2JN22) ( both to H.S.). The authors declare no conflict of interest.	Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frenzel K, 2012, MED MICROBIOL IMMUN, V201, P277, DOI 10.1007/s00430-012-0229-2; George SN, 2014, EUR RESPIR J, V44, P87, DOI 10.1183/09031936.00223113; Gielen V, 2015, J ALLERGY CLIN IMMUN, V136, P177, DOI 10.1016/j.jaci.2014.11.039; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Gulraiz F, 2015, FASEB J, V29, P849, DOI 10.1096/fj.14-254359; Gutbier B, 2015, AM J PHYSIOL-LUNG C, V309, pL250, DOI 10.1152/ajplung.00265.2014; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Matsumoto K, 2014, RESPIR INVESTIG, V52, P92, DOI 10.1016/j.resinv.2013.08.005; McManus TE, 2008, RESP MED, V102, P1575, DOI 10.1016/j.rmed.2008.06.006; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Mohan A, 2010, RESPIROLOGY, V15, P536, DOI 10.1111/j.1440-1843.2010.01722.x; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Pan ZK, 2011, INT IMMUNOL, V23, P357, DOI 10.1093/intimm/dxr019; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Parker LC, 2014, CLIN EXP ALLERGY, V44, P20, DOI 10.1111/cea.12182; Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002; Sajjan US, 2006, FASEB J, V20, P2121, DOI 10.1096/fj.06-5806fje; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sethi Sanjay, 2008, N Engl J Med, V359, P2355, DOI 10.1056/NEJMra0800353; Singer BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094106; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Slevogt H, 2006, AM J PHYSIOL-LUNG C, V290, pL818, DOI 10.1152/ajplung.00428.2005; Slevogt H, 2006, MED MICROBIOL IMMUN, V195, P73, DOI 10.1007/s00430-005-0003-9; Spaniol V, 2008, MICROBES INFECT, V10, P3, DOI 10.1016/j.micinf.2007.09.014; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Thibaut H. J., 2015, REV MED VIROL; Vareille M, 2012, THORAX, V67, P517, DOI 10.1136/thoraxjnl-2011-200405; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2013, RESPIROLOGY, V18, P996, DOI 10.1111/resp.12099; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; World Health Organization, 2016, CHRON RESP DIS CHRON; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Zaika AI, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005099; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	46	13	13	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2426	2434		10.1096/fj.201500172R	http://dx.doi.org/10.1096/fj.201500172R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26979086				2022-12-26	WOS:000376878300030
J	Sun, T; Fu, JJ; Shen, T; Lin, X; Liao, L; Feng, XH; Xu, JM				Sun, Tong; Fu, Junjiang; Shen, Tao; Lin, Xia; Liao, Lan; Feng, Xin-Hua; Xu, Jianming			The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)(68)-Twist1 to Accelerate Twist1 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; TUMOR-METASTASIS; PROMOTES INVASION; POOR SURVIVAL; EXPRESSION; PHOSPHORYLATION; FAMILY; CARCINOMA; APOPTOSIS; COMPLEX	Twist1 is a basic helix-loop-helix transcription factor that strongly promotes epithelial-to-mesenchymal transition, migration, invasion, and metastasis of cancer cells. The MAPK-phosphorylated Twist1 on its serine 68 (Ser(P)(68)-Twist1) has a significantly enhanced stability and function to drive cancer cell invasion and metastasis. However, the phosphatase that dephosphorylates Ser(P)(68)-Twist1 and destabilizes Twist1 has not been identified and characterized. In this study, we screened a serine/threonine phosphatase cDNA expression library in HEK293T cells with ectopically coexpressed Twist1. We found that the small C-terminal domain phosphatase 1 (SCP1) specifically dephosphorylates Ser(P)(68)-Twist1 in both cell-free reactions and living cells. SCP1 uses its amino acid residues 43-63 to interact with the N terminus of Twist1. Increased SCP1 expression in cells decreased Ser(P)(68)-Twist1 and total Twist1 proteins, whereas knockdown of SCP1 increased Ser(P)(68)-Twist1 and total Twist1 proteins. Furthermore, the levels of SCP1 are negatively correlated with Twist1 protein levels in several cancer cell lines. SCP1-dephosphorylated Twist1 undergoes fast degradation via the ubiquitin-proteasome pathway. Importantly, an increase in SCP1 expression in breast cancer cells with either endogenous or ectopically expressed Twist1 largely inhibits the Twist1-induced epithelial-to-mesenchymal transition phenotype and the migration and invasion capabilities of these cells. These results indicate that SCP1 is the phosphatase that counterregulates the MAPK-mediated phosphorylation of Ser(68)-Twist1. Thus, an increase in SCP1 expression and activity may be a useful strategy for eliminating the detrimental roles of Twist1 in cancer cells.	[Sun, Tong; Fu, Junjiang; Shen, Tao; Liao, Lan; Feng, Xin-Hua; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, 1 Baylor Plaza, Houston, TX 77030 USA; [Fu, Junjiang; Xu, Jianming] Southwest Med Univ, Res Ctr Preclin Med, Inst Canc Med, Luzhou 646000, Sichuan, Peoples R China; [Fu, Junjiang; Xu, Jianming] Southwest Med Univ, Coll Basic Med Sci, Luzhou 646000, Sichuan, Peoples R China; [Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Signaling Networks, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Tong] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Southwest Medical University; Southwest Medical University; Zhejiang University; Zhejiang University; Nanjing Medical University	Xu, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	jxu@bcm.edu	Sun, Tong/E-8493-2017		National Institutes of Health [CA112403, CA193455, DK073932, AR053591]; Cancer Prevention and Research Institute of Texas [RP120732-P5, RP150197]; Department of Defense Breast Cancer Research Program [1W81XWH-15-1-0650]; NATIONAL CANCER INSTITUTE [R01CA112403, R01CA193455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants CA112403 and CA193455 (to J. X.), DK073932 (to X. L.), and AR053591 (to X. H. F.); Cancer Prevention and Research Institute of Texas Grants RP120732-P5 and RP150197 (to J. X.), and Department of Defense Breast Cancer Research Program Grant 1W81XWH-15-1-0650 (to X. H. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3054; Chandrasekaran S, 2014, INT J MOL SCI, V15, P20209, DOI 10.3390/ijms151120209; Chen HF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5697; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Fu JJ, 2012, INT J BIOL SCI, V8, P522, DOI 10.7150/ijbs.4164; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim YJ, 2014, BIOCHEM BIOPH RES CO, V448, P189, DOI 10.1016/j.bbrc.2014.04.089; Lander R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2543; Li S, 2014, INT J ONCOL, V44, P1806, DOI 10.3892/ijo.2014.2362; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Ma G, 2015, INT J BIOL SCI, V11, P618, DOI 10.7150/ijbs.11380; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Scherbakov AM, 2012, J CELL BIOCHEM, V113, P2147, DOI 10.1002/jcb.24087; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shibata K, 2008, ANN ONCOL, V19, P81, DOI 10.1093/annonc/mdm344; Su YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019412; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wang Yifan, 2013, Cancer Hallm, V1, P38; Weinberg RA, 2007, BIOL CANC; Weiss MB, 2012, CANCER RES, V72, P6382, DOI 10.1158/0008-5472.CAN-12-1033; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zhong JT, 2013, DISCOV MED, V15, P7	41	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11518	11528		10.1074/jbc.M116.721795	http://dx.doi.org/10.1074/jbc.M116.721795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	26975371	Green Published, hybrid			2022-12-26	WOS:000377264800005
J	Fajardo, AM; MacKenzie, DA; Olguin, SL; Scariano, JK; Rabinowitz, I; Thompson, TA				Fajardo, Alexandra M.; MacKenzie, Debra A.; Olguin, Sarah L.; Scariano, John K.; Rabinowitz, Ian; Thompson, Todd A.			Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells	PLOS ONE			English	Article							PREVENTION TRIAL SELECT; VITAMIN-E; BRONCHOALVEOLAR LAVAGE; TOCOPHEROL QUINONES; BETA-CAROTENE; LINE LNCAP; RISK; GROWTH; EXPRESSION; CASTRATION	Tocopherylquinone (TQ), the oxidation product of alpha-tocopherol (AT), is a bioactive molecule with distinct properties from AT. In this study, AT and TQ are investigated for their comparative effects on growth and androgenic activity in prostate cancer cells. TQ potently inhibited the growth of androgen-responsive prostate cancer cell lines (e.g., LAPC4 and LNCaP cells), whereas the growth of androgen-independent prostate cancer cells (e.g., DU145 cells) was not affected by TQ. Due to the growth inhibitory effects induced by TQ on androgen-responsive cells, the anti-androgenic properties of TQ were examined. TQ inhibited the androgen-induced activation of an androgen-responsive reporter and inhibited the release of prostate specific antigen from LNCaP cells. TQ pretreatment was also found to inhibit AR activation as measured using the Multifunctional Androgen Receptor Screening assay. Furthermore, TQ decreased androgen-responsive gene expression, including TM4SF1, KLK2, and PSA over 5-fold, whereas AT did not affect the expression of androgen- responsive genes. Of importance, the antiandrogenic effects of TQ on prostate cancer cells were found to result from androgen receptor protein down-regulation produced by TQ that was not observed with AT treatment. Moreover, none of the androgenic endpoints assessed were affected by AT. The down-regulation of androgen receptor protein by TQ was abrogated by co-treatment with antioxidants. Overall, the biological actions of TQ were found to be distinct from AT, where TQ was found to be a potent inhibitor of cell growth and androgenic activity in androgen-responsive prostate cancer cells.	[Fajardo, Alexandra M.; MacKenzie, Debra A.; Olguin, Sarah L.; Thompson, Todd A.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Scariano, John K.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Rabinowitz, Ian] Univ New Mexico, Sch Med, Dept Internal Med, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Rabinowitz, Ian; Thompson, Todd A.] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico	Thompson, TA (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.; Thompson, TA (corresponding author), Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA.	tthompson@salud.unm.edu			National Institutes of Health Grant [1 R03 CA133941]; University of New Mexico Cancer Center Focus-Interactive Group Award; NATIONAL CANCER INSTITUTE [R03CA133941] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Cancer Center Focus-Interactive Group Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by National Institutes of Health Grant, grant number: 1 R03 CA133941 (TAT) and the University of New Mexico Cancer Center Focus-Interactive Group Award (TAT and IR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigelius-Flohe R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145; Chan JM, 1999, CANCER EPIDEM BIOMAR, V8, P893; Cheng TYD, 2011, J NUTR, V141, P1731, DOI 10.3945/jn.111.141713; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Cornwell DG, 2007, VITAM HORM, V76, P99, DOI 10.1016/S0083-6729(07)76005-3; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199; Dennis MK, 2008, CYTOM PART A, V73A, P390, DOI 10.1002/cyto.a.20552; Dolfi SC, 2013, J AGR FOOD CHEM, V61, P8533, DOI 10.1021/jf401076g; DOWD P, 1995, P NATL ACAD SCI USA, V92, P8171, DOI 10.1073/pnas.92.18.8171; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gomez L, 2015, STEROIDS, V95, P80, DOI 10.1016/j.steroids.2014.12.021; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Heer R, 2007, J CELL PHYSIOL, V212, P572, DOI 10.1002/jcp.21154; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Kirsh VA, 2006, JNCI-J NATL CANCER I, V98, P245, DOI 10.1093/jnci/djj050; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; LANGELER EG, 1993, PROSTATE, V23, P213, DOI 10.1002/pros.2990230304; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Ni J, 2003, BIOCHEM BIOPH RES CO, V300, P357, DOI 10.1016/S0006-291X(02)02851-6; Peters U, 2008, CANCER CAUSE CONTROL, V19, P75, DOI 10.1007/s10552-007-9072-y; Prins G S, 2000, Mayo Clin Proc, V75 Suppl, pS32; Rodriguez C, 2004, CANCER EPIDEM BIOMAR, V13, P378; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; TANGNEY CC, 1989, J AM COLL NUTR, V8, P203; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Thompson IM, 2009, J UROLOGY, V182, P499, DOI 10.1016/j.juro.2009.04.015; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thompson TA, 2003, MOL CANCER THER, V2, P797; THOMPSON TA, 1993, IN VITRO CELL DEV-AN, V29, P165, DOI 10.1007/BF02630949; WILDING G, 1995, CANCER SURV, V23, P43; WURZEL H, 1995, J BIOCHEM TOXICOL, V10, P11; Xu JC, 2001, CANCER RES, V61, P1563; Yang Q, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-8; YOUNG CYF, 1991, CANCER RES, V51, P3748; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zhang Y, 2002, P NATL ACAD SCI USA, V99, P7408, DOI 10.1073/pnas.102014399; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	41	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151525	10.1371/journal.pone.0151525	http://dx.doi.org/10.1371/journal.pone.0151525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986969	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300083
J	Hicks, KM; Onambele, GL; Winwood, K; Morse, CI				Hicks, K. M.; Onambele, G. L.; Winwood, K.; Morse, C. I.			Muscle Damage following Maximal Eccentric Knee Extensions in Males and Females	PLOS ONE			English	Article							CREATINE-KINASE RESPONSE; GENDER-DIFFERENCES; SEX-DIFFERENCES; IN-VIVO; EXERCISE; TENDON; FORCE; BEHAVIOR; CONTRACTIONS; FATIGUE	Aim To investigate whether there is a sex difference in exercise induced muscle damage. Materials and Method Vastus Lateralis and patella tendon properties were measured in males and females using ultrasonography. During maximal voluntary eccentric knee extensions (12 reps x 6 sets), Vastus Lateralis fascicle lengthening and maximal voluntary eccentric knee extensions torque were recorded every 10 degrees of knee joint angle (20-90 degrees). Isometric torque, Creatine Kinase and muscle soreness were measured pre, post, 48, 96 and 168 hours post damage as markers of exercise induced muscle damage. Results Patella tendon stiffness and Vastus Lateralis fascicle lengthening were significantly higher in males compared to females (p<0.05). There was no sex difference in isometric torque loss and muscle soreness post exercise induced muscle damage (p>0.05). Creatine Kinase levels post exercise induced muscle damage were higher in males compared to females (p<0.05), and remained higher when maximal voluntary eccentric knee extension torque, relative to estimated quadriceps anatomical cross sectional area, was taken as a covariate (p<0.05). Conclusion Based on isometric torque loss, there is no sex difference in exercise induced muscle damage. The higher Creatine Kinase in males could not be explained by differences in maximal voluntary eccentric knee extension torque, Vastus Lateralis fascicle lengthening and patella tendon stiffness. Further research is required to understand the significant sex differences in Creatine Kinase levels following exercise induced muscle damage.	[Hicks, K. M.] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Hicks, K. M.; Onambele, G. L.; Winwood, K.; Morse, C. I.] Manchester Metropolitan Univ Cheshire, Dept Exercise & Sport Sci, Inst Performance Res, Manchester, Lancs, England	Northumbria University; Manchester Metropolitan University	Hicks, KM (corresponding author), Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.; Hicks, KM (corresponding author), Manchester Metropolitan Univ Cheshire, Dept Exercise & Sport Sci, Inst Performance Res, Manchester, Lancs, England.	Kirsty.Hicks@northumbria.ac.uk	Onambélé-Pearson, Gladys Leopoldine/F-1679-2013; Morse, Christopher/AAE-7913-2022	Onambélé-Pearson, Gladys Leopoldine/0000-0002-1466-3265; Morse, Christopher/0000-0002-5261-2637; Winwood, Keith/0000-0002-8696-9976; Hicks, Kirsty/0000-0002-5057-9191	Institute for Performance Research at Manchester Metropolitan University Cheshire; Liverpool Football Club	Institute for Performance Research at Manchester Metropolitan University Cheshire; Liverpool Football Club	The funder (Liverpool Football Club) provided support in the form of salaries for authors (KMH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was also supported by the Institute for Performance Research at Manchester Metropolitan University Cheshire. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; Borsa PA, 2000, MED SCI SPORT EXER, V32, P891; BROWN JB, 1955, LANCET, V1, P320; Bryant AL, 2008, J APPL PHYSIOL, V105, P1035, DOI 10.1152/japplphysiol.01281.2007; CAROLAN B, 1992, J APPL PHYSIOL, V73, P911, DOI 10.1152/jappl.1992.73.3.911; Chapman D, 2006, INT J SPORTS MED, V27, P591, DOI 10.1055/s-2005-865920; Chapman DW, 2008, BRIT J SPORT MED, V42, P585, DOI 10.1136/bjsm.2007.037929; Chen TC, 2011, EUR J APPL PHYSIOL, V111, P211, DOI 10.1007/s00421-010-1648-7; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Dannecker EA, 2012, J PAIN, V13, P1242, DOI 10.1016/j.jpain.2012.09.014; Erskine RM, 2014, J BIOMECHANICS; Finni T, 2003, ACTA PHYSIOL SCAND, V177, P483, DOI 10.1046/j.1365-201X.2003.01069.x; Fredsted A, 2008, J STRENGTH COND RES, V22, P1136, DOI 10.1519/JSC.0b013e318173db9b; Friden J, 2001, SCAND J MED SCI SPOR, V11, P126, DOI 10.1034/j.1600-0838.2001.011002126.x; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Grosset JF, 2008, ANAT REC, V291, P1673, DOI 10.1002/ar.20759; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Heled Y, 2007, J APPL PHYSIOL, V103, P504, DOI 10.1152/japplphysiol.00081.2007; Hicks KM, 2013, ACTA PHYSIOL, V209, P235, DOI 10.1111/apha.12159; Hody S, 2013, SCAND J MED SCI SPOR, V23, P501, DOI 10.1111/j.1600-0838.2011.01413.x; Hoffman BW, 2014, J APPL PHYSIOL, V116, P1455, DOI 10.1152/japplphysiol.01431.2012; Jamurtas AZ, 2005, EUR J APPL PHYSIOL, V95, P179, DOI 10.1007/s00421-005-1345-0; Joyce S, 2014, EUROPEAN J APPL PHYS, P1; Komulainen J, 1999, ACTA PHYSIOL SCAND, V165, P57; Lichtwark GA, 2007, J BIOMECH, V40, P1768, DOI 10.1016/j.jbiomech.2006.07.025; LIEBER RL, 1993, J APPL PHYSIOL, V74, P520, DOI 10.1152/jappl.1993.74.2.520; LIPPOLD OCJ, 1952, J PHYSIOL-LONDON, V117, P492, DOI 10.1113/jphysiol.1952.sp004763; Machado M, 2012, RES Q EXERCISE SPORT, V83, P276, DOI 10.1080/02701367.2012.10599858; McHugh MP, 1999, AM J SPORT MED, V27, P594, DOI 10.1177/03635465990270050801; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; NEWHAM DJ, 1983, MUSCLE NERVE, V6, P380, DOI 10.1002/mus.880060507; Nosaka K, 1996, INT J SPORTS MED, V17, P120, DOI 10.1055/s-2007-972819; Onambele GNL, 2007, J ORTHOP RES, V25, P1635, DOI 10.1002/jor.20404; Reeves ND, 2004, EUR J APPL PHYSIOL, V91, P116, DOI 10.1007/s00421-003-0961-9; Reeves ND, 2003, J APPL PHYSIOL, V95, P1090, DOI 10.1152/japplphysiol.01046.2002; Rinard J, 2000, J SPORT SCI, V18, P229, DOI 10.1080/026404100364965; Roberts TJ, 2013, EXERC SPORT SCI REV, V41, P186, DOI 10.1097/JES.0b013e3182a4e6d5; Roberts TJ, 2010, J APPL PHYSIOL, V109, P396, DOI 10.1152/japplphysiol.01272.2009; Sayers SP, 2001, EUR J APPL PHYSIOL, V84, P122, DOI 10.1007/s004210000346; Sewright KA, 2008, MED SCI SPORT EXER, V40, P242, DOI 10.1249/mss.0b013e31815aedda; Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325; Tsakoniti AE, 2008, J APPL PHYSIOL, V105, P800, DOI 10.1152/japplphysiol.00961.2007; Walsh LD, 2004, J PHYSIOL-LONDON, V558, P705, DOI 10.1113/jphysiol.2004.062703; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; WARREN GL, 1993, J PHYSIOL-LONDON, V464, P457, DOI 10.1113/jphysiol.1993.sp019645; WISEMAN H, 1994, FREE RADICAL RES, V21, P187, DOI 10.3109/10715769409056569; Wolf MR, 2012, EUR J APPL PHYSIOL, V112, P3335, DOI 10.1007/s00421-012-2314-z	47	39	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150848	10.1371/journal.pone.0150848	http://dx.doi.org/10.1371/journal.pone.0150848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986066	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000372580300029
J	Hu, XJ; Zhang, H; Lu, HF; Qian, GR; Lv, LX; Zhang, CX; Guo, J; Jiang, HY; Zheng, BW; Yang, FL; Gu, SL; Chen, YT; Bao, QL; Yu, L; Jiang, XW; Hu, Q; Shi, HY; Gao, HN; Li, LJ				Hu, Xinjun; Zhang, Hua; Lu, Haifeng; Qian, Guirong; Lv, Longxian; Zhang, Chunxia; Guo, Jing; Jiang, Haiyin; Zheng, Beiwen; Yang, Fengling; Gu, Silan; Chen, Yuanting; Bao, Qiongling; Yu, Liang; Jiang, Xiawei; Hu, Qian; Shi, Haiyan; Gao, Hainv; Li, Lanjuan			The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus	PLOS ONE			English	Article							GEL-ELECTROPHORESIS ANALYSIS; 16S RIBOSOMAL-RNA; CLOSTRIDIUM-BUTYRICUM; IMMUNE-RESPONSES; GUT MICROBIOTA; DOUBLE-BLIND; BACTERIA; COMMUNITIES; DIVERSITY; MUTUALISM	Background A novel avian-origin influenza A (H7N9) virus emerged and spread among humans in Eastern China in 2013. Prophylactic treatment with antibiotics and probiotics for secondary infection is as important as antiviral treatment. This study aims to assess the ability of probiotic treatment to restore internal homeostasis under antibiotic pressure and to reduce/ameliorate the risk of secondary infections resulting from infection with the H7N9 virus. Methods This is a retrospective study in archival samples. Between April 1 and May 10, 2013, 113 stool, sputum, and blood specimens were collected and analyzed by denaturing gradient gel electrophoresis (DGGE) to determine the composition of the patient microbiomes. Microbial diversity was calculated using Gel-Pro analyzer and Past software. Cluster analysis of DGGE pattern profiles was employed to create a phylogenetic tree for each patient, and multidimensional scaling (MDS) and principal component analysis (PCA) were performed to visualize relationships between individual lanes. Results Five patients had secondary infections, including Klebsiella pneumonia, Acinetobacter baumanii and Candida albicans infection. The DGGE profiles of fecal samples obtained at different time points from the same individual were clearly different, particularly for patients with secondary infections. Shannon's diversity index and evenness index were lower in all infected groups compared to the control group. After B. subtilis and E. faecium or C. butyricum administration, the fecal bacterial profiles of patients who had not been treated with antibiotics displayed a trend of increasing diversity and evenness. C. butyricum failed to reduce/ameliorate secondary infection in H7N9-infected patients, but administration of B. subtilis and E. faecium appeared to reduce/ameliorate secondary infection in one patient. Conclusion H7N9 infection might decrease intestinal microbial diversity and species richness in humans. C. butyricum failed to reduce/ameliorate secondary infection in H7N9-infected patients. B. subtilis and E. faecium may also play a role in reducing/ameliorating secondary infection in these patients.	[Hu, Xinjun; Zhang, Hua; Lu, Haifeng; Qian, Guirong; Lv, Longxian; Guo, Jing; Jiang, Haiyin; Zheng, Beiwen; Yang, Fengling; Gu, Silan; Chen, Yuanting; Bao, Qiongling; Yu, Liang; Jiang, Xiawei; Hu, Qian; Shi, Haiyan; Gao, Hainv; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Xinjun] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Infect Dis, Luoyang 471003, Peoples R China; [Hu, Xinjun] Henan Univ Sci & Technol, Coll Clin Med, Luoyang 471003, Peoples R China; [Zhang, Chunxia] Zhejiang Univ, Affiliated Hosp 1, Dept Geriatr, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Henan University of Science & Technology; Henan University of Science & Technology; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			National Basic Research Program of China (973 program) [2013CB531401]; Key Program of the National Natural Science Foundation of China [81330011]; Scientific Research Fund of the Department of Education of Zhejiang Province [Y200805384]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of the Department of Education of Zhejiang Province	This study was supported by the National Basic Research Program of China (973 program) (No. 2013CB531401), the Key Program of the National Natural Science Foundation of China (No. 81330011), and the Scientific Research Fund of the Department of Education of Zhejiang Province (Y200805384).; This study was supported by the National Basic Research Program of China (973 program) (No. 2013CB531401), the Key Program of the National Natural Science Foundation of China (No. 81330011), and the Scientific Research Fund of the Department of Education of Zhejiang Province (Y200805384). The authors do not have any commercial or other associations that might pose a conflict of interest.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763; de Vrese M, 2006, VACCINE, V24, P6670, DOI 10.1016/j.vaccine.2006.05.048; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fooladi AAI, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.7521; Forsythe P, 2011, CHEST, V139, P901, DOI 10.1378/chest.10-1861; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Hedlund M, 2010, J INFECT DIS, V201, P1007, DOI 10.1086/651170; Hogenauer C, 1998, CLIN INFECT DIS, V27, P702, DOI 10.1086/514958; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Imase K, 2008, MICROBIOL IMMUNOL, V52, P156, DOI 10.1111/j.1348-0421.2008.00026.x; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Karlsson C, 2010, ATHEROSCLEROSIS, V208, P228, DOI 10.1016/j.atherosclerosis.2009.06.019; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Macfarlane S, 2014, ENVIRON MICROBIOL, V16, P919, DOI 10.1111/1462-2920.12399; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Morrow LE, 2010, AM J RESP CRIT CARE, V182, P1058, DOI 10.1164/rccm.200912-1853OC; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sato R, 1997, MICROBIOL IMMUNOL, V41, P665, DOI 10.1111/j.1348-0421.1997.tb01909.x; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Wang C, 2014, CLIN INFECT DIS, V58, P1095, DOI 10.1093/cid/ciu053; Wilks J, 2013, IMMUNOL REV, V255, P222, DOI 10.1111/imr.12097; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	43	11	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151976	10.1371/journal.pone.0151976	http://dx.doi.org/10.1371/journal.pone.0151976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987119	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300157
J	Meyer, HE; Stoer, NC; Samuelsen, SO; Blomhoff, R; Robsahm, TE; Brustad, M; Giovannucci, EL; Bjorge, T				Meyer, Haakon E.; Stoer, Nathalie C.; Samuelsen, Sven O.; Blomhoff, Rune; Robsahm, Trude E.; Brustad, Magritt; Giovannucci, Edward L.; Bjorge, Tone			Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men	PLOS ONE			English	Article							NESTED CASE-CONTROL; PROSTATE-CANCER RISK; VITAMIN-D CONCENTRATIONS; J-SHAPED ASSOCIATION; CARDIOVASCULAR-DISEASE; GENETIC-VARIATION; METAANALYSIS; CONSORTIUM	Objective A number of observational studies have shown an inverse association between circulating 25-hydroxyvitamin D and total mortality, but a reverse J-shaped association has also been reported. In a large nested case-control study, serum-25-hydroxyvitamin D (s-25(OH)D) was positively associated with incident prostate cancer. Based on the same study population, the primary aim of the present study was to investigate the association between s-25 (OH)D and total mortality. Methods Men participating in population based health screenings during 1981-1991 and enrolled in a nested case-control study were followed throughout 2007 with respect to all-cause and cause-specific mortality. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated using Cox proportional hazards regression. Results In men with prostate cancer (n = 2282), there was a significant inverse association between s-25(OH)D and total mortality after controlling for potential confounders (HR = 1.25 (95% CI 1.05-1.50), s-25(OH)D <50 nmol/l versus s-25(OH)D >= 50 nmol/l). The corresponding figure among controls (n = 2147) was HR = 1.15 (95% CI 0.88-1.50) and in the total study population HR = 1.19 (95% CI 1.03-1.38). For cause-specific deaths, we found no significant associations. Conclusions In this study population, s-25(OH)D was inversely associated with total mortality during more than two decades of follow-up, despite, as previous reported, high s-25(OH)D was associated with increased risk of prostate cancer.	[Meyer, Haakon E.] Univ Oslo, Fac Med, Dept Community Med, Oslo, Norway; [Meyer, Haakon E.; Stoer, Nathalie C.; Samuelsen, Sven O.] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Meyer, Haakon E.; Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Stoer, Nathalie C.; Samuelsen, Sven O.] Univ Oslo, Dept Math, Fac Math & Nat Sci, Oslo, Norway; [Stoer, Nathalie C.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Blomhoff, Rune] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Blomhoff, Rune] Oslo Univ Hosp, Div Canc Surg & Transplantat, N-0450 Oslo, Norway; [Robsahm, Trude E.] Canc Registry Norway, Inst Populat Based Canc Res, Oslo, Norway; [Brustad, Magritt] Artic Univ Norway, Dept Community Med, UIT, Tromso, Norway; [Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bjorge, Tone] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; Karolinska Institutet; University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; Harvard University; Harvard T.H. Chan School of Public Health; University of Bergen	Meyer, HE (corresponding author), Univ Oslo, Fac Med, Dept Community Med, Oslo, Norway.; Meyer, HE (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.; Meyer, HE (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	h.e.meyer@medisin.uio.no	Meyer, Haakon E./AAH-9333-2019	Bjorge, Tone/0000-0002-9096-5257; Meyer, Haakon E/0000-0002-3262-8260; Stoer, Nathalie C./0000-0001-8994-9332	Norwegian Cancer Society; Throne Holst Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Throne Holst Foundation	The serum analysis of vitamins was supported by a grant from the Norwegian Cancer Society and the Throne Holst Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Albanes D, 2011, CANCER EPIDEM BIOMAR, V20, P1850, DOI 10.1158/1055-9965.EPI-11-0403; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007469.pub2; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Durup D, 2015, J CLIN ENDOCR METAB, V100, P2339, DOI 10.1210/jc.2014-4551; Keum N, 2014, BRIT J CANCER, V111, P976, DOI 10.1038/bjc.2014.294; Khaw KT, 2014, AM J CLIN NUTR, V100, P1361, DOI 10.3945/ajcn.114.086413; Meyer HE, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h321; Meyer HE, 2013, AM J CLIN NUTR, V97, P147, DOI 10.3945/ajcn.112.039222; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; Samuelsen SO, 1997, BIOMETRIKA, V84, P379, DOI 10.1093/biomet/84.2.379; Schenk JM, 2014, CANCER EPIDEM BIOMAR, V23, P1484, DOI 10.1158/1055-9965.EPI-13-1340; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Schottker B, 2013, AGEING RES REV, V12, P708, DOI 10.1016/j.arr.2012.02.004; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; Shui IM, 2015, CANCER-AM CANCER SOC, V121, P1949, DOI 10.1002/cncr.29320; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Stoer NC, 2014, EPIDEMIOLOGY, V25, P315, DOI 10.1097/EDE.0000000000000057; Tretli S, 2009, BRIT J CANCER, V100, P450, DOI 10.1038/sj.bjc.6604865; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375	25	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151441	10.1371/journal.pone.0151441	http://dx.doi.org/10.1371/journal.pone.0151441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986958	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300071
J	Chirebvu, E; Chimbari, MJ; Ngwenya, BN; Sartorius, B				Chirebvu, Elijah; Chimbari, Moses John; Ngwenya, Barbara Ntombi; Sartorius, Benn			Clinical Malaria Transmission Trends and Its Association with Climatic Variables in Tubu Village, Botswana: A Retrospective Analysis	PLOS ONE			English	Article							EXPLORING 30 YEARS; ANOPHELES-ARABIENSIS; USAMBARA MOUNTAINS; SOUTH-AFRICA; IMPACT; RAINFALL; TEMPERATURE; HIGHLANDS; EPIDEMIOLOGY; VARIABILITY	Good knowledge on the interactions between climatic variables and malaria can be very useful for predicting outbreaks and preparedness interventions. We investigated clinical malaria transmission patterns and its temporal relationship with climatic variables in Tubu village, Botswana. A 5-year retrospective time series data analysis was conducted to determine the transmission patterns of clinical malaria cases at Tubu Health Post and its relationship with rainfall, flood discharge, flood extent, mean minimum, maximum and average temperatures. Data was obtained from clinical records and respective institutions for the period July 2005 to June 2010, presented graphically and analysed using the Univariate ANOVA and Pearson cross-correlation coefficient tests. Peak malaria season occurred between October and May with the highest cumulative incidence of clinical malaria cases being recorded in February. Most of the cases were individuals aged > 5 years. Associations between the incidence of clinical malaria cases and several factors were strong at lag periods of 1 month; rainfall (r = 0.417), mean minimum temperature (r = 0.537), mean average temperature (r = 0.493); and at lag period of 6 months for flood extent (r = 0.467) and zero month for flood discharge (r = 0.497). The effect of mean maximum temperature was strongest at 2-month lag period (r = 0.328). Although malaria transmission patterns varied from year to year the trends were similar to those observed in sub-Saharan Africa. Age group > 5 years experienced the greatest burden of clinical malaria probably due to the effects of the national malaria elimination programme. Rainfall, flood discharge and extent, mean minimum and mean average temperatures showed some correlation with the incidence of clinical malaria cases.	[Chirebvu, Elijah; Ngwenya, Barbara Ntombi] Univ Botswana, Okavango Res Inst, Private Bag 285, Maun, Botswana; [Chimbari, Moses John] Univ KwaZulu Natal, Coll Hlth Sci, Howard Campus, ZA-4041 Durban, South Africa; [Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa	University of Botswana; University of Kwazulu Natal; University of Kwazulu Natal	Chimbari, MJ (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Howard Campus, ZA-4041 Durban, South Africa.	chimbari@ukzn.ac.za		, bennsartorius/0000-0001-6761-2325	International Development Centre, Canada [106024-001]	International Development Centre, Canada	This work was supported by International Development Centre, Canada. Grant Number: 106024-001 (MJC). The funder had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Alsop Z, 2007, LANCET, V370, P925, DOI 10.1016/S0140-6736(07)61428-7; [Anonymous], 2009, TRANSBOUNDARY DIAGNO; Bell D, 1991, LECT NOTES TROPICAL; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bonora S, 2001, TRENDS PARASITOL, V17, P572, DOI 10.1016/S1471-4922(01)02095-5; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111; Campanella N, 1998, PUBLIC HLTH REV, V27, P311; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Central Statistics Office, 2001, POP HOUS CENS PREL R; Chirebvu E, 1995, MALARIA INFECT DIS A, V2; Chirebvu E, 2015, J VECTOR ECOL, V40, P129, DOI 10.1111/jvec.12141; Craig MH, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-44; Craig MH, 2004, TROP MED INT HEALTH, V9, P1258, DOI 10.1111/j.1365-3156.2004.01341.x; Craig MH, 2004, TROP MED INT HEALTH, V9, P1247, DOI 10.1111/j.1365-3156.2004.01340.x; Devi N. Pemola, 2013, European Journal of Experimental Biology, V3, P28; Dominion, 2006, INT FLOOD RISK RED A; El Sayed BB, 2000, ACTA TROP, V75, P163, DOI 10.1016/S0001-706X(99)00098-4; Government of Botswana [GoB], 2001, BOTSW NAT ATL; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Kim YM, 2012, ENVIRON HEALTH PERSP, V120, P1314, DOI 10.1289/ehp.1104577; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Kondo Hisayoshi, 2002, Prehosp Disaster Med, V17, P126; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Mabaso MLH, 2005, TROP MED INT HEALTH, V10, P909, DOI 10.1111/j.1365-3156.2005.01462.x; MATOLA YG, 1987, J TROP MED HYG, V90, P127; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Midekisa A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0954-7; Ministry of Health, 2012, MAL SURV GUID; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Najera JA., 1998, MALARIA EPIDEMICS DE; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; RAMASAMY R, 1992, ANN TROP MED PARASIT, V86, P591, DOI 10.1080/00034983.1992.11812714; Ramberg L, 2006, AQUAT SCI, V68, P310, DOI 10.1007/s00027-006-0857-y; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Silal SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076640; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-44; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98; World Health Organization, 2011, MAL FACT SHEET; Worrall E, 2007, TROP MED INT HEALTH, V12, P75, DOI 10.1111/j.1365-3156.2006.01772.x; Yamana T, 2014, MALARIA J S1, V13, pP94; Zhang Y, 2010, ENVIRON INT, V36, P439, DOI 10.1016/j.envint.2010.03.005; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; Zinszer K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0758-4	56	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0139843	10.1371/journal.pone.0139843	http://dx.doi.org/10.1371/journal.pone.0139843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983035	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900010
J	Ascensao, F; Mata, C; Malo, JE; Ruiz-Capillas, P; Silva, C; Silva, AP; Santos-Reis, M; Fernandes, C				Ascensao, Fernando; Mata, Cristina; Malo, Juan E.; Ruiz-Capillas, Pablo; Silva, Catarina; Silva, Andre P.; Santos-Reis, Margarida; Fernandes, Carlos			Disentangle the Causes of the Road Barrier Effect in Small Mammals through Genetic Patterns	PLOS ONE			English	Article							MOUSE APODEMUS-SYLVATICUS; EFFECTIVE POPULATION-SIZE; MICROSATELLITE NULL ALLELES; RED-BACKED SALAMANDERS; PER-GENERATION RULE; WOOD MICE; LINKAGE DISEQUILIBRIUM; GENOTYPING ERRORS; CLETHRIONOMYS-GLAREOLUS; SMALL RODENT	Road barrier effect is among the foremost negative impacts of roads on wildlife. Knowledge of the factors responsible for the road barrier effect is crucial to understand and predict species' responses to roads, and to improve mitigation measures in the context of management and conservation. We built a set of hypothesis aiming to infer the most probable cause of road barrier effect (traffic effect or road surface avoidance), while controlling for the potentially confounding effects road width, traffic volume and road age. The wood mouse Apodemus sylvaticus was used as a model species of small and forest-dwelling mammals, which are more likely to be affected by gaps in cover such as those resulting from road construction. We confront genetic patterns from opposite and same roadsides from samples of three highways and used computer simulations to infer migration rates between opposite roadsides. Genetic patterns from 302 samples (ca. 100 per highway) suggest that the highway barrier effect for wood mouse is due to road surface avoidance. However, from the simulations we estimated a migration rate of about 5% between opposite roadsides, indicating that some limited gene flow across highways does occur. To reduce highway impact on population genetic diversity and structure, possible mitigation measures could include retrofitting of culverts and underpasses to increase their attractiveness and facilitate their use by wood mice and other species, and setting aside roadside strips without vegetation removal to facilitate establishment and dispersal of small mammals.	[Ascensao, Fernando; Silva, Catarina; Silva, Andre P.; Santos-Reis, Margarida; Fernandes, Carlos] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, Ed C2-5 Piso, Lisbon, Portugal; [Mata, Cristina; Malo, Juan E.] Univ Autonoma Madrid, Dept Ecol, Terr Ecol Grp, Madrid, Spain; [Ruiz-Capillas, Pablo] Obrascon Huarte Lain SA, Direcc Innovac & Sostenibilidad, Madrid, Spain; [Ascensao, Fernando] Inst Super Agron, InBIO Rede Invest Biodiversidade & Biol Evolut, CIBIO Res Ctr Biodivers & Genet Resources, Infraestruturas Portugal Biodivers Chair, P-1349017 Lisbon, Portugal	Universidade de Lisboa; Autonomous University of Madrid; Universidade de Lisboa	Ascensao, F (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, Ed C2-5 Piso, Lisbon, Portugal.; Ascensao, F (corresponding author), Inst Super Agron, InBIO Rede Invest Biodiversidade & Biol Evolut, CIBIO Res Ctr Biodivers & Genet Resources, Infraestruturas Portugal Biodivers Chair, P-1349017 Lisbon, Portugal.	fernandoascensao@gmail.com	Afonso Silva, Ana Catarina/I-5462-2019; Fernandes, Carlos/J-3045-2013; Mata, Cristina/ABF-1169-2021; Fernandes, Carlos/AAB-5256-2019; Malo, Juan E/K-8305-2014; Ascensão, Fernando/G-1513-2014; Santos-Reis, Margarida/H-4064-2011; Silva, André P./J-1700-2012; Ascensão, Fernando/ABF-9787-2021; Arrazola, Juan Esteban Malo/Q-4819-2019	Afonso Silva, Ana Catarina/0000-0002-8808-1452; Fernandes, Carlos/0000-0002-1386-8103; Mata, Cristina/0000-0002-6206-1015; Fernandes, Carlos/0000-0002-1386-8103; Malo, Juan E/0000-0002-6033-5035; Ascensão, Fernando/0000-0003-1704-0212; Silva, André P./0000-0002-4722-8497; Ascensão, Fernando/0000-0003-1704-0212; Arrazola, Juan Esteban Malo/0000-0002-6033-5035; Santos-Reis, Margarida/0000-0002-0337-963X	Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal) [PTDC/BIA-BEC/101511/2008, SFRH/BD/38053/2007, C2007-UL-342-CBA1]; Centro para el Desarrollo Tecnologico e Industrial, CDTI, of the Spanish Ministry of Science and Innovation; Comunidad de Madrid; European Social Fund through the REMEDINAL-3 Research Network [S-2013/MAE-2719]	Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal)(Portuguese Foundation for Science and Technology); Centro para el Desarrollo Tecnologico e Industrial, CDTI, of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Comunidad de Madrid(Comunidad de Madrid); European Social Fund through the REMEDINAL-3 Research Network	The study was funded by Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal) through the project 'Effects of habitat fragmentation on the population structure and connectivity of forest-dwelling species: a comparative landscape genetics approach' (PTDC/BIA-BEC/101511/2008), a PhD grant (FA, SFRH/BD/38053/2007), and a Ciencia 2007 contract (CF, C2007-UL-342-CBA1). Obrascon Huarte Lain, S.A. provided support in the form of salaries for PRC. This study also forms part of the CENIT-OASIS project funded by a consortium of companies supported by the Centro para el Desarrollo Tecnologico e Industrial, CDTI, of the Spanish Ministry of Science and Innovation. The Comunidad de Madrid, together with the European Social Fund, supports the TEG research group through the REMEDINAL-3 Research Network (S-2013/MAE-2719). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Alexander SM, 2005, CAN GEOGR-GEOGR CAN, V49, P321, DOI 10.1111/j.0008-3658.2005.00099.x; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; [Anonymous], CORK OAK WOODLANDS E; [Anonymous], 1996, 5000 CNRS UMR; Ascensao F., 2006, P 2005 INT C ECOLOGY, P641; Ascensao F, 2015, HANDBOOK OF ROAD ECOLOGY, P325; Ascensao F, 2012, BIODIVERS CONSERV, V21, P3681, DOI 10.1007/s10531-012-0390-3; ASHBY KR, 1967, J ZOOL, V152, P389; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; BALLOUX F, 2001, J HERED, V92, P301; BENGTSON S A, 1976, Acta Theriologica, V21, P389; Berckmoes V, 2005, ENVIRON TOXICOL CHEM, V24, P2898, DOI 10.1897/04-483R.1; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Booth W, 2009, J ZOOL, V279, P219, DOI 10.1111/j.1469-7998.2009.00608.x; Borkovcova M, 2012, TRANSPORT RES D-TR E, V17, P66, DOI 10.1016/j.trd.2011.09.011; Brehme CS, 2013, CONSERV BIOL, V27, P710, DOI 10.1111/cobi.12081; Butet Alain, 1997, Arvicola, V9, P7; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chakraborty R, 1991, HDB STATISTICS, V8, P203; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Clark RW, 2010, CONSERV BIOL, V24, P1059, DOI 10.1111/j.1523-1739.2009.01439.x; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Corp N, 1997, OECOLOGIA, V109, P242, DOI 10.1007/s004420050079; CRAWLEY MC, 1969, OIKOS, V20, P310, DOI 10.2307/3543198; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DALLAS JF, 1992, MAMM GENOME, V3, P452, DOI 10.1007/BF00356155; De Meeus T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-443; Diaz M, 2010, ACTA THERIOL, V55, P251, DOI 10.4098/j.at.0001-7051.046.2009; DICKMAN CR, 1989, J ANIM ECOL, V58, P119, DOI 10.2307/4989; DIETRICH W, 1992, GENETICS, V131, P423; Dileo MF, 2013, MOL ECOL, V22, P4483, DOI 10.1111/mec.12411; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dolan L, 2006, P 2005 INT C EC TRAN, P608; Encarnacao JA, 2015, J NAT CONSERV, V27, P37, DOI 10.1016/j.jnc.2015.06.003; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Fedy BC, 2008, MOL ECOL, V17, P1905, DOI 10.1111/j.1365-294X.2008.03720.x; Finnegan LA, 2012, EUR J WILDLIFE RES, V58, P415, DOI 10.1007/s10344-011-0590-2; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; Gerlach G, 2000, CONSERV BIOL, V14, P1066, DOI 10.1046/j.1523-1739.2000.98519.x; Gibbs James P., 2005, Wetlands Ecology and Management, V13, P281, DOI 10.1007/s11273-004-7522-9; GIBSON DSC, 1984, J ZOOL, V203, P63; Goldberg CS, 2010, MOL ECOL RESOUR, V10, P304, DOI 10.1111/j.1755-0998.2009.02755.x; Gomez JM, 2008, OECOLOGIA, V155, P529, DOI 10.1007/s00442-007-0928-3; Goncalves P, 2012, AGROFOREST SYST, V85, P383, DOI 10.1007/s10457-011-9439-7; Goosem M, 2001, WILDLIFE RES, V28, P351, DOI 10.1071/WR99093; Goudet J, 1996, GENETICS, V144, P1933; GREEN R, 1979, J ZOOL, V188, P357; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Gu XD, 2009, CONSERV GENET, V10, P1961, DOI 10.1007/s10592-009-9868-2; Hacker H. P., 1951, Journal of the Linnean Society Zoology, V42, P1; HACKER HP, 1946, BIOMETRIKA, V33, P333, DOI 10.1093/biomet/33.4.333; HALLE S, 1993, OECOLOGIA, V94, P120, DOI 10.1007/BF00317312; Harr B, 2000, MOL ECOL, V9, P1664, DOI 10.1046/j.1365-294x.2000.01043-3.x; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; HOLM S, 1979, SCAND J STAT, V6, P65; Jaarsma CF, 2006, TRANSPORT RES D-TR E, V11, P264, DOI 10.1016/j.trd.2006.05.001; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Kalinowski ST, 2002, CONSERV BIOL, V16, P129, DOI 10.1046/j.1523-1739.2002.00134.x; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; KIKKAWA J, 1964, J ANIM ECOL, V33, P259, DOI 10.2307/2631; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KOZAKIEWICZ M, 1993, ACTA THERIOL, V38, P1; Lalis A, 2016, J ZOOL SYST EVOL RES, V54, P1, DOI 10.1111/jzs.12111; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Leng L, 2013, J SYST EVOL, V51, P44, DOI 10.1111/j.1759-6831.2012.00231.x; Leng L, 2011, MOL ECOL, V20, P2494, DOI 10.1111/j.1365-294X.2011.05108.x; Lode T, 2000, AMBIO, V29, P163, DOI 10.1579/0044-7447-29.3.163; Macdonald D., 1993, MAMMALS BRITAIN EURO; Macpherson D, 2011, APPL ECOL ENV RES, V9, P167, DOI 10.15666/aeer/0902_167180; Makova KD, 1998, MOL ECOL, V7, P247; Marsh DM, 2007, CAN J ZOOL, V85, P319, DOI 10.1139/Z07-008; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; Marsh DM, 2005, CONSERV BIOL, V19, P2004, DOI 10.1111/j.1523-1739.2005.00238.x; Mata C, 2005, BIOL CONSERV, V124, P397, DOI 10.1016/j.biocon.2005.01.044; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McDonald W, 2004, J APPL ECOL, V41, P82, DOI 10.1111/j.1365-2664.2004.00877.x; McDonald WR, 2004, OIKOS, V105, P397; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; McLaren AAD, 2011, CAN J ZOOL, V89, P1214, DOI 10.1139/Z11-100; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; MONTGOMERY WI, 1989, J ANIM ECOL, V58, P477, DOI 10.2307/4843; MORENO S, 1988, ACTA THERIOL, V33, P79, DOI 10.4098/AT.arch.88-7; Nagylaki T, 1998, GENETICS, V148, P1325; Orlowski G, 2006, POL J ECOL, V54, P283; OXLEY DJ, 1974, J APPL ECOL, V11, P51, DOI 10.2307/2402004; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pergams ORW, 2001, GENETICA, V112, P245, DOI 10.1023/A:1013343923155; Pinto-Correia T, 1999, LANDSCAPE URBAN PLAN, V46, P125, DOI 10.1016/S0169-2046(99)00036-5; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reed DH, 2007, ANIM CONSERV, V10, P275, DOI 10.1111/j.1469-1795.2007.00120.x; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Richardson JH, 1997, J ZOOL, V243, P840, DOI 10.1111/j.1469-7998.1997.tb01982.x; Rico A, 2009, ACTA THERIOL, V54, P297, DOI 10.4098/j.at.0001-7051.068.2008; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Roedenbeck IA, 2008, EUR J WILDLIFE RES, V54, P425, DOI 10.1007/s10344-007-0166-3; Rosalino LM, 2002, MAMMALIA, V66, P195, DOI 10.1515/mamm.2002.66.2.195; Rosalino LM, 2011, MAMM BIOL, V76, P268, DOI 10.1016/j.mambio.2010.08.004; Rosario IT, 2004, MAMMALIA, V68, P133, DOI 10.1515/mamm.2004.014; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruiz-Capillas P, 2015, ECOL RES, V30, P417, DOI 10.1007/s11284-014-1235-1; Ruiz-Capillas P, 2013, BIOL CONSERV, V158, P223, DOI 10.1016/j.biocon.2012.09.025; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SMAL CM, 1982, J ZOOL, V196, P1; Tallmon DA, 2002, MOL ECOL, V11, P699, DOI 10.1046/j.1365-294X.2002.01480.x; TELLERIA JL, 1991, J MAMMAL, V72, P183, DOI 10.2307/1381994; TEW TE, 1993, BIOL CONSERV, V65, P279, DOI 10.1016/0006-3207(93)90060-E; Thurfjell H, 2015, LANDSCAPE URBAN PLAN, V133, P98, DOI 10.1016/j.landurbplan.2014.09.015; Tkadlec E, 1998, EVOL ECOL, V12, P191, DOI 10.1023/A:1006583713042; Torre I., 2002, Galemys, V14, P1; Underhill JE, 2002, THESIS U BIRMINGHAM; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Wieren SE, 2001, NETH J ZOOL, V51, P97, DOI 10.1163/156854201750210869; VanderRee R, 2015, HANDBOOK OF ROAD ECOLOGY, P1, DOI 10.1002/9781118568170; Vucetich JA, 2000, ANIM CONSERV, V3, P261, DOI 10.1017/S1367943000000986; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2014, GENETICS, V197, P769, DOI 10.1534/genetics.114.164822; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; Waples RS, 2002, GENETICS, V161, P783; WATTS CHS, 1970, J ZOOL, V161, P247; WATTS CHS, 1969, J ANIM ECOL, V38, P285, DOI 10.2307/2772; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Wilson A, 2016, ECOGRAPHY, V39, P87, DOI 10.1111/ecog.01297; WOLTON RJ, 1985, J ZOOL, V206, P203; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1943, GENETICS, V28, P114; Wu H, 2008, CONSERV GENET, V9, P1691, DOI 10.1007/s10592-008-9535-z; YANES M, 1995, BIOL CONSERV, V71, P217, DOI 10.1016/0006-3207(94)00028-O; ZHANG ZB, 1991, ACTA THERIOL, V36, P239, DOI 10.4098/AT.arch.91-24	152	28	30	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151500	10.1371/journal.pone.0151500	http://dx.doi.org/10.1371/journal.pone.0151500			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978779	Green Published, gold			2022-12-26	WOS:000372572800079
J	Chipperfield, JG; Perry, RP; Pekrun, R; Barchfeld, P; Lang, FR; Hamm, JM				Chipperfield, Judith G.; Perry, Raymond P.; Pekrun, Reinhard; Barchfeld, Petra; Lang, Frieder R.; Hamm, Jeremy M.			The Paradoxical Role of Perceived Control in Late Life Health Behavior	PLOS ONE			English	Article							CONTROL STRATEGIES; RISK; OUTCOMES; LOCUS; MORTALITY; BELIEFS; SENSE; VULNERABILITY; INFORMATION; PERCEPTIONS	Research has established the health benefits of psychological factors, including the way individuals appraise outcomes. Although many studies confirm that appraising outcomes as controllable is adaptive for health, a paradoxical possibility is largely ignored: Perceived control may be detrimental under some conditions. Our premise was that appraising health as controllable but at the same time ascribing little value to it might signal a dysfunctional psychological mindset that fosters a mistaken sense of invincibility. During face-to-face interviews with a representative sample of older adults (age range = 72-99), we identified individuals with such a potentially maladaptive "invincible" mindset (high perceived control and low health value) and compared them to their counterparts on several outcomes. The findings were consistent with our hypotheses. The invincibles denied future risks, they lacked the activating emotion of fear, and they visited their physicians less often over a subsequent five-year period. Moreover, in contrast to their counterparts, the invincibles did not appear strategic in their approach to seeking care: Even poor health did not prompt them to seek the counsel of a physician. The recognition that psychological appraisals are modifiable highlights the promise of remedial methods to alter maladaptive mindsets, potentially improving quality of life.	[Chipperfield, Judith G.; Perry, Raymond P.; Hamm, Jeremy M.] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada; [Pekrun, Reinhard; Barchfeld, Petra] Univ Munich, Dept Psychol, Munich, Germany; [Lang, Frieder R.] Univ Erlangen Nurnberg, Inst Psychogerontol, Nurnberg, Germany	University of Manitoba; University of Munich; University of Erlangen Nuremberg	Chipperfield, JG (corresponding author), Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada.	Judith.Chipperfield@umanitoba.ca	Perry, Raymond/AAU-6160-2021; Lang, Frieder R./A-9846-2012; Pekrun, Reinhard/B-1208-2014; Chipperfield, Judith/AAC-9766-2020	Lang, Frieder R./0000-0002-2660-1619; Pekrun, Reinhard/0000-0003-4489-3827; Chipperfield, Judith/0000-0001-5047-9206	Manitoba Health Research Grant [201209RPA-297329-SDA-CDAA-49702]; Canadian Institutes of Health Research [MOP-130382]; Royal Society of Canada; Alexander von Humboldt Foundation; University of Munich; John G. Diefenbaker Award from the Canada Council of Arts; Social Sciences and Humanities Research Council Doctoral Canada Graduate Scholarship	Manitoba Health Research Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Royal Society of Canada; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); University of Munich; John G. Diefenbaker Award from the Canada Council of Arts; Social Sciences and Humanities Research Council Doctoral Canada Graduate Scholarship	This research was funded by a Manitoba Health Research Grant (201209RPA-297329-SDA-CDAA-49702) and Canadian Institutes of Health Research grants to (MOP-130382) to the first (JGC), second (RPP), and third (RP) authors; a Konrad Adenauer Award from the Royal Society of Canada and the Alexander von Humboldt Foundation to the second author (RPP); a Research Chair grant from the University of Munich and a John G. Diefenbaker Award from the Canada Council of Arts and the Alexander von Humboldt Foundation to the third (RP) author; and a Social Sciences and Humanities Research Council Doctoral Canada Graduate Scholarship to the sixth (JMH) author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2002, J SOC ISSUES, V58, P749, DOI 10.1111/1540-4560.00288; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Bailis DS, 2006, PSYCHOL AGING, V21, P291, DOI 10.1037/0882-7974.21.2.291; Bailis DS, 2010, J HEALTH PSYCHOL, V15, P326, DOI 10.1177/1359105309342296; Baltes P.B., 1990, SUCCESSFUL AGING PER, P1, DOI [10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; Bennett P, 1997, HEALTH PSYCHOL, V16, P179, DOI 10.1037/0278-6133.16.2.179; Bernoulli D., 1738, COMMENTARII ACAD SCI; Bollini AM, 2004, BIOL PSYCHOL, V67, P245, DOI 10.1016/j.biopsycho.2003.11.002; Bond L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-943; Branch L G, 1987, Clin Geriatr Med, V3, P29; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; BURTON LC, 1995, AM J PUBLIC HEALTH, V85, P387, DOI 10.2105/AJPH.85.3.387; Carstensen L.L., 1998, MOTIVATION SELF REGU, P341, DOI 10.1017/CBO9780511527869.015; Chipperfield J. G., 1993, J AGING HEALTH, V5, P123, DOI [DOI 10.1177/089826439300500106, DOI 10.1177/]; Chipperfield JG, 2006, HEALTH PSYCHOL, V25, P226, DOI 10.1037/0278-6133.25.2.226; Chipperfield JG, 2004, J AGING HEALTH, V16, P116, DOI 10.1177/0898264303260447; Chipperfield JG, 2003, J GERONTOL B-PSYCHOL, V58, pP23, DOI 10.1093/geronb/58.1.P23; Chipperfield JG, 1999, J GERONTOL B-PSYCHOL, V54, pP146, DOI 10.1093/geronb/54B.3.P146; Chipperfield JG, 1997, CAN J AGING, V16, P606, DOI 10.1017/S0714980800010990; Chipperfield JG, 2012, PERS SOC PSYCHOL B, V38, P1081, DOI 10.1177/0146167212444758; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Hoog N, 2007, REV GEN PSYCHOL, V11, P258, DOI 10.1037/1089-2680.11.3.258; DeCoster J, 2009, PSYCHOL METHODS, V14, P349, DOI 10.1037/a0016956; Dubayova T, 2010, INT J PUBLIC HEALTH, V55, P459, DOI 10.1007/s00038-010-0149-0; Earl A, 2007, HEALTH PSYCHOL, V26, P496, DOI 10.1037/0278-6133.26.4.496; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Franzini L, 2008, J AM GERIATR SOC, V56, P667, DOI 10.1111/j.1532-5415.2007.01629.x; FRIEDMAN HS, 1987, AM PSYCHOL, V42, P539, DOI 10.1037/0003-066X.42.6.539; Fry PS, 2006, INT J AGING HUM DEV, V62, P303, DOI 10.2190/3VAT-D77G-VCNQ-6T61; Galbreath AD, 2004, CIRCULATION, V110, P3518, DOI 10.1161/01.CIR.0000148957.62328.89; Goetz T, 2013, PSYCHOL SCI, V24, P2079, DOI 10.1177/0956797613486989; Goetz T, 2010, MOTIV EMOTION, V34, P49, DOI 10.1007/s11031-009-9152-2; Griffin MJ, 2006, PSYCHOSOM MED, V68, P493, DOI 10.1097/01.psy.0000221367.96439.da; Hamm JM, 2014, J GERONTOL B-PSYCHOL, V69, P533, DOI 10.1093/geronb/gbu048; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; HOOKER K, 1992, J GERONTOL, V47, pP85, DOI 10.1093/geronj/47.2.P85; Infurna FJ, 2014, HEALTH PSYCHOL, V33, P85, DOI 10.1037/a0030208; Infurna FJ, 2013, DEV PSYCHOL, V49, P1833, DOI 10.1037/a0031041; Infurna FJ, 2011, DEV PSYCHOL, V47, P9, DOI 10.1037/a0021022; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; Klein WMP, 2010, PSYCHOL HEALTH, V25, P1195, DOI 10.1080/08870440903261970; Krause N, 2000, PSYCHOL AGING, V15, P617, DOI 10.1037/0882-7974.15.4.617; Kunzmann U, 2002, J GERONTOL B-PSYCHOL, V57, pP484, DOI 10.1093/geronb/57.6.P484; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lachman ME, 1998, PSYCHOL AGING, V13, P553, DOI 10.1037/0882-7974.13.4.553; Lang FR, 2001, J PERS SOC PSYCHOL, V81, P509, DOI 10.1037//0022-3514.81.3.509; Lang FR, 2013, PSYCHOL AGING, V28, P249, DOI 10.1037/a0030797; LANGER EJ, 1976, J PERS SOC PSYCHOL, V34, P191, DOI 10.1037/0022-3514.34.2.191; LAU RR, 1986, HEALTH PSYCHOL, V5, P25, DOI 10.1037/0278-6133.5.1.25; Leotti LA, 2011, PSYCHOL SCI, V22, P1310, DOI 10.1177/0956797611417005; Mayne TJ, 2001, EMO SOC BEH, P361; Menec VH, 1999, J GERONTOL B-PSYCHOL, V54, pP85, DOI 10.1093/geronb/54B.2.P85; Menec VH, 1997, J GERONTOL B-PSYCHOL, V52, pP118, DOI 10.1093/geronb/52B.3.P118; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; National Center for Health Statistics (U.S.), 2014, HLTH US 2013 SPEC FE; Norman P, 1998, J Health Psychol, V3, P171, DOI 10.1177/135910539800300202; PEKRUN R, 1992, S HLTH PSYC, P23; Pekrun R, 2006, EDUC PSYCHOL REV, V18, P315, DOI 10.1007/s10648-006-9029-9; Pekrun R, 2010, J EDUC PSYCHOL, V102, P531, DOI 10.1037/a0019243; Perry RP, 2014, ADV MOTIV A, V18, P1, DOI 10.1108/S0749-742320140000018000; Perry RP, 2010, J SOC CLIN PSYCHOL, V29, P668, DOI 10.1521/jscp.2010.29.6.668; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; ROSENBERG SJ, 1987, INT J PSYCHIAT MED, V17, P85, DOI 10.2190/JWMW-8Q1U-71DJ-AN6E; Ruthig JC, 2008, J SOC PSYCHOL, V148, P667, DOI 10.3200/SOCP.148.6.667-688; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Sirois FM, 2015, J BEHAV MED, V38, P578, DOI 10.1007/s10865-015-9629-2; Tolman EC, 1938, PSYCHOL REV, V45, P1, DOI 10.1037/h0062733; TOLMAN EC, 1955, PSYCHOL REV, V62, P315, DOI 10.1037/h0049079; Waldrop D, 2001, J COUNS PSYCHOL, V48, P233, DOI 10.1037/0022-0167.48.2.233; WALLSTON KA, 1976, J RES PERS, V10, P215, DOI 10.1016/0092-6566(76)90074-X; Williams DA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2094; Wrosch C, 2008, PSYCHOL SCI, V19, P537, DOI 10.1111/j.1467-9280.2008.02120.x; WYLER AR, 1970, J PSYCHOSOM RES, V14, P59, DOI 10.1016/0022-3999(70)90070-X	74	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0148921	10.1371/journal.pone.0148921	http://dx.doi.org/10.1371/journal.pone.0148921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26974153	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600008
J	McIntosh, ACS; Macdonald, SE; Quideau, SA				McIntosh, Anne C. S.; Macdonald, S. Ellen; Quideau, Sylvie A.			Understory Plant Community Composition Is Associated with Fine-Scale Above- and Below-Ground Resource Heterogeneity in Mature Lodgepole Pine (Pinus contorta) Forests	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; BOREAL MIXEDWOOD; MYCORRHIZAL FUNGI; STAND COMPOSITION; SOIL; DIVERSITY; PATTERNS; VEGETATION; BIOMASS; CANOPY	Understory plant communities play critical ecological roles in forest ecosystems. Both above- and below-ground ecosystem properties and processes influence these communities but relatively little is known about such effects at fine (i.e., one to several meters within-stand) scales, particularly for forests in which the canopy is dominated by a single species. An improved understanding of these effects is critical for understanding how understory biodiversity is regulated in such forests and for anticipating impacts of changing disturbance regimes. Our primary objective was to examine the patterns of fine-scale variation in understory plant communities and their relationships to above-and below-ground resource and environmental heterogeneity within mature lodgepole pine forests. We assessed composition and diversity of understory vegetation in relation to heterogeneity of both the above ground (canopy tree density, canopy and tall shrub basal area and cover, downed wood biomass, litter cover) and below-ground (soil nutrient availability, decomposition, forest floor thickness, pH, and phospholipid fatty acids (PLFAs) and multiple carbon-source substrate-induced respiration (MSIR) of the forest floor microbial community) environment. There was notable variation in fine-scale plant community composition; cluster and indicator species analyses of the 24 most commonly occurring understory species distinguished four assemblages, one for which a pioneer forb species had the highest cover levels, and three others that were characterized by different bryophyte species having the highest cover. Constrained ordination (distance-based redundancy analysis) showed that two above-ground (mean tree diameter, litter cover) and eight below-ground (forest floor pH, plant available boron, microbial community composition and function as indicated by MSIR and PLFAs) properties were associated with variation in understory plant community composition. These results provide novel insights into the important ecological associations between understory plant community composition and heterogeneity in ecosystem properties and processes within forests dominated by a single canopy species.	[McIntosh, Anne C. S.; Macdonald, S. Ellen; Quideau, Sylvie A.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [McIntosh, Anne C. S.] Univ Alberta, Augustana Fac, Dept Sci, Camrose, AB, Canada	University of Alberta; University of Alberta	McIntosh, ACS (corresponding author), Univ Alberta, Augustana Fac, Dept Sci, Camrose, AB, Canada.	amcintos@ualberta.ca	Quideau, Sylvie A/C-9646-2015	Quideau, Sylvie A/0000-0002-2297-9024; McIntosh, Anne/0000-0002-7802-2205	Natural Sciences and Engineering Research Council of Canada - Canada Graduate Scholarship; Izaak Walton Killam Memorial Scholarship; Forest Resource Improvement Association of Alberta; Foothills Research Institute	Natural Sciences and Engineering Research Council of Canada - Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Izaak Walton Killam Memorial Scholarship; Forest Resource Improvement Association of Alberta; Foothills Research Institute	This project was supported by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) - Canada Graduate Scholarship and an Izaak Walton Killam Memorial Scholarship (http://killamlaureates.ca/) awarded to A.C.S.M. and funding from the Forest Resource Improvement Association of Alberta (http://www.friaa.ab.ca/) and Foothills Research Institute (http://foothillsri.ca/) awarded to S.E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M., 1977, Introduction to soil microbiology.; Anderson J. E., 1991, International Journal of Wildland Fire, V1, P119, DOI 10.1071/WF9910119; ANDERSON TH, 1985, SOIL BIOL BIOCHEM, V17, P197, DOI 10.1016/0038-0717(85)90115-4; BAATH E, 1992, APPL ENVIRON MICROB, V58, P4026; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Bartels SF, 2013, J VEG SCI, V24, P543, DOI 10.1111/j.1654-1103.2012.01479.x; Bartels SF, 2010, ECOLOGY, V91, P1931, DOI 10.1890/09-1376.1; Beckingham J. D., 1996, FIELD GUIDE ECOSITES; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennan PJ, 1988, MICROBIAL LIPIDS, V1, P203; Brown J. K., 1974, USDA Forest Service General Technical Report, Intermountain Forest and Range Experiment Station; Brown J. K., 1982, HDB INVENTORYING SUR; Cameron C. M., 2008, MICRORESP TECHNICAL; Campbell CD, 2003, APPL ENVIRON MICROB, V69, P3593, DOI 10.1128/AEM.69.6.3593-3599.2003; CAREY AB, 1995, ECOL APPL, V5, P336, DOI 10.2307/1942026; CARLETON TJ, 1981, CAN J BOT, V59, P1709, DOI 10.1139/b81-229; Chapman SJ, 2007, J SOIL SEDIMENT, V7, P406, DOI 10.1065/jss2007.10.259; Chavez V, 2010, FOREST ECOL MANAG, V259, P1067, DOI 10.1016/j.foreco.2009.12.013; Committee NR, 2006, GOVT ALB PUBL T; CROZIER CR, 1984, OECOLOGIA, V62, P337, DOI 10.1007/BF00384265; Degens BP, 2000, SOIL BIOL BIOCHEM, V32, P189, DOI 10.1016/S0038-0717(99)00141-8; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; FREGO KA, 1995, CAN J BOT, V73, P544, DOI 10.1139/b95-056; Frelich LE, 2003, J ECOL, V91, P283, DOI 10.1046/j.1365-2745.2003.00765.x; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gendreau-Berthiaume B, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00308.1; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; Goldberg S, 1997, PLANT SOIL, V193, P35, DOI 10.1023/A:1004203723343; Gundale MJ, 2006, ECOL APPL, V16, P479, DOI 10.1890/1051-0761(2006)016[0479:NSHIDF]2.0.CO;2; Hamman ST, 2007, SOIL BIOL BIOCHEM, V39, P1703, DOI 10.1016/j.soilbio.2007.01.018; Hannam KD, 2006, SOIL BIOL BIOCHEM, V38, P2565, DOI 10.1016/j.soilbio.2006.03.015; Hart SA, 2008, ECOL MONOGR, V78, P123, DOI 10.1890/06-2140.1; Hart SA, 2006, CRIT REV PLANT SCI, V25, P381, DOI 10.1080/07352680600819286; Hassett JE, 2005, SOIL SCI SOC AM J, V69, P227, DOI 10.2136/sssaj2005.0227; Hogberg MN, 2003, NEW PHYTOL, V160, P225, DOI 10.1046/j.1469-8137.2003.00867.x; Hu HN, 1997, PLANT SOIL, V193, P49, DOI 10.1023/A:1004255707413; HUE NV, 1986, SOIL SCI SOC AM J, V50, P28, DOI 10.2136/sssaj1986.03615995005000010006x; Kalra Y. P., 1991, Information Report - Northwest Region, Forestry Canada; Kroppenstedt RM, 1985, CHEM METHODS BACTERI, P173; Laliberte E, 2013, TRENDS ECOL EVOL, V28, P331, DOI 10.1016/j.tree.2013.02.008; Legare S, 2002, SILVA FENN, V36, P353, DOI 10.14214/sf.567; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leps J., 2003, MULTIVARIATE ANAL EC; LIEFFERS VI, 1993, CAN J FOREST RES, V23, P2070, DOI 10.1139/x93-258; MacKenzie MD, 2010, APPL SOIL ECOL, V44, P32, DOI 10.1016/j.apsoil.2009.09.002; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Marialigeti S, 2009, BIODIVERS CONSERV, V18, P2223, DOI 10.1007/s10531-009-9586-6; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; Matoh T, 1997, PLANT SOIL, V193, P59, DOI 10.1023/A:1004207824251; McCune B, 2002, ANAL ECOLOGICAL COMM; McIntosh ACS, 2012, ECOLOGY UNDERSTORY B; McIntosh ACS, 2013, SOIL BIOL BIOCHEM, V63, P61, DOI 10.1016/j.soilbio.2013.03.028; McIntosh ACS, 2013, FOREST ECOL MANAG, V295, P11, DOI 10.1016/j.foreco.2012.12.050; MILLIGAN GW, 1989, MULTIVAR BEHAV RES, V24, P163, DOI 10.1207/s15327906mbr2402_2; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Nalder IA, 1997, CAN J FOREST RES, V27, P1513, DOI 10.1139/cjfr-27-9-1513; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Olsson S, 2000, SOIL BIOL BIOCHEM, V32, P1443, DOI 10.1016/S0038-0717(00)00062-6; Pennanen T, 1999, MICROB ECOL, V38, P168, DOI 10.1007/s002489900161; Prescott CE, 2002, TREE PHYSIOL, V22, P1193, DOI 10.1093/treephys/22.15-16.1193; Reich PB, 2012, J ECOL, V100, P539, DOI 10.1111/j.1365-2745.2011.01922.x; Rhoades C, 2001, ECOSCIENCE, V8, P89, DOI 10.1080/11956860.2001.11682634; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Soil Classification Working Group, 1998, CAN SYST SOIL CLASS, V3rd; Stevenson BA, 2004, SOIL BIOL BIOCHEM, V36, P49, DOI 10.1016/j.soilbio.2003.08.018; STRONG WL, 1991, CAN J FOREST RES, V21, P1675, DOI 10.1139/x91-231; ter Braak CJF, 2009, CANOCO WINDOWS V 4 5; Urban D, 2002, ECOSCIENCE, V9, P200, DOI 10.1080/11956860.2002.11682706; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van Wagner CE, 1982, PRACTICAL ASPECTS LI; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; White David C., 1998, P255; Woodard P. M, 1988, 45 NO FOR CTR P M CA; Work TT, 2004, CAN J FOREST RES, V34, P417, DOI 10.1139/X03-238; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	80	13	14	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151436	10.1371/journal.pone.0151436	http://dx.doi.org/10.1371/journal.pone.0151436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975055	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600079
J	Petty, RD; McCarthy, NE; Le Dieu, R; Kerr, JR				Petty, Robert D.; McCarthy, Neil E.; Le Dieu, Rifca; Kerr, Jonathan R.			MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION PROFILE; PERIPHERAL-BLOOD; IMMUNOLOGICAL ABNORMALITIES; CANCER CELLS; IDENTIFICATION; PCR; EXPLORATION; ACTIVATION; MECHANISMS	Background Chronic Fatigue Syndrome (CFS/ME) is a complex multisystem disease of unknown aetiology which causes debilitating symptoms in up to 1% of the global population. Although a large cohort of genes have been shown to exhibit altered expression in CFS/ME patients, it is currently unknown whether microRNA (miRNA) molecules which regulate gene translation contribute to disease pathogenesis. We hypothesized that changes in microRNA expression in patient leukocytes contribute to CFS/ME pathology, and may therefore represent useful diagnostic biomarkers that can be detected in the peripheral blood of CFS/ME patients. Methods miRNA expression in peripheral blood mononuclear cells (PBMC) from CFS/ME patients and healthy controls was analysed using the Ambion Bioarray V1. miRNA demonstrating differential expression were validated by qRT-PCR and then replicated in fractionated blood leukocyte subsets from an independent patient cohort. The CFS/ME associated miRNA identified by these experiments were then transfected into primary NK cells and gene expression analyses conducted to identify their gene targets. Results Microarray analysis identified differential expression of 34 miRNA, all of which were up-regulated. Four of the 34 miRNA had confirmed expression changes by qRT-PCR. Fractionating PBMC samples by cell type from an independent patient cohort identified changes in miRNA expression in NK-cells, B-cells and monocytes with the most significant abnormalities occurring in NK cells. Transfecting primary NK cells with hsa-miR-99b or hsa-miR-330-3p, resulted in gene expression changes consistent with NK cell activation but diminished cytotoxicity, suggesting that defective NK cell function contributes to CFS/ME pathology. Conclusion This study demonstrates altered microRNA expression in the peripheral blood mononuclear cells of CFS/ME patients, which are potential diagnostic biomarkers. The greatest degree of miRNA deregulation was identified in NK cells with targets consistent with cellular activation and altered effector function.	[Petty, Robert D.; Kerr, Jonathan R.] St Georges Univ London, CFS Grp, Cranmer Terrace, London, England; [Petty, Robert D.; Le Dieu, Rifca] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England; [McCarthy, Neil E.] Queen Mary Univ London, Blizzard Inst, Ctr Immunobiol, London, England; [Kerr, Jonathan R.] Univ Rosario, Escuela Med & Ciencias Salud, Grp Salud Publ, Bogota 111221, Colombia	St Georges University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Universidad del Rosario	Petty, RD (corresponding author), St Georges Univ London, CFS Grp, Cranmer Terrace, London, England.; Petty, RD (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England.	r.d.petty@qmul.ac.uk	McCarthy, Neil E/B-6064-2008	McCarthy, Neil E/0000-0002-4330-4747	chronic fatigue syndrome research foundation (CFSRF); RDP; ME research UK; Joseph Hotung	chronic fatigue syndrome research foundation (CFSRF); RDP(Centre National de la Recherche Scientifique (CNRS)); ME research UK; Joseph Hotung	This work was partially funded by the chronic fatigue syndrome research foundation (CFSRF), who also funded the salary of RDP, and partially funded by ME research UK (http://www.meresearch.org.uk/). The salary of JRK was funded by Joseph Hotung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo J, 2014, NAT IMMUNOL, V15, P54, DOI 10.1038/ni.2767; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Bjersing JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078762; Braun M, 2011, J INNATE IMMUN, V3, P420, DOI 10.1159/000322720; Brenu EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102783; Brenu EW, 2012, J AFFECT DISORDERS, V141, P261, DOI 10.1016/j.jad.2012.03.037; Brenu EW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-88; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; Brenu EW, 2014, INT IMMUNOL, V26, P233, DOI 10.1093/intimm/dxt068; Broderick G, 2006, PHARMACOGENOMICS, V7, P407, DOI 10.2217/14622416.7.3.407; Carmel L, 2006, PHARMACOGENOMICS, V7, P375, DOI 10.2217/14622416.7.3.375; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Case AJ, 2011, FREE RADICAL BIO MED, V50, P448, DOI 10.1016/j.freeradbiomed.2010.11.025; Cerda-Olmedo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121903; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Fan HM, 2014, J PSYCHIATR RES, V59, P45, DOI 10.1016/j.jpsychires.2014.08.007; Fang H, 2006, PHARMACOGENOMICS, V7, P429, DOI 10.2217/14622416.7.3.429; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Fletcher MA, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-76; Fletcher MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010817; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Fostel J, 2006, PHARMACOGENOMICS, V7, P441, DOI 10.2217/14622416.7.3.441; Frampton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016872; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Grans H, 2005, J INTERN MED, V258, P388, DOI 10.1111/j.1365-2796.2005.01548.x; group Tcmosw, 2002, REP CFS ME WORK GROU; Hisaoka M, 2011, GENE CHROMOSOME CANC, V50, P137, DOI 10.1002/gcc.20837; Holgate ST, 2011, NAT REV NEUROSCI, V12, P539, DOI 10.1038/nrn3087; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kaminski MM, 2012, BBA-MOL CELL RES, V1823, P1041, DOI 10.1016/j.bbamcr.2012.03.003; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Kerr JR, 2008, J CLIN PATHOL, V61, P730, DOI 10.1136/jcp.2007.053553; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Kerr Jonathan R, 2008, Curr Rheumatol Rep, V10, P482; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Laytragoon-Lewin N, 2011, ANTICANCER RES, V31, P1527; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li YF, 2013, BIOCHEM BIOPH RES CO, V431, P560, DOI 10.1016/j.bbrc.2013.01.016; Light AR, 2009, J PAIN, V10, P1099, DOI 10.1016/j.jpain.2009.06.003; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu QQ, 2009, J VIROL, V83, P8705, DOI 10.1128/JVI.02666-08; Maher KJ, 2005, CLIN EXP IMMUNOL, V142, P505, DOI 10.1111/j.1365-2249.2005.02935.x; Mao YQ, 2013, ONCOL REP, V30, P327, DOI 10.3892/or.2013.2452; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Meade JL, 2006, BLOOD, V107, P3665, DOI 10.1182/blood-2005-03-1140; Melas PA, 2012, INT J NEUROPSYCHOPH, V15, P669, DOI 10.1017/S1461145711000940; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; Olsson J, 2011, NEPHROL DIAL TRANSPL, V26, P2195, DOI 10.1093/ndt/gfq673; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Papanicolaou DA, 2004, NEUROIMMUNOMODULAT, V11, P65, DOI 10.1159/000075315; Powell R, 2003, CLIN EXP ALLERGY, V33, P1450, DOI 10.1046/j.1365-2222.2003.01745.x; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Steinau M, 2004, J MOL MED, V82, P750, DOI 10.1007/s00109-004-0586-4; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Turchinovich A, 2012, RNA BIOL, V9, P1066, DOI 10.4161/rna.21083; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; Wan YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121975; Whistler T, 2006, PHARMACOGENOMICS, V7, P395, DOI 10.2217/14622416.7.3.395; Whistler Toni, 2005, BMC Physiol, V5, P5, DOI 10.1186/1472-6793-5-5; Whistler Toni, 2003, J Transl Med, V1, P10, DOI 10.1186/1479-5876-1-10; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Wurmbach E, 2003, METHODS, V31, P306, DOI 10.1016/S1046-2023(03)00161-0	84	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150904	10.1371/journal.pone.0150904	http://dx.doi.org/10.1371/journal.pone.0150904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967895	Green Published, gold			2022-12-26	WOS:000371989200018
J	Lee, T; Paquet, M; Larsson, O; Pelletier, J				Lee, T.; Paquet, M.; Larsson, O.; Pelletier, J.			Tumor cell survival dependence on the DHX9 DExH-box helicase	ONCOGENE			English	Article							BREAST-CANCER CELLS; RNA-POLYMERASE-II; TRANSLATION INITIATION; MESSENGER-RNAS; A INTERACTS; MUTANT P53; DNA; PROTEIN; PROLIFERATION; INHIBITOR	The NTP-dependent DExH/D-box helicase DHX9 is a key participant in a number of gene regulatory steps, including transcriptional, translational, and microRNA-mediated control, DNA replication and maintenance of genomic stability. DHX9 has also been implicated in tumor cell maintenance and drug response. Here we report that inhibition of DHX9 expression is lethal to human cancer cell lines and murine E mu-Myc lymphomas. Using a novel conditional shDHX9 mouse model, we demonstrate that sustained and prolonged (6 months) suppression of DHX9 does not result in any deleterious effects at the organismal level. Body weight, blood biochemistry and histology of various tissues were comparable to control mice. Global gene expression profiling revealed that, although reduction of DHX9 expression resulted in multiple transcriptome changes, these were relatively benign and did not lead to any discernible phenotype. Our results demonstrate a robust tolerance for systemic DHX9 suppression in vivo and support the targeting of DHX9 as an effective and specific chemotherapeutic approach.	[Lee, T.; Pelletier, J.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Paquet, M.] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [Larsson, O.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Pelletier, J.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Pelletier, J.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada	McGill University; Universite de Montreal; Karolinska Institutet; McGill University; McGill University	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	jerry.pelletier@mcgill.ca	Paquet, Marilene/L-3414-2019	Paquet, Marilene/0000-0002-3562-4636; Larsson, Ola/0000-0003-1412-1308	CIHR; Canadian Cancer Society Research Institute [701362]; National Institutes of Health [CA163291]; Swedish Research Council; Swedish Cancer Society; NATIONAL CANCER INSTITUTE [R01CA163291] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Francis Robert for performing tail-vein injections of lymphoma cells into mice. TL was supported by a Maysie MacSporran graduate studentship and fellowships from the CIHR-sponsored Chemical Biology and Systems Biology Training Programs. This work is supported by grants from the Canadian Cancer Society Research Institute (no. 701362) and National Institutes of Health (CA163291) to JP and grants from the Swedish Research Council and the Swedish Cancer Society to OL.	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Barde I., 2010, CURR PROTOC NEUROSCI; Calcabrini A, 2006, CARCINOGENESIS, V27, P1699, DOI 10.1093/carcin/bgl044; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Dardenne E, 2012, NAT STRUCT MOL BIOL, V19, P1139, DOI 10.1038/nsmb.2390; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gartel AL, 2002, MOL CANCER THER, V1, P639; HARPER JW, 1993, CELL, V75, P805; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Jain A, 2013, NUCLEIC ACIDS RES, V41, P10345, DOI 10.1093/nar/gkt804; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; LEE CG, 1993, J BIOL CHEM, V268, P16822; Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709; LEE CG, 1992, J BIOL CHEM, V267, P4398; Lee T, 2014, J BIOL CHEM, V289, P22798, DOI 10.1074/jbc.M114.568535; Lin CJ, 2012, CELL REPORTS, V1, P325, DOI 10.1016/j.celrep.2012.02.010; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; Mazurek A, 2014, CELL REP, V7, P1887, DOI 10.1016/j.celrep.2014.05.019; McJunkin K, 2011, P NATL ACAD SCI USA, V108, P7113, DOI 10.1073/pnas.1104097108; Mills JR, 2013, BLOOD, V121, P3402, DOI 10.1182/blood-2012-06-434365; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Parsyan A, 2009, P NATL ACAD SCI USA, V106, P22217, DOI 10.1073/pnas.0909773106; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Robert F, 2014, P NATL ACAD SCI USA, V111, P13421, DOI 10.1073/pnas.1402650111; Saporita AJ, 2011, CANCER RES, V71, P6708, DOI 10.1158/0008-5472.CAN-11-1472; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tang H, 1999, MOL CELL BIOL, V19, P3540; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; Walstrom KM, 2005, MECH DEVELOP, V122, P707, DOI 10.1016/j.mod.2004.12.002; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; ZHANG SS, 1994, BIOCHEMISTRY-US, V33, P3906, DOI 10.1021/bi00179a016; Zhang SS, 1997, J BIOL CHEM, V272, P11487; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933; ZHANG SS, 1991, J BIOL CHEM, V266, P20483; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	47	33	33	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5093	5105		10.1038/onc.2016.52	http://dx.doi.org/10.1038/onc.2016.52			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	26973242	Green Accepted, Bronze			2022-12-26	WOS:000384433000002
J	Bueno, AB; Showalter, AD; Wainscott, DB; Stutsman, C; Marin, A; Ficorilli, J; Cabrera, O; Willard, FS; Sloop, KW				Bueno, Ana B.; Showalter, Aaron D.; Wainscott, David B.; Stutsman, Cynthia; Marin, Aranzazu; Ficorilli, James; Cabrera, Over; Willard, Francis S.; Sloop, Kyle W.			Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; EVOLUTIONARILY CONSERVED RESIDUES; STIMULATED INSULIN-SECRETION; CLASS-B GPCRS; DRUG DISCOVERY; GLP-1 RECEPTOR; IRREVERSIBLE INHIBITORS; ASSAY INTERFERENCE; DISULFIDE PATTERN; LIGAND-BINDING	Therapeutic intervention to activate the glucagon-like peptide-1 receptor (GLP-1R) enhances glucose-dependent insulin secretion and improves energy balance in patients with type 2 diabetes mellitus. Studies investigating mechanisms whereby peptide ligands activate GLP-1R have utilized mutagenesis, receptor chimeras, photo-affinity labeling, hydrogen-deuterium exchange, and crystallography of the ligand-binding ectodomain to establish receptor homology models. However, this has not enabled the design or discovery of drug-like non-peptide GLP-1R activators. Recently, studies investigating 4-(3-benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl) pyrimidine (BETP), a GLP-1R-positive allosteric modulator, determined that Cys-347 in the GLP-1R is required for positive allosteric modulator activity via covalent modification. To advance small molecule activation of the GLP-1R, we characterized the insulinotropic mechanism of BETP. In guanosine 5'-3-O-(thio) triphosphate binding and INS1 832-3 insulinoma cell cAMP assays, BETP enhanced GLP-1(9-36)-NH2-stimulated cAMP signaling. Using isolated pancreatic islets, BETP potentiated insulin secretion in a glucose-dependent manner that requires both the peptide ligand and GLP-1R. In studies of the covalent mechanism, PAGE fluorography showed labeling of GLP-1R in immunoprecipitation experiments from GLP-1R-expressing cells incubated with [H-3] BETP. Furthermore, we investigated whether other reported GLP-1R activators and compounds identified from screening campaigns modulate GLP-1R by covalent modification. Similar to BETP, several molecules were found to enhance GLP-1R signaling in a Cys-347-dependent manner. These chemotypes are electrophiles that react with GSH, and LC/MS determined the cysteine adducts formed upon conjugation. Together, our results suggest covalent modification may be used to stabilize the GLP-1R in an active conformation. Moreover, the findings provide pharmacological guidance for the discovery and characterization of small molecule GLP-1R ligands as possible therapeutics.	[Bueno, Ana B.; Marin, Aranzazu] Eli Lilly & Co, Ctr Invest Lilly, Alcobendas 28108, Spain; [Showalter, Aaron D.; Stutsman, Cynthia; Ficorilli, James; Cabrera, Over; Sloop, Kyle W.] Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA; [Wainscott, David B.; Willard, Francis S.] Eli Lilly & Co, Lilly Res Labs, Quantitat Biol, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Sloop, KW (corresponding author), Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA.	sloop_kyle_w@lilly.com		Bueno, Ana Belen/0000-0002-4190-6891				Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bauer RA, 2015, DRUG DISCOV TODAY, V20, P1061, DOI 10.1016/j.drudis.2015.05.005; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Bhumralkar D., 2000, U. S. Patent, Patent No. [WO2000/42026, 200042026]; Bruns RF, 2012, J MED CHEM, V55, P9763, DOI 10.1021/jm301008n; Campbell R. M., 2004, ASSAY GUIDANCE MANUA; Chein R.-J., 2015, U. S. Patent, Patent No. [9,193,665, 9193665]; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Deacon CF, 2012, DIABETES OBES METAB, V14, P762, DOI 10.1111/j.1463-1326.2012.01603.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eng H, 2013, DRUG METAB DISPOS, V41, P1470, DOI 10.1124/dmd.113.052183; Epps DE, 2001, ANAL BIOCHEM, V295, P101, DOI 10.1006/abio.2001.5173; Erlanson DA, 2015, J MED CHEM, V58, P2088, DOI 10.1021/acs.jmedchem.5b00294; Flanagan ME, 2014, J MED CHEM, V57, P10072, DOI 10.1021/jm501412a; Gelbert LM, 2014, INVEST NEW DRUG, V32, P825, DOI 10.1007/s10637-014-0120-7; GOERDELER J, 1964, CHEM BER-RECL, V97, P225, DOI 10.1002/cber.19640970133; Gong YD, 2010, B KOREAN CHEM SOC, V31, P3760, DOI 10.5012/bkcs.2010.31.12.3760; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hofmann BA, 2001, PROTEIN SCI, V10, P2050, DOI 10.1110/ps.12101; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Jun LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093746; Kirkpatrick A, 2012, P NATL ACAD SCI USA, V109, P19988, DOI [10.1073/pnas.1218051109, 10.1073/pnas.12180511091]; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Knudsen S. M., 2006, U. S. Patent, Patent No. [WO2006/003096, 2006003096]; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Kopin A. S., 2004, U. S. Patent, Patent No. [WO2004/203310, 2004203310]; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lebakken CS, 2009, J BIOMOL SCREEN, V14, P924, DOI 10.1177/1087057109339207; Li NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047936; Liao J., 2014, U. S. Patent, Patent No. [8,748,412, 8748412]; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Moon H. S., 2011, U. S. Patent, Patent No. [WO2011/122815, 2011122815]; Moon HS, 2011, ARCH PHARM RES, V34, P1041, DOI 10.1007/s12272-011-0721-z; Moon MJ, 2015, J BIOL CHEM, V290, P5696, DOI 10.1074/jbc.M114.612606; Moon MJ, 2012, J BIOL CHEM, V287, P3873, DOI 10.1074/jbc.M111.276808; Morris LC, 2014, J MED CHEM, V57, P10192, DOI 10.1021/jm501375c; Nakane A, 2015, ANAL BIOCHEM, V491, P23, DOI 10.1016/j.ab.2015.08.026; NOGUCHI T, 1968, Yakugaku Zasshi, V88, P1437; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PLAPP BV, 1982, METHOD ENZYMOL, V87, P469; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Singh J, 1997, J MED CHEM, V40, P1130, DOI 10.1021/jm960380s; Siu FY, 2010, STRUCTURE, V18, P1067, DOI 10.1016/j.str.2010.08.004; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Takahashi K, 2009, BIOL PHARM BULL, V32, P475, DOI 10.1248/bpb.32.475; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Willard FS, 2012, MOL PHARMACOL, V82, P1066, DOI 10.1124/mol.112.080432; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Wu R.-Y., 2015, U. S. Patent, Patent No. [9,150,482, 9150482]; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859	65	40	42	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10700	10715		10.1074/jbc.M115.696039	http://dx.doi.org/10.1074/jbc.M115.696039			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26975372	hybrid, Green Published			2022-12-26	WOS:000377042600022
J	Shimizu, T; Tomita, T; Kuzuyama, T; Nishiyama, M				Shimizu, Tetsu; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto			Crystal Structure of the LysY.LysW Complex from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST 2 STEPS; LYSINE BIOSYNTHESIS; GLUTAMATE KINASE; CARRIER PROTEIN; ENZYME; DEHYDROGENASE; PHOSPHATE; BACTERIUM; PROLINE; BINDING	Several bacteria and archaea utilize the amino group-carrier protein, LysW, for lysine biosynthesis, in which an isopeptide bond is formed between the C-terminal Glu of LysW and an amino group of a-aminoadipate (AAA), The resulting LysW-gamma-AAA is phosphorylated by LysZ to form LysW-gamma-AAA phosphate, which is subsequently reduced to LysW-gamma-aminoadipic semialdehyde (LysW-gamma-AASA) through a reaction catalyzed by LysY. In this study, we determined the crystal structures of LysY from Thermus thermophilus HB27 (TtLysY) complexed with TtLysW-gamma-AASA and TtLysW-gamma-AAA, respectively. In both structures, the globular domain of TtLysW was recognized by positively charged residues on helix alpha 9 and the beta 11-alpha 10 loop of TtLysY through conformational changes. A mutational analysis confirmed that the interactions observed between TtLysY and LysW are important for the function of TtLysY. The extended LysW recognition loop and conserved arginine residue were identified as signatures to discriminate LysY from ArgC, which is involved in arginine biosynthesis. Combined with the previously determined TtLysZ.TtLysW complex structure, TtLysW may simultaneously bind TtLysZ and TtLysY. These structural insights suggest the formation of a TtLysWZY ternary complex, in which the flexible C-terminal extension of TtLysW promotes the efficient transfer of the labile intermediate from the active site of TtLysZ to that of TtLysY during the sequential reactions catalyzed by TtLysZY.	[Shimizu, Tetsu; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan	University of Tokyo	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Kuzuyama, Tomohisa/0000-0002-7221-5858	Japan Society for the Promotion of Science [24228001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 24228001 (to M. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abadjieva A, 2001, J BIOL CHEM, V276, P42869, DOI 10.1074/jbc.M103732200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aral B, 1996, CR ACAD SCI III-VIE, V319, P171; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLACK S, 1955, J BIOL CHEM, V213, P27; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Cherney LT, 2007, J MOL BIOL, V367, P1357, DOI 10.1016/j.jmb.2007.01.033; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Demmer U, 2013, J BIOL CHEM, V288, P6363, DOI 10.1074/jbc.M112.421263; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faehnle CR, 2006, J BIOL CHEM, V281, P31031, DOI 10.1074/jbc.M605926200; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; Hadfield A, 2001, BIOCHEMISTRY-US, V40, P14475, DOI 10.1021/bi015713o; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; James CL, 2002, BIOCHEMISTRY-US, V41, P3726, DOI 10.1021/bi0159074; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KATCHALSKY A, 1954, J AM CHEM SOC, V76, P6042, DOI 10.1021/ja01652a053; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; KOSHLAND DE, 1952, J AM CHEM SOC, V74, P2286, DOI 10.1021/ja01129a035; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLoughlin SY, 2008, P NATL ACAD SCI USA, V105, P13497, DOI 10.1073/pnas.0804804105; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki T, 2004, MICROBIOL-SGM, V150, P2327, DOI 10.1099/mic.0.27037-0; Mukherjee S, 2010, J MOL BIOL, V401, P949, DOI 10.1016/j.jmb.2010.07.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouchi T, 2013, NAT CHEM BIOL, V9, P277, DOI [10.1038/NCHEMBIO.1200, 10.1038/nchembio.1200]; Pavlovsky AG, 2014, ACTA CRYSTALLOGR D, V70, P3244, DOI 10.1107/S1399004714023979; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SEDDON AP, 1989, J BIOL CHEM, V264, P11326; STRASSMAN M, 1953, J AM CHEM SOC, V75, P1680, DOI 10.1021/ja01103a049; Udaka S., 1958, J GEN APPL MICROBIOL, V4, P272; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Yoshida A, 2015, J BIOL CHEM, V290, P435, DOI 10.1074/jbc.M114.595983; YOSHINAGA F, 1967, BIOCHEM BIOPH RES CO, V27, P143, DOI 10.1016/S0006-291X(67)80053-6	42	3	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9948	9959		10.1074/jbc.M115.707034	http://dx.doi.org/10.1074/jbc.M115.707034			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26966182	Green Published, hybrid			2022-12-26	WOS:000375602800010
J	Leventhal, JS; Ni, J; Osmond, M; Lee, K; Gusella, GL; Salem, F; Ross, MJ				Leventhal, Jeremy S.; Ni, Jie; Osmond, Morgan; Lee, Kyung; Gusella, G. Luca; Salem, Fadi; Ross, Michael J.			Autophagy Limits Endotoxemic Acute Kidney Injury and Alters Renal Tubular Epithelial Cell Cytokine Expression	PLOS ONE			English	Article							SEPSIS; MICE; PROTECTS; DISEASE; INACTIVATION; APOPTOSIS; PREVENTS; FAILURE; PLAYS; GENE	Sepsis related acute kidney injury (AKI) is a common in-hospital complication with a dismal prognosis. Our incomplete understanding of disease pathogenesis has prevented the identification of hypothesis-driven preventive or therapeutic interventions. Increasing evidence in ischemia-reperfusion and nephrotoxic mouse models of AKI support the theory that autophagy protects renal tubular epithelial cells (RTEC) from injury. However, the role of RTEC autophagy in septic AKI remains unclear. We observed that lipopolysaccharide (LPS), a mediator of gram-negative bacterial sepsis, induces RTEC autophagy in vivo and in vitro through TLR4-initiated signaling. We modeled septic AKI through intraperitoneal LPS injection in mice in which autophagy-related protein 7 was specifically knocked out in the renal proximal tubules (ATG7KO). Compared to control littermates, ATG7KO mice developed more severe renal dysfunction (24hr BUN 100.1mg/dl +/- 14.8 vs 54.6mg/dl +/- 11.3) and parenchymal injury. After injection with LPS, analysis of kidney lysates identified higher IL-6 expression and increased STAT3 activation in kidney lysates from ATG7KO mice compared to controls. In vitro experiments confirmed an altered response to LPS in RTEC with genetic or pharmacological impairment of autophagy. In conclusion, RTEC autophagy protects against endotoxin induced injury and regulates downstream effects of RTEC TLR4 signaling.	[Leventhal, Jeremy S.; Ni, Jie; Osmond, Morgan; Lee, Kyung; Gusella, G. Luca; Ross, Michael J.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Leventhal, Jeremy S.; Ross, Michael J.] James J Peters Bronx VA Med Ctr, Div Renal, Bronx, NY USA; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Leventhal, JS (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA.; Leventhal, JS (corresponding author), James J Peters Bronx VA Med Ctr, Div Renal, Bronx, NY USA.	jeremy.leventhal@mssm.edu	Salem, Fadi/AAP-9399-2020; Lee, Kyung/AAD-5009-2021	Salem, Fadi/0000-0002-2603-2778; Lee, Kyung/0000-0002-9756-1765	NIH/NIDDK grant [R01 DK101338, DK108346, K08 DK090217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108346, R01DK101338, K08DK090217] Funding Source: NIH RePORTER	NIH/NIDDK grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the NIH/NIDDK grant R01 DK101338 and DK108346 (MR) and an NIH/NIDDK K08 DK090217 grant (JSL).; This research was supported by the NIH/NIDDK grant R01 DK101338 and DK108346 (M.R.) and an NIH/NIDDK K08 DK090217 (J.S.L). Microscopy was performed at the Microscopy CORE at the Icahn School of Medicine at Mount Sinai.	CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Chen P, 2011, J AM SOC NEPHROL, V22, P496, DOI 10.1681/ASN.2010040379; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; El-Achkar TM, 2008, EUR J CLIN INVEST, V38, P39, DOI 10.1111/j.1365-2362.2008.02007.x; Escobar DA, 2015, J SURG RES, V194, P262, DOI 10.1016/j.jss.2014.10.009; Evans RG, 2008, AM J PHYSIOL-RENAL, V295, pF1259, DOI 10.1152/ajprenal.90230.2008; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Hartleben B, 2010, J CLIN INVEST; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Hsiao HW, 2012, SHOCK, V37, P289, DOI 10.1097/SHK.0b013e318240b52a; Jiang M, 2010, AM J PATHOL; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Kalakeche R, 2011, J AM SOC NEPHROL, V22, P1505, DOI 10.1681/ASN.2011020203; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lee K, 2015, J AM SOC NEPHROL, V26, P888, DOI 10.1681/ASN.2013111179; Leventhal JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020688; Liu SY, 2012, AUTOPHAGY, V8, P826, DOI 10.4161/auto.19419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097985; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007	32	27	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150001	10.1371/journal.pone.0150001	http://dx.doi.org/10.1371/journal.pone.0150001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990086	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800023
J	Ma, QF; Wu, M; Pei, WF; Wang, XY; Zhai, HH; Wang, WK; Li, XL; Zhang, JF; Yu, JW; Yu, SX				Ma, Qifeng; Wu, Man; Pei, Wenfeng; Wang, Xiaoyan; Zhai, Honghong; Wang, Wenkui; Li, Xingli; Zhang, Jinfa; Yu, Jiwen; Yu, Shuxun			RNA-Seq-Mediated Transcriptome Analysis of a Fiberless Mutant Cotton and Its Possible Origin Based on SNP Markers	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; DISEASE RESISTANCE; IDENTIFICATION; DIVERSITY; EVOLUTION; SEQUENCE; GENES; YIELD; LIGHT	As the longest known single-celled trichomes, cotton (Gossypium L.) fibers constitute a classic model system to investigate cell initiation and elongation. In this study, we used a high-throughput transcriptome sequencing technology to identify fiber-initiation-related single nucleotide polymorphism (SNP) markers and differentially expressed genes (DEGs) between the wild-type (WT) Upland cotton (G. hirsutum) Xuzhou 142 and its natural fuzzless-lintless mutant Xuzhou 142 fl. Approximately 700 million high-quality cDNA reads representing over 58 Gb of sequences were obtained, resulting in the identification of 28,610 SNPs-of which 17,479 were novel-from 13,960 expressed genes. Of these SNPs, 50% of SNPs in fl were identical to those of G. barbadense, which suggests the likely origin of the fl mutant from an interspecific hybridization between Xuzhou 142 and an unknown G. barbadense genotype. Of all detected SNPs, 15,555, 12,750, and 305 were classified as non-synonymous, synonymous, and pre-terminated ones, respectively. Moreover, 1,352 insertion/deletion polymorphisms (InDels) were also detected. A total of 865 DEGs were identified between the WT and fl in ovules at -3 and 0 days post-anthesis, with 302 candidate SNPs selected from these DEGs for validation by a high-resolution melting analysis and Sanger sequencing in seven cotton genotypes. The number of genotypic pairwise polymorphisms varied from 43 to 302, indicating that the identified SNPs are reliable. These SNPs should serve as good resources for breeding and genetic studies in cotton.	[Ma, Qifeng; Wu, Man; Pei, Wenfeng; Zhai, Honghong; Wang, Wenkui; Li, Xingli; Yu, Jiwen; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Wang, Xiaoyan] Anyang Inst Technol, Coll Biol & Food Technol, Anyang, Peoples R China; [Zhang, Jinfa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Anyang Institute of Technology; New Mexico State University	Yu, JW; Yu, SX (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.; Zhang, JF (corresponding author), New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.	jinzhang@nmsu.edu; yujw666@hotmail.com; yu@cricaas.com.cn			National Natural Science Foundation of China [31301367, 31301368]; National High Technology Research and Development Program of China [2013AA102601-01-14]; New Mexico Agricultural Experiment Station	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); New Mexico Agricultural Experiment Station	This program was financially supported in part by the National Natural Science Foundation of China (grant No. 31301367 and grant No. 31301368), the National High Technology Research and Development Program of China (grant No. 2013AA102601-01-14), and the New Mexico Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An C, 2008, THEOR APPL GENET, V116, P1015, DOI 10.1007/s00122-008-0732-4; [Anonymous], 2012, GENOME BIOL; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Campbell BT, 2010, CROP SCI, V50, P1161, DOI 10.2135/cropsci2009.09.0551; ENDRIZZI JE, 1980, J HERED, V71, P45, DOI 10.1093/oxfordjournals.jhered.a109309; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hulse-Kemp AM, 2015, G3-GENES GENOM GENET, V4, P1; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu YZ, 2009, CROP SCI, V49, P1695, DOI 10.2135/cropsci2008.12.0693; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Ma QF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-466; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Malik W, 2014, SCI WORLD J, V2014; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Nagalakshmi U, CURR PROTO MOL BIOL, V4, P1; Pang MX, 2012, MOL BREEDING, V30, P1143, DOI 10.1007/s11032-012-9702-2; Park JE, 2007, PLANT CELL PHYSIOL, V48, P1236, DOI 10.1093/pcp/pcm086; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; Said JI, 2015, MOL GENET GENOMICS, P1; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Schunter C, 2014, MOL ECOL RESOUR, V14, P157, DOI 10.1111/1755-0998.12155; Shan CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6519; Singla B, 2006, J EXP BOT, V57, P4059, DOI 10.1093/jxb/erl182; STEWART JM, 1975, AM J BOT, V62, P723, DOI 10.2307/2442061; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Van Deynze A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-125; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wan Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097313; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Yao Y, 2014, PLOS ONE, V10; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Yu J, 2014, NUCLEIC ACIDS RES, V42, pD1229, DOI 10.1093/nar/gkt1064; Zhang JinFa, 2000, Journal of Cotton Science, V4, P193; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang TZ, 1991, JIANGSU J AGR SCI, V7, P13	48	27	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151994	10.1371/journal.pone.0151994	http://dx.doi.org/10.1371/journal.pone.0151994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990639	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800128
J	Zhu, H; Behr, B; Reddy, VV; Hughes, M; Pan, YQ; Baker, J				Zhu, Hui; Behr, Barry; Reddy, Vikrant V.; Hughes, Mark; Pan, Yuqiong; Baker, Julie			Human Embryonic Stem Cell Lines with Lesions in FOXP3 and NF1	PLOS ONE			English	Article							ENTEROPATHY; GENE; POLYENDOCRINOPATHY; OLIGODENDROCYTES; DIFFERENTIATION; GENERATION; DERIVATION; MYELINATE; PROTEIN; IPEX	Human embryonic stem cells (hESCs) are derived from the inner cell mass (ICM) of blastocyst staged embryos. Spare blastocyst staged embryos were obtained by in vitro fertilization (IVF) and donated for research purposes. hESCs carrying specific mutations can be used as a powerful cell system in modeling human genetic disorders. We obtained preimplantation genetic diagnosed (PGD) blastocyst staged embryos with genetic mutations that cause human disorders and derived hESCs from these embryos. We applied laser assisted micromanipulation to isolate the inner cell mass from the blastocysts and plated the ICM onto the mouse embryonic fibroblast cells. Two hESC lines with lesions in FOXP3 and NF1 were established. Both lines maintain a typical undifferentiated hESCs phenotype and present a normal karyotype. The two lines express a panel of pluripotency markers and have the potential to differentiate to the three germ layers in vitro and in vivo. The hESC lines with lesions in FOXP3 and NF1 are available for the scientific community and may serve as an important resource for research into these disease states.	[Zhu, Hui; Baker, Julie] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Behr, Barry; Reddy, Vikrant V.] Lucile Packard Childrens Hosp, Stanford Fertil & Reprod Hlth, Stanford IVF Lab, Palo Alto, CA 94304 USA; [Behr, Barry] Stanford Univ, Sch Med, Dept Obstet Gynecol, Stanford, CA 94305 USA; [Hughes, Mark] Genesis Genet Inst, Plymouth, MI 48170 USA; [Pan, Yuqiong] Stanford Univ, Dept Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University	Baker, J (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jbaker@stanford.edu			California Institute of Regenerative Medicine [RL1-00630-1]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute of Regenerative Medicine: Grant number RL1-00630-1, https://www.cirm.ca.gov/node/6722/review. JB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the California Institute of Regenerative Medicine: Grant number RL1-00630-1.	Ben-Yosef D, 2008, MOL CELL ENDOCRINOL, V282, P153, DOI 10.1016/j.mce.2007.11.010; Bennett CL, 2001, CURR OPIN PEDIATR, V13, P533, DOI 10.1097/00008480-200112000-00007; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chronopoulou E, 2015, HUM REPROD UPDATE, V21, P39, DOI 10.1093/humupd/dmu040; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Ferner Rosalie E, 2010, Pract Neurol, V10, P82, DOI 10.1136/jnnp.2010.206532; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turetsky T, 2008, HUM REPROD, V23, P46, DOI 10.1093/humrep/dem351; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	27	0	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151836	10.1371/journal.pone.0151836	http://dx.doi.org/10.1371/journal.pone.0151836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990425	Green Published, gold			2022-12-26	WOS:000372582800106
J	Bonaterra, GA; Then, H; Oezel, L; Schwarzbach, H; Ocker, M; Thieme, K; Di Fazio, P; Kinscherf, R				Bonaterra, Gabriel Alejandro; Then, Hanna; Oezel, Lisa; Schwarzbach, Hans; Ocker, Matthias; Thieme, Kati; Di Fazio, Pietro; Kinscherf, Ralf			Morphological Alterations in Gastrocnemius and Soleus Muscles in Male and Female Mice in a Fibromyalgia Model	PLOS ONE			English	Article							EXPERIMENTAL MOUSE MODEL; STRESS; HYPERALGESIA; INFLAMMATION; ANALGESIA; BREAKDOWN; ATROPHY; PAIN	Background Fibromyalgia (FM) is a chronic musculoskeletal pain disorder, characterized by chronic widespread pain and bodily tenderness and is often accompanied by affective disturbances, however often with unknown etiology. According to recent reports, physical and psychological stress trigger FM. To develop new treatments for FM, experimental animal models for FM are needed to be development and characterized. Using a mouse model for FM including intermittent cold stress (ICS), we hypothesized that ICS leads to morphological alterations in skeletal muscles in mice. Methods Male and female ICS mice were kept under alternating temperature (4 degrees C/room temperature [22 degrees C]); mice constantly kept at room temperature served as control. After scarification, gastrocnemius and soleus muscles were removed and snap-frozen in liquid nitrogen-cooled isopentane or fixed for electron microscopy. Results In gastrocnemius/soleus muscles of male ICS mice, we found a 21.6% and 33.2% decrease of fiber cross sectional area (FCSA), which in soleus muscle concerns the loss of type IIa and IIx FCSA. This phenomenon was not seen in muscles of female ICS mice. However, this loss in male ICS mice was associated with an increase in gastrocnemius of the density of MIF+ (8.6%)-, MuRF(+) (14.7%)-, Fbxo32(+) (17.8%)-cells, a 12.1% loss of capillary contacts/muscle fiber as well as a 30.7% increase of damaged mitochondria in comparison with male control mice. Moreover, significant positive correlations exist among densities (n/mm(2)) of MIF+, MuRF(+), Fbxo32(+)-cells in gastrocnemius/soleus muscles of male ICS mice; these cell densities inversely correlate with FCSA especially in gastrocnemius muscle of male ICS mice. Conclusion The ICS-induced decrease of FCSA mainly concerns gastrocnemius muscle of male mice due to an increase of inflammatory and atrogenic cells. In soleus muscle of male ICS and soleus/gastrocnemius muscles of female ICS mice morphological alterations seem to occur not at all or delayed. The sex-specificity of findings, which is not easily reconciled with the epidemiology of FM (female predominance), implicate that gastrocnemius muscle of male ICS mice should preferentially be used for future investigations with FM. Moreover, we suggest to investigate morphological and/or molecular alterations at different time-points (up to two weeks) after ICS.	[Bonaterra, Gabriel Alejandro; Then, Hanna; Schwarzbach, Hans; Kinscherf, Ralf] Univ Marburg, Dept Med Cell Biol, Anat & Cell Biol, Marburg, Hessen, Germany; [Oezel, Lisa; Ocker, Matthias; Di Fazio, Pietro] Univ Marburg, Inst Surg Res, Marburg, Hessen, Germany; [Thieme, Kati] Univ Marburg, Inst Med Psychol, Marburg, Hessen, Germany; [Ocker, Matthias] Bayer Pharma AG, Expt Med Oncol, Berlin, Germany; [Di Fazio, Pietro] Univ Marburg, Dept Visceral Thorac & Vasc Surg, Marburg, Hessen, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Bayer AG; Bayer Healthcare Pharmaceuticals; Philipps University Marburg	Bonaterra, GA (corresponding author), Univ Marburg, Dept Med Cell Biol, Anat & Cell Biol, Marburg, Hessen, Germany.	gabriel.bonaterra@staff.uni-marburg.de	Di Fazio, Pietro/ABC-1524-2020; Di Fazio, Pietro/AAU-4575-2020; Kinscherf, Ralf/AAV-7164-2021	Di Fazio, Pietro/0000-0003-0091-8498; Ocker, Matthias/0000-0001-8263-6288				Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Attaix Didier, 2003, P219, DOI 10.1079/9780851996790.0219; Bazzichi L, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-36; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Brown AS, 2008, J NEUROIMMUNOL, V205, P25, DOI 10.1016/j.jneuroim.2008.08.005; Cordero MD, 2014, ANTIOXID REDOX SIGN, V20, P1169, DOI 10.1089/ars.2013.5198; Cordero MD, 2013, ANTIOXID REDOX SIGN, V18, P800, DOI 10.1089/ars.2012.4892; Cordero Mario D, 2011, PLoS One, V6, pe26915, DOI 10.1371/journal.pone.0026915; Friedmann-Bette B, 2010, EUR J APPL PHYSIOL, V108, P821, DOI 10.1007/s00421-009-1292-2; Gerdle B, 2013, EUR J PAIN, V17, P1205, DOI 10.1002/j.1532-2149.2013.00284.x; KALYANRAMAN UP, 1984, J RHEUMATOL, V11, P808; Khasar SG, 2003, J PAIN, V4, P278, DOI 10.1016/S1526-5900(03)00631-X; KITA T, 1979, JPN J PHARMACOL, V29, P479, DOI 10.1254/jjp.29.479; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Le Goff P, 2006, JOINT BONE SPINE, V73, P239, DOI 10.1016/j.jbspin.2005.03.022; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; LUND N, 1986, SCAND J RHEUMATOL, V15, P165, DOI 10.3109/03009748609102084; Manfredi LH, 2013, J APPL PHYSIOL, V115, P1496, DOI 10.1152/japplphysiol.00474.2013; Montserrat-de La Paz S, 2015, MOD RHEUMATOL, V25, P116, DOI 10.3109/14397595.2014.924194; Nasu T, 2010, EUR J PAIN, V14, P236, DOI 10.1016/j.ejpain.2009.05.009; Nishiyori M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-69; Nishiyori M, 2010, NEUROSCI LETT, V472, P184, DOI 10.1016/j.neulet.2010.01.080; Nishiyori M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-52; OHARA H, 1991, JPN J PHARMACOL, V57, P243, DOI 10.1254/jjp.57.243; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Pongratz D, 2001, FORTSCHR NEUROL PSYC, V69, P189, DOI 10.1055/s-2001-12677; Schmelzer C, 2008, BIOFACTORS, V32, P179, DOI 10.1002/biof.5520320121; Sprott H, 2004, ANN RHEUM DIS, V63, P245, DOI 10.1136/ard.2002.004762; Srikuea R, 2013, ARTHRITIS RHEUM-US, V65, P519, DOI 10.1002/art.37763; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Wallace DJ, 2001, RHEUMATOLOGY, V40, P743, DOI 10.1093/rheumatology/40.7.743; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; YUNUS MB, 1986, AM J MED, V81, P38, DOI 10.1016/0002-9343(86)90872-7	35	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151116	10.1371/journal.pone.0151116	http://dx.doi.org/10.1371/journal.pone.0151116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986947	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300047
J	Cui, HW; Zhu, YJ; Jiang, DM				Cui, Hongwang; Zhu, Yongjun; Jiang, Dianming			The RIP1-RIP3 Complex Mediates Osteocyte Necroptosis after Ovariectomy in Rats	PLOS ONE			English	Article							PROTEIN-KINASE 1; BONE LOSS; CELL-DEATH; TNF-ALPHA; APOPTOSIS; OSTEOPOROSIS; MODEL; ESTROGEN; INJURY; MICE	Osteocyte apoptosis has been reported to play a central role in bone remodeling. In addition to apoptosis, other mechanisms may be involved in osteocyte loss. This study aimed to investigate the effect of necroptosis on osteocytes in ovariectomized (OVX) rats. Ninety-six female Sprague-Dawley rats were randomly divided into an OVX group and a sham group. At 0, 4, 8 and 12 weeks after surgery, specimens from each group (n = 12 each) were harvested. Bone mineral density (BMD) and body weight were measured. Transmission electron microscopy (TEM) and micro-CT were used to observe the changes in cellular morphology and bone microarchitecture induced by estrogen deficiency. Osteocyte apoptosis and necroptosis were evaluated via TUNEL and immunofluorescence staining for active caspase-3. At 8 weeks after ovariectomy, a greater number of osteocytes with typical necrotic morphological features were TUNEL positive but negative for active caspase-3. Western blotting, quantitative real-time PCR and immunofluorescence assessments demonstrated that the levels of receptor-interacting serine/threonine protein kinase 1 (RIP1) and RIP3 in osteocytes were significantly increased at 8 weeks after ovariectomy. These data are the first to suggest that necroptosis accelerates osteocyte loss under conditions of estrogen deficiency-induced osteoporosis in OVX rats. These findings provide evidence of a potential mechanism through which osteocyte necroptosis is associated with postmenopausal osteoporosis.	[Cui, Hongwang; Jiang, Dianming] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Chongqing, Peoples R China; [Zhu, Yongjun] Chongqing Med Univ, Affiliated Hosp 1, Dept Nephrol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Cui, HW; Jiang, DM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Chongqing, Peoples R China.	cqchw2013@sina.com; jdm571026@vip.163.com			National Science Foundation of China [81171685]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Science Foundation of China (81171685).	Abuohashish HM, 2015, ACTA PHARMACOL SIN, V36, P209, DOI 10.1038/aps.2014.111; Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Bjorkerud S, 1996, AM J PATHOL, V149, P367; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; Dunai Z, 2011, PATHOL ONCOL RES, V17, P791, DOI 10.1007/s12253-011-9433-4; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Feng M, 2014, J STEROID BIOCHEM, V144, P455, DOI 10.1016/j.jsbmb.2014.09.005; FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Heino TJ, 2004, EXP CELL RES, V294, P458, DOI 10.1016/j.yexcr.2003.11.016; Imai K, 2009, OSTEOPOROSIS INT, V20, P801, DOI 10.1007/s00198-008-0750-8; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; KENZORA JE, 1978, CLIN ORTHOP RELAT R, P8; KIMMEL DB, 1980, CALCIFIED TISSUE INT, V32, P113, DOI 10.1007/BF02408530; KIMMEL DB, 1990, CALCIFIED TISSUE INT, V46, P101, DOI 10.1007/BF02556093; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; McCreadie BR, 2004, J BIOMECH, V37, P563, DOI 10.1016/S0021-9290(03)00287-2; Notomi T, 2003, J BONE MINER RES, V18, P140, DOI 10.1359/jbmr.2003.18.1.140; Rudman KE, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-12; Santollo J, 2007, AM J PHYSIOL-REG I, V293, pR2194, DOI 10.1152/ajpregu.00385.2007; Singer FR, 2008, CLEV CLIN J MED, V75, P739, DOI 10.3949/ccjm.75.10.739; Sloop GD, 1999, ARCH PATHOL LAB MED, V123, P529; Smith SY, 2009, AM J PRIMATOL, V71, P752, DOI 10.1002/ajp.20715; Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; Tomkinson A, 1998, J BONE MINER RES, V13, P1243, DOI 10.1359/jbmr.1998.13.8.1243; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Waarsing JH, 2006, J ORTHOP RES, V24, P926, DOI 10.1002/jor.20063; Weinstein RS, 2000, AM J MED, V108, P153, DOI 10.1016/S0002-9343(99)00420-9; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhu YJ, 2015, BIOCHEM BIOPH RES CO, V461, P575, DOI 10.1016/j.bbrc.2015.03.164	40	14	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150805	10.1371/journal.pone.0150805	http://dx.doi.org/10.1371/journal.pone.0150805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985994	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300028
J	Heckman, MG; Robinson, JL; Tzou, KS; Parker, AS; Wu, KJ; Hilton, TW; Howat, WJ; Miller, JL; Kreinest, PA; Pisansky, TM; Schild, SE; Peterson, JL; Vallow, LA; Carroll, JS; Buskirk, SJ				Heckman, Michael G.; Robinson, Jessica L.; Tzou, Katherine S.; Parker, Alexander S.; Wu, Kevin J.; Hilton, Tracy W.; Howat, William J.; Miller, Jodi L.; Kreinest, Pamela A.; Pisansky, Thomas M.; Schild, Steven E.; Peterson, Jennifer L.; Vallow, Laura A.; Carroll, Jason S.; Buskirk, Steven J.			An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; ANDROGEN RECEPTOR; RADIOTHERAPY; TRANSCRIPTION; PROGRESSION; METASTASIS; VALIDATION; CHROMATIN; ANTIGEN; DEATH	Background Standardly collected clinical and pathological patient information has demonstrated only moderate ability to predict risk of biochemical recurrence (BCR) of prostate cancer in men undergoing salvage radiation therapy (SRT) for a rising PSA after radical prostatectomy (RP). Although elevated FOXA1 staining has been associated with poor patient outcomes following RP, it has not been studied in the specific setting of SRT after RP. The aim of this study was to evaluate the association between FOXA1 staining level and BCR after SRT for recurrent prostate cancer. Methods A total of 141 men who underwent SRT at our institution were included. FOXA1 staining levels in primary tumor samples were detected using immunohistochemistry. FOXA1 staining percentage and intensity were measured and multiplied together to obtain a FOXA1 H-score (range 0-12) which was our primary staining measure. P-values <= 0.0056 were considered as statistically significant after applying a Bonferroni correction for multiple comparisons. Results There was not a significant association between FOXA1 H-score and risk of BCR when considering H-score as an ordinal variable or as a categorical variable (all P >= 0.090). Similarly, no significant associations with BCR were observed for FOXA1 staining percentage or staining intensity (all P >= 0.14). Conclusions FOXA1 staining level does not appear to have a major impact on risk of BCR after SRT.	[Heckman, Michael G.; Parker, Alexander S.; Hilton, Tracy W.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Robinson, Jessica L.; Howat, William J.; Miller, Jodi L.; Carroll, Jason S.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Tzou, Katherine S.; Peterson, Jennifer L.; Vallow, Laura A.; Buskirk, Steven J.] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL 32224 USA; [Wu, Kevin J.] Mayo Clin, Dept Pathol, Jacksonville, FL 32224 USA; [Kreinest, Pamela A.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Pisansky, Thomas M.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Schild, Steven E.] Mayo Clin, Dept Radiat Oncol, Scottsdale, AZ USA	Mayo Clinic; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Heckman, MG (corresponding author), Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA.	heckman.michael@mayo.edu		Carroll, Jason/0000-0003-3643-0080	Cancer Research UK; Cancer Research UK [22310, 20411] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	JSC has funding from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buskirk SJ, 2006, J UROLOGY, V176, P985, DOI 10.1016/j.juro.2006.04.083; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; Imamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042456; Jackson W, 2013, CANCER-AM CANCER SOC, V119, P3287, DOI 10.1002/cncr.28215; Jain RK, 2011, HISTOPATHOLOGY, V58, P766, DOI 10.1111/j.1365-2559.2011.03796.x; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Johnson S, 2014, PRACT RADIAT ONCOL, V4, P422, DOI 10.1016/j.prro.2014.02.003; Katz MS, 2003, J CLIN ONCOL, V21, P483, DOI 10.1200/JCO.2003.12.043; Lee R, BJU INT IN PRESS; Leventis AK, 2001, J CLIN ONCOL, V19, P1030, DOI 10.1200/JCO.2001.19.4.1030; Moreira DM, 2009, BJU INT, V104, P1452, DOI 10.1111/j.1464-410X.2009.08623.x; Patel AR, 2011, NAT REV UROL, V8, P385, DOI 10.1038/nrurol.2011.80; Robinson JLL, 2014, ONCOGENE, V33, P5666, DOI 10.1038/onc.2013.508; Robinson Jessica L L, 2012, Front Endocrinol (Lausanne), V3, P68, DOI 10.3389/fendo.2012.00068; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Sunkel B, NUCL ACIDS IN PRESS; Swanson GP, 2011, INT J RADIAT ONCOL, V80, P62, DOI 10.1016/j.ijrobp.2010.01.043; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006	23	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151785	10.1371/journal.pone.0151785	http://dx.doi.org/10.1371/journal.pone.0151785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986977	Green Submitted, gold, Green Published			2022-12-26	WOS:000372580300131
J	Park, JB				Park, Jae B.			Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor	PLOS ONE			English	Article							PROSTATE-CANCER; CRYSTAL-STRUCTURE; CONSUMPTION; RISK; ACETYLATION; MECHANISM; BETA; TAU	Recent studies suggest that Sirt inhibition may have beneficial effects on several human diseases such as neurodegenerative diseases and cancer. Coffee is one of most popular beverages with several positive health effects. Therefore, in this paper, potential Sirt inhibitors were screened using coffee extract. First, HPLC was utilized to fractionate coffee extract, then screened using a Sirt1/2 inhibition assay. The screening led to the isolation of a potent Sirt1/2 inhibitor, whose structure was determined as javamide-II (N-caffeoyltryptophan) by NMR. For confirmation, the amide was chemically synthesized and its capacity of inhibiting Sirt1/2 was also compared with the isolated amide. Javamide-II inhibited Sirt2 (IC50; 8.7 mu M) better than Sirt1(IC50; 34 mu M). Since javamide-II is a stronger inhibitor for Sirt2 than Sirt1. The kinetic study was performed against Sirt2. The amide exhibited noncompetitive Sirt2 inhibition against the NAD(+) (K-i = 9.8 mu M) and showed competitive inhibition against the peptide substrate (K-i = 5.3 mu M). Also, a docking simulation showed stronger binding pose of javamide-II to Sirt2 than AGK2. In cellular levels, javamide-II was able to increase the acetylation of total lysine, cortactin and histone H3 in neuronal NG108-15 cells. In the same cells, the amide also increased the acetylation of lysine (K382) in p53, but not (K305). This study suggests that Javamide-II found in coffee may be a potent Sirt1/2 inhibitor, probably with potential use in some conditions of human diseases.	[Park, Jae B.] ARS, Diet Genom & Immunol Lab, BHNRC, USDA, Bldg 307C,Rm 131, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA)	Park, JB (corresponding author), ARS, Diet Genom & Immunol Lab, BHNRC, USDA, Bldg 307C,Rm 131, Beltsville, MD 20705 USA.	jae.park@ars.usda.gov			ARS/USDA grant [8040-51000-057-00]	ARS/USDA grant	This study was supported by an ARS/USDA grant (project number 8040-51000-057-00). The funder had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Alonso-Salces RM, 2009, J AGR FOOD CHEM, V57, P4224, DOI 10.1021/jf8037117; Arendash GW, 2010, J ALZHEIMERS DIS, V20, pS117, DOI 10.3233/JAD-2010-091249; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002; CHARRIER A, 1985, COFFEE BOT BIOCH PRO; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Dai H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8645; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Goate A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P341; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hou HL, 2012, J CLIN PATHOL, V65, P1088, DOI 10.1136/jclinpath-2012-200940; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Liu H, 2015, NUTR CANCER, V67, P392, DOI 10.1080/01635581.2015.1004727; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Musiek Erik S, 2013, Mo Med, V110, P395; O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Park JB, 2012, NAT PROD RES, V26, P1465, DOI 10.1080/14786419.2011.562207; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Reitz C, 2012, BIOCHEM PHARMACOL, V88, P640; Rumpf T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7263; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004; Tatum PR, 2014, BIOORG MED CHEM LETT, V24, P1871, DOI 10.1016/j.bmcl.2014.03.026; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tverdal A, 2015, BRIT J CANCER, V112, P576, DOI 10.1038/bjc.2014.645; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y	45	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150392	10.1371/journal.pone.0150392	http://dx.doi.org/10.1371/journal.pone.0150392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986569	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300020
J	Ratzinger, F; Tsirkinidou, I; Haslacher, H; Perkmann, T; Schmetterer, KG; Mitteregger, D; Makristathis, A; Burgmann, H				Ratzinger, Franz; Tsirkinidou, Irene; Haslacher, Helmuth; Perkmann, Thomas; Schmetterer, Klaus G.; Mitteregger, Dieter; Makristathis, Athanasios; Burgmann, Heinz			Evaluation of the Septifast M-Grade Test on Standard Care Wards-A Cohort Study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; BLOOD-STREAM PATHOGENS; MOLECULAR-DETECTION; RAPID DETECTION; ANTIMICROBIAL TREATMENT; LIGHTCYCLER SEPTIFAST; SERUM PROCALCITONIN; SUSPECTED SEPSIS; PROGNOSTIC VALUE	Background The immediate need for appropriate antimicrobial therapy in septic patients requires the detection of the causative pathogen in a timely and reliable manner. In this study, the realtime PCR Septifast M-Grade test was evaluated in adult patients meeting the systemic inflammatory response syndrome (SIRS) criteria that were treated at standard care wards. Methods Patients with clinical suspected infection, drawn blood cultures (BC), the Septifast M-Grade test (SF) and sepsis biomarkers were prospectively screened for fulfillment of SIRS criteria and evaluated using the criteria of the European Centre of Disease Control (ECDC) for infection point prevalence studies. Results In total, 220 patients with SIRS were prospectively enrolled, including 56 patients with detection of bacteria in the blood (incidence: 25.5%). BC analysis resulted in 75.0% sensitivity (95% confidence interval, CI: 61.6%-85.6%) with 97.6% specificity (CI: 93.9%-99.3%) for detecting bacteria in the blood. In comparison to BC, SF presented with 80.4% sensitivity (CI: 67.6%-89.8%) and with 97.6% specificity (CI: 93.9%-99.3%). BC and SF analysis yielded comparable ROC-AUCs (0.86, 0.89), which did not differ significantly (p = 0.558). A trend of a shorter time-to-positivity of BC analysis was not seen in bacteremic patients with a positive SF test than those with a negative test result. Sepsis biomarkers, including PCT, IL-6 or CRP, did not help to explain discordant test results for BC and SF. Conclusion Since negative results do not exclude bacteremia, the Septifast M-Grade test is not suited to replacing BC, but it is a valuable tool with which to complement BC for faster detection of pathogens.	[Ratzinger, Franz; Haslacher, Helmuth; Perkmann, Thomas; Schmetterer, Klaus G.] Med Univ Vienna, Div Med & Chem Lab Diagnost, Dept Lab Med, Vienna, Austria; [Tsirkinidou, Irene; Burgmann, Heinz] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Mitteregger, Dieter; Makristathis, Athanasios] Med Univ Vienna, Div Clin Microbiol, Dept Lab Med, Vienna, Austria; [Mitteregger, Dieter] Grp Practice Labors, Div Microbiol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Burgmann, H (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria.	heinz.burgmann@meduniwien.ac.at	Haslacher, Helmuth/D-4233-2013; Perkmann, Thomas/F-3074-2012	Haslacher, Helmuth/0000-0003-4605-2503; Ratzinger, Franz/0000-0002-1910-1018; Burgmann, Heinz/0000-0002-2114-0999; Perkmann, Thomas/0000-0002-7976-0285				Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; [Anonymous], 2012, POINT PREV SURV HEAL; Ataoglu HE, 2010, J INT MED RES, V38, P52, DOI 10.1177/147323001003800106; Avolio M, 2014, SHOCK, V42, P86, DOI 10.1097/SHK.0000000000000191; Avolio M, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181d49299; Bacconi A, 2014, J CLIN MICROBIOL, V52, P3164, DOI 10.1128/JCM.00801-14; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Chang SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062323; Charles PE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-38; Chuang YC, 2012, CRIT CARE MED, V40, P2273, DOI 10.1097/CCM.0b013e3182515190; Conti G, 2005, J NEPHROL, V18, P282; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Grif K, 2012, WIEN KLIN WOCHENSCHR, V124, P266, DOI 10.1007/s00508-012-0159-4; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hanon FX, 2002, SCAND J INFECT DIS, V34, P520, DOI 10.1080/00365540110080827; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Idelevich E, 2015, MED MICROBIOL IMMUN, V204, P585, DOI 10.1007/s00430-014-0385-7; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lehmann LE, 2009, CRIT CARE MED, V37, P3085, DOI 10.1097/CCM.0b013e3181b033d7; Leli C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/701480; Leli C, 2014, SCAND J INFECT DIS, V46, P745, DOI 10.3109/00365548.2014.936493; Lichtenstern C, 2012, CURR OPIN INFECT DIS, V25, P328, DOI 10.1097/QCO.0b013e3283522038; Lodes U, 2009, ZBL CHIR, V134, P249, DOI 10.1055/s-0028-1098776; Machens A, 2014, J CLIN ENDOCR METAB, V99, P2986, DOI 10.1210/jc.2014-1278; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Mauro MV, 2012, DIAGN MICR INFEC DIS, V73, P308, DOI 10.1016/j.diagmicrobio.2012.04.006; Mencacci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053279; Molter GP, 2003, ANAESTHESIST, V52, P210, DOI 10.1007/s00101-003-0460-8; Pasqualini L, 2012, J CLIN MICROBIOL, V50, P1285, DOI 10.1128/JCM.06793-11; Patout M, 2014, CLIN BIOCHEM, V47, P263, DOI 10.1016/j.clinbiochem.2014.09.002; Rao GG, 1998, DRUGS, V55, P323, DOI 10.2165/00003495-199855030-00001; Ratzinger F, 2015, INFECTION; Ratzinger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082946; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Sulyok I, 2012, BRIT J ANAESTH, V109, P754, DOI 10.1093/bja/aes248; Tafelski S, 2015, J INT MED RES, V43, P364, DOI 10.1177/0300060514561135; Tschaikowsky K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023615; Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0; Vincent JL, 2015, CRIT CARE MED, V43, P2283, DOI 10.1097/CCM.0000000000001249; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Willems E, 2012, DIAGN MICR INFEC DIS, V73, P1, DOI 10.1016/j.diagmicrobio.2012.01.009; Yanagihara K, 2010, CRIT CARE, V14, DOI 10.1186/cc9234; Yu CW, 2013, AM J EMERG MED, V31, P935, DOI 10.1016/j.ajem.2013.03.008	49	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151108	10.1371/journal.pone.0151108	http://dx.doi.org/10.1371/journal.pone.0151108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986826	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300046
J	Djossou, F; Vesin, G; Bidaud, B; Mosnier, E; Simonnet, C; Matheus, S; Prince, C; Balcaen, J; Donutil, G; Egmann, G; Okandze, A; Malvy, D; Nacher, M				Djossou, Felix; Vesin, Guillaume; Bidaud, Bastien; Mosnier, Emilie; Simonnet, Christine; Matheus, Severine; Prince, Christelle; Balcaen, John; Donutil, Gerd; Egmann, GRald; Okandze, Antoine; Malvy, Denis; Nacher, Mathieu			Incidence and Predictive Factors of Central Nervous System Dysfunction in Patients Consulting for Dengue Fever in Cayenne Hospital, French Guiana	PLOS ONE			English	Article							NEUROLOGICAL MANIFESTATIONS; CASE CLASSIFICATION; CASE DEFINITIONS; IMMUNOPATHOGENESIS; INFECTION; NEED	Introduction The frequency, the clinical characteristics, and the prognosis of dengue is highly variable. Dengue fever is associated with a range of neurological manifestations. The objective of the present study was to determine the incidence of neurological signs and their predictive factors using data from cases of dengue seen and followed in Cayenne Hospital during the Dengue 2 epidemic in 2013. Methods In 2013, a longitudinal study using data from all cases of dengue seen in Cayenne hospital was collected. Medical records used a standardized form to collect demographic information, clinical signs and biological results and the date at which they were present. The analysis used Cox proportional modeling to obtain adjusted Hazard ratios. Results A total of 1574 patients were included 221 of whom developed central nervous system signs. These signs were spontaneously resolutive. There were 9298person days of follow-up and the overall incidence rate for central nervous system signs was 2.37 per 100 person-days. The variables independently associated with central nervous system anomalies were headache, Adjusted Hazard ratio (AHR) = 1.9(95% CI = 1.4-2.6), bleeding AHR = 2 ((95% CI = 1.3-3.1), P = 0.001, abdominal pain AHR = 1.9 ((95% CI = 1.4-2.6), P<0.001, aches AHR = 2.1 ((95% CI = 1.5-2.9), P<0.001, and fatigue AHR = 1.5 ((95% CI = 1.3-1.7), P<0.001. Discussion Overall, the present study suggests that neurological signs of dengue are not exceptional even in patients without the most severe features of dengue. These manifestations were spontaneously resolutive. Here it was not possible to distinguish between encephalitis or encephalopathy. Further studies would require more in depth exploration of the patients.	[Djossou, Felix; Vesin, Guillaume; Bidaud, Bastien; Mosnier, Emilie; Prince, Christelle] Ctr Hosp Cayenne, Dept Infect & Trop Dis, Cayenne, French Guiana; [Djossou, Felix; Nacher, Mathieu] Univ Guyane, Equipe Accueil Ecosyst Amazoniens & Pathol Trop E, Cayenne, French Guiana; [Simonnet, Christine; Okandze, Antoine] Ctr Hosp Cayenne, Lab, Cayenne, French Guiana; [Matheus, Severine] Inst Pasteur, Virol Lab, Cayenne, French Guiana; [Balcaen, John] Ctr Hosp Cayenne, Dept Pediat, Cayenne, French Guiana; [Donutil, Gerd; Egmann, GRald] Ctr Hosp Cayenne, Serv Aide Med Urgente, Serv Accueil Urgences, Cayenne, French Guiana; [Malvy, Denis] Ctr Hosp Univ Bordeaux, Unite Malad Trop & Voyageur, Bordeaux, France; [Nacher, Mathieu] Ctr Hosp Cayenne, INSERM 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana	CHU Bordeaux	Nacher, M (corresponding author), Univ Guyane, Equipe Accueil Ecosyst Amazoniens & Pathol Trop E, Cayenne, French Guiana.	mathieu.nacher@ch-cayenne.fr	MOSNIER, Emilie/GXV-4053-2022; nacher, mathieu/AAH-4796-2021; Djossou, Felix/AAM-8640-2020; MALVY, Denis/T-7930-2019	MOSNIER, Emilie/0000-0002-6004-3323; nacher, mathieu/0000-0001-9397-3204; Matheus, Severine/0000-0001-9171-1964	grant "Investissement d'Avenir" from the Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-0025]	grant "Investissement d'Avenir" from the Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	This study was supported by the grant "Investissement d'Avenir" from the Agence Nationale de la Recherche (CEBA reference no. ANR-10-LABX-0025) which provides yearly funding to the EA3593 laboratory.	Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bordignon J, 2007, J MED VIROL, V79, P1506, DOI 10.1002/jmv.20958; Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040; HENDARTO S K, 1992, Acta Paediatrica Japonica, V34, P350; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Malavige G N, 2007, Indian J Med Microbiol, V25, P143; Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341; Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068; Solbrig MV, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0550-4; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Soundravally R, 2007, HUM IMMUNOL, V68, P973, DOI 10.1016/j.humimm.2007.09.007; Thangaratham PS, 2007, LANCET INFECT DIS, V7, P81, DOI 10.1016/S1473-3099(07)70005-1; Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504; van de Weg CAM, 2012, AM J TROP MED HYG, V86, P166, DOI 10.4269/ajtmh.2012.11-0491; Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150828	10.1371/journal.pone.0150828	http://dx.doi.org/10.1371/journal.pone.0150828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981859	Green Submitted, gold, Green Published			2022-12-26	WOS:000372574900052
J	Dorso, L; Bigot-Corbel, E; Abadie, J; Diab, M; Gouard, S; Bruchertseifer, F; Morgenstern, A; Maurel, C; Cherel, M; Davodeau, F				Dorso, Laetitia; Bigot-Corbel, Edith; Abadie, Jerome; Diab, Maya; Gouard, Sebastien; Bruchertseifer, Frank; Morgenstern, Alfred; Maurel, Catherine; Cherel, Michel; Davodeau, Francois			Long-Term Toxicity of Bi-213-Labelled BSA in Mice	PLOS ONE			English	Article							TARGETED ALPHA-THERAPY; PARTICLE IMMUNOTHERAPY; MYELOID-LEUKEMIA; RENAL-FUNCTION; LOW-LET; BI-213; RADIOIMMUNOTHERAPY; RADIATION; ANTIBODY; MODEL	Background Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 (Bi-213). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation due to the circulating radiopharmaceutical in the blood. To assess this, an acute and chronic toxicity study was carried out in mice injected with Bi-213-labelled Bovine Serum Albumin (Bi-213-BSA) as an example of a long-term circulating vector. Method Biodistribution of Bi-213-BSA and 125I-BSA were compared in order to evaluate Bi-213 uptake by healthy organs. The doses to organs for injected Bi-213-BSA were calculated. Groups of nude mice were injected with 3.7, 7.4 and 11.1 MBq of Bi-213-BSA and monitored for 385 days. Plasma parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine, were measured and blood cell counts (white blood cells, platelets and red blood cells) were performed. Mouse organs were examined histologically at different time points. Results Haematological toxicity was transient and non-limiting for all evaluated injected activities. At the highest injected activity (11.1 MBq), mice died from liver and kidney failure (median survival of 189 days). This liver toxicity was identified by an increase in both ALT and AST and by histological examination. Mice injected with 7.4 MBq of Bi-213-BSA (median survival of 324 days) had an increase in plasma BUN and creatinine due to impaired kidney function, confirmed by histological examination. Injection of 3.7 MBq of Bi-213-BSA was safe, with no plasma enzyme modifications or histological abnormalities. Conclusion Haematological toxicity was not limiting in this study. Liver failure was observed at the highest injected activity (11.1 MBq), consistent with liver damage observed in human clinical trials. Intermediate injected activity (7.4 MBq) should be used with caution because of the risk of long-term toxicity to kidneys.	[Dorso, Laetitia; Bigot-Corbel, Edith; Diab, Maya; Gouard, Sebastien; Maurel, Catherine; Cherel, Michel; Davodeau, Francois] INSERM, Nantes Angers Canc Res Ctr CRCNA, UMR 892, Nucl Oncol, Nantes, France; [Dorso, Laetitia; Bigot-Corbel, Edith; Diab, Maya; Gouard, Sebastien; Maurel, Catherine; Cherel, Michel; Davodeau, Francois] Univ Nantes, Nantes, France; [Dorso, Laetitia; Bigot-Corbel, Edith; Diab, Maya; Gouard, Sebastien; Maurel, Catherine; Cherel, Michel; Davodeau, Francois] CNRS, UMR 6299, Nantes, France; [Bigot-Corbel, Edith] Laenneck Hosp, Dept Biochem, Nantes, France; [Dorso, Laetitia] LUNAM Univ, Oniris, AMaROC Unit, Nantes, France; [Bruchertseifer, Frank; Morgenstern, Alfred] Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany; [Cherel, Michel] Ctr Rene Gauducheau, ICO, Nucl Med, F-44035 Nantes, France; [Davodeau, Francois] Univ Hosp, Nucl Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; European Commission Joint Research Centre; EC JRC Institute for Transuranium Elements (ITU); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite; CHU de Nantes	Davodeau, F (corresponding author), INSERM, Nantes Angers Canc Res Ctr CRCNA, UMR 892, Nucl Oncol, Nantes, France.; Davodeau, F (corresponding author), Univ Nantes, Nantes, France.; Davodeau, F (corresponding author), CNRS, UMR 6299, Nantes, France.; Davodeau, F (corresponding author), Univ Hosp, Nucl Med, Nantes, France.	davodeau@nantes.inserm.fr	Chérel, Michel/F-8298-2013; Gouard, Sébastien/L-5465-2015; François, Davodeau/GLU-4061-2022; Abadie, Jérôme/ABF-5089-2020	Gouard, Sébastien/0000-0002-0973-5420; François, Davodeau/0000-0001-8181-0192; DORSO, Laetitia/0000-0001-7790-951X	Labex IRON project [ANR-11-LABX-0018-01]; ArronaxPlus Equipex project - "Investissements d'Avenir" French Government program [ANR-11-EQPX-0004]; region "Pays de la Loire": NUCSAN project [2010 10255]	Labex IRON project; ArronaxPlus Equipex project - "Investissements d'Avenir" French Government program(French National Research Agency (ANR)); region "Pays de la Loire": NUCSAN project(Region Pays de la Loire)	This work was supported by the Labex IRON project (no ANR-11-LABX-0018-01), and the ArronaxPlus Equipex project (no ANR-11-EQPX-0004) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR). This work was also supported by the region "Pays de la Loire": NUCSAN project (no 2010 10255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolidis C, 2005, ANAL CHEM, V77, P6288, DOI 10.1021/ac0580114; Back T, 2009, CANCER BIOTHER RADIO, V24, P649, DOI 10.1089/cbr.2009.0628; Behr TM, 1999, CANCER RES, V59, P2635; Bethge WA, 2003, BLOOD, V101, P5068, DOI 10.1182/blood-2002-12-3867; Cherel M, 2013, J NUCL MED, V54, P1597, DOI 10.2967/jnumed.112.111997; Essler M, 2012, EUR J NUCL MED MOL I, V39, P602, DOI 10.1007/s00259-011-2023-6; Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204; Fraker PJ, 1978, BIOCHEM BIOPH RES CO, P80; GREGUS Z, 1986, TOXICOL APPL PHARM, V85, P24, DOI 10.1016/0041-008X(86)90384-4; HACKBARTH H, 1982, J GERONTOL, V37, P540, DOI 10.1093/geronj/37.5.540; Jaggi JS, 2005, J AM SOC NEPHROL, V16, P2677, DOI 10.1681/ASN.2004110945; Jurcic JG, 2002, BLOOD, V100, P1233, DOI 10.1182/blood.V100.4.1233.h81602001233_1233_1239; Kennel SJ, 1999, BRIT J CANCER, V80, P175, DOI 10.1038/sj.bjc.6990337; Michel CC, 1996, CARDIOVASC RES, V32, P644, DOI 10.1016/0008-6363(96)00064-8; Milano MT, 2007, SEMIN RADIAT ONCOL, V17, P131, DOI 10.1016/j.semradonc.2006.11.009; Nakamae H, 2009, CANCER RES, V69, P2408, DOI 10.1158/0008-5472.CAN-08-4363; NIKULA TK, 1995, NUCL MED BIOL, V22, P387, DOI 10.1016/0969-8051(94)00126-5; Norenberg JP, 2006, CLIN CANCER RES, V12, P897, DOI 10.1158/1078-0432.CCR-05-1264; Pouget JP, 2001, EUR J NUCL MED, V28, P541, DOI 10.1007/s002590100484; Rosenblat TL, 2010, CLIN CANCER RES, V16, P5303, DOI 10.1158/1078-0432.CCR-10-0382; Sandmaier BM, 2002, BLOOD, V100, P318, DOI 10.1182/blood-2001-12-0322; Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14; Schmitt R, 2008, AM J PHYSIOL-RENAL, V294, pF1265, DOI 10.1152/ajprenal.00543.2007; Schwartz J, 2011, PHYS MED BIOL, V56, P721, DOI 10.1088/0031-9155/56/3/012; Sgouros G, 1999, J NUCL MED, V40, P1935; Song EY, 2007, CANCER BIOL THER, V6, P898, DOI 10.4161/cbt.6.6.4097; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Watchman CJ, 2007, J NUCL MED, V48, P645, DOI 10.2967/jnumed.106.035337; Wild D, 2011, CANCER RES, V71, P1009, DOI 10.1158/0008-5472.CAN-10-1186; Yao ZS, 2004, CLIN CANCER RES, V10, P3137, DOI 10.1158/1078-0432.CCR-03-0171	30	10	10	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151330	10.1371/journal.pone.0151330	http://dx.doi.org/10.1371/journal.pone.0151330			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982495	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900076
J	Gorski, MM; Lotta, LA; Pappalardo, E; de Haan, HG; Passamonti, SM; Vlieg, AV; Martinelli, I; Peyvandi, F				Gorski, Marcin M.; Lotta, Luca A.; Pappalardo, Emanuela; de Haan, Hugoline G.; Passamonti, Serena M.; Vlieg, Astrid van Hylckama; Martinelli, Ida; Peyvandi, Flora			Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis	PLOS ONE			English	Article							VENOUS THROMBOEMBOLIC DISEASE; WHOLE-GENOME ASSOCIATION; ISCHEMIC-STROKE; Z DEFICIENCY; RISK; MUTATIONS; POLYMORPHISMS; THROMBOPHILIA; COMMON; LOCI	Rare mutations in PROC, PROS1 or SERPINC1 as well as common variants in F5, F2, F11 and SERPINC1 have been identified as risk factors for deep vein thrombosis (DVT). To identify novel genetic risk factors for DVT, we have developed and applied next-generation DNA sequencing (NGS) of the coding area of hemostatic and proinflammatory genes. Using this strategy, we previously identified a single nucleotide variant (SNV) rs6050 in the FGA gene and novel, rare SNVs in the ADAMTS13 gene associated with DVT. To identify novel coding variants in the genetic predisposition to DVT, we applied NGS analysis of the coding area of 186 hemostatic and proinflammatory genes in 94 DVT cases and 98 controls and we identified 18 variants with putative role in DVT. A group of 585 Italian idiopathic DVT patients and 550 healthy controls was used to genotype all the 18 risk-associated variants identified by NGS. Replication study in the Italian population identified the rs2232710 variant in the protein Z-dependent protease inhibitor (ZPI) gene to be associated with an increased risk of DVT (OR 2.74; 95% CI 1.33-5.65; P = 0.0045; Bonferroni P = 0.081). However, the rs2232710 SNV showed no association with DVT in two Dutch replication cohorts the LETS study (454 patients and 451 controls) and the MEGA study (3799 patients and 4399 controls), indicating that the rs2232710 variant is not a risk factor for DVT.	[Gorski, Marcin M.; Pappalardo, Emanuela; Peyvandi, Flora] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Lotta, Luca A.; Passamonti, Serena M.; Martinelli, Ida; Peyvandi, Flora] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Lotta, Luca A.; Passamonti, Serena M.; Martinelli, Ida; Peyvandi, Flora] Fdn Luigi Villa, Milan, Italy; [de Haan, Hugoline G.; Vlieg, Astrid van Hylckama] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Peyvandi, F (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.; Peyvandi, F (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy.; Peyvandi, F (corresponding author), Fdn Luigi Villa, Milan, Italy.	flora.peyvandi@unimi.it	Peyvandi, Flora/AAK-7437-2020; Martinelli, ida/J-2287-2015; van Hylckama Vlieg, Astrid/A-3323-2017	Peyvandi, Flora/0000-0001-7423-9864; Martinelli, ida/0000-0001-9218-3622; de Haan, Hugoline/0000-0003-1126-4776; Lotta, Luca Andrea/0000-0002-2619-5956; Gorski, Marcin M./0000-0002-8276-3866; Passamonti, Serena Maria/0000-0003-2875-8860	Italian Ministry of Health [RF-2009-1530493]; Fondazione Cariplo [2011-0524]	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by the Italian Ministry of Health Grant No. RF-2009-1530493 and the Fondazione Cariplo Grant No. 2011-0524.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bezemer ID, 2009, ARCH INTERN MED, V169, P610, DOI 10.1001/archinternmed.2008.589; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Corral J, 2007, BRIT J HAEMATOL, V137, P99, DOI 10.1111/j.1365-2141.2007.06548.x; Corral J, 2006, BLOOD, V108, P177, DOI 10.1182/blood-2005-08-3249; Dahlback B, 2008, BLOOD, V112, P19, DOI 10.1182/blood-2008-01-077909; Fabbro D, 2007, J THROMB THROMBOLYS, V23, P77, DOI 10.1007/s11239-006-9003-x; Foo JN, 2012, NAT REV NEUROL, V8, P508, DOI 10.1038/nrneurol.2012.148; Germain M, 2015, AM J HUM GENET, V96, P532, DOI 10.1016/j.ajhg.2015.01.019; Gris JC, 2002, BLOOD, V99, P2606, DOI 10.1182/blood.V99.7.2606; Kobelt K, 2001, BRIT J HAEMATOL, V114, P169, DOI 10.1046/j.1365-2141.2001.02913.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lotta LA, 2013, J THROMB HAEMOST, V11, P1228, DOI 10.1111/jth.12291; Lotta LA, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-7; Martinelli I, 2014, NAT REV CARDIOL, V11, P140, DOI 10.1038/nrcardio.2013.211; McQuillan AM, 2003, STROKE, V34, P2415, DOI 10.1161/01.STR.0000092124.52084.4B; Morange PE, 2010, AM J HUM GENET, V86, P592, DOI 10.1016/j.ajhg.2010.02.011; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Razzari C, 2006, THROMB HAEMOSTASIS, V95, P909, DOI 10.1160/TH06-01-0060; Refaai MA, 2006, J THROMB HAEMOST, V4, P1628, DOI 10.1111/j.1538-7836.2006.02012.x; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Rosendaal FR, 2009, J THROMB HAEMOST, V7, P301, DOI 10.1111/j.1538-7836.2009.03394.x; Sherry ST, 1999, GENOME RES, V9, P677; Sofi F, 2009, J THROMB HAEMOST, V7, P731, DOI 10.1111/j.1538-7836.2009.03325.x; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Van de Water N, 2004, BRIT J HAEMATOL, V127, P190, DOI 10.1111/j.1365-2141.2004.05189.x; vanderMeer FJM, 1997, THROMB HAEMOSTASIS, V78, P631; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Young LK, 2012, THROMB HAEMOSTASIS, V107, P854, DOI 10.1160/TH11-10-0708; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151347	10.1371/journal.pone.0151347	http://dx.doi.org/10.1371/journal.pone.0151347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982741	Green Published, gold			2022-12-26	WOS:000372574900078
J	Groot, MP; Kooke, R; Knoben, N; Vergeer, P; Keurentjes, JJB; Ouborg, NJ; Verhoeven, KJF				Groot, Maartje P.; Kooke, Rik; Knoben, Nieke; Vergeer, Philippine; Keurentjes, Joost J. B.; Ouborg, N. Joop; Verhoeven, Koen J. F.			Effects of Multi-Generational Stress Exposure and Offspring Environment on the Expression and Persistence of Transgenerational Effects in Arabidopsis thaliana	PLOS ONE			English	Article							EPIGENETIC VARIATION; EVOLUTION; INHERITANCE; PLASTICITY; MEMORY; ADAPTATION; MECHANISMS; BEHAVIOR; PLANTS	Plant phenotypes can be affected by environments experienced by their parents. Parental environmental effects are reported for the first offspring generation and some studies showed persisting environmental effects in second and further offspring generations. However, the expression of these transgenerational effects proved context-dependent and their reproducibility can be low. Here we study the context-dependency of transgenerational effects by evaluating parental and transgenerational effects under a range of parental induction and offspring evaluation conditions. We systematically evaluated two factors that can influence the expression of transgenerational effects: single-versus multiple-generation exposure and offspring environment. For this purpose, we exposed a single homozygous Arabidopsis thaliana Col-0 line to salt stress for up to three generations and evaluated offspring performance under control and salt conditions in a climate chamber and in a natural environment. Parental as well as transgenerational effects were observed in almost all traits and all environments and traced back as far as great-grandparental environments. The length of exposure exerted strong effects; multiple-generation exposure often reduced the expression of the parental effect compared to single-generation exposure. Furthermore, the expression of transgenerational effects strongly depended on offspring environment for rosette diameter and flowering time, with opposite effects observed in field and greenhouse evaluation environments. Our results provide important new insights into the occurrence of transgenerational effects and contribute to a better understanding of the context-dependency of these effects.	[Groot, Maartje P.; Knoben, Nieke; Ouborg, N. Joop] Radboud Univ Nijmegen, Inst Water & Wetland Res, Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands; [Kooke, Rik] Wageningen Univ, Dept Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Vergeer, Philippine] Plant Ecol & Nat Conservat Grp, Wageningen, Netherlands; [Keurentjes, Joost J. B.] Wageningen Univ, Dept Genet, NL-6700 AP Wageningen, Netherlands; [Verhoeven, Koen J. F.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Kooke, Rik; Keurentjes, Joost J. B.] Ctr BioSyst Genom, Wageningen, Netherlands	Radboud University Nijmegen; Wageningen University & Research; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Centre for BioSystems Genomics	Groot, MP (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands.	m.groot@science.ru.nl	Verhoeven, Koen JF/C-9920-2010; Ouborg, Joop/C-1028-2011; KNAW, NIOO-KNAW/A-4320-2012	Verhoeven, Koen JF/0000-0003-3002-4102; Keurentjes, Joost/0000-0001-8918-0711; KNAW, NIOO-KNAW/0000-0002-3835-159X; Novoplansky, Ariel/0000-0003-0988-786X	European Science Foundation [EpiCOL]; Netherlands Organization for International Cooperation in Higher Education [864.10.008]; Centre of BioSystems Genomics [AA3-WU-PL]; Centre for BioSystems Genomics, Wageningen	European Science Foundation(European Science Foundation (ESF)European Commission); Netherlands Organization for International Cooperation in Higher Education; Centre of BioSystems Genomics; Centre for BioSystems Genomics, Wageningen	This work was supported by the following: Grant number: EpiCOL, URL: http://www.esf.org/home.html, Full name: European Science Foundation, author: MP; Grant number: 864.10.008, URL: http://www.nwo.nl/, full name: Netherlands Organization for International Cooperation in Higher Education, author: KV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Grant number: AA3-WU-PL, URL: http://www.narcis.nl/organisation/RecordID/ORG1242298, Full name: the Centre of BioSystems Genomics, author: RK. Centre for BioSystems Genomics, Wageningen, provided support in the form of salaries for authors RK and JJBK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2014, R LANG ENV STAT COMP; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bonduriansky R, 2012, EVOL APPL, V5, P192, DOI 10.1111/j.1752-4571.2011.00213.x; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Castro BM, 2013, J ECOL, V101, P1281, DOI 10.1111/1365-2745.12125; CLAUSS MJ, 1994, J ECOL, V82, P447, DOI 10.2307/2261254; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Furrow RE, 2014, EVOLUTION, V68, P673, DOI 10.1111/evo.12225; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Hafer N, 2011, BIOL LETTERS, V7, P755, DOI 10.1098/rsbl.2011.0139; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Holeski LM, 2012, TRENDS ECOL EVOL; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Jung SY, 2004, PLANT SCI, V166, P459, DOI 10.1016/j.plantsci.2003.10.012; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kim SG, 2007, PLANTA, V226, P647, DOI 10.1007/s00425-007-0513-3; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P734; Latzel V, 2014, OIKOS, V123, P41, DOI 10.1111/j.1600-0706.2013.00537.x; Latzel V, 2012, ANN BOT-LONDON, V110, P1423, DOI 10.1093/aob/mcs088; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Reboud X, 2004, Plant Adaptation: Molecular Genetics and Ecology, P135; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Sani E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r59; Sultan SE, 2009, ECOLOGY, V90, P1831, DOI 10.1890/08-1064.1; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080819; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060364; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Uller T, 2011, EVOLUTION, V65, P2075, DOI 10.1111/j.1558-5646.2011.01282.x; Verhoeven KJF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038605; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010	47	37	39	10	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151566	10.1371/journal.pone.0151566	http://dx.doi.org/10.1371/journal.pone.0151566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982489	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900096
J	Vaidya, H; Rumph, C; Katula, KS				Vaidya, Himani; Rumph, Candie; Katula, Karen S.			Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; CANCER; EXPRESSION; GENE; MIGRATION; ACTIVATION; INVASIVENESS; MALIGNANCIES; METASTASIS	WNT5A is a secreted ligand involved in Wnt pathway signaling and has a role in cell movement and differentiation. Altered WNT5A expression is associated with various cancers, although in most studies the focus has been on only one of the known WNT5A isoforms. In this study, we analyzed expression from two of the major WNT5A promoters, termed promoter A and promoter B, in normal human osteoblasts, SaOS-2 and U2OS osteosarcoma cell lines, and osteosarcoma tumor tissue. We found that both promoters A and B are active in normal osteoblasts with nearly 11-fold more promoter B than A transcripts. Promoter B but not promoter A transcripts are decreased or nearly undetectable in the SaOS-2 and U2OS cell lines and osteosarcoma tumor tissues. Transient transfection of promoter A and promoter B reporter constructs confirmed that SaOS-2 cells have the necessary factors to transcribe both promoters. Bisulfite sequencing analysis revealed that three CpG enriched regions upstream of the promoter B exon 1 beta are highly methylated in both SaOS-2 and U2OS cells. The CpG island sub-region R6 located in promoter B exon 1 beta was approximately 51% methylated in SaOS-2 and 25% methylated in U2OS. Region 3 was approximately 28% methylated in normal osteoblasts, whereas the others were unmethylated. Promoter B was re-activated by treatment of SaOS-2 cells with 1 mu M 5-azacytidine, which was associated with only a small insignificant change in methylation of sub-region R6. ChIP analysis of U2OS and SaOS-2 cells indicated that the promoter B region is less enriched in the active histone mark H3K4me3, in comparison to promoter A and that there is increased enrichment of the repressive mark H3K27me3 in association with the promoter B genomic region in the cell line SaOS-2. These findings show that epigenetic inactivation of the WNT5A promoter B involves both DNA methylation and histone modifications and suggest that differential expression of the WNT5A alternative promoters A and B is a characteristic of osteosarcomas.	[Vaidya, Himani] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA; [Rumph, Candie; Katula, Karen S.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of North Carolina; University of North Carolina Greensboro	Katula, KS (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	kskatula@uncg.edu			National Institutes of Health [R15 DK070581-01A1]; UNCG-Regular Faculty Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK070581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCG-Regular Faculty Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health R15 DK070581-01A1, 5/1/06 - 4/30/09 "Linking folate deficiency to changes in gene expression." KSK - PI www.nih.gov. Some of the data for this manuscript was derived from this grant, although not directly related. UNCG-Regular Faculty Grant, "Functional analysis of the WNT5A isoforms A and B." 1/2013-6/2014, KSK-PI, http://research.uncg.edu/internal-grants-and-awards/. Some of the data for this manuscript was derived from this grant.	Bauer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080526; Bo HJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-496; Davalos-Salas M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-232; Deng G, 2011, ONCOL REP, V25, P367, DOI 10.3892/or.2010.1108; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Estecio MRH, 2012, MOL CANCER RES, V10, P1332, DOI 10.1158/1541-7786.MCR-12-0351; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Fernandez-Cobo M, 2007, ONCOL REP, V17, P903; Gao F, 2014, GENOMICS, V103, P204, DOI 10.1016/j.ygeno.2013.12.006; Geng M, 2012, WORLD J GASTROENTERO, V18, P1328, DOI 10.3748/wjg.v18.i12.1328; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hibi K, 2012, HEPATO-GASTROENTEROL, V59, P2661, DOI 10.5754/hge09664; Hibi K, 2009, HEPATO-GASTROENTEROL, V56, P1007; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Kanzawa M, 2013, PATHOBIOLOGY, V80, P235, DOI 10.1159/000346843; Katula KS, 2012, DNA CELL BIOL, V31, P1585, DOI 10.1089/dna.2012.1698; Kemp CJ, 2014, CELL REP, V7, P1020, DOI 10.1016/j.celrep.2014.04.004; Khaja ASS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026539; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Lai C, 2011, J PATHOL, V223, P584, DOI 10.1002/path.2835; Li JS, 2010, CANCER BIOL THER, V10, P617, DOI 10.4161/cbt.10.6.12609; Li Q, 2012, EPIGENETICS-US, V7, P551, DOI 10.4161/epi.20050; Liu JJ, 2013, CELL SIGNAL, V25, P447, DOI 10.1016/j.cellsig.2012.10.012; Lu BJ, 2012, MOL MED REP, V5, P1033, DOI 10.3892/mmr.2012.772; Lu WL, 2014, INT J CLIN ONCOL, V19, P1011, DOI 10.1007/s10147-013-0648-0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Prasad CP, 2013, MOL ONCOL, V7, P870, DOI 10.1016/j.molonc.2013.04.005; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Wei W, 2014, HEPATOB PANCREAT DIS, V13, P529, DOI 10.1016/S1499-3872(14)60277-0; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Ying J, 2007, BLOOD, V110, P4130, DOI 10.1182/blood-2007-06-094870; Zhang AL, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-15; Zhu YC, 2013, CELL SIGNAL, V25, P1075, DOI 10.1016/j.cellsig.2013.01.015	46	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151392	10.1371/journal.pone.0151392	http://dx.doi.org/10.1371/journal.pone.0151392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978652	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800070
J	El-Bassel, N; Gilbert, L; Shaw, SA; Mergenova, G; Terlikbayeva, A; Primbetova, S; Ma, X; Chang, M; Ismayilova, L; Hunt, T; West, B; Wu, E; Beyrer, C				El-Bassel, Nabila; Gilbert, Louisa; Shaw, Stacey A.; Mergenova, Gaukhar; Terlikbayeva, Assel; Primbetova, Sholpan; Ma, Xin; Chang, Mingway; Ismayilova, Leyla; Hunt, Tim; West, Brooke; Wu, Elwin; Beyrer, Chris			The Silk Road Health Project: How Mobility and Migration Status Influence HIV Risks among Male Migrant Workers in Central Asia	PLOS ONE			English	Article							SEXUAL RISK; MEXICAN MIGRANTS; POTENTIAL ROLE; BEHAVIORS; DISEASE; CHINA; PREVENTION; INFECTION; MUMBAI; MEN	Objectives We examined whether mobility, migrant status, and risk environments are associated with sexually transmitted infections (STIs) and HIV risk behaviors (e.g. sex trading, multiple partners, and unprotected sex). Methods We used Respondent Driven Sampling (RDS) to recruit external male migrant market vendors from Kyrgyzstan, Uzbekistan, and Tajikistan as well internal migrant and non-migrant market vendors from Kazakhstan. We conducted multivariate logistic regressions to examine the effects of mobility combined with the interaction between mobility and migration status on STIs and sexual risk behaviors, when controlling for risk environment characteristics. Results Mobility was associated with increased risk for biologically-confirmed STIs, sex trading, and unprotected sex among non-migrants, but not among internal or external migrants. Condom use rates were low among all three groups, particularly external migrants. Risk environment factors of low-income status, debt, homelessness, and limited access to medical care were associated with unprotected sex among external migrants. Conclusion Study findings underscore the role mobility and risk environments play in shaping HIV/STI risks. They highlight the need to consider mobility in the context of migration status and other risk environment factors in developing effective prevention strategies for this population.	[El-Bassel, Nabila; Gilbert, Louisa; Shaw, Stacey A.; Ma, Xin; Chang, Mingway; Wu, Elwin] Columbia Univ, Sch Social Work, New York, NY USA; [Mergenova, Gaukhar; Terlikbayeva, Assel; Primbetova, Sholpan] Columbia Univ, Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan; [Ismayilova, Leyla] Univ Chicago, Sch Social Serv Adm, Chicago, IL 60637 USA; [West, Brooke] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Beyrer, Chris] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Epidemiol, Int Hlth, Baltimore, MD USA	Columbia University; University of Chicago; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	El-Bassel, N (corresponding author), Columbia Univ, Sch Social Work, New York, NY USA.	ne5@columbia.edu	Mergenova, Gaukhar/AAZ-1336-2020; Ma, Xin/I-7741-2019	Mergenova, Gaukhar/0000-0003-4702-1944; Ma, Xin/0000-0001-6631-9223; West, Brooke S./0000-0003-0496-5769; Ismayilova, Leyla/0000-0002-0027-4824; Terlikbayeva, Assel/0000-0002-4067-1998	National Institute of Health [NIMH R01 MH082684]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA041233, T32DA023356] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institute of Health, NIMH R01 MH082684 to Dr. Nabila El-Bassel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOB REP UNAIDS REP; Apostolopoulos Yorghos, 2006, J Immigr Minor Health, V8, P291, DOI 10.1007/s10903-006-9334-2; Beyrer C, 2007, CLIN INFECT DIS, V44, P981, DOI 10.1086/512371; Booth RE, 2004, JAIDS-J ACQ IMM DEF, V35, P82, DOI 10.1097/00126334-200401010-00012; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; El-Bassel N., 2015, J AIDS CLIN RES, V6, P1, DOI [10.4172/2155-6113.1000486, DOI 10.4172/2155-6113.1000486]; El-Bassel N, 2011, AM J PUBLIC HEALTH, V101, P1075, DOI 10.2105/AJPH.2010.300085; Godinho J., 2004, REVERSING TIDE PRIOR; Goldenberg SM, 2012, J IMMIGR MINOR HEALT, V14, P48, DOI 10.1007/s10903-011-9505-2; Gushulak BD, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-3; Heckathorn D. D., 2003, CHANGING BEAT STUDY, P48; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; International Organization for Migration, 2018, WORLD MIGRATION REPO, DOI DOI 10.1787/ECO_SURVEYS-USA-2018-EN; International Organization of Migration (iom), 2010, WORLD MIGRATION REPO; IOM, 2006, MIGR PERSP E EUR CEN; Keezhangatte JJ, 2006, TRANSNATIONAL MIGRAT; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Laruelle M., 2008, CENTRAL ASIA CAUCASU, V10; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Magis-Rodriguez C, 2009, JAIDS-J ACQ IMM DEF, V51, pS21, DOI 10.1097/QAI.0b013e3181a26433; Napper LE, 2010, AIDS BEHAV, V14, P152, DOI 10.1007/s10461-009-9575-5; NEEDLE R, 1995, PSYCHOL ADDICT BEHAV, V9, P242, DOI 10.1037/0893-164X.9.4.242; Organista KC, 2004, JAIDS-J ACQ IMM DEF, V37, pS227, DOI 10.1097/01.qai.0000141250.08475.91; Poudel KC, 2003, TROP MED INT HEALTH, V8, P933, DOI 10.1046/j.1365-3156.2003.01110.x; RAC, 2011, HIV SURV UPD KAZ OBL; RAC, 2013, SIT HIV AIDS REP KAZ; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2012, RETHINKING SOCIAL EPIDEMIOLOGY: TOWARDS A SCIENCE OF CHANGE, P205, DOI 10.1007/978-94-007-2138-8_10; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vaglio Joseph Jr, 2004, Health Qual Life Outcomes, V2, P24, DOI 10.1186/1477-7525-2-24; Volz E., 2012, RESPONDENT DRIVEN SA; Wang W, 2010, INT J STD AIDS, V21, P410, DOI 10.1258/ijsa.2009.008518; Weine S, 2013, J IMMIGR MINOR HEALT, V15, P700, DOI 10.1007/s10903-012-9718-z; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4; Wong DFK, 2008, INT J SOC PSYCHIATR, V54, P131, DOI 10.1177/0020764007083877; Yessenova S, 2005, RUSS REV, V64, P661, DOI 10.1111/j.1467-9434.2005.00380.x; Young H, 1998, J CLIN MICROBIOL, V36, P913, DOI 10.1128/JCM.36.4.913-917.1998	48	20	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151278	10.1371/journal.pone.0151278	http://dx.doi.org/10.1371/journal.pone.0151278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967159	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200040
J	Gonzalez, A; Bes, MT; Peleato, ML; Fillat, MF				Gonzalez, Andres; Teresa Bes, M.; Luisa Peleato, M.; Fillat, Maria F.			Expanding the Role of FurA as Essential Global Regulator in Cyanobacteria	PLOS ONE			English	Article							SP PCC 7120; SP-STRAIN PCC-7120; OXIDATIVE STRESS; GENE-EXPRESSION; PHYCOBILISOME DEGRADATION; DIFFERENTIAL EXPRESSION; POSITIVE REGULATION; ESCHERICHIA-COLI; IRON HOMEOSTASIS; ANABAENA	In the nitrogen-fixing heterocyst-forming cyanobacterium Anabaena sp. PCC 7120, the ferric uptake regulator FurA plays a global regulatory role. Failures to eliminate wild-type copies of furA gene from the polyploid genome suggest essential functions. In the present study, we developed a selectively regulated furA expression system by the replacement of furA promoter in the Anabaena sp. chromosomes with the Co2+/Zn2+ inducible coaT promoter from Synechocystis sp. PCC 6803. By removing Co2+ and Zn2+ from the medium and shutting off furA expression, we showed that FurA was absolutely required for cyanobacterial growth. RNA-seq based comparative transcriptome analyses of the furA-turning off strain and its parental wild-type in conjunction with subsequent electrophoretic mobility shift assays and semi-quantitative RT-PCR were carried out in order to identify direct transcriptional targets and unravel new biological roles of FurA. The results of such approaches led us to identify 15 novel direct iron-dependent transcriptional targets belonging to different functional categories including detoxification and defences against oxidative stress, phycobilisome degradation, chlorophyll catabolism and programmed cell death, light sensing and response, heterocyst differentiation, exopolysaccharide biosynthesis, among others. Our analyses evidence novel interactions in the complex regulatory network orchestrated by FurA in cyanobacteria.	[Gonzalez, Andres; Teresa Bes, M.; Luisa Peleato, M.; Fillat, Maria F.] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain	University of Zaragoza	Gonzalez, A; Fillat, MF (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain.	andresglezrod@gmail.com; fillat@unizar.es	González, Andrés/Y-3559-2019; Bes, M. Teresa/AAA-1035-2019; Fillat, María F/G-2609-2015	González, Andrés/0000-0002-0531-0943; /0000-0002-2742-3711; Fillat Castejon, Maria Francisca/0000-0001-8644-4574	Ministerio de Economia y Competitividad. Gobierno de Espana [BFU2012-31458]; Fondos FEDER; B18, Grupo Consolidado Biologia structural, Gobierno de Aragon	Ministerio de Economia y Competitividad. Gobierno de Espana; Fondos FEDER(European Commission); B18, Grupo Consolidado Biologia structural, Gobierno de Aragon	Support was provided by BFU2012-31458 Ministerio de Economia y Competitividad. Gobierno de Espana and Fondos FEDER [http://www.mineco.gob.es/portal/site/mineco/] to AG MTB MLP MFF; and B18, Grupo Consolidado Biologia structural, Gobierno de Aragon [http://www.aragon.es/] to AG MTB MLP MFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; Bender KS, 2007, APPL ENVIRON MICROB, V73, P5389, DOI 10.1128/AEM.00276-07; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; Bihani SC, 2013, ACTA CRYSTALLOGR F, V69, P1299, DOI 10.1107/S1744309113028017; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Boileau C, 2011, NEW PHYTOL, V191, P1108, DOI 10.1111/j.1469-8137.2011.03774.x; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; Cheng D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101743; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Craig SA, 2011, J BACTERIOL, V193, P6505, DOI 10.1128/JB.05681-11; Neto JFD, 2009, NUCLEIC ACIDS RES, V37, P4812, DOI 10.1093/nar/gkp509; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Dubrac S, 2000, J BACTERIOL, V182, P3802, DOI 10.1128/JB.182.13.3802-3808.2000; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fan YP, 2014, ENV MICROBIOL REP, V6, P468, DOI 10.1111/1758-2229.12157; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Ghassemian M, 1996, MICROBIOL-SGM, V142, P1469, DOI 10.1099/13500872-142-6-1469; Gilbreath JJ, 2012, J BACTERIOL, V194, P6490, DOI 10.1128/JB.01226-12; Gonzalez A, 2014, NUCLEIC ACIDS RES, V42, P4833, DOI 10.1093/nar/gku123; Gonzalez A, 2013, FEBS LETT, V587, P2682, DOI 10.1016/j.febslet.2013.07.007; Gonzalez A, 2012, ENVIRON MICROBIOL, V14, P3175, DOI 10.1111/j.1462-2920.2012.02897.x; Gonzalez A, 2011, J PROTEOMICS, V74, P660, DOI 10.1016/j.jprot.2011.02.001; Gonzalez A, 2010, PLANT CELL PHYSIOL, V51, P1900, DOI 10.1093/pcp/pcq148; Hernandez JA, 2006, BIOMETALS, V19, P259, DOI 10.1007/s10534-005-7750-3; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hernandez JA, 2002, BIOCHEM J, V366, P315, DOI 10.1042/BJ20020135; Hernandez JA, 2009, J PLANT PHYSL; Hernandez JA, 2007, FEBS LETT, V581, P1351, DOI 10.1016/j.febslet.2007.02.053; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Irieda H, 2012, J BIOL CHEM, V287, P32485, DOI 10.1074/jbc.M112.390864; Jittawuttipoka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055564; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latifi A, 2005, J BACTERIOL, V187, P6596, DOI 10.1128/JB.187.18.6596-6598.2005; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lopez-Gomollon S, 2007, MICROBIOL-SGM, V153, P42, DOI 10.1099/mic.0.2006/000091-0; Lopez-Gomollon S, 2007, J MOL BIOL, V374, P267, DOI 10.1016/j.jmb.2007.09.010; Lopez-Gomollon S, 2009, BIOCHEM J, V418, P201, DOI 10.1042/BJ20081066; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Montgomery BL, 2007, MOL MICROBIOL, V64, P16, DOI 10.1111/j.1365-2958.2007.05622.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolaisen K, 2008, J BACTERIOL, V190, P7500, DOI 10.1128/JB.01062-08; Okamoto S, 2004, PHOTOCHEM PHOTOBIOL, V80, P429, DOI 10.1562/0031-8655(2004)080&lt;0429:APPATT&gt;2.0.CO;2; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Peca L, 2008, FEMS MICROBIOL LETT, V289, P258, DOI 10.1111/j.1574-6968.2008.01393.x; Pellicer S, 2010, PROCESS BIOCHEM, V45, P292, DOI 10.1016/j.procbio.2009.09.019; Pelliciari S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00840; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Pinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034983; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Richaud C, 2001, J BACTERIOL, V183, P2989, DOI 10.1128/JB.183.10.2989-2994.2001; Richier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035571; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sambrook J., 2001, MOL CLONING LAB MANU; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; Sein-Echaluce VC, 2015, ENVIRON MICROBIOL, V17, P2006, DOI 10.1111/1462-2920.12628; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Singh AK, 2000, J BACTERIOL, V182, P3536, DOI 10.1128/JB.182.12.3536-3543.2000; Stevanovic M, 2013, BIOMETALS, V26, P549, DOI 10.1007/s10534-013-9644-0; Stevanovic M, 2012, ENVIRON MICROBIOL, V14, P1655, DOI 10.1111/j.1462-2920.2011.02619.x; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004; Whitton BA, 2000, ECOLOGY CYANOBACTERI, Vxvii; Yang YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S11; Yu CX, 2012, J BACTERIOL, V194, P6372, DOI 10.1128/JB.00262-12; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	84	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151384	10.1371/journal.pone.0151384	http://dx.doi.org/10.1371/journal.pone.0151384			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967347	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200050
J	Smith, BE; Johnston, MK; Lucking, R				Smith, B. Eugene; Johnston, Mark K.; Luecking, Robert			From GenBank to GBIF: Phylogeny-Based Predictive Niche Modeling Tests Accuracy of Taxonomic Identifications in Large Occurrence Data Repositories	PLOS ONE			English	Article							USNEA-LONGISSIMA; DNA BARCODE; SPECIES DISTRIBUTIONS; EPIPHYTIC LICHENS; ALIGNMENT; PERFORMANCE; BIAS; TOOL	Accuracy of taxonomic identifications is crucial to data quality in online repositories of species occurrence data, such as the Global Biodiversity Information Facility (GBIF), which have accumulated several hundred million records over the past 15 years. These data serve as basis for large scale analyses of macroecological and biogeographic patterns and to document environmental changes over time. However, taxonomic identifications are often unreliable, especially for non-vascular plants and fungi including lichens, which may lack critical revisions of voucher specimens. Due to the scale of the problem, restudy of millions of collections is unrealistic and other strategies are needed. Here we propose to use verified, georeferenced occurrence data of a given species to apply predictive niche modeling that can then be used to evaluate unverified occurrences of that species. Selecting the charismatic lichen fungus, Usnea longissima, as a case study, we used georeferenced occurrence records based on sequenced specimens to model its predicted niche. Our results suggest that the target species is largely restricted to a narrow range of boreal and temperate forest in the Northern Hemisphere and that occurrence records in GBIF from tropical regions and the Southern Hemisphere do not represent this taxon, a prediction tested by comparison with taxonomic revisions of Usnea for these regions. As a novel approach, we employed Principal Component Analysis on the environmental grid data used for predictive modeling to visualize potential ecogeographical barriers for the target species; we found that tropical regions conform a strong barrier, explaining why potential niches in the Southern Hemisphere were not colonized by Usnea longissima and instead by morphologically similar species. This approach is an example of how data from two of the most important biodiversity repositories, GenBank and GBIF, can be effectively combined to remotely address the problem of inaccuracy of taxonomic identifications in occurrence data repositories and to provide a filtering mechanism which can considerably reduce the number of voucher specimens that need critical revision, in this case from 4,672 to about 100.	[Smith, B. Eugene; Luecking, Robert] Field Museum, Integrat Res Ctr, Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA; [Smith, B. Eugene; Luecking, Robert] Field Museum, Gantz Family Collect Ctr, Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA; [Johnston, Mark K.] Field Museum, Sci Act Ctr, Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA; [Luecking, Robert] Bot Garden, Konigin Luise Str 6-8, D-14195 Berlin, Germany; [Luecking, Robert] Bot Museum, Konigin Luise Str 6-8, D-14195 Berlin, Germany	Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago)	Lucking, R (corresponding author), Field Museum, Gantz Family Collect Ctr, Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA.; Lucking, R (corresponding author), Bot Garden, Konigin Luise Str 6-8, D-14195 Berlin, Germany.; Lucking, R (corresponding author), Bot Museum, Konigin Luise Str 6-8, D-14195 Berlin, Germany.	rlucking@fieldmuseum.org		Lucking, Robert/0000-0002-3431-4636; Johnston, Mark/0000-0002-2431-7083	National Science Foundation [NSF-EF 1115002, NSF-EF 1115116, NSF-EF 1115210]	National Science Foundation(National Science Foundation (NSF))	This study was conceived as part of a large digitization project of North American lichen and bryophyte collections funded by the National Science Foundation: Digitization TCN Collaborative Research: North American Lichens and Bryophytes: Sensitive Indicators of Environmental Quality and Change (NSF-EF 1115002 to The Field Museum; PI Robert Lucking, co-PI Matt von Konrat; coordinated by NSF-EF 1115116 to the University of Wisconsin-Madison; PI Corinna Gries, co-PI Thomas Nash) and Digitization HUB: A Collections Digitization Framework for the 21st Century (NSF-EF 1115210 to the University of Florida; PI Lawrence Page, co-PIs Bruce MacFadden, Jose Fortes, Pamela Soltis, Gregory Riccardi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097556; Articus K, 2004, TAXON, V53, P925, DOI 10.2307/4135560; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Beaman RS, 2012, ZOOKEYS, P7, DOI 10.3897/zookeys.209.3313; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berendsohn WG, 2010, J BIODIV INFORM, V7, P1; Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Braidwood D, 2012, BOTANY, V90, P1316, DOI 10.1139/b2012-103; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Brodo IM, 2001, LICHENS N AM; Costello MJ, 2013, TRENDS ECOL EVOL, V28, P454, DOI 10.1016/j.tree.2013.05.002; Crisci JV, 2006, SYST BOT, V31, P217, DOI 10.1600/036364406775971859; de Carvalho MR, 2007, EVOL BIOL, V34, P140, DOI 10.1007/s11692-007-9011-6; de Carvalho MR, 2005, SCIENCE, V307, P353; Derr C, 2003, SURVEY PROTOCOLS SUR; Doell J, 2004, B CALIF LICHEN SOC, V11, P37; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellis CJ, 2014, BIOL CONSERV, V180, P153, DOI 10.1016/j.biocon.2014.09.046; ESSEEN PA, 1981, LICHENOLOGIST, V13, P177, DOI 10.1017/S0024282981000224; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gaiji S., 2013, BIODIVERS INFORM, V8, P94; GAMS H., 1961, BERICHTE GEOBOT FORSCHUNGSINST RUBEL ZURICH/32, V32, P167; Garcia-Rosello E, 2015, GLOBAL ECOL BIOGEOGR, V24, P335, DOI 10.1111/geb.12260; Gilbert EE, SYMBIOTA PROMOTING B; Gries Corinna, 2014, Biodivers Data J, pe1114, DOI 10.3897/BDJ.2.e1114; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Halonen P, 1997, GRAPH SCR, V8, P51; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herrera-Campos MA, 1998, BRYOLOGIST, V101, P303; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jansson U, 2010, BIOFOKUS RAPPORT, V36, P1; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Josefsson T, 2005, LICHENOLOGIST, V37, P555, DOI 10.1017/S0024282905015355; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Keon DB, 2002, BRYOLOGIST, V105, P233, DOI 10.1639/0007-2745(2002)105[0233:GOULAA]2.0.CO;2; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kroken S, 2001, MYCOLOGIA, V93, P38, DOI 10.2307/3761604; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lucking R., 2013, DIGITIZATION TAXONOM; Lucking R, 2012, 7 IAL S LICH GEN EC; Lucking R, 2014, P NATL ACAD SCI USA, V111, P11091, DOI 10.1073/pnas.1403517111; Lucking R, 2008, ARCH SCI, V61, P75; McNeill J, 2012, REGNUM VEGETABILE; Moncada B, 2014, FUNGAL DIVERS, V64, P205, DOI 10.1007/s13225-013-0230-0; Nascimbene J, 2009, PLANT BIOSYST, V143, P14, DOI 10.1080/11263500802633188; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Ohmura Y, 2002, J HATTORI BOT LAB, P231; Ohmura Y, 2001, J HATTORI BOT LAB, P1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Rolstad Jorund, 2008, Blyttia, V66, P208; Rolstad J, 2013, BOTANY, V91, P69, DOI 10.1139/cjb-2012-0202; RUNDEL PW, 1978, LICHENOLOGIST, V10, P141, DOI 10.1017/S0024282978000262; Santos AMC, 2010, INSECT CONSERV DIVER, V3, P72, DOI 10.1111/j.1752-4598.2010.00079.x; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schoch CL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau061; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scotland Robert, 2003, Systematics and Biodiversity, V1, P139, DOI 10.1017/S1477200003001178; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Smith CW, 2009, LICHENS GREAT BRITAI, P1046; Smith VS, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.209.3699; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stevens G. N., 1999, BIBLIOTHECA LICHENOL, V72, P1; STEVENS GN, 2004, FLORA AUSTR A, V56, P78; Storaunet KO, 2014, SILVA FENN, V48, P685, DOI 10.14214/sf.949; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Truong C, 2013, LICHENOLOGIST, V45, P505, DOI 10.1017/S0024282913000133; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Vollmar A, 2010, BIODIVERSITY INFORM, V7, P93, DOI DOI 10.17161/BI.V7I2.3992; Walker ER, 1910, PLANT WORLD, V13, P173; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wheeler QD, 2008, SYST ASSOC SPEC VOL, V76, P211; Wirth V, 2013, FLECHTEN DTSCH 1 2	85	20	22	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151232	10.1371/journal.pone.0151232	http://dx.doi.org/10.1371/journal.pone.0151232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967999	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200037
J	Kumar, A; Gupta, C; Nair, DT; Salunke, DM				Kumar, Ashish; Gupta, Chitra; Nair, Deepak T.; Salunke, Dinakar M.			MP-4 Contributes to Snake Venom Neutralization by Mucuna pruriens Seeds through an Indirect Antibody-mediated Mechanism (Publication with Expression of Concern. See vol. 293, pg. 11253, 2018) (Publication with Expression of Concern. See vol. 293, pg. 11253, 2018) (Publication with Expression of Concern. See vol. 293, pg. 11253, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Publication with Expression of Concern						antibody; crystal structure; humoral response; protease inhibitor; snake venom	ECHIS-CARINATUS VENOM; EXTRACT; GLYCOPROTEIN; BITES	Mortality due to snakebite is a serious public health problem, and available therapeutics are known to induce debilitating side effects. Traditional medicine suggests that seeds of Mucuna pruriens can provide protection against the effects of snakebite. Our aim is to identify the protein(s) that may be important for snake venom neutralization and elucidate its mechanism of action. To this end, we have identified and purified a protein from M. pruriens, which we have named MP-4. The full-length polypeptide sequence of MP-4 was obtained through N-terminal sequencing of peptide fragments. Sequence analysis suggested that the protein may belong to the Kunitz-type protease inhibitor family and therefore may potentially neutralize the proteases present in snake venom. Using various structural and biochemical tools coupled with in vivo assays, we are able to show that MP-4 does not afford direct protection against snake venom because it is actually a poor inhibitor of serine proteases. Further experiments showed that antibodies generated against MP-4 cross-react with the whole venom and provide protection to mice against Echis carinatus snake venom. This study shows that the MP-4 contributes significantly to the snake venom neutralization activity of M. pruriens seeds through an indirect antibody-mediated mechanism.	[Kumar, Ashish; Gupta, Chitra; Salunke, Dinakar M.] Natl Inst Immunol, Struct Biol Unit, Aruna Asaf Ali Rd, New Delhi 110067, India; [Kumar, Ashish; Nair, Deepak T.; Salunke, Dinakar M.] NCR Biotech Sci Cluster, Reg Ctr Biotechnol, 3rd Milestone,POB 3, Faridabad 121001, India; [Salunke, Dinakar M.] Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Nair, DT (corresponding author), NCR Biotech Sci Cluster, Reg Ctr Biotechnol, 3rd Milestone,POB 3, Faridabad 121001, India.; Salunke, DM (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, Delhi 110067, India.	deepak@rcb.res.in; dinakar.salunke@gmail.com	Nair, Deepak T/AAR-5234-2020	Nair, Deepak/0000-0002-0677-9444	Department of Biotechnology (Government of India); National Institute of Immunology (New Delhi, India)	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); National Institute of Immunology (New Delhi, India)	This work was supported by funds provided by the Department of Biotechnology (Government of India) to the Regional Centre for Biotechnology (Faridabad, India) and the National Institute of Immunology (New Delhi, India). The authors declare that they have no conflicts of interest with the contents of this article.	Adepoju GKA, 2009, J MED PLANTS RES, V3, P73; Aguiyi JC, 1999, FITOTERAPIA, V70, P21, DOI 10.1016/S0367-326X(98)00004-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amin MR, 2008, J VENOM ANIM TOXINS, V14, P660, DOI 10.1590/S1678-91992008000400009; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; CROWTHER RA, 1967, ACTA CRYSTALLOGR, V23, P544, DOI 10.1107/S0365110X67003172; Dey A, 2012, AFR J TRADIT COMPLEM, V9, P153, DOI 10.4314/ajtcam.v9i1.20; Dhananjaya BL, 2011, INDIAN J BIOCHEM BIO, V48, P175; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Fung SY, 2009, TROP BIOMED, V26, P80; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Guerranti R, 2004, BIOCHEM BIOPH RES CO, V323, P484, DOI 10.1016/j.bbrc.2004.08.122; Guerranti R, 2002, J BIOL CHEM, V277, P17072, DOI 10.1074/jbc.M201387200; Guerranti R, 2001, J ETHNOPHARMACOL, V75, P175, DOI 10.1016/S0378-8741(00)00401-3; Guerranti R., 1999, J PREV MED HYG, V40, P25; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hope-Onyekwere NS, 2012, PHYTOTHER RES, V26, P1913, DOI 10.1002/ptr.4663; Horigome D, 2007, J BIOL CHEM, V282, P6525, DOI 10.1074/jbc.M609458200; Hsu J, 2015, SCI AM, V313, P14, DOI 10.1038/scientificamerican1215-14; JOHNSON EK, 1987, TOXICON, V25, P1347, DOI 10.1016/0041-0101(87)90013-4; Kastritis PL, 2011, PROTEIN SCI, V20, P482, DOI 10.1002/pro.580; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kavitha C., 2014, Journal of Medicinal Plants Research, V8, P138; Koh DCI, 2006, CELL MOL LIFE SCI, V63, P3030, DOI 10.1007/s00018-006-6315-0; Lake S., 2004, NC HERPS NEWSLETTER, V27; Lauk L., 1993, INT J PHARMACOL, V31, P213, DOI DOI 10.3109/13880209309082944; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Makhija I. K., 2010, Der Pharmacia Lettre, V2, P399; Manyam BV, 2004, PHYTOTHER RES, V18, P706, DOI 10.1002/ptr.1514; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Otlewski J, 2001, ACTA BIOCHIM POL, V48, P419; Reimers AR, 2000, CLIN EXP ALLERGY, V30, P276; Rita Paul, 2011, International Journal of Research in Ayurveda and Pharmacy (IJRAP), V2, P1060; Salau AO, 2007, AFR J BIOTECHNOL, V6, P2091; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scire A, 2011, PHYTOMEDICINE, V18, P887, DOI 10.1016/j.phymed.2011.02.004; Siddhuraju P, 2003, J SCI FOOD AGR, V83, P1517, DOI 10.1002/jsfa.1587; Tan NH, 2009, J ETHNOPHARMACOL, V123, P356, DOI 10.1016/j.jep.2009.03.025; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2	41	10	11	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11373	11384		10.1074/jbc.M115.699173	http://dx.doi.org/10.1074/jbc.M115.699173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26987900	Green Published, hybrid			2022-12-26	WOS:000377042100035
J	Cirillo, F; Ghiroldi, A; Fania, C; Piccoli, M; Torretta, E; Tettamanti, G; Gelfi, C; Anastasia, L				Cirillo, Federica; Ghiroldi, Andrea; Fania, Chiara; Piccoli, Marco; Torretta, Enrica; Tettamanti, Guido; Gelfi, Cecilia; Anastasia, Luigi			NEU3 Sialidase Protein Interactors in the Plasma Membrane and in the Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT ENDOCYTIC PATHWAY; GLUCOSE-REGULATED PROTEINS; APOPTOSIS SUPPRESSION; CELL-SURFACE; ENDOPLASMIC-RETICULUM; STRESS; DIFFERENTIATION; GROWTH; MICRODOMAINS; EXPRESSION	NEU3 sialidase has been shown to be a key player in many physio- and pathological processes, including cell differentiation, cellular response to hypoxic stress, and carcinogenesis. The enzyme, peculiarly localized on the outer leaflet of the plasma membrane, has been shown to be able to remove sialic acid residues from the gangliosides present on adjacent cells, thus creating cell to cell interactions. Nonetheless, herein we report that the enzyme localization is dynamically regulated between the plasma membrane and the endosomes, where a substantial amount of NEU3 is stored with low enzymatic activity. However, under opportune stimuli, NEU3 is shifted from the endosomes to the plasma membrane, where it greatly increases the sialidase activity. Finally, we found that NEU3 possesses also the ability to interact with specific proteins, many of which are different in each cell compartment. They were identified by mass spectrometry, and some selected ones were also confirmed by cross-immunoprecipitation with the enzyme, supporting NEU3 involvement in the cell stress response, protein folding, and intracellular trafficking.	[Cirillo, Federica; Ghiroldi, Andrea; Fania, Chiara; Piccoli, Marco; Tettamanti, Guido; Gelfi, Cecilia; Anastasia, Luigi] Ist Ricovero Cura Carattere Sci Policlin San Dona, I-20097 Milan, Italy; [Torretta, Enrica; Gelfi, Cecilia; Anastasia, Luigi] Univ Milan, Dept Biomed Sci Hlth, I-20122 Milan, Italy	University of Milan	Anastasia, L (corresponding author), Univ Milan, Dept Biomed Sci Hlth, I-20122 Milan, Italy.	luigi.anastasia@unimi.it	torretta, enrica/I-8793-2012; Piccoli, Marco/S-3731-2019; Gelfi, Cecilia/L-1490-2016; Anastasia, Luigi/AAN-1964-2020; Cirillo, Federica/ABE-3480-2020; Ghiroldi, Andrea/AAO-4409-2020	torretta, enrica/0000-0002-6374-3325; Piccoli, Marco/0000-0002-9461-2715; Gelfi, Cecilia/0000-0002-2996-6912; Anastasia, Luigi/0000-0002-0712-2161; Cirillo, Federica/0000-0002-0196-5977; Ghiroldi, Andrea/0000-0002-2896-7390; Fania, Chiara/0000-0003-3949-8769				Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Aureli M, 2011, J NEUROCHEM, V116, P891, DOI 10.1111/j.1471-4159.2010.07019.x; Bonardi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099405; Costa M, 1999, NUCLEIC ACIDS RES, V27, P817, DOI 10.1093/nar/27.3.817; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li RL, 2012, PLANT CELL, V24, P2105, DOI 10.1105/tpc.112.095695; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Mandal C, 2010, INT J CANCER, V126, P337, DOI 10.1002/ijc.24733; Meister M, 2014, FEBS J, V281, P2956, DOI 10.1111/febs.12834; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyata M, 2011, CANCER SCI, V102, P2139, DOI 10.1111/j.1349-7006.2011.02086.x; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Nomura H, 2006, ONCOL RES, V16, P289, DOI 10.3727/000000006783981035; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Papini N, 2012, J CELL BIOCHEM, V113, P2967, DOI 10.1002/jcb.24174; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Saito M, 1995, BIOL SIALIC ACIDS, P261, DOI [10.1007/978-1-4757-9504-2_8, DOI 10.1007/978-1-4757-9504-2_8]; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Scaringi R, 2013, J BIOL CHEM, V288, P3153, DOI 10.1074/jbc.M112.404327; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Tringali C, 2012, J BIOL CHEM, V287, P42835, DOI 10.1074/jbc.M112.407718; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yamamoto K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120578; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479	51	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10615	10624		10.1074/jbc.M116.719518	http://dx.doi.org/10.1074/jbc.M116.719518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26987901	hybrid, Green Published			2022-12-26	WOS:000377042600015
J	Auge, AC; Auld, HL; Sherratt, TN; Godin, JGJ				Auge, Anne-Christine; Auld, Heather L.; Sherratt, Thomas N.; Godin, Jean-Guy J.			Do Males Form Social Associations Based on Sexual Attractiveness in a Fission-Fusion Fish Society?	PLOS ONE			English	Article							MALE TRINIDADIAN GUPPIES; ALTERNATIVE MATING TACTICS; SPERM COMPETITION RISK; FEMALE MATE PREFERENCE; POECILIA-RETICULATA; MALE PHENOTYPE; INTERACTING PHENOTYPES; SHOALING PREFERENCES; MULTIPLE PATERNITY; PREDATION RISK	Recent theory predicts that males should choose social environments that maximize their relative attractiveness to females by preferentially associating with less attractive rivals, so as to enhance their mating success. Using the Trinidadian guppy (Poecilia reticulata), a highly social species, we tested for non-random social associations among males in mixedsex groups based on two phenotypic traits (body length and coloration) that predict relative sexual attractiveness to females and sexual (sperm) competitiveness. Based on a well-replicated laboratory dichotomous-choice test of social group preference, we could not reject the null hypothesis that focal males chose randomly between a mixed-sex group that comprised a female and a rival male that was less sexually attractive than themselves and another mixed-sex group containing a sexually more attractive male. The same conclusion was reached when females were absent from the two groups. As might be expected from these laboratory findings, free-ranging males in the field were not assorted by either body length or colour in mixed-sex shoals. The apparent lack of an evolved and expressed preference in wild male guppies from our study population to form social associations with other males based on their relative sexual attractiveness and competitiveness might be due to the fission-fusion dynamics of guppy shoals in nature. Such social dynamics likely places constraints on the formation of stable phenotype-based social associations among males. This possibility is supported by a simulation model which assumes group departure rules based on relative body size and coloration in males.	[Auge, Anne-Christine; Auld, Heather L.; Sherratt, Thomas N.; Godin, Jean-Guy J.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Auge, Anne-Christine] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	Carleton University; University of Ottawa	Godin, JGJ (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	jgodin@carleton.ca	Auld, Heather/V-6772-2019	Auld, Heather/0000-0002-8239-1572; Auge, Anne-Christine/0000-0002-1111-2003	Natural Sciences and Engineering Research Council of Canada; Research Grant (RGPIN) [8074-2010]; German Academic Exchange Service (DAAD)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research Grant (RGPIN); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (www.nserc.ca); Research Grant (RGPIN 8074-2010) awarded to JGJG and a German Academic Exchange Service (DAAD) (www.daad.de/en/) Scholarship Awarded to ACA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 2013, MATLAB STAT TOOLB RE; Auld HL, 2015, BEHAV ECOL SOCIOBIOL, V69, P1191, DOI 10.1007/s00265-015-1933-x; Bailey NW, 2012, TRENDS ECOL EVOL, V27, P561, DOI 10.1016/j.tree.2012.05.011; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; BISAZZA A, 1989, ETHOLOGY, V83, P335, DOI 10.1111/j.1439-0310.1989.tb00541.x; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Blumstein DT, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00034; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Callander S, 2013, BEHAV ECOL, V24, P730, DOI 10.1093/beheco/ars208; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; Croft DP, 2012, OECOLOGIA, V170, P955, DOI 10.1007/s00442-012-2379-8; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Croft DP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1495, DOI 10.1007/s00265-009-0802-x; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; Croft DP, 2004, P ROY SOC B-BIOL SCI, V271, pS516, DOI 10.1098/rsbl.2004.0206; DUGATKIN LA, 1994, BEHAV ECOL SOCIOBIOL, V35, P141, DOI 10.1007/BF00171504; DUGATKIN LA, 1995, ETHOLOGY, V99, P265; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; Evans JP, 1999, ANIM BEHAV, V58, P1001, DOI 10.1006/anbe.1999.1212; FARR JA, 1976, EVOLUTION, V30, P707, DOI 10.1111/j.1558-5646.1976.tb00951.x; Formica VA, 2011, EVOLUTION, V65, P2771, DOI 10.1111/j.1558-5646.2011.01340.x; Gasparini C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3072; Godin JGJ, 2013, ECOL EVOL, V3, P2020, DOI 10.1002/ece3.607; GODIN JGJ, 1995, OECOLOGIA, V103, P224, DOI 10.1007/BF00329084; Godin JGJ, 2003, CAN J ZOOL, V81, P1899, DOI [10.1139/z03-186, 10.1139/Z03-186]; Godin JGJ, 1996, ANIM BEHAV, V51, P117, DOI 10.1006/anbe.1996.0010; Griffiths SW, 1997, ANIM BEHAV, V53, P945, DOI 10.1006/anbe.1996.0315; Griffiths SW, 1997, P ROY SOC B-BIOL SCI, V264, P547, DOI 10.1098/rspb.1997.0078; Guevara-Fiore P, 2010, ANIM BEHAV, V79, P1191, DOI 10.1016/j.anbehav.2010.02.027; Guevara-Fiore P, 2009, ANIM BEHAV, V77, P425, DOI 10.1016/j.anbehav.2008.10.018; Hofmann HA, 2014, TRENDS ECOL EVOL, V29, P581, DOI 10.1016/j.tree.2014.07.008; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Jeswiet SB, 2011, ETHOLOGY, V117, P422, DOI 10.1111/j.1439-0310.2011.01891.x; Jeswiet SB, 2011, ANIM BEHAV, V81, P639, DOI 10.1016/j.anbehav.2010.12.013; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; Jirotkul M, 1999, ANIM BEHAV, V58, P1169, DOI 10.1006/anbe.1999.1248; Jirotkul M, 2000, J FISH BIOL, V56, P1427, DOI 10.1111/j.1095-8649.2000.tb02154.x; Jordan LA, 2012, EVOLUTION, V66, P280, DOI 10.1111/j.1558-5646.2011.01421.x; Kelley JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024280; Kelly CD, 1999, P ROY SOC B-BIOL SCI, V266, P2403, DOI 10.1098/rspb.1999.0938; Krause J, 2002, LIVING GROUPS; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Magellan K, 2005, BEHAV ECOL SOCIOBIOL, V58, P366, DOI 10.1007/s00265-005-0950-6; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; McGlothlin JW, 2010, EVOLUTION, V64, P2558, DOI 10.1111/j.1558-5646.2010.01012.x; Miller LK, 2005, EVOLUTION, V59, P2414; Neff BD, 2008, MOL ECOL, V17, P2975, DOI 10.1111/j.1365-294X.2008.03816.x; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Oh KP, 2010, AM NAT, V176, pE80, DOI 10.1086/655216; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Pilastro A, 1999, P ROY SOC B-BIOL SCI, V266, P1887, DOI 10.1098/rspb.1999.0862; Pitcher TE, 2007, J FISH BIOL, V70, P165, DOI 10.1111/j.1095-8649.2006.01292.x; Pitcher TE, 2001, CAN J ZOOL, V79, P1891, DOI 10.1139/cjz-79-10-1891; Pitcher TE, 2003, P ROY SOC B-BIOL SCI, V270, P1623, DOI 10.1098/rspb.2002.2280; Pitcher Tony J., 1993, Fish and Fisheries Series, V7, P363; R Core Team, 2021, R LANGUAGE ENV STAT; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; RODD FH, 1995, ANIM BEHAV, V49, P1139, DOI 10.1006/anbe.1995.0149; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Song ZB, 2011, ETHOLOGY, V117, P1009, DOI 10.1111/j.1439-0310.2011.01952.x; Taborsky B, 2012, TRENDS ECOL EVOL, V27, P679, DOI 10.1016/j.tree.2012.09.003; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wolf JB, 1999, AM NAT, V153, P254, DOI 10.1086/303168	71	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151243	10.1371/journal.pone.0151243	http://dx.doi.org/10.1371/journal.pone.0151243			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986565	Green Published, gold			2022-12-26	WOS:000372580300056
J	Kidd, S; Lieber, T				Kidd, Simon; Lieber, Toby			Mechanism of Notch Pathway Activation and Its Role in the Regulation of Olfactory Plasticity in Drosophila melanogaster	PLOS ONE			English	Article							LONG-TERM-MEMORY; TARGETED GENE-EXPRESSION; ANTENNAL LOBE; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; ADULT DROSOPHILA; HIPPOCAMPAL NETWORKS; TRANSGENIC RNAI; NEURAL ACTIVITY; MOSAIC ANALYSIS	The neural plasticity of sensory systems is being increasingly recognized as playing a role in learning and memory. We have previously shown that Notch, part of an evolutionarily conserved intercellular signaling pathway, is required in adult Drosophila melanogaster olfactory receptor neurons (ORNs) for the structural and functional plasticity of olfactory glomeruli that is induced by chronic odor exposure. In this paper we address how long-term exposure to odor activates Notch and how Notch in conjunction with chronic odor mediates olfactory plasticity. We show that upon chronic odor exposure a non-canonical Notch pathway mediates an increase in the volume of glomeruli by a mechanism that is autonomous to ORNs. In addition to activating a pathway that is autonomous to ORNs, chronic odor exposure also activates the Notch ligand Delta in second order projection neurons (PNs), but this does not appear to require acetylcholine receptor activation in PNs. Delta on PNs then feeds back to activate canonical Notch signaling in ORNs, which restricts the extent of the odor induced increase in glomerular volume. Surprisingly, even though the pathway that mediates the increase in glomerular volume is autonomous to ORNs, nonproductive transsynaptic Delta/Notch interactions that do not activate the canonical pathway can block the increase in volume. In conjunction with chronic odor, the canonical Notch pathway also enhances cholinergic activation of PNs. We present evidence suggesting that this is due to increased acetylcholine release from ORNs. In regulating physiological plasticity, Notch functions solely by the canonical pathway, suggesting that there is no direct connection between morphological and physiological plasticity.	[Kidd, Simon; Lieber, Toby] Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, 701 W 168th St, New York, NY USA	Columbia University	Lieber, T (corresponding author), Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, 701 W 168th St, New York, NY USA.	toby.lieber@gmail.com			National Institutes of Health/National Institute of General Medical Sciences [RO1GM095797, RO1GM109183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095797, R01GM109183] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences grants RO1GM095797 and RO1GM109183 to Gary Struhl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2014, ELIFE, V3, DOI 10.7554/eLife.02109; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Arenas A, 2012, EUR J NEUROSCI, V35, P682, DOI 10.1111/j.1460-9568.2012.07999.x; Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Arenas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008046; Brai E, 2014, EUR J NEUROSCI, V40, P3436, DOI 10.1111/ejn.12719; Busto GU, 2010, PHYSIOLOGY, V25, P338, DOI 10.1152/physiol.00026.2010; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chakraborty TS, 2009, J NEUROGENET, V23, P210, DOI 10.1080/01677060802491559; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Conboy L, 2007, NEUROBIOL LEARN MEM, V88, P342, DOI 10.1016/j.nlm.2007.04.006; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dahlhaus M, 2008, J NEUROSCI, V28, P10794, DOI 10.1523/JNEUROSCI.1348-08.2008; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Dias BG, 2014, NEURON, V83, P906, DOI 10.1016/j.neuron.2014.07.019; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; Guven-Ozkan T, 2014, LEARN MEMORY, V21, P519, DOI 10.1101/lm.034363.114; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Hourcade B, 2009, LEARN MEMORY, V16, P607, DOI 10.1101/lm.1445609; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Kass MD, 2013, SCIENCE, V342, P1389, DOI 10.1126/science.1244916; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kidd S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005244; Ko KI, 2015, ELIFE, V4, DOI 10.7554/eLife.08298; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuzina I, 2011, DEVELOPMENT, V138, P1839, DOI 10.1242/dev.062471; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; Lee KS, 2013, GENE DEV, V27, P2642, DOI 10.1101/gad.225169.113; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li Q, 2015, CURR BIOL, V25, pR120, DOI 10.1016/j.cub.2014.11.044; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Lieber T, 2011, NEURON, V69, P468, DOI 10.1016/j.neuron.2010.12.015; Liu SX, 2015, HIPPOCAMPUS, V25, P670, DOI 10.1002/hipo.22402; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Matsuno M, 2009, P NATL ACAD SCI USA, V106, P310, DOI 10.1073/pnas.0807665106; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McNabb SL, 2008, J EXP BIOL, V211, P2263, DOI 10.1242/jeb.015818; Mejia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064685; Morrison FG, 2015, P NATL ACAD SCI USA; Morsut L, 2016, CELL, P1; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pavlopoulos E, 2008, P NATL ACAD SCI USA, V105, P14674, DOI 10.1073/pnas.0801605105; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Sargin D, 2013, NEUROBIOL LEARN MEM, V103, P39, DOI 10.1016/j.nlm.2013.03.001; Song JK, 2011, DEV DYNAM, V240, P324, DOI 10.1002/dvdy.22525; Spors H, 2012, J NEUROSCI, V32, P14102, DOI 10.1523/JNEUROSCI.3328-12.2012; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Twick I, 2014, PROG BRAIN RES, V208, P3, DOI 10.1016/B978-0-444-63350-7.00001-2; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; Xie XH, 2012, DEV BIOL, V363, P399, DOI 10.1016/j.ydbio.2012.01.004; Yew JY, 2009, J PROTEOME RES, V8, P1271, DOI 10.1021/pr800601x; Yoon KJ, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-40; Zhang JB, 2013, J NEUROSCI, V33, P12825, DOI 10.1523/JNEUROSCI.0783-13.2013; Zhang Jun-Jie, 2015, Chin J Integr Med	81	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151279	10.1371/journal.pone.0151279	http://dx.doi.org/10.1371/journal.pone.0151279			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986723	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300057
J	Pallis, M; Harvey, T; Russell, N				Pallis, Monica; Harvey, Tamsin; Russell, Nigel			Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation	PLOS ONE			English	Article							MAMMALIAN TARGET; RAPAMYCIN MTOR; GROWTH; BLASTS; CD45; PROLIFERATION; INHIBITION; METABOLISM; 4E-BP1; ROLES	Mechanistic/mammalian target of rapamycin (mTOR) activity drives a number of key metabolic processes including growth and protein synthesis. Inhibition of the mTOR pathway promotes cellular dormancy. Since cells from patients with acute myeloid leukaemia (AML) can be phenotypically dormant (quiescent), we examined biomarkers of their mTOR pathway activity concurrently with Ki-67 and CD71 (indicators of cycling cells) by quantitative flow cytometry. Using antibodies to phosphorylated epitopes of mTOR (S2448) and its downstream targets ribosomal protein S6 (rpS6, S235/236) and 4E-BP1 (T36/45), we documented that these phosphorylations were negligible in lymphocytes, but evident in dormant as well as proliferating subsets of both mobilised normal stem cell harvest CD34+ cells and AML blasts. Although mTOR phosphorylation in AML blasts was lower than that of the normal CD34+ cells, p-4E-BP1 was 2.6-fold higher and p-rpS6 was 22-fold higher. Moreover, in contrast to 4E-BP1, rpS6 phosphorylation was higher in dormant than proliferating AML blasts, and was also higher in the immature CD34+ CD38-blast subset. Data from the Cancer Genome Atlas show that rpS6 expression is associated with that of respiratory chain enzymes in AML. We conclude that phenotypic quiescence markers do not necessarily predict metabolic dormancy and that elevated rpS6 ser235/236 phosphorylation is characteristic of AML.	[Pallis, Monica; Russell, Nigel] Univ Nottingham Hosp, Clin Haematol, Nottingham NG7 2UH, England; [Harvey, Tamsin; Russell, Nigel] Univ Nottingham, Dept Haematol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Pallis, M (corresponding author), Univ Nottingham Hosp, Clin Haematol, Nottingham NG7 2UH, England.	monica.pallis@nottingham.ac.uk			Nottinghamshire Leukaemia Appeal	Nottinghamshire Leukaemia Appeal	This study was supported by Nottinghamshire Leukaemia Appeal, http://www.nlaappeal.org/ (Chair and address, professor John Fletcher, Medical Research Centre, NUH City Hospital Campus, Nottingham NG5 1PB, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; BOROWITZ MJ, 1993, AM J CLIN PATHOL, V100, P534, DOI 10.1093/ajcp/100.5.534; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cargnello M, 2015, MUTAGENESIS, V30, P169, DOI 10.1093/mutage/geu045; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chow S, 2006, EXP HEMATOL, V34, P1183, DOI 10.1016/j.exphem.2006.05.002; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dieterlen MT, 2012, CYTOM PART B-CLIN CY, V82B, P151, DOI 10.1002/cyto.b.21005; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gerdes J, 1984, Hematol Oncol, V2, P365; GERDES J, 1984, J IMMUNOL, V133, P1710; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guo FK, 2013, HAEMATOLOGICA, V98, P1353, DOI 10.3324/haematol.2012.080424; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hoshii T, 2014, J BIOCHEM, V156, P73, DOI 10.1093/jb/mvu037; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; Lacombe F, 1997, LEUKEMIA, V11, P1878, DOI 10.1038/sj.leu.2400847; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Mony U, 2008, LEUKEMIA, V22, P1395, DOI 10.1038/leu.2008.125; Pallis M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-32; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Perl AE, 2012, CLIN CANCER RES, V18, P1716, DOI 10.1158/1078-0432.CCR-11-2346; RAINER RO, 1995, CYTOMETRY, V22, P139, DOI 10.1002/cyto.990220210; Rosner M, 2011, AMINO ACIDS, V40, P595, DOI 10.1007/s00726-010-0684-2; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shults Keith, 2009, Cancer Manag Res, V1, P49; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063; TAFURI A, 1990, LEUKEMIA, V4, P826; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210	56	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151480	10.1371/journal.pone.0151480	http://dx.doi.org/10.1371/journal.pone.0151480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985829	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300075
J	Salunkhe, VA; Elvstam, O; Eliasson, L; Wendt, A				Salunkhe, Vishal A.; Elvstam, Olof; Eliasson, Lena; Wendt, Anna			Rosuvastatin Treatment Affects Both Basal and Glucose-Induced Insulin Secretion in INS-1 832/13 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CA2+ CHANNELS; RAB3 EFFECTOR; STATINS; RIM; ATORVASTATIN; METAANALYSIS; SIMVASTATIN; INVOLVEMENT; PRAVASTATIN	Rosuvastatin is a member of the statin family. Like the other statins it is prescribed to lower cholesterol levels and thereby reduce the risk of cardiovascular events. Rosuvastatin lowers the cholesterol levels by inhibiting the key enzyme 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase) in the cholesterol producing mevalonate pathway. It has been recognized that apart from their beneficial lipid lowering effects, statins also exhibit diabetogenic properties. The molecular mechanisms behind these remain unresolved. To investigate the effects of rosuvastatin on insulin secretion, we treated INS-1 832/13 cells with varying doses (20 nM to 20 mu M) of rosuvastatin for 48 h. At concentrations of 2 mu M and above basal insulin secretion was significantly increased. Using diazoxide we could determine that rosuvastatin did not increase basal insulin secretion by corrupting the K-ATP channels. Glucose-induced insulin secretion on the other hand seemed to be affected differently at different rosuvastatin concentrations. Rosuvastatin treatment (20 mu M) for 24-48 h inhibited voltage-gated Ca2+ channels, which lead to reduced depolarization-induced exocytosis of insulin-containing granules. At lower concentrations of rosuvastatin (<= 2 mu M) the stimulus-secretion coupling pathway was intact downstream of the K-ATP channels as assessed by the patch clamp technique. However, a reduction in glucose-induced insulin secretion could be observed with rosuvastatin concentrations as low as 200 nM. The inhibitory effects of rosuvastatin on glucose-induced insulin secretion could be reversed with mevalonate, but not squalene, indicating that rosuvastatin affects insulin secretion through its effects on the mevalonate pathway, but not through the reduction of cholesterol biosynthesis. Taken together, these data suggest that rosuvastatin has the potential to increase basal insulin secretion and reduce glucose-induced insulin secretion. The latter is possibly an unavoidable side effect of rosuvastatin treatment as it occurs through the same mechanisms as the lipid-lowering effects of the drug.	[Salunkhe, Vishal A.; Elvstam, Olof; Eliasson, Lena; Wendt, Anna] Lund Univ, Clin Res Ctr, Unit Islet Cell Exocytosis, Diabet Ctr,Dept Clin Sci Malmo,SUS Malmo, Malmo, Sweden	Lund University	Salunkhe, VA (corresponding author), Lund Univ, Clin Res Ctr, Unit Islet Cell Exocytosis, Diabet Ctr,Dept Clin Sci Malmo,SUS Malmo, Malmo, Sweden.	vishal.salunkhe@med.lu.se	Eliasson, Lena/E-9294-2012; Elvstam, Olof/AAH-6991-2020	Eliasson, Lena/0000-0002-6467-5029; Elvstam, Olof/0000-0003-3799-9869; Wendt, Anna/0000-0001-8807-5979	Swedish Research Council [K2012-55X-13147]; Diabetes Foundation; Albert Pahlssons Foundation; Ake Wiberg Foundation; medical faculty at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Diabetes Foundation; Albert Pahlssons Foundation; Ake Wiberg Foundation; medical faculty at Lund University	The study was funded by the Swedish Research Council (Project grant K2012-55X-13147 to LE; Linneus grant to LUDC; SFO-EXODIAB), The Diabetes Foundation (LE), the Albert Pahlssons Foundation (AW, LE), and the Ake Wiberg Foundation (LE). OE was supported by the medical faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Banach M, 2015, PHARMACOL RES, V99, P329, DOI 10.1016/j.phrs.2015.07.008; Bugliani M, 2013, ACTA DIABETOL, V50, P983, DOI 10.1007/s00592-013-0465-y; Cederberg H, 2015, DIABETOLOGIA, V58, P1962, DOI 10.1007/s00125-015-3674-9; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; DeGorter MK, 2013, CIRC-CARDIOVASC GENE, V6, P400, DOI 10.1161/CIRCGENETICS.113.000099; Del Prato S, 2002, DIABETES, V51, pS109, DOI 10.2337/diabetes.51.2007.S109; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Ishikawa M, 2006, J ATHEROSCLER THROMB, V13, P329, DOI 10.5551/jat.13.329; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kitamura S, 2008, DRUG METAB DISPOS, V36, P2014, DOI 10.1124/dmd.108.021410; Koh KK, 2011, ATHEROSCLEROSIS, V215, P1, DOI 10.1016/j.atherosclerosis.2010.10.036; LI GD, 1993, BIOCHEM J, V289, P379, DOI 10.1042/bj2890379; Li XN, 2010, CLIN THER, V32, P575, DOI 10.1016/j.clinthera.2010.03.015; MacDonald PE, 2011, AM J PHYSIOL-ENDOC M, V301, pE1065, DOI 10.1152/ajpendo.00426.2011; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Salunkhe VA, 2015, ACTA PHYSIOL, V213, P882, DOI 10.1111/apha.12460; Sampson UK, 2011, CURR OPIN CARDIOL, V26, P342, DOI 10.1097/HCO.0b013e3283470359; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schwabedissen HEMZ, 2014, DIABETES, V63, P775, DOI 10.2337/db13-1005; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; White CM, 2002, J CLIN PHARMACOL, V42, P963; Yada T, 1999, BRIT J PHARMACOL, V126, P1205, DOI 10.1038/sj.bjp.0702397; Yaluri N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142902; Zuniga-Hertz JP, 2015, J ENDOCRINOL, V224, P75, DOI 10.1530/JOE-14-0348	34	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151592	10.1371/journal.pone.0151592	http://dx.doi.org/10.1371/journal.pone.0151592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986474	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300091
J	Saynes-Vasquez, A; Vibrans, H; Vergara-Silva, F; Caballero, J				Saynes-Vasquez, Alfredo; Vibrans, Heike; Vergara-Silva, Francisco; Caballero, Javier			Intracultural Differences in Local Botanical Knowledge and Knowledge Loss among the Mexican Isthmus Zapotecs	PLOS ONE			English	Article							INDIGENOUS KNOWLEDGE; CULTURAL-CHANGE; ETHNOBOTANICAL KNOWLEDGE; NATURAL-RESOURCES; MEDICINAL-PLANTS; MAYA; SIERRA; COMMUNITIES; MANAGEMENT; DIVERSITY	This study reports on the socio-demographic and locality factors that influence ethnobiological knowledge in three communities of Zapotec indigenous people of the Isthmus of Tehuantepec, Mexico. It uses local botanical nomenclature as a proxy for general ethnobiological knowledge. In each of these communities (one urban and two rural), 100 adult men were interviewed aided with a field herbarium. Fifty had a background in farming, and 50 worked in the secondary or tertiary sector as their main economic activity, totaling 300 interviews. Using a field herbarium with samples of 30 common and rare wild regional species, we documented visual recognition, knowledge of the local life form, generic and specific names and uses (five knowledge levels measuring knowledge depth). The relationship between sociodemographic variables and knowledge was analyzed with simple correlations. Differences between the three communities and the five knowledge levels were then evaluated with a discriminant analysis. A general linear analysis identified factors and covariables that influenced the observed differences. Differences between the groups with different economic activities were estimated with a t-test for independent samples. Most of the relationships found between sociodemographic variables and plant knowledge were expected: age and rurality were positively related with knowledge and years of formal schooling was negatively related. However, the somewhat less rural site had more traditional knowledge due to local circumstances. The general linear model explained 70-77% of the variation, a high value. It showed that economic activity was by far the most important factor influencing knowledge, by a factor of five. The interaction of locality and economic activity followed. The discriminant analysis assigned interviewees correctly to their localities in 94% of the cases, strengthening the evidence for intracultural variation. Both sociodemographic and historic intracultural differences heavily influence local knowledge.	[Saynes-Vasquez, Alfredo; Vibrans, Heike] Colegio Postgrad, Postgrad Bot, Campus Montecillo, Montecillo, Texcoco, Mexico; [Vergara-Silva, Francisco; Caballero, Javier] Univ Nacl Autonoma Mexico, Inst Biol, Jardin Bot, Ciudad Univ, Mexico City 04510, DF, Mexico	Colegio de Postgraduados - Mexico; Universidad Nacional Autonoma de Mexico	Vibrans, H (corresponding author), Colegio Postgrad, Postgrad Bot, Campus Montecillo, Montecillo, Texcoco, Mexico.	heike@colpos.mx		Vergara-Silva, Francisco/0000-0001-5024-268X; Vibrans, Heike/0000-0002-1800-4320	Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencias y Tecnologia (CONACyT); National Council of Science and Technology (CONACyT), Mexico;  [172714]	Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencias y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council of Science and Technology (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	The study was financed by grants to the first author for his doctoral and postdoctoral studies from the Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (UNAM) and the Consejo Nacional de Ciencias y Tecnologia (CONACyT); this institution is the national science foundation of Mexico and is funded by the government. There was no other specific funding. The first author file number (which identifies the grants) is 172714. The website is http://www.conacyt.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Ovet Fuentes Trujillo (Juchitan), Andres Sanchez (Ejido Zapata), Victoriano Manuel Gomez, Rubicel Santiago Guerra and Roque Jimenez (Santa Maria Xadani), Octavio Morales and Rogelio de Sales (San Blas Atempa) and finally Juan Luis Sanchez (Ejido Alvaro Obregon) for their hospitality, willingness to share their knowledge, and collaboration with this research. The authors also thank the Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (UNAM) and the National Council of Science and Technology (CONACyT), Mexico, for academic and financial support for the Ph.D. and postdoc studies of the first author. Rafael Torres Colin and Veronica Juarez Jaimes of the MEXU herbarium helped to confirm some plant identifications. Polo Gomez kindly provided assistance with the statistical analysis. Arturo Nava, Kenia Velazco and Patricia Martinez gave valuable support in fieldwork. The Botany Department of the Colegio de Postgraduados, Texcoco, supported the final stages of the paper by hosting the first author for a postdoctoral stay. Finally, the suggestions of the anonymous reviewers improved the manuscript.	Arguello Suarez, 2013, CAMINO TEHUANTEPEC D; Atran S, 2002, CURR ANTHROPOL, V43, P421, DOI 10.1086/339528; Atran S, 1999, P NATL ACAD SCI USA, V96, P7598, DOI 10.1073/pnas.96.13.7598; Ayantunde A, 2008, HUM ECOL, V36, P881, DOI 10.1007/s10745-008-9200-7; Barnard Alan., 2000, HIST THEORY ANTHR; Beltran-Rodriguez L, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-14; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; Berlin B., 1972, LANG SOC, V1, P51, DOI [10.1017/S0047404500006540, DOI 10.1017/S0047404500006540]; BINFORD L, 1985, J LAT AM STUD, V17, P179, DOI 10.1017/S0022216X0000924X; Binford L., 1993, ZAPOTEC STRUGGLES HI; BOSTER JS, 1986, AM ANTHROPOL, V88, P428, DOI 10.1525/aa.1986.88.2.02a00100; Brown C.H., 1981, Journal of Anthropological Research, V37, P61; BURTON M, 1979, AM ANTHROPOL, V81, P841, DOI 10.1525/aa.1979.81.4.02a00050; Camou-Guerrero A, 2008, HUM ECOL, V36, P259, DOI 10.1007/s10745-007-9152-3; Campbell H, 1994, ZAPOTEC RENAISSANCE; Campbell HB, 1989, REV MEX SOCIOL, V51, P247, DOI 10.2307/3540686; Case RJ, 2005, ECON BOT, V59, P356, DOI 10.1663/0013-0001(2005)059[0356:FIMIKA]2.0.CO;2; Cortes-Gonzalez, 2007, THESIS U NACL AUTONO; Cruz S, 1992, ETNIAS DESARROLLO RE; Luna-Jose AD, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-24; Diamond J, 1999, FOLKBIOLOGY, P17; Fernandez MacGregor G., 1954, ISTMO TEHUANTEPEC ES; Frei B, 1998, J APPL BOT-ANGEW BOT, V72, P82; Frei B, 1998, PHYTOMEDICINE, V5, P177, DOI 10.1016/S0944-7113(98)80025-1; Frei B, 2000, ECON BOT, V54, P73, DOI 10.1007/BF02866601; Frei B, 1998, J ETHNOPHARMACOL, V62, P149, DOI 10.1016/S0378-8741(98)00051-8; GARRO LC, 1986, AM ANTHROPOL, V88, P351, DOI 10.1525/aa.1986.88.2.02a00040; Gimenez G., 2007, ESTUDIOS CULTURA IDE; Goodenough WH, 1957, REPORT 7TH ANN ROUND, P167; Hunn E.S., 2001, BIOCULTURAL DIVERSIT; Hunn ES, 2002, ETHNOBIOLOGY BIOCULT; Hunn Eugene, 2008, ZAPOTEC NATURAL HIST; Instituto Nacional de Estadistica y Geografia (INEGI), 2000, 12 CNES GEN POBL VIV; Kakudidi EK, 2004, AFR J ECOL, V42, P57, DOI 10.1111/j.1365-2028.2004.00462.x; Kottak CP, 2004, HUM ORGAN, V63, P501, DOI 10.17730/humo.63.4.g35k2c3t0tpyqgh3; Kuper A, 1999, CULTURE ANTHR ACCOUN; Lizarralde M., 2001, BIOCULTURAL DIVERSIT, P265; Luna-Jose A de L, 2006, THESIS COLEGIO POSTG; Machuca Gallegos L, 2013, REPRESENTADO PASADO; Maffi L, 2005, ANNU REV ANTHROPOL, V34, P599, DOI 10.1146/annurev.anthro.34.081804.120437; Maldonado-Almanza B, 2013, THESIS U NACL AUTONO; Manzo C, 2011, COMUNALIDAD RESISTEN; Marcus J, 2001, CUAD, V7, P5; Marcus Joyce, 1996, ZAPOTEC CIVILIZATION; Marino Flores A, 1963, DISTRIBUCION MUNICIP; Martin G.J., 1995, ETHNOBOTANY METHODS; Martinez-Balleste A, 2006, ECOL SOC, V11; Medin DL, 1999, FOLKBIOLOGY, P1; Messer E., 1978, ZAPOTEC PLANT KNOWLE; Nahmad Salomon., 2014, VISION ACTORES SOCIA; Nazarea V, 1998, HUM ORGAN, V57, P159, DOI 10.17730/humo.57.2.n8844vw5085w71x7; Nesheim I, 2006, HUM ECOL, V34, P99, DOI 10.1007/s10745-005-9004-y; Nguyen MLT, 2003, ECON BOT, V57, P472, DOI 10.1663/0013-0001(2003)057[0472:COFPKB]2.0.CO;2; Norton JB, 1998, J ARID ENVIRON, V39, P331, DOI 10.1006/jare.1998.0397; Ohmagari K, 1997, HUM ECOL, V25, P197, DOI 10.1023/A:1021922105740; Pelto P., 1975, AM ETHNOL, V2, P1, DOI DOI 10.1525/AE.1975.2.1.02A00010; Peterson Royce A, 1975, PRESTIGIO AFILIACION; Pickett V, 1967, HDB MIDDLE AM INDIAN; Pickett V. and collaborators, 1988, VOCABULARIO ZAPOTECO; Reko B., 1945, MITOBOTANICA ZAPOTEC; Ross N, 2002, HUM ORGAN, V61, P125, DOI 10.17730/humo.61.2.9bhqghxvpfh2qebc; Ross N, 2002, LACANDON MAYA INTERG, P585; Saynes-Vasquez A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-40; Saynes-Vazquez FE, 2002, THESIS U ARIZONA; Shenton J, 2011, ETHOS, V39, P349, DOI 10.1111/j.1548-1352.2011.01197.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Thompson RA, 1974, WINDS TOMORROW SOCIA; Toledo A, 1995, GEOPOLITICA DESARROL; Trejo I, 2002, BIODIVERS CONSERV, V11, P2063, DOI 10.1023/A:1020876316013; Turner NJ, 2000, ECOL APPL, V10, P1275, DOI 10.1890/1051-0761(2000)010[1275:TEKAWO]2.0.CO;2; Tylor E.B., 1871, PRIMITIVE CULTURE RE, V6th ed.; Valdes Luz Maria, 1995, INDIOS CENSOS POBLAC; Vandebroek I, 2004, SOC SCI MED, V59, P837, DOI 10.1016/j.socscimed.2003.11.030; Voeks RA, 2004, ECON BOT, V58, pS294, DOI 10.1663/0013-0001(2004)58[S294:FTFAMP]2.0.CO;2; VSSsquez Donato Acuca, 2001, CUADERNOS ANO, V7, P21; Weller S C, 1993, Med Anthropol, V15, P109; Wester Lyndon, 1995, Journal of Ethnobiology, V15, P71; Whitecotton J.W., 1977, ZAPOTECS PRINCES PRI; Yates S, 2004, ECON BOT, V58, P72, DOI 10.1663/0013-0001(2004)058[0072:EKOBAM]2.0.CO;2; Zarger RK, 2004, CURR ANTHROPOL, V45, P413, DOI 10.1086/420908; Zent S, 2001, BIOCULTURAL DIVERSIT, P90; Zent S., 1999, ETHNOECOLOGY KNOWLED, P90	82	17	17	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151693	10.1371/journal.pone.0151693	http://dx.doi.org/10.1371/journal.pone.0151693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26986077	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300113
J	Tapio, I; Shingfield, KJ; McKain, N; Bonin, A; Fischer, D; Bayat, AR; Vilkki, J; Taberlet, P; Snelling, TJ; Wallace, RJ				Tapio, Ilma; Shingfield, Kevin J.; McKain, Nest; Bonin, Aurelie; Fischer, Daniel; Bayat, Ali R.; Vilkki, Johanna; Taberlet, Pierre; Snelling, Timothy J.; Wallace, R. John			Oral Samples as Non-Invasive Proxies for Assessing the Composition of the Rumen Microbial Community	PLOS ONE			English	Article							RESIDUAL FEED-INTAKE; METHANOGENIC ARCHAEA; METHANE EMISSIONS; ANAEROBIC FUNGI; DIVERSITY; BACTERIAL; DIGESTA; DISCOVERY; BREAKDOWN; MARKERS	Microbial community analysis was carried out on ruminal digesta obtained directly via rumen fistula and buccal fluid, regurgitated digesta (bolus) and faeces of dairy cattle to assess if non-invasive samples could be used as proxies for ruminal digesta. Samples were collected from five cows receiving grass silage based diets containing no additional lipid or four different lipid supplements in a 5 x 5 Latin square design. Extracted DNA was analysed by qPCR and by sequencing 16S and 18S rRNA genes or the fungal ITS1 amplicons. Faeces contained few protozoa, and bacterial, fungal and archaeal communities were substantially different to ruminal digesta. Buccal and bolus samples gave much more similar profiles to ruminal digesta, although fewer archaea were detected in buccal and bolus samples. Bolus samples overall were most similar to ruminal samples. The differences between both buccal and bolus samples and ruminal digesta were consistent across all treatments. It can be concluded that either proxy sample type could be used as a predictor of the rumen microbial community, thereby enabling more convenient large-scale animal sampling for phenotyping and possible use in future animal breeding programs aimed at selecting cattle with a lower environmental footprint.	[Tapio, Ilma; Shingfield, Kevin J.; Fischer, Daniel; Bayat, Ali R.; Vilkki, Johanna] Nat Resources Inst Finland, Green Technol, Jokioinen, Finland; [McKain, Nest; Snelling, Timothy J.; Wallace, R. John] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Bonin, Aurelie; Taberlet, Pierre] CNRS, Lab Ecol Alpine, Grenoble, France; [Shingfield, Kevin J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Dyfed, Wales	Natural Resources Institute Finland (Luke); University of Aberdeen; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Wallace, RJ (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	john.wallace@abdn.ac.uk	Fischer, Daniel/C-8791-2017; Bayat, Ali-Reza/O-5769-2016	Fischer, Daniel/0000-0002-7513-683X; Bayat, Ali-Reza/0000-0002-4894-0662; /0000-0002-8952-8826; Tapio, Ilma/0000-0002-0752-9551; Bonin, Aurelie/0000-0001-7800-8609	European Commission [289319]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission 289319.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Duffield T, 2004, J DAIRY SCI, V87, P59, DOI 10.3168/jds.S0022-0302(04)73142-2; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farthing MJG, 2006, NAT CLIN PRACT GASTR, V3, P436, DOI 10.1038/ncpgasthep0557; Franzolin R, 2012, MICROB ECOL, V64, P131, DOI 10.1007/s00248-012-0007-0; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Fuller Z, 2007, BRIT J NUTR, V98, P364, DOI 10.1017/S0007114507709091; Gill FL, 2010, ORG GEOCHEM, V41, P467, DOI 10.1016/j.orggeochem.2010.02.001; Gruninger RJ, 2014, FEMS MICROBIOL ECOL, V90, P1, DOI 10.1111/1574-6941.12383; Hegarty RS, 2007, J ANIM SCI, V85, P1479, DOI 10.2527/jas.2006-236; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hook SE, 2009, APPL ENVIRON MICROB, V75, P374, DOI 10.1128/AEM.01672-08; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; KENNEDY PM, 1985, AUST J AGR RES, V36, P819, DOI 10.1071/AR9850819; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Khejornsart P, 2010, J ANIM VET ADV, V9, P3062; Kittelmann S, 2015, APPL ENVIRON MICROB, V81, P7470, DOI 10.1128/AEM.02385-15; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Koetschan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091928; Lodge-Ivey SL, 2009, J ANIM SCI, V87, P2333, DOI 10.2527/jas.2008-1472; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; McAllister TA, 2015, J ANIM SCI, V93, P1431, DOI 10.2527/jas.2014-8329; McCartney CA, 2013, ANIMAL, V7, P409, DOI 10.1017/S1751731113000694; McCartney CA, 2013, J DAIRY SCI, V96, P1211, DOI 10.3168/jds.2012-6042; MCLEOD MN, 1988, J ANIM SCI, V66, P992; Michelland RJ, 2009, J APPL MICROBIOL, V107, P1642, DOI 10.1111/j.1365-2672.2009.04346.x; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Odongo NE, 2007, J DAIRY SCI, V90, P1851, DOI 10.3168/jds.2006-541; Pfeffer E, 2005, NITROGEN AND PHOSPHORUS NUTRITION OF CATTLE: REDUCING THE ENVIRONMENTAL IMPACT OF CATTLE OPERATIONS, P1, DOI 10.1079/9780851990132.0001; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; Robinson D L, 2014, J Anim Sci, V92, P4349, DOI 10.2527/jas.2014-8042; Rochfort S, 2008, PHYTOCHEMISTRY, V69, P299, DOI 10.1016/j.phytochem.2007.08.017; Roehe R, BMC GENOMIC IN PRESS; Romero-Perez GA, 2011, APPL ENVIRON MICROB, V77, P258, DOI 10.1128/AEM.01289-09; Seedorf H, 2014, PEERJ, V2, DOI 10.7717/peerj.494; Shen JS, 2012, J DAIRY SCI, V95, P5978, DOI 10.3168/jds.2012-5499; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tap J, 2009, MICROB ECOL, V57, P580; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Wallace RJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05892; Williams A.G., 1997, RUMEN MICROBIAL ECOS, P73, DOI DOI 10.1007/978-94-009-1453-7_3; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	58	47	49	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151220	10.1371/journal.pone.0151220	http://dx.doi.org/10.1371/journal.pone.0151220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986467	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300055
J	Guerriero, EN; Smith, PM; Stergiou-Kita, M; Colantonio, A				Guerriero, E. Niki; Smith, Peter M.; Stergiou-Kita, Mary; Colantonio, Angela			Rehabilitation Utilization following a Work-Related Traumatic Brain Injury: A Sex-Based Examination of Workers' Compensation Claims in Victoria, Australia	PLOS ONE			English	Article							SERVICE UTILIZATION; HEALTH-CARE; GENDER-DIFFERENCES; MEDICAL-CARE; EPIDEMIOLOGY; DISABILITY; POPULATION; BEHAVIOR; OUTCOMES; TBI	Objectives To report on and examine differences in the use of four types of rehabilitation services (occupational therapy, physiotherapy, psychology, and speech therapy) by men and women following a work-related traumatic brain injury in Victoria, Australia; and to examine the importance of demographic, need, work-related and geographic factors in explaining these differences. Methods A retrospective cohort design was used to analyze 1786 work-related traumatic brain injury workers' compensation claims lodged between 2004 and 2012 in Victoria, Australia. ZINB regressions were conducted for each type of rehabilitation service to examine the relationship between sex and rehabilitation use. Covariates included demographic, need-related, work-related, and geographic factors. Results Out of all claims (63% male, 37% female), 13% used occupational therapy, 23% used physiotherapy, 9% used psychology, and 2% used speech therapy at least once during the first year of service utilization. After controlling for demographic, need-related, work-related, and geographic factors, women were more likely to use physiotherapy compared to men. Men and women were equally likely to use occupational therapy and psychology services. The number of visits in the first year for each type of service did not differ between male and female users. Conclusions Our findings support a sex-based approach to studying rehabilitation utilization in work-related populations. Future research is needed to examine other factors associated with rehabilitation utilization and to determine the implications of different rehabilitation utilization patterns on health and return-to-work outcomes.	[Guerriero, E. Niki; Stergiou-Kita, Mary; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Smith, Peter M.] Inst Work & Hlth, Toronto, ON, Canada; [Smith, Peter M.; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Smith, Peter M.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Stergiou-Kita, Mary; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Stergiou-Kita, Mary; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada	University of Toronto; Institute for Work & Health; University of Toronto; Monash University; University of Toronto; University of Toronto; University Health Network Toronto; Toronto Rehabilitation Institute	Guerriero, EN (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada.	eileennicolina@gmail.com	Smith, Peter/AAE-4293-2021	Smith, Peter/0000-0001-8286-4563; Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health Research [494372]; Research Chair in Gender, Work, & Health from the Canadian Institutes of Health Research [201210CGW]; Transport Accident Commission (TAC); WorkSafe Victoria (WSV); Monash University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Chair in Gender, Work, & Health from the Canadian Institutes of Health Research; Transport Accident Commission (TAC); WorkSafe Victoria (WSV); Monash University(Monash University)	This study, including support for ENG and AC, was funded by the Canadian Institutes of Health Research (#494372). PMS is supported by a Research Chair in Gender, Work, & Health from the Canadian Institutes of Health Research (#201210CGW). The Canadian Institutes of Health Research had no involvement in the study design; collection, analysis, and interpretation of the data; writing of the manuscript; and decision to submit the paper for publication. For more information about the Canadian Institutes of Health Research, go to http://www.cihr-irsc.gc.ca. Data for the analysis conducted uses unit record data from the Compensation Research Database (CRD), which was initiated and funded by the Transport Accident Commission (TAC), WorkSafe Victoria (WSV), and Monash University, and is managed by the Institute for Safety, Compensation, and Recovery Research (ISCRR). The findings and views reported in this paper, however, are those of the authors and should not be attributed to TAC, WSV, or ISCRR. For more information about ISCRR, go to http://www.iscrr.com.au.; The authors would like to thank the staff at the Institute for Safety, Compensation, and Recovery Research for data extraction, and Amber Bielecky for her assistance with SAS programming. Peter M. Smith and Angela Colantonio are both supported by a Research Chair in Gender, Work & Health from the Canadian Institutes of Health Research.	ABS (Australian Bureau of Statistics), 2006, AUSTR NZ STAND IND C; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Australian Bureau of Statistics, 2006, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA, V5; Australian Bureau of Statistics, 2005, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2011, SOCIO EC INDEXES ARE; Australian Safety and Compensation Council, 2008, TYP OCC CLASS SYST, VCanberra: 3rd ed, Revision 1 ed; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Borkhoff CM, 2008, CAN MED ASSOC J, V178, P681, DOI 10.1503/cmaj.071168; Brasure M., 2012, AHRQ PUBLICATION, V12-EHC101-EF; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Collie A, 2013, INJURY, V44, P1514, DOI 10.1016/j.injury.2013.03.006; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Foster M, 2000, BRAIN INJURY, V14, P1035; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Keene J, 2005, J PUBLIC HEALTH-UK, V27, P74, DOI 10.1093/pubmed/fdh208; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS295, DOI 10.1016/j.apmr.2013.08.296; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Menard MR, 1996, J OCCUP ENVIRON MED, V38, P1161, DOI 10.1097/00043764-199611000-00017; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Ruseckaite R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002396; Siqueira FV, 2005, REV SAUDE PUBL, V39, P663, DOI 10.1590/S0034-89102005000400022; The Victorian Neurotrauma Initiative, 2009, EC COST SPIN CORD IN; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327	34	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151462	10.1371/journal.pone.0151462	http://dx.doi.org/10.1371/journal.pone.0151462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982491	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900086
J	Pandey, S; Sharma, A; Tripathi, D; Kumar, A; Khubaib, M; Bhuwan, M; Chaudhuri, TK; Hasnain, SE; Ehtesham, NZ				Pandey, Saurabh; Sharma, Ashish; Tripathi, Deeksha; Kumar, Ashutosh; Khubaib, Mohd; Bhuwan, Manish; Chaudhuri, Tapan Kumar; Hasnain, Seyed Ehtesham; Ehtesham, Nasreen Zafar			Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Also Exhibit Chaperone like Activity In-Vitro and In-Vivo	PLOS ONE			English	Article							CIS-TRANS-ISOMERASES; HEAT-SHOCK-PROTEIN; HYDROPHOBIC SURFACES; ALPHA-CRYSTALLIN; HUMAN RESISTIN; CYCLOPHILIN-A; MACROPHAGES; CELLS; DISEASE; ROLES	Peptidyl-prolyl cis-trans isomerases (Ppiases), also known as cyclophilins, are ubiquitously expressed enzymes that assist in protein folding by isomerization of peptide bonds preceding prolyl residues. Mycobacterium tuberculosis (M.tb) is known to possess two Ppiases, PpiA and PpiB. However, our understanding about the biological significance of mycobacterial Ppiases with respect to their pleiotropic roles in responding to stress conditions inside the macrophages is restricted. This study describes chaperone-like activity of mycobacterial Ppiases. We show that recombinant rPpiA and rPpiB can bind to non-native proteins in vitro and can prevent their aggregation. Purified rPpiA and rPpiB exist in oligomeric form as evident from gel filtration chromatography. E. coli cells overexpressing PpiA and PpiB of M.tb could survive thermal stress as compared to plasmid vector control. HEK293T cells transiently expressing M.tb PpiA and PpiB proteins show increased survival as compared to control cells in response to oxidative stress and hypoxic conditions generated after treatment with H2O2 and CoCl2 thereby pointing to their likely role in adaption under host generated oxidative stress and conditions of hypoxia. The chaperone-like function of these M. tuberculosis cyclophilins may possibly function as a stress responder and consequently contribute to virulence.	[Pandey, Saurabh; Khubaib, Mohd; Bhuwan, Manish; Ehtesham, Nasreen Zafar] Natl Inst Pathol, Inflammat Biol & Cell Signaling Lab, New Delhi, India; [Pandey, Saurabh; Khubaib, Mohd; Hasnain, Seyed Ehtesham] Dr Reddys Inst Life Sci, Univ Hyderabad Campus,Prof CR Rao Rd, Hyderabad, Andhra Pradesh, India; [Sharma, Ashish; Tripathi, Deeksha; Kumar, Ashutosh; Hasnain, Seyed Ehtesham] Indian Inst Technol, Kusuma Sch Biol Sci, Mol Infect & Funct Biol Lab, New Delhi, India; [Chaudhuri, Tapan Kumar] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Ehtesham, NZ (corresponding author), Natl Inst Pathol, Inflammat Biol & Cell Signaling Lab, New Delhi, India.; Hasnain, SE (corresponding author), Dr Reddys Inst Life Sci, Univ Hyderabad Campus,Prof CR Rao Rd, Hyderabad, Andhra Pradesh, India.; Hasnain, SE (corresponding author), Indian Inst Technol, Kusuma Sch Biol Sci, Mol Infect & Funct Biol Lab, New Delhi, India.	seyedhasnain@gmail.com; nzehtesham@gmail.com	ALAM, ANWAR/AAI-3963-2020; EHTESHAM, NASREEN ZAFAR/AAI-3169-2020; Pandey, Saurabh/I-3460-2019; Kumar, Ashutosh/HDN-1519-2022	Kumar, Ashutosh/0000-0002-1699-2951; Pandey, Saurabh/0000-0002-5339-095X; Hasnain, Seyed/0000-0002-2967-0791; Tripathi, Deeksha/0000-0001-7059-5159	UGC/CSIR/ICMR, Government of India (GoI); Department of Biotechnology, GoI, India; Centre of Excellence Grant from the Department of Biotechnology, Ministry of Science and Technology, GoI [BT/PR12817/COE/34/23/2015]	UGC/CSIR/ICMR, Government of India (GoI); Department of Biotechnology, GoI, India; Centre of Excellence Grant from the Department of Biotechnology, Ministry of Science and Technology, GoI	SP, MK, AS and MB thank the UGC/CSIR/ICMR, Government of India (GoI) for the award of Research Fellowship. DT is a recipient of Research Associateship from Department of Biotechnology, GoI, India. This research was supported by Centre of Excellence Grant to SEH and NZE from the Department of Biotechnology, Ministry of Science and Technology, GoI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Ashok Kumar Patel for his help in protein oligomerization study. SP, MK, AS and MB thank the UGC/CSIR/ICMR, Government of India (GoI) for the award of Research Fellowship. DT is a recipient of Research Associateship from Department of Biotechnology, GoI, India. This research was supported by Centre of Excellence Grant (BT/PR12817/COE/34/23/2015) to SEH and NZE from the Department of Biotechnology, Ministry of Science and Technology, GoI.	[Anonymous], 2015, WHO TB REPORT GLOBAL; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banerjee S, 2004, P NATL ACAD SCI USA, V101, P12652, DOI 10.1073/pnas.0404347101; Banerjee S, 2007, J BACTERIOL, V189, P4046, DOI 10.1128/JB.00026-07; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Bhaduri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088090; Bhuwan M, 2016, MBIO IN PRESS; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127668; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Goyal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115877; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Henderson B, 2010, HEAT SHOCK PROTEINS, V4, P185, DOI 10.1007/978-90-481-2976-8_10; Henriksson LM, 2004, EUR J BIOCHEM, V271, P4107, DOI 10.1111/j.1432-1033.2004.04348.x; Huang DD, 2016, J MICROBIOL IMMUNOL, V49, P859, DOI 10.1016/j.jmii.2014.11.008; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Krishnan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085427; Kromina KA, 2008, BIOCHEM MOSC SUPPL S, V2, P195, DOI 10.1134/S199074780803001X; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P62, DOI 10.1038/nri3604; LILIE H, 1993, PROTEIN SCI, V2, P1490, DOI 10.1002/pro.5560020913; Lin CH, 2015, EXP BIOL MED, V240, P403, DOI 10.1177/1535370215570829; Liu TZ, 2014, BIOCHEM BIOPH RES CO, V452, P468, DOI 10.1016/j.bbrc.2014.08.089; Lu KP, 1996, NATURE, V380, P544; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Mark PJ, 2001, CELL STRESS CHAPERON, V6, P59, DOI 10.1379/1466-1268(2001)006<0059:HCIAHS>2.0.CO;2; Mukhopadhyay S, 2007, CURR SIGNAL TRANSD T, V2, P121, DOI 10.2174/157436207780619536; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Ow WB, 2001, PROTEIN SCI, V10, P2346, DOI 10.1110/ps.23301; Paul S, 2008, J APPL MICROBIOL, V104, P35, DOI 10.1111/j.1365-2672.2007.03519.x; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Restelli M, 2014, HUM MOL GENET, V23, P3830, DOI 10.1093/hmg/ddu096; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shukla S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004471; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Stebbins CE, 2005, CELL MICROBIOL, V7, P1227, DOI 10.1111/j.1462-5822.2005.00564.x; Suragani M, 2013, P NATL ACAD SCI USA, V110, P20467, DOI 10.1073/pnas.1306145110; Sydenham M, 2000, INFECT IMMUN, V68, P1109, DOI 10.1128/IAI.68.3.1109-1115.2000; SYKES K, 1993, P NATL ACAD SCI USA, V90, P5853, DOI 10.1073/pnas.90.12.5853; Thapar R, 2015, BIOMOLECULES, V5, P974, DOI 10.3390/biom5020974; Triantafyllou A, 2006, FREE RADICAL RES, V40, P847, DOI 10.1080/10715760600730810; Tsurubuchi T, 2014, CHILD NERV SYST, V30, P1343, DOI 10.1007/s00381-014-2428-1; Tundup S, 2014, FEBS OPEN BIO, V4, P822, DOI 10.1016/j.fob.2014.09.001; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Wijeratne SSK, 2005, J AGR FOOD CHEM, V53, P8768, DOI 10.1021/jf0512003; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Yang HM, 1999, PROTEIN SCI, V8, P174; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; Yao QZ, 2005, WORLD J SURG, V29, P276, DOI 10.1007/s00268-004-7812-7; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	67	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150288	10.1371/journal.pone.0150288	http://dx.doi.org/10.1371/journal.pone.0150288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981873	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900032
J	Pilczynska, J; Cocito, S; Boavida, J; Serrao, E; Queiroga, H				Pilczynska, Joanna; Cocito, Silvia; Boavida, Joana; Serrao, Ester; Queiroga, Henrique			Genetic Diversity and Local Connectivity in the Mediterranean Red Gorgonian Coral after Mass Mortality Events	PLOS ONE			English	Article							PARAMURICEA-CLAVATA; LARVAL DISPERSAL; POPULATION-STRUCTURE; COMPUTER-PROGRAM; LIFE-HISTORY; LIGURIAN SEA; RECOVERY; SOFTWARE; RUBRUM; EVOLUTIONARY	Estimating the patterns of connectivity in marine taxa with planktonic dispersive stages is a challenging but crucial task because of its conservation implications. The red gorgonian Paramuricea clavata is a habitat forming species, characterized by short larval dispersal and high reproductive output, but low recruitment. In the recent past, the species was impacted by mass mortality events caused by increased water temperatures in summer. In the present study, we used 9 microsatellites to investigate the genetic structure and connectivity in the highly threatened populations from the Ligurian Sea (NW Mediterranean). No evidence for a recent bottleneck neither decreased genetic diversity in sites impacted by mass mortality events were found. Significant IBD pattern and high global F-ST confirmed low larval dispersal capability in the red gorgonian. The maximum dispersal distance was estimated at 20-60 km. Larval exchange between sites separated by hundreds of meters and between different depths was detected at each site, supporting the hypothesis that deeper subpopulations unaffected by surface warming peaks may provide larvae for shallower ones, enabling recovery after climatically induced mortality events.	[Pilczynska, Joanna; Queiroga, Henrique] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Pilczynska, Joanna; Queiroga, Henrique] Univ Aveiro, CESAM Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Pilczynska, Joanna] Univ Pavia, Dept Earth & Environm Sci, Via Palestro 3, I-27100 Pavia, Italy; [Cocito, Silvia] ENEA, Marine Environm Res Ctr, La Spezia, Italy; [Boavida, Joana; Serrao, Ester] Univ Algarve, CCMAR Ctr Ciencias Mar, Faro, Portugal	Universidade de Aveiro; Universidade de Aveiro; University of Pavia; Italian National Agency New Technical Energy & Sustainable Economics Development; Universidade do Algarve	Pilczynska, J (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.; Pilczynska, J (corresponding author), Univ Aveiro, CESAM Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal.; Pilczynska, J (corresponding author), Univ Pavia, Dept Earth & Environm Sci, Via Palestro 3, I-27100 Pavia, Italy.	jpilczynska@ua.pt	Queiroga, Henrique/C-5134-2008; Serrao, Ester A/C-6686-2012; boavida, joana/M-5744-2013	Queiroga, Henrique/0000-0002-2338-0013; Serrao, Ester A/0000-0003-1316-658X; boavida, joana/0000-0001-5265-2498	Erasmus Mundus Marine Ecosystem Health and Conservation (MARES) doctoral program; Fundacao para a Ciencia e Tecnologia (FCT) under the COMPETE program - European Regional Development Fund [PTDC/BIA-BIC/114526/2009]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BIC/114526/2009] Funding Source: FCT	Erasmus Mundus Marine Ecosystem Health and Conservation (MARES) doctoral program; Fundacao para a Ciencia e Tecnologia (FCT) under the COMPETE program - European Regional Development Fund; Fundação para a Ciência e a Tecnologia	JP was supported by a Ph.D. grant from the Erasmus Mundus Marine Ecosystem Health and Conservation (MARES) doctoral program; http://www.mares-eu.org/. This work is a part of the DiverseShores - Testing associations between genetic and community diversity in European rocky shore environments (PTDC/BIA-BIC/114526/2009) research project, funded by the Fundacao para a Ciencia e Tecnologia (FCT) under the COMPETE program supported by the European Regional Development Fund.	Agell G, 2009, CONSERV GENET, V10, P2025, DOI 10.1007/s10592-009-9885-1; Arizmendi-Mejia R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119585; Arnaud-Haond S, 2009, MAR ECOL PROG SER, V390, P129, DOI 10.3354/meps08183; ASTRALDI M, 1992, J GEOPHYS RES-OCEANS, V97, P9531, DOI 10.1029/92JC00114; Aurelle D, 2010, MOL ECOL RESOUR, V10, P751, DOI 10.1111/j.1755-0998.2010.02871.x; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Belkhir K, 2004, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2005, AQUAT CONSERV, V15, P147, DOI 10.1002/aqc.661; Cerrano C, 2008, CHEM ECOL, V24, P73, DOI 10.1080/02757540801979648; Cerrano C, 2009, ECOL STUD-ANAL SYNTH, V206, P295, DOI 10.1007/978-3-540-92704-4_21; Colson I, 2004, MOL ECOL, V13, P2223, DOI 10.1111/j.1365-294X.2004.02245.x; COMA R, 1995, MAR ECOL PROG SER, V117, P185, DOI 10.3354/meps117185; COMA R, 1995, MAR ECOL PROG SER, V117, P173, DOI 10.3354/meps117173; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Costantini F, 2007, MOL ECOL, V16, P5168, DOI 10.1111/j.1365-294X.2007.03579.x; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; Cupido R, 2008, AQUAT CONSERV, V18, P984, DOI 10.1002/aqc.904; Cupido R, 2012, MAR ECOL PROG SER, V469, P25, DOI 10.3354/meps09976; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gutierrez-Rodriguez C, 2004, MOL ECOL, V13, P2211, DOI 10.1111/j.1365-294X.2004.02247.x; Haza AC, 2010, OCEAN DYNAM, V60, P861, DOI 10.1007/s10236-010-0301-7; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Hughes JM, 2007, FRESHWATER BIOL, V52, P616, DOI 10.1111/j.1365-2427.2006.01722.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Ledoux JB, 2010, MOL ECOL, V19, P675, DOI 10.1111/j.1365-294X.2009.04516.x; Ledoux JB, 2014, 2 S MED CONS COR AUT; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2008, INVERTEBR BIOL, V127, P1, DOI 10.1111/j.1744-7410.2007.00109.x; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Magalon H, 2005, MOL ECOL, V14, P1861, DOI 10.1111/j.1365-294X.2005.02430.x; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Maier E, 2005, MAR BIOL, V147, P1109, DOI 10.1007/s00227-005-0013-6; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; Mokhtar-Jamai K, 2013, ECOL EVOL, V3, P1765, DOI 10.1002/ece3.588; NCSS LLC, 2015, POWER ANAL SAMPLE SI; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; OZTURK B, 2004, MARINE ED SERIES, V10; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palumbi SR, 2003, ECOL APPL, V13, pS146; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Peirano A, 2009, P 1 MED S COR OTH CA, P233; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Pujolar JM, 2011, CONSERV GENET, V12, P813, DOI 10.1007/s10592-011-0188-y; Pujolar JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023822; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Romano JC, 2000, CR ACAD SCI III-VIE, V323, P415, DOI 10.1016/S0764-4469(00)00141-4; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santangelo G, 2015, HYDROBIOLOGIA, P1; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	73	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150590	10.1371/journal.pone.0150590	http://dx.doi.org/10.1371/journal.pone.0150590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982334	Green Submitted, gold, Green Published			2022-12-26	WOS:000372574900045
J	Schmid, T; Blees, JS; Bajer, MM; Wild, J; Pescatori, L; Crucitti, GC; Scipione, L; Costi, R; Henrich, CJ; Brune, B; Colburn, NH; Di Santo, R				Schmid, Tobias; Blees, Johanna S.; Bajer, Magdalena M.; Wild, Janine; Pescatori, Luca; Crucitti, Giuliana Cuzzucoli; Scipione, Luigi; Costi, Roberta; Henrich, Curtis J.; Bruene, Bernhard; Colburn, Nancy H.; Di Santo, Roberto			Diaryl Disulfides as Novel Stabilizers of Tumor Suppressor Pdcd4	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TRANSLATION INHIBITOR; CELL-DEATH-4; DEGRADATION; EXPRESSION; PROTEIN; TRANSCRIPTION; INFLAMMATION; APOPTOSIS; OXIDATION	The translation inhibitor and tumor suppressor Pdcd4 was reported to be lost in various tumors and put forward as prognostic marker in tumorigenesis. Decreased Pdcd4 protein stability due to PI3K-mTOR-p70(S6K1) dependent phosphorylation of Pdcd4 followed by beta-TrCP1-mediated ubiquitination, and proteasomal destruction of the protein was characterized as a major mechanism contributing to the loss of Pdcd4 expression in tumors. In an attempt to identify stabilizers of Pdcd4, we used a luciferase-based high-throughput compatible cellular assay to monitor phosphorylation-dependent proteasomal degradation of Pdcd4 in response to mitogen stimulation. Following a screen of approximately 2000 compounds, we identified 1,2-bis(4-chlorophenyl)disulfide as a novel Pdcd4 stabilizer. To determine an initial structure-activity relationship, we used 3 additional compounds, synthesized according to previous reports, and 2 commercially available compounds for further testing, in which either the linker between the aryls was modified (compounds 2-4) or the chlorine residues were replaced by groups with different electronic properties (compounds 5 and 6). We observed that those compounds with alterations in the sulfide linker completely lost the Pdcd4 stabilizing potential. In contrast, modifications in the chlorine residues showed only minor effects on the Pdcd4 stabilizing activity. A reporter with a mutated phospho-degron verified the specificity of the compounds for stabilizing the Pdcd4 reporter. Interestingly, the active diaryl disulfides inhibited proliferation and viability at concentrations where they stabilized Pdcd4, suggesting that Pdcd4 stabilization might contribute to the anti-proliferative properties. Finally, computational modelling indicated that the flexibility of the disulfide linker might be necessary to exert the biological functions of the compounds, as the inactive compound appeared to be energetically more restricted.	[Schmid, Tobias; Blees, Johanna S.; Bajer, Magdalena M.; Wild, Janine; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60590 Frankfurt, Germany; [Pescatori, Luca; Crucitti, Giuliana Cuzzucoli; Scipione, Luigi; Costi, Roberta; Di Santo, Roberto] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, Ist Pasteur, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Henrich, Curtis J.] NCI, Mol Targets Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Henrich, Curtis J.] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Colburn, Nancy H.] NCI, Lab Canc Prevent, Ctr Canc Res, Frederick, MD 21702 USA	Goethe University Frankfurt; Fondazione Cenci Bolognetti; Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schmid, T (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60590 Frankfurt, Germany.	T.Schmid@biochem.uni-frankfurt.de	Pescatori, Luca/H-5917-2016; Scipione, Luigi/AAG-8097-2019	Pescatori, Luca/0000-0003-4734-7856; Scipione, Luigi/0000-0002-2006-7005; Di Santo, Roberto/0000-0002-4279-7666; Schmid, Tobias/0000-0002-1952-5259	DFG [GRK1172, SCHM2663/3]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Leidos Biomedical Research, Inc.	DFG(German Research Foundation (DFG)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health; Leidos Biomedical Research, Inc.	This work was supported by the DFG (GRK1172 (MMB) and SCHM2663/3 (TS)). This research was further supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project was also funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Furthermore, Leidos Biomedical Research, Inc., a contractor to the National Cancer Institute, provided support in the form of salaries for one author [CJH]. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Bajer MM, 2014, BIOCHEM PHARMACOL, V88, P313, DOI 10.1016/j.bcp.2014.01.034; Blees JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046567; Blees JS, 2010, J BIOMOL SCREEN, V15, P21, DOI 10.1177/1087057109351028; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Ruano JLG, 2008, GREEN CHEM, V10, P706, DOI 10.1039/b800705e; Gilbert AM, 2006, J MED CHEM, V49, P6027, DOI 10.1021/jm060499t; Grkovic T, 2011, J NAT PROD, V74, P1015, DOI 10.1021/np100918z; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Oba M, 2011, J ORG CHEM, V76, P4173, DOI 10.1021/jo200496r; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; van den Nieuwendijk AMCH, 2004, J MED CHEM, V47, P663, DOI 10.1021/jm030863d; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; White K, 2014, HYPERTENSION, V64, P185, DOI 10.1161/HYPERTENSIONAHA.113.03037; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhao LX, 2011, J NAT PROD, V74, P1990, DOI 10.1021/np200603g	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151643	10.1371/journal.pone.0151643	http://dx.doi.org/10.1371/journal.pone.0151643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982744	gold, Green Published			2022-12-26	WOS:000372574900108
J	Bender, AC; Luikart, BW; Lenck-Santini, PP				Bender, Alex C.; Luikart, Bryan W.; Lenck-Santini, Pierre-Pascal			Cognitive Deficits Associated with Na(v)1.1 Alterations: Involvement of Neuronal Firing Dynamics and Oscillations	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; HIPPOCAMPAL THETA-RHYTHM; REDUCED SODIUM CURRENT; SEPTUM-DIAGONAL BAND; MEDIAL SEPTUM; DRAVET-SYNDROME; MOUSE MODEL; SPATIAL MEMORY; SENSORIMOTOR INTEGRATION; REVERSIBLE INACTIVATION	Brain oscillations play a critical role in information processing and may, therefore, be essential to uncovering the mechanisms of cognitive impairment in neurological disease. In Dravet syndrome (DS), a mutation in SCN1A, coding for the voltage-gated sodium channel Na(v)1.1, is associated with severe cognitive impairment and seizures. While seizure frequency and severity do not correlate with the extent of impairment, the slowing of brain rhythms may be involved. Here we investigate the role of Na(v)1.1 on brain rhythms and cognition using RNA interference. We demonstrate that knockdown of Na(v)1.1 impairs fast-and burst-firing properties of neurons in the medial septum in vivo. The proportion of neurons that fired phase-locked to hippocampal theta oscillations was reduced, and medial septal regulation of theta rhythm was disrupted. During a working memory task, this deficit was characterized by a decrease in theta frequency and was negatively correlated with performance. These findings suggest a fundamental role for Na(v)1.1 in facilitating fast-firing properties in neurons, highlight the importance of precise temporal control of theta frequency for working memory, and imply that Na(v)1.1 deficits may disrupt information processing in DS via a dysregulation of brain rhythms.	[Bender, Alex C.] Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA; [Luikart, Bryan W.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA; [Lenck-Santini, Pierre-Pascal] Univ Vermont, Dept Neurol Sci, Burlington, VT USA; [Lenck-Santini, Pierre-Pascal] INSERM, Inst Neurobiol Mediterranee, F-13258 Marseille, France	Dartmouth College; Dartmouth College; University of Vermont; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lenck-Santini, PP (corresponding author), Univ Vermont, Dept Neurol Sci, Burlington, VT USA.; Lenck-Santini, PP (corresponding author), INSERM, Inst Neurobiol Mediterranee, F-13258 Marseille, France.	pierre-pascal.lenck-santini@inserm.fr	lenck-santini, pierre-pascal/N-3662-2016	lenck-santini, pierre-pascal/0000-0001-9925-9220; Luikart, Bryan/0000-0002-3181-6075	National Institutes of Health [F31NS077537, R01MH097949, R01NS076763]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077537, R01NS076763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health to ACB (F31NS077537), BWL (R01MH097949), and PPLS (R01NS076763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hangya B, 2009, J NEUROSCI, V29, P8094, DOI 10.1523/JNEUROSCI.5665-08.2009; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bender AC, 2013, NEUROBIOL DIS, V54, P297, DOI 10.1016/j.nbd.2012.12.021; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; BLAND BH, 1993, PROG NEUROBIOL, V41, P157, DOI 10.1016/0301-0082(93)90007-F; Bland BH, 1999, J NEUROSCI, V19, P3223; Buard I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00742; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Caplan JB, 2003, J NEUROSCI, V23, P4726; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Colom LV, 2005, SYNAPSE, V58, P151, DOI 10.1002/syn.20184; Doesburg SM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00785; Dravet C, 2006, ADV NEUROL, P89; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; Dwyer TA, 2007, J NEUROSCI, V27, P299, DOI 10.1523/JNEUROSCI.4189-06.2007; Fisher NI, 1995, STAT ANAL CIRCULAR D; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Genton P, 2011, EPILEPSIA, V52, P44, DOI 10.1111/j.1528-1167.2011.03001.x; GIVENS B, 1994, J NEUROSCI, V14, P3578; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Gupta AS, 2012, NAT NEUROSCI, V15, P1032, DOI 10.1038/nn.3138; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Harkin LA, 2007, BRAIN, V130, P843, DOI 10.1093/brain/awm002; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Holmes GL, 2012, BRAIN DEV-JPN, V34, P469, DOI 10.1016/j.braindev.2011.08.009; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kalume F, 2007, J NEUROSCI, V27, P11065, DOI 10.1523/JNEUROSCI.2162-07.2007; KELSEY JE, 1993, BEHAV NEUROSCI, V107, P565, DOI 10.1037/0735-7044.107.4.565; King C, 1998, EUR J NEUROSCI, V10, P464, DOI 10.1046/j.1460-9568.1998.00026.x; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Manseau F, 2005, J PHYSIOL-LONDON, V566, P865, DOI 10.1113/jphysiol.2005.089664; Marini C, 2011, EPILEPSIA, V52, P24, DOI 10.1111/j.1528-1167.2011.02997.x; MARKRAM H, 1990, BRAIN RES, V513, P171, DOI 10.1016/0006-8993(90)91106-Q; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Nabbout R, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-176; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331; Ohmori I, 2002, BIOCHEM BIOPH RES CO, V295, P17, DOI 10.1016/S0006-291X(02)00617-4; OHTSUKA Y, 1991, JPN J PSYCHIAT NEUR, V45, P416; Pang KCH, 2011, HIPPOCAMPUS, V21, P835, DOI 10.1002/hipo.20799; Papale LA, 2013, EPILEPSIA, V54, P625, DOI 10.1111/epi.12060; POUCET B, 1994, HIPPOCAMPUS, V4, P315, DOI 10.1002/hipo.450040315; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ragona F, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2011.03000.x; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Richard GR, 2013, HIPPOCAMPUS, V23, P1269, DOI 10.1002/hipo.22164; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Simon AP, 2006, J NEUROSCI, V26, P9038, DOI 10.1523/JNEUROSCI.1401-06.2006; SMYTHE JW, 1991, J NEUROSCI, V11, P2241; Sotty F, 2003, J PHYSIOL-LONDON, V551, P927, DOI 10.1113/jphysiol.2003.046847; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; VERTES RP, 1993, EXP BRAIN RES, V96, P419; Villette V, 2010, J NEUROSCI, V30, P10991, DOI 10.1523/JNEUROSCI.6284-09.2010; Vinogradova O S, 1998, Membr Cell Biol, V11, P715; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Walsh TJ, 1998, BEHAV NEUROSCI, V112, P1114, DOI 10.1037/0735-7044.112.5.1114; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wolff M, 2006, EPILEPSIA, V47, P45, DOI 10.1111/j.1528-1167.2006.00688.x; Womelsdorf T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00210; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	70	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151538	10.1371/journal.pone.0151538	http://dx.doi.org/10.1371/journal.pone.0151538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978272	gold, Green Published, Green Submitted			2022-12-26	WOS:000372572800084
J	Kugler, P				Kuegler, Philipp			Early Afterdepolarizations with Growing Amplitudes via Delayed Subcritical Hopf Bifurcations and Unstable Manifolds of Saddle Foci in Cardiac Action Potential Dynamics	PLOS ONE			English	Article							GENESIS; MODEL; REPOLARIZATION; TRANSIENT; MYOCYTES	Early afterdepolarizations (EADs) are pathological oscillations in cardiac action potentials during the repolarization phase and may be caused by drug side effects, ion channel disease or oxidative stress. The most widely observed EAD pattern is characterized by oscillations with growing amplitudes. So far, its occurence has been explained in terms of a supercritical Hopf bifurcation in the fast subsystem of the action potential dynamics from which stable limit cycles with growing amplitudes emerge. The novel contribution of this article is the introduction of two alternative explanations of EAD genesis with growing amplitudes that do not involve stable limit cycles in fast subsystems. In particular, we demonstrate that EAD patterns with growing amplitudes may alternatively arise due to a delayed subcritical Hopf bifurcation or an unstable manifold of a saddle focus fixed point in the full fast-slow system modelling the action potential. Our work extends the list of possible dynamical EAD mechanisms and may contribute to a classification of drug effects in preclinical cardiotoxicity testing.	[Kuegler, Philipp] Univ Hohenheim, Inst Appl Math & Stat, Schloss 1, D-70599 Stuttgart, Germany; [Kuegler, Philipp] Radon Inst Computat & Appl Math, Res Grp Math Methods Mol & Syst Biol, Altenbergerstr 69, A-4040 Linz, Austria	University Hohenheim	Kugler, P (corresponding author), Univ Hohenheim, Inst Appl Math & Stat, Schloss 1, D-70599 Stuttgart, Germany.; Kugler, P (corresponding author), Radon Inst Computat & Appl Math, Res Grp Math Methods Mol & Syst Biol, Altenbergerstr 69, A-4040 Linz, Austria.	philipp.kuegler@uni-hohenheim.de						Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Engl HW, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123014; Fermini B, 2003, NAT REV DRUG DISCOV, V2, P439, DOI 10.1038/nrd1108; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Karagueuzian HS, 2013, AM J CARDIOVASC DIS, V3, P1; Krogh-Madsen T, 2012, ANNU REV BIOMED ENG, V14, P179, DOI [10.1146/annurev-bioeng-071811-150106, 10.1146/annurev.bioeng-071811-150106]; Kuegler P, 2012, SIAM J APPL MATH, V72, P982, DOI 10.1137/110834780; Kuehn C, 2015, MULTIPLE TIME SCALE, V191; Kuznetsov Y.A., 2013, ELEMENTS APPL BIFURC, V112; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Martin CA, 2012, HEART, V98, P536, DOI 10.1136/heartjnl-2011-300953; MATLAB, 2014, MATLAB VERS 8 3 0 53; NEISHTADT AI, 1987, DIFF EQUAT+, V23, P1385; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Paci M, 2013, ANN BIOMED ENG, V41, P2334, DOI 10.1007/s10439-013-0833-3; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Sato D, 2010, BIOPHYS J, V99, P765, DOI 10.1016/j.bpj.2010.05.019; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Shilnikov A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056214; Shilnikov L. P., 1968, MAT SB, V77, P461, DOI 10.1070/SM1968v006n03ABEH001069; Song Z, 2015, BIOPHYS J, V108, P1908, DOI 10.1016/j.bpj.2015.03.011; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; WANG XJ, 1993, PHYSICA D, V62, P263, DOI 10.1016/0167-2789(93)90286-A; Wisniowska B, 2014, EUROPACE, V16, P724, DOI 10.1093/europace/euu009; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; Xie YF, 2014, BIOPHYS J, V106, P1391, DOI 10.1016/j.bpj.2013.12.050	27	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151178	10.1371/journal.pone.0151178	http://dx.doi.org/10.1371/journal.pone.0151178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977805	Green Submitted, Green Published, gold			2022-12-26	WOS:000372572800049
J	Zhou, K; Motamed, S; Thouas, GA; Bernard, CC; Li, D; Parkington, HC; Coleman, HA; Finkelstein, DI; Forsythe, JS				Zhou, Kun; Motamed, Sepideh; Thouas, George A.; Bernard, Claude C.; Li, Dan; Parkington, Helena C.; Coleman, Harold A.; Finkelstein, David I.; Forsythe, John S.			Graphene Functionalized Scaffolds Reduce the Inflammatory Response and Supports Endogenous Neuroblast Migration when Implanted in the Adult Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; INJURED BRAIN; PEPTIDE; NEURONS; OXIDE; DIFFERENTIATION; CYTOTOXICITY; REGENERATION	Electroactive materials have been investigated as next-generation neuronal tissue engineering scaffolds to enhance neuronal regeneration and functional recovery after brain injury. Graphene, an emerging neuronal scaffold material with charge transfer properties, has shown promising results for neuronal cell survival and differentiation in vitro. In this in vivo work, electrospun microfiber scaffolds coated with self-assembled colloidal graphene, were implanted into the striatum or into the subventricular zone of adult rats. Microglia and astrocyte activation levels were suppressed with graphene functionalization. In addition, self-assembled graphene implants prevented glial scarring in the brain 7 weeks following implantation. Astrocyte guidance within the scaffold and redirection of neuroblasts from the subventricular zone along the implants was also demonstrated. These findings provide new functional evidence for the potential use of graphene scaffolds as a therapeutic platform to support central nervous system regeneration.	[Zhou, Kun; Motamed, Sepideh; Li, Dan; Forsythe, John S.] Monash Univ, Monash Inst Med Engn, Dept Mat Sci & Engn, Melbourne, Vic 3004, Australia; [Zhou, Kun; Bernard, Claude C.] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia; [Parkington, Helena C.; Coleman, Harold A.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Thouas, George A.] Monash Univ, Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Zhou, Kun; Finkelstein, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Monash University; Australian Regenerative Medicine Institute; Monash University; Monash University; Hudson Institute of Medical Research; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Forsythe, JS (corresponding author), Monash Univ, Monash Inst Med Engn, Dept Mat Sci & Engn, Melbourne, Vic 3004, Australia.	john.forsythe@monash.edu	Wang, Huanting/G-8399-2011; Finkelstein, David/B-9617-2009; Li, Dan/B-9316-2008	Wang, Huanting/0000-0002-9887-5555; Finkelstein, David/0000-0002-8167-4917; Li, Dan/0000-0003-3461-5751; Forsythe, John/0000-0003-2849-229X; Bernard, Claude Charles Andre/0000-0003-2816-5328	Australian Research Council [DP0985433, DP140100803]; National Health and Medical Research Council of Australia/CIRM [APP1053621]; Victoria/CIRM Joint Project [RMI-01739]; Department of Industry, Commonwealth of Australia [AISRF06680]; Australian Research Council's Future Fellowships [FT110100341]; Monash Micro Imaging; Monash University Centre for Electron Microscopy	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia/CIRM(National Health and Medical Research Council (NHMRC) of Australia); Victoria/CIRM Joint Project; Department of Industry, Commonwealth of Australia; Australian Research Council's Future Fellowships(Australian Research Council); Monash Micro Imaging; Monash University Centre for Electron Microscopy	This research was supported under Australian Research Council's Discovery Projects funding scheme (DP0985433 & DP140100803). Prof. Claude Bernard is supported by grants from the National Health and Medical Research Council of Australia/CIRM Joint Project (APP1053621), the Victoria/CIRM Joint Project (RMI-01739) and the Department of Industry, Commonwealth of Australia (AISRF06680). Prof. Dan Li was supported under Australian Research Council's Future Fellowships scheme (FT110100341).; The authors wish to thank Monash Micro Imaging and Monash University Centre for Electron Microscopy for providing imaging instrumentation and general support. The authors also like to thank Guizhi Sun for her kind advice in immunostaining and imaging.	Abidian MR, 2012, ADV HEALTHC MATER, V1, P762, DOI 10.1002/adhm.201200182; Baiguera S, 2014, BIOMATERIALS, V35, P1205, DOI 10.1016/j.biomaterials.2013.10.060; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bendali A, 2013, ADV HEALTHC MATER, V2, P929, DOI 10.1002/adhm.201200347; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Chowdhury SM, 2013, BIOMATERIALS, V34, P283, DOI 10.1016/j.biomaterials.2012.09.057; Fang Z, 2006, ACTA NEUROPATHOL, V111, P213, DOI 10.1007/s00401-005-0019-7; Feng ZQ, 2013, POLYMER, V54, P702, DOI 10.1016/j.polymer.2012.10.057; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fon D, 2014, ADV HEALTHC MATER, V3, P761, DOI 10.1002/adhm.201300287; Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; Gerardo-Nava J, 2009, NANOMEDICINE-UK, V4, P11, DOI 10.2217/17435889.4.1.11; Gold SM, 2009, IMMUNOL ALLERGY CLIN, V29, P309, DOI 10.1016/j.iac.2009.02.008; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Hosseinkhani H, 2013, ACS CHEM NEUROSCI, V4, P1229, DOI 10.1021/cn400075h; Hu SH, 2014, ADV FUNCT MATER, V24, P4144, DOI 10.1002/adfm.201400080; Kam NWS, 2009, NANO LETT, V9, P273, DOI 10.1021/nl802859a; Kim SY, 2011, ACS APPL MATER INTER, V3, P16, DOI 10.1021/am1008369; Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Li N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01604; Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707; Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v; Liu Q, 2013, NANO LETT, V13, P2436, DOI 10.1021/nl400368v; Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007; Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062; Mucksch C, 2011, LANGMUIR, V27, P12938, DOI 10.1021/la201972f; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ou LC, 2011, J PHYS CHEM B, V115, P9813, DOI 10.1021/jp201474m; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175; Rong PF, 2014, THERANOSTICS, V4, P229, DOI 10.7150/thno.8070; Shi SX, 2013, BIOMATERIALS, V34, P3002, DOI 10.1016/j.biomaterials.2013.01.047; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song Q, 2014, BIOMATERIALS, V35, P6930, DOI 10.1016/j.biomaterials.2014.05.002; Tang ML, 2013, BIOMATERIALS, V34, P6402, DOI 10.1016/j.biomaterials.2013.05.024; Thevenot P, 2008, CURR TOP MED CHEM, V8, P270; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Wang AX, 2013, J APPL TOXICOL, V33, P1156, DOI 10.1002/jat.2877; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang K, 2012, ADV MATER, V24, P1868, DOI 10.1002/adma.201104964; Zhou K, 2014, NANOMEDICINE-UK, V9, P1239, DOI [10.2217/nnm.13.112, 10.2217/NNM.13.112]; Zhou K, 2012, ACS APPL MATER INTER, V4, P4524, DOI 10.1021/am3007565; Zuidema J, 2015, EXTRACELLULAR MATRIX, P181	53	62	64	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151589	10.1371/journal.pone.0151589	http://dx.doi.org/10.1371/journal.pone.0151589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978268	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800092
J	Hsieh, MC; Tsai, CY; Liao, MC; Yang, JL; Su, CH; Chen, JH				Hsieh, Meng-Chi; Tsai, Ching-Yi; Liao, Min-Chiao; Yang, Jenq-Lin; Su, Chia-Hao; Chen, Jyh-Horng			Quantitative Susceptibility Mapping-Based Microscopy of Magnetic Resonance Venography (QSM-mMRV) for In Vivo Morphologically and Functionally Assessing Cerebromicrovasculature in Rat Stroke Model	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; PHASE-UNWRAPPING ALGORITHM; OXYGEN-SATURATION; BRAIN IMAGES; HIGH-FIELD; SIGNAL BEHAVIOR; ISCHEMIC-STROKE; CONTRAST AGENTS; MRI PHASE; ANGIOGRAPHY	Abnormal cerebral oxygenation and vessel structure is a crucial feature of stroke. An imaging method with structural and functional information is necessary for diagnosis of stroke. This study applies QSM-mMRV (quantitative susceptibility mapping-based microscopic magnetic resonance venography) for noninvasively detecting small cerebral venous vessels in rat stroke model. First, susceptibility mapping is optimized and calculated from magnetic resonance (MR) phase images of a rat brain. Subsequently, QSM-mMRV is used to simultaneously provide information on microvascular architecture and venous oxygen saturation (SvO(2)), both of which can be used to evaluate the physiological and functional characteristics of microvascular changes for longitudinally monitoring and therapeutically evaluating a disease model. Morphologically, the quantification of vessel sizes using QSM-mMRV was 30% smaller than that of susceptibility-weighted imaging (SWI), which eliminated the overestimation of conventional SWI. Functionally, QSM-mMRV estimated an average SvO(2) ranging from 73% to 85% for healthy rats. Finally, we also applied QSM to monitor the revascularization of post-stroke vessels from 3 to 10 days after reperfusion. QSM estimations of SvO(2) were comparable to those calculated using the pulse oximeter standard metric. We conclude that QSM-mMRV is useful for longitudinally monitoring blood oxygen and might become clinically useful for assessing cerebrovascular diseases.	[Hsieh, Meng-Chi; Chen, Jyh-Horng] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 106, Taiwan; [Hsieh, Meng-Chi; Chen, Jyh-Horng] Natl Taiwan Univ, Mol Imaging Ctr, Taipei 106, Taiwan; [Hsieh, Meng-Chi; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Taipei 106, Taiwan; [Tsai, Ching-Yi; Liao, Min-Chiao; Yang, Jenq-Lin; Su, Chia-Hao] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung 833, Taiwan; [Su, Chia-Hao] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University	Chen, JH (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 106, Taiwan.; Chen, JH (corresponding author), Natl Taiwan Univ, Mol Imaging Ctr, Taipei 106, Taiwan.; Chen, JH (corresponding author), Natl Taiwan Univ, Dept Elect Engn, Taipei 106, Taiwan.; Su, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung 833, Taiwan.; Su, CH (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	chiralsu@gmail.com; jhchen@ntu.edu.tw	Tsai, CY/AAV-9723-2021	Tsai, CY/0000-0002-9548-9851; Yang, Jenq-Lin/0000-0002-9897-8087	National Taiwan University under Excellent Research Projects [NTU-ERP-105R891602]; Ministry of Science and Technology [NSC-104-2321-B-002-040, MOST103-2320-B-182A-004MY3, MOST103-2633-B-182A-001-]; National Health Research Institute [NHRI-EX105-10424EI]; Chang Gung Medical Foundation, Taiwan [CMRPG8C1171, CMRPG8C1172, CMRPG8E1461]	National Taiwan University under Excellent Research Projects; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institute(National Health Research Institutes - Taiwan); Chang Gung Medical Foundation, Taiwan	This work was supported by grants from the National Taiwan University under Excellent Research Projects (NTU-ERP-105R891602), the Ministry of Science and Technology (NSC-104-2321-B-002-040 to JHC; MOST103-2320-B-182A-004MY3 and MOST103-2633-B-182A-001- to CHS), the National Health Research Institute (NHRI-EX105-10424EI), and Chang Gung Medical Foundation, Taiwan (CMRPG8C1171, CMRPG8C1172, and CMRPG8E1461 to CHS). The authors have declared that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Bilgic B, 2014, MAGN RESON MED, V72, P1444, DOI 10.1002/mrm.25029; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chen ZK, 2015, J NEUROSCI METH, V241, P85, DOI 10.1016/j.jneumeth.2014.12.014; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Driver ID, 2014, NEUROIMAGE, V101, P458, DOI 10.1016/j.neuroimage.2014.07.050; DUMOULIN CL, 1989, MAGN RESON MED, V9, P139, DOI 10.1002/mrm.1910090117; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fan AP, 2014, MAGN RESON MED, V72, P149, DOI 10.1002/mrm.24918; Fan AP, 2012, MAGN RESON MED, V67, P669, DOI 10.1002/mrm.23050; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; Gursoy Ozdemir Y, 2012, J NEUROCHEM, V123, P2, DOI [10.1111/j.1471-4159.2012.07938.x, DOI 10.1111/J.1471-4159.2012.07938.X]; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Haacke EM, 2011, SUSCEPTIBILITY WEIGH; Hammond KE, 2008, NEUROIMAGE, V39, P1682, DOI 10.1016/j.neuroimage.2007.10.037; HANSEN PC, 1992, SIAM REV, V34, P561, DOI 10.1137/1034115; Hsieh CY, 2015, MAGN RESON IMAGING, V33, P420, DOI 10.1016/j.mri.2015.01.004; Huang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078186; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jiang Q, 2008, SUSCEPTIBILITY WEIGH, P304; Kressler B, 2010, IEEE T MED IMAGING, V29, P273, DOI 10.1109/TMI.2009.2023787; Krishnamurthy LC, 2014, MAGN RESON MED, V71, P978, DOI 10.1002/mrm.24750; Langham MC, 2009, MAGN RESON MED, V62, P333, DOI 10.1002/mrm.21981; Lee J, 2010, NEUROIMAGE, V49, P193, DOI 10.1016/j.neuroimage.2009.07.017; Li DB, 1998, MAGNET RESON MED, V39, P685, DOI 10.1002/mrm.1910390503; Li W, 2014, NMR BIOMED, V27, P219, DOI 10.1002/nbm.3056; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Lin CY, 2009, NEUROIMAGE, V45, P824, DOI 10.1016/j.neuroimage.2008.12.030; Lin VL, 1999, J CEREBR BLOOD F MET, V19, P853, DOI 10.1097/00004647-199908000-00004; Lin WL, 1998, J CEREBR BLOOD F MET, V18, P1018, DOI 10.1097/00004647-199809000-00011; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Liu T, 2012, IEEE T MED IMAGING, V31, P816, DOI 10.1109/TMI.2011.2182523; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Marques JP, 2009, NEUROIMAGE, V46, P345, DOI 10.1016/j.neuroimage.2009.02.023; Miraux S, 2004, MAGN RESON MATER PHY, V17, P348, DOI 10.1007/s10334-004-0064-6; NAPEL S, 1992, RADIOLOGY, V185, P607, DOI 10.1148/radiology.185.2.1410382; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Park SH, 2008, MAGN RESON MED, V59, P855, DOI 10.1002/mrm.21573; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Reese T, 1999, NMR BIOMED, V12, P189, DOI 10.1002/(SICI)1099-1492(199906)12:4<189::AID-NBM557>3.0.CO;2-O; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; SAKAI F, 1985, J CEREBR BLOOD F MET, V5, P207, DOI 10.1038/jcbfm.1985.27; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; Schweser F, 2013, MAGN RESON MED, V69, P1581, DOI 10.1002/mrm.24405; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Sedlacik J, 2007, MAGN RESON MED, V58, P1035, DOI 10.1002/mrm.21283; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; Wang S, 2013, STROKE, V44, P2315, DOI 10.1161/STROKEAHA.113.001638; WEISSKOFF RM, 1992, MAGNET RESON MED, V24, P375, DOI 10.1002/mrm.1910240219; Wharton S, 2010, NEUROIMAGE, V53, P515, DOI 10.1016/j.neuroimage.2010.06.070; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000; Xia S, 2014, MAGN RESON IMAGING, V32, P1272, DOI 10.1016/j.mri.2014.08.012; Xu B, 2014, MAGN RESON MED, V72, P438, DOI 10.1002/mrm.24937; Zhang JW, 2015, MAGN RESON MED, V74, P945, DOI 10.1002/mrm.25463	72	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149602	10.1371/journal.pone.0149602	http://dx.doi.org/10.1371/journal.pone.0149602			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974842	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600013
J	Li, Y; Liu, HZ; Barta, CL; Judge, PD; Zhao, LD; Zhang, WPJ; Gong, SS; Beisel, KW; He, DZZ				Li, Yi; Liu, Huizhan; Barta, Cody L.; Judge, Paul D.; Zhao, Lidong; Zhang, Weiping J.; Gong, Shusheng; Beisel, Kirk W.; He, David Z. Z.			Transcription Factors Expressed in Mouse Cochlear Inner and Outer Hair Cells	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; GENE-EXPRESSION; GENOME-WIDE; IDENTIFICATION; PROTEIN; BCL-2	Regulation of gene expression is essential to determining the functional complexity and morphological diversity seen among different cells. Transcriptional regulation is a crucial step in gene expression regulation because the genetic information is directly read from DNA by sequence-specific transcription factors (TFs). Although several mouse TF data-bases created from genome sequences and transcriptomes are available, a cell type-specific TF database from any normal cell populations is still lacking. We identify cell type-specific TF genes expressed in cochlear inner hair cells (IHCs) and outer hair cells (OHCs) using hair cell-specific transcriptomes from adult mice. IHCs and OHCs are the two types of sensory receptor cells in the mammalian cochlea. We show that 1,563 and 1,616 TF genes are respectively expressed in IHCs and OHCs among 2,230 putative mouse TF genes. While 1,536 are commonly expressed in both populations, 73 genes are differentially expressed (with at least a twofold difference) in IHCs and 13 are differentially expressed in OHCs. Our datasets represent the first cell type-specific TF databases for two populations of sensory receptor cells and are key informational resources for understanding the molecular mechanism underlying the biological properties and phenotypical differences of these cells.	[Li, Yi] Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Li, Yi; Liu, Huizhan; Barta, Cody L.; Zhao, Lidong; Beisel, Kirk W.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Judge, Paul D.] Univ Nebraska Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Omaha, NE 68198 USA; [Zhao, Lidong] Chinese Peoples Liberat Army Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing 100853, Peoples R China; [Zhang, Weiping J.] Second Mil Med Univ, Dept Pathophysiol, Shanghai 200433, Peoples R China; [Gong, Shusheng] Beijing Friendship Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China	Capital Medical University; Creighton University; University of Nebraska System; University of Nebraska Medical Center; Chinese People's Liberation Army General Hospital; Naval Medical University; Capital Medical University	He, DZZ (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	hed@creighton.edu		He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Li (li yi), Yi/0000-0002-9986-6546; Zhao, Lidong/0000-0002-0810-0941	NIH from the NIDCD [R01 DC004696]; Major State Basic Research Development Program of China (973 Program) [2011CB504503]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	NIH from the NIDCD; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work has been supported by NIH grant R01 DC004696 to DZH from the NIDCD. YL and SSG are supported by the Major State Basic Research Development Program of China (973 Program) (no. 2011CB504503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bettuzzi S, 2009, ADV CANCER RES, V104, P59, DOI 10.1016/S0065-230X(09)04005-6; Briegel KJ, 2001, DEV BIOL, V233, P291, DOI 10.1006/dbio.2001.0225; Burns JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048704; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1992, J NEUROSCI, V12, P4575; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Felder E, 1995, HEARING RES, V91, P19, DOI 10.1016/0378-5955(95)00158-1; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gnedeva K, 2015, P NATL ACAD SCI USA, V112, P14066, DOI 10.1073/pnas.1517371112; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; Harding GW, 2004, J ACOUST SOC AM, V115, P2207, DOI 10.1121/1.1689961; He DZZ, 2000, HEARING RES, V145, P156, DOI 10.1016/S0378-5955(00)00084-8; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kopecky BJ, 2012, BRAIN RES, V1484, P1, DOI 10.1016/j.brainres.2012.09.027; Kurima K, NAT GENET, V30, P277; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Locker J., 2001, TRANSCRIPTION FACTOR; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; O'Shea JM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014258; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schimmang T, 2013, HEARING RES, V297, P84, DOI 10.1016/j.heares.2012.11.001; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yang Sienhung, 2012, Evid Based Complement Alternat Med, V2012, P521780, DOI 10.1155/2012/521780; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	58	15	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151291	10.1371/journal.pone.0151291	http://dx.doi.org/10.1371/journal.pone.0151291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974322	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600065
J	Malafoglia, V; Traversetti, L; Del Grosso, F; Scalici, M; Lauro, F; Russo, V; Persichini, T; Salvemini, D; Mollace, V; Fini, M; Raffaeli, W; Muscoli, C; Colasanti, M				Malafoglia, Valentina; Traversetti, Lorenzo; Del Grosso, Floriano; Scalici, Massimiliano; Lauro, Filomena; Russo, Valeria; Persichini, Tiziana; Salvemini, Daniela; Mollace, Vincenzo; Fini, Massimo; Raffaeli, William; Muscoli, Carolina; Colasanti, Marco			Transient Receptor Potential Melastatin-3 (TRPM3) Mediates Nociceptive-Like Responses in Hydra vulgaris	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NEUROPATHIC PAIN; OXIDATIVE STRESS; HEAT-STRESS; PATHWAY; CHANNEL; CLASSIFICATION; HYPERALGESIA; INVOLVEMENT; ACTIVATION	The ability of mammals to feel noxious stimuli lies in a heterogeneous group of primary somatosensory neurons termed nociceptors, which express specific membrane receptors, such as the Transient Receptor Potential (TRP) family. Here, we show that one of the most important nociceptive-like pathways is conserved in the freshwater coelenterate Hydra vulgaris, the most primitive organism possessing a nervous system. In particular, we found that H. vulgaris expresses TRPM3, a nociceptor calcium channel involved in the detection of noxious heat in mammals. Furthermore, we detected that both heat shock and TRPM3 specific agonist (i.e., pregnenolone sulfate) induce the modulation of the heat shock protein 70 (HSP70) and the nitric oxide synthase (NOS), two genes activated by TRP-mediated heat painful stimuli in mammals. As expected, these effects are inhibited by a TRPM3 antagonist (i.e., mefenamic acid). Interestingly, the TRPM3 agonist and heat shock also induce the expression of nuclear transcription erythroid 2-related factor (Nrf2) and superoxide dismutase (SOD), known markers of oxidative stress; noteworthy gene expression was also inhibited by the TRPM3 antagonist. As a whole, our results demonstrate the presence of conserved molecular oxidative/nociceptive-like pathways at the primordial level of the animal kingdom.	[Malafoglia, Valentina; Traversetti, Lorenzo; Del Grosso, Floriano; Scalici, Massimiliano; Russo, Valeria; Persichini, Tiziana; Colasanti, Marco] Univ Roma Tre, Dept Sci, Rome, Italy; [Malafoglia, Valentina; Raffaeli, William] ISAL Fdn, Inst Res Pain, Torre Pedrera, RN, Italy; [Malafoglia, Valentina; Lauro, Filomena; Fini, Massimo] IRCCS San Raffaele Pisana, Rome, Italy; [Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Mollace, Vincenzo; Muscoli, Carolina] Magna Graecia Univ Catanzaro, Dept Hlth Sci, IRC FSH, Catanzaro, Italy	Italfarmaco; Roma Tre University; IRCCS San Raffaele Pisana; Saint Louis University; Magna Graecia University of Catanzaro	Colasanti, M (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	marco.colasanti@uniroma3.it	Fini, Massimo/AAA-9948-2021; Malafoglia, Valentina/K-6495-2016; COLASANTI, MARCO/A-5616-2010	Malafoglia, Valentina/0000-0002-1533-704X; COLASANTI, MARCO/0000-0002-5752-4943; Raffaeli, William/0000-0003-0240-8993; SCALICI, Massimiliano/0000-0002-5677-8837; PERSICHINI, TIZIANA/0000-0001-8291-6706; Lauro, Filomena/0000-0001-8212-8603	University "ROMA TRE" contribution for the laboratory (CAL);  [PON03PE_00078_2]	University "ROMA TRE" contribution for the laboratory (CAL); 	This work was supported by University "ROMA TRE" contribution for the laboratory (CAL) to MC and by PON03PE_00078_2 to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone A, 2014, NANOMEDICINE-UK, V9, P1913, DOI [10.2217/NNM.14.100, 10.2217/nnm.14.100]; BOSCH TCG, 1988, P NATL ACAD SCI USA, V85, P7927, DOI 10.1073/pnas.85.21.7927; Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; Brennecke T, 1998, EUR J BIOCHEM, V255, P703, DOI 10.1046/j.1432-1327.1998.2550703.x; Bromberg Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057149; Campana G, 2010, INT IMMUNOPHARMACOL, V10, P1149, DOI 10.1016/j.intimp.2010.06.016; Cargnin S, 2013, J PAIN, V14, P1097, DOI 10.1016/j.jpain.2013.04.006; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; COLASANTI M, 1995, NATURE, V374, P505, DOI 10.1038/374505a0; Colasanti M, 1997, J NEUROSCI, V17, P493, DOI 10.1523/JNEUROSCI.17-01-00493.1997; Colasanti M, 2010, NITRIC OXIDE-BIOL CH, V23, P94, DOI 10.1016/j.niox.2010.05.286; Colasanti M, 2009, NITRIC OXIDE-BIOL CH, V21, P164, DOI 10.1016/j.niox.2009.07.003; Dash B, 2007, GENE, V387, P93, DOI 10.1016/j.gene.2006.08.020; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Doyle T, 2012, J NEUROSCI, V32, P6149, DOI 10.1523/JNEUROSCI.6343-11.2012; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; GELLNER K, 1992, EUR J BIOCHEM, V210, P683, DOI 10.1111/j.1432-1033.1992.tb17469.x; Gigliuto C, 2014, J PAIN RES, V7, P227, DOI 10.2147/JPR.S59161; Gracheva EO, 2015, CURR OPIN NEUROBIOL, V34, P67, DOI 10.1016/j.conb.2015.01.021; Harteneck C, 2013, MOLECULES, V18, P12012, DOI 10.3390/molecules181012012; Hawkins TD, 2013, FASEB J, V27, P4790, DOI 10.1096/fj.13-235051; Hervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014321; Keilhoff G, 2013, NEUROSCI RES, V77, P215, DOI 10.1016/j.neures.2013.08.008; Klose C, 2011, BRIT J PHARMACOL, V162, P1757, DOI 10.1111/j.1476-5381.2010.01186.x; Laing R. J., 2015, NEUROSCIENTIST; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Leonelli M, 2013, CELL MOL NEUROBIOL, V33, P379, DOI 10.1007/s10571-012-9904-5; Lesch A, 2014, BRIT J PHARMACOL, V171, P2645, DOI 10.1111/bph.12524; Li YS, 2014, ACTA HISTOCHEM, V116, P883, DOI 10.1016/j.acthis.2014.02.008; LOOMIS WF, 1953, SCIENCE, V117, P565, DOI 10.1126/science.117.3047.565; Malafoglia V, 2014, J CELL PHYSIOL, V229, P300, DOI 10.1002/jcp.24447; Malafoglia V, 2013, J CELL PHYSIOL, V228, P1956, DOI 10.1002/jcp.24379; Mickle AD, 2015, PROG MOL BIOL TRANSL, V131, P73, DOI 10.1016/bs.pmbts.2015.01.002; Miyake T, 2014, BIOCHEM BIOPH RES CO, V444, P212, DOI 10.1016/j.bbrc.2014.01.022; Muscoli C, 2004, PAIN, V111, P96, DOI 10.1016/j.pain.2004.06.004; Muscoli C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/950947; Nassini R, 2014, REV PHYSIOL BIOCH P, V167, P1, DOI 10.1007/112_2014_18; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Peng GD, 2015, MOL PHYLOGENET EVOL, V84, P145, DOI 10.1016/j.ympev.2014.06.016; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Raffaeli W, 2012, AM J HOSP PALLIAT ME, V29, P604, DOI 10.1177/1049909111435810; Rosa AO, 2008, PAIN, V137, P332, DOI 10.1016/j.pain.2007.09.015; Safavi-Hemami H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010379; Sung CS, 2004, BRAIN RES, V1015, P145, DOI 10.1016/j.brainres.2004.04.068; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Venturini G, 1999, NITRIC OXIDE-BIOL CH, V3, P375, DOI 10.1006/niox.1999.0250; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wenger Y, 2014, SEMIN IMMUNOL, V26, P277, DOI 10.1016/j.smim.2014.06.004; Woo S, 2012, COMP BIOCHEM PHYS C, V156, P37, DOI 10.1016/j.cbpc.2012.03.005	50	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151386	10.1371/journal.pone.0151386	http://dx.doi.org/10.1371/journal.pone.0151386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974325	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600073
J	Wultsch, C; Waits, LP; Kelly, MJ				Wultsch, Claudia; Waits, Lisette P.; Kelly, Marcella J.			A Comparative Analysis of Genetic Diversity and Structure in Jaguars (Panthera onca), Pumas (Puma concolor), and Ocelots (Leopardus pardalis) in Fragmented Landscapes of a Critical Mesoamerican Linkage Zone	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; POPULATION-STRUCTURE; MOUNTAIN LIONS; HABITAT USE; COMPUTER-PROGRAM; TEMPORAL INTERACTIONS; SYMPATRIC JAGUARS; FOREST RESERVE; DETECTION DOGS; CONSERVATION	With increasing anthropogenic impact and landscape change, terrestrial carnivore populations are becoming more fragmented. Thus, it is crucial to genetically monitor wild carnivores and quantify changes in genetic diversity and gene flow in response to these threats. This study combined the use of scat detector dogs and molecular scatology to conduct the first genetic study on wild populations of multiple Neotropical felids coexisting across a fragmented landscape in Belize, Central America. We analyzed data from 14 polymorphic microsatellite loci in 1053 scat samples collected from wild jaguars (Panthera onca), pumas (Puma concolor), and ocelots (Leopardus pardalis). We assessed levels of genetic diversity, defined potential genetic clusters, and examined gene flow for the three target species on a countrywide scale using a combination of individualand populationbased analyses. Wild felids in Belize showed moderate levels of genetic variation, with jaguars having the lowest diversity estimates (H-E = 0.57 +/- 0.02; A(R) = 3.36 +/- 0.09), followed by pumas (H-E = 0.57 +/- 0.08; A(R) = 4.20 +/- 0.16), and ocelots (H-E = 0.63 +/- 0.03; A(R) = 4.16 +/- 0.08). We observed low to moderate levels of genetic differentiation for all three target species, with jaguars showing the lowest degree of genetic subdivision across the country, followed by ocelots and pumas. Although levels of genetic diversity and gene flow were still fairly high, we detected evidence of finescale genetic subdivision, indicating that levels of genetic connectivity for wild felids in Belize are likely to decrease if habitat loss and fragmentation continue at the current rate. Our study demonstrates the value of understanding finescale patterns of gene flow in multiple cooccurring felid species of conservation concern, which is vital for wildlife movement corridor planning and prioritizing future conservation and management efforts within human-impacted landscapes.	[Wultsch, Claudia; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Wultsch, Claudia] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	Virginia Polytechnic Institute & State University; Idaho; University of Idaho; American Museum of Natural History (AMNH)	Wultsch, C (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	cwultsch@amnh.org	Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873; Waits, Lisette/0000-0002-1323-0812	Panthera; National Geographic/Waits Grant; Jaguar Conservation Fund; Oregon Zoo Conservation Fund; Woodland Park Zoo Jaguar Conservation Fund; Philadelphia Zoo; Explorers Club Exploration Fund; Acorn Alcinda Foundation; Department of Fish and Wildlife Conservation, Virginia Tech	Panthera; National Geographic/Waits Grant; Jaguar Conservation Fund; Oregon Zoo Conservation Fund; Woodland Park Zoo Jaguar Conservation Fund; Philadelphia Zoo; Explorers Club Exploration Fund; Acorn Alcinda Foundation; Department of Fish and Wildlife Conservation, Virginia Tech	This work was funded by the following institutions and/or grant programs: Panthera (http://www.panthera.org/; received by CW); National Geographic/Waits Grant (http://www.nationalgeographic.com/explorers/grants-programs/waitt-grants/; received by CW); Jaguar Conservation Fund (http://www.wcs.org/saving-wildlife/big-cats/jaguar.aspx; received by CW); Oregon Zoo Conservation Fund (http://www.oregonzoo.org/conserve/future-wildlife-program; received by CW); Woodland Park Zoo Jaguar Conservation Fund (https://www.zoo.org/conservation/jaguar; received by CW); Philadelphia Zoo (http://www.philadelphiazoo.org/; received by MJK); Explorers Club Exploration Fund (https://explorers.org/expeditions/funding/expedition_grants; received by CW); Acorn Alcinda Foundation (received by MJK); Department of Fish and Wildlife Conservation, Virginia Tech (http://www.fishwild.vt.edu/; received by CW and MJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; Amos JN, 2014, ECOLOGY, V95, P1556, DOI 10.1890/13-1328.1; Anderson CR, 2004, J MAMMAL, V85, P1207, DOI 10.1644/BEL-111.1; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; Baillie JEM, 2013, KEY TOPICS CONSERVAT, V2, P23, DOI DOI 10.1002/9781118520178.CH2; Balkenhol N, 2014, ECOGRAPHY, V37, P552, DOI 10.1111/j.1600-0587.2013.00462.x; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Biek R, 2006, BIOL LETT-UK, V2, P312, DOI 10.1098/rsbl.2005.0437; Bridgewater SGM, 2006, ECON BOT, V60, P265, DOI 10.1663/0013-0001(2006)60[265:CXITGM]2.0.CO;2; Briggs VS, 2013, HUM ECOL RISK ASSESS, V19, P317, DOI 10.1080/10807039.2012.685809; Carmichael LE, 2001, MOL ECOL, V10, P2787, DOI 10.1046/j.1365-294X.2001.t01-1-01408.x; Caso A., 2008, IUCN RED LIST THREAT; Castilho CS, 2012, GENET MOL BIOL, V35, P65, DOI 10.1590/S1415-47572011005000062; Castilho CS, 2011, MAMM BIOL, V76, P476, DOI 10.1016/j.mambio.2010.08.002; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chepko-Sade BD, 1987, MAMMALIAN DISPERSAL; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Dalerum F, 2009, BIOL LETTERS, V5, P35, DOI 10.1098/rsbl.2008.0520; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; DeClerck FAJ, 2010, BIOL CONSERV, V143, P2301, DOI 10.1016/j.biocon.2010.03.026; DeMatteo KE, 2014, INTEGR ZOOL, V9, P623, DOI 10.1111/1749-4877.12113; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Ek E., 2010, FOREST COVER DEFORES; Elbroch M, 2009, REV CHIL HIST NAT, V82, P459; Emch M, 2005, PROF GEOGR, V57, P256, DOI 10.1111/j.0033-0124.2005.476_1.x; Epperson BK, 1999, GENET RES, V73, P251, DOI 10.1017/S001667239900378X; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Ernest HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107985; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2020, GLOBAL FOREST RESOUR; Feer F, 1997, NEOTROPICAL RAINFORE; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frankham R., 2006, CONNECTIVITY CONSERV, P72; Frantz AC, 2012, MOL ECOL, V21, P3445, DOI 10.1111/j.1365-294X.2012.05623.x; Goldberg CS, 2010, MOL ECOL, V19, P3650, DOI 10.1111/j.1365-294X.2010.04673.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grisolia AB, 2007, GENET MOL RES, V6, P382; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Haag T, 2009, GENETICA, V136, P505, DOI 10.1007/s10709-008-9347-6; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Harveson PM, 2004, WILDLIFE SOC B, V32, P948, DOI 10.2193/0091-7648(2004)032[0948:HUBOIS]2.0.CO;2; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Holbrook JD, 2012, J MAMMAL, V93, P989, DOI 10.1644/11-MAMM-A-326.2; Hu YB, 2010, CONSERV GENET, V11, P2145, DOI 10.1007/s10592-010-0100-1; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IRIARTE JA, 1990, OECOLOGIA, V85, P185, DOI 10.1007/BF00319400; Jackson P., 1996, BIOL CONSERVATION; Jackson VL, 2005, J WILDLIFE MANAGE, V69, P733, DOI 10.2193/0022-541X(2005)069[0733:LMAWHU]2.0.CO;2; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janecka JE, 2011, ANIM CONSERV, V14, P608, DOI 10.1111/j.1469-1795.2011.00475.x; Janecka JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089384; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kay E., 2015, CENTRAL BELIZE CORRI; Kelly MJ, 2012, TECH ECOL CONSERVAT, P47; KITCHENER A., 1991, NATURAL HIST WILD CA; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Logan Kenneth A., 2010, P105; Loxterman JL, 2011, CONSERV GENET, V12, P1049, DOI 10.1007/s10592-011-0208-y; Macdonald David W., 2010, P471; Manier MK, 2006, P R SOC B, V273, P3001, DOI 10.1098/rspb.2006.3678; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Michalski F, 2011, MOL ECOL RESOUR, V11, P862, DOI 10.1111/j.1755-0998.2011.03031.x; Miotto RA, 2011, CONSERV GENET, V12, P1447, DOI 10.1007/s10592-011-0243-8; Napolitano C, 2015, J HERED, V106, P522, DOI 10.1093/jhered/esv025; Nicholson KL, 2011, EUR J WILDLIFE RES, V57, P1151, DOI 10.1007/s10344-011-0528-8; Nielsen C., 2015, IUCN RED LIST THREAT, V2015, pET18868A97216466, DOI 10.2305/IUCN.UK.2015-4.RLTS.T18868A50663436.en; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Paviolo A, 2015, IUCN RED LIST THREAT; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Petracca LS, 2014, J NAT CONSERV, V22, P436, DOI 10.1016/j.jnc.2014.04.002; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2016, R FDN STAT COMP; Rannala B, 1997, P NATL ACAD SCI US; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rousset F, 1996, GENETICS, V142, P1357; Ruell EW, 2012, AM MIDL NAT, V168, P265, DOI 10.1674/0003-0031-168.2.265; Ruiz-Garcia M, 2012, MOL POPULATION GENET; Ruiz-Garcia M, 2006, GENES GENET SYST, V81, P115, DOI 10.1266/ggs.81.115; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; SEYMOUR K L, 1989, Mammalian Species, P1, DOI 10.2307/3504096; Sotiropoulos K, 2013, CONSERV GENET, V14, P385, DOI 10.1007/s10592-013-0452-4; Soto Fournier S, 2014, DIVERSIDAD GENETICA; Spinozzi F, 2012, REND LINCEI-SCI FIS, V23, P365, DOI 10.1007/s12210-012-0184-2; Stoner DC, 2008, J WILDLIFE MANAGE, V72, P933, DOI 10.2193/2007-219; Sunquist ME, 2002, WILD CATS WORLD; SWANK W G, 1989, Oryx, V23, P14; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Thompson DJ, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00028.1; Urquiza-Haas T, 2009, BIOL CONSERV, V142, P134, DOI 10.1016/j.biocon.2008.10.007; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wultsch C, 2015, WILDLIFE SOC B, V39, P403, DOI 10.1002/wsb.540; Wultsch C, 2014, MOL ECOL RESOUR, V14, P1171, DOI 10.1111/1755-0998.12266; Young CA, 2008, TROP CONSERV SCI, V1, P18, DOI 10.1177/194008290800100102; ZELLER K., 2007, JAGUARS NEW MILLENNI	121	23	24	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151043	10.1371/journal.pone.0151043	http://dx.doi.org/10.1371/journal.pone.0151043			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974968	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600046
J	Qian, BY; Xue, LY; Huang, HL				Qian, Baoying; Xue, Liangyi; Huang, Hongli			Liver Transcriptome Analysis of the Large Yellow Croaker (Larimichthys crocea) during Fasting by Using RNA-Seq	PLOS ONE			English	Article							PROTEIN-METABOLISM; GENE-EXPRESSION; GROWTH; STARVATION; MUSCLE; BRAIN	The large yellow croaker (Larimichthys crocea) is an economically important fish species in Chinese mariculture industry. To understand the molecular basis underlying the response to fasting, Illumina HiSeq (TM) 2000 was used to analyze the liver transcriptome of fasting large yellow croakers. A total of 54,933,550 clean reads were obtained and assembled into 110,364 contigs. Annotation to the NCBI database identified a total of 38,728 unigenes, of which 19,654 were classified into Gene Ontology and 22,683 were found in Kyoto Encyclopedia of Genes and Genomes (KEGG). Comparative analysis of the expression profiles between fasting fish and normal-feeding fish identified a total of 7,623 differentially expressed genes (P < 0.05), including 2,500 upregulated genes and 5,123 downregulated genes. Dramatic differences were observed in the genes involved in metabolic pathways such as fat digestion and absorption, citrate cycle, and glycolysis/gluconeogenesis, and the similar results were also found in the transcriptome of skeletal muscle. Further qPCR analysis confirmed that the genes encoding the factors involved in those pathways significantly changed in terms of expression levels. The results of the present study provide insights into the molecular mechanisms underlying the metabolic response of the large yellow croaker to fasting as well as identified areas that require further investigation.	[Qian, Baoying; Xue, Liangyi; Huang, Hongli] Ningbo Univ, Coll Marine Sci, Ningbo 315211, Zhejiang, Peoples R China; [Qian, Baoying] Taizhou Univ, Sch Iife Sci, Taizhou, Zhejiang, Peoples R China; [Xue, Liangyi] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Taizhou University; Ningbo University	Xue, LY (corresponding author), Ningbo Univ, Coll Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.; Xue, LY (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo 315211, Zhejiang, Peoples R China.	xueliangyi@nbu.edu.cn			National Natural Science Foundation of China [31172398]; Science and Technology Department of Ningbo Municipality [2015C110005]; Zhejiang Provincial Natural Science Foundation of China [LY15C190005]; Zhejiang Provincial top key discipline of aquaculture in Ningbo University [xkzsc1410]; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Ningbo Municipality; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial top key discipline of aquaculture in Ningbo University; K. C. Wong Magna Fund in Ningbo University	The project was supported by National Natural Science Foundation of China (Grant No. 31172398), http://www.nsfc.gov.cn/publish/portal0/, LX: $. 96,660; Science and Technology Department of Ningbo Municipality (Grant No. 2015C110005), http://www.nbsti.gov.cn/gb/, LX: $. 84,577.5; The Project Supported by Zhejiang Provincial Natural Science Foundation of China (Grant No. LY15C190005), http://www.zjnsf.gov.cn/, LX: $. 14,449; The open fund of Zhejiang Provincial top key discipline of aquaculture in Ningbo University (Grant No. xkzsc1410), http://www.nbu.edu.cn/, BQ: $.12,888; K. C. Wong Magna Fund in Ningbo University, http://www.nbu.edu.cn/, LX: $.0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda A, 2001, PHYSIOL BEHAV, V73, P105, DOI 10.1016/S0031-9384(01)00464-4; Beckman BR, 2011, GEN COMP ENDOCR, V170, P233, DOI 10.1016/j.ygcen.2010.08.009; Caballero MJ, 1999, AQUACULTURE, V179, P277, DOI 10.1016/S0044-8486(99)00165-9; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Fox SE, 2014, MAR GENOM, V15, P13, DOI 10.1016/j.margen.2013.12.001; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Frick NT, 2008, COMP BIOCHEM PHYS A, V151, P85, DOI 10.1016/j.cbpa.2008.06.003; Gabillard JC, 2006, J ENDOCRINOL, V191, P15, DOI 10.1677/joe.1.06869; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Havel R J, 1975, Adv Exp Med Biol, V63, P37; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Johansen KA, 2006, COMP BIOCHEM PHYS B, V144, P119, DOI 10.1016/j.cbpb.2006.02.001; Liu RZ, 2003, EUR J BIOCHEM, V270, P3223, DOI 10.1046/j.1432-1033.2003.03705.x; Magnanou E, 2014, GENE, V544, P56, DOI 10.1016/j.gene.2014.04.032; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Meton I, 2003, AQUACULTURE, V225, P99, DOI 10.1016/S0044-8486(03)00281-3; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mommsen TP, 2004, COMP BIOCHEM PHYS B, V139, P383, DOI 10.1016/j.cbpc.2004.09.018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097471; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Picha ME, 2008, N AM J AQUACULT, V70, P196, DOI 10.1577/A07-038.1; Power DM, 2000, J FISH BIOL, V56, P374, DOI 10.1111/j.1095-8649.2000.tb02112.x; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Salem M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-328; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Takahashi LS, 2011, J ANIM PHYSIOL AN N, V95, P259, DOI 10.1111/j.1439-0396.2010.01050.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATANABE T, 1982, COMP BIOCHEM PHYS B, V73, P3, DOI 10.1016/0305-0491(82)90196-1; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Xiao SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124432; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319	36	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150240	10.1371/journal.pone.0150240	http://dx.doi.org/10.1371/journal.pone.0150240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967898	gold, Green Published, Green Submitted			2022-12-26	WOS:000371989200009
J	Pham, DD; Do, HT; Bruelle, C; Kukkonen, JP; Eriksson, O; Mogollon, I; Korhonen, LT; Arumae, U; Lindholm, D				Dan Duc Pham; Hai Thi Do; Bruelle, Celine; Kukkonen, Jyrki P.; Eriksson, Ove; Mogollon, Isabel; Korhonen, Laura T.; Arumae, Urmas; Lindholm, Dan			p75 Neurotrophin Receptor Signaling Activates Sterol Regulatory Element-binding Protein-2 in Hepatocyte Cells via p38 Mitogen-activated Protein Kinase and Caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; DEGENERATION INVOLVEMENT; SELECTIVE ACTIVATION; HIPPOCAMPAL-NEURONS; LINKED INHIBITOR; P75(NTR); CLEAVAGE; PATHWAY; STRESS	Nerve growth factor (NGF) influences the survival and differentiation of a specific population of neurons during development, but its role in non-neuronal cells has been less studied. We observed here that NGF and its pro-form, pro-NGF, are elevated in fatty livers from leptin-deficient mice compared with controls, concomitant with an increase in low density lipoprotein receptors (LDLRs). Stimulation of mouse primary hepatocytes withNGFor pro-NGF increased LDLR expression through the p75 neurotrophin receptor (p75NTR). Studies using Huh7 human hepatocyte cells showed that the neurotrophins activate the sterol regulatory element-binding protein-2 (SREBP2) that regulates genes involved in lipid metabolism. The mechanisms for this were related to stimulation of p38 mitogen-activated protein kinase (p38 MAPK) and activation of caspase-3 and SREBP2 cleavage following NGF and pro-NGF stimulations. Cell fractionation experiments showed that caspase-3 activity was increased particularly in the membrane fraction that harbors SREBP2 and caspase-2. Experiments showed further that caspase-2 interacts with pro-caspase-3 and that p38 MAPK reduced this interaction and caused caspase-3 activation. Because of the increased caspase-3 activity, the cells did not undergo cell death following p75NTR stimulation, possibly due to concomitant activation of nuclear factor-kappa B (NF-kappa B) pathway by the neurotrophins. These results identify a novel signaling pathway triggered by ligand-activated p75NTR that via p38MAPK and caspase-3 mediate the activation of SREBP2. This pathway may regulate LDLRs and lipid uptake particularly after injury or during tissue inflammation accompanied by an increased production of growth factors, including NGF and pro-NGF.	[Dan Duc Pham; Hai Thi Do; Bruelle, Celine; Eriksson, Ove; Mogollon, Isabel; Korhonen, Laura T.; Lindholm, Dan] Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, Med, POB 63, FIN-00014 Helsinki, Finland; [Dan Duc Pham; Hai Thi Do; Bruelle, Celine; Mogollon, Isabel; Korhonen, Laura T.; Lindholm, Dan] Minerva Fdn, Biomed 2,Tukholmankatu 8, FIN-00290 Helsinki, Finland; [Kukkonen, Jyrki P.] Univ Helsinki, Dept Vet Biosci, Biochem & Cell Biol, POB 66, FIN-00014 Helsinki, Finland; [Arumae, Urmas] Univ Helsinki, Inst Biotechnol, Res Program Dev Biol, POB 65, FIN-00014 Helsinki, Finland; [Arumae, Urmas] Tallinn Univ Technol, Dept Gene Technol, Akad Tee 15, EE-12618 Tallinn, Estonia	University of Helsinki; University of Helsinki; University of Helsinki; Tallinn University of Technology	Lindholm, D (corresponding author), Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, Med, POB 63, FIN-00014 Helsinki, Finland.; Lindholm, D (corresponding author), Minerva Fdn, Biomed 2,Tukholmankatu 8, FIN-00290 Helsinki, Finland.	dan.lindholm@helsinki.fi	Eriksson-Rosenberg, Ove/GVU-6692-2022; Pham, dan/F-5009-2019; Arumäe, Urmas/E-8290-2016; Korhonen, Laura/AAW-3256-2020	Pham, dan/0000-0003-1956-2794; Arumäe, Urmas/0000-0003-3658-6464; Kukkonen, Jyrki/0000-0002-6989-1564; Korhonen, Laura/0000-0002-1837-5930	Academy of Finland; Novo Nordisk Fonden; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Finska Lakaresallskapet; Parkinson Foundation; Minerva Foundation; Novo Nordisk Fonden [NNF16OC0021492, NNF15OC0016558] Funding Source: researchfish	Academy of Finland(Academy of Finland); Novo Nordisk Fonden(Novo Nordisk Foundation); Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Finska Lakaresallskapet; Parkinson Foundation; Minerva Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by grants from Academy of Finland (to D. L., L. T. K., and U. A.), the Novo Nordisk Fonden (to D. L.), the Magnus Ehrnrooth Foundation (to J. P. K. and D. L.), the Liv och Halsa Foundation (to J. P. K., D. L., O. E., and L. T. K), Finska Lakaresallskapet (to D. L., L T. K., and O. E.), the Parkinson Foundation (to C. B. and D. L.), and the Minerva Foundation (to D. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aalto K, 2002, CYTOKINE, V20, P136, DOI 10.1006/cyto.2002.1991; Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; ALOE L, 1993, GROWTH FACTORS, V9, P149, DOI 10.3109/08977199309010830; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; Ammoun S, 2006, J BIOL CHEM, V281, P834, DOI 10.1074/jbc.M508603200; Baeza-Raja B, 2016, CELL REP, V14, P255, DOI 10.1016/j.celrep.2015.12.028; Baeza-Raja B, 2012, P NATL ACAD SCI USA, V109, P5838, DOI 10.1073/pnas.1103638109; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Bouchier-Hayes L, 2010, CELL CYCLE, V9, P12, DOI 10.4161/cc.9.1.10477; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Deponti D, 2009, MOL BIOL CELL, V20, P3620, DOI 10.1091/mbc.E09-01-0012; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Eriksson O, 1999, AM J PHYSIOL-CELL PH, V276, pC1297, DOI 10.1152/ajpcell.1999.276.6.C1297; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Do HT, 2016, J NEUROCHEM, V136, P306, DOI 10.1111/jnc.13397; Do HT, 2013, J BIOL CHEM, V288, P29613, DOI 10.1074/jbc.M113.500967; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hempstead B L, 2014, Handb Exp Pharmacol, V220, P17, DOI 10.1007/978-3-642-45106-5_2; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hyrskyluoto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.170; Hyrskyluoto A, 2014, HUM MOL GENET, V23, P5928, DOI 10.1093/hmg/ddu317; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Korhonen L, 2004, EXP CELL RES, V295, P290, DOI 10.1016/j.yexcr.2003.12.026; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Peeraully MR, 2004, AM J PHYSIOL-ENDOC M, V287, pE331, DOI 10.1152/ajpendo.00076.2004; Riikonen RS, 1998, PEDIATR NEUROL, V18, P231, DOI 10.1016/S0887-8994(97)00204-X; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Vakifahmetoglu-Norberg H, 2010, TRENDS CELL BIOL, V20, P150, DOI 10.1016/j.tcb.2009.12.006; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; Wootz H, 2004, BIOCHEM BIOPH RES CO, V322, P281, DOI 10.1016/j.bbrc.2004.07.118; Yu LY, 2003, J CELL BIOL, V163, P987, DOI 10.1083/jcb.200305083; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	45	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10747	10758		10.1074/jbc.M116.722272	http://dx.doi.org/10.1074/jbc.M116.722272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26984409	Green Published, hybrid			2022-12-26	WOS:000377042600026
J	Zhao, HL; Wang, HB; Bauzon, F; Lu, ZL; Fu, H; Cui, JH; Zhu, L				Zhao, Hongling; Wang, Hongbo; Bauzon, Frederick; Lu, Zhonglei; Fu, Hao; Cui, Jinhua; Zhu, Liang			Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; SUPPRESSES APOPTOSIS; NERVOUS-SYSTEM; MUTANT MICE; MUTATION; DEFICIENT; DEFECTS; PROLIFERATION; TUMORIGENESIS; EXTENDS	Tumor suppressor pith represses Skp2, a substrate-recruiting subunit of the SCFSkp2 ubiquitin ligase. Rb1(+/-) mice incur "two hit" pituitary tumorigenesis; Skp2(-/-);Rb1(+/-) mice do not Rb1(-/-) embryos die on embryonic day (E) 14.5-15.5. Here, we report that Skp2(-/-);Rb1(-/-) embryos died on F11.5, establishing an organismal level synthetic lethal relationship between Rbi and Skp2. On E10.5, Rb1(-/-) placentas showed similarly active proliferation and similarly inactive apoptosis as WT placenta, whereas Rb1(-/-) embryos showed ectopic proliferation without increased apoptosis in the brain. Combining Skp2-1did not reduce proliferation or increase apoptosis in the placentas but induced extensive apoptosis in the brain. We conditionally deleted Rb1 in neuronal lineage with Nes-Cre and reproduced the brain apoptosis in E13.5 Nes-Cre; Rb1(-/-);Skp2(-/-) embryos, demonstrating their synthetic lethal relationship at a cell autonomous level. Nes-Cre-mediated.Rbl deletion increased expression of proliferative E2F target genes in the brains of Skp2(+/+) embryos; the increases rose higher with activation of expression of apoptotic E2F target genes in Skp2(-/-) embryos. The brain apoptosis was independent of p53 but coincident with proliferation. The highly activated expression of proliferative and apoptotic E2F target genes subsided with gradually reduced roles of Skp2 in preventing p27 protein accumulation in the brain in late gestation, allowing the embryos to reach full term with normally sized brains. These findings establish that Rbi and Skp2 deletions are synthetic lethal and suggest how this lethal relationship might be circumvented, which could help design better therapies for pRb-deficient cancer.	Albert Einstein Coll Med, Dept Dev & Mol Biol & Ophthalmol & Visual Sci Med, Albert Einstein Comprehens Canc Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Liver Res Ctr, Bronx, NY 10461 USA; [Wang, Hongbo] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Health San Antonio	Zhu, L (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave,Rm U-521, Bronx, NY 10461 USA.	liang.zhu@einstein.yu.edu		Lu, Zhonglei/0000-0002-8915-4828	National Institutes of Health [RO1CA127901, RO1CA131421]; Albert Einstein Comprehensive Cancer Research Center [5P30CA13330]; Liver Research Center [5P30DK061153]; Department of Defense Prostate Cancer Research Program (PCRP) Postdoctoral Fellowship [PC121837]; NATIONAL CANCER INSTITUTE [R01CA127901, R01CA131421, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK061153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Comprehensive Cancer Research Center; Liver Research Center; Department of Defense Prostate Cancer Research Program (PCRP) Postdoctoral Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants RO1CA127901and RO1CA131421 (to L. Z.), Albert Einstein Comprehensive Cancer Research Center Grant 5P30CA13330, and Liver Research Center Grant 5P30DK061153. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Department of Defense Prostate Cancer Research Program (PCRP) Postdoctoral Fellowship PC121837.	Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lu ZL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4463; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; Marino S, 2000, GENE DEV, V14, P994; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wenzel PL, 2007, GENE DEV, V21, P85, DOI 10.1101/gad.1485307; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	25	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10201	10209		10.1074/jbc.M116.718049	http://dx.doi.org/10.1074/jbc.M116.718049			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26966181	hybrid, Green Published			2022-12-26	WOS:000375602800029
J	Hegazy, R; Salama, A; Mansour, D; Hassan, A				Hegazy, Rehab; Salama, Abeer; Mansour, Dina; Hassan, Azza			Renoprotective Effect of Lactoferrin against Chromium-Induced Acute Kidney Injury in Rats: Involvement of IL-18 and IGF-1 Inhibition	PLOS ONE			English	Article							GROWTH-FACTOR-I; INDUCED OXIDATIVE STRESS; NF-KAPPA-B; BOVINE LACTOFERRIN; INDUCED NEPHROTOXICITY; FACTOR SYSTEM; RENAL DAMAGE; TNF-ALPHA; CELLS; INTERLEUKIN-18	Hexavalent chromium (CrVI) is a heavy metal widely used in more than 50 industries. Nephrotoxicity is a major adverse effect of chromium poisoning. The present study investigated the potential renoprotective effect of lactoferrin (Lf) against potassium dichromate (PDC)-induced acute kidney injury (AKI) in rats. Beside, because previous studies suggest that interlukin-18 (IL-18) and insulin-like growth factor-1 (IGF-1) play important roles in promoting kidney damage, the present work aimed to evaluate the involvement of these two cytokines in PDC model of AKI and in the potential renoprotective effect of lactoferrin. Adult male albino Wistar rats were pretreated with Lf (200mg/kg/day, p.o.) or (300mg/kg/day, p.o.); the doses that are usually used in the experiment studies, for 14 days followed by a single dose of PDC (15mg/kg, s.c.). PDC caused significant increase in serum urea, creatinine, and total protein levels. This was accompanied with decreased renal glutathione content, and increased renal malondialdehyde, IL-18, IL-4, nuclear factor kappa B (NF kappa B), IGF-1, and the phosphorylated form of forkhead box protein O1 (FoxO1) levels. Moreover, normal expression IFN-gamma mRNA and enhanced expression of TNF-alpha mRNA was demonstrated in renal tissues. Histopathological investigations provoked deleterious changes in the renal tissues. Tubular epithelial hyperplasia and apoptosis were demonstrated immunohistochemically by positive proliferating cell nuclear antigen (PCNA), Bax, and Caspase-3 expression, respectively. Pretreatment of rats with Lf in both doses significantly corrected all previously mentioned PDC-induced changes with no significant difference between both doses. In conclusion, the findings of the present study demonstrated the involvement of oxidative stress, inflammatory reactions, tubular hyperplasia and apoptosis in PDC-induced AKI. It suggested a role of IL-18 through stimulation of IL-4-induced inflammatory pathway, and IGF-1 through triggering FoxO1-induced cell proliferation. Moreover, the study revealed that Lf protected the kidney against Cr-induced AKI in rats and significantly showed antioxidant, anti-inflammatory, and anti-proliferative properties with down-regulation of IL-18 and IGF-1.	[Hegazy, Rehab; Salama, Abeer; Mansour, Dina] Natl Res Ctr, Div Med, Dept Pharmacol, Giza, Egypt; [Hassan, Azza] Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University	Hegazy, R (corresponding author), Natl Res Ctr, Div Med, Dept Pharmacol, Giza, Egypt.	rehab_hegazy@hotmail.com		Hegazy, Rehab/0000-0002-2586-2104; Salama, Abeer/0000-0001-9870-5583; Mansour, Dina/0000-0002-5656-2462				Abrink M, 2000, KIDNEY INT, V57, P2004, DOI 10.1046/j.1523-1755.2000.00050.x; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Alfaro-Lira S, 2012, INT J ENV RES PUB HE, V9, P1630, DOI 10.3390/ijerph9051630; [Anonymous], 2003, EXP GROUP VIT MIN EV; Arreola-Mendoza L, 2006, TOXICOLOGY, V218, P237, DOI 10.1016/j.tox.2005.11.010; Aruldhas MM, 2005, HUM REPROD, V20, P2801, DOI 10.1093/humrep/dei148; Aukema HM, 2001, KIDNEY INT, V59, P52, DOI 10.1046/j.1523-1755.2001.00465.x; Bartoskova A, 2009, REPROD DOMEST ANIM, V44, P193, DOI 10.1111/j.1439-0531.2009.01409.x; Beaver LM, 2009, TOXICOL APPL PHARM, V235, P47, DOI 10.1016/j.taap.2008.11.018; Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992; BERRY JP, 1978, J HISTOCHEM CYTOCHEM, V26, P651, DOI 10.1177/26.8.690404; Carvalho CAM, 2014, VIROLOGY, V452, P297, DOI 10.1016/j.virol.2014.01.022; COCCHETTO DM, 1983, J PHARM SCI-US, V72, P465, DOI 10.1002/jps.2600720503; Cumberbatch M, 2003, CLIN EXP IMMUNOL, V132, P352, DOI 10.1046/j.1365-2249.2003.02146.x; Drury R.A.B., 1967, CARLETONS HISTOLOGIC, P432; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Elass E, 2002, INFECT IMMUN, V70, P1860, DOI 10.1128/IAI.70.4.1860-1866.2002; Eldridge SR, 1996, FUND APPL TOXICOL, V32, P159, DOI 10.1006/faat.1996.0119; Fang B, 2014, BBA-MOL CELL BIOL L, V1841, P535, DOI 10.1016/j.bbalip.2013.12.008; Fatima S, 2007, CLIN CHIM ACTA, V386, P94, DOI 10.1016/j.cca.2007.08.006; Faubel S, 2007, J PHARMACOL EXP THER, V322, P8, DOI 10.1124/jpet.107.119792; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Flores A, 1999, TOXICOL APPL PHARM, V161, P75, DOI 10.1006/taap.1999.8779; GAHR M, 1991, J LEUKOCYTE BIOL, V49, P427, DOI 10.1002/jlb.49.5.427; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Halade GV, 2010, J IMMUNOL, V184, P5280, DOI 10.4049/jimmunol.0903282; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; Hessin Alyaa, 2015, Open Access Maced J Med Sci, V3, P195, DOI 10.3889/oamjms.2015.038; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirschberg R, 1998, AM J KIDNEY DIS, V31, P901, DOI 10.1053/ajkd.1998.v31.pm9631833; Ibrahim MA, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1068-z; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kanwar JR, 2015, MOLECULES, V20, P9703, DOI 10.3390/molecules20069703; Keane M, 2015, J OCCUP ENV HYG, V0; Kimoto Y, 2013, J VET MED SCI, V75, P159, DOI 10.1292/jvms.12-0154; Kuhara T, 2000, NUTR CANCER, V38, P192, DOI 10.1207/S15327914NC382_8; Latorre D, 2010, TOXINS, V2, P54, DOI 10.3390/toxins2010054; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Liu YH, 2002, CURR OPIN NEPHROL HY, V11, P23, DOI 10.1097/00041552-200201000-00004; Liu ZQ, 2015, CELL PHYSIOL BIOCHEM, V37, P225, DOI 10.1159/000430347; Lopez-Franco O, 2002, AM J PATHOL, V161, P1497, DOI 10.1016/S0002-9440(10)64425-2; MACHNICKI M, 1993, INT J EXP PATHOL, V74, P433; Maneva A, 2003, Z NATURFORSCH C, V58, P256; Melnikov VY, 2001, J CLIN INVEST, V107, P1145, DOI 10.1172/JCI12089; Mignini F, 2009, ENVIRON TOXICOL, V24, P594, DOI 10.1002/tox.20464; MILLER SB, 1992, P NATL ACAD SCI USA, V89, P11876, DOI 10.1073/pnas.89.24.11876; MILLER SB, 1994, AM J PHYSIOL, V266, pF949, DOI 10.1152/ajprenal.1994.266.6.F949; Mohan KVPC, 2006, BBA-GEN SUBJECTS, V1760, P1536, DOI 10.1016/j.bbagen.2006.06.009; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Morel JCM, 2001, LAB INVEST, V81, P1371, DOI 10.1038/labinvest.3780351; NAKAMURA T, 1993, J AM SOC NEPHROL, V3, P1378; Norrby K, 2001, INT J CANCER, V91, P236, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1024&gt;3.3.CO;2-K; Nudler SI, 2009, TOXICOL LETT, V185, P187, DOI 10.1016/j.toxlet.2009.01.003; Ogasawara Y, 2014, INT J MOL SCI, V15, P1003, DOI 10.3390/ijms15011003; Oh YM, 2012, KIDNEY RES CLIN PRAC, V31, P26, DOI 10.1016/j.krcp.2011.12.005; Parikh CR, 2005, J AM SOC NEPHROL, V16, P3046, DOI 10.1681/ASN.2005030236; Parker E, 2007, KIDNEY INT, V72, P157, DOI 10.1038/sj.ki.5002229; Pesch B, 2015, INT J HYG ENVIR HEAL, V218, P500, DOI 10.1016/j.ijheh.2015.04.004; Roelfsema V, 2001, J AM SOC NEPHROL, V12, P1297, DOI 10.1681/ASN.V1261297; Salama A. A. A., 2014, Journal of Chemical and Pharmaceutical Research, V6, P168; Shi HP, 2014, ONCOL LETT, V7, P820, DOI 10.3892/ol.2013.1776; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sorimachi K, 1997, BIOCHEM MOL BIOL INT, V43, P79; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Swain SL, 2001, J EXP MED, V194, pF11, DOI 10.1084/jem.194.3.F11; Tsubota A, 2008, J HEPATOL, V48, P486, DOI 10.1016/j.jhep.2007.11.013; Varadhachary A, 2004, INT J CANCER, V111, P398, DOI 10.1002/ijc.20271; Velusamy SK, 2014, ANTIMICROB AGENTS CH, V58, P397, DOI 10.1128/AAC.00020-13; Vesce F, 2014, GYNECOL OBSTET INVES; Wu HL, 2008, J AM SOC NEPHROL, V19, P2331, DOI 10.1681/ASN.2008020170; Xiao Y, 2004, CLIN CANCER RES, V10, P8683, DOI 10.1158/1078-0432.CCR-04-0988; Xue HM, 2015, CELL PHYSIOL BIOCHEM, V36, P2456, DOI 10.1159/000430206; Yam-Canul P, 2008, FOOD CHEM TOXICOL, V46, P1089, DOI 10.1016/j.fct.2007.11.003; Yamada Y, 2008, J VET MED SCI, V70, P443, DOI 10.1292/jvms.70.443; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhou XW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/786528; Zimecki M, 2001, ARCH IMMUNOL THER EX, V49, P325; Zimecki Michal, 2007, Postepy Hig Med Dosw (Online), V61, P283	82	40	42	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151486	10.1371/journal.pone.0151486	http://dx.doi.org/10.1371/journal.pone.0151486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990190	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800064
J	Gong, YN; Chen, GW; Yang, SL; Lee, CJ; Shih, SR; Tsao, KC				Gong, Yu-Nong; Chen, Guang-Wu; Yang, Shu-Li; Lee, Ching-Ju; Shih, Shin-Ru; Tsao, Kuo-Chien			A Next-Generation Sequencing Data Analysis Pipeline for Detecting Unknown Pathogens from Mixed Clinical Samples and Revealing Their Genetic Diversity	PLOS ONE			English	Article							HUMAN PARECHOVIRUS; VIRUS DETECTION; IDENTIFICATION; ENTEROVIRUS; RECOMBINATION; PREVALENCE; DISCOVERY; ALIGNMENT; GENOMES; CULTURE	Forty-two cytopathic effect (CPE)-positive isolates were collected from 2008 to 2012. All isolates could not be identified for known viral pathogens by routine diagnostic assays. They were pooled into 8 groups of 5-6 isolates to reduce the sequencing cost. Next-generation sequencing (NGS) was conducted for each group of mixed samples, and the proposed data analysis pipeline was used to identify viral pathogens in these mixed samples. Polymerase chain reaction (PCR) or enzyme-linked immunosorbent assay (ELISA) was individually conducted for each of these 42 isolates depending on the predicted viral types in each group. Two isolates remained unknown after these tests. Moreover, iteration mapping was implemented for each of these 2 isolates, and predicted human parechovirus (HPeV) in both. In summary, our NGS pipeline detected the following viruses among the 42 isolates: 29 human rhinoviruses (HRVs), 10 HPeVs, 1 human adenovirus (HAdV), 1 echovirus and 1 rotavirus. We then focused on the 10 identified Taiwanese HPeVs because of their reported clinical significance over HRVs. Their genomes were assembled and their genetic diversity was explored. One novel 6-bp deletion was found in one HPeV-1 virus. In terms of nucleotide heterogeneity, 64 genetic variants were detected from these HPeVs using the mapped NGS reads. Most importantly, a recombination event was found between our HPeV-3 and a known HPeV-4 strain in the database. Similar event was detected in the other HPeV-3 strains in the same clade of the phylogenetic tree. These findings demonstrated that the proposed NGS data analysis pipeline identified unknown viruses from the mixed clinical samples, revealed their genetic identity and variants, and characterized their genetic features in terms of viral evolution.	[Gong, Yu-Nong; Chen, Guang-Wu; Yang, Shu-Li; Lee, Ching-Ju; Shih, Shin-Ru; Tsao, Kuo-Chien] Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Gong, Yu-Nong; Chen, Guang-Wu] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Chen, Guang-Wu; Shih, Shin-Ru; Tsao, Kuo-Chien] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Yang, Shu-Li; Shih, Shin-Ru; Tsao, Kuo-Chien] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Tsao, KC (corresponding author), Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan.; Tsao, KC (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.; Tsao, KC (corresponding author), Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.	kctsao@cgmh.org.tw	Shih, Shin-Ru/M-9711-2016; Chen, Guang-Wu/M-6768-2016	Shih, Shin-Ru/0000-0003-4874-401X; Gong, Yu-Nong/0000-0002-6799-1561	Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPG3C0731, CMRPG3C0733, CLRPG3B0042, CLRPG3B0043]; Ministry of Science and Technology, Taiwan [MOST-103-2221-E-182022]	Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	KCT received five grants from Chang Gung Memorial Hospital, Taoyuan, Taiwan (from No. CMRPG3C0731 to CMRPG3C0733, CLRPG3B0042 and CLRPG3B0043; http://www.cgmh.org.tw). GWC received one grant from the Ministry of Science and Technology, Taiwan (No. MOST-103-2221-E-182022; http://www.most.gov.tw/). A total of 6 grants partially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017722; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aw TG, 2014, J VIROL METHODS, V210, P15, DOI 10.1016/j.jviromet.2014.09.017; Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08; Benschop KSM, 2010, J GEN VIROL, V91, P145, DOI 10.1099/vir.0.014670-0; Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647; Chen GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045946; de Crom SCM, 2013, J CLIN VIROL, V58, P449, DOI 10.1016/j.jcv.2013.07.017; Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002; Esposito S, 2014, J CLIN VIROL, V60, P84, DOI 10.1016/j.jcv.2014.03.003; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Ho T, 2014, VIROLOGY, V471, P54, DOI 10.1016/j.virol.2014.09.019; Huang YP, 2016, J MICROBIOL IMMUNOL, V49, P321, DOI 10.1016/j.jmii.2014.06.013; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuo RL, 2014, J VIROL METHODS, V208, P41, DOI 10.1016/j.jviromet.2014.07.020; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Tan LV, 2013, MBIO, V4, DOI 10.1128/mBio.00231-13; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu XY, 2013, J CLIN MICROBIOL, V51, P1089, DOI 10.1128/JCM.03297-12; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Mok CK, 2015, J MICROBIOL IMMUNOL, V48, P465, DOI 10.1016/j.jmii.2013.09.010; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Shah G, 2014, CAN J INFECT DIS MED, V25, P186, DOI 10.1155/2014/602501; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H; Suwantarat N, 2015, CURR OPIN INFECT DIS, V28, P349, DOI 10.1097/QCO.0000000000000183; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsao KC, 2010, J VIROL METHODS, V165, P330, DOI 10.1016/j.jviromet.2010.03.001; van der Sanden S, 2008, J CLIN MICROBIOL, V46, P2884, DOI 10.1128/JCM.00168-08; Vezzi F, 2011, EMBNET J, V17, P46, DOI DOI 10.14806/EJ.17.1.208; Wang QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064465; Westerhuis BM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-146; Wong S, 2008, J MED VIROL, V80, P856, DOI 10.1002/jmv.21136; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	43	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151495	10.1371/journal.pone.0151495	http://dx.doi.org/10.1371/journal.pone.0151495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986479	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300079
J	Schimmer, RC; Urner, M; Voigtsberger, S; Booy, C; Z'Graggen, BR; Beck-Schimmer, B; Schlapfer, M				Schimmer, Ralph C.; Urner, Martin; Voigtsberger, Stefanie; Booy, Christa; Z'Graggen, Birgit Roth; Beck-Schimmer, Beatrice; Schlaepfer, Martin			Inflammatory Kidney and Liver Tissue Response to Different Hydroxyethylstarch (HES) Preparations in a Rat Model of Early Sepsis	PLOS ONE			English	Article							ORGAN FAILURE; INJURY; RESUSCITATION; SEVOFLURANE; DISEASE; PATHOPHYSIOLOGY; MECHANISMS; MORTALITY; SEVERITY; THERAPY	Background Tissue hypoperfusion and inflammation in sepsis can lead to organ failure including kidney and liver. In sepsis, mortality of acute kidney injury increases by more than 50%. Which type of volume replacement should be used is still an ongoing debate. We investigated the effect of different volume strategies on inflammatory mediators in kidney and liver in an early sepsis model. Material and Methods Adult male Wistar rats were subjected to sepsis by cecal ligation and puncture (CLP) and assigned to three fluid replenishment groups. Animals received 30mL/kg of Ringer's lactate (RL) for 2h, thereafter RL (75mL/kg), hydroxyethyl starch (HES) balanced (25mL/kg), containing malate and acetate, or HES saline (25mL/kg) for another 2h. Kidney and liver tissue was assessed for inflammation. In vitro rat endothelial cells were exposed to RL, HES balanced or HES saline for 2h, followed by stimulation with tumor necrosis factor-alpha (TNF-alpha) for another 4h. Alternatively, cells were exposed to malate, acetate or a mixture of malate and acetate, reflecting the according concentration of these substances in HES balanced. Pro-inflammatory cytokines were determined in cell supernatants. Results Cytokine mRNA in kidney and liver was increased in CLP animals treated with HES balanced compared to RL, but not after application of HES saline. MCP-1 was 3.5fold (95% CI: 1.3, 5.6) (p<0.01) and TNF-alpha 2.3fold (95% CI: 1.2, 3.3) (p<0.001) upregulated in the kidney. Corresponding results were seen in liver tissue. TNF-alpha-stimulated endothelial cells co-exposed to RL expressed 3529 +/- 1040pg/mL MCP-1 and 59 +/- 23pg/mL CINC-1 protein. These cytokines increased by 2358pg/mL (95% CI: 1511, 3204) (p<0.001) and 29pg/ml (95% CI: 14, 45) (p<0.01) respectively when exposed to HES balanced instead. However, no further upregulation was observed with HES saline. PBS supplemented with acetate increased MCP-1 by 1325pg/mL (95% CI: 741, 1909) (p<0.001) and CINC-1 by 24pg/mL (95% CI: 9, 38) (p<0.01) compared to RL. Malate as well as HES saline did not affect cytokine expression. Conclusion We identified HES balanced and specifically its component acetate as pro-inflammatory factor. How important this additional inflammatory burden on kidney and liver function is contributing to the sepsis-associated inflammatory burden in early sepsis needs further evaluation.	[Schimmer, Ralph C.] Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland; [Urner, Martin; Voigtsberger, Stefanie; Beck-Schimmer, Beatrice; Schlaepfer, Martin] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Urner, Martin; Booy, Christa; Z'Graggen, Birgit Roth; Beck-Schimmer, Beatrice; Schlaepfer, Martin] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Urner, Martin; Booy, Christa; Z'Graggen, Birgit Roth; Beck-Schimmer, Beatrice; Schlaepfer, Martin] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Beck-Schimmer, Beatrice] Univ Illinois, Dept Anesthesiol, Chicago, IL USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Schimmer, RC (corresponding author), Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland.	ralphchristian.schimmer@uzh.ch	Urner, Martin/AAK-5701-2020; Schlaepfer, Martin/B-9243-2017; Schlaepfer, Martin/AAA-3587-2021	Urner, Martin/0000-0003-1133-4885; Schlaepfer, Martin/0000-0003-4288-7124; Schlaepfer, Martin/0000-0003-4288-7124	Swiss National Science Foundation [3200B0-122305]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Institutional funding and the Swiss National Science Foundation, Grant number 3200B0-122305, www.snsf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2006, CURR OPIN CRIT CARE, V12, P527, DOI 10.1097/01.ccx.0000247446.09500.ac; Bayer O, 2011, CRIT CARE MED, V39, P1335, DOI 10.1097/CCM.0b013e318212096a; BINGEL M, 1987, LANCET, V1, P14; Bion J, 2014, INTENS CARE MED, V40, P256, DOI 10.1007/s00134-013-3167-6; Blumenthal S, 2006, ANESTHESIOLOGY, V104, P961, DOI 10.1097/00000542-200605000-00012; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Coriat P, 2014, BRIT J ANAESTH, V113, P194, DOI 10.1093/bja/aeu217; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; Gillies MA, 2014, BRIT J ANAESTH, V112, P25, DOI 10.1093/bja/aet303; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Hartog CS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5981; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Karimova A, 2001, INTENS CARE MED, V27, P19, DOI 10.1007/s001340000790; Kuznetsova A., 2013, LMERTEST TESTS RANDO, V2; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; MURPHY HS, 1992, AM J PHYSIOL, V263, pL51, DOI 10.1152/ajplung.1992.263.1.L51; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ronco C, 2008, CLIN J AM SOC NEPHRO, V3, P531, DOI 10.2215/CJN.03830907; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schlaepfer M, 2012, CLIN EXP IMMUNOL, V168, P125, DOI 10.1111/j.1365-2249.2012.04562.x; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Suter D, 2007, ANESTH ANALG, V104, P638, DOI 10.1213/01.ane.0000255046.06058.58; Thaha M, 2005, Acta Med Indones, V37, P145; Van Der Linden P, 2013, ANESTH ANALG, V116, P35, DOI 10.1213/ANE.0b013e31827175da; VEECH RL, 1988, ADV ENZYME REGUL, V27, P313, DOI 10.1016/0065-2571(88)90024-6; Vermont CL, 2006, CRIT CARE, V10, DOI 10.1186/cc4836; Voigtsberger S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093863; Voigtsberger S, 2009, ANESTHESIOLOGY, V111, P1238, DOI 10.1097/ALN.0b013e3181bdf857; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	35	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151903	10.1371/journal.pone.0151903	http://dx.doi.org/10.1371/journal.pone.0151903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985992	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000372580300148
J	Tytgat, HLP; van Teijlingen, NH; Sullan, RMA; Douillard, FP; Rasinkangas, P; Messing, M; Reunanen, J; Satokari, R; Vanderleyden, J; Dufrene, YF; Geijtenbeek, TBH; de Vos, WM; Lebeer, S				Tytgat, Hanne L. P.; van Teijlingen, Nienke H.; Sullan, Ruby May A.; Douillard, Francois P.; Rasinkangas, Pia; Messing, Marcel; Reunanen, Justus; Satokari, Reetta; Vanderleyden, Jos; Dufrene, Yves F.; Geijtenbeek, Teunis B. H.; de Vos, Willem M.; Lebeer, Sarah			Probiotic Gut Microbiota Isolate Interacts with Dendritic Cells via Glycosylated Heterotrimeric Pili	PLOS ONE			English	Article							LACTOBACILLUS-RHAMNOSUS GG; ATOMIC-FORCE MICROSCOPY; GRAM-POSITIVE BACTERIA; INTESTINAL EPITHELIAL-CELLS; LECTIN DC-SIGN; FUNCTIONAL-ANALYSIS; BIFIDOBACTERIUM-BIFIDUM; ISOPEPTIDE BONDS; ADHESION; IDENTIFICATION	Mapping of the microbial molecules underlying microbiota-host interactions is key to understand how microbiota preserve mucosal homeostasis. A pivotal family of such bacterial molecules are pili. Pili are proteinaceous cell wall appendages with a well-documented role in adhesion, whilst their role in immune interaction with the host is less established. Gram-positive pili are often posttranslationally modified by sortase-specific cleavage reactions and the formation of intramolecular peptide bonds. Here we report glycosylation as a new level of posttranslational modification of sortase-dependent pili of a beneficial microbiota species and its role in immune modulation. We focused on the SpaCBA pili of the model probiotic and beneficial human gut microbiota isolate Lactobacillus rhamnosus GG. A unique combination of molecular techniques, nanoscale mechanical and immunological approaches led to the identification of mannose and fucose residues on the SpaCBA pili. These glycans on the pili are recognized by human dendritic cells via the C-type lectin receptor DC-SIGN, a key carbohydrate-dependent immune tailoring pattern recognition receptor. This specific lectin-sugar interaction is moreover of functional importance and modulated the cytokine response of dendritic cells. This provides insight into the direct role bacterial glycoproteins can play in the immunomodulation of the host. Modification of the complex heterotrimeric pili of a model probiotic and microbiota isolate with mannose and fucose is of importance for the functional interaction with the host immune lectin receptor DC-SIGN on human dendritic cells. Our findings shed light on the yet underappreciated role of glycoconjugates in bacteria-host interactions.	[Tytgat, Hanne L. P.; Vanderleyden, Jos; Lebeer, Sarah] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium; [Tytgat, Hanne L. P.; Lebeer, Sarah] Univ Antwerp, Dept Biosci Engn Environm Ecol & Appl Microbiol, B-2020 Antwerp, Belgium; [Tytgat, Hanne L. P.; Dufrene, Yves F.; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [van Teijlingen, Nienke H.; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Sullan, Ruby May A.] Catholic Univ Louvain, Inst Life Sci, Louvain La Neuve, Belgium; [Douillard, Francois P.; Rasinkangas, Pia; Reunanen, Justus; Satokari, Reetta; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Messing, Marcel; de Vos, Willem M.] Univ Helsinki, Immunobiol Res Program, Helsinki, Finland; [Messing, Marcel; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Sullan, Ruby May A.] Max Planck Inst Colloids & Interfaces, Mechanobiochem Res Grp, Potsdam, Germany	KU Leuven; University of Antwerp; Wageningen University & Research; University of Amsterdam; Universite Catholique Louvain; University of Helsinki; University of Helsinki; University of Helsinki; Max Planck Society	Lebeer, S (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium.; Lebeer, S (corresponding author), Univ Antwerp, Dept Biosci Engn Environm Ecol & Appl Microbiol, B-2020 Antwerp, Belgium.	sarah.lebeer@uantwerpen.be	Lebeer, Sarah/D-5156-2014; Tytgat, Hanne L.P./B-4388-2013; Lebeer, Sarah/S-9951-2019; Sullan, Ruby May A./L-7511-2016	Lebeer, Sarah/0000-0002-9400-6918; Tytgat, Hanne L.P./0000-0001-6270-2110; Lebeer, Sarah/0000-0002-9400-6918; Sullan, Ruby May A./0000-0002-8927-2605; Satokari, Reetta/0000-0002-4258-3414; Dufrene, Yves/0000-0002-7289-4248	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen); University of Leuven [PF3M100234]; UAntwerp; AMC PhD Scholarship; NWO [VICI 918.10.619]; European Research Council grant MicrobesInside of WMdV [250172]; Academy of Finland [138902, 254439, 141140]; National Fund for Scientific Research (FNRS); UCLouvain (Fondation Louvain-Prix de Merre); Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme); Research Department of the Communaute francaise de Belgique (Concerted Research Action)	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); University of Leuven(KU Leuven); UAntwerp; AMC PhD Scholarship; NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council grant MicrobesInside of WMdV; Academy of Finland(Academy of Finland); National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); UCLouvain (Fondation Louvain-Prix de Merre); Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme); Research Department of the Communaute francaise de Belgique (Concerted Research Action)	HLPT acknowledges the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen) for her PhD scholarship. SL holds a 'Krediet aan Navorsers' (28960) from FWO-Vlaanderen. JV, SL and HLPT are grateful for the financial support of the University of Leuven via PF3M100234 and UAntwerp via BOF and IOF-SBO funding. NHvT is sponsored by the AMC PhD Scholarship. TBHG is sponsored by NWO; VICI 918.10.619. PR and FPD are funded by the European Research Council grant MicrobesInside (250172) of WMdV. JR, RS and WMdV want to acknowledge the financial support from the Academy of Finland (138902, 254439 and 141140). Work at UCLouvain was supported by the National Fund for Scientific Research (FNRS), the UCLouvain (Fondation Louvain-Prix de Merre), the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the Research Department of the Communaute francaise de Belgique (Concerted Research Action). YFD is a research Director of the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Brittan JL, 2015, MICROBES INFECT, V17, P360, DOI 10.1016/j.micinf.2014.12.013; Coyne MJ, 2013, MOL MICROBIOL, V88, P772, DOI 10.1111/mmi.12220; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Douillard FP, 2014, J BIOL CHEM, V289, P15764, DOI 10.1074/jbc.M113.542332; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Fletcher CM, 2011, J BIOL CHEM, V286, P3219, DOI 10.1074/jbc.M110.194506; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65; Garcia CEV, 2015, APPL ENVIRON MICROB, V81, P2050, DOI 10.1128/AEM.03949-14; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6074; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kainulainen V, 2013, APPL ENVIRON MICROB, V79, P6989, DOI 10.1128/AEM.01993-13; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Laakso K, 2011, MICROB BIOTECHNOL, V4, P746, DOI 10.1111/j.1751-7915.2011.00275.x; Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Morello E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138103; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rogers EA, 2011, ADV EXP MED BIOL, V715, P91, DOI 10.1007/978-94-007-0940-9_6; Segers ME, 2014, LACTOBACILLUS RHAMNO; Soriani M, 2010, FUTURE MICROBIOL, V5, P735, DOI [10.2217/fmb.10.37, 10.2217/FMB.10.37]; Sullan RMA, 2014, NANOSCALE, V6, P1134, DOI 10.1039/c3nr05462d; Thompson R, 2011, ANAL BIOCHEM, V413, P114, DOI 10.1016/j.ab.2011.02.013; Tillisch K, 2014, GUT MICROBES, V5, P404, DOI 10.4161/gmic.29232; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Tripathi P, 2012, LANGMUIR, V28, P2211, DOI 10.1021/la203834d; Turroni F, 2014, FEMS MICROBIOL LETT, V357, P23, DOI 10.1111/1574-6968.12509; Tytgat HLP, 2015, MICROB BIOTECHNOL, V8, P164, DOI 10.1111/1751-7915.12150; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Gisbergen KPJM, 2005, IMMUNOL LETT, V97, P199, DOI 10.1016/j.imlet.2004.11.008; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09	60	44	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151824	10.1371/journal.pone.0151824	http://dx.doi.org/10.1371/journal.pone.0151824			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985831	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300135
J	Wang, Y; Miao, F; Yan, LL				Wang, Ying; Miao, Fang; Yan, Liuling			Branching Shoots and Spikes from Lateral Meristems in Bread Wheat	PLOS ONE			English	Article							SUPERNUMERARY SPIKELETS; CHROMOSOMAL LOCATION; GENE; INHERITANCE; EVOLUTION; GENOME; BARLEY	Wheat grain yield consists of three components: spikes per plant, grains per spike (i.e. head or ear), and grain weight; and the grains per spike can be dissected into two subcomponents: spikelets per spike and grains per spikelet. An increase in any of these components will directly contribute to grain yield. Wheat morphology biology tells that a wheat plant has no lateral meristem that forms any branching shoot or spike. In this study, we report two novel shoot and spike traits that were produced from lateral meristems in bread wheat. One is supernumerary shoot that was developed from an axillary bud at the axil of leaves on the elongated internodes of the main stem. The other is supernumerary spike that was generated from a spikelet meristem on a spike. In addition, supernumerary spikelets were generated on the same rachis node of the spike in the plant that had supernumerary shoot and spikes. All of these supernumerary shoots/spikes/spikelets found in the super wheat plants produced normal fertility and seeds, displaying huge yield potential in bread wheat.	[Wang, Ying; Miao, Fang; Yan, Liuling] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Miao, Fang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Oklahoma State University System; Oklahoma State University - Stillwater; Northwest A&F University - China	Yan, LL (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	liuling.yan@okstate.edu						AHRENS J. F., 1963, CROP SCI, V3, P463, DOI 10.2135/cropsci1963.0011183X000300060001x; Alieva A. Dzh., 2009, Russian Agricultural Sciences, V35, P144, DOI 10.3103/S1068367409030033; Alieva AJ, 2013, RUSS J GENET+, V49, P1119, DOI 10.1134/S1022795413110021; Aliyeva AJ, 2011, GENET RESOUR CROP EV, V58, P621, DOI 10.1007/s10722-011-9702-9; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Dobrovolskaya O, 2009, THEOR APPL GENET, V119, P867, DOI 10.1007/s00122-009-1095-1; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DVORAK J, 1993, GENOME, V36, P21, DOI 10.1139/g93-004; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gao ZY, 2009, PLANT MOL BIOL, V71, P265, DOI 10.1007/s11103-009-9522-x; GARDNER JS, 1985, AM J BOT, V72, P548, DOI 10.2307/2443587; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Kebrom TH, 2012, PLANT PHYSIOL, V160, P308, DOI 10.1104/pp.112.197954; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; KIRBY EJM, 1974, J AGR SCI, V82, P437, DOI 10.1017/S0021859600051339; KLINDWORTH DL, 1990, GENOME, V33, P509, DOI 10.1139/g90-075; KLINDWORTH DL, 1990, GENOME, V33, P515, DOI 10.1139/g90-076; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lin QB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1716; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; McMaster GS, 2005, J AGR SCI-CAMBRIDGE, V143, P137, DOI 10.1017/S0021859605005083; MILLET E, 1986, THEOR APPL GENET, V72, P105, DOI 10.1007/BF00261463; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; PATIL J. A., 1958, CURRENT SCI, V27, P404; Peng ZS, 1998, EUPHYTICA, V103, P109, DOI 10.1023/A:1018323310621; PENNELL AL, 1983, EUPHYTICA, V32, P767, DOI 10.1007/BF00042157; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; RAWSON HM, 1970, AUST J BIOL SCI, V23, P1, DOI 10.1071/BI9700001; Sears E. R., 1954, ANEUPLOIDS COMMON WH, P3; Sharman BC, 1944, NATURE, V153, P497, DOI 10.1038/153497a0; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; WILLIAMS RF, 1966, AUST J BIOL SCI, V19, P949, DOI 10.1071/BI9660949; Yang W.Y., 2011, TRITICEAE GENOM GENE, V2, P1; Yang WY, 2005, GENET RESOUR CROP EV, V52, P847, DOI 10.1007/s10722-003-6089-2; Zhang RuiQi, 2013, Acta Agronomica Sinica, V39, P29, DOI 10.3724/SP.J.1006.2013.00029; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108; Zuo J, 2013, NATL SCI REV, P1	42	7	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151656	10.1371/journal.pone.0151656	http://dx.doi.org/10.1371/journal.pone.0151656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986738	Green Submitted, gold, Green Published			2022-12-26	WOS:000372580300105
J	Liu, SL; Xia, ZY; Liu, JH; Xu, J; Ren, H; Lu, T; Yang, XD				Liu, Shaoli; Xia, Zeyang; Liu, Jianhua; Xu, Jing; Ren, He; Lu, Tong; Yang, Xiangdong			Automatic Multiple-Needle Surgical Planning of Robotic-Assisted Microwave Coagulation in Large Liver Tumor Therapy	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; TRAJECTORIES; PLACEMENT; SYSTEM; EXPERIENCE; SURFACES; REGIONS	The "robotic-assisted liver tumor coagulation therapy" (RALTCT) system is a promising candidate for large liver tumor treatment in terms of accuracy and speed. A prerequisite for effective therapy is accurate surgical planning. However, it is difficult for the surgeon to perform surgical planning manually due to the difficulties associated with robot-assisted large liver tumor therapy. These main difficulties include the following aspects: (1) multiple needles are needed to destroy the entire tumor, (2) the insertion trajectories of the needles should avoid the ribs, blood vessels, and other tissues and organs in the abdominal cavity, (3) the placement of multiple needles should avoid interference with each other, (4) an inserted needle will cause some deformation of liver, which will result in changes in subsequently inserted needles' operating environment, and (5) the multiple needle-insertion trajectories should be consistent with the needle-driven robot's movement characteristics. Thus, an effective multiple-needle surgical planning procedure is needed. To overcome these problems, we present an automatic multiple-needle surgical planning of optimal insertion trajectories to the targets, based on a mathematical description of all relevant structure surfaces. The method determines the analytical expression of boundaries of every needle "collision-free reachable workspace" (CFRW), which are the feasible insertion zones based on several constraints. Then, the optimal needle insertion trajectory within the optimization criteria will be chosen in the needle CFRW automatically. Also, the results can be visualized with our navigation system. In the simulation experiment, three needle-insertion trajectories were obtained successfully. In the in vitro experiment, the robot successfully achieved insertion of multiple needles. The proposed automatic multiple-needle surgical planning can improve the efficiency and safety of robot-assisted large liver tumor therapy, significantly reduce the surgeon's workload, and is especially helpful for an inexperienced surgeon. The methodology should be easy to adapt in other body parts.	[Liu, Shaoli; Liu, Jianhua] Beijing Inst Technol, Sch Mech Engn, Beijing 100081, Peoples R China; [Xia, Zeyang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Xu, Jing; Yang, Xiangdong] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China; [Ren, He] Navy Gen Hosp PLA, Dept Ultrasound Med, Beijing, Peoples R China; [Lu, Tong] Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing 100853, Peoples R China	Beijing Institute of Technology; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Tsinghua University; Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Liu, SL (corresponding author), Beijing Inst Technol, Sch Mech Engn, Beijing 100081, Peoples R China.	liushaoli@bit.edu.cn	xu, jing/GRR-8698-2022	w, yufan/0000-0003-2609-4706	National Natural Science Foundation of China (NSFC) [50675109]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Financial support is provided by National Natural Science Foundation of China (NSFC) under Grant No. 50675109, the URL is: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. Put the NO. and the year 2006, the information of the funding can be searched. Yang received the funding. The funder designed parts of the robot and agreed to publish the manuscript.	Abbott JJ, 2007, SPRINGER TRAC ADV RO, V28, P49; Azimian H, 2010, ROB AUT ICRA 2010 IE; Baegert C, 2007, STUD HEALTH TECHNOL, V125, P31; Baegert C, 2007, LECT NOTES COMPUT SC, V4792, P676; Boctor EM, 2008, INT J MED ROBOT COMP, V4, P180, DOI 10.1002/rcs.184; Boyd S., 2004, CONVEX OPTIMIZATION; Butnariu S, 2014, APPL MECH MATER, V332, P503, DOI 10.4028/www.scientific.net/AMM.332.503; Chakraborty N, 2008, IEEE T ROBOT, V24, P211, DOI 10.1109/TRO.2007.914851; Chen MH, 2004, RADIOLOGY, V232, P260, DOI 10.1148/radiol.2321030821; Davies BL, 1997, P I MECH ENG H, V211, P285, DOI 10.1243/0954411971534403; Dodd GD, 2001, AM J ROENTGENOL, V177, P777, DOI 10.2214/ajr.177.4.1770777; Gervais DA, 2011, AM J ROENTGENOL, V197, P789, DOI 10.2214/AJR.11.7656; Gettman MT, 2004, UROLOGY, V64, P914, DOI 10.1016/j.urology.2004.06.049; Hong JS, 2002, LECT NOTES COMPUT SC, V2488, P122; Inokuchi R, 2010, ONCOL REP, V24, P621, DOI 10.3892/or_00000900; Kapoor A, 2008, ROB AUT 2008 ICRA 20; Kapoor A, 2011, PROC SPIE, V7964, DOI 10.1117/12.876499; Khaianchee YS, 2004, SURG ENDOSC, V18, P696, DOI 10.1007/s00464-003-8180-3; Kosari K, 2002, J GASTROINTEST SURG, V6, P255, DOI 10.1016/S1091-255X(02)00002-1; LI SX, 1994, COMPUT AIDED DESIGN, V26, P165, DOI 10.1016/0010-4485(94)90040-X; Liang P, 2008, J UROLOGY, V180, P844, DOI 10.1016/j.juro.2008.05.012; liu S L, 2011, ROB BIOM ROBIO 2011; [刘少丽 Liu Shaoli], 2012, [高技术通讯, Chinese High Technology Letters], V22, P832; Livraghi T, 2000, RADIOLOGY, V214, P761, DOI 10.1148/radiology.214.3.r00mr02761; Lu MD, 2001, RADIOLOGY, V221, P167, DOI 10.1148/radiol.2211001783; Mundeleer L, 2009, INT J MED ROBOT COMP, V5, P458, DOI 10.1002/rcs.278; Park S., 2001, P 4 INT C MED IM COM, P1419, DOI DOI 10.1007/3-540-45468-3_; Ren HL, 2014, IEEE J BIOMED HEALTH, V18, P920, DOI 10.1109/JBHI.2013.2287202; Rheinboldt W.C., 1986, NUMERICAL ANAL PARAM; Rosenberg L.B., 1993, VIRT REAL ANN INT S; Schumann C, 2012, INT J COMPUT ASS RAD, V7, P191, DOI 10.1007/s11548-011-0624-y; Schumann C, 2010, PROC SPIE, V7625, DOI 10.1117/12.844186; Seitel A, 2011, MED PHYS, V38, P3246, DOI 10.1118/1.3590374; Shamir RR, 2010, LECT NOTES COMPUT SC, V6363, P457; Spencer A, 2008, ROB AUT 2008 ICRA 20; Suarez-Mejias Cristina, 2013, Clinical Image-Based Procedures. From Planning to Intervention. International Workshop, CLIP 2012 Held in Conjunction with MICCAI 2012. Revised Selected Papers, P83, DOI 10.1007/978-3-642-38079-2_11; TAUBIN G, 1994, IEEE T PATTERN ANAL, V16, P287, DOI 10.1109/34.276128; Taylor R, 1999, INT J ROBOT RES, V18, P1201, DOI 10.1177/02783649922067807; Villard C, 2005, LECT NOTES COMPUT SC, V3750, P49, DOI 10.1007/11566489_7; Villard Caroline, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P215, DOI 10.1080/10255840500289988; Wu J, 2011, FUZZ SYST KNOWL DISC; Xu J., 2007, THESIS TSINGHUA U BE; Xu J, 2010, INT J MED ROBOT COMP, V6, P256, DOI 10.1002/rcs.313; Yang LJ, 2010, IEEE-ASME T MECH, V15, P887, DOI 10.1109/TMECH.2010.2078827; Yang XD, 2010, MECH MACH THEORY, V45, P1024, DOI 10.1016/j.mechmachtheory.2010.02.002	45	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149482	10.1371/journal.pone.0149482	http://dx.doi.org/10.1371/journal.pone.0149482			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982341	Green Submitted, gold, Green Published			2022-12-26	WOS:000372574900015
J	Pajek, MB; Cuk, I; Leskosek, B; Mlinsek, G; Ponikvar, JB; Pajek, J				Pajek, Maja Bucar; Cuk, Ivan; Leskosek, Bojan; Mlinsek, Gregor; Ponikvar, Jadranka Buturovic; Pajek, Jernej			Six-Minute Walk Test in Renal Failure Patients: Representative Results, Performance Analysis and Perceived Dyspnea Predictors	PLOS ONE			English	Article							IRON-BINDING-CAPACITY; REFERENCE EQUATIONS; DIALYSIS PATIENTS; PHYSICAL PERFORMANCE; CLINICAL-OUTCOMES; HEMODIALYSIS; SURVIVAL; EXERCISE; ASSOCIATION; MORTALITY	Objectives Six-minute walk test in dialysis population hasn't been consistently evaluated for the isolated impact of renal failure and other predictive factors. We measured six-minute walk distance in patients representative for low level of comorbidity and searched for potentially modifiable predictive factors of performance and dyspnea. Methods This was a cross-sectional study with hemodialysis patients (N = 90) and control subjects (N = 140). Main outcome measures: six-minute walk test distance and dyspnea severity using the 10-item Borg scale. Results Median distance decreased from 600m below the 6th decade to 420m in the 8th decade of age. Dialysis dependence predicted 101.5m shorter distance in the adjusted model that explained 70% of variability in results. Adjusted for significant covariates of age, height and spontaneous gait speed, fat mass (but not lean body mass) and serum total iron binding capacity were significantly associated with distance (95% CI for B coefficients -4.6 to -1.4 m/kg and 0.1 to 5 m/mu mol/l, respectively). Serum total iron binding capacity as an explanatory variable was superior to C-reactive protein and albumin. Dialysis dependence, odds ratio (OR) 2.97 (1.11-7.94), spontaneous gait speed, OR 0.08 (0.02-0.41), rate-pressure product, OR 1.15 (1.08-1.23) and hemoglobin, OR 0.95 (0.92-0.98) predicted dyspnea in the adjusted model. Conclusions Renal failure without the confounding effect of comorbidity is a significant negative predictor of performance at six-minute walk test and perceived level of dyspnea. Body fat mass and serum total iron binding capacity are the main potentially modifiable predictors of performance, total iron binding capacity being superior to C-reactive protein and albumin. Although hemoglobin is not associated with test performance, it negatively predicts perceived shortness of breath.	[Pajek, Maja Bucar; Cuk, Ivan; Leskosek, Bojan] Univ Ljubljana, Fac Sport, Ljubljana, Slovenia; [Mlinsek, Gregor; Ponikvar, Jadranka Buturovic; Pajek, Jernej] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Pajek, J (corresponding author), Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia.	Jernej.pajek@mf.uni-lj.si	Pajek, Jernej/AAD-6776-2020	Pajek, Jernej/0000-0003-3265-8053; Cuk, Ivan/0000-0003-3300-5839; Buturovic-Ponikvar, Jadranka/0000-0001-7473-3731; Pajek, Maja/0000-0002-2706-7729	Slovenian Research Agency [P3-0323]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grant number P3-0323 from Slovenian Research Agency to JP and JBP (https://www.arrs.gov.si/en/novo.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Bossola M, 2014, BLOOD PURIFICAT, V38, P24, DOI 10.1159/000363599; Britto RR, 2013, BRAZ J PHYS THER, V17, P556, DOI 10.1590/S1413-35552012005000122; Bross R, 2009, AM J NEPHROL, V29, P571, DOI 10.1159/000191470; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Davies SJ, 2002, NEPHROL DIAL TRANSPL, V17, P1085, DOI 10.1093/ndt/17.6.1085; Delgado C, 2012, NEPHROL DIAL TRANSPL, V27, P1152, DOI 10.1093/ndt/gfr404; Eloot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076838; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Gambino R, 1997, CLIN CHEM, V43, P2408; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hamilton AL, 1996, CHEST, V110, P1255, DOI 10.1378/chest.110.5.1255; Kakiya R, 2006, KIDNEY INT, V70, P549, DOI 10.1038/sj.ki.5000331; Kalantar-Zadeh K, 1998, AM J KIDNEY DIS, V31, P263, DOI 10.1053/ajkd.1998.v31.pm9469497; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Keown PA, 2010, HEMODIAL INT, V14, P168, DOI 10.1111/j.1542-4758.2009.00422.x; Kohl LD, 2012, CLINICS, V67, P581, DOI 10.6061/clinics/2012(06)06; Kono K, 2014, THER APHER DIAL, V18, P623, DOI 10.1111/1744-9987.12177; Koufaki P, 2010, SPORTS MED, V40, P1055, DOI 10.2165/11536880-000000000-00000; MAK VHF, 1993, THORAX, V48, P33, DOI 10.1136/thx.48.1.33; Martinson M, 2014, CLIN J AM SOC NEPHRO, V9, P1082, DOI 10.2215/CJN.09200913; Matsuzawa R, 2012, CLIN J AM SOC NEPHRO, V7, P2010, DOI 10.2215/CJN.03660412; McDermott MM, 2008, J AM GERIATR SOC, V56, P724, DOI 10.1111/j.1532-5415.2008.01633.x; Pilutti LA, 2013, J NEUROL SCI, V334, P72, DOI 10.1016/j.jns.2013.07.2511; Pollentier Brittany, 2010, Cardiopulm Phys Ther J, V21, P13; Port FK, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341061; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Soper D.S., 2015, A PRIORI SAMPLE SIZE; Torino C, 2014, KIDNEY BLOOD PRESS R, V39, P205, DOI 10.1159/000355798; Tsirpanlis G, 2006, KIDNEY INT, V70, P1991, DOI 10.1038/sj.ki.5001848; Tveter AT, 2014, ARCH PHYS MED REHAB, V95, P1366, DOI 10.1016/j.apmr.2014.02.016; WIJKSTRA PJ, 1994, THORAX, V49, P468, DOI 10.1136/thx.49.5.468; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B	33	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150414	10.1371/journal.pone.0150414	http://dx.doi.org/10.1371/journal.pone.0150414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982967	gold, Green Published			2022-12-26	WOS:000372574900039
J	Baumann, A; Kerruth, S; Fitter, J; Buldt, G; Heberle, J; Schlesinger, R; Ataka, K				Baumann, Axel; Kerruth, Silke; Fitter, Joerg; Bueldt, Georg; Heberle, Joachim; Schlesinger, Ramona; Ataka, Kenichi			In-Situ Observation of Membrane Protein Folding during Cell-Free Expression	PLOS ONE			English	Article							INFRARED-ABSORPTION SPECTROSCOPY; CYTOCHROME-C-OXIDASE; GOLD ELECTRODE; 2-STAGE MODEL; ALPHA-HELIX; BACTERIORHODOPSIN; STABILITY; NANODISCS; SPECTRA; RECONSTITUTION	Proper insertion, folding and assembly of functional proteins in biological membranes are key processes to warrant activity of a living cell. Here, we present a novel approach to trace folding and insertion of a nascent membrane protein leaving the ribosome and penetrating the bilayer. Surface Enhanced IR Absorption Spectroscopy selectively monitored insertion and folding of membrane proteins during cell-free expression in a label-free and non-invasive manner. Protein synthesis was performed in an optical cell containing a prism covered with a thin gold film with nanodiscs on top, providing an artificial lipid bilayer for folding. In a pilot experiment, the folding pathway of bacteriorhodopsin via various secondary and tertiary structures was visualized. Thus, a methodology is established with which the folding reaction of other more complex membrane proteins can be observed during protein biosynthesis (in situ and in operando) at molecular resolution.	[Baumann, Axel; Fitter, Joerg; Bueldt, Georg] Forschungszentrum Julich, Inst Complex Syst, Mol Biophys ICS 5, D-52425 Julich, Germany; [Kerruth, Silke; Heberle, Joachim; Ataka, Kenichi] Free Univ Berlin, Dept Phys, Expt Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany; [Bueldt, Georg] Moscow Inst Phys & Technol, Lab Adv Studies Membrane Proteins, Dolgoprudnyi 141700, Russia; [Schlesinger, Ramona] Free Univ Berlin, Dept Phys, Genet Biophys, Arnimallee 14, D-14195 Berlin, Germany; [Fitter, Joerg] Rhein Westfal TH Aachen, Phys Inst IA, AG Biophys, Sommerfeldstr 14, D-52074 Aachen, Germany	Helmholtz Association; Research Center Julich; Free University of Berlin; Moscow Institute of Physics & Technology; Free University of Berlin; RWTH Aachen University	Ataka, K (corresponding author), Free Univ Berlin, Dept Phys, Expt Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany.; Schlesinger, R (corresponding author), Free Univ Berlin, Dept Phys, Genet Biophys, Arnimallee 14, D-14195 Berlin, Germany.	rschlesinger@zedat.fu-berlin.de; ataka@zedat.fu-berlin.de	Heberle, Joachim/D-8605-2016; Schlesinger, Ramona/W-2620-2018; Fitter, Joerg/J-3294-2013	Heberle, Joachim/0000-0001-6321-2615; Schlesinger, Ramona/0000-0002-7716-4439; Fitter, Joerg/0000-0002-4503-2079; Kerruth, Silke/0000-0003-4117-3189				Adato R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3154; Ataka K, 2006, J PHYS CHEM B, V110, P9339, DOI 10.1021/jp0534131; Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h; Ataka K, 2007, ANAL BIOANAL CHEM, V388, P47, DOI 10.1007/s00216-006-1071-4; Ataka K, 2013, BBA-BIOMEMBRANES, V1828, P2283, DOI 10.1016/j.bbamem.2013.04.026; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Booth PJ, 1997, FOLD DES, V2, pR85, DOI 10.1016/S1359-0278(97)00045-X; BOOTH PJ, 1995, NAT STRUCT BIOL, V2, P139, DOI 10.1038/nsb0295-139; Booth PJ, 1997, BIOCHEMISTRY-US, V36, P197, DOI 10.1021/bi962200m; Booth PJ, 2001, CRIT REV BIOCHEM MOL, V36, P501, DOI 10.1080/20014091074246; Booth PJ, 2000, BBA-BIOENERGETICS, V1460, P4, DOI 10.1016/S0005-2728(00)00125-0; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chalmers J.M., 2002, HDB VIBRATIONAL SPEC; Compton ELR, 2006, J MOL BIOL, V357, P325, DOI 10.1016/j.jmb.2005.12.042; Curnow P, 2010, J MOL BIOL, V403, P630, DOI 10.1016/j.jmb.2010.09.003; Dale H, 1999, J BIOL CHEM, V274, P22693, DOI 10.1074/jbc.274.32.22693; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; Grechko M, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764861; HUANG KS, 1981, J BIOL CHEM, V256, P3802; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Johnson PJM, 2014, PHYS CHEM CHEM PHYS, V16, P21310, DOI 10.1039/c4cp01826e; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P8829, DOI 10.1021/bi00152a020; Karjalainen EL, 2012, J PHYS CHEM B, V116, P4448, DOI 10.1021/jp300329k; Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023; Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065; Kiefer H, 2003, BBA-BIOMEMBRANES, V1610, P57, DOI 10.1016/S0005-2736(02)00717-4; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; LONDON E, 1982, J BIOL CHEM, V257, P7003; Nagy JK, 2001, BIOCHEMISTRY-US, V40, P8971, DOI 10.1021/bi010202n; NEVSKAYA NA, 1976, BIOPOLYMERS, V15, P637, DOI 10.1002/bip.1976.360150404; OSAWA M, 1993, APPL SPECTROSC, V47, P1497, DOI 10.1366/0003702934067478; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Riley ML, 1997, BIOCHEMISTRY-US, V36, P192, DOI 10.1021/bi962199r; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Swartz James R, 2004, Methods Mol Biol, V267, P169; Torres J, 1995, BIOCHEMISTRY-US, V34, P16320, DOI 10.1021/bi00050a012; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; Zaitseva E, 2010, BIOPHYS J, V99, P2327, DOI 10.1016/j.bpj.2010.06.054	47	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151051	10.1371/journal.pone.0151051	http://dx.doi.org/10.1371/journal.pone.0151051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978519	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000372572800045
J	Davis, JS; Gupta, V; Gagea, M; Wu, XW				Davis, Jennifer S.; Gupta, Vineet; Gagea, Mihai; Wu, Xiangwei			An Advanced Histologic Method for Evaluation of Intestinal Adenomas in Mice Using Digital Slides	PLOS ONE			English	Article							NEOPLASIA; MUTATION	Background and Methods Mice are used for modelling the biology of many human diseases, including colorectal cancer (CRC). Mouse models recapitulate many aspects of human disease and are invaluable tools for studying the biology, treatment and prevention of CRC. Unlike humans, many mouse models develop lesions primarily in the small intestine, which necessitates removal and examination of this organ in order to evaluate treatment efficacy. Commonly, the small intestine is visually examined for gross lesions and then selectively embedded in paraffin blocks for further microscopic analysis. Unfortunately, this method suffers from inherent bias toward counting large lesions and simultaneously missing smaller lesions. Even more, this method leaves no permanent record of diagnosed and measured lesions. We evaluated inter-observer variability in a mouse model of CRC using visual examination, and directly compared the visual, gross examination with a histologic analytic method using digital slides of hematoxylin and eosin stained tissue sections. Results Using visual examination, there was a high degree of inter-observer variability. As this method does not provide a permanent record of measurements, there is no capability to arbitrate between differing observations. In contrast, histologic analysis allowed for the creation of a permanent record of lesion measurements taken. When compared directly, histologic analysis of annotated digital images has significantly improved accuracy. Using this method we were able to distinguish mutant mice from wild type littermates even at a very young age. With gross visual examination, this distinction was not possible. Conclusion Histologic analysis of digital images of murine intestinal tissue provides a vital improvement over the commonly used visual, gross examination method. Unlike visual gross examination, histologic analysis is not biased by the size of intestinal adenoma, misdiagnosis of another lesion type, or presence of a Peyer's patch. It also provides accountability in the form of a permanent record of lesions counted. Histologic analysis using digital slides represents a critical improvement over the current, widely used method of visual gross examination and should be considered for future studies using mouse models of CRC.	[Davis, Jennifer S.; Gupta, Vineet; Wu, Xiangwei] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Unit 1013, Houston, TX 77030 USA; [Gagea, Mihai] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Unit 0063, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, XW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Unit 1013, Houston, TX 77030 USA.	xwwu@mdanderson.org		Davis, Jennifer/0000-0001-9456-1682	Janice Davis Gordon Memorial Postdoctoral Fellowship in Colorectal Cancer Prevention Research; CPRIT [RP120280]	Janice Davis Gordon Memorial Postdoctoral Fellowship in Colorectal Cancer Prevention Research; CPRIT	JS Davis is supported by the Janice Davis Gordon Memorial Postdoctoral Fellowship in Colorectal Cancer Prevention Research. Research is supported by CPRIT grant RP120280 to X Wu.	FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Spahn TW, 2004, GUT, V53, P456, DOI 10.1136/gut.2003.023671; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534	6	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151463	10.1371/journal.pone.0151463	http://dx.doi.org/10.1371/journal.pone.0151463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974326	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600081
J	Fernandez-Gil, A; Naves, J; Ordiz, A; Quevedo, M; Revilla, E; Delibes, M				Fernandez-Gil, Alberto; Naves, Javier; Ordiz, Andres; Quevedo, Mario; Revilla, Eloy; Delibes, Miguel			Conflict Misleads Large Carnivore Management and Conservation: Brown Bears and Wolves in Spain	PLOS ONE			English	Article							WOLF CANIS-LUPUS; URSUS-ARCTOS; HUMAN ATTITUDES; RISK; DEPREDATION; LIVESTOCK; PREY; ECOLOGY; PERCEPTION; PREDATORS	Large carnivores inhabiting human-dominated landscapes often interact with people and their properties, leading to conflict scenarios that can mislead carnivore management and, ultimately, jeopardize conservation. In northwest Spain, brown bears Ursus arctos are strictly protected, whereas sympatric wolves Canis lupus are subject to lethal control. We explored ecological, economic and societal components of conflict scenarios involving large carnivores and damages to human properties. We analyzed the relation between complaints of depredations by bears and wolves on beehives and livestock, respectively, and bear and wolf abundance, livestock heads, number of culled wolves, amount of paid compensations, and media coverage. We also evaluated the efficiency of wolf culling to reduce depredations on livestock. Bear damages to beehives correlated positively to the number of female bears with cubs of the year. Complaints of wolf predation on livestock were unrelated to livestock numbers; instead, they correlated positively to the number of wild ungulates harvested during the previous season, the number of wolf packs, and to wolves culled during the previous season. Compensations for wolf complaints were fivefold higher than for bears, but media coverage of wolf damages was thirty-fold higher. Media coverage of wolf damages was unrelated to the actual costs of wolf damages, but the amount of news correlated positively to wolf culling. However, wolf culling was followed by an increase in compensated damages. Our results show that culling of the wolf population failed in its goal of reducing damages, and suggest that management decisions are at least partly mediated by press coverage. We suggest that our results provide insight to similar scenarios, where several species of large carnivores share the landscape with humans, and management may be reactive to perceived conflicts.	[Fernandez-Gil, Alberto; Naves, Javier; Revilla, Eloy; Delibes, Miguel] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Ordiz, Andres] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Quevedo, Mario] Univ Oviedo, UMIB, Dept Biol Organismos & Sistemas, Oviedo, Spain; [Ordiz, Andres] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Norwegian University of Life Sciences; University of Oviedo; Swedish University of Agricultural Sciences	Fernandez-Gil, A (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	albertofg@ebd.csic.es	Revilla, Eloy/B-5100-2008; Delibes, Miguel/K-2744-2014	Revilla, Eloy/0000-0001-5534-5581; Delibes, Miguel/0000-0002-3569-567X; Naves, Javier/0000-0003-3773-0288; Ordiz, Andres/0000-0002-6141-8457	Consejeria de Medio Ambiente, Ordenacion del Territorio e Infraestracturas, Principado de Asturias [2008-2010 EBD-CSIC]; HARMONIA project [2013/08/M/NZ9/00469]; Spanish Ministerio de Ciencia e Innovacion [CGL2009-07301, CGL2012-35931]; FEDER	Consejeria de Medio Ambiente, Ordenacion del Territorio e Infraestracturas, Principado de Asturias; HARMONIA project; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission)	This work was partially funded by Consejeria de Medio Ambiente, Ordenacion del Territorio e Infraestracturas, Principado de Asturias (Brown Bear Project 2008-2010 EBD-CSIC) and by cooperation within HARMONIA project 2013/08/M/NZ9/00469 (Polish National Science Centre). ER was supported by projects CGL2009-07301 and CGL2012-35931 from the Spanish Ministerio de Ciencia e Innovacion, co-funded with FEDER funds.	Alvares F, 2005, C FRONT WOLF REC SW, P76; [Anonymous], 2014, R LANG ENV STAT COMP; BLANCO JC, 1992, BIOL CONSERV, V60, P73, DOI 10.1016/0006-3207(92)91157-N; Borg BL, 2015, J ANIM ECOL, V84, P177, DOI 10.1111/1365-2656.12256; Bruskotter J. T., 2010, Human Dimensions of Wildlife, V15, P311, DOI 10.1080/10871209.2010.508068; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; CLEVENGER AP, 1994, ACTA THERIOL, V39, P267, DOI 10.4098/AT.arch.94-30; CUESTA L, 1991, MAMMALIA, V55, P239, DOI 10.1515/mamm.1991.55.2.239; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Dressel S, 2015, CONSERV BIOL, V29, P565, DOI 10.1111/cobi.12420; European Commission (EC), 2015, COMM AGR POL 2013; Fernandez-Gil A, 2013, THESIS U OVIEDO; Frank LG, 2005, CONSERV BIOL SER, V9, P286; Gore ML, 2009, J WILDLIFE MANAGE, V73, P1407, DOI 10.2193/2008-343; Gore ML, 2005, WILDLIFE SOC B, V33, P507, DOI 10.2193/0091-7648(2005)33[507:EORPOM]2.0.CO;2; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Haber GC, 1996, CONSERV BIOL, V10, P1068, DOI 10.1046/j.1523-1739.1996.10041068.x; Harper EK, 2008, J WILDLIFE MANAGE, V72, P778, DOI 10.2193/2007-273; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Jacobs MH, 2014, EUR J WILDLIFE RES, V60, P589, DOI 10.1007/s10344-014-0823-2; Kaczensky Petra, 1999, Ursus, V11, P59; Karlsson J, 2007, BIOL CONSERV, V137, P610, DOI 10.1016/j.biocon.2007.03.023; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Naves J, 2006, J MAMMAL, V87, P899, DOI 10.1644/05-MAMM-A-318R2.1; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Ordiz A, 2013, BIOL CONSERV, V168, P128, DOI 10.1016/j.biocon.2013.09.024; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Perez T, 2014, WILDLIFE BIOL, V20, P300, DOI 10.2981/wlb.00069; Peterson RO, 1984, WILDLIFE MONOGR, P3; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Pooley SP, 2014, CONSERV BIOL, V28, P22, DOI 10.1111/cobi.12183; Principado de Asturias, 2002, PLAN GESTION LOBO PR; Principado de Asturias, 2002, PLAN RECUPERACION OS; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith JA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2711; Sociedad Asturiana de Estudios Economicos e Industriales (SADEI), 2015, CAB GAN; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; THURBER JM, 1993, J MAMMAL, V74, P879, DOI 10.2307/1382426; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Treves A, 2010, URSUS, V21, P30, DOI 10.2192/09GR012.1; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Treves A, 2009, BIODIVERS CONSERV, V18, P4003, DOI 10.1007/s10531-009-9695-2; Vucetich JA, 2014, OXFORD HDB ANIMAL ST, DOI [10.1093/oxfordhb/9780199927142.013.007, DOI 10.1093/OXFORDHB/9780199927142.013.007]; Vucetich JA, 2012, BEHAV ECOL SOCIOBIOL, V66, P295, DOI 10.1007/s00265-011-1277-0; Wallach A.D., 2015, OIKOS; Weber W, 1996, CONSERV BIOL, V10, P1046, DOI 10.1046/j.1523-1739.1996.10041046.x; White Lynsey A., 2009, Human Dimensions of Wildlife, V14, P419; White RM, 2009, LAND USE POLICY, V26, P242, DOI 10.1016/j.landusepol.2008.03.005; Wiegand T, 1998, ECOL MONOGR, V68, P539, DOI 10.1890/0012-9615(1998)068[0539:ATROEF]2.0.CO;2; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R., 2005, CONSERV BIOL	61	66	67	10	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151541	10.1371/journal.pone.0151541	http://dx.doi.org/10.1371/journal.pone.0151541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974962	gold, Green Published, Green Accepted			2022-12-26	WOS:000372570600086
J	Liu, J; Tian, ZY; Xiao, YC; Wang, XL; Jin, ML; Shi, DS				Liu, Jin; Tian, Zhong-Yuan; Xiao, Yun-Cai; Wang, Xi-Liang; Jin, Mei-Lin; Shi, De-Shi			The Role of Porcine Monocyte Derived Dendritic Cells (MoDC) in the Inflammation Storm Caused by Streptococcus suis Serotype 2 Infection	PLOS ONE			English	Article							PATHOGENESIS; MENINGITIS; RECEPTORS; PIGS	Background Streptococcus suis is an important swine pathogen and zoonotic agent. Infection with this highly pathogenic strain can cause streptococcal toxic shock-like syndrome (STSLS), characterized by a Th-1 inflammatory cytokine storm, and a high mortality rate. Monocyte derived dendritic cells (MoDCs) are known to stimulate Th-1 cell differentiation, but the role of MoDCs in STSLS remains to be elucidated. Methodology and Findings Porcine CD14-positive monocytes, purified from peripheral blood mononuclear cells (PBMCs), were used to generate MoDCs using granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). Highly pure MoDCs were generated, as proved by their morphology, phenotype analysis, phagocytic ability, and induction of T cells proliferation. The MoDCs were further stimulated by the virulent S. suis serotype 2 (SS2) SC19 strain which triggered a strong release of several pro-inflammatory cytokines, including IL-1 beta, IL-8, TNF-alpha, IFN-gamma, and IL-12. Furthermore, the stimulated MoDCs induced CD4(+) T cell differentiation towards Th-1 cells in vitro. Conclusions The results of this study indicated that the porcine MoDCs stimulated by SS2 could release high levels of Th-1 inflammatory cytokines and induce CD4(+) T cell differentiation towards Th-1 cells. Hence, it is likely that porcine MoDCs play an important role in the STSLS caused by SS2.	[Liu, Jin; Tian, Zhong-Yuan; Xiao, Yun-Cai; Wang, Xi-Liang; Jin, Mei-Lin; Shi, De-Shi] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Liu, Jin; Tian, Zhong-Yuan; Xiao, Yun-Cai; Wang, Xi-Liang; Jin, Mei-Lin; Shi, De-Shi] Huazhong Agr Univ, Coll Vet Med, Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Shi, DS (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.; Shi, DS (corresponding author), Huazhong Agr Univ, Coll Vet Med, Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan 430070, Hubei, Peoples R China.	rock@mail.hzau.edu.cn			China National Natural Science Foundation of China [31372484]; Natural Science Foundation of Hubei Province of China [2012FFB02906]; Fundamental Research Funds for the Central Universities [2015PY117]	China National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by: De-Shi Shi: China National Natural Science Foundation of China (31372484); De-Shi Shi: the Natural Science Foundation of Hubei Province of China (2012FFB02906); De-Shi Shi: the Fundamental Research Funds for the Central Universities (2015PY117).	Araki H, 2001, BRIT J HAEMATOL, V114, P681, DOI 10.1046/j.1365-2141.2001.02973.x; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bi YH, 2014, VET MICROBIOL, V173, P299, DOI 10.1016/j.vetmic.2014.08.010; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Cecere TE, 2012, VET MICROBIOL, V160, P233, DOI 10.1016/j.vetmic.2012.04.040; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Ezquerra A, 2009, DEV COMP IMMUNOL, V33, P284, DOI 10.1016/j.dci.2008.06.002; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Higgins R, 1996, CAN VET J, V37, P242; Ip M, 2007, DIAGN MICR INFEC DIS, V57, P15, DOI 10.1016/j.diagmicrobio.2006.05.011; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; Knosp CA, 2012, IMMUNOLOGY, V135, P101, DOI 10.1111/j.1365-2567.2011.03520.x; Lecours MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044746; LEVIN D, 1993, J IMMUNOL, V151, P6742; Liu ML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-253; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Silva-Campa E, 2009, VIROLOGY, V387, P373, DOI 10.1016/j.virol.2009.02.033; Smith HE, 1999, INFECT IMMUN, V67, P1750; Speyer CL, 2011, J INVEST SURG, V24, P18, DOI 10.3109/08941939.2010.521232; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Yao Y, 2009, CLIN PEDIATR, V24, P789; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang QF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01180; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	33	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151256	10.1371/journal.pone.0151256	http://dx.doi.org/10.1371/journal.pone.0151256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974437	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600058
J	Gossmann, J; Stolte, M; Lohoff, M; Yu, P; Moll, R; Finkernagel, F; Garn, H; Brendel, C; Bittner, A; Neubauer, A; Huynh, MQ				Gossmann, Jennifer; Stolte, Manfred; Lohoff, Michael; Yu, Philipp; Moll, Roland; Finkernagel, Florian; Garn, Holger; Brendel, Cornelia; Bittner, Alwina; Neubauer, Andreas; Huynh, Minh Q.			A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma	PLOS ONE			English	Article							REGULATORY T-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PYLORI-ASSOCIATED GASTRITIS; FOXP3(+) TREG CELLS; SEE VOL. 79; B-CELLS; TISSUE LYMPHOMA; PHOSPHOLIPASE C-GAMMA-2; RHEUMATOID-ARTHRITIS; IMMUNE SUPPRESSION	Gastric mucosa-associated lymphoid tissue (MALT) lymphomas develop from a chronic Helicobacter infection. Phospholipase C gamma 2 (PLCG2) is important for B-cell survival and proliferation. We used BALB/c mice with a gain-of-function mutation in the Plcg2 gene (Ali5) to analyze its role in the development of gastric MALT lymphoma. Heterozygous BALB/c Plcg2(Ali5/+) and wildtype (WT) mice were infected with Helicobacter felis (H. felis) and observed up to 16 months for development of gastric MALT lymphomas. In contrast to our initial hypothesis, Plcg2(Ali5/+) mice developed MALT lymphomas less frequently than their WT littermates after long-term infection of 16 months. Infected Plcg2(Ali5/+) mice showed downregulation of proinflammatory cytokines and decreased H. felis-specific IgG1 and IgG2a antibody responses. These results suggested a blunted immune response of Plcg2(Ali5/+) mice towards H. felis infection. Intriguingly, Plcg2(Ali5/+) mice harboured higher numbers of CD73 expressing regulatory T cells (Tregs), possibly responsible for impaired immune response towards Helicobacter infection. We suggest that Plcg2(Ali5/+) mice may be protected from developing gastric MALT lymphomas as a result of elevated Treg numbers, reduced response to H. felis and decrease of proinflammatory cytokines.	[Gossmann, Jennifer; Brendel, Cornelia; Bittner, Alwina; Neubauer, Andreas; Huynh, Minh Q.] Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany; [Gossmann, Jennifer; Brendel, Cornelia; Bittner, Alwina; Neubauer, Andreas; Huynh, Minh Q.] Univ Hosp Giessen & Marburg, Marburg, Germany; [Stolte, Manfred] Kulmbach Hosp, Inst Pathol, Kulmbach, Germany; [Lohoff, Michael] Univ Marburg, Inst Med Microbiol, Marburg, Germany; [Yu, Philipp] Univ Marburg, Inst Immunol, Marburg, Germany; [Moll, Roland] Univ Marburg, Inst Pathol, Marburg, Germany; [Finkernagel, Florian] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany; [Garn, Holger] Univ Marburg, Inst Lab Med & Pathobiochem Mol Diagnost, Marburg, Germany; [Neubauer, Andreas] Univ Marburg, Inst Pharmacol & Clin Pharm, Marburg, Germany; [Huynh, Minh Q.] Landeskrankenhaus Bregenz, Bregenz, Austria	Philipps University Marburg; University Hospital of Giessen & Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Neubauer, A (corresponding author), Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany.; Neubauer, A (corresponding author), Univ Hosp Giessen & Marburg, Marburg, Germany.	neubauer@staff.uni-marburg.de	Brendel, Cornelia/U-5901-2019	Brendel, Cornelia/0000-0003-1612-9557; Garn, Holger/0000-0002-5178-4023	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) grant "Tumor and Inflammation"; University Hospital Giessen and Marburg (UKGM) [11/2013 MR]; Deutsche Forschungsgemeinschaft [KFO 210, NE 310/14-2, SFB TR22, 491.000]; Jose Carreras Leukamie-Stiftung [AH06-01]; Behring-Rontgen-Stiftung [TP3, 51-0057, 600.000]	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) grant "Tumor and Inflammation"; University Hospital Giessen and Marburg (UKGM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jose Carreras Leukamie-Stiftung; Behring-Rontgen-Stiftung	This work was supported by Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) grant "Tumor and Inflammation" (http://www.imt.uni-marburg.de/loewe/, project A1, to AN); research grant of the University Hospital Giessen and Marburg (UKGM, 11/2013 MR, to JG and MQH); Deutsche Forschungsgemeinschaft (KFO 210, NE 310/14-2, to AN and SFB TR22, 491.000., to ML; http://www.dfg.de); Jose Carreras Leukamie-Stiftung (https://www.carreras-stiftung.de, AH06-01, to AN); Behring-Rontgen-Stiftung (TP3, 51-0057, to AN and fellowship, 600.000., to ML; http://www.br-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2009, J INFECT DIS, V199, P494, DOI 10.1086/596205; Alvarado-Sanchez B, 2006, J AUTOIMMUN, V27, P110, DOI 10.1016/j.jaut.2006.06.005; BAYERDORFFER E, 1995, LANCET, V345, P1591, DOI 10.1016/S0140-6736(95)90113-2; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Bell SE, 2004, EUR J IMMUNOL, V34, P2237, DOI 10.1002/eji.200425054; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Cheng TY, 2006, J CLIN ONCOL, V24, P3483, DOI 10.1200/JCO.2005.05.5434; Chiu BCH, 2005, BRIT J HAEMATOL, V128, P610, DOI 10.1111/j.1365-2141.2004.05358.x; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; D'Elios MM, 2007, FEMS IMMUNOL MED MIC, V50, P157, DOI 10.1111/j.1574-695X.2007.00258.x; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Flores-Borja F, 2008, P NATL ACAD SCI USA, V105, P19396, DOI 10.1073/pnas.0806855105; Hellmig S, 2004, BLOOD, V104, P2994, DOI 10.1182/blood-2004-05-1792; Herz U, 1998, CLIN EXP ALLERGY, V28, P625; Huynh MQ, 2015, LEUKEMIA LYMPHOMA, V56, P1088, DOI 10.3109/10428194.2014.941832; Huynh MQ, 2008, LEUKEMIA LYMPHOMA, V49, P974, DOI 10.1080/10428190802007734; ISAACSON P, 1983, CANCER, V51, P80, DOI 10.1002/1097-0142(19830101)51:1<80::AID-CNCR2820510118>3.0.CO;2-0; Kaparakis M, 2006, INFECT IMMUN, V74, P3519, DOI 10.1128/IAI.01314-05; Kudo T, 2005, INFECT IMMUN, V73, P7602, DOI 10.1128/IAi.73.11.7602-7612.2005; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lindholm C, 2001, SCAND J GASTROENTERO, V36, P1022, DOI 10.1080/003655201750422602; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Lyssuk EY, 2007, ADV EXP MED BIOL, V601, P113; MANDLER R, 1993, J IMMUNOL, V150, P407; Mori N, 2003, INFECT IMMUN, V71, P3748, DOI 10.1128/IAI.71.7.3748-3756.2003; Neubauer A, 1997, JNCI-J NATL CANCER I, V89, P1350, DOI 10.1093/jnci/89.18.1350; Nielsen CH, 2005, TRANSFUS MED HEMOTH, V32, P339, DOI 10.1159/000089121; Nishi T, 2003, INFECT IMMUN, V71, P2153, DOI 10.1128/IAI.71.4.2153-2162.2003; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Petro JB, 2001, J BIOL CHEM, V276, P1715, DOI 10.1074/jbc.M009137200; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Rollinson S, 2003, BLOOD, V102, P1007, DOI 10.1182/blood-2002-12-3803; Sagaert X, 2010, NAT REV GASTRO HEPAT, V7, P336, DOI 10.1038/nrgastro.2010.58; Sarigul M, 2010, LUPUS, V19, P138, DOI 10.1177/0961203309348234; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; SNAPPER CM, 1988, J IMMUNOL, V141, P489; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; STOLTE M, 1992, LANCET, V339, P745, DOI 10.1016/0140-6736(92)90645-J; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Tomimori K, 2007, INFECT IMMUN, V75, P5223, DOI 10.1128/IAI.00731-07; Valencia X, 2007, NAT CLIN PRACT RHEUM, V3, P619, DOI 10.1038/ncprheum0624; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Wundisch T, 2006, LEUKEMIA LYMPHOMA, V47, P2110, DOI 10.1080/10428190600783536; Wundisch T, 2012, GASTROENTEROLOGY, V143, P936, DOI 10.1053/j.gastro.2012.06.035; Wundisch T, 2005, J CLIN ONCOL, V23, P8018, DOI 10.1200/JCO.2005.02.3903; Yamaoka Y, 1998, GUT, V42, P609, DOI 10.1136/gut.42.5.609; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Yoshida A, 2009, CLIN IMMUNOL, V130, P290, DOI 10.1016/j.clim.2008.09.016; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	54	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150411	10.1371/journal.pone.0150411	http://dx.doi.org/10.1371/journal.pone.0150411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966907	Green Submitted, gold, Green Published			2022-12-26	WOS:000371989200012
J	Liu, CC; Janke, LJ; Kawedia, JD; Ramsey, LB; Cai, XJ; Mattano, LA; Boyd, KL; Funk, AJ; Relling, MV				Liu, Chengcheng; Janke, Laura J.; Kawedia, Jitesh D.; Ramsey, Laura B.; Cai, Xiangjun; Mattano, Leonard A., Jr.; Boyd, Kelli L.; Funk, Amy J.; Relling, Mary V.			Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse Model	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; AVASCULAR NECROSIS; FEMORAL-HEAD; CHILDREN; THERAPY; DEXAMETHASONE; RISK; PHARMACOKINETICS; ARTERIOPATHY; COMPLICATION	Osteonecrosis is a common dose-limiting toxicity of glucocorticoids. Data from clinical trials suggest that other medications can increase the risk of glucocorticoid-induced osteonecrosis. Here we utilized a mouse model to study the effect of asparaginase treatment on dexamethasone-induced osteonecrosis. Mice receiving asparaginase along with dexamethasone had a higher rate of osteonecrosis than those receiving only dexamethasone after 6 weeks of treatment (44% vs. 10%, P = 0.006). Similarly, epiphyseal arteriopathy, which we have shown to be an initiating event for osteonecrosis, was observed in 58% of mice receiving asparaginase and dexamethasone compared to 17% of mice receiving dexamethasone only (P = 0.007). As in the clinic, greater exposure to asparaginase was associated with greater plasma exposure to dexamethasone (P = 0.0001). This model also recapitulated other clinical risk factors for osteonecrosis, including age at start of treatment, and association with the systemic exposure to dexamethasone (P = 0.027) and asparaginase (P = 0.036). We conclude that asparaginase can potentiate the osteonecrotic effect of glucocorticoids.	[Liu, Chengcheng; Cai, Xiangjun; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Janke, Laura J.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kawedia, Jitesh D.] Univ Texas MD Anderson Canc Ctr, Dept Pharm Res, Houston, TX 77030 USA; [Ramsey, Laura B.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Mattano, Leonard A., Jr.] HARP Pharma Consulting, Mystic, CT USA; [Boyd, Kelli L.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Funk, Amy J.] St Jude Childrens Res Hosp, Anim Resource Ctr Vet Serv, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Texas System; UTMD Anderson Cancer Center; Cincinnati Children's Hospital Medical Center; Vanderbilt University; St Jude Children's Research Hospital	Relling, MV (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	mary.relling@stjude.org	Ramsey, Laura/ABD-6113-2020; Janke, Laura/N-8121-2018; Relling, Mary/N-5032-2018	Ramsey, Laura/0000-0001-6417-3961; Janke, Laura/0000-0002-9871-6239; Kawedia, Jitesh/0000-0001-9685-9378	NIH; HARP Pharma Consulting; NATIONAL CANCER INSTITUTE [R01CA142665, P30CA021765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HARP Pharma Consulting; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grants provided by the NIH to MVR. HARP Pharma Consulting provided support in the form of salary for author LAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Appel IM, 2008, THROMB HAEMOSTASIS, V100, P330, DOI 10.1160/TH07-10-0620; Arico M, 2003, HAEMATOLOGICA, V88, P747; Athale UH, 2003, THROMB RES, V111, P199, DOI 10.1016/j.thromres.2003.10.007; Bhat V, 2015, AM J HEMATOL, V90, P1027, DOI 10.1002/ajh.24133; Bhojwani D, 2014, EUR J CANCER, V50, P2685, DOI 10.1016/j.ejca.2014.06.023; Bielinski SJ, 2014, MAYO CLIN PROC, V89, P25, DOI 10.1016/j.mayocp.2013.10.021; Burckart GJ, 2006, THER DRUG MONIT, V28, P23, DOI 10.1097/01.ftd.0000194502.85763.bc; Burger B, 2005, PEDIATR BLOOD CANCER, V44, P220, DOI 10.1002/pbc.20244; Chalothorn D, 2010, PHYSIOL GENOMICS, V42, P469, DOI 10.1152/physiolgenomics.00070.2010; Fernandez CA, 2013, INT J CLIN EXP MED, V6, P478; Halton JM, 1998, CANCER, V83, P379, DOI 10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P; HANADA T, 1989, EUR J PEDIATR, V149, P162, DOI 10.1007/BF01958270; Hawkins DS, 2004, CLIN CANCER RES, V10, P5335, DOI 10.1158/1078-0432.CCR-04-0222; Janke LJ, 2013, AM J PATHOL, V183, P19, DOI 10.1016/j.ajpath.2013.03.004; Kawedia JD, 2012, COMPARATIVE MED, V62, P466; Kawedia JD, 2012, BLOOD, V119, P1658, DOI 10.1182/blood-2011-09-381731; Kawedia JD, 2011, BLOOD, V117, P2340, DOI 10.1182/blood-2010-10-311969; Kerachian MA, 2009, J STEROID BIOCHEM, V114, P121, DOI 10.1016/j.jsbmb.2009.02.007; Liu C, 2012, LEUKEMIA, V26, P2303, DOI 10.1038/leu.2012.102; Mattano Jr LA, 2014, BLOOD; Mattano LA, 2000, J CLIN ONCOL, V18, P3262, DOI 10.1200/JCO.2000.18.18.3262; Mattano LAJ, 2012, BLOOD; Mitchell LG, 2003, CANCER, V97, P508, DOI 10.1002/cncr.11042; Muller HJ, 2000, BRIT J HAEMATOL, V110, P379, DOI 10.1046/j.1365-2141.2000.02187.x; Muller HJ, 2002, CANCER CHEMOTH PHARM, V49, P149, DOI 10.1007/s00280-001-0391-5; Murata M, 2007, J ORTHOP SCI, V12, P289, DOI 10.1007/s00776-007-1129-y; Niinimaki RA, 2007, J CLIN ONCOL, V25, P1498, DOI 10.1200/JCO.2006.06.2539; Parsons SK, 1997, BLOOD, V89, P1886, DOI 10.1182/blood.V89.6.1886; Patel B, 2008, LEUKEMIA, V22, P308, DOI 10.1038/sj.leu.2405032; Ramsey LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135134; Relling MV, 2004, J CLIN ONCOL, V22, P3930, DOI 10.1200/JCO.2004.11.020; Ribeiro RC, 2001, LEUKEMIA, V15, P891, DOI 10.1038/sj.leu.2402139; SAITO S, 1992, CLIN ORTHOP RELAT R, P98; Szymanska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033894; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Winkel MLT, 2008, HAEMATOL-HEMATOL J, V93, P1570, DOI 10.3324/haematol.12956; Winkel MLT, 2011, J CLIN ONCOL, V29, P4143, DOI 10.1200/JCO.2011.37.3217; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; Yang L, 2009, J ORTHOP RES, V27, P169, DOI 10.1002/jor.20733	39	34	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151433	10.1371/journal.pone.0151433	http://dx.doi.org/10.1371/journal.pone.0151433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967741	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200053
J	Tabrizi, ST; Sawicki, A; Zhou, SX; Luo, MZ; Willows, RD				Tabrizi, Shabnam Tarahi; Sawicki, Artur; Zhou, Shuaixiang; Luo, Meizhong; Willows, Robert D.			GUN4-Protoporphyrin IX Is a Singlet Oxygen Generator with Consequences for Plastid Retrograde Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG-PROTOPORPHYRIN IX; BIOCHEMICAL-CHARACTERIZATION; CHLOROPHYLL BIOSYNTHESIS; MAGNESIUM CHELATASE; GENE-EXPRESSION; PHOTOSYSTEM-II; QUANTUM YIELD; GUN4 PROTEIN; CHLOROPLAST; NUCLEUS	The genomes uncoupled 4 (GUN4) protein is a nuclear-encoded, chloroplast-localized, porphyrin-binding protein implicated in retrograde signaling between the chloroplast and nucleus, although its exact role in this process is still unclear. Functionally, it enhances Mg-chelatase activity in the chlorophyll biosynthesis pathway. Because GUN4 is present only in organisms that carry out oxygenic photosynthesis and because it binds protoporphyrin IX (PPIX) and Mg-PPIX, it has been suggested that it prevents production of light-and PPIX-or Mg-PPIX-dependent reactive oxygen species. A chld-1/GUN4 mutant with elevated PPIX has a light-dependent up-regulation of GUN4, implicating this protein in light-dependent sensing of PPIX, with the suggestion that GUN4 reduces PPIX-generated singlet oxygen, O-2(a(1)Delta(g)), and subsequent oxidative damage (Brzezowski, P., Schlicke, H., Richter, A., Dent, R. M., Niyogi, K. K., and Grimm, B. (2014) Plant J. 79, 285-298). In direct contrast, our results show that purified GUN4 and oxidatively damaged ChlH increase the rate of PPIX-generated singlet oxygen production in the light, by a factor of 5 and 10, respectively, when compared with PPIX alone. Additionally, the functional GUN4-PPIX-ChlH complex and ChlH-PPIX complexes generate O-2(a(1)Delta(g)) at a reduced rate when compared with GUN4-PPIX. As O-2(a(1)Delta(g)) is a potential plastid-to-nucleus signal, possibly through second messengers, light-dependent O-2(a(1)Delta(g)) generation by GUN4-PPIX is proposed to be part of a signal transduction pathway from the chloroplast to the nucleus. GUN4 thus senses the availability and flux of PPIX through the chlorophyll biosynthetic pathway and also modulates Mg-chelatase activity. The light-dependent O-2(a(1)Delta(g)) generation from GUN4-PPIX is thus proposed as the first step in retrograde signaling from the chloroplast to the nucleus.	[Tabrizi, Shabnam Tarahi; Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Sawicki, Artur] Jagiellonian Univ, Dept Biophys, Gronostajowa 7, PL-30387 Krakow, Poland; [Zhou, Shuaixiang; Luo, Meizhong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China	Macquarie University; Jagiellonian University; Huazhong Agricultural University	Willows, RD (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	robert.willows@mq.edu.au	Willows, Robert/C-1537-2010; Sawicki, Artur/G-7984-2016	Willows, Robert/0000-0002-0731-2950; Sawicki, Artur/0000-0001-6187-042X; Sawicki, Artur/0000-0002-1469-0845	National Natural Science Foundation of China [30971748]; Macquarie University Safety Net Scheme grant; MQRES scholarship from Macquarie University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Macquarie University Safety Net Scheme grant; MQRES scholarship from Macquarie University	This work was supported by the National Natural Science Foundation of China (Grant No. 30971748) and by a Macquarie University Safety Net Scheme 2014 grant. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an MQRES scholarship from Macquarie University.	Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Adhikari ND, 2009, J BIOL CHEM, V284, P24783, DOI 10.1074/jbc.M109.025205; Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Bosio GN, 2013, J AM CHEM SOC, V135, P272, DOI 10.1021/ja308930a; Brancaleon L, 2002, BIOPHYS CHEM, V96, P77, DOI 10.1016/S0301-4622(02)00035-2; Brzezowski P, 2014, PLANT J, V79, P285, DOI 10.1111/tpj.12560; Chen XM, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.125, 10.1038/NPLANTS.2015.125]; Chen XM, 2015, MOL PLANT, V8, P1125, DOI 10.1016/j.molp.2015.04.013; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Dawson R.M.C., 1986, DATA BIOCH RES, P128; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Formighieri C, 2012, MOL PLANT, V5, P1242, DOI 10.1093/mp/sss051; Fuhrhop J., 1971, BIOCH PREPARATIONS, V13, P55; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Kuimova MK, 2009, J AM CHEM SOC, V131, P332, DOI 10.1021/ja807484b; Laloi C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00039; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Mendez-Hurtado J, 2012, CHEM-EUR J, V18, P8437, DOI 10.1002/chem.201103680; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Muller AH, 2014, PROTEIN EXPRES PURIF, V101, P61, DOI 10.1016/j.pep.2014.06.004; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Rehman AU, 2013, BBA-BIOENERGETICS, V1827, P689, DOI 10.1016/j.bbabio.2013.02.016; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Shapiguzov A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00292; Singh R, 2015, J PLANT PHYSIOL, V181, P55, DOI 10.1016/j.jplph.2015.04.001; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Szechynska-Hebda M, 2013, J PLANT PHYSIOL, V170, P1501, DOI 10.1016/j.jplph.2013.06.005; Tabrizi ST, 2015, ACTA CRYSTALLOGR F, V71, P1094, DOI 10.1107/S2053230X15012248; TELFER A, 1994, J BIOL CHEM, V269, P13244; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Tripathy BC, 2007, BBA-BIOENERGETICS, V1767, P860, DOI 10.1016/j.bbabio.2007.03.008; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; VERLHAC JB, 1984, NOUV J CHIM, V8, P401; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Zhou SX, 2012, FEBS LETT, V586, P205, DOI 10.1016/j.febslet.2011.12.026	46	28	28	5	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8978	8984		10.1074/jbc.C116.719989	http://dx.doi.org/10.1074/jbc.C116.719989			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26969164	hybrid, Green Published			2022-12-26	WOS:000374849000011
J	Dave, JA; Levitt, NS; Ross, IL; Lacerda, M; Maartens, G; Blom, D				Dave, Joel A.; Levitt, Naomi S.; Ross, Ian L.; Lacerda, Miguel; Maartens, Gary; Blom, Dirk			Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; INSULIN SENSITIVITY; CARDIOVASCULAR RISK; LIPID-LEVELS; ABNORMALITIES; LIPODYSTROPHY; CHOLESTEROL; HYPERTRIGLYCERIDEMIA; PLASMA	Purpose Data on the prevalence of dyslipidaemia and associated risk factors in HIV-infected patients from sub-Saharan Africa is sparse. We performed a cross-sectional analysis in a cohort of HIV-infected South African adults. Methods We studied HIV-infected patients who were either antiretroviral therapy (ART)-naive or receiving non-nucleoside reverse transcriptase inhibitor (NNRTI)-based or protease inhibitor (PI)-based ART. Evaluation included fasting lipograms, oral glucose tolerance tests and clinical anthropometry. Dyslipidemia was defined using the NCEP ATPIII guidelines. Results The median age of the participants was 34 years (range 19-68 years) and 78% were women. The prevalence of dyslipidemia in 406 ART-naive and 551 participants on ART was 90.0% and 85%, respectively. Low HDL-cholesterol (HDLC) was the most common abnormality [290/406 (71%) ART-naive and 237/551 (43%) ART-participants]. Participants on ART had higher triglycerides (TG), total cholesterol (TC), LDL-cholesterol (LDLC) and HDLC than the ART-naive group. Severe dyslipidaemia, (LDLC > 4.9 mmol/L or TG > 5.0 mmol/L) was present in <5% of participants. In multivariate analyses there were complex associations between age, gender, type and duration of ART and body composition and LDLC, HDLC and TG, which differed between ART-naive and ART-participants. Conclusion Participants on ART had higher TG, TC, LDLC and HDLC than those who were ART-naive but severe lipid abnormalities requiring evaluation and treatment were uncommon.	[Dave, Joel A.; Levitt, Naomi S.; Ross, Ian L.] Univ Cape Town, Dept Med, Div Diabet Med, ZA-7925 Cape Town, South Africa; [Dave, Joel A.; Levitt, Naomi S.; Ross, Ian L.] Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa; [Lacerda, Miguel] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Blom, Dirk] Univ Cape Town, Dept Med, Div Lipidol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Dave, JA (corresponding author), Univ Cape Town, Dept Med, Div Diabet Med, ZA-7925 Cape Town, South Africa.; Dave, JA (corresponding author), Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa.	joel.dave@uct.ac.za	Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019; Ross, Ian Louis/N-7420-2017	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Levitt, Naomi/0000-0001-6480-8066; Dave, joel/0000-0003-3084-7408; Ross, Ian Louis/0000-0002-5308-7563	World Diabetes Foundation; South African Department of Health; National Research Foundation of South Africa	World Diabetes Foundation; South African Department of Health; National Research Foundation of South Africa(National Research Foundation - South Africa)	JD and NL received grants from the World Diabetes Foundation and the South African Department of Health. GM acknowledges partial support by the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams Z, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-26; Ali MK, 2014, JAIDS-J ACQ IMM DEF, V67, pS27, DOI 10.1097/QAI.0000000000000256; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Anastos K, 2007, JAIDS-J ACQ IMM DEF, V45, P34, DOI 10.1097/QAI.0b013e318042d5fe; Asiki G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126166; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Bekolo CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-236; Carey RAB, 2013, J POSTGRAD MED, V59, P258, DOI 10.4103/0022-3859.123145; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dave JA, 2011, JAIDS-J ACQ IMM DEF, V57, P284, DOI 10.1097/QAI.0b013e318221863f; De Requena DG, 2003, AIDS PATIENT CARE ST, V17, P443, DOI 10.1089/108729103322395465; de Waal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063623; Dube MP, 2001, J ACQ IMMUN DEF SYND, V27, P506; Ekali LG, 2013, DIABETES METAB, V39, P71, DOI 10.1016/j.diabet.2012.08.012; Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Friis-Moller N, 2008, CURR OPIN HIV AIDS, V3, P220, DOI 10.1097/COH.0b013e3282fb7bcf; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; GRUNFELD C, 1989, AM J MED, V86, P27, DOI 10.1016/0002-9343(89)90225-8; GRUNFELD C, 1991, AM J MED, V90, P154, DOI 10.1016/0002-9343(91)80154-E; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; Hammond R, 2008, INT J STD AIDS, V19, P291, DOI 10.1258/ijsa.2007.007248; Hurley E, 2011, SAMJ S AFR MED J, V101, P645; Janiszewski PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025032; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; Krentz AJ, 2003, DIABETES OBES METAB, V5, pS19, DOI 10.1046/j.1462-8902.2003.0310.x; Kuti Modupe Akinrele, 2015, J Int Assoc Provid AIDS Care, V14, P355, DOI 10.1177/2325957414555227; Liu E, 2013, CLIN INFECT DIS, V56, P1820, DOI 10.1093/cid/cit120; Martinez E, 2004, CLIN INFECT DIS, V38, P1017, DOI 10.1086/382531; Menezes CN, 2014, HIV MED, V15, P3, DOI 10.1111/hiv.12074; Muhammad S, 2013, ANN AFR MED, V12, P24, DOI 10.4103/1596-3519.108246; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; Norman R, 2007, S AFR MED J 2, V97, P708; Oka F, 2012, J INFECT CHEMOTHER, V18, P17, DOI 10.1007/s10156-011-0275-5; Schwartz SL, 2006, DIABETES OBES METAB, V8, P355, DOI 10.1111/j.1463-1326.2005.00516.x; SEEDAT YK, 1992, S AFR MED J, V82, P251; Stein JH, 2008, J CLIN LIPIDOL, V2, P464, DOI 10.1016/j.jacl.2008.08.442; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; van der Voort PHJ, 2003, INTENS CARE MED, V29, P2199, DOI 10.1007/s00134-003-2021-7; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	44	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151911	10.1371/journal.pone.0151911	http://dx.doi.org/10.1371/journal.pone.0151911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986065	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300149
J	Garces-Rimon, M; Gonzalez, C; Uranga, JA; Lopez-Miranda, V; Lopez-Fandino, R; Miguel, M				Garces-Rimon, M.; Gonzalez, C.; Uranga, J. A.; Lopez-Miranda, V.; Lopez-Fandino, R.; Miguel, M.			Pepsin Egg White Hydrolysate Ameliorates Obesity-Related Oxidative Stress, Inflammation and Steatosis in Zucker Fatty Rats	PLOS ONE			English	Article							LONG-TERM INTAKE; ARTERIAL-BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ANTIOXIDANT ACTIVITY; ADIPOSE-TISSUE; PEPTIDES; PLASMA; MODEL; ADIPONECTIN; PROTEINS	The aim of this work was to evaluate the effect of the administration of egg white hydrolysates on obesity-related disorders, with a focus on lipid metabolism, inflammation and oxidative stress, in Zucker fatty rats. Obese Zucker rats received water, pepsin egg white hydrolysate (750 mg/kg/day) or Rhizopus aminopeptidase egg white hydrolysate (750 mg/kg/day) for 12 weeks. Lean Zucker rats received water. Body weight, solid and liquid intakes were weekly measured. At the end of the study, urine, faeces, different organs and blood samples were collected. The consumption of egg white hydrolysed with pepsin significantly decreased the epididymal adipose tissue, improved hepatic steatosis, and lowered plasmatic concentration of free fatty acids in the obese animals. It also decreased plasma levels of tumor necrosis factor-alpha and reduced oxidative stress. Pepsin egg white hydrolysate could be used as a tool to improve obesity-related complications.	[Garces-Rimon, M.; Lopez-Fandino, R.; Miguel, M.] UAM, CSIC, CIAL, Inst Invest Ciencias Alimentac, Madrid, Spain; [Gonzalez, C.; Uranga, J. A.; Lopez-Miranda, V.] Univ Rey Juan Carlos, Fac Ciencias Salud, Dept Ciencias Basicas Salud, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); Universidad Rey Juan Carlos	Garces-Rimon, M (corresponding author), UAM, CSIC, CIAL, Inst Invest Ciencias Alimentac, Madrid, Spain.	m.garces.rimon@gmail.com	Garces-Rimon, Marta/AAD-3050-2021; MIGUEL, MARTA/F-6112-2011; López-Fandiño, Rosina/H-4132-2012; Uranga, Jose A/M-4343-2018; Lopez-Miranda, Visitacion/E-1116-2012	Garces-Rimon, Marta/0000-0002-3888-4150; MIGUEL, MARTA/0000-0002-5525-1056; López-Fandiño, Rosina/0000-0002-6979-9258; Uranga, Jose A/0000-0003-4656-8569; Lopez-Miranda, Visitacion/0000-0003-1378-0387	Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2012-32387, SAF2012-40075-C02-01]	Spanish Ministry of Economy and Competitiveness (MINECO)	This study has received financial support from the project AGL2012-32387 and SAF2012-40075-C02-01 from the Spanish Ministry of Economy and Competitiveness (MINECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1990, OFFICIAL METHODS ANA, VII; ARGILES JM, 1989, BIOCHEM J, V259, P673, DOI 10.1042/bj2590673; Bauer S, 2010, ARCH MED RES, V41, P75, DOI 10.1016/j.arcmed.2010.02.010; Beaulieu J, 2010, J MED FOOD, V13, P509, DOI 10.1089/jmf.2009.0083; Bjorndal B, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-143; Chentouf M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022954; Davalos A, 2004, J FOOD PROTECT, V67, P1939, DOI 10.4315/0362-028X-67.9.1939; DeMarco VG, 2010, CURR HYPERTENS REP, V12, P93, DOI 10.1007/s11906-010-0095-5; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Galisteo M, 2005, J NUTR, V135, P2399, DOI 10.1093/jn/135.10.2399; Galisteo M, 2010, CLIN NUTR, V29, P261, DOI 10.1016/j.clnu.2009.08.011; Garces-Rimon M, 2016, EUR FOOD RES TECHNOL, V242, P61, DOI 10.1007/s00217-015-2518-7; Gomez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; KASISKE BL, 1992, HYPERTENSION, V19, pI110, DOI 10.1161/01.HYP.19.1_Suppl.I110; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Lassoued I, 2014, FOOD FUNCT, V5, P1224, DOI 10.1039/c3fo60705d; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Manso MA, 2008, FOOD CHEM, V109, P361, DOI 10.1016/j.foodchem.2007.12.049; Matsunami T, 2011, METABOLISM, V60, P805, DOI 10.1016/j.metabol.2010.07.032; Matsunami T, 2010, INT J CLIN EXP PATHO, V3, P472; Miguel M, 2005, BRIT J NUTR, V94, P731, DOI 10.1079/BJN20051570; Miguel M, 2004, J FOOD PROTECT, V67, P1914, DOI 10.4315/0362-028X-67.9.1914; Miguel M, 2007, J AGR FOOD CHEM, V55, P10615, DOI 10.1021/jf072307o; Miguel M, 2007, MOL NUTR FOOD RES, V51, P555, DOI 10.1002/mnfr.200700012; Miguel M, 2006, LIFE SCI, V78, P2960, DOI 10.1016/j.lfs.2005.11.025; Miguel M, 2010, MOL NUTR FOOD RES, V54, P1422, DOI 10.1002/mnfr.200900448; Moran-Ramos S, 2012, J NUTR, V142, P1956, DOI 10.3945/jn.112.165563; Moughan PJ, 2014, NUTR RES REV, V27, P16, DOI 10.1017/S0954422413000206; Oana F, 2005, METABOLISM, V54, P995, DOI 10.1016/j.metabol.2005.02.016; Otani H, 2011, ANTIOXID REDOX SIGN, V15, P1911, DOI 10.1089/ars.2010.3739; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Picchi A, 2006, CIRC RES, V99, P69, DOI 10.1161/01.RES.0000229685.37402.80; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Ratliff J, 2010, NUTR RES, V30, P96, DOI 10.1016/j.nutres.2010.01.002; Richards RJ, 2001, KIDNEY INT, V59, P37, DOI 10.1046/j.1523-1755.2001.00463.x; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Sanchez D, 2011, PHARMACOL RES, V64, P31, DOI 10.1016/j.phrs.2011.02.005; Tovar AR, 2005, J LIPID RES, V46, P1823, DOI 10.1194/jlr.M500067-JLR200; VASSELLI JR, 1980, PHYSIOL BEHAV, V25, P565, DOI 10.1016/0031-9384(80)90123-7; Vaughn N, 2008, PLANT FOOD HUM NUTR, V63, P41, DOI 10.1007/s11130-007-0067-3; Vendrame S, 2013, J NUTR BIOCHEM, V24, P1508, DOI 10.1016/j.jnutbio.2012.12.010; Wang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046781; Wergedahl H, 2004, J NUTR, V134, P1320, DOI 10.1093/jn/134.6.1320; ZUCKER TF, 1962, P SOC EXP BIOL MED, V110, P165, DOI 10.3181/00379727-110-27455	48	54	57	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151193	10.1371/journal.pone.0151193	http://dx.doi.org/10.1371/journal.pone.0151193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985993	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300052
J	Liu, SY; Yue, LT; Gu, WR; Li, XY; Zhang, LP; Sun, SJ				Liu, Shuyuan; Yue, Longtao; Gu, Wenrui; Li, Xiuyun; Zhang, Liuping; Sun, Shujuan			Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; IN-VITRO INTERACTION; CLINICAL BREAKPOINTS; ANTIFUNGAL ACTIVITY; DRUG-RESISTANCE; HYPHAL GROWTH; CALCINEURIN; COMBINATION; AMIODARONE; VIRULENCE	Candidiasis has increased significantly recently that threatens patients with low immunity. However, the number of antifungal drugs on the market is limited in comparison to the number of available antibacterial drugs. This fact, coupled with the increased frequency of fungal resistance, makes it necessary to develop new therapeutic strategies. Combination drug therapy is one of the most widely used and effective strategy to alleviate this problem. In this paper, we were aimed to evaluate the combined antifungal effects of four CCBs (calcium channel blockers), amlodipine (AML), nifedipine (NIF), benidipine (BEN) and flunarizine (FNZ) with fluconazole against C. albicans by checkerboard and time-killing method. In addition, we determined gene (CCH1, MID1, CNA1, CNB1, YVC1, CDR1, CDR2 and MDR1) expression by quantitative PCR and investigated the efflux pump activity of resistant candida albicans by rhodamine 6G assay to reveal the potential mechanisms. Finally, we concluded that there was a synergy when fluconazole combined with the four tested CCBs against resistant strains, with fractional inhibitory concentration index (FICI) <0.5, but no interaction against sensitive strains (FICI = 0.56 similar to 2). The mechanism studies revealed that fluconazole plus amlodipine caused down-regulating of CNA1, CNB1 (encoding calcineurin) and YVC1 (encoding calcium channel protein in vacuole membrane).	[Liu, Shuyuan; Gu, Wenrui; Li, Xiuyun] Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China; [Liu, Shuyuan] Ordos Cent Hosp, Dept Pharm, Ordos 017000, Inner Mongolia, Peoples R China; [Yue, Longtao] Shandong Univ, Qianfoshan Hosp, Translat Med Res Ctr, Jinan 250014, Shandong, Peoples R China; [Zhang, Liuping] Taishan Med Univ, Sch Pharmaceut Sci, Tai An 271000, Shandong, Peoples R China; [Sun, Shujuan] Shandong Univ, Qianfoshan Hosp, Dept Pharm, Jinan 250014, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Sun, SJ (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Pharm, Jinan 250014, Shandong, Peoples R China.	sunshujuan888@163.com			Department of Science and Technology of Shandong Province [2013GSF11848]; Shandong Provincial Natural Science Foundation China [ZR2011HL049]	Department of Science and Technology of Shandong Province; Shandong Provincial Natural Science Foundation China(Natural Science Foundation of Shandong Province)	This work was supported by the Department of Science and Technology of Shandong Province (2013GSF11848) and Shandong Provincial Natural Science Foundation China (ZR2011HL049).	Afeltra J, 2004, ANTIMICROB AGENTS CH, V48, P1335, DOI 10.1128/AAC.48.4.1335-1343.2004; Azevedo MM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00669; Bagar T, 2012, FUNGAL GENET BIOL, V49, P779, DOI 10.1016/j.fgb.2012.07.007; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Bulatova NR, 2008, MED PRIN PRACT, V17, P117, DOI 10.1159/000112964; Chen TC, 2012, KAOHSIUNG J MED SCI, V28, P306, DOI 10.1016/j.kjms.2011.11.011; Chen YL, 2014, EUKARYOT CELL, V13, P844, DOI 10.1128/EC.00302-13; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Cui JJ, 2009, FEMS YEAST RES, V9, P1137, DOI 10.1111/j.1567-1364.2009.00552.x; da Silva CR, 2013, ANTIMICROB AGENTS CH, V57, P1691, DOI 10.1128/AAC.00966-12; Eddouzi J, 2013, ANTIMICROB AGENTS CH, V57, P3182, DOI 10.1128/AAC.00555-13; Gao Y, 2013, FEMS YEAST RES, V13, P453, DOI 10.1111/1567-1364.12048; Golabek K, 2015, ACTA BIOCHIM POL, V62, P247, DOI 10.18388/abp.2014_940; Guo FM, 2013, J ANTIMICROB CHEMOTH, V68, P1660, DOI 10.1093/jac/dkt083; Guo Q, 2008, J MED MICROBIOL, V57, P457, DOI 10.1099/jmm.0.47651-0; Jensen RH, 2015, J ANTIMICROB CHEMOTH, V70, P2551, DOI 10.1093/jac/dkv140; Krajewska-Kulak Elzbieta, 1993, Materia Medica Polona, V25, P143; Liu FF, 2015, FUNGAL GENET BIOL, V81, P182, DOI 10.1016/j.fgb.2014.12.005; Liu SY, 2015, EUKARYOT CELL, V14, P324, DOI 10.1128/EC.00271-14; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Lockhart SR, 2011, J CLIN MICROBIOL, V49, P4322, DOI 10.1128/JCM.05479-11; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Orasch C, 2014, CLIN MICROBIOL INFEC, V20, P698, DOI 10.1111/1469-0691.12440; Patenaude C, 2013, J BIOL CHEM, V288, P26256, DOI 10.1074/jbc.M113.494815; Pfaller MA, 2015, DIAGN MICR INFEC DIS, V82, P303, DOI 10.1016/j.diagmicrobio.2015.04.008; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2004, CLIN MICROBIOL REV, V17, P268, DOI 10.1128/CMR.17.2.268-280.2004; Pierce CG, 2013, EXPERT OPIN DRUG DIS, V8, P1117, DOI 10.1517/17460441.2013.807245; Rodrigues AAG, 2000, CURR MICROBIOL, V40, P145, DOI 10.1007/s002849910030; Sharma M, 2015, J CLIN DIAGN RES, V9, pDC20, DOI 10.7860/JCDR/2015/10094.5494; Shi WN, 2010, FEMS YEAST RES, V10, P885, DOI 10.1111/j.1567-1364.2010.00664.x; Sun LM, 2015, J APPL MICROBIOL, V118, P826, DOI 10.1111/jam.12737; Sun S, 2008, ANTIMICROB AGENTS CH, V52, P409, DOI 10.1128/AAC.01070-07; Teng JF, 2008, MICROBIOL-SGM, V154, P3775, DOI 10.1099/mic.0.2008/021089-0; Yu QL, 2014, FREE RADICAL BIO MED, V77, P152, DOI 10.1016/j.freeradbiomed.2014.09.011; Yu QL, 2014, FEMS YEAST RES, V14, P633, DOI 10.1111/1567-1364.12150; Yu QL, 2014, INT J MED MICROBIOL, V304, P339, DOI 10.1016/j.ijmm.2013.11.022; Yu QL, 2014, MYCOPATHOLOGIA, V177, P167, DOI 10.1007/s11046-014-9735-7; Yu QL, 2013, INT J ANTIMICROB AG, V41, P179, DOI 10.1016/j.ijantimicag.2012.10.009; Yu SJ, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov016; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044192	41	48	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150859	10.1371/journal.pone.0150859	http://dx.doi.org/10.1371/journal.pone.0150859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986478	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300031
J	Mendoza, MLZ; Lundberg, J; Ivarsson, M; Campos, P; Nylander, JAA; Sallstedt, T; Dalen, L				Mendoza, Marie Lisandra Zepeda; Lundberg, Johannes; Ivarsson, Magnus; Campos, Paula; Nylander, Johan A. A.; Sallstedt, Therese; Dalen, Love			Metagenomic Analysis from the Interior of a Speleothem in Tjuv-Ante's Cave, Northern Sweden	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; RNA GENE DATABASE; ANCIENT DNA; CARBONATE; ADSORPTION; GROWTH; STONE; EXOPOLYSACCHARIDES; EUSTIGMATOPHYCEAE; CONTAMINATION	Speleothems are secondary mineral deposits normally formed by water supersaturated with calcium carbonate percolating into underground caves, and are often associated with low-nutrient and mostly non-phototrophic conditions. Tjuv-Ante's cave is a shallow-depth cave formed by the action of waves, with granite and dolerite as major components, and opal-A and calcite as part of the speleothems, making it a rare kind of cave. We generated two DNA shotgun sequencing metagenomic datasets from the interior of a speleothem from Tjuv-Ante's cave representing areas of old and relatively recent speleothem formation. We used these datasets to perform i) an evaluation of the use of these speleothems as past biodiversity archives, ii) functional and taxonomic profiling of the speleothem's different formation periods, and iii) taxonomic comparison of the metagenomic results to previous microscopic analyses from a nearby speleothem of the same cave. Our analyses confirm the abundance of Actinobacteria and fungi as previously reported by microscopic analyses on this cave, however we also discovered a larger biodiversity. Interestingly, we identified photosynthetic genes, as well as genes related to iron and sulphur metabolism, suggesting the presence of chemoautotrophs. Furthermore, we identified taxa and functions related to biomineralization. However, we could not confidently establish the use of this type of speleothems as biological paleoarchives due to the potential leaching from the outside of the cave and the DNA damage that we propose has been caused by the fungal chemical etching.	[Mendoza, Marie Lisandra Zepeda; Campos, Paula] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Lundberg, Johannes] Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden; [Ivarsson, Magnus; Sallstedt, Therese] Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden; [Ivarsson, Magnus; Sallstedt, Therese] Swedish Museum Nat Hist, NordCEE, S-10405 Stockholm, Sweden; [Nylander, Johan A. A.; Dalen, Love] Swedish Museum Nat Hist, Dept Bioinformat & Genet, S-10405 Stockholm, Sweden	University of Copenhagen; Swedish Museum of Natural History; Swedish Museum of Natural History; Swedish Museum of Natural History; Swedish Museum of Natural History	Mendoza, MLZ (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	lisandracady@gmail.com	Dalén, Love/A-6686-2008; Campos, Paula F/B-1634-2010; Campos, Paula/ABF-9898-2021; Mendoza, Marie Lisandra Zepeda/C-2001-2015; Lundberg, Johannes/E-5844-2011	Dalén, Love/0000-0001-8270-7613; Campos, Paula F/0000-0003-1285-4671; Mendoza, Marie Lisandra Zepeda/0000-0002-1126-8219; Lundberg, Johannes/0000-0003-4316-9183	Danish Council for Independent Research grant [10-081390]; Lundbeck Foundation grant [R52-A5062]; Swedish Research Council [2012-4364, 2010-3929]; Danish National Research Foundation [DNRF53]; Tjuv-Ante's cave [521-6864-2010]	Danish Council for Independent Research grant; Lundbeck Foundation grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Tjuv-Ante's cave	MLZM acknowledges funding from the Danish Council for Independent Research grant 10-081390 and Lundbeck Foundation grant R52-A5062. MI acknowledges funding from the Swedish Research Council (Contracts 2012-4364 and 2010-3929) and the Danish National Research Foundation (DNRF53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very thankful to the Lansstyrelsen Vasterbotten, which granted us sampling permit for Tjuv-Ante's cave (case number 521-6864-2010). We are also grateful to M. Thomas P. Gilbert for mentoring and support. We are also grateful to Thomas Sicheritz-Ponten for providing access to the server at the Center for Biological Sequence Analysis (CBS) in The Technical University of Denmark (DTU) and for useful insights on the identified bacteria. We are also thankful to Rabbe Sjoberg and Juan Ramon Vidal Romani for initiating the studies of Tjuv-Ante's speleothems. We also acknowledge the Danish National High-Throughput DNA Sequencing Centre for performing the sequencing of the samples.	Abdullahi AS, 2006, J PHYCOL, V42, P363, DOI 10.1111/j.1529-8817.2006.00193.x; Abraham WR, 1999, INT J SYST BACTERIOL, V49, P1053, DOI 10.1099/00207713-49-3-1053; Andersen RA, 1998, PROTIST, V149, P61, DOI 10.1016/S1434-4610(98)70010-0; Arnstein HRV, 1988, FEBS LETT, V234, P506; ASHWORTH JM, 1975, BIOL SLIME MOULDS; Baranasic D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00581-13; BEZANILLA M, 1995, LANGMUIR, V11, P655, DOI 10.1021/la00002a050; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Brace S, 2012, P NATL ACAD SCI USA, V109, P20532, DOI 10.1073/pnas.1213322109; Braissant O, 2003, J SEDIMENT RES, V73, P485, DOI 10.1306/111302730485; Braissant O, 2012, J CAVE KARST STUD, V74, P116, DOI 10.4311/2011JCKS0213; Bricelj VM, 1997, LIMNOL OCEANOGR, V42, P1023, DOI 10.4319/lo.1997.42.5_part_2.1023; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chouaia B, 2012, J BACTERIOL, V194, P2752, DOI 10.1128/JB.00320-12; Cleaves HJ, 2011, CHEMOSPHERE, V83, P1560, DOI 10.1016/j.chemosphere.2011.01.023; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; de Boer W, 2004, INT J SYST EVOL MICR, V54, P857, DOI 10.1099/ijs.0.02920-0; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhami NK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00314; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fawley KP, 2007, PROTIST, V158, P325, DOI 10.1016/j.protis.2007.03.003; GarciaValles M, 1997, APPL GEOCHEM, V12, P255, DOI 10.1016/S0883-2927(96)00057-1; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Gonzalez JM, 2005, INT MICROBIOL, V8, P189; GORING CAI, 1952, SOIL SCI, V74, P149, DOI 10.1097/00010694-195208000-00005; Groth I, 1999, GEOMICROBIOL J, V16, P1, DOI 10.1080/014904599270703; Hammes Frederik, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P3, DOI 10.1023/A:1015135629155; Hasman H, 2014, J CLIN MICROBIOL, V52, P3136, DOI 10.1128/JCM.01369-14; Hill C., 1997, CAVE MINERALS WORLD; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HOLO H, 1986, ARCH MICROBIOL, V145, P173, DOI 10.1007/BF00446776; Holtzel A, 1998, J ANTIBIOT, V51, P699; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ivanova N, 2010, STAND GENOMIC SCI, V2, P158, DOI 10.4056/sigs.711311; Jones B, 2001, GEOMICROBIOL J, V18, P345, DOI 10.1080/01490450152467831; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kamennaya NA, 2012, MINERALS-BASEL, V2, P338, DOI 10.3390/min2040338; Klatt CG, 2013, ISME J, V7, P1775, DOI 10.1038/ismej.2013.52; Kouduka M, 2012, FEMS MICROBIOL LETT, V326, P47, DOI 10.1111/j.1574-6968.2011.02437.x; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Lauritzen SE, 1999, HOLOCENE, V9, P643, DOI 10.1191/095968399666229065; Le Metayer-Levrel G, 1999, SEDIMENT GEOL, V126, P25, DOI 10.1016/S0037-0738(99)00029-9; Liu N, 2005, FUEL PROCESS TECHNOL, V86, P1615, DOI 10.1016/j.fuproc.2005.01.008; Lundberg JEK, 2013, INT C SPEL P, P461; Luttge A, 2004, APPL ENVIRON MICROB, V70, P1627, DOI 10.1128/AEM.70.3.1627-1632.2004; MADIGAN MT, 1979, J BACTERIOL, V137, P524, DOI 10.1128/JB.137.1.524-530.1979; Maechler M., 2014, DIPTEST HARTIGANS DI; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Misiak K, 2011, WATER RES, V45, P3512, DOI 10.1016/j.watres.2011.04.020; OLTMANNS RH, 1989, APPL ENVIRON MICROB, V55, P2499, DOI 10.1128/AEM.55.10.2499-2504.1989; Oostergetel GT, 2010, PHOTOSYNTH RES, V104, P245, DOI 10.1007/s11120-010-9533-0; Ortiz M, 2014, ISME J, V8, P478, DOI 10.1038/ismej.2013.159; Ortiz M, 2013, MICROB ECOL, V65, P371, DOI 10.1007/s00248-012-0143-6; Persoons A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00450; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rodriguez-Navarro C, 2003, APPL ENVIRON MICROB, V69, P2182, DOI 10.1128/AEM.69.4.2182-2193.2003; Rosenbaum L., 2006, WALL STREET J, pD6; Sallstedt T, 2014, INT J SPELEOL, V43, P305, DOI 10.5038/1827-806X.43.3.7; Schleheck D, 2011, STAND GENOMIC SCI, V5, P298, DOI 10.4056/sigs.2215005; Sjooberg R, 1982, TUNNEL CAVES SO VAAS; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; Spear JR, 2007, APPL ENVIRON MICROB, V73, P6172, DOI 10.1128/AEM.00393-07; Stamm I, 2005, MOL MICROBIOL, V56, P1386, DOI 10.1111/j.1365-2958.2005.04640.x; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Stocks-Fischer S, 1999, SOIL BIOL BIOCHEM, V31, P1563, DOI 10.1016/S0038-0717(99)00082-6; Sutherland IW, 2001, WATER SCI TECHNOL, V43, P77, DOI 10.2166/wst.2001.0345; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; UFFEN RL, 1970, J BACTERIOL, V104, P462, DOI 10.1128/JB.104.1.462-472.1970; Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013; Webster A, 2006, TRENDS BIOTECHNOL, V24, P255, DOI 10.1016/j.tibtech.2006.04.005; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004; Yucel S, 2010, PAK J PHARM SCI, V23, P1	83	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151577	10.1371/journal.pone.0151577	http://dx.doi.org/10.1371/journal.pone.0151577			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985997	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300088
J	Shan, J; Oshima, T; Wu, LP; Fukui, H; Watari, J; Miwa, H				Shan, Jing; Oshima, Tadayuki; Wu, Liping; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto			Interferon gamma-Induced Nuclear Interleukin-33 Potentiates the Release of Esophageal Epithelial Derived Cytokines	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; BARRIER FUNCTION; GASTROESOPHAGEAL-REFLUX; IFN-GAMMA; INCREASED EXPRESSION; IL-33 EXPRESSION; KAPPA-B; CELLS; MUCOSA; INFLAMMATION	Background Esophageal epithelial cells are an initiating cell type in esophageal inflammation, playing an essential role in the pathogenesis of gastroesophageal reflux disease (GERD). A new tissue-derived cytokine, interleukin-33 (IL-33), has been shown to be upregulated in esophageal epithelial cell nuclei in GERD, taking part in mucosal inflammation. Here, inflammatory cytokines secreted by esophageal epithelial cells, and their regulation by IL-33, were investigated. Methods In an in vitro stratified squamous epithelial model, IL-33 expression was examined using quantitative RT-PCR, western blot, ELISA, and immunofluorescence. Epithelial cell secreted inflammatory cytokines were examined using multiplex flow immunoassay. IL-33 was knocked down with small interfering RNA (siRNA) in normal human esophageal epithelial cells (HEECs). Pharmacological inhibitors and signal transducers and activators of transcription 1 (STAT1) siRNA were used to explore the signaling pathways. Results Interferon (IFN)gamma treatment upregulated nuclear IL-33 in HEECs. Furthermore, HEECs can produce various inflammatory cytokines, such as IL-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), regulated on activation normal T-cell expressed and presumably secreted (RANTES), and granulocyte-macrophage colony-stimulating factor (GM-CSF) in response to IFN gamma. Nuclear, but not exogenous IL-33, amplified IFN induction of these cytokines. P38 mitogen-activated protein kinase (MAPK) and janus protein tyrosine kinases (JAK)/STAT1 were the common signaling pathways of IFN gamma-mediated induction of IL-33 and other cytokines. Conclusions Esophageal epithelial cells can actively participate in GERD pathogenesis through the production of various cytokines, and epithelial-derived IL-33 might play a central role in the production of these cytokines.	[Shan, Jing; Oshima, Tadayuki; Wu, Liping; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan; [Shan, Jing; Wu, Liping] Third Peoples Hosp Chengdu, Dept Gastroenterol, Chengdu, Peoples R China	Hyogo College of Medicine	Oshima, T (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan.	t-oshima@hyo-med.ac.jp			Japan Society for the Promotion of Science (JSPS) [25460939]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) (25460939 to TO); Grant-in-Aid for Researchers, Hyogo College of Medicine, 2014.	Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Buzzelli JN, 2015, CELL MOL GASTROENTER, V1, P203, DOI 10.1016/j.jcmgh.2014.12.003; Chen X, 2012, AM J PHYSIOL-GASTR L, V303, pG199, DOI 10.1152/ajpgi.00454.2011; Chen X, 2011, AM J PHYSIOL-GASTR L, V301, pG203, DOI 10.1152/ajpgi.00096.2011; Egea L, 2013, J IMMUNOL, V190, P1702, DOI 10.4049/jimmunol.1202368; Fitzgerald RC, 2002, GUT, V50, P451, DOI 10.1136/gut.50.4.451; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Hamaguchi M, 2003, DIGESTION, V68, P189, DOI 10.1159/000075698; Huo XF, 2014, GUT, V63, P1042, DOI 10.1136/gutjnl-2013-305533; Isomoto H, 2003, AM J GASTROENTEROL, V98, P551, DOI 10.1016/S0002-9270(02)06025-2; Isomoto H, 2007, SCAND J GASTROENTERO, V42, P410, DOI 10.1080/00365520600931469; Judd LM, 2016, AM J PHYSIOL-GASTR L, V310, pG13, DOI 10.1152/ajpgi.00290.2015; Lin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060963; Liu L, 2004, J INTERF CYTOK RES, V24, P334, DOI 10.1089/107999004323142196; Lopetuso LR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-18; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Nomura K, 2012, LARYNGOSCOPE, V122, P1185, DOI 10.1002/lary.23261; Oshima T, 2012, LAB INVEST, V92, P22, DOI 10.1038/labinvest.2011.139; Oshima T, 2011, AM J PHYSIOL-CELL PH, V300, pC1422, DOI 10.1152/ajpcell.00376.2010; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Rieder F, 2007, GASTROENTEROLOGY, V132, P154, DOI 10.1053/j.gastro.2006.10.009; Rieder F, 2010, AM J PHYSIOL-GASTR L, V298, pG571, DOI 10.1152/ajpgi.00454.2009; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076; Shan J, 2015, J GASTROENTEROL, V50, P414, DOI 10.1007/s00535-014-0988-1; Shan J, 2013, J GASTROEN HEPATOL, V28, P823, DOI 10.1111/jgh.12139; Shan J, 2012, AM J PHYSIOL-GASTR L, V303, pG1105, DOI 10.1152/ajpgi.00220.2012; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Yin H, 2013, INT IMMUNOPHARMACOL, V17, P432, DOI 10.1016/j.intimp.2013.07.008	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151701	10.1371/journal.pone.0151701	http://dx.doi.org/10.1371/journal.pone.0151701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986625	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300116
J	Yang, SS; Deng, HC; Zhang, QZ; Xie, J; Zeng, H; Jin, XL; Ling, ZX; Shan, QY; Liu, MM; Ma, YF; Tang, J; Wei, QP				Yang, Shasha; Deng, Huacong; Zhang, Qunzhou; Xie, Jing; Zeng, Hui; Jin, Xiaolong; Ling, Zixi; Shan, Qiaoyun; Liu, Momo; Ma, Yuefei; Tang, Juan; Wei, Qianping			Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling	PLOS ONE			English	Article							BINDING PROTEIN 10; CELL PROLIFERATION; APOPTOSIS; MICE; DISRUPTION; ADAPTER; CANCER; INJURY; LIPIDS; GAMMA	Growth factor receptor-bound protein 10 (Grb10) is an adaptor protein that can negatively regulate the insulin-like growth factor 1 receptor (IGF-1R). The IGF1-1R pathway is critical for cell growth and apoptosis and has been implicated in kidney diseases; however, it is still unknown whether Grb10 expression is up-regulated and plays a role in diabetic nephropathy. Catalpol, a major active ingredient of a traditional Chinese medicine, Rehmannia, has been reported to possess anti-inflammatory and anti-aging activities and then used to treat diabetes. Herein, we aimed to assess the therapeutic effect of catalpol on a mouse model diabetic nephropathy and the potential role of Grb10 in the pathogenesis of this diabetes-associated complication. Our results showed that catalpol treatment improved diabetes-associated impaired renal functions and ameliorated pathological changes in kidneys of diabetic mice. We also found that Grb10 expression was significantly elevated in kidneys of diabetic mice as compared with that in non-diabetic mice, while treatment with catalpol significantly abrogated the elevated Grb10 expression in diabetic kidneys. On the contrary, IGF-1 mRNA levels and IGF-1R phosphorylation were significantly higher in kidneys of catalpol-treated diabetic mice than those in non-treated diabetic mice. Our results suggest that elevated Grb10 expression may play an important role in the pathogenesis of diabetic nephropathy through suppressing IGF-1/IGF-1R signaling pathway, which might be a potential molecular target of catalpol for the treatment of this diabetic complication.	[Yang, Shasha; Xie, Jing; Zeng, Hui; Jin, Xiaolong; Ling, Zixi; Shan, Qiaoyun; Liu, Momo; Ma, Yuefei; Tang, Juan; Wei, Qianping] Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China; [Deng, Huacong] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China; [Zhang, Qunzhou] Univ Penn, Sch Dent Med, Dept Oral Surg & Pharmacol, Philadelphia, PA 19104 USA	Chongqing Medical University; Chongqing Medical University; University of Pennsylvania	Wei, QP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China.	wqp68894940@163.com			National Key Clinical Specialties Construction Program of China [[2013]544]; Chongqing Postgraduate Research Innovation Project [CYS14120]	National Key Clinical Specialties Construction Program of China; Chongqing Postgraduate Research Innovation Project	This work was supported by National Key Clinical Specialties Construction Program of China (No. [2013]544), The Chongqing Postgraduate Research Innovation Project (CYS14120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Uzri A, 2013, PEDIATR NEPHROL, V28, P2323, DOI 10.1007/s00467-013-2570-0; Alarcon-Aguilar FJ, 2000, J ETHNOPHARMACOL, V72, P21, DOI 10.1016/S0378-8741(00)00202-6; [Anonymous], 2012, SYST URD USRDS 2012; Bi J, 2013, TOXICOL IN VITRO, V27, P543, DOI 10.1016/j.tiv.2012.09.023; Chen CJ, 2013, J RADIAT RES, V54, P76, DOI 10.1093/jrr/rrs080; Chen WN, 2013, BRIT J PHARMACOL, V169, P1140, DOI 10.1111/bph.12200; Deng YP, 2003, J BIOL CHEM, V278, P39311, DOI 10.1074/jbc.M304599200; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Dong Z, 2013, PHYTOMEDICINE, V20, P1023, DOI 10.1016/j.phymed.2013.04.007; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Faraj M, 2004, BIOCHEM CELL BIOL, V82, P170, DOI 10.1139/o03-078; Fu K, 2014, INT IMMUNOPHARMACOL, V23, P400, DOI 10.1016/j.intimp.2014.07.011; Gao N, 2014, INT J MOL SCI, V15, P19394, DOI 10.3390/ijms151119394; Giovannone B, 2003, J BIOL CHEM, V278, P31564, DOI 10.1074/jbc.M211572200; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Holt LJ, 2012, FASEB J, V26, P3658, DOI 10.1096/fj.11-199349; Hu ZQ, 2010, MOL BIOL REP, V37, P3547, DOI 10.1007/s11033-010-0002-9; Ising C, 2015, EMBO MOL MED, V7, P275, DOI 10.15252/emmm.201404916; Kang BPS, 2003, AM J PHYSIOL-RENAL, V284, pF455, DOI 10.1152/ajprenal.00137.2002; Lawal AO, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0040-y; Lawrence JM, 2004, ATHEROSCLEROSIS, V174, P141, DOI 10.1016/j.atherosclerosis.2004.01.016; Lee MJ, 2010, J ETHNOPHARMACOL, V132, P497, DOI 10.1016/j.jep.2010.07.057; Li L, 2013, CLIN EXP PHARMACOL P, V40, P841, DOI 10.1111/1440-1681.12160; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Ma L, 2013, J NEUROENDOCRINOL, V25, P626, DOI 10.1111/jne.12040; Mokbel N, 2014, J CELL PHYSIOL, V229, P1753, DOI 10.1002/jcp.24628; Mroue R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005235; O-Sullivan I, 2008, CANCER RES, V68, P2463, DOI 10.1158/0008-5472.CAN-07-5685; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Varga ZV, 2015, BBA-MOL BASIS DIS, V1852, P232, DOI 10.1016/j.bbadis.2014.06.030; White KE, 2000, J AM SOC NEPHROL, V11, P1667, DOI 10.1681/ASN.V1191667; Xie JL, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-91; Yang S, 2005, AM J PHYSIOL-RENAL, V289, pF1144, DOI 10.1152/ajprenal.00094.2005; Yin DK, 2014, J ETHNOPHARMACOL, V151, P667, DOI 10.1016/j.jep.2013.11.025; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang JJ, 2012, DIABETES, V61, P3189, DOI 10.2337/db12-0249; Zhou HC, 2014, CHINESE MED J-PEKING, V127, P916, DOI 10.3760/cma.j.issn.0366-6999.20132137; Zhu JL, 2015, INT J CLIN EXP MED, V8, P2038	40	11	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151857	10.1371/journal.pone.0151857	http://dx.doi.org/10.1371/journal.pone.0151857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986757	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300141
J	Yen, YF; Jen, I; Chen, M; Chuang, PH; Liu, YL; Sharp, GB; Chen, YMA				Yen, Yung-Feng; Jen, Ian; Chen, Marcelo; Chuang, Pei-Hung; Liu, Yen-Ling; Sharp, Gerald B.; Chen, Yi-Ming Arthur			Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SMOOTH-MUSCLE-CELLS; RISK; TAIWAN; VIRUS; EXPRESSION; INFARCTION; EVENTS; BURDEN	Objectives Cytomegalovirus (CMV) infection might increase the risk of cardiovascular event. However, data on the link between incident stroke and co-infections of CMV and human immunodeficiency virus (HIV) are limited and inconsistent. This nationwide population-based cohort study analyzed the association of CMV end-organ disease and stroke among people living with HIV/AIDS (PLWHA). Methods From January 1, 1998, this study identified adult HIV individuals with and without CMV endorgan disease in the Taiwan National Health Insurance Research Database. All patients were observed for incident stroke and were followed until December 31, 2012. Time-dependent analysis was used to evaluate associations of CMV end-organ disease with stroke. Results Of the 22,581 PLWHA identified (439 with CMV end-organ disease and 22,142 without CMV end-organ disease), 228 (1.01%) had all-cause stroke during a mean follow-up period of 4.85 years, including 169 (0.75%) with ischemic stroke and 59 (0.26%) with hemorrhagic stroke. After adjusting for age, sex, comorbidities, opportunistic infections after HIV diagnosis, and antiretroviral treatment, CMV end-organ disease was found to be an independent risk factor for incident all-cause stroke (adjusted hazard ratio [AHR], 3.07; 95% confidence interval [CI], 1.70 to 5.55). When stroke type was considered, CMV end-organ disease was significantly positively associated with the risk of ischemic stroke (AHR, 3.14; 95% CI, 1.49 to 6.62) but not hemorrhagic stroke (AHR, 2.52; 95% CI, 0.64 to 9.91). Conclusions This study suggested that CMV end-organ disease was an independent predictor of ischemic stroke among PLWHA.	[Yen, Yung-Feng] Taipei City Hosp, Taipei City Govt, Infect Dis Sect, Taipei, Taiwan; [Yen, Yung-Feng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yen, Yung-Feng; Jen, Ian; Chuang, Pei-Hung; Liu, Yen-Ling; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Jen, Ian] Natl Yang Ming Univ, Dept & Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Marcelo] Mackay Mem Hosp, Dept Urol, Taipei, Taiwan; [Chen, Marcelo] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chuang, Pei-Hung] Taipei Vet Gen Hosp, Ctr Prevent & Treatment Occupat Injury & Dis, Taipei, Taiwan; [Chuang, Pei-Hung] Taipei Vet Gen Hosp, Dept Med, Div Clin Toxicol & Occupat Med, Taipei, Taiwan; [Sharp, Gerald B.] NIAID, Epidemiol Branch, Basic Sci Program, Div AIDS,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Dept Microbiol, Kaohsiung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Inst Med Res, Kaohsiung, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kaohsiung Medical University; Kaohsiung Medical University	Chen, YMA (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.; Chen, YMA (corresponding author), Kaohsiung Med Univ, Dept Microbiol, Kaohsiung, Taiwan.; Chen, YMA (corresponding author), Kaohsiung Med Univ, Inst Med Res, Kaohsiung, Taiwan.	arthur@kmu.edu.tw			amfAR (The Foundation for AIDS Research); U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute, International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01AI069907]; Kaohsiung Medical University "Aim for the Top Universities Grant" grant [KMU-TP103E01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	amfAR (The Foundation for AIDS Research); U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute, International Epidemiologic Databases to Evaluate AIDS (IeDEA); Kaohsiung Medical University "Aim for the Top Universities Grant" grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from amfAR (The Foundation for AIDS Research), with support from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Cancer Institute, as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA; U01AI069907). This study was also supported by Kaohsiung Medical University "Aim for the Top Universities Grant" grant No. KMU-TP103E01. The interpretation and conclusions contained herein are solely the responsibility of the authors and do not represent any of the above-mentioned institutions.	Anderson AM, 2010, J NEUROVIROL, V16, P179, DOI 10.3109/13550281003735717; Bolovan-Fritts CA, 2008, BLOOD, V111, P175, DOI 10.1182/blood-2007-08-107730; Chen M, 2015, J ACQUIR IMMUNE DEFI; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Collett, 2003, MODELLING SURVIVAL D; Ford N, 2013, CLIN INFECT DIS, V57, P1351, DOI 10.1093/cid/cit494; Huang ZR, 2012, CNS NEUROSCI THER, V18, P457, DOI 10.1111/j.1755-5949.2012.00326.x; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Juang HT, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0345-x; KOWALIK TF, 1993, P NATL ACAD SCI USA, V90, P1107, DOI 10.1073/pnas.90.3.1107; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Muller BT, 2005, VASA-J VASCULAR DIS, V34, P163, DOI 10.1024/0301-1526.34.3.163; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nagel M. A., 2010, Infectious Disorders - Drug Targets, V10, P105; Qiu H, 2008, J EXP MED, V205, P19, DOI 10.1084/jem.20070201; Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Shen YH, 2006, CARDIOVASC RES, V69, P502, DOI 10.1016/j.cardiores.2005.10.007; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Speir E, 1998, CIRC RES, V83, P210, DOI 10.1161/01.RES.83.2.210; Streblow DN, 2008, CURR TOP MICROBIOL, V325, P397; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yen YF, 2015, J CLIN PSYCHIAT, V76, pE505, DOI 10.4088/JCP.14m09403; Zhang XH, 2011, CNS NEUROSCI THER, V17, P590, DOI 10.1111/j.1755-5949.2011.00271.x	27	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151684	10.1371/journal.pone.0151684	http://dx.doi.org/10.1371/journal.pone.0151684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986005	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300112
J	Brekelmans, MP; Fens, N; Brinkman, P; Bos, LD; Sterk, PJ; Tak, PP; Gerlag, DM				Brekelmans, Marjolein P.; Fens, Niki; Brinkman, Paul; Bos, Lieuwe D.; Sterk, Peter J.; Tak, Paul P.; Gerlag, Danielle M.			Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study	PLOS ONE			English	Article							PSORIATIC-ARTHRITIS; BREATH ANALYSIS; EXHALED BREATH; RHEUMATOID-ARTHRITIS; CLINICAL-APPLICATION; LUNG; DISCRIMINATION; CANCER	Objective To investigate whether exhaled breath analysis using an electronic nose can identify differences between inflammatory joint diseases and healthy controls. Methods In a cross-sectional study, the exhaled breath of 21 rheumatoid arthritis (RA) and 18 psoriatic arthritis (PsA) patients with active disease was compared to 21 healthy controls using an electronic nose (Cyranose 320; Smiths Detection, Pasadena, CA, USA). Breathprints were analyzed with principal component analysis, discriminant analysis, and area under curve (AUC) of receiver operating characteristics (ROC) curves. Volatile organic compounds (VOCs) were identified by gas chromatography and mass spectrometry (GC-MS), and relationships between breathprints and markers of disease activity were explored. Results Breathprints of RA patients could be distinguished from controls with an accuracy of 71% (AUC 0.75, 95% CI 0.60-0.90, sensitivity 76%, specificity 67%). Breathprints from PsA patients were separated from controls with 69% accuracy (AUC 0.77, 95% CI 0.61-0.92, sensitivity 72%, specificity 71%). Distinction between exhaled breath of RA and PsA patients exhibited an accuracy of 69% (AUC 0.72, 95% CI 0.55-0.89, sensitivity 71%, specificity 72%). There was a positive correlation in RA patients of exhaled breathprints with disease activity score (DAS28) and number of painful joints. GC-MS identified seven key VOCs that significantly differed between the groups. Conclusions Exhaled breath analysis by an electronic nose may play a role in differential diagnosis of inflammatory joint diseases. Data from this study warrant external validation.	[Brekelmans, Marjolein P.; Tak, Paul P.; Gerlag, Danielle M.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Fens, Niki; Brinkman, Paul; Bos, Lieuwe D.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Bos, Lieuwe D.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Tak, Paul P.] Univ Cambridge, Cambridge, England; [Tak, Paul P.] Univ Ghent, B-9000 Ghent, Belgium; [Tak, Paul P.] GlaxoSmithKline, Stevenage, Herts, England; [Gerlag, Danielle M.] GlaxoSmithKline, Cambridge, England	University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Cambridge; Ghent University; GlaxoSmithKline; GlaxoSmithKline	Brekelmans, MP; Tak, PP (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Tak, PP (corresponding author), Univ Cambridge, Cambridge, England.; Tak, PP (corresponding author), Univ Ghent, B-9000 Ghent, Belgium.; Tak, PP (corresponding author), GlaxoSmithKline, Stevenage, Herts, England.	m.p.brekelmans@amc.nl; p.p.tak@amc.nl	Bos, Lieuwe/H-2578-2018; Sterk, P.J./AAK-8175-2020; Brinkman, Paul/AAV-5110-2021	Bos, Lieuwe/0000-0003-2911-4549; Brinkman, Paul/0000-0003-4546-8478				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Boots AW, 2015, TRENDS MOL MED, V21, P633, DOI 10.1016/j.molmed.2015.08.001; Buszewski B, 2007, BIOMED CHROMATOGR, V21, P553, DOI 10.1002/bmc.835; de Hair MJH, 2013, ANN RHEUM DIS, V72, P1654, DOI 10.1136/annrheumdis-2012-202254; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Fend R, 2006, J CLIN MICROBIOL, V44, P2039, DOI 10.1128/JCM.01591-05; Fens N, 2013, CLIN EXP ALLERGY, V43, P705, DOI 10.1111/cea.12052; Fens N, 2011, EUR RESPIR J, V38, P1301, DOI 10.1183/09031936.00032911; Fens N, 2011, CLIN EXP ALLERGY, V41, P1371, DOI 10.1111/j.1365-2222.2011.03800.x; Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Firestein GS, 2013, KELLEYS TXB RHEUMATO, V9th; Gladman DD, 2006, ANN RHEUM DIS, V65, P22, DOI 10.1136/ard.2006.058453; Greiter MB, 2010, DIABETES TECHNOL THE, V12, P455, DOI 10.1089/dia.2009.0181; Haick H, 2014, CHEM SOC REV, V43, P1423, DOI 10.1039/c3cs60329f; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Leopold JH, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/4/046002; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Mandl P, 2014, RHEUMATOLOGY, V53, P2136, DOI 10.1093/rheumatology/keu211; Mease PJ, 2011, ANN RHEUM DIS, V70, pI77, DOI 10.1136/ard.2010.140582; Mikuls TR, 2006, ANN RHEUM DIS, V65, P1252, DOI 10.1136/ard.2005.050641; Moser B, 2005, RESP PHYSIOL NEUROBI, V145, P295, DOI 10.1016/j.resp.2004.02.002; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Pereira J, 2015, METABOLITES, V5, P3, DOI 10.3390/metabo5010003; Phillips M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090226; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sethi S, 2013, CLIN MICROBIOL REV, V26, P462, DOI 10.1128/CMR.00020-13; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van de Sande MGH, 2012, RHEUMATOLOGY, V51, P1240, DOI 10.1093/rheumatology/kes011; van der Schee MP, 2015, CHEST, V147, P224, DOI 10.1378/chest.14-0781; Wilson AD, 2015, METABOLITES, V5, P140, DOI 10.3390/metabo5010140	41	18	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151715	10.1371/journal.pone.0151715	http://dx.doi.org/10.1371/journal.pone.0151715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982569	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900117
J	Kim, SH; Park, WS; Kim, SH; Park, B; Joo, J; Lee, GK; Joung, JY; Seo, HK; Chung, J; Lee, KH				Kim, Sung Han; Park, Weon Seo; Kim, Sun Ho; Park, Boram; Joo, Jungnam; Lee, Geon Kook; Joung, Jae Young; Seo, Ho Kyung; Chung, Jinsoo; Lee, Kang Hyun			Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy	PLOS ONE			English	Article							SEMINAL-VESICLE INVASION; ANDROGEN DEPRIVATION THERAPY; POSITIVE SURGICAL MARGINS; CARCINOMA; ADENOCARCINOMA; RADIATION; SURGERY; BENIGN	We aimed to identify tissue biomarkers that predict early biochemical recurrence (BCR) in patients with high-risk prostate cancer (PC), toward the goal of increasing the benefits of neoadjuvant hormonal therapy (NHT). In 2005-2012, prostatectomy specimens were collected from 134 PC patients who had received NHT and radical prostatectomy. The expression of 13 tissue biomarkers was assessed in the specimens via immunohistochemistry. Time to BCR and factors predictive of BCR were determined by using the Cox proportional hazards model. During the follow-up period (median, 57.5 months), 67 (50.0%) patients experienced BCR. Four (3.0%) patients were tumor-free in the final pathology assessment, and 101 (75.4%) had negative resection margins. Prostate stem cell antigen (PSCA) was the only significant prognostic tissue biomarker of BCR [hazard ratio (HR), 2.58; 95% confidence interval (CI), 1.06-6.27; p = 0.037] in a multivariable analysis adjusted by the clinicopathological variables that also significantly predicted BCR; these were seminal vesicle invasion (HR, 2.39; 95% CI, 1.32-4.34), initial prostate serum antigen level (HR 1.01; 95% CI, 1.001-1.020), prostate size (HR, 0.93; 95% CI, 0.90-0.97), and the Gleason score of preoperative biopsies (HR, 1.34; 95% CI, 1.01-1.79). We suggest that PSCA is a useful tissue marker for predicting BCR in patients with high risk PC receiving NHT and radical prostatectomy.	[Kim, Sung Han; Park, Weon Seo; Joung, Jae Young; Seo, Ho Kyung; Chung, Jinsoo; Lee, Kang Hyun] Natl Canc Ctr, Res Inst & Hosp, Dept Urol, Ctr Prostate Canc, Goyang, South Korea; [Park, Weon Seo; Lee, Geon Kook] Natl Canc Ctr, Res Inst & Hosp, Dept Pathol, Ctr Prostate Canc, Goyang, South Korea; [Kim, Sun Ho] Natl Canc Ctr, Res Inst & Hosp, Dept Radiol, Ctr Prostate Canc, Goyang, South Korea; [Park, Boram; Joo, Jungnam] Natl Canc Ctr, Res Inst & Hosp, Biometr Res Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Lee, KH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Dept Urol, Ctr Prostate Canc, Goyang, South Korea.	uroonco@ncc.re.kr		KIM, Sung Han/0000-0002-1689-5203; Park, Boram/0000-0003-2683-8795	Korean National Cancer Center Grants [1510170]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [20110010731]	Korean National Cancer Center Grants; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by the Korean National Cancer Center Grants (nos. 1510170). This treatise was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110010731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 2004, J UROLOGY, V171, P2221, DOI 10.1097/01.ju.0000124381.93689.b4; Bastide C, 2012, BJU INT, V109, P525, DOI 10.1111/j.1464-410X.2011.10332.x; Bazinet M, 1997, UROLOGY, V49, P721, DOI 10.1016/S0090-4295(97)00062-9; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Cho IC, 2011, J KOREAN MED SCI, V26, P807, DOI 10.3346/jkms.2011.26.6.807; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; DiPaola RS, 1999, SEMIN ONCOL, V26, P112; Epstein J. I., 2004, ACINAR ADENOCARCINOM; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Gleave ME, 2001, J UROLOGY, V166, P500, DOI 10.1016/S0022-5347(05)65971-X; Hamada R, 2016, INT J CLIN ONCOL, V21, P595, DOI 10.1007/s10147-015-0923-3; Han KR, 2004, J UROLOGY, V171, P1117, DOI 10.1097/01.ju.0000109982.60619.93; Joung JY, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0079-5; Kim SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/292454; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122498; Kristiansen A, 2013, HISTOPATHOLOGY, V62, P1049, DOI 10.1111/his.12104; Kusumi T, 2008, PATHOL INT, V58, P687, DOI 10.1111/j.1440-1827.2008.02294.x; Lam JS, 2005, CLIN CANCER RES, V11, P2591, DOI 10.1158/1078-0432.CCR-04-1842; Lou DY, 2014, UROLOGIC ONCOLOGY, DOI 10.1016/j.urolonc.2013.12.001; Mckay RR, 2013, DRUGS, V73, P1417, DOI 10.1007/s40265-013-0107-2; Petraki CD, 2007, HISTOL HISTOPATHOL, V22, P107, DOI 10.14670/HH-22.107; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Reuter VE, 1997, UROLOGY, V49, P16, DOI 10.1016/S0090-4295(97)00164-7; Richard V, 2014, PROG UROL, V24, P595, DOI 10.1016/j.purol.2014.02.005; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Shelley MD, 2009, CANCER TREAT REV, V35, P9, DOI 10.1016/j.ctrv.2008.08.002; Stamey TA, 2000, J UROLOGY, V163, P1155, DOI 10.1016/S0022-5347(05)67713-0; Szende B, 2001, PROSTATE, V49, P93, DOI 10.1002/pros.1122; TETU B, 1991, AM J SURG PATHOL, V15, P111, DOI 10.1097/00000478-199102000-00002; Vaillancourt L, 1996, AM J SURG PATHOL, V20, P86, DOI 10.1097/00000478-199601000-00010; Vogel UF, 2006, AM J CLIN PATHOL, V126, P342, DOI 10.1309/F2Q38DXN1V1V4GQM; Yossepowitch O, 2014, EUR UROL, V65, P303, DOI 10.1016/j.eururo.2013.07.039; Zhao ZG, 2005, PROSTATE, V65, P299, DOI 10.1002/pros.20290; Zhao ZG, 2007, PROSTATE, V67, P653, DOI 10.1002/pros.20536; Zhigang Zhao, 2006, Jpn J Clin Oncol, V36, P121, DOI 10.1093/jjco/hyi253	35	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151646	10.1371/journal.pone.0151646	http://dx.doi.org/10.1371/journal.pone.0151646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982980	Green Submitted, gold, Green Published			2022-12-26	WOS:000372574900109
J	DiNofia, AM; Salazar, E; Seif, AE; Li, YM; Huang, YSV; Bagatell, R; Fisher, BT; Aplenc, R				DiNofia, Amanda M.; Salazar, Elizabeth; Seif, Alix E.; Li, Yimei; Huang, Yuan-Shung Vera; Bagatell, Rochelle; Fisher, Brian T.; Aplenc, Richard			Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States	PLOS ONE			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; ACUTE LYMPHOBLASTIC-LEUKEMIA; ANTIBODY-MEDIATED REJECTION; ONCOLOGY GROUP; PEDIATRIC-PATIENTS; PHASE-I; THERAPEUTIC ADVANCES; CHILDHOOD LEUKEMIA; SOLID TUMORS; TRANSPLANT	This study is a pharmacoepidemiologic description of pediatric bortezomib use. Exposure was identified through billing codes in patients admitted to US children's hospitals that participated with the Pediatric Health Information System between 2004 and 2013. Associated information on underlying diseases, demographics, institutional use, mortality, and physician type was collected. Exposure to bortezomib was identified in 314 patients. Hematologist/Oncologists prescribed half of the bortezomib used. Use increased during the study period. Inpatient volume was positively correlated with bortezomib utilization. Bortezomib use in pediatrics is increasing for a variety of diseases. Variation in use exists across institutions. Further studies are needed to characterize bortezomib's efficacy in pediatric diseases.	[DiNofia, Amanda M.; Salazar, Elizabeth; Seif, Alix E.; Li, Yimei; Bagatell, Rochelle; Aplenc, Richard] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Seif, Alix E.; Bagatell, Rochelle; Fisher, Brian T.; Aplenc, Richard] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Yimei; Fisher, Brian T.; Aplenc, Richard] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Huang, Yuan-Shung Vera; Fisher, Brian T.; Aplenc, Richard] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Fisher, Brian T.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	DiNofia, AM (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA.	dinofiaa@email.chop.edu	; Seif, Alix/B-9918-2013	Fisher, Brian/0000-0002-8224-4281; Seif, Alix/0000-0002-1799-2582	National Cancer Institute [R01CA165277, 5T32CA009679-24]; National Institute of Child Health and Human Development [5T32HD064567-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD064567] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009679, P30CA016520, R01CA165277] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RA's work on this project was supported by the National Cancer Institute grant: R01CA165277 (http://www.cancer.gov). AD's work on this project was supported by the National Institute of Child Health and Human Development grant: 5T32HD064567-05 (https://www.nichd.nih.gov) and the National Cancer Institute grant: 5T32CA009679-24 (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaney SM, 2004, J CLIN ONCOL, V22, P4804, DOI 10.1200/JCO.2004.12.185; Claes DJ, 2014, PEDIATR TRANSPLANT, V18, pE100, DOI 10.1111/petr.12256; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Horton TM, 2015, BRIT J HAEMATOL, V170, P118, DOI 10.1111/bjh.13388; Horton TM, 2014, PEDIATR BLOOD CANCER, V61, P1754, DOI 10.1002/pbc.25117; Kavcic M, 2013, J PEDIATR-US, V162, P1252, DOI 10.1016/j.jpeds.2012.11.038; Khandelwal P, 2014, BIOL BLOOD MARROW TR, V20, pS174, DOI 10.1016/j.bbmt.2014.06.032; May LJ, 2014, PEDIATR TRANSPLANT, V18, pE280, DOI 10.1111/petr.12347; Mehta B, 2014, PEDIATR BLOOD CANCER, V61, P2324, DOI 10.1002/pbc.25172; Messinger Y, 2010, PEDIATR BLOOD CANCER, V55, P254, DOI 10.1002/pbc.22456; Messinger YH, 2012, BLOOD, V120, P285, DOI 10.1182/blood-2012-04-418640; Morrow WR, 2012, TRANSPLANTATION, V93, P319, DOI 10.1097/TP.0b013e31823f7eea; Muscal JA, 2013, PEDIATR BLOOD CANCER, V60, P390, DOI 10.1002/pbc.24271; Richardson PG, 2004, ANN MED, V36, P304, DOI 10.1080/07853890410030877; United Stated Census Bureau, 2015, STAT COUNT QUICK FAC; van Balen T, 2014, EUR J HAEMATOL, V92, P80, DOI 10.1111/ejh.12206; Zinn MD, 2014, PEDIATR TRANSPLANT, V18, P469, DOI 10.1111/petr.12300	18	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151362	10.1371/journal.pone.0151362	http://dx.doi.org/10.1371/journal.pone.0151362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978062	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800067
J	Knapp, M				Knapp, Michal			Relative Importance of Sex, Pre-Starvation Body Mass and Structural Body Size in the Determination of Exceptional Starvation Resistance of Anchomenus dorsalis (Coleoptera: Carabidae)	PLOS ONE			English	Article							ENERGY RESERVES; DROSOPHILA-MELANOGASTER; FOOD LIMITATION; BEETLE; FIELD; INSECTS; AVAILABILITY; POPULATION; DIMORPHISM; PHYSIOLOGY	In nature, almost all animals have to cope with periods of food shortage during their lifetimes. Starvation risks are especially high for carnivorous predatory species, which often experience long intervals between stochastic prey capturing events. A laboratory experiment using the common predatory carabid beetle Anchomenus dorsalis revealed an exceptional level of starvation resistance in this species: males survived up to 137 days and females up to 218 days without food at 20 degrees C. Individual starvation resistance was strongly positively affected by pre-starvation body mass but only slightly by beetle structural body size per se. Females outperformed males even when the effect of gender was corrected for the effects of structural body size and pre-starvation body mass. The better performance of females compared to males and of beetles with higher relative pre-starvation body mass could be linked to higher fat content and lean dry mass before starvation, followed by a greater decrease in both during starvation. There was also a difference between the sexes in the extent of body mass changes both during ad libitum feeding and following starvation; the body masses of females fluctuated more compared to males. This study stresses the need to distinguish between body mass and structural body size when investigating the ecological and evolutionary consequences of body size. Investigation of the net effects of body size and sex is necessary to disentangle the causes of differences in individual performances in studies of species with significant sexual size dimorphism.	[Knapp, Michal] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Kamycka 129, CZ-16521 Prague 6, Suchdol, Czech Republic	Czech University of Life Sciences Prague	Knapp, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Kamycka 129, CZ-16521 Prague 6, Suchdol, Czech Republic.	knapp@fzp.czu.cz	Knapp, Michal/AAF-4864-2020	Knapp, Michal/0000-0003-4487-7317	Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences in Prague (IGA) [42900/1312/3166, 42110/1312/3123]	Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences in Prague (IGA)	The work was supported by Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences in Prague (IGA); http://ga.czu.cz/; grant no. 42900/1312/3166 and 42110/1312/3123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal DD, 2014, J EXP BIOL, V217, P1849, DOI 10.1242/jeb.096792; [Anonymous], 2014, LANG ENV STAT COMP; [Anonymous], 1996, CARABIDAE CZECH SLOV; Baranovska E, 2014, EUR J ENTOMOL, V111, P608, DOI 10.14411/eje.2014.085; Baranovska E, 2014, CENT EUR J BIOL, V9, P476, DOI 10.2478/s11535-013-0282-x; Bilde T, 1998, OECOLOGIA, V115, P54, DOI 10.1007/s004420050490; BILDE T, 1994, ENTOMOL EXP APPL, V73, P151, DOI 10.1007/BF02383421; Blanckenhorn WU, 2007, PHYSIOL ENTOMOL, V32, P372, DOI 10.1111/j.1365-3032.2007.00589.x; Bommarco R, 1998, ENVIRON ENTOMOL, V27, P863, DOI 10.1093/ee/27.4.863; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Chaabane K, 1996, ANN ZOOL FENN, V33, P97; Chen H, 2011, B ENTOMOL RES, V101, P53, DOI 10.1017/S0007485310000209; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Gergs A, 2014, J ANIM ECOL, V83, P758, DOI 10.1111/1365-2656.12195; Goenaga J, 2013, EVOL BIOL, V40, P601, DOI 10.1007/s11692-013-9235-6; Hering D, 1997, OECOLOGIA, V111, P261, DOI 10.1007/s004420050234; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; Knapp M, 2013, J INSECT SCI, P13; Knapp M, 2014, J INSECT SCI, P14; Knapp M, 2012, ENTOMOL EXP APPL, V143, P185, DOI 10.1111/j.1570-7458.2012.01247.x; Krasnov BR, 2002, J VECTOR ECOL, V27, P70; Lang A, 2003, OECOLOGIA, V134, P144, DOI 10.1007/s00442-002-1091-5; Laparie M, 2012, COMP BIOCHEM PHYS A, V161, P122, DOI 10.1016/j.cbpa.2011.09.011; Lease HM, 2011, PHYSIOL ENTOMOL, V36, P29, DOI 10.1111/j.1365-3032.2010.00767.x; Lease HM, 2010, J MORPHOL, V271, P759, DOI 10.1002/jmor.10835; Lee KP, 2014, FUNCT ECOL, V28, P1144, DOI 10.1111/1365-2435.12247; Leps J, 2014, MULTIVARIATE ANAL EC; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; McCue M.D., 2012, COMP PHYSL FASTING S; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; McKemey AR, 2003, B ENTOMOL RES, V93, P227, DOI 10.1079/BER2003240; NEDVED O, 1994, EUR J ENTOMOL, V91, P307; Osawa N, 2005, EUR J ENTOMOL, V102, P503, DOI 10.14411/eje.2005.072; Ostman O, 2005, ECOL ENTOMOL, V30, P63, DOI 10.1111/j.0307-6946.2005.00661.x; Pijpe J, 2007, EVOL ECOL, V21, P589, DOI 10.1007/s10682-006-9137-5; Reim C, 2006, EVOL ECOL RES, V8, P1215; Resh VH., 2009, ENCY INSECTS; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; Saastamoinen M, 2009, P ROY SOC B-BIOL SCI, V276, P1313, DOI 10.1098/rspb.2008.1464; Stahlschmidt ZR, 2013, FUNCT ECOL, V27, P800, DOI 10.1111/1365-2435.12071; Stern DL, 1999, DEVELOPMENT, V126, P1091; Teder T, 2014, FUNCT ECOL, V28, P479, DOI 10.1111/1365-2435.12172; Tejeda MT, 2014, J INSECT PHYSIOL, V70, P73, DOI 10.1016/j.jinsphys.2014.08.011; van Uitregt VO, 2012, J ANIM ECOL, V81, P108, DOI 10.1111/j.1365-2656.2011.01880.x; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Young OP, 2008, ANN ENTOMOL SOC AM, V101, P104, DOI 10.1603/0013-8746(2008)101[104:BWASOC]2.0.CO;2	46	16	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151459	10.1371/journal.pone.0151459	http://dx.doi.org/10.1371/journal.pone.0151459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978071	gold, Green Published			2022-12-26	WOS:000372572800075
J	Langlois, A; Mura, C; Bietiger, W; Seyfritz, E; Dollinger, C; Peronet, C; Maillard, E; Pinget, M; Jeandidier, N; Sigrist, S				Langlois, Allan; Mura, Carole; Bietiger, William; Seyfritz, Elodie; Dollinger, Camille; Peronet, Claude; Maillard, Elisa; Pinget, Michel; Jeandidier, Nathalie; Sigrist, Severine			In Vitro and In Vivo Investigation of the Angiogenic Effects of Liraglutide during Islet Transplantation	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ENDOTHELIAL GROWTH-FACTOR; BETA-CELLS; PANCREATIC-ISLETS; SURVIVAL; ANALOG; VEGF; VIABILITY; APOPTOSIS; PATHWAY	Introduction This study investigated the angiogenic properties of liraglutide in vitro and in vivo and the mechanisms involved, with a focus on Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) and mammalian target of rapamycin (mTOR). Materials and Methods Rat pancreatic islets were incubated in vitro with 10 mu mol/L of liraglutide (Lira) for 12, 24 and 48 h. Islet viability was studied by fluorescein diacetate/propidium iodide staining and their function was assessed by glucose stimulation. The angiogenic effect of liraglutide was determined in vitro by the measure of vascular endothelial growth factor (VEGF) secretion using enzyme-linked immunosorbent assay and by the evaluation of VEGF and platelet-derived growth factor-a (PDGF alpha) expression with quantitative polymerase chain reaction technic. Then, in vitro and in vivo, angiogenic property of Lira was evaluated using immunofluorescence staining targeting the cluster of differentiation 31 (CD31). To understand angiogenic mechanisms involved by Lira, HIF-1a and mTOR activation were studied using western blotting. In vivo, islets (1000/kg body-weight) were transplanted into diabetic (streptozotocin) Lewis rats. Metabolic control was assessed for 1 month by measuring body-weight gain and fasting blood glucose. Results Islet viability and function were respectively preserved and enhanced (p<0.05) with Lira, versus control. Lira increased CD31-positive cells, expression of VEGF and PDGFa (p<0.05) after 24 h in culture. Increased VEGF secretion versus control was also observed at 48 h (p<0.05). Moreover, Lira activated mTOR (p<0.05) signalling pathway. In vivo, Lira improved vascular density (p<0.01), body-weight gain (p<0.01) and reduced fasting blood glucose in transplanted rats (p<0.001). Conclusion The beneficial effects of liraglutide on islets appeared to be linked to its angiogenic properties. These findings indicated that glucagon-like peptide-1 analogues could be used to improve transplanted islet revascularisation.	[Langlois, Allan; Mura, Carole; Bietiger, William; Seyfritz, Elodie; Dollinger, Camille; Peronet, Claude; Maillard, Elisa; Pinget, Michel; Jeandidier, Nathalie; Sigrist, Severine] Univ Strasbourg, Ctr Europeen Etude Diabete, UMR DIATHEC, EA 7294,FMTS, Bld Rene Leriche, F-67200 Strasbourg, France; [Pinget, Michel; Jeandidier, Nathalie] Hop Univ Strasbourg, Pole NUDE, Serv Endocrinol, Diabete,Malad Metabol, F-67000 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sigrist, S (corresponding author), Univ Strasbourg, Ctr Europeen Etude Diabete, UMR DIATHEC, EA 7294,FMTS, Bld Rene Leriche, F-67200 Strasbourg, France.	s.sigrist@ceed-diabete.org			Novo Nordisk; ASDIA; Vaincre le diabete	Novo Nordisk(Novo Nordisk); ASDIA; Vaincre le diabete	This work was funded by Novo Nordisk, ASDIA and Vaincre le diabete. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Bloch K, 2012, HISTOCHEM CELL BIOL, V137, P801, DOI 10.1007/s00418-012-0925-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Carmeliet P, 2004, J INTERN MED, V255, P538, DOI 10.1111/j.1365-2796.2003.01297.x; Coppens V, 2013, DIABETOLOGIA, V56, P382, DOI 10.1007/s00125-012-2754-3; Cornu M, 2009, ISLETS, V1, P280, DOI 10.4161/isl.1.3.9932; Cross SE, 2007, DIABETOLOGIA, V50, P1423, DOI 10.1007/s00125-007-0670-8; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254; Emamaullee JA, 2009, ENDOCRINOLOGY, V150, P2145, DOI 10.1210/en.2008-1116; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Kang HM, 2013, BIOCHEM BIOPH RES CO, V434, P150, DOI 10.1016/j.bbrc.2013.03.053; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Langlois A, 2011, CELL TRANSPLANT, V20, P1333, DOI 10.3727/096368910X557182; Langlois A, 2009, J DRUG TARGET, V17, P415, DOI 10.1080/10611860902929832; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merani S, 2008, ENDOCRINOLOGY, V149, P4322, DOI 10.1210/en.2008-0501; Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x; Narang AS, 2006, PHARM RES, V23, P1970, DOI 10.1007/s11095-006-9065-7; Nishimura R, 2013, TRANSPL P, V45, P1892, DOI 10.1016/j.transproceed.2013.01.047; Padmasekar M, 2013, ENDOCRINOLOGY, V154, P1424, DOI 10.1210/en.2012-1983; Pepper AR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/352315; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Samikannu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082639; Sato K, 2013, INT J MOL SCI, V14, P21513, DOI 10.3390/ijms141121513; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sigrist S, 2003, CELL TRANSPLANT, V12, P627, DOI 10.3727/000000003108747109; Stokes RA, 2013, CELL TRANSPLANT, V22, P253, DOI 10.3727/096368912X647180; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Toso C, 2010, TRANSPL INT, V23, P259, DOI 10.1111/j.1432-2277.2009.00984.x; Wittig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069975; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963	39	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0147068	10.1371/journal.pone.0147068	http://dx.doi.org/10.1371/journal.pone.0147068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974949	Green Published, gold			2022-12-26	WOS:000372570600007
J	Loibner, M; Buzina, W; Viertler, C; Groelz, D; Hausleitner, A; Siaulyte, G; Kufferath, I; Kolli, B; Zatloukal, K				Loibner, Martina; Buzina, Walter; Viertler, Christian; Groelz, Daniel; Hausleitner, Anja; Siaulyte, Gintare; Kufferath, Iris; Koelli, Bettina; Zatloukal, Kurt			Pathogen Inactivating Properties and Increased Sensitivity in Molecular Diagnostics by PAXgene, a Novel Non-Crosslinking Tissue Fixative	PLOS ONE			English	Article							STERILIZATION; FORMALIN; TRANSPLANTS; MORPHOLOGY; VIRUS	Background Requirements on tissue fixatives are getting more demanding as molecular analysis becomes increasingly relevant for routine diagnostics. Buffered formaldehyde in pathology laboratories for tissue fixation is known to cause chemical modifications of biomolecules which affect molecular testing. A novel non-crosslinking tissue preservation technology, PAXgene Tissue (PAXgene), was developed to preserve the integrity of nucleic acids in a comparable way to cryopreservation and also to preserve morphological features comparable to those of formalin fixed samples. Methods Because of the excellent preservation of biomolecules by PAXgene we investigated its pathogen inactivation ability and biosafety in comparison to formalin by in-vitro testing of bacteria, human relevant fungi and human cytomegalovirus (CMV). Guidelines for testing disinfectants served as reference for inactivation assays. Furthermore, we tested the properties of PAXgene for detection of pathogens by PCR based assays. Results All microorganisms tested were similarly inactivated by PAXgene and formalin except Clostridium sporogenes, which remained viable in seven out of ten assays after PAXgene treatment and in three out of ten assays after formalin fixation. The findings suggest that similar biosafety measures can be applied for PAXgene and formalin fixed samples. Detection of pathogens in PCR-based diagnostics using two CMV assays resulted in a reduction of four to ten quantification cycles of PAXgene treated samples which is a remarkable increase of sensitivity. Conclusion PAXgene fixation might be superior to formalin fixation when molecular diagnostics and highly sensitive detection of pathogens is required in parallel to morphology assessment.	[Loibner, Martina; Hausleitner, Anja; Siaulyte, Gintare; Kufferath, Iris; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Christian Doppler Lab Biospecimen Res & Biobankin, Graz, Austria; [Loibner, Martina; Viertler, Christian; Siaulyte, Gintare; Kufferath, Iris; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Buzina, Walter; Koelli, Bettina] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria; [Groelz, Daniel] Qiagen GmbH, Res & Dev, Hilden, Germany; [Hausleitner, Anja] LKH Hosp Weiz, Dept Lab Med, Weiz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; QIAGEN GmbH	Zatloukal, K (corresponding author), Med Univ Graz, Inst Pathol, Christian Doppler Lab Biospecimen Res & Biobankin, Graz, Austria.; Zatloukal, K (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	kurt.zatloukal@medunigraz.at			Christian Doppler Research Fund for Biospecimen Research and Biobanking Technologies; Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; Hygiene-Funds of the Medical University of Graz; Christian Doppler Laboratory for Biospecimen Research and Biobanking Technologies	Christian Doppler Research Fund for Biospecimen Research and Biobanking Technologies; Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; Hygiene-Funds of the Medical University of Graz; Christian Doppler Laboratory for Biospecimen Research and Biobanking Technologies	This work was supported by the Christian Doppler Research Fund for Biospecimen Research and Biobanking Technologies, the Austrian Federal Ministry of Science, Research and Economy, the National Foundation for Research, Technology and Development and the Hygiene-Funds of the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to Dr. Ralf Wyrich (Qiagen GmbH) for critical reading and scientific discussions, Dr. Penelope Kungl (Medical University of Graz) for critical reading and reviewing for verbal skills, Dr. Clemes Kittinger and Rita Baumert for their excellent support with Mycobacteria experiments. The work was supported by the Christian Doppler Laboratory for Biospecimen Research and Biobanking Technologies.	[Anonymous], 2008, HEALTHCARE INFECT CO; Blum F, 1983, Z WISS MIKROSK, V10, P314; BROWN F, 1993, DEV BIOL STAND, V81, P103; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; DellIsola G., 1895, BOLL ACAD MED GENOVA, V10, P84; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Ergin B, 2010, J PROTEOME RES, V9, P5188, DOI 10.1021/pr100664e; Gebel J, 2007, GMS KRANKENHAUSHYGIE, V2, pDoc17; Gebel J., 2002, STANDARDMETHODEN DGH; Grizzle WE, 2001, BIOTECH HISTOCHEM, V76, P183, DOI 10.1080/714028143; Groelz D, 2013, EXP MOL PATHOL, V94, P188, DOI 10.1016/j.yexmp.2012.07.002; Gundisch S, 2014, VIRCHOWS ARCH, V465, P509, DOI 10.1007/s00428-014-1624-4; Gundisch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060638; Gullett JC, 2015, CLIN CHEM, V61, P72, DOI 10.1373/clinchem.2014.223289; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Kap M, 2013, BIOPRESERV BIOBANK, V11, P229, DOI 10.1089/bio.2013.0010; Kap M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027704; Kashofer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070714; Nadji M, 2005, APPL IMMUNOHISTO M M, V13, P277, DOI 10.1097/01.pai.0000146544.51771.79; Nietner T, 2012, VIRCHOWS ARCH, V461, P259, DOI 10.1007/s00428-012-1248-5; Olert J, 2001, PATHOL RES PRACT, V197, P823, DOI 10.1078/0344-0338-00166; Pruss A, 2001, BIOLOGICALS, V29, P59, DOI 10.1006/biol.2001.0286; Pruss A, 1999, BIOLOGICALS, V27, P195, DOI 10.1006/biol.1999.0177; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P107, DOI 10.1086/650197; Sagripanti JL, 1997, AM J INFECT CONTROL, V25, P335, DOI 10.1016/S0196-6553(97)90026-2; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Staff S, 2013, J CLIN PATHOL, V66, P807, DOI 10.1136/jclinpath-2012-201283; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Thatcher SA, 2015, CLIN CHEM, V61, P89, DOI 10.1373/clinchem.2014.221374; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Viertler C, 2012, J MOL DIAGN, V14, P458, DOI 10.1016/j.jmoldx.2012.05.002	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151383	10.1371/journal.pone.0151383	http://dx.doi.org/10.1371/journal.pone.0151383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974150	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600072
J	Loiola, CM; Azevedo, AON; Diniz, LEC; Aragao, WM; Azevedo, CDD; Santos, PHAD; Ramos, HCC; Pereira, MG; Ramos, SRR				Loiola, Carina Mendes; Nunes Azevedo, Alinne Oliveira; Diniz, Leandro E. C.; Aragao, Wilson Menezes; Azevedo, Carlos Diego de O.; Santos, Pedro Henrique A. D.; Ramos, Helaine Christine C.; Pereira, Messias Gonzaga; Ramalho Ramos, Semiramis R.			Genetic Relationships among Tall Coconut Palm (Cocos nucifera L.) Accessions of the International Coconut Genebank for Latin America and the Caribbean (ICG-LAC), Evaluated Using Microsatellite Markers (SSRs)	PLOS ONE			English	Article							DIVERSITY; POPULATIONS	The diversity and genetic relationships among two accessions of tall coconut palms collected in Brazil and seven accessions introduced from different geographic regions of the world were analyzed using 25 microsatellite primers, 19 of which were polymorphic and detected between 4 and 10 alleles per locus, with an average of 6.57. The observed and expected heterozygosity ranged from 0.25 and 0.40 in the Rennell Islands Tall (RIT) accession to 0.54 and 0.62 in the Polynesian Tall (PYT) accession. The analysis of genetic structure resulted in the formation of five distinct groups. The first group was formed by the accessions Brazilian Tall-Praia do Forte (BRTPF), Brazilian Tall-Merepe (BRTMe) and West African Tall (WAT); the second group consisted of Malaysian Tall (MLT); the third group of RIT; the fourth group of Vanuatu Tall (VTT); and the fifth group of Rotuman Tall (RTMT), Tonga Tall (TONT) and PYT. The dendrogram based on the nearest-neighbor method detected the formation of two main groups and five subgroups, indicating that the genetic relationships of the accessions are based on their geographic regions of origin. The analyses revealed genetic relationships between the accessions collected in Brazil and the accession from Africa, and among palms from South East Asia and the South Pacific, confirming the common origin of these accessions. The information obtained in this study can guide decisions on germplasm conservation activities and the efficient selection of genetically divergent parents for use in coconut breeding programs in Brazil, which are attempting to select for disease resistance, mainly to lethal yellowing, among other characteristics.	[Loiola, Carina Mendes] Fed Rural Univ Semiarido, Embrapa Coastal Tablelands, Aracaju, Sergipe, Brazil; [Nunes Azevedo, Alinne Oliveira; Azevedo, Carlos Diego de O.; Santos, Pedro Henrique A. D.; Ramos, Helaine Christine C.; Pereira, Messias Gonzaga] North Fluminense State Univ UENF, Campos Goytacazes, Rio De Janeiro, Brazil; [Diniz, Leandro E. C.; Aragao, Wilson Menezes; Ramalho Ramos, Semiramis R.] Embrapa Coastal Tablelands, Aracaju, Sergipe, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Ramos, SRR (corresponding author), Embrapa Coastal Tablelands, Aracaju, Sergipe, Brazil.	semiramis.ramos@embrapa.br	Pereira, Messias G/G-4782-2015; Santos, Pedro/W-2641-2019; Pereira, Messias/AAS-4261-2020	Pereira, Messias/0000-0002-3463-3768; Ramos, Semiramis/0000-0003-1289-1341; Cancela Ramos, Helaine Christine/0000-0002-0098-1027; Diniz, Leandro E C/0000-0003-1980-9945; Santos, PedroHenrique Araujo Diniz/0000-0002-7781-215X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Projeto Nacional de Acoes Integradas Publico-Privadas para Biodiversidade (PROBIO II); National Project for Public-Private Integrated Actions for Biodiversity-PROBIO II	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Projeto Nacional de Acoes Integradas Publico-Privadas para Biodiversidade (PROBIO II); National Project for Public-Private Integrated Actions for Biodiversity-PROBIO II	CML was supported by 'Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior' (CAPES) with a Scholarship during her PhD. 'Projeto Nacional de Acoes Integradas Publico-Privadas para Biodiversidade (PROBIO II)' gave financial support for developing all steps of this work.; We are very thankful to the National Project for Public-Private Integrated Actions for Biodiversity-PROBIO II for supporting this work and Dr. Clara Goedert for providing research facilities.	Abreu FAP, 2002, COCO COLHEITA, P29; Aragao WM, 2003, COCO PRODUCAO ASPECT, P21; Baudouin, 2005, COCONUT GENETIC RESO, P225; Baudouin L, 2009, APO08007 LOA, P1; Baudouin L, 2014, ANN BOT-LONDON, V113, P1, DOI 10.1093/aob/mct244; Baudouin L, 2009, OCL OILS FAT CROP LI, V16, P127, DOI 10.1051/ocl.2009.0244; Clement CR, 2013, BOT REV, V79, P342, DOI 10.1007/s12229-013-9121-z; Daher R. F., 2002, Crop Breeding and Applied Biotechnology, V2, P431; Dias BC, 1980, SUBSIDIOS AO GRUPO T, P1; Dollet M, 2009, OCL OILS FAT CROP LI, V16, P97, DOI 10.1051/ocl.2009.0246; Doyle J. J., 1987, PHYTOCHEM B, P11; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gunn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021143; HARRIES H C, 1992, Principes, V36, P155; HARRIES HC, 1977, TURRIALBA, V27, P227; HARRIES HC, 1978, BOT REV, V44, P265, DOI 10.1007/BF02957852; HOLCOMB J, 1977, EUPHYTICA, V26, P441, DOI 10.1007/BF00027006; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lebrun P, 1998, EUPHYTICA, V101, P103, DOI 10.1023/A:1018323721803; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Manjula C., 2014, J PLANT CROPS, V42, P301; Martinez RT, 2010, TREE GENET GENOMES, V6, P73, DOI 10.1007/s11295-009-0229-6; Martins CR, 2011, EVOLUCAO PRODUCAO CO, P30; Myrie WA, 2006, PLANT DIS, V90, P834, DOI 10.1094/PD-90-0834A; Okwuagwu C.O., 2005, COCONUT GENETIC RESO, P667; Peakall R, 2009, GENAIEX TUTORIALS 1; Pearson K, 1900, PHILOS MAG, V50, P1; Perera L, 2000, GENOME, V43, P15, DOI 10.1139/gen-43-1-15; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2006, LANG ENV STAT COMP; Rajesh MK, 2014, J PLANT CROPS, V42, P277; Ribeiro FE, 1999, PESQUI AGROPECU BRAS, V34, P1615, DOI 10.1590/S0100-204X1999000900012; Ribeiro FE, 2011, CARACTERIZACAO POPUL, P16; Ribeiro FE, 2010, GENET MOL BIOL, V33, P696, DOI 10.1590/S1415-47572010005000077; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Romney DH, 1979, SESSION FAO TECHNICA, V5, P4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer J, 1971, MAN SEA, P309; Teulat B, 2000, THEOR APPL GENET, V100, P764, DOI 10.1007/s001220051350; ZizumboVillarreal D, 1996, GENET RESOUR CROP EV, V43, P505, DOI 10.1007/BF00138827	40	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151309	10.1371/journal.pone.0151309	http://dx.doi.org/10.1371/journal.pone.0151309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974540	gold, Green Submitted, Green Published			2022-12-26	WOS:000372570600067
J	Turner, ML; Cronin, JG; Noleto, PG; Sheldon, IM				Turner, Matthew L.; Cronin, James G.; Noleto, Pablo G.; Sheldon, I. Martin			Glucose Availability and AMP-Activated Protein Kinase Link Energy Metabolism and Innate Immunity in the Bovine Endometrium	PLOS ONE			English	Article							DAIRY-COWS; ESCHERICHIA-COLI; UTERINE DISEASE; STROMAL CELLS; IN-VITRO; EXPRESSION; BALANCE; SYSTEM; GROWTH; INFLAMMATION	Defences against the bacteria that usually infect the endometrium of postpartum cattle are impaired when there is metabolic energy stress, leading to endometritis and infertility. The endometrial response to bacteria depends on innate immunity, with recognition of pathogen-associated molecular patterns stimulating inflammation, characterised by secretion of interleukin (IL)-1 beta, IL-6 and IL-8. How metabolic stress impacts tissue responses to pathogens is unclear, but integration of energy metabolism and innate immunity means that stressing one system might affect the other. Here we tested the hypothesis that homeostatic pathways integrate energy metabolism and innate immunity in bovine endometrial tissue. Glucose deprivation reduced the secretion of IL-1 beta, IL-6 and IL-8 from ex vivo organ cultures of bovine endometrium challenged with the pathogen-associated molecular patterns lipopolysaccharide and bacterial lipopeptide. Endometrial inflammatory responses to lipopolysaccharide were also reduced by small molecules that activate or inhibit the intracellular sensor of energy, AMP-activated protein kinase (AMPK). However, inhibition of mammalian target of rapamycin, which is a more global metabolic sensor than AMPK, had little effect on inflammation. Similarly, endometrial inflammatory responses to lipopolysaccharide were not affected by insulin-like growth factor-1, which is an endocrine regulator of metabolism. Interestingly, the inflammatory responses to lipopolysaccharide increased endometrial glucose consumption and induced the Warburg effect, which could exacerbate deficits in glucose availability in the tissue. In conclusion, metabolic energy stress perturbed inflammatory responses to pathogen-associated molecular patterns in bovine endometrial tissue, and the most fundamental regulators of cellular energy, glucose availability and AMPK, had the greatest impact on innate immunity.	[Turner, Matthew L.; Cronin, James G.; Noleto, Pablo G.; Sheldon, I. Martin] Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales; [Noleto, Pablo G.] Univ Fed Uberlandia, Fac Vet Med, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil	Swansea University; Universidade Federal de Uberlandia	Sheldon, IM (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales.	i.m.sheldon@swansea.ac.uk	Sheldon, I Martin/E-1567-2013	Sheldon, I Martin/0000-0001-7902-5558; Cronin, James/0000-0002-0590-9462; Turner, Matthew/0000-0002-1369-4051; NOLETO, PABLO/0000-0003-1787-951X	Biotechnology and Biological Sciences Research Council [BB/F017596/1, BB/I017240/1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [99999.010219/2014-05]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [486143/2013-9]; BBSRC [BB/I017240/1, BB/F005121/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005121/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Doctoral training for MLT was funded by the Biotechnology and Biological Sciences Research Council (BB/F017596/1), and the work was supported in part by a project grant to IMS funded by the Biotechnology and Biological Sciences Research Council (BB/I017240/1). PGN was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (99999.010219/2014-05) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (486143/2013-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos MR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115972; ARCHBALD LF, 1972, J REPROD FERTIL, V29, P133, DOI 10.1530/jrf.0.0290133; Badinga L, 2002, J DAIRY SCI, V85, P537, DOI 10.3168/jds.S0022-0302(02)74106-4; Borges AM, 2012, AM J REPROD IMMUNOL, V67, P526, DOI 10.1111/j.1600-0897.2012.01106.x; Chagas LM, 2007, J DAIRY SCI, V90, P4022, DOI 10.3168/jds.2006-852; Chamberlain A., 1996, FEEDING DAIRY COW, P28; CHASE CC, 1992, J ANIM SCI, V70, P1496, DOI 10.2527/1992.7051496x; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Esposito G, 2014, ANIM REPROD SCI, V144, P60, DOI 10.1016/j.anireprosci.2013.11.007; Franca MR, 2015, DOMEST ANIM ENDOCRIN, V50, P83, DOI 10.1016/j.domaniend.2014.09.005; Frolova AI, 2011, REPRODUCTION, V142, P211, DOI 10.1530/REP-11-0114; Gabler C, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-152; Giuliodori MJ, 2013, J DAIRY SCI, V96, P3621, DOI 10.3168/jds.2012-5922; Gutierrez CG, 1997, BIOL REPROD, V56, P608, DOI 10.1095/biolreprod56.3.608; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Healey GD, 2016, J IMMUNOL, V196, P823, DOI 10.4049/jimmunol.1501080; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hou XY, 2010, ENDOCRINOLOGY, V151, P2846, DOI 10.1210/en.2009-1032; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Llewellyn S, 2008, DOMEST ANIM ENDOCRIN, V34, P391, DOI 10.1016/j.domaniend.2007.11.003; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Moyes KM, 2009, J DAIRY SCI, V92, P4301, DOI 10.3168/jds.2009-2170; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Rinaldi M, 2008, VET IMMUNOL IMMUNOP, V126, P199, DOI 10.1016/j.vetimm.2008.07.001; Saut JPE, 2014, REPRODUCTION, V148, P593, DOI 10.1530/REP-14-0230; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Turner ML, 2014, ENDOCRINOLOGY, V155, P1453, DOI 10.1210/en.2013-1822; Wathes DC, 2011, REPRODUCTION, V141, P269, DOI 10.1530/REP-10-0177; Wathes DC, 2009, PHYSIOL GENOMICS, V39, P1, DOI 10.1152/physiolgenomics.00064.2009; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	50	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151416	10.1371/journal.pone.0151416	http://dx.doi.org/10.1371/journal.pone.0151416			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974839	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600077
J	Tran, QK; Firkins, R; Giles, J; Francis, S; Matnishian, V; Tran, P; VerMeer, M; Jasurda, J; Burgard, MA; Gebert-Oberle, B				Tran, Quang-Kim; Firkins, Rachel; Giles, Jennifer; Francis, Sarah; Matnishian, Vahe; Phuong Tran; VerMeer, Mark; Jasurda, Jake; Burgard, Michelle Ann; Gebert-Oberle, Briana			Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR RECEPTOR; CANCER-ASSOCIATED FIBROBLASTS; PLASMA-MEMBRANE CA2+-ATPASE; TRANSCRIPTIONAL ACTIVITY; CELLS; GPR30; PHOSPHORYLATION; CA2+; ACTIVATION	Estrogen exerts many effects on the vascular endothelium. Calmodulin (CaM) is the transducer of Ca2+ signals and is a limiting factor in cardiovascular tissues. It is unknown whether and how estrogen modifies endothelial functions via the network of CaM-dependent proteins. Here we show that 17 beta-estradiol (E-2) up-regulates total CaM level in endothelial cells. Concurrent measurement of Ca2+ and Ca2+-CaM indicated that E2 also increases free Ca2+-CaM. Pharmacological studies, gene silencing, and receptor expression-specific cell studies indicated that the G protein-coupled estrogen receptor 1 (GPER/GPR30) mediates these effects via transactivation of EGFR and subsequent MAPK activation. The outcomes were then examined on four distinct members of the intracellular CaM target network, including GPER/GPR30 itself and estrogen receptor a, the plasma membrane Ca2+-ATPase (PMCA), and endothelial nitric-oxide synthase (eNOS). E2 substantially increases CaM binding to estrogen receptor a and GPER/GPR30. Mutations that reduced CaM binding to GPER/GPR30 in separate binding domains do not affect GPER/GPR30-G(beta gamma) preassociation but decrease GPER/GPR30-mediated ERK1/2 phosphorylation. E2 increases CaM-PMCA association, but the expected stimulation of Ca2+ efflux is reversed by E-2-stimulated tyrosine phosphorylation of PMCA. These effects sustain Ca2+ signals and promote Ca2+-dependent CaM interactions with other CaM targets. Consequently, E-2 doubles CaM-eNOS interaction and also promotes dual phosphorylation of eNOS at Ser-617 and Ser-1179. Calculations using in-cell and in vitro data revealed substantial individual and combined contribution of these effects to total eNOS activity. Taken together, E-2 generates a feedforward loop via GPER/GPR30, which enhances Ca2+/CaM signals and functional linkage in the endothelial CaM target network.	[Tran, Quang-Kim; Firkins, Rachel; Giles, Jennifer; Francis, Sarah; Matnishian, Vahe; Phuong Tran; VerMeer, Mark; Jasurda, Jake; Burgard, Michelle Ann; Gebert-Oberle, Briana] Des Moines Univ, Coll Osteopath Med, Dept Physiol & Pharmacol, Ryan Hall 258,3200 Grand Ave, Des Moines, IA 50312 USA		Tran, QK (corresponding author), Des Moines Univ, Coll Osteopath Med, Dept Physiol & Pharmacol, Ryan Hall 258,3200 Grand Ave, Des Moines, IA 50312 USA.	kim.tran@dmu.edu		Tran, Kim/0000-0003-1881-1357	National Institutes of Health [HL112184]; Iowa Osteopathic and Educational Research Funds; Des Moines University's Mentored Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL112184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Osteopathic and Educational Research Funds; Des Moines University's Mentored Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Grant HL112184 (to Q.-K.T.) and Iowa Osteopathic and Educational Research Funds (to Q.-K.T). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Des Moines University's Mentored Research Program.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Albanito L, 2015, ENVIRON HEALTH PERSP, V123, P493, DOI 10.1289/ehp.1408586; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; CASTORIA G, 1988, MOL ENDOCRINOL, V2, P167, DOI 10.1210/mend-2-2-167; Chakrabarti S, 2014, CAN J CARDIOL, V30, P705, DOI 10.1016/j.cjca.2013.08.006; Das SK, 2000, J BIOL CHEM, V275, P28834, DOI 10.1074/jbc.M003827200; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Ding Q, 2009, AM J PHYSIOL-CELL PH, V297, pC1178; El-Beialy W, 2010, ENDOCR J, V57, P93, DOI 10.1507/endocrj.K09E-247; Filardo EJ, 2008, STEROIDS, V73, P870, DOI 10.1016/j.steroids.2007.12.025; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; KUHNE W, 1993, AM J PHYSIOL, V264, pH1599, DOI 10.1152/ajpheart.1993.264.5.H1599; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Li L, 2007, CELL SIGNAL, V19, P439, DOI 10.1016/j.cellsig.2006.08.018; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Lin BC, 2009, CANCER RES, V69, P5415, DOI 10.1158/0008-5472.CAN-08-1622; LUBYPHELPS K, 1995, J BIOL CHEM, V270, P21532, DOI 10.1074/jbc.270.37.21532; McConnell EJ, 2000, CIRC RES, V86, P191, DOI 10.1161/01.RES.86.2.191; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Prossnitz ER, 2015, PHARMACOL REV, V67, P505, DOI 10.1124/pr.114.009712; Tran QK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089669; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Spahr R., 1990, CELL CULTURE TECHNIQ, P220; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tran QK, 2008, BIOCHEMISTRY-US, V47, P7557, DOI 10.1021/bi8003186; Tran QK, 2015, J BIOL CHEM, V290, P13293, DOI 10.1074/jbc.M114.628743; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Vladusic EA, 2000, ONCOL REP, V7, P157; Wang X, 2002, CELL CALCIUM, V31, P265, DOI 10.1016/S0143-4160(02)00075-1; Watanabe H, 1996, BIOCHEM BIOPH RES CO, V225, P777, DOI 10.1006/bbrc.1996.1250; WATANABE H, 1991, AM J PHYSIOL, V260, pH1344, DOI 10.1152/ajpheart.1991.260.4.H1344; Watanabe H, 2001, FASEB J, V15, P282, DOI 10.1096/fj.00-0587fje; Wu X, 2007, CELL CALCIUM, V41, P353, DOI 10.1016/j.ceca.2006.07.011; Zhang RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065266; Zhang YH, 2012, J BIOL CHEM, V287, P9336, DOI 10.1074/jbc.M111.334797	64	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10805	10823		10.1074/jbc.M115.697334	http://dx.doi.org/10.1074/jbc.M115.697334			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26987903	Green Published, hybrid			2022-12-26	WOS:000377042600031
J	Nebenzahl, YM; Blau, K; Kushnir, T; Shagan, M; Portnoi, M; Cohen, A; Azriel, S; Malka, I; Adawi, A; Kafka, D; Dotan, S; Guterman, G; Troib, S; Fishilevich, T; Gershoni, JM; Braiman, A; Mitchell, AM; Mitchell, TJ; Porat, N; Goliand, I; Caspi, VC; Swiatlo, E; Tal, M; Ellis, R; Elia, N; Dagan, R				Nebenzahl, Yaffa Mizrachi; Blau, Karin; Kushnir, Tatyana; Shagan, Marilou; Portnoi, Maxim; Cohen, Aviad; Azriel, Shalhevet; Malka, Itai; Adawi, Asad; Kafka, Daniel; Dotan, Shahar; Guterman, Gali; Troib, Shany; Fishilevich, Tali; Gershoni, Jonathan M.; Braiman, Alex; Mitchell, Andrea M.; Mitchell, Timothy J.; Porat, Nurith; Goliand, Inna; Caspi, Vered Chalifa; Swiatlo, Edwin; Tal, Michael; Ellis, Ronald; Elia, Natalie; Dagan, Ron			Streptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a Vaccine	PLOS ONE			English	Article							PROTECTIVE IMMUNE-RESPONSE; EPITHELIAL-CELLS; SURFACE PROTEIN; PNEUMOCOCCAL INFECTIONS; BACTERIAL-INFECTION; ANTIBODY-RESPONSES; PUTATIVE ADHESIN; BINDING PROTEIN; FUSION PROTEIN; PHT PROTEINS	In Streptococcus pneumonia, phosphoenolpyruvate protein phosphotransferase (PtsA) is an intracellular protein of the monosaccharide phosphotransferase systems. Biochemical and immunostaining methods were applied to show that PtsA also localizes to the bacterial cell-wall. Thus, it was suspected that PtsA has functions other than its main cytoplasmic enzymatic role. Indeed, recombinant PtsA and anti-rPtsA antiserum were shown to inhibit adhesion of S. pneumoniae to cultured human lung adenocarcinoma A549 cells. Screening of a combinatorial peptide library expressed in a filamentous phage with rPtsA identified epitopes that were capable of inhibiting S. pneumoniae adhesion to A549 cells. The insert peptides in the phages were sequenced, and homologous sequences were found in human BMPER, multimerin1, protocadherin19, integrin beta 4, epsin1 and collagen type VII alpha 1 proteins, all of which can be found in A549 cells except the latter. Six peptides, synthesized according to the homologous sequences in the human proteins, specifically bound rPtsA in the micromolar range and significantly inhibited pneumococcal adhesion in vitro to lung- and tracheal-derived cell lines. In addition, the tested peptides inhibited lung colonization after intranasal inoculation of mice with S. pneumoniae. Immunization with rPtsA protected the mice against a sublethal intranasal and a lethal intravenous pneumococcal challenge. In addition, mouse anti rPtsA antiserum reduced bacterial virulence in the intravenous inoculation mouse model. These findings showed that the surface-localized PtsA functions as an adhesin, PtsA binding peptides derived from its putative target molecules can be considered for future development of therapeutics, and rPtsA should be regarded as a candidate for vaccine development.	[Nebenzahl, Yaffa Mizrachi; Blau, Karin; Kushnir, Tatyana; Shagan, Marilou; Portnoi, Maxim; Cohen, Aviad; Azriel, Shalhevet; Malka, Itai; Adawi, Asad; Kafka, Daniel; Guterman, Gali; Troib, Shany; Fishilevich, Tali; Porat, Nurith] Soroka Univ, Med Ctr, Pediat Infect Dis Unit, Beer Sheva, Israel; [Nebenzahl, Yaffa Mizrachi; Blau, Karin; Kushnir, Tatyana; Shagan, Marilou; Portnoi, Maxim; Cohen, Aviad; Azriel, Shalhevet; Malka, Itai; Adawi, Asad; Kafka, Daniel; Guterman, Gali; Troib, Shany; Fishilevich, Tali; Braiman, Alex; Porat, Nurith] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Nebenzahl, Yaffa Mizrachi; Blau, Karin; Kushnir, Tatyana; Shagan, Marilou; Portnoi, Maxim; Cohen, Aviad; Azriel, Shalhevet; Malka, Itai; Adawi, Asad; Kafka, Daniel; Guterman, Gali; Troib, Shany; Fishilevich, Tali; Porat, Nurith; Dagan, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Dotan, Shahar; Tal, Michael; Ellis, Ronald] NasVax Ltd, Ness Ziona, Israel; [Gershoni, Jonathan M.; Mitchell, Timothy J.] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Mitchell, Andrea M.] Univ Birmingham, Inst Microbiol & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Goliand, Inna; Caspi, Vered Chalifa; Elia, Natalie] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Goliand, Inna; Elia, Natalie] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Swiatlo, Edwin] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Tel Aviv University; University of Birmingham; Ben Gurion University; Ben Gurion University; University of Mississippi; University of Mississippi Medical Center	Nebenzahl, YM (corresponding author), Soroka Univ, Med Ctr, Pediat Infect Dis Unit, Beer Sheva, Israel.; Nebenzahl, YM (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel.; Nebenzahl, YM (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.	ymizr@bgu.ac.il	Braiman, Alex/F-2179-2012; Braiman, Alex/ABC-3482-2021	Braiman, Alex/0000-0003-2802-1148; Braiman, Alex/0000-0003-2802-1148; Mitchell, Timothy/0000-0002-8309-5556; Mitchell, Andrea/0000-0002-2530-4460; Chalifa-Caspi, Vered/0000-0001-6030-5816; Guterman-Ram, Gali/0000-0002-8583-3401	Israel Ministry of Health [4776, 5540, 3000003867]; BG Negev Technologies, Ben-Gurion University of the Negev [80904101]; Center of Emerging Diseases [2506]; Israel Academy of Science [613/04]; Israel Ministry of Commerce and Industry; Medical Research Council; Wellcome Trust; NasVax Ltd.; Israeli minister of Health; center of immerging disease; BG Negev; Israel Academy of Science; Israel ministry of commerce; NasVax	Israel Ministry of Health; BG Negev Technologies, Ben-Gurion University of the Negev; Center of Emerging Diseases; Israel Academy of Science; Israel Ministry of Commerce and Industry; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NasVax Ltd.; Israeli minister of Health; center of immerging disease; BG Negev; Israel Academy of Science; Israel ministry of commerce; NasVax	Work in the Y.M.N. laboratory is supported by grants from The Israel Ministry of Health (grants 4776, 5540 and 3000003867) to Y.M.N., from BG Negev Technologies, Ben-Gurion University of the Negev (grant 80904101) to Y.M.N., from The Center of Emerging Diseases (grant 2506) to Y.M.N., from The Israel Academy of Science (grant 613/04) to Y.M.N., and from The Israel Ministry of Commerce and Industry to NasVax Ltd. Work in TJM laboratory is supported by the Medical Research Council and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NasVax Ltd. provided support in the form of salaries for authors SD, MTand RE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Role of the funders: Israeli minister of Health, The center of immerging disease, BG Negev and The Israel Academy of Science, The Israel ministry of commerce provided support in the form of salaries for authors [MS, SA, IM, AA, GG, ST, TF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funders BG Negev and NasVax provided support in the form of salaries for authors [MP, DK, SD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Asmat TM, 2011, J BIOL CHEM, V286, P17861, DOI 10.1074/jbc.M110.212225; Ausubel FM, 1988, MOL REPROD DEV; AVERY OT, 1995, MOL MED, V1, P344, DOI 10.1007/BF03401572; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; BALIS JU, 1984, EXP LUNG RES, V6, P197, DOI 10.3109/01902148409109248; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Basset A, 2013, J BIOL CHEM, V288, P2665, DOI 10.1074/jbc.M112.398875; Benisty R, 2010, BBA-MOL CELL BIOL L, V1801, P1098, DOI 10.1016/j.bbalip.2010.06.004; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Binsker U, 2015, J BIOL CHEM, V290, P14542, DOI 10.1074/jbc.M114.623876; Biswas S, 2010, J CELL BIOL, V191, P1029, DOI 10.1083/jcb.201007008; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Brock SC, 2002, INFECT IMMUN, V70, P5091, DOI 10.1128/IAI.70.9.5091-5095.2002; Brown AO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004383; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Cherian Thomas, 2007, Vaccine, V25, P6557, DOI 10.1016/j.vaccine.2007.06.044; Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X; Cron LE, 2011, INFECT IMMUN, V79, P3697, DOI 10.1128/IAI.01383-10; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dagan R, 2010, VACCINE, V28, P5513, DOI 10.1016/j.vaccine.2010.06.026; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; Daniely D, 2006, CLIN EXP IMMUNOL, V144, P254, DOI 10.1111/j.1365-2249.2006.03047.x; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Elm C, 2004, INDIAN J MED RES, V119, P61; Freund Natalia Tarnovitski, 2009, Curr Protoc Immunol, VChapter 9, DOI 10.1002/0471142735.im0908s86; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Gravelle S, 2010, INNATE IMMUN-LONDON, V16, P14, DOI 10.1177/1753425909106170; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hagerman A, 2013, EUR J CLIN MICROBIOL, V32, P43, DOI 10.1007/s10096-012-1712-9; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammitt LL, 2011, VACCINE, V29, P2287, DOI 10.1016/j.vaccine.2011.01.029; Harfouche C, 2012, INFECT IMMUN, V80, P451, DOI 10.1128/IAI.05780-11; Henderson B, 2014, BIOCHEM SOC T, V42, P1720, DOI 10.1042/BST20140236; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kallio A, 2014, INFECT IMMUN, V82, P1683, DOI 10.1128/IAI.00699-13; Kayhty H, 1996, EMERG INFECT DIS, V2, P289, DOI 10.3201/eid0204.9604; Khan MN, 2012, VACCINE, V30, P2900, DOI 10.1016/j.vaccine.2012.02.023; Laine C, 2004, INFECT IMMUN, V72, P3331, DOI 10.1128/IAI.72.6.3331-3335.2004; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lifshitz S, 2002, CLIN EXP IMMUNOL, V127, P344, DOI 10.1046/j.1365-2249.2002.01745.x; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; MCDANIEL LS, 1991, INFECT IMMUN, V59, P222, DOI 10.1128/IAI.59.1.222-228.1991; Menoud A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038823; Mitchell Tim J, 2014, Subcell Biochem, V80, P145, DOI 10.1007/978-94-017-8881-6_8; Mlacha SZK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-383; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Muchnik L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061128; Nau R, 2013, EXPERT REV ANTI-INFE, V11, P1079, DOI 10.1586/14787210.2013.839381; Nebenzahl YM, 2007, J INFECT DIS, V196, P945, DOI 10.1086/521028; Nebenzahl YM, 2004, FEMS MICROBIOL LETT, V233, P147, DOI 10.1016/j.femsle.2004.02.003; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Oldak M, 2006, INT J MOL MED, V17, P195; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Pope C, 2015, VACCINE, V33, P1711, DOI 10.1016/j.vaccine.2015.02.012; Portnoi M, 2006, VACCINE, V24, P1868, DOI 10.1016/j.vaccine.2005.10.053; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Price KE, 2012, J BACTERIOL, V194, P3651, DOI 10.1128/JB.00114-12; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SELA BA, 1975, J BIOL CHEM, V250, P7535; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; SIEGEL JL, 1981, INFECT IMMUN, V31, P808, DOI 10.1128/IAI.31.2.808-815.1981; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; WATSON DA, 1990, INFECT IMMUN, V58, P3135, DOI 10.1128/IAI.58.9.3135-3138.1990; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zhang QB, 2006, EUR J IMMUNOL, V36, P46, DOI 10.1002/eji.200535101	88	12	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150320	10.1371/journal.pone.0150320	http://dx.doi.org/10.1371/journal.pone.0150320			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990554	Green Published, gold			2022-12-26	WOS:000372582800027
J	Liu, YL; Wang, SC; Hwu, HG; Fann, CSJ; Yang, UC; Yang, WC; Hsu, PC; Chang, CC; Wen, CC; Tsai-Wu, JJ; Hwang, TJ; Hsieh, MH; Liu, CC; Chien, YL; Fang, CP; Faraone, SV; Tsuang, MT; Chen, WJ; Liu, CM				Liu, Yu-Li; Wang, Sheng-Chang; Hwu, Hai-Gwo; Fann, Cathy Shen-Jang; Yang, Ueng-Cheng; Yang, Wei-Chih; Hsu, Pei-Chun; Chang, Chien-Ching; Wen, Chun-Chiang; Tsai-Wu, Jyy-Jih; Hwang, Tzung-Jeng; Hsieh, Ming H.; Liu, Chen-Chung; Chien, Yi-Ling; Fang, Chiu-Ping; Faraone, Stephen V.; Tsuang, Ming T.; Chen, Wei J.; Liu, Chih-Min			Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive Deficits	PLOS ONE			English	Article							CARD SORTING TEST; SUSTAINED ATTENTION DEFICITS; GENOMIC DNA-SEQUENCES; NONPSYCHOTIC RELATIVES; MISMATCH NEGATIVITY; NMDA RECEPTOR; GLYCINE SITE; TAIWAN; DAAO; LINKAGE	D-amino acid oxidase (DAO) has been reported to be associated with schizophrenia. This study aimed to search for genetic variants associated with this gene. The genomic regions of all exons, highly conserved regions of introns, and promoters of this gene were sequenced. Potentially meaningful single-nucleotide polymorphisms (SNPs) obtained from direct sequencing were selected for genotyping in 600 controls and 912 patients with schizophrenia and in a replicated sample consisting of 388 patients with schizophrenia. Genetic associations were examined using single-locus and haplotype association analyses. In single-locus analyses, the frequency of the C allele of a novel SNP rs55944529 located at intron 8 was found to be significantly higher in the original large patient sample (p = 0.016). This allele was associated with a higher level of DAO mRNA expression in the Epstein-Barr virus-transformed lymphocytes. The haplotype distribution of a haplotype block composed of rs11114083-rs2070586-rs2070587-rs55944529 across intron 1 and intron 8 was significantly different between the patients and controls and the haplotype frequencies of AAGC were significantly higher in patients, in both the original (corrected p < 0.0001) and replicated samples (corrected p = 0.0003). The CGTC haplotype was specifically associated with the subgroup with deficits in sustained attention and executive function and the AAGC haplotype was associated with the subgroup without such deficits. The DAO gene was a susceptibility gene for schizophrenia and the genomic region between intron 1 and intron 8 may harbor functional genetic variants, which may influence the mRNA expression of DAO and neurocognitive functions in schizophrenia.	[Liu, Yu-Li; Wang, Sheng-Chang; Fang, Chiu-Ping] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli 35053, Taiwan; [Liu, Yu-Li; Hwu, Hai-Gwo; Wen, Chun-Chiang; Hwang, Tzung-Jeng; Hsieh, Ming H.; Liu, Chen-Chung; Chien, Yi-Ling; Liu, Chih-Min] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei 10051, Taiwan; [Liu, Yu-Li; Hwu, Hai-Gwo; Wen, Chun-Chiang; Hwang, Tzung-Jeng; Hsieh, Ming H.; Liu, Chen-Chung; Chien, Yi-Ling; Liu, Chih-Min] Natl Taiwan Univ, Coll Med, Taipei 10051, Taiwan; [Hwu, Hai-Gwo; Hwang, Tzung-Jeng; Liu, Chen-Chung; Liu, Chih-Min] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10051, Taiwan; [Fann, Cathy Shen-Jang; Yang, Wei-Chih; Chang, Chien-Ching] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Yang, Ueng-Cheng] Natl Yang Ming Univ, Inst Bioinformat, Taipei 112, Taiwan; [Hsu, Pei-Chun] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10051, Taiwan; [Tsai-Wu, Jyy-Jih] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10051, Taiwan; [Faraone, Stephen V.] SUNY Upstate Med Univ, Med Genet Res Ctr, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat & Neurosci & Physiol, Syracuse, NY 13210 USA; [Tsuang, Ming T.] Harvard Univ, Harvard Inst Psychiat Epidemiol & Genet, Boston, MA 02115 USA; [Tsuang, Ming T.] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Tsuang, Ming T.] Harvard Univ, Dept Psychiat, Boston, MA 02115 USA; [Tsuang, Ming T.] Univ Calif San Diego, Inst Behav Genom, San Diego, CA 92093 USA; [Chen, Wei J.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10051, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard University; University of California System; University of California San Diego; National Taiwan University	Liu, CM (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Taipei 10051, Taiwan.; Liu, CM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10051, Taiwan.	cmliu1968@ntu.edu.tw	Faraone, Stephen/AAE-7334-2019; Hwang, TJ/K-4768-2019; Faraone, Stephen V/O-7239-2018; Fann, Cathy SJ/F-9410-2010; Hsieh, Ming H./B-2970-2010	Faraone, Stephen/0000-0002-9217-3982; Faraone, Stephen V/0000-0002-9217-3982; Fann, Cathy SJ/0000-0001-9025-2276; Hsieh, Ming H./0000-0002-3585-7843; LIU, CHEN-CHUNG/0000-0002-9290-110X; LIU, CHIH-MIN/0000-0001-7016-8990; Chen, Wei Jen/0000-0001-5899-5870; Hwang, Tzung-Jeng/0000-0001-7894-9484; CHIEN, YI-LING/0000-0002-3477-3015	National Research Program for Genomic Medicine (NRPGM), National Science Council, Taiwan [NSC91-2314-B-002-216, NSC91-3112-B-002-011, NSC 92-3112-B-002-019, NSC93-3112-B-002-012, NSC94-3112-B-002-020, NSC95-3112-B002-011, NSC 97-3112-B-002-046-, NSC 97-2321-B-002-041, NSC 98-2321-B-002-008-, NSC 97-2314-B-400-001-MY3, NSC 101-2325-B-400-018]; National Health Research Institute, Taiwan [NHRI-EX-91, NHRI-EX-92, NHRI-EX-93-9113PP, MD095PP14, MD097PP02, MD096PP12, MD097PP14, MD096SP01, MD097SP01, PH098, 99-46]; National Institutes of Health, U.S.A. [IR01 MH 59624-01]; National Taiwan University [97HM00271similar to7]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059624] Funding Source: NIH RePORTER	National Research Program for Genomic Medicine (NRPGM), National Science Council, Taiwan; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Institutes of Health, U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Taiwan University(National Taiwan University); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Research Program for Genomic Medicine (NRPGM), National Science Council, Taiwan [grant number NSC91-2314-B-002-216, NSC91-3112-B-002-011, NSC 92-3112-B-002-019, NSC93-3112-B-002-012, NSC94-3112-B-002-020, NSC95-3112-B002-011, NSC 97-3112-B-002-046-, NSC 97-2321-B-002-041, NSC 98-2321-B-002-008- to HGW, NSC 97-2314-B-400-001-MY3, NSC 101-2325-B-400-018 to HGW and LCM], the National Health Research Institute, Taiwan [grant number NHRI-EX-91,92,93-9113PP, MD095PP14, MD096PP12, MD097PP02, MD096PP12, MD097PP14, MD096SP01, MD097SP01 to HGW, and PH098, 99-46 to SCW], the National Institutes of Health, U.S.A. [grant number IR01 MH 59624-01 to MTT], and National Taiwan University [grant number 97HM00271 similar to 7 to HGW and LCM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burnet PWJ, 2008, MOL PSYCHIATR, V13, P658, DOI 10.1038/mp.2008.47; Chang SS, 2009, SCHIZOPHRENIA BULL, V35, P213, DOI 10.1093/schbul/sbm153; Chen CH, 1999, AM J PSYCHIAT, V156, P1273; Chen WJ, 2000, AM J MED GENET, V97, P52, DOI 10.1002/(SICI)1096-8628(200021)97:1<52::AID-AJMG7>3.0.CO;2-6; Chen WJ, 2004, BIOL PSYCHIAT, V55, P995, DOI 10.1016/j.biopsych.2004.01.010; Chen WJ, DIAGNOSTIC INTERVIEW; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P31, DOI 10.1093/schbul/20.1.31; Corvin A, 2007, AM J MED GENET B, V144B, P949, DOI 10.1002/ajmg.b.30452; Coyle JT, 2012, SCHIZOPHRENIA BULL, V38, P920, DOI 10.1093/schbul/sbs076; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Faraone SV, 1999, J ABNORM PSYCHOL, V108, P176, DOI 10.1037/0021-843X.108.1.176; Faraone SV, 2000, BIOL PSYCHIAT, V48, P120, DOI 10.1016/S0006-3223(99)00263-2; FARAONE SV, 1995, AM J PSYCHIAT, V152, P1286; Fu CL, 2004, THESIS NATL YANG MIN; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GOLDBERG TE, 1987, ARCH GEN PSYCHIAT, V44, P1008; Goldberg TE, 2006, NEUROPSYCHOPHARMACOL, V31, P2022, DOI 10.1038/sj.npp.1301049; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hwu H. G., 1999, PSYCHIAT DIAGNOSTIC; Hwu HG, 2005, AM J MED GENET B, V134B, P30, DOI 10.1002/ajmg.b.30139; Hwu HG, 2002, SCHIZOPHR RES, V56, P105, DOI 10.1016/S0920-9964(01)00251-1; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Kapoor R, 2006, BRAIN RES, V1106, P205, DOI 10.1016/j.brainres.2006.05.082; Koren D, 1998, NEUROPSYCHOLOGY, V12, P289, DOI 10.1037/0894-4105.12.2.289; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034454; Liu XM, 2004, NEUROSCI LETT, V369, P228, DOI 10.1016/j.neulet.2004.07.078; Liu YL, 2006, SCHIZOPHR RES, V87, P15, DOI 10.1016/j.schres.2006.06.020; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Nuechterlein KH, 1991, VIGILANCE SCHIZOPHRE, P397; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Papagni SA, 2011, NEUROIMAGE, V56, P2283, DOI 10.1016/j.neuroimage.2011.03.037; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rodi CP, 2002, BIOTECHNIQUES, P62; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Roussos P, 2011, NEUROPSYCHOPHARMACOL, V36, P1677, DOI 10.1038/npp.2011.49; Rozen S, 2000, Methods Mol Biol, V132, P365; *SAS I INC, 2002, SAS GEN US GUID; Schell MJ, 2004, PHILOS T R SOC B, V359, P943, DOI 10.1098/rstb.2003.1399; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Tien Allen Y., 1996, Kaohsiung Journal of Medical Sciences, V12, P479; Tost J, 2005, CLIN BIOCHEM, V38, P335, DOI 10.1016/j.clinbiochem.2004.12.005; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2002, BIOL PSYCHIAT, V51, P400, DOI 10.1016/S0006-3223(01)01242-2; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; Verrall L, 2007, EUR J NEUROSCI, V26, P1657, DOI 10.1111/j.1460-9568.2007.05769.x; Wolf LE, 2002, SCHIZOPHR RES, V57, P173, DOI 10.1016/S0920-9964(01)00301-2; Wong EHM, 2014, SCHIZOPHRENIA BULL, V40, P777, DOI 10.1093/schbul/sbt104; Wood LS, 2007, BIOL PSYCHIAT, V61, P1195, DOI 10.1016/j.biopsych.2006.07.005; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024; Yang HC, 2006, J BIOMED SCI, V13, P489, DOI 10.1007/s11373-006-9077-7	59	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150435	10.1371/journal.pone.0150435	http://dx.doi.org/10.1371/journal.pone.0150435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986737	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300021
J	Xie, XS; Chen, W; Fu, Q; Zhang, PH; An, TC; Cui, AM; An, DR				Xie, Xiansheng; Chen, Wei; Fu, Qiang; Zhang, Penghui; An, Tianci; Cui, Aimin; An, Derong			Molecular Variability and Distribution of Sugarcane Mosaic Virus in Shanxi, China	PLOS ONE			English	Article							RECOMBINATION	Background Sugarcane mosaic virus (SCMV) is responsible for large-scale economic losses in the global production of sugarcane, maize, sorghum, and some other graminaceous species. To understand the evolutionary mechanism of SCMV populations, this virus was studied in Shanxi, China. A total of 86 maize leaf samples (41 samples in 2012 and 45 samples in 2013) were collected from 4 regions of Shanxi. Results Double-antibody sandwich (DAS)-ELISA and RT-PCR showed 59 samples (30 samples in 2012 and 29 samples in 2013) to be positive for SCMV, from which 10 new isolates of SCMV were isolated and sequenced. The complete genomes of these isolates are 9610 nt long, including the 50 and 30 non-coding regions, and encode a 3063-amino acid polyprotein. Phylogenetic analyses revealed that 24 SCMV isolates could be divided on the basis of the whole genome into 2 divergent evolutionary groups, which were associated with the host species. Among the populations, 15 potential recombination events were identified. The selection pressure on the genes of these SCMV isolates was also calculated. The results confirmed that all the genes were under negative selection. Conclusions Negative selection and recombination appear to be important evolutionary factors shaping the genetic structure of these SCMV isolates. SCMV is distributed widely in China and exists as numerous strains with distinct genetic diversity. Our findings will provide a foundation for evaluating the epidemiological characteristics of SCMV in China and will be useful in designing long-term, sustainable management strategies for SCMV.	[Xie, Xiansheng; Fu, Qiang; Zhang, Penghui; An, Tianci; An, Derong] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Xie, Xiansheng; Cui, Aimin] Shanxi Acad Agr Sci, Wheat Res Inst, Linfen, Shanxi, Peoples R China; [Chen, Wei] Shanxi Normal Univ, Coll Life Sci, Linfen, Shanxi, Peoples R China	Northwest A&F University - China; Shanxi Agricultural University; Shanxi Normal University	An, DR (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	anderong323@163.com			111 Project from the Education Ministry of China [B07049]; National Natural Science Foundation of China [31471816]	111 Project from the Education Ministry of China(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the 111 Project from the Education Ministry of China (No. B07049) and the National Natural Science Foundation of China (No. 31471816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ISRN STROKE, DOI [DOI 10.1007/S00531-013-0931-3, DOI 10.1155/2013/858945]; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Elena SF, 2005, J VIROL, V79, P11555, DOI 10.1128/JVI.79.18.11555-11558.2005; Gell G, 2015, VIRUS GENES, V50, P79, DOI 10.1007/s11262-014-1142-0; Gemechu AL, 2006, ARCH VIROL, V151, P167, DOI 10.1007/s00705-005-0643-5; Goncalves MC, 2011, PESQUI AGROPECU BRAS, V46, P362, DOI 10.1590/S0100-204X2011000400004; Ilbagi H, 2006, PHYTOPROTECTION, V87, P115, DOI 10.7202/015853ar; Keizerweerd AT, 2015, J VIROL METHODS, V212, P23, DOI 10.1016/j.jviromet.2014.10.013; Li YC, 2010, J NANOMATER, V2010, DOI 10.1155/2010/261748; Liu XH, 2009, AFR J BIOTECHNOL, V8, P3747; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Moury B, 2002, J GEN VIROL, V83, P2563, DOI 10.1099/0022-1317-83-10-2563; Ohshima K, 2007, J GEN VIROL, V88, P298, DOI 10.1099/vir.0.82335-0; Padhi A, 2011, VIRUS GENES, V42, P282, DOI 10.1007/s11262-010-0564-6; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Wang Xingguo, 2015, Journal of Chinese Institute of Food Science and Technology, V15, P1; Wu LJ, 2013, J PROTEOMICS, V89, P124, DOI 10.1016/j.jprot.2013.06.005; Wu LJ, 2012, CROP PROT, V42, P74, DOI 10.1016/j.cropro.2012.07.005; Wu LJ, 2013, PLOS ONE, V7; Xu DL, 2008, ARCH VIROL, V153, P1031, DOI 10.1007/s00705-008-0072-3; Yang Z. Y., 2005, J SHANXI AGR U, V25, P223; Zhang CL, 2011, VIRUS RES, V158, P188, DOI 10.1016/j.virusres.2011.03.031; Zhang XM, 2008, VIROLOGY, V374, P351, DOI 10.1016/j.virol.2007.12.045; Zheng XY, 2015, CHIN AGR SCI B, V31, P68; Zhu M, 2014, NEW PHYTOL, V203, P1291, DOI 10.1111/nph.12890	29	20	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151549	10.1371/journal.pone.0151549	http://dx.doi.org/10.1371/journal.pone.0151549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987060	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300084
J	Bethke, K; Andrei, V; Rademann, K				Bethke, Kevin; Andrei, Virgil; Rademann, Klaus			Decreasing the Effective Thermal Conductivity in Glass Supported Thermoelectric Layers	PLOS ONE			English	Article							DIFFUSIVE HEAT-CONDUCTION; THIN-FILMS; ORGANIC COMPOSITES; PERFORMANCE; POWER; TRANSPORT; GENERATOR; BULK; OXYTELLURIDE; SIMULATIONS	As thermoelectric devices begin to make their way into commercial applications, the emphasis is put on decreasing the thermal conductivity. In this purely theoretical study, finite element analysis is used to determine the effect of a supporting material on the thermal conductivity of a thermoelectric module. The simulations illustrate the heat transfer along a sample, consisting from Cu, Cu2O and PbTe thermoelectric layers on a 1 mm thick Pyrex glass substrate. The influence of two different types of heating, at a constant temperature and at a constant heat flux, is also investigated. It is revealed that the presence of a supporting material plays an important role on lowering the effective thermal conductivity of the layer-substrate ensemble. By using thinner thermoelectric layers the effective thermal conductivity is further reduced, almost down to the value of the glass substrate. As a result, the temperature gradient becomes steeper for a fixed heating temperature, which allows the production of devices with improved performance under certain conditions. Based on the simulation results, we also propose a model for a robust thin film thermoelectric device. With this suggestion, we invite the thermoelectric community to prove the applicability of the presented concept for practical purposes.	[Bethke, Kevin; Andrei, Virgil; Rademann, Klaus] Humboldt Univ, Dept Chem, D-10099 Berlin, Germany	Humboldt University of Berlin	Rademann, K (corresponding author), Humboldt Univ, Dept Chem, D-10099 Berlin, Germany.	klaus.rademann@chemie.hu-berlin.de		Andrei, Virgil/0000-0002-6914-4841; Bethke, Kevin/0000-0002-0528-8635	International Max-Planck Research School at the Fritz Haber Institute; Gesellschaft Deutscher Chemiker; German Federal Government; Bayer Foundations	International Max-Planck Research School at the Fritz Haber Institute; Gesellschaft Deutscher Chemiker; German Federal Government; Bayer Foundations	K.B. is most grateful for the scholarship from the International Max-Planck Research School at the Fritz Haber Institute. V.A. is most grateful to the Gesellschaft Deutscher Chemiker for the August-Wilhelm-von-Hofmann-Scholarship and to the German Federal Government and the Bayer Foundations for the "Deutschlandstipendium" scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Melanie Nossler (COMSOL) for support and helpful discussions. K.B. is most grateful for the scholarship from the International Max-Planck Research School at the Fritz Haber Institute. V.A. is most grateful to the Gesellschaft Deutscher Chemiker for the August-Wilhelm-von-Hofmann-Scholarship and to the German Federal Government and the Bayer Foundations for the "Deutschlandstipendium" scholarship.	Agrawal N, 2007, ANGEW CHEM INT EDIT, V46, P4316, DOI 10.1002/anie.200700306; Amasia M, 2012, SENSOR ACTUAT B-CHEM, V161, P1191, DOI 10.1016/j.snb.2011.11.080; Andrei V, 2016, PHYS CHEM CHEM PHYS, V18, P10700, DOI 10.1039/c5cp06828b; Andrei V, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4903832; Apertet Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4897350; Baranowski LL, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807314; Belytschko T, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/4/043001; Bentley RE, 1998, HD TEMPERATURE MEASU, V3; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Bosbach WA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143011; Boukai AI, 2008, NATURE, V451, P168, DOI 10.1038/nature06458; Cahill DG, 2003, J APPL PHYS, V93, P793, DOI 10.1063/1.1524305; Cahill DG, 2004, REV SCI INSTRUM, V75, P5119, DOI 10.1063/1.1819431; Chani MTS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095287; Chen G, 1998, PHYS REV B, V57, P14958, DOI 10.1103/PhysRevB.57.14958; Christensen M, 2008, NAT MATER, V7, P811, DOI 10.1038/nmat2273; CUSACK N, 1958, P PHYS SOC LOND, V72, P898, DOI 10.1088/0370-1328/72/5/429; De Bellis L, 2000, J THERMOPHYS HEAT TR, V14, P144; Dong Y, 2015, PHYSICA E, V66, P1, DOI 10.1016/j.physe.2014.09.011; Dong Y, 2014, PHYSICA E, V56, P256, DOI 10.1016/j.physe.2013.10.006; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Endrodi B, 2014, RSC ADV, V4, P55328, DOI 10.1039/c4ra09037c; Endrodi B, 2015, J POLYM SCI POL PHYS, V53, P1507, DOI 10.1002/polb.23782; Endrodi B, 2015, J PHYS CHEM C, V119, P8472, DOI 10.1021/acs.jpcc.5b00135; Fleurial JP, 2009, JOM-US, V61, P79, DOI 10.1007/s11837-009-0057-z; Freeman DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047822; Hartung D, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4923031; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; Hogblom O, 2014, J ELECTRON MATER, V43, P2247, DOI 10.1007/s11664-014-3020-x; Holgate TC, 2014, J ALLOY COMPD, V582, P827, DOI 10.1016/j.jallcom.2013.08.096; Hu XK, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4916545; Hua YC, 2016, INT J THERM SCI, V101, P126, DOI 10.1016/j.ijthermalsci.2015.10.037; Hua YC, 2014, INT J HEAT MASS TRAN, V78, P755, DOI 10.1016/j.ijheatmasstransfer.2014.07.037; Huber TE, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816621; Jood P, 2014, RSC ADV, V4, P6363, DOI 10.1039/c3ra46813e; Kim SJ, 2014, ENERG ENVIRON SCI, V7, P1959, DOI 10.1039/c4ee00242c; Komine T, 2010, J ELECTRON MATER, V39, P1606, DOI 10.1007/s11664-010-1266-5; Kraemer D, 2011, NAT MATER, V10, P532, DOI [10.1038/NMAT3013, 10.1038/nmat3013]; Kuhn R, 2015, MATER TODAY-PROC, V2, P761, DOI 10.1016/j.matpr.2015.05.096; Kurosaki K, 2013, PHYS STATUS SOLIDI A, V210, P82, DOI 10.1002/pssa.201228680; LaLonde AD, 2011, MATER TODAY, V14, P526, DOI 10.1016/S1369-7021(11)70278-4; Lan JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07783; Landry ES, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165304; Lee Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4640; Liebl H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116907; LIEBL J., 2009, MTZ MOTORTECHNISCHE, V70, P272, DOI DOI 10.1007/BF03225479; Losego MD, 2012, NAT MATER, V11, P502, DOI [10.1038/NMAT3303, 10.1038/nmat3303]; Loureiro J, 2014, J MATER CHEM A, V2, P6649, DOI 10.1039/c3ta15052f; Loureiro J, 2014, J MATER CHEM A, V2, P6456, DOI 10.1039/c3ta15168a; Luu SDN, 2015, J SOLID STATE CHEM, V226, P219, DOI 10.1016/j.jssc.2015.02.026; Matoso RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111192; Meng XN, 2015, J ELECTRON MATER, V44, P1469, DOI 10.1007/s11664-014-3418-5; Mitdank R, 2012, J APPL PHYS, V111, DOI 10.1063/1.4721896; Music D, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864078; Pei YZ, 2012, ADV MATER, V24, P6125, DOI 10.1002/adma.201202919; POLLACK GL, 1969, REV MOD PHYS, V41, P48, DOI 10.1103/RevModPhys.41.48; Prasher RS, 2001, J HEAT TRANS-T ASME, V123, P105, DOI 10.1115/1.1338138; Qiu B, 2012, COMP MATER SCI, V53, P278, DOI 10.1016/j.commatsci.2011.08.016; Reddy P, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2133890; Rodriguez-Barreiro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056358; Rowe DM, 1995, CRC HDB THERMOELECTR; Sharma R., 2015, Journal of the Institution of Engineers (India): Series C (Mechanical, Production, Aerospace and Marine Engineering), V96, P73, DOI 10.1007/s40032-014-0125-1; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Sondergaard M, 2013, ACTA MATER, V61, P3314, DOI 10.1016/j.actamat.2013.02.021; Sootsman JR, 2009, ANGEW CHEM INT EDIT, V48, P8616, DOI 10.1002/anie.200900598; SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605; Takahashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01501; Thiel P, 2013, J APPL PHYS, V114, DOI 10.1063/1.4854475; Vaqueiro P, 2013, J MATER CHEM A, V1, P520, DOI 10.1039/c2ta00878e; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Vogel-Schauble N, 2012, THIN SOLID FILMS, V520, P6869, DOI 10.1016/j.tsf.2012.07.046; Vogt W., 1930, ANN PHYS, V399, P183, DOI [10.1002/andp.19303990204, DOI 10.1002/ANDP.19303990204]; Walia S, 2013, PROG MATER SCI, V58, P1443, DOI 10.1016/j.pmatsci.2013.06.003; Wan CL, 2015, NAT MATER, V14, P622, DOI [10.1038/nmat4251, 10.1038/NMAT4251]; Wang Z, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/12/125707; Weidemann S, 2015, J NANOMATER, V2015, DOI 10.1155/2015/672305; Wilson RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6075; Xu B, 2014, J APPL PHYS, V115, DOI 10.1063/1.4881781; Yu C, 2011, ACS NANO, V5, P7885, DOI 10.1021/nn202868a; Yuan GD, 2012, J PHYS CHEM C, V116, P13767, DOI 10.1021/jp212427g; Zhang JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140567; Zhang K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03448; Zhang Q, 2014, ADV MATER, V26, P6829, DOI 10.1002/adma.201305371; Zhao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07671; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184; Zhao WY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7197; Zhou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08099; Zhou WX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07150	88	11	11	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151708	10.1371/journal.pone.0151708	http://dx.doi.org/10.1371/journal.pone.0151708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982458	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900116
J	Hillary, CJ; Roman, S; Bullock, AJ; Green, NH; Chapple, CR; MacNeil, S				Hillary, Christopher J.; Roman, Sabiniano; Bullock, Anthony J.; Green, Nicola H.; Chapple, Christopher R.; MacNeil, Sheila			Developing Repair Materials for Stress Urinary Incontinence to Withstand Dynamic Distension	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; BIOMECHANICAL PROPERTIES; TISSUE; COMPLICATIONS; SCAFFOLDS; FASCIA; WOMEN; MESH	Background Polypropylene mesh used as a mid-urethral sling is associated with severe clinical complications in a significant minority of patients. Current in vitro mechanical testing shows that polypropylene responds inadequately to mechanical distension and is also poor at supporting cell proliferation. Aims and Objectives Our objective therefore is to produce materials with more appropriate mechanical properties for use as a sling material but which can also support cell integration. Methods Scaffolds of two polyurethanes (PU), poly-L-lactic acid (PLA) and co-polymers of the two were produced by electrospinning. Mechanical properties of materials were assessed and compared to polypropylene. The interaction of adipose derived stem cells (ADSC) with the scaffolds was also assessed. Uniaxial tensiometry of scaffolds was performed before and after seven days of cyclical distension. Cell penetration (using DAPI and a fluorescent red cell tracker dye), viability (AlamarBlue assay) and total collagen production (Sirius red assay) were measured for ADSC cultured on scaffolds. Results Polypropylene was stronger than polyurethanes and PLA. However, polypropylene mesh deformed plastically after 7 days of sustained cyclical distention, while polyurethanes maintained their elasticity. Scaffolds of PU containing PLA were weaker and stiffer than PU or polypropylene but were significantly better than PU scaffolds alone at supporting ADSC. Conclusions Therefore, prolonged mechanical distension in vitro causes polypropylene to fail. Materials with more appropriate mechanical properties for use as sling materials can be produced using PU. Combining PLA with PU greatly improves interaction of cells with this material.	[Hillary, Christopher J.; Roman, Sabiniano; Bullock, Anthony J.; Green, Nicola H.; MacNeil, Sheila] Univ Sheffield, Kroto Res Inst, Broad Lane, Sheffield, S Yorkshire, England; [Hillary, Christopher J.; Chapple, Christopher R.] Royal Hallamshire Hosp, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield	MacNeil, S (corresponding author), Univ Sheffield, Kroto Res Inst, Broad Lane, Sheffield, S Yorkshire, England.	s.macneil@sheffield.ac.uk	Green, Nicola/K-4674-2019; Bullock, Anthony/AAC-2773-2021	Green, Nicola/0000-0001-5413-0642; Bullock, Anthony/0000-0003-0579-3997; Roman Regueros, Sabiniano/0000-0002-2368-7955; Chapple, Christopher/0000-0002-2960-9931	TRUST European Marie Curie Network; Urology Foundation Scholarship; Robert Luff Foundation; Rosetrees Trust [M293-F1] Funding Source: researchfish	TRUST European Marie Curie Network; Urology Foundation Scholarship; Robert Luff Foundation; Rosetrees Trust(Rosetrees Trust)	This work was supported by a grant from the TRUST European Marie Curie Network, The Urology Foundation Scholarship 2015 (CH) and the Robert Luff Foundation (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the TRUST European Marie Curie Network, The Urology Foundation and the Robert Luff Foundation.	Abdel-fattah M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000206; Abed H, 2011, INT UROGYNECOL J, V22, P789, DOI 10.1007/s00192-011-1384-5; Aboushwareb T, 2011, NEUROUROL URODYNAM, V30, P775, DOI 10.1002/nau.21101; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Bergmeister H, 2015, ACTA BIOMATER, V11, P104, DOI 10.1016/j.actbio.2014.09.003; Boennelycke M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.020; Brubaker L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.011; Bye FJ, 2013, BIOMATER SCI-UK, V1, P942, DOI 10.1039/c3bm60074b; Claerhout F, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.032; Gigliobianco G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/968087; Guerrero KL, 2010, BJOG-INT J OBSTET GY, V117, P1493, DOI 10.1111/j.1471-0528.2010.02696.x; Hung MJ, 2010, INT UROGYNECOL J, V21, P1085, DOI 10.1007/s00192-010-1168-3; Jackson WM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt111; Jones R, 2010, NEUROUROL URODYNAM, V29, P40, DOI 10.1002/nau.20851; Kruger JA, 2015, NEUROUROL URODYNAM, V34, P133, DOI 10.1002/nau.22537; Lei LL, 2007, INT UROGYNECOL J, V18, P603, DOI 10.1007/s00192-006-0214-7; Li XX, 2014, J MECH BEHAV BIOMED, V37, P48, DOI 10.1016/j.jmbbm.2014.05.005; Mangera A, 2013, BJU INT, V112, P674, DOI 10.1111/bju.12186; Mangera A, 2012, NEUROUROL URODYNAM, V31, P13, DOI 10.1002/nau.21156; Manodoro S, 2013, BJOG-INT J OBSTET GY, V120, P244, DOI 10.1111/1471-0528.12081; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; McBride AW, 2005, AM J OBSTET GYNECOL, V192, P1677, DOI 10.1016/j.ajog.2005.01.078; McGuire E J, 1981, Prog Clin Biol Res, V78, P351; Petros PEP, 1990, ACTA OBSTET GYN SCAN, V69, P7, DOI 10.1111/j.1600-0412.1990.tb08027.x; Petros PEP, 1990, ACTA OBSTET GYN SCAN, V69, P53, DOI 10.1111/j.1600-0412.1990.tb08032.x; Regueros SR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/853610; Roman S, 2014, NEUROUROL URODYNAM, V33, P531, DOI 10.1002/nau.22443; Takanari K, 2016, J TISSUE ENG REGEN M, V10, P748, DOI 10.1002/term.1834; Woodruff AJ, 2008, UROLOGY, V72, P85, DOI 10.1016/j.urology.2008.03.012	29	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149971	10.1371/journal.pone.0149971	http://dx.doi.org/10.1371/journal.pone.0149971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981860	Green Published, Green Accepted, gold			2022-12-26	WOS:000372574900022
J	Ibanez, C; Criscioni, P; Arriaga, H; Merino, P; Espinos, FJ; Fernandez, C				Ibanez, Carla; Criscioni, Patricia; Arriaga, Haritz; Merino, Pilar; Juan Espinos, Francisco; Fernandez, Carlos			Murciano-Granadina Goat Performance and Methane Emission after Replacing Barley Grain with Fibrous By-Products	PLOS ONE			English	Article							MANURE-DERIVED METHANE; CHAIN FATTY-ACIDS; DAIRY-COWS; MILK; ENERGY; LACTATION; NITROGEN; METABOLISM; BIOMARKERS; OXIDATION	The aim of this experiment was to study the effects of substituting dietary barley grain with orange pulp or soybean hulls on energy, nitrogen and carbon balance, methane emission and milk performance in dairy goats. Twelve Murciano-Granadina dairy goats in midlactation were selected and divided into three groups based on similar body weight (42.1 +/- 1.2 kg) and milk yield (2.16 +/- 0.060 kg/goat/day). The experiment was conducted in an incomplete crossover design where one group of four goats was fed a mixed ration of barley grain (BRL), another group of four goats replaced barley grain with orange pulp (OP) and the last group of four goats with soybean hulls (SH). After adaptation to diets, the goats were allocated to individual metabolism cages and intake, faeces, urine and milk were recorded and analysed. Then, gas exchange measurements were recorded by a mobile open-circuit indirect calorimetry system using a head box. Dry matter intake was similar for all three groups (2.03 kg/d, on average). No influence of the diet was observed for energy balance and the efficiency of use of metabolizable energy for milk production was 0.61. The OP and SH diets showed greater (P < 0.05) fat mobilization (-42.8 kJ/kg of BW0.75, on average) than BRL (19.2 kJ/kg of BW0.75). Pentadecanoic acid (15: 0) and heptadecanoic acid (17: 0) were potential biomarkers of rumen function because the higher contents found in the milk of OP and SH goats than BRL suggest a negative impact of these diets on rumen bacterial metabolism; probably linked to the lower nitrogen supply of diet OP to synthesize microbial protein and greater content of fat in diet SH. Replacement of cereal grain with fibrous by-products did not increased enteric methane emissions (54.7 L/goat per day, on average). Therefore, lactating goats could utilize dry orange pulp and soybean hulls diets with no detrimental effect on milk performance.	[Ibanez, Carla] Univ Catolica Valencia, Dept Prod Anim & Salud Publ, Fac Vet & Ciencias Expt, Valencia 46001, Spain; [Criscioni, Patricia; Juan Espinos, Francisco; Fernandez, Carlos] Univ Politecn Valencia, Dept Anim Sci, Res Ctr ACUMA, Valencia 46022, Spain; [Arriaga, Haritz; Merino, Pilar] NEIKER Tecnalia, Environm Qual Dept, Bizkaia Technol Pk,P 812, Derio 48160, Bizkaia, Spain	Universidad Catolica de Valencia San Vicente Martir; Universitat Politecnica de Valencia	Fernandez, C (corresponding author), Univ Politecn Valencia, Dept Anim Sci, Res Ctr ACUMA, Valencia 46022, Spain.	cjfernandez@dca.upv.es	Fernández, Carlos Javier/I-4027-2015; Merino, Pilar/K-4555-2014	Fernández, Carlos Javier/0000-0002-0368-0158; Merino, Pilar/0000-0002-5242-5479; IBANEZ SANCHIS, CARLA/0000-0001-5280-2740; Arriaga, Haritz/0000-0002-7552-0735	Spanish National Institute for Agronomic Research [RTA2011-00107-C02]; European Regional Development Fund (ERDF)	Spanish National Institute for Agronomic Research; European Regional Development Fund (ERDF)(European Commission)	This study was supported by the Spanish National Institute for Agronomic Research (RTA2011-00107-C02) and the European Regional Development Fund (ERDF).	AFRC, 1993, ENERGY PROTEIN REQUI; AGUILERA JF, 1990, BRIT J NUTR, V63, P165, DOI 10.1079/BJN19900104; AGUILERA JF, 1986, ARCH TIERERNAHR, V36, P1009, DOI 10.1080/17450398609429522; Angelidaki Irini, 2004, Reviews in Environmental Science and Bio/Technology, V3, P117, DOI 10.1007/s11157-004-2502-3; [Anonymous], 2006, IPCC GUIDELINES NATL; [Anonymous], 2001, US GUID VERS 8 02; AOAC, 2000, OFFICIAL METHODS ANA, V17th; BATEY IL, 1982, STARKE, V34, P125, DOI 10.1002/star.19820340407; Bava L, 2001, J DAIRY SCI, V84, P2450, DOI 10.3168/jds.S0022-0302(01)74695-4; BROCKWAY JM, 1971, J APPL PHYSIOL, V31, P296, DOI 10.1152/jappl.1971.31.2.296; Brouwer E., 1958, EAAP PUBLICATION, P182; Brouwer E., 1965, EAAP PUB, V11, P441, DOI DOI 10.4236/NS.2011.312129; Casper DP, 1999, J DAIRY SCI, V82, P1779, DOI 10.3168/jds.S0022-0302(99)75408-1; Chilliard Y, 2003, J DAIRY SCI, V86, P1751, DOI 10.3168/jds.S0022-0302(03)73761-8; Chwalibog A, 1997, Z ERNAHRUNGSWISS, V36, P313, DOI 10.1007/BF01617806; de Bias C, 2010, TABL FEDNA COMP VAL; Fahey G. C., 1988, RUMINANT ANIMAL DIGE, P269; Fernandez C, 2015, J AGR SCI-CAMBRIDGE, V153, P1302, DOI 10.1017/S0021859615000416; Fernandez C, 2012, ANIM FEED SCI TECH, V172, P242, DOI 10.1016/j.anifeedsci.2012.01.006; Fievez V, 2012, ANIM FEED SCI TECH, V172, P51, DOI 10.1016/j.anifeedsci.2011.12.008; Godbout S, 2010, ENVIRON TECHNOL, V31, P1371, DOI 10.1080/09593331003743096; Gonzalez-Avalos E, 2001, BIORESOURCE TECHNOL, V80, P63, DOI 10.1016/S0960-8524(01)00052-9; GRASSER LA, 1995, J DAIRY SCI, V78, P962, DOI 10.3168/jds.S0022-0302(95)76711-X; Hellwing ALF, 2014, LIVEST SCI, V165, P189, DOI 10.1016/j.livsci.2014.04.011; Jarret G, 2011, LIVEST SCI, V140, P275, DOI 10.1016/j.livsci.2011.04.006; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Jorjong S, 2015, J DAIRY SCI, V98, P5211, DOI 10.3168/jds.2014-8728; Jouany J. P., 1982, SCI ALIMENTS, V2, P131; Kebreab E, 2010, PUBL EAAP, P417; Klevenhusen F, 2011, ANIMAL, V5, P450, DOI 10.1017/S1751731110001795; Knapp JR, 2014, J DAIRY SCI, V97, P3231, DOI 10.3168/jds.2013-7234; Lopez MC, 2013, J DAIRY SCI, V96, P4542, DOI 10.3168/jds.2012-6473; McLean JA, 1990, ANIMAL HUMAN CALORIM; Mertens DR, 2002, J AOAC INT, V85, P1217; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; PALMQUIST DL, 1980, J DAIRY SCI, V63, P1, DOI 10.3168/jds.S0022-0302(80)82881-5; Robertson J.B., 1981, ANAL DIETARY FIBER F, V123, DOI DOI 10.1016/S0031-9384(00)00286-9; Spek JW, 2013, J AGR SCI-CAMBRIDGE, V151, P407, DOI 10.1017/S0021859612000561; Tovar-Luna I, 2010, J DAIRY SCI, V93, P4818, DOI 10.3168/jds.2010-3315; Triolo JM, 2011, BIORESOURCE TECHNOL, V102, P9395, DOI 10.1016/j.biortech.2011.07.026; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; van Knegsel ATM, 2007, J DAIRY SCI, V90, P1467, DOI 10.3168/jds.S0022-0302(07)71632-6; Vasta V, 2008, ANIM FEED SCI TECH, V147, P223, DOI 10.1016/j.anifeedsci.2007.09.020; Vedrenne F, 2008, BIORESOURCE TECHNOL, V99, P146, DOI 10.1016/j.biortech.2006.11.043; Velthof GL, 2005, J ENVIRON QUAL, V34, P698, DOI 10.2134/jeq2005.0698; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Vlaeminck B, 2015, J DAIRY SCI, V98, P4829, DOI 10.3168/jds.2014-9207	48	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151215	10.1371/journal.pone.0151215	http://dx.doi.org/10.1371/journal.pone.0151215			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983120	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900070
J	Zhou, SJ; Tanaka, K; O'Keeffe, M; Qi, M; El-Assaad, F; Weaver, JC; Chen, G; Weatherall, C; Wang, Y; Giannakopoulos, B; Chen, LM; Yu, D; Hamilton, MJ; Wensing, LA; Stevens, RL; Krilis, SA				Zhou, Saijun; Tanaka, Kumiko; O'Keeffe, Meredith; Qi, Miao; El-Assaad, Fatima; Weaver, James C.; Chen, Gang; Weatherall, Christopher; Wang, Ying; Giannakopoulos, Bill; Chen, Liming; Yu, DeMint; Hamilton, Matthew J.; Wensing, Lislaine A.; Stevens, Richard L.; Krilis, Steven A.			CD117(+) Dendritic and Mast Cells Are Dependent on RasGRP4 to Function as Accessory Cells for Optimal Natural Killer Cell-Mediated Responses to Lipopolysaccharide	PLOS ONE			English	Article							NUCLEOTIDE-RELEASING PROTEIN-4; SULFATE-E-PROTEOGLYCAN; C-KIT; MOLECULAR-CLONING; NK CELL; SIGNALING PROTEIN; SERINE-PROTEASE; TYROSINE KINASE; MOUSE; RECEPTOR	Ras guanine nucleotide-releasing protein-4 (RasGRP4) is an evolutionarily conserved calcium-regulated, guanine nucleotide exchange factor and diacylglycerol/phorbol ester receptor. While an important intracellular signaling protein for CD117(+) mast cells (MCs), its roles in other immune cells is less clear. In this study, we identified a subset of in vivo-differentiated splenic CD117(+) dendritic cells (DCs) in wild-type (WT) C57BL/6 mice that unexpectedly contained RasGRP4 mRNA and protein. In regard to the biologic significance of these data to innate immunity, LPS-treated splenic CD117(+) DCs from WT mice induced natural killer (NK) cells to produce much more interferon-gamma (IFN-gamma) than comparable DCs from RasGRP4-null mice. The ability of LPS-responsive MCs to cause NK cells to increase their expression of IFN-gamma was also dependent on this intracellular signaling protein. The discovery that RasGRP4 is required for CD117(+) MCs and DCs to optimally induce acute NK cell-dependent immune responses to LPS helps explain why this signaling protein has been conserved in evolution.	[Zhou, Saijun; Tanaka, Kumiko; Qi, Miao; El-Assaad, Fatima; Weaver, James C.; Chen, Gang; Weatherall, Christopher; Wang, Ying; Giannakopoulos, Bill; Stevens, Richard L.; Krilis, Steven A.] Univ New S Wales, St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia; [Zhou, Saijun; Tanaka, Kumiko; Qi, Miao; El-Assaad, Fatima; Weaver, James C.; Chen, Gang; Weatherall, Christopher; Wang, Ying; Giannakopoulos, Bill; Stevens, Richard L.; Krilis, Steven A.] Univ New S Wales, Fac Med, St George & Sutherland Clin Sch, Sydney, NSW, Australia; [Zhou, Saijun; Chen, Liming; Yu, DeMint] Tianjin Med Univ, Lab Hormones & Dev, Metab Hosp, Minist Hlth, Tianjin, TJ, Peoples R China; [Zhou, Saijun; Chen, Liming; Yu, DeMint] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, TJ, Peoples R China; [O'Keeffe, Meredith] Burnet Inst, Dendrit Cell Res Lab, Immun Vaccines & Immunisat, Prahran, Vic, Australia; [Weaver, James C.] St George Hosp, Dept Cardiol, Sydney, NSW, Australia; [Hamilton, Matthew J.; Stevens, Richard L.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Hamilton, Matthew J.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Wensing, Lislaine A.] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil	St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Tianjin Medical University; Tianjin Medical University; Burnet Institute; St George Hospital; University of Newcastle; Harvard University; Brigham & Women's Hospital; Universidade de Sao Paulo	Krilis, SA (corresponding author), Univ New S Wales, St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia.; Krilis, SA (corresponding author), Univ New S Wales, Fac Med, St George & Sutherland Clin Sch, Sydney, NSW, Australia.	s.krilis@unsw.edu.au	O'Keeffe, Meredith/U-9347-2017	O'Keeffe, Meredith/0000-0002-0779-4654	National Health and Medical Research Council of Australia [630402]; USA National Institutes of Health [DK09497]; Mastocytosis Society of the United States; St George and Sutherland Medical Research Foundation; University of New South Wales; Fundacao de Amparo a Pesquisa do Estado de Sao-FAPESP [2015/11868-7]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK094971] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mastocytosis Society of the United States; St George and Sutherland Medical Research Foundation; University of New South Wales; Fundacao de Amparo a Pesquisa do Estado de Sao-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/), #630402: SK; USA National Institutes of Health (http://www.nih.gov/), DK09497, and the Mastocytosis Society of the United States (http://www.tmsforacure.org/welcome.php): RLS; and St George and Sutherland Medical Research Foundation (http://www.stgeorgemrf.com.au/): RLS. FE-A obtained a Vice Chancellors Fellowship grant from the University of New South Wales (https://www.unsw.edu.au/). LAW obtained a Fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao-FAPESP, (http://www.fapesp.br/en/), 2015/11868-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Fogel-Petrovic M, 2004, IMMUNOL CELL BIOL, V82, P47, DOI 10.1111/j.1440-1711.2004.01213.x; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; GHILDYAL N, 1992, J IMMUNOL, V149, P2123; Hansbro PM, 2014, J BIOL CHEM, V289, P18214, DOI 10.1074/jbc.M114.548594; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; Katsoulotos GP, 2008, J BIOL CHEM, V283, P1610, DOI 10.1074/jbc.M707042200; Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835; Kono M, 2015, ARTHRITIS RHEUMATOL, V67, P396, DOI 10.1002/art.38924; Li LX, 2003, J IMMUNOL, V171, P390, DOI 10.4049/jimmunol.171.1.390; Li LX, 2003, J BIOL CHEM, V278, P4725, DOI 10.1074/jbc.C200635200; Li LX, 2002, MOL IMMUNOL, V38, P1283, DOI 10.1016/S0161-5890(02)00076-7; Marcenaro E, 2012, ADV EXP MED BIOL, V946, P295, DOI 10.1007/978-1-4614-0106-3_17; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; METZGER H, 1982, FED PROC, V41, P8; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Pulendran B, 1997, J IMMUNOL, V159, P2222; Ray P, 2010, ANN NY ACAD SCI, V1183, P104, DOI 10.1111/j.1749-6632.2009.05122.x; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; RAZIN E, 1984, J IMMUNOL, V132, P1479; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907; Stevens Richard L, 2005, Novartis Found Symp, V271, P54; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Tang SQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5657; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Trong H Le, 1989, BIOCHEMISTRY-US, V28, P391, DOI 10.1021/BI00427A054; Varma TK, 2002, CLIN DIAGN LAB IMMUN, V9, P530, DOI 10.1128/CDLI.9.3.530-543.2002; Vosskuhl K, 2010, J IMMUNOL, V185, P119, DOI 10.4049/jimmunol.0902406; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580	53	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151638	10.1371/journal.pone.0151638	http://dx.doi.org/10.1371/journal.pone.0151638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982501	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900106
J	Chen, QF; Chen, HJ; Liu, J; Sun, T; Shen, QT				Chen, Qiu-Feng; Chen, Hua-Jun; Liu, Jun; Sun, Tao; Shen, Qun-Tai			Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL GLUCOSE-METABOLISM; ANTERIOR CINGULATE CORTEX; HBV-RELATED CIRRHOSIS; NEURAL MECHANISM; DIAGNOSIS; ABNORMALITIES; SPECTROSCOPY; IMPAIRMENT; PREDICTION	Machine learning-based approaches play an important role in examining functional magnetic resonance imaging (fMRI) data in a multivariate manner and extracting features predictive of group membership. This study was performed to assess the potential for measuring brain intrinsic activity to identify minimal hepatic encephalopathy (MHE) in cirrhotic patients, using the support vector machine (SVM) method. Resting-state fMRI data were acquired in 16 cirrhotic patients with MHE and 19 cirrhotic patients without MHE. The regional homogeneity (ReHo) method was used to investigate the local synchrony of intrinsic brain activity. Psychometric Hepatic Encephalopathy Score (PHES) was used to define MHE condition. SVM-classifier was then applied using leave-one-out cross-validation, to determine the discriminative ReHo-map for MHE. The discrimination map highlights a set of regions, including the prefrontal cortex, anterior cingulate cortex, anterior insular cortex, inferior parietal lobule, precentral and postcentral gyri, superior and medial temporal cortices, and middle and inferior occipital gyri. The optimized discriminative model showed total accuracy of 82.9% and sensitivity of 81.3%. Our results suggested that a combination of the SVM approach and brain intrinsic activity measurement could be helpful for detection of MHE in cirrhotic patients.	[Chen, Qiu-Feng; Shen, Qun-Tai] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Chen, Hua-Jun; Liu, Jun; Sun, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing 210029, Jiangsu, Peoples R China	Central South University; Nanjing Medical University	Chen, QF (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China.; Chen, HJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing 210029, Jiangsu, Peoples R China.	chenqiufeng0204@126.com; chj0075@126.com			Priority Academic Program Development of Jiangsu Higher Education Institutions [JX 10231801]; National Natural Science Foundation of China [81501450]; China Postdoctoral Science Foundation	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX 10231801), a grant from the National Natural Science Foundation of China (No. 81501450), and the Project Funded by China Postdoctoral Science Foundation.	Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen HJ, 2015, AM J NEURORADIOL, V36, P481, DOI 10.3174/ajnr.A4146; Chen HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089684; Chen HJ, 2013, RADIOLOGY, V266, P261, DOI 10.1148/radiol.12120026; Chen HJ, 2012, J NEUROL SCI, V318, P140, DOI 10.1016/j.jns.2012.02.019; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; Dhiman RK, 2010, DIGEST DIS SCI, V55, P2381, DOI 10.1007/s10620-010-1249-7; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Kato A, 2000, HEPATOL RES, V17, P237, DOI 10.1016/S1386-6346(99)00080-7; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Li SW, 2013, WORLD J GASTROENTERO, V19, P8745, DOI 10.3748/wjg.v19.i46.8745; Lockwood AH, 2002, METAB BRAIN DIS, V17, P431, DOI 10.1023/A:1021978422783; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Lv XF, 2013, METAB BRAIN DIS, V28, P485, DOI 10.1007/s11011-013-9420-4; Lv XF, 2013, LIVER INT, V33, P375, DOI 10.1111/liv.12096; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Montagnese S, 2007, J HEPATOL, V46, P447, DOI 10.1016/j.jhep.2006.10.015; Nakanishi H, 2014, HEPATOL RES, V44, P319, DOI 10.1111/hepr.12127; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Saxena N, 2002, LIVER, V22, P190, DOI 10.1034/j.1600-0676.2002.01431.x; Seo YS, 2012, J GASTROEN HEPATOL, V27, P1695, DOI 10.1111/j.1440-1746.2012.07217.x; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053206; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x	42	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151263	10.1371/journal.pone.0151263	http://dx.doi.org/10.1371/journal.pone.0151263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978777	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800055
J	Dou, FG; Soriano, J; Tabien, RE; Chen, K				Dou, Fugen; Soriano, Junel; Tabien, Rodante E.; Chen, Kun			Soil Texture and Cultivar Effects on Rice (Oryza sativa, L.) Grain Yield, Yield Components and Water Productivity in Three Water Regimes	PLOS ONE			English	Article							ORGANIC-MATTER; MANAGEMENT; INCREASE; QTL	The objective of this study was to determine the effects of water regime/soil condition (continuous flooding, saturated, and aerobic), cultivar ('Cocodrie' and 'Rondo'), and soil texture (clay and sandy loam) on rice grain yield, yield components and water productivity using a greenhouse trial. Rice grain yield was significantly affected by soil texture and the interaction between water regime and cultivar. Significantly higher yield was obtained in continuous flooding than in aerobic and saturated soil conditions but the latter treatments were comparable to each other. For Rondo, its grain yield has decreased with soil water regimes in the order of continuous flooding, saturated and aerobic treatments. The rice grain yield in clay soil was 46% higher than in sandy loam soil averaged across cultivar and water regime. Compared to aerobic condition, saturated and continuous flooding treatments had greater panicle numbers. In addition, panicle number in clay soil was 25% higher than in sandy loam soil. The spikelet number of Cocodrie was 29% greater than that of Rondo, indicating that rice cultivar had greater effect on spikelet number than soil type and water management. Water productivity was significantly affected by the interaction of water regime and cultivar. Compared to sandy loam soil, clay soil was 25% higher in water productivity. Our results indicated that cultivar selection and soil texture are important factors in deciding what water management option to practice.	[Dou, Fugen; Tabien, Rodante E.] Texas A&M AgriLife Res Ctr Beaumont, 1509 Aggie Dr, Beaumont, TX 77713 USA; [Soriano, Junel] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Telangana, India; [Chen, Kun] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Connecticut	Dou, FG (corresponding author), Texas A&M AgriLife Res Ctr Beaumont, 1509 Aggie Dr, Beaumont, TX 77713 USA.	f-dou@aesrg.tamu.edu	Chen, Kun/C-2975-2015	Chen, Kun/0000-0003-3579-5467; Tabien, Rodante/0000-0001-8573-4123	Fulbright-Philippine Agriculture Scholarship Program under the Philippine-American Educational Foundation; Bureau of Agricultural Research of the Department of Agriculture in the Philippines; Bulacan Agricultural State College; International Rice Research Institute	Fulbright-Philippine Agriculture Scholarship Program under the Philippine-American Educational Foundation; Bureau of Agricultural Research of the Department of Agriculture in the Philippines; Bulacan Agricultural State College; International Rice Research Institute(CGIAR)	This research was partially funded by the Fulbright-Philippine Agriculture Scholarship Program under the Philippine-American Educational Foundation, Bureau of Agricultural Research of the Department of Agriculture in the Philippines, Bulacan Agricultural State College and International Rice Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, METHODS SOIL ANAL 1; Bond JA, 2008, AGRON J, V100, P393, DOI 10.2134/agronj2007.0107; Bouman BAM, 2006, FIELD CROP RES, V97, P53, DOI 10.1016/j.fcr.2005.08.015; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; Brodersen CR, 2008, PLANT CELL ENVIRON, V31, P159, DOI 10.1111/j.1365-3040.2007.01751.x; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Kachurina OM, 2000, COMMUN SOIL SCI PLAN, V31, P893, DOI 10.1080/00103620009370485; Kato Y, 2009, FIELD CROP RES, V113, P328, DOI 10.1016/j.fcr.2009.06.010; Kreye C, 2009, FIELD CROP RES, V111, P197, DOI 10.1016/j.fcr.2008.12.007; Linscombe SD, 2000, CROP SCI, V40, P294, DOI 10.2135/cropsci2000.0007rcv; Liu MJ, 2013, FIELD CROP RES, V150, P19, DOI 10.1016/j.fcr.2013.06.005; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; MISHRA HS, 1990, AGR WATER MANAGE, V18, P231, DOI 10.1016/0378-3774(90)90045-Z; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Peng SB, 2006, FIELD CROP RES, V96, P252, DOI 10.1016/j.fcr.2005.07.007; Powers RF, 2005, FOREST ECOL MANAG, V220, P31, DOI 10.1016/j.foreco.2005.08.003; Ramamasy S, 2007, CLIMATE VARIABILITY; Rao PR, 2013, J PLANT NUTR, V36, P390, DOI 10.1080/01904167.2012.744420; Schofield R. K, 1955, SOIL SCI SOC AM J, V19, P164, DOI DOI 10.2136/SSSAJ1955.03615995001900020013X; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Tsubo M, 2007, PLANT PROD SCI, V10, P232, DOI 10.1626/pps.10.232; Tuong T. P., 1999, Journal of Crop Production, V2, P241; Wang H, 2002, WATER WISE RICE PROD, P143; Wight JP, 2012, BIOMASS BIOENERG, V46, P593, DOI 10.1016/j.biombioe.2012.06.036; Wilson CE, 2008, ARKANSAS RICE PERFOR; Wu GW, 1998, AGRON J, V90, P317, DOI 10.2134/agronj1998.00021962009000030001x; Yan J, 2010, FIELD CROP RES, V116, P252, DOI 10.1016/j.fcr.2010.01.002; Ye Quanbao, 2007, Frontiers of Agriculture in China, V1, P30, DOI 10.1007/s11703-007-0005-z; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Yoshida S, 1981, FUNDAMENTALS RICE CR; Zhang XiaoCui, 2012, Acta Agronomica Sinica, V38, P1494, DOI 10.3724/SP.J.1006.2012.01494; Zhang YS, 2009, THEOR APPL GENET, V118, P1035, DOI 10.1007/s00122-008-0960-7; Zhao DL, 2010, CROP SCI, V50, P2268, DOI 10.2135/cropsci2010.10.0028; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	35	47	49	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150549	10.1371/journal.pone.0150549	http://dx.doi.org/10.1371/journal.pone.0150549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978525	Green Published, gold			2022-12-26	WOS:000372572800029
J	Csagola, A; Zadori, Z; Meszaros, I; Tuboly, T				Csagola, Attila; Zadori, Zoltan; Meszaros, Istvan; Tuboly, Tamas			Detection of Porcine Parvovirus 2 (Ungulate Tetraparvovirus 3) Specific Antibodies and Examination of the Serological Profile of an Infected Swine Herd	PLOS ONE			English	Article							PIG FARMS; IDENTIFICATION; SAMPLES; PPV2	Porcine parvovirus 2 (PPV2) is a member of a recently discovered group of swine parvoviruses occurring worldwide. It is frequently detected in lung samples suggesting some pathological role of the virus in diseases. To study this possibility an indirect ELISA was developed to detect PPV2 specific antibodies and to examine the serological profile of an infected swine herd where 185 serum samples collected from different age groups including sows were analyzed. According to the results maternal antibody levels decreased until 14 days of age and PPV2 specific antibodies started to rise between 28 to 43 days of age when respiratory signs were also observed in the examined swine herd. At 57 days of age the clinical signs disappeared and a rapid increase of PPV2 specific antibody levels could be measured simultaneously, peaking at 57 days of age. The viraemic status of different age groups was determined by qPCR using serum samples. At least a low level of viraemia was measured in every age group, but higher copy number of PPV2 was only detected at 57 days of age and the level decreased in older age groups. The changes in virus load and antibody levels together with the onset and decrease of clinical signs suggested that PPV2 had a role in the development of respiratory signs.	[Csagola, Attila; Tuboly, Tamas] Szent Istvan Univ, Fac Vet Sci, Dept Microbiol & Infect Dis, Budapest, Hungary; [Zadori, Zoltan; Meszaros, Istvan] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Csagola, A (corresponding author), Szent Istvan Univ, Fac Vet Sci, Dept Microbiol & Infect Dis, Budapest, Hungary.	Csagola.Attila@aotk.szie.hu			OTKA of the Hungarian Government [PD 100405]; KK-UK of the Hungarian Government; KTIA-AIK of the Hungarian Government; Hungarian Government [9877-3/2015/FEKUT]	OTKA of the Hungarian Government(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); KK-UK of the Hungarian Government; KTIA-AIK of the Hungarian Government; Hungarian Government	Research was funded by OTKA PD 100405, KK-UK 2014, KTIA-AIK and 9877-3/2015/FEKUT grants of the Hungarian Government.	Agbandje-McKenna M., 2006, PARVOVIRUSES, P125; Cadar D, 2013, J GEN VIROL, V94, P2330, DOI 10.1099/vir.0.055129-0; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Csagola A, 2012, ARCH VIROL, V157, P1003, DOI 10.1007/s00705-012-1257-3; Hijikata M, 2001, JPN J INFECT DIS, V54, P244; Kaufmann B, 2004, P NATL ACAD SCI USA, V101, P11628, DOI 10.1073/pnas.0402992101; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Opriessnig T, 2014, VET MICROBIOL, V173, P9, DOI 10.1016/j.vetmic.2014.06.024; Opriessnig T, 2013, VET MICROBIOL, V163, P177, DOI 10.1016/j.vetmic.2012.12.019; Saekhow P, 2014, MICROBIOL IMMUNOL, V58, P382, DOI 10.1111/1348-0421.12159; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simpson AA, 2002, J MOL BIOL, V315, P1189, DOI 10.1006/jmbi.2001.5319; Wang F, 2010, VIRUS GENES, V41, P305, DOI 10.1007/s11262-010-0506-3; Xiao CT, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00021-12; Xiao CT, 2013, INFECT GENET EVOL, V16, P369, DOI 10.1016/j.meegid.2013.03.017; Xiao CT, 2013, VET MICROBIOL, V161, P325, DOI 10.1016/j.vetmic.2012.07.038; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4	19	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151036	10.1371/journal.pone.0151036	http://dx.doi.org/10.1371/journal.pone.0151036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974825	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600045
J	Li, X; Zhao, J; Liu, JX; Li, G; Zhao, Y; Zeng, X				Li, Xiong; Zhao, Jin; Liu, Jianxing; Li, Geng; Zhao, Ya; Zeng, Xing			Systematic Analysis of Absorbed Anti-Inflammatory Constituents and Metabolites of Sarcandra glabra in Rat Plasma Using Ultra-High-Pressure Liquid Chromatography Coupled with Linear Trap Quadrupole Orbitrap Mass Spectrometry	PLOS ONE			English	Article							NF-KAPPA-B; ROSMARINIC ACID; CAFFEIC ACID; BIOACTIVE CONSTITUENTS; CHLOROGENIC ACID; ABSORPTION; ASTILBIN	Ultra-high-pressure liquid chromatography (UHPLC) was coupled with linear ion trap quad-rupole Orbitrap mass spectrometry (LTQ-Orbitrap) and was used for the first time to systematically analyze the absorbed components and metabolites in rat plasma after oral administration of the water extract of Sarcandra glabra. This extract is a well-known Chinese herbal medicine for the treatment of inflammation and immunity related diseases. The anti-inflammatory activities of the absorbed components were evaluated by measuring nitric oxide (NO) production and proinflammatory genes expression in lipopolysaccharide (LPS)stimulated murine RAW 264.7 macrophages. As a result, 54 components in Sarcandra glabra were detected in dosed rat plasma, and 36 of them were positively identified. Moreover, 23 metabolites were characterized and their originations were traced. Furthermore, 20 of the 24 studied components showed anti-inflammatory activities. These results provide evidence that this method efficiency detected constituents in plasma based on the anti-inflammatory mechanism of multiple components and would be a useful technique for screening multiple targets for natural medicine research.	[Li, Xiong; Zhao, Ya; Zeng, Xing] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Zhao, Jin] Zhongshan City Peoples Hosp, Zhongshan, Peoples R China; [Liu, Jianxing; Li, Geng] Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Zhao, Ya] Guangzhou Univ Chinese Med, Postdoctoral Res Stn, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Zhao, Y; Zeng, X (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China.; Zhao, Y (corresponding author), Guangzhou Univ Chinese Med, Postdoctoral Res Stn, Guangzhou, Guangdong, Peoples R China.	22355795@qq.com; zengxing-china@163.com			National Natural Science Foundation of China [81202888]; Natural Science Foundation of Guangdong Province [S2013030011515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by a National Natural Science Foundation of China ( No. 81202888) and partly supported by Natural Science Foundation of Guangdong Province ( No. S2013030011515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PHARM PEOPL REP CHIN, p[223, 409, 861, 1102]; Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q; Baba S, 2005, EUR J NUTR, V44, P1, DOI 10.1007/s00394-004-0482-2; Baba S, 2004, LIFE SCI, V75, P165, DOI 10.1016/j.lfs.2003.11.028; Bufalo MC, 2013, J ETHNOPHARMACOL, V149, P84, DOI 10.1016/j.jep.2013.06.004; Fan DS, 2011, FITOTERAPIA, V82, P805, DOI 10.1016/j.fitote.2011.04.007; Huang HQ, 2011, J AGR FOOD CHEM, V59, P4562, DOI 10.1021/jf2002969; Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4; Jiang WL, 2009, SHOCK, V32, P608, DOI 10.1097/SHK.0b013e3181a48e86; Lee DS, 2014, ARCH PHARM RES, V37, P947, DOI 10.1007/s12272-013-0243-y; Li X, 2014, ANAL METHODS-UK, V6, P7989, DOI 10.1039/c4ay01259c; [黎雄 Li Xiong], 2012, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V23, P295; Li X, 2012, HELV CHIM ACTA, V95, P998, DOI 10.1002/hlca.201100352; Li Xiong, 2011, Yaoxue Xuebao, V46, P1349; Li X, 2011, RAPID COMMUN MASS SP, V25, P2439, DOI 10.1002/rcm.5123; Liu Shumin, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1840; Min SW, 2010, INT IMMUNOPHARMACOL, V10, P959, DOI 10.1016/j.intimp.2010.05.009; Nakazawa T, 1998, J NAT PROD, V61, P993, DOI 10.1021/np980072s; Niu XF, 2012, INT IMMUNOPHARMACOL, V14, P164, DOI 10.1016/j.intimp.2012.06.022; Pei LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057414; Pragasam SJ, 2013, INFLAMMATION, V36, P169, DOI 10.1007/s10753-012-9532-8; Wang M., 2015, NANOTOXICOLOGY, V1, P1; [王文艳 Wang Wenyan], 2011, [质谱学报, Journal of Chinese Mass Spectrometry Society], V32, P36; Wu HF, 2013, J PHARMACEUT BIOMED, V72, P267, DOI 10.1016/j.jpba.2012.09.004; Xie Cen, 2011, Yaoxue Xuebao, V46, P88; Zhang QF, 2013, J AGR FOOD CHEM, V61, P12085, DOI 10.1021/jf404420s	26	10	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150063	10.1371/journal.pone.0150063	http://dx.doi.org/10.1371/journal.pone.0150063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974321	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600017
J	Xu, WT; Chen, L; Guo, S; Wu, LX; Zhang, JH				Xu, Wanting; Chen, Ling; Guo, Sheng; Wu, Liangxia; Zhang, Jianhua			Intranasal Administration of Recombinant Mycobacterium smegmatis Inducing IL-17A Autoantibody Attenuates Airway Inflammation in a Murine Model of Allergic Asthma	PLOS ONE			English	Article							T-CELL; MOUSE MODEL; HYPERRESPONSIVENESS; INTERLEUKIN-13; PATHOGENESIS; CYTOKINES; IMMUNITY; TUBERCULOSIS; EOSINOPHILS; VACCINATION	Asthma is a chronic inflammatory disorder, previous studies have shown that IL-17A contributes to the development of asthma, and there is a positive correlation between the level of IL-17A and the severity of disease. Here, we constructed recombinant Mycobacterium smegmatis expressing fusion protein Ag85A-IL-17A (rMS-Ag85a-IL-17a) and evaluated whether it could attenuate allergic airway inflammation, and further investigated the underlying mechanism. In this work, the murine model of asthma was established with ovalbumin, and mice were intranasally vaccinated with rMS-Ag85a-IL-17a. Autoantibody of IL-17A in sera was detected, and the airway inflammatory cells infiltration, the local cytokines and chemokines production and the histopathological changes of lung tissue were investigated. We found that the administration of rMS-Ag85a-IL-17a induced the autoantibody of IL-17A in sera. The vaccination of rMS-Ag85a-IL-17a remarkably reduced the infiltration of inflammatory cells and the secretion of mucus in lung tissue and significantly decreased the numbers of the total cells, eosinophils and neutrophils in BALF. Th1 cells count in spleen, Th1 cytokine levels in BALF and supernatant of splenocytes and mediastinal lymph nodes, and T-bet mRNA in lung tissue were significantly increased with rMS-Ag85a-IL-17a administration. Meanwhile, rMS-Ag85a-IL-17a vaccination markedly decreased Th2 cells count, Th2 cytokine and Th17 cytokine levels in BALF and supernatant of splenocytes and mediastinal lymph nodes, and chemokines mRNA expression in lung tissue. These data confirmed that recombinant Mycobacterium smegmatis in vivo could induce autoantibody of IL-17A, which attenuated asthmatic airway inflammation.	[Xu, Wanting; Chen, Ling; Wu, Liangxia; Zhang, Jianhua] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Paediat, Shanghai 200030, Peoples R China; [Guo, Sheng] Shanghai Jiao Tong Univ, Affiliated Childrens Hosp, Dept Endocrinol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, JH (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Paediat, Shanghai 200030, Peoples R China.	zhangjh12195@aliyun.com		Chen, Ling/0000-0001-8604-6808	National Natural Science Foundation of China [81172887]; Science and Technology Commission of Shanghai Municipality [14JC1492000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China, No. 81172887, http://www.nsfc.gov.cn, to Jianhua Zhang; and Science and Technology Commission of Shanghai Municipality, No. 14JC1492000, http://www.stcsm.gov.cn, to Jianhua Zhang.	Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Bergquist M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-110; Boyce JA, 2012, J ALLERGY CLIN IMMUN, V129, P335, DOI 10.1016/j.jaci.2011.12.968; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chen L, 2015, APPL BIOCHEM BIOTECH, V176, P2018, DOI 10.1007/s12010-015-1697-9; Chiarella SE, 2015, J ALLERGY CLIN IMMUN, V135, P290, DOI 10.1016/j.jaci.2014.09.037; Davoine F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00570; Delavallee L, 2008, ANN MED, V40, P343, DOI 10.1080/07853890801995298; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Elamin AA, 2011, MOL MICROBIOL, V81, P1577, DOI 10.1111/j.1365-2958.2011.07792.x; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Huang W., 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/910520; Ildiko F, 2011, ACTA MICROBIOL IMM H, V58, P13, DOI 10.1556/AMicr.58.2011.1.2; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Kumar RK, 2002, CLIN EXP ALLERGY, V32, P1104, DOI 10.1046/j.1365-2222.2002.01420.x; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Li J, 2014, ANN ALLERG ASTHMA IM, V113, P173, DOI 10.1016/j.anai.2014.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu L, 2011, CLIN VACCINE IMMUNOL, V18, P1957, DOI 10.1128/CVI.05306-11; Manni ML, 2014, EXPERT REV RESP MED, V8, P25, DOI 10.1586/17476348.2014.854167; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; O'Byrne PM, 2001, J ALLERGY CLIN IMMUN, V108, P503, DOI 10.1067/mai.2001.119149; Olin JT, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5517; Ota K, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/602846; Robinson DS, 2015, EXPERT OPIN BIOL TH, V15, P909, DOI 10.1517/14712598.2015.1041911; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spencer AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033555; Sterk PJ, 2014, J ALLERGY CLIN IMMUN, V133, P395, DOI 10.1016/j.jaci.2013.10.008; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tomita K, 2002, CLIN IMMUNOL, V102, P258, DOI 10.1006/clim.2001.5176; Tournoy KG, 2001, J IMMUNOL, V166, P6982, DOI 10.4049/jimmunol.166.11.6982; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Zietkowski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-110; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	48	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151581	10.1371/journal.pone.0151581	http://dx.doi.org/10.1371/journal.pone.0151581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974537	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600091
J	Wang, ZQ; Wu, WZ; Liu, YK; Wang, TY; Chen, X; Zhang, JH; Zhou, GX; Chen, R				Wang, Zhongqiu; Wu, Wenzhong; Liu, Yongkang; Wang, Tianyao; Chen, Xiao; Zhang, Jianhua; Zhou, Guoxing; Chen, Rong			Altered Cerebellar White Matter Integrity in Patients with Mild Traumatic Brain Injury in the Acute Stage	PLOS ONE			English	Article							AXONAL INJURY; DEFICITS	Background and Purpose Imaging studies of traumatic brain injury demonstrate that the cerebellum is often affected. We aim to examine fractional anisotropy alteration in acute-phase mild traumatic brain injury patients in cerebellum-related white matter tracts. Materials and Methods This prospective study included 47 mild traumatic brain injury patients in the acute stage and 37 controls. MR imaging and neurocognitive tests were performed in patients within 7 days of injury. White matter integrity was examined by using diffusion tensor imaging. We used three approaches, tract-based spatial statistics, graphical-model-based multivariate analysis, and region-of-interest analysis, to detect altered cerebellar white matter integrity in mild traumatic brain injury patients. Results Results from three analysis methods were in accordance with each other, and suggested fractional anisotropy in the middle cerebellar peduncle and the pontine crossing tract was changed in the acute-phase mild traumatic brain injury patients, relative to controls (adjusted p-value < 0.05). Higher fractional anisotropy in the middle cerebellar peduncle was associated with worse performance in the fluid cognition composite (r = -0.289, p-value = 0.037). Conclusion Altered cerebellar fractional anisotropy in acute-phase mild traumatic brain injury patients is localized in specific regions and statistically associated with cognitive deficits detectable on neurocognitive testing.	[Wang, Zhongqiu; Liu, Yongkang; Chen, Xiao] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wu, Wenzhong] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Acupuncture & Rehabil, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Tianyao] Fudan Univ, Peoples Hosp Shanghai 5, Dept Radiol, Shanghai 200240, Peoples R China; [Zhang, Jianhua; Zhou, Guoxing] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Radiol, Shanghai 200120, Peoples R China; [Chen, Rong] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Fudan University; Tongji University; University System of Maryland; University of Maryland Baltimore	Wang, ZQ (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.; Chen, R (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA.	Zhq2001us@163.com; rchen@umm.edu						Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Chen R, 2005, IEEE T MED IMAGING, V24, P1237, DOI 10.1109/TMI.2005.854305; Chen R, 2007, NEUROIMAGE, V35, P635, DOI 10.1016/j.neuroimage.2006.11.040; Chen R, 2012, NEUROINFORMATICS, V10, P119, DOI 10.1007/s12021-011-9129-7; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellison-Wright I, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-99; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Lupi A, 2007, CLIN NUCL MED, V32, P445, DOI 10.1097/RLU.0b013e3180537621; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mendoza J., 2007, CLIN NEUROANATOMY NE; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7	34	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151489	10.1371/journal.pone.0151489	http://dx.doi.org/10.1371/journal.pone.0151489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967320	Green Submitted, Green Published, gold			2022-12-26	WOS:000371989200059
J	Cheng, HL; Bao, X; Rao, H				Cheng, Haili; Bao, Xin; Rao, Hai			The F-box Protein Rcy1 Is Involved in the Degradation of Histone H3 Variant Cse4 and Genome Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; ECTOPIC LOCALIZATION; MEDIATED PROTEOLYSIS; CENTROMERE PROTEINS; CENP-A; YEAST; PSH1; PROTEASOME	Cse4, a histone H3-like centromeric protein, plays critical functions in chromosome segregation. Cse4 level is tightly regulated, but the underlying mechanism remains poorly understood. We employed a toxicity-based screen to look for the degradation components involved in Cse4 regulation. Here, we show that the F-box containing protein Rcy1 is required for efficient Cse4 turnover as Cse4 degradation is compromised in yeast cells lacking RCY1. Excessive Cse4 accumulation in rcy1 Delta cells leads to growth retardation. Furthermore, the deletion of RCY1 is tied to enhanced chromosome instability and temperature-sensitive cell growth. Our results reveal the involvement of Rcy1 in chromosome regulation and another regulatory pathway controlling the Cse4 level and activity.	[Cheng, Haili; Bao, Xin; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Rao, H (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	raoh@uthscsa.edu	Cheng, Haili/AGG-8193-2022	Cheng, Haili/0000-0002-1860-3585; RAO, HAI/0000-0002-4235-2210	Welch Foundation [AQ 1747]; William AMP; Ella Owens Medical Research Foundation; Helen F. Kerr Foundation; Department of Defense [W911NF-11-10466]; National Institutes of Health [GM 078085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); William AMP; Ella Owens Medical Research Foundation; Helen F. Kerr Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Welch Foundation Grant AQ 1747, the William & Ella Owens Medical Research Foundation, the Helen F. Kerr Foundation, Department of Defense Grant W911NF-11-10466, and National Institutes of Health Grant GM 078085 (to H. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that there is no conflict of interest for this study.	Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Athane A, 2015, INT J BIOCHEM CELL B, V64, P167, DOI 10.1016/j.biocel.2015.04.002; Au WC, 2013, GENETICS, V194, P513, DOI 10.1534/genetics.113.149898; Au WC, 2008, GENETICS, V179, P263, DOI 10.1534/genetics.108.088518; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; Chen Shu H, 2011, Cell Logist, V1, P21, DOI 10.4161/cl.1.1.14695; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; da Rosa JL, 2011, GENETICS, V187, P9, DOI 10.1534/genetics.110.123117; Deyter GMR, 2014, GENE DEV, V28, P1815, DOI 10.1101/gad.243113.114; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Earnshaw WC, 2015, NAT REV MOL CELL BIO, V16, P443, DOI 10.1038/nrm4001; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gkikopoulos T, 2011, EMBO J, V30, P1919, DOI 10.1038/emboj.2011.112; Herrero S, 2014, EUKARYOT CELL, V13, P1085, DOI 10.1128/EC.00042-14; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Hewawasam GS, 2014, J BIOL CHEM, V289, P29297, DOI 10.1074/jbc.M114.580589; Hewawasam GS, 2011, CELL CYCLE, V10, P566, DOI 10.4161/cc.10.4.14770; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Lafourcade C, 2003, GENETICS, V164, P469; Liu C, 2011, J BIOL CHEM, V286, P43660, DOI 10.1074/jbc.M111.286229; Liu C, 2010, TRENDS BIOTECHNOL, V28, P461, DOI 10.1016/j.tibtech.2010.06.003; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Lomonte P, 2001, J BIOL CHEM, V276, P5829, DOI 10.1074/jbc.M008547200; Love Ian M, 2012, Genes Cancer, V3, P249, DOI 10.1177/1947601912455198; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mukherjee D, 2013, J CELL SCI, V126, P4560, DOI 10.1242/jcs.117663; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Ohkuni K, 2014, GENETICS, V196, P1041, DOI 10.1534/genetics.114.161224; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Singh RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036295; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Westhorpe FG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015818; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397	39	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10372	10377		10.1074/jbc.M115.701813	http://dx.doi.org/10.1074/jbc.M115.701813			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26975376	Green Published, hybrid			2022-12-26	WOS:000375602800042
J	Xu, X; Han, KK; Tang, XW; Zeng, YY; Lin, X; Zhao, Y; Zhang, ZB; Cao, BY; Wu, DP; Mao, XL				Xu, Xin; Han, Kunkun; Tang, Xiaowen; Zeng, Yuanying; Lin, Xu; Zhao, Yun; Zhang, Zubin; Cao, Biyin; Wu, Depei; Mao, Xinliang			The Ring Finger Protein RNF6 Induces Leukemia Cell Proliferation as a Direct Target of Pre-B-cell Leukemia Homeobox 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; PRECLINICAL ACTIVITY; LUNG ADENOCARCINOMA; MULTIPLE-MYELOMA; TRANSCRIPTION; E2A-PBX1; GENE; PBX1; DIFFERENTIATION; UBIQUITINATION	RNF6 is a little-studied ring finger protein. In the present study, we found that RNF6 was overexpressed in various leukemia cells and that it accelerated leukemia cell proliferation, whereas knockdown of RNF6 delayed tumor growth in xeno-grafts. To find out the mechanism of RNF6 overexpression in leukemia, we designed a series of truncated constructs of RNF6 regulatory regions in the luciferase reporter system. The results revealed that the region between -144 and -99 upstream of the RNF6 transcription start site was critical and that this region contained a PBX1 recognition element (PRE). PBX1 modulated RNF6 expression by binding to the specific PRE. When PRE was mutated, RNF6 transcription was completely abolished. Further studies showed that PBX1 collaborated with PREP1 but not MEIS1 to modulate RNF6 expression. Moreover, RNF6 expression could be suppressed by doxorubicin, a major anti-leukemia agent, via down-regulating PBX1. This study thus suggests that RNF6 overexpression in leukemia is under the direction of PBX1 and that the PBX1/RNF6 axis can be developed as a novel therapeutic target of leukemia.	[Xu, Xin; Han, Kunkun; Zeng, Yuanying; Lin, Xu; Zhang, Zubin; Cao, Biyin; Mao, Xinliang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Jiangsu Key Lab Translat Res & Therapeut Neuropsy, Suzhou 215123, Jiangsu, Peoples R China; [Tang, Xiaowen; Wu, Depei] Soochow Univ, Affiliated Hosp 1, Dept Hematol, Suzhou 215006, Jiangsu, Peoples R China; [Zhao, Yun] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Jiangsu, Peoples R China; [Mao, Xinliang] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Jiangsu, Peoples R China; [Han, Kunkun] Asclepius Technol Co Grp, Suzhou 215123, Jiangsu, Peoples R China; [Han, Kunkun] Asclepius Canc Res Ctr, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Mao, XL (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, 199 Ren Rd,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	xinliangmao@suda.edu.cn	xu, xu/GQP-5096-2022	Lin, Xu/0000-0002-6382-7414	National Natural Science Foundation of China [81320108023, 81272632, 81270645]; Natural Science Foundation of Jiangsu Province [BE2014630]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Key Laboratory for Translational Research and Therapeutics of Neuro-Psycho-Diseases [BK2013003]; Suzhou City Science and Technology Programs [SYS201457]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Key Laboratory for Translational Research and Therapeutics of Neuro-Psycho-Diseases; Suzhou City Science and Technology Programs	This work was partly supported by National Natural Science Foundation of China Grants 81320108023 (to X. M.), 81272632 (to X. M.), 81270645 (to X. T.), by Natural Science Foundation of Jiangsu Province Grant BE2014630 (to X. M.), by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by Jiangsu Key Laboratory for Translational Research and Therapeutics of Neuro-Psycho-Diseases Grant BK2013003 (to X. M.), and by Suzhou City Science and Technology Programs Grant SYS201457 (to X. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; Bruserud O, 2015, EXPERT REV HEMATOL, V8, P29, DOI 10.1586/17474086.2015.971005; Calvo KR, 1999, ONCOGENE, V18, P8033, DOI 10.1038/sj.onc.1203377; Cao BY, 2013, J BIOL CHEM, V288, P34181, DOI 10.1074/jbc.M113.472563; Chao SH, 2003, MOL CELL BIOL, V23, P831, DOI 10.1128/MCB.23.3.831-841.2003; Chen G, 2014, BRIT J CANCER, V110, P63, DOI 10.1038/bjc.2013.711; Collins CT, 2016, ONCOGENE, V35, P1090, DOI 10.1038/onc.2015.174; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; Duque-Afonso J, 2015, J CLIN INVEST, V125, P3667, DOI 10.1172/JCI81158; Imperato MR, 2015, INT J HEMATOL, V101, P319, DOI 10.1007/s12185-015-1762-8; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; Li XM, 2010, JNCI-J NATL CANCER I, V102, P1069, DOI 10.1093/jnci/djq198; Lo HS, 2002, CANCER RES, V62, P4191; Lopez P, 2002, MOL CELL BIOL, V22, P3488, DOI 10.1128/MCB.22.10.3488-3496.2002; Macdonald DHC, 1999, GENOMICS, V58, P94, DOI 10.1006/geno.1999.5802; Mao XL, 2008, BLOOD, V112, P760, DOI 10.1182/blood-2008-02-142687; Mao XL, 2011, MOL PHARMACOL, V79, P672, DOI 10.1124/mol.110.068122; Mao XL, 2011, BLOOD, V117, P1986, DOI 10.1182/blood-2010-05-284810; Qin X, 2012, INT J MOL MED, V29, P791, DOI 10.3892/ijmm.2012.912; Risolino M, 2014, P NATL ACAD SCI USA, V111, pE3775, DOI 10.1073/pnas.1407074111; Shi M, 2014, TOXICOL LETT, V228, P133, DOI 10.1016/j.toxlet.2014.05.003; Somasundaram R, 2015, BLOOD, V126, P144, DOI 10.1182/blood-2014-12-575688; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	24	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9617	9628		10.1074/jbc.M115.701979	http://dx.doi.org/10.1074/jbc.M115.701979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26971355	Green Published, hybrid			2022-12-26	WOS:000375602300020
J	Ahmed, S; Zhan, CS; Yang, YY; Wang, XK; Yang, TW; Zhao, ZY; Zhang, QY; Li, XH; Hu, XB				Ahmed, Shakeel; Zhan, Chuansong; Yang, Yanyan; Wang, Xuekui; Yang, Tewu; Zhao, Zeying; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo			The Transcript Profile of a Traditional Chinese Medicine, Atractylodes lancea, Revealing Its Sesquiterpenoid Biosynthesis of the Major Active Components	PLOS ONE			English	Article							SSR MARKER DEVELOPMENT; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; GENE-EXPRESSION; SYNTHASE GENES; ESSENTIAL OILS; RNA-SEQ; RHIZOMES; L.; EVOLUTION	Atractylodes lancea (Thunb.) DC., named "Cangzhu" in China, which belongs to the Asteraceae family. In some countries of Southeast Asia (China, Thailand, Korea, Japan etc.) its rhizome, commonly called rhizoma atractylodis, is used to treat many diseases as it contains a variety of sesquiterpenoids and other components of medicinal importance. Despite its medicinal value, the information of the sesquiterpenoid biosynthesis is largely unknown. In this study, we investigated the transcriptome analysis of different tissues of non-model plant A. lancea by using short read sequencing technology (Illumina). We found 62,352 high quality unigenes with an average sequence length of 913 bp in the transcripts of A. Lancea. Among these, 43,049 (69.04%), 30,264 (48.53%), 26,233 (42.07%), 17,881 (28.67%) and 29,057(46.60%) unigenes showed significant similarity (E-value<1e(-5)) to known proteins in Nr, KEGG, SWISS- PROT, GO, and COG databases, respectively. Of the total 62,352 unigenes, 43,049 (Nr Database) open reading frames were predicted. On the basis of different bioinformatics tools we identify all the enzymes that take part in the terpenoid biosynthesis as well as five different known sesquiterpenoids via cytosolic mevalonic acid (MVA) pathway and plastidal methylerythritol phosphate (MEP) pathways. In our study, 6, 864 Simple Sequence Repeats (SSRs) were also found as great potential markers in A. lancea. This transcriptomic resource of A. lancea provides a great contribution in advancement of research for this specific medicinal plant and more specifically for the gene mining of different classes of terpenoids and other chemical compounds that have medicinal as well as economic importance.	[Ahmed, Shakeel; Zhan, Chuansong; Yang, Yanyan; Wang, Xuekui; Yang, Tewu; Zhao, Zeying; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo] Huazhong Agr Univ, Dept Med Plant, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Ahmed, Shakeel; Zhan, Chuansong; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo] Huazhong Agr Univ, Ctr Plant Funct Components, Wuhan 430070, Peoples R China; [Ahmed, Shakeel; Zhan, Chuansong; Yang, Yanyan; Wang, Xuekui; Yang, Tewu; Zhao, Zeying; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo] Huazhong Agr Univ, Natl Reg Joint Engn Res Ctr Hubei Med Plant Breed, Wuhan 430070, Peoples R China; [Ahmed, Shakeel; Zhan, Chuansong; Yang, Yanyan; Wang, Xuekui; Yang, Tewu; Zhao, Zeying; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo] Huazhong Agr Univ, Engn Res Ctr Med Plants, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Hu, XB (corresponding author), Huazhong Agr Univ, Dept Med Plant, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China.; Hu, XB (corresponding author), Huazhong Agr Univ, Ctr Plant Funct Components, Wuhan 430070, Peoples R China.; Hu, XB (corresponding author), Huazhong Agr Univ, Natl Reg Joint Engn Res Ctr Hubei Med Plant Breed, Wuhan 430070, Peoples R China.; Hu, XB (corresponding author), Huazhong Agr Univ, Engn Res Ctr Med Plants, Wuhan 430070, Peoples R China.	xuebohu@mail.hzau.edu.cn	Awan, Shakeel Ahmed/AAG-2097-2019	Awan, Shakeel Ahmed/0000-0003-0086-2279	Fundamental Research Funds for the Central Universities Program [2014PY057]; Natural Science Foundation of Hubei Province, China [2015CFA091]	Fundamental Research Funds for the Central Universities Program; Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This research was supported by the Fundamental Research Funds for the Central Universities Program No. 2014PY057 (XH) and Natural Science Foundation of Hubei Province, China, No. 2015CFA091 (XH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MH, 2002, PHYTOCHEMISTRY, V60, P255, DOI 10.1016/S0031-9422(02)00103-6; Bushman BS, 2011, THEOR APPL GENET, V123, P119, DOI 10.1007/s00122-011-1571-2; Cane D.E., 1999, COMPR NAT PROD CHEM, V2, P155, DOI [10.1016/B978-0-08-091283-7.00039-4, DOI 10.1016/B978-0-08-091283-7.00039-4]; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Chen HP, 2015, CHEM BIODIVERS, V12, P593, DOI 10.1002/cbdv.201400161; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chung J, 2009, J KOREAN SOC INT AGR; CORNWELL PA, 1994, J PHARM PHARMACOL, V46, P261, DOI 10.1111/j.2042-7158.1994.tb03791.x; Crock J, 1997, P NATL ACAD SCI USA, V94, P12833, DOI 10.1073/pnas.94.24.12833; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; de Kraker JW, 2001, PLANT PHYSIOL, V125, P1930, DOI 10.1104/pp.125.4.1930; Di Sotto A, 2008, MUTAT RES-GEN TOX EN, V653, P130, DOI 10.1016/j.mrgentox.2008.04.004; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dong SB, 2014, GENE, V544, P220, DOI 10.1016/j.gene.2014.04.031; Duan JA, 2008, ARCH PHARM RES, V31, P965, DOI 10.1007/s12272-001-1252-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Herb ECoNCMMBC, 1999, HERB ECONCMMBC; Inagaki N, 2001, PLANTA MED, V67, P428, DOI 10.1055/s-2001-15822; Irmisch S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-84; Iseli C, 1999, ESTSCAN PROGRAM DETE; Jia Chunxiao, 2004, Zhong Yao Cai, V27, P571; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kitajima J, 2003, CHEM PHARM BULL, V51, P673, DOI 10.1248/cpb.51.673; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lange BM, 2013, PLANT BIOTECHNOL J, V11, P169, DOI 10.1111/pbi.12022; Legault J, 2007, J PHARM PHARMACOL, V59, P1643, DOI 10.1211/jpp.59.12.0005; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Liu MH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1477-5; Liu Yanju, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2276; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074441; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masuda Y, 2015, J NAT MED-TOKYO, V69, P332, DOI 10.1007/s11418-015-0897-5; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Na-Bangchang Kesara, 2014, Trop Med Health, V42, P3, DOI 10.2149/tmh.2014-S01; Nakai Y, 2003, J ETHNOPHARMACOL, V84, P51, DOI 10.1016/S0378-8741(02)00260-X; Neeraja CN, 2007, THEOR APPL GENET, V115, P767, DOI 10.1007/s00122-007-0607-0; Parshikov IA, 2014, PROCESS BIOCHEM, V49, P2086, DOI 10.1016/j.procbio.2014.09.005; Picaud S, 2005, PHYTOCHEMISTRY, V66, P961, DOI 10.1016/j.phytochem.2005.03.027; Picaud S, 2006, ARCH BIOCHEM BIOPHYS, V452, P17, DOI 10.1016/j.abb.2006.06.007; Prosser I, 2002, PHYTOCHEMISTRY, V60, P691, DOI 10.1016/S0031-9422(02)00165-6; Prosser I, 2004, ARCH BIOCHEM BIOPHYS, V432, P136, DOI 10.1016/j.abb.2004.06.030; Reineccius G. A., 2007, FLAVOURS FRAGRANCES; Resch M, 1998, J NAT PROD, V61, P347, DOI 10.1021/np970430b; Resch M, 2001, PLANTA MED, V67, P437, DOI 10.1055/s-2001-15817; Sangwan RS, 2013, GENE, V525, P58, DOI 10.1016/j.gene.2013.04.057; Senior ML, 1998, CROP SCI, V38, P1088, DOI 10.2135/cropsci1998.0011183X003800040034x; Sharon-Asa L, 2003, PLANT J, V36, P664, DOI 10.1046/j.1365-313X.2003.01910.x; Simonsen H.T., 2013, NATURAL PRODUCTS, P3069, DOI [10.1007/978-3-642-22144-6_134, DOI 10.1007/978-3-642-22144-6_134]; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Hoeven RS, 2000, PLANT CELL, V12, P2283, DOI 10.1105/tpc.12.11.2283; Verma VK, 2007, SCI HORTIC-AMSTERDAM, V113, P231, DOI 10.1016/j.scienta.2007.03.019; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HX, 2008, PHYTOCHEMISTRY, V69, P2088, DOI 10.1016/j.phytochem.2008.04.008; Wang KT, 2010, J PHARM PHARMACOL, V62, P381, DOI 10.1211/jpp.62.03.0014; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Y, 2002, GENOME, V45, P319, DOI 10.1139/G01-153; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Xia JH, 2012, PHYTOCHEMISTRY, V74, P178, DOI 10.1016/j.phytochem.2011.11.011; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Yang Y, 2014, GENE, V534, P155, DOI 10.1016/j.gene.2013.10.073; Yin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073767; Yu F, 2008, FEBS LETT, V582, P565, DOI 10.1016/j.febslet.2008.01.020; Yu Y, 2015, J ETHNOPHARMACOL, V160, P211, DOI 10.1016/j.jep.2014.10.066; Zhao CL, 2010, NAT PROD COMMUN, V5, P1147; Zhao WG, 2009, J INTEGR PLANT BIOL, V51, P1126, DOI 10.1111/j.1744-7909.2009.00883.x; Zhuang XF, 2012, PLANT J, V69, P70, DOI 10.1111/j.1365-313X.2011.04771.x; Zwenger S., 2008, Biotechnology and Molecular Biology Reviews, V3, P001	79	20	23	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151975	10.1371/journal.pone.0151975	http://dx.doi.org/10.1371/journal.pone.0151975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990438	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800126
J	Yuan, WF; Li, L; Hu, YJ; Li, WF; Guo, ZH; Huang, WJ				Yuan Weifeng; Li Li; Hu Yujie; Li Weifeng; Guo Zhenhui; Huang Wenjie			Inhibition of Acute Lung Injury by TNFR-Fc through Regulation of an Inflammation-Oxidative Stress Pathway	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; RESPIRATORY-DISTRESS-SYNDROME; RHEUMATOID-ARTHRITIS; SEPTIC SHOCK; ALPHA; ETANERCEPT; CACHECTIN; ENDOTOXIN; MICE	Background Acute lung injury (ALI), characterized by disruption of the lung alveolar-capillary membrane barrier and resultant pulmonary edema, and associated with a proteinaceous alveolar exudate, is a leading cause of morbidity and mortality. Currently, inflammation-oxidative stress interaction between TNF-alpha and NF-kappa B was identified as a key pathway of ALI. We hypothesized that a TNFR-Fc fusion protein would have beneficial effects in experimental ALI, and sought to test this idea in mice by blocking TNF-alpha. Methods and Results Intratracheal instillation of lipopolysaccharide (LPS) into the lungs of ALI mice led to histiocyte apoptosis, and detection of serum and bronchoalveolar lavage fluid (BALF) cytokines, feedback between NF-kappa B and TNF-alpha, lung albumin leakage, lung damage, I kappa B kinase (IKK) and NF-kappa B activation, I-kappa B degradation, and oxidative injury. LPS administration raised pulmonary inflammation as reflected by increased inflammatory cytokines, alveoli protein concentration, and ALI scores. IKK is phosphorylated following LPS challenge, leading to I-kappa B degradation and NF-kappa B p65 phosphorylation. Furthermore, NF-kappa B is translocated into the nucleus and up-regulates TNF-alpha gene transcription. Infusion of TNFR-Fc 24h before LPS challenge significantly abrogated the increase of inflammatory cytokines, especially serum TNF-alpha concentration, as well as pulmonary alveoli protein levels, and diminished IKK and NF-kappa B activation and I-kappa B degradation. The nuclear translocation of NF-kappa B was inhibited, following by down-regulation of TNF-alpha gene transcription. In addition, LPS intratracheal instillation induced marked oxidative damage, such as a decrease in total anti-oxidation products and an increase in malondialdehyde (MDA), as well as up-regulation of oxidation enzymes. Histologic analysis and apoptosis scores revealed that the extent of tissue lesions was significantly reduced, but not abrogated, by TNF-alpha blockade. Conclusion Treatment with LPS alone increased inflammation and oxidative stress in ALI mice, whil administration of TNFR-Fc 24h before LPS challenge broke the feedback between NF-kappa B and TNF-alpha, resulting in decreased pulmonary inflammation/oxidative damage and tissue destruction. These results suggest a potential role for TNF-alpha therapy to treat clinical ALI.	[Yuan Weifeng; Li Li; Li Weifeng; Huang Wenjie] PLA, Guangzhou Mil Command, Gen Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Hu Yujie] PLA, Hosp 458, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Guo Zhenhui] PLA, Guangzhou Mil Command, Gen Hosp, MICU,Key Lab Geriatr Infect & Organ Funct Support, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Theater Command General Hospital	Huang, WJ (corresponding author), PLA, Guangzhou Mil Command, Gen Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	huangyelu1029@vip.163.com			National Nature Science Foundation of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Nature Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Nature Science Foundation of China. We also thank our colleagues in our laboratory for their scientific contributions and thought-provoking discussions.	Ahmad SF, 2015, IMMUNOBIOLOGY, V220, P889, DOI 10.1016/j.imbio.2015.01.008; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Genovese MC, 2004, ARTHRITIS RHEUM-US, V50, P1412, DOI 10.1002/art.20221; Kataoka H, 2015, EUR J PHARMACOL, V746, P174, DOI 10.1016/j.ejphar.2014.11.013; KATSIKIS PD, 1994, J EXP MED, V179, P1517, DOI 10.1084/jem.179.5.1517; Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065; Kotyla P, 2015, ISR MED ASSOC J, V17, P14; Li L, 2013, INFLAMM RES, V62, P387, DOI 10.1007/s00011-013-0590-7; Liu YF, 2014, EXP THER MED, V8, P1585, DOI 10.3892/etm.2014.1974; Lyseng-Williams KA, 2004, PHARMACOECONOMICS, V22, P107, DOI 10.2165/00019053-200422020-00004; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mikawa K, 2003, ANESTH ANALG, V97, P1751, DOI 10.1213/01.ANE.0000086896.90343.13; MILLAR AB, 1989, LANCET, V2, P712, DOI 10.1016/S0140-6736(89)90772-1; ROTEN R, 1991, AM REV RESPIR DIS, V143, P590, DOI 10.1164/ajrccm/143.3.590; SCHIRMER WJ, 1989, ARCH SURG-CHICAGO, V124, P445; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Tang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102967; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Valente AJ, 2008, FREE RADICAL BIO MED, V44, P430, DOI 10.1016/j.freeradbiomed.2007.10.035; van der Vliet A, 2011, BBA-GEN SUBJECTS, V1810, P1035, DOI 10.1016/j.bbagen.2011.03.004; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VINCENT JL, 1992, CHEST, V101, P810, DOI 10.1378/chest.101.3.810; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yuan Wei-feng, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P435	26	20	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151672	10.1371/journal.pone.0151672	http://dx.doi.org/10.1371/journal.pone.0151672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990441	Green Published, gold			2022-12-26	WOS:000372582800086
J	Gao, LF; Jia, JZ; Kong, XY				Gao, LiFeng; Jia, JiZeng; Kong, XiuYing			A SNP-Based Molecular Barcode for Characterization of Common Wheat	PLOS ONE			English	Article							POLYMORPHISM; DIVERSITY; TRAITS; MARKER; ARRAY; MAP	Wheat is grown as a staple crop worldwide. It is important to develop an effective genotyping tool for this cereal grain both to identify germplasm diversity and to protect the rights of breeders. Single-nucleotide polymorphism (SNP) genotyping provides a means for developing a practical, rapid, inexpensive and high-throughput assay. Here, we investigated SNPs as robust markers of genetic variation for typing wheat cultivars. We identified SNPs from an array of 9000 across a collection of 429 well-known wheat cultivars grown in China, of which 43 SNP markers with high minor allele frequency and variations discriminated the selected wheat varieties and their wild ancestors. This SNP-based barcode will allow for the rapid and precise identification of wheat germplasm resources and newly released varieties and will further assist in the wheat breeding program.	[Gao, LiFeng; Jia, JiZeng; Kong, XiuYing] CAAS, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,MOA, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Kong, XY (corresponding author), CAAS, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,MOA, Beijing 100081, Peoples R China.	kongxiuying@caas.cn			State Hi-Tech Research and Development Program (863 Program) [2012AA021602]; National Natural Science Foundation of China [31271292]; National 948 Project [2011-G9]	State Hi-Tech Research and Development Program (863 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 948 Project	This study was supported by the State Hi-Tech Research and Development Program (863 Program, no. 2012AA021602); the National Natural Science Foundation of China (no. 31271292); and the National 948 Project (2011-G9).	Baniecki ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003539; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BRUNEL D, 1994, PLANT MOL BIOL, V24, P397, DOI 10.1007/BF00020177; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; Chen XH, 1986, JIANGSU AGR SCI, DOI [10.1589/j.issn.1002-1302, DOI 10.1589/J.ISSN.1002-1302]; Cheng BaoShan, 2011, Acta Agriculturae Zhejiangensis, V23, P20; Coissac E, 2016, MOL ECOL, DOI 10.1111/mec.13549; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Faris JD, 2014, THEOR APPL GENET, V127, P2333, DOI 10.1007/s00122-014-2380-1; Frey JE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-106; Grover A, 2016, CRIT REV BIOTECHNOL, V36, P290, DOI 10.3109/07388551.2014.959891; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hao ChenYang, 2005, Acta Agronomica Sinica, V31, P144; Hulse-Kemp AM, 2015, G3-GENES GENOM GENET, V5, P1187, DOI 10.1534/g3.115.018416; Lee YG, 2015, PLANT J, V81, P625, DOI 10.1111/tpj.12755; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Roder MS, 1998, GENETICS, V149, P2007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; [王忠华 Wang Zhonghua], 2006, [分子植物育种, Molecular Plant Breeding], V4, P425; WU KS, 1993, MOL GEN GENET, V241, P225, DOI 10.1007/BF00280220; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; [张金波 Zhang Jinbo], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P29	27	32	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150947	10.1371/journal.pone.0150947	http://dx.doi.org/10.1371/journal.pone.0150947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985664	Green Submitted, gold, Green Published			2022-12-26	WOS:000372580300038
J	Liu, XL; Li, XJ; Liu, HB; Xu, CH; Lin, XQ; Li, CJ; Deng, ZH				Liu, Xinlong; Li, Xujuan; Liu, Hongbo; Xu, Chaohua; Lin, Xiuqin; Li, Chunjia; Deng, Zuhu			Phylogenetic Analysis of Different Ploidy Saccharum spontaneum Based on rDNA-ITS Sequences	PLOS ONE			English	Article							SUGARCANE; POLYMORPHISM; SOFTWARE; POACEAE; GENES; WHEAT; DNA	Saccharum spontaneum L. is a crucial wild parent of modern sugarcane cultivars whose ploidy clones have been utilized successfully in improving the stress resistance and yield related traits of sugarcane cultivars. To establish knowledge regarding the genetic variances and evolutional relationships of ploidy clones of Saccharum spontaneum collected in China, the rDNA-ITS sequences of 62 ploidy clones including octaploid clones (2n = 64), nonaploid clones (2n = 72), decaploid clones (2n = 80), and dodecaploid clones (2n = 96), were obtained and analyzed. The rDNA-ITS sequences of four species from Saccharumand Sorghumbicolor selected as controls. The results showed that decaploid clones (2n = 80) possess the most abundant variances with 58 variable sites and 20 parsim-informative sites in ITS sequences, which were then followed by octaploid clones with 43 variable sites and 17 parsim-informative sites. In haplotype diversity, all four population exhibited high diversity, especially nonaploid and decaploid populations. By comparing the genetic distances among four ploidy populations, the dodecaploid population exhibited the closest relationship with the nonaploid population, and then the relationship strength decreased successively for the decaploid population and then for the octaploid population. Population differentiation analysis showed that the phenomena of population differentiation were not found among different ploidy populations, and low coefficient of gene differentiation(Gst) and high gene flow(Nm) occur among these populations possessing close genetic relationship. These results mentioned above will contribute to the understanding of the evolution of different ploidy populations of Saccharumspontaneum and provide vital knowledge for their utilization in sugarcane breeding and innovation.	[Liu, Xinlong; Deng, Zuhu] Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Peoples R China; [Liu, Xinlong; Li, Xujuan; Liu, Hongbo; Xu, Chaohua; Lin, Xiuqin; Li, Chunjia] Yunnan Acad Agr Sci, Sugarcane Res Inst, Yunnan Key Lab Sugarcane Genet Improvement, Kaiyuan, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Yunnan Academy of Agricultural Sciences	Deng, ZH (corresponding author), Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Peoples R China.	dengzuhu@163.com		Li, Chunjia/0000-0001-5181-4328	Yunnan Natural Science Foundation [2011FB120]; National Natural Science Foundation of China [31360359]; Earmarked Fund for the Modern Agriculture Technology of China [CARS-20-1-5]; Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province [2014HB038]	Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for the Modern Agriculture Technology of China; Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province	This work was supported by the Yunnan Natural Science Foundation (2011FB120) funder name: Xinlong Liu, conceived and designed the experiments, the National Natural Science Foundation of China (31360359) funder name: Xinlong Liu, conceived and designed the experiments; the Earmarked Fund for the Modern Agriculture Technology of China (CARS-20-1-5), funder name: Zuhu Deng, conceived and designed the experiments; Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province (2014HB038), funder name: Xinlong Liu, conceived and designed the experiments.	Bacci M, 2001, GENET MOL BIOL, V24, P169, DOI 10.1590/S1415-47572001000100023; Cai Qing, 2002, Southwest China Journal of Agricultural Sciences, V15, P16; CHEN H, 2001, ACTA AGRONOMICA SINI, V27, P645; Chen Hui, 2003, Acta Agronomica Sinica, V29, P379; Cuadrado A, 2004, J EXP BOT, V55, P847, DOI 10.1093/jxb/erh093; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; DASILVA J, 1995, MOL BREEDING, V1, P165, DOI 10.1007/BF01249701; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Giles RJ, 2006, THEOR APPL GENET, V112, P1563, DOI 10.1007/s00122-006-0259-5; Guo BZ, 1987, THE FLORA OF CHINA; Guzman C, 2012, ANN BOT-LONDON, V110, P1161, DOI 10.1093/aob/mcs201; Ha S, 1999, PLANT MOL BIOL, V39, P1165, DOI 10.1023/A:1006133804170; Henry R, 2010, GENETICS GENOMICS BR; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; HSIAO C, 1995, GENOME, V38, P211, DOI 10.1139/g95-026; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu SM, 2011, SUGARCANE CANESUGAR, V4, P5; LIU X L, 2013, J HUNAN AGR U NAT SC, V38, P574; Liu XinLong, 2010, Acta Agronomica Sinica, V36, P1853, DOI 10.3724/SP.J.1006.2010.01853; Mary S, 2006, GENET RESOUR CROP EV, V53, P1221, DOI 10.1007/s10722-005-2433-z; MUKHERJEE SUNIL KUMAR, 1957, BOT GAZ, V119, P55, DOI 10.1086/335962; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Nei M., 1987, MOL EVOLUTIONARY GEN; Pan YB, 2004, GENET RESOUR CROP EV, V51, P895, DOI 10.1007/s10722-005-1933-1; PANJE R. R., 1960, CYTOLOGIA, V25, P152, DOI 10.1508/cytologia.25.152; Qian Jin, 2009, Acta Agronomica Sinica, V35, P1021; Qiu JW, 2007, THEOR APPL GENET, V115, P159, DOI 10.1007/s00122-007-0551-z; Simko I, 2006, GENETICS, V173, P2237, DOI 10.1534/genetics.106.060905; Speranskaya AS, 2012, BIOCHIMIE, V94, P1687, DOI 10.1016/j.biochi.2012.03.010; SREENIVASAN TV, 1975, P INDIAN ACAD SCI B, V81, P131; Tai PYP, 1997, SUGAR CANE, V1, P15; Takahashi S, 2005, THEOR APPL GENET, V110, P1523, DOI 10.1007/s00122-005-1990-z; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang SQ, 1996, SUGARCANE CANESUGAR, V5, P9; Yang QH, 1996, CHINA SUGARCANE, V1, P10; Zhang GeMin, 2006, Southwest China Journal of Agricultural Sciences, V19, P1127; Zhang Yun-Wu, 2002, Acta Botanica Yunnanica, V24, P29	39	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151524	10.1371/journal.pone.0151524	http://dx.doi.org/10.1371/journal.pone.0151524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986847	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300082
J	Agardh, A; Ross, M; Ostergren, PO; Larsson, M; Tumwine, G; Mansson, SA; Simpson, JA; Patton, G				Agardh, Anette; Ross, Michael; Ostergren, Per-Olof; Larsson, Markus; Tumwine, Gilbert; Mansson, Sven-Axel; Simpson, Julie A.; Patton, George			Health Risks in Same-Sex Attracted Ugandan University Students: Evidence from Two Cross-Sectional Studies	PLOS ONE			English	Article							HIV-RISK; BISEXUAL MEN; BEHAVIOR; GAY; POPULATION; VALIDITY; KAMPALA	Widespread discrimination across much of sub-Saharan Africa against persons with same-sex sexuality, including recent attempts in Uganda to extend criminal sanctions against same-sex behavior, are likely to have profound effects on this group's health, health care access, and well-being. Yet knowledge of the prevalence of same-sex sexuality in this region is scarce. This study aimed to systematically examine prevalence of same-sex sexuality and related health risks in young Ugandan adults. We conducted two cross-sectional survey studies in south-western Uganda targeting student samples (n = 980, n = 1954) representing 80% and 72% of the entire undergraduate classes attending a university in 2005 and 2010, respectively. A questionnaire assessed items concerning same-sex sexuality (same-sex attraction/fantasies, same-sex sexual relations), mental health, substance use, experience of violence, risky sexual behavior, and sexual health counseling needs. Our findings showed that same-sex sexual attraction/fantasies and behavior were common among male and female students, with 10-25% reporting having sexual attraction/fantasies regarding persons of the same-sex, and 6-16% reporting same-sex sexual relations. Experiences of same-sex sexuality were associated with health risks, e.g. poor mental health (2010, AOR = 1.5; 95% CI: 1.0-2.3), sexual coercion (2010, AOR 2.9; CI: 1.9-4.6), and unmet sexual health counseling needs (2010, AOR 2.2; CI: 1.4-3.3). This first study of young adults in Uganda with same-sex sexuality found high levels of health needs but poor access to health care. Effective response is likely to require major shifts in current policy, efforts to reduce stigmatization, and reorientation of health services to better meet the needs of this vulnerable group of young people.	[Agardh, Anette; Ostergren, Per-Olof; Larsson, Markus] Lund Univ, Dept Clin Sci, Social Med & Global Hlth, Malmo, Sweden; [Ross, Michael] Univ Minnesota, Sch Med, Dept Family Med & Community Hlth, Minneapolis, MN 55455 USA; [Tumwine, Gilbert] St Francis Hosp, Dept Obstet & Gynaecol, Nsambya, Uganda; [Mansson, Sven-Axel] Malmo Univ, Ctr Sexol & Sexual Studies, Malmo, Sweden; [Simpson, Julie A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Patton, George] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Adolescent Hlth,Dept Paediat, Melbourne, Vic, Australia	Lund University; University of Minnesota System; University of Minnesota Twin Cities; Malmo University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Agardh, A (corresponding author), Lund Univ, Dept Clin Sci, Social Med & Global Hlth, Malmo, Sweden.	anette.agardh@med.lu.se	Ribeiro, Ana Cristina/HHN-7466-2022; Patton, George C/B-5246-2013	Ribeiro, Ana Cristina/0000-0002-0493-8376; Patton, George C/0000-0001-5039-8326; Ross, Michael/0000-0002-5718-9989	Swedish International Cooperation Agency (SIDA) [SWE-2004-200A, 2005-147]	Swedish International Cooperation Agency (SIDA)	This study was supported by grants from the Swedish International Cooperation Agency (SIDA), project grant number SWE-2004-200A and PhD grant number 2005-147 (URL: www.sida.se - author: AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-527; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Brown R., 2012, ANN SURVEY INT COMP, V18, P45; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Chapleau KM, 2014, J TRAUMA DISSOCIATIO, V15, P204, DOI 10.1080/15299732.2014.867573; Dingeta T, 2012, PAN AFR MED J, V12; Dunkle KL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001472; Faulkner AH, 1998, AM J PUBLIC HEALTH, V88, P262, DOI 10.2105/AJPH.88.2.262; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; Hayes J, 2012, ARCH SEX BEHAV, V41, P631, DOI 10.1007/s10508-011-9856-8; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; Kinyanda E, 2011, SOC PSYCH PSYCH EPID, V46, P35, DOI 10.1007/s00127-009-0164-8; LEWIN B, 2000, SEX SWEDEN SWEDISH S; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Nala R, 2015, AIDS BEHAV, V19, P393, DOI 10.1007/s10461-014-0895-8; Nyanzi S, 2013, CULT HEALTH SEX, V15, P952, DOI 10.1080/13691058.2013.798684; Olukya G, 2010, HUFFING POST; Peltzer K, 2014, J PSYCHOL AFR, V24, P241, DOI 10.1080/14330237.2014.906083; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; Ross MW, 2013, INT J STD AIDS, V24, P409, DOI 10.1177/0956462412472793; SELL RL, 1995, ARCH SEX BEHAV, V24, P235, DOI 10.1007/BF01541598; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Statistics UBos, 2006, 2002 UG POP HOUS CEN; Windle M, 1996, J STUD ALCOHOL, V57, P627, DOI 10.15288/jsa.1996.57.627	27	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150627	10.1371/journal.pone.0150627	http://dx.doi.org/10.1371/journal.pone.0150627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982494	Green Published, gold			2022-12-26	WOS:000372574900046
J	Lafferriere, NAR; Antelo, R; Alda, F; Martensson, D; Hailer, F; Castroviejo-Fisher, S; Ayarzaguena, J; Ginsberg, JR; Castroviejo, J; Doadrio, I; Vila, C; Amato, G				Lafferriere, Natalia A. Rossi; Antelo, Rafael; Alda, Fernando; Martensson, Dick; Hailer, Frank; Castroviejo-Fisher, Santiago; Ayarzagueena, Jose; Ginsberg, Joshua R.; Castroviejo, Javier; Doadrio, Ignacio; Vila, Carles; Amato, George			Multiple Paternity in a Reintroduced Population of the Orinoco Crocodile (Crocodylus intermedius) at the El Frio Biological Station, Venezuela	PLOS ONE			English	Article							GENETIC DIVERSITY; SPERM STORAGE; AMERICAN ALLIGATOR; PARENTAGE ANALYSIS; MATING SYSTEMS; MATE CHOICE; REPRODUCTIVE SUCCESS; NATURAL-POPULATIONS; MICROSATELLITE DATA; GENOTYPING ERRORS	The success of a reintroduction program is determined by the ability of individuals to reproduce and thrive. Hence, an understanding of the mating system and breeding strategies of reintroduced species can be critical to the success, evaluation and effective management of reintroduction programs. As one of the most threatened crocodile species in the world, the Orinoco crocodile (Crocodylus intermedius) has been reduced to only a few wild populations in the Llanos of Venezuela and Colombia. One of these populations was founded by reintroduction at Cano Macanillal and La Ramera lagoon within the El Frio Biological Station, Venezuela. Twenty egg clutches of C. intermedius were collected at the El Frio Biological Station for incubation in the lab and release of juveniles after one year. Analyzing 17 polymorphic microsatellite loci from 335 hatchlings we found multiple paternity in C. intermedius, with half of the 20 clutches fathered by two or three males. Sixteen mothers and 14 fathers were inferred by reconstruction of multilocus parental genotypes. Our findings showed skewed paternal contributions to multiple-sired clutches in four of the clutches (40%), leading to an overall unequal contribution of offspring among fathers with six of the 14 inferred males fathering 90% of the total offspring, and three of those six males fathering more than 70% of the total offspring. Our results provide the first evidence of multiple paternity occurring in the Orinoco crocodile and confirm the success of reintroduction efforts of this critically endangered species in the El Frio Biological Station, Venezuela.	[Lafferriere, Natalia A. Rossi; Ginsberg, Joshua R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Lafferriere, Natalia A. Rossi; Amato, George] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Antelo, Rafael] Fdn Palmarito Casanare, Bogota, Colombia; [Antelo, Rafael; Alda, Fernando; Doadrio, Ignacio] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolutiva, E-28006 Madrid, Spain; [Antelo, Rafael; Ayarzagueena, Jose; Castroviejo, Javier] Estn Biol Frio, Apure, Venezuela; [Alda, Fernando] Louisiana State Univ, Dept Biol Sci, LSU Museum Nat Sci, Baton Rouge, LA 70803 USA; [Martensson, Dick] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden; [Hailer, Frank] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hailer, Frank] Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Castroviejo-Fisher, Santiago] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Sistemat Vertebrados, Porto Alegre, RS, Brazil; [Ginsberg, Joshua R.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Castroviejo, Javier] Asociac Amigos Donana, Seville, Spain; [Vila, Carles] CSIC, EBD, Conservat & Evolutionary Genet Grp, E-41080 Seville, Spain	Columbia University; American Museum of Natural History (AMNH); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Louisiana State University System; Louisiana State University; Uppsala University; Cardiff University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Pontificia Universidade Catolica Do Rio Grande Do Sul; Cary Institute of Ecosystem Studies; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lafferriere, NAR (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA.; Lafferriere, NAR (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	nar2118@columbia.edu	Doadrio, Ignacio/F-8448-2016; Hailer, Frank/C-9114-2012; Castroviejo-Fisher, Santiago/G-9007-2013; Hailer, Frank/Y-3595-2019; Vila, Carles/H-4893-2013; Alda, Fernando/C-5646-2011	Doadrio, Ignacio/0000-0003-4863-9711; Hailer, Frank/0000-0002-2340-1726; Castroviejo-Fisher, Santiago/0000-0002-1048-2168; Hailer, Frank/0000-0002-2340-1726; Vila, Carles/0000-0002-4206-5246; Alda, Fernando/0000-0002-6858-9566	Department of Evolutionary biology, Uppsala University, Uppsala, Sweden; Dpto. Biodiversidad y Biologia Evolutiva, Museo Nacional de Ciencias Naturales, CSIC, Madrid, Spain; Sackler Institute of Comparative Genomics at the American Museum of Natural History (NARL)	Department of Evolutionary biology, Uppsala University, Uppsala, Sweden; Dpto. Biodiversidad y Biologia Evolutiva, Museo Nacional de Ciencias Naturales, CSIC, Madrid, Spain; Sackler Institute of Comparative Genomics at the American Museum of Natural History (NARL)	Funders included the Department of Evolutionary biology, Uppsala University, Uppsala, Sweden (DM), to support fieldwork and laboratory work; Dpto. Biodiversidad y Biologia Evolutiva, Museo Nacional de Ciencias Naturales, CSIC, Madrid, Spain (RA FA SCF ID), to support fieldwork and laboratory work; Sackler Institute of Comparative Genomics at the American Museum of Natural History (NARL), to support data analysis and preparation of manuscript.	Adams EM, 2005, MOL ECOL, V14, P1803, DOI 10.1111/j.1365-294X.2005.02539.x; Alonso-Tabet M, 2009, COMPORTAMIENTO COCOD; Amavet P, 2008, J EXP ZOOL PART A, V309A, P637, DOI 10.1002/jez.496; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; [Anonymous], 2010, R LANG ENV STAT COMP; Antelo R, 2008, THESIS U AUTONOMA MA; Antelo R, 2010, HERPETOL J, V20, P51; Bach L, 2012, AQUAT TOXICOL, V114, P58, DOI 10.1016/j.aquatox.2012.02.003; Ballouard JM, 2010, AQUAT CONSERV, V20, P756, DOI 10.1002/aqc.1151; Barros Tito, 2010, Conservation Evidence, V7, P111; Birkhead TR, 2000, EVOLUTION, V54, P1057; Boomer JJ, 2013, J HERED, V104, P371, DOI 10.1093/jhered/est010; Brante A, 2011, J EXP MAR BIOL ECOL, V396, P83, DOI 10.1016/j.jembe.2010.10.001; Budd KM, 2015, S AM J HERPETOL, V10, P4, DOI 10.2994/SAJH-D-14-00022.1; Calsbeek R, 2007, EVOL ECOL RES, V9, P495; Canal D, 2012, BEHAV ECOL SOCIOBIOL, V66, P67, DOI 10.1007/s00265-011-1253-8; Castro Casal Antonio, 2013, Biota Colombiana, V14, P65; Chave C., 2002, VIDA SILVESTRE NEOTR, V11, P23; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Daltry Jennifer C., 2010, P118; Davenport Michael, 1995, Herpetological Review, V26, P14; Dever JA, 2002, COPEIA, P1078; Dever JA, 2001, J HERPETOL, V35, P541, DOI 10.2307/1565981; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; Elsey RM, 2008, SOUTHEAST NAT, V7, P737, DOI 10.1656/1528-7092-7.4.737; Espinosa-Blanco AS, 2013, INTERCIENCIA, V38, P358; Farias IP, 2004, ANIM CONSERV, V7, P265, DOI 10.1017/S136794300400143X; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; FitzSimmons N, 2001, MICROSATELLITE MARKE, P51; GARRICK LD, 1977, AM ZOOL, V17, P225; Gist DH, 2008, J EXP ZOOL PART A, V309A, P581, DOI 10.1002/jez.434; Grigg G, 2015, BIOLOGY AND EVOLUTION OF CROCODYLIANS, P1; Gumilla J, 1745, HIST NATURAL; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; Hernandez O, 2014, VENEZUELA B ACAD CIE, V2, P53; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hu Y, 2010, AMPHIBIA-REPTILIA, V31, P419, DOI 10.1163/156853810791769446; Jamieson IG, 2012, REINTRODUCTION BIOL, V12, P441; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones B, 2007, GENETICS, V176, P2427, DOI 10.1534/genetics.106.067066; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KOFRON CP, 1990, J ZOOL, V221, P477, DOI 10.1111/j.1469-7998.1990.tb04014.x; LANCE VA, 1989, AM ZOOL, V29, P999; Lewis JL, 2013, J HERPETOL, V47, P24, DOI 10.1670/10-303; Liu JX, 2011, MAR BIOL, V158, P893, DOI 10.1007/s00227-010-1616-0; Martinez JL, 2000, MOL ECOL, V9, P293, DOI 10.1046/j.1365-294x.2000.00857.x; McVay JD, 2008, J EXP ZOOL PART A, V309A, P643, DOI 10.1002/jez.500; Medem F., 1981, CROCODYLIA AM; Miles LG, 2009, CONSERV GENET, V10, P963, DOI 10.1007/s10592-008-9600-7; Milian-Garcia Y, 2011, J EXP ZOOL PART A, V315A, P358, DOI 10.1002/jez.683; Moller AP, 2000, BEHAV ECOL, V11, P161, DOI 10.1093/beheco/11.2.161; Moorhouse TP, 2009, BIOL CONSERV, V142, P53, DOI 10.1016/j.biocon.2008.09.023; Muniz FL, 2011, AMPHIBIA-REPTILIA, V32, P428, DOI 10.1163/017353711X587741; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; Neuman W, 2013, NY TIMES, pA4; Nonacs P, 2003, ANIM BEHAV, V65, P615, DOI 10.1006/anbe.2003.2096; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Oliveira DP, 2014, J HERED, V105, P485, DOI 10.1093/jhered/esu020; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Perez I, 2012, FRONT ECOL ENVIRON, V10, P494, DOI 10.1890/110175; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Rafajlovic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075587; RAMO C, 1992, BIOL CONSERV, V60, P101, DOI 10.1016/0006-3207(92)91160-T; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reynolds John D., 1996, Trends in Ecology and Evolution, V11, P68, DOI 10.1016/0169-5347(96)81045-7; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Rodriguez-Soberon R., 1996, CROCODILE SPECIALIST, V15, P10; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rubenstein DR, 2007, P R SOC B, V274, P1895, DOI 10.1098/rspb.2007.0424; Schmidt F., 2015, International Zoo Yearbook, V49, P125, DOI 10.1111/izy.12082; Sefc KM, 2009, J HERED, V100, P197, DOI 10.1093/jhered/esn095; SUGG DW, 1994, GENETICS, V137, P1147; Taylor ML, 2014, TRENDS ECOL EVOL, V29, P376, DOI 10.1016/j.tree.2014.04.005; Thorbjarnarson J. B., 1989, CROCODILES THEIR ECO, P228; THORBJARNARSON JB, 1992, BIOL CONSERV, V62, P179, DOI 10.1016/0006-3207(92)91046-U; Thorbjarnarson JB, 1993, J HERPETOL, P363; Thorbjarnarson JB, 1993, J HERPETOL, P371; Thorbjarnarson JB, 1996, HERPETOLOGICA, P8; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Weerd M, 2010, ORYX, V44, P13; Vliet KA, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P383; Wang, 2012, MICRODROP PROGRAM ES; Wang CL, 2012, GENETICS, V192, P651, DOI 10.1534/genetics.112.139519; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang ZH, 2011, CHINESE SCI BULL, V56, P2586, DOI 10.1007/s11434-011-4615-8; Willoughby JR, 2015, MOL ECOL, V24, P98, DOI 10.1111/mec.13020; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	94	14	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150245	10.1371/journal.pone.0150245	http://dx.doi.org/10.1371/journal.pone.0150245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982578	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900027
J	Li, X; Niu, X; Wang, B; Gao, P; Liu, Y				Li, Xiao; Niu, Xiang; Wang, Bing; Gao, Peng; Liu, Yu			Driving Forces of Dynamic Changes in Soil Erosion in the Dahei Mountain Ecological Restoration Area of Northern China Based on GIS and RS	PLOS ONE			English	Article							COVER CHANGE; LAND-USE; RISK; VEGETATION; IMPACT; BASIN	Dynamic change in soil erosion is an important focus of regional ecological restoration research. Here, the dynamic changes of soil erosion and its driving forces in the Dahei Mountain ecological restoration area of northern China were analyzed by LANDSAT TM remote sensing captured via geographic information system (GIS) technologies during three typical periods in 2004, 2008 and 2013. The results showed the following: (1) a decrease in intensive erosion and moderate erosion areas, as well as an increase in light erosion areas, was observed during two periods: one from 2004 to 2008 and the other from 2008 to 2013. (2) Between 2004 and 2008, the variation in the range of slight erosion was the largest (24.28%), followed by light erosion and intensive erosion; between 2008 and 2013, the variation in the range of intensive erosion area was the largest (9.89%), followed by slight erosion and moderate erosion. (3) Socioeconomic impact, accompanied by natural environmental factors, was the main driving force underlying the change in soil erosion within the ecological restoration area. In particular, the socioeconomic factors of per capita forest area and land reclamation rate, as well as the natural environmental factor of terrain slope, significantly influenced soil erosion changes within the ecological restoration area.	[Li, Xiao; Gao, Peng; Liu, Yu] Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Tai An 271018, Shandong, Peoples R China; [Niu, Xiang; Wang, Bing] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing 100091, Peoples R China	Shandong Agricultural University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Gao, P (corresponding author), Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Tai An 271018, Shandong, Peoples R China.; Niu, X (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing 100091, Peoples R China.	niuxiang0603@163.com; gaopengy@163.com			Special Fund for Forestry Scientific Research in the Public Interest [201204101, 201404303]; CFERN Award Fund; GENE Award Fund	Special Fund for Forestry Scientific Research in the Public Interest; CFERN Award Fund; GENE Award Fund	The study was supported by the Special Fund for Forestry Scientific Research in the Public Interest (No.201204101; No.201404303). In addition, this paper was supported by CFERN & GENE Award Funds for Ecological Papers.	Alkharabsheh MM, 2013, PROCEDIA ENVIRON SCI, V19, P912, DOI 10.1016/j.proenv.2013.06.101; Andrade RFS, 2006, EUR PHYS J B, V50, P33, DOI 10.1140/epjb/e2006-00114-1; Arekhi S, 2012, ARAB J GEOSCI, V5, P285, DOI 10.1007/s12517-010-0220-4; Bahadur KCK, 2009, ENVIRON GEOL, V57, P695, DOI 10.1007/s00254-008-1348-3; Bhandari KP, 2015, NAT HAZARDS, V75, P321, DOI 10.1007/s11069-014-1321-2; Dotterweich M, 2013, GEOMORPHOLOGY, V201, P1, DOI 10.1016/j.geomorph.2013.07.021; Duan WX, 2011, SCI SOIL WATER CONSE, P38; Fan JR, 2001, J SOIL WATER CONSERV, V15, P25; Nacinovic MGG, 2014, SOIL TILL RES, V144, P164, DOI 10.1016/j.still.2014.07.002; Hu SW, 2006, YUNNAN GEOGRAPHIC EN, V18, P40; Jain SK, 2001, WATER RESOUR MANAG, V15, P41, DOI 10.1023/A:1012246029263; Jellinek S, 2014, BIOL CONSERV, V169, P60, DOI 10.1016/j.biocon.2013.10.023; Jin JS, 2011, ECOL COMPLEX, V8, P161, DOI 10.1016/j.ecocom.2011.01.005; Kachouri S, 2015, ARAB J GEOSCI, V8, P4257, DOI 10.1007/s12517-014-1464-1; Lin WH, 2007, YELLOW RIVER, V29, P71; Liu X, 2008, SPORTS ETHICS, V6, P27; [吕航 LV Hang], 2007, [遥感技术与应用, Remote Sensing Technology and Application], V22, P715; Lv XZ, 2012, J FOOD AGRIC ENVIRON, V10, P1045; [孟国才 MENG Guocai], 2007, [干旱区地理, Arid Land Geography], V30, P759; Mosbahi M, 2013, ARAB J GEOSCI, V6, P4011, DOI 10.1007/s12517-012-0658-7; Na B., 2008, GRASSLAND TURF, P13; Naqvi HR, 2013, ARAB J GEOSCI, V6, P4045, DOI 10.1007/s12517-012-0661-z; Niu RQ, 2014, ENVIRON EARTH SCI, V72, P2741, DOI 10.1007/s12665-014-3179-8; Pijanowski B. C., 2002, Computers, Environment and Urban Systems, V26, P553, DOI 10.1016/S0198-9715(01)00015-1; Pradhan B, 2012, ENVIRON MONIT ASSESS, V184, P715, DOI 10.1007/s10661-011-1996-8; Ren ZP, 2009, EVALUATION REGIONAL; Rozos D, 2013, ENVIRON EARTH SCI, V70, P3255, DOI 10.1007/s12665-013-2390-3; Uchida S, 2015, PROCEDIA ENVIRON SCI, V24, P29, DOI 10.1016/j.proenv.2015.03.005; WANG B., 2011, OBSERVATION METHODOL, P133; Wang SJ, 2009, SOIL BIOL BIOCHEM, V41, P891, DOI 10.1016/j.soilbio.2008.12.016; Wijitkosum S, 2012, SOIL WATER RES, V7, P10, DOI 10.17221/32/2011-SWR; Wu YongHong, 2004, Ganhanqu Yanjiu (Arid Zone Research), V21, P259; YANG H.L., 2009, SCI SOIL WATER CONSE, V7, P52; Yang QY, 2014, ENVIRON EARTH SCI, V71, P287, DOI 10.1007/s12665-013-2432-x; Yoo K, 2015, SCI TOTAL ENVIRON, V521, P326, DOI 10.1016/j.scitotenv.2015.03.084; Yu X. X., 2004, SCI SOIL WATER CONSE, V2, P4; Zang S., 2007, J BEIJING FOR UNIV, V29, P216; [张喜旺 Zhang Xiwang], 2010, [土壤通报, Journal of Soil Science], V41, P1010; Zhao XN, 2014, NAT HAZARDS, V70, P957, DOI 10.1007/s11069-013-0849-x; [郑云龙 Zheng Yunlong], 2014, [山地学报, Mountain Research], V32, P691; Zhuang D., 1997, J NAT RESOUR, V12, P105, DOI DOI 10.11849/ZRZYXB.1997.02.002	41	7	8	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0142331	10.1371/journal.pone.0142331	http://dx.doi.org/10.1371/journal.pone.0142331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981637	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900011
J	Ma, TT; Chen, LK; Wu, LH; Zhang, HB; Luo, YM				Ma, Tingting; Chen, Li'ke; Wu, Longhua; Zhang, Haibo; Luo, Yongming			Oxidative Stress, Cytotoxicity and Genotoxicity in Earthworm Eisenia fetida at Different Di-n-Butyl Phthalate Exposure Levels	PLOS ONE			English	Article							NEUTRAL RED RETENTION; DNA-DAMAGE; COMET ASSAY; FOETIDA; ESTERS; SOIL; CELOMOCYTES; BIOMARKER; CELLS; EXPRESSION	Recognized as ubiquitous contaminants in soil, the environmental risk of phthalic acid esters (PAEs) is of great concern recently. Effects of di-n-butyl phthalate (DnBP), an extensively used PAE compound to Eisenia fetida have been investigated in spiked natural brown yellow soil (Alfisol) for soil contact test. The toxicity of DnBP to E. fetida on the activity of superoxide dismutase (SOD) activity, peroxidase (POD), reactive oxygen species (ROS) content, and the apoptosis of coelomocytes and DNA damage at the 7th, 14th, 21st and 28th day of the incubation have been paid close attention to. In general, SOD activity and ROS content were significantly induced, opposite to total protein content and POD activity, during the toxicity test of 28 days especially under concentrations higher than 2.5 mg kg(-1). The reduction in neutral red retention (NRR) time along with the increase of dead coelomocytes as the increasing of DnBP concentrations, indicating severe damage to cell viability under varying pollutant stress during cultivation, which could also be proved by comet assay results for exerting evident DNA damage in coelomocytes. DnBP in spiked natural soil could indeed cause damage to tissues, coelomocytes and the nucleus of E. fetida. The key point of the apparent change in different indices presented around 2.5 mg DnBP kg(-1) soil, which could be recommended as the threshold of DnBP soil contamination, so that further investigation on threshold values to other soil animals or microorganisms could be discussed.	[Ma, Tingting] Hubei Univ Arts & Sci, Inst Hanjiang, Xiangyang, Peoples R China; [Ma, Tingting; Chen, Li'ke; Wu, Longhua; Zhang, Haibo; Luo, Yongming] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China; [Chen, Li'ke] Shanghai Res Inst Chem Ind, Shanghai, Peoples R China; [Zhang, Haibo; Luo, Yongming] Chinese Acad Sci, Yantai Inst Costal Zone Res, Key Lab Coastal Zone Environm Proc, Yantai, Peoples R China	Hubei University of Arts & Science; Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Luo, YM (corresponding author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China.; Luo, YM (corresponding author), Chinese Acad Sci, Yantai Inst Costal Zone Res, Key Lab Coastal Zone Environm Proc, Yantai, Peoples R China.	ymluo@yic.ac.cn		WU, Longhua/0000-0002-0287-8963	National Natural Science Foundation of China [41401581, 41271326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this work was provided by National Natural Science Foundation of China (41401581 & 41271326).; This research was supported by the National Natural Science Foundation of China (41401581 & 41271326). We thank Hui Zhao who worked in Life Science Experiment Teaching Center of Nanjing Normal University for the help in the Instrument use of FACScan Flow Cytometer and data analysis of apoptosis experiment.	BATE CM, 1976, EXPERIENTIA, V32, P451, DOI 10.1007/BF01920789; Bigorgne E, 2011, ENVIRON POLLUT, V159, P2698, DOI 10.1016/j.envpol.2011.05.024; BILEJ M, 1990, CELL BIOL INT REP, V14, P831, DOI 10.1016/0309-1651(90)90010-V; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Ding JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119216; Duan XC, 2015, ENVIRON TOXICOL CHEM, V34, P283, DOI 10.1002/etc.2785; EYAMBE GS, 1991, LAB ANIM, V25, P61, DOI 10.1258/002367791780808095; Garcia-Gomez C, 2014, ARCH ENV CONTAM TOXI, V67, P1; Gichner T, 2004, MUTAT RES-GEN TOX EN, V559, P49, DOI 10.1016/j.mrgentox.2003.12.008; Hu CW, 2014, SOIL BIOL BIOCHEM, V70, P123, DOI 10.1016/j.soilbio.2013.12.018; Il Kwak J, 2014, ENVIRON RES, V134, P118, DOI 10.1016/j.envres.2014.07.014; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; KONO Y, 1982, J BIOL CHEM, V257, P5751; Liu S, 2011, CHEMOSPHERE, V83, P1080, DOI 10.1016/j.chemosphere.2011.01.046; Loeb MJ, 2000, ARCH INSECT BIOCHEM, V45, P12, DOI 10.1002/1520-6327(200009)45:1&lt;12::AID-ARCH2&gt;3.0.CO;2-P; Ma TT, 2013, FRONT ENV SCI ENG, V7, P31, DOI 10.1007/s11783-012-0463-2; Pant N, 2014, ENVIRON SCI POLLUT R, V21, P11066, DOI 10.1007/s11356-014-2986-5; Plytycz B, 2007, EUR J SOIL BIOL, V43, pS116, DOI 10.1016/j.ejsobi.2007.08.050; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; Rieder SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061215; ROBERTS R, 2000, APOPTOSIS TOXICOLOGY; Sabatini SE, 2009, ECOTOX ENVIRON SAFE, V72, P1200, DOI 10.1016/j.ecoenv.2009.01.003; Scott-Fordsmand JJ, 2000, REV ENVIRON CONTAM T, V165, P117; Song Y, 2009, SOIL BIOL BIOCHEM, V41, P905, DOI 10.1016/j.soilbio.2008.09.009; Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Svendsen C, 2004, ECOTOX ENVIRON SAFE, V57, P20, DOI 10.1016/j.ecoenv.2003.08.009; TAN GH, 1995, B ENVIRON CONTAM TOX, V54, P171, DOI 10.1007/BF00197427; Teil MJ, 2006, SCI TOTAL ENVIRON, V354, P212, DOI 10.1016/j.scitotenv.2004.12.083; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang J, 2013, ENVIRON POLLUT, V180, P265, DOI 10.1016/j.envpol.2013.05.036; Weeks JM, 1996, ENVIRON TOXICOL CHEM, V15, P1801, DOI [10.1002/etc.5620151022, 10.1897/1551-5028(1996)015&lt;1801:NRRBLF&gt;2.3.CO;2]; Xue YG, 2009, ECOTOXICOLOGY, V18, P693, DOI 10.1007/s10646-009-0333-2; Yin R, 2003, CHEMOSPHERE, V50, P801, DOI 10.1016/S0045-6535(02)00222-9; Zhang W, 2015, ECOTOX ENVIRON SAFE, V113, P45, DOI 10.1016/j.ecoenv.2014.11.014	35	32	33	11	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151128	10.1371/journal.pone.0151128	http://dx.doi.org/10.1371/journal.pone.0151128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982081	gold, Green Published			2022-12-26	WOS:000372574900063
J	Krukowski, RA; Bursac, Z; Little, MA; Klesges, RC				Krukowski, Rebecca A.; Bursac, Zoran; Little, Melissa A.; Klesges, Robert C.			The Relationship between Body Mass Index and Post-Cessation Weight Gain in the Year after Quitting Smoking: A Cross-Sectional Study	PLOS ONE			English	Article							MORTALITY; HEIGHT	Introduction There is wide variability in the amount of weight gained when quitting smoking, but little is known about key predictors of weight gain. We examined the impact of body mass index (BMI) category and sociodemographic variables on post-cessation weight gain. Materials and Methods We utilized National Health and Nutrition Examination Survey data from five consecutive cycles of data collection from 2003-2004 to 2011-2012 to estimate post-cessation weight gain by BMI category among recent quitters (n = 654). We analyzed data on their "current weight" and their "past year weight". We also compared the recent quitters with current smokers, in order to estimate the amount of weight that could be attributed to quitting smoking. Results Recent quitters gained 1.4 kg (95% CI: 0.8 to 2.0), while current smokers had a non-significant weight change (-0.01 kg (95% CI: -0.3 to 0.2). Weight gain was significant for those in the normal weight (3.1 kg, 95% CI: 2.3 to 3.9) and overweight BMI categories (2.2 kg, 95% CI: 1.1 to 3.2). Conclusions BMI category is a key factor in the extent of post-cessation weight gain, with normal and overweight recent quitters gaining significant amounts of weight.	[Krukowski, Rebecca A.; Bursac, Zoran; Little, Melissa A.; Klesges, Robert C.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Ctr Populat Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Krukowski, RA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Ctr Populat Sci, Memphis, TN 38163 USA.	rkrukows@uthsc.edu	Krukowski, Becca/GVU-7068-2022; Krukowski, Rebecca/AAS-4304-2020; Bursac, Zoran/AAH-9152-2021; Krukowski, Becca/GQI-3653-2022	Krukowski, Becca/0000-0001-9193-2783; Krukowski, Rebecca/0000-0001-9193-2783; Krukowski, Becca/0000-0001-9193-2783; Bursac, Zoran/0000-0001-9306-0907				Aubin Henri-Jean, 2012, BMJ, V345, pe4439, DOI 10.1136/bmj.e4439; BROWMAN GP, 1993, NEW ENGL J MED, V328, P159, DOI 10.1056/NEJM199301213280302; Bush TM, 2014, ANN BEHAV MED, V47, P208, DOI 10.1007/s12160-013-9537-z; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; Flegal KM, 2012, PREV MED, V54, P193, DOI 10.1016/j.ypmed.2012.01.015; Godtfredsen NS, 2008, EUR RESPIR J, V32, P844, DOI 10.1183/09031936.00160007; Janzon E, 2004, J INTERN MED, V255, P266, DOI 10.1046/j.1365-2796.2003.01293.x; Kasteridis P, 2012, HEALTH SERV RES, V47, P1580, DOI 10.1111/j.1475-6773.2012.01380.x; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; KLESGES RC, 1989, PSYCHOL BULL, V106, P204, DOI 10.1037/0033-2909.106.2.204; KLESGES RC, 1988, HEALTH PSYCHOL, V7, P575, DOI 10.1037/0278-6133.7.6.575; KLESGES RC, 1992, HEALTH PSYCHOL, V11, P1, DOI 10.1037/h0090339; Komiyama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072010; Lycett D, 2011, ADDICTION, V106, P188, DOI 10.1111/j.1360-0443.2010.03136.x; Merrill RM, 2009, PREV CHRONIC DIS, V6; MUST A, 1993, AM J EPIDEMIOL, V138, P56, DOI 10.1093/oxfordjournals.aje.a116777; Nilsson P, 1996, J INTERN MED, V240, P189, DOI 10.1046/j.1365-2796.1996.16844000.x; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Siahpush M, 2013, IT IS BETTER BE FAT; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Travier N, 2012, PREV MED, V54, P183, DOI 10.1016/j.ypmed.2011.09.003; Veldheer S, 2015, INT J OBESITY, V39, P1727, DOI 10.1038/ijo.2015.127; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106	26	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151290	10.1371/journal.pone.0151290	http://dx.doi.org/10.1371/journal.pone.0151290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977598	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800056
J	Morrill, HJ; Caffrey, AR; Gaitanis, MM; LaPlante, KL				Morrill, Haley J.; Caffrey, Aisling R.; Gaitanis, Melissa M.; LaPlante, Kerry L.			Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program at a Veterans Affairs Medical Center: A Six-Point Assessment	PLOS ONE			English	Article							INTERRUPTED TIME-SERIES; CLOSTRIDIUM-DIFFICILE INFECTION; RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE EPIDEMIOLOGY; DISEASES SOCIETY; ANTIBIOTIC USE; PRESCRIPTION; OUTCOMES; GUIDELINES; REDUCTION	Background Prospective audit and feedback is a core antimicrobial stewardship program (ASP) strategy; however its impact is difficult to measure. Methods Our quasi-experimental study measured the effect of an ASP on clinical outcomes, antimicrobial use, resistance, costs, patient safety (adverse drug events [ADE] and Clostridium difficile infection [CDI]), and process metrics pre-(9/10-10/11) and post-ASP (9/12-10/13) using propensity adjusted and matched Cox proportional-hazards regression models and interrupted time series (ITS) methods. Results Among our 2,696 patients, median length of stay was 1 day shorter post-ASP (5, interquartile range [IQR] 3-8 vs. 4, IQR 2-7 days, p < 0.001). Mortality was similar in both periods. Mean broad-spectrum (-11.3%), fluoroquinolone (-27.0%), and anti-pseudomonal (-15.6%) use decreased significantly (p < 0.05). ITS analyses demonstrated a significant increase in monthly carbapenem use post-ASP (trend: + 1.5 days of therapy/1,000 patient days [1000PD] per month; 95% CI 0.1-3.0). Total antimicrobial costs decreased 14%. Resistance rates did not change in the one-year post-ASP period. Mean CDI rates/10,000PD were low pre-and post-ASP (14.2 +/- 10.4 vs. 13.8 +/- 10.0, p = 0.94). Fewer patients experienced ADEs post-ASP (6.0% vs. 4.4%, p = 0.06). Conclusions Prospective audit and feedback has the potential to improve antimicrobial use and outcomes, and contain bacterial resistance. Our program demonstrated a trend towards decreased length of stay, broad-spectrum antimicrobial use, antimicrobial costs, and adverse events.	[Morrill, Haley J.; Caffrey, Aisling R.; Gaitanis, Melissa M.; LaPlante, Kerry L.] Vet Affairs Med Ctr, Infect Dis Res Program, Providence, RI USA; [Morrill, Haley J.; Caffrey, Aisling R.; LaPlante, Kerry L.] Univ Rhode Isl, Coll Pharm, Dept Pharm Practice, Kingston, RI 02881 USA; [Morrill, Haley J.; Caffrey, Aisling R.; LaPlante, Kerry L.] Vet Affairs Med Ctr, Ctr Ctr Innovat Long Term Serv & Supports, Providence, RI USA; [Gaitanis, Melissa M.; LaPlante, Kerry L.] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; University of Rhode Island; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	LaPlante, KL (corresponding author), Vet Affairs Med Ctr, Infect Dis Res Program, Providence, RI USA.; LaPlante, KL (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Pharm Practice, Kingston, RI 02881 USA.; LaPlante, KL (corresponding author), Vet Affairs Med Ctr, Ctr Ctr Innovat Long Term Serv & Supports, Providence, RI USA.; LaPlante, KL (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA.	KerryLaPlante@uri.edu		LaPlante, Kerry/0000-0002-9650-4275	Office of Research and Development, Department of Veterans Affairs	Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs)	These authors have no support or funding to report. This material is based upon work supported, in part, by the Office of Research and Development, Department of Veterans Affairs.	Ashley ESD, 2014, CLIN INFECT DIS, V59, pS112, DOI 10.1093/cid/ciu546; Bauer KA, 2014, CLIN INFECT DIS, V59, pS134, DOI 10.1093/cid/ciu547; Bornard L, 2011, MED MALADIES INFECT, V41, P480, DOI 10.1016/j.medmal.2010.12.022; Brown SH, 2003, INT J MED INFORM, V69, P135, DOI 10.1016/S1386-5056(02)00131-4; Caffrey AR, 2015, ADV PHARMACOEPIDEMIO, V4, P176, DOI DOI 10.4172/2167-1052.1000176; Camins BC, 2009, INFECT CONT HOSP EP, V30, P931, DOI 10.1086/605924; Centers for Disease Control and Prevention, 2014, ANT US RES AUR MOD; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Centers for Medicare and Medicaid Services, HOSP COMP DAT ARCH; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cook PP, 2004, J ANTIMICROB CHEMOTH, V53, P853, DOI 10.1093/jac/dkh163; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; Dickey DA, STATIONARITY ISSUES; Dunn K, 2011, INT J CLIN PHARM-NET, V33, P208, DOI 10.1007/s11096-010-9475-9; Elligsen M, 2012, INFECT CONT HOSP EP, V33, P354, DOI 10.1086/664757; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Fridkin SK, 2014, CLIN INFECT DIS, V58, P401, DOI 10.1093/cid/cit710; GILLINGS D, 1981, AM J PUBLIC HEALTH, V71, P38, DOI 10.2105/AJPH.71.1.38; Huttner B, 2013, J ANTIMICROB CHEMOTH, V68, P2393, DOI 10.1093/jac/dkt171; Huttner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036649; Lautenbach E, 2006, INFECT CONT HOSP EP, V27, P893, DOI 10.1086/507274; Lesprit P, 2013, CLIN MICROBIOL INFEC, V19, pE91, DOI 10.1111/1469-0691.12062; Manuel O, 2010, J HOSP INFECT, V74, P326, DOI 10.1016/j.jhin.2009.07.011; Masia M, 2008, EUR J CLIN MICROBIOL, V27, P597, DOI 10.1007/s10096-008-0482-x; Maynard C, 2004, DIABETES CARE, V27, pB22, DOI 10.2337/diacare.27.suppl_2.B22; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Rhee SM, 2014, INFECT DIS CLIN N AM, V28, P237, DOI 10.1016/j.idc.2014.01.001; Rhode Island Department of Health Division of Infectious Disease & Epidemiology, INFL EP SUMM REP RHO; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Septimus E, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0433-x; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Standiford HC, 2012, INFECT CONT HOSP EP, V33, P338, DOI 10.1086/664909; Teo J, 2012, EUR J CLIN MICROBIOL, V31, P947, DOI 10.1007/s10096-011-1391-y; The White House, 2015, NAT ACT PLAN COMB AN; VA Inpatient Evaluation Center (IPEC), 2014, CLOSTR DIFF DAT REP; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Weiss CH, 2011, AM J RESP CRIT CARE, V184, P680, DOI 10.1164/rccm.201101-0037OC	40	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150795	10.1371/journal.pone.0150795	http://dx.doi.org/10.1371/journal.pone.0150795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978263	Green Submitted, Green Published, gold			2022-12-26	WOS:000372572800036
J	Yang, ZN; Zhou, K; Liu, H; Wu, AD; Mei, L; Liu, QZ				Yang, Zhouning; Zhou, Ke; Liu, Hao; Wu, Andong; Mei, Long; Liu, Qingzhen			SfDredd, a Novel Initiator Caspase Possessing Activity on Effector Caspase Substrates in Spodoptera frugiperda	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DROSOPHILA CASPASE; IN-VIVO; INSECT CELLS; APOPTOSIS; P35; ACTIVATION; INHIBITOR; PROTEASE; IDENTIFICATION	Sf9, a cell line derived from Spodoptera frugiperda, is an ideal model organism for studying insect apoptosis. The first notable study that attempted to identify the apoptotic pathway in Sf9 was performed in 1997 and included the discovery of Sf-caspase-1, an effector caspase of Sf9. However, it was not until 2013 that the first initiator caspase in Sf9, SfDronc, was discovered, and the apoptotic pathway in Sf9 became clearer. In this study, we report another caspase of Sf9, SfDredd. SfDredd is highly similar to insect initiator caspase Dredd homologs. Experimentally, recombinant SfDredd underwent autocleavage and exhibited different efficiencies in cleavage of synthetic caspase substrates. This was attributed to its caspase activity for the predicted active site mutation blocked the above autocleavage and synthetic caspase substrates cleavage activity. SfDredd was capable of not only cleaving Sf-caspase-1 in vitro but also cleaving Sf-caspase-1 and inducing apoptosis when it was co-expressed with Sf-caspase-1 in Sf9 cells. The protein level of SfDredd was increased when Sf9 cells were treated by Actinomycin D, whereas silencing of SfDredd reduced apoptosis and Sf-caspase-1 cleavage induced by Actinomycin D treatment. These results clearly indicate that SfDredd functioned as an apoptotic initiator caspase. Apoptosis induced in Sf9 cells by overexpression of SfDredd alone was not as obvious as that induced by SfDronc alone, and the cleavage sites of Sf-caspase-1 for SfDredd and SfDronc are different. In addition, despite sharing a sequence homology with initiator caspases and possessing weak activity on initiator caspase substrates, SfDredd showed strong activity on effector caspase substrates, making it the only insect caspase reported so far functioning similar to human caspase-2 in this aspect. We believe that the discovery of SfDredd, and its different properties from SfDronc, will improve the understanding of apoptosis pathway in Sf9 cells.	[Liu, Qingzhen] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Liu, QZ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	qzhliu@whu.edu.cn			National Natural Science Foundation of China [31070686]; Chinese 111 project from The Department of Science & Technology, Ministry of Education [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project from The Department of Science & Technology, Ministry of Education	This project was supported by the grant from National Natural Science Foundation of China (#31070686; recipient: QL; http://www.nsfc.gov.cn/publish/portal1/) and was partially supported by the Chinese 111 project from The Department of Science & Technology, Ministry of Education (#B06018; http://www.dost.moe.edu.cn/dostmoe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1997, J BIOL CHEM, V272, P1421, DOI 10.1074/jbc.272.3.1421; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; CARTIER JL, 1994, J VIROL, V68, P7728, DOI 10.1128/JVI.68.12.7728-7737.1994; Chen P, 1998, DEV BIOL, V201, P202, DOI 10.1006/dbio.1998.9000; Clem RJ, 2007, CURR DRUG TARGETS, V8, P1069, DOI 10.2174/138945007782151405; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cooper DM, 2007, INSECT BIOCHEM MOLEC, V37, P559, DOI 10.1016/j.ibmb.2007.03.005; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; Courtiade J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-357; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Dorstyn L, 1999, J BIOL CHEM, V274, P30778, DOI 10.1074/jbc.274.43.30778; Doumanis J, 2001, CELL DEATH DIFFER, V8, P387, DOI 10.1038/sj.cdd.4400864; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fraser AG, 1997, EMBO J, V16, P2805, DOI 10.1093/emboj/16.10.2805; Harvey NL, 2001, J BIOL CHEM, V276, P25342, DOI 10.1074/jbc.M009444200; Huang N, 2013, INSECT BIOCHEM MOLEC, V43, P444, DOI 10.1016/j.ibmb.2013.02.005; Kitevska T, 2014, BIOSCIENCE REP, V34, P127, DOI 10.1042/BSR20140025; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; LaCount DJ, 2000, J BIOL CHEM, V275, P15657, DOI 10.1074/jbc.M000791200; LaCount DJ, 1997, J VIROL, V71, P1530, DOI 10.1128/JVI.71.2.1530-1537.1997; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu Q, 2006, APOPTOSIS, V11, P487, DOI 10.1007/s10495-006-5059-5; Manji GA, 1997, J VIROL, V71, P4509, DOI 10.1128/JVI.71.6.4509-4516.1997; Manji GA, 2001, J BIOL CHEM, V276, P16704, DOI 10.1074/jbc.M010179200; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Pop C, 2008, METHOD ENZYMOL, V446, P351, DOI 10.1016/S0076-6879(08)01621-2; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Troy CM, 2003, CELL DEATH DIFFER, V10, P101, DOI 10.1038/sj.cdd.4401175; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Ying ZF, 2013, ARCH INSECT BIOCHEM, V83, P195, DOI 10.1002/arch.21106; Zoog SJ, 2002, EMBO J, V21, P5130	38	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151016	10.1371/journal.pone.0151016	http://dx.doi.org/10.1371/journal.pone.0151016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977926	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800042
J	de Menezes, RRPPB; Mello, CP; Lima, DB; Tessarolo, LD; Sampaio, TL; Paes, LCF; Alves, NTQ; Assis, EM; Lima, RCP; Toyama, MH; Martins, AMC				de Menezes, Ramon R. P. P. B.; Mello, Clarissa P.; Lima, Danya B.; Tessarolo, Louise D.; Sampaio, Tiago Lima; Paes, Livia C. F.; Alves, Natacha T. Q.; Assis Junior, Eudmar M.; Lima Junior, Roberto C. P.; Toyama, Marcos H.; Martins, Alice M. C.			Involvement of Nitric Oxide on Bothropoides insularis Venom Biological Effects on Murine Macrophages In Vitro	PLOS ONE			English	Article							ASPER SNAKE-VENOM; ACID OXIDASE; INFLAMMATORY MEDIATORS; PHOSPHOLIPASE A(2); METALLOPROTEINASE; PURIFICATION; EXPRESSION; TOXINS; CELLS; MOUSE	Viperidae venom has several local and systemic effects, such as pain, edema, inflammation, kidney failure and coagulopathy. Additionally, bothropic venom and its isolated components directly interfere on cellular metabolism, causing alterations such as cell death and proliferation. Inflammatory cells are particularly involved in pathological envenomation mechanisms due to their capacity of releasing many mediators, such as nitric oxide (NO). NO has many effects on cell viability and it is associated to the development of inflammation and tissue damage caused by Bothrops and Bothropoides venom. Bothropoides insularis is a snake found only in Queimada Grande Island, which has markedly toxic venom. Thus, the aim of this work was to evaluate the biological effects of Bothropoides insularis venom (BiV) on RAW 264.7 cells and assess NO involvement. The venom was submitted to colorimetric assays to identify the presence of some enzymatic components. We observed that BiV induced H2O2 production and showed proteolytic and phospholipasic activities. RAW 264.7 murine macrophages were incubated with different concentrations of BiV and then cell viability was assessed by MTT reduction assay after 2, 6, 12 and 24 hours of incubation. A time-and concentration-dependent effect was observed, with a tendency to cell proliferation at lower BiV concentrations and cell death at higher concentrations. The cytotoxic effect was confirmed after lactate dehydrogenase (LDH) measurement in the supernatant from the experimental groups. Flow cytometry analyses revealed that necrosis is the main cell death pathway caused by BiV. Also, BiV induced NO release. The inhibition of both proliferative and cytotoxic effects with L-NAME were demonstrated, indicating that NO is important for these effects. Finally, BiV induced an increase in iNOS expression. Altogether, these results demonstrate that B. insularis venom have proliferative and cytotoxic effects on macrophages, with necrosis participation. We also suggest that BiV acts by inducing iNOS expression and causing NO release.	[de Menezes, Ramon R. P. P. B.; Sampaio, Tiago Lima; Paes, Livia C. F.; Alves, Natacha T. Q.; Lima Junior, Roberto C. P.] Univ Fed Ceara, Sch Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Mello, Clarissa P.; Lima, Danya B.; Tessarolo, Louise D.; Martins, Alice M. C.] Univ Fed Ceara, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil; [Assis Junior, Eudmar M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Toyama, Marcos H.] Sao Paulo State Univ UNESP, Sao Vicente Unit, Paulista Coastal Campus, Sao Paulo, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; University of Bristol; Universidade Estadual Paulista	de Menezes, RRPPB (corresponding author), Univ Fed Ceara, Sch Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil.	ramonppessoa@gmail.com	Martins, Alice Maria Costa/AAX-3093-2020; Lima, Danya Bandeira/ABG-1565-2020; Menezes, Ramon/ABA-1109-2021; Lima-Júnior, Roberto CP/W-5095-2019; Toyama, Marcos H/P-4673-2017; Assis-Junior, Eudmar/F-7102-2012	Menezes, Ramon/0000-0003-3109-9683; Lima-Júnior, Roberto CP/0000-0002-7033-655X; Toyama, Marcos H/0000-0001-6836-3084; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) and "Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES).	Ash D, 2015, AM J CANCER RES, V5, P481; Baldo C, 2008, TOXICON, V51, P54, DOI 10.1016/j.toxicon.2007.08.005; Bonfim VL, 2009, CELL BIOL TOXICOL, V25, P523, DOI 10.1007/s10565-008-9106-6; Brenes O, 2010, EXP MOL PATHOL, V88, P424, DOI 10.1016/j.yexmp.2010.02.002; Bustillo S, 2012, TOXICON, V59, P338, DOI 10.1016/j.toxicon.2011.11.007; Chae HS, 2015, INT IMMUNOPHARMACOL, V29, P966, DOI 10.1016/j.intimp.2015.09.008; Chaves F, 2006, INFLAMM RES, V55, P245, DOI 10.1007/s00011-006-0078-9; COGO JC, 1993, TOXICON, V31, P1237, DOI 10.1016/0041-0101(93)90397-2; Cogo JC, 2006, BIOCHIMIE, V88, P1947, DOI 10.1016/j.biochi.2006.10.006; Torres AFC, 2010, TOXICON, V55, P795, DOI 10.1016/j.toxicon.2009.11.013; Cotrim CA, 2011, CHEM-BIOL INTERACT, V189, P9, DOI 10.1016/j.cbi.2010.10.016; Menezes RRPPB, 2012, NAT PROD COMMUN, V7, P71; de Souza Carlos At, 2012, J Venom Res, V3, P28; Furtado JL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/683123; Giannotti KC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/807982; Gomes MSR, 2015, J BIOCHEM, V157, P137, DOI 10.1093/jb/mvu058; Gomes MSR, 2011, COMP BIOCHEM PHYS C, V153, P290, DOI 10.1016/j.cbpc.2010.11.008; Goncalves LR, 2016, J MAR BIOL ASSOC UK, V96, P943, DOI 10.1017/S0025315415001812; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Grishin EV, 1996, ADV EXPT MED BIOL, P231; Grzegorz B, 1996, ACTA BIOCHIM POL, P645; Gutierrez JM, 2006, MICROVASC RES, V71, P55, DOI 10.1016/j.mvr.2005.10.007; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Izidoro LFM, 2006, BIOORGAN MED CHEM, V14, P7034, DOI 10.1016/j.bmc.2006.06.025; Jorge Roberta J B, 2011, J Exp Ther Oncol, V9, P249; Jorge RJB, 2015, J PROTEOMICS, V114, P93, DOI 10.1016/j.jprot.2014.11.011; Khan MW, 2015, HUM EXP TOXICOL, P1; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; Li W, 2015, INT J CLIN EXP PATHO, V8, P2274; Lira MS, 2007, TOXICON, V49, P982, DOI 10.1016/j.toxicon.2007.01.009; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; LOMONTE B, 1993, INFLAMMATION, V17, P93, DOI 10.1007/BF00916097; Lopes DS, 2012, TOXICON, V60, P1072, DOI 10.1016/j.toxicon.2012.07.004; Braga MDM, 2008, TOXICON, V51, P199, DOI 10.1016/j.toxicon.2007.09.003; Marangoni FA, 2013, UNMASKING SNAKE VENO, V2013; Marcussi S, 2013, TOXICON, V65, P9, DOI 10.1016/j.toxicon.2012.12.020; Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X; Mello CP, 2014, TOXICON, V88, P107, DOI 10.1016/j.toxicon.2014.05.009; Monteiro-Machado M, 2015, TOXICON, V98, P20, DOI 10.1016/j.toxicon.2015.02.010; Moreira V, 2011, TOXICON, V57, P288, DOI 10.1016/j.toxicon.2010.12.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moura-Da-Silva AM, 2007, CURR PHARM DESIGN, V13, P2893, DOI 10.2174/138161207782023711; Naumann GB, 2011, BBA-GEN SUBJECTS, V1810, P683, DOI 10.1016/j.bbagen.2011.04.003; de Souza DLN, 2012, COMP BIOCHEM PHYS B, V161, P102, DOI 10.1016/j.cbpb.2011.10.002; Nunes ES, 2012, TOXICON, V59, P667, DOI 10.1016/j.toxicon.2012.03.002; de Morais ICO, 2013, TOXICON, V61, P38, DOI 10.1016/j.toxicon.2012.10.005; Oliveira-Carvalho AL, 2008, TOXICON, V51, P659, DOI 10.1016/j.toxicon.2007.11.026; de Paula FFP, 2014, COMP BIOCHEM PHYS D, V12, P74, DOI 10.1016/j.cbd.2014.09.001; Rajendra W, 2004, TOXICON, V44, P1, DOI 10.1016/j.toxicon.2004.04.014; Ramos OHP, 2007, ARCH BIOCHEM BIOPHYS, V461, P1, DOI 10.1016/j.abb.2007.02.021; Rucavado A, 2008, TOXICON, V52, P754, DOI 10.1016/j.toxicon.2008.08.009; Rueda AQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/789689; Saturnino-Oliveira J., 2014, BIOMED RES INT, V2014, P1; Setubal SD, 2013, TOXICON, V76, P143, DOI 10.1016/j.toxicon.2013.09.019; Souza JM, 2012, MACROPHAGE ACTIVATIO, V417, P223; Sucasaca-monzon G, 2015, BP 13 PLA 2 PURIFICA, V2015; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Ullah A, 2012, ACTA CRYSTALLOGR F, V68, P1222, DOI 10.1107/S1744309112036603; Valente RH, 2009, J PROTEOMICS, V72, P241, DOI 10.1016/j.jprot.2009.01.001; Wanderley CWS, 2014, TOXICON, V90, P134, DOI 10.1016/j.toxicon.2014.08.001; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Yang CA, 2012, J AGR FOOD CHEM, V60, P2464, DOI 10.1021/jf203883u; Zhang WY, 2015, MOL CELL BIOCHEM, V405, P281, DOI 10.1007/s11010-015-2418-y	63	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151029	10.1371/journal.pone.0151029	http://dx.doi.org/10.1371/journal.pone.0151029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974665	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600044
J	Kim, G; Lee, YH; Han, MH; Lee, EK; Kim, CH; Kwon, HS; Jeong, IK; Kang, ES; Kim, DJ				Kim, Gyuri; Lee, Yong-ho; Han, Mi Hye; Lee, Eui-Kyung; Kim, Chong Hwa; Kwon, Hyuk Sang; Jeong, In Kyung; Kang, Eun Seok; Kim, Dae Jung			Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea	PLOS ONE			English	Article							RISK; COMPLICATIONS; COSTS	Background Hypoglycemia is a very serious complication in patients with type 2 diabetes mellitus (T2DM) and affects the economic burden of treatment. This study aims to create models of the cost of treating hypoglycemia in patients with T2DM based upon physician estimates of medical resource usage. Methods Using a literature review and personal advice from endocrinologists and emergency physicians, we developed several models for managing patients with hypoglycemia. The final model was approved by the consulting experts. We also developed 3 unique surveys to allow endocrinologists, emergency room (ER) physicians, and primary care physicians to evaluate the resource usage of patients with hypoglycemia. Medical costs were calculated by multiplying the estimated medical resource usage by the corresponding health insurance medical care costs reported in 2014. Results In total, 40 endocrinologists, 20 ER physicians, and 30 primary care physicians completed the survey. We identified 12 types of standard medical models for secondary or tertiary hospitals and 4 for primary care clinics based on the use of ER, general ward, or intensive care unit (ICU) and patients' status of consciousness and self-respiration. Estimated medical costs per person per hypoglycemic event ranged from $17.28 to $1,857.09 for secondary and tertiary hospitals. These costs were higher for patients who were unconscious and for those requiring ICU admission. Conclusion Hypoglycemia has a substantial impact on the medical costs and its prevention will result in economic benefits for T2DM patients and society.	[Kim, Gyuri; Lee, Yong-ho; Kang, Eun Seok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Gyuri] Yonsei Univ, Coll Med, Grad Sch, Seoul, South Korea; [Han, Mi Hye] Merck Sharp & Dohme Ltd, Market Access, Seoul, South Korea; [Han, Mi Hye; Lee, Eui-Kyung] Sungkyunkwan Univ, Sch Pharm, Pharmaceut Policy & Outcomes Res, Seoul, South Korea; [Kim, Chong Hwa] Sejong Gen Hosp, Dept Internal Med, Bucheon, South Korea; [Kwon, Hyuk Sang] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Jeong, In Kyung] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Kim, Dae Jung] Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon 441749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Sejong General Hospital; Catholic University of Korea; Kyung Hee University; Ajou University	Kang, ES (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, DJ (corresponding author), Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon 441749, South Korea.	edgo@yuhs.ac; djkim@ajou.ac.kr	Jeong, In-Kyung/AAI-6488-2020; Kim, Gyuri/E-8992-2018; Lee, Yong-ho/AAT-4106-2020	Jeong, In-Kyung/0000-0001-7857-546X; Kim, Gyuri/0000-0002-2242-2816; Lee, Yong-ho/0000-0002-6219-4942; Kang, Eun Seok/0000-0002-0364-4675; Kim, Dae Jung/0000-0003-1025-2044	MSD Korea LTD, Merck & Co., Inc., Kenilworth, NJ, USA	MSD Korea LTD, Merck & Co., Inc., Kenilworth, NJ, USA	Funding for this study was provided by MSD Korea LTD, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. The sponsor participated in part of study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. GK, Y-hL, E-KL, CHK, HSK, IKJ, ESK, DJK have no financial disclosures. MHH is employee of MSD Korea.	Brandle M, 2003, DIABETES CARE, V26, P2300, DOI 10.2337/diacare.26.8.2300; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; Brown JB, 1999, ARCH INTERN MED, V159, P1873, DOI 10.1001/archinte.159.16.1873; Chan Siew-Pheng, 2010, Diabetes Res Clin Pract, V89, pe30, DOI 10.1016/j.diabres.2010.05.008; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giorda CB, 2015, ACTA DIABETOL, V52, P845, DOI 10.1007/s00592-015-0713-4; Ha WC, 2012, DIABETES METAB J, V36, P280, DOI 10.4093/dmj.2012.36.4.280; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Henriksson F, 2000, J INTERN MED, V248, P387, DOI 10.1046/j.1365-2796.2000.00749.x; Ho KM, 2009, J CRIT CARE, V24, P101, DOI 10.1016/j.jcrc.2007.11.015; Hoste EAJ, 2003, J AM SOC NEPHROL, V14, P1022, DOI 10.1097/01.ASN.0000059863.48590.E9; Liu SQ, 2012, EXPERT REV PHARM OUT, V12, P47, DOI [10.1586/ERP.11.87, 10.1586/erp.11.87]; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Unger J, 2012, DIABETES METAB SYNDR, V5, P57, DOI 10.2147/DMSO.S29367; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	18	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151282	10.1371/journal.pone.0151282	http://dx.doi.org/10.1371/journal.pone.0151282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975054	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600063
J	Zhang, XN; Wang, YY; Han, SS; Xiang, HY; Peng, Y; Wu, YH; Pan, SW; Zhang, Y; Ruan, JL				Zhang, Xuenong; Wang, Yanyan; Han, Shishi; Xiang, Huiyao; Peng, Yan; Wu, Yinghua; Pan, Songwei; Zhang, Ye; Ruan, Jinlan			RY10-4 Inhibits the Proliferation of Human Hepatocellular Cancer HepG2 Cells by Inducing Apoptosis In Vitro and In Vivo	PLOS ONE			English	Article							HUMAN TUMOR XENOGRAFTS; ANTITUMOR COMPOUND; PROTOAPIGENONE; STRESS; GROWTH; STAT3; STRATEGIES; AUTOPHAGY; INVASION; PATHWAY	This study aimed to investigate the anti-tumor activity of RY10-4, a small molecular that was designed and synthesized based on the structure of protoapigenone. A previous screening study showed that RY10-4 possessed anti-proliferative effects against HepG2 human hepatocellular carcinoma cells. However, the full range of RY10-4 anti-cancer effects on liver tumors and the underlying mechanisms have not been identified. Herein, employing flow cytometry, and Western blot analysis, we demonstrate that RY10-4 can induce cell cycle arrest, intracellular reactive oxygen species (ROS) production and apoptosis in HepG2 cells. In HepG2 cell xenograft tumor model, RY10-4 significantly inhibited the growth of tumors and induced apoptosis in tumor cells, with little side effects. Moreover, RY10-4 caused the suppression of STAT3 activation, which may be involved the apoptosis induction. In addition, RY10-4 inhibited the proliferation of Hep3B and HuH-7 human hepatocellular carcinoma cells in a concentration-dependent manner. Taken together, our results suggest that RY10-4 has a great potential to develop as chemotherapeutic agent for liver cancer.	[Zhang, Xuenong; Wang, Yanyan; Han, Shishi; Peng, Yan; Wu, Yinghua; Pan, Songwei; Zhang, Ye] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Pharm, Yichang 443003, Peoples R China; [Zhang, Xuenong; Wang, Yanyan; Han, Shishi; Xiang, Huiyao; Peng, Yan; Wu, Yinghua; Pan, Songwei; Zhang, Ye] Yichang Cent Peoples Hosp, Yichang 443003, Peoples R China; [Zhang, Xuenong; Han, Shishi; Ruan, Jinlan] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan 430030, Peoples R China; [Xiang, Huiyao] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Clin Lab, Yichang 443003, Peoples R China	China Three Gorges University; Huazhong University of Science & Technology; China Three Gorges University	Zhang, XN; Wang, YY (corresponding author), China Three Gorges Univ, Coll Clin Med Sci 1, Dept Pharm, Yichang 443003, Peoples R China.; Zhang, XN; Wang, YY (corresponding author), Yichang Cent Peoples Hosp, Yichang 443003, Peoples R China.; Zhang, XN (corresponding author), Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan 430030, Peoples R China.	13986258801@163.com; wangyy1001@163.com	wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022		National Natural Science Foundation of China [31270390]; Natural Science Foundation of Hubei Province [2015CFC852]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (No. 31270390, to YYW) and the Natural Science Foundation of Hubei Province (No. 2015CFC852, to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486; Badr CE, 2013, JNCI-J NATL CANCER I, V105, P643, DOI 10.1093/jnci/djt037; Chan SL, 2004, CLIN EXP PHARMACOL P, V31, P119, DOI 10.1111/j.1440-1681.2004.03975.x; Chang HL, 2008, CANCER LETT, V267, P85, DOI 10.1016/j.canlet.2008.03.007; Chaveli-Lopez Begonya, 2014, J Clin Exp Dent, V6, pe81, DOI 10.4317/jced.51337; Chen HM, 2011, FREE RADICAL BIO MED, V50, P1151, DOI 10.1016/j.freeradbiomed.2011.01.015; Chen YJ, 2013, BASIC CLIN PHARMACOL, V113, P8, DOI 10.1111/bcpt.12057; Chiu CC, 2009, DNA CELL BIOL, V28, P501, DOI 10.1089/dna.2009.0852; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hao WH, 2014, PEERJ, V2, DOI 10.7717/peerj.555; Hather G, 2014, CANCER INFORM, V13, P65, DOI 10.4137/CIN.S13974; Hong B, 2014, CURR DRUG TARGETS, V15, P80, DOI 10.2174/1389450114666140106101412; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Liu ZW, 2012, CANCER CHEMOTH PHARM, V69, P1633, DOI 10.1007/s00280-012-1873-3; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pflaumf J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00285; Poor M, 2013, J PHOTOCH PHOTOBIO B, V124, P20, DOI 10.1016/j.jphotobiol.2013.04.002; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Tomasetti M, 2015, CURR MED CHEM, V22, P552, DOI 10.2174/0929867321666140915142219; Tomek M, 2012, J PHARM PHARMACOL, V64, P1695, DOI 10.1111/j.2042-7158.2012.01526.x; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Xue PP, 2014, CHEM-BIOL INTERACT, V209, P25, DOI 10.1016/j.cbi.2013.11.014; Yuan QY, 2012, CANCER LETT, V324, P210, DOI 10.1016/j.canlet.2012.05.025; Yuan QY, 2011, BIOORG MED CHEM LETT, V21, P3427, DOI 10.1016/j.bmcl.2011.03.108; Zhang XN, 2013, TOXICOL APPL PHARM, V270, P122, DOI 10.1016/j.taap.2013.04.011; Zips D, 2005, IN VIVO, V19, P1	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151679	10.1371/journal.pone.0151679	http://dx.doi.org/10.1371/journal.pone.0151679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974964	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600094
J	Hoenigl, M; Chaillon, A; Kessler, HH; Haas, B; Stelzl, E; Weninger, K; Little, SJ; Mehta, SR				Hoenigl, Martin; Chaillon, Antoine; Kessler, Harald H.; Haas, Bernhard; Stelzl, Evelyn; Weninger, Karin; Little, Susan J.; Mehta, Sanjay R.			Characterization of HIV Transmission in South-East Austria	PLOS ONE			English	Article							INFECTION; RISK; EVOLUTION; HISTORY; COHORT; VIRUS; MEN; SEX	To gain deeper insight into the epidemiology of HIV-1 transmission in South-East Austria we performed a retrospective analysis of 259 HIV-1 partial pol sequences obtained from unique individuals newly diagnosed with HIV infection in South-East Austria from 2008 through 2014. After quality filtering, putative transmission linkages were inferred when two sequences were <= 1.5% genetically different. Multiple linkages were resolved into putative transmission clusters. Further phylogenetic analyses were performed using BEAST v1.8.1. Finally, we investigated putative links between the 259 sequences from South-East Austria and all publicly available HIV polymerase sequences in the Los Alamos National Laboratory HIV sequence database. We found that 45.6% (118/259) of the sampled sequences were genetically linked with at least one other sequence from South-East Austria forming putative transmission clusters. Clustering individuals were more likely to be men who have sex with men (MSM; p<0.001), infected with subtype B (p<0.001) or subtype F (p = 0.02). Among clustered males who reported only heterosexual (HSX) sex as an HIV risk, 47% clustered closely with MSM (either as pairs or within larger MSM clusters). One hundred and seven of the 259 sequences (41.3%) from South-East Austria had at least one putative inferred linkage with sequences from a total of 69 other countries. In conclusion, analysis of HIV-1 sequences from newly diagnosed individuals residing in South-East Austria revealed a high degree of national and international clustering mainly within MSM. Interestingly, we found that a high number of heterosexual males clustered within MSM networks, suggesting either linkage between risk groups or misrepresentation of sexual risk behaviors by subjects.	[Hoenigl, Martin; Chaillon, Antoine; Little, Susan J.; Mehta, Sanjay R.] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA; [Hoenigl, Martin] Med Univ Graz, Dept Internal Med, Sect Infect Dis & Trop Med, Graz, Austria; [Hoenigl, Martin] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Kessler, Harald H.; Stelzl, Evelyn; Weninger, Karin] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria; [Haas, Bernhard] Landeskrankenhaus Graz West, Dept Infect Dis, Graz, Austria; [Mehta, Sanjay R.] Vet Affairs Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; Medical University of Graz; Medical University of Graz; Medical University of Graz	Kessler, HH (corresponding author), Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria.	harald.kessler@medunigraz.at	Hoenigl, Martin/E-8802-2010; Little, Susan/AAA-6116-2019; chaillon, antoine/GNH-1623-2022; Chaillon, Antoine/GNH-6121-2022	Hoenigl, Martin/0000-0002-1653-2824; 	Max Kade Foundation, New York (Max Kade Postdoctoral Research grant); Interdisciplicinary Research Fellowship in NeuroAIDS [R25-MH081482]; Bettencourt-Schueller Foundation; California HIV/AIDS Research Program (CHRP) [F13SD321]; National Institutes of Health: NIH [AI106039, AI43638, AI074621, AI108351, MH100974, AI036214, AI093163, AI100665, DA034978]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074621, K23AI093163, R24AI106039, R21AI108351, K24AI100665, P30AI036214, U01AI043638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100974, R25MH081482] Funding Source: NIH RePORTER	Max Kade Foundation, New York (Max Kade Postdoctoral Research grant); Interdisciplicinary Research Fellowship in NeuroAIDS; Bettencourt-Schueller Foundation; California HIV/AIDS Research Program (CHRP); National Institutes of Health: NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funds from the following: the Max Kade Foundation, New York (Max Kade Postdoctoral Research grant), Interdisciplicinary Research Fellowship in NeuroAIDS (R25-MH081482), the Bettencourt-Schueller Foundation, the California HIV/AIDS Research Program (CHRP) Grant F13SD321, and grants from the National Institutes of Health: NIH Grants including AI106039, AI43638, AI074621, AI108351, MH100974, AI036214, AI093163, AI100665, DA034978, and AI036214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52; Chaillon A, 2016, C RETR OPP INF CROI; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; European Union Agency for Fundamental Rights, 2014, EUR UN LES GAY BIS T; Gisinger M, 2014, 26 REPORT AUSTRIAN H, P26; Hightower GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068188; Hoenigl M, 2016, EMERG INFECT DIS, V22, P532, DOI 10.3201/eid2203.151607; Hoenigl M, 2016, CLIN INFECT DIS, V62, P501, DOI 10.1093/cid/civ912; Hoenigl M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0458-5; Hoenigl M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001242; Hoenigl M, 2015, CLIN INFECT DIS, V61, P468, DOI 10.1093/cid/civ335; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098443; Mehta SR, 2011, INFECT GENET EVOL, V11, P975, DOI 10.1016/j.meegid.2011.03.009; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Salzer HJF, 2011, INT J HYG ENVIR HEAL, V214, P407, DOI 10.1016/j.ijheh.2011.05.002; Stamatakis A, 2015, CURR PROTOC BIOINFOR, V51, DOI DOI 10.1002/0471250953.BI0614S51; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; UNAIDS, 2012, AUSTR COUNTR PROGR R	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151478	10.1371/journal.pone.0151478	http://dx.doi.org/10.1371/journal.pone.0151478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967154	Green Published, gold			2022-12-26	WOS:000371989200058
J	Sanvisens, N; Romero, AM; Zhang, CG; Wu, XR; An, XX; Huang, MX; Puig, S				Sanvisens, Nerea; Romero, Antonia M.; Zhang, Caiguo; Wu, Xiaorong; An, Xiuxiang; Huang, Mingxia; Puig, Sergi			Yeast Dun1 Kinase Regulates Ribonucleotide Reductase Small Subunit Localization in Response to Iron Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE CHECKPOINT PATHWAYS; SULFUR PROTEIN BIOGENESIS; RNA-BINDING-PROTEINS; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; MESSENGER-RNA; INHIBITOR SML1; SUBCELLULAR-LOCALIZATION; NUCLEAR IMPORT; CLUSTER	Ribonucleotide reductase (RNR) is an essential iron-dependent enzyme that catalyzes deoxyribonucleotide synthesis in eukaryotes. Living organisms have developed multiple strategies to tightly modulate RNR function to avoid inadequate or unbalanced deoxyribonucleotide pools that cause DNA damage and genome instability. Yeast cells activate RNR in response to genotoxic stress and iron deficiency by facilitating redistribution of its small heterodimeric subunit Rnr2-Rnr4 from the nucleus to the cytoplasm, where it forms an active holoenzyme with large Rnr1 subunit. Dif1 protein inhibits RNR by promoting nuclear import of Rnr2-Rnr4. Upon DNA damage, Dif1 phosphorylation by the Dun1 checkpoint kinase and its subsequent degradation enhances RNR function. In this report, we demonstrate that Dun1 kinase triggers Rnr2-Rnr4 redistribution to the cytoplasm in response to iron deficiency. We show that Rnr2-Rnr4 relocalization by low iron requires Dun1 kinase activity and phosphorylation site Thr-380 in the Dun1 activation loop, but not the Dun1 forkhead-associated domain. By using different Dif1 mutant proteins, we uncover that Dun1 phosphorylates Dif1 Ser-104 and Thr-105 residues upon iron scarcity. We observe that the Dif1 phosphorylation pattern differs depending on the stimuli, which suggests different Dun1 activating pathways. Importantly, the Dif1-S104A/T105A mutant exhibits defects in nucleus-to-cytoplasm redistribution of Rnr2-Rnr4 by iron limitation. Taken together, these results reveal that, in response to iron starvation, Dun1 kinase phosphorylates Dif1 to stimulate Rnr2-Rnr4 relocalization to the cytoplasm and promote RNR function.	[Sanvisens, Nerea; Romero, Antonia M.; Puig, Sergi] CSIC, IATA, Dept Biotecnol, Valencia 46980, Spain; [Zhang, Caiguo; Wu, Xiaorong; An, Xiuxiang; Huang, Mingxia] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Sanvisens, Nerea] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco	Huang, MX (corresponding author), 12801 E 17th Ave, Aurora, CO 80045 USA.; Puig, S (corresponding author), Catedrat Agustin Escardino 7, E-46980 Valencia, Spain.	mingxia.huang@ucdenver.edu; spuig@iata.csic.es	Puig, Sergi/E-4788-2010; Romero, Antonia Maria/AAG-8260-2019; Zhang, Caiguo/J-1421-2016	Puig, Sergi/0000-0002-1856-490X; Romero, Antonia Maria/0000-0002-2727-279X; Zhang, Caiguo/0000-0002-9055-3279	Conselleria d'Educacio de la Generalitat Valenciana; Spanish Ministry of Economy and Competitiveness; Spanish Ministry of Economy and Competitiveness [AGL2011-29099, BIO2014-56298-P]; National Institutes of Health [CA125574]; NATIONAL CANCER INSTITUTE [R01CA125574] Funding Source: NIH RePORTER	Conselleria d'Educacio de la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by a predoctoral fellowship from "Conselleria d'Educacio de la Generalitat Valenciana" (to N. S.), a predoctoral fellowship from the Spanish Ministry of Economy and Competitiveness (to A. M. R.), Spanish Ministry of Economy and Competitiveness Grants AGL2011-29099 and BIO2014-56298-P (to S. P.), and National Institutes of Health Grant CA125574 (to M. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	An XX, 2006, GENETICS, V173, P63, DOI 10.1534/genetics.105.055236; Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; de la Loza MDD, 2011, NUCLEIC ACIDS RES, V39, P6002, DOI 10.1093/nar/gkr193; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Ge H, 2001, P NATL ACAD SCI USA, V98, P10067, DOI 10.1073/pnas.181336498; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lee YD, 2008, MOL CELL, V32, P70, DOI 10.1016/j.molcel.2008.08.018; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Martinez-Pastor M, 2013, MOL CELL BIOL, V33, P2178, DOI 10.1128/MCB.01458-12; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; Niida H, 2010, CANCER SCI, V101, P2505, DOI 10.1111/j.1349-7006.2010.01719.x; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Pijuan J, 2015, J CELL SCI, V128, P4653, DOI 10.1242/jcs.178046; Pike BL, 2003, J BIOL CHEM, V278, P30421, DOI 10.1074/jbc.C300227200; Prouteau M, 2008, EMBO J, V27, P2966, DOI 10.1038/emboj.2008.212; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Sanvisens N, 2014, MOL CELL BIOL, V34, P3259, DOI 10.1128/MCB.00472-14; Sanvisens Nerea, 2013, Biomed J, V36, P51, DOI 10.4103/2319-4170.110398; Sanvisens N, 2011, MOL CELL, V44, P759, DOI 10.1016/j.molcel.2011.09.021; Shao JM, 2013, EXPERT OPIN THER TAR, V17, P1423, DOI 10.1517/14728222.2013.840293; SIKORSKI RS, 1989, GENETICS, V122, P19; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tsaponina O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002061; Uchiki T, 2004, J BIOL CHEM, V279, P11293, DOI 10.1074/jbc.M309751200; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vergara SV, 2011, MOL CELL BIOL, V31, P417, DOI 10.1128/MCB.00754-10; Wanrooij PH, 2015, DNA REPAIR, V32, P17, DOI 10.1016/j.dnarep.2015.04.009; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; Wolter R, 1996, MOL GEN GENET, V250, P162, DOI 10.1007/s004380050063; Wu XR, 2008, MOL CELL BIOL, V28, P7156, DOI 10.1128/MCB.01388-08; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100; Zhang CG, 2014, PROTEIN CELL, V5, P750, DOI 10.1007/s13238-014-0083-7; Zhang Z, 2006, P NATL ACAD SCI USA, V103, P1422, DOI 10.1073/pnas.0510516103; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; Zhao XL, 2000, MOL CELL BIOL, V20, P9076, DOI 10.1128/MCB.20.23.9076-9083.2000; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	60	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9807	9817		10.1074/jbc.M116.720862	http://dx.doi.org/10.1074/jbc.M116.720862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26970775	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000375602300037
J	Faizy, TD; Thaler, C; Kumar, D; Sedlacik, J; Broocks, G; Grosser, M; Stellmann, JP; Heesen, C; Fiehler, J; Siemonsen, S				Faizy, Tobias Djamsched; Thaler, Christian; Kumar, Dushyant; Sedlacik, Jan; Broocks, Gabriel; Grosser, Malte; Stellmann, Jan-Patrick; Heesen, Christoph; Fiehler, Jens; Siemonsen, Susanne			Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging	PLOS ONE			English	Article							APPEARING BRAIN-TISSUE; MAGNETIZATION-TRANSFER; DIFFUSION TENSOR; WHITE-MATTER; INSIGHTS; EVOLUTION; INJURY; IMAGES; MRI	Purpose To assess neuroprotection and remyelination in Multiple Sclerosis (MS), we applied a more robust myelin water imaging (MWI) processing technique, including spatial priors into image reconstruction, which allows for lower SNR, less averages and shorter acquisition times. We sought to evaluate this technique in MS-patients and healthy controls (HC). Materials and Methods Seventeen MS-patients and 14 age-matched HCs received a 3T Magnetic Resonance Imaging (MRI) examination including MWI (8 slices, 12 minutes acquisition time), T2w and T1mprage pre and post gadolinium (GD) administration. Black holes (BH), contrast enhancing lesions (CEL) and T2 lesions were marked and registered to MWI. Additionally, regions of interest (ROI) were defined in the frontal, parietal and occipital normal appearing white matter (NAWM)/white matter (WM), the corticospinal tract (CST), the splenium (SCC) and genu (GCC) of the corpus callosum in patients and HCs. Mean values of myelin water fraction (MWF) were determined for each ROI. Results Significant differences (p < 0.05) of the MWF were found in all three different MS-lesion types (BH, CEL, T2 lesions), compared to the WM of HCs. The mean MWF values among the different lesion types were significantly differing from each other. Comparing MS-patients vs. HCs, we found a significant (p < 0.05) difference of the MWF in all measured ROIs except of GCC and SCC. The mean reduction of MWF in the NAWM of MS-patients compared to HCs was 37%. No age, sex, disability score and disease duration dependency was found for the NAWM MWF. Conclusion MWF measures were in line with previous studies and lesions were clearly visible in MWI. MWI allows for quantitative assessment of NAWM and lesions in MS, which could be used as an additional sensitive imaging endpoint for larger MS studies. Measurements of the MWF also differ between patients and healthy controls.	[Faizy, Tobias Djamsched; Thaler, Christian; Kumar, Dushyant; Sedlacik, Jan; Broocks, Gabriel; Grosser, Malte; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Stellmann, Jan-Patrick; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Kumar, Dushyant; Stellmann, Jan-Patrick; Heesen, Christoph; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS INIMS, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Faizy, TD (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	T.Faizy@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833; Gellissen, Susanne/0000-0002-7444-7265	German Federal Ministry of Education and Research [0315610-0315620 NEU2]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (Proposal/Contract 0315610-0315620 NEU2).	Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Billiet T, 2015, NEUROBIOL AGING, V36, P2107, DOI 10.1016/j.neurobiolaging.2015.02.029; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053; Filippi M, 2000, NEUROLOGY, V55, P940, DOI 10.1212/WNL.55.7.940; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Hein T, 2000, NERVENARZT, V71, P288, DOI 10.1007/s001150050559; HIEHLE JF, 1995, AM J NEURORADIOL, V16, P69; Kappos L, 2015, NEUROLOGY, V84, P1582, DOI 10.1212/WNL.0000000000001462; Kitzler HH, 2012, NEUROIMAGE, V59, P2670, DOI 10.1016/j.neuroimage.2011.08.052; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kolind S, 2012, NEUROIMAGE, V60, P263, DOI 10.1016/j.neuroimage.2011.11.070; Kumar D, 2012, MAGN RESON MED, V68, P1536, DOI 10.1002/mrm.24170; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Laule C, 2007, J MAGN RESON IMAGING, V26, P1117, DOI 10.1002/jmri.21132; Laule C, 2011, MULT SCLER J, V17, P144, DOI 10.1177/1352458510384008; LOEVNER LA, 1995, RADIOLOGY, V196, P511, DOI 10.1148/radiology.196.2.7617869; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Oh J, 2004, J NEUROL NEUROSUR PS, V75, P1281, DOI 10.1136/jnnp.2004.039032; Oh J, 2007, J NEUROIMAGING, V17, P156, DOI 10.1111/j.1552-6569.2007.00098.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pichler A, 2013, MULT SCLER J, V19, P167, DOI 10.1177/1352458512448107; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; REVESZ T, 1994, BRAIN, V117, P759, DOI 10.1093/brain/117.4.759; Siemonsen S, 2015, CLIN NEURORADIOL; Tortorella C, 2000, NEUROLOGY, V54, P186, DOI 10.1212/WNL.54.1.186; TRAUGOTT U, 1983, J NEUROIMMUNOL, V4, P201, DOI 10.1016/0165-5728(83)90036-X; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Vavasour IM, 1998, MAGNET RESON MED, V40, P763, DOI 10.1002/mrm.1910400518; Vavasour IM, 2007, J NEUROL, V254, P1653, DOI 10.1007/s00415-007-0604-x; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Vrenken H, 2007, MULT SCLER, V13, P708, DOI 10.1177/1352458506075521; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Ziemssen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138243	41	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151496	10.1371/journal.pone.0151496	http://dx.doi.org/10.1371/journal.pone.0151496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990645	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800068
J	Hansen, JF; Brorson, MM; Boas, M; Frederiksen, H; Nielsen, CH; Lindstrom, ES; Hofman-Bang, J; Hartoft-Nielsen, ML; Frisch, T; Main, KM; Bendtzen, K; Rasmussen, AK; Feldt-Rasmussen, U				Hansen, Juliana Frohnert; Brorson, Marianne Moller; Boas, Malene; Frederiksen, Hanne; Nielsen, Claus Henrik; Lindstrom, Emma Sofie; Hofman-Bang, Jacob; Hartoft-Nielsen, Marie-Louise; Frisch, Thomas; Main, Katharina M.; Bendtzen, Klaus; Rasmussen, Ase Krogh; Feldt-Rasmussen, Ulla			Phthalates Are Metabolised by Primary Thyroid Cell Cultures but Have Limited Influence on Selected Thyroid Cell Functions In Vitro	PLOS ONE			English	Article							ENDOCRINE DISRUPTING CHEMICALS; DI(2-ETHYL HEXYL) PHTHALATE; EPITHELIAL-CELLS; HORMONE LEVELS; ENVIRONMENTAL CHEMICALS; URINARY PHTHALATE; MALE RATS; EXPOSURE; SERUM; THYROGLOBULIN	Phthalates are plasticisers added to a wide variety of products, resulting in measurable exposure of humans. They are suspected to disrupt the thyroid axis as epidemiological studies suggest an influence on the peripheral thyroid hormone concentration. The mechanism is still unknown as only few in vitro studies within this area exist. The aim of the present study was to investigate the influence of three phthalate diesters (di-ethyl phthalate, di-n-butyl phthalate (DnBP), di-(2-ethylhexyl) phthalate (DEHP)) and two monoesters (mono-n-butyl phthalate and mono-(2-ethylhexyl) phthalate (MEHP)) on the differentiated function of primary human thyroid cell cultures. Also, the kinetics of phthalate metabolism were investigated. DEHP and its monoester, MEHP, both had an inhibitory influence on 3'-5'-cyclic adenosine monophosphate secretion from the cells, and MEHP also on thyroglobulin (Tg) secretion from the cells. Results of the lactate dehydrogenase-measurements indicated that the MEHP-mediated influence was caused by cell death. No influence on gene expression of thyroid specific genes (Tg, thyroid peroxidase, sodium iodine symporter and thyroid stimulating hormone receptor) by any of the investigated diesters could be demonstrated. All phthalate diesters were metabolised to the respective monoester, however with a fall in efficiency for high concentrations of the larger diesters DnBP and DEHP. In conclusion, human thyroid cells were able to metabolise phthalates but this phthalate-exposure did not appear to substantially influence selected functions of these cells.	[Hansen, Juliana Frohnert; Brorson, Marianne Moller; Lindstrom, Emma Sofie; Hofman-Bang, Jacob; Hartoft-Nielsen, Marie-Louise; Rasmussen, Ase Krogh; Feldt-Rasmussen, Ulla] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, PE 2132, DK-2100 Copenhagen, Denmark; [Boas, Malene; Frederiksen, Hanne; Main, Katharina M.] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Nielsen, Claus Henrik; Bendtzen, Klaus] Univ Copenhagen, Rigshosp, Inst Inflammat Res, Sect 7521, DK-2100 Copenhagen, Denmark; [Frisch, Thomas] Univ Copenhagen, Rigshosp, Dept ENT Head & Neck Surg, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Feldt-Rasmussen, U (corresponding author), Univ Copenhagen, Rigshosp, Dept Med Endocrinol, PE 2132, DK-2100 Copenhagen, Denmark.	ufeldt@rh.dk	Frederiksen, Hanne/N-8632-2013; Feldt-Rasmussen, Ulla/AAB-9218-2021	Frederiksen, Hanne/0000-0002-3180-9879; Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Nielsen, Claus Henrik/0000-0001-7543-9016; Main, Katharina Maria/0000-0001-7259-1039	Arvid Nilsson's Fund; Novo Nordisk Foundation; Capital Region of Denmark; Danish Council for Independent Research [11-107874]; Musikforlaeggerne Agnes og Knut Morks Fond; Rigshospitalets Forskningspuljer; Novo Nordisk A/S Denmark; Novo Nordisk Fonden [NNF15OC0014622] Funding Source: researchfish	Arvid Nilsson's Fund; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Capital Region of Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Musikforlaeggerne Agnes og Knut Morks Fond; Rigshospitalets Forskningspuljer; Novo Nordisk A/S Denmark(Novo Nordisk); Novo Nordisk Fonden(Novo Nordisk Foundation)	Ulla Feldt-Rasmussen has received funding for her research salary by Arvid Nilsson's Fund and Novo Nordisk Foundation. JFH received salary from three Danish public funds and one private fund: The Capital Region of Denmark, Rigshospitalets Forskningspuljer, the Danish Council for Independent Research (grant number: 11-107874) and Musikforlaeggerne Agnes og Knut Morks Fond. Equipment and materials were also sponsored by the three public funds as well as by the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novo Nordisk A/S Denmark funder provided support in the form of salaries for authors [MLHN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALBRO PW, 1989, TOXICOL APPL PHARM, V100, P193, DOI 10.1016/0041-008X(89)90305-0; Bernal CA, 2002, FOOD ADDIT CONTAM, V19, P1091, DOI 10.1080/02652030210157709; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009; Brucker-Davis F, 2011, THYROID, V21, P1133, DOI 10.1089/thy.2010.0459; de Cock M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-106; Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069; Dhanya C. R., 2004, Indian Journal of Experimental Biology, V42, P871; DIAMANT M, 1991, AUTOIMMUNITY, V11, P21, DOI 10.3109/08916939108994704; Elcombe CR, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110363; FELDTRASMUSSEN U, 1978, J IMMUNOL METHODS, V21, P295, DOI 10.1016/0022-1759(78)90156-4; Frederiksen H, 2014, ENV HLTH PERSPECT; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Frederiksen H, 2014, REPRODUCTION, V147, P555, DOI 10.1530/REP-13-0522; Frederiksen H, 2010, J ANAL TOXICOL, V34, P400, DOI 10.1093/jat/34.7.400; Gayathri NS, 2004, INDIAN J MED RES, V119, P139; Ghisari M, 2009, TOXICOL LETT, V189, P67, DOI 10.1016/j.toxlet.2009.05.004; Hansen J, SCANDINAVIAN J CLIN; HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356; Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205; Ishihara A, 2003, MOL CELL ENDOCRINOL, V199, P105, DOI 10.1016/S0303-7207(02)00302-7; Ishihara A, 2003, GEN COMP ENDOCR, V134, P36, DOI 10.1016/S0016-6480(03)00197-7; Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755; Kay VR, 2014, CRIT REV TOXICOL, V44, P467, DOI 10.3109/10408444.2013.875983; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635; Lhuguenot J-C, 1985, TOXICOLOGY APPL PHAR, V80, P1985; Liu C, 2015, ENV SCI POLLUT RES I; MADSEN SN, 1976, ACTA ENDOCRINOL-COP, V81, P208, DOI 10.1530/acta.0.0810208; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Muczynski V, 2012, TOXICOL APPL PHARM, V261, P97, DOI 10.1016/j.taap.2012.03.016; O'Connor JC, 2002, TOXICOL SCI, V69, P92, DOI 10.1093/toxsci/69.1.92; Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901; Rajoria S, 2012, BIOMED PHARMACOTHER, V66, P151, DOI 10.1016/j.biopha.2011.11.010; RASMUSSEN AK, 1994, J ENDOCRINOL, V143, P359, DOI 10.1677/joe.0.1430359; RASMUSSEN AK, 1990, ACTA ENDOCRINOL-COP, V122, P520, DOI 10.1530/acta.0.1220520; RASMUSSEN AK, 1988, ALLERGY, V43, P435, DOI 10.1111/j.1398-9995.1988.tb00915.x; Rasmussen AK, 2000, EXP CLIN ENDOCR DIAB, V108, P67, DOI 10.1055/s-2000-5797; Rasmussen AK, 1997, ENDOCRINOLOGY, V138, P2043, DOI 10.1210/en.138.5.2043; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P173, DOI 10.1016/0303-7207(95)03712-8; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P165, DOI 10.1016/0303-7207(95)03711-X; SANDERMANN H, 1984, ECOTOX ENVIRON SAFE, V8, P167, DOI 10.1016/0147-6513(84)90059-9; Santini F, 2003, J ENDOCRINOL INVEST, V26, P950, DOI 10.1007/BF03348190; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Song M, 2011, ENVIRON SCI TECHNOL, V45, P7906, DOI 10.1021/es200475k; Spitzweg C, 2002, CLIN ENDOCRINOL, V57, P559, DOI 10.1046/j.1365-2265.2002.01640.x; Tonk ECM, 2012, TOXICOL APPL PHARM, V260, P48, DOI 10.1016/j.taap.2012.01.018; Wang Q, 2011, ENVIRON SCI POLLUT R, V18, P987, DOI 10.1007/s11356-010-0420-1; Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008	55	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151192	10.1371/journal.pone.0151192	http://dx.doi.org/10.1371/journal.pone.0151192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985823	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300051
J	Krishna, YC; Kumar, A; Isvaran, K				Krishna, Yarlagadda Chaitanya; Kumar, Ajith; Isvaran, Kavita			Wild Ungulate Decision-Making and the Role of Tiny Refuges in Human-Dominated Landscapes	PLOS ONE			English	Article							PREDATION RISK; HABITAT SELECTION; BLACKBUCK ANTELOPE; FORAGE QUALITY; STRATEGIES; HERBIVORES; ECOLOGY; CATTLE; FEAR; DEER	Wildlife conservation in human-dominated landscapes requires that we understand how animals, when making habitat-use decisions, obtain diverse and dynamically occurring resources while avoiding risks, induced by both natural predators and anthropogenic threats. Little is known about the underlying processes that enable wild animals to persist in densely populated human-dominated landscapes, particularly in developing countries. In a complex, semi-arid, fragmented, human-dominated agricultural landscape, we analyzed the habitat-use of blackbuck, a large herbivore endemic to the Indian sub-continent. We hypothesized that blackbuck would show flexible habitat-use behaviour and be risk averse when resource quality in the landscape is high, and less sensitive to risk otherwise. Overall, blackbuck appeared to be strongly influenced by human activity and they offset risks by using small protected patches (similar to 3 km(2)) when they could afford to do so. Blackbuck habitat use varied dynamically corresponding with seasonally-changing levels of resources and risks, with protected habitats registering maximum use. The findings show that human activities can strongly influence and perhaps limit ungulate habitat-use and behaviour, but spatial heterogeneity in risk, particularly the presence of refuges, can allow ungulates to persist in landscapes with high human and livestock densities.	[Krishna, Yarlagadda Chaitanya; Isvaran, Kavita] Indian Inst Sci, Ctr Ecol Sci, Bengaluru, Karnataka, India; [Krishna, Yarlagadda Chaitanya] Manipal Univ, Manipal, Karnataka, India; [Krishna, Yarlagadda Chaitanya; Kumar, Ajith] Wildlife Conservat Soc, India Program, Ctr Wildlife Studies, Bengaluru, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Manipal Academy of Higher Education (MAHE)	Krishna, YC (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bengaluru, Karnataka, India.; Krishna, YC (corresponding author), Manipal Univ, Manipal, Karnataka, India.; Krishna, YC (corresponding author), Wildlife Conservat Soc, India Program, Ctr Wildlife Studies, Bengaluru, Karnataka, India.	chethikrishna@yahoo.com			Royal Norwegian Embassy, New Delhi; Ministry of Environment, Forest and Climate Change, Government of India	Royal Norwegian Embassy, New Delhi; Ministry of Environment, Forest and Climate Change, Government of India	This study was funded by grants from the Royal Norwegian Embassy, New Delhi (http://www.norwayemb.org.in/) and the Ministry of Environment, Forest and Climate Change, Government of India (http://www.moef.nic.in/) to KI.	Barton K., 2013, MUMIN MULTIMODEL INF; Beecham JA, 1998, ECOL MODEL, V113, P141, DOI 10.1016/S0304-3800(98)00139-2; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Brashares JS, 2002, J ANIM ECOL, V71, P626, DOI 10.1046/j.1365-2656.2002.00633.x; DEUTSCH JC, 1994, J ANIM ECOL, V63, P101, DOI 10.2307/5587; Frid A, 2002, CONSERV ECOL, V6; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; GORDON IJ, 1988, J APPL ECOL, V25, P1, DOI 10.2307/2403605; Isvaran K, 2007, OECOLOGIA, V154, P435, DOI 10.1007/s00442-007-0840-x; Jhala YV, 1997, J APPL ECOL, V34, P1348, DOI 10.2307/2405252; Johst K, 2001, ECOL APPL, V11, P60, DOI 10.1890/1051-0761(2001)011[0060:FIAPAD]2.0.CO;2; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Kotler BP, 1995, OIKOS, V74, P251, DOI 10.2307/3545654; KUDO G, 1992, ECOL RES, V7, P297, DOI 10.1007/BF02347098; Kumar S, 2008, INT J ECOL ENV SCI, V34, P9; LARTER NC, 1991, CAN J ZOOL, V69, P2677, DOI 10.1139/z91-376; LOFT ER, 1991, J WILDLIFE MANAGE, V55, P16, DOI 10.2307/3809236; Namgail T, 2007, ECOL RES, V22, P25, DOI 10.1007/s11284-006-0015-y; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; R Core Team, 2012, R LANG ENV STAT COMP; Rahmani A.R., 1991, Journal of the Bombay Natural History Society, V88, P35; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Skaug H., 2013, GEN LINEAR MIXED MOD; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; WallisDeVries MF, 1999, OECOLOGIA, V121, P355, DOI 10.1007/s004420050939; WILMSHURST JF, 1995, BEHAV ECOL, V6, P209, DOI 10.1093/beheco/6.2.209; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x	34	10	12	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151748	10.1371/journal.pone.0151748	http://dx.doi.org/10.1371/journal.pone.0151748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985668	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000372580300122
J	Thibert, J; Farine, JP; Cortot, J; Ferveur, JF				Thibert, Julien; Farine, Jean-Pierre; Cortot, Jerome; Ferveur, Jean-Francois			Drosophila Food-Associated Pheromones: Effect of Experience, Genotype and Antibiotics on Larval Behavior	PLOS ONE			English	Article							SEX-PHEROMONES; MELANOGASTER; AGGRESSION; COURTSHIP; COMMUNICATION; RECOGNITION; ATTRACTION; EVOLUTION; MUTATION; INSECTS	Animals ubiquitously use chemical signals to communicate many aspects of their social life. These chemical signals often consist of environmental cues mixed with species-specific signals-pheromones-emitted by conspecifics. During their life, insects can use pheromones to aggregate, disperse, choose a mate, or find the most suitable food source on which to lay eggs. Before pupariation, larvae of several Drosophila species migrate to food sources depending on their composition and the presence of pheromones. Some pheromones derive from microbiota gut activity and these food-associated cues can enhance larval attraction or repulsion. To explore the mechanisms underlying the preference (attraction/repulsion) to these cues and clarify their effect, we manipulated factors potentially involved in larval response. In particular, we found that the (i) early exposure to conspecifics, (ii) genotype, and (iii) antibiotic treatment changed D. melanogaster larval behavior. Generally, larvae-tested either individually or in groups-strongly avoided food processed by other larvae. Compared to previous reports on larval attractive pheromones, our data suggest that such attractive effects are largely masked by food-associated compounds eliciting larval aversion. The antagonistic effect of attractive vs. aversive compounds could modulate larval choice of a pupariation site and impact the dispersion of individuals in nature.	[Thibert, Julien; Farine, Jean-Pierre; Cortot, Jerome; Ferveur, Jean-Francois] Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, CNRS, UMR6265,UMR1324,INRA, 6 Bd Gabriel, F-21000 Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Ferveur, JF (corresponding author), Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, CNRS, UMR6265,UMR1324,INRA, 6 Bd Gabriel, F-21000 Dijon, France.	jean-francois.ferveur@u-bourgogne.fr			Centre National de la Recherche Scientifique (Insb); Burgundy Regional Council (PARI); UNiversite de Bourgogne; Agence nationale de la Recherche (GUSTAILE); CONICYT [MEC80140013]	Centre National de la Recherche Scientifique (Insb)(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council (PARI)(Region Bourgogne-Franche-Comte); UNiversite de Bourgogne; Agence nationale de la Recherche (GUSTAILE)(French National Research Agency (ANR)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funded by Centre National de la Recherche Scientifique (Insb) http://www.cnrs.fr/insb/ (JPF, JFF and JC), Burgundy Regional Council (PARI 2012) http://www.region-bourgogne.fr/ (JFF), UNiversite de Bourgogne http://www.u-bourgogne.fr/ (JT), Agence nationale de la Recherche (GUSTAILE2012) http://www.agence-nationale-recherche.fr/ (JFF), and CONICYT (MEC80140013) http://www.conicyt.cl/ (JFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee WC, 1932, J EXP ZOOL, V61, P185, DOI 10.1002/jez.1400610202; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Beltrami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039393; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; Bubak AN, 2014, CURR ZOOL, V60, P778, DOI 10.1093/czoolo/60.6.778; COBB M, 1992, P ROY SOC B-BIOL SCI, V248, P103, DOI 10.1098/rspb.1992.0048; Coureaud G, 2006, CURR BIOL, V16, P1956, DOI 10.1016/j.cub.2006.08.030; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; Del Pino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102159; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Durisko Z, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1398; Farine JP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0043; Fernandez MP, 2013, J COMP PHYSIOL A, V199, P1065, DOI 10.1007/s00359-013-0851-5; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Flaven-Pouchon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092352; Flowers RW, 2003, ANN ENTOMOL SOC AM, V96, P336, DOI 10.1603/0013-8746(2003)096[0336:LCAGFD]2.0.CO;2; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gomez-Diaz C, 2013, EMBO REP, V14, P874, DOI 10.1038/embor.2013.140; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Hassanali A, 2005, ANNU REV ENTOMOL, V50, P223, DOI 10.1146/annurev.ento.50.071803.130345; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Mas F, 2008, ANIM BEHAV, V76, P1121, DOI 10.1016/j.anbehav.2008.06.011; Mast JD, 2014, ELIFE, V3, DOI 10.7554/eLife.04205; Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13; North G, 2007, COLD SPRING HARB MON, V49, pIX; Pires HHR, 2002, ACTA TROP, V81, P47, DOI 10.1016/S0001-706X(01)00185-1; Poivet E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2050; Secondi J, 2014, EVOL BIOL, V41, P71, DOI 10.1007/s11692-013-9248-1; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Venu I, 2014, J EXP BIOL, V217, P1346, DOI 10.1242/jeb.099648; Witzgall P, 2012, J CHEM ECOL, V38, P949, DOI 10.1007/s10886-012-0158-y; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	37	12	12	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151451	10.1371/journal.pone.0151451	http://dx.doi.org/10.1371/journal.pone.0151451			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987117	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300073
J	Widderich, N; Kobus, S; Hoppner, A; Riclea, R; Seubert, A; Dickschat, JS; Heider, J; Smits, SHJ; Bremer, E				Widderich, Nils; Kobus, Stefanie; Hoeppner, Astrid; Riclea, Ramona; Seubert, Andreas; Dickschat, Jeroen S.; Heider, Johann; Smits, Sander H. J.; Bremer, Erhard			Biochemistry and Crystal Structure of Ectoine Synthase: A Metal-Containing Member of the Cupin Superfamily	PLOS ONE			English	Article							COMPATIBLE SOLUTE ECTOINE; ESCHERICHIA-COLI; MARINE BACTERIUM; OSMOTIC-STRESS; AMINO-ACID; HYDROXYECTOINE; BIOSYNTHESIS; OSMOLYTES; RESPONSES; BINDING	Ectoine is a compatible solute and chemical chaperone widely used by members of the Bacteria and a few Archaea to fend-off the detrimental effects of high external osmolarity on cellular physiology and growth. Ectoine synthase (EctC) catalyzes the last step in ectoine production and mediates the ring closure of the substrate N-gamma-acetyl-L-2,4-diaminobutyric acid through a water elimination reaction. However, the crystal structure of ectoine synthase is not known and a clear understanding of how its fold contributes to enzyme activity is thus lacking. Using the ectoine synthase from the cold-adapted marine bacterium Sphingopyxis alaskensis (Sa), we report here both a detailed biochemical characterization of the EctC enzyme and the high-resolution crystal structure of its apo-form. Structural analysis classified the (Sa) EctC protein as a member of the cupin superfamily. EctC forms a dimer with a head-to-tail arrangement, both in solution and in the crystal structure. The interface of the dimer assembly is shaped through backbone-contacts and weak hydrophobic interactions mediated by two beta-sheets within each monomer. We show for the first time that ectoine synthase harbors a catalytically important metal co-factor; metal depletion and reconstitution experiments suggest that EctC is probably an iron-dependent enzyme. We found that EctC not only effectively converts its natural substrate N-gamma-acetyl-L-2,4-diaminobutyric acid into ectoine through a cyclocondensation reaction, but that it can also use the isomer N-alpha-acetyl-L-2,4-diaminobutyric acid as its substrate, albeit with substantially reduced catalytic efficiency. Structure-guided site-directed mutagenesis experiments targeting amino acid residues that are evolutionarily highly conserved among the extended EctC protein family, including those forming the presumptive iron-binding site, were conducted to functionally analyze the properties of the resulting EctC variants. An assessment of enzyme activity and iron content of these mutants give important clues for understanding the architecture of the active site positioned within the core of the EctC cupin barrel.	[Widderich, Nils; Heider, Johann; Bremer, Erhard] Univ Marburg, Dept Biol, Microbiol Lab, D-35043 Marburg, Germany; [Kobus, Stefanie; Hoeppner, Astrid] Univ Dusseldorf, Xray Facil & Crystal Farm, Dusseldorf, Germany; [Riclea, Ramona; Dickschat, Jeroen S.] Univ Bonn, Kekule Inst Organ Chem & Biochem, Bonn, Germany; [Riclea, Ramona; Dickschat, Jeroen S.] TU Braunschweig, Inst Organ Chem, Braunschweig, Germany; [Seubert, Andreas] Univ Marburg, Dept Chem, Analyt Chem, D-35043 Marburg, Germany; [Heider, Johann; Bremer, Erhard] Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany; [Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany	Philipps University Marburg; University of Bonn; Braunschweig University of Technology; Philipps University Marburg; Philipps University Marburg; Heinrich Heine University Dusseldorf	Bremer, E (corresponding author), Univ Marburg, Dept Biol, Microbiol Lab, D-35043 Marburg, Germany.; Bremer, E (corresponding author), Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany.; Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany.	sander.smits@hhu.de; bremer@staff.uni-marburg.de	Heider, Johann/ABA-7877-2021; Heider, Johann/Y-2291-2018; Heider, Johann/A-1833-2012	Heider, Johann/0000-0001-8328-9716; Heider, Johann/0000-0001-8328-9716	Deutsche Forschungsgemeinschaft (DFG) [SFB 987, SFB TR41]; LOEWE program of the state of Hessen (via the Center for Synthetic Microbiology, Marburg); Strategischer Forschungs-Fond (SFF) (Heinrich-Heine-University Dusseldorf); Strategischer Forschungs-Fond (SFF) (Institute of Biochemistry); International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); LOEWE program of the state of Hessen (via the Center for Synthetic Microbiology, Marburg); Strategischer Forschungs-Fond (SFF) (Heinrich-Heine-University Dusseldorf); Strategischer Forschungs-Fond (SFF) (Institute of Biochemistry); International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg)	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (DFG) through the SFB 987 (Philipps-University Marburg; to J.H. and E.B.), by the LOEWE program of the state of Hessen (via the Center for Synthetic Microbiology, Marburg; to J.H. and E.B.), by the Strategischer Forschungs-Fond (SFF) (Heinrich-Heine-University Dusseldorf and its Institute of Biochemistry; to S.H.J.S.) and the DFG-funded Transregio SFB TR41 (Braunschweig/Oldenburg; to J.S.D.). N.W. is the recipient of a Ph.D. fellowship from the International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg) and gratefully acknowledges its generous support.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Cayley S, 2003, BIOCHEMISTRY-US, V42, P12596, DOI 10.1021/bi0347297; Claesson M, 2012, J MOL BIOL, V417, P279, DOI 10.1016/j.jmb.2012.02.001; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fetzner S, 2012, APPL ENVIRON MICROB, V78, P2505, DOI 10.1128/AEM.07651-11; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gopal B, 2005, BIOCHEMISTRY-US, V44, P193, DOI 10.1021/bi0484421; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Hajnal I, 2013, FEBS J, V280, P5815, DOI 10.1111/febs.12501; Harishchandra RK, 2010, BIOPHYS CHEM, V150, P37, DOI 10.1016/j.bpc.2010.02.007; Hoppner A, 2014, J BIOL CHEM, V289, P29570, DOI 10.1074/jbc.M114.576769; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; INBAR L, 1988, J BIOL CHEM, V263, P16014; Jaroszewski L, 2004, PROTEINS, V56, P611, DOI 10.1002/prot.20130; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Kobus S, 2015, ACTA CRYSTALLOGR F, V71, P1027, DOI 10.1107/S2053230X15011115; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; KUNTE HJ, 1993, J MICROBIOL METH, V17, P129; Kunte HJ, 2014, CURR BIOTECHNOL, V3, P10, DOI [10.2174/22115501113026660037, DOI 10.2174/22115501113026660037]; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; Link H, 2015, NAT METHODS, V12, P1091, DOI [10.1038/NMETH.3584, 10.1038/nmeth.3584]; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; Louis P, 1997, MICROBIOL-UK, V143, P1141, DOI 10.1099/00221287-143-4-1141; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Moritz KD, 2015, EXTREMOPHILES, V19, P87, DOI 10.1007/s00792-014-0687-0; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Ono H, 1998, J FERMENT BIOENG, V85, P362, DOI 10.1016/S0922-338X(98)80078-0; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; Reshetnikov AS, 2006, ARCH MICROBIOL, V184, P286, DOI 10.1007/s00203-005-0042-z; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Silvennoinen L, 2009, FEBS LETT, V583, P2917, DOI 10.1016/j.febslet.2009.07.061; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Tanne C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00150; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Uberto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074477; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; Widderich N, 2016, ENVIRON MICROBIOL, V18, P1227, DOI 10.1111/1462-2920.13156; Widderich N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093809; Widderich N, 2014, J MOL BIOL, V426, P586, DOI 10.1016/j.jmb.2013.10.028; Witt EMHJ, 2011, APPL MICROBIOL BIOT, V91, P113, DOI 10.1007/s00253-011-3211-9; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Yancey Paul H., 2004, Science Progress, V87, P1, DOI 10.3184/003685004783238599; Yoshida H, 2014, FEBS J, V281, P3150, DOI 10.1111/febs.12850	69	19	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151285	10.1371/journal.pone.0151285	http://dx.doi.org/10.1371/journal.pone.0151285			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986827	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300058
J	Li, GY; Zhang, DG				Li, Guangye; Zhang, Dingguo			Brain-Computer Interface Controlled Cyborg: Establishing a Functional Information Transfer Pathway from Human Brain to Cockroach Brain	PLOS ONE			English	Article							EEG; STIMULATION; BEHAVIOR; FATIGUE; SYSTEM; BCI	An all-chain-wireless brain-to-brain system (BTBS), which enabled motion control of a cyborg cockroach via human brain, was developed in this work. Steady-state visual evoked potential (SSVEP) based brain-computer interface (BCI) was used in this system for recognizing human motion intention and an optimization algorithm was proposed in SSVEP to improve online performance of the BCI. The cyborg cockroach was developed by surgically integrating a portable microstimulator that could generate invasive electrical nerve stimulation. Through Bluetooth communication, specific electrical pulse trains could be triggered from the microstimulator by BCI commands and were sent through the antenna nerve to stimulate the brain of cockroach. Serial experiments were designed and conducted to test overall performance of the BTBS with six human subjects and three cockroaches. The experimental results showed that the online classification accuracy of three-mode BCI increased from 72.86% to 78.56% by 5.70% using the optimization algorithm and the mean response accuracy of the cyborgs using this system reached 89.5%. Moreover, the results also showed that the cyborg could be navigated by the human brain to complete walking along an S-shape track with the success rate of about 20%, suggesting the proposed BTBS established a feasible functional information transfer pathway from the human brain to the cockroach brain.	[Li, Guangye; Zhang, Dingguo] Shanghai Jiao Tong Univ, Inst Robot, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, DG (corresponding author), Shanghai Jiao Tong Univ, Inst Robot, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China.	dgzhang@sjtu.edu.cn		Zhang, Dingguo/0000-0003-4803-7489	National Natural Science Foundation of China [41751475292]; National Basic Research Program (973 program) of China [2011CB013305]; National High Technology Research and Development Program (863 Program) of 419 China [2015AA020501]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020501] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 program) of China(National Basic Research Program of China); National High Technology Research and Development Program (863 Program) of 419 China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Natural Science Foundation of China (No. 41751475292), the National Basic Research Program (973 program) of China (2011CB013305), and the National High Technology Research and Development Program (863 Program) of 419 China (2015AA020501).; This work was supported by the National Natural Science Foundation of China (No. 51475292), the National Basic Research Program (973 program) of China (2011CB013305), the National High Technology Research and Development Program (863 Program) of China (2015AA020501). The authors would like to thank all the subjects for their participation in the experiments.	Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Bobrov P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020674; Burdohan JA, 1996, J NEUROSCI, V16, P5830; Cao T, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-28; Chang MH, 2014, CLIN NEUROPHYSIOL, V125, P1380, DOI 10.1016/j.clinph.2013.11.016; Comer C, 2011, PHILOS T R SOC B, V366, P3006, DOI 10.1098/rstb.2011.0149; Comer CM, 2003, J COMP PHYSIOL A, V189, P97, DOI 10.1007/s00359-002-0384-9; Craig A, 2012, PSYCHOPHYSIOLOGY, V49, P574, DOI 10.1111/j.1469-8986.2011.01329.x; Debener S, 2012, PSYCHOPHYSIOLOGY, V49, P1617, DOI 10.1111/j.1469-8986.2012.01471.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Graimann B, 2010, FRONT COLLECT, P1, DOI 10.1007/978-3-642-02091-9_1; Krames ES, 2009, NEUROMODULATION, VOLS 1 AND 2, P3, DOI 10.1016/B978-0-12-374248-3.00002-1; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Latif T, 2012, IEEE ENG MED BIO, P972, DOI 10.1109/EMBC.2012.6346095; Louwerse M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00385; Mika S., 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P41, DOI 10.1109/NNSP.1999.788121; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Pais-Vieira M, 2012, SCI REPORTS, V3, P1319; Pinheiro CG, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-31; Rao RPN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111332; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Shih JJ, 2012, BRAIN COMPUTER INTER, P268; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Volosyak I, 2011, IEEE T NEUR SYS REH, V19, P232, DOI 10.1109/TNSRE.2011.2121919; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu SH, 2004, J NEUROSCI METH, V133, P57, DOI 10.1016/j.jneumeth.2003.09.012; Ye SP, 1996, J NEUROSCI, V16, P5844; Yoo SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060410	35	27	28	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150667	10.1371/journal.pone.0150667	http://dx.doi.org/10.1371/journal.pone.0150667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982717	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900048
J	Tian, RBD; Niamke, S; Tissot-Dupont, H; Drancourt, M				Tian, Roger Bi Diangone; Niamke, Sebastian; Tissot-Dupont, Herve; Drancourt, Michel			Detection of Mycobacterium ulcerans DNA in the Environment, Ivory Coast	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; REAL-TIME PCR; BURULI ULCER; COTE-DIVOIRE; TRANSMISSION; ECOLOGY; MYCOLACTONE; MACROLIDE; DISEASE; SAMPLES	Background Ivory Coast is a West African country with the highest reported cases of Buruli ulcer, a disabling subcutaneous infection due to Mycobacterium ulcerans. However, the prevalence of environmental M. ulcerans is poorly known in this country. Methods We collected 496 environmental specimens consisting of soil (n = 100), stagnant water (n = 200), plants (n = 100) and animal feces (n = 96) in Ivory Coast over five months in the dry and wet seasons in regions which are free of Buruli ulcer (control group A; 250 specimens) and in regions where the Buruli ulcer is endemic (group B; 246 specimens). After appropriate total DNA extraction incorporating an internal control, the M. ulcerans IS2404 and KR-B gene were amplified by real-time PCR in samples. In parallel, a calibration curve was done for M. ulcerans Agy99 IS2404 and KR-B gene. Results Of 460 samples free of PCR inhibition, a positive real-time PCR detection of insertion sequence IS2404 and KR-B gene was observed in 1/230 specimens in control group A versus 9/230 specimens in group B (P = 0.02; Fisher exact test). Positive specimens comprised seven stagnant water specimens, two feces specimens confirmed to be of Thryonomys swinderianus (agouti) origin by real-time PCR of the cytb gene; and one soil specimen. Extrapolation from the calibration curves indicated low inoculums ranging from 1 to 102 mycobacteria/mL. Conclusion This study confirms the presence of M. ulcerans in the watery environment surrounding patients with Buruli ulcer in Ivory Coast. It suggests that the agouti, which is in close contacts with populations, could play a role in the environmental cycle of M. ulcerans, as previously suggested for the closely related possums in Australia.	[Tian, Roger Bi Diangone; Tissot-Dupont, Herve; Drancourt, Michel] Aix Marseille Univ, INSERM 1095, URMITE, UMR,CNRS 7278,IRD 198,Fac Med, Marseille, France; [Tian, Roger Bi Diangone; Niamke, Sebastian] Univ Felix Houphouet Boigny, UFR Biosci, Lab Biotechnol, Abidjan, Cote Ivoire	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Drancourt, M (corresponding author), Aix Marseille Univ, INSERM 1095, URMITE, UMR,CNRS 7278,IRD 198,Fac Med, Marseille, France.	Michel.Drancourt@univ-amu.fr	TISSOT-DUPONT, Hervé/P-5808-2016					Addo P, 2006, INTERNET J TROP MED, V2; Brou T, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000271; Doannio J M C, 2011, Med Trop (Mars), V71, P53; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; Garchitorena A, 2015, ELIFE, V4, DOI 10.7554/eLife.07616; Gryseels S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001764; Konan KL, 2015, MED SANTE TROP, V25, P44, DOI 10.1684/mst.2014.0363; Landier J, 2015, EMERG INFECT DIS, V21, P1414, DOI 10.3201/eid2108.141336; Marion E, 2011, Med Trop (Mars), V71, P169; Marion E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000731; Marsollier L, 2003, PATHOL BIOL, V51, P490, DOI 10.1016/S0369-8114(03)00151-2; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Morris A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002660; Mve-Obiang A, 2005, INFECT IMMUN, V73, P3307, DOI 10.1128/IAI.73.6.3307-3312.2005; Narh CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003437; Ngazoa-Kakou ES, 2011, AFR J MICROBIOL RES, V5, P2211; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Ranger BS, 2006, INFECT IMMUN, V74, P6037, DOI 10.1128/IAI.00970-06; Robert B, 1997, J CLIN MICROBIOL, V35, P2709, DOI 10.1128/JCM.35.10.2709-2711.1997; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tian RDB, 2015, AM J TROP MED HYG; Tobias NJ, 2013, J BACTERIOL, V195, P556, DOI 10.1128/JB.02132-12; WHO, WHO GLOBAL HLTH OBSE; Williamson HR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000205; Williamson HR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001506	28	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151567	10.1371/journal.pone.0151567	http://dx.doi.org/10.1371/journal.pone.0151567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982581	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900097
J	Zhu, XX; Li, QY; Shen, CC; Duan, ZB; Yu, DY; Niu, JS; Ni, YJ; Jiang, YM				Zhu, Xin-Xin; Li, Qiao-Yun; Shen, Chun-Cai; Duan, Zong-Biao; Yu, Dong-Yan; Niu, Ji-Shan; Ni, Yong-Jing; Jiang, Yu-Mei			Transcriptome Analysis for Abnormal Spike Development of the Wheat Mutant dms	PLOS ONE			English	Article							MADS-BOX GENES; PISTIL-LIKE STRUCTURES; FLORAL ORGAN IDENTITY; TRITICUM-AESTIVUM L.; RICE ORYZA-SATIVA; HOMEOTIC TRANSFORMATION; ARABIDOPSIS-THALIANA; FLOWER DEVELOPMENT; ALLOPLASMIC WHEAT; COMMON WHEAT	Background Wheat (Triticum aestivum L.) spike development is the foundation for grain yield. We obtained a novel wheat mutant, dms, characterized as dwarf, multi-pistil and sterility. Although the genetic changes are not clear, the heredity of traits suggests that a recessive gene locus controls the two traits of multi-pistil and sterility in self-pollinating populations of the medium plants (M), such that the dwarf genotype (D) and tall genotype (T) in the progeny of the mutant are ideal lines for studies regarding wheat spike development. The objective of this study was to explore the molecular basis for spike abnormalities of dwarf genotype. Results Four unigene libraries were assembled by sequencing the mRNAs of the super-bulked differentiating spikes and stem tips of the D and T plants. Using integrative analysis, we identified 419 genes highly expressed in spikes, including nine typical homeotic genes of the MADS-box family and the genes TaAP2, TaFL and TaDL. We also identified 143 genes that were significantly different between young spikes of T and D, and 26 genes that were putatively involved in spike differentiation. The result showed that the expression levels of TaAP1-2, TaAP2, and other genes involved in the majority of biological processes such as transcription, translation, cell division, photosynthesis, carbohydrate transport and metabolism, and energy production and conversion were significantly lower in D than in T. Conclusions We identified a set of genes related to wheat floral organ differentiation, including typical homeotic genes. Our results showed that the major causal factors resulting in the spike abnormalities of dms were the lower expression homeotic genes, hormonal imbalance, repressed biological processes, and deficiency of construction materials and energy. We performed a series of studies on the homeotic genes, however the other three causal factors for spike abnormal phenotype of dms need further study.	[Zhu, Xin-Xin; Li, Qiao-Yun; Shen, Chun-Cai; Duan, Zong-Biao; Yu, Dong-Yan; Niu, Ji-Shan; Ni, Yong-Jing; Jiang, Yu-Mei] Henan Agr Univ, Natl Ctr Engn & Technol Res Wheat, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Henan, Peoples R China; [Ni, Yong-Jing] Shangqiu Acad Agr & Forestry Sci, Shangqiu, Henan, Peoples R China	Henan Agricultural University	Niu, JS (corresponding author), Henan Agr Univ, Natl Ctr Engn & Technol Res Wheat, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Henan, Peoples R China.	jsniu@263.net			National High-tech R&D Program (863 Program) [2012AA101105]; National Natural Science Fundation of China [31571646]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a National High-tech R&D Program (863 Program) (program.most.gov.cn) grant (2012AA101105) to JSN and National Natural Science Fundation of China (www.nsfc.gov.cn) grant (31571646) to JSN.	BEFFA RS, 1993, P NATL ACAD SCI USA, V90, P8792, DOI 10.1073/pnas.90.19.8792; BHATIA CR, 1963, GENETICA, V34, P58, DOI 10.1007/BF01664179; Brock MT, 2012, NEW PHYTOL, V195, P58, DOI 10.1111/j.1469-8137.2012.04145.x; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Chen J S, 1983, ACTA AGRONOMICA SINI, V9, P67; Chen LY, 2013, MOL PLANT, V6, P1388, DOI 10.1093/mp/sst005; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Chujo A, 2003, PLANT CELL PHYSIOL, V44, P1311, DOI 10.1093/pcp/pcg155; Ciaffi M, 2011, SEX PLANT REPROD, V24, P247, DOI 10.1007/s00497-011-0175-y; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Dai XY, 2007, PLANT GROWTH REGUL, V52, P229, DOI 10.1007/s10725-007-9194-y; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Duan ZB, 2015, J INTEGR AGR, V14, P1706, DOI 10.1016/S2095-3119(14)60936-9; Fambrini M, 2011, PLANT MOL BIOL, V75, P431, DOI 10.1007/s11103-011-9740-x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hama E, 2004, PLANTA, V218, P712, DOI 10.1007/s00425-003-1157-6; Hames C, 2008, EMBO J, V27, P2628, DOI 10.1038/emboj.2008.184; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Jang S, 2004, PLANT MOL BIOL, V56, P133, DOI 10.1007/s11103-004-2648-y; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kinjo H, 2012, MOL GENET GENOMICS, V287, P283, DOI 10.1007/s00438-012-0679-7; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Laudencia-Chingcuanco DL, 2007, PLANT MOL BIOL, V63, P651, DOI 10.1007/s11103-006-9114-y; Li QY, 2014, J PLANT DIS PROTECT, V121, P79, DOI 10.1007/BF03356495; Liu T, 2011, AFR J BIOTECHNOL, V10, P3978; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Ma H, 2013, NAT GENET, V45, P472, DOI 10.1038/ng.2618; Ma ShouCai, 2006, Journal of Triticeae Crops, V26, P35; Mathews S, 2012, NEW PHYTOL, V194, P910, DOI 10.1111/j.1469-8137.2012.04091.x; Matsumura Y, 2009, PLANT J, V58, P525, DOI 10.1111/j.1365-313X.2009.03797.x; Meiyalaghan S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-2; Mizumoto K, 2009, DEV GENES EVOL, V219, P175, DOI 10.1007/s00427-009-0275-y; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murai K, 2002, PLANT J, V29, P169, DOI 10.1046/j.0960-7412.2001.01203.x; Murai Koji, 2013, Plants-Basel, V2, P379, DOI 10.3390/plants2030379; Nagasawa N, 2003, DEVELOPMENT, V130, P705, DOI 10.1242/dev.00294; O'Maoileidigh DS, 2014, NEW PHYTOL, V201, P16, DOI 10.1111/nph.12444; Ohmori S, 2009, PLANT CELL, V21, P3008, DOI 10.1105/tpc.109.068742; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Paolacci AR, 2008, P 11 INT WHEAT GEN S, P1; Paollacci AR, 2007, MOL GENET GENOMICS, V278, P689, DOI 10.1007/s00438-007-0285-2; Pearce S, 2013, PLANT PHYSIOL, V163, P1433, DOI 10.1104/pp.113.225854; Peng ZS, 2008, J APPL GENET, V49, P135, DOI 10.1007/BF03195606; Peng ZhengSong, 2013, Australian Journal of Crop Science, V7, P159; Peng ZS, 2004, HEREDITAS, V141, P15, DOI 10.1111/j.1601-5223.2004.01787.x; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rijpkema AS, 2010, SEMIN CELL DEV BIOL, V21, P100, DOI 10.1016/j.semcdb.2009.11.002; Robert HS, 2009, PLANT J, V58, P109, DOI 10.1111/j.1365-313X.2008.03764.x; Rubinovich L, 2014, MOL PLANT, V7, P244, DOI 10.1093/mp/sst141; Saraike T, 2007, PLANTA, V227, P211, DOI 10.1007/s00425-007-0608-x; Shen Guanghua, 1992, Acta Genetica Sinica, V19, P513; Shi LF, 1998, PLANT MOL BIOL, V38, P1053, DOI 10.1023/A:1006007315718; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Theissen G, 1999, DEV GENET, V25, P181, DOI 10.1002/(SICI)1520-6408(1999)25:3<181::AID-DVG1>3.0.CO;2-F; Tong Y Z, 1984, J SHANGHAI NORMAL U, V2, P48; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Vahamidis P, 2014, ANN APPL BIOL, V164, P220, DOI 10.1111/aab.12097; Wang H, 2013, PLANT J, V74, P511, DOI 10.1111/tpj.12146; Wang X L, 2000, ACTA BOT BOREALI-OCC, V20, P949; Wang Y., 1990, J LANZHOU U NAT SCI, V26, P80; WANG Y-Z, 1991, Acta Botanica Sinica, V33, P176; Wang Y-Z., 1989, ACTA BOT BOREALI-OCC, V9, P131; Wang ZG, 2009, CAN J PLANT SCI, V89, P845, DOI 10.4141/CJPS09022; Wei SH, 2011, GENET MOL BIOL, V34, P606, DOI 10.1590/S1415-47572011000400013; Winfield MO, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-55; Wu J, 2000, J NW AGR U, V28, P58; Xu GX, 2007, J INTEGR PLANT BIOL, V49, P927, DOI 10.1111/j.1744-7909.2007.00502.x; Xu P, 2008, J EXP BOT, V59, P1375, DOI 10.1093/jxb/ern068; Yamada K, 2009, PLANT MOL BIOL, V71, P1, DOI 10.1007/s11103-009-9504-z; Yamaguchi T, 2004, PLANT CELL, V16, P500, DOI 10.1105/tpc.018044; Yamamoto M, 2013, PLANTA, V237, P1001, DOI 10.1007/s00425-012-1812-x; Yoshida K, 2006, PLANT CELL PHYSIOL, V47, P1555, DOI 10.1093/pcp/pcl021; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x; Zhang LongYu, 2011, Acta Agronomica Sinica, V37, P620; Zhao ZG, 2013, DEV CELL, V27, P113, DOI 10.1016/j.devcel.2013.09.005; Zheng YS, 2013, J INTEGR AGR, V12, P398, DOI [10.1016/S2095-3119(13)60239-7, 10.1016/s2095-3119(13)60239-7]; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149; Zhu Y, 2008, PLANT CELL PHYSIOL, V49, P1723, DOI 10.1093/pcp/pcn143	79	6	7	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149287	10.1371/journal.pone.0149287	http://dx.doi.org/10.1371/journal.pone.0149287			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982202	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900014
J	Ates, D; Sever, T; Aldemir, S; Yagmur, B; Temel, HY; Kaya, HB; Alsaleh, A; Kahraman, A; Ozkan, H; Vandenberg, A; Tanyolac, B				Ates, Duygu; Sever, Tugce; Aldemir, Secil; Yagmur, Bulent; Temel, Hulya Yilmaz; Kaya, Hilal Betul; Alsaleh, Ahmad; Kahraman, Abdullah; Ozkan, Hakan; Vandenberg, Albert; Tanyolac, Bahattin			Identification QTLs Controlling Genes for Se Uptake in Lentil Seeds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; SERUM SELENIUM LEVELS; MINERAL CONCENTRATIONS; LINKAGE MAP; ZINC; BIOFORTIFICATION; IRON; SELENOPROTEINS; PREVENTION; NUTRIENTS	Lentil (Lens culinaris Medik.) is an excellent source of protein and carbohydrates and is also rich in essential trace elements for the human diet. Selenium (Se) is an essential micronutrient for human health and nutrition, providing protection against several diseases and regulating important biological systems. Dietary intake of 55 mu g of Se per day is recommended for adults, with inadequate Se intake causing significant health problems. The objective of this study was to identify and map quantitative trait loci (QTL) of genes controlling Se accumulation in lentil seeds using a population of 96 recombinant inbred lines (RILs) developed from the cross "PI 320937" x "Eston" grown in three different environments for two years (2012 and 2013). Se concentration in seed varied between 119 and 883 mu g/kg. A linkage map consisting of 1,784 markers (4 SSRs, and 1,780 SNPs) was developed. The map spanned a total length of 4,060.6 cM, consisting of 7 linkage groups (LGs) with an average distance of 2.3 cM between adjacent markers. Four QTL regions and 36 putative QTL markers, with LOD scores ranging from 3.00 to 4.97, distributed across two linkage groups (LG2 and LG5) were associated with seed Se concentration, explaining 6.3-16.9% of the phenotypic variation.	[Ates, Duygu; Sever, Tugce; Aldemir, Secil; Yagmur, Bulent; Temel, Hulya Yilmaz; Kaya, Hilal Betul; Tanyolac, Bahattin] Ege Univ, Fac Engn, Dept Bioengn, Izmir, Turkey; [Kahraman, Abdullah] Harran Univ, Fac Agr, Dept Field Crops, Sanli Urfa, Turkey; [Alsaleh, Ahmad; Ozkan, Hakan] Cukurova Univ, Dept Field Crops, Fac Agr, Adana, Turkey; [Vandenberg, Albert] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK S7N 0W0, Canada	Ege University; Harran University; Cukurova University; University of Saskatchewan	Tanyolac, B (corresponding author), Ege Univ, Fac Engn, Dept Bioengn, Izmir, Turkey.	bahattin.tanyolac@ege.edu.tr	Kahraman, Abdullah/AAB-1400-2020; Aldemir, Seçil/AAZ-4351-2020; ÖZKAN, Hakan/C-8510-2011; Aldemir, Secil/AAE-6246-2019; ALSALEH, Ahmad/AAB-6508-2021; Tanyolac, Bahattin/AAD-3762-2019; ALSALEH, Ahmad/CAA-2655-2022; Kahraman, Abdullah/W-1029-2017	ÖZKAN, Hakan/0000-0003-3530-2626; Aldemir, Secil/0000-0003-1025-4875; ALSALEH, Ahmad/0000-0001-7078-3221; ALSALEH, Ahmad/0000-0001-7078-3221; Kaya, Hilal Betul/0000-0002-2543-7212; Yilmaz Temel, Hulya/0000-0003-1842-0145; Kahraman, Abdullah/0000-0002-8829-3797; Vandenberg, Albert/0000-0001-6177-1392	Scientific and Technological Research Foundation of Turkey [TUBITAK-COST-114O446]	Scientific and Technological Research Foundation of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The Study was funded by Scientific and Technological Research Foundation of Turkey, with grant number TUBITAK-COST-114O446.	Acikgoz N, 2004, COMPUTER EVALUATIONS; Adams ML, 2002, J SCI FOOD AGR, V82, P1160, DOI 10.1002/jsfa.1167; Anoma A., 2014, African Journal of Food, Agriculture, Nutrition and Development, V14, P9529; [Anonymous], 1972, CHEM ANAL PLANT SOIL; BINGHAM FRANK T., 1949, CALIFORNIA AGRIC, V3, P11; Bjelakovic G, 2008, ALIMENT PHARM THER, V28, P689, DOI 10.1111/j.1365-2036.2008.03785.x; Black C.A., 1965, METHODS SOIL ANAL 2, P1372; Blair M, 2009, MOL BREEDING, V23, P197, DOI 10.1007/s11032-008-9225-z; Bleys J, 2008, ARCH INTERN MED, V168, P404, DOI 10.1001/archinternmed.2007.74; Bordoni A, 2008, BRIT J NUTR, V99, P191, DOI 10.1017/S0007114507793911; Bouyoucos G.J., 1955, AGRON J, V4, P434, DOI DOI 10.2134/AGRONJ1951.00021962004300090005X; Broadley MR, 2006, P NUTR SOC, V65, P169, DOI 10.1079/PNS2006490; Broome CS, 2004, AM J CLIN NUTR, V80, P154; Cakir O, 2012, ADVANCES IN SELECTED PLANT PHYSIOLOGY ASPECTS, P209; CHURCHILL GA, 1994, GENETICS, V138, P963; Coppinger RJ, 2001, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, P219; Della Rovere F, 2006, ANTICANCER RES, V26, P2937; Duran Y, 2004, THEOR APPL GENET, V108, P1265, DOI 10.1007/s00122-003-1542-3; Ellis DR, 2003, CURR OPIN PLANT BIOL, V6, P273, DOI 10.1016/S1369-5266(03)00030-X; Farnham MW, 2007, PLANT BREEDING, V126, P195, DOI 10.1111/j.1439-0523.2007.01294.x; Fleet JC, 1997, NUTR REV, V55, P277, DOI 10.1111/j.1753-4887.1997.tb01617.x; Flores-Mateo G, 2006, AM J CLIN NUTR, V84, P762, DOI 10.1093/ajcn/84.4.762; Gore F, 2010, J WATER HEALTH; Gupta M, 2012, J GENET, V91, P279, DOI 10.1007/s12041-012-0180-4; Gupta UC, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P171; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Karunasinghe N, 2004, CANCER EPIDEM BIOMAR, V13, P391; Kellen E, 2006, INT J UROL, V13, P1180, DOI 10.1111/j.1442-2042.2006.01526.x; KIEN CL, 1983, AM J CLIN NUTR, V37, P319, DOI 10.1093/ajcn/37.2.319; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; Navarro-Alarcon M, 2000, SCI TOTAL ENVIRON, V249, P347, DOI 10.1016/S0048-9697(99)00526-4; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; Peters U, 2008, MOL NUTR FOOD RES, V52, P1261, DOI 10.1002/mnfr.200800103; PILLEN K, 1992, THEOR APPL GENET, V84, P129, DOI 10.1007/BF00223992; Pitts MW, 2014, BIOL TRACE ELEM RES, V161, P231, DOI 10.1007/s12011-014-0060-2; Pratt PE., 1965, METHOD SOIL ANAL 2, P1022, DOI DOI 10.2134/AGRONMONOGR9.2.C20; Pu ZE, 2013, J INTEGR AGR, P2095; Rahman WMM, 2013, FOOD RES INT, V54, P1596; Ramamurthy RK, 2014, MOL BREEDING, V34, P431, DOI 10.1007/s11032-014-0045-z; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Rayman MP, 2004, BRIT J NUTR, V92, P557, DOI 10.1079/BJN20041251; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; Rubeena, 2003, THEOR APPL GENET, V107, P910, DOI 10.1007/s00122-003-1326-9; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; Schlicting E, 1966, BODENKUNDLICHES PRAC, P94; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Shi RL, 2008, PLANT SOIL, V306, P95, DOI 10.1007/s11104-007-9483-2; SLOCUM MK, 1990, THEOR APPL GENET, V80, P57, DOI 10.1007/BF00224016; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Tezuka K, 2010, THEOR APPL GENET, V120, P1175, DOI 10.1007/s00122-009-1244-6; Thavarajah D, 2008, J AGR FOOD CHEM, V56, P10747, DOI 10.1021/jf802307h; Thavarajah D, 2011, EUPHYTICA, V180, P123, DOI 10.1007/s10681-011-0365-6; Tiwari VK, 2009, J HERED, V100, P771, DOI 10.1093/jhered/esp030; United States Department of Agriculture ARS [USDA] USDA Nutrient Data Laboratory., 2008, USDA NAT NUTR DAT ST; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2004, JOINMAP 4 0 SOFTWARE; WAGNER H, 1992, PLANT BREEDING, V108, P89, DOI 10.1111/j.1439-0523.1992.tb00106.x; Wang N, 2006, FOOD CHEM, V95, P493, DOI 10.1016/j.foodchem.2005.02.001; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Zhang S, 2010, MECH AGEING DEV, V131, P253, DOI 10.1016/j.mad.2010.02.006; [张现伟 Zhang Xianwei], 2010, [植物遗传资源学报, Journal of Plant Genetic Resources], V11, P445	67	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149210	10.1371/journal.pone.0149210	http://dx.doi.org/10.1371/journal.pone.0149210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978666	gold, Green Published			2022-12-26	WOS:000372572800014
J	Morgan, TJ; Turn, SQ; Sun, N; George, A				Morgan, Trevor James; Turn, Scott Q.; Sun, Ning; George, Anthe			Fast Pyrolysis of Tropical Biomass Species and Influence of Water Pretreatment on Product Distributions	PLOS ONE			English	Article							FLUIDIZED-BED PYROLYSIS; BIO-OIL; FLASH PYROLYSIS; ELEPHANT GRASS; SECONDARY REACTIONS; EUCALYPTUS-GRANDIS; REACTOR; LIGNIN; CONVERSION; BANAGRASS	The fast pyrolysis behaviour of pretreated banagrass was examined at four temperatures (between 400 and 600 C) and four residence times (between similar to 1.2 and 12 s). The pretreatment used water washing/leaching to reduce the inorganic content of the banagrass. Yields of bio-oil, permanent gases and char were determined at each reaction condition and compared to previously published results from untreated banagrass. Comparing the bio-oil yields from the untreated and pretreated banagrass shows that the yields were greater from the pretreated banagrass by 4 to 11 wt%(absolute) at all reaction conditions. The effect of pretreatment (i.e. reducing the amount of ash, and alkali and alkali earth metals) on pyrolysis products is: 1) to increase the dry bio-oil yield, 2) to decrease the amount of undetected material, 3) to produce a slight increase in CO yield or no change, 4) to slightly decrease CO2 yield or no change, and 5) to produce a more stable bio-oil (less aging). Char yield and total gas yield were unaffected by feedstock pretreatment. Four other tropical biomass species were also pyrolyzed under one condition (450 degrees C and 1.4 s residence time) for comparison to the banagrass results. The samples include two hardwoods: leucaena and eucalyptus, and two grasses: sugarcane bagasse and energy-cane. A sample of pretreated energy-cane was also pyrolyzed. Of the materials tested, the best feedstocks for fast pyrolysis were sugarcane bagasse, pretreated energy cane and eucalyptus based on the yields of 'dry bio-oil', CO and CO2. On the same basis, the least productive feedstocks are untreated banagrass followed by pretreated banagrass and leucaena.	[Morgan, Trevor James; Turn, Scott Q.] Univ Hawaii Manoa, Hawaii Nat Energy Inst, Honolulu, HI 96822 USA; [Sun, Ning] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [George, Anthe] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94550 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories	Morgan, TJ (corresponding author), Univ Hawaii Manoa, Hawaii Nat Energy Inst, Honolulu, HI 96822 USA.	morgatr@gmail.com			U.S. Department of Energy [DE-EE0003507]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was conducted under the Hawai'i Energy Sustainability Program with funding from the U.S. Department of Energy (Cooperative Agreement #DE-EE0003507). The funding was provided to the Hawaii Natural Energy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LK, 2013, ENERG FUEL, V27, P7439, DOI 10.1021/ef4015394; Boateng AA, 2007, IND ENG CHEM RES, V46, P1891, DOI 10.1021/ie0614529; Braga RM, 2014, J THERM ANAL CALORIM, V117, P1341, DOI 10.1007/s10973-014-3884-2; Cetinkol OP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052820; Cui H, FUEL PROCESSING TECH; Eom IY, 2013, BIORESOURCE TECHNOL, V128, P664, DOI 10.1016/j.biortech.2012.09.082; Fahmi R, 2008, FUEL, V87, P1230, DOI 10.1016/j.fuel.2007.07.026; Fahmi R, 2007, J ANAL APPL PYROL, V80, P16, DOI 10.1016/j.jaap.2006.12.018; FRAGA AR, 1991, FUEL, V70, P803, DOI 10.1016/0016-2361(91)90186-E; George A, 2014, ENERG FUEL, V28, P6918, DOI 10.1021/ef501459c; Greenhalf CE, 2013, FUEL, V108, P216, DOI 10.1016/j.fuel.2013.01.075; Heidari A, 2014, J IND ENG CHEM, V20, P2594, DOI 10.1016/j.jiec.2013.10.046; Islam MR, 2010, J THERM SCI TECH-JPN, V5, P11, DOI 10.1299/jtst.5.11; Joubert JE, 2015, FUEL PROCESS TECHNOL, V131, P389, DOI 10.1016/j.fuproc.2014.12.012; Keffer VI, 2009, BIOMASS BIOENERG, V33, P247, DOI 10.1016/j.biombioe.2008.05.018; Kim KH, 2013, RENEW ENERG, V50, P188, DOI 10.1016/j.renene.2012.06.030; Lee MK, 2010, J ANAL APPL PYROL, V88, P110, DOI 10.1016/j.jaap.2010.03.003; LIDEN AG, 1988, CHEM ENG COMMUN, V65, P207, DOI 10.1080/00986448808940254; Mesa-Perez JM, 2014, APPL THERM ENG, V65, P322, DOI 10.1016/j.applthermaleng.2013.12.072; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Montoya JI, 2015, J ANAL APPL PYROL, V112, P379, DOI 10.1016/j.jaap.2014.11.007; Morgan TJ, 2015, ENERG FUEL, V29, P1669, DOI 10.1021/ef502380x; Morgan TJ, 2014, CHEM REV, V114, P1547, DOI 10.1021/cr400194p; Morgan TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136511; Mourant D, 2011, FUEL, V90, P2915, DOI 10.1016/j.fuel.2011.04.033; Mythili R, 2013, BIORESOURCE TECHNOL, V138, P71, DOI 10.1016/j.biortech.2013.03.161; Oasmaa A, 2010, ENERG FUEL, V24, P1380, DOI 10.1021/ef901107f; Ogoshi R., 2008, CROP ASSESSMEN UNPUB; Phan BMQ, 2014, BIOMASS BIOENERG, V62, P74, DOI 10.1016/j.biombioe.2014.01.012; Samolada MC, 1993, EFFECT EXPT CONDITIO; Shafizedeh F, 1985, FUNDAMENTALS THERMOC, P183, DOI DOI 10.1007/978-94-009-4932-4_11; Sluiter A, 2008, NRELTP51042618; Steele P. H, 2013, US Patent, Patent No. [US 8,603,199 B2, 8603199, 8,603,199B2]; STILES HN, 1989, FUEL, V68, P275, DOI 10.1016/0016-2361(89)90087-2; Strezov V, 2008, BIORESOURCE TECHNOL, V99, P8394, DOI 10.1016/j.biortech.2008.02.039; Tran N, 2011, BIOMASS BIOENERG, V35, P1756, DOI 10.1016/j.biombioe.2011.01.012; Turn SQ, 1998, FUEL, V77, P135, DOI 10.1016/S0016-2361(97)00190-7; TYLER RJ, 1979, FUEL, V58, P680, DOI 10.1016/0016-2361(79)90223-0; Vassilev SV, 2012, FUEL, V94, P1, DOI 10.1016/j.fuel.2011.09.030; Xu R, 2011, J ANAL APPL PYROL, V91, P263, DOI 10.1016/j.jaap.2011.03.001; Yoshida T, 2008, IND ENG CHEM RES, V47, P9882, DOI 10.1021/ie801123a	41	18	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151368	10.1371/journal.pone.0151368	http://dx.doi.org/10.1371/journal.pone.0151368			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978265	Green Submitted, Green Published, gold			2022-12-26	WOS:000372572800068
J	Kuchta, SR; Brown, AD; Converse, PE; Highton, R				Kuchta, Shawn R.; Brown, Ashley D.; Converse, Paul E.; Highton, Richard			Multilocus Phylogeography and Species Delimitation in the Cumberland Plateau Salamander, Plethodon kentucki: Incongruence among Data Sets and Methods	PLOS ONE			English	Article							NORTH-AMERICAN SALAMANDERS; ANCESTRAL POPULATION SIZES; GENE TREES; PHYLOGENETIC ANALYSIS; DIVERGENCE TIME; DNA-SEQUENCES; MULTISPECIES COALESCENT; ENSATINA-ESCHSCHOLTZII; BAYES ESTIMATION; SPECIATION	Species are a fundamental unit of biodiversity, yet can be challenging to delimit objectively. This is particularly true of species complexes characterized by high levels of population genetic structure, hybridization between genetic groups, isolation by distance, and limited phenotypic variation. Previous work on the Cumberland Plateau Salamander, Plethodon kentucki, suggested that it might constitute a species complex despite occupying a relatively small geographic range. To examine this hypothesis, we sampled 135 individuals from 43 populations, and used four mitochondrial loci and five nuclear loci (5693 base pairs) to quantify phylogeographic structure and probe for cryptic species diversity. Rates of evolution for each locus were inferred using the multidistribute package, and time calibrated gene trees and species trees were inferred using BEAST 2 and *BEAST 2, respectively. Because the parameter space relevant for species delimitation is large and complex, and all methods make simplifying assumptions that may lead them to fail, we conducted an array of analyses. Our assumption was that strongly supported species would be congruent across methods. Putative species were first delimited using a Bayesian implementation of the GMYC model (bGMYC), Geneland, and Brownie. We then validated these species using the genealogical sorting index and BPP. We found substantial phylogeographic diversity using mtDNA, including four divergent clades and an inferred common ancestor at 14.9 myr (95% HPD: 10.8-19.7 myr). By contrast, this diversity was not corroborated by nuclear sequence data, which exhibited low levels of variation and weak phylogeographic structure. Species trees estimated a far younger root than did the mtDNA data, closer to 1.0 myr old. Mutually exclusive putative species were identified by the different approaches. Possible causes of data set discordance, and the problem of species delimitation in complexes with high levels of population structure and introgressive hybridization, are discussed.	[Kuchta, Shawn R.; Brown, Ashley D.; Converse, Paul E.] Ohio Univ, Dept Biol Sci, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Highton, Richard] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Ohio University; University System of Maryland; University of Maryland College Park	Kuchta, SR (corresponding author), Ohio Univ, Dept Biol Sci, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA.	kuchta@ohio.edu			Ohio University	Ohio University	Funding was provided to SRK by Ohio University.	Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blair C, 2015, MOL PHYLOGENET EVOL, V84, P254, DOI 10.1016/j.ympev.2015.01.003; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Camargo A, 2013, SPECIES PROBLEM ONGO, P225; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chatfield MWH, 2009, EVOLUTIONARY DYNAMIC, P1; Chung YJ, 2011, SYST BIOL, V60, P261, DOI 10.1093/sysbio/syr003; CLAY WILLIAM M., 1955, TRANS KENTUCKY ACAD SCI, V16, P57; Coyne J.A., 2004, SPECIATION; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; Dellicour S, 2015, SYST BIOL, V64, P900, DOI 10.1093/sysbio/syu130; Drummond A. J., 2015, BAYESIAN EVOLUTIONAR, DOI [10.1017/CBO9781139095112, DOI 10.1017/CBO9781139095112]; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Fisher-Reid MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-300; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Flot JF, 2006, MOL ECOL NOTES, V6, P627, DOI 10.1111/j.1471-8286.2006.01355.x; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Good D.A., 1992, U CALIFORNIA PUBLICA, V126, P1; Gottscho AD, 2014, ECOL EVOL, V4, P2546, DOI 10.1002/ece3.1111; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guillot G, 2012, SYST BIOL, V61, P897, DOI 10.1093/sysbio/sys038; Guillot G, 2009, MOL ECOL RESOUR, V9, P1112, DOI 10.1111/j.1755-0998.2008.02496.x; Heibl C, LAGOPUS BAYESIAN REL; Heled J, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-44, 10.1186/1471-2148-13-221]; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HIGHTON R, 1995, ANNU REV ECOL SYST, V26, P579, DOI 10.1146/annurev.es.26.110195.003051; HIGHTON R, 1990, HERPETOLOGICA, V46, P114; HIGHTON R, 1983, HERPETOLOGICA, V39, P189; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P215; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P31; Highton R, 1998, HERPETOLOGICA, V54, P254; Highton R., 1989, ILLINOIS BIOL MONGRA, P1; Highton R, 2014, MOL PHYLOGENET EVOL, V71, P127, DOI 10.1016/j.ympev.2013.11.002; Highton R, 2012, MOL PHYLOGENET EVOL, V63, P278, DOI 10.1016/j.ympev.2011.12.018; HIGHTON RICHARD, 1962, BULL FLORIDA STATE MUS, V6, P235; Holman JA, 2006, FOSSIL SALAMANDERS N; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; JACKMAN TR, 1994, EVOLUTION, V48, P876, DOI 10.1111/j.1558-5646.1994.tb01369.x; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; KLEEBERGER SR, 1982, COPEIA, P409, DOI 10.2307/1444622; Knowles LL, 2010, ESTIMATING SPECIES T; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Kuchta S, 2016, COPEIA IN PRESS; Kuchta SR, 2007, HERPETOLOGICA, V63, P332, DOI 10.1655/0018-0831(2007)63[332:CZASLH]2.0.CO;2; Kuchta SR, 2009, MOL PHYLOGENET EVOL, V50, P240, DOI 10.1016/j.ympev.2008.10.019; Kuchta SR, 2005, MOL ECOL, V14, P225, DOI 10.1111/j.1365-294X.2004.02388.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2014, SYST BIOL, V63, P534, DOI 10.1093/sysbio/syu018; Leache AD, 2014, SYST BIOL, V63, P17, DOI 10.1093/sysbio/syt049; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MADISON DM, 1969, ANIM BEHAV, V17, P25, DOI 10.1016/0003-3472(69)90109-2; Martinez-Solano I, 2007, MOL ECOL, V16, P4335, DOI 10.1111/j.1365-294X.2007.03527.x; Marvin GA, 2009, COPEIA, P227, DOI 10.1643/CH-08-116; Mayr E., 1942, P1; Mead LS, 2001, EVOLUTION, V55, P2287; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MITTLEMAN M. B., 1951, HERPETOLOGICA, V7, P105; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Myers EA, 2013, MOL ECOL, V22, P5418, DOI 10.1111/mec.12478; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Pelletier TA, 2015, SYST BIOL, V64, P909, DOI 10.1093/sysbio/syu090; Polihronakis M, 2010, EVOLUTION, V64, P1048, DOI 10.1111/j.1558-5646.2009.00884.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rannala B, 2003, GENETICS, V164, P1645; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Reid NM, 2014, SYST BIOL, V63, P322, DOI 10.1093/sysbio/syt057; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Reilly SB, 2015, J BIOGEOGR, V42, P280, DOI 10.1111/jbi.12413; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ruane S, 2014, SYST BIOL, V63, P231, DOI 10.1093/sysbio/syt099; Rundell RJ, 2009, TRENDS ECOL EVOL, V24, P394, DOI 10.1016/j.tree.2009.02.007; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Sequeira F, 2006, AMPHIBIA-REPTILIA, V27, P409, DOI 10.1163/156853806778190114; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; SLATKIN M, 1989, GENETICS, V123, P603; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tilley SG, 2013, ECOL EVOL, V3, P2547, DOI 10.1002/ece3.636; Tilley Stephen G., 1996, Herpetological Monographs, V10, P1, DOI 10.2307/1466979; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vieites DR, 2011, MOL PHYLOGENET EVOL, V59, P623, DOI 10.1016/j.ympev.2011.03.012; Wake DB, 2009, ANNU REV ECOL EVOL S, V40, P333, DOI 10.1146/annurev.ecolsys.39.110707.173552; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; WAKE DB, 1983, J THEOR BIOL, V101, P211, DOI 10.1016/0022-5193(83)90335-1; Wake DB, 1998, HERPETOLOGICA, V54, P279; Wakeley J, 1999, GENETICS, V153, P1863; Weisrock DW, 2012, MOL BIOL EVOL, V29, P1615, DOI 10.1093/molbev/mss008; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Wiens JJ, 2006, EVOLUTION, V60, P2585; Yang ZH, 2002, GENETICS, V162, P1811; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	126	17	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150022	10.1371/journal.pone.0150022	http://dx.doi.org/10.1371/journal.pone.0150022			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974148	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600016
J	McDonald, AT; Campbell, CE; Thomas, B				McDonald, Andrew T.; Campbell, Carl E.; Thomas, Brian			A New Specimen of the Controversial Chasmosaurine Torosaurus latus (Dinosauria: Ceratopsidae) from the Upper Cretaceous Hell Creek Formation of Montana	PLOS ONE			English	Article							CRANIOFACIAL ONTOGENY; ORNITHISCHIA; TRICERATOPS; ALBERTA; CANADA	Torosaurus latus is an uncommon and contentious taxon of chasmosaurine ceratopsid known from several upper Maastrichtian units in western North America. We describe a partial parietal of To. latus from the Hell Creek Formation of Montana. Although the specimen's ontogenetic maturity means that it cannot inform the ongoing debate over whether To. latus is the old adult form of the contemporary Triceratops, the specimen is one of the best-preserved To. latus parietals and supplements previous descriptions.	[McDonald, Andrew T.; Thomas, Brian] St Louis Sci Ctr, Earth Sci, St Louis, MO USA; [Campbell, Carl E.] St Louis Community Coll Meramec, Geol, St Louis, MO USA	Saint Louis University	McDonald, AT (corresponding author), St Louis Sci Ctr, Earth Sci, St Louis, MO USA.	atmcdonald28@gmail.com						Brown CM, 2015, CURR BIOL, V25, P1641, DOI 10.1016/j.cub.2015.04.041; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; COLBERT EDWIN H., 1947, PROC ACAD NAT SCI PHILADELPHIA, V99, P93; Farke Andrew A., 2007, P235; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P259, DOI 10.1080/02724634.1996.10011313; Frederickson JA, 2014, PEERJ, V2, DOI 10.7717/peerj.252; GILMORE CW, 1946, US GEOLOGICAL SURV C, V210, P29; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Longrich NR, 2014, CRETACEOUS RES, V51, P292, DOI 10.1016/j.cretres.2014.06.011; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Maiorino L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081608; Mallon JC, 2014, CAN J EARTH SCI, V51, P618, DOI 10.1139/cjes-2014-0028; MARSH OC, 1891, AM J SCI 3, V42, P265, DOI DOI 10.2475/AJS.S3-42.249.265; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2014, P NATL ACAD SCI USA, V111, P10245, DOI 10.1073/pnas.1313334111; Scannella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028705; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Sullivan RM, 2005, J PALEONTOL, V79, P564, DOI 10.1666/0022-3360(2005)079<0564:ROTCDT>2.0.CO;2; Sullivan Robert M., 2010, P169; Tumarkin-Deratzian Allison R., 2010, P251; Wu XC, 2007, CAN J EARTH SCI, V44, P1243, DOI 10.1139/e07-011	25	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151453	10.1371/journal.pone.0151453	http://dx.doi.org/10.1371/journal.pone.0151453			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974149	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600080
J	Stebler, N; Schuepbach-Regula, G; Braam, P; Falzon, LC				Stebler, Nadine; Schuepbach-Regula, Gertraud; Braam, Peter; Falzon, Laura Cristina			Weighting of Criteria for Disease Prioritization Using Conjoint Analysis and Based on Health Professional and Student Opinion	PLOS ONE			English	Article							SETTING PRIORITIES; ANIMAL DISEASES; RISKS; LAY	Disease prioritization exercises have been used by several organizations to inform surveillance and control measures. Though most methodologies for disease prioritization are based on expert opinion, it is becoming more common to include different stakeholders in the prioritization exercise. This study was performed to compare the weighting of disease criteria, and the consequent prioritization of zoonoses, by both health professionals and students in Switzerland using a Conjoint Analysis questionnaire. The health professionals comprised public health and food safety experts, cantonal physicians and cantonal veterinarians, while the student group comprised first-year veterinary and agronomy students. Eight criteria were selected for this prioritization based on expert elicitation and literature review. These criteria, described on a 3-tiered scale, were evaluated through a choice-based Conjoint Analysis questionnaire with 25 choice tasks. Questionnaire results were analyzed to obtain importance scores (for each criterion) and mean utility values (for each criterion level), and the latter were then used to rank 16 zoonoses. While the most important criterion for both groups was "Severity of the disease in humans", the second ranked criteria by the health professionals and students were "Economy" and "Treatment in humans", respectively. Regarding the criterion "Control and Prevention", health professionals tended to prioritize a disease when the control and preventive measures were described to be 95% effective, while students prioritized a disease if there were almost no control and preventive measures available. Bovine Spongiform Encephalopathy was the top-ranked disease by both groups. Health professionals and students agreed on the weighting of certain criteria such as "Severity" and "Treatment of disease in humans", but disagreed on others such as "Economy" or "Control and Prevention". Nonetheless, the overall disease ranking lists were similar, and these may be taken into consideration when making future decisions regarding resource allocation for disease control and prevention in Switzerland.	[Stebler, Nadine; Schuepbach-Regula, Gertraud; Falzon, Laura Cristina] Univ Bern, Vet Publ Hlth Inst, Liebefeld, Switzerland; [Braam, Peter] Fed Food Safety & Vet Off, Liebefeld, Switzerland	University of Bern	Falzon, LC (corresponding author), Univ Bern, Vet Publ Hlth Inst, Liebefeld, Switzerland.	laura.falzon@vetsuisse.unibe.ch	Schüpbach-Regula, Gertraud/S-1971-2017	Schüpbach-Regula, Gertraud/0000-0002-2310-7105; Falzon, Laura Cristina/0000-0002-4043-1644	Federal Food Safety and Veterinary Office, Liebefeld, Switzerland [1.14.10]	Federal Food Safety and Veterinary Office, Liebefeld, Switzerland	This research was supported by a grant from the Federal Food Safety and Veterinary Office, Liebefeld, Switzerland (Project Number: 1.14.10). Funding was received by GS-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Ridder B, 2015, VET REC, V177, P148, DOI 10.1136/vr.h4196; [Anonymous], 2002, EMERG INFECT DIS; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Cediel N, 2013, REV PANAM SALUD PUBL, V33, P316, DOI 10.1590/S1020-49892013000500002; Cohen NE, 2007, AGR HUM VALUES, V24, P499, DOI 10.1007/s10460-007-9086-9; Council of the European Union, 2008, NONP PRIOR AN REL TH; Cox R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068338; Cox R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041590; European Food Safety Authority, 2013, ZOON MON SWITZ TREND; Federal Food Safety and Veterinary Office, 2013, OV ZOON; Federal Office of Public Health, 2013, INFECT DIS; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hansen J, 2003, APPETITE, V41, P111, DOI 10.1016/S0195-6663(03)00079-5; Hansen J., 2014, EUR COLL VET PUBL HL; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Horby P, 2001, Commun Dis Public Health, V4, P8; Horst HS, 1998, LIVEST PROD SCI, V53, P253, DOI 10.1016/S0301-6226(97)00098-5; Jensen KK, 2005, INT J FOOD MICROBIOL, V99, P245, DOI 10.1016/j.ijfoodmicro.2004.09.004; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lomas J, 2003, MILBANK Q, V81, P363, DOI 10.1111/1468-0009.t01-1-00060; LUCE RD, 1964, J MATH PSYCHOL, V1, P1, DOI 10.1016/0022-2496(64)90015-X; Morgan D, 2009, EPIDEMIOL INFECT, V137, P1521, DOI 10.1017/S0950268809990227; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048519; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029752; O'Brien D, 2012, PRIORITISING RES CON; Palmer SR, 2013, OXFORD TXB ZOONOSES; Parker G, 1985, PREHISTORIC FARMING; Sawtooth Software Inc, 2013, AN TIN SAMPL SIZ; Stebler N, 2015, PREV VET MED, V121, P165, DOI 10.1016/j.prevetmed.2015.05.006; Swiss Federal Statistical Office, 2010, LANDW KENNZ INT VERG; Swiss Food Safety and Veterinary Office, 2012, AN HLTH STRAT 2010; Vilas VJD, 2013, PREV VET MED, V108, P94, DOI 10.1016/j.prevetmed.2012.08.007; Voelk V, 2014, J DAIRY SCI, V97, P4184, DOI 10.3168/jds.2013-7291; Wauters E., 2014, Society for Veterinary Epidemiology and Preventive Medicine, Proceedings of a meeting held in Dublin, Irish Republic, 26-28 March 2014, P133; WHO, 2006, SETT PRIOR COMM DIS; World Health Organisation, RAT INV GLOB EL DOG; World Health Organization, 2003, WHO M BUCH ROM 21 23	39	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151394	10.1371/journal.pone.0151394	http://dx.doi.org/10.1371/journal.pone.0151394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967655	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200052
J	Sundarrajan, S; Arumugam, M				Sundarrajan, Sudharsana; Arumugam, Mohanapriya			Comorbidities of Psoriasis - Exploring the Links by Network Approach	PLOS ONE			English	Article							GENE-EXPRESSION; INNATE IMMUNITY; DISEASE; INFLAMMATION; PATHOGENESIS; METAANALYSIS; DATABASE; RISK	Increasing epidemiological studies in patients with psoriasis report the frequent occurrence of one or more associated disorders. Psoriasis is associated with multiple comorbidities including autoimmune disease, neurological disorders, cardiometabolic diseases and inflammatory-bowel disease. An integrated system biology approach is utilized to decipher the molecular alliance of psoriasis with its comorbidities. An unbiased integrative network medicine methodology is adopted for the investigation of diseasome, biological process and pathways of five most common psoriasis associated comorbidities. A significant overlap was observed between genes acting in similar direction in psoriasis and its comorbidities proving the mandatory occurrence of either one of its comorbidities. The biological processes involved in inflammatory response and cell signaling formed a common basis between psoriasis and its associated comorbidities. The pathway analysis revealed the presence of few common pathways such as angiogenesis and few uncommon pathways which includes CCKR signaling map and gonadotrophin-realising hormone receptor pathway overlapping in all the comorbidities. The work shed light on few common genes and pathways that were previously overlooked. These fruitful targetsmay serve as a starting point for diagnosis and/or treatment of psoriasis comorbidities. The current research provides an evidence for the existence of shared component hypothesis between psoriasis and its comorbidities.	[Sundarrajan, Sudharsana; Arumugam, Mohanapriya] Vellore Inst Technol Univ, Sch Biosci & Technol, Div Bioinformat, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Arumugam, M (corresponding author), Vellore Inst Technol Univ, Sch Biosci & Technol, Div Bioinformat, Vellore, Tamil Nadu, India.	mohanapriyaa@vit.ac.in	Arumugam, Mohanapriya/AAV-8106-2020; Arumugam, Mohanapriya/AAA-6232-2019	Arumugam, Mohanapriya/0000-0002-1647-3182; Sundarrajan, Sudharsana/0000-0002-2828-0310				Al Harthi F, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/239645; Aurangabadkar SJ, 2013, INDIAN J DERMATOL VE, V79, pS10, DOI 10.4103/0378-6323.115506; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bechtel Mark, 2009, J Clin Aesthet Dermatol, V2, P27; Christophers E, 2007, CLIN DERMATOL, V25, P529, DOI 10.1016/j.clindermatol.2007.08.006; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Frers RAK, 2015, IJC METAB ENDOCR, V6, P43, DOI 10.1016/j.ijcme.2015.01.005; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gottlieb AB, 2008, J DERMATOL TREAT, V19, P5, DOI 10.1080/09546630701364768; GRIBBLE MD, 1955, ANN RHEUM DIS, V14, P198, DOI 10.1136/ard.14.2.198; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jeong SH, 2014, EXP DERMATOL, V23, P890, DOI 10.1111/exd.12554; Karpouzis Anthony, 2014, ISRN Dermatol, V2014, P845272, DOI 10.1155/2014/845272; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; KOCH AE, 1994, J CLIN INVEST, V93, P921, DOI 10.1172/JCI117097; Liu Y, 2007, GENES IMMUN, V8, P1, DOI 10.1038/sj.gene.6364351; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; McGowan JW, 2005, ARCH DERMATOL, V141, P1601, DOI 10.1001/archderm.141.12.1601; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Melamed RD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8033; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Nalls MA, 2014, HUM MOL GENET, V23, P831, DOI 10.1093/hmg/ddt465; Nazir N, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0103-8; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Sitras V, 2015, PLACENTA, V36, P170, DOI 10.1016/j.placenta.2014.11.017; Sticherling M., 2005, DRUG DISCOV TODAY DI, V2, P275, DOI DOI 10.1016/J.DDMEC.2005.05.019; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Wolf N, 2008, J MED GENET, V45, P114, DOI 10.1136/jmg.2007.053595	41	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149175	10.1371/journal.pone.0149175	http://dx.doi.org/10.1371/journal.pone.0149175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966903	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200003
J	Garcia-Palmero, I; Torres, S; Bartolome, RA; Pelaez-Garcia, A; Larriba, MJ; Lopez-Lucendo, M; Pena, C; Escudero-Paniagua, B; Munoz, A; Casal, JI				Garcia-Palmero, I.; Torres, S.; Bartolome, R. A.; Pelaez-Garcia, A.; Larriba, M. J.; Lopez-Lucendo, M.; Pena, C.; Escudero-Paniagua, B.; Munoz, A.; Casal, J. I.			Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen alpha 1(VI)	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-ASSOCIATED FIBROBLASTS; BUNDLING PROTEIN PALLADIN; RENAL-CELL CARCINOMA; POOR-PROGNOSIS; COLON-CANCER; COLORECTAL-CANCER; TUMOR-METASTASIS; BREAST-CANCER; INVADOPODIA FORMATION	The transcription factor Twist1 is involved in the epithelial-mesenchymal transition and contributes to cancer metastasis through mostly unknown mechanisms. In colorectal cancer, Twist1 expression is mainly restricted to the tumor stroma. We found that human fibroblast cell lines stably transfected with Twist1 acquired characteristics of activated cancer-associated fibroblasts (CAFs), such as hyperproliferation, an increased ability to migrate and an alignment of the actin cytoskeleton. Further, Twist1-activated fibroblasts promoted increased matrix stiffness. Using quantitative proteomics, we identified palladin and collagen alpha 1(VI) as two major mediators of the Twist1 effects in fibroblast cell lines. Co-immunoprecipitation studies indicated that palladin and Twist1 interact within the nucleus, suggesting that palladin could act as a transcription regulator. Palladin was found to be more relevant for the cellular biomechanical properties, orientation and polarity, and collagen alpha 1(VI) for the migration and invasion capacity, of Twist1-activated fibroblasts. Both palladin and collagen alpha 1(VI) were observed to be overexpressed in colorectal CAFs and to be associated with poor colorectal cancer patient survival and relapse prediction. Our results demonstrate that Twist1-expressing fibroblasts mimic the properties of CAFs present at the tumor invasive front, which likely explains the prometastatic activities of Twist1. Twist1 appears to require both palladin and collagen alpha 1(VI) as downstream effectors for its prometastatic effects, which could be future therapeutic targets in cancer metastasis.	[Garcia-Palmero, I.; Torres, S.; Bartolome, R. A.; Pelaez-Garcia, A.; Escudero-Paniagua, B.; Casal, J. I.] CSIC, CIB, Dept Cellular & Mol Med, Ramiro de Maeztu 9, Madrid 28040, Spain; [Larriba, M. J.; Munoz, A.] UAM, CSIC, Inst Invest Biomed Alberto Sols, IdiPAZ, Madrid, Spain; [Lopez-Lucendo, M.] CSIC, CIB, Prote Core Facil, Madrid, Spain; [Pena, C.] Hosp Univ Puerta de Hierro, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Puerta de Hierro-Majadahonda	Casal, JI (corresponding author), CSIC, CIB, Dept Cellular & Mol Med, Ramiro de Maeztu 9, Madrid 28040, Spain.	icasal@cib.csic.es	Munoz, Alberto/O-6393-2014; LARRIBA, MARIA JESUS/O-4652-2014; Casal, Ignacio/M-2312-2014; Bartolome, Ruben A/M-1873-2014	Munoz, Alberto/0000-0003-3890-4251; LARRIBA, MARIA JESUS/0000-0001-9035-7414; Casal, Ignacio/0000-0003-1085-2840; Pelaez Garcia, Alberto/0000-0002-5401-3216; Bartolome, Ruben A/0000-0002-3292-1491	Comunidad de Madrid [S2010/BMD-2344/Colomics2]; Juan de la Cierva programme; Asociacion Espanola Contra el Cancer (AECC); ProteoRed contract; Ministry of Economy and Competitiveness (MINECO); Comunidad de Madrid, 'Asociacion Espanola Contra el Cancer (AECC) [S2010/BMD-2344/Colomics2]; MINECO [BIO2012-31023]; Instituto de Salud Carlos III-FEDER [PRB2 (IPT13/0001-ISCIII-SGEFI/FEDER), RD12/0036/0041, RD12/0036/0021]	Comunidad de Madrid(Comunidad de Madrid); Juan de la Cierva programme; Asociacion Espanola Contra el Cancer (AECC); ProteoRed contract; Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Comunidad de Madrid, 'Asociacion Espanola Contra el Cancer (AECC)(Comunidad de Madrid); MINECO(Spanish Government); Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission)	IG-P was supported by a contract S2010/BMD-2344/Colomics2 from the Comunidad de Madrid. ST was a recipient of a Juan de la Cierva programme. RAB was supported by a grant to established research groups of the Asociacion Espanola Contra el Cancer (AECC). ML-L was a recipient of a ProteoRed contract. AP-G and BE-P were FPI fellows from the Ministry of Economy and Competitiveness (MINECO). This research was supported by grants to established research groups of the S2010/BMD-2344/Colomics2 from the Comunidad de Madrid, 'Asociacion Espanola Contra el Cancer (AECC)', BIO2012-31023 from the MINECO, PRB2 (IPT13/0001-ISCIII-SGEFI/FEDER), RD12/0036/0041 and RD12/0036/0021 from the Instituto de Salud Carlos III-FEDER.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; Bartolome RA, 2015, CANCER RES, V75, P2434, DOI 10.1158/0008-5472.CAN-14-3650; Bartolome RA, 2014, J BIOL CHEM, V289, P34801, DOI 10.1074/jbc.M114.600502; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Cannon AR, 2015, CYTOSKELETON, V72, P402, DOI 10.1002/cm.21239; Chen PW, 2013, TRENDS MOL MED, V19, P410, DOI 10.1016/j.molmed.2013.04.001; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Chin YR, 2010, FEBS LETT, V584, P4769, DOI 10.1016/j.febslet.2010.10.056; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Chiu KH, 2011, J PROTEOME RES, V10, P1110, DOI 10.1021/pr1008724; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Goicoechea SM, 2014, ONCOGENE, V33, P1265, DOI 10.1038/onc.2013.68; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Gomez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018023; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Gupta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021494; Larriba MJ, 2009, CARCINOGENESIS, V30, P1459, DOI 10.1093/carcin/bgp140; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012823; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142547; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MAYNE LV, 1986, EXP CELL RES, V162, P530, DOI 10.1016/0014-4827(86)90356-3; McLane JS, 2015, BIOPHYS J, V109, P249, DOI 10.1016/j.bpj.2015.06.033; Ohba K, 2014, INT J CLIN EXP PATHO, V7, P3158; Ou DL, 2008, ANTICANCER RES, V28, P1355; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Riaz M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3317; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Somasundaram R, 1996, J BIOL CHEM, V271, P26884, DOI 10.1074/jbc.271.43.26884; Sung CO, 2011, AM J PATHOL, V179, P1827, DOI 10.1016/j.ajpath.2011.06.032; Torres S, 2015, CLIN CANCER RES, V21, P4892, DOI 10.1158/1078-0432.CCR-14-3096; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wan FN, 2015, ONCOTARGET, V6, P27378, DOI 10.18632/oncotarget.4860; Watson MA, 2007, CLIN CANCER RES, V13, P5001, DOI 10.1158/1078-0432.CCR-07-0024; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Xie FW, 2009, CLIN EXP METASTAS, V26, P1025, DOI 10.1007/s10585-009-9292-5; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	53	39	40	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5224	5236		10.1038/onc.2016.57	http://dx.doi.org/10.1038/onc.2016.57			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	26973246				2022-12-26	WOS:000386053000002
J	Accordini, S; Calciano, L; Bombieri, C; Malerba, G; Belpinati, F; Lo Presti, AR; Baldan, A; Ferrari, M; Perbellini, L; de Marco, R				Accordini, Simone; Calciano, Lucia; Bombieri, Cristina; Malerba, Giovanni; Belpinati, Francesca; Lo Presti, Anna Rita; Baldan, Alessandro; Ferrari, Marcello; Perbellini, Luigi; de Marco, Roberto			An Interleukin 13 Polymorphism Is Associated with Symptom Severity in Adult Subjects with Ever Asthma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IL-13 GENE POLYMORPHISMS; TOBACCO-SMOKE; PROMOTER POLYMORPHISM; INCREASED EXPRESSION; PATHWAY GENES; LUNG-FUNCTION; IL13; HYPERRESPONSIVENESS; VARIANTS	Different genes are associated with categorical classifications of asthma severity. However, continuous outcomes should be used to catch the heterogeneity of asthma phenotypes and to increase the power in association studies. Accordingly, the aim of this study was to evaluate the association between single nucleotide polymorphisms (SNPs) in candidate gene regions and continuous measures of asthma severity, in adult patients from the general population. In the Gene Environment Interactions in Respiratory Diseases (GEIRD) study (www.geird.org), 326 subjects (aged 20q-64) with ever asthma were identified from the general population in Verona (Italy) between 2007 and 2010. A panel of 236 SNPs tagging 51 candidate gene regions (including one or more genes) was analysed. A symptom and treatment score (STS) and preq-bronchodilator FEV1% predicted were used as continuous measures of asthma severity. The association of each SNP with STS and FEV1% predicted was tested by fitting quasiq-gamma and linear regression models, respectively, with gender, body mass index and smoking habits as potential confounders. The Simes multipleq-test procedure was used for controlling the false discovery rate (FDR). SNP rs848 in the IL13 gene region (IL5/RAD50/IL13/IL4) was associated with STS (TG/GG vs TT genotype: uncorrected pq-value = 0.00006, FDRq-corrected pq-value = 0.04), whereas rs20541 in the same gene region, in linkage disequilibrium with rs848 (r(2) = 0.94) in our sample, did not reach the statistical significance after adjusting for multiple testing (TC/CC vs TT: uncorrected pq-value = 0.0003, FDRq-corrected pq-value = 0.09). Polymorphisms in other gene regions showed a nonq-significant moderate association with STS (IL12B, TNS1) or lung function (SERPINE2, GATA3, IL5, NPNT, FAM13A) only. After adjusting for multiple testing and potential confounders, SNP rs848 in the IL13 gene region is significantly associated with a continuous measure of symptom severity in adult subjects with ever asthma.	[Accordini, Simone; Calciano, Lucia; de Marco, Roberto] Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, I-37100 Verona, Italy; [Bombieri, Cristina; Malerba, Giovanni; Belpinati, Francesca; Lo Presti, Anna Rita; Baldan, Alessandro] Univ Verona, Dept Neurol Biomed & Movement Sci, Sect Biol & Genet, I-37100 Verona, Italy; [Ferrari, Marcello] Univ Verona, Dept Med, Resp Med Unit, I-37100 Verona, Italy; [Perbellini, Luigi] Univ Verona, Dept Diagnost & Publ Hlth, Unit Occupat Med, I-37100 Verona, Italy	University of Verona; University of Verona; University of Verona; University of Verona	Accordini, S (corresponding author), Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, I-37100 Verona, Italy.	simone.accordini@univr.it	Malerba, Giovanni/T-3278-2019	Calciano, Lucia/0000-0001-9801-5080; Baldan, Alessandro/0000-0002-5129-3419	Cariverona Foundation (Bando); Italian Ministry of Health [RF-2009-1471235]; Chiesi Farmaceutici; Italian Medicines Agency (AIFA)	Cariverona Foundation (Bando)(Fondazione Cariverona); Italian Ministry of Health(Ministry of Health, Italy); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Italian Medicines Agency (AIFA)	The GEIRD project was funded by the Cariverona Foundation (Bando 2006), the Italian Ministry of Health (RF-2009-1471235), Chiesi Farmaceutici and the Italian Medicines Agency (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2013, WIRES COMPUT STAT, V5, P149, DOI 10.1002/wics.1246; Battle NC, 2007, AM J RESP CRIT CARE, V175, P881, DOI 10.1164/rccm.200607-992OC; Beghe B, 2010, ALLERGY, V65, P474, DOI 10.1111/j.1398-9995.2009.02167.x; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Bouzigon E, 2007, EUR RESPIR J, V30, P253, DOI 10.1183/09031936.00162206; Chen CH, 2012, PEDIAT ALLERG IMM-UK, V23, P456, DOI 10.1111/j.1399-3038.2012.01278.x; Chiang CH, 2007, RESPIROLOGY, V12, P42, DOI 10.1111/j.1440-1843.2006.00960.x; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Cui L, 2012, CLIN BIOCHEM, V45, P285, DOI 10.1016/j.clinbiochem.2011.12.012; Cunningham J, 2011, ANN ALLERG ASTHMA IM, V106, P381, DOI 10.1016/j.anai.2011.01.030; de Marco R, 2010, INT ARCH ALLERGY IMM, V152, P255, DOI 10.1159/000283034; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; Dijkstra A, 2011, EUR RESPIR J, V38, P1036, DOI 10.1183/09031936.00182410; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P863, DOI 10.1016/j.jaci.2006.12.665; *GLOB IN ASTHM, 1995, NIH PUBL; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Harada M, 2009, AM J RESP CRIT CARE, V180, P1048, DOI 10.1164/rccm.200905-0652OC; Hawkins GA, 2012, J ALLERGY CLIN IMMUN, V130, P510, DOI 10.1016/j.jaci.2012.03.018; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Himes BE, 2011, CHEST, V140, P667, DOI 10.1378/chest.10-2973; Holloway JW, 2000, CLIN EXP ALLERGY, V30, P1097; Hong SJ, 2005, J ALLERGY CLIN IMMUN, V115, P758, DOI 10.1016/j.jaci.2004.10.047; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V120, P84, DOI 10.1016/j.jaci.2007.04.032; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Lee SY, 2002, CHEST, V122, P171, DOI 10.1378/chest.122.1.171; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; McCullagh P, 1989, GEN LINEAR MODELS; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Noonan M, 2013, J ALLERGY CLIN IMMUN, V132, P567, DOI 10.1016/j.jaci.2013.03.051; Palikhe NS, 2010, ALLERGY ASTHMA IMMUN, V2, P134, DOI 10.4168/aair.2010.2.2.134; Pascual RM, 2009, AM J RESP CRIT CARE, V179; Postma Dirkje S, 2004, Chest, V126, p96S, DOI 10.1378/chest.126.2_suppl_1.96S; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Pulleyn LJ, 2001, HUM GENET, V109, P623, DOI 10.1007/s00439-001-0617-y; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Rose G., 1992, STRATEGY PREVENTIVE; Sadeghnejad A, 2007, AM J RESP CRIT CARE, V176, P748, DOI 10.1164/rccm.200704-543OC; Sadeghnejad A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-2; Song GG, 2013, HUM IMMUNOL, V74, P256, DOI 10.1016/j.humimm.2012.11.003; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Tripathi P, 2011, J GENET, V90, P265, DOI 10.1007/s12041-011-0073-y; Tsai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051970; Utsumi Y, 2013, RESPIR INVESTIG, V51, P147, DOI 10.1016/j.resinv.2013.02.003; Vonk JM, 2010, PHARMACOGENET GENOM, V20, P179, DOI 10.1097/FPC.0b013e328336c7fd; Wenzel SE, 2007, AM J RESP CRIT CARE, V175, P570, DOI 10.1164/rccm.200607-909OC; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Zhang Q, 2011, J INVEST ALLERG CLIN, V21, P370	53	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151292	10.1371/journal.pone.0151292	http://dx.doi.org/10.1371/journal.pone.0151292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986948	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300059
J	Chen, L; Mongan, M; Meng, QH; Wang, Q; Kao, W; Xia, Y				Chen, Liang; Mongan, Maureen; Meng, Qinghang; Wang, Qin; Kao, Winston; Xia, Ying			Corneal Wound Healing Requires IKB kinase beta Signaling in Keratocytes	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; CELL; ACTIVATION; EXPRESSION; MYOFIBROBLAST; INHIBITOR; PROLIFERATION; DEFICIENCY; APOPTOSIS	kinase beta (IKK beta) is a key signaling kinase for inflammatory responses, but it also plays diverse cell type-specific roles that are not yet fully understood. Here we investigated the role of IKK beta in the cornea using Ikk beta(Delta CS) mice in which the Ikk beta gene was specifically deleted in the corneal stromal keratocytes. The Ikk beta(Delta CS) corneas had normal morphology, transparency and thickness; however, they did not heal well from mild alkali burn injury. In contrast to the Ikk beta(F/F) corneas that restored transparency in 2 weeks after injury, over 50% of the Ikk beta(Delta CS) corneas failed to fully recover. They instead developed recurrent haze with increased stromal thickness, severe inflammation and apoptosis. This pathogenesis correlated with sustained myofibroblast transformation with increased alpha smooth muscle actin (alpha-SMA) expression, higher levels of senescence beta-Gal activity and scar tissue formation at the late stage of wound healing. In addition, the Ikk beta(Delta CS) corneas displayed elevated expression of hemo-oxygenase-1 (HO-1), a marker of oxidative stress, and activation of stress signaling pathways with increased JNK, c-Jun and SMAD2/3 phosphorylation. These data suggest that IKK beta in keratocytes is required to repress oxidative stress and attenuate fibrogenesis and senescence in corneal wound healing.	[Chen, Liang; Mongan, Maureen; Meng, Qinghang; Wang, Qin; Xia, Ying] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Chen, Liang; Mongan, Maureen; Meng, Qinghang; Wang, Qin; Xia, Ying] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA; [Kao, Winston] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Chen, Liang] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Meng, Qinghang] Cincinnati Childrens Hosp, Dept Mol Cardiovasc Biol, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center	Xia, Y (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA.; Xia, Y (corresponding author), Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA.	ying.xia@uc.edu	Chen, Liang/G-2990-2013	Chen, Liang/0000-0002-6748-9416	National Eye Institute [EY15227]; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Eye Institute, Grant EY15227. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Bockhart V, 2009, J NEUROSCI, V29, P12919, DOI 10.1523/JNEUROSCI.1496-09.2009; Chae S, 2006, J IMMUNOL, V177, P1214, DOI 10.4049/jimmunol.177.2.1214; Chen F, 2003, CANCER RES, V63, P7689; Chen LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016132; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fleckenstein K, 2007, INT J RADIAT ONCOL, V68, P196, DOI 10.1016/j.ijrobp.2006.12.056; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Kubota M, 2011, INVEST OPHTH VIS SCI, V52, P427, DOI 10.1167/iovs.10-6167; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu CY, 2000, GENE, V250, P85, DOI 10.1016/S0378-1119(00)00165-7; Liu HS, 2012, J CELL MOL MED, V16, P1114, DOI 10.1111/j.1582-4934.2011.01418.x; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Miyazaki KI, 2008, INVEST OPHTH VIS SCI, V49, P1367, DOI 10.1167/iovs.07-1007; Myrna KE, 2009, VET OPHTHALMOL, V12, P25, DOI 10.1111/j.1463-5224.2009.00742.x; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Peng Z, 2010, MOL PHARM; Peng ZM, 2007, J BIOL CHEM, V282, P21487, DOI 10.1074/jbc.M702510200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pfister RR, 1998, INVEST OPHTH VIS SCI, V39, P1744; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Roy S, 2011, BIOL TRACE ELEM RES, V139, P55, DOI 10.1007/s12011-010-8635-z; Saika S, 2006, AM J PATHOL, V168, P1848, DOI 10.2353/ajpath.2006.050980; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sarchahi AA, 2008, OPHTHALMIC RES, V40, P41, DOI 10.1159/000111158; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	42	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151869	10.1371/journal.pone.0151869	http://dx.doi.org/10.1371/journal.pone.0151869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987064	Green Published, gold			2022-12-26	WOS:000372580300144
J	Przybylowski, M; Ghosh, P; Gibou, F				Przybylowski, Magda; Ghosh, Pratim; Gibou, Frederic			An Efficient Object Tracking Method on Quad-/Oc-Trees	PLOS ONE			English	Article							LEVEL SET METHOD; SEGMENTATION; REGISTRATION; ALGORITHMS	We introduce a fast error-free tracking method applicable to sequences of two and three dimensional images. The core idea is to use Quadtree (resp. Octree) data structures for representing the spatial discretization of an image in two (resp. three) spatial dimensions. This representation enables one to merge into large computational cells the regions that can be faithfully described with such a coarse representation, thus significantly reducing the total number of degrees of freedom that are processed, without compromising accuracy. This encoding is particularly effective in the case of algorithms based on moving fronts, since the adaptive refinement provides a natural means to focus the processing resources on information near the moving front. In this paper, we use an existing contour based tracker and reformulate it to the case of Quad-/Oc-tree data structures. Relevant mathematical assumptions and derivations are presented for this purpose. We then demonstrate that, on standard biomedical image sequences, a speed up of 5X is easily achieved in 2D and about 10X in 3D.	[Gibou, Frederic] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Przybylowski, Magda; Gibou, Frederic] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Ghosh, Pratim] Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Przybylowski, M (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	magda.przyby@gmail.com	Gibou, Frederic/AAU-4944-2020		National Science Foundation [CHE 1027817]; NSF [CHE 1027817]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This research was supported by the National Science Foundation under agreement CHE 1027817.; This research was supported by NSF CHE 1027817.	An JH, 2005, LECT NOTES COMPUT SC, V3749, P286; Aujol JF, 2006, INT J COMPUT VISION, V67, P111, DOI 10.1007/s11263-006-4331-z; Avidan S, 2007, IEEE T PATTERN ANAL, V29, P261, DOI 10.1109/TPAMI.2007.35; Babenko B, 2011, IEEE T PATTERN ANAL, V33, P1619, DOI 10.1109/TPAMI.2010.226; Black MJ, 1996, COMPUT VIS IMAGE UND, V63, P75, DOI 10.1006/cviu.1996.0006; Bresson X, 2007, J MATH IMAGING VIS, V28, P151, DOI 10.1007/s10851-007-0002-0; Brox T, 2004, LECT NOTES COMPUT SC, V2034, P25, DOI 10.1007/978-3-540-24673-2_3; Chan TF, 2006, SIAM J APPL MATH, V66, P1632, DOI 10.1137/040615286; Cremers D, 2005, INT J COMPUT VISION, V62, P249, DOI 10.1007/s11263-005-4882-4; Cremers D., 2003, IEEE 2 INT WORKSH VA, P169; Ghosh P, 2013, IEEE T PATTERN ANAL, V35, P425, DOI 10.1109/TPAMI.2012.103; Ghosh P, 2010, PROC CVPR IEEE, P1363, DOI 10.1109/CVPR.2010.5539809; Ghosh P, 2009, IEEE I CONF COMP VIS, P709, DOI 10.1109/ICCV.2009.5459170; Ishikawa H, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P509, DOI 10.1109/ICCV.2001.937559; Liu X.-D, 1996, J COMPUT PHYS, V126, P202; Mei X., 2009, P INT C COMP VIS; Min C, 2007, J COMPUT PHYS, V225, P300, DOI 10.1016/j.jcp.2006.11.034; Mitchell SC, 2001, IEEE T MED IMAGING, V20, P415, DOI 10.1109/42.925294; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Papenberg N, 2006, INT J COMPUT VISION, V67, P141, DOI 10.1007/s11263-005-3960-y; Russo G, 2000, J COMPUT PHYS, V163, P51, DOI 10.1006/jcph.2000.6553; Samet H., 1990, APPL SPATIAL DATA ST; Samet H., 1989, DESIGN ANAL SPATIAL; Schoenemann T, 2008, P IEEE C COMP VIS PA, P1; Schoenemann T, 2009, IEEE T PAMI, P1153; SHU CW, 1989, J COMPUT PHYS, V83, P32, DOI 10.1016/0021-9991(89)90222-2; Strain J, 1999, J COMPUT PHYS, V151, P616, DOI 10.1006/jcph.1999.6205; SUSSMAN M, 1994, J COMPUT PHYS, V114, P146, DOI 10.1006/jcph.1994.1155; Taron M, 2009, IEEE T PATTERN ANAL, V31, P99, DOI 10.1109/TPAMI.2008.36; Tsai A, 2003, IEEE T MED IMAGING, V22, P137, DOI 10.1109/TMI.2002.808355; Unal G, 2005, PROC CVPR IEEE, P168; Wedel A, 2009, LECT NOTES COMPUT SC, V5604, P23, DOI 10.1007/978-3-642-03061-1_2; Zhu Y.P., 2008, SMALL ANGLE XRAY SCA, V406, P57	33	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150889	10.1371/journal.pone.0150889	http://dx.doi.org/10.1371/journal.pone.0150889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986970	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300035
J	Wen, CH; Zhang, J; Rebelo, A; Cheng, FY				Wen, Cuihong; Zhang, Jing; Rebelo, Ana; Cheng, Fanyong			A Directed Acyclic Graph-Large Margin Distribution Machine Model for Music Symbol Classification	PLOS ONE			English	Article							ALGORITHMS; NETWORKS; SCORES	Optical Music Recognition (OMR) has received increasing attention in recent years. In this paper, we propose a classifier based on a new method named Directed Acyclic Graph-Large margin Distribution Machine (DAG-LDM). The DAG-LDM is an improvement of the Large margin Distribution Machine (LDM), which is a binary classifier that optimizes the margin distribution by maximizing the margin mean and minimizing the margin variance simultaneously. We modify the LDM to the DAG-LDM to solve the multi-class music symbol classification problem. Tests are conducted on more than 10000 music symbol images, obtained from handwritten and printed images of music scores. The proposed method provides superior classification capability and achieves much higher classification accuracy than the state-of-the-art algorithms such as Support Vector Machines (SVMs) and Neural Networks (NNs).	[Wen, Cuihong; Zhang, Jing; Cheng, Fanyong] Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China; [Rebelo, Ana] Univ Porto, INESC Porto, Rua Campo Alegre 823, P-4100 Oporto, Portugal	Hunan University; INESC TEC; Universidade do Porto	Wen, CH (corresponding author), Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China.	cuihong_wen@hnu.edu.cn	Rebelo, Ana/I-1121-2015	Rebelo, Ana/0000-0003-4776-6057	Fund of Doctoral Program of the Ministry of Education [20110161110035]; China National Natural Science Foundation [61174140, 61573299]	Fund of Doctoral Program of the Ministry of Education; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work is financed by Fund of Doctoral Program of the Ministry of Education (Approval No. 20110161110035) and China National Natural Science Foundation (Approval No. 61174140 and 61573299) (http://www.nsfc.gov.cn/).	[Anonymous], 1998, NEURAL NETWORKS COMP; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cotter A, 2013, P INT C MACH LEARN, P266; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dalitz C, 2008, IEEE T PATTERN ANAL, V30, P753, DOI [10.1109/TPAMI.2007.70749, 10.1109/TPAM1.2007.70749]; Hui M, 2010, PATTERN RECOGN, V31, P100; Jiu MY, 2014, PATTERN RECOGN LETT, V50, P122, DOI 10.1016/j.patrec.2013.09.021; Miyao H, 1996, IEICE T INF SYST, VE79D, P548; Ng KC, 1996, IMAGE VISION COMPUT, V14, P39, DOI 10.1016/0262-8856(95)01038-6; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Platt JC, 2000, ADV NEUR IN, V12, P547; Pugin L, 2006, OPTICAL MUSIC RECOGN, P53; Rebelo A, 2010, INT J DOC ANAL RECOG, V13, P19, DOI 10.1007/s10032-009-0100-1; Rebelo A, 2011, 10 INT C MACH LEARN, P18; Vapnik V., 1999, NATURE STAT LEARNING; Wen CH, 2015, PATTERN RECOGN LETT, V58, P1, DOI 10.1016/j.patrec.2015.02.002; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Zhang T., 2014, P 20 ACM SIGKDD INT, P313, DOI [10.1145/2623330.2623710, DOI 10.1145/2623330.2623710]; ZHOU Z, 2014, MEM ASSOC AUSTRALAS, P1, DOI DOI 10.1007/S11042-014-2162-4	19	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0149688	10.1371/journal.pone.0149688	http://dx.doi.org/10.1371/journal.pone.0149688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985826	Green Published, gold			2022-12-26	WOS:000372580300015
J	ten Have, R; Reubsaet, K; van Herpen, P; Kersten, G; Amorij, JP				ten Have, R.; Reubsaet, K.; van Herpen, P.; Kersten, G.; Amorij, J. -P.			Demonstrating Functional Equivalence of Pilot and Production Scale Freeze-Drying of BCG	PLOS ONE			English	Article							VACCINE POWDER; DESIGN; FORMULATIONS; CHALLENGES; PRINCIPLES; FROZEN	Process analytical technology (PAT)-tools were used to monitor freeze-drying of Bacille Calmette-Guerin (BCG) at pilot and production scale. Among the evaluated PAT-tools, there is the novel use of the vacuum valve open/close frequency for determining the end-point of primary drying at production scale. The duration of primary drying, the BCG survival rate, and the residual moisture content (RMC) were evaluated using two different freeze-drying protocols and were found to be independent of the freeze-dryer scale evidencing functional equivalence. The absence of an effect of the freeze-dryer scale on the process underlines the feasibility of the pilot scale freeze-dryer for further BCG freeze-drying process optimization which may be carried out using a medium without BCG.	[ten Have, R.; Reubsaet, K.; van Herpen, P.; Kersten, G.; Amorij, J. -P.] Intravacc, POB 450, NL-3720 AL Bilthoven, Netherlands; [Kersten, G.] Leiden Acad Ctr Drug Res, Drug Delivery Technol, POB 9502, NL-2300 RA Leiden, Netherlands; [Reubsaet, K.] Sanquin, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands; [Amorij, J. -P.] Virtuvax BV, Odijk, Netherlands		ten Have, R (corresponding author), Intravacc, POB 450, NL-3720 AL Bilthoven, Netherlands.	Rimko.ten.Have@intravacc.nl						Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; Amorij JP, 2012, J CONTROL RELEASE, V161, P363, DOI 10.1016/j.jconrel.2011.12.039; Barresi AA, 2011, PHARM TECHNOLOGY EUR, V23, P29; Barresi AA, 2009, CHEM ENG PROCESS, V48, P408, DOI 10.1016/j.cep.2008.05.004; Christensen D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015043; Debruyne F M, 1988, Prog Clin Biol Res, V269, P511; Fissore D, 2008, DRY TECHNOL, V26, P685, DOI 10.1080/07373930802046161; Franks F, 1998, EUR J PHARM BIOPHARM, V45, P221, DOI 10.1016/S0939-6411(98)00004-6; Vazquez-Lavista LG, 2007, REV INVEST CLIN, V59, P146; Gheorghiu M, 1996, DEV BIOL STAND, V87, P251; Hirschberg HJHB, 2008, VACCINE, V26, P2389, DOI 10.1016/j.vaccine.2008.02.067; Hirschberg HJHB, 2010, J CONTROL RELEASE, V147, P211, DOI 10.1016/j.jconrel.2010.06.028; Jennings TA, 2002, AM PHARM REV, V5, P34; Kraan H, 2014, J CONTROL RELEASE, V190, P580, DOI 10.1016/j.jconrel.2014.05.060; Kramer T, 2009, J PHARM SCI-US, V98, P307, DOI 10.1002/jps.21430; Kuu WY, 2005, INT J PHARMACEUT, V302, P56, DOI 10.1016/j.ijpharm.2005.06.022; Liu JS, 2006, PHARM DEV TECHNOL, V11, P3, DOI 10.1080/10837450500463729; Patel SM, 2010, J PHARM SCI-US, V99, P4363, DOI 10.1002/jps.22132; Patel SM, 2010, AAPS PHARMSCITECH, V11, P73, DOI 10.1208/s12249-009-9362-7; Patel SM, 2011, AAPS PHARMSCITECH, V12, P372, DOI 10.1208/s12249-011-9599-9; Pisano R, 2013, AAPS PHARMSCITECH, V14, P1137, DOI 10.1208/s12249-013-0003-9; Rahmat JN, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2012.01.017; Rambhatla Shailaja, 2003, AAPS PharmSciTech, V4, pE14; ROY ML, 1989, J PARENT SCI TECHN, V43, P60; Saluja V, 2010, J CONTROL RELEASE, V144, P127, DOI 10.1016/j.jconrel.2010.02.025; Sane SU, 2007, AM PHARM REV, V41, P132; Searles JA, 2001, J PHARM SCI, V90, P860, DOI 10.1002/jps.1039; Soema PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092806; Tang XL, 2005, PHARM RES-DORDR, V22, P685, DOI 10.1007/s11095-005-2501-2; Tang XL, 2004, PHARM RES-DORDR, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75; Tsinontides SC, 2004, INT J PHARM, V280, P1, DOI 10.1016/j.ijpharm.2004.04.018; van Hemert P, 1974, Prog Ind Microbiol, V13, P151	32	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151239	10.1371/journal.pone.0151239	http://dx.doi.org/10.1371/journal.pone.0151239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981867	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900072
J	Zhuo, L; Tao, H; Wei, H; Wu, CZ				Zhuo, Lin; Tao, Hong; Wei, Hong; Wu Chengzhen			Compatible Models of Carbon Content of Individual Trees on a Cunninghamia lanceolata Plantation in Fujian Province, China	PLOS ONE			English	Article							ALLOMETRIC EQUATIONS; ABOVEGROUND BIOMASS; FOREST BIOMASS; STOCKS; BALANCE; HEIGHT; POOLS; NORTH	We tried to establish compatible carbon content models of individual trees for a Chinese fir (Cunninghamia lanceolata (Lamb.) Hook.) plantation from Fujian province in southeast China. In general, compatibility requires that the sum of components equal the whole tree, meaning that the sum of percentages calculated from component equations should equal 100%. Thus, we used multiple approaches to simulate carbon content in boles, branches, foliage leaves, roots and the whole individual trees. The approaches included (i) single optimal fitting (SOF), (ii) nonlinear adjustment in proportion (NAP) and (iii) nonlinear seemingly unrelated regression (NSUR). These approaches were used in combination with variables relating diameter at breast height (D) and tree height (H), such as D, (DH)-H-2, DH and D&H (where D&H means two separate variables in bivariate model). Power, exponential and polynomial functions were tested as well as a new general function model was proposed by this study. Weighted least squares regression models were employed to eliminate heteroscedasticity. Model performances were evaluated by using mean residuals, residual variance, mean square error and the determination coefficient. The results indicated that models with two dimensional variables (DH, (DH)-H-2 and D&H) were always superior to those with a single variable (D). The D&H variable combination was found to be the most useful predictor. Of all the approaches, SOF could establish a single optimal model separately, but there were deviations in estimating results due to existing incompatibilities, while NAP and NSUR could ensure predictions compatibility. Simultaneously, we found that the new general model had better accuracy than others. In conclusion, we recommend that the new general model be used to estimate carbon content for Chinese fir and considered for other vegetation types as well.	[Zhuo, Lin; Tao, Hong; Wei, Hong; Wu Chengzhen] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian Province, Peoples R China; [Wu Chengzhen] Wuyi Univ, Wuyishan City, Fujian Province, Peoples R China	Fujian Agriculture & Forestry University; Wuyi University, Fujian	Wu, CZ (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian Province, Peoples R China.; Wu, CZ (corresponding author), Wuyi Univ, Wuyishan City, Fujian Province, Peoples R China.	fafuwcz@163.com			Science and Technology Major Project of the Hall of Science and Technology of Fujian Fujian provincial department of science and technology [2012NZ0001]; Project of National Natural Science Fund of China, National Natural Science foundation of China [30671664]	Science and Technology Major Project of the Hall of Science and Technology of Fujian Fujian provincial department of science and technology; Project of National Natural Science Fund of China, National Natural Science foundation of China	The Science and Technology Major Project of the Hall of Science and Technology of Fujian (No. 2012NZ0001) Fujian provincial department of science and technology http://www.fjkjt.gov.cn/ WCZ. The Project of National Natural Science Fund of China (No. 30671664), National Natural Science foundation of China http://www.nsfc.gov.cn/ WCZ.	Alvarez E, 2012, FOREST ECOL MANAG, V267, P297, DOI 10.1016/j.foreco.2011.12.013; Amichev BY, 2008, FOREST ECOL MANAG, V256, P1949, DOI 10.1016/j.foreco.2008.07.020; Asante P, 2011, J FOREST ECON, V17, P3, DOI 10.1016/j.jfe.2010.07.001; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; BOX GEP, 1957, ANN MATH STAT, V28, P195, DOI 10.1214/aoms/1177707047; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chojnacky DC, 2014, FORESTRY, V87, P129, DOI 10.1093/forestry/cpt053; DETWILER RP, 1988, SCIENCE, V239, P42, DOI 10.1126/science.239.4835.42; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Djomo AN, 2010, FOREST ECOL MANAG, V260, P1873, DOI 10.1016/j.foreco.2010.08.034; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fayolle A, 2013, FOREST ECOL MANAG, V305, P29, DOI 10.1016/j.foreco.2013.05.036; Fu LiYong, 2014, Scientia Silvae Sinicae, V50, P42; Han FXX, 2007, CLIMATIC CHANGE, V84, P191, DOI 10.1007/s10584-007-9244-5; Henry M, 2011, SILVA FENN, V45, P477, DOI 10.14214/sf.38; Holst J, 2008, AGR FOREST METEOROL, V148, P1815, DOI 10.1016/j.agrformet.2008.06.008; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; [黄贤松 Huang Xiansong], 2013, [自然资源学报, Journal of Natural Resources], V28, P349; Kangas AS, 1997, FOREST ECOL MANAG, V96, P207, DOI 10.1016/S0378-1127(97)00056-X; Kenzo T, 2009, J FOREST RES-JPN, V14, P365, DOI 10.1007/s10310-009-0149-1; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Kittredge Joseph, 1944, JOUR FOREST, V42, P905; Li GZ, 1987, J HENAN U SCI TECHNO, V2; Lin CQ, 1996, J FUJIAN FORESTRY SC, V3, P21; Lin JQ, 2004, SCI TECHNOLOGY QINGH, V4, P29; Lin KM, 1996, SCI SILVAE SINICAE, V5, p[386, 389]; [刘雯雯 Liu Wenwen], 2010, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V30, P7; Mate R, 2014, FORESTS, V5, P535, DOI 10.3390/f5030535; Meng SX, 2009, FOREST SCI, V55, P238; Moore JR, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010042; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Lima AJN, 2012, FOREST ECOL MANAG, V277, P163, DOI 10.1016/j.foreco.2012.04.028; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parresol BR, 2001, CAN J FOREST RES, V31, P865, DOI 10.1139/cjfr-31-5-865; Qiu GY, 1999, J FUJIAN FORESTRY SC, V3, P21; Rutishauser E, 2013, FOREST ECOL MANAG, V307, P219, DOI 10.1016/j.foreco.2013.07.013; Shvidenko A, 2002, CLIMATIC CHANGE, V55, P5, DOI 10.1023/A:1020243304744; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; Singh V, 2011, FOREST ECOL MANAG, V261, P1945, DOI 10.1016/j.foreco.2011.02.019; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Tang ShouZheng, 2000, Scientia Silvae Sinicae, V36, P19; Vedrova EF, 2002, J VEG SCI, V13, P341, DOI 10.1111/j.1654-1103.2002.tb02058.x; Viana H, 2012, ECOL MODEL, V226, P22, DOI 10.1016/j.ecolmodel.2011.11.027; Weng X, 2011, ANHUI FORESTRY SCI T, V3, P18; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Williamson GB, 2010, AM J BOT, V97, P519, DOI 10.3732/ajb.0900243; WOODWELL GM, 1978, SCIENCE, V199, P141, DOI 10.1126/science.199.4325.141; Wu CZ, 1999, CHINESE J APPL ECOLO, V10, P395; Wu CZ, 1998, J INNER MONGOLIA FOR, V2, P21; Wu Z. X., 1991, J FUJIAN FORESTRY S, V11, P19; Wulder MA, 2010, ENVIRON MONIT ASSESS, V166, P543, DOI 10.1007/s10661-009-1022-6; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Yang YuSheng, 1999, Journal of Northeast Forestry University, V27, P9; Ye JZ, 1984, J NANJING FOR U, V4, P1; Yu XT, 1982, CHINESE FIR CUNNINGH; Zeng Wei-sheng, 2010, Forest Research, V23, P797; Zhou HS, 1999, J FUJIAN COLL FOREST, V2, P51; Zianis D, 2011, EUR J FOREST RES, V130, P145, DOI 10.1007/s10342-010-0417-9	58	2	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151527	10.1371/journal.pone.0151527	http://dx.doi.org/10.1371/journal.pone.0151527			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982054	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900093
J	Jung, JY; Lee, HJ; Chun, BH; Jeon, CO				Jung, Ji Young; Lee, Hyo Jung; Chun, Byung Hee; Jeon, Che Ok			Effects of Temperature on Bacterial Communities and Metabolites during Fermentation of Myeolchi-Aekjeot, a Traditional Korean Fermented Anchovy Sauce	PLOS ONE			English	Article							FISH SAUCE; TETRAGENOCOCCUS-HALOPHILUS; MICROBIAL SUCCESSION; HISTAMINE FORMATION; GENOME SEQUENCE; ORGANIC-ACIDS; RICE BRAN; PRODUCTS; GENE; CHROMOHALOBACTER	Myeolchi-aekjeot (MA) in Korea is produced outdoors without temperature controls, which is a major obstacle to produce commercial MA products with uniform quality. To investigate the effects of temperature on MA fermentation, pH, bacterial abundance and community, and metabolites were monitored during fermentation at 15 degrees C, 20 degrees C, 25 degrees C, and 30 degrees C. Initial pH values were approximately 6.0, and pH values increased after approximately 42 days, with faster increases at higher temperatures. Bacterial abundances increased rapidly in all MA samples after quick initial decreases during early fermentation and then they again steadily decreased after reaching their maxima, which were significantly greater at higher temperatures. Bacterial community analysis revealed that Proteobacteria and Tenericutes were predominant in all initial MA samples, but they were rapidly displaced by Firmicutes as fermentation progressed. Photobacterium and Mycoplasma belonging to Proteobacteria and Tenericutes, respectively, which may include potentially pathogenic strains, were dominant in initial MA, but decreased with the growth of Chromohalobacter, which occurred faster at higher temperatures--they were dominant until 273 and 100 days at 15 degrees C and 20 degrees C, respectively, but not detected after 30 days at 25 degrees C and 30 degrees C. Chromohalobacter also decreased with the appearance of subsequent genera belonging to Firmicutes in all MA samples. Tetragenococcus, halophilic lactic acid bacteria, appeared predominantly at 20 degrees C, 25 degrees C, and 30 degrees C; they were most abundant at 30 degrees C, but not detected at 15 degrees C. Alkalibacillus and Lentibacillus appeared as dominant genera with the decrease of Tetragenococcus at 25 degrees C and 30 degrees C, but only Lentibacillus was dominant at 15 degrees C and 20 degrees C. Metabolite analysis showed that amino acids related to tastes were major metabolites and their concentrations were relatively higher at high temperatures. This study suggests that high temperatures (approximately 30 degrees C) may be appropriate in MA fermentation, in the light of faster disappearance of potentially pathogenic genera, higher amino acids, growth of Tetragenococcus, and faster fermentation.	[Jung, Ji Young; Lee, Hyo Jung; Chun, Byung Hee; Jeon, Che Ok] Chung Ang Univ, Dept Life Sci, Seoul 06974, South Korea	Chung Ang University	Jeon, CO (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 06974, South Korea.	cojeon@cau.ac.kr	Lee, Hyo Jung/AAE-9943-2020	Jung, Ji Young/0000-0002-6703-3072	Cooperative Research Program for Agriculture Science & Technology Development, RDA [PJ00999302]; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs (as part of the (multi-ministerial) Genome Technology to Business Translation Program, Republic of Korea)	Cooperative Research Program for Agriculture Science & Technology Development, RDA; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs (as part of the (multi-ministerial) Genome Technology to Business Translation Program, Republic of Korea)	This work was supported by the Cooperative Research Program for Agriculture Science & Technology Development (project no. PJ00999302), RDA and the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs (as part of the (multi-ministerial) Genome Technology to Business Translation Program, Republic of Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2000, OFFICIAL METHODS ANA; Aubourg SP, 2001, FOOD SCI TECHNOL INT, V7, P199, DOI 10.1106/4H8U-9GAD-VMG0-3GLR; BARRETT EL, 1985, ANNU REV MICROBIOL, V39, P131, DOI 10.1146/annurev.mi.39.100185.001023; Beutling DM, 2009, EUR FOOD RES TECHNOL, V229, P725, DOI 10.1007/s00217-009-1106-0; Cho Young Je, 1999, Journal of the Korean Fisheries Society, V32, P385; Chuon MR, 2014, J SCI FOOD AGR, V94, P1124, DOI 10.1002/jsfa.6379; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Copeland A, 2011, STAND GENOMIC SCI, V5, P379, DOI 10.4056/sigs.2285059; Ercolini D, 2011, APPL ENVIRON MICROB, V77, P7372, DOI 10.1128/AEM.05521-11; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Figueiredo IM, 2006, J AGR FOOD CHEM, V54, P4102, DOI 10.1021/jf0525176; Fukui Y, 2012, J GEN APPL MICROBIOL, V58, P273; Guan L, 2011, FOOD MICROBIOL, V28, P101, DOI 10.1016/j.fm.2010.09.001; HALASZ A, 1994, TRENDS FOOD SCI TECH, V5, P42, DOI 10.1016/0924-2244(94)90070-1; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; IMHOFF JF, 1984, J BACTERIOL, V160, P478, DOI 10.1128/JB.160.1.478-479.1984; Jung JY, 2015, J FOOD SCI, V80, pM2853, DOI 10.1111/1750-3841.13114; Jung JY, 2013, FOOD MICROBIOL, V34, P360, DOI 10.1016/j.fm.2013.01.009; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Jung MJ, 2011, J BACTERIOL, V193, P6414, DOI 10.1128/JB.06139-11; Kim MS, 2014, J FOOD SCI, V79, pM927, DOI 10.1111/1750-3841.12431; Kimura B, 2001, INT J FOOD MICROBIOL, V70, P71, DOI 10.1016/S0168-1605(01)00514-1; Kiyohara M, 2012, BIOSCI BIOTECH BIOCH, V76, P48, DOI 10.1271/bbb.110424; Kobayashi T, 2004, J APPL MICROBIOL, V96, P1215, DOI 10.1111/j.1365-2672.2004.02267.x; Kosaka Y, 2012, FISHERIES SCI, V78, P463, DOI 10.1007/s12562-011-0457-1; Kuda T, 2012, FOOD CHEM, V130, P569, DOI 10.1016/j.foodchem.2011.07.074; Lee C. H., 1993, FISH FERMENTATION TE; Lee HJ, 2012, APPL ENVIRON MICROB, V78, P5983, DOI 10.1128/AEM.00104-12; Lee SH, 2015, INT J FOOD MICROBIOL, V203, P15, DOI 10.1016/j.ijfoodmicro.2015.02.031; Lee SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090115; Lee SH, 2014, FOOD MICROBIOL, V38, P16, DOI 10.1016/j.fm.2013.08.004; Lopetcharat K, 2001, FOOD REV INT, V17, P65, DOI 10.1081/FRI-100000515; Lopez JR, 2012, AQUACULTURE, V324, P33, DOI 10.1016/j.aquaculture.2011.10.043; MIZUTANI T, 1992, Journal of Food Composition and Analysis, V5, P152, DOI 10.1016/0889-1575(92)90031-E; Osako K, 2005, FISHERIES SCI, V71, P1347, DOI 10.1111/j.1444-2906.2005.01101.x; Rawal CM, 2012, J BACTERIOL, V194, P4775, DOI 10.1128/JB.01031-12; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Saisithi P., 1994, FISHERIES PROCESSING, P111, DOI [10.1007/978-1-4615-5303-8_5, DOI 10.1007/978-1-4615-5303-8_5]; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Satomi M, 2014, FISHERIES SCI, V80, P849, DOI 10.1007/s12562-014-0756-4; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sitdhipol J, 2013, ANN MICROBIOL, V63, P745, DOI 10.1007/s13213-012-0529-1; Taira W, 2007, FISHERIES SCI, V73, P913, DOI 10.1111/j.1444-2906.2007.01414.x; Tungkawachara S, 2003, J FOOD SCI, V68, P855, DOI 10.1111/j.1365-2621.2003.tb08255.x; Udomsil N, 2011, J AGR FOOD CHEM, V59, P8401, DOI 10.1021/jf201953v; Udomsil N, 2010, INT J FOOD MICROBIOL, V141, P186, DOI 10.1016/j.ijfoodmicro.2010.05.016; VENTOSA A, 2005, BERGEYS MANUAL SYSTE, V2, P316; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xiao YZ, 2014, FOOD ANAL METHOD, V7, P1634, DOI 10.1007/s12161-014-9799-5; Yongsawatdigul J, 2007, J FOOD SCI, V72, pM382, DOI 10.1111/j.1750-3841.2007.00532.x; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	53	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151351	10.1371/journal.pone.0151351	http://dx.doi.org/10.1371/journal.pone.0151351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977596	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800064
J	Cabezon, O; Cerda-Cuellar, M; Morera, V; Garcia-Bocanegra, I; Gonzalez-Solis, J; Napp, S; Ribas, MP; Blanch-Lazaro, B; Fernandez-Aguilar, X; Antilles, N; Lopez-Soria, S; Lorca-Oro, C; Dubey, JP; Almeria, S				Cabezon, Oscar; Cerda-Cuellar, Marta; Morera, Virginia; Garcia-Bocanegra, Ignacio; Gonzalez-Solis, Jacob; Napp, Sebastian; Ribas, Maria P.; Blanch-Lazaro, Berta; Fernandez-Aguilar, Xavier; Antilles, Noelia; Lopez-Soria, Sergio; Lorca-Oro, Cristina; Dubey, Jitender P.; Almeria, Sonia			Toxoplasma gondii Infection in Seagull Chicks Is Related to the Consumption of Freshwater Food Resources	PLOS ONE			English	Article							NEOSPORA-CANINUM; ARCTIC FOXES; WILD; SEROPREVALENCE; PREVALENCE; OOCYSTS; TRANSMISSION; ANTIBODIES; SURVIVAL; PARASITE	Understanding the spread of Toxoplasma gondii (T. gondii) in wild birds, particularly in those with opportunistic feeding behavior, is of interest for elucidating the epidemiological involvement of these birds in the maintenance and dissemination of the parasite. Overall, from 2009 to 2011, we collected sera from 525 seagull chicks (Yellow-legged gull (Larus michahellis) and Audouin's gull (L. audouinii)) from 6 breeding colonies in Spain and tested them using the modified agglutination test (MAT) for the presence of antibodies against T. gondii. Chick age was estimated from bill length. Main food source of seagull chicks was evaluated using stable isotope analyses from growing scapular feathers. Overall T. gondii seroprevalence was 21.0% (IC95% 17.5-24.4). A generalized linear mixed-effects model indicated that year (2009) and food source (freshwater) were risk factors associated to the individual risk of infection by T. gondii, while age (days) was close to significance. Freshwater food origin was related to the highest seroprevalence levels, followed by marine origin, supporting freshwater and sewages as important routes of dispersion of T. gondii. Year differences could indicate fluctuating rates of exposure of seagull chicks to T. gondii. Age ranged from 4 to 30 days and seropositivity tended to increase with age (P = 0.07), supporting that seropositivity is related to T. gondii infection rather than to maternal transfer of antibodies, which in gulls is known to sharply decrease with chick age. This study is the first to report T. gondii antibodies in Yellow-legged and Audouin's gulls, thereby extending the range of intermediate hosts for this parasite and underscoring the complexity of its epidemiology.	[Cabezon, Oscar; Ribas, Maria P.; Blanch-Lazaro, Berta; Fernandez-Aguilar, Xavier] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Spain; [Cabezon, Oscar; Cerda-Cuellar, Marta; Napp, Sebastian; Fernandez-Aguilar, Xavier; Antilles, Noelia; Lopez-Soria, Sergio; Lorca-Oro, Cristina; Almeria, Sonia] Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Morera, Virginia; Gonzalez-Solis, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Morera, Virginia; Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Garcia-Bocanegra, Ignacio] UCO, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Dubey, Jitender P.] ARS, Anim Parasit Dis Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA; [Almeria, Sonia] Univ Autonoma Barcelona, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; University of Barcelona; University of Barcelona; Universidad de Cordoba; United States Department of Agriculture (USDA); Autonomous University of Barcelona	Cabezon, O (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Spain.; Cabezon, O (corresponding author), Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona, Spain.	ocabezon@yahoo.com	González-Solís, Jacob/AAB-1161-2019; Cabezón, Oscar/AAV-7876-2020; Fernandez Aguilar, Xavier/P-9919-2017; Gonzalez-Solis, Jacob/C-3942-2008; Bocanegra, Ignacio Garcia/G-1443-2016; Cerda, Marta/U-4534-2018; Napp, Sebastian/F-3331-2016; Lopez-Soria, Sergio/F-9858-2012; Morera-Pujol, Virginia/AAE-6412-2020; Gonzalez-Solis, Jacob/AAZ-5338-2021; Lorca-Oró, Cristina/ABE-7268-2021; Cabezon, Oscar/L-3812-2014	Fernandez Aguilar, Xavier/0000-0002-4939-6048; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Cerda, Marta/0000-0001-6842-1299; Napp, Sebastian/0000-0001-5813-7286; Lopez-Soria, Sergio/0000-0001-7134-2014; Morera-Pujol, Virginia/0000-0001-6500-5548; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Lorca-Oró, Cristina/0000-0001-5351-4169; Cabezon, Oscar/0000-0001-7543-8371; Antilles, Noelia/0000-0002-3762-3135; Puig Ribas, Maria/0000-0003-3242-0758	Spanish MINECO grant [AGL2012-39830-C02, CGL2009-11278/BOS]; INIA grant [FAU2008-00012-C02-01]; Fondos FEDER funds; FEDER funds	Spanish MINECO grant(Spanish Government); INIA grant; Fondos FEDER funds; FEDER funds(European Commission)	This study was partially supported by Spanish MINECO grant AGL2012-39830-C02, Spanish MINECO grant CGL2009-11278/BOS, INIA grant FAU2008-00012-C02-01 and Fondos FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks for the legal permissions to develop this work to the Dept. de Medi Ambient i Habitatge de la Generalitat de Catalunya; Conselleria de Medi Ambient i Mobilitat del Govern de les Illes Balears; Conselleria de Medi Ambient de la Generalitat Valenciana; Consejeria de Medio Ambiente de la Junta de Andalucia; Conselleria do Medio Rural de la Xunta de Galicia; Parc Natural del Delta de l'Ebre, Parc Natural del Montgri, les Illes Medes i el Baix Ter; Parc Natural illes Columbrets; Parc Natural de sa Dragonera; Parque Nacional Maritimo-Terrestre de las Islas Atlanticas; and to Mariano Paracuellos, Juan Carlos Nevado, Jose Antonio Fernandez Bouzas, Joan Mayol, Jose Vicente Escobar and the guarderia de Columbrets, for their help in logistics and sampling. The authors would also like to thank our many colleagues at University of Barcelona and the staff of CReSA for their help in the field. This study was partially supported by the Spanish MINECO grant AGL2012-39830-C02, CGL2009-11278/BOS and INIA grant FAU2008-00012-C02-01 and FEDER funds.	Afonso E, 2010, EPIDEMIOL INFECT, V138, P1105, DOI 10.1017/S0950268809991270; Arnal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089601; Cabezon O, 2004, J PARASITOL, V90, P643, DOI 10.1645/GE-257R; Cabezon O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029549; Chadwick EA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-75; Darwich L, 2012, VET PARASITOL, V183, P377, DOI 10.1016/j.vetpar.2011.07.024; Dubey JP, 2010, ZOONOSES PUBLIC HLTH, V57, P60, DOI 10.1111/j.1863-2378.2009.01274.x; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Fernandez-Aguilar X, 2013, VET PARASITOL, V196, P194, DOI 10.1016/j.vetpar.2013.01.061; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Garnier R, 2014, INTEGR COMP BIOL, V54, P363, DOI 10.1093/icb/icu022; Gotteland C, 2014, VECTOR-BORNE ZOONOT, V14, P403, DOI 10.1089/vbz.2013.1304; Jensen SK, 2010, POLAR BIOL, V33, P599, DOI 10.1007/s00300-009-0735-x; KAPPERUD G, 1978, J WILDLIFE DIS, V14, P157, DOI 10.7589/0090-3558-14.2.157; Ladeiro MP, 2013, ENVIRON SCI POLLUT R, V20, P778, DOI 10.1007/s11356-012-1189-1; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Lindsay DS, 2004, J PARASITOL, V90, P1054, DOI 10.1645/GE-296R; Lopes AP, 2011, PARASITOL RES, V108, P1163, DOI 10.1007/s00436-010-2158-6; Mancianti F, 2013, J PARASITOL, V99, P561, DOI 10.1645/12-34.1; Massie GN, 2010, VET PARASITOL, V169, P296, DOI 10.1016/j.vetpar.2010.01.002; Miao Q, 2014, J WILDLIFE DIS, V50, P717, DOI 10.7589/2014-01-016; Miller MA, 2002, INT J PARASITOL, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; Molina-Lopez R, 2012, RES VET SCI, V93, P300, DOI 10.1016/j.rvsc.2011.05.011; Moreno R, 2010, MAR BIOL, V157, P545, DOI 10.1007/s00227-009-1340-9; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Prestrud KW, 2007, VET PARASITOL, V150, P6, DOI 10.1016/j.vetpar.2007.09.006; Ramos R, 2009, J ORNITHOL, V150, P265, DOI 10.1007/s10336-008-0346-2; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Resendes AR, 2002, J PARASITOL, V88, P1029, DOI 10.1645/0022-3395(2002)088[1029:DTIAMP]2.0.CO;2; ROSE ME, 1981, DEV COMP IMMUNOL, V5, P15, DOI 10.1016/S0145-305X(81)80003-1; Sandstrom CAM, 2013, VET PARASITOL, V194, P9, DOI 10.1016/j.vetpar.2012.12.027; Shapiro K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1287; Sorensen KK, 2005, RES VET SCI, V78, P161, DOI 10.1016/j.rvsc.2004.07.010; Staszewski V, 2007, J ANIM ECOL, V76, P1215, DOI 10.1111/j.1365-2656.2007.01293.x; Steigerwald EC, 2015, IBIS, V157, P439, DOI 10.1111/ibi.12252; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Yu L, 2013, PARASITOL RES, V112, P1333, DOI 10.1007/s00436-012-3187-0; Zoller B, 2013, PARASITOL RES, V112, P1841, DOI 10.1007/s00436-013-3337-z; Zuur Alain F., 2009, P1	40	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150249	10.1371/journal.pone.0150249	http://dx.doi.org/10.1371/journal.pone.0150249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974667	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600020
J	Jin, Z; Li, RC; Zhou, CX; Shi, LY; Zhang, XL; Yang, ZX; Zhang, D				Jin, Zhen; Li, Ruichao; Zhou, Chunxiang; Shi, Liya; Zhang, Xiaolan; Yang, Zhixia; Zhang, Dong			Efficient Gene Knockdown in Mouse Oocytes through Peptide Nanoparticle-Mediated SiRNA Transfection	PLOS ONE			English	Article							DELIVERY; CELLS	The use of mouse oocytes as a model for studying female meiosis is very important in reproductive medicine. Gene knockdown by specific small interfering RNA (siRNA) is usually the first step in the study of the function of a target gene in mouse oocytes during in vitro maturation. Traditionally, the only way to introduce siRNA into mouse oocytes is through microinjection, which is certainly less efficient and strenuous than siRNA transfection in somatic cells. Recently, in research using somatic cells, peptide nanoparticle-mediated siRNA transfection has been gaining popularity over liposome nanoparticle-mediated methods because of its high efficiency, low toxicity, good stability, and strong serum compatibility. However, no researchers have yet tried transfecting siRNA into mouse oocytes because of the existence of the protective zona pellucida surrounding the oocyte membrane (vitelline membrane). We therefore tested whether peptide nanoparticles can introduce siRNA into mouse oocytes. In the present study, we showed for the first time that our optimized program can efficiently knock down a target gene with high specificity. Furthermore, we achieved the expected meiotic phenotypes after we knocked down a test unknown target gene TRIM75. We propose that peptide nanoparticles may be superior for preliminary functional studies of unknown genes in mouse oocytes.	[Jin, Zhen; Li, Ruichao; Zhou, Chunxiang; Shi, Liya; Zhang, Xiaolan; Yang, Zhixia; Zhang, Dong] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, ZX; Zhang, D (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	yang_zhixia@sina.com; dong.ray.zhang@njmu.edu.cn	shi, liya/HDM-6854-2022; Zhang, Dong/AAM-8146-2021		National Basic Research Program of China (973 Program) [2013CB945504]; National Natural Science Foundation of China [31271441, 31471406]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program; Grant No: 2013CB945504, http://program.most.gov.cn/); General Program of the National Natural Science Foundation of China (Grant No: 31271441 and 31471406; http://isis.nsfc.gov.cn).	Baumann C, 2015, JOVE-J VIS EXP, DOI 10.3791/53586; Carballada R, 2000, MOL REPROD DEV, V56, P360, DOI 10.1002/1098-2795(200007)56:3&lt;360::AID-MRD5&gt;3.0.CO;2-8; Crombez L, 2011, METHODS MOL BIOL, V683, P349, DOI [10.1007/978-1-60751-919-2_25, 10.1007/978-1-60761-919-2_25]; Farkhani SM, 2014, PEPTIDES, V57, P78, DOI 10.1016/j.peptides.2014.04.015; Gallardo TD, 2007, GENETICS, V177, P179, DOI 10.1534/genetics.107.074823; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Huang CJ, 2012, MOL CELL BIOCHEM, V360, P121, DOI 10.1007/s11010-011-1050-8; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Lambeth Luke S, 2013, Methods Mol Biol, V942, P205, DOI 10.1007/978-1-62703-119-6_12; Miyajima N, 2009, BIOCHEM BIOPH RES CO, V381, P383, DOI 10.1016/j.bbrc.2009.02.059; Petersson J, 2010, EXP CELL RES, V316, P568, DOI 10.1016/j.yexcr.2009.12.007; Pfender S, 2015, NATURE, V524, P239, DOI 10.1038/nature14568; Presente A, 2013, CURR PHARM DESIGN, V19, P2943; Safinya CR, 2014, NEW J CHEM, V38, P5164, DOI 10.1039/c4nj01314j; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Stein Paula, 2013, Methods Mol Biol, V957, P135, DOI 10.1007/978-1-62703-191-2_9	16	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150462	10.1371/journal.pone.0150462	http://dx.doi.org/10.1371/journal.pone.0150462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974323	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600025
J	Malenfant, RM; Davis, CS; Cullingham, CI; Coltman, DW				Malenfant, Rene M.; Davis, Corey S.; Cullingham, Catherine I.; Coltman, David W.			Circumpolar Genetic Structure and Recent Gene Flow of Polar Bears: A Reanalysis	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; URSUS-MARITIMUS; POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; PHYLOGENETIC TREES; COMPUTER-PROGRAM; HUDSON-BAY; R-PACKAGE; ICE; SOFTWARE	Recently, an extensive study of 2,748 polar bears (Ursus maritimus) from across their circumpolar range was published in PLOS ONE, which used microsatellites and mitochondrial haplotypes to apparently show altered population structure and a dramatic change in directional gene flow towards the Canadian Archipelago-an area believed to be a future refugium for polar bears as their southernmost habitats decline under climate change. Although this study represents a major international collaborative effort and promised to be a baseline for future genetics work, methodological shortcomings and errors of interpretation undermine some of the study's main conclusions. Here, we present a reanalysis of this data in which we address some of these issues, including: (1) highly unbalanced sample sizes and large amounts of systematically missing data; (2) incorrect calculation of FST and of significance levels; (3) misleading estimates of recent gene flow resulting from non-convergence of the program BAYESASS. In contrast to the original findings, in our reanalysis we find six genetic clusters of polar bears worldwide: the Hudson Bay Complex, the Western and Eastern Canadian Arctic Archipelago, the Western and Eastern Polar Basin, and-importantly-we reconfirm the presence of a unique and possibly endangered cluster of bears in Norwegian Bay near Canada's expected last sea-ice refugium. Although polar bears' abundance, distribution, and population structure will certainly be negatively affected by ongoing-and increasingly rapid-loss of Arctic sea ice, these genetic data provide no evidence of strong directional gene flow in response to recent climate change.	[Malenfant, Rene M.; Davis, Corey S.; Cullingham, Catherine I.; Coltman, David W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Malenfant, RM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	rene.malenfant@ualberta.ca	Davis, Corey/I-4058-2014; Cullingham, Catherine/AAE-9591-2020; Malenfant, René Michael/A-2916-2010; Coltman, David W/A-4453-2012	Davis, Corey/0000-0003-4362-0659; Cullingham, Catherine/0000-0002-6715-0674; Malenfant, René Michael/0000-0003-1505-3669; Coltman, David W/0000-0002-1268-2307	Alberta Innovates Technology Futures; University of Alberta; Province of Alberta; Natural Sciences and Engineering Research Council of Canada [312207-2011]	Alberta Innovates Technology Futures; University of Alberta(University of Alberta); Province of Alberta; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	RMM has been funded by scholarships from Alberta Innovates Technology Futures, the University of Alberta, and the Province of Alberta. Part of this work was funded by a Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/ ( Grant ID 312207-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup SC, 2005, ARCTIC, V58, P247; Amstrup SC, 2001, CAN J ZOOL, V79, P2147, DOI 10.1139/cjz-79-12-2147; AMSTRUP SC, 1994, J WILDLIFE MANAGE, V58, P1, DOI 10.2307/3809542; Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Beerli Peter, 2009, V17, P42; Bethke R, 1996, ECOL APPL, V6, P311, DOI 10.2307/2269574; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bohling JH, 2013, MOL ECOL, V22, P74, DOI 10.1111/mec.12109; Campagna L, 2013, ECOL EVOL, V3, P3152, DOI 10.1002/ece3.662; Cheng L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-302; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Chesser RK, 1996, GENETICS, V144, P1225; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2006, FISH B-NOAA, V104, P550; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crompton AE, 2008, BIOL CONSERV, V141, P2528, DOI 10.1016/j.biocon.2008.07.018; Cronin MA, 2012, J HERED, V103, P873, DOI 10.1093/jhered/ess090; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Drummond CS, 2007, MOL ECOL, V16, P753, DOI 10.1111/j.1365-294X.2006.03186.x; Durner GM, 1995, ARCTIC, V48, P338; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Ferguson SH, 1999, ECOL LETT, V2, P311, DOI 10.1046/j.1461-0248.1999.00090.x; Fetterer F., 2010, MULTISENSOR ANAL SEA; Fung T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085925; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hamilton SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113746; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; HOLM S, 1979, SCAND J STAT, V6, P65; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; IUCN/SSC Polar Bear Specialist Group, 2014, 2014 POL BEAR STAT T; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2009, HEREDITY, V102, P506, DOI 10.1038/hdy.2008.136; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Laidre KL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2371; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Lone K, 2013, POLAR BIOL, V36, P27, DOI 10.1007/s00300-012-1235-y; Malenfant RM, 2015, MOL ECOL RESOUR, V15, P587, DOI 10.1111/1755-0998.12327; Mauritzen M, 2003, ANIM BEHAV, V66, P107, DOI 10.1006/anbe.2003.2171; Mauritzen M, 2001, CAN J ZOOL, V79, P1704, DOI 10.1139/z01-126; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Meirmans PG, 2014, MOL ECOL RESOUR, V14, P726, DOI 10.1111/1755-0998.12216; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Michalakis Y, 1996, GENETICS, V142, P1061; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1978, GENETICS, V89, P583; Nei M., 1987, MOL EVOLUTIONARY GEN; Obbard ME, 2012, URSUS, V23, P134, DOI 10.2192/URSUS-D-11-00030.1; Obbard ME, 2010, POLAR BEARS; Oksanen J, 2015, COMMUNITY ECOLOGY PA; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Peacock E, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P93, DOI 10.1007/978-90-481-9121-5_5; Peacock E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136126; Peacock E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112021; Peacock E, 2013, J WILDLIFE MANAGE, V77, P463, DOI 10.1002/jwmg.489; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Pop M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0668-z; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; R Core Team, 2013, R LANG ENV STAT COMP; RAMSAY MA, 1986, CAN J ZOOL, V64, P2142, DOI 10.1139/z86-329; Rode KD, 2015, FRONT ECOL ENVIRON, V13, P138, DOI 10.1890/140202; Rodriguez-Ramilo ST, 2012, MOL ECOL RESOUR, V12, P873, DOI 10.1111/j.1755-0998.2012.03156.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sahanatien V, 2010, FOXE BASIN POLAR B 1, P29; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; SLATKIN M, 1995, GENETICS, V139, P457; Smith BJ, 2007, J STAT SOFTW, V21, P1; Takezaki N, 1996, GENETICS, V144, P389; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TAYLOR M, 1995, ARCTIC, V48, P147; Taylor MK, 2008, ARCTIC, V61, P143; Taylor MK, 2001, CAN J ZOOL, V79, P690, DOI 10.1139/cjz-79-4-690; Thiemann GW, 2008, ORYX, V42, P504, DOI 10.1017/S0030605308001877; Viengkone M, 2015, THESIS U ALBERTA EDM; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang J, 2015, MOL ECOL, V24, P3546, DOI 10.1111/mec.13204; Waples RS, 2015, J HERED, V106, P1, DOI 10.1093/jhered/esu062; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wilson GW, 2005, DOCUMENTATION BAYESA; Zeyl E, 2009, MOL ECOL, V18, P735, DOI 10.1111/j.1365-294X.2008.04049.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	108	15	17	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0148967	10.1371/journal.pone.0148967	http://dx.doi.org/10.1371/journal.pone.0148967			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974333	Green Submitted, gold, Green Published			2022-12-26	WOS:000372570600009
J	Xu, SX; Shi, XZ; Wang, MY; Zhao, YC				Xu, Shengxiang; Shi, Xuezheng; Wang, Meiyan; Zhao, Yongcun			Effects of Subsetting by Parent Materials on Prediction of Soil Organic Matter Content in a Hilly Area Using Vis-NIR Spectroscopy	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; LEAST-SQUARE REGRESSION; CHEMICAL-PROPERTIES; CARBON FRACTIONS; FIELD-SCALE; QUALITY; CALIBRATION; PERFORMANCE; COMPONENTS; LIBRARY	Assessment and monitoring of soil organic matter (SOM) quality are important for understanding SOM dynamics and developing management practices that will enhance and maintain the productivity of agricultural soils. Visible and near-infrared (Vis-NIR) diffuse reflectance spectroscopy (350-2500 nm) has received increasing attention over the recent decades as a promising technique for SOM analysis. While heterogeneity of sample sets is one critical factor that complicates the prediction of soil properties from Vis-NIR spectra, a spectral library representing the local soil diversity needs to be constructed. The study area, covering a surface of 927 km(2) and located in Yujiang County of Jiangsu Province, is characterized by a hilly area with different soil parent materials (e.g., red sandstone, shale, Quaternary red clay, and river alluvium). In total, 232 topsoil (0-20 cm) samples were collected for SOM analysis and scanned with a Vis-NIR spectrometer in the laboratory. Reflectance data were related to surface SOM content by means of a partial least square regression (PLSR) method and several data pre-processing techniques, such as first and second derivatives with a smoothing filter. The performance of the PLSR model was tested under different combinations of calibration/validation sets (global and local calibrations stratified according to parent materials). The results showed that the models based on the global calibrations can only make approximate predictions for SOM content (RMSE (root mean squared error) = 4.23-4.69 g kg(-1); R-2 (coefficient of determination) = 0.80-0.84; RPD (ratio of standard deviation to RMSE) = 2.19-2.44; RPIQ (ratio of performance to inter-quartile distance) = 2.88-3.08). Under the local calibrations, the individual PLSR models for each parent material improved SOM predictions (RMSE = 2.55-3.49 g kg(-1); R-2 = 0.87-0.93; RPD = 2.67-3.12; RPIQ = 3.15-4.02). Among the four different parent materials, the largest R-2 and the smallest RMSE were observed for the shale soils, which had the lowest coefficient of variation (CV) values for clay (18.95%), free iron oxides (15.93%), and pH (1.04%). This demonstrates the importance of a practical subsetting strategy for the continued improvement of SOM prediction with Vis-NIR spectroscopy.	[Xu, Shengxiang; Shi, Xuezheng; Wang, Meiyan; Zhao, Yongcun] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Xu, Shengxiang; Shi, Xuezheng; Wang, Meiyan; Zhao, Yongcun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, XZ (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.; Shi, XZ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	xzshi@issas.ac.cn			National Natural Science Foundation of China [41301242]; National Key Technology Research and Development Program of China [2013BAD11B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (41301242) and the National Key Technology Research and Development Program of China (2013BAD11B00).	Araujo SR, 2014, EUR J SOIL SCI, V65, P718, DOI 10.1111/ejss.12165; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; Ben-Dor E., 1999, MANUAL REMOTE SENSIN, V3, P111; Bilgili AV, 2010, J ARID ENVIRON, V74, P229, DOI 10.1016/j.jaridenv.2009.08.011; Brown DJ, 2006, GEODERMA, V132, P273, DOI 10.1016/j.geoderma.2005.04.025; Brown DJ, 2005, GEODERMA, V129, P251, DOI 10.1016/j.geoderma.2005.01.001; Brunet D, 2008, BIOSYST ENG, V100, P448, DOI 10.1016/j.biosystemseng.2008.04.008; Cecillon L, 2009, EUR J SOIL SCI, V60, P770, DOI 10.1111/j.1365-2389.2009.01178.x; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; Couteaux MM, 2003, SOIL BIOL BIOCHEM, V35, P1587, DOI 10.1016/j.soilbio.2003.08.003; DALAL RC, 1986, SOIL SCI SOC AM J, V50, P120, DOI 10.2136/sssaj1986.03615995005000010023x; Dardenne P, 2000, J NEAR INFRARED SPEC, V8, P229, DOI 10.1255/jnirs.283; Dematte JAM, 1999, SOIL SCI SOC AM J, V63, P327, DOI 10.2136/sssaj1999.03615995006300020010x; Dunn BW, 2002, AUST J EXP AGR, V42, P607, DOI 10.1071/EA01172; Fystro G, 2002, PLANT SOIL, V246, P139, DOI 10.1023/A:1020612319014; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; HENDERSON TL, 1992, SOIL SCI SOC AM J, V56, P865, DOI 10.2136/sssaj1992.03615995005600030031x; Hunt G. R., 1982, HDB PHYS PROPERTIES, P295; Jenny H., 1941, FACTORS SOIL FORMATI; Kuang B, 2011, EUR J SOIL SCI, V62, P629, DOI 10.1111/j.1365-2389.2011.01358.x; Ladoni M, 2010, PRECIS AGRIC, V11, P82, DOI 10.1007/s11119-009-9123-3; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; LEE KS, 2007, ASABE ANN INT M ST J; Lu R.K., 2000, SOIL AGR CHEM ANAL; Madari BE, 2005, SPECTROSC LETT, V38, P721, DOI 10.1080/00387010500315876; Martens H., 1992, MULTIVARIATE CALIBRA; McDowell M.L., 2012, APPL ENVIRON SOIL SC, DOI [10.1155/2012/294121, DOI 10.1155/2012/294121]; MEHRA O. P., 1960, Proceedings 7th nat. Conf. Clays, V5, P317; Mouazen AM, 2007, SOIL TILL RES, V93, P13, DOI 10.1016/j.still.2006.03.009; Nelson D.W., 1982, AGRONOMY SERIES, V9, P570; Nocita M, 2014, SOIL BIOL BIOCHEM, V68, P337, DOI 10.1016/j.soilbio.2013.10.022; O'Rourke SM, 2012, SOIL SCI SOC AM J, V76, P586, DOI 10.2136/sssaj2011.0053; Peng Y, 2013, J NEAR INFRARED SPEC, V21, P213, DOI 10.1255/jnirs.1053; Rawlins BG, 2011, GEODERMA, V166, P84, DOI 10.1016/j.geoderma.2011.07.015; Reeves J, 2002, ENVIRON POLLUT, V116, pS277, DOI 10.1016/S0269-7491(01)00259-7; Rinnan R, 2007, SOIL BIOL BIOCHEM, V39, P1664, DOI 10.1016/j.soilbio.2007.01.022; Rossel RAV, 2008, AUST J SOIL RES, V46, P1, DOI 10.1071/SR07099; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Rossel RAV, 2009, GEODERMA, V150, P253, DOI 10.1016/j.geoderma.2009.01.025; Rossel RAV, 2009, EUR J SOIL SCI, V60, P453, DOI 10.1111/j.1365-2389.2009.01121.x; Sankey JB, 2008, GEODERMA, V148, P149, DOI 10.1016/j.geoderma.2008.09.019; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Savvides A, 2010, GEODERMA, V154, P353, DOI 10.1016/j.geoderma.2009.11.007; [沙晋明 Sha Jinming], 2003, [水土保持研究, Research of Soil and Water Conservation], V10, P21; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Shi Z, 2015, EUR J SOIL SCI, V66, P679, DOI 10.1111/ejss.12272; Shi Z, 2014, SCI CHINA EARTH SCI, V57, P1671, DOI 10.1007/s11430-013-4808-x; Soil Survey Office of Yujiang County, 1986, SOIL SPEC YUJ COUNT, P23; St Luce M, 2014, GEODERMA, V232, P449, DOI 10.1016/j.geoderma.2014.05.023; Stevens A, 2010, GEODERMA, V158, P32, DOI 10.1016/j.geoderma.2009.11.032; STONER ER, 1981, SOIL SCI SOC AM J, V45, P1161, DOI 10.2136/sssaj1981.03615995004500060031x; Tian YC, 2013, GEODERMA, V202, P161, DOI 10.1016/j.geoderma.2013.03.018; Udelhoven T, 2003, PLANT SOIL, V251, P319, DOI 10.1023/A:1023008322682; Van Waes C, 2005, J AGR SCI, V143, P487, DOI 10.1017/S0021859605005630; Vasques GM, 2010, J ENVIRON QUAL, V39, P923, DOI 10.2134/jeq2009.0314; Vasques GM, 2009, SOIL SCI SOC AM J, V73, P176, DOI 10.2136/sssaj2008.0015; Waiser TH, 2007, SOIL SCI SOC AM J, V71, P389, DOI 10.2136/sssaj2006.0211; Wetterlind J, 2010, GEODERMA, V156, P152, DOI 10.1016/j.geoderma.2010.02.012; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zornoza R, 2008, SOIL BIOL BIOCHEM, V40, P1923, DOI 10.1016/j.soilbio.2008.04.003	63	12	14	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151536	10.1371/journal.pone.0151536	http://dx.doi.org/10.1371/journal.pone.0151536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974821	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600085
J	Prieto-Torres, DA; Rojas-Soto, OR				Prieto-Torres, David A.; Rojas-Soto, Octavio R.			Reconstructing the Mexican Tropical Dry Forests via an Autoecological Niche Approach: Reconsidering the Ecosystem Boundaries	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; GEOGRAPHICAL DISTRIBUTIONS; SELECTING THRESHOLDS; CLOUD FOREST; PREDICTION; BIODIVERSITY; REGIONALIZATION; PERFORMANCE; VEGETATION	We used Ecological Niche Modeling (ENM) of individual species of two taxonomic groups (plants and birds) in order to reconstruct the climatic distribution of Tropical Dry Forests (TDFs) in Mexico and to analyze their boundaries with other terrestrial ecosystems. The reconstruction for TDFs' distribution was analyzed considering the prediction and omission errors based upon the combination of species, obtained from the overlap of individual models (only plants, only birds, and all species combined). Two verifications were used: a primary vegetation map and 100 independent TDFs localities. We performed a Principal Component (PCA) and Discriminant Analysis (DA) to evaluate the variation in the environmental variables and ecological overlap among ecosystems. The modeling strategies showed differences in the ecological patterns and prediction areas, where the "all species combined" model (with a threshold of >= 10 species) was the best strategy to use in the TDFs reconstruction. We observed a concordance of 78% with the primary vegetation map and a prediction of 98% of independent locality records. Although PCA and DA tests explained 75.78% and 97.9% of variance observed, respectively, we observed an important overlap among the TDFs with other adjacent ecosystems, confirming the existence of transition zones among them. We successfully modeled the distribution of Mexican TDFs using a number of bioclimatic variables and co-distributed species. This autoecological niche approach suggests the necessity of rethinking the delimitations of ecosystems based on the recognition of transition zones among them in order to understand the real nature of communities and association patterns of species.	[Prieto-Torres, David A.; Rojas-Soto, Octavio R.] Inst Ecol AC, Lab Bioclimatol, Red Biol Evolut, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Rojas-Soto, OR (corresponding author), Inst Ecol AC, Lab Bioclimatol, Red Biol Evolut, Xalapa, Veracruz, Mexico.	octavio.rojas@inecol.mx	Rojas-Soto, Octavio/Q-6252-2018; Prieto-Torres, David A./N-1157-2017	Rojas-Soto, Octavio/0000-0002-0201-1454; Prieto-Torres, David A./0000-0002-0493-5941	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico); Smithsonian-Mason School of Conservation [MCCS 0500]; Rufford Foundation [16017-1]; Idea Wild;  [CONACyT 152060]	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Smithsonian-Mason School of Conservation; Rufford Foundation; Idea Wild; 	The first author offers thanks to Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) for a doctoral scholarship, and the Smithsonian-Mason School of Conservation for the scholarship during the course "Spatial Ecology, Geospatial Analysis and Remote Sensing for Conservation (MCCS 0500)" that provided the tools and skills necessary for the spatial analysis in this study. The Rufford Foundation (D. Prieto-Torres 16017-1), Idea Wild (D. Prieto-Torres), and the project CONACyT 152060 (O. Rojas-Soto) provided financial and logistical support.; The first author offers thanks to Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) for a doctoral scholarship, and the Smithsonian-Mason School of Conservation for the scholarship during the course "Spatial Ecology, Geospatial Analysis and Remote Sensing for Conservation (MCCS 0500)" that provided the tools and skills necessary for the spatial analysis in this study. The Rufford Foundation (D. Prieto-Torres 16017-1), Idea Wild (D. Prieto-Torres), and the project CONACyT 152060 (O. Rojas-Soto) provided financial and logistical support. Rosario Landgrave, H. Mauricio Ortega-Navarro and Claudio Mota-Vargas helped with the statistical analyses. Pablo C. Hernandez and Mayitza Ramirez kindly providing data for DTFs locality records. Alejandro Gordillo coordinated the geocoding of bird localities in the Atlas database. This manuscript was improved by comments from Diego Santiago, Elisa A. Bonaccorso, Adolfo G. Navarro-Siguenza Luis A. Sanchez-Gonzalez, and Cesar A. Rios-Munoz. Allison M. Jermain and Cristina Vallejo kindly reviewed the English translation.	Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; AUSTIN MP, 1989, VEGETATIO, V83, P35, DOI 10.1007/BF00031679; Bailey RG, 2014, ECOREGIONS ECOSYSTEM, V2nd; BARVE N, 2008, TOOL PARTIAL ROC VER; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Berger YG, 2007, BIOMETRIKA, V94, P953, DOI 10.1093/biomet/asm072; Challenger A, 2008, CAPITAL NATURAL MEXI, VI, DOI DOI 10.32800/ABC.2019.42.0187; Collevatti R. G., 2013, American Journal of Plant Sciences, V4, P792, DOI 10.4236/ajps.2013.44098; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dupin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020957; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2010, ARCMAP 10 0; Feria TP, 2002, DIVERS DISTRIB, V8, P49, DOI 10.1046/j.1472-4642.2002.00127.x; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2309, DOI 10.1023/A:1021374009951; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Gentry Alwyn H., 1995, P146, DOI 10.1017/CBO9780511753398.007; Giraldo J. P., 2011, Seasonally dry tropical forests: ecology and conservation, P129; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2000, PHYTOCOENOLOGIA, V30, P353; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUNTLEY B, 1991, ANN BOT-LONDON, V67, P15, DOI 10.1093/oxfordjournals.aob.a088205; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Krebs C., 1985, ECOLOGA ESTUDIO DIST; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Leibold MA, 1998, EVOL ECOL, V12, P95, DOI 10.1023/A:1006511124428; Linares-Palomino R., 2011, Seasonally dry tropical forests: ecology and conservation, P3; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Ortega-Andrade HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121137; Mayer AL, 2004, BIOSCIENCE, V54, P1013, DOI 10.1641/0006-3568(2004)054[1013:TDRCFE]2.0.CO;2; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; MCINTOSH RP, 1967, BOT REV, V33, P130, DOI 10.1007/BF02858667; Meloun M, 2002, ANALYST, V127, P433, DOI 10.1039/b110779h; MIRANDA F., 1963, BOL SOC BOT MEXICO, V28, P29; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Morrone JJ, 2014, CLADISTICS, V30, P202, DOI 10.1111/cla.12039; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Navarro S. Adolfo G., 2003, Bulletin of the British Ornithologists' Club, V123A, P207; Nie N. H., 1975, SPSS STAT PACKAGE SO, V227; Nood?n L.D., 1988, SENESCENCE AGING PLA, P329, DOI DOI 10.1016/B978-0-12-520920-5.50007-9.; Olden JD, 2003, CONSERV BIOL, V17, P854, DOI 10.1046/j.1523-1739.2003.01280.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Perez-Garcia EA, 2012, ACTA BOT MEX, V100, P149; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ponce-Reyes R, 2012, NAT CLIM CHANGE, V2, P448, DOI 10.1038/NCLIMATE1453; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Pottier J, 2013, GLOBAL ECOL BIOGEOGR, V22, P52, DOI 10.1111/j.1466-8238.2012.00790.x; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Prieto-Torres DA, 2016, GLOBAL CHANGE BIOL, V22, P364, DOI 10.1111/gcb.13090; Rios-Munoz CA, 2012, STUD NEOTROP FAUNA E, V47, P171, DOI 10.1080/01650521.2012.734175; RITCHIE JC, 1986, VEGETATIO, V67, P65, DOI 10.1007/BF00037358; Rojas-Soto OR, 2012, BIODIVERS CONSERV, V21, P2671, DOI 10.1007/s10531-012-0327-x; Rojas-Soto OR, 2003, J BIOGEOGR, V30, P449, DOI 10.1046/j.1365-2699.2003.00836.x; Rzedowski J., 1978, VEGETACION MEXICO; Rzedowski J, 1979, TOPICOS ECOLOGIA CON, P37; Sanchez-Azofeifa GA, 2005, BIOTROPICA, V37, P477, DOI 10.1111/j.1744-7429.2005.00066.x; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stoner K. E., 2004, BIODIVERS CONSERV, P8; Stoner Kathryn E., 2011, P85; Thompson J. N., 2005, INTERSPEC INTERACT; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; TREJO I, 1998, DISTRIBUCION DIVERSI; Trejo Vazquez I, 1999, INVESTIGACIONES GEOG, P40, DOI DOI 10.14350/RIG.59082; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142	84	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150932	10.1371/journal.pone.0150932	http://dx.doi.org/10.1371/journal.pone.0150932			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968031	Green Submitted, gold, Green Published			2022-12-26	WOS:000371989200020
J	Kim, JH; Kang, MS; Eltohamy, M; Kim, TH; Kim, HW				Kim, Joong-Hyun; Kang, Min Sil; Eltohamy, Mohamed; Kim, Tae-Hyun; Kim, Hae-Won			Dynamic Mechanical and Nanofibrous Topological Combinatory Cues Designed for Periodontal Ligament Engineering	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; CELLS IN-VITRO; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; OSTEOBLAST DIFFERENTIATION; MINERALIZED NODULES; GENE-EXPRESSION; CYCLIC STRETCH; STRESS; REGENERATION	Complete reconstruction of damaged periodontal pockets, particularly regeneration of periodontal ligament (PDL) has been a significant challenge in dentistry. Tissue engineering approach utilizing PDL stem cells and scaffolding matrices offers great opportunity to this, and applying physical and mechanical cues mimicking native tissue conditions are of special importance. Here we approach to regenerate periodontal tissues by engineering PDL cells supported on a nanofibrous scaffold under a mechanical-stressed condition. PDL stem cells isolated from rats were seeded on an electrospun polycaprolactone/ gelatin directionally-oriented nanofiber membrane and dynamic mechanical stress was applied to the cell/nanofiber construct, providing nanotopological and mechanical combined cues. Cells recognized the nanofiber orientation, aligning in parallel, and the mechanical stress increased the cell alignment. Importantly, the cells cultured on the oriented nanofiber combined with the mechanical stress produced significantly stimulated PDL specific markers, including periostin and tenascin with simultaneous down-regulation of osteogenesis, demonstrating the roles of topological and mechanical cues in altering phenotypic change in PDL cells. Tissue compatibility of the tissue-engineered constructs was confirmed in rat subcutaneous sites. Furthermore, in vivo regeneration of PDL and alveolar bone tissues was examined under the rat premaxillary periodontal defect models. The cell/nanofiber constructs engineered under mechanical stress showed sound integration into tissue defects and the regenerated bone volume and area were significantly improved. This study provides an effective tissue engineering approach for periodontal regeneration-culturing PDL stem cells with combinatory cues of oriented nanotopology and dynamic mechanical stretch.	[Kim, Joong-Hyun; Kang, Min Sil; Eltohamy, Mohamed; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea; [Kim, Joong-Hyun; Kang, Min Sil; Eltohamy, Mohamed; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Kim, Joong-Hyun; Kang, Min Sil; Eltohamy, Mohamed; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan, South Korea	Dankook University; Dankook University; Dankook University; Dankook University	Kim, HW (corresponding author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea.; Kim, HW (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.; Kim, HW (corresponding author), Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea.; Kim, HW (corresponding author), Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan, South Korea.	kimhw@dku.edu	Eltohamy, Mohamed/J-8507-2015	Eltohamy, Mohamed/0000-0003-2344-3501	National Research Foundation, South Korea [2009-0093829, NRF-2013R1A1A2013414, 2015032163]	National Research Foundation, South Korea(National Research Foundation of Korea)	This study was supported by grants from the Priority Research Centers Program (2009-0093829), Basic Research Program (NRF-2013R1A1A2013414), and Global Research Laboratory Program (GRL; 2015032163), National Research Foundation, South Korea.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bartold PM, 2006, PERIODONTOL 2000, V41, P123, DOI 10.1111/j.1600-0757.2006.00156.x; BENES AJ, 1985, J CELL SCI, V75, P35; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326; Chiba M, 2004, CELL BIOCHEM FUNCT, V22, P249, DOI 10.1002/cbf.1097; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; CHO MI, 1992, CALCIFIED TISSUE INT, V50, P459, DOI 10.1007/BF00296778; Cillo JE, 2000, ORAL SURG ORAL MED O, V90, P147, DOI 10.1067/moe.2000.107531; Doi T, 2003, ARCH ORAL BIOL, V48, P573, DOI 10.1016/S0003-9969(03)00103-1; Doroski DM, 2010, TISSUE ENG PT A, V16, P3457, DOI 10.1089/ten.tea.2010.0233; Edwards Paul C, 2006, Head Face Med, V2, P16, DOI 10.1186/1746-160X-2-16; English A, 2015, ACTA BIOMATER, V27, P3, DOI 10.1016/j.actbio.2015.08.035; Fujii S, 2010, CELL TISSUE RES, V342, P233, DOI 10.1007/s00441-010-1037-x; Gauvin R, 2011, ACTA BIOMATER, V7, P3294, DOI 10.1016/j.actbio.2011.05.034; Han J, 2014, AUST DENT J, V59, P117, DOI 10.1111/adj.12100; Hasegawa D, 2015, J CELL PHYSIOL, V230, P2647, DOI 10.1002/jcp.24950; Jin Y, 2015, ANGLE ORTHOD, V85, P87, DOI 10.2319/123113-955.1; Kaku M, 2016, J CELL PHYSIOL, V231, P926, DOI 10.1002/jcp.25184; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Kim JH, 2014, J DENT RES, V93, P1203, DOI 10.1177/0022034514540682; Kono K, 2013, CELL TISSUE RES, V352, P249, DOI 10.1007/s00441-012-1543-0; Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037; Li L, 2013, DNA CELL BIOL, V32, P488, DOI 10.1089/dna.2013.2070; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Liu MY, 2012, GENE, V491, P187, DOI 10.1016/j.gene.2011.09.031; Ma JY, 2015, ARCH ORAL BIOL, V60, P447, DOI 10.1016/j.archoralbio.2014.11.019; MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796; Matsuda N, 1998, ARCH ORAL BIOL, V43, P987, DOI 10.1016/S0003-9969(98)00079-X; Monnouchi S, 2015, J PERIODONTAL RES, V50, P231, DOI 10.1111/jre.12200; Morioka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026384; Oortgiesen DAW, 2012, TISSUE ENG PART C-ME, V18, P81, DOI [10.1089/ten.tec.2011.0367, 10.1089/ten.TEC.2011.0367]; Ozaki S, 2005, J PERIODONTAL RES, V40, P110, DOI 10.1111/j.1600-0765.2004.00782.x; RAMAKRISHNAN PR, 1995, CALCIFIED TISSUE INT, V57, P52, DOI 10.1007/BF00298997; Ren DP, 2015, J CELL PHYSIOL, V230, P2426, DOI 10.1002/jcp.24972; Saminathan A, 2012, J PERIODONTAL RES, V47, P212, DOI 10.1111/j.1600-0765.2011.01423.x; Saminathan A, 2015, TISSUE ENG PT A, V21, P518, DOI [10.1089/ten.tea.2014.0221, 10.1089/ten.TEA.2014.0221]; Shin SH, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412443530; Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15; Yamashiro K, 2007, INT J BIOCHEM CELL B, V39, P910, DOI 10.1016/j.biocel.2007.01.015; Yang L, 2015, ARCH ORAL BIOL, V60, P416, DOI 10.1016/j.archoralbio.2014.11.012; Yang Y, 2010, BIOMATERIALS, V31, P8574, DOI 10.1016/j.biomaterials.2010.06.026; Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083; Yu N, 2013, J PERIODONTOL, V84, P1504, DOI 10.1902/jop.2012.120513; ZHANG XL, 1993, J HISTOCHEM CYTOCHEM, V41, P245, DOI 10.1177/41.2.7678270; Ziegler N, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-10	46	34	35	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0149967	10.1371/journal.pone.0149967	http://dx.doi.org/10.1371/journal.pone.0149967			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989897	gold, Green Published			2022-12-26	WOS:000372582800022
J	Pohle, S; Baty, F; Brutsche, M				Pohle, Susanne; Baty, Florent; Brutsche, Martin			In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012	PLOS ONE			English	Article							UNITED-STATES; CANCER-RISK; FOLLOW-UP; MORTALITY; POPULATION	Sarcoidosis is a multisystem disease with an unpredictable and sometimes fatal course while the underlying pathomechanism is still unclear. Reasons of the increasing hospitalization rate and mortality in the United States remain in dispute but incriminated are a number of distinct comorbidities and risk factors as well as the application of more aggressive therapeutic agents. Studies reflecting the recent development in central Europe are lacking. Our aim was to investigate the recent mortality and hospitalization rates as well as the underlying comorbidities of hospitalized sarcoidosis patients in Switzerland. In this longitudinal, nested case-control study, a nation-wide database provided by the Swiss Federal Office for Statistics enclosing every hospital entry covering the years 2002-2012 (n = 15,627,573) was analyzed. There were 8,385 cases with a diagnosis of sarcoidosis representing 0.054% (8,385 / 15,627,573) of all hospitalizations in Switzerland. These cases were compared with age- and sex-matched controls without the diagnosis of sarcoidosis. Hospitalization and mortality rates in Switzerland remained stable over the observed time period. Comorbidity analysis revealed that sarcoidosis patients had significantly higher medication-related comorbidities compared to matched controls, probably due to systemic corticosteroids and immunosuppressive therapy. Sarcoidosis patients were also more frequently re-hospitalized (median annual hospitalization rate 0.28 [IQR 0.15-0.65] vs. 0.19 [IQR 0.13-0.36] per year; p < 0.001), had a longer hospital stay (6 [IQR 2-13] vs. 4 [IQR 1-8] days; p < 0.001), had more comorbidities (4 [IQR 2-7] vs. 2 [IQR 1-5]; p < 0.001), and had a significantly higher in-hospital mortality (2.6% [95% CI 2.3%-2.9%] vs. 1.8% [95% CI 1.5%-2.1%] (p < 0.001). A worse outcome was observed among sarcoidosis patients having co-occurrence of associated respiratory diseases. Moreover, age was an important risk factor for re-hospitalization.	[Pohle, Susanne; Baty, Florent; Brutsche, Martin] Cantonal Hosp St Gallen, Dept Pulm Med, St Gallen, Switzerland	Kantonsspital St. Gallen	Baty, F (corresponding author), Cantonal Hosp St Gallen, Dept Pulm Med, St Gallen, Switzerland.	florent.baty@kssg.ch		Brutsche, Martin/0000-0002-1612-3609	Lungenliga St. Gallen; Kantonsspital St. Gallen	Lungenliga St. Gallen; Kantonsspital St. Gallen	The study was supported by an unconditional research grant by the Lungenliga St. Gallen and an institutional grant by the Kantonsspital St. Gallen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by an unconditional research grant by the Lungenliga St. Gallen and an institutional grant by the Kantonsspital St. Gallen.	[Anonymous], 2010, BIPLOTS PRACTICE; [Anonymous], 2014, R LANG ENV STAT COMP; Baty F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063285; Bonifazi M, 2015, CHEST, V147, P778, DOI 10.1378/chest.14-1475; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deubelbeiss U, 2010, EUR RESPIR J, V35, P1088, DOI 10.1183/09031936.00197808; Duncan ME, 2012, INT J TUBERC LUNG D, V16, P38, DOI 10.5588/ijtld.11.0077; Foreman MG, 2006, SARCOIDOSIS VASC DIF, V23, P124; Gerke AK, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-19; Gideon NM, 1996, AM J MED, V100, P423, DOI 10.1016/S0002-9343(97)89518-6; Ji J, 2009, ANN ONCOL, V20, P1121, DOI 10.1093/annonc/mdn767; Le Jeune I, 2007, RESP MED, V101, P2534, DOI 10.1016/j.rmed.2007.07.012; Mirsaeidi M, 2015, CHEST, V147, P438, DOI 10.1378/chest.14-1120; Nardi A, 2011, EUR RESPIR J, V38, P1368, DOI 10.1183/09031936.00187410; Oksanen, 2010, MULTIVARIATE ANAL EC; Romer FK, 1998, EUR RESPIR J, V12, P906, DOI 10.1183/09031936.98.12040906; Swigris JJ, 2011, CHEST, V140, P1261, DOI 10.1378/chest.11-0324; Swigris JJ, 2011, AM J RESP CRIT CARE, V183, P1524, DOI 10.1164/rccm.201010-1679OC; Tukey MH, 2013, SARCOIDOSIS VASC DIF, V30, P128; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7	20	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151940	10.1371/journal.pone.0151940	http://dx.doi.org/10.1371/journal.pone.0151940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987059	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300156
J	Urbaniak, M; Tygielska, A; Krauze, K; Mankiewicz-Boczek, J				Urbaniak, Magdalena; Tygielska, Adrianna; Krauze, Kinga; Mankiewicz-Boczek, Joanna			Effects of Stormwater and Snowmelt Runoff on ELISA-EQ Concentrations of PCDD/PCDF and Triclosan in an Urban River	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; WATER TREATMENT-PLANT; DIBENZO-P-DIOXINS; WASTE-WATER; POLYCHLORINATED-BIPHENYLS; SURFACE WATERS; SPATIAL-DISTRIBUTION; 1ST FLUSH; SEDIMENTS; POLLUTANTS	The aim of the study was to determine the effects of stormwater and snowmelt runoff on the ELISA EQ PCDD/PCDF and triclosan concentrations in the small urban Sokolowka River (Central Poland). The obtained results demonstrate the decisive influence of hydrological conditions occurring in the river itself and its catchment on the quoted PCDD/PCDF ELISA EQ concentrations. The lowest PCDD/PCDF values of 87, 60 and 67 ng EQ L-1 in stormwater, the river and its reservoirs, respectively, were associated with the highest river flow of 0.02 m(3) s(-1) and high precipitation (11.2 mm) occurred five days before sampling. In turn, the highest values of 353, 567 and 343 ng EQ L-1 in stormwater, the river and its reservoirs, respectively, were observed during periods of intensive snow melting (stormwater samples) and spring rainfall preceded by a rainless phase (river and reservoir samples) followed by low and moderate river flows of 0.01 and 0.005 m3 s(-1). An analogous situation was observed for triclosan, with higher ELISA EQ concentrations (444 to 499 ng EQ L-1) noted during moderate river flow and precipitation, and the lowest (232 to 288 ng EQ L-1) observed during high river flow and high precipitation preceded by violent storms. Stormwater was also found to influence PCDD/PCDF EQ concentrations of the river and reservoirs, however only during high and moderate flow, and no such effect was observed for triclosan. The study clearly demonstrates that to mitigate the high peaks of the studied pollutants associated with river hydrology, the increased in-site stormwater infiltration and purification, the development of buffering zones along river course and the systematic maintenance of reservoirs to avoid the accumulation of the studied micropollutants and their subsequent release after heavy rainfall are required.	[Urbaniak, Magdalena; Krauze, Kinga; Mankiewicz-Boczek, Joanna] Polish Acad Sci, European Reg Ctr Ecohydrol, Tylna 3, PL-90364 Lodz, Poland; [Urbaniak, Magdalena; Tygielska, Adrianna; Mankiewicz-Boczek, Joanna] Univ Lodz, Fac Biol & Environm Protect, Dept Appl Ecol, Banacha 12-16, PL-90237 Lodz, Poland	Polish Academy of Sciences; European Regional Centre for Ecohydrology of the Polish Academy of Sciences; University of Lodz	Urbaniak, M (corresponding author), Polish Acad Sci, European Reg Ctr Ecohydrol, Tylna 3, PL-90364 Lodz, Poland.; Urbaniak, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Appl Ecol, Banacha 12-16, PL-90237 Lodz, Poland.	m.urbaniak@unesco.lodz.pl	Mankiewicz-Boczek, Joanna/J-2427-2018	Mankiewicz-Boczek, Joanna/0000-0001-7358-0673; Krauze, Kinga/0000-0002-8767-0183; Urbaniak, Magdalena/0000-0001-5118-4530	Life+ EnvEurope [LIFE08 ENV/IT/0003999]	Life+ EnvEurope	This work was funded by the Life+ EnvEurope project No LIFE08 ENV/IT/0003999 (www.enveurope.eu).; The sampling and analyses have been conducted as a contribution to Life+ EnvEurope project No LIFE08 ENV/IT/0003999 (www.enveurope.eu).	Aguera A, 2003, ANAL CHIM ACTA, V480, P193, DOI 10.1016/S0003-2670(03)00040-0; Aranami K, 2007, CHEMOSPHERE, V66, P1052, DOI 10.1016/j.chemosphere.2006.07.010; Bartnik A, 2008, PROBLEMY EKOLOGII KR, VXXII, P39; Brausch JM, 2011, CHEMOSPHERE, V82, P1518, DOI 10.1016/j.chemosphere.2010.11.018; Chalew TEA, 2009, J AM WATER RESOUR AS, V45, P4, DOI 10.1111/j.1752-1688.2008.00284.x; Engelhard C, 2007, SCI TOTAL ENVIRON, V382, P286, DOI 10.1016/j.scitotenv.2007.04.008; Gilbreath AN, 2015, SCI TOTAL ENVIRON, V526, P251, DOI 10.1016/j.scitotenv.2015.04.052; Gobel P, 2007, J CONTAM HYDROL, V91, P26, DOI 10.1016/j.jconhyd.2006.08.008; GREGOR DJ, 1995, SCI TOTAL ENVIRON, V160-61, P117, DOI 10.1016/0048-9697(95)04349-6; Gromaire-Mertz MC, 1999, WATER SCI TECHNOL, V39, P1, DOI 10.1016/S0273-1223(99)00002-5; Hathaway JM, 2012, WATER AIR SOIL POLL, V223, P5903, DOI 10.1007/s11270-012-1327-x; Hathaway JM, 2011, WATER AIR SOIL POLL, V217, P135, DOI 10.1007/s11270-010-0574-y; Herbert BMJ, 2006, ECOTOX ENVIRON SAFE, V63, P3, DOI 10.1016/j.ecoenv.2005.05.012; HORSTMANN M, 1995, CHEMOSPHERE, V31, P2887, DOI 10.1016/0045-6535(95)00156-3; Hua WY, 2005, ENVIRON INT, V31, P621, DOI 10.1016/j.envint.2004.10.019; Jartun M, 2008, SCI TOTAL ENVIRON, V396, P147, DOI 10.1016/j.scitotenv.2008.02.002; Kanda R, 2003, J ENVIRON MONITOR, V5, P823, DOI 10.1039/b306355k; Kantiani L, 2008, J HYDROL, V361, P1, DOI 10.1016/j.jhydrol.2008.07.016; Katz DR, 2013, SCI TOTAL ENVIRON, V443, P123, DOI 10.1016/j.scitotenv.2012.10.052; KAWAMURA K, 1986, ATMOS ENVIRON, V20, P527, DOI 10.1016/0004-6981(86)90093-4; Kayhanian M, 2003, J ENVIRON ENG-ASCE, V129, P975, DOI 10.1061/(ASCE)0733-9372(2003)129:11(975); Kim SW, 2014, ENVIRON EARTH SCI, V71, P483, DOI 10.1007/s12665-013-2933-7; Kishida M, 2013, J ENVIRON SCI-CHINA, V25, P441, DOI 10.1016/S1001-0742(12)60091-6; Kundzewicz ZW, 2009, NATURE, V459, P31, DOI 10.1038/459031a; Latch DE, 2005, ENVIRON TOXICOL CHEM, V24, P517, DOI 10.1897/04-243R.1; Latch DE, 2003, J PHOTOCH PHOTOBIO A, V158, P63, DOI 10.1016/S1010-6030(03)00103-5; Lei YD, 2004, ATMOS ENVIRON, V38, P3557, DOI 10.1016/j.atmosenv.2004.03.039; Levy W, 2014, TOXICOL IN VITRO, V28, P1036, DOI 10.1016/j.tiv.2014.04.009; Li W, 2012, FRONT ENV SCI ENG, V6, P692, DOI 10.1007/s11783-012-0444-5; Lindstrom A, 2002, ENVIRON SCI TECHNOL, V36, P2322, DOI 10.1021/es0114254; Lohmann R, 1998, SCI TOTAL ENVIRON, V219, P53, DOI 10.1016/S0048-9697(98)00237-X; Marsalek J, 2006, TECHNICAL DOCUMENTS; McAvoy DC, 2002, ENVIRON TOXICOL CHEM, V21, P1323, DOI 10.1897/1551-5028(2002)021<1323:MOTIWT>2.0.CO;2; McLachlan MS, 1996, SCI TOTAL ENVIRON, V185, P109, DOI 10.1016/0048-9697(96)05046-2; Meharg AA, 2003, SCI TOTAL ENVIRON, V314, P439, DOI 10.1016/S0048-9697(03)00067-6; Mezcua M, 2004, ANAL CHIM ACTA, V524, P241, DOI 10.1016/j.aca.2004.05.050; Montagner CC, 2014, ENVIRON SCI POLLUT R, V21, P1850, DOI 10.1007/s11356-013-2063-5; NAF C, 1990, CHEMOSPHERE, V20, P1503, DOI 10.1016/0045-6535(90)90304-C; Negussie Yohannes Zerihun, 2012, Ecohydrology & Hydrobiology, V12, P271, DOI 10.2478/v10104-012-0028-9; Nichkova M, 2004, TALANTA, V63, P1213, DOI 10.1016/j.talanta.2004.05.030; Rossi L, 2004, SCI TOTAL ENVIRON, V322, P179, DOI 10.1016/S0048-9697(03)00361-9; Rule KL, 2005, ENVIRON SCI TECHNOL, V39, P3176, DOI 10.1021/es048943+; Sabaliunas D, 2003, WATER RES, V37, P3145, DOI 10.1016/S0043-1354(03)00164-7; Sanchez-Prado L, 2006, CHEMOSPHERE, V65, P1338, DOI 10.1016/j.chemosphere.2006.04.025; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Sriyaraj K, 2002, ENVIRON INT, V26, P433; Stolarska M, 2011, RAINWATER EXTREME EV, P215; Sugawara Y, 2002, CHEMOSPHERE, V46, P1471, DOI 10.1016/S0045-6535(01)00267-3; Szklarek S, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4252-1; Urbaniak M, 2008, POL J ENVIRON STUD, V17, P941; Urbaniak M, 2015, INT J ENVIRON RES, V9, P745; Urbaniak M, 2013, HYDROL RES, V44, P614, DOI 10.2166/nh.2012.236; Urbaniak M, 2012, CHEMOSPHERE, V88, P1358, DOI 10.1016/j.chemosphere.2012.05.040; Urbaniak M, 2010, FRESEN ENVIRON BULL, V19, P2710; Urbaniak M, 2010, POL J ENVIRON STUD, V19, P201; Urbaniak M, 2009, ENVIRON PROT ENG, V35, P93; Van Emon JM, 2008, CHEMOSPHERE, V72, P95, DOI 10.1016/j.chemosphere.2008.01.012; von der Ohe PC, 2012, ENVIRON SCI POLLUT R, V19, P585, DOI 10.1007/s11356-011-0580-7; Wagner Iwona, 2013, Ecohydrology & Hydrobiology, V13, P113, DOI 10.1016/j.ecohyd.2013.06.002; Waltman EL, 2006, ENVIRON TOXICOL CHEM, V25, P367, DOI 10.1897/05-112R.1; Wilson B, 2009, MAR POLLUT BULL, V59, P207, DOI 10.1016/j.marpolbul.2009.03.026; Zgheib S, 2012, WATER RES, V46, P6683, DOI 10.1016/j.watres.2011.12.012; Zhao JL, 2013, WATER RES, V47, P395, DOI 10.1016/j.watres.2012.10.022	64	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151756	10.1371/journal.pone.0151756	http://dx.doi.org/10.1371/journal.pone.0151756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985830	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300123
J	Cobos-Trigueros, N; Sole, M; Castro, P; Torres, JL; Rinaudo, M; De Lazzari, E; Morata, L; Hernandez, C; Fernandez, S; Soriano, A; Nicolas, JM; Mensa, J; Vila, J; Martinez, JA				Cobos-Trigueros, Nazaret; Sole, Mar; Castro, Pedro; Luis Torres, Jorge; Rinaudo, Mariano; De lazzari, Elisa; Morata, Laura; Hernandez, Cristina; Fernandez, Sara; Soriano, Alex; Maria Nicolas, Jose; Mensa, Josep; Vila, Jordi; Antonio Martinez, Jose			Evaluation of a Mixing versus a Cycling Strategy of Antibiotic Use in Critically-Ill Medical Patients: Impact on Acquisition of Resistant Microorganisms and Clinical Outcomes	PLOS ONE			English	Article							REDUCE ANTIMICROBIAL RESISTANCE; VENTILATOR-ASSOCIATED PNEUMONIA; INFECTIOUS-DISEASES SOCIETY; GRAM-NEGATIVE BACTERIA; ROTATION; UNIT; EPIDEMIOLOGY; GUIDELINES; EXPERIENCE; HOSPITALS	Objective To compare the effect of two strategies of antibiotic use (mixing vs. cycling) on the acquisition of resistant microorganisms, infections and other clinical outcomes. Methods Prospective cohort study in an 8-bed intensive care unit during 35- months in which a mixing-cycling policy of antipseudomonal beta-lactams (meropenem, ceftazidime/piperacillin-tazobactam) and fluoroquinolones was operative. Nasopharyngeal and rectal swabs and respiratory secretions were obtained within 48h of admission and thrice weekly thereafter. Target microorganisms included methicillin-resistant S. aureus, vancomycin-resistant enterococci, third-generation cephalosporin-resistant Enterobacteriaceae and non-fermenters. Results A total of 409 (42%) patients were included in mixing and 560 (58%) in cycling. Exposure to ceftazidime/piperacillin-tazobactam and fluoroquinolones was significantly higher in mixing while exposure to meropenem was higher in cycling, although overall use of antipseudomonals was not significantly different (37.5/100 patient-days vs. 38.1/100 patient-days). There was a barely higher acquisition rate of microorganisms during mixing, but this difference lost its significance when the cases due to an exogenous Burkholderia cepacia outbreak were excluded (19.3% vs. 15.4%, OR 0.8, CI 0.5-1.1). Acquisition of Pseudomonas aeruginosa resistant to the intervention antibiotics or with multiple-drug resistance was similar. There were no significant differences between mixing and cycling in the proportion of patients acquiring any infection (16.6% vs. 14.5%, OR 0.9, CI 0.6-1.2), any infection due to target microorganisms (5.9% vs. 5.2%, OR 0.9, CI 0.5-1.5), length of stay (median 5 d for both groups) or mortality (13.9 vs. 14.3%, OR 1.03, CI 0.7-1.3). Conclusions A cycling strategy of antibiotic use with a 6-week cycle duration is similar to mixing in terms of acquisition of resistant microorganisms, infections, length of stay and mortality.	[Cobos-Trigueros, Nazaret; Luis Torres, Jorge; Morata, Laura; Soriano, Alex; Mensa, Josep; Antonio Martinez, Jose] Univ Barcelona, Dept Infect Dis, Hosp Clin, IDIBAPS, Barcelona, Spain; [Sole, Mar; Vila, Jordi] Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain; [Castro, Pedro; Rinaudo, Mariano; Hernandez, Cristina; Fernandez, Sara; Maria Nicolas, Jose] Univ Barcelona, Med Intens Care Unit, IDIBAPS, Hosp Clin, Barcelona, Spain; [De lazzari, Elisa] Univ Barcelona, Hlth Biostat, IDIBAPS, Hosp Clin, Barcelona, Spain; [Vila, Jordi] Univ Barcelona, Dept Clin Microbiol, Sch Med, Hosp Clin, Barcelona, Spain; [Luis Torres, Jorge] Univ Hosp Salamanca, Dept Internal Med, Inst Biomed Res Salamanca IBSAL, Salamanca, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Salamanca	Cobos-Trigueros, N (corresponding author), Univ Barcelona, Dept Infect Dis, Hosp Clin, IDIBAPS, Barcelona, Spain.	fncobos@clinic.ub.es	Rebollo, Pedro Castro/AAF-4792-2021; Soriano, Alex/I-1210-2017; Vila, Jordi/P-3613-2016; Fernandez, Sara/AGZ-0326-2022; Morata, Laura/B-1817-2019; Castro, Pedro/AAG-2513-2021; Triana, Jorge Luis Torres/AAA-7819-2019	Rebollo, Pedro Castro/0000-0002-6118-8970; Soriano, Alex/0000-0002-9374-0811; Vila, Jordi/0000-0002-8025-3926; Morata, Laura/0000-0001-5795-0814; Triana, Jorge Luis Torres/0000-0001-6853-9115; De Lazzari, Elisa/0000-0003-2614-6545	Fondo de Investigaciones Sanitarias, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Ciencia e Innovacion, Gobierno de Espana [PI050167]	Fondo de Investigaciones Sanitarias, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Ciencia e Innovacion, Gobierno de Espana	This study was supported by a grant from the Fondo de Investigaciones Sanitarias, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Ciencia e Innovacion, Gobierno de Espana (PI050167 to JAM).	Allegranzi B, 2002, J HOSP INFECT, V52, P136, DOI 10.1053/jhin.2002.1277; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Bal AM, 2010, ANN NY ACAD SCI, V1213, P81, DOI 10.1111/j.1749-6632.2010.05867.x; Bennett KM, 2007, J TRAUMA, V63, P307, DOI 10.1097/TA.0b013e318120595e; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Cadena J, 2007, BONE MARROW TRANSPL, V40, P151, DOI 10.1038/sj.bmt.1705704; Chong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054190; Chow Karen, 2011, Journal of Biological Dynamics, V5, P27, DOI 10.1080/17513758.2010.488300; CLSI, 2009, M100S19 CLSI S; Damas P, 2006, INTENS CARE MED, V32, P67, DOI 10.1007/s00134-005-2805-z; Evans Heather L, 2005, Surg Infect (Larchmt), V6, P223, DOI 10.1089/sur.2005.6.223; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; GERDING DN, 1991, ANTIMICROB AGENTS CH, V35, P1284, DOI 10.1128/AAC.35.7.1284; Gruson D, 2003, CRIT CARE MED, V31, P1908, DOI 10.1097/01.CCM.0000069729.06687.DE; Gruson D, 2000, AM J RESP CRIT CARE, V162, P837, DOI 10.1164/ajrccm.162.3.9905050; Hedrick TL, 2008, SURG INFECT, V9, P139, DOI 10.1089/sur.2006.102; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Magee JT, 2005, J ANTIMICROB CHEMOTH, V56, P427, DOI 10.1093/jac/dki229; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Martinez JA, 2006, CRIT CARE MED, V34, P329, DOI 10.1097/01.CCM.0000195010.63855.45; MCGOWAN JE, 1983, REV INFECT DIS, V5, P1033; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Moss WJ, 2002, CRIT CARE MED, V30, P1877, DOI 10.1097/00003246-200208000-00034; Nijssen S, 2010, INTENS CARE MED, V36, P512, DOI 10.1007/s00134-009-1714-y; Raymond DP, 2001, CRIT CARE MED, V29, P1101, DOI 10.1097/00003246-200106000-00001; Ruiz M, 2000, AM J RESP CRIT CARE, V162, P119, DOI 10.1164/ajrccm.162.1.9907090; Sandiumenge A, 2006, J ANTIMICROB CHEMOTH, V57, P1197, DOI 10.1093/jac/dkl097; Sarraf-Yazdi S, 2012, J SURG RES, V176, pE73, DOI 10.1016/j.jss.2011.12.014; Shlaes DM, 1997, CLIN INFECT DIS, V25, P584, DOI 10.1086/513766; Smith RL, 2008, SURG INFECT, V9, P423, DOI 10.1089/sur.2007.024; Takesue Y, 2010, J HOSP INFECT, V75, P28, DOI 10.1016/j.jhin.2009.11.022; Toltzis P, 2002, PEDIATRICS, V110, P707, DOI 10.1542/peds.110.4.707; van Duijn PJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-277; van Loon HJ, 2005, AM J RESP CRIT CARE, V171, P480, DOI 10.1164/rccm.200401-070OC; Warren DK, 2004, CRIT CARE MED, V32, P2450, DOI 10.1097/01.CCM.0000147685.79487.28; zur Wiesch PA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004225	39	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150274	10.1371/journal.pone.0150274	http://dx.doi.org/10.1371/journal.pone.0150274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982807	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900029
J	Farran, LK; Lee, CC; Yoo, H; Oller, DK				Farran, Lama K.; Lee, Chia-Cheng; Yoo, Hyunjoo; Oller, D. Kimbrough			Cross-Cultural Register Differences in Infant-Directed Speech: An Initial Study	PLOS ONE			English	Article							MOTHERS SPEECH; VOCABULARY GROWTH; MATERNAL SPEECH; LANGUAGE; CHILDREN; PITCH; AGE; SPECIFICITY; ADJUSTMENTS; BEHAVIORS	Infant-directed speech (IDS) provides an environment that appears to play a significant role in the origins of language in the human infant. Differences have been reported in the use of IDS across cultures, suggesting different styles of infant language-learning. Importantly, both cross-cultural and intra-cultural research suggest there may be a positive relationship between the use of IDS and rates of language development, underscoring the need to investigate cultural differences more deeply. The majority of studies, however, have conceptualized IDS monolithically, granting little attention to a potentially key distinction in how IDS manifests across cultures during the first two years. This study examines and quantifies for the first time differences within IDS in the use of baby register (IDS/BR), an acoustically identifiable type of IDS that includes features such as high pitch, long duration, and smooth intonation (the register that is usually assumed to occur in IDS), and adult register (IDS/AR), the type of IDS that does not include such features and thus sounds as if it could have been addressed to an adult. We studied IDS across 19 American and 19 Lebanese mother-infant dyads, with particular focus on the differential use of registers within IDS as mothers interacted with their infants ages 0-24 months. Our results showed considerable usage of IDS/AR (>30% of utterances) and a tendency for Lebanese mothers to use more IDS than American mothers. Implications for future research on IDS and its role in elucidating how language evolves across cultures are explored.	[Farran, Lama K.] Univ West Georgia, Commun Sci & Disorders, Carrollton, GA USA; [Lee, Chia-Cheng; Yoo, Hyunjoo; Oller, D. Kimbrough] Univ Memphis, Commun Sci & Disorders, Memphis, TN 38152 USA; [Oller, D. Kimbrough] Konrad Lorenz Inst Evolut & Cognit Res, Klosterneuburg, Austria	University System of Georgia; University of West Georgia; University of Memphis	Farran, LK (corresponding author), Univ West Georgia, Commun Sci & Disorders, Carrollton, GA USA.	lfarran@westga.edu	Lee, Chia-Cheng/J-3439-2019; Oller, D. Kimbrough/G-1804-2010; Lee, Chia-Cheng/I-7459-2016	Lee, Chia-Cheng/0000-0002-9324-6645; Lee, Chia-Cheng/0000-0002-9324-6645	National Institute on Deafness and Other Communication Disorders [R01 DC006099, DC011027]; Plough Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011027, R01DC006099] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Plough Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported in part by grants R01 DC006099 and DC011027 to DKO from the National Institute on Deafness and Other Communication Disorders and by the Plough Foundation, which supports DKO's Chair of Excellence at the University of Memphis (http://www.nidcd.nih.gov/Pages/default.aspx) (http://plough.org/grantinformation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin DD, 1996, INFANT BEHAV DEV, V19, P401, DOI 10.1016/S0163-6383(96)90002-8; Bates E., 1976, LANGUAGE CONTEXT ACQ; Boersma P., 2014, PRAAT DOING PHONETIC; Bornstein M, 1992, DEV INFANCY INTRO; Bornstein MH, 2012, J CROSS CULT PSYCHOL, V43, P171, DOI 10.1177/0022022110388563; Bornstein MH, 2000, J CHILD LANG, V27, P407, DOI 10.1017/S0305000900004165; BORNSTEIN MH, 1992, DEV PSYCHOL, V28, P593, DOI 10.1037/0012-1649.28.4.593; Bryant GA, 2007, PSYCHOL SCI, V18, P746, DOI 10.1111/j.1467-9280.2007.01970.x; CARROLL SB, 2005, ENDLESS FORMS MOST B; COHN JF, 1988, DEV PSYCHOL, V24, P386, DOI 10.1037/0012-1649.24.3.386; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; Deacon T., 1997, SYMBOLIC SPECIES COE; Deacon TW, 2010, P NATL ACAD SCI USA, V107, P9000, DOI 10.1073/pnas.0914624107; Estes KG, 2013, INFANCY, V18, P797, DOI 10.1111/infa.12006; FERGUSON CA, 1964, AM ANTHROPOL, V66, P103, DOI 10.1525/aa.1964.66.suppl_3.02a00060; FERGUSON CA, 1959, WORD, V15, P325, DOI 10.1080/00437956.1959.11659702; FERNALD A, 1989, J CHILD LANG, V16, P477, DOI 10.1017/S0305000900010679; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; Fernald A, 1991, ANN CHILD DEV; Fernald A., 1992, ADAPTED MIND EVOLUTI; Golinkoff RM, 2015, CURR DIR PSYCHOL SCI, V24, P339, DOI 10.1177/0963721415595345; Hart B., 1995, MEANINGFUL DIFFERENC; Heath S, 1983, WAYS WORDS ETHNOGRAP; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Hoff E, 2002, CHILD DEV, V73, P418, DOI 10.1111/1467-8624.00415; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; Huttenlocher J, 2010, COGNITIVE PSYCHOL, V61, P343, DOI 10.1016/j.cogpsych.2010.08.002; Jaffe J, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00137; KAPLAN PS, 1995, DEV PSYCHOBIOL, V28, P45, DOI 10.1002/dev.420280105; Keller H, 2007, INT J BEHAV DEV, V31, P210, DOI 10.1177/0165025407074633; Kitamura C, 2003, INFANCY, V4, P85, DOI 10.1207/S15327078IN0401_5; Kitamura C, 2002, INFANT BEHAV DEV, V24, P372; KLEIN RP, 1979, PSYCHOL REP, V44, P1059, DOI 10.2466/pr0.1979.44.3c.1059; Liu HM, 2009, J CHILD LANG, V36, P909, DOI 10.1017/S030500090800929X; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; LYNCH MP, 1995, DEV PSYCHOBIOL, V28, P3, DOI 10.1002/dev.420280103; Ma WY, 2011, LANG LEARN DEV, V7, P185, DOI 10.1080/15475441.2011.579839; Milenkovic P, 2001, TF32 U WISC MAD; Monnot M, 1999, HUM NATURE-INT BIOS, V10, P415, DOI 10.1007/s12110-999-1010-0; Newport E., 1977, TALKING CHILDREN LAN; Newport E, 1977, COGNITIVE THEORY; OCHS E, 1982, LANG SOC, V11, P77, DOI 10.1017/S0047404500009040; Odling-Smee F.J., 1988, P73; Oller D.K, 2000, EMERGENCE SPEECH CAP, DOI [10.4324/9781410602565, DOI 10.4324/9781410602565]; PAPOUSEK M, 1991, INFANT BEHAV DEV, V14, P415, DOI 10.1016/0163-6383(91)90031-M; PAPOUSEK M, 1987, J PSYCHOLINGUIST RES, V16, P491, DOI 10.1007/BF01073274; Papousek M., 1985, SOCIAL PERCEPTION IN, P269; RATNER NB, 1984, J CHILD LANG, V11, P515, DOI 10.1017/S0305000900005924; Saiegh-Haddad E., 2014, HDB ARABIC LITERACY, P3; Saint-Georges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078103; Shneidman LA, 2013, J CHILD LANG, V40, P672, DOI 10.1017/S0305000912000141; Shneidman LA, 2012, DEVELOPMENTAL SCI, V15, P659, DOI 10.1111/j.1467-7687.2012.01168.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SNOW CE, 1972, CHILD DEV, V43, P549, DOI 10.1111/j.1467-8624.1972.tb01123.x; Thiemann-Bourque KS, 2014, AM J SPEECH-LANG PAT, V23, P474, DOI 10.1044/2014_AJSLP-12-0010; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; TRONICK ED, 1977, J COMMUN, V27, P74, DOI 10.1111/j.1460-2466.1977.tb01829.x; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; West M.J., 1988, Handbook of Behavioral Neurobiology, V9, P41	61	29	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151518	10.1371/journal.pone.0151518	http://dx.doi.org/10.1371/journal.pone.0151518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26981626	gold, Green Submitted, Green Published			2022-12-26	WOS:000372574900091
J	Herlihy, MV; Talamas, EJ; Weber, DC				Herlihy, Megan V.; Talamas, Elijah J.; Weber, Donald C.			Attack and Success of Native and Exotic Parasitoids on Eggs of Halyomorpha halys in Three Maryland Habitats	PLOS ONE			English	Article							PODISUS-MACULIVENTRIS HEMIPTERA; MARMORATED STINK BUG; ASHMEAD HYMENOPTERA; NATURAL ENEMIES; PENTATOMIDAE; HETEROPTERA; SCELIONIDAE; ATTRACTION; MORTALITY	Egg parasitoids of the exotic invasive brown marmorated stink bug, Halyomorpha halys (Stal), were investigated using lab-reared fresh (live) and frozen (killed) lab-reared sentinel egg masses deployed for 72h on foliage in three habitats-woods, orchard, and soybean field-in Maryland, USA, in summer 2014. Four native hymenopteran species, Telenomus podisi Ashmead (Scelionidae), Trissolcus euschisti (Ashmead) and Tr. brochymenae Ashmead (Scelionidae), and Anastatus reduvii (Howard) (Eupelmidae), developed and emerged from H. halys eggs. One exotic parasitoid, Trissolcus japonicus (Ashmead), emerged, providing the first known occurrence of this species in North America. Native parasitoids emerged from frozen eggs significantly more often than from fresh eggs (89.3% of egg masses and 98.1% of individual eggs), whereas the exotic Tr. japonicus did not show a similar difference, strongly suggesting adaptation to H. halys as a host by Tr. japonicus but not by the native species. Parasitoids were habitat-specific: all three Trissolcus species were significantly more likely to occur in the woods habitat, whereas Te. podisi was found exclusively in the soybean field. Further investigations are required to elucidate evolving host-parasitoid relationships, habitat specificity, and non-target effects of Tr. japonicus over the expanded range of H. halys in North America.	[Herlihy, Megan V.; Weber, Donald C.] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD USA; [Talamas, Elijah J.] ARS, Systemat Entomol Lab, USDA, Washington, DC USA; [Talamas, Elijah J.] Smithsonian Inst, Washington, DC 20560 USA	United States Department of Agriculture (USDA); Smithsonian Institution; United States Department of Agriculture (USDA); Smithsonian Institution	Weber, DC (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD USA.	Don.Weber@ars.usda.gov		Talamas, Elijah/0000-0002-1048-6345	Systematic Entomology Laboratory; Invasive Insect Biocontrol and Behavior Laboratory, USDA ARS	Systematic Entomology Laboratory; Invasive Insect Biocontrol and Behavior Laboratory, USDA ARS	This work was made possible by funding from the Systematic Entomology Laboratory and the Invasive Insect Biocontrol and Behavior Laboratory, USDA ARS. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA; USDA is an equal opportunity provider and employer.	Abram PK, 2014, BIOL INVASIONS, V16, P1387, DOI 10.1007/s10530-013-0576-y; BURKS B. D., 1967, TRANS AMER ENTOMOL SOC, V93, P423; ELKINTON JS, 1992, RES POPUL ECOL, V34, P29, DOI 10.1007/BF02513520; Gariepy TD, 2014, MOL ECOL, V23, P3912, DOI 10.1111/mec.12515; Haye T, 2015, J PEST SCI, V88, P693, DOI 10.1007/s10340-015-0671-1; Haye T, 2015, J PEST SCI, V88, P665, DOI 10.1007/s10340-015-0670-2; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hoffmann M. P., 1993, NATURAL ENEMIES VEGE; Johnson NF., 1984, BULL OHIO BIOL SURV, V6, P1; Jones AL, 2014, BIOL CONTROL, V78, P61, DOI 10.1016/j.biocontrol.2014.07.011; JONES WA, 1981, ENVIRON ENTOMOL, V10, P409, DOI 10.1093/ee/10.3.409; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey TC, 2015, ENVIRON ENTOMOL, V44, P746, DOI 10.1093/ee/nvv049; Lowry R., 2015, VASSARSTATS WEBSITE; MCPHERSON JE, 1980, GREAT LAKES ENTOMOL, V13, P17; Montemayor CO, 2011, ENVIRON ENTOMOL, V40, P948, DOI 10.1603/EN10275; Northeastern IPM Center, 2014, WHER IS BMSB; Northeastern IPM Center, 2014, HOST PLANTS BROWN MA; Okuda MS, 1998, ENVIRON ENTOMOL, V17, P795; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; Talamas EJ, 2015, J HYMENOPT RES, V43, P45, DOI 10.3897/JHR.43.8560; Talamas EJ, 2015, J HYMENOPT RES, V43, P119, DOI 10.3897/JHR.43.4661; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Weber DC, 2014, J ECON ENTOMOL, V107, P1061, DOI 10.1603/EC13502; Wiedenmann Robert N., 1996, P94	25	82	83	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150275	10.1371/journal.pone.0150275	http://dx.doi.org/10.1371/journal.pone.0150275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983012	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900030
J	Zhang, C; Li, XM; Liu, Y; Qiao, S; Zhang, LY; Zhou, YJ; Tang, ZZ; Shen, ZY; Chen, Y				Zhang, Chen; Li, Xiaoming; Liu, Yu; Qiao, Shan; Zhang, Liying; Zhou, Yuejiao; Tang, Zhenzhu; Shen, Zhiyong; Chen, Yi			Stigma against People Living with HIV/AIDS in China: Does the Route of Infection Matter?	PLOS ONE			English	Article							HIV-RELATED STIGMA; INJECTION-DRUG USERS; FEMALE SEX WORKERS; QUALITY-OF-LIFE; SOCIAL SUPPORT; REDUCTION INTERVENTION; DISCRIMINATION; HEALTH; DISCLOSURE; ATTITUDES	In the current study, we tested the hypothesis that people who contracted HIV from "blameless" routes (e.g., blood transfusion, sex with stable partners) are less stigmatized compared to people who contracted HIV from "blamable" routes (e.g., injection drug use, sex with sex workers). A cross-sectional study was conducted among 2,987 participants in Guangxi province, China, between 2012 and 2013. We employed both explanatory and predictive modeling strategy by using multivariate linear regression models. In the explanatory models, we assessed the association between routes of infection and three types of stigma (perceived, internalized, and enacted). From identified routes of infection that significantly contributed to higher stigma, we employed predictive modeling to explore predictors for the specific type of stigma. Multiple-imputation was employed for sensitivity analyses. Of the total sample, 63% were male and the average age was 42.9 years (ranged between 18 and 88). Multivariate regression models revealed that contraction from commercial sex increased the perceived (beta = 0.46, 95% CI = 0.02, 0.90) and internalized stigma (beta = 0.60, 95% CI = 0.09, 1.10), while injecting drug use increased the perceived (beta = 0.65, 95% CI = 0.07, 1.22) and enacted stigma (beta = 0.09, 95% CI = 0.02, 0.16) after controlling for confounders. Among PLWHA who were infected via commercial sex partners, social support was negatively associated with perceived (beta = -0.47, 95% CI = -0.79, -0.14) and internalized stigma (beta = -0.80, 95% CI = -1.24, -0.35). Among PLWHA who were infected via injecting drugs, no adherence to antiretroviral treatment (beta = 0.41, 95% CI = 0.01, 0.82) was positively associated with perceived stigma, and disclosure of serostatus to others was negatively associated with enacted stigma (beta = -0.20, 95% CI = -0.34, -0.05). Knowledge of the association between routes of infection and stigma can guide health professionals and policy makers to develop tailored intervention strategies to mitigate the effects of stigma and enhance HIV care utilization among PLWHA in China.	[Zhang, Chen; Liu, Yu] Vanderbilt Univ, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Li, Xiaoming; Qiao, Shan] Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Zhang, Liying] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Zhou, Yuejiao; Tang, Zhenzhu; Shen, Zhiyong; Chen, Yi] Guangxi CDC, Dept HIV STD Prevent, Nanning, Guangxi, Peoples R China	Vanderbilt University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Wayne State University	Zhang, C (corresponding author), Vanderbilt Univ, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	chen.zhang.1@vanderbilt.edu	Li, Xiaoming/AAF-1362-2019	Li, Xiaoming/0000-0002-5555-9034; Zhang, Chen/0000-0002-8771-561X	National Institute of Child and Human Development Grant [R01HD074221]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074221] Funding Source: NIH RePORTER	National Institute of Child and Human Development Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by the National Institute of Child and Human Development Grant (#R01HD074221) (URL: https://www.nichd.nih.gov/Pages/index.aspx). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Child and Human Development.	Akena D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048671; Alemu T, 2013, SAHARA J-J SOC ASP H, V10, P1, DOI 10.1080/17290376.2013.806645; [Anonymous], 2008, HLTH BEHAV HLTH ED T; AVERT, 2014, HIV AIDS STIGM DISCR; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Cao HJ, 2010, AIDS EDUC PREV, V22, P445, DOI 10.1521/aeap.2010.22.5.445; Cao Xiao-bin, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1022; Cao XB, 2006, AIDS EDUC PREV, V18, P518, DOI 10.1521/aeap.2006.18.6.518; Chen JJ, 2005, AIDS EDUC PREV, V17, P1, DOI 10.1521/aeap.17.1.1.58689; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Gaskins Susan, 2011, Issues Ment Health Nurs, V32, P367, DOI 10.3109/01612840.2011.571807; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Greene MC, 2013, AIDS BEHAV, V17, P1775, DOI 10.1007/s10461-012-0396-6; Hong Y, 2008, AIDS PATIENT CARE ST, V22, P823, DOI 10.1089/apc.2008.0001; Hong Y, 2010, J TRANSCULT NURS, V21, P29, DOI 10.1177/1043659609349063; King EJ, 2013, AIDS BEHAV, V17, P2597, DOI 10.1007/s10461-013-0447-7; Knowlton A, 2004, AIDS BEHAV, V8, P357, DOI 10.1007/s10461-004-7320-7; Knowlton AR, 2005, AIDS CARE, V17, P479, DOI 10.1080/0954012051233131314349; Lee SJ, 2007, AIDS PATIENT CARE ST, V21, P409, DOI 10.1089/apc.2006.0066; Li L, 2007, AIDS PATIENT CARE ST, V21, P753, DOI 10.1089/apc.2006.0219; Li L, 2014, SOC PSYCH PSYCH EPID, V49, P991, DOI 10.1007/s00127-013-0808-6; Li L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18710; Li Li, 2008, Fam Syst Health, V26, P431; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Li MJ, 2014, AIDS EDUC PREV, V26, P471, DOI 10.1521/aeap.2014.26.5.471; Li XH, 2012, J ASSOC NURSE AIDS C, V23, DOI 10.1016/j.jana.2011.07.002; Li XH, 2011, AIDS PATIENT CARE ST, V25, P665, DOI 10.1089/apc.2011.0174; Li XH, 2009, J ASSOC NURSE AIDS C, V20, P22, DOI 10.1016/j.jana.2008.09.007; Liao MZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/143738; Lindberg MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114867; Liu HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056815, 10.1371/journal.pone.0055680]; Liu Yan, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P658, DOI 10.11817/j.issn.1672-7347.2014.07.002; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parsons JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127392; Peretti-Watel P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000411; Phillips Kenneth D, 2011, Issues Ment Health Nurs, V32, P359, DOI 10.3109/01612840.2011.575533; Qian HZ, 2007, AIDS CARE, V19, P1283, DOI 10.1080/09540120701402814; Qiao S, 2015, AIDS CARE, V27, P28, DOI 10.1080/09540121.2015.1034648; Qiao Shan, 2015, AIDS, V29 Suppl 1, pS25, DOI 10.1097/QAD.0000000000000670; Rao D, 2008, SOC SCI MED, V67, P1541, DOI 10.1016/j.socscimed.2008.07.024; Rezvan Panteha Hayati, 2015, BMC Med Res Methodol, V15, P83, DOI 10.1186/s12874-015-0074-2; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Steward Wayne T, 2013, J Int Assoc Provid AIDS Care, V12, P103, DOI 10.1177/1545109711432315; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Sullivan SG, 2010, AIDS CARE, V22, P104, DOI 10.1080/09540120903012528; Tang YL, 2007, ADDICTION, V102, P1057, DOI 10.1111/j.1360-0443.2007.01849.x; Thi MDA, 2008, AIDS BEHAV, V12, pS63, DOI 10.1007/s10461-008-9374-4; UNAIDS, 2015, 2015 CHIN AIDS RESP; Valdiserri RO, 2002, AM J PUBLIC HEALTH, V92, P341, DOI 10.2105/AJPH.92.3.341; Wang JW, 2010, HEALTH PROMOT INT, V25, P394, DOI 10.1093/heapro/daq039; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; Wong LP, 2011, SE ASIAN J TROP MED, V42, P1119; Wong WCW, 2011, SOCIOL HEALTH ILL, V33, P50, DOI 10.1111/j.1467-9566.2010.01276.x; Wu F, 2015, GLOB PUBLIC HEALTH, V10, P1032, DOI 10.1080/17441692.2014.1003572; Wu LY, 2013, HEALTH PSYCHOL BEHAV, V1, P31, DOI 10.1080/21642850.2013.822798; Yang Y, 2004, BIOMED ENVIRON SCI, V17, P410; Zhang C, 2016, AIDS CARE, V28, P124, DOI 10.1080/09540121.2016.1146206; Zhang YJ, 2015, INT J NURS PRACT, V21, P221, DOI 10.1111/ijn.12254; Zukoski AP, 2009, AIDS PATIENT CARE ST, V23, P267, DOI 10.1089/apc.2008.0168	64	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151078	10.1371/journal.pone.0151078	http://dx.doi.org/10.1371/journal.pone.0151078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26981636	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900061
J	Yu, WQ; Eom, YS; Shin, JA; Nair, D; Grzywacz, SXZ; Grzywacz, NM; Craft, CM; Lee, EJ				Yu, Wan-Qing; Eom, Yun Sung; Shin, Jung-A; Nair, Divya; Grzywacz, Sara X. Z.; Grzywacz, Norberto M.; Craft, Cheryl Mae; Lee, Eun-Jin			Reshaping the Cone-Mosaic in a Rat Model of Retinitis Pigmentosa: Modulatory Role of ZO-1 Expression in DL-Alpha-Aminoadipic Acid Reshaping	PLOS ONE			English	Article							PHOTORECEPTOR DEGENERATION; TIGHT JUNCTION; MULLER CELLS; TARGETED DISRUPTION; ADAPTIVE OPTICS; PROTEINS; REARRANGEMENT; ORGANIZATION; INTEGRATION; ADHESION	In S334ter-line-3 rat model of Retinitis Pigmentosa (RP), rod cell death induces the rearrangement of cones into mosaics of rings while the fibrotic processes of Muller cells remodel to fill the center of the rings. In contrast, previous work established that DL-alpha-aminoadipic-acid (AAA), a compound that transiently blocks Muller cell metabolism, abolishes these highly structured cone rings. Simultaneously, adherens-junction associated protein, Zonula occludens-1 (ZO-1) expression forms in a network between the photoreceptor segments and Muller cells processes. Thus, we hypothesized that AAA treatment alters the cone mosaic rings by disrupting the distal sealing formed by these fibrotic processes, either directly or indirectly, by down regulating the expression of ZO-1. Therefore, we examined these processes and ZO-1 expression at the outer retina after intravitreal injection of AAA and observed that AAA treatment transiently disrupts the distal glial sealing in RP retina, plus induces cones in rings to become more homogeneous. Moreover, ZO-1 expression is actively suppressed after 3 days of AAA treatment, which coincided with cone ring disruption. Similar modifications of glial sealing and cone distribution were observed after injection of siRNA to inhibit ZO-1 expression. These findings support our hypothesis and provide additional information about the critical role played by ZO-1 in glial sealing and shaping the ring mosaic in RP retina. These studies represent important advancements in the understanding of retinal degeneration's etiology and pathophysiology.	[Yu, Wan-Qing; Grzywacz, Norberto M.] Univ So Calif, Neurosci Grad Program, Los Angeles, CA USA; [Grzywacz, Sara X. Z.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Los Angeles, CA USA; [Eom, Yun Sung; Shin, Jung-A; Craft, Cheryl Mae; Lee, Eun-Jin] Univ So Calif, USC Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA USA; [Nair, Divya; Grzywacz, Norberto M.; Lee, Eun-Jin] Univ So Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA; [Craft, Cheryl Mae; Lee, Eun-Jin] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Craft, Cheryl Mae] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Shin, Jung-A] Ewha Womans Univ, Sch Med, Dept Anat, Seoul, South Korea; [Grzywacz, Norberto M.] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Grzywacz, Norberto M.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Yu, Wan-Qing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Ewha Womans University; Georgetown University; Georgetown University; University of Washington; University of Washington Seattle	Lee, EJ (corresponding author), Univ So Calif, USC Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA USA.; Lee, EJ (corresponding author), Univ So Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA.; Lee, EJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA.	eunjinl@usc.edu		Yu, Wan-Qing/0000-0002-9275-391X	VSoE Research Innovation Fund; National Science Foundation [0310723]; National Eye Institute [EY016093, EY11170, EY015851, EY03040]; Research to Prevent Blindness; Mary D. Allen Foundation; NATIONAL EYE INSTITUTE [R01EY011170, R01EY016093, R01EY015851, P30EY003040] Funding Source: NIH RePORTER	VSoE Research Innovation Fund; National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Mary D. Allen Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by a VSoE Research Innovation Fund to EJL, and by National Science Foundation Grant 0310723 and National Eye Institute Grants EY016093 and EY11170 to NMG, EY015851 to CMC, EY03040 (Core, Doheny Eye Institute), Research to Prevent Blindness (USC Ophthalmology) and the Mary D. Allen Foundation (CMC).	Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; BIGNAMI A, 1979, EXP EYE RES, V28, P63; BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; Bringmann A, 2001, FRONT BIOSCI-LANDMRK, V6, pE77, DOI 10.2741/Bringman; Campbell M, 2006, EXP EYE RES, V83, P484, DOI 10.1016/j.exer.2006.01.032; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997; Daniele LL, 2007, J COMP NEUROL, V505, P166, DOI 10.1002/cne.21489; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; EISENFELD AJ, 1984, INVEST OPHTH VIS SCI, V25, P1321; Fredriksson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117074; Garcia-Ayuso D, 2013, INVEST OPHTH VIS SCI, V54, P5888, DOI 10.1167/iovs.13-12643; Hombrebueno JR, 2010, BRAIN RES, V1321, P60, DOI 10.1016/j.brainres.2010.01.051; Jablonski MM, 2000, GLIA, V32, P192, DOI 10.1002/1098-1136(200011)32:2<192::AID-GLIA80>3.0.CO;2-6; Ji Y, 2015, INVEST OPHTH VIS SCI, V56, P352, DOI 10.1167/iovs.14-15398; Ji Y, 2012, J COMP NEUROL, V520, P874, DOI 10.1002/cne.22800; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; KARLSEN RL, 1982, EXP EYE RES, V35, P305; Lee EJ, 2011, GLIA, V59, P1107, DOI 10.1002/glia.21183; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; LEWIS GP, 1989, EXP EYE RES, V49, P93, DOI 10.1016/0014-4835(89)90079-1; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; LINSER PJ, 1981, DEV BRAIN RES, V1, P103, DOI 10.1016/0165-3806(81)90097-3; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; Marc RE, 2003, MOL NEUROBIOL, V28, P139, DOI 10.1385/MN:28:2:139; Milam AH, 1996, INVEST OPHTH VIS SCI, V37, P753; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; PEDERSEN OO, 1979, EXP EYE RES, V28, P569, DOI 10.1016/0014-4835(79)90044-7; Puller C, 2009, J NEUROSCI, V29, P6266, DOI 10.1523/JNEUROSCI.5867-08.2009; Ray A, 2010, CELL TISSUE RES, V339, P481, DOI 10.1007/s00441-009-0916-5; Reichelt W, 1997, NEUROSCIENCE, V77, P1213, DOI 10.1016/S0306-4522(96)00509-X; Rossi EA, 2011, EYE, V25, P301, DOI 10.1038/eye.2010.221; Shin JA, 2015, EXP EYE RES, V140, P41, DOI 10.1016/j.exer.2015.08.005; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Tserentsoodol N, 1998, HISTOCHEM CELL BIOL, V110, P543, DOI 10.1007/s004180050316; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Zhu CL, 2013, CELL TISSUE RES, V351, P29, DOI 10.1007/s00441-012-1522-5; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	44	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151668	10.1371/journal.pone.0151668	http://dx.doi.org/10.1371/journal.pone.0151668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977812	Green Published, gold			2022-12-26	WOS:000372572800097
J	Hubel, N; Ullah, G				Huebel, Niklas; Ullah, Ghanim			Anions Govern Cell Volume: A Case Study of Relative Astrocytic and Neuronal Swelling in Spreading Depolarization	PLOS ONE			English	Article							DEPRESSION SD; HUMAN BRAIN; SEIZURES; MIGRAINE; DYNAMICS; CHANNELS; INJURY; TISSUE; ISCHEMIA; RELEASE	Cell volume changes are ubiquitous in normal and pathological activity of the brain. Nevertheless, we know little about the dynamics of cell and tissue swelling, and the differential changes in the volumes of neurons and glia during pathological states such as spreading depolarizations (SD) under ischemic and non-ischemic conditions, and epileptic seizures. By combining the Hodgkin-Huxley type spiking dynamics, dynamic ion concentrations, and simultaneous neuronal and astroglial volume changes into a comprehensive model, we elucidate why glial cells swell more than neurons in SD and the special case of anoxic depolarization (AD), and explore the relative contributions of the two cell types to tissue swelling. Our results demonstrate that anion channels, particularly Cl-, are intrinsically connected to cell swelling and blocking these currents prevents changes in cell volume. The model is based on a simple and physiologically realistic description. We introduce model extensions that are either derived purely from first physical principles of electroneutrality, osmosis, and conservation of particles, or by a phenomenological combination of these principles and known physiological facts. This work provides insights into numerous studies related to neuronal and glial volume changes in SD that otherwise seem contradictory, and is broadly applicable to swelling in other cell types and conditions.	[Huebel, Niklas; Ullah, Ghanim] Univ S Florida, Dept Phys, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Hubel, N (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	niklas.huebel@gmail.com			College of Arts and Sciences, University of South Florida	College of Arts and Sciences, University of South Florida	This work was funded by a startup grant from College of Arts and Sciences, University of South Florida to G Ullah.	Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Barreto E, 2011, J BIOL PHYS, V37, P361, DOI 10.1007/s10867-010-9212-6; Basarsky TA, 1999, J NEUROSCI, V19, P6439; Brisson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079589; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; Chang JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070469; Cressman JR, 2011, J COMPUT NEUROSCI, V30, P781, DOI 10.1007/s10827-011-0333-0; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; CZEH G, 1993, BRAIN RES, V632, P195, DOI 10.1016/0006-8993(93)91154-K; Dahlem MA, 2014, PEERJ, V2, DOI 10.7717/peerj.379; Dahlem MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005007; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2013, NEUROSCIENTIST, V19, P25, DOI 10.1177/1073858412453340; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Endresen LP, 2000, EUR BIOPHYS J BIOPHY, V29, P90, DOI 10.1007/s002490050254; Ermentrout B., 2002, SIMULATING ANAL ANIM, DOI DOI 10.1137/1.9780898718195; Ermentrout B, 2012, XPPAUT 7 0; Gutkin BS, 2001, J COMPUT NEUROSCI, V11, P121, DOI 10.1023/A:1012837415096; HAGLUND MM, 1990, J NEUROPHYSIOL, V63, P225, DOI 10.1152/jn.1990.63.2.225; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hubel N, 2015, LARGE EXTRA IN PRESS; Hubel N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003941; Hubel N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003551; Ingram J, 2014, J NEUROPHYSIOL, V112, P205, DOI 10.1152/jn.00540.2013; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; JAKOBSSON E, 1980, AM J PHYSIOL, V238, pC196, DOI 10.1152/ajpcell.1980.238.5.C196; JING J, 1994, J NEUROPHYSIOL, V71, P2548, DOI 10.1152/jn.1994.71.6.2548; Kager H, 2007, J COMPUT NEUROSCI, V22, P105, DOI 10.1007/s10827-006-0001-y; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kimelberg HK, 2000, NEUROSCIENTIST, V6, P14, DOI 10.1177/107385840000600110; Kofuji Paulo, 2009, P151, DOI 10.1007/978-0-387-79492-1_6; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Lascola CD, 1998, J NEUROSCI, V18, P1679; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lee J, 2010, NEUROIMAGE, V51, P713, DOI 10.1016/j.neuroimage.2010.02.076; Mazel T, 1998, NEUROREPORT, V9, P1299; MCBAIN CJ, 1990, SCIENCE, V249, P674, DOI 10.1126/science.2382142; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Ostby I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000272; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rogawski M. A., 2012, JASPERS BASIC MECH E; Rogawski MA, 2010, EPILEPSIA, V51, P80, DOI 10.1111/j.1528-1167.2010.02866.x; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shandilya SG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013004; Shapiro BE, 2001, J COMPUT NEUROSCI, V10, P99, DOI 10.1023/A:1008924227961; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Ullah G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004414; Volman V, 2012, FRONT COMPUT NEUROSC, V6, P1; WALZ W, 1985, BRAIN RES, V343, P44, DOI 10.1016/0006-8993(85)91156-4; WALZ W, 1991, ANN NY ACAD SCI, V633, P589; Walz W, 2002, GLIA, V40, P1, DOI 10.1002/glia.10125; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Wei YN, 2014, J NEUROPHYSIOL, V112, P213, DOI 10.1152/jn.00541.2013; Witthoft A, 2013, BIOPHYS J, V105, P2046, DOI 10.1016/j.bpj.2013.09.012; Yao CG, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061129; Zandt BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022127; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	72	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0147060	10.1371/journal.pone.0147060	http://dx.doi.org/10.1371/journal.pone.0147060			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974767	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600006
J	Kotzybik, K; Graf, V; Kugler, L; Stoll, DA; Greiner, R; Geisen, R; Schmidt-Heydt, M				Kotzybik, Kathrin; Graef, Volker; Kugler, Lena; Stoll, Dominic A.; Greiner, Ralf; Geisen, Rolf; Schmidt-Heydt, Markus			Influence of Different Nanomaterials on Growth and Mycotoxin Production of Penicillium verrucosum	PLOS ONE			English	Article							OXIDATIVE STRESS; SILVER NANOPARTICLES; WATER ACTIVITY; CANDIDA-ALBICANS; IN-VITRO; BIOSYNTHESIS; TEMPERATURE; OCHRATOXIN; FUNGI; ACQUISITION	Nanoparticles are ubiquitous in the environment. They originate from anthropogenic or natural sources or they are intentionally produced for different purposes. There exist manifold applications of nanoparticles in modern life leading unavoidably to a confrontation and interaction between nanomaterial and living organisms. Based on their wide distribution tending to increase steadily, the influence of particles based on silica and silver, exhibiting nominal sizes between 0.65 nm and 200 nm, on the physiology of the mycotoxigenic filamentous fungus Penicillium verrucosum was analyzed. The applied concentration and time-point, the size and the chemical composition of the particles was shown to have a strong influence on growth and mycotoxin biosynthesis. On microscopic scale it could be shown that silver nanoparticles attach to the mycelial surface. Moreover, silver nanoparticles with 0.65 nm and 5 nm in size were shown to internalize within the cell, form agglomerates in the cytoplasm and associate to cell organelles.	[Kotzybik, Kathrin; Kugler, Lena; Stoll, Dominic A.; Geisen, Rolf; Schmidt-Heydt, Markus] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Safety & Qual Fruits & Vegetables, Karlsruhe, Germany; [Graef, Volker; Greiner, Ralf] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Food Technol & Bioproc Engn, Karlsruhe, Germany		Schmidt-Heydt, M (corresponding author), Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Safety & Qual Fruits & Vegetables, Karlsruhe, Germany.	Markus.Schmidt-Heydt@mri.bund.de	Schmidt-Heydt, Markus/AAC-3278-2022	Schmidt-Heydt, Markus/0000-0003-2844-9873; Stoll, Dominic/0000-0003-2982-6458				Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; [Anonymous], 800041 ISOTS; Astoreca AL, 2010, WORLD MYCOTOXIN J, V3, P175, DOI 10.3920/WMJ2009.1164; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bundschuh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048956; Cox PW, 1998, MICROBIOL-SGM, V144, P817, DOI 10.1099/00221287-144-4-817; Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6; FAO, 2001, FAO FOOD NUTR PAP, P73; Feng YZ, 2013, ENVIRON SCI TECHNOL, V47, P9496, DOI 10.1021/es402109n; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; Gaikwad S, 2013, INT J NANOMED, V8, P4303, DOI 10.2147/IJN.S50070; Gibbs PA, 2000, CRIT REV BIOTECHNOL, V20, P17, DOI 10.1080/07388550091144177; Gonzalez-Parraga P, 2003, YEAST, V20, P1161, DOI 10.1002/yea.1029; Hassan A. A., 2013, STUDIES CHEM PROCESS, V1, P66; Heider EM, 2006, TETRAHEDRON, V62, P1199, DOI 10.1016/j.tet.2005.10.066; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Kim SW, 2009, J MICROBIOL BIOTECHN, V19, P760, DOI 10.4014/jmb.0812.649; Lamsal Kabir, 2011, Mycobiology, V39, P194, DOI 10.5941/MYCO.2011.39.3.194; Magan N, 2011, PLANT PATHOL, V60, P150, DOI 10.1111/j.1365-3059.2010.02412.x; Mittal A, 2015, NANOMED-NANOTECHNOL, V11, P147, DOI 10.1016/j.nano.2014.08.009; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Pardo E, 2005, J SCI FOOD AGR, V85, P1681, DOI 10.1002/jsfa.2171; Paul G C, 1998, Adv Biochem Eng Biotechnol, V60, P1; Ponts N, 2006, FEMS MICROBIOL LETT, V258, P102, DOI 10.1111/j.1574-6968.2006.00200.x; Ren HX, 2011, J BIOMED NANOTECHNOL, V7, P677, DOI 10.1166/jbn.2011.1338; Romero SM, 2007, INT J FOOD MICROBIOL, V115, P140, DOI 10.1016/j.ijfoodmicro.2006.10.014; Schmidt-Heydt M, 2008, FEMS MICROBIOL LETT, V284, P142, DOI 10.1111/j.1574-6968.2008.01182.x; Schmidt-Heydt M, 2015, INT J FOOD MICROBIOL, V192, P1, DOI 10.1016/j.ijfoodmicro.2014.09.008; Schmidt-Heydt M, 2012, FOOD MICROBIOL, V29, P233, DOI 10.1016/j.fm.2011.08.003; Simonelli F, 2015, J PHYS CHEM LETT, V6, P3175, DOI 10.1021/acs.jpclett.5b01469; Stoll DA, 2014, INT J FOOD MICROBIOL, V175, P20, DOI 10.1016/j.ijfoodmicro.2014.01.010; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Van de Perre E, 2015, FOOD RES INT, V68, P41, DOI 10.1016/j.foodres.2014.10.014; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zhang SL, 2015, ACS NANO, V9, P8655, DOI 10.1021/acsnano.5b03184	38	18	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150855	10.1371/journal.pone.0150855	http://dx.doi.org/10.1371/journal.pone.0150855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974550	Green Published, gold			2022-12-26	WOS:000372570600035
J	van den Boom, J; Trusch, F; Hoppstock, L; Beuck, C; Bayer, P				van den Boom, Johannes; Trusch, Franziska; Hoppstock, Lukas; Beuck, Christine; Bayer, Peter			Structural Characterization of the Loop at the Alpha-Subunit C-Terminus of the Mixed Lineage Leukemia Protein Activating Protease Taspase1	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; CHEMICAL-SHIFTS; FORCE-FIELD; MLL; ASPARTYLGLUCOSAMINIDASE; MECHANISM; SUBSTRATE; N-15	Type 2 asparaginases, a subfamily of N- terminal nucleophile (Ntn) hydrolases, are activated by limited proteolysis. This activation yields a heterodimer and a loop region at the Cterminus of the alpha-subunit is released. Since this region is unresolved in all type 2 asparaginase crystal structures but is close to the active site residues, we explored this loop region in six members of the type 2 asparaginase family using homology modeling. As the loop model for the childhood cancer-relevant protease Taspase1 differed from the other members, Taspase1 activation as well as the conformation and dynamics of the 56 amino acids loop were investigated by CD and NMR spectroscopy. We propose a helix-turn-helix motif, which can be exploited as novel anticancer target to inhibit Taspase1 proteolytic activity.	[van den Boom, Johannes; Hoppstock, Lukas; Beuck, Christine; Bayer, Peter] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Dept Struct & Med Biochem, Essen, Germany; [Trusch, Franziska] Univ Aberdeen, Inst Med Sci, Aberdeen Oomycetes Lab, Aberdeen, Scotland	University of Duisburg Essen; University of Aberdeen	Bayer, P (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Dept Struct & Med Biochem, Essen, Germany.	peter.bayer@uni-due.de	Bayer, Peter/B-8803-2009; Beuck, Christine/E-1242-2015	Bayer, Peter/0000-0003-0435-7202; Beuck, Christine/0000-0001-7513-7384	Fonds of Chemical Industry, Chemiefonds grant; DFG [CRC 1093]	Fonds of Chemical Industry, Chemiefonds grant; DFG(German Research Foundation (DFG))	The authors acknowledge the Fonds of Chemical Industry for funding JvdB by their Chemiefonds grant and the DFG for funding PB and CB (CRC 1093).	Bier C, 2011, TRAFFIC, V12, P703, DOI 10.1111/j.1600-0854.2011.01191.x; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Bush LA, 2002, MOL REPROD DEV, V62, P233, DOI 10.1002/mrd.10092; Chen DY, 2012, CANCER RES, V72, P736, DOI 10.1158/0008-5472.CAN-11-2584; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dong Y. M., 2014, ACTA CHROMATOGR, V1, P1, DOI DOI 10.1007/S13277-014-2631-4; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Grum D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065346; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Harris RK, 2008, MAGN RESON CHEM, V46, P582, DOI 10.1002/mrc.2225; Hayouka Z, 2010, BIOCHEM BIOPH RES CO, V394, P260, DOI 10.1016/j.bbrc.2010.02.100; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018253; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Levin A, 2011, BBA-MOL CELL RES, V1813, P1646, DOI 10.1016/j.bbamcr.2010.07.010; Michalska K, 2008, J BIOL CHEM, V283, P13388, DOI 10.1074/jbc.M800746200; NERI D, 1992, P NATL ACAD SCI USA, V89, P4397, DOI 10.1073/pnas.89.10.4397; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nomme J, 2012, BIOCHEMISTRY-US, V51, P6816, DOI 10.1021/bi300870g; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Qi GF, 2005, J IMMUNOL METHODS, V299, P9, DOI 10.1016/j.jim.2004.11.018; Saarela J, 1998, J BIOL CHEM, V273, P25320, DOI 10.1074/jbc.273.39.25320; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; Stauber RH, 2016, FASEB J, V30, P1012, DOI 10.1096/fj.15-270611; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vranken WF, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-20; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wunsch D, 2016, ONCOGENE, V35, P3351, DOI 10.1038/onc.2015.436; Xuan JC, 1998, PROTEIN SCI, V7, P774, DOI 10.1002/pro.5560070327; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	40	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151431	10.1371/journal.pone.0151431	http://dx.doi.org/10.1371/journal.pone.0151431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974973	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600078
J	Wang, SL; Yu, LJ; Yang, H; Li, CS; Hui, Z; Xu, Y; Zhu, XL				Wang, Sulei; Yu, Linjie; Yang, Hui; Li, Chaosheng; Hui, Zhen; Xu, Yun; Zhu, Xiaolei			Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an A beta(1-42)-Induced Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA OLIGOMER; AMYLOID-BETA; OXIDATIVE STRESS; BDNF; PLASTICITY; BRAIN; SYNAPTOSOMES; IMPAIRMENT; CORTEX; MICE	Synaptic loss induced by beta-amyloid (A beta) plays a critical role in the pathophysiology of Alzheimer's disease (AD), but the mechanisms underlying this process remain unknown. In this study, we found that oridonin (Ori) rescued synaptic loss induced by A beta(1-42) in vivo and in vitro and attenuated the alterations in dendritic structure and spine density observed in the hippocampus of AD mice. In addition, Ori increased the expression of PSD-95 and synaptophysin and promoted mitochondrial activity in the synaptosomes of AD mice. Ori also activated the BDNF/TrkB/CREB signaling pathway in the hippocampus of AD mice. Furthermore, in the Morris water maze test, Ori reduced latency and searching distance and increased the number of platform crosses in AD mice. These data suggest that Ori might prevent synaptic loss and improve behavioral symptoms in A beta(1-42)-induced AD mice.	[Wang, Sulei; Yang, Hui; Li, Chaosheng; Hui, Zhen; Xu, Yun] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Yu, Linjie; Xu, Yun; Zhu, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Yun] Jiangsu Stroke Res Collaborat Grp, Nanjing, Jiangsu, Peoples R China; [Xu, Yun] Jiangsu Prov Stroke Ctr Diag & Therapy, Nanjing, Jiangsu, Peoples R China; [Xu, Yun] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University; Nanjing University	Xu, Y (corresponding author), Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China.; Xu, Y; Zhu, XL (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China.; Xu, Y (corresponding author), Jiangsu Stroke Res Collaborat Grp, Nanjing, Jiangsu, Peoples R China.; Xu, Y (corresponding author), Jiangsu Prov Stroke Ctr Diag & Therapy, Nanjing, Jiangsu, Peoples R China.; Xu, Y (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; zhuquelee@126.com			National Nature Science Foundation of China [81200839, 81230026, 81171085]; Nanjing Medical Technology Development Project [YKK13086]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical Technology Development Project	This work was supported by National Nature Science Foundation of China (No. 81200839, No. 81230026, and No. 81171085) and Nanjing Medical Technology Development Project (No. YKK13086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Bayrakdar ET, 2014, CELL BIOCHEM FUNCT, V32, P557, DOI 10.1002/cbf.3049; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Chen K, 2007, MOL CELL NEUROSCI, V36, P108, DOI 10.1016/j.mcn.2007.06.004; Chen YT, 2012, CLIN EXP PHARMACOL P, V39, P751, DOI 10.1111/j.1440-1681.2012.05729.x; Ciaramella A, 2013, BRAIN BEHAV IMMUN, V32, P29, DOI 10.1016/j.bbi.2013.04.001; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Evans Gareth J O, 2015, Cold Spring Harb Protoc, V2015, P421, DOI 10.1101/pdb.top074450; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Francis BM, 2012, NEUROBIOL AGING, V33, P555, DOI 10.1016/j.neurobiolaging.2010.04.003; Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Jin JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10224; Kim BK, 2014, J EXERC REHABIL, V10, P2, DOI 10.12965/jer.140086; Kim J, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00044; Kirkwood CM, 2013, J NEUROPATH EXP NEUR, V72, P791, DOI 10.1097/NEN.0b013e31829ecc89; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Liu X, 2015, J ALZHEIMERS DIS, V44, P251, DOI 10.3233/JAD-141062; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; MASLIAH E, 1991, AM J PATHOL, V138, P235; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Middei S, 2013, HIPPOCAMPUS, V23, P488, DOI 10.1002/hipo.22108; Mo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116802; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Postupna NO, 2014, LAB INVEST, V94, P1161, DOI 10.1038/labinvest.2014.103; Pozueta J, 2013, NEUROSCIENCE, V251, P51, DOI 10.1016/j.neuroscience.2012.05.050; Price KA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-41; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Rodriguez-Tornos FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053848; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shao CY, 2011, ACTA NEUROPATHOL, V122, P285, DOI 10.1007/s00401-011-0843-x; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Sokolow S, 2015, J NEUROCHEM, V133, P368, DOI 10.1111/jnc.12991; Sokolow S, 2012, CYTOM PART A, V81A, P248, DOI 10.1002/cyto.a.22009; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Wang SB, 2014, CANC CELL RES, V1, P1, DOI DOI 10.1093/EJCTS/EZU215; Wei L, 2015, FITOTERAPIA, V101, P208, DOI 10.1016/j.fitote.2015.01.017; Wilcox KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125263; Xu SJ, 2014, J ALZHEIMERS DIS, V39, P239, DOI 10.3233/JAD-130680; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yu LJ, 2015, LIFE SCI, V121, P104, DOI 10.1016/j.lfs.2014.11.021; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130; Zeng YQ, 2015, J NEUROCHEM, V133, P38, DOI 10.1111/jnc.13056; Zhang F, 2012, J CLIN NEUROSCI, V19, P946, DOI 10.1016/j.jocn.2011.12.022; Zhao H, 2013, CNS NEUROSCI THER, V19, P117, DOI 10.1111/cns.12043; Zhu XL, 2014, INT J NEUROPSYCHOPH, V17, P1511, DOI 10.1017/S1461145714000315; Zhu XL, 2013, AGING CELL, V12, P85, DOI 10.1111/acel.12022	54	38	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151397	10.1371/journal.pone.0151397	http://dx.doi.org/10.1371/journal.pone.0151397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974541	Green Published, gold			2022-12-26	WOS:000372570600075
J	Beaumont, E; Roch, E; Chopin, L; Roingeard, P				Beaumont, Elodie; Roch, Emmanuelle; Chopin, Lucie; Roingeard, Philippe			Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties	PLOS ONE			English	Article							CELL-CULTURE SYSTEMS; GLYCOPROTEIN COMPLEX; VACCINE; CLEARANCE; INFECTION; CHIMPANZEES; RESPONSES; LOCALIZATION; TOLERABILITY; IMMUNIZATION	Various strategies involving the use of hepatitis C virus (HCV) E1 and E2 envelope glycoproteins as immunogens have been developed for prophylactic vaccination against HCV. However, the ideal mode of processing and presenting these immunogens for effective vaccination has yet to be determined. We used our recently described vaccine candidate based on full-length HCV E1 or E2 glycoproteins fused to the heterologous hepatitis B virus S envelope protein to compare the use of the E1 and E2 proteins as separate immunogens with their use as the E1E2 heterodimer, in terms of immunogenetic potential and the capacity to induce neutralizing antibodies. The specific anti-E1 and anti-E2 antibody responses induced in animals immunized with vaccine particles harboring the heterodimer were profoundly impaired with respect to those in animals immunized with particles harboring E1 and E2 separately. Moreover, the anti-E1 and anti-E2 antibodies had additive neutralizing properties that increase the cross-neutralization of heterologous strains of various HCV genotypes, highlighting the importance of including both E1 and E2 in the vaccine for an effective vaccination strategy. Our study has important implications for the optimization of HCV vaccination strategies based on HCV envelope proteins, regardless of the platform used to present these proteins to the immune system.	[Roingeard, Philippe] Univ Tours, INSERM U966, Tours, France; CHRU Tours, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Roingeard, P (corresponding author), Univ Tours, INSERM U966, Tours, France.	roingeard@med.univ-tours.fr			Agence Nationale pour la Recherche (ANR, France) [ANR-11-EMMA-026]; Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS, France) [2014-1]; Ligue contre le Cancer (Comites de l'Indre et Loire, du Maine et Loire, de la Sarthe, France); Academie Nationale de Medecine, France	Agence Nationale pour la Recherche (ANR, France)(French National Research Agency (ANR)); Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS, France)(French National Research Agency (ANR)); Ligue contre le Cancer (Comites de l'Indre et Loire, du Maine et Loire, de la Sarthe, France); Academie Nationale de Medecine, France	This study was supported by the "Hepatibivax" grant from the "Emergence" program of the Agence Nationale pour la Recherche (ANR, France, grant ANR-11-EMMA-026), the Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS, France, grant 2014-1), the Ligue contre le Cancer (Comites de l'Indre et Loire, du Maine et Loire, de la Sarthe, France), and the Academie Nationale de Medecine, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2014, LIVER INT, V34, P60, DOI 10.1111/liv.12424; Ball JK, 2014, ANTIVIR RES, V105, P100, DOI 10.1016/j.antiviral.2014.02.013; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Baumert TF, 2014, J HEPATOL, V61, pS34, DOI 10.1016/j.jhep.2014.09.009; Beaumont E, 2015, VACCINE, V33, P973, DOI 10.1016/j.vaccine.2015.01.007; Beaumont E, 2013, HEPATOLOGY, V57, P1303, DOI 10.1002/hep.26132; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Dahari H, 2010, GASTROENTEROLOGY, V139, P965, DOI 10.1053/j.gastro.2010.05.077; Duvet S, 1998, J BIOL CHEM, V273, P32088, DOI 10.1074/jbc.273.48.32088; Edwards VC, 2012, J GEN VIROL, V93, P1, DOI 10.1099/vir.0.035956-0; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Garrone P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002330; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hagan LM, 2013, TRENDS MICROBIOL, V21, P625, DOI 10.1016/j.tim.2013.09.008; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2004, J VIROL, V78, P7257, DOI 10.1128/JVI.78.13.7257-7263.2004; Leroux-Roels G, 2004, VACCINE, V22, P3080, DOI 10.1016/j.vaccine.2004.02.002; Leroux-Roels G, 2005, HUM VACCINES, V1, P61, DOI 10.4161/hv.1.2.1554; LerouxRoels G, 1996, HEPATOLOGY, V23, P8, DOI 10.1002/hep.510230102; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Meunier JC, 2011, J INFECT DIS, V204, P1186, DOI 10.1093/infdis/jir511; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Netter HJ, 2001, J VIROL, V75, P2130, DOI 10.1128/JVI.75.5.2130-2141.2001; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Pape GR, 1999, J VIRAL HEPATITIS, V6, P36, DOI 10.1046/j.1365-2893.1999.00006.x; Patient R, 2009, NEW BIOTECHNOL, V25, P226, DOI 10.1016/j.nbt.2009.01.001; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Raghuraman S, 2012, J INFECT DIS, V205, P763, DOI 10.1093/infdis/jir835; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Reyes-del Valle J, 2012, J VIROL, V86, P11558, DOI 10.1128/JVI.01776-12; Ruwona TB, 2014, J VIROL, V88, P10459, DOI 10.1128/JVI.01584-14; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Sominskaya I, 2006, MOL IMMUNOL, V43, P1941, DOI 10.1016/j.molimm.2005.11.018; SPAETE RR, 1992, VIROLOGY, V188, P819, DOI 10.1016/0042-6822(92)90537-Y; Stamataki Z, 2007, VACCINE, V25, P7773, DOI 10.1016/j.vaccine.2007.08.053; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Verstrepen BE, 2011, J INFECT DIS, V204, P837, DOI 10.1093/infdis/jir423; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Ward John W, 2013, Top Antivir Med, V21, P15	48	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151626	10.1371/journal.pone.0151626	http://dx.doi.org/10.1371/journal.pone.0151626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966906	gold, Green Published, Green Submitted			2022-12-26	WOS:000371989200066
J	Jin, H; Lee, K; Kim, YH; Oh, HK; Maeng, YI; Kim, TH; Suh, DS; Bae, J				Jin, H.; Lee, K.; Kim, Y-H; Oh, H. K.; Maeng, Y-I; Kim, T-H; Suh, D-S; Bae, J.			Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells	ONCOGENE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; UBIQUITIN-PROTEASOME SYSTEM; LIM-ONLY PROTEIN; GENE IEX-1; TRIGGERS APOPTOSIS; IN-VIVO; P53; EXPRESSION; TARGET; IDENTIFICATION	The expression of immediate early response 3 (IER3), a protein with a short half-life, is rapidly induced by various cellular stimuli. We recently reported that IER3 induces the apoptosis of cervical cancer cells and that its expression is downregulated in patients with cervical cancer. However, the molecular mechanism involved in the rapid degradation of IER3 remains unknown. Here, we demonstrate that MDM2 is an E3 ligase that interacts with IER3 and promotes its ubiquitination, followed by proteasomal degradation. Polyubiquitination of the conserved lysine 60 of IER3 is essential for its degradation. In addition, four and a half LIM domains protein 2 (FHL2) binds to both IER3 and MDM2, allowing for efficient MDM2-mediated IER3 degradation by facilitating an association between MDM2 and IER3. Moreover, IER3 induces cell cycle arrest in cervical cancer cells and its activity is further enhanced in cells in which FHL2 or MDM2 was silenced, thereby preventing IER3 degradation. The E6 and E7 oncoproteins of human papilloma virus 18 regulated IER3 expression. FHL2 expression was significantly higher in the squamous epithelium of cervical carcinoma tissues than in non-cancerous cervical tissues, whereas cervical carcinoma expression of IER3 was downregulated in this region. Thus, we determined the molecular mechanism responsible for IER3 degradation, involving a ternary complex of IER3, MDM2 and FHL2, which may contribute to cervical tumor growth. Furthermore, we demonstrated that FHL2 serves as a scaffold for E3 ligase and its substrate during the ubiquitination reaction, a function that has not been previously reported for this protein.	[Jin, H.; Bae, J.] Chung Ang Univ, Sch Pharm, 84 Heukseok Ro, Seoul 156756, South Korea; [Lee, K.] Chung Ang Univ, Dept Life Sci, Seoul, South Korea; [Kim, Y-H] Catholic Univ Daegu, Sch Med, Dept Microbiol, Daegu, South Korea; [Oh, H. K.; Maeng, Y-I] Catholic Univ Daegu, Sch Med, Dept Pathol, Daegu, South Korea; [Kim, T-H] Chosun Univ, Sch Med, Dept Biochem, Gwangju, South Korea; [Suh, D-S] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea	Chung Ang University; Chung Ang University; Catholic University of Daegu; Catholic University of Daegu; Chosun University; University of Ulsan; Asan Medical Center	Bae, J (corresponding author), Chung Ang Univ, Sch Pharm, 84 Heukseok Ro, Seoul 156756, South Korea.	jeehyeon@cau.ac.kr	Park, Sang-Youel/D-5966-2012	Park, Sang-Youel/0000-0003-0575-6045; Jin, Hanyong/0000-0002-5850-0791	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014R1A2A2A01006839, NRF-2015R1A5A1008958, NRF-2015R1A2A1A15054332]; Next-Generation BioGreen 21 Program, the Rural Development Administration of the Republic of Korea [PJ01117703]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Next-Generation BioGreen 21 Program, the Rural Development Administration of the Republic of Korea	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2014R1A2A2A01006839; NRF-2015R1A5A1008958; NRF-2015R1A2A1A15054332) and by the Next-Generation BioGreen 21 Program (PJ01117703), the Rural Development Administration of the Republic of Korea.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Arlt A, 2001, ONCOGENE, V20, P69, DOI 10.1038/sj.onc.1204061; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Bae JY, 2003, J BIOL CHEM, V278, P5195, DOI 10.1074/jbc.M201988200; Balsas P, 2012, LEUKEMIA RES, V36, P212, DOI 10.1016/j.leukres.2011.09.011; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Campo-Fernandez B, 2007, J VIROL, V81, P1027, DOI 10.1128/JVI.01699-06; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chen JZ, 2015, REV MED VIROL, V25, P24, DOI 10.1002/rmv.1823; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Genini M, 1997, DNA CELL BIOL, V16, P433, DOI 10.1089/dna.1997.16.433; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi H, 2009, ARTERIOSCL THROM VAS, V29, P909, DOI 10.1161/ATVBAHA.108.178541; HECK DV, 1992, P NATL ACAD SCI USA, V89, P4442, DOI 10.1073/pnas.89.10.4442; Hwang SG, 2002, J BIOL CHEM, V277, P2923, DOI 10.1074/jbc.M109113200; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Jin H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08367; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Jung CR, 2010, J CLIN INVEST, V120, P4493, DOI 10.1172/JCI42674; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim JH, 2014, J REPROD DEVELOP, V60, P14, DOI 10.1262/jrd.2013-090; Kim JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3936; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; Kleiber K, 2007, ANTICANCER RES, V27, P55; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee MJ, 2013, PROG NEUROBIOL, V105, P49, DOI 10.1016/j.pneurobio.2013.03.001; Li HY, 2001, CELL MOTIL CYTOSKEL, V48, P11, DOI 10.1002/1097-0169(200101)48:1<11::AID-CM2>3.0.CO;2-I; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Manzo-Merino J, 2015, VIROLOGY, V476, P100, DOI 10.1016/j.virol.2014.11.025; Mille F, 2009, NAT CELL BIOL, V11, P739, DOI 10.1038/ncb1880; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Muerkoster SS, 2008, ONCOGENE, V27, P1122, DOI 10.1038/sj.onc.1210728; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Ng CF, 2011, CANCER LETT, V304, P97, DOI 10.1016/j.canlet.2011.02.001; Pawlikowska P, 2010, CELL DEATH DIFFER, V17, P1739, DOI 10.1038/cdd.2010.56; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Qian Z, 2009, LEUKEMIA, V23, P1650, DOI 10.1038/leu.2009.78; Ryou SM, 2014, J CONTROL RELEASE, V196, P287, DOI 10.1016/j.jconrel.2014.10.021; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schilling D, 2001, ONCOGENE, V20, P7992, DOI 10.1038/sj.onc.1204965; Suh DS, 2015, J PROTEOME RES, V14, P2446, DOI 10.1021/pr501230b; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Wu MX, 2013, EXPERT OPIN THER TAR, V17, P593, DOI 10.1517/14728222.2013.768234; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Yoon S, 2009, BIOCHEM BIOPH RES CO, V382, P400, DOI 10.1016/j.bbrc.2009.03.037; Zienert E, 2015, CANCER LETT, V364, P17, DOI 10.1016/j.canlet.2015.04.019	50	22	23	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5106	5118		10.1038/onc.2016.54	http://dx.doi.org/10.1038/onc.2016.54			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	26973248	hybrid, Green Published			2022-12-26	WOS:000384433000003
J	Bostrom, JE; Dimitrova, M; Canton, C; Hastad, O; Qvarnstrom, A; Odeen, A				Bostrom, Jannika E.; Dimitrova, Marina; Canton, Cindy; Hastad, Olle; Qvarnstrom, Anna; Odeen, Anders			Ultra-Rapid Vision in Birds	PLOS ONE			English	Article							FLICKER FUSION FREQUENCY; GALLUS-GALLUS-DOMESTICUS; CLUTCH-SIZE; INFORMATION; THRESHOLDS; INCUBATION; ACUITY; COSTS	Flying animals need to accurately detect, identify and track fast-moving objects and these behavioral requirements are likely to strongly select for abilities to resolve visual detail in time. However, evidence of highly elevated temporal acuity relative to non-flying animals has so far been confined to insects while it has been missing in birds. With behavioral experiments on three wild passerine species, blue tits, collared and pied flycatchers, we demonstrate temporal acuities of vision far exceeding predictions based on the sizes and metabolic rates of these birds. This implies a history of strong natural selection on temporal resolution. These birds can resolve alternating light-dark cycles at up to 145 Hz (average: 129, 127 and 137, respectively), which is ca. 50 Hz over the highest frequency shown in any other vertebrate. We argue that rapid vision should confer a selective advantage in many bird species that are ecologically similar to the three species examined in our study. Thus, rapid vision may be a more typical avian trait than the famously sharp vision found in birds of prey.	[Bostrom, Jannika E.; Dimitrova, Marina; Canton, Cindy; Qvarnstrom, Anna; Odeen, Anders] Uppsala Univ, Dept Anim Ecol, Norbyvagen 18D, S-75236 Uppsala, Sweden; [Dimitrova, Marina] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Hastad, Olle; Odeen, Anders] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Box 7011, S-75007 Uppsala, Sweden	Uppsala University; Stockholm University; Swedish University of Agricultural Sciences	Odeen, A (corresponding author), Uppsala Univ, Dept Anim Ecol, Norbyvagen 18D, S-75236 Uppsala, Sweden.; Odeen, A (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Box 7011, S-75007 Uppsala, Sweden.	anders.odeen@ebc.uu.se	Håstad, Olle E/H-6235-2017	Håstad, Olle E/0000-0001-9280-3051	Carl Trygger's Foundation [CTS 09: 425, CTS10: 432]; Swedish Research Council Formas [22-2007-729]; Swedish Research Council [621-2012-3722]	Carl Trygger's Foundation; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Financial support was provided by Carl Trygger's Foundation (grant numbers CTS 09: 425 and CTS10: 432, to AO; URL: http://www.carltryggersstiftelse.se), The Swedish Research Council Formas (grant number 22-2007-729, to AO; URL: http://www.formas.se) and The Swedish Research Council (grant number 621-2012-3722, to AQ; URL: http://www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTRUM H., 1952, BIOL ZENTRALBL, V71, P129; Bouma PJ, 1941, PHILIPS TECHNISCHE R, V6, P299; DODT E, 1953, ACTA PHYSIOL SCAND, V30, P80; Evans JE, 2006, ANIM BEHAV, V72, P393, DOI 10.1016/j.anbehav.2005.10.031; GINSBURG N, 1971, J EXP ANAL BEHAV, V15, P189, DOI 10.1901/jeab.1971.15-189; Greenwood VJ, 2004, APPL ANIM BEHAV SCI, V86, P145, DOI 10.1016/j.applanim.2003.11.008; Healy K, 2013, ANIM BEHAV, V86, P685, DOI 10.1016/j.anbehav.2013.06.018; HENDRICKS J, 1966, J EXP ANAL BEHAV, V9, P501, DOI 10.1901/jeab.1966.9-501; Inger R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098631; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Lind O, 2012, J COMP PHYSIOL A, V198, P69, DOI 10.1007/s00359-011-0689-7; Lisney TJ, 2012, VISION RES, V62, P125, DOI 10.1016/j.visres.2012.04.002; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; Martin GR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0040; Meyer D.B., 1977, VISUAL SYSTEM VERTEB, V5, P550; MORENO J, 1989, ORNIS SCAND, V20, P123, DOI 10.2307/3676879; MORENO J, 1991, IBIS, V133, P186, DOI 10.1111/j.1474-919X.1991.tb04830.x; NUBOER JFW, 1992, BRIT POULTRY SCI, V33, P123, DOI 10.1080/00071669208417449; Purves D., 2001, NEUROSCIENCE; Qvarnstrom A, 2009, ECOLOGY, V90, P1948, DOI 10.1890/08-0494.1; REYMOND L, 1985, VISION RES, V25, P1477, DOI 10.1016/0042-6989(85)90226-3; SHUMAKE SA, 1968, PSYCHOL REC, V18, P537, DOI 10.1007/BF03393804; SRINIVASAN MV, 1984, J COMP PHYSIOL, V155, P297, DOI 10.1007/BF00610583; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4	26	33	33	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151099	10.1371/journal.pone.0151099	http://dx.doi.org/10.1371/journal.pone.0151099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990087	Green Submitted, gold, Green Published			2022-12-26	WOS:000372582800043
J	Barbuti, R; Chessa, S; Micheli, A; Pucci, R				Barbuti, Roberto; Chessa, Stefano; Micheli, Alessio; Pucci, Rita			Localizing Tortoise Nests by Neural Networks	PLOS ONE			English	Article							TIME; BEHAVIOR; SYSTEM; TOOLS; EGGS	The goal of this research is to recognize the nest digging activity of tortoises using a device mounted atop the tortoise carapace. The device classifies tortoise movements in order to discriminate between nest digging, and non-digging activity (specifically walking and eating). Accelerometer data was collected from devices attached to the carapace of a number of tortoises during their two-month nesting period. Our system uses an accelerometer and an activity recognition system (ARS) which is modularly structured using an artificial neural network and an output filter. For the purpose of experiment and comparison, and with the aim of minimizing the computational cost, the artificial neural network has been modelled according to three different architectures based on the input delay neural network (IDNN). We show that the ARS can achieve very high accuracy on segments of data sequences, with an extremely small neural network that can be embedded in programmable low power devices. Given that digging is typically a long activity (up to two hours), the application of ARS on data segments can be repeated over time to set up a reliable and efficient system, called Tortoise@, for digging activity recognition.	[Barbuti, Roberto; Chessa, Stefano; Micheli, Alessio; Pucci, Rita] Univ Pisa, Dept Comp Sci, Pisa, Italy	University of Pisa	Pucci, R (corresponding author), Univ Pisa, Dept Comp Sci, Pisa, Italy.	pucci@di.unipi.it	Pucci, Rita/U-4201-2018; Pucci, Rita/AAX-2555-2020	Pucci, Rita/0000-0002-2970-1180; Pucci, Rita/0000-0002-2970-1180; Chessa, Stefano/0000-0002-1248-9478; MICHELI, ALESSIO/0000-0001-5764-5238				Aguilera WT, 2013, GIANT TORTOISES HATC; [Anonymous], 2013, PROJECT REPORT PLOUG; Barbuti R, 2014, 50 ANN CONV AISB; Barbuti Roberto, 2012, Atti della Societa Toscana di Scienze Naturali Residente in Pisa Memorie Serie B, V119, P89; Baronti P, 2007, COMPUT COMMUN, V30, P1655, DOI 10.1016/j.comcom.2006.12.020; Bettini C, 2010, PERVASIVE MOB COMPUT, V6, P161, DOI 10.1016/j.pmcj.2009.06.002; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Colbourne R, 2005, DEV OPERATION NEST E; Gaill F., 2012, SENSORS ECOLOGY INTE, P17; Gao LL, 2013, ECOL INFORM, V13, P47, DOI 10.1016/j.ecoinf.2012.09.003; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Haykin S., 2009, NEURAL NETWORKS COMP; Kays R, 2011, ACTA OECOL, V37, P625, DOI 10.1016/j.actao.2011.06.007; Kooyman Gerald L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P15; Kuehler C, 2000, ZOO BIOL, V19, P263, DOI 10.1002/1098-2361(2000)19:4<263::AID-ZOO4>3.0.CO;2-G; Ladha C, 2013, UBICOMP'13: PROCEEDINGS OF THE 2013 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P415, DOI 10.1145/2493432.2493519; LANG KJ, 1990, NEURAL NETWORKS, V3, P23, DOI 10.1016/0893-6080(90)90044-L; Lara OD, 2013, IEEE COMMUN SURV TUT, V15, P1192, DOI 10.1109/SURV.2012.110112.00192; LeCun Y., 1995, Neural Networks: The Statistical Mechanics Perspective. Proceedings of the CTP-PBSRI. Joint Workshop on Theoretical Physics, P261; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; LeCun Y, 2010, IEEE INT SYMP CIRC S, P253, DOI 10.1109/ISCAS.2010.5537907; Levasseur K, 2011, MONITORING ERETMOCHE; Lopez-Risueno G, 2002, LECT NOTES COMPUT SC, V2415, P1150; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; Milligan H, 2014, FREEMAN R PROTECTING; Mitrus S, 2005, AMPHIBIA-REPTILIA, V26, P333, DOI 10.1163/156853805774408504; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Oczak M, 2014, BIOSYST ENG, V119, P89, DOI 10.1016/j.biosystemseng.2014.01.005; Rogoza V, 2014, ADV SYSTEMS SCI; Ropert-Coudert Yan, 2010, Endangered Species Research, V10, P21, DOI 10.3354/esr00188; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sejnowski T. J., 1987, Complex Systems, V1, P145; Sermanet P, 2012, INT C PATT RECOG, P3288; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Smith SW, 1997, SCI ENG GUIDE DIGITA; Soltis Joseph, 2012, Endangered Species Research, V18, P255, DOI 10.3354/esr00452; Technology C, 2007, TECHN C MICAZ WIR ME; Thornton I., 1971, DARWINS ISLANDS NATU; Waibel A, 1989, NEURAL COMPUT, V1, P39, DOI 10.1162/neco.1989.1.1.39; Zylstra ER, 2013, OECOLOGIA, V173, P107, DOI 10.1007/s00442-012-2464-z	46	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151168	10.1371/journal.pone.0151168	http://dx.doi.org/10.1371/journal.pone.0151168			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985660	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300050
J	Lin, CF; Hsu, SPC; Lin, CJ; Guo, WY; Liao, CH; Chu, WF; Hung, SC; Shih, YS; Lin, YT				Lin, Chun Fu; Hsu, Sanford P. C.; Lin, Chung Jung; Guo, Wan Yuo; Liao, Chih Hsiang; Chu, Wei Fa; Hung, Sheng Che; Shih, Yang Shin; Lin, Yen Tzu			Prolonged Cerebral Circulation Time Is the Best Parameter for Predicting Vasospasm during Initial CT Perfusion in Subarachnoid Hemorrhagic Patients	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CEREBROVASCULAR RESERVE; DIGITAL-SUBTRACTION; BLOOD-FLOW; ANGIOGRAPHY; IMPACT	Purpose We sought to imitate angiographic cerebral circulation time (CCT) and create a similar index from baseline CT perfusion (CTP) to better predict vasospasm in patients with subarachnoid hemorrhage (SAH). Methods Forty-one SAH patients with available DSA and CTP were retrospectively included. The vasospasm group was comprised of patients with deterioration in conscious functioning and newly developed luminal narrowing; remaining cases were classified as the control group. The angiography CCT (XA-CCT) was defined as the difference in TTP (time to peak) between the selected arterial ROIs and the superior sagittal sinus (SSS). Four arterial ROIs were selected to generate four corresponding XA-CCTs: the right and left anterior cerebral arteries (XA-CCTRA2 and XA-CCTLA2) and right-and left-middle cerebral arteries (XA-CCTRM2 and XA-CCTLM2). The CCTs from CTP (CT-CCT) were defined as the differences in TTP from the corresponding arterial ROIs and the SSS. Correlations of the different CCTs were calculated and diagnostic accuracy in predicting vasospasm was evaluated. Results Intra-class correlations ranged from 0.96 to 0.98. The correlations of XA-CCTRA2, XA-CCTRM2, XA-CCTLA2, and XA-CCTLM2 with the corresponding CT-CCTs were 0.64, 0.65, 0.53, and 0.68, respectively. All CCTs were significantly prolonged in the vasospasm group (5.8-6.4 s) except for XA-CCTLA2. CT-CCTA2 of 5.62 was the optimal cut-off value for detecting vasospasm with a sensitivity of 84.2% and specificity 82.4% Conclusion CT-CCTs can be used to interpret cerebral flow without deconvolution algorithms, and outperform both MTT and TTP in predicting vasospasm risk. This finding may help facilitate management of patients with SAH.	[Lin, Chun Fu; Hsu, Sanford P. C.; Liao, Chih Hsiang; Shih, Yang Shin] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Lin, Chung Jung; Guo, Wan Yuo; Chu, Wei Fa; Hung, Sheng Che; Lin, Yen Tzu] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lin, Chun Fu; Hsu, Sanford P. C.; Lin, Chung Jung; Guo, Wan Yuo; Liao, Chih Hsiang; Chu, Wei Fa; Hung, Sheng Che; Shih, Yang Shin; Lin, Yen Tzu] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Guo, WY (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.; Guo, WY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	wyguo@vghtpe.gov.tw	Hung, Sheng Che/Q-3778-2019	Hung, Sheng Che/0000-0001-6288-3556; Liao, Chih-Hsiang/0000-0003-3459-1913	National Science Council [MOST 104-2314-B-010-037]; Taipei Veterans General Hospital (VGHTPE) grant [T1100200]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital (VGHTPE) grant	This research was co-sponsored by National Science Council of (grant number: MOST 104-2314-B-010-037) and Taipei Veterans General Hospital (VGHTPE) grant T1100200.	Abels B, 2011, AM J NEURORADIOL, V32, P1632, DOI 10.3174/ajnr.A2576; Aikawa H, 2010, NEUROL MED-CHIR, V50, P269, DOI 10.2176/nmc.50.269; [Anonymous], 1979, PHYSL PATHOPHYSIOLOG; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; CONNOLLY ES, 2012, STROKE J CEREBRAL CI, V43, P1711, DOI [DOI 10.1161/STR.0B013E3182587839, 10.1161/STR.0b013e3182587839]; Dankbaar JW, 2009, NEURORADIOLOGY, V51, P813, DOI 10.1007/s00234-009-0575-y; Figueiredo G, 2012, AM J NEURORADIOL, V33, P1702, DOI 10.3174/ajnr.A3071; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Greenberg ED, 2010, AM J NEURORADIOL, V31, P1853, DOI 10.3174/ajnr.A2246; Greitz T., 1956, RADIOLOGIC STUDY BRA; Heyn C, 2010, AM J NEURORADIOL, V31, P862, DOI 10.3174/ajnr.A1922; Iseda T, 2000, CLIN RADIOL, V55, P679, DOI 10.1053/crad.2000.0507; Jestaedt L, 2008, NEUROSURGERY, V62, P610, DOI 10.1227/01.NEU.0000311351.32904.8B; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Kudo K, 2011, J CEREBR BLOOD F MET, V31, P908, DOI 10.1038/jcbfm.2010.169; Levitt MR, 2014, J NEUROIMAGING, V24, P387, DOI 10.1111/jon.12046; Lin CJ, 2014, AM J NEURORADIOL, V35, P1132, DOI 10.3174/ajnr.A3838; Lin CJ, 2012, AM J NEURORADIOL, V33, P1685, DOI 10.3174/ajnr.A3049; Lin CJ, 2013, J CHIN MED ASSOC, V76, P218, DOI 10.1016/j.jcma.2012.12.009; McGuinness B, 2010, NEUROSURG CLIN N AM, V21, P281, DOI 10.1016/j.nec.2009.10.007; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Ohkuma H, 2000, STROKE, V31, P1621, DOI 10.1161/01.STR.31.7.1621; Petralia G, 2009, AM J NEURORADIOL, V30, P1107, DOI 10.3174/ajnr.A1540; Rim NJ, 2008, AM J NEURORADIOL, V29, P1658, DOI 10.3174/ajnr.A1229; Rosovsky M, 2006, RADIOLOGY, V240, DOI 10.1148/radiol.2402051816; Sanelli PC, 2011, AM J NEURORADIOL, V32, P2047, DOI 10.3174/ajnr.A2693; Siebert E, 2009, BRIT J RADIOL, V82, P561, DOI 10.1259/bjr/27721218; Straka M, 2010, J MAGN RESON IMAGING, V32, P1024, DOI 10.1002/jmri.22338; Strother CM, 2010, AM J NEURORADIOL, V31, P919, DOI 10.3174/ajnr.A2020; Struffert T, 2015, AM J NEURORADIOL, V36, P1964, DOI 10.3174/ajnr.A4383; Turowski B, 2005, NEURORADIOLOGY, V47, P134, DOI 10.1007/s00234-004-1281-4; Udoetuk JD, 2007, NEUROSURGERY, V61, P1152, DOI 10.1227/01.neu.0000306092.07647.6d; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Yamamoto S, 2004, AM J NEURORADIOL, V25, P242	34	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151772	10.1371/journal.pone.0151772	http://dx.doi.org/10.1371/journal.pone.0151772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986626	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300128
J	Lopez-Campos, JL; Arranz, MA; Calero-Acuna, C; Romero-Valero, F; Ayerbe-Garcia, R; Hidalgo-Molina, A; Aguilar-Perez-Grovas, RI; Garcia-Gil, F; Casas-Maldonado, F; Caballero-Ballesteros, L; Sanchez-Palop, M; Perez-Tejero, D; Segado, A; Calvo-Bonachera, J; Hernandez-Sierra, B; Domenech, A; Arroyo-Varela, M; Gonzalez-Vargas, F; Cruz-Rueda, JJ				Lopez-Campos, Jose L.; Abad Arranz, Maria; Calero-Acuna, Carmen; Romero-Valero, Fernando; Ayerbe-Garcia, Ruth; Hidalgo-Molina, Antonio; Aguilar-Perez-Grovas, Ricardo I.; Garcia-Gil, Francisco; Casas-Maldonado, Francisco; Caballero-Ballesteros, Laura; Sanchez-Palop, Maria; Perez-Tejero, Dolores; Segado, Alejandro; Calvo-Bonachera, Jose; Hernandez-Sierra, Barbara; Domenech, Adolfo; Arroyo-Varela, Macarena; Gonzalez-Vargas, Francisco; Cruz-Rueda, Juan J.			Guideline Adherence in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Results from a Clinical Audit	PLOS ONE			English	Article							COPD PATIENTS; INHALED CORTICOSTEROIDS; BODE INDEX; APPROPRIATENESS; EXACERBATIONS; MANAGEMENT; RISK; LIFE; CARE; POPULATION	Objectives Previous clinical audits of COPD have provided relevant information about medical intervention in exacerbation admissions. The present study aims to evaluate adherence to current guidelines in COPD through a clinical audit. Methods This is a pilot clinical audit performed in hospital outpatient respiratory clinics in Andalusia, Spain (eight provinces with more than 8 million inhabitants), including 9 centers (20% of the public centers in the area) between 2013 and 2014. Cases with an established diagnosis of COPD based on risk factors, clinical symptoms, and a post-bronchodilator FEV1/FVC ratio of less than 0.70 were deemed eligible. The performance of the outpatient clinics was benchmarked against three guidance documents available at the time of the audit. The appropriateness of the performance was categorized as excellent (>80%), good (60-80%), adequate (40-59%), inadequate (20-39%), and highly inadequate (<20%). Results During the audit, 621 clinical records were audited. Adherence to the different guidelines presented a considerable variability among the different participating hospitals, with an excellent or good adherence for symptom recording, MRC or CAT use, smoking status evaluation, spirometry, or bronchodilation therapy. The most outstanding areas for improvement were the use of the BODE index, the monitoring of treatments, the determination of alpha1-antitrypsin, the performance of exercise testing, and vaccination recommendations. Conclusions The present study reflects the situation of clinical care for COPD patients in specialized secondary care outpatient clinics. Adherence to clinical guidelines shows considerable variability in outpatient clinics managing COPD patients, and some aspects of the clinical care can clearly be improved.	[Lopez-Campos, Jose L.; Abad Arranz, Maria; Calero-Acuna, Carmen] Univ Seville, Unidad Med Quirurg Enfermedades Resp, Inst Biomed Sevilla IBiS, Hosp Univ Virgen del Rocio, Seville, Spain; [Lopez-Campos, Jose L.; Calero-Acuna, Carmen] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Romero-Valero, Fernando; Hidalgo-Molina, Antonio] Hosp Puerta del Mar, Cadiz, Spain; [Ayerbe-Garcia, Ruth; Aguilar-Perez-Grovas, Ricardo I.] Hosp Juan Ramon Jimenez, Huelva, Spain; [Garcia-Gil, Francisco; Caballero-Ballesteros, Laura] Hosp Univ Reina Sofia, Cordoba, Spain; [Casas-Maldonado, Francisco; Sanchez-Palop, Maria] Hosp Univ San Cecilio, Granada, Spain; [Perez-Tejero, Dolores; Segado, Alejandro] Hosp Infanta Margarita, Cordoba, Spain; [Calvo-Bonachera, Jose; Hernandez-Sierra, Barbara] Hosp Torrecardenas, Almeria, Spain; [Domenech, Adolfo; Arroyo-Varela, Macarena] Hosp Reg Univ Malaga, Malaga, Spain; [Gonzalez-Vargas, Francisco; Cruz-Rueda, Juan J.] Hosp Univ Virgen de las Nieves, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital Juan Ramon Jimenez; Hospital Universitario Reina Sofia - Cordoba; Hospital Universitario San Cecilio; Hospital Torrecardenas; Hospital Universitario Virgen de las Nieves	Lopez-Campos, JL (corresponding author), Univ Seville, Unidad Med Quirurg Enfermedades Resp, Inst Biomed Sevilla IBiS, Hosp Univ Virgen del Rocio, Seville, Spain.; Lopez-Campos, JL (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain.	lcampos@separ.es	Bodineau, José Luis López-Campos/AAG-5203-2019	Bodineau, José Luis López-Campos/0000-0003-1703-1367; Domenech del Rio, Adolfo/0000-0002-3127-9150; Arroyo Varela, Macarena/0000-0003-4939-9174; Casas, Francisco/0000-0002-8007-9323	Laboratorios Menarini, SA (Barcelona, Spain)	Laboratorios Menarini, SA (Barcelona, Spain)	This study was financially supported by an unrestricted grant from Laboratorios Menarini, SA (Barcelona, Spain).	Agabiti N, 2010, EUR RESPIR J, V35, P1031, DOI 10.1183/09031936.00056209; Navarrete BA, 2015, ARCH BRONCONEUMOL, V51, P193, DOI 10.1016/j.arbres.2014.11.001; Asche CV, 2012, INT J CHRONIC OBSTR, V7, P201, DOI 10.2147/COPD.S25805; Sorroche PB, 2015, ARCH BRONCONEUMOL, V51, P539, DOI 10.1016/j.arbres.2015.01.008; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Casas F, 2015, ARCH BRONCONEUMOL, V51, P185, DOI 10.1016/j.arbres.2014.05.008; Chorostowska-Wynimko J, 2015, EUR RESPIR REV, V24, P40, DOI 10.1183/09059180.00010614; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Flottorp SA, 2010, USING AUDIT FEEDBACK; Ivers NM, 2014, J GEN INTERN MED, V29, P1534, DOI 10.1007/s11606-014-2913-y; Soler-Cataluna JJ, 2009, ARCH BRONCONEUMOL, V45, P196, DOI 10.1016/j.arbres.2008.05.008; Soler-Cataluna JJ, 2009, RESP MED, V103, P692, DOI 10.1016/j.rmed.2008.12.005; Liaaen ED, 2010, RESP MED, V104, P1304, DOI 10.1016/j.rmed.2010.03.007; Lopez-Campos JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141856; Lopez-Campos JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110394; Lopez-Campos JL, 2014, EUR RESPIR J, V43, P754, DOI 10.1183/09031936.00074413; Lopez-Campos JL, 2013, EUR RESPIR J, V41, P270, DOI 10.1183/09031936.00021812; Marcos PJ, 2015, ARCH BRONCONEUMOL, V51, P360, DOI 10.1016/j.arbres.2014.05.007; Miravitlles M, 2016, ARCH BRONCONEUMOL, V52, P1, DOI 10.1016/j.arbres.2015.04.001; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P155, DOI 10.1016/j.arbres.2013.09.001; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; de Oca MM, 2015, ARCH BRONCONEUMOL, V51, P403, DOI 10.1016/j.arbres.2014.11.017; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nardini S, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-40; Nonato NL, 2015, ARCH BRONCONEUMOL, V51, P315, DOI 10.1016/j.arbres.2014.02.017; Perez-Rubio G, 2015, ARCH BRONCONEUMOL, V51, P80, DOI 10.1016/j.arbres.2014.09.010; Pozo-Rodriguez F, 2015, INT J CLIN PRACT, V69, P938, DOI 10.1111/ijcp.12601; Pozo-Rodriguez F, 2010, ARCH BRONCONEUMOL, V46, P349, DOI 10.1016/j.arbres.2010.04.004; Pretto JJ, 2012, INTERN MED J, V42, P380, DOI 10.1111/j.1445-5994.2011.02475.x; Price D, 2014, INT J CHRONIC OBSTR, V9, P889, DOI 10.2147/COPD.S62750; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Roberts CM, 2001, EUR RESPIR J, V17, P343, DOI 10.1183/09031936.01.17303430; Roisin RR, 2015, ARCH BRONCONEUMOL, V51, P57, DOI 10.1016/j.arbres.2014.11.003; Rossi A, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-77; Sanchez-Salcedo P, 2015, ARCH BRONCONEUMOL, V51, P169, DOI 10.1016/j.arbres.2014.09.019; Sanchez-Salcedo P, 2015, ARCH BRONCONEUMOL, V51, P311, DOI 10.1016/j.arbres.2015.03.003; Stephenson M, 2016, INT J QUAL HEALTH C, V28, P92, DOI 10.1093/intqhc/mzv113; Teckman J, 2014, J PEDIATR GASTR NUTR, V58, P199, DOI 10.1097/MPG.0000000000000196; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914	41	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151896	10.1371/journal.pone.0151896	http://dx.doi.org/10.1371/journal.pone.0151896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985822	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300147
J	Chien, CH; Lee, MJ; Liou, HC; Liou, HH; Fu, WM				Chien, Chia-Hung; Lee, Ming-Jen; Liou, Houng-Chi; Liou, Horng-Huei; Fu, Wen-Mei			Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice	PLOS ONE			English	Article							NITRIC-OXIDE; PARKINSONS-DISEASE; INTERFERON-GAMMA; DJ-1-DEFICIENT MICE; GLIAL RESPONSES; CELLS; ACTIVATION; LIPOPOLYSACCHARIDE; EXPRESSION; MODEL	Mutation of DJ-1 (PARK7) has been linked to the development of early-onset Parkinson's disease (PD). However, the underlying molecular mechanism is still unclear. This study is aimed to compare the sensitivity of nigrostriatal dopaminergic neurons to lipopolysaccharide (LPS) challenge between DJ-1 knockout (KO) and wild-type (WT) mice, and explore the underlying cellular and molecular mechanisms. Our results found that the basal levels of interferon (IFN)-gamma (the hub cytokine) and interferon-inducible T-cell alpha chemoattractant (I-TAC) (a downstream mediator) were elevated in the substantia nigra of DJ-1 KO mice and in microglia cells with DJ-1 deficiency, and the release of cytokine/chemokine was greatly enhanced following LPS administration in the DJ-1 deficient conditions. In addition, direct intranigral LPS challenge caused a greater loss of nigrostriatal dopaminergic neurons and striatal dopamine content in DJ-1 KO mice than in WT mice. Furthermore, the sensitization of microglia cells to LPS challenge to release IFN-gamma and I-TAC was via the enhancement of NF-kappa B signaling, which was antagonized by NF-kappa B inhibitors. LPS-induced increase in neuronal death in the neuron-glia co-culture was enhanced by DJ-1 deficiency in microglia, which was antagonized by the neutralizing antibodies against IFN-gamma or I-TAC. These results indicate that DJ-1 deficiency sensitizes microglia cells to release IFN-gamma and I-TAC and causes inflammatory damage to dopaminergic neurons. The interaction between the genetic defect (i.e. DJ-1) and inflammatory factors (e.g. LPS) may contribute to the development of PD.	[Chien, Chia-Hung; Fu, Wen-Mei] Natl Taiwan Univ, Dept Life Sci, Coll Life Sci, Taipei 10764, Taiwan; [Lee, Ming-Jen; Liou, Horng-Huei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chien, Chia-Hung; Liou, Houng-Chi; Liou, Horng-Huei; Fu, Wen-Mei] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Chien, Chia-Hung; Fu, Wen-Mei] Natl Taiwan Univ, Coll Med, Drug Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Fu, WM (corresponding author), Natl Taiwan Univ, Dept Life Sci, Coll Life Sci, Taipei 10764, Taiwan.; Fu, WM (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.; Fu, WM (corresponding author), Natl Taiwan Univ, Coll Med, Drug Res Ctr, Taipei, Taiwan.	wenmei@ntu.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C. [MOST 102-2321-B-002-016]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	The study was financially supported by the grant MOST 102-2321-B-002-016 from the Ministry of Science and Technology, Taiwan, R.O.C. to H.H.L. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Arai H, 2004, J BIOL CHEM, V279, P51647, DOI 10.1074/jbc.M407328200; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bifsha P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004863; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chung KKK, 2003, J NEUROL, V250, P15, DOI 10.1007/s00415-003-1304-9; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Delgado M, 2003, J BIOL CHEM, V278, P27620, DOI 10.1074/jbc.M303199200; Domanskyi A, 2011, FASEB J, V25, P2898, DOI 10.1096/fj.11-181958; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; GALEA E, 1992, P NATL ACAD SCI USA, V89, P10945, DOI 10.1073/pnas.89.22.10945; Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006; Guadagno J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.59; Hayley S, 2004, J NEUROSCI, V24, P2045, DOI 10.1523/JNEUROSCI.4564-03.2004; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Huang Y, 2004, BRAIN RES REV, V46, P44, DOI 10.1016/j.brainresrev.2004.04.007; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jung SH, 2014, ATHEROSCLEROSIS, V235, P503, DOI 10.1016/j.atherosclerosis.2014.05.955; Kim JH, 2013, NEUROBIOL DIS, V60, P1, DOI 10.1016/j.nbd.2013.08.007; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Lin YC, 2007, J PHARMACOL EXP THER, V323, P877, DOI 10.1124/jpet.107.125955; Long-Smith CM, 2010, J NEUROIMMUNOL, V226, P20, DOI 10.1016/j.jneuroim.2010.05.030; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mclaughlin P, 2006, GLIA, V53, P567, DOI 10.1002/glia.20294; Mcnally RS, 2011, J BIOL CHEM, V286, P4098, DOI 10.1074/jbc.M110.147371; Molina-Holgado F, 2001, GLIA, V33, P97, DOI 10.1002/1098-1136(200102)33:2<97::AID-GLIA1009>3.0.CO;2-N; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Nguyen TA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-50; Ock J, 2010, BRIT J PHARMACOL, V159, P1646, DOI 10.1111/j.1476-5381.2010.00659.x; Pham TT, 2010, GENES BRAIN BEHAV, V9, P305, DOI 10.1111/j.1601-183X.2009.00559.x; Platten M, 2001, BRIT J PHARMACOL, V134, P1279, DOI 10.1038/sj.bjp.0704373; Rock RB, 2005, GENES IMMUN, V6, P712, DOI 10.1038/sj.gene.6364246; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tanaka S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-143; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Thomas KJ, 2009, INT J BIOCHEM CELL B, V41, P2025, DOI 10.1016/j.biocel.2009.02.018; Trudler D, 2014, J NEUROCHEM, V129, P434, DOI 10.1111/jnc.12633; Waak J, 2009, FASEB J, V23, P2478, DOI 10.1096/fj.08-125153; Weinstein JR, 2008, GLIA, V56, P16, DOI 10.1002/glia.20585; Xie Z, 2003, EXP NEUROL, V182, P135, DOI 10.1016/S0014-4886(03)00057-8; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056	53	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151569	10.1371/journal.pone.0151569	http://dx.doi.org/10.1371/journal.pone.0151569			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982707	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900098
J	Lehtinen, L; Vesterkvist, P; Roering, P; Korpela, T; Hattara, L; Kaipio, K; Mpindi, JP; Hynninen, J; Auranen, A; Davidson, B; Haglund, C; Iljin, K; Grenman, S; Siitari, H; Carpen, O				Lehtinen, Laura; Vesterkvist, Pia; Roering, Pia; Korpela, Taina; Hattara, Liisa; Kaipio, Katja; Mpindi, John-Patrick; Hynninen, Johanna; Auranen, Annika; Davidson, Ben; Haglund, Caj; Iljin, Kristiina; Grenman, Seija; Siitari, Harri; Carpen, Olli			REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker	PLOS ONE			English	Article							IV; CARCINOMA; INVASION; PATTERN; TUMORS	Preoperative diagnostics of ovarian neoplasms rely on ultrasound imaging and the serum biomarkers CA125 and HE4. However, these markers may be elevated in non-neoplastic conditions and may fail to identify most non-serous epithelial cancer subtypes. The objective of this study was to identify histotype-specific serum biomarkers for mucinous ovarian cancer. The candidate genes with mucinous histotype specific expression profile were identified from publicly available gene-expression databases and further in silico data mining was performed utilizing the MediSapiens database. Candidate biomarker validation was done using qRT-PCR, western blotting and immunohistochemical staining of tumor tissue microarrays. The expression level of the candidate gene in serum was compared to the serum CA125 and HE4 levels in a patient cohort of prospectively collected advanced ovarian cancer. Database searches identified REG4 as a potential biomarker with specificity for the mucinous ovarian cancer subtype. The specific expression within epithelial ovarian tumors was further confirmed by mRNA analysis. Immunohistochemical staining of ovarian tumor tissue arrays showed distinctive cytoplasmic expression pattern only in mucinous carcinomas and suggested differential expression between benign and malignant mucinous neoplasms. Finally, an ELISA based serum biomarker assay demonstrated increased expression only in patients with mucinous ovarian cancer. This study identifies REG4 as a potential serum biomarker for histotype-specific detection of mucinous ovarian cancer and suggests serum REG4 measurement as a non-invasive diagnostic tool for postoperative follow-up of patients with mucinous ovarian cancer.	[Lehtinen, Laura; Roering, Pia; Korpela, Taina; Kaipio, Katja; Carpen, Olli] Univ Turku, Dept Pathol, Turku, Finland; [Lehtinen, Laura; Roering, Pia; Korpela, Taina; Kaipio, Katja; Carpen, Olli] Turku Univ Hosp, FIN-20520 Turku, Finland; [Vesterkvist, Pia; Hattara, Liisa; Iljin, Kristiina; Siitari, Harri] VTT Tech Res Ctr Finland, Espoo, Finland; [Vesterkvist, Pia; Hattara, Liisa; Iljin, Kristiina; Siitari, Harri] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Mpindi, John-Patrick] Univ Helsinki, Inst Mol Med Finland, FIMM, Helsinki, Finland; [Hynninen, Johanna; Auranen, Annika; Grenman, Seija] Univ Turku, Turku Univ Hosp, Dept Obstet & Gynecol, Turku, Finland; [Davidson, Ben] Norwegian Radium Hosp, Dept Pathol, Oslo Univ Hosp, Oslo, Norway; [Davidson, Ben] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Haglund, Caj] Univ Helsinki, Translat Canc Biol, Res Programs Unit, Helsinki, Finland	University of Turku; University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki; University of Turku; University of Oslo; University of Oslo; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Lehtinen, L (corresponding author), Univ Turku, Dept Pathol, Turku, Finland.; Lehtinen, L (corresponding author), Turku Univ Hosp, FIN-20520 Turku, Finland.	lauleh@utu.fi	Haglund, Caj/N-1240-2019; Hynninen, Johanna/AAX-5424-2021; Hynninen, Johanna/AAY-5269-2020	Hynninen, Johanna/0000-0002-0854-7225; Hynninen, Johanna/0000-0002-0854-7225; Iljin, Kristiina/0000-0002-5161-0584; Auranen, Annika/0000-0002-9678-4684; Roering, Pia/0000-0003-1650-0918	Sigrid Juselius Foundation; Finnish Cancer Society; Turku University Hospital Research Fund; European Regional Development Fund [A31859]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; Turku University Hospital Research Fund; European Regional Development Fund(European Commission)	This study was supported by Sigrid Juselius Foundation, http://www.sigridjuselius.fi/foundation, to LL, TK, KK; Finnish Cancer Society, https://www.cancersociety.fi/grants/, to LL, PR, TK, KK; Turku University Hospital Research Fund, http://www.vsshp.fi/en/toimipaikat/tyks/Pages/default.aspx, to LL, PR, KK; European Regional Development Fund (A31859), http://ec.europa.eu/regional_policy/EN/funding/erdf/, to LL, PR, KK, PV, LH, KI, HS, OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1435-2; Coward JIG, 2015, INT J WOMENS HEALTH, V7, P189, DOI 10.2147/IJWH.S52379; HALILA H, 1988, BRIT J CANCER, V57, P304, DOI 10.1038/bjc.1988.67; Hayashi T, 2009, ONCOL REP, V21, P95, DOI 10.3892/or_00000194; Heiskala K, 2006, VIRCHOWS ARCH, V448, P295, DOI 10.1007/s00428-005-0105-1; Hellstrom I, 2003, CANCER RES, V63, P3695; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; Holcomb K, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.017; Kaprio T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109600; Kelly PJ, 2010, J CLIN PATHOL, V63, P169, DOI 10.1136/jcp.2009.072355; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Ludwick C, 2005, INT J GYNECOL PATHOL, V24, P205, DOI 10.1097/01.pgp.0000159935.38913.57; Miller K, 2011, AM J SURG PATHOL, V35, P1331, DOI 10.1097/PAS.0b013e3182233fce; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Mpindi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017259; Myohanen TT, 2012, J HISTOCHEM CYTOCHEM, V60, P706, DOI 10.1369/0022155412453051; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Pectasides D, 2005, GYNECOL ONCOL, V97, P436, DOI 10.1016/j.ygyno.2004.12.056; Prat Jaime, 2009, Eur J Cancer, V45 Suppl 1, P427, DOI 10.1016/S0959-8049(09)70076-0; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Tabrizi AD, 2010, INT J GYNECOL PATHOL, V29, P99, DOI 10.1097/PGP.0b013e3181bbbcc1; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635	25	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151590	10.1371/journal.pone.0151590	http://dx.doi.org/10.1371/journal.pone.0151590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981633	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900101
J	Zaatreh, S; Wegner, K; Strauss, M; Pasold, J; Mittelmeier, W; Podbielski, A; Kreikemeyer, B; Bader, R				Zaatreh, Sarah; Wegner, Katharina; Strauss, Madlen; Pasold, Juliane; Mittelmeier, Wolfram; Podbielski, Andreas; Kreikemeyer, Bernd; Bader, Rainer			Co-Culture of S. epidermidis and Human Osteoblasts on Implant Surfaces: An Advanced In Vitro Model for Implant-Associated Infections	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; GROWTH; ARTHROPLASTY; ADHESION	Objectives Total joint arthroplasty is one of the most frequent and effective surgeries today. However, despite improved surgical techniques, a significant number of implant-associated infections still occur. Suitable in vitro models are needed to test potential approaches to prevent infection. In the present study, we aimed to establish an in vitro co-culture setup of human primary osteoblasts and S. epidermidis to model the onset of implant-associated infections, and to analyze antimicrobial implant surfaces and coatings. Materials and Methods For initial surface adhesion, human primary osteoblasts (hOB) were grown for 24 hours on test sample discs made of polystyrene, titanium alloy Ti6Al4V, bone cement PALACOS R (R), and PALACOS R (R) loaded with antibiotics. Co-cultures were performed as a single-species infection on the osteoblasts with S. epidermidis (multiplicity of infection of 0.04), and were incubated for 2 and 7 days under aerobic conditions. Planktonic S. epidermidis was quantified by centrifugation and determination of colony-forming units (CFU). The quantification of biofilm-bound S. epidermidis on the test samples was performed by sonication and CFU counting. Quantification of adherent and vital primary osteoblasts on the test samples was performed by trypan-blue staining and counting. Scanning electron microscopy was used for evaluation of topography and composition of the species on the sample surfaces. Results After 2 days, we observed approximately 10(4) CFU/ml biofilm-bound S. epidermidis (10(3) CFU/ml initial population) on the antibiotics-loaded bone cement samples in the presence of hOB, while no bacteria were detected without hOB. No biofilm-bound bacteria were detectable after 7 days in either case. Similar levels of planktonic bacteria were observed on day 2 with and without hOB. After 7 days, about 10(5) CFU/ml planktonic bacteria were present, but only in the absence of hOB. Further, no bacteria were observed within the biofilm, while the number of hOB was decreased to 10% of its initial value compared to 150% in the mono-culture of hOB. Conclusion We developed a co-culture setup that serves as a more comprehensive in vitro model for the onset of implant-associated infections and provides a test method for antimicrobial implant materials and coatings. We demonstrate that observations can be made that are unavailable from mono-culture experiments.	[Zaatreh, Sarah; Wegner, Katharina; Strauss, Madlen; Pasold, Juliane; Mittelmeier, Wolfram; Bader, Rainer] Univ Med Rostock, Biomech & Implant Technol Res Lab, Dept Orthoped, Rostock, Mecklenburg Wes, Germany; [Podbielski, Andreas; Kreikemeyer, Bernd] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Mecklenburg Wes, Germany	University of Rostock; University of Rostock	Zaatreh, S (corresponding author), Univ Med Rostock, Biomech & Implant Technol Res Lab, Dept Orthoped, Rostock, Mecklenburg Wes, Germany.	sarah.zaatreh@med.uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098; Ekat, Katharina/0000-0003-2423-201X				Borens O, 2012, HIP INT, V22, pS9, DOI 10.5301/HIP.2012.9565; Borghetti P, 2005, VET RES COMMUN, V29, P221, DOI 10.1007/s11259-005-0047-8; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1; GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205; Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010; Jonitz A, 2011, J MATER SCI-MATER M, V22, P2089, DOI 10.1007/s10856-011-4384-6; Lee HS, 2014, J BONE JOINT SURG AM, V96A, P1468, DOI 10.2106/JBJS.M.01280; Lee JH, 2008, BIOMED MICRODEVICES, V10, P489, DOI 10.1007/s10544-007-9157-0; Lee JH, 2011, TISSUE ENG PART C-ME, V17, P39, DOI [10.1089/ten.tec.2010.0285, 10.1089/ten.TEC.2010.0285]; Lee JH, 2010, ACTA BIOMATER, V6, P4422, DOI 10.1016/j.actbio.2010.05.021; Leunig M, 1998, INT ORTHOP, V22, P209, DOI 10.1007/s002640050244; Maduka-Ezeh AN, 2012, DIAGN MICR INFEC DIS, V74, P224, DOI 10.1016/j.diagmicrobio.2012.06.029; Salvati Eduardo A, 2003, Instr Course Lect, V52, P223; Sendi P, 2012, INT J ARTIF ORGANS, V35, P913, DOI 10.5301/ijao.5000150; Shaikh AA, 2014, CLIN ORTHOP RELAT R, V472, P2201, DOI 10.1007/s11999-014-3545-6; Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648; Smith SL, 2001, P I MECH ENG H, V215, P161, DOI 10.1243/0954411011533724; Stormer M, 2008, TRANSFUSION, V48, P836, DOI 10.1111/j.1537-2995.2008.01644.x; Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827; Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0; Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011; Uchiyama K, 2013, SCI WORLD J, DOI 10.1155/2013/147248; Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]; Vaudaux P, 2006, INJURY, V37, P15, DOI 10.1016/j.injury.2006.04.004; Weber WP, 2008, ANN SURG, V247, P918, DOI 10.1097/SLA.0b013e31816c3fec; Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003; Zmistowski B, 2011, J ARTHROPLASTY, V26, P104, DOI 10.1016/j.arth.2011.03.044	28	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151534	10.1371/journal.pone.0151534	http://dx.doi.org/10.1371/journal.pone.0151534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982194	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900094
J	Moges, AD; Admassu, B; Belew, D; Yesuf, M; Njuguna, J; Kyalo, M; Ghimire, SR				Moges, Asmare D.; Admassu, Belayneh; Belew, Derbew; Yesuf, Mohammed; Njuguna, Joyce; Kyalo, Martina; Ghimire, Sita R.			Development of Microsatellite Markers and Analysis of Genetic Diversity and Population Structure of Colletotrichum gloeosporioides from Ethiopia	PLOS ONE			English	Article							SEQUENCE REPEAT MARKERS; PATHOGENIC RUST FUNGUS; LINKAGE MAP; CAUSAL AGENT; DNA; ANTHRACNOSE; SPP.; VARIABILITY; SOFTWARE; DISEASE	Twenty three polymorphic microsatellite markers were developed for citrus plant pathogenic fungus, Colletotrichum gloeosporioides, and were used to analyze genetic diversity and population structure of 163 isolates from four different geographical regions of Ethiopia. These loci produced a total of 118 alleles with an average of 5.13 alleles per microsatellite marker. The polymorphic information content values ranged from 0.104 to 0.597 with an average of 0.371. The average observed heterozygosity across all loci varied from 0.046 to 0.058. The gene diversity among the loci ranged from 0.106 to 0.664. Unweighted Neighbor-joining and population structure analysis grouped these 163 isolates into three major groups. The clusters were not according to the geographic origin of the isolates. Analysis of molecular variance showed 85% of the total variation within populations and only 5% among populations. There was low genetic differentiation in the total populations (FST = 0.049) as evidenced by high level of gene flow estimate (N-m = 4.8 per generation) among populations. The results show that Ethiopian C. gloeosporioides populations are generally characterized by a low level of genetic diversity. The newly developed microsatellite markers were useful in analyzing the genetic diversity and population structure of the C. gloeosporioides populations. Information obtained from this study could be useful as a base to design strategies for better management of leaf and fruit spot disease of citrus in Ethiopia.	[Moges, Asmare D.; Yesuf, Mohammed] Ethiopian Inst Agr Res, Dept Hort, Adama, Ethiopia; [Admassu, Belayneh] Ethiopian Inst Agr Res, Dept Agr Biotechnol, Holetta, Ethiopia; [Moges, Asmare D.; Belew, Derbew] Jimma Univ, Dept Hort & Plant Sci, Coll Agr & Vet Med, Jimma, Ethiopia; [Moges, Asmare D.; Njuguna, Joyce; Kyalo, Martina; Ghimire, Sita R.] Int Livestock Res Inst, Biosci Eastern & Cent Africa Hub, Nairobi, Kenya; [Admassu, Belayneh] USDA ARS, Aberdeen, MD USA	Ethiopian Institute of Agricultural Research (EIAR); Ethiopian Institute of Agricultural Research (EIAR); Jimma University; CGIAR; International Livestock Research Institute (ILRI); United States Department of Agriculture (USDA)	Ghimire, SR (corresponding author), Int Livestock Res Inst, Biosci Eastern & Cent Africa Hub, Nairobi, Kenya.	S.ghimire@cgiar.org		Njuguna, Joyce/0000-0003-2008-3387	BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; Syngenta Foundation for Sustainable Agriculture (SFSA); Bill & Melinda Gates Foundation (BMGF); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida)	BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership(Australian Government); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida)	This project was supported by the BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program. The ABCF Program is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and; the Swedish International Development Cooperation Agency (Sida), recipient: ADM. The funder had no role in preparation of the manuscript and the decision to publish.	Abang Mathew M., 2003, African Journal of Biotechnology, V2, P486; Abang MM, 2006, J PHYTOPATHOL, V154, P51, DOI 10.1111/j.1439-0434.2005.01060.x; Adaskaveg JE, 2000, COLLETOTRICHUM, P317; Admassu B, 2010, J PHYTOPATHOL, V158, P806, DOI 10.1111/j.1439-0434.2010.01702.x; Afanador-Kafuri L, 2003, PHYTOPATHOLOGY, V93, P579, DOI 10.1094/PHYTO.2003.93.5.579; Aiello D, 2015, J PHYTOPATHOL, V163, P168, DOI 10.1111/jph.12299; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Babu TK, 2013, PHYSIOL MOL PLANT P, V84, P10, DOI 10.1016/j.pmpp.2013.06.001; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bayraktar H, 2007, J PLANT PATHOL, V89, P341; Benali S., 2011, EUR J SCI RES, V50, P110; Bennett RS, 2005, PHYTOPATHOLOGY, V95, P300, DOI 10.1094/PHYTO-95-0300; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brouwer DJ, 1999, THEOR APPL GENET, V99, P1194, DOI 10.1007/s001220051324; Buddie AG, 1999, MYCOL RES, V103, P385, DOI 10.1017/S0953756298007254; Burdon JJ, 1997, PHYTOPATHOLOGY, V87, P664, DOI 10.1094/PHYTO.1997.87.7.664; Cai ZY, 2013, MICROBIOL RES, V168, P340, DOI 10.1016/j.micres.2013.01.005; Cannon PF, 2008, MYCOTAXON, V104, P189; Cannon PF, 2000, COLLETOTRICHUM, P1; Capote N., 2012, PLANT PATHOL, P151, DOI DOI 10.5772/38011; Carvalho Flavia M. S., 2000, Fitopatologia Brasileira, V25, P72; Ciampi MB, 2011, CONSERV GENET RESOUR, V3, P651, DOI 10.1007/s12686-011-9425-4; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; Derso E., 1999, Fruits (Paris), V54, P225; Dessalegn Y., 2002, AgriTopia, V17, P12; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Farr DF, 2006, MYCOL RES, V110, P1395, DOI 10.1016/j.mycres.2006.09.001; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freeman S, 2013, ACTA HORTIC, V975, P209; Freeman S, 2000, COLLETOTRICHUM, P131; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Gebre-Mariam Seifu., 2003, STATUS COMMERCIAL FR; Ghimire SR, 2011, FUNGAL DIVERS, V47, P19, DOI 10.1007/s13225-010-0085-6; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hancock JM, 1995, J MOL EVOL, V41, P1038; Heip Carlo H. R., 1998, Oceanis, V24, P61; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Jana T, 2005, MYCOL RES, V109, P81, DOI 10.1017/S0953756204001364; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; JIN L, 1994, MOL BIOL EVOL, V11, P120; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KISTLER HC, 1992, ANNU REV PHYTOPATHOL, V30, P131, DOI 10.1146/annurev.py.30.090192.001023; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LITT M, 1989, AM J HUM GENET, V44, P397; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Mahmodi F, 2014, PLANT PATHOLOGY J, V30, P10, DOI 10.5423/PPJ.OA.05.2013.0054; Martin MP, 1999, EUR J PLANT PATHOL, V105, P733, DOI 10.1023/A:1008785703330; Marulanda ML, 2014, GENET MOL RES, V13, P7673, DOI 10.4238/2014.September.26.5; Matsuoka Y, 2002, THEOR APPL GENET, V104, P436, DOI 10.1007/s001220100694; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; McDonald BA, 1997, PHYTOPATHOLOGY, V87, P448, DOI 10.1094/PHYTO.1997.87.4.448; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Mekbib SB, 2007, THESIS U PRETORIA; Milgroom MG, 2003, PLANT DIS, V87, P608, DOI 10.1094/PDIS.2003.87.6.608; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peixoto RF, 2014, GENET MOL RES, V13, P7852, DOI 10.4238/2014.September.26.23; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Pritchard JK, 2000, GENETICS, V155, P945; Ramos A. P., 2006, Bulletin OILB/SROP, V29, P317; Rampersad SN, 2013, PHYTOPATHOLOGY, V103, P182, DOI 10.1094/PHYTO-07-12-0160-R; Ranathunge NP, 2009, MOL ECOL RESOUR, V9, P1175, DOI 10.1111/j.1755-0998.2009.02608.x; Rizatto S, 2010, CONSERV GENET RESOUR, V2, P55, DOI 10.1007/s12686-009-9144-2; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sharopova N, 2008, GENOME, V51, P79, DOI [10.1139/G07-110, 10.1139/g07-110]; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SMITH BJ, 1990, PLANT DIS, V74, P69, DOI 10.1094/PD-74-0069; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sreenivasaprasad S, 2005, MOL PLANT PATHOL, V6, P361, DOI 10.1111/J.1364-3703.2005.00291.X; SUTTON B, 1992, CL LIB APPL, P1; Szabo LJ, 2007, MOL ECOL NOTES, V7, P92, DOI 10.1111/j.1471-8286.2006.01540.x; Szabo LJ, 2007, MOL ECOL NOTES, V7, P708, DOI 10.1111/j.1471-8286.2007.01686.x; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Timmer LW, 2000, COLLETOTRICHUM, P300; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Urena-Padilla AR, 2002, PHYTOPATHOLOGY, V92, P1245, DOI 10.1094/PHYTO.2002.92.11.1245; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weeds PL, 2003, PHYTOPATHOLOGY, V93, P176, DOI 10.1094/PHYTO.2003.93.2.176; Weir BS, 1996, SINAUER ASS SUNDERL; WEISING K, 1995, PCR METH APPL, V4, P249; Winton LM, 2007, MOL ECOL NOTES, V7, P1077, DOI 10.1111/j.1471-8286.2007.01782.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xie L, 2010, J ZHEJIANG UNIV-SC B, V11, P61, DOI 10.1631/jzus.B0900174; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Yesuf Mohammed, 2007, Fruits, V62, P99, DOI 10.1051/fruits:2007003; Yimenu J, 1993, PRELIMINARY SURVEY R; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	121	33	33	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151257	10.1371/journal.pone.0151257	http://dx.doi.org/10.1371/journal.pone.0151257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978654	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800054
J	Ha, HR; Oh, DY; Kim, TY; Lee, K; Kim, K; Lee, KH; Han, SW; Chie, EK; Jang, JY; Im, SA; Kim, TY; Kim, SW; Bang, YJ				Ha, Hye Rim; Oh, Do-Youn; Kim, Tae-Yong; Lee, KyoungBun; Kim, Kyubo; Lee, Kyung-Hun; Han, Sae-Won; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Bang, Yung-Jue			Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; INFLAMMATION; THERAPY; TUMOR	Background Ampulla of Vater cancer (AoV Ca) is a rare tumor, and its adjuvant treatment has not been established. The purpose of this study was to find out prognostic factors including host immunity and role of adjuvant treatment in AoV Ca. Methods and Findings We reviewed 227 AoV Ca patients with curative resection. Clinical characteristics, adjuvant treatment, disease-free survival (DFS) and overall survival (OS) were analyzed. Among all patients, 63.9, 36.1 and 33.9% had T1/T2, T3/T4 stage and lymph node-positive disease (LN+), respectively. OS of all patients was 90.9months (95% CI: 52.9-129.0). OS was different according to neutrophil-to-lymphocyte ratio (HR 1.651, 95% CI: 1.11-2.47), platelet-tolymphocyte ratio (HR 1.488, 95% CI: 1.00-2.21) and systemic inflammatory index (HR 1.669, 95% CI: 1.13-2.47). In multivariate analysis, adverse prognostic factors for OS included vascular invasion (HR 2.571, 95% CI: 1.20-5.53) and elevated CA 19-9 (HR 1.794, 95% CI: 1.07-3.05). A total of 104 patients (46.3%) received adjuvant treatment (25 out of 111of T1/T2 & LN (-), 79 out of 116 of T3/T4 or LN (+)). In T3/T4 or LN (+) stage, adjuvant CCRT with maintenance chemotherapy provided the longest OS (5-year OS rate: 47.0 vs. 41.4%). Conclusions Vascular invasion and elevated CA 19-9 were adverse prognostic factors in resected AoV Ca. In T3/T4 or LN (+) stage, adjuvant CCRT with maintenance chemotherapy provided the best survival outcome. Adjuvant treatment should be further defined in AoV Ca, especially with poor prognostic factors.	[Ha, Hye Rim; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, KyoungBun] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Kim, Kyubo; Chie, Eui Kyu] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul 110744, South Korea; [Jang, Jin-Young; Kim, Sun-Whe] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Oh, DY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.; Oh, DY (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	ohdoyoun@snu.ac.kr	Bang, Yung Jue/J-2759-2012; Kim, Sun/GSN-4867-2022; Kim, Kyubo/R-8061-2019; Lee, Kyoungbun/J-2571-2016	Bang, Yung Jue/0000-0001-6000-4597; Chie, Eui Kyu/0000-0003-2027-7472; Lee, Kyoungbun/0000-0001-8427-3003	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1320090]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (Grant No. 1320090).	Beger HG, 1999, ARCH SURG-CHICAGO, V134, P526, DOI 10.1001/archsurg.134.5.526; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Haddad LBD, 2010, J GASTROINTEST SURG, V14, P719, DOI 10.1007/s11605-010-1156-4; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horgan AM, 2012, J CLIN ONCOL, V30, P1934, DOI 10.1200/JCO.2011.40.5381; Howe JR, 1998, ANN SURG, V228, P87, DOI 10.1097/00000658-199807000-00013; Hu B, 2014, CLIN CANCER RES, V20, P6212, DOI 10.1158/1078-0432.CCR-14-0442; Jang JY, 2005, ANN SURG, V241, P77, DOI 10.1097/01.sla.0000150166.94732.88; Jarnagin WR, 2012, NAT REV GASTRO HEPAT, V9, P622, DOI 10.1038/nrgastro.2012.186; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Kim K, 2009, INT J RADIAT ONCOL, V75, P436, DOI 10.1016/j.ijrobp.2008.11.067; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Krishnan S, 2008, INT J RADIAT ONCOL, V70, P735, DOI 10.1016/j.ijrobp.2007.07.2327; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Narang AK, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-126; Perez DR, 2013, ANN SURG ONCOL, V20, P593, DOI 10.1245/s10434-012-2682-y; Randi G, 2009, ANN ONCOL, V20, P146, DOI 10.1093/annonc/mdn533; Riall TS, 2006, SURGERY, V140, P764, DOI 10.1016/j.surg.2006.04.006; Sikora SS, 2005, EJSO-EUR J SURG ONC, V31, P158, DOI 10.1016/j.ejso.2004.08.013; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Valsangkar NP, 2015, SURGERY, V157, P260, DOI 10.1016/j.surg.2014.08.092; Woo SM, 2007, ANN SURG ONCOL, V14, P3195, DOI 10.1245/s10434-007-9537-y; Zhang YJ, 2012, INT J HYPERTHER, V28, P132, DOI 10.3109/02656736.2011.654374; Zhou J, 2009, RADIOTHER ONCOL, V92, P244, DOI 10.1016/j.radonc.2009.05.006	30	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151406	10.1371/journal.pone.0151406	http://dx.doi.org/10.1371/journal.pone.0151406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974670	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600076
J	Javidpour, P; Deutsch, S; Mutalik, VK; Hillson, NJ; Petzold, CJ; Keasling, JD; Beller, HR				Javidpour, Pouya; Deutsch, Samuel; Mutalik, Vivek K.; Hillson, Nathan J.; Petzold, Christopher J.; Keasling, Jay D.; Beller, Harry R.			Investigation of Proposed Ladderane Biosynthetic Genes from Anammox Bacteria by Heterologous Expression in E-coli	PLOS ONE			English	Article							ACID-DERIVED FUELS; MICROBIAL-PRODUCTION; BIOLOGY; PROTEIN; TRANSCRIPTION; POLYMERASE; CHEMICALS; PRODUCTS; PATHWAY; COMPLEX	Ladderanes are hydrocarbon chains with three or five linearly concatenated cyclobutane rings that are uniquely produced as membrane lipid components by anammox (anaerobic ammonia-oxidizing) bacteria. By virtue of their angle and torsional strain, ladderanes are unusually energetic compounds, and if produced biochemically by engineered microbes, could serve as renewable, high-energy-density jet fuel components. The biochemistry and genetics underlying the ladderane biosynthetic pathway are unknown, however, previous studies have identified a pool of 34 candidate genes from the anammox bacterium, Kuenenia stuttgartiensis, some or all of which may be involved with ladderane fatty acid biosynthesis. The goal of the present study was to establish a systematic means of testing the candidate genes from K. stuttgartiensis for involvement in ladderane biosynthesis through heterologous expression in E. coli under anaerobic conditions. This study describes an efficient means of assembly of synthesized, codon-optimized candidate ladderane biosynthesis genes in synthetic operons that allows for changes to regulatory element sequences, as well as modular assembly of multiple operons for simultaneous heterologous expression in E. coli (or potentially other microbial hosts). We also describe in vivo functional tests of putative anammox homologs of the phytoene desaturase CrtI, which plays an important role in the hypothesized ladderane pathway, and a method for soluble purification of one of these enzymes. This study is, to our knowledge, the first experimental effort focusing on the role of specific anammox genes in the production of ladderanes, and lays the foundation for future efforts toward determination of the ladderane biosynthetic pathway. Our substantial, but far from comprehensive, efforts at elucidating the ladderane biosynthetic pathway were not successful. We invite the scientific community to take advantage of the considerable synthetic biology resources and experimental results developed in this study to elucidate the biosynthetic pathway that produces unique and intriguing ladderane lipids.	[Javidpour, Pouya; Hillson, Nathan J.; Petzold, Christopher J.; Keasling, Jay D.; Beller, Harry R.] Joint BioEnergy Inst, 5885 Hollis Ave, Emeryville, CA USA; [Javidpour, Pouya; Hillson, Nathan J.; Petzold, Christopher J.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Syst & Engn, Berkeley, CA 94720 USA; [Deutsch, Samuel; Hillson, Nathan J.] Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA USA; [Mutalik, Vivek K.] LBNL, Environm Genom & Syst Biol, Berkeley, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Beller, Harry R.] LBNL, Earth & Environm Sci, Berkeley, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Beller, HR (corresponding author), Joint BioEnergy Inst, 5885 Hollis Ave, Emeryville, CA USA.; Beller, HR (corresponding author), LBNL, Earth & Environm Sci, Berkeley, CA USA.	HRBeller@lbl.gov	Beller, Harry R/H-6973-2014; Mutalik, Vivek/AAB-6827-2021; Keasling, Jay D/J-9162-2012	Beller, Harry R/0000-0001-9637-3650; Mutalik, Vivek/0000-0001-7934-0400; Keasling, Jay D/0000-0003-4170-6088; Petzold, Christopher/0000-0002-8270-5228	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Synthetic Biology Tools for Yeast] Funding Source: researchfish	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U. S. Department of Energy (http://www.energy.gov/), Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy. Work conducted by the Joint Genome Institute was supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batth Tanveer S, 2012, Methods Mol Biol, V944, P237, DOI 10.1007/978-1-62703-122-6_17; Beller HR, 2015, NAT PROD REP, V32, P1508, DOI 10.1039/c5np00068h; Cambray G, 2013, NUCLEIC ACIDS RES, V41, P5139, DOI 10.1093/nar/gkt163; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chen J, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-1; Chou HH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3595; Damste JSS, 2005, FEBS J, V272, P4270, DOI 10.1111/j.1742-4658.2005.04842.x; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fernandez-Nino SMG, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00044; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goh EB, 2014, METAB ENG, V26, P67, DOI 10.1016/j.ymben.2014.09.003; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; Grawert T, 2004, J AM CHEM SOC, V126, P12847, DOI 10.1021/ja0471727; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Ham TS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks531; Heins RA, 2014, ACS CHEM BIOL, V9, P2082, DOI 10.1021/cb500244v; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Jetten MSM, 2009, CRIT REV BIOCHEM MOL, V44, P65, DOI 10.1080/10409230902722783; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kartal B, 2012, ADV MICROB PHYSIOL, V60, P211, DOI 10.1016/B978-0-12-398264-3.00003-6; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kumar S, 2012, METAB ENG, V14, P19, DOI 10.1016/j.ymben.2011.11.005; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lennen RM, 2013, CURR OPIN BIOTECH, V24, P1044, DOI 10.1016/j.copbio.2013.02.028; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mascitti V, 2006, J AM CHEM SOC, V128, P3118, DOI 10.1021/ja058370g; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Nouri DH, 2006, CURR ORG CHEM, V10, P2055, DOI 10.2174/138527206778742678; Nouri DH, 2012, ORG BIOMOL CHEM, V10, P5514, DOI 10.1039/c2ob25717c; Novak I, 2008, J PHYS CHEM A, V112, P10059, DOI 10.1021/jp805377c; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Rattray JE, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-8; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; van Niftrik L, 2012, MICROBIOL MOL BIOL R, V76, P585, DOI 10.1128/MMBR.05025-11; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18	42	16	17	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151087	10.1371/journal.pone.0151087	http://dx.doi.org/10.1371/journal.pone.0151087			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975050	Green Published, gold			2022-12-26	WOS:000372570600047
J	Bernhard, FP; Heinzel, S; Binder, G; Weber, K; Apel, A; Roeben, B; Deuschle, C; Maechtel, M; Heger, T; Nussbaum, S; Gasser, T; Maetzler, W; Berg, D				Bernhard, Felix P.; Heinzel, Sebastian; Binder, Gerhard; Weber, Karin; Apel, Anja; Roeben, Benjamin; Deuschle, Christian; Maechtel, Mirjam; Heger, Tanja; Nussbaum, Susanne; Gasser, Thomas; Maetzler, Walter; Berg, Daniela			Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; FACTOR-I; SERUM-LEVELS; ADULTS; RISK; AGE; DEPRESSION; BIOMARKERS; NEURONS; SYSTEM	Introduction Biomarkers indicating trait, progression and prediction of pathology and symptoms in Parkinson's disease (PD) often lack specificity or reliability. Investigating biomarker variance between individuals and over time and the effect of confounding factors is essential for the evaluation of biomarkers in PD, such as insulin-like growth factor 1 (IGF-1). Materials and Methods IGF-1 serum levels were investigated in up to 8 biannual visits in 37 PD patients and 22 healthy controls (HC) in the longitudinal MODEP study. IGF-1 baseline levels and annual changes in IGF-1 were compared between PD patients and HC while accounting for baseline disease duration (19 early stage: <= 3.5 years; 18 moderate stage: >4 years), age, sex, body mass index (BMI) and common medical factors putatively modulating IGF-1. In addition, associations of baseline IGF-1 with annual changes of motor, cognitive and depressive symptoms and medication dose were investigated. Results PD patients in moderate (130 +/- 26 ng/mL; p = .004), but not early stages (115 +/- 19, p>.1), showed significantly increased baseline IGF-1 levels compared with HC (106 +/- 24 ng/mL; p = .017). Age had a significant negative correlation with IGF-1 levels in HC (r = -.47, p = .028) and no correlation in PD patients (r = -.06, p>.1). BMI was negatively correlated in the overall group (r = -.28, p = .034). The annual changes in IGF-1 did not differ significantly between groups and were not correlated with disease duration. Baseline IGF-1 levels were not associated with annual changes of clinical parameters. Discussion Elevated IGF-1 in serum might differentiate between patients in moderate PD stages and HC. However, the value of serum IGF-1 as a trait-, progression- and prediction marker in PD is limited as IGF-1 showed large inter- and intraindividual variability and may be modulated by several confounders.	[Bernhard, Felix P.; Heinzel, Sebastian; Apel, Anja; Roeben, Benjamin; Deuschle, Christian; Maechtel, Mirjam; Heger, Tanja; Nussbaum, Susanne; Gasser, Thomas; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany; [Roeben, Benjamin; Gasser, Thomas; Maetzler, Walter; Berg, Daniela] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Binder, Gerhard; Weber, Karin] Univ Childrens Hosp Tuebingen, Dept Pediat Endocrinol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Bernhard, FP (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany.	felix.bernhard@med.uni-tuebingen.de	Maetzler, Walter/A-6796-2011; Heinzel, Sebastian/AFK-4188-2022; Berg, Daniela/A-8728-2019; Maetzler, Walter/AAE-5831-2020; Gasser, Thomas/GNH-5293-2022	Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Gasser, Thomas/0000-0002-1069-1146; Heinzel, Sebastian/0000-0003-4516-0529	Solvay Pharmaceuticals; Teva Pharmaceutical Industries Ltd.; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University; Bundesministerium fur Bildung und Forschung (BMBF) Neuroallianz D13B project	Solvay Pharmaceuticals(Solvay SA); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University; Bundesministerium fur Bildung und Forschung (BMBF) Neuroallianz D13B project(Federal Ministry of Education & Research (BMBF))	The MODEP study was initially supported by Solvay Pharmaceuticals and recently received financial support by Teva Pharmaceutical Industries Ltd. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. Moreover, the authors acknowledge support of the Bundesministerium fur Bildung und Forschung (BMBF) Neuroallianz D13B project. These funders were not involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Aimaretti G, 2008, J ENDOCRINOL INVEST, V31, P445, DOI 10.1007/BF03346389; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Benarroch EE, 2012, NEUROLOGY, V79, P2148, DOI 10.1212/WNL.0b013e3182752eef; Blum W.F., 1994, GROWTH REGUL S1, V4, P11; Chahine Lama M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS99, DOI 10.1016/S1353-8020(13)70025-7; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Erro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070244; Faupel-Badger JM, 2009, ANN EPIDEMIOL, V19, P841, DOI 10.1016/j.annepidem.2009.08.005; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Gerlach M, 2012, J NEURAL TRANSM, V119, P39, DOI 10.1007/s00702-011-0682-x; Godau J, 2011, ARCH NEUROL-CHICAGO, V68, P925, DOI 10.1001/archneurol.2011.129; Godau J, 2010, J NEUROL NEUROSUR PS, V81, P536, DOI 10.1136/jnnp.2009.175752; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Heinzel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114566; Iglesias P, 2001, THYROID, V11, P1043, DOI 10.1089/105072501753271734; JUUL A, 1994, CLIN ENDOCRINOL, V41, P85, DOI 10.1111/j.1365-2265.1994.tb03788.x; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Kang J-H, 2012, JAMA NEUROL, V127, P358; Katsanos KH, 2001, GROWTH HORM IGF RES, V11, P364, DOI 10.1054/ghir.2001.0248; Kopczak A, 2015, EUR NEUROPSYCHOPHARM, V25, P864, DOI 10.1016/j.euroneuro.2014.12.013; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Lin CM, 2009, YONSEI MED J, V50, P407, DOI 10.3349/ymj.2009.50.3.407; Ma JF, 2015, DEMENT GERIATR COGN, V39, P251, DOI 10.1159/000371510; Maetzler W, 2015, TIME FREQUENCY DOMAI, P419, DOI [10.1007/s00702-014-1276-1, DOI 10.1007/S00702-014-1276-1]; Maetzler W, 2011, MOVEMENT DISORD, V26, P176, DOI 10.1002/mds.23358; Mashayekhi F, 2010, J CLIN NEUROSCI, V17, P623, DOI 10.1016/j.jocn.2009.08.013; Melkersson KI, 1999, J CLIN PSYCHIAT, V60, P783, DOI 10.4088/JCP.v60n1112; Mielke MM, 2014, BIOMARK MED, V8, P225, DOI 10.2217/bmm.13.139; Numao A, 2014, PARKINSONISM RELAT D, V20, P212, DOI 10.1016/j.parkreldis.2013.11.005; Offen D, 2001, NEUROSCI LETT, V316, P129, DOI 10.1016/S0304-3940(01)02344-8; Pellecchia MT, 2014, EUR J NEUROL, V21, P802, DOI 10.1111/ene.12137; Perlmutter JS, 2014, ANN NEUROL, V76, P769, DOI 10.1002/ana.24291; Picillo M, 2013, J NEUROL, V260, P2849, DOI [10.1007/s00415-013-7085-x, 10.1007/s00415-013-6851-0]; Rabinovsky ED, 2004, NEUROL RES, V26, P204, DOI 10.1179/016164104225013851; Rajpathak SN, 2009, INSULIN LIKE GROWTH, V18, P166; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Schaefer S, 2008, J NEUROENDOCRINOL, V20, P104, DOI 10.1111/j.1365-2826.2007.01622.x; Strasburger CJ, 2001, HORM RES, V55, P100, DOI 10.1159/000063484; Teppala S, 2010, DIABETES CARE, V33, P2257, DOI 10.2337/dc10-0770; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trejo JL, 2004, J MOL MED, V82, P156, DOI 10.1007/s00109-003-0499-7; Tuncel D, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/132464; van Varsseveld NC, 2015, PSYCHONEUROENDOCRINO, V54, P31, DOI 10.1016/j.psyneuen.2015.01.014; Vestergaard PF, 2014, EUR J ENDOCRINOL, V170, P229, DOI 10.1530/EJE-13-0661; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382; Zawada WM, 1996, EXP NEUROL, V140, P60, DOI 10.1006/exnr.1996.0115	51	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150552	10.1371/journal.pone.0150552	http://dx.doi.org/10.1371/journal.pone.0150552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967642	Green Submitted, gold, Green Published			2022-12-26	WOS:000371989200016
J	Kim, J; Lee, KJ; Kim, JS; Rho, JG; Shin, JJ; Song, WK; Lee, EK; Egan, JM; Kim, W				Kim, Jihye; Lee, Kyung Jin; Kim, Jung Seok; Rho, Jun Gi; Shin, Jung Jae; Song, Woo Keun; Lee, Eun Kyung; Egan, Josephine M.; Kim, Wook			Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic beta Cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; PROSTATE-CANCER; DEATH; RECEPTOR; PHOSPHORYLATION; SURVIVAL; P27(KIP1); KNOCKOUT; BINDING; MICE	Recent reports have shown that cannabinoid 1 receptors (CB1Rs) are expressed in pancreatic beta cells, where they induce cell death and cell cycle arrest by directly inhibiting insulin receptor activation. Here, we report that CB1Rs regulate the expression of the anti-apoptotic protein Bcl-2 and cell cycle regulator cyclin D2 in pancreatic beta cells. Treatment of MIN6 and beta TC6 cells with a synthetic CB1R agonist, WIN55,212-2, led to a decrease in the expression of Bcl-2 and cyclin D2, in turn inducing cell cycle arrest in G0/G1 phase and caspase-3-dependent apoptosis. Additionally, genetic deletion and pharmacological blockade of CB1Rs after injury in mice led to increased levels of Bcl-2 and cyclin D2 in pancreatic beta cells. These findings provide evidence for the involvement of Bcl-2 and cyclin D2 mediated by CB1Rs in the regulation of beta-cell survival and growth, and will serve as a basis for developing new therapeutic interventions to enhance beta-cell function and growth in diabetes.	[Kim, Jihye; Kim, Jung Seok; Rho, Jun Gi; Shin, Jung Jae; Kim, Wook] Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea; [Lee, Kyung Jin] Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Convergence Med,Asan Med Ctr, Seoul 05505, South Korea; [Song, Woo Keun] Gwangju Inst Sci & Technol, Dept Life Sci, Bio Imaging & Cell Dynam Res Ctr, Kwangju 61005, South Korea; [Lee, Eun Kyung] Catholic Univ Korea, Dept Biochem, Coll Med, Seoul 06591, South Korea; [Egan, Josephine M.] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA	Ajou University; University of Ulsan; Gwangju Institute of Science & Technology (GIST); Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kim, W (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea.; Egan, JM (corresponding author), NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA.	eganj@grc.nia.nih.gov; wookkim21@ajou.ac.kr			Ministry of Education [NRF-2015R1A2A1A15054227, NRF-2009-0093826, NRF-2014R1A2A1A11053431]; Intramural Research Program of the NIH/NIA; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future; NATIONAL INSTITUTE ON AGING [ZIAAG000905, ZIAAG000960] Funding Source: NIH RePORTER	Ministry of Education; Intramural Research Program of the NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future and the Ministry of Education (NRF-2015R1A2A1A15054227 and NRF-2009-0093826 for WK and NRF-2014R1A2A1A11053431 for EKL). JME was supported by the Intramural Research Program of the NIH/NIA.	Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Georgia S, 2010, DIABETES, V59, P987, DOI 10.2337/db09-0838; Gonzalez-Mariscal I, 2016, MOL CELL ENDOCRINOL, V423, P1, DOI 10.1016/j.mce.2015.12.015; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Iwahashi H, 1996, DIABETOLOGIA, V39, P530, DOI 10.1007/s001250050475; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rabinovitch A, 1999, DIABETES, V48, P1223, DOI 10.2337/diabetes.48.6.1223; Sarfaraz S, 2005, CANCER RES, V65, P1635, DOI 10.1158/0008-5472.CAN-04-3410; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; SHIN I, NAT MED, V8, P1145; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	26	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150981	10.1371/journal.pone.0150981	http://dx.doi.org/10.1371/journal.pone.0150981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967640	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200025
J	Loftus, JC; Smith, ML; Seeley, TD				Loftus, J. Carter; Smith, Michael L.; Seeley, Thomas D.			How Honey Bee Colonies Survive in the Wild: Testing the Importance of Small Nests and Frequent Swarming	PLOS ONE			English	Article							VARROA-JACOBSONI OUD; APIS-MELLIFERA; DRONE BROOD; POPULATION; DESTRUCTOR; INFECTIONS; WINTER	The ectoparasitic mite, Varroa destructor, and the viruses that it transmits, kill the colonies of European honey bees (Apis mellifera) kept by beekeepers unless the bees are treated with miticides. Nevertheless, there exist populations of wild colonies of European honey bees that are persisting without being treated with miticides. We hypothesized that the persistence of these wild colonies is due in part to their habits of nesting in small cavities and swarming frequently. We tested this hypothesis by establishing two groups of colonies living either in small hives (42 L) without swarm-control treatments or in large hives (up to 168 L) with swarm-control treatments. We followed the colonies for two years and compared the two groups with respect to swarming frequency, Varroa infesttion rate, disease incidence, and colony survival. Colonies in small hives swarmed more often, had lower Varroa infestation rates, had less disease, and had higher survival compared to colonies in large hives. These results indicate that the smaller nest cavities and more frequent swarming of wild colonies contribute to their persistence without mite treatments.	[Loftus, J. Carter; Smith, Michael L.; Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Seeley, TD (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	tds5@cornell.edu		Smith, Michael/0000-0002-3454-962X	Eastern Apiculture Society of North America; National Institute of Food and Agriculture [NYC-191400]; National Science Foundation Graduate Research Fellowship [DGE-1144153]	Eastern Apiculture Society of North America; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This study was supported by the Eastern Apiculture Society of North America, the National Institute of Food and Agriculture (Project No. NYC-191400), and a National Science Foundation Graduate Research Fellowship (DGE-1144153) to MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, HONEY BEE PESTS PRED; Cervo R, 2014, J EXP BIOL, V217, P2998, DOI 10.1242/jeb.099978; Chauzat MP, 2010, J APICULT RES, V49, P40, DOI 10.3896/IBRA.1.49.1.06; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DeJong D, 1997, AM BEE J, V137, P742; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Feldman S, 2011, AM BEE J, V151, P579; Fries I, 2001, APIDOLOGIE, V38, P525; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; FUCHS S, 1990, APIDOLOGIE, V21, P193, DOI 10.1051/apido:19900304; GREATTI M, 1992, EXP APPL ACAROL, V16, P279, DOI 10.1007/BF01218569; Hansen H, 1987, HONEY BEE BROOD DIS; KORPELA S, 1992, J APICULT RES, V31, P157, DOI 10.1080/00218839.1992.11101278; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; MARTIN SJ, 1995, EXP APPL ACAROL, V19, P199, DOI 10.1007/BF00130823; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mikheyev AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8991; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rangel J, 2012, INSECT SOC, V59, P453, DOI 10.1007/s00040-012-0239-5; Rinderer TE, 2001, APIDOLOGIE, V32, P381, DOI 10.1051/apido:2001138; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Seeley TD, 2015, APIDOLOGIE, V46, P716, DOI 10.1007/s13592-015-0361-2; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Simpson J., 1963, Journal of Apicultural Research London, V2, P50; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; WINSTON ML, 1980, INSECT SOC, V27, P391, DOI 10.1007/BF02223731	32	42	43	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150362	10.1371/journal.pone.0150362	http://dx.doi.org/10.1371/journal.pone.0150362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968000	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200010
J	John, S; Seetharaman, S				John, Sona; Seetharaman, Sarada			Exploiting the Adaptation Dynamics to Predict the Distribution of Beneficial Fitness Effects	PLOS ONE			English	Article							CLONAL INTERFERENCE; ADAPTIVE WALKS; DIMINISHING RETURNS; MUTATIONS; SELECTION; SUBSTITUTIONS; RESISTANCE; LANDSCAPE; STEPS; COST	Adaptation of asexual populations is driven by beneficial mutations and therefore the dynamics of this process, besides other factors, depends on the distribution of beneficial fitness effects. It is known that on uncorrelated fitness landscapes, this distribution can only be of three types: truncated, exponential and power law. We performed extensive stochastic simulations to study the adaptation dynamics on rugged fitness landscapes, and identified two quantities that can be used to distinguish the underlying distribution of beneficial fitness effects. The first quantity studied here is the fitness difference between successive mutations that spread in the population, which is found to decrease in the case of truncated distributions, remains nearly a constant for exponentially decaying distributions and increases when the fitness distribution decays as a power law. The second quantity of interest, namely, the rate of change of fitness with time also shows quantitatively different behaviour for different beneficial fitness distributions. The patterns displayed by the two aforementioned quantities are found to hold good for both low and high mutation rates. We discuss how these patterns can be exploited to determine the distribution of beneficial fitness effects in microbial experiments.	[John, Sona; Seetharaman, Sarada] Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Jakkur PO, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	John, S (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Jakkur PO, Bangalore 560064, Karnataka, India.	sonajohn@jncasr.ac.in	John, Sona/HGB-1723-2022	John, Sona/0000-0002-2827-0008				Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; Bataillon T, 2011, GENETICS, V189, P939, DOI 10.1534/genetics.111.130468; Bull JJ, 2005, NAT GENET, V37, P342, DOI 10.1038/ng0405-342; Campos PRA, 2010, EVOLUTION, V64, P1973, DOI 10.1111/j.1558-5646.2010.00981.x; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Foll M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004185; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gifford DR, 2011, EVOLUTION, V65, P3070, DOI 10.1111/j.1558-5646.2011.01380.x; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; Jain K, 2011, GENETICS, V189, P1029, DOI 10.1534/genetics.111.134163; Jain K, 2011, EVOLUTION, V65, P1945, DOI 10.1111/j.1558-5646.2011.01280.x; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; MacLean RC, 2010, GENETICS, V186, P1345, DOI 10.1534/genetics.110.123083; MacLean RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000406; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Orr HA, 2003, GENETICS, V163, P1519; Park SC, 2007, P NATL ACAD SCI USA, V104, P18135, DOI 10.1073/pnas.0705778104; Park SC, 2010, J STAT PHYS, V138, P381, DOI 10.1007/s10955-009-9915-x; Park SC, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/04/P04014; Rokyta DR, 2009, J MOL EVOL, V69, P229, DOI 10.1007/s00239-009-9267-9; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Rosenberg NA, 2005, J THEOR BIOL, V237, P17, DOI 10.1016/j.jtbi.2005.03.026; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Schenk MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002783; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Seetharaman S, 2011, THESIS JNCASR BANGAL; Seetharaman S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032703; Seetharaman S, 2014, EVOLUTION, V68, P965, DOI 10.1111/evo.12327; Somette D, 2000, SPRINGER SERIES SYNE, P178; Sousa A, 2012, MOL BIOL EVOL, V29, P1417, DOI 10.1093/molbev/msr302; Wilke CO, 1999, PHYS REV E, V60, P2154, DOI 10.1103/PhysRevE.60.2154	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151795	10.1371/journal.pone.0151795	http://dx.doi.org/10.1371/journal.pone.0151795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990188	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800104
J	Singh, KD; Roschitzki, B; Snoek, LB; Grossmann, J; Zheng, X; Elvin, M; Kamkina, P; Schrimpf, SP; Poulin, GB; Kammenga, JE; Hengartner, MO				Singh, Kapil Dev; Roschitzki, Bernd; Snoek, L. Basten; Grossmann, Jonas; Zheng, Xue; Elvin, Mark; Kamkina, Polina; Schrimpf, Sabine P.; Poulin, Gino B.; Kammenga, Jan E.; Hengartner, Michael O.			Natural Genetic Variation Influences Protein Abundances in C. elegans Developmental Signalling Pathways	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PHOSPHATIDYLSERINE RECEPTOR; TRANSGRESSIVE SEGREGATION; EXPRESSION; HERITABILITY; PROTEOMICS; APOPTOSIS; DATABASE; COMMON	Complex traits, including common disease-related traits, are affected by many different genes that function in multiple pathways and networks. The apoptosis, MAPK, Notch, and Wnt signalling pathways play important roles in development and disease progression. At the moment we have a poor understanding of how allelic variation affects gene expression in these pathways at the level of translation. Here we report the effect of natural genetic variation on transcript and protein abundance involved in developmental signalling pathways in Caenorhabditis elegans. We used selected reaction monitoring to analyse proteins from the abovementioned four pathways in a set of recombinant inbred lines (RILs) generated from the wild-type strains N2 (Bristol) and CB4856 (Hawaii) to enable quantitative trait locus (QTL) mapping. About half of the cases from the 44 genes tested showed a statistically significant change in protein abundance between various strains, most of these were however very weak (below 1.3-fold change). We detected a distant QTL on the left arm of chromosome II that affected protein abundance of the phosphatidylserine receptor protein PSR-1, and two separate QTLs that influenced embryonic and ionizing radiation-induced apoptosis on chromosome IV. Our results demonstrate that natural variation in C. elegans is sufficient to cause significant changes in signalling pathways both at the gene expression (transcript and protein abundance) and phenotypic levels.	[Singh, Kapil Dev; Zheng, Xue; Kamkina, Polina; Schrimpf, Sabine P.; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Roschitzki, Bernd; Grossmann, Jonas] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Roschitzki, Bernd; Grossmann, Jonas] Swiss Fed Inst Technol, Zurich, Switzerland; [Snoek, L. Basten; Kammenga, Jan E.] Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands; [Elvin, Mark; Poulin, Gino B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; University of Manchester	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@uzh.ch	Snoek, Basten L/E-4713-2014	Snoek, Basten L/0000-0001-5321-2996; Singh, Kapil Dev/0000-0002-5682-0708; Poulin, Gino/0000-0003-1016-348X; Hengartner, Michael/0000-0002-7584-596X	Swiss National Science Foundation [31003A_143932]; European Community's Health Seventh Framework Programme under project PANACEA [222936]; Netherlands Organisation for Scientific Research [823.01.001]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Health Seventh Framework Programme under project PANACEA; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Swiss National Science Foundation (grant No. 31003A_143932; http://www.snf.ch) to MOH and the European Community's Health Seventh Framework Programme under project PANACEA (project No. 222936; http://www.panaceaproject.eu) to JEK. LBS was funded by the Netherlands Organisation for Scientific Research (project No. 823.01.001; http://www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRENNER S, 1974, GENETICS, V77, P71; Chang CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014662; Choi M., 2014, MSSTATS PROTEIN SIGN; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Conradt Barbara, 2005, WormBook, P1; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Elvin M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-510; Escher C, 2012, PROTEOMICS, V12, P1111, DOI 10.1002/pmic.201100463; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Gallien S, 2011, J MASS SPECTROM, V46, P298, DOI 10.1002/jms.1895; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Green Iain, 2005, P1; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hodgkin J, 1997, GENETICS, V146, P149; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kamkina P, 2015, MOL CELL PR IN PRESS; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kristensen VN, 2006, P NATL ACAD SCI USA, V103, P7735, DOI 10.1073/pnas.0601893103; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Li Y, 2010, GENETICS, V186, P405, DOI 10.1534/genetics.110.119677; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; NICHOLAS WL, 1959, ANN NY ACAD SCI, V77, P218, DOI 10.1111/j.1749-6632.1959.tb36902.x; Page BD, 2007, DEVELOPMENT, V134, P2303, DOI 10.1242/dev.02855; Parts L, 2014, GENOME RES, V24, P1363, DOI 10.1101/gr.170506.113; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; R Core Team, R LANG ENV STAT COMP; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Rieseberg LH, 2003, PHILOS T R SOC B, V358, P1141, DOI 10.1098/rstb.2003.1283; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Rodriguez M, 2012, EXP GERONTOL, V47, P581, DOI 10.1016/j.exger.2012.05.005; Saito RM, 2002, CANCER INVEST, V20, P264, DOI 10.1081/CNV-120001153; Salido EC, 2006, P NATL ACAD SCI USA, V103, P18249, DOI 10.1073/pnas.0607218103; Schmid T, 2015, CURR OPIN GENET DEV, V32, P1, DOI 10.1016/j.gde.2015.01.006; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Seitz S, 2006, GENE CHROMOSOME CANC, V45, P612, DOI 10.1002/gcc.20325; Sendoel A, 2014, NAT CELL BIOL, V16, P812, DOI 10.1038/ncb3010; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Snoek LB, 2014, G3-GENES GENOM GENET, V4, P1813, DOI 10.1534/g3.114.013151; Snoek L Basten, 2014, Worm, V3, pe28357, DOI 10.4161/worm.28357; Snoek LB, 2014, SCI REP-UK, V4, DOI 10.1038/srep03912; Snoek LB, 2013, NUCLEIC ACIDS RES, V41, pD738, DOI 10.1093/nar/gks1124; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Sundaram Meera V, 2006, WormBook, P1; Thompson DA, 2005, HUM MOL GENET, V14, P3865, DOI 10.1093/hmg/ddi411; Thompson OA, 2015, GENETICS, V200, P975, DOI 10.1534/genetics.115.175950; Tsuchiya N, 2006, J HUM GENET, V51, P741, DOI 10.1007/s10038-006-0030-4; van der Velde KJ, 2014, NUCLEIC ACIDS RES, V42, pD794, DOI 10.1093/nar/gkt1044; Vinuela A, 2012, G3-GENES GENOM GENET, V2, P597, DOI 10.1534/g3.112.002212; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Yang HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6717	69	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0149418	10.1371/journal.pone.0149418	http://dx.doi.org/10.1371/journal.pone.0149418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985669	Green Published, gold, Green Accepted			2022-12-26	WOS:000372580300014
J	Kagy, V; Wong, M; Vandenbroucke, H; Jenny, C; Dubois, C; Ollivier, A; Cardi, C; Mournet, P; Tuia, V; Roux, N; Dolezel, J; Perrier, X				Kagy, Valerie; Wong, Maurice; Vandenbroucke, Henri; Jenny, Christophe; Dubois, Cecile; Ollivier, Anthony; Cardi, Celine; Mournet, Pierre; Tuia, Valerie; Roux, Nicolas; Dolezel, Jaroslav; Perrier, Xavier			Traditional Banana Diversity in Oceania: An Endangered Heritage	PLOS ONE			English	Article							MUSA; ASIA; SSR; DNA	This study aims to understand the genetic diversity of traditional Oceanian starchy bananas in order to propose an efficient conservation strategy for these endangered varieties. SSR and DArT molecular markers are used to characterize a large sample of Pacific accessions, from New Guinea to Tahiti and Hawaii. All Pacific starchy bananas are shown of New Guinea origin, by interspecific hybridization between Musa acuminata (AA genome), more precisely its local subspeciesM. acuminata ssp. banksii, and M. balbisiana (BB genome) generating triploid AAB Pacific starchy bananas. These AAB genotypes do not form a subgroup sensu stricto and genetic markers differentiate two subgroups across the three morphotypes usually identified: Iholena versus Popoulu and Maoli. The Popoulu/Maoli accessions, even if morphologically diverse throughout the Pacific, cluster in the same genetic subgroup. However, the subgroup is not strictly monophyletic and several close, but different genotypes are linked to the dominant genotype. One of the related genotypes is specific to New Caledonia (NC), with morphotypes close to Maoli, but with some primitive characters. It is concluded that the diffusion of Pacific starchy AAB bananas results from a series of introductions of triploids originating in New Guinea area from several sexual recombination events implying different genotypes of M. acuminata ssp. banksii. This scheme of multiple waves from the New Guinea zone is consistent with the archaeological data for peopling of the Pacific. The present geographic distribution suggests that a greater diversity must have existed in the past. Its erosion finds parallels with the erosion of cultural traditions, inexorably declining in most of the Polynesian or Melanesian Islands. Symmetrically, diversity hot spots appear linked to the local persistence of traditions: Maoli in New Caledonian Kanak traditions or Iholena in a few Polynesian islands. These results will contribute to optimizing the conservation strategy for the ex-situ Pacific Banana Collection supported collectively by the Pacific countries.	[Kagy, Valerie; Ollivier, Anthony] Inst Agron Neo Caledonien, Connaissance & Ameliorat Agrosyst, BP 32, La Foa 98880, New Caledonia; [Wong, Maurice] SDR, Dept Rech Agron, BP 100, F-98713 Papeete, France; [Vandenbroucke, Henri; Jenny, Christophe; Dubois, Cecile; Cardi, Celine; Mournet, Pierre; Perrier, Xavier] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Ave Agropolis, F-34398 Montpellier 5, France; [Tuia, Valerie] Ctr Pacific Crops & Trees CePaCT, Land Resources Div, Pacific Community, Suva, Fiji; [Roux, Nicolas] Biovers Int, Parc Sci Agropolis 2, F-34397 Montpellier 5, France; [Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Slechtitelu 31, CZ-78371 Olomouc, Czech Republic	CIRAD; Alliance; Bioversity International; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Kagy, V (corresponding author), Inst Agron Neo Caledonien, Connaissance & Ameliorat Agrosyst, BP 32, La Foa 98880, New Caledonia.	kagy@iac.nc	Dolezel, Jaroslav/B-7716-2008; Roux, Nicolas/ABG-4156-2020	Dolezel, Jaroslav/0000-0002-6263-0492; PERRIER, Xavier/0000-0002-0092-003X; Mournet, Pierre/0000-0001-8011-8647; Jenny, Christophe/0000-0001-6165-6888	South Pacific Integrated Observatory For Environment and Terrestrial and Marine Biodiversity (GOPS); French National Research Agency (ANR); National Program of Sustainability [LO 2014]	South Pacific Integrated Observatory For Environment and Terrestrial and Marine Biodiversity (GOPS); French National Research Agency (ANR)(French National Research Agency (ANR)); National Program of Sustainability	The authors acknowledge the South Pacific Integrated Observatory For Environment and Terrestrial and Marine Biodiversity (GOPS), which funded this project associating the following: the 'Institut Agronomique neo Caledonien' (IAC), New Caledonia; the 'Regional Pacific Plantain Collection' at the 'Centre for Pacific Crops and Trees' (CePaCT), Secretariat of the Pacific Community (SPC); 'Bioversity International'; 'Service de Developpement Rural de la Polynesie Francaise'; and UMR AGAP Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD). The project Leader was Valerie Kagy (IAC, New Caledonia). The authors thank also the French National Research Agency (ANR), program SYSTERRA, which funded the 'Vegeculture' project associating CIRAD-AGAP, IRD, University of Montpellier 2 (France), Jean Monnet University of Saint Etienne (France), CNRS-CREDO, Geo-Consult, and CTRAV (Technical Centre for Agricultural Research in the Vanuatu). The 'Vegeculture' project coordinator was Vincent Lebot (CIRAD-AGAP, Vanuatu). Jaroslav Dolezel has been supported by the National Program of Sustainability (award no. LO 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Angela Kepler for help to obtain samples of leaf tissues of some Hawaian Musa accessions, and who together with Edmond de Langhe contributed to the improvement of the manuscript. We thank also Severine Bouard and Melissa Nayral for advice on Oceanian culture and traditions, and Anne Vezina and Julie Sardos for advice on agricultural systems in Oceania, and Elodie Cinquin, Ines Van Den Houwe, Amit Sukal and Eva Hribova for valuable technical assistance. We acknowledge the South Pacific Integrated Observatory For Environment and Terrestrial and Marine Biodiversity (GOPS), which funded this project associating:r the 'Institut Agronomique neo Caledonien' (IAC), New Caledoniar the 'Regional Pacific Plantain Collection' at the 'Centre for Pacific Crops and Trees' (CePaCT), Secretariat of the Pacific Community (SPC)r 'Bioversity International'r 'Service de Developpement Rural de la Polynesie Francaise'r UMR AGAP Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD).r We thank also the French National Research Agency (ANR), program SYSTERRA, which funded the 'Vegeculture' project associating CIRAD- AGAP, IRD, University of Montpellier 2 (France), Jean Monnet University of Saint Etienne (France), CNRS- CREDO, Geo-Consult, CTRAV (Technical Centre for Agricultural Research in the Vanuatu). The 'Vegeculture' project coordinator was Vincent Lebot (CIRAD-AGAP, Vanuatu).r Jaroslav Dolezel has been supported by the National Program of Sustainability (award no. LO 2014).	Barrau J, 1956, JSO, V12, P181; Barrau J, 1957, THESIS; Barrau J., 1954, ETUDES MELANESIENNES, V6, P61; Bonnemaison J, 1997, GENS LIEUX HIST GEOS; Carreel F, 2002, GENOME, V45, P679, DOI [10.1139/g02-033, 10.1139/G02-033]; CARREEL F, 1994, GENET SEL EVOL, V26, pS125, DOI 10.1051/gse:19940709; Christelova P, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr024; Daniells J., 1990, MUSARAMA, V1, P6; Daniells J., 1995, ILLUSTRATED GUIDE ID; Denham T, 2004, ANTIQUITY, V78, P839, DOI 10.1017/S0003598X00113481; Donohue M., 2009, ETHNOBOTANY RES APPL, V7, P293, DOI [DOI 10.17348/ERA.7.0.293-332, 10.17348/era.7.0.293-332]; Englberger L, 2010, J FOOD COMPOS ANAL, V23, P624, DOI 10.1016/j.jfca.2010.03.002; Galipaud J-C, 2011, LAPITA NOMADES PACIF; Haudricourt G. A., 1964, LHOMME, V4, P93, DOI [10.3406/HOM.1964.366613, 10.3406/hom.1964.366613, DOI 10.3406/HOM.1964.366613]; Hermanto C, 2012, TRIANGLE BANANA EXPL, P18; Higgins JE, 1904, THE BANANA IN HAWAII; Hippolyte I, 2012, ANN BOT-LONDON, V109, P937, DOI 10.1093/aob/mcs010; Hippolyte I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-65; Horrocks M, 2009, J ARCHAEOL SCI, V36, P2048, DOI 10.1016/j.jas.2009.05.024; Horrocks M, 2009, J ARCHAEOL SCI, V36, P1115, DOI 10.1016/j.jas.2008.12.014; Horry J-P, 1989, FRUITS, V44, P573; Jeanneney A., 1894, NOUVELLE CALEDONIE A; Jenny Christophe, 2003, P99; Kagy V., 2004, ETHNOBOT RES APPL, V2, P29; Kagy V, 2012, B CHAMB AGR PECHE LA, P12; Kagy V, 1998, IMPORTANCE CULTURELL, P40; Kennedy J, 2009, ETHNOBOT J APPL, V7, P179, DOI [10.17348/era.7.0.179-197, DOI 10.17348/ERA.7.0.179-197, DOI 10.17348/era.7.0.179-197]; KENNEDY J, 2008, ASIAN PERSPECT, V47, P75, DOI DOI 10.1353/ASI.2008.0004; Kepler A.K., 2011, WORLD BANANAS HAWAII; Kirch P.V, 1997, LAPITA PEOPLEANCES; Lagoda PJL, 1998, MOL ECOL, V7, P659; Langhe E. de, 2015, Ethnobotany Research and Applications, V14, P299, DOI 10.17348/era.14.0.299-312; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; LEBOT V, 1993, EUPHYTICA, V67, P163, DOI 10.1007/BF00040618; Lebot Vincent, 1994, Pacific Science, V48, P16; Li R, 2008, J VIROL METHODS, V154, P48, DOI 10.1016/j.jviromet.2008.09.008; MacDaniels L.H., 1947, STUDY FEI BANANA ITS; Merrill ED., 1954, CHRON BOT, V14, P161; Noyer JL, 2005, GENETICA, V124, P61, DOI 10.1007/s10709-004-7319-z; Pawley A, 2010, LAPITA OCEANIC ANCES, P76; Perrier X., 2006, DARWIN SOFTWARE; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Ploetz RC., 2007, BANANA PLANTAIN OVER; Pope WT., 1926, BANANA CULTURE HAWAI; Risterucci AM, 2009, THEOR APPL GENET, V119, P1093, DOI 10.1007/s00122-009-1111-5; Sacher-Smith G, 2011, SOLOMON ISLANDS BANA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sand C., 1989, MIGRATIONS IDENTITES, P39; Santos JRU, 2010, BIOCHEM SYST ECOL, V38, P1010, DOI 10.1016/j.bse.2010.10.001; Sharrock S, 2001, INIBAP ANN REPORT 20, P14; Sheppard P.J., 2010, LAPITA ANCETRES OCEA, P105; SIMMONDS N, 1959, BANANAS; SIMONDS N. W., 1956, Tropical Agriculture, V33, P251; SIMMONDS N. W., 1954, PACIFIC SCI, V8, P226; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stover RH, 1987, BANANAS, P486; Tezenas du Montcel H, 1990, IDENTIFICATION GENET, P211; Viellard E, 1863, ESSAIS NOUVELLE CALE; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Yen D. E., 1991, MAN HALF ESSAYS PACI, P558; YEN DE, 1993, ECON BOT, V47, P3, DOI 10.1007/BF02862202	64	8	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151208	10.1371/journal.pone.0151208	http://dx.doi.org/10.1371/journal.pone.0151208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982801	gold, Green Published			2022-12-26	WOS:000372574900068
J	Kozowyk, PRB; Langejans, GHJ; Poulis, JA				Kozowyk, P. R. B.; Langejans, G. H. J.; Poulis, J. A.			Lap Shear and Impact Testing of Ochre and Beeswax in Experimental Middle Stone Age Compound Adhesives	PLOS ONE			English	Article							MODERN HUMAN-BEHAVIOR; SOUTH-AFRICA; COMPLEX COGNITION; EXPERIMENTAL ARCHAEOLOGY; HOWIESONS POORT; ACACIA-SEYAL; EVOLUTION; TOOLS; IDENTIFICATION; TECHNOLOGY	The production of compound adhesives using disparate ingredients is seen as some of the best evidence of advanced cognition outside of the use of symbolism. Previous field and laboratory testing of adhesives has shown the complexities involved in creating an effective Middle Stone Age glue using Acacia gum. However, it is currently unclear how efficient different adhesive recipes are, how much specific ingredients influence their performance, and how difficult it may have been for those ingredients to be combined to maximum effect. We conducted a series of laboratory-based lap shear and impact tests, following modern adhesion testing standards, to determine the efficacy of compound adhesives, with particular regard to the ingredient ratios. We tested rosin (colophony) and gum adhesives, containing additives of beeswax and ochre in varying ratios. During both lap shear and impact tests compound rosin adhesives performed better than single component rosin adhesives, and pure acacia gum was the strongest. The large difference in performance between each base adhesive and the significant changes in performance that occur due to relatively small changes in ingredient ratios lend further support to the notion that high levels of skill and knowledge were required to consistently produce the most effective adhesives.	[Kozowyk, P. R. B.; Langejans, G. H. J.] Leiden Univ, Fac Archaeol, Leiden, Netherlands; [Langejans, G. H. J.] Univ Johannesburg, Dept Anthropol & Dev Studies, Johannesburg, South Africa; [Poulis, J. A.] Delft Univ Technol, Adhes Inst, Delft, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Johannesburg; Delft University of Technology	Kozowyk, PRB (corresponding author), Leiden Univ, Fac Archaeol, Leiden, Netherlands.	p.r.b.kozowyk@arch.leidenuniv.nl		Langejans, Geeske/0000-0003-3640-9054	Netherlands Organization for Scientific Research Veni grant [275-60-007]; Archon National Research School of Archaeology the Netherlands	Netherlands Organization for Scientific Research Veni grant; Archon National Research School of Archaeology the Netherlands	This work was supported by the Netherlands Organization for Scientific Research Veni grant (file number 275-60-007), http://www.nwo.nl/ GHJL; and the Archon National Research School of Archaeology the Netherlands, PhD grant (file number N/A). http://www.archonline.nl/ PRBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN J, 1986, ANTHROPOLOGIE, V90, P713; Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Ambrose SH, 2010, CURR ANTHROPOL, V51, pS135, DOI 10.1086/650296; ASTM, 2011, D95003 ASTM INT; ASTM-International, 2010, D100210 ASTM INT, V15.06, DOI [10.1520/D1002-99, DOI 10.1520/D1002-99]; Barham L, 2013, HAND HANDLE 1 IND RE, DOI DOI 10.1073/pnas.1221285110; BARTON RNE, 1982, WORLD ARCHAEOL, V14, P237, DOI 10.1080/00438243.1982.9979864; Boeda E, 2008, ANTIQUITY, V82, P853, DOI 10.1017/S0003598X00097623; Brockmann W., 2009, ADHESIVE BONDING MAT, VVolume 1; Broughton B, 2001, MEASUREMENT GOOD PRA; Callister William D., 2021, MAT SCI ENG INTRO; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; Clark JD., 1977, PALEORIENT, V3, P127, DOI [10.3406/paleo.1975.4193, DOI 10.3406/PALEO.1975.4193]; Coles J. M, 1979, EXPT ARCHAEOLOGY; Cunningham ML., 2011, FOOD PRODUCT DESIGNS, V21, P1; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; Flindt C, 2005, FOOD HYDROCOLLOID, V19, P687, DOI 10.1016/j.foodhyd.2004.09.006; Gaillard Y, 2016, ARCHAEOMETRY, V58, P465, DOI 10.1111/arcm.12175; Gaillard Y, 2011, THERMOCHIM ACTA, V521, P90, DOI 10.1016/j.tca.2011.04.010; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Girard M, 2014, MECH MATER, V69, P185, DOI 10.1016/j.mechmat.2013.10.005; Haidle MN, 2015, J ANTHROPOL SCI, V93, P43, DOI [10.4436/jass.93011, 10.4436/JASS.93011]; Hassan EA, 2005, FOOD HYDROCOLLOID, V19, P669, DOI 10.1016/j.foodhyd.2004.09.004; Helwig K, 2014, J ARCHAEOL SCI, V41, P655, DOI 10.1016/j.jas.2013.09.010; Imam SH, 2013, J ADHES SCI TECHNOL, V27, P1972, DOI 10.1080/01694243.2012.696892; Iovita R, 2014, J ARCHAEOL SCI, V48, P73, DOI 10.1016/j.jas.2013.01.031; Kennedy JF, 2011, GUM ARABIC ROYAL SOC; Koller J., 2001, EUR J ARCHAEOL, V4, P385, DOI DOI 10.3346/jkms.2014.29.12.1597; Lombard M, 2004, S AFR ARCHAEOL BULL, V59, P37, DOI 10.2307/3889241; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P27; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P57; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Marsh EJ, 2010, DESIGNING EXPERIMENTAL RESEARCH IN ARCHAEOLOGY: EXAMINING TECHNOLOGY THROUGH PRODUCTION AND USE, P1; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mhinzi GS, 2008, FOOD CHEM, V107, P1407, DOI 10.1016/j.foodchem.2007.09.069; Moss EH., 1982, TAILLER POURQUOI FAI, P289; Norlin L-H, 2005, TALL OIL ULLMANNS EN; Outram AK, 2008, WORLD ARCHAEOL, V40, P1, DOI 10.1080/00438240801889456; Pawlik AF, 2011, J ARCHAEOL SCI, V38, P1699, DOI 10.1016/j.jas.2011.03.001; Petillon JM, 2011, J ARCHAEOL SCI, V38, P1266, DOI 10.1016/j.jas.2011.01.002; Pope Saxton T., 1918, U CALIFORNIA PUBLICA, V13, P103; Regert M, 2004, J SEP SCI, V27, P244, DOI 10.1002/jssc.200301608; Rots V, 2006, J ARCHAEOL SCI, V33, P360, DOI 10.1016/j.jas.2005.08.002; Rots V, 2011, J HUM EVOL, V60, P637, DOI 10.1016/j.jhevol.2011.01.001; Rots Veerle, 2008, Anthropozoologica, V43, P43; Sato C., 2005, ADHESIVE BONDING SCI, P164; Shea JJ., 2002, EXPT ARCHAEOLOGY REP, P55; Villa P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131273; Wadley L, 2005, J HUM EVOL, V49, P587, DOI 10.1016/j.jhevol.2005.06.007; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L., 2004, WORLD ARCHAEOL, V26, P19; Wadley L, 2013, CAMB ARCHAEOL J, V23, P163, DOI 10.1017/S0959774313000309; Wadley L, 2010, CURR ANTHROPOL, V51, pS111, DOI 10.1086/649836; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wragg Sykes RM, 2015, SETTLEMENT SOC COGNI; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106; Zipkin AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112560	60	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150436	10.1371/journal.pone.0150436	http://dx.doi.org/10.1371/journal.pone.0150436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DH1WF	26983080	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900040
J	Maruo, N; Sakagami, R; Yoshinaga, Y; Okamura, K; Sawa, Y				Maruo, Naoki; Sakagami, Ryuji; Yoshinaga, Yasunori; Okamura, Kazuhiko; Sawa, Yoshihiko			Differentiation of Apical Bud Cells in a Newly Developed Apical Bud Transplantation Model Using GFP Transgenic Mice as Donor	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; EPITHELIAL ROOT SHEATH; STEM-CELLS; IN-VIVO; IMMUNOHISTOCHEMICAL EXAMINATION; TOOTH DEVELOPMENT; REGENERATION; PODOPLANIN; CEMENTOGENESIS; EXPRESSION	Rodent mandibular incisors have a unique anatomical structure that allows teeth to grow throughout the lifetime of the rodent. This report presents a novel transplantation technique for studying the apical bud differentiation of rodent mandibular incisors. Incisal apical end tissue with green fluorescent protein from transgenic mouse was transplanted to wild type mice, and the development of the transplanted cells were immunohistologically observed for 12 weeks after the transplantation. Results indicate that the green fluorescent apical end tissue replaced the original tissue, and cells from the apical bud differentiated and extended toward the incisal edge direction. The immunostaining with podoplanin also showed that the characteristics of the green fluorescent tissue were identical to those of the original. The green fluorescent cells were only found in the labial side of the incisor up to 4 weeks. After 12 weeks, however, they were also found in the lingual side. Here the green fluorescent cementocyte-like cells were only present in the cementum close to the dentin surface. This study suggests that some of the cells that form the cellular cementum come from the apical tissue including the apical bud in rodent incisors.	[Maruo, Naoki; Sakagami, Ryuji; Yoshinaga, Yasunori] Fukuoka Dent Coll, Dept Odontol, Sect Periodontol, Fukuoka, Japan; [Okamura, Kazuhiko] Fukuoka Dent Coll, Sect Pathol, Dept Morphol Biol, Fukuoka, Japan; [Sawa, Yoshihiko] Fukuoka Dent Coll, Sect Funct Struct, Dept Morphol Biol, Fukuoka, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Sakagami, R (corresponding author), Fukuoka Dent Coll, Dept Odontol, Sect Periodontol, Fukuoka, Japan.	sakagami@college.fdcnet.ac.jp		Sakagami, Ryuji/0000-0002-5720-6929	ministry of Japanese education, science, sports and culture, Japan	ministry of Japanese education, science, sports and culture, Japan	This work was supported by Project for control of aging, industry to support private universities building up their foundations of strategic research 2012, the ministry of Japanese education, science, sports and culture, Japan.	Bosshardt DD, 2005, J DENT RES, V84, P390, DOI 10.1177/154405910508400501; Brazelton TR, 2005, STEM CELLS, V23, P1251, DOI 10.1634/stemcells.2005-0149; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2004, ARCH HISTOL CYTOL, V67, P1, DOI 10.1679/aohc.67.1; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; IKAWA M, 1995, DEV GROWTH DIFFER, V37, P455, DOI 10.1046/j.1440-169X.1995.t01-2-00012.x; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Imaizumi Y, 2010, ACTA HISTOCHEM CYTOC, V43, P115, DOI 10.1267/ahc.10023; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Masaoka T, 2009, J PERIODONTAL RES, V44, P489, DOI 10.1111/j.1600-0765.2008.01142.x; Morotomi T, 2005, ARCH ORAL BIOL, V50, P695, DOI 10.1016/j.archoralbio.2004.12.006; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Noda Y, 2010, ACTA HISTOCHEM CYTOC, V43, P61, DOI 10.1267/ahc.10008; Ohshima H, 2005, ARCH ORAL BIOL, V50, P153, DOI 10.1016/j.archoralbio.2004.09.008; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Sawa Y, 2008, ACTA HISTOCHEM CYTOC, V41, P121, DOI 10.1267/ahc.08019; Slavkin H C, 1974, Oral Sci Rev, V4, P7; THOMAS HF, 1995, INT J DEV BIOL, V39, P231; Xu XY, 2010, MOL THER, V18, P835, DOI 10.1038/mt.2010.3; Yamamoto T, 2015, ACTA HISTOCHEM CYTOC, V48, P95, DOI 10.1267/ahc.15006; Yamamoto T, 2009, ANN ANAT, V191, P547, DOI 10.1016/j.aanat.2009.07.004; Yang Z, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-55; Zeichner-David M, 2006, PERIODONTOL 2000, V41, P196, DOI 10.1111/j.1600-0757.2006.00162.x; Zhang L, 2012, GENE EXPR PATTERNS, V12, P273, DOI 10.1016/j.gep.2012.07.001	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150766	10.1371/journal.pone.0150766	http://dx.doi.org/10.1371/journal.pone.0150766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978064	gold, Green Published, Green Submitted			2022-12-26	WOS:000372572800035
J	Schlieve, CR; Mojica, SG; Holoyda, KA; Hou, XG; Fowler, KL; Grikscheit, TC				Schlieve, Christopher R.; Mojica, Salvador Garcia; Holoyda, Kathleen A.; Hou, Xiaogang; Fowler, Kathryn L.; Grikscheit, Tracy C.			Vascular Endothelial Growth Factor (VEGF) Bioavailability Regulates Angiogenesis and Intestinal Stem and Progenitor Cell Proliferation during Postnatal Small Intestinal Development	PLOS ONE			English	Article							ENGINEERED SMALL-INTESTINE; CRE-MEDIATED RECOMBINATION; MOUSE INTESTINE; NEONATAL MICE; SELF-RENEWAL; IN-VITRO; RECEPTOR; EXPRESSION; EPITHELIUM; NOTCH	Background Vascular endothelial growth factor (VEGF) is a highly conserved, master regulatory molecule required for endothelial cell proliferation, organization, migration and branching morphogenesis. Podocoryne carnea and drosophila, which lack endothelial cells and a vascular system, express VEGF homologs, indicating potential roles beyond angiogenesis and vasculogenesis. The role of VEGF in the development and homeostasis of the postnatal small intestine is unknown. We hypothesized regulating VEGF bioavailability in the postnatal small intestine would exhibit effects beyond the vasculature and influence epithelial cell stem/progenitor populations. Methods VEGF mutant mice were created that overexpressed VEGF in the brush border of epithelium via the villin promotor following doxycycline treatment. To decrease VEGF bioavailability, sFlt-1 mutant mice were generated that overexpressed the soluble VEGF receptor sFlt-1 upon doxycycline administration in the intestinal epithelium. Mice were analyzed after 21 days of doxycycline administration. Results Increased VEGF expression was confirmed by RT-qPCR and ELISA in the intestine of the VEGF mutants compared to littermates. The VEGF mutant duodenum demonstrated increased angiogenesis and vascular leak as compared to littermate controls. The VEGF mutant duodenum revealed taller villi and increased Ki-67-positive cells in the transit-amplifying zone with reduced Lgr5 expression. The duodenum of sFlt-1 mutants revealed shorter villi and longer crypts with reduced proliferation in the transit-amplifying zone, reduced expression of Dll1, Bmp4 and VE-cadherin, and increased expression of Sox9 and EphB2. Conclusions Manipulating VEGF bioavailability leads to profound effects on not only the intestinal vasculature, but epithelial stem and progenitor cells in the intestinal crypt. Elucidation of the crosstalk between VEGF signaling in the vasculature, mesenchyme and epithelial stem/progenitor cell populations may direct future cell therapies for intestinal dysfunction or disease.	[Schlieve, Christopher R.; Mojica, Salvador Garcia; Holoyda, Kathleen A.; Hou, Xiaogang; Fowler, Kathryn L.; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Schlieve, Christopher R.; Holoyda, Kathleen A.; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Dept Surg, Div Pediat Surg, Los Angeles, CA 90027 USA; [Mojica, Salvador Garcia] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; California State University System; California State University San Bernardino	Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.; Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Dept Surg, Div Pediat Surg, Los Angeles, CA 90027 USA.	tgrikscheit@chla.usc.edu	Schlieve, Christopher/I-6167-2019	Schlieve, Christopher/0000-0002-8355-4046; Fowler, Kathryn/0000-0003-1252-8905	California Institute for Regenerative Medicine [RN2-00946-1, RN3-06425]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute for Regenerative Medicine (https://www.cirm.ca.gov/); RN2-00946-1 and RN3-06425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres SF, 2013, J CELL SCI, V126, P5645, DOI 10.1242/jcs.132985; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Berendsen AD, 2014, J HISTOCHEM CYTOCHEM, V62, P103, DOI 10.1369/0022155413516347; Bond D, 2012, J BIOL CHEM, V287, P27359, DOI 10.1074/jbc.M112.378018; Boquoi A, 2009, GASTROENTEROLOGY, V136, P596, DOI 10.1053/j.gastro.2008.10.028; BREIER G, 1992, DEVELOPMENT, V114, P521; CALVERT R, 1990, ANAT REC, V227, P199, DOI 10.1002/ar.1092270208; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carulli AJ, 2015, DEV BIOL, V402, P98, DOI 10.1016/j.ydbio.2015.03.012; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Delcombel R, 2013, ANGIOGENESIS, V16, P353, DOI 10.1007/s10456-012-9320-y; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Goel HL, 2012, CANCER DISCOV, V2, P906, DOI 10.1158/2159-8290.CD-12-0085; Grikscheit TC, 2004, ANN SURG, V240, P748, DOI 10.1097/01.sla.0000143246.07277.73; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4024, DOI 10.3748/wjg.v11.i26.4024; Haigh J. J, 2008, ORGANOGENESIS, V4, P247, DOI DOI 10.4161/0RG.4.4.7415; Han J, 2015, CELL REP, V10, P1158, DOI 10.1016/j.celrep.2015.01.049; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Holmes K, 2008, PEDIATR RES, V63, P143, DOI 10.1203/PDR.0b013e31815f00e0; Karlsson L, 2000, DEVELOPMENT, V127, P3457; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Landeghem LV, 2012, AM J PHYSIOL-GASTR L, V302, pG1111; Levin DE, 2013, J PEDIATR SURG, V48, P129, DOI 10.1016/j.jpedsurg.2012.10.029; Lopez-Arribillaga E, 2015, DEVELOPMENT, V142, P41, DOI 10.1242/dev.107714; Matthews JA, 2012, J SURG RES, V172, P40, DOI 10.1016/j.jss.2011.04.043; May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105; Nankervis CA, 2001, MICROCIRCULATION, V8, P377; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Sabnis A, 2015, NEONATOLOGY, V107, P191, DOI 10.1159/000368879; Sala FG, 2011, TISSUE ENG PT A, V17, P1841, DOI [10.1089/ten.TEA.2010.0564, 10.1089/ten.tea.2010.0564]; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seipel K, 2004, DEV DYNAM, V231, P303, DOI 10.1002/dvdy.20139; Shi ZC, 2013, AM J PHYSIOL-GASTR L, V305, pG74, DOI 10.1152/ajpgi.00086.2013; Shimizu H, 2014, PEERJ, V2, DOI 10.7717/peerj.370; Siafakas CG, 1999, PEDIATR RES, V45, P652, DOI 10.1203/00006450-199905010-00007; Simmen AF, 2007, AM J PHYSL GASTROINT, V292, pG1757; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Landeghem L, 2015, FASEB J, V29, P2828, DOI 10.1096/fj.14-264010; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vuorela P, 2000, AM J CLIN NUTR, V72, P1196; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	58	19	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151396	10.1371/journal.pone.0151396	http://dx.doi.org/10.1371/journal.pone.0151396			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978773	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800071
J	Zappia, KJ; Garrison, SR; Palygin, O; Weyer, AD; Barabas, ME; Lawlor, MW; Staruschenko, A; Stucky, CL				Zappia, Katherine J.; Garrison, Sheldon R.; Palygin, Oleg; Weyer, Andy D.; Barabas, Marie E.; Lawlor, Michael W.; Staruschenko, Alexander; Stucky, Cheryl L.			Mechanosensory and ATP Release Deficits following Keratin14-Cre-Mediated TRPA1 Deletion Despite Absence of TRPA1 in Murine Keratinocytes	PLOS ONE			English	Article							SENSORY NEURONS; MECHANICAL STIMULATION; CONTRIBUTES; IDENTIFICATION; NOCICEPTION; EXPRESSION; RESPONSES; IMMUNE; NERVE; MODEL	Keratinocytes are the first cells that come into direct contact with external tactile stimuli; however, their role in touch transduction in vivo is not clear. The ion channel Transient Receptor Potential Ankyrin 1 (TRPA1) is essential for some mechanically-gated currents in sensory neurons, amplifies mechanical responses after inflammation, and has been reported to be expressed in human and mouse skin. Other reports have not detected Trpa1 mRNA transcripts in human or mouse epidermis. Therefore, we set out to determine whether selective deletion of Trpa1 from keratinocytes would impact mechanosensation. We generated K14Cre-Trpa1(fl/fl) mice lacking TRPA1 in K14-expressing cells, including keratinocytes. Surprisingly, Trpa1 transcripts were very poorly detected in epidermis of these mice or in controls, and detection was minimal enough to preclude observation of Trpa1 mRNA knockdown in the K14Cre-Trpa1(fl/fl) mice. Unexpectedly, these K14Cre-Trpa1(fl/fl) mice nonetheless exhibited a pronounced deficit in mechanosensitivity at the behavioral and primary afferent levels, and decreased mechanically-evoked ATP release from skin. Overall, while these data suggest that the intended targeted deletion of Trpa1 from keratin 14-expressing cells of the epidermis induces functional deficits in mechanotransduction and ATP release, these deficits are in fact likely due to factors other than reduction of Trpa1 expression in adult mouse keratinocytes because they express very little, if any, Trpa1.	[Zappia, Katherine J.; Garrison, Sheldon R.; Weyer, Andy D.; Barabas, Marie E.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Palygin, Oleg; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Lawlor, Michael W.] Med Coll Wisconsin, Dept Pathol, Div Pediat Pathol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Zappia, KJ; Stucky, CL (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	kzappia@mcw.edu; cstucky@mcw.edu	Palygin, Oleg/AAT-3047-2020; Garrison, Sheldon/AAA-2740-2021; Barabas, Marie-Elizabeth/AAG-8822-2021	Palygin, Oleg/0000-0002-3680-5527; Garrison, Sheldon/0000-0003-0745-629X; Barabas, Marie-Elizabeth/0000-0002-4240-6979; Zappia, Katherine/0000-0002-4419-4834; Staruschenko, Alexander/0000-0002-5190-8356; Weyer, Andy/0000-0003-4485-9530	National Institute of Neurological Disorders and Stroke [NS040538, NS070711, NS087716]; National Heart, Lung, and Blood Institute [HL108880]; Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; National Institute of General Medical Sciences [GM080202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070711, F31NS087716, R01NS040538] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Projects were supported by funding from the National Institute of Neurological Disorders and Stroke, grants NS040538 and NS070711 to C.L.S., Research Supplement to NS070711 to S.R.G., and grant NS087716 to K.J.Z. Funding was also obtained through the National Heart, Lung, and Blood Institute, grant HL108880 to A.S. Partial support provided by the Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin. Further, K.J.Z is a member of the MCW-MSTP which is partially supported by a T32 grant from the National Institute of General Medical Sciences, GM080202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Azorin N, 2011, EXP DERMATOL, V20, P401, DOI 10.1111/j.1600-0625.2010.01219.x; Barabas ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047988; Barr TP, 2014, PAIN, V155, P1091, DOI 10.1016/j.pain.2014.02.014; Barr TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056744; Baumbauer KM, 2015, ELIFE, V4, DOI 10.7554/eLife.09674; Birklein F, 2014, J PAIN, V15, P485, DOI 10.1016/j.jpain.2014.01.490; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen LH, 2013, PROSTAG OTH LIPID M, V104, P58, DOI 10.1016/j.prostaglandins.2012.08.006; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Denda M, 2010, J INVEST DERMATOL, V130, P1942, DOI 10.1038/jid.2010.32; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Garrison SR, 2012, J NEUROPHYSIOL, V107, P913, DOI 10.1152/jn.00658.2011; Gil MP, 2012, BLOOD, V120, P3718, DOI 10.1182/blood-2012-05-428672; Gilchrist LS, 2005, BRAIN RES, V1044, P197, DOI 10.1016/j.brainres.2005.02.081; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Hudecova I, 2015, CLIN BIOCHEM, P30; Inoue K, 2013, J INVEST DERMATOL, P1; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klusch A, 2013, J INVEST DERMATOL, V133, P1387, DOI 10.1038/jid.2012.471; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Levy H, 2012, GENES IMMUN, V13, P593, DOI 10.1038/gene.2012.41; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Manjavachi MN, 2010, PAIN, V151, P345, DOI 10.1016/j.pain.2010.07.018; McGrath JA, 2004, ROOKS TXB DERMATOLOG, V7th; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Pang ZX, 2015, PAIN, V156, P656, DOI 10.1097/j.pain.0000000000000092; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Shi XY, 2011, ANESTH ANALG, V113, P175, DOI 10.1213/ANE.0b013e31821a0258; Sieber-Blum M, 2004, PROG BRAIN RES, V146, P63, DOI 10.1016/S0079-6123(03)46004-4; Soya M, 2014, CELL CALCIUM, V55, P208, DOI 10.1016/j.ceca.2014.02.015; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Wacnik PW, 2001, J NEUROSCI, V21, P9355, DOI 10.1523/JNEUROSCI.21-23-09355.2001; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Woo SH, 2010, DEVELOPMENT, V137, P3965, DOI 10.1242/dev.055970; Wright MC, 2015, J CELL BIOL, V208, P367, DOI 10.1083/jcb.201407101; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhou YM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3399; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	59	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151602	10.1371/journal.pone.0151602	http://dx.doi.org/10.1371/journal.pone.0151602			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978657	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800094
J	Maheshwari, N; Kantipudi, S; Maheshwari, A; Arora, K; Kwatra, VN; Sahni, G				Maheshwari, Neeraj; Kantipudi, Satish; Maheshwari, Anand; Arora, Kashika; Kwatra, Vandana Neha; Sahni, Girish			Amino-Terminal Fusion of Epidermal Growth Factor 4,5,6 Domains of Human Thrombomodulin on Streptokinase Confers Anti-Reocclusion Characteristics along with Plasmin-Mediated Clot Specificity	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; FIBRIN DEGRADATION-PRODUCTS; ACUTE MYOCARDIAL-INFARCTION; HEPARIN-ANTITHROMBIN; INTRACRANIAL HEMORRHAGE; INDEPENDENT INHIBITORS; FIBRINOPEPTIDE-A; HOMOLOGY DOMAIN; BINDING-SITE; THROMBIN	Streptokinase (SK) is a potent clot dissolver but lacks fibrin clot specificity as it activates human plasminogen (HPG) into human plasmin (HPN) throughout the system leading to increased risk of bleeding. Another major drawback associated with all thrombolytics, including tissue plasminogen activator, is the generation of transient thrombin and release of clot-bound thrombin that promotes reformation of clots. In order to obtain anti-thrombotic as well as clot-specificity properties in SK, cDNAs encoding the EGF 4,5,6 domains of human thrombomodulin were fused with that of streptokinase, either at its N- or C-termini, and expressed these in Pichia pastoris followed by purification and structural-functional characterization, including plasminogen activation, thrombin inhibition, and Protein C activation characteristics. Interestingly, the N-terminal EGF fusion construct (EGF-SK) showed plasmin-mediated plasminogen activation, whereas the C-terminal (SK-EGF) fusion construct exhibited 'spontaneous' plasminogen activation which is quite similar to SK i.e. direct activation of systemic HPG in absence of free HPN. Since HPN is normally absent in free circulation due to rapid serpin-based inactivation (such as alpha-2-antiplasmin and alpha-2-Macroglobin), but selectively present in clots, a plasmin-dependent mode of HPG activation is expected to lead to a desirable fibrin clot-specific response by the thrombolytic. Both the N- and C-terminal fusion constructs showed strong thrombin inhibition and Protein C activation properties as well, and significantly prevented re-occlusion in a specially designed assay. The EGF-SK construct exhibited fibrin clot dissolution properties with much-lowered levels of fibrinogenolysis, suggesting unmistakable promise in clot dissolver therapy with reduced hemorrhage and re-occlusion risks.	[Maheshwari, Neeraj; Kantipudi, Satish; Maheshwari, Anand; Arora, Kashika; Kwatra, Vandana Neha; Sahni, Girish] CSIR Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sahni, G (corresponding author), CSIR Inst Microbial Technol, Chandigarh, India.	sahni@imtech.res.in		arora, kashika/0000-0002-1354-4811	Council of Scientific and Industrial Research (C.S.I.R.), government of India	Council of Scientific and Industrial Research (C.S.I.R.), government of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from the Council of Scientific and Industrial Research (C.S.I.R.), government of India.	Aneja R, 2009, J BIOL CHEM, V284, P32642, DOI 10.1074/jbc.M109.046573; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; Buerke M, 2000, EXS, V89, P193; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; CHRISTENSEN U, 1977, BIOCHEM J, V163, P389, DOI 10.1042/bj1630389; COLLEN D, 1990, BIOCHEM PHARMACOL, V40, P177, DOI 10.1016/0006-2952(90)90676-C; DAVEY MG, 1967, NATURE, V216, P857, DOI 10.1038/216857a0; DEJAEGERE PP, 1992, J AM COLL CARDIOL, V19, P289, DOI 10.1016/0735-1097(92)90480-B; EISENBERG PR, 1986, J AM COLL CARDIOL, V7, P1255, DOI 10.1016/S0735-1097(86)80144-9; EISENBERG PR, 1987, J AM COLL CARDIOL, V10, P527, DOI 10.1016/S0735-1097(87)80194-8; FAY PJ, 1988, BIOCHIM BIOPHYS ACTA, V952, P181, DOI 10.1016/0167-4838(88)90114-8; FRANCIS CW, 1991, PROG CARDIOVASC DIS, V34, P193, DOI 10.1016/0033-0620(91)90013-C; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Goldstein J, 1996, THROMB HAEMOSTASIS, V76, P429; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; Johnston SC, 2010, STROKE, V41, pS59, DOI 10.1161/STROKEAHA.110.597351; KASE CS, 1990, ANN INTERN MED, V112, P17, DOI 10.7326/0003-4819-112-1-17; Keramati Malihe, 2013, Cardiovascular & Hematological Agents in Medicinal Chemistry, V11, P218, DOI 10.2174/187152571103140120103816; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LANDI G, 1990, STROKE, V21, P424, DOI 10.1161/01.STR.21.3.424; Lijnen H R, 1983, Behring Inst Mitt, P43; LIJNEN HR, 1988, BLUT, V57, P147, DOI 10.1007/BF00319543; LORAND L, 1964, ARCH BIOCHEM BIOPHYS, V105, P58, DOI 10.1016/0003-9861(64)90235-8; LOUGHEED JC, 1995, PROTEIN SCI, V4, P773; LUESCHER EF, 1961, VOX SANG, V6, P116, DOI 10.1111/j.1423-0410.1961.tb03141.x; Maheshwari N, 2013, GOOGLE PATENTS; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; MERLINI PA, 1995, J AM COLL CARDIOL, V25, P203, DOI 10.1016/0735-1097(94)00360-3; MOSESSON M W, 1992, Seminars in Hematology, V29, P177; Nihalani D, 1998, PROTEIN SCI, V7, P637, DOI 10.1002/pro.5560070313; OHMAN EM, 1990, CIRCULATION, V82, P781, DOI 10.1161/01.CIR.82.3.781; Parrado J, 1996, PROTEIN SCI, V5, P693; RAMPLING MW, 1976, CLIN CHIM ACTA, V67, P43, DOI 10.1016/0009-8981(76)90215-1; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Reed GL, 1999, P NATL ACAD SCI USA, V96, P8879, DOI 10.1073/pnas.96.16.8879; SAKHAROV DV, 1995, CIRCULATION, V92, P1883, DOI 10.1161/01.CIR.92.7.1883; Sakharov DV, 1996, J BIOL CHEM, V271, P2133, DOI 10.1074/jbc.271.4.2133; Sazonova IY, 2009, J THROMB HAEMOST, V7, P1321, DOI 10.1111/j.1538-7836.2009.03491.x; SCHUMACHER WA, 1989, J CARDIOVASC PHARM, V13, P853, DOI 10.1097/00005344-198906000-00007; SHI GY, 1994, BIOCHEM J, V304, P235, DOI 10.1042/bj3040235; STEARNS DJ, 1989, J BIOL CHEM, V264, P3352; STENFLO J, 1988, J BIOL CHEM, V263, P21; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; VALI Z, 1988, BIOCHEMISTRY-US, V27, P1956, DOI 10.1021/bi00406a023; Wang H, 1999, J CONTROL RELEASE, V59, P119, DOI 10.1016/S0168-3659(99)00019-X; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang XD, 2009, THROMB HAEMOSTASIS, V102, P1194, DOI 10.1160/TH09-04-0235; WEITZ JI, 1991, J CLIN INVEST, V87, P1082, DOI 10.1172/JCI115069; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Weitz JI, 1998, CIRCULATION, V97, P544; White CE, 1995, PROTEIN ENG, V8, P1177, DOI 10.1093/protein/8.11.1177; WOHL RC, 1980, J BIOL CHEM, V255, P2005; ZUSHI M, 1991, J BIOL CHEM, V266, P19886	59	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150315	10.1371/journal.pone.0150315	http://dx.doi.org/10.1371/journal.pone.0150315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974970	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600022
J	Chao, Z; Cui, Q; Tian, EW; Zeng, WP; Cai, X; Li, XL; Tanaka, H; Shoyama, Y; Wu, YS				Chao, Zhi; Cui, Qian; Tian, Enwei; Zeng, Weiping; Cai, Xuan; Li, Xiaolei; Tanaka, Hiroyuki; Shoyama, Yukihiro; Wu, Yingsong			Ultrasensitive Time-Resolved Fluoroimmunoassay for Saikosaponin a in Chaihu (Bupleuri Radix)	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; ASSAY; DERIVATIVES; ACTIVATION; COMPONENTS; INDUCTION; CELLS; ELISA	The aim of this study is to establish a time-resolved fluoroimmunoassay (TRFIA) system for quantitative analysis of saikosaponin a (SSa) in the crude drug of Chaihu (Bupleuri Radix). A 96-well microplate coated with rabbit anti-mouse IgG was incubated with the methanol extracts of Chaihu samples and a mouse anti-SSa monoclonal antibody, and a Eu3+-labeled SSa-human serum albumin conjugate was used as the tracer. The established competitive TRFIA showed a good fourth order polynomial fitting from 0.01 to 10.0 mu g/mL for standard SSa sample with a detection limit of 0.006 mu g/mL. The intra-and inter-assay coefficients of variation of the assay were 7.3% and 8.9%, respectively, and the average SSa recovery was 119.2%. For samples of Chaihu extract, the results of this assay showed a good correlation with those by enzyme-linked immunosorbent assay established previously. This TRFIA system is ultrasensitive for detecting SSa with a wide detection range and a good stability and represents the first attempt of using TRFIA for quality evaluation of the crude drug of Chaihu.	[Chao, Zhi; Cui, Qian; Tian, Enwei; Zeng, Weiping; Cai, Xuan; Li, Xiaolei] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China; [Tanaka, Hiroyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Shoyama, Yukihiro] Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo 8593298, Japan; [Wu, Yingsong] Southern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Kyushu University; Nagasaki International University; Southern Medical University - China	Chao, Z (corresponding author), Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China.; Wu, YS (corresponding author), Southern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China.	chaozhi@smu.edu.cn; wg@smu.edu.cn		Chao, Zhi/0000-0002-3583-9848	NSFC [81373905, 30873387]; GDNSF [2014A030313321]	NSFC(National Natural Science Foundation of China (NSFC)); GDNSF	The work was supported by the following: NSFC no. 81373905 and no. 30873387, http://www.nsfc.gov.cn/, ZC; NSFC no. 81373905 and no. 30873387, http://www.nsfc.gov.cn/; GDNSF no. 2014A030313321, http://pro.gdstc.gov.cn/egrantweb/; ZC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YW, 2004, ANAL CHEM, V76, P4208, DOI 10.1021/ac0499423; Chao Z, 2014, PHYTOMEDICINE, V21, P1767, DOI 10.1016/j.phymed.2014.09.001; Chao Z, 2013, J NAT MED-TOKYO, V67, P512, DOI 10.1007/s11418-012-0708-1; Chen JC, 2003, AM J CHINESE MED, V31, P363, DOI 10.1142/S0192415X03001065; Chen Y, 2011, MOLECULES, V16, P9600, DOI 10.3390/molecules16119600; Crowther J. R., 2001, ELISA GUIDEBOOK; Fang JH, 2009, J CHIN U METROL, V20, P211; Fujii S, 2014, J NAT MED-TOKYO, V68, P717, DOI 10.1007/s11418-014-0847-7; [郭智 Guo Zhi], 2014, [天然产物研究与开发, Natural Product Research and Development], V26, P716; HATTORI T, 1991, FOLIA PHARMACOL JPN, V97, P13, DOI 10.1254/fpj.97.1_13; Jung DW, 1998, CHEM PHARM BULL, V46, P1140, DOI 10.1248/cpb.46.1140; Kim BM, 2011, APOPTOSIS, V16, P184, DOI 10.1007/s10495-010-0557-x; Li XQ, 2005, BIOL PHARM BULL, V28, P1736, DOI 10.1248/bpb.28.1736; Liang QN, 2015, LUMINESCENCE, V30, P649, DOI 10.1002/bio.2800; Lin XL, 2005, ANAL BIOANAL CHEM, V382, P1610, DOI 10.1007/s00216-005-3371-5; Liu ZJ, 2013, ANAL METHODS-UK, V5, P3572, DOI 10.1039/c3ay00033h; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Ma Li-ling, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1006; Morinaga O, 2009, FITOTERAPIA, V80, P28, DOI 10.1016/j.fitote.2008.09.004; MOTOO Y, 1994, CANCER LETT, V86, P91, DOI 10.1016/0304-3835(94)90184-8; National Pharmacopoeia Committee, 2010, PHARMACOPOEIA PEOPLE; NOSE M, 1989, CHEM PHARM BULL, V37, P2736, DOI 10.1248/cpb.37.2736; Park IS, 2000, J CHROMATOGR SCI, V38, P229, DOI 10.1093/chromsci/38.6.229; Paudel MK, 2011, ANAL CHIM ACTA, V701, P189, DOI 10.1016/j.aca.2011.05.054; Peng K, 2014, MABS-AUSTIN, V6, P1500, DOI 10.4161/mabs.36208; Secundo F, 2012, J FOOD COMPOS ANAL, V25, P221, DOI 10.1016/j.jfca.2011.09.003; Sheng YJ, 2014, BIOMED ENVIRON SCI, V27, P126, DOI 10.3967/bes2014.027; Sritularak B, 2009, J NAT MED-TOKYO, V63, P360, DOI 10.1007/s11418-009-0332-x; Sun Y, 2009, INT IMMUNOPHARMACOL, V9, P978, DOI 10.1016/j.intimp.2009.04.006; [汤芳玲 TANG Fangling], 2011, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V31, P1654; Tsai YJ, 2002, PHYTOTHER RES, V16, P117, DOI 10.1002/ptr.752; [卫吴 Wei Hao], 2013, [中成药, Chinese Traditional Patent Medicine], V35, P342; Wu SJ, 2008, J MED FOOD, V11, P224, DOI 10.1089/jmf.2007.555; Wu WS, 2003, ONCOGENE, V22, P955, DOI 10.1038/sj.onc.1206237; Xu WW, 2010, J MOL THER, V2, P140; YEN MH, 1991, J ETHNOPHARMACOL, V34, P155, DOI 10.1016/0378-8741(91)90033-A; YEN MH, 1995, PHYTOTHER RES, V9, P351, DOI 10.1002/ptr.2650090509; Yu T, 2013, J IMMUNOASS IMMUNOCH, V34, P365, DOI 10.1080/15321819.2012.744999; Zhang GuoSong, 2014, Chinese Journal of Information on Traditional Chinese Medicine, V21, P74; [张宏娜 ZHANG Hongna], 2007, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V27, P1150; [周琼 Zhou Qiong], 2012, [天然产物研究与开发, Natural Product R & D], V24, P644; Zhu SH, 2004, BIOL PHARM BULL, V27, P66, DOI 10.1248/bpb.27.66	42	11	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151032	10.1371/journal.pone.0151032	http://dx.doi.org/10.1371/journal.pone.0151032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968034	Green Submitted, Green Published, gold			2022-12-26	WOS:000371989200029
J	Eger, C; Siebert, N; Seidel, D; Zumpe, M; Juttner, M; Brandt, S; Muller, HP; Lode, HN				Eger, Christin; Siebert, Nikolai; Seidel, Diana; Zumpe, Maxi; Juettner, Madlen; Brandt, Sven; Mueller, Hans-Peter; Lode, Holger N.			Generation and Characterization of a Human/Mouse Chimeric GD(2)-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma	PLOS ONE			English	Article							TUMOR-CELLS; GD2; THERAPY; GANGLIOSIDE; METASTASES; INDUCTION; IMMUNITY; GROWTH; CANCER; TRIAL	Vaccination with proteins mimicking GD(2) that is highly expressed on neuroblastoma (NB) cells is a promising strategy in treatment of NB, a pediatric malignancy with poor prognosis. We previously showed efficacy of ganglidiomab in vivo, a murine anti-idiotype (anti-Id) IgG1. In order to tailor immune responses to variable regions, we generated a new human/mouse chimeric anti-Id antibody (Ab) ganglidiximab by replacing murine constant fragments with corresponding human IgG1 regions. DNA sequences encoding for variable regions of heavy (VH) and light chains (VL) were synthesized by RT-PCR from total RNA of ganglidiomab-producing hybridoma cells and further ligated into mammalian expression plasmids with coding sequences for constant regions of human IgG1 heavy and light chains, respectively. We established a stable production cell line using Chinese hamster ovarian (CHO) cells co-transfected with two expression plasmids driving the expression of either ganglidiximab heavy or light chain. After purification from supernatants, anti-idiotypic characteristics of ganglidiximab were demonstrated. Binding of ganglidiximab to anti-GD(2) Abs of the 14.18 family as well as to NK-92tr cells expressing a GD(2)-specific chimeric antigen receptor (scFv(ch14.18)-zeta) was shown using standard ELISA and flow cytometry analysis, respectively. Ganglidiximab binding affinities to anti-GD(2) Abs were further determined by surface plasmon resonance technique. Moreover, binding of anti-GD(2) Abs to the nominal antigen GD(2) as well as GD(2)-specific Ab-mediated cytotoxicity (ADCC, CDC) was competitively inhibited by ganglidiximab. Finally, ganglidiximab was successfully used as a protein vaccine in vivo to induce a GD(2)-specific humoral immune response. In summary, we report generation and characterization of a new human/mouse chimeric anti-Id Ab ganglidiximab for active immunotherapy against NB. This Ab may be useful to tailor immune responses to the paratope regions mimicking GD(2) overexpressed in NB.	[Eger, Christin; Siebert, Nikolai; Seidel, Diana; Zumpe, Maxi; Juettner, Madlen; Lode, Holger N.] Univ Med Greifswald, Dept Pediat Oncol & Hematol, D-17475 Greifswald, Germany; [Brandt, Sven; Mueller, Hans-Peter] Ernst Moritz Arndt Univ Greifswald, Ctr Innovat Competence Humoral Immune React Cardi, ZIK HIKE, Greifswald, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald	Siebert, N (corresponding author), Univ Med Greifswald, Dept Pediat Oncol & Hematol, D-17475 Greifswald, Germany.	nikolai.siebert@uni-greifswald.de		Lode, Holger/0000-0002-1201-208X	University Medicine Greifswald, Germany [97237000]; H.W. & J. Hector Stiftung, Germany [M57]; Deutsche Kinderkrebsstiftung, Germany [DKS 2014.05 A/B]; APEIRON Biologics AG, Austria [APN]	University Medicine Greifswald, Germany; H.W. & J. Hector Stiftung, Germany; Deutsche Kinderkrebsstiftung, Germany; APEIRON Biologics AG, Austria	This work was funded by University Medicine Greifswald, Germany (grant number 97237000; http://www2.medizin.uni-greifswald.de/; recipient: HL); H.W. & J. Hector Stiftung, Germany (grant number M57; http://www.hector-stiftung.de/; recipient: HL); Deutsche Kinderkrebsstiftung, Germany (grant number: DKS 2014.05 A/B; http://www.kinderkrebsstiftung.de/; recipient: HL); and APEIRON Biologics AG, Austria (grant number: APN; http://www.apeiron-biologics.com/; recipient: HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice L.Yu., PROGR TREATMENT HIGH; Basak S, 2003, CANCER IMMUNOL IMMUN, V52, P145, DOI 10.1007/s00262-002-0340-0; Becker R, 2002, BRIT J NEUROSURG, V16, P269, DOI 10.1080/02688690220148860; Bhattacharya-Chatterjee M, 2002, EXPERT OPIN BIOL TH, V2, P869, DOI 10.1517/14712598.2.8.869; CHEUNG NKV, 1987, J NUCL MED, V28, P1577; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; DeNardo GL, 2003, CANCER IMMUNOL IMMUN, V52, P309, DOI 10.1007/s00262-002-0350-y; Esser R, 2012, J CELL MOL MED, V16, P569, DOI 10.1111/j.1582-4934.2011.01343.x; Fest S, 2006, CANCER RES, V66, P10567, DOI 10.1158/0008-5472.CAN-06-1158; GILLIES SD, 1992, P NATL ACAD SCI USA, V89, P1428, DOI 10.1073/pnas.89.4.1428; GILLIES SD, 1989, J IMMUNOL METHODS, V125, P191, DOI 10.1016/0022-1759(89)90093-8; Herlyn D, 1996, CANCER IMMUNOL IMMUN, V43, P65, DOI 10.1007/s002620050305; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Khan KH, 2013, ADV PHARM BULL, V3, P257, DOI 10.5681/apb.2013.042; Ladenstein R, 2013, MABS-AUSTIN, V5, P801, DOI 10.4161/mabs.25215; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Lode HN, 2015, IMMUNE ACTIVATION CL; Lode HN, 2013, CANCER IMMUNOL IMMUN, V62, P999, DOI 10.1007/s00262-013-1413-y; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MUELLER BM, 1990, P NATL ACAD SCI USA, V87, P5702, DOI 10.1073/pnas.87.15.5702; MUJOO K, 1989, CANCER RES, V49, P2857; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; SCHULZ G, 1984, CANCER RES, V44, P5914; SEEGER RC, 1977, CANCER RES, V37, P1364; Seidel D, 2015, CANCER IMMUNOL IMMUN, V64, P621, DOI 10.1007/s00262-015-1669-5; Sen G, 1998, J IMMUNOTHER, V21, P75, DOI 10.1097/00002371-199801000-00010; Siebert N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107692; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; SVENNERHOLM L, 1994, BBA-LIPID LIPID MET, V1214, P115, DOI 10.1016/0005-2760(94)90034-5; Yang RK, 2010, DRUG FUTURE, V35, P665, DOI 10.1358/dof.2010.035.08.1513490	33	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150479	10.1371/journal.pone.0150479	http://dx.doi.org/10.1371/journal.pone.0150479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967324	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200014
J	Nantasanti, S; Toussaint, MJM; Youssef, SA; Tooten, PCJ; de Bruin, A				Nantasanti, Sathidpak; Toussaint, Mathilda J. M.; Youssef, Sameh A.; Tooten, Peter C. J.; de Bruin, Alain			Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MOUSE-LIVER; CANCER; CRE; DISEASE; CELLS; POLYPLOIDIZATION; CARCINOGENESIS; PLOIDY; STEM	The tumor suppressors Retinoblastoma (Rb) and p53 are frequently inactivated in liver diseases, such as hepatocellular carcinomas (HCC) or infections with Hepatitis B or C viruses. Here, we discovered a novel role for Rb and p53 in xenobiotic metabolism, which represent a key function of the liver for metabolizing therapeutic drugs or toxins. We demonstrate that Rb and p53 cooperate to metabolize the xenobiotic 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). DDC is metabolized mainly by cytochrome P450 (Cyp)3a enzymes resulting in inhibition of heme synthesis and accumulation of protoporphyrin, an intermediate of heme pathway. Protoporphyrin accumulation causes bile injury and ductular reaction. We show that loss of Rb and p53 resulted in reduced Cyp3a expression decreased accumulation of protoporphyrin and consequently less ductular reaction in livers of mice fed with DDC for 3 weeks. These findings provide strong evidence that synergistic functions of Rb and p53 are essential for metabolism of DDC. Because Rb and p53 functions are frequently disabled in liver diseases, our results suggest that liver patients might have altered ability to remove toxins or properly metabolize therapeutic drugs. Strikingly the reduced biliary injury towards the oxidative stress inducer DCC was accompanied by enhanced hepatocellular injury and formation of HCCs in Rb and p53 deficient livers. The increase in hepatocellular injury might be related to reduce protoporphyrin accumulation, because protoporphrin is well known for its anti-oxidative activity. Furthermore our results indicate that Rb and p53 not only function as tumor suppressors in response to carcinogenic injury, but also in response to non-carcinogenic injury such as DDC.	[Nantasanti, Sathidpak; Toussaint, Mathilda J. M.; Youssef, Sameh A.; Tooten, Peter C. J.; de Bruin, Alain] Univ Utrecht, Dept Pathobiol, Fac Vet Med, NL-3584 CL Utrecht, Netherlands; [de Bruin, Alain] Univ Groningen, Univ Med Ctr Groningen, Div Mol Genet, Dept Pediat, NL-9713 AV Groningen, Netherlands	Utrecht University; University of Groningen	de Bruin, A (corresponding author), Univ Utrecht, Dept Pathobiol, Fac Vet Med, NL-3584 CL Utrecht, Netherlands.; de Bruin, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Mol Genet, Dept Pediat, NL-9713 AV Groningen, Netherlands.	a.debruin@uu.nl	de Bruin, Alain/AAL-9195-2020	de Bruin, Alain/0000-0001-8579-2649	Netherlands Organization for Scientific Research [NWO-ALW-IN/11-28, 834.11.002]; Dutch Cancer Society [KWF UU 2013-5777]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Netherlands Organization for Scientific Research (A. d.B., NWO-ALW-IN/11-28; 834.11.002.) and the Dutch Cancer Society (A.d.B. KWF UU 2013-5777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgo RJ, 2011, MOL BIOL CELL, V22, P931, DOI 10.1091/mbc.E10-11-0895; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Gentric G, 2015, J CLIN INVEST, V125, P981, DOI 10.1172/JCI73957; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hutcheson J, 2014, HEPATOLOGY, V60, P1231, DOI 10.1002/hep.27217; Casanova-Gonzalez MJ, 2010, WORLD J GASTROENTERO, V16, P4526, DOI 10.3748/wjg.v16.i36.4526; Koike H, 2012, J HEPATO-BIL-PAN SCI, V19, P587, DOI 10.1007/s00534-012-0544-4; Kurinna S, 2013, HEPATOLOGY, V57, P2004, DOI 10.1002/hep.26233; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; McClendon AK, 2011, GASTROENTEROLOGY, V141, P1439, DOI 10.1053/j.gastro.2011.06.046; McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202; Meeks RG., 1991, HEPATOTOXICOLOGY; Nassar AF, 2009, DRUG METABOLISM HDB; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Oh-McGinnis R, 2010, BRIEF FUNCT GENOMICS, V9, P281, DOI 10.1093/bfgp/elq017; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Pflaumf J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00285; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Reed C, 2014, AM J PATHOL, V184, P1853, DOI 10.1016/j.ajpath.2014.02.025; Robles MTS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026019; Sancho-Bru P, 2009, GUT, V58, P594, DOI 10.1136/gut.2008.171116; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Thompson MD, 2010, AM J PATHOL, V177, P1812, DOI 10.2353/ajpath.2010.100173; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Weinberg R. A., 2013, BIOL CANC; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790	38	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150064	10.1371/journal.pone.0150064	http://dx.doi.org/10.1371/journal.pone.0150064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967735	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200008
J	Wang, QQ; Qian, LL; Jiang, SW; Cai, CB; Ma, DZ; Gao, PF; Li, HG; Jiang, K; Tang, MX; Hou, J; Liu, J; Cui, WT				Wang, Qingqing; Qian, Lili; Jiang, Shengwang; Cai, Chunbo; Ma, Dezun; Gao, Pengfei; Li, Hegang; Jiang, Ke; Tang, Maoxue; Hou, Jian; Liu, Jie; Cui, Wentao			Safety Evaluation of Neo Transgenic Pigs by Studying Changes in Gut Microbiota Using High-Throughput Sequencing Technology	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GENES; INTEGRONS; EXPRESSION; RESISTANCE; DIVERSITY; EVOLUTION; PROMOTER	The neo (neomycin phosphotransferase) gene is widely used as a selection marker in the production of genetically engineered animals and plants. Recent attention has been focused on safety concerns regarding neo transgene expression. In this study, neo transgenic and non-transgenic piglets were randomly assigned into Group A and Group B to evaluate effects of neo transgene by studying changes in gut microbiota using high-throughput sequencing. Group A pigs were fed a standard diet supplemented with antibiotic neomycin; Group B pigs were fed a standard diet. We examined horizontal transfer of exogenous neo gene using multiplex PCR; and investigated if the presence of secreted NPT II (neo expression product) in the intestine could lead to some protection against neomycin in transgenic pigs by monitoring different patterns of changes in gut microbiota in Group A animals. The unintended effects of neo transgene on gut microbiota were studied in Group B animals. Horizontal gene transfer was not detected in gut microbiota of any transgenic pigs. In Group A, a significant difference was observed between transgenic pigs and non-transgenic pigs in pattern of changes in Proteobacteria populations in fecal samples during and post neomycin feeding. In Group B, there were significant differences in the relative abundance of phyla Firmicutes, Bacteroidetes and Proteobacteria, and genera Lactobacillus and Escherichia-Shigella-Hafnia between transgenic pigs and non-transgenic pigs. We speculate that the secretion of NPT II from transgenic tissues/cells into gut microbiota results in the inhibition of neomycin activity and the different patterns of changes in bacterial populations. Furthermore, the neo gene also leads to unintended effects on gut microbiota in transgenic pigs that were fed with basic diet (not supplemented with neomycin). Thus, our data in this study caution that wide use of the neo transgene in genetically engineered animals should be carefully considered and fully assessed.	[Wang, Qingqing; Qian, Lili; Jiang, Shengwang; Cai, Chunbo; Ma, Dezun; Gao, Pengfei; Tang, Maoxue; Cui, Wentao] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Qian, Lili; Cai, Chunbo; Hou, Jian] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Li, Hegang; Jiang, Ke] Inst Anim Sci, Qingdao 266100, Peoples R China; [Gao, Pengfei; Liu, Jie] Qingdao Univ Sci & Technol, Dept Bioengn & Biotechnol, Coll Chem Engn, Qingdao 266042, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University; Qingdao University of Science & Technology	Cui, WT (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	cuiwentao@caas.cn	钱, 钱丽丽/GWV-8162-2022		National Transgenic Project of China from Ministry of Agriculture of china [2011ZX08011-004]; Agricultural Science and Technology Innovation Program (ASTIP-IAS) from Chinese Academy of Agricultural Sciences; Safety Evaluation Project of Transgenic Animals and Feeding Materials [2011-G11]	National Transgenic Project of China from Ministry of Agriculture of china; Agricultural Science and Technology Innovation Program (ASTIP-IAS) from Chinese Academy of Agricultural Sciences; Safety Evaluation Project of Transgenic Animals and Feeding Materials	This work was supported by the National Transgenic Project of China (2011ZX08011-004) from Ministry of Agriculture of china (www.moa.gov.cn), the Agricultural Science and Technology Innovation Program (ASTIP-IAS05) from Chinese Academy of Agricultural Sciences (www.caas.net.cn) and Safety Evaluation Project of Transgenic Animals and Feeding Materials (2011-G11). WTC received above fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank BGI ARK Biotechnology Co. LTD. (Shenzhen, China) for providing the transgenic pigs as a good model. This work was supported by the National Transgenic Project of China (2011ZX08011-004) from Ministry of Agriculture of china (www.moa.gov.cn), the Agricultural Science and Technology Innovation Program (ASTIP-IAS05) from Chinese Academy of Agricultural Sciences(www.caas.net.cn) and Safety Evaluation Project of Transgenic Animals and Feeding Materials (2011-G11). W.T.C received above fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow RS, 2004, ANTIMICROB AGENTS CH, V48, P838, DOI 10.1128/AAC.48.3.838-842.2004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen LP, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000051; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; Isaacson Richard, 2012, Animal Health Research Reviews, V13, P100, DOI 10.1017/S1466252312000084; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; Ladics GS, 2015, TRANSGENIC RES, V24, P587, DOI 10.1007/s11248-015-9867-7; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Laparra JM, 2010, PHARMACOL RES, V61, P219, DOI 10.1016/j.phrs.2009.11.001; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Liu Y, 2008, CLONING STEM CELLS, V10, P421, DOI 10.1089/clo.2008.0015; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Freijo P, 1998, J ANTIMICROB CHEMOTH, V42, P689, DOI 10.1093/jac/42.6.689; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; PENG JY, 1995, PLANT MOL BIOL, V27, P91, DOI 10.1007/BF00019181; Ploy MC, 2000, CLIN CHEM LAB MED, V38, P483, DOI 10.1515/CCLM.2000.070; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Ruth MR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-27; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tang MX, 2011, TRANSGENIC RES, V20, P749, DOI 10.1007/s11248-010-9457-7; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; VELTEN J, 1984, EMBO J, V3, P2723, DOI 10.1002/j.1460-2075.1984.tb02202.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; YENOFSKY RL, 1990, P NATL ACAD SCI USA, V87, P3435, DOI 10.1073/pnas.87.9.3435	34	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150937	10.1371/journal.pone.0150937	http://dx.doi.org/10.1371/journal.pone.0150937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966911	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200021
J	Aman, TK; Gordon, SE; Zagotta, WN				Aman, Teresa K.; Gordon, Sharona E.; Zagotta, William N.			Regulation of CNGA1 Channel Gating by Interactions with the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNEL; METAL ION FRET; ACTIVATED CHANNELS; PLASMA-MEMBRANE; ENERGY-TRANSFER; SYNAPTIC PLASTICITY; PACEMAKER CHANNELS; FLUORESCENT-PROBE; MAMMALIAN-CELLS; DISTANCE PROBES	Cyclic nucleotide-gated (CNG) channels are expressed in rod photoreceptors and open in response to direct binding of cyclic nucleotides. We have previously shown that potentiation of CNGA1 channels by transition metals requires a histidine in the A' helix following the S6 transmembrane segment. Here, we used transition metal ion FRET and patch clamp fluorometry with a fluorescent, noncanonical amino acid (3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (Anap)) to show that the potentiating transition metal Co2+ binds in or near the A' helix. Adding high-affinity metal-binding sites to the membrane (stearoyl-nitrilotriacetic acid (C18-NTA)) increased potentiation for low Co2+ concentrations, indicating that the membrane can coordinate metal ions with the A' helix. These results suggest that restraining the A' helix to the plasma membrane potentiates CNGA1 channel opening. Similar interactions between the A' helix and the plasma membrane may underlie regulation of structurally related hyperpolarization-activated cyclic nucleotide-gated (HCN) and voltage-gated potassium subfamily H (KCNH) channels by plasma membrane components.	[Aman, Teresa K.; Gordon, Sharona E.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	zagotta@uw.edu			NEI of the National Institutes of Health [R01EY010329, R01EY017564]; NINDS [F32NS077622]; National Institute of Mental Health [R01MH102378]; National Institutes of Health [R01GM100718]; American Heart Association [14IRG18770000]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025429] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010329, P30EY001730, R01EY017564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077622] Funding Source: NIH RePORTER	NEI of the National Institutes of Health; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NEI of the National Institutes of Health under Grants R01EY010329 (to W. N. Z.) and R01EY017564 (to S. E. G.), by the NINDS under Grant F32NS077622 (to T. K. A.), by the National Institute of Mental Health under Grant R01MH102378 (to W. N. Z.), by the NIGMS of the National Institutes of Health under Grant R01GM100718 (to S. E. G. and W. N. Z.), and by the American Heart Association under Grant 14IRG18770000 (to W. N. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDEREGG G, 1982, PURE APPL CHEM, V54, P2693, DOI 10.1351/pac198254122693; Bradley J, 1997, J NEUROSCI, V17, P1993; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Charles A, 2001, MOL ENDOCRINOL, V15, P997, DOI 10.1210/me.15.6.997; Chatterjee A, 2013, J AM CHEM SOC, V135, P12540, DOI 10.1021/ja4059553; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Flynn GE, 2011, J BIOL CHEM, V286, P15535, DOI 10.1074/jbc.M110.214650; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; Gordon SE, 2016, J GEN PHYSIOL, V147, P189, DOI 10.1085/jgp.201511530; HORROCKS WD, 1975, P NATL ACAD SCI USA, V72, P4764, DOI 10.1073/pnas.72.12.4764; Hsieh TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099395; Hua L, 2005, J GEN PHYSIOL, V125, P335, DOI 10.1085/jgp.200409187; ILDEFONSE M, 1991, J MEMBRANE BIOL, V123, P133, DOI 10.1007/BF01998084; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Kalstrup T, 2013, P NATL ACAD SCI USA, V110, P8272, DOI 10.1073/pnas.1220398110; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; Kesters D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116369; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; LATT SA, 1972, BIOCHEMISTRY-US, V11, P3015, DOI 10.1021/bi00766a013; LATT SA, 1970, P NATL ACAD SCI USA, V67, P1383, DOI 10.1073/pnas.67.3.1383; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Li XF, 2015, J GEN PHYSIOL, V146, P357, DOI 10.1085/jgp.201511491; Michalakis S, 2011, GENES BRAIN BEHAV, V10, P137, DOI 10.1111/j.1601-183X.2010.00646.x; Puljung MC, 2013, J BIOL CHEM, V288, P12944, DOI 10.1074/jbc.M113.464123; Richmond TA, 2000, BIOCHEM BIOPH RES CO, V268, P462, DOI 10.1006/bbrc.1999.1244; Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073; SILLEN LG, 1964, SPECIAL PUBLICATION, V17; Taraska JW, 2009, P NATL ACAD SCI USA, V106, P16227, DOI 10.1073/pnas.0905207106; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Wen M, 2015, CHEM COMMUN, V51, P8153, DOI 10.1039/c5cc01418b; Womack KB, 2000, J NEUROSCI, V20, P2792; Yu XZ, 2013, STRUCTURE, V21, P9, DOI 10.1016/j.str.2012.11.013; Zagotta WN, 2016, J GEN PHYSIOL, V147, P201, DOI 10.1085/jgp.201511531; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243	41	18	18	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9939	9947		10.1074/jbc.M116.723932	http://dx.doi.org/10.1074/jbc.M116.723932			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26969165	Green Published, hybrid			2022-12-26	WOS:000375602800009
J	Ganesh, D; Kumarathasan, P; Thomson, EM; St-Germain, C; Blais, E; Crapo, J; Vincent, R				Ganesh, Devi; Kumarathasan, Prem; Thomson, Errol M.; St-Germain, Carly; Blais, Erica; Crapo, James; Vincent, Renaud			Impact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 Rats	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; OXIDATIVE STRESS; REACTIVE OXYGEN; NITRIC-OXIDE; ETB-RECEPTOR; PLASMA ENDOTHELIN-1; CELL-PROLIFERATION; HEART-FAILURE; LUNG; EXPRESSION	Endothelin-1 is a potent vasoconstrictor and mitogenic peptide involved in the regulation of vasomotor tone and maintenance of blood pressure. Oxidative stress activates the endothelin system, and is implicated in pulmonary and cardiovascular diseases including hypertension, congestive heart failure, and atherosclerosis. Superoxide dismutase mimetics designed with the aim of treating diseases that involve reactive oxygen species in their pathophysiology may exert a hypotensive effect, but effects on the endothelin system are unknown. Our objective was to determine the effect of the superoxide dismutase mimetic AEOL 10150 on the basal endothelin system in vivo. Male Fischer-344 rats were injected subcutaneously with 0, 2 or 5 mg/kg body weight of AEOL 10150 in saline. Plasma oxidative stress markers and endothelins (bigET-1, ET-1, ET-2, ET-3) as well as lung and heart endothelin/nitric oxide system gene expressions were measured using HPLC-Coularray, HPLC-Fluorescence and RT-PCR respectively. AEOL 10150 reduced (p<0.05) the circulating levels of isoprostane (-25%) and 3-nitrotyrosine (-50%) measured in plasma 2h and 24h after treatment, confirming delivery of a physiologically-relevant dose and the potent antioxidant activity of the drug. The reduction in markers of oxidative stress coincided with sustained 24h decrease (p<0.05) of plasma levels of ET-1 (-50%) and ET-3 (-10%). Expression of preproET-1 and endothelin converting enzyme-1 mRNA were not altered significantly in the lungs. However preproET-1 (not significant) and ECE-1 mRNA (p<0.05) were increased (10-25%) in the heart. Changes in the lungs included decrease (p<0.05) of mRNA for the ET-1 clearance receptor ETB and the vasoconstriction-signaling ETA receptor (-30%), and an early surge of inducible nitric oxide synthase expression followed by sustained decrease (-40% after 24 hours). The results indicate that interception of the endogenous physiological flux of reactive nitrogen species and reactive oxygen species in rats impacts the endothelin/nitric oxide system, supporting a homeostatic relationship between those systems.	[Ganesh, Devi; Vincent, Renaud] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ganesh, Devi; Kumarathasan, Prem; Thomson, Errol M.; St-Germain, Carly; Blais, Erica; Vincent, Renaud] Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm & Radiat Hlth Sci Directorate, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Crapo, James] Natl Jewish Hlth, Denver, CO USA	University of Ottawa; Health Canada; National Jewish Health	Vincent, R (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Vincent, R (corresponding author), Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm & Radiat Hlth Sci Directorate, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	renaud.vincent@sympatico.ca		Thomson, Errol/0000-0003-1295-5384	Toxic Substance Research Initiative (Health Canada); Genomic Research and Development Initiative (Health Canada); Clean Air Regulatory Agenda (Health Canada)	Toxic Substance Research Initiative (Health Canada); Genomic Research and Development Initiative (Health Canada); Clean Air Regulatory Agenda (Health Canada)	Toxic Substance Research Initiative (Health Canada) RV, Genomic Research and Development Initiative (Health Canada) RV, and Clean Air Regulatory Agenda (Health Canada) RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battistini B, 2006, EXP BIOL MED, V231, P653; Bielecki A, 2012, J ANAL TOXICOL, V36, P595, DOI 10.1093/jat/bks070; Bourgoin F, 2013, CAN J PHYSIOL PHARM, V91, P547, DOI 10.1139/cjpp-2012-0273; Bowler RP, 2003, AM J PHYSIOL-LUNG C, V284, pL680, DOI 10.1152/ajplung.00191.2002; Bowler RP, 2002, FREE RADICAL BIO MED, V33, P1141, DOI 10.1016/S0891-5849(02)01008-0; Channick R., 2001, Journal of Heart and Lung Transplantation, V20, P262, DOI 10.1016/S1053-2498(00)00606-9; Cingolani HE, 2006, HYPERTENSION, V47, P727, DOI 10.1161/01.HYP.0000208302.62399.68; Cowburn PJ, 1998, LANCET, V352, P201, DOI 10.1016/S0140-6736(05)77807-7; Day BJ, 1996, TOXICOL APPL PHARM, V140, P94, DOI 10.1006/taap.1996.0201; De Giusti VC, 2008, LIFE SCI, V83, P264, DOI 10.1016/j.lfs.2008.06.008; Dong F, 2005, BRIT J PHARMACOL, V145, P323, DOI 10.1038/sj.bjp.0706193; Estevez AG, 2006, J NEUROSCI, V26, P8512, DOI 10.1523/JNEUROSCI.0728-06.2006; Galie N, 2005, J AM COLL CARDIOL, V46, P529, DOI 10.1016/j.jacc.2005.04.050; Hemmrich K, 2003, J APPL PHYSIOL, V95, P1937, DOI 10.1152/japplphysiol.00419.2003; Hoffmann E, 1998, AM HEART J, V135, P684, DOI 10.1016/S0002-8703(98)70286-8; Kaehler A, 2002, CLIN SCI, V103, p176S, DOI 10.1042/CS103S176S; Kelland NF, 2010, CAN J PHYSIOL PHARM, V88, P644, DOI 10.1139/Y10-041; Kelland NF, 2010, J VASC RES, V47, P16, DOI 10.1159/000231717; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; KIOWSKI W, 1995, LANCET, V346, P732, DOI 10.1016/S0140-6736(95)91504-4; Knappe D, 2007, J INVEST MED, V55, P306, DOI 10.2310/6650.2007.00013; Kubin AM, 2011, J MOL CELL CARDIOL, V50, P884, DOI 10.1016/j.yjmcc.2011.02.005; Kumarathasan P, 2003, J CHROMATOGR A, V987, P349, DOI 10.1016/S0021-9673(02)01598-4; Kumarathasan P, 2001, ANAL BIOCHEM, V299, P37, DOI 10.1006/abio.2001.5362; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGovern T, 2011, FREE RADICAL BIO MED, V50, P602, DOI 10.1016/j.freeradbiomed.2010.12.001; MCMURRAY JJ, 1992, CIRCULATION, V85, P1374, DOI 10.1161/01.CIR.85.4.1374; Neuhold S, 2010, CLIN CHEM, V56, P121, DOI 10.1373/clinchem.2009.125856; NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1; O'Neill HC, 2011, AM J RESP CELL MOL, V45, P323, DOI 10.1165/rcmb.2010-0214OC; Pfeiffer S, 1998, MOL PHARMACOL, V53, P795, DOI 10.1124/mol.53.4.795; Pollock David M., 2005, Current Vascular Pharmacology, V3, P365, DOI 10.2174/157016105774329408; Quan HH, 2013, NEUROL SCI, V34, P1621, DOI 10.1007/s10072-013-1295-y; Rabbani ZN, 2007, FREE RADICAL RES, V41, P1273, DOI 10.1080/10715760701689550; Rodrigo R, 2011, HYPERTENS RES, V34, P431, DOI 10.1038/hr.2010.264; Rosales MAB, 2010, INVEST OPHTH VIS SCI, V51, P4327, DOI 10.1167/iovs.09-4690; Ross AD, 2002, FREE RADICAL BIO MED, V33, P1657, DOI 10.1016/S0891-5849(02)01140-1; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Ruef J, 2001, CARDIOVASC PATHOL, V10, P311, DOI 10.1016/S1054-8807(01)00095-3; Sakai S, 1996, J AM COLL CARDIOL, V28, P1580, DOI 10.1016/S0735-1097(96)00336-1; SATO K, 1995, AM J PHYSIOL-LUNG C, V269, pL668, DOI 10.1152/ajplung.1995.269.5.L668; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; SCHUMACHER WA, 1990, PROSTAGLANDINS, V40, P71, DOI 10.1016/0090-6980(90)90057-3; Sen S, 2011, PHYTOMEDICINE, V18, P1110, DOI 10.1016/j.phymed.2011.06.013; Skalska AB, 2009, CLIN BIOCHEM, V42, P358, DOI 10.1016/j.clinbiochem.2008.11.002; Smith KR, 2002, FREE RADICAL BIO MED, V33, P1106, DOI 10.1016/S0891-5849(02)01003-1; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; Thomson E, 2005, TOXICOL SCI, V88, P103, DOI 10.1093/toxsci/kfi272; Thomson E, 2005, ANAL BIOCHEM, V337, P347, DOI 10.1016/j.ab.2004.10.047; Thomson E, 2006, EXP BIOL MED, V231, P979; Thomson EM, 2007, ENVIRON RES, V105, P224, DOI 10.1016/j.envres.2007.06.005; Upmacis RK, 2011, AM J PHYSIOL-HEART C, V301, pH617, DOI 10.1152/ajpheart.00667.2010; Vincent R, 2001, Res Rep Health Eff Inst, P5; Wedgwood S, 2001, AM J PHYSIOL-LUNG C, V281, pL1058, DOI 10.1152/ajplung.2001.281.5.L1058	56	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151810	10.1371/journal.pone.0151810	http://dx.doi.org/10.1371/journal.pone.0151810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990293	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800105
J	Tondo, ML; Delprato, ML; Kraiselburd, I; Zenoff, MVF; Farias, ME; Orellano, EG				Laura Tondo, Maria; Laura Delprato, Maria; Kraiselburd, Ivana; Fernandez Zenoff, Maria Veronica; Eugenia Farias, Maria; Orellano, Elena G.			KatG, the Bifunctional Catalase of Xanthomonas citri subsp citri, Responds to Hydrogen Peroxide and Contributes to Epiphytic Survival on Citrus Leaves	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; BIOFILM FORMATION; ESCHERICHIA-COLI; PLANT; RADIATION; OXYGEN; BACTERIA; ENZYMES; PROTEIN	Xanthomonas citri subsp. citri (Xcc) is the bacterium responsible for citrus canker. This bacterium is exposed to reactive oxygen species (ROS) at different points during its life cycle, including those normally produced by aerobic respiration or upon exposition to ultraviolet (UV) radiation. Moreover, ROS are key components of the host immune response. Among enzymatic ROS-detoxifying mechanisms, catalases eliminate H2O2, avoiding the potential damage caused by this specie. Xcc genome includes four catalase genes. In this work, we studied the physiological role of KatG, the only bifunctional catalase of Xcc, through the construction and characterization of a modified strain (XcckatG), carrying an insertional mutation in the katG gene. First, we evaluated the involvement of KatG in the bacterial adaptive response to H2O2. XcckatG cultures exhibited lower catalase activity than those of the wild-type strain, and this activity was not induced upon treatment with sub-lethal doses of H2O2. Moreover, the KatG-deficient mutant exhibited decreased tolerance to H2O2 toxicity compared to wild-type cells and accumulated high intracellular levels of peroxides upon exposure to sub-lethal concentrations of H2O2. To further study the role of KatG in Xcc physiology, we evaluated bacterial survival upon exposure to UV-A or UV-B radiation. In both conditions, XcckatG showed a high mortality in comparison to Xcc wild-type. Finally, we studied the development of bacterial biofilms. While structured biofilms were observed for the Xcc wild-type, the development of these structures was impaired for XcckatG. Based on these results, we demonstrated that KatG is responsible for Xcc adaptive response to H2O2 and a key component of the bacterial response to oxidative stress. Moreover, this enzyme plays an important role during Xcc epiphytic survival, being essential for biofilm formation and UV resistance.	[Laura Tondo, Maria; Laura Delprato, Maria; Kraiselburd, Ivana; Orellano, Elena G.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Mol Biol Div,Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Fernandez Zenoff, Maria Veronica; Eugenia Farias, Maria] Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc Ind Microbiol, San Miguel De Tucuman, Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Orellano, EG (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Mol Biol Div,Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina.	orellano@ibr-conicet.gov.ar	Kraiselburd, Ivana/AAI-8743-2020	Kraiselburd, Ivana/0000-0002-9677-6094; Tondo, Maria Laura/0000-0002-0160-1882; Farias, Maria Eugenia/0000-0002-2771-8915	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-1762]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 00873]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 2010-1762 to EGO (http://www.agencia.mincyt.gob.ar/), and Consejo Nacional de Investigaciones Cientificas y Tecnicas, PIP 00873 to EGO (http://www.conicet.gov.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; BEERS RF, 1952, J BIOL CHEM, V195, P133; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Charoenlap N, 2011, CURR MICROBIOL, V63, P232, DOI 10.1007/s00284-011-9970-9; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Costa CS, 2010, PHOTOCHEM PHOTOBIOL, V86, P1334, DOI 10.1111/j.1751-1097.2010.00800.x; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeLong JM, 2002, J AGR FOOD CHEM, V50, P248, DOI 10.1021/jf0106695; DEMPLE B, 1991, ANNU REV GENET, V25, P315, DOI 10.1146/annurev.ge.25.120191.001531; Di Capua C, 2011, FEMS MICROBIOL LETT, V317, P181, DOI 10.1111/j.1574-6968.2011.02231.x; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Gnanamanickam SS, 2006, PLANT-ASSOCIATED BACTERIA, P131; Guo M, 2012, J BACTERIOL, V194, P5054, DOI 10.1128/JB.00999-12; Hader DP, 2011, PHOTOCHEM PHOTOBIOL, V87, P263, DOI 10.1111/j.1751-1097.2011.00888.x; HIRANO SS, 1983, ANNU REV PHYTOPATHOL, V21, P243, DOI 10.1146/annurev.py.21.090183.001331; Hoerter JD, 2005, J PHOTOCH PHOTOBIO B, V81, P171, DOI 10.1016/j.jphotobiol.2005.07.005; Italiani VCS, 2010, FEMS MICROBIOL LETT, V303, P48, DOI 10.1111/j.1574-6968.2009.01860.x; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kang Kyong-Suk, 1999, Journal of Plant Biology, V42, P187; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kraiselburd I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038226; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Matallana-Surget S, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1020070; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; MITCHELL RL, 1965, SCIENCE, V150, P74, DOI 10.1126/science.150.3692.74; Mongkolsuk S, 1997, FEMS MICROBIOL LETT, V146, P217, DOI 10.1111/j.1574-6968.1997.tb10196.x; Moyano AJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004163; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Pattison DI, 2006, EXP SUPPL, V96, P131; Pezzoni M, 2014, J PHOTOCH PHOTOBIO B, V131, P53, DOI 10.1016/j.jphotobiol.2014.01.005; Prapagdee B, 2004, FEMS MICROBIOL LETT, V232, P217, DOI 10.1016/S0378-1097(04)00075-8; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Ryder VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047695; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos AL, 2013, ARCH MICROBIOL, V195, P63, DOI 10.1007/s00203-012-0847-5; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; SCANDALIOS JG, 1968, ANN NY ACAD SCI, V151, P274, DOI 10.1111/j.1749-6632.1968.tb11896.x; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; SWITALA J, 1990, CAN J MICROBIOL, V36, P728, DOI 10.1139/m90-123; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zigman S, 1996, PHOTOCHEM PHOTOBIOL, V63, P818, DOI 10.1111/j.1751-1097.1996.tb09637.x	65	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151657	10.1371/journal.pone.0151657	http://dx.doi.org/10.1371/journal.pone.0151657			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990197	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800084
J	Martin-Clouaire, R; Rellier, JP; Pare, N; Voltz, M; Biarnes, A				Martin-Clouaire, Roger; Rellier, Jean-Pierre; Pare, Nakie; Voltz, Marc; Biarnes, Anne			Modelling Management Practices in Viticulture while Considering Resource Limitations: The Dhivine Model	PLOS ONE			English	Article							DECISION-MAKING PROCESSES; FARM-MANAGEMENT; RUNOFF; ORGANIZATION; SIMULATION; CATCHMENT; VINEYARDS; SYSTEMS; CROP	Many farming-system studies have investigated the design and evaluation of crop-management practices with respect to economic performance and reduction in environmental impacts. In contrast, little research has been devoted to analysing these practices in terms of matching the recurrent context-dependent demand for resources (labour in particular) with those available on the farm. This paper presents Dhivine, a simulation model of operational management of grape production at the vineyard scale. Particular attention focuses on representing a flexible plan, which organises activities temporally, the resources available to the vineyard manager and the process of scheduling and executing the activities. The model relies on a generic production-system ontology used in several agricultural production domains. The types of investigations that the model supports are briefly illustrated. The enhanced realism of the production-management situations simulated makes it possible to examine and understand properties of resource-constrained work-organisation strategies and possibilities for improving them.	[Martin-Clouaire, Roger; Rellier, Jean-Pierre] INRA, UR Math & Informat Appl Toulouse 875, F-31326 Castanet Tolosan, France; [Pare, Nakie] CAPNODIS, Paris, France; [Voltz, Marc] INRA, UMR LISAH, F-34060 Montpellier, France; [Biarnes, Anne] IRD, UMR LISAH, Montpellier, France	INRAE; INRAE; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Martin-Clouaire, R (corresponding author), INRA, UR Math & Informat Appl Toulouse 875, F-31326 Castanet Tolosan, France.	rmc@toulouse.inra.fr		Martin-Clouaire, Roger/0000-0002-1364-7474	French Ministry of Ecology, Sustainable Development, Transport and Housing [10-MBGD-GESSOL-8-CVS-077]; French Ministry of National Education, Advanced Instruction, and Research; Capnodis	French Ministry of Ecology, Sustainable Development, Transport and Housing; French Ministry of National Education, Advanced Instruction, and Research; Capnodis	This work was performed with the financial support of the French Ministry of Ecology, Sustainable Development, Transport and Housing under the third GESSOL programme (Environmental function and management of soil heritage, project 10-MBGD-GESSOL-8-CVS-077, SP3A). The authors are grateful to the French Ministry of National Education, Advanced Instruction, and Research for co-funding this research. NP received funding from Capnodis in the form of a salary. The specific roles of this author are articulated in the 'Author Contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attonaty J-M, 1993, P EURAGENG C OCT 1 2; Aubry C, 1998, AGR SYST, V56, P45, DOI 10.1016/S0308-521X(97)00034-6; Bergez JE, 2001, ECOL MODEL, V137, P43, DOI 10.1016/S0304-3800(00)00431-2; Chahinian N, 2006, J HYDROL, V326, P135, DOI 10.1016/j.jhydrol.2005.10.038; Chandrasekaran B, 1999, IEEE INTELL SYST APP, V14, P20, DOI 10.1109/5254.747902; Chardon X, 2012, ANIMAL, V6, P1711, DOI 10.1017/S1751731112000687; Chavas JP, 2010, AM J AGR ECON, V92, P356, DOI 10.1093/ajae/aaq004; Commissariat General au Developpement Durable, 2015, CHIFFR STAT, V697; deVoil P, 2009, P 18 WORLD IMACS MOD; Goldammer T., 2013, GRAPE GROWERS HDB CO; Hardaker J. B., 2011, AFBM Journal, V8, P1; IUSS Working Group WRB, 2006, WORLD SOIL RES REP; Janssen S, 2007, AGR SYST, V94, P622, DOI 10.1016/j.agsy.2007.03.001; Joannon A, 2005, AGR ECOSYST ENVIRON, V111, P13, DOI 10.1016/j.agee.2005.04.021; Kenny S, 2009, EXTENSION FARMING SY, V5; Lagacherie P, 2004, ORG SPATIALE CONDUIT, P79; Le Gal PY, 2010, ENVIRON MODELL SOFTW, V25, P258, DOI 10.1016/j.envsoft.2008.12.013; Lennartz B, 1997, J ENVIRON QUAL, V26, P1493, DOI 10.2134/jeq1997.00472425002600060007x; Leonard J, 1998, CATENA, V32, P209, DOI 10.1016/S0341-8162(98)00049-6; Louchart X, 2001, J ENVIRON QUAL, V30, P982, DOI 10.2134/jeq2001.303982x; Martin G, 2011, ENVIRON MODELL SOFTW, V26, P371, DOI 10.1016/j.envsoft.2010.10.002; Martin G, 2013, AGRON SUSTAIN DEV, V33, P131, DOI 10.1007/s13593-011-0075-4; Martin Philippe, 1998, Cahiers Agricultures, V7, P111; Martin-Clouaire Roger, 2009, International Journal of Metadata, Semantics and Ontologies, V4, P42, DOI 10.1504/IJMSO.2009.026253; Martin-Clouaire R, 2011, P MODSIM2011 DEC PER; Martin-Clouaire R, 2011, FONDEMENTS ONTOLOGIQ; Merot A, 2008, AGR SYST, V98, P108, DOI 10.1016/j.agsy.2008.05.001; Mottes C, 2014, AGRON SUSTAIN DEV, V34, P229, DOI 10.1007/s13593-013-0176-3; Moussa R, 2002, HYDROL PROCESS, V16, P393, DOI 10.1002/hyp.333; Muehlen M. Z., 2004, Information Technology & Management, V5, P271, DOI 10.1023/B:ITEM.0000031582.55219.2b; PAPY F, 1988, AGR SYST, V27, P295, DOI 10.1016/0308-521X(88)90037-6; Pare N, 2011, THESIS SUPAGRO MONTP; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Rellier J-P, 2011, TRAVAIL AGR SON ORG, P205; Ripoche A, 2011, ENVIRON MODELL SOFTW, V26, P1467, DOI 10.1016/j.envsoft.2011.08.003; Rivera-Ferre MG, 2013, SUSTAINABILITY-BASEL, V5, P3858, DOI 10.3390/su5093858; Rivington M, 2007, ENVIRON MODELL SOFTW, V22, P202, DOI 10.1016/j.envsoft.2005.07.018; Robertson M. J., 2012, AFBM Journal, V9, P13; Rodriguez D, 2014, AGR SYST, V126, P50, DOI 10.1016/j.agsy.2013.04.003; Rolon M, 2012, COMPUT IND, V63, P53, DOI 10.1016/j.compind.2011.10.005; Sierhuis M, 2009, AGENT DIRECTED SIMUL, P475; Van Der Aalst W., 2004, WORKFLOW MANAGEMENT; van Wijk M, 2012, REV FARM HOUSEHOLD M; Yilmaz Levent, 2009, AGENT DIRECTED SIMUL	44	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151952	10.1371/journal.pone.0151952	http://dx.doi.org/10.1371/journal.pone.0151952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990089	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800123
J	Chan, YH; Wu, LS; Chang, SH; Lee, HF; Liu, JR; See, LC; Yeh, YH; Kuo, CT				Chan, Yi-Hsin; Wu, Lung-Sheng; Chang, Shang-Hung; Lee, Hsin-Fu; Liu, Jia-Rou; See, Lai-Chu; Yeh, Yung-Hsin; Kuo, Chi-Tai			Young Male Patients with Atrial Fibrillation and CHA(2)DS(2)-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study	PLOS ONE			English	Article							ISCHEMIC-STROKE; RISK STRATIFICATION; PREDICTING STROKE; WARFARIN; VALIDATION; THROMBOEMBOLISM; DYSFUNCTION; DIAGNOSIS; CHADS(2); SCHEMES	Background It is unclear whether oral anticoagulants are beneficial for atrial fibrillation (AF) patients with low CHA(2)DS(2)-VASc score. Age could be important in determining the risk of thromboembolism in low risk AF patients (CHA(2)DS(2)-VASc score of 1 for male or 2 for female). Methods The Taiwan National Health Insurance Research Database (NHIRD) was used and 27,521 AF patients with CHA(2)DS(2)-VASc score of 1 (male) or 2 (female) not receiving anticoagulants were acquired as the study cohort, which were classified into three age groups: 20-49, 50-64, and 65-74 years. The clinical endpoint was the occurrence of ischemic thromboembolism within one year of follow up. Results During the follow-up of 0.94 +/- 0.19 years, 385 (2.19%) male patients experienced ischemic thromboembolism, with annual rate of 2.32%. The annual risk ranged from 1.29%, 2.43% to 2.77% for male patients aged 20-49, 50-64 and 65-74 years respectively. Of the female patients, 218 (2.20%) experienced clinical event with annual rate of 2.32%. The annual risk increased from 1.87%, 2.28% to 2.64% for female patients aged 20-49, 50-64 and 65-74 years respectively. There was no difference in risk between the male patients aged 20-49 years with CHA(2)DS(2)-VASc score of 1 and overall male patients with CHA(2)DS(2)-VASc score of 0. (P = 0.631) The female patients aged 20-49 years with CHA(2)DS(2)-VASc score of 2 was associated with a higher risk of thromboembolic events than overall female patients with CHA(2)DS(2)-VASc score of 1 (HR = 1.93; P = 0.008). Conclusions Age is important in determining the risk of thromboembolism in AF patients with single risk factor. In male patients <50 years old with CHA(2)DS(2)-VASc score of 1, the risk of ischemic thromboembolism was low. Considering the benefits and the risk of bleeding, oral anticoagulation therapy may not be favorable in these patients.	[Chan, Yi-Hsin; Wu, Lung-Sheng; Chang, Shang-Hung; Lee, Hsin-Fu; Yeh, Yung-Hsin; Kuo, Chi-Tai] Chang Gung Mem Hosp, Cardiovasc Dept, Taoyuan, Taiwan; [Chan, Yi-Hsin; Wu, Lung-Sheng; Chang, Shang-Hung; Lee, Hsin-Fu; Yeh, Yung-Hsin; Kuo, Chi-Tai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Liu, Jia-Rou; See, Lai-Chu] Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan; [See, Lai-Chu] Chang Gung Univ, Mol Med Res Ctr, Biostat Core Lab, Taoyuan, Taiwan; [See, Lai-Chu] Chang Gung Mem Hosp, Dept Internal Med, Div Rheumat & Allergy & Immunol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Yeh, YH; Kuo, CT (corresponding author), Chang Gung Mem Hosp, Cardiovasc Dept, Taoyuan, Taiwan.; Yeh, YH; Kuo, CT (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	yeongshinn@cgmh.org.tw; chitai@cgmh.org.tw	Chan, Yi-Hsin/ABA-5023-2021; Yeh, Yung-Hsin/ABD-9351-2021; Lee, Hsin-Fu/AAC-1560-2019	See, Lai-Chu/0000-0002-1379-8969; Chang, Shang-hung/0000-0003-0462-2344; Chan, Yi-Hsin/0000-0002-1406-8503	 [CMRPG3B0991];  [CMRPG3E0291]	; 	This study was supported by CMRPG3B0991 and CMRPG3E0291. https://www.cgmh.org.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum Arnon, 2012, J Vasc Interv Neurol, V5, P33; Camm AJ, 2012, EUR HEART J, V33; Chang CH, 2014, ATHEROSCLEROSIS, V232, P224, DOI 10.1016/j.atherosclerosis.2013.11.036; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Chao TF, 2011, J AM COLL CARDIOL, V58, P2380, DOI 10.1016/j.jacc.2011.08.045; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2008, STROKE, V39, P1901, DOI 10.1161/STROKEAHA.107.501825; Hart RG, 2007, NEUROLOGY, V69, P546; Higashi Y, 2012, HYPERTENS RES, V35, P1039, DOI 10.1038/hr.2012.138; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Jones C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3655; Jung BC, 2015, KOREAN CIRC J, V45, P9, DOI 10.4070/kcj.2015.45.1.9; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lin LJ, 2008, CLIN THER, V30, P1726, DOI 10.1016/j.clinthera.2008.09.010; Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Maaijwee NAMM, 2014, NAT REV NEUROL, V10, P315, DOI 10.1038/nrneurol.2014.72; Mayhan WG, 2008, MICROCIRCULATION, V15, P225, DOI 10.1080/10739680701641421; Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pena-Silva RA, 2012, STROKE, V43, P3358, DOI 10.1161/STROKEAHA.112.667063; Sohrabji F, 2013, NEUROCHEM INT, V63, P291, DOI 10.1016/j.neuint.2013.06.013; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551	32	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151485	10.1371/journal.pone.0151485	http://dx.doi.org/10.1371/journal.pone.0151485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986069	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300077
J	Hao, WR; Schlesinger, LS; Friedman, A				Hao, Wenrui; Schlesinger, Larry S.; Friedman, Avner			Modeling Granulomas in Response to Infection in the Lung	PLOS ONE			English	Article							MATHEMATICAL-MODEL; HOST IMMUNITY; TUBERCULOSIS; MACROPHAGES; INTERLEUKIN-4; INFLAMMATION; ALPHA; IL-13	Alveolar macrophages play a large role in the innate immune response of the lung. However, when these highly immune-regulatory cells are unable to eradicate pathogens, the adaptive immune system, which includes activated macrophages and lymphocytes, particularly T cells, is called upon to control the pathogens. This collection of immune cells surrounds, isolates and quarantines the pathogen, forming a small tissue structure called a granuloma for intracellular pathogens like Mycobacterium tuberculosis (Mtb). In the present work we develop a mathematical model of the dynamics of a granuloma by a system of partial differential equations. The 'strength' of the adaptive immune response to infection in the lung is represented by a parameter a, the flux rate by which T cells and M1 macrophages that immigrated from the lymph nodes enter into the granuloma through its boundary. The parameter a is negatively correlated with the 'switching time', namely, the time it takes for the number of M1 type macrophages to surpass the number of infected, M2 type alveolar macrophages. Simulations of the model show that as a increases the radius of the granuloma and bacterial load in the granuloma both decrease. The model is used to determine the efficacy of potential host-directed therapies in terms of the parameter a, suggesting that, with fixed dosing level, an infected individual with a stronger immune response will receive greater benefits in terms of reducing the bacterial load.	[Hao, Wenrui; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	hao.50@mbi.osu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation under Grant DMS [0931642]; NIH [AI059639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059639, R01AI059639] Funding Source: NIH RePORTER	Mathematical Biosciences Institute; National Science Foundation under Grant DMS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WH and AF have been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642. LS has been supported under Grant NIH AI059639.	Bajetta E, 1998, CLIN CANCER RES, V4, P75; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bona CA, 2001, CYTOKINES CYTOKINE R; Buttner C, 1997, AM J RESP CELL MOL, V17, P315; Calaras D, 2015, OVERVIEW SARCOIDOSIS; Calaras D, 2012, EURO RESP J; Cardona P-J, 2012, UNDERSTANDING TUBERC; Chroneos ZC, 2012, IMMUNOREGULATORY ROL; Cilfone NA, 2015, J IMMUNOL, V194, P664, DOI 10.4049/jimmunol.1400734; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Co DO, 2004, CLIN IMMUNOL, V113, P130, DOI 10.1016/j.clim.2004.08.012; Conlon P J, 1989, Biotechnol Ther, V1, P31; Cosio MG, 2002, CHEST, V121, p160S, DOI 10.1378/chest.121.5_suppl.160S; Datta M, 2016, ANN BIOMED ENG, V44, P863, DOI 10.1007/s10439-015-1415-3; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; Deepak P, 2010, INT IMMUNOL, V22, P53, DOI 10.1093/intimm/dxp114; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Fallahi-Sichani M, 2011, J IMMUNOL, V186, P3472, DOI 10.4049/jimmunol.1003299; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; Gammack D, 2005, MULTISCALE MODEL SIM, V3, P312, DOI 10.1137/040603127; Gammack D, 2004, J MATH BIOL, V48, P218, DOI 10.1007/s00285-003-0232-8; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Hao WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135097; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Hasskamp JH, 2005, AM J HEMATOL, V78, P314, DOI 10.1002/ajh.20296; Janeway CA, 2001, IMMUNOBIOLOGY; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; LI L, 1994, J IMMUNOL, V153, P3967; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin YG, 1998, INFECT IMMUN, V66, P2319, DOI 10.1128/IAI.66.5.2319-2322.1998; Linderman JJ, 2015, INTEGR BIOL-UK, V7, P591, DOI [10.1039/c4ib00295d, 10.1039/C4IB00295D]; Lo W, 2015, PREPRINT; LU ZY, 1995, BLOOD, V86, P3123; Ma JJ, 2014, FASEB J, V28, P3238, DOI 10.1096/fj.13-247056; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marino S, 2015, INFECT IMMUN, V83, P324, DOI 10.1128/IAI.02494-14; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Medicinenet, 2015, DEF GRAN; Miranda MS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139127; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; OKADA M, 2011, CLIN DEV IMMUNOL, V2011, DOI DOI 10.1155/2011/404929; Orme IM, 2014, SEMIN IMMUNOL, V26, P601, DOI 10.1016/j.smim.2014.09.009; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Pienaar E, 2015, J THEOR BIOL, V367, P166, DOI 10.1016/j.jtbi.2014.11.021; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Repasy T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003190; Reyes N, 2015, COLOMB MEDICA, V46, P26, DOI 10.25100/cm.v46i1.1570; Shaler CR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00030; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Steckelberg JM, 2015, GRANULOMA WHAT DOES; VanHeyningen TK, 1997, J IMMUNOL, V158, P330; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013	68	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0148738	10.1371/journal.pone.0148738	http://dx.doi.org/10.1371/journal.pone.0148738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986986	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300011
J	Ioannoni, R; Brault, A; Labbe, S				Ioannoni, Raphael; Brault, Ariane; Labbe, Simon			Cuf2 Is a Transcriptional Co-Regulator that Interacts with Mei4 for Timely Expression of Middle-Phase Meiotic Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; DNA-BINDING DOMAIN; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; MINOR-GROOVE; DIVISION CYCLE; MEIOSIS; COPPER; SPORULATION	The Schizosaccharomyces pombe cuf2(+) gene encodes a nuclear regulator that is required for timely activation and repression of several middle-phase genes during meiotic differentiation. In this study, we sought to gain insight into the mechanism by which Cuf2 regulates meiotic gene expression. Using a chromatin immunoprecipitation approach, we demonstrate that Cuf2 is specifically associated with promoters of both activated and repressed target genes, in a time-dependent manner. In case of the fzr1(+) gene whose transcription is positively affected by Cuf2, promoter occupancy by Cuf2 results in a concomitant increased association of RNA polymerase II along its coding region. In marked contrast, association of RNA polymerase II with chromatin decreases when Cuf2 negatively regulates target gene expression such as wtf13(+). Although Cuf2 operates through a transcriptional mechanism, it is unable to perform its function in the absence of the Mei4 transcription factor, which is a member of the conserved forkhead protein family. Using coimmunoprecipitation experiments, results showed that Cuf2 is a binding partner of Mei4. Bimolecular fluorescence complementation experiments brought further evidence that an association between Cuf2 and Mei4 occurs in the nucleus. Analysis of fzr1(+) promoter regions revealed that two FLEX-like elements, which are bound by the transcription factor Mei4, are required for chromatin occupancy by Cuf2. Together, results reported here revealed that Cuf2 and Mei4 co-regulate the timely expression of middle-phase genes during meiosis.	[Ioannoni, Raphael; Brault, Ariane; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X	 [MOP-114986]		This work was supported by grant number: MOP-114986 http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, GENETICS, V154, P1497; Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Aoi Y, 2013, EMBO REP, V14, P553, DOI 10.1038/embor.2013.52; Asakawa H, 2001, MOL GENET GENOMICS, V265, P424, DOI 10.1007/s004380000429; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Blanco MA, 2001, J CELL SCI, V114, P2135; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029917; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Doll E, 2008, GENETICS, V180, P727, DOI 10.1534/genetics.108.092619; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; HEPWORTH SR, 1995, MOL CELL BIOL, V15, P3934; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Ioannoni R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036338; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; Jacques JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098959; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jensen LT, 1998, J BIOL CHEM, V273, P23805, DOI 10.1074/jbc.273.37.23805; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kimata Y, 2011, MOL BIOL CELL, V22, P1486, DOI 10.1091/mbc.E10-09-0774; Klutstein M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-478; Koch KA, 1996, MOL CELL BIOL, V16, P724; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Labbe S., 2013, METALS IN CELLS, P163; Larochelle M, 2012, NUCLEIC ACIDS RES, V40, P10240, DOI 10.1093/nar/gks838; Li YF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-125; Lindgren A, 2000, EMBO J, V19, P6489, DOI 10.1093/emboj/19.23.6489; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Nakase Y, 2009, GENETICS, V183, P1195, DOI 10.1534/genetics.109.106906; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Papadopoulou K, 2008, J CELL SCI, V121, P38, DOI 10.1242/jcs.019489; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Staub C, 2001, J ANDROL, V22, P911; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhang MZM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001597	58	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151914	10.1371/journal.pone.0151914	http://dx.doi.org/10.1371/journal.pone.0151914			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986212	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300150
J	Lobo, GP; Au, A; Kiser, PD; Hagstrom, SA				Lobo, Glenn P.; Au, Adrian; Kiser, Philip D.; Hagstrom, Stephanie A.			Involvement of Endoplasmic Reticulum Stress in TULP1 Induced Retinal Degeneration	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TUBBY-LIKE PROTEIN-1; RETINITIS-PIGMENTOSA; VALPROIC ACID; CELL-DEATH; ER STRESS; IN-VIVO; MUTATIONS; ACTIVATION; MECHANISMS	Inherited retinal disorders (IRDs) result in severe visual impairments in children and adults. A challenge in the field of retinal degenerations is identifying mechanisms of photoreceptor cell death related to specific genetic mutations. Mutations in the gene TULP1 have been associated with two forms of IRDs, early-onset retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA). TULP1 is a cytoplasmic, membrane-associated protein shown to be involved in transportation of newly synthesized proteins destined for the outer segment compartment of photoreceptor cells; however, how mutant TULP1 causes cell death is not understood. In this study, we provide evidence that common missense mutations in TULP1 express as misfolded protein products that accumulate within the endoplasmic reticulum (ER) causing prolonged ER stress. In an effort to maintain protein homeostasis, photoreceptor cells then activate the unfolded protein response (UPR) complex. Our results indicate that the two major apoptotic arms of the UPR pathway, PERK and IRE1, are activated. Additionally, we show that retinas expressing mutant TULP1 significantly upregulate the expression of CHOP, a UPR signaling protein promoting apoptosis, and undergo photoreceptor cell death. Our study demonstrates that the ER-UPR, a known mechanism of apoptosis secondary to an overwhelming accumulation of misfolded protein, is involved in photoreceptor degeneration caused by missense mutations in TULP1. These observations suggest that modulating the UPR pathways might be a strategy for therapeutic intervention.	[Lobo, Glenn P.; Au, Adrian; Hagstrom, Stephanie A.] Cleveland Clin, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA; [Kiser, Philip D.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kiser, Philip D.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH 44106 USA; [Hagstrom, Stephanie A.] Case Western Reserve Univ, Cleveland Clin, Dept Ophthalmol, Lerner Coll Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Cleveland Clinic Foundation	Hagstrom, SA (corresponding author), Cleveland Clin, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA.; Hagstrom, SA (corresponding author), Case Western Reserve Univ, Cleveland Clin, Dept Ophthalmol, Lerner Coll Med, Cleveland, OH 44195 USA.	hagstrs@ccf.org	Au, Adrian/AAE-9654-2019; Lobo, Glenn P./AAI-9736-2020	Au, Adrian/0000-0001-8110-9988; 	National Institute of Health/National Eye Institute [RO1EY016072]; Knights Templar Eye Foundation Career Grants [KTEF2014/06GL, KTEF2015/07GL]; Howard Hughes Medical Institute-Foundation; Veterans Affairs (VA) Career Development Award [IK2BX002683]; NATIONAL EYE INSTITUTE [R01EY016072] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation Career Grants; Howard Hughes Medical Institute-Foundation(Howard Hughes Medical Institute); Veterans Affairs (VA) Career Development Award(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Institute of Health/National Eye Institute (RO1EY016072) to SAH; Knights Templar Eye Foundation Career Grants (KTEF2014/06GL) and (KTEF2015/07GL) to GPL; a Howard Hughes Medical Institute-Foundation to Fight Blindness Medical Research Fellows Award to AA; and a Veterans Affairs (VA) Career Development Award (IK2BX002683) to PDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AH, 2008, MOL VIS, V14, P675; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Athanasiou D, 2012, MOL BIOL CELL, V23, P3522, DOI 10.1091/mbc.E12-02-0168; Beryozkin A, 2014, INVEST OPHTH VIS SCI, V55, P1149, DOI 10.1167/iovs.13-13625; Cai X, 2015, EXP EYE RES, V140, P130, DOI 10.1016/j.exer.2015.08.022; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; Chiang WC, 2012, INVEST OPHTH VIS SCI, V53, P7159, DOI 10.1167/iovs.12-10222; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; Chinskey ND, 2014, CURR OPIN OPHTHALMOL, V25, P228, DOI 10.1097/ICU.0000000000000043; Choudhury S, 2014, ADV EXP MED BIOL, V801, P455, DOI 10.1007/978-1-4614-3209-8_58; Clemson CM, 2011, BRIT J OPHTHALMOL, V95, P89, DOI 10.1136/bjo.2009.175356; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Datta R, 2009, P NATL ACAD SCI USA, V106, P3437, DOI 10.1073/pnas.0813178106; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Ebke LA, 2016, ADV EXP MED BIOL, V854, P605, DOI 10.1007/978-3-319-17121-0_80; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Gregory-Evans CY, 2013, PROG RETIN EYE RES, V33, P40, DOI 10.1016/j.preteyeres.2012.10.003; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Grossman GH, 2014, ADV EXP MED BIOL, V801, P511, DOI 10.1007/978-1-4614-3209-8_65; Grossman GH, 2013, VISUAL NEUROSCI, V30, P129, DOI 10.1017/S0952523813000138; Grossman GH, 2011, EXP EYE RES, V93, P658, DOI 10.1016/j.exer.2011.08.005; Haeri Mohammad, 2012, J Ophthalmic Vis Res, V7, P45; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hagstrom SA, 2001, INVEST OPHTH VIS SCI, V42, P1955; Hagstrom SA, 2012, ADV EXP MED BIOL, V723, P783, DOI 10.1007/978-1-4614-0631-0_100; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Inokuchi Y, 2009, INVEST OPHTH VIS SCI, V50, P334, DOI 10.1167/iovs.08-2123; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jacobson SG, 2014, INVEST OPHTH VIS SCI, V55, P5354, DOI 10.1167/iovs.14-14570; Jayakody SA, 2015, PROG RETIN EYE RES, V46, P31, DOI 10.1016/j.preteyeres.2015.01.003; Jing G, 2012, EXP DIABETES RES, V17, P233; Jing GJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/589589; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Khan MI, 2011, OPHTHALMOLOGY, V118, P1444, DOI 10.1016/j.ophtha.2010.10.047; Kumar A, 2014, J OCUL PHARMACOL TH, V30, P580, DOI 10.1089/jop.2013.0166; Kunte MM, 2012, INVEST OPHTH VIS SCI, V53, P3792, DOI 10.1167/iovs.11-9235; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lobo GP, 2013, J BIOL CHEM, V288, P9017, DOI 10.1074/jbc.M112.444240; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Lobo GP, 2009, HUM MOL GENET, V18, P2851, DOI 10.1093/hmg/ddp220; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Rebello G, 2004, P NATL ACAD SCI USA, V101, P6617, DOI 10.1073/pnas.0401529101; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tian LF, 2015, GENOMICS, V105, P253, DOI 10.1016/j.ygeno.2015.01.008; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Volgyi K, 2015, CURR ALZHEIMER RES, V12, P655, DOI 10.2174/1567205012666150710095035; Weleber RG, 2004, LEBER CONGENITAL AMA, P1993; Wert KJ, 2014, DEV OPHTHALMOL, V53, P33, DOI 10.1159/000357294; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Xi QS, 2005, INVEST OPHTH VIS SCI, V46, P4754, DOI 10.1167/iovs.05-0693; Xi QS, 2007, INVEST OPHTH VIS SCI, V48, P2837, DOI 10.1167/iovs.06-0059; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015	69	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151806	10.1371/journal.pone.0151806	http://dx.doi.org/10.1371/journal.pone.0151806			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987071	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300132
J	Messaoudi, M; Milenkov, M; Albrich, WC; van der Linden, MPG; Benet, T; Chou, M; Sylla, M; Costa, PB; Richard, N; Klugman, KP; Endtz, HP; Paranhos-Baccala, G; Telles, JN				Messaoudi, Melina; Milenkov, Milen; Albrich, Werner C.; van der Linden, Mark P. G.; Benet, Thomas; Chou, Monidarin; Sylla, Mariam; Costa, Patricia Barreto; Richard, Nathalie; Klugman, Keith P.; Endtz, Hubert P.; Paranhos-Baccala, Glaucia; Telles, Jean-Noel			The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; REAL-TIME PCR; CONJUGATE VACCINE; CAPSULAR SEROTYPES; MULTIPLEX PCR; LATEX AGGLUTINATION; CHILDREN; CARRIAGE; ADULTS; IDENTIFICATION	For epidemiological and surveillance purposes, it is relevant to monitor the distribution and dynamics of Streptococcus pneumoniae serotypes. Conventional serotyping methods do not provide rapid or quantitative information on serotype loads. Quantitative serotyping may enable prediction of the invasiveness of a specific serotype compared to other serotypes carried. Here, we describe a novel, rapid multiplex real-time PCR assay for identification and quantification of the 40 most prevalent pneumococcal serotypes and the assay impacts in pneumonia specimens from emerging and developing countries. Eleven multiplex PCR to detect 40 serotypes or serogroups were optimized. Quantification was enabled by reference to standard dilutions of known bacterial load. Performance of the assay was evaluated to specifically type and quantify S. pneumoniae in nasopharyngeal and blood samples from adult and pediatric patients hospitalized with pneumonia (n = 664) from five different countries. Serogroup 6 was widely represented in nasopharyngeal specimens from all five cohorts. The most frequent serotypes in the French, South African, and Brazilian cohorts were 1 and 7A/F, 3 and 19F, and 14, respectively. When both samples were available, the serotype in blood was always present as carriage with other serotypes in the nasopharynx. Moreover, the ability of a serotype to invade the bloodstream may be linked to its nasopharyngeal load. The mean nasopharyngeal concentration of the serotypes that moved to the blood was 3 log-fold higher than the ones only found in the nasopharynx. This novel, rapid, quantitative assay may potentially predict some of the S. pneumoniae serotypes invasiveness and assessment of pneumococcal serotype distribution.	[Messaoudi, Melina; Milenkov, Milen; Endtz, Hubert P.; Paranhos-Baccala, Glaucia; Telles, Jean-Noel] Fdn Merieux, CIRI, Emerging Pathogens Lab, Lyon, France; [Endtz, Hubert P.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Albrich, Werner C.] Kantonsspital, Dept Infect Dis & Hosp Epidemiol, St Gallen, Switzerland; [Albrich, Werner C.; Klugman, Keith P.] Univ Witwatersrand, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa; [van der Linden, Mark P. G.] Univ Hosp RWTH Aachen, Inst Med Microbiol, Natl Reference Ctr Streptococci, Aachen, Germany; [Benet, Thomas] Hosp Civils Lyon, Hop Edouard Herriot, Serv Hygiene Epidemiol & Prevent, Lyon, France; [Chou, Monidarin] Univ Hlth Sci, Fac Pharm, Phnom Penh, Cambodia; [Sylla, Mariam] CHU Gabriel Toure, Bamako, Mali; [Costa, Patricia Barreto] Inst Oswaldo Cruz Fiocruz, Lab Virus Resp Sarampo, Rio De Janeiro, Brazil; [Richard, Nathalie] Groupement Hosp Est, HFME, Serv Reanimat Pediat Med Chirurg, Bron, France; [Klugman, Keith P.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Klugman, Keith P.] Bill & Melinda Gates Fdn, Pneumonia Program, Seattle, WA USA	Ecole Normale Superieure de Lyon (ENS de LYON); Erasmus University Rotterdam; Erasmus MC; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Witwatersrand; RWTH Aachen University; RWTH Aachen University Hospital; CHU Lyon; Fundacao Oswaldo Cruz; CHU Lyon; Emory University; Emory University; Bill & Melinda Gates Foundation	Paranhos-Baccala, G (corresponding author), Fdn Merieux, CIRI, Emerging Pathogens Lab, Lyon, France.	glaucia.baccala@fondation-merieux.org	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313; MESSAOUDI, Melina/0000-0002-7049-7206	Fondation Merieux; Fondation Anber	Fondation Merieux; Fondation Anber	The authors received no specific funding for this work. This research study was funded by the authors' own budget from Fondation Merieux and Fondation Anber.; The authors wish to thank Elodie Paredes and Sandra Dollet for their technical assistance, Drs Florence Komurian-Pradel and Leticia Lobo-Luppi for their scientific support and Dr Jonathan Hoffmann for his help with the Graph Pad software. This work was partly supported by Fondation Anber.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Albrich WC, 2014, J CLIN MICROBIOL, V52, P4224, DOI 10.1128/JCM.01553-14; Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Bandettini R, 2012, J Prev Med Hyg, V53, P85; BELL LM, 1985, PEDIATRICS, V76, P901; Benet T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145447; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blaschke AJ, 2011, PEDIATR INFECT DIS J, V30, P289, DOI 10.1097/INF.0b013e3182002d14; Bogaert D, 2004, FEMS IMMUNOL MED MIC, V41, P259, DOI 10.1016/j.femsim.2004.03.013; Bosch AATM, 2016, VACCINE, V34, P531, DOI 10.1016/j.vaccine.2015.11.060; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Bronsdon MA, 2004, J CLIN MICROBIOL, V42, P1596, DOI 10.1128/JCM.42.4.1596-1600.2004; Fenoll A, 1997, J CLIN MICROBIOL, V35, P764, DOI 10.1128/JCM.35.3.764-766.1997; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kendall BA, 2016, VACCINE, V34, P474, DOI 10.1016/j.vaccine.2015.12.010; Lipsitch M, 2001, AM J EPIDEMIOL, V154, P85, DOI 10.1093/aje/154.1.85; Magomani V, 2014, J CLIN MICROBIOL, V52, P3271, DOI 10.1128/JCM.01061-14; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001; Menezes APD, 2016, VACCINE, V34, P791, DOI 10.1016/j.vaccine.2015.12.042; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pasinato A, 2014, VACCINE, V32, P1375, DOI 10.1016/j.vaccine.2014.01.023; Peralta G, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-79; Pickering JW, 2012, METHODS MOL BIOL, V808, P361, DOI 10.1007/978-1-61779-373-8_24; Picot VS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0635-8; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Reynisson E, 2006, J MICROBIOL METH, V66, P206, DOI 10.1016/j.mimet.2005.11.006; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Slotved HC, 2016, VACCINE, V34, P769, DOI 10.1016/j.vaccine.2015.12.056; Slotved HC, 2004, J CLIN MICROBIOL, V42, P2518, DOI 10.1128/JCM.42.6.2518-2522.2004; SNIADACK DH, 1995, PEDIATR INFECT DIS J, V14, P503, DOI 10.1097/00006454-199506000-00007; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; SULLIVAN TD, 1982, PEDIATRICS, V69, P699; Telles JN, 2012, PNEUMONIA, V1, P11, DOI 10.15172/pneu.2012.1/228; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; Vernet G, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03496.x; Wagenvoort GHJ, 2016, VACCINE, V34, P1077, DOI 10.1016/j.vaccine.2015.12.066; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Zhou F, 2007, J CLIN MICROBIOL, V45, P3411, DOI 10.1128/JCM.01076-07	50	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151428	10.1371/journal.pone.0151428	http://dx.doi.org/10.1371/journal.pone.0151428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986831	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300070
J	Weiser, AA; Thons, C; Filter, M; Falenski, A; Appel, B; Kasbohrer, A				Weiser, Armin A.; Thoens, Christian; Filter, Matthias; Falenski, Alexander; Appel, Bernd; Kaesbohrer, Annemarie			FoodChain-Lab: A Trace-Back and Trace-Forward Tool Developed and Applied during Food-Borne Disease Outbreak Investigations in Germany and Europe	PLOS ONE			English	Article							TRACEABILITY	FoodChain-Lab is modular open-source software for trace-back and trace-forward analysis in food-borne disease outbreak investigations. Development of FoodChain-Lab has been driven by a need for appropriate software in several food-related outbreaks in Germany since 2011. The software allows integrated data management, data linkage, enrichment and visualization as well as interactive supply chain analyses. Identification of possible outbreak sources or vehicles is facilitated by calculation of tracing scores for food-handling stations (companies or persons) and food products under investigation. The software also supports consideration of station-specific cross-contamination, analysis of geographical relationships, and topological clustering of the tracing network structure. FoodChain-Lab has been applied successfully in previous outbreak investigations, for example during the 2011 EHEC outbreak and the 2013/14 European hepatitis A outbreak. The software is most useful in complex, multi-area outbreak investigations where epidemiological evidence may be insufficient to discriminate between multiple implicated food products. The automated analysis and visualization components would be of greater value if trading information on food ingredients and compound products was more easily available.	[Weiser, Armin A.; Thoens, Christian; Filter, Matthias; Falenski, Alexander; Appel, Bernd; Kaesbohrer, Annemarie] BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany	Federal Institute for Risk Assessment	Weiser, AA (corresponding author), BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany.	armin.weiser@bfr.bund.de		Filter, Matthias/0000-0001-9347-021X	Federal Ministry of Education and Research [13N11202]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work is part of the German national research project SiLeBAT and is funded by the Federal Ministry of Education and Research, research grant 13N11202.	Abe K, 2002, J FOOD PROTECT, V65, P66, DOI 10.4315/0362-028X-65.1.66; [Anonymous], 2013, BERICHTE LEBENSMITTE; [Anonymous], 2012, EPIDEMIOL B, V41, P414; [Anonymous], 2010, EC COST FOODBORNE DI; Berthold M., 2009, ACM SIGKDD EXPLOR NE, V11, P26, DOI [10.1145/1656274.1656280, DOI 10.1145/1656274.1656280]; Donnelly Kathryn Anne-Marie, 2008, International Journal of Metadata, Semantics and Ontologies, V3, P283, DOI 10.1504/IJMSO.2008.023575; Dupuy C., 2002, IEEE INT C SYST MAN, P494; DWYER DM, 1994, EPIDEMIOL REV, V16, P109, DOI 10.1093/oxfordjournals.epirev.a036137; EFSA, 2013, REQ EFSA SCI ASS MUL; ESRI, 1998, ESRI SHAP TECHN DESC; Ester M., 1996, P 2 INT C KNOWL DISC, V1996, P226, DOI DOI 10.1023/A:1009745219419; European Food Safety Authority, 2014, TRAC FOOD IT CONN MU, V12, P1; Filter M., 2013, 5 INT WORKSH COLD CH; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Kaufman J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003692; Kaufman JH, 2014, SPATIO TEMPORAL EPID; LeBlanc DI, 2015, J FOOD ENG, V147, P24, DOI 10.1016/j.jfoodeng.2014.09.026; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; O'Madadhain J, 2005, J STAT SOFTW, VVV, P1; Regattieri A, 2007, J FOOD ENG, V81, P347, DOI 10.1016/j.jfoodeng.2006.10.032; Riden CP, 2007, BIOSYST ENG, V98, P401, DOI 10.1016/j.biosystemseng.2007.07.004; SIMONE B, 2014, INVESTIGATING OUTBRE, V19, P16; Weiser AA, 2014, FOODPROCESS LAB; Weiser AA, 2013, FOODBORNE PATHOG DIS, V10, P263, DOI 10.1089/fpd.2012.1296	26	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151977	10.1371/journal.pone.0151977	http://dx.doi.org/10.1371/journal.pone.0151977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985673	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300158
J	Liou, LB; Huang, CC				Liou, Lieh-bang; Huang, Che-ching			Sialyltransferase and Neuraminidase Levels/Ratios and Sialic Acid Levels in Peripheral Blood B Cells Correlate with Measures of Disease Activity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Pilot Study	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITY; T-LYMPHOCYTES; BIOMARKERS; EXPRESSION; MACROPHAGES; VALIDATION; ACTIVATION; CANCER; SCORE; FC	Objective We attempted to determine whether the level of enzymes sialyltransferase (ST) and neuraminidase (Neu) and sialic acid (SIA) in patients with systemic lupus erythematosus (SLE) correlates with the SLE Disease Activity Index (SLEDAI) and in patients with rheumatoid arthritis (RA) correlates with the Disease Activity Score28 (DAS28). Methods We examined cell-surface levels of ST6Gal-1, Neu1, ST3Gal-1, Neu3, alpha-2,6-SIA, and alpha-2,3-SIA by using fluorescent anti-enzyme antibodies, fluorescent-conjugated Sambucus nigra lectin, and fluorescent-conjugated Maackia amurensis lectin on blood cells in SLE and RA patients and assessed correlations of these levels with SLEDAI and with DAS28. Areas under the curve (AUC) were calculated for different variables against SLEDAI. Results The B-cell ST3Gal-1/Neu3 ratio positively correlated with SLEDAI scores (rho = 0.409 and P = 0.002, statistically significant after Bonferroni' correction for multiple analyses.). It was supported by the inverse correlation of B-cell Neu3 levels with SLEDAI scores (rho = -0.264, P = 0.048). The B-cell ST3Gal-1/Neu3 ratio against SLEDAI yielded an AUC of 0.689, which was comparable to that of anti-dsDNA levels at 0.635. In contrast, both ST3Gal-1 and Neu3 levels of RA B cells (r = 0.376, P = 0.013; r = 0.425, P = 0.005, respectively) correlated positively with high disease-activity DAS28 scores. Conclusion B-cell ST3Gal-1/Neu3 ratios in SLE and B-cell ST3Gal-1 and Neu3 levels in RA with high disease-activity DAS28 scores correlated with disease activity measures and may be useful in monitoring disease activities.	[Liou, Lieh-bang; Huang, Che-ching] Chang Gung Mem Hosp Lin Kou, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Liou, Lieh-bang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Liou, LB (corresponding author), Chang Gung Mem Hosp Lin Kou, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan.; Liou, LB (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	b890121@cgmh.org.tw; lblhome.f260127@msa.hinet.net			Chang Gung Medical Foundation, Taiwan; Ministry of Science and Technology, Taiwan, ROC [CMRPG3B0171, NSC 102-2314-B-182A-093]	Chang Gung Medical Foundation, Taiwan; Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Medical Foundation, Taiwan and Ministry of Science and Technology, Taiwan, ROC (CMRPG3B0171 and NSC 102-2314-B-182A-093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand D, 2014, CLIN EXP IMMUNOL, V176, P327, DOI 10.1111/cei.12274; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Bakker MF, 2012, ANN RHEUM DIS, V71, P1692, DOI 10.1136/annrheumdis-2011-200963; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Bauer JW, 2009, ARTHRITIS RHEUM-US, V60, P3098, DOI 10.1002/art.24803; Castro-Villegas C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0555-z; Cerezo LA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/740357; Chen XP, 1997, J IMMUNOL, V158, P3070; Costa-Nogueira C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-431; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Crowson CS, 2010, J INTERN MED, V268, P552, DOI 10.1111/j.1365-2796.2010.02296.x; Cutis JR, 2012, ARTHRIT CARE RES, V64, P1794; Fabrizio C, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/328078; Fuushima K, 1993, BIOCHEM BIOPH RES CO, V192, P333; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; GORCZYCA W, 1989, FEBS LETT, V259, P99, DOI 10.1016/0014-5793(89)81504-2; Greisen SR, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0434-z; Ha YJ, 2014, J KOREAN MED SCI, V29, P1199, DOI 10.3346/jkms.2014.29.9.1199; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Illei GG, 2004, ARTHRITIS RHEUM-US, V50, P1709, DOI 10.1002/art.20344; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Jones MB, 2012, J BIOL CHEM, V287, P15365, DOI 10.1074/jbc.M112.345710; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kao AH, 2010, ARTHRITIS RHEUM-US, V62, P837, DOI 10.1002/art.27267; Kidder D, 2013, J IMMUNOL, V190, P2593, DOI 10.4049/jimmunol.1201172; Klime E, 2014, MEDIAT INFLAMM, P1; Lateef A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3919; Lehoux S, 2010, GLYCOCONJUGATE J, V27, P99, DOI 10.1007/s10719-009-9260-y; Lepers AH, 2001, BIOCHIMIE, V83, P727; Liou LB, 2003, CLIN EXP RHEUMATOL, V21, P437; Liou LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055346; Liu CC, 2009, BEST PRACT RES CL RH, V23, P507, DOI 10.1016/j.berh.2009.01.008; Mondal S, 2010, LEUKEMIA RES, V34, P463, DOI 10.1016/j.leukres.2009.07.042; NARAPARAJU VR, 1994, IMMUNOL LETT, V43, P143, DOI 10.1016/0165-2478(94)90214-3; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Pincus T, 2005, CLIN EXP RHEUMATOL, V23, pS109; Podolska MJ, 2015, J INFLAMM RES, V8, P161, DOI 10.2147/JIR.S70325; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rajasekhar L, 2004, CLIN EXP RHEUMATOL, V22, P597; Riboldi P, 2005, AUTOIMMUNITY, V38, P39, DOI 10.1080/08916930400022616; Seyrantepe V, 2010, J BIOL CHEM, V285, P206, DOI 10.1074/jbc.M109.055475; Smith MF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2834; Stypinska B, 2015, INT J MOL SCI, V16, P24194, DOI 10.3390/ijms161024194; Urata Y, 2012, ANN RHEUM DIS, V71, P534, DOI 10.1136/annrheumdis-2011-200108; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151669	10.1371/journal.pone.0151669	http://dx.doi.org/10.1371/journal.pone.0151669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981635	gold, Green Published			2022-12-26	WOS:000372574900111
J	Zhou, HY; Gao, M; Skolnick, J				Zhou, Hongyi; Gao, Mu; Skolnick, Jeffrey			ENTPRISE: An Algorithm for Predicting Human Disease-Associated Amino Acid Substitutions from Sequence Entropy and Predicted Protein Structures	PLOS ONE			English	Article							BENCHMARK DATABASE; SOMATIC MUTATIONS; DATA-BANK; CANCER; VARIANTS; SEARCH; IMPACT; SCORE; SNVS	The advance of next-generation sequencing technologies has made exome sequencing rapid and relatively inexpensive. A major application of exome sequencing is the identification of genetic variations likely to cause Mendelian diseases. This requires processing large amounts of sequence information and therefore computational approaches that can accurately and efficiently identify the subset of disease-associated variations are needed. The accuracy and high false positive rates of existing computational tools leave much room for improvement. Here, we develop a boosted tree regression machine-learning approach to predict human disease-associated amino acid variations by utilizing a comprehensive combination of protein sequence and structure features. On comparing our method, ENTPRISE, to the state-of-the-art methods SIFT, PolyPhen-2, MUTATIONASSESSOR, MUTATIONTASTER, FATHMM, ENTPRISE exhibits significant improvement. In particular, on a testing dataset consisting of only proteins with balanced disease-associated and neutral variations defined as having the ratio of neutral/disease-associated variations between 0.3 and 3, the Mathews Correlation Coefficient by ENTPRISE is 0.493 as compared to 0.432 by PPH2-HumVar, 0.406 by SIFT, 0.403 by MUTATIONASSESSOR, 0.402 by PPH2-HumDiv, 0.305 by MUTATIONTASTER, and 0.181 by FATHMM. ENTPRISE is then applied to nucleic acid binding proteins in the human proteome. Disease-associated predictions are shown to be highly correlated with the number of protein-protein interactions. Both these predictions and the ENTPRISE server are freely available for academic users as a web service at http://cssb.biology.gatech.edu/entprise/.	[Zhou, Hongyi; Gao, Mu; Skolnick, Jeffrey] Georgia Inst Technol, Sch Biol, Ctr Study Syst Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Skolnick, J (corresponding author), Georgia Inst Technol, Sch Biol, Ctr Study Syst Biol, Atlanta, GA 30332 USA.	skolnick@gatech.edu	Gao, Mu/I-2826-2013	Gao, Mu/0000-0002-0378-3704	National Institutes of Health [GM-37408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118039, R01GM037408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant No GM-37408.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Byron P., 2006, STAT PROBLEMS PARTIC, V40, P139; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Dudley J, 2014, EXPLORING PERSONAL G; Finn R, 2009, NUCLEIC ACIDS RES, V36, pD281; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gao M, 2015, STRUCTURE IN PRESS; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenberg RA, 2006, CANCER BIOL THER, V5, P1103, DOI 10.4161/cbt.5.9.3370; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li MR, 2013, ELECTRON J DIFFER EQ; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nair PS, 2013, HUM MUTAT, V34, P42, DOI 10.1002/humu.22204; Ogutu Joseph O, 2011, BMC Proc, V5 Suppl 3, pS11, DOI 10.1186/1753-6561-5-S3-S11; Reardon S, 2013, NATURE, V503, P449, DOI 10.1038/503449a; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schaafsma GCP, 2015, HUM MUTAT, V36, P161, DOI 10.1002/humu.22727; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Skolnick J, 2004, PROTEINS, V56, P502, DOI 10.1002/prot.20106; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Weiss GM, 2003, J ARTIF INTELL RES, V19, P315, DOI 10.1613/jair.1199; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yates CM, 2014, J MOL BIOL, V426, P2692, DOI 10.1016/j.jmb.2014.04.026; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhou HY, 2007, PROTEINS, V69, P90, DOI 10.1002/prot.21649; Zhou HY, 2013, J CHEM INF MODEL, V53, P230, DOI 10.1021/ci300510n; Zhou HY, 2012, MOL PHARMACEUT, V9, P1775, DOI 10.1021/mp3000716; Zhou HY, 2012, PROTEINS, V80, P352, DOI 10.1002/prot.23183	59	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150965	10.1371/journal.pone.0150965	http://dx.doi.org/10.1371/journal.pone.0150965			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982818	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900059
J	Mhlongo, MI; Piater, LA; Madala, NE; Steenkamp, PA; Dubery, IA				Mhlongo, Msizi I.; Piater, Lizelle A.; Madala, Ntakadzeni E.; Steenkamp, Paul A.; Dubery, Ian A.			Phenylpropanoid Defences in Nicotiana tabacum Cells: Overlapping Metabolomes Indicate Common Aspects to Priming Responses Induced by Lipopolysaccharides, Chitosan and Flagellin-22	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; LC-MSN IDENTIFICATION; DISEASE-RESISTANCE; CHLOROGENIC ACID; ABSCISIC-ACID; ARABIDOPSIS; METABOLITES; EXPRESSION; HORMONES; PATHOGEN	Plants have evolved both constitutive and inducible defence strategies to cope with different biotic stimuli and stresses. Exposure of a plant to a challenging stress can lead to a primed state that allows it to launch a more rapid and stronger defence. Here we applied a metabolomic approach to study and compare the responses induced in Nicotiana tabacum cells by microbe-associated molecular pattern (MAMP) molecules, namely lipopolysaccharides (LPS), chitosan (CHT) and flagellin-22 (FLG22). Early response metabolites, extracted with methanol, were analysed by UHPLC-MS/MS. Using multivariate statistical tools the metabolic profiles induced by these elicitors were analysed. In the metabolic fingerprint of these agents a total of 19 cinnamic acid derivatives conjugated to quinic acids (chlorogenic acids), shikimic acid, tyramine, polyamines or glucose were found as discriminant biomarkers. In addition, treatment with the phytohormones salicylic acid (SA), methyljasmonic acid (MJ) and abscisic acid (ABA) resulted in differentially-induced phenylpropanoid pathway metabolites. The results indicate that the phenylpropanoid pathway is activated by these elicitors while hydroxycinnamic acid derivatives are commonly associated with the metabolic response to the MAMPs, and that the activated responses are modulated by both SA and MJ, with ABA not playing a role.	[Mhlongo, Msizi I.; Piater, Lizelle A.; Madala, Ntakadzeni E.; Steenkamp, Paul A.; Dubery, Ian A.] Univ Johannesburg, Dept Biochem, Auckland Pk, Johannesburg, South Africa; [Steenkamp, Paul A.] CSIR Biosci, Nat Prod & Agroproc Grp, Pretoria, South Africa	University of Johannesburg; Council for Scientific & Industrial Research (CSIR) - South Africa	Dubery, IA (corresponding author), Univ Johannesburg, Dept Biochem, Auckland Pk, Johannesburg, South Africa.	idubery@uj.ac.za	Madala, Ntakadzeni/AAR-3437-2021; Dubery, Ian/A-6346-2013	Dubery, Ian/0000-0002-9079-4769; Mhlongo, Msizi/0000-0002-6418-6620; Piater, Lizelle/0000-0002-9526-0109	South African National Research Foundation (ZA) [95818]; NRF; University of Johannesburg; South African National Research Foundation (NRF) [95818]	South African National Research Foundation (ZA); NRF; University of Johannesburg; South African National Research Foundation (NRF)(National Research Foundation - South Africa)	The South African National Research Foundation (ZA) funded the research through a grant (95818) to IAD. The NRF and the University of Johannesburg are thanked for fellowship support to MIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The South African National Research Foundation (NRF) is thanked for grant support (number 95818) to IAD. The NRF and the University of Johannesburg are thanked for fellowship support to MIM.	Alon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076619; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Balmer A, 2015, TRENDS PLANT SCI, V20, P443, DOI 10.1016/j.tplants.2015.04.002; Balmerl D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00082; Bautista-Banos S, 2006, CROP PROT, V25, P108, DOI 10.1016/j.cropro.2005.03.010; Benton HP, 2008, ANAL CHEM, V80, P6382, DOI 10.1021/ac800795f; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Bostock RM, 1999, PHYSIOL MOL PLANT P, V54, P37, DOI 10.1006/pmpp.1998.0189; Chakraborty M, 2009, J PLANT PHYSIOL, V166, P63, DOI 10.1016/j.jplph.2008.02.004; Clifford MN, 2008, FOOD CHEM, V106, P379, DOI 10.1016/j.foodchem.2007.05.081; Clifford MN, 2005, J AGR FOOD CHEM, V53, P3821, DOI 10.1021/jf050046h; Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; De Vleesschauwer D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00611; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dempsey DA, 2012, TRENDS PLANT SCI, V17, P538, DOI 10.1016/j.tplants.2012.05.011; Denance N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00155; Desaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051953; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Faoro F, 2008, BIOCONTROL, V53, P387, DOI 10.1007/s10526-007-9091-3; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gamir J, 2014, PLANT J, V78, P227, DOI 10.1111/tpj.12465; Gao XQ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003127; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; Gust AA, 2010, CURR OPIN BIOTECH, V21, P204, DOI 10.1016/j.copbio.2010.02.004; Hammerschmidt R, 2014, PHYSIOL MOL PLANT P, V88, pIII, DOI 10.1016/j.pmpp.2014.11.002; Hao GX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0211-9; Homayoun S.B., 2011, SCI RES ESSAYS, V6, P4369, DOI [10.5897/SRE10.1147, DOI 10.5897/SRE10.1147]; Hossain MB, 2010, J AGR FOOD CHEM, V58, P10576, DOI 10.1021/jf102042g; Huang P, 2012, PLANT CELL PHYSIOL, V53, P193, DOI 10.1093/pcp/pcr162; Ibrahim MH, 2013, MOLECULES, V18, P7957, DOI 10.3390/molecules18077957; Iriti M, 2007, MYCOPATHOLOGIA, V164, P57, DOI 10.1007/s11046-007-9026-7; Iriti M, 2010, BIOL CONTROL, V54, P241, DOI 10.1016/j.biocontrol.2010.05.012; Iriti M, 2009, PLANT SIGNAL BEHAV, V4, P66, DOI 10.4161/psb.4.1.7408; Jaiswal R, 2014, J AGR FOOD CHEM, V62, P9252, DOI 10.1021/jf501210s; Jansen JJ, 2009, METABOLOMICS, V5, P150, DOI 10.1007/s11306-008-0124-4; Joet T, 2010, PLANT CELL ENVIRON, V33, P1220, DOI 10.1111/j.1365-3040.2010.02141.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Keyu G, 2002, TRENDS PLANT SCI, V7, P196, DOI [10.1016/S1360-1385(02)02264-1, DOI 10.1016/S1360-1385(02)02264-1]; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kovacik J, 2009, PLANT CELL REP, V28, P135, DOI 10.1007/s00299-008-0627-5; Lee MH, 2007, PHYTOPATHOLOGY, V97, P269, DOI 10.1094/PHYTO-97-3-0269; Leiss KA, 2011, PHYTOCHEM REV, V10, P205, DOI 10.1007/s11101-010-9175-z; Li Y, 2013, PHYSIOL MOL PLANT P, V83, P51, DOI 10.1016/j.pmpp.2013.05.001; Liang YS, 2006, J CHROMATOGR A, V1112, P148, DOI 10.1016/j.chroma.2005.11.114; Madala NE, 2014, J ANAL METHODS CHEM, V2014, DOI 10.1155/2014/650879; Madala NE, 2012, INNATE IMMUN-LONDON, V18, P140, DOI 10.1177/1753425910392609; Martinez-Medina A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00206; MATHEIS G, 1984, J FOOD BIOCHEM, V8, P137, DOI 10.1111/j.1745-4514.1984.tb00322.x; Mhlongo MI, 2014, PHYSIOL MOL PLANT P, V88, P61, DOI 10.1016/j.pmpp.2014.09.002; Mikulic-Petkovsek M, 2011, PHYSIOL MOL PLANT P, V76, P159, DOI 10.1016/j.pmpp.2011.09.006; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Ncube EN, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0066-z; New SA, 2015, BIOL PLANTARUM, V59, P18, DOI 10.1007/s10535-014-0478-6; Newman MA, 2002, PLANT J, V29, P487, DOI 10.1046/j.0960-7412.2001.00233.x; Ni Y, 2008, FEBS LETT, V582, P2627, DOI 10.1016/j.febslet.2008.06.040; O'Donnell PJ, 2003, PLANT PHYSIOL, V133, P1181, DOI 10.1104/pp.103.030379; Pastor V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00295; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Peng B, 2015, PROTEIN CELL, V6, P628, DOI 10.1007/s13238-015-0185-x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; Ramabulana T, 2016, J PHOTOCH PHOTOBIO B, V156, P79, DOI 10.1016/j.jphotobiol.2016.01.013; RANJEVA R, 1987, ANNU REV PLANT PHYS, V38, P73, DOI 10.1146/annurev.pp.38.060187.000445; Sanabria NM, 2006, BIOCHEM BIOPH RES CO, V344, P1001, DOI 10.1016/j.bbrc.2006.03.216; Sanabria NM, 2009, SELF NONSELF IMMUNE, V1, P1, DOI [10.4161/self.1.1.10442, DOI 10.4161/SELF.1.1.10442]; Song WW, 2011, PLANT PHYSIOL BIOCH, V49, P693, DOI 10.1016/j.plaphy.2011.03.018; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sun XiaoJuan, 2008, Agricultural Sciences in China, V7, P615, DOI 10.1016/S1671-2927(08)60060-7; Tugizimana F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087846; Tugizimana F, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20120005; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Villarino M, 2011, J AGR FOOD CHEM, V59, P3205, DOI 10.1021/jf104251z; Walters D, 2002, J EXP BOT, V53, P747, DOI 10.1093/jexbot/53.369.747; Wei CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041056; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wojciechowska E, 2014, EUR J PLANT PATHOL, V139, P735, DOI 10.1007/s10658-014-0428-3	83	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151350	10.1371/journal.pone.0151350	http://dx.doi.org/10.1371/journal.pone.0151350			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978774	Green Published, gold			2022-12-26	WOS:000372572800063
J	Moharana, TR; Byreddy, AR; Puri, M; Barrow, C; Rao, NM				Moharana, Tushar Ranjan; Byreddy, Avinesh R.; Puri, Munish; Barrow, Colin; Rao, Nalam Madhusudhana			Selective Enrichment of Omega-3 Fatty Acids in Oils by Phospholipase A1	PLOS ONE			English	Article							STAPHYLOCOCCUS-HYICUS LIPASE; POLYUNSATURATED FATTY-ACIDS; FISH-OIL; DOCOSAHEXAENOIC ACID; SOYBEAN OIL; EICOSAPENTAENOIC ACID; LECITASE(R) ULTRA; STRUCTURAL BASIS; TUNA OIL; HYDROLYSIS	Omega fatty acids are recognized as key nutrients for healthier ageing. Lipases are used to release omega-3 fatty acids from oils for preparing enriched omega-3 fatty acid supplements. However, use of lipases in enrichment of omega-3 fatty acids is limited due to their insufficient specificity for omega-3 fatty acids. In this study use of phospholipase A1 (PLA1), which possesses both sn-1 specific activity on phospholipids and lipase activity, was explored for hydrolysis of omega-3 fatty acids from anchovy oil. Substrate specificity of PLA1 from Thermomyces lenuginosus was initially tested with synthetic p-nitrophenyl esters along with a lipase from Bacillus subtilis (BSL), as a lipase control. Gas chromatographic characterization of the hydrolysate obtained upon treatment of anchovy oil with these enzymes indicated a selective retention of omega-3 fatty acids in the triglyceride fraction by PLA1 and not by BSL. C-13 NMR spectroscopy based position analysis of fatty acids in enzyme treated and untreated samples indicated that PLA1 preferably retained omega-3 fatty acids in oil, while saturated fatty acids were hydrolysed irrespective of their position. Hydrolysis of structured triglyceride, 1,3-dioleoyl-2-palmitoylglycerol, suggested that both the enzymes hydrolyse the fatty acids at both the positions. The observed discrimination against omega-3 fatty acids by PLA1 appears to be due to its fatty acid selectivity rather than positional specificity. These studies suggest that PLA1 could be used as a potential enzyme for selective concentration of omega-3 fatty acids.	[Moharana, Tushar Ranjan; Rao, Nalam Madhusudhana] Ctr Cellular & Mol Biol, CSIR, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Byreddy, Avinesh R.; Puri, Munish; Barrow, Colin] Deakin Univ, Ctr Chem & Biotechnol, 75 Pigdons Rd, Waurn Ponds, Vic 3220, Australia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Deakin University	Rao, NM (corresponding author), Ctr Cellular & Mol Biol, CSIR, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.; Barrow, C (corresponding author), Deakin Univ, Ctr Chem & Biotechnol, 75 Pigdons Rd, Waurn Ponds, Vic 3220, Australia.	colin.barrow@deakin.edu.au; madhu@ccmb.res.in	Puri, Munish/C-2398-2013; Puri, Munish/M-5577-2019	Puri, Munish/0000-0003-2469-3326; Barrow, Colin/0000-0002-2153-7267	Indo-Australian Biotechnology Fund [GAP373]; CSIR	Indo-Australian Biotechnology Fund; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Indo-Australian Biotechnology Fund (http://www.science.gov.au/international/CollaborativeOpportunities/AISRF/Pages/default.aspx) GAP373. TRM acknowledges the fellowship received from CSIR.	Ackman RG, 2002, ANAL CHIM ACTA, V465, P175, DOI 10.1016/S0003-2670(02)00098-3; Akanbi TO, 2014, FOOD CHEM, V160, P61, DOI 10.1016/j.foodchem.2014.03.092; Akanbi TO, 2013, FOOD CHEM, V138, P615, DOI 10.1016/j.foodchem.2012.11.007; Aloulou A, 2014, BBA-MOL CELL BIOL L, V1841, P581, DOI 10.1016/j.bbalip.2013.12.009; Aoki J, 2007, BIOCHIMIE, V89, P197, DOI 10.1016/j.biochi.2006.09.021; Carriere F, 1998, BBA-REV BIOMEMBRANES, V1376, P417, DOI 10.1016/S0304-4157(98)00016-1; Casas-Godoy L, 2014, J BIOTECHNOL, V180, P30, DOI 10.1016/j.jbiotec.2014.03.018; Christie W. W., 2010, LIPID ANAL ISOLATION, V4; DARTOIS V, 1992, BIOCHIM BIOPHYS ACTA, V1131, P253, DOI 10.1016/0167-4781(92)90023-S; Fernandez-Lorente G, 2008, J MOL CATAL B-ENZYM, V51, P110, DOI 10.1016/j.molcatb.2007.11.017; Gamez-Meza N, 2003, FOOD RES INT, V36, P721, DOI 10.1016/S0963-9969(03)00052-8; Halldorsson A, 2004, EUR J LIPID SCI TECH, V106, P79, DOI 10.1002/ejlt.200300867; Kamal MZ, 2015, FOOD CHEM, V173, P1030, DOI 10.1016/j.foodchem.2014.10.124; Klinkesorn U, 2004, FOOD CHEM, V87, P415, DOI 10.1016/j.foodchem.2003.12.021; KOSUGI Y, 1994, J AM OIL CHEM SOC, V71, P1397, DOI 10.1007/BF02541362; Kralovec JA, 2012, FOOD CHEM, V131, P639, DOI 10.1016/j.foodchem.2011.08.085; Kralovec JA, 2010, AUST J CHEM, V63, P922, DOI 10.1071/CH10087; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Liu N, 2012, FOOD CHEM, V134, P301, DOI 10.1016/j.foodchem.2012.02.145; Lyberg AM, 2008, BBA-PROTEINS PROTEOM, V1784, P343, DOI 10.1016/j.bbapap.2007.11.003; Miller MR, 2008, NUTR RES REV, V21, P85, DOI 10.1017/S0954422408102414; Mishra MK, 2009, TETRAHEDRON-ASYMMETR, V20, P2854, DOI 10.1016/j.tetasy.2009.11.012; Molfino A, 2014, NUTRIENTS, V6, P4058, DOI 10.3390/nu6104058; Nalder TD, 2014, J FUNCT FOODS, V6, P259, DOI 10.1016/j.jff.2013.10.015; NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221; Okada T, 2007, FOOD CHEM, V103, P1411, DOI 10.1016/j.foodchem.2006.10.057; Richmond GS, 2011, INT J MOL SCI, V12, P588, DOI 10.3390/ijms12010588; Shahidi F, 1998, TRENDS FOOD SCI TECH, V9, P230, DOI 10.1016/S0924-2244(98)00044-2; Sheelu G, 2008, J AM OIL CHEM SOC, V85, P739, DOI 10.1007/s11746-008-1261-7; Shimada Y, 1998, J AM OIL CHEM SOC, V75, P1565, DOI 10.1007/s11746-998-0095-7; Shimada Y, 1997, J AM OIL CHEM SOC, V74, P1441, DOI 10.1007/s11746-997-0251-5; Suarez ER, 2010, J AM OIL CHEM SOC, V87, P1425, DOI 10.1007/s11746-010-1638-2; Tiesinga JJW, 2007, J MOL BIOL, V371, P447, DOI 10.1016/j.jmb.2007.05.041; van Kampen MD, 1998, CHEM PHYS LIPIDS, V93, P39, DOI 10.1016/S0009-3084(98)00027-9; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Wang Y, 2010, FOOD CHEM, V121, P1066, DOI 10.1016/j.foodchem.2010.01.051; Yang B, 2008, J AM OIL CHEM SOC, V85, P421, DOI 10.1007/s11746-008-1225-y; Yang JG, 2006, FOOD TECHNOL BIOTECH, V44, P101	38	24	25	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151370	10.1371/journal.pone.0151370	http://dx.doi.org/10.1371/journal.pone.0151370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978518	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800069
J	Nicolas, G; Robinson, TP; Wint, GRW; Conchedda, G; Cinardi, G; Gilbert, M				Nicolas, Galle; Robinson, Timothy P.; Wint, G. R. William; Conchedda, Giulia; Cinardi, Giuseppina; Gilbert, Marius			Using Random Forest to Improve the Downscaling of Global Livestock Census Data	PLOS ONE			English	Article							DUCKS	Large scale, high-resolution global data on farm animal distributions are essential for spatially explicit assessments of the epidemiological, environmental and socio-economic impacts of the livestock sector. This has been the major motivation behind the development of the Gridded Livestock of the World (GLW) database, which has been extensively used since its first publication in 2007. The database relies on a downscaling methodology whereby census counts of animals in sub-national administrative units are redistributed at the level of grid cells as a function of a series of spatial covariates. The recent upgrade of GLW1 to GLW2 involved automating the processing, improvement of input data, and downscaling at a spatial resolution of 1 km per cell (5 km per cell in the earlier version). The underlying statistical methodology, however, remained unchanged. In this paper, we evaluate new methods to downscale census data with a higher accuracy and increased processing efficiency. Two main factors were evaluated, based on sample census datasets of cattle in Africa and chickens in Asia. First, we implemented and evaluated Random Forest models (RF) instead of stratified regressions. Second, we investigated whether models that predicted the number of animals per rural person (per capita) could provide better downscaled estimates than the previous approach that predicted absolute densities (animals per km(2)). RF models consistently provided better predictions than the stratified regressions for both continents and species. The benefit of per capita over absolute density models varied according to the species and continent. In addition, different technical options were evaluated to reduce the processing time while maintaining their predictive power. Future GLW runs (GLW 3.0) will apply the new RF methodology with optimized modelling options. The potential benefit of per capita models will need to be further investigated with a better distinction between rural and agricultural populations.	[Nicolas, Galle; Gilbert, Marius] Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium; [Nicolas, Galle; Gilbert, Marius] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Robinson, Timothy P.] ILRI, LSE, Nairobi, Kenya; [Wint, G. R. William] Univ Oxford, Dept Zool, ERGO, S Parks Rd, Oxford, England; [Conchedda, Giulia; Cinardi, Giuseppina] United Nations FAO, Anim Prod & Hlth Div AGA, FAO, Rome, Italy	Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; CGIAR; International Livestock Research Institute (ILRI); University of Oxford; Food & Agriculture Organization of the United Nations (FAO)	Nicolas, G (corresponding author), Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium.; Nicolas, G (corresponding author), Fonds Natl Rech Sci, B-1050 Brussels, Belgium.	gaelle.nicolas6@gmail.com		Wint, William/0000-0003-0916-0847; Nicolas, Gaelle/0000-0002-7116-2811	FNRS [PDR T.0073.13]; CGIAR	FNRS(Fonds de la Recherche Scientifique - FNRS); CGIAR(CGIAR)	GN and MG were funded by the FNRS project "Mapping people and livestock" (PDR T.0073.13). TPR is funded by the CGIAR Research Programmes on the Humid tropics; Climate Change, Agriculture and Food Security (CCAFS) and Agriculture for Nutrition and Health (A4NH).	Anderson W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100037; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davy RJ, 2010, BOUND-LAY METEOROL, V135, P161, DOI 10.1007/s10546-009-9462-7; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FAO, 2007, GRIDD LIV WORLD 2007; Fritz S., 2013, T AM GEOPHYS UNION, V94, P31, DOI DOI 10.1002/2013E0030006; Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882; GILBERT M, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0133381; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Grace D., 2012, MAPPING POVERTY LIKE; Griguolo S, 1996, SDGCPINT578NET FAO; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Havlik P, 2014, P NATL ACAD SCI USA, V111, P3709, DOI 10.1073/pnas.1308044111; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Jones PG, 2009, ENVIRON SCI POLICY, V12, P427, DOI 10.1016/j.envsci.2008.08.006; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Linard C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-7; Mottet, 2013, TACKLING CLIMATE CHA; Nelson A., 2008, TRAVEL TIME MAJOR CI; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Prosser DJ, 2011, AGR ECOSYST ENVIRON, V141, P381, DOI 10.1016/j.agee.2011.04.002; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson T., 2011, Global livestock production systems; Robinson Timothy P, 2014, PLoS One, V9, pe96084, DOI 10.1371/journal.pone.0096084; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Tatem AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-8; Vaca RA, 2011, APPL VEG SCI, V14, P388, DOI 10.1111/j.1654-109X.2011.01132.x; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; Van Boeckel TP, 2011, AGR ECOSYST ENVIRON, V141, P373, DOI 10.1016/j.agee.2011.04.013; Wint W., 2007, GRIDDED LIVESTOCK WO; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9	39	36	38	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150424	10.1371/journal.pone.0150424	http://dx.doi.org/10.1371/journal.pone.0150424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977807	gold, Green Submitted, Green Published			2022-12-26	WOS:000372572800025
J	Verma, SK; Willetts, JL; Corns, HL; Marucci-Wellman, HR; Lombardi, DA; Courtney, TK				Verma, Santosh K.; Willetts, Joanna L.; Corns, Helen L.; Marucci-Wellman, Helen R.; Lombardi, David A.; Courtney, Theodore K.			Falls and Fall-Related Injuries among Community-Dwelling Adults in the United States	PLOS ONE			English	Article							OLDER-ADULTS; POSTURAL STABILITY; PHYSICAL-ACTIVITY; IMPACT FORCES; RISK-FACTORS; POPULATION; WOMEN; HOME; PREVENTION; YOUNG	Introduction Falls are the leading cause of unintentional injuries in the U.S.; however, national estimates for all community-dwelling adults are lacking. This study estimated the national incidence of falls and fall-related injuries among community-dwelling U.S. adults by age and gender and the trends in fall-related injuries across the adult life span. Methods Nationally representative data from the National Health Interview Survey (NHIS) 2008 Balance and Dizziness supplement was used to develop national estimates of falls, and pooled data from the NHIS was used to calculate estimates of fall-related injuries in the U.S. and related trends from 2004-2013. Costs of unintentional fall-related injuries were extracted from the CDC's Web-based Injury Statistics Query and Reporting System. Results Twelve percent of community-dwelling U.S. adults reported falling in the previous year for a total estimate of 80 million falls at a rate of 37.2 falls per 100 person-years. On average, 9.9 million fall-related injuries occurred each year with a rate of 4.38 fall-related injuries per 100 person-years. In the previous three months, 2.0% of older adults (65+), 1.1% of middle-aged adults (45-64) and 0.7% of young adults (18-44) reported a fall-related injury. Of all fall-related injuries among community-dwelling adults, 32.3% occurred among older adults, 35.3% among middle-aged adults and 32.3% among younger adults. The age-adjusted rate of fall-related injuries increased 4% per year among older women (95% CI 1%-7%) from 2004 to 2013. Among U.S. adults, the total lifetime cost of annual unintentional fall-related injuries that resulted in a fatality, hospitalization or treatment in an emergency department was 111 billion U.S. dollars in 2010. Conclusions Falls and fall-related injuries represent a significant health and safety problem for adults of all ages. The findings suggest that adult fall prevention efforts should consider the entire adult lifespan to ensure a greater public health benefit.	[Verma, Santosh K.; Willetts, Joanna L.; Corns, Helen L.; Marucci-Wellman, Helen R.; Lombardi, David A.; Courtney, Theodore K.] Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA USA; [Verma, Santosh K.] Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA; [Lombardi, David A.; Courtney, Theodore K.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA	Liberty Mutual Research Institute for Safety; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard T.H. Chan School of Public Health	Verma, SK (corresponding author), Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA USA.; Verma, SK (corresponding author), Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA.	Santosh.Verma@LibertyMutual.com	Courtney, Theodore K./P-4829-2019; Courtney, Theodore/J-8902-2013	Courtney, Theodore K./0000-0001-8139-1565; Courtney, Theodore/0000-0001-8139-1565; Verma, Santosh/0000-0001-9285-0325; Lombardi, David/0000-0001-6151-2024				Adams PE, 2010, VITAL HLTH STAT, V10, P1; Adams PE, 2012, VITAL HLTH STAT, V10, P2013; Andresen EM, 2006, GERONTOLOGIST, V46, P249, DOI 10.1093/geront/46.2.249; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Barrett-Connor E, 2009, OSTEOPOROSIS INT, V20, P715, DOI 10.1007/s00198-008-0748-2; Brault M., 2012, US CENSUS BUREAU CUR, V5; Brown MJ, 2011, PUBLIC HEALTH REP, V126, P131, DOI 10.1177/00333549111260S117; Caban-Martinez AJ, 2015, AM J PREV MED, V49, P888, DOI 10.1016/j.amepre.2015.05.022; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Carande-Kulis V, 2015, J SAFETY RES, V52, P65, DOI 10.1016/j.jsr.2014.12.007; Centers for Disease Control and Prevention, 2012, DAT STAT WISQARS COS; Centers for Disease Control and Prevention, 2014, FALLS OLD AD 2014; Centers for Disease Control and Prevention, 2010, 10 LEAD CAUS INJ DEA; Centers for Disease Control and Prevention National Center for Health Statistics, 2014, NAT HLTH INT SURV 20; Choy NL, 2003, J GERONTOL A-BIOL, V58, P525; Cigolle CT, 2015, JAMA INTERN MED, V175, P443, DOI 10.1001/jamainternmed.2014.7533; Cohen HH, 2016, APPL ERGON, V52, P112, DOI 10.1016/j.apergo.2015.07.002; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P57, DOI 10.4103/2229-5151.79283; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Gillespie L.D., 2012, COCHRANE DATABASE SY; Gorina Y, 2005, TRENDS CAUSES DEATH; Groen BE, 2007, J BIOMECH, V40, P458, DOI 10.1016/j.jbiomech.2005.12.014; Gustavsson J, 2015, INJURY PREV, V21, P320, DOI 10.1136/injuryprev-2014-041468; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hoidrup S, 2003, SCAND J PUBLIC HEALT, V31, P24, DOI 10.1080/14034940210134185; Howe TE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000333, 10.1002/14651858.CD000333.pub2]; Hu GQ, 2009, AM J PREV MED, V37, P188, DOI 10.1016/j.amepre.2009.04.023; Hu GQ, 2012, PUBLIC HEALTH REP, V127, P275, DOI 10.1177/003335491212700307; Institute for Health Metrics and Evaluation (IHME), 2013, GBD PROF US SEATTL; Isles RC, 2004, J AM GERIATR SOC, V52, P1367, DOI 10.1111/j.1532-5415.2004.52370.x; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kool B, 2012, INJURY PREV, V18, P200, DOI 10.1136/injuryprev-2011-040202; Kool B, 2010, NEW ZEAL MED J, V123, P75; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Liu Jian, 2015, Biomed Sci Instrum, V51, P189; Lombardi DA, 2010, CHRONOBIOL INT, V27, P1013, DOI 10.3109/07420528.2010.489466; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; Mertz KJ, 2010, AM J PREV MED, V39, P15, DOI 10.1016/j.amepre.2010.03.013; Murphy SL, 2013, NATL VITAL STAT REP, P61; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nemire K, 2016, APPL ERGON, V52, P309, DOI 10.1016/j.apergo.2015.07.021; Nitz JC, 2003, CLIN REHABIL, V17, P765, DOI 10.1191/0269215503cr675oa; Orces CH, 2014, INJURY PREV, V20, P421, DOI 10.1136/injuryprev-2014-041268; Orces Carlos H, 2008, Tex Med, V104, P55; Pai YC, 2007, PHYS THER, V87, P1478, DOI 10.2522/ptj.20060326; Parijat P, 2015, ANN BIOMED ENG, V43, P958, DOI 10.1007/s10439-014-1128-z; Porell FW, 2012, J AM GERIATR SOC, V60, P1498, DOI 10.1111/j.1532-5415.2012.04053.x; Santesso N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub5; Sihvonen S, 2004, AGING CLIN EXP RES, V16, P139; Smith GS, 2005, AM J PUBLIC HEALTH, V95, P1213, DOI 10.2105/AJPH.2004.049338; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Warner M, 2005, INJURY PREV, V11, P282, DOI 10.1136/ip.2004.006965; Warner M, 2000, Vital Health Stat 10, P1; Weerdesteyn V, 2008, J ELECTROMYOGR KINES, V18, P235, DOI 10.1016/j.jelekin.2007.06.010; Wells G., 2008, COCHRANE DATABASE SY, V1	60	146	151	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150939	10.1371/journal.pone.0150939	http://dx.doi.org/10.1371/journal.pone.0150939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977599	Green Submitted, Green Published, gold			2022-12-26	WOS:000372572800040
J	Wang, ZY; Zhou, QJ; Duan, HY; Wang, Y; Dong, MC; Shi, WY				Wang, Zhenyu; Zhou, Qingjun; Duan, Haoyun; Wang, Yao; Dong, Muchen; Shi, Weiyun			Immunological Properties of Corneal Epithelial-Like Cells Derived from Human Embryonic Stem Cells	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; NATURAL-KILLER-CELLS; OCULAR SURFACE; IN-VITRO; HLA-G; AMNIOTIC MEMBRANE; TRANSPLANTATION; DIFFERENTIATION; IMMUNE; RECONSTRUCTION	Transplantation of ex vivo expanded corneal limbal stem cells (LSCs) has been the main treatment for limbal stem cell deficiency, although the shortage of donor corneal tissues remains a major concern for its wide application. Due to the development of tissue engineering, embryonic stem cells (ESCs)-derived corneal epithelial-like cells (ESC-CECs) become a new direction for this issue. However, the immunogenicity of ESC-CECs is a critical matter to be solved. In the present study, we explored the immunological properties of ESC-CECs, which were differentiated from ESCs. The results showed that ESC-CECs had a similar character and function with LSCs both in vitro and in vivo. In ESC-CECs, a large number of genes related with immune response were down-regulated. The expressions of MHC-I, MHC-II, and co-stimulatory molecules were low, but the expression of HLA-G was high. The ESC-CECs were less responsible for T cell proliferation and NK cell lysis in vitro, and there was less immune cell infiltration after transplantation in vivo compared with LSCs. Moreover, the immunological properties were not affected by interferon-gamma All these results indicated a low immunogenicity of ESC-CECs, and they can be promising in clinical use.	[Wang, Zhenyu] Qingdao Univ, Qingdao 266071, Shandong, Peoples R China; [Wang, Zhenyu; Zhou, Qingjun; Duan, Haoyun; Wang, Yao; Dong, Muchen; Shi, Weiyun] Shandong Acad Med Sci, Shandong Prov Key Lab Ophthalmol, Shandong Eye Inst, Qingdao, Shandong, Peoples R China	Qingdao University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Shi, WY (corresponding author), Shandong Acad Med Sci, Shandong Prov Key Lab Ophthalmol, Shandong Eye Inst, Qingdao, Shandong, Peoples R China.	weiyunshi@163.com			State Basic Research Development Program of China (973 Program) [2013CB967004]	State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	The study was supported by the State Basic Research Development Program of China (973 Program, 2013CB967004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2007, STEM CELLS, V25, P1145, DOI 10.1634/stemcells.2006-0516; Apps R, 2008, TRENDS IMMUNOL, V29, P313, DOI 10.1016/j.it.2008.02.012; Boyd AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010965; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Brzeszczynska J, 2014, INT J MOL MED, V33, P1597, DOI 10.3892/ijmm.2014.1714; Buja LM, 2010, J AM COLL CARDIOL, V56, P1693, DOI 10.1016/j.jacc.2010.06.041; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Daniels JT, 2001, WOUND REPAIR REGEN, V9, P483, DOI 10.1046/j.1524-475x.2001.00483.x; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Grinnemo KH, 2006, REPROD BIOMED ONLINE, V13, P712, DOI 10.1016/S1472-6483(10)60663-3; Hanson C, 2013, ACTA OPHTHALMOL, V91, P127, DOI 10.1111/j.1755-3768.2011.02358.x; Hayashi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045435; Horuzsko A, 2001, INT IMMUNOL, V13, P385, DOI 10.1093/intimm/13.3.385; Ideguchi M, 2008, J NEUROSCI RES, V86, P1936, DOI 10.1002/jnr.21652; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Kanayama S, 2009, BRIT J OPHTHALMOL, V93, P263, DOI 10.1136/bjo.2008.141580; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Koch CA, 2008, STEM CELLS, V26, P89, DOI 10.1634/stemcells.2007-0151; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Li De-Quan, 2014, J Stem Cells, V9, P79; Ma DHK, 2006, PROG RETIN EYE RES, V25, P563, DOI 10.1016/j.preteyeres.2006.09.001; Mikhailova A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14684; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Opelz G, 2005, LANCET, V365, P1570, DOI 10.1016/S0140-6736(05)66458-6; Pan ZQ, 2002, CHINESE MED J-PEKING, V115, P767; Pauklin M, 2009, OPHTHALMOLOGY, V116, P1048, DOI 10.1016/j.ophtha.2009.01.005; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2014, STEM CELLS, V32, P26, DOI 10.1002/stem.1517; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Qi XL, 2014, AM J OPHTHALMOL, V158, P1192, DOI 10.1016/j.ajo.2014.08.019; Qi XL, 2013, OPHTHALMOLOGY, V120, P931, DOI 10.1016/j.ophtha.2012.11.001; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Roopenian D, 2002, IMMUNOL REV, V190, P86, DOI 10.1034/j.1600-065X.2002.19007.x; Tanaka K, 2001, INVEST OPHTH VIS SCI, V42, P2878; Tang C, 2011, SEMIN IMMUNOPATHOL, V33, P563, DOI 10.1007/s00281-011-0269-5; Toivonen S, 2013, STEM CELL TRANSL MED, V2, P83, DOI 10.5966/sctm.2012-0047; Tseng HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011590; Tseng SCG, 1996, MOL BIOL REP, V23, P47, DOI 10.1007/BF00357072; Wen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101841; Wylegala E, 2008, EUR J OPHTHALMOL, V18, P886, DOI 10.1177/112067210801800605; Yokoyama WM, 2008, NAT IMMUNOL, V9, P481, DOI 10.1038/ni1583; Zhou PY, 2015, J CELL SCI, V128, P2169, DOI 10.1242/jcs.169086; Zhu J, 2013, TISSUE ENG PT A, V19, P2412, DOI [10.1089/ten.tea.2013.0097, 10.1089/ten.TEA.2013.0097]	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150731	10.1371/journal.pone.0150731	http://dx.doi.org/10.1371/journal.pone.0150731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977925	Green Submitted, gold, Green Published			2022-12-26	WOS:000372572800034
J	Shih, TY; Wu, J; Shih, CT; Lee, YT; Wu, SH; Yao, CH; Hsieh, BT				Shih, Tian-Yu; Wu, Jay; Shih, Cheng-Ting; Lee, Yao-Ting; Wu, Shin-Hua; Yao, Chun-Hsu; Hsieh, Bor-Tsung			Small-Field Measurements of 3D Polymer Gel Dosimeters through Optical Computed Tomography	PLOS ONE			English	Article							RADIATION-DOSE DISTRIBUTIONS; NMR	With advances in therapeutic instruments and techniques, three-dimensional dose delivery has been widely used in radiotherapy. The verification of dose distribution in a small field becomes critical because of the obvious dose gradient within the field. The study investigates the dose distributions of various field sizes by using NIPAM polymer gel dosimeter. The dosimeter consists of 5% gelatin, 5% monomers, 3% cross linkers, and 5 mM THPC. After irradiation, a 24 to 96 hour delay was applied, and the gel dosimeters were read by a cone beam optical computed tomography (optical CT) scanner. The dose distributions measured by the NIPAM gel dosimeter were compared to the outputs of the treatment planning system using gamma evaluation. For the criteria of 3%/3 mm, the pass rates for 5 x 5, 3 x 3, 2 x 2, 1 x 1, and 0.5 x 0.5 cm(2) were as high as 91.7%, 90.7%, 88.2%, 74.8%, and 37.3%, respectively. For the criteria of 5%/5 mm, the gamma pass rates of the 5 x 5, 3 x 3, and 2 x 2 cm2 fields were over 99%. The NIPAM gel dosimeter provides high chemical stability. With cone-beam optical CT readouts, the NIPAM polymer gel dosimeter has potential for clinical dose verification of small-field irradiation.	[Shih, Tian-Yu; Yao, Chun-Hsu] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Shih, Tian-Yu; Lee, Yao-Ting; Hsieh, Bor-Tsung] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Shih, Tian-Yu; Wu, Shin-Hua] Cheng Ching Hosp Chung Kang, Dept Radiol, Taichung, Taiwan; [Wu, Jay] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Shih, Cheng-Ting] China Med Univ Hosp, Printing Med Res Ctr 3D, Taichung, Taiwan; [Yao, Chun-Hsu] China Med Univ, Coll Hlth Care, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Yao, Chun-Hsu] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; Central Taiwan University Science & Technology; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Yao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Hsieh, BT (corresponding author), Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.; Yao, CH (corresponding author), China Med Univ, Coll Hlth Care, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.; Yao, CH (corresponding author), Asia Univ, Dept Biomed Informat, Taichung, Taiwan.	chyao@mail.cmu.edu.tw; bthsieh@ctust.edu.tw	Shih, Cheng-Ting/Q-2842-2019	Shih, Cheng-Ting/0000-0002-8554-9136	Cheng Ching Hospital [CTU103-CCGH-001]; Central Taiwan University of Science and Technology [CTU103-CCGH-001]	Cheng Ching Hospital; Central Taiwan University of Science and Technology	The research fund comes from the collaborated project between Cheng Ching Hospital and Central Taiwan University of Science and Technology; Project No.: CTU103-CCGH-001.	Baxter P, 2007, MED PHYS, V34, P1934, DOI 10.1118/1.2732032; Chang KY, 2011, NUCL INSTRUM METH A, V652, P775, DOI 10.1016/j.nima.2010.09.099; Chang YJ, 2014, RADIAT PHYS CHEM, V104, P180, DOI 10.1016/j.radphyschem.2013.11.031; Chang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044905; Chang YJ, 2011, NUCL INSTRUM METH A, V652, P783, DOI 10.1016/j.nima.2010.09.097; Chiang CM, 2013, J RADIOANAL NUCL CH, V298, P1435, DOI 10.1007/s10967-013-2564-1; GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002; Gore JC, 1996, PHYS MED BIOL, V41, P2695, DOI 10.1088/0031-9155/41/12/009; Hassani H, 2014, MED DOSIM, V39, P102, DOI 10.1016/j.meddos.2013.10.007; Hsieh LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031836; Jirasek A, 2010, PHYS MED BIOL, V55, P5269, DOI 10.1088/0031-9155/55/18/002; Karlsson A, 2007, PHYS MED BIOL, V52, P4697, DOI 10.1088/0031-9155/52/15/021; Mesbahi A, 2012, REP PRACT ONCOL RADI, V17, P146, DOI 10.1016/j.rpor.2012.03.009; Olding T, 2011, J MED PHYS, V36, P3, DOI 10.4103/0971-6203.75466; Senden RJ, 2006, PHYS MED BIOL, V51, P3301, DOI 10.1088/0031-9155/51/14/001; Shih CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067281; Shih CT, 2013, IEEE T NUCL SCI, V60, P2155, DOI 10.1109/TNS.2013.2258038	17	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151300	10.1371/journal.pone.0151300	http://dx.doi.org/10.1371/journal.pone.0151300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974434	Green Published, gold			2022-12-26	WOS:000372570600066
J	Choi, YY; An, JY; Katai, H; Seto, Y; Fukagawa, T; Okumura, Y; Kim, DW; Kim, HI; Cheong, JH; Hyung, WJ; Noh, SH				Choi, Yoon Young; An, Ji Yeong; Katai, Hitoshi; Seto, Yasuyuki; Fukagawa, Takeo; Okumura, Yasuhiro; Kim, Dong Wook; Kim, Hyoung-Il; Cheong, Jae-Ho; Hyung, Woo Jin; Noh, Sung Hoon			A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; AMERICAN JOINT COMMITTEE; TNM CLASSIFICATION; 7TH EDITION; N RATIO; METASTASIS; JAPANESE; SURVIVAL	Although changing a lymph node staging system from an anatomically based system to a numerically based system in gastric cancer offers better prognostic performance, several problems can arise: it does not offer information on the anatomical extent of disease and cannot represent the extent of lymph node dissection. The purpose of this study was to discover an alternative lymph node staging system for gastric cancer. Data from 6025 patients who underwent gastrectomy for primary gastric cancer between January 2000 and December 2010 were reviewed. The lymph node groups were reclassified into lesser-curvature, greater-curvature, and extra-perigastric groups. Presence of any metastatic lymph node in one group was considered positive. Lymph node groups were further stratified into four (new N0-new N3) according to the number of positive lymph node groups. Survival outcomes with this new N staging were compared with those of the current TNM system. For validation, two centers in Japan (large center, n = 3443; medium center, n = 560) were invited. Even among the same pN stages, the more advanced new N stage showed worse prognosis, indicating that the anatomical extent of metastatic lymph nodes is important. The prognostic performance of the new staging system was as good as that of the current TNM system for overall advanced gastric cancer as well as lymph node-positive gastric cancer (Harrell C-index was 0.799, 0.726, and 0.703 in current TNM and 0.799, 0.727, and 0.703 in new TNM stage). Validation sets supported these outcomes. The new N staging system demonstrated prognostic performance equal to that of the current TNM system and could thus be used as an alternative.	[Choi, Yoon Young; An, Ji Yeong; Kim, Hyoung-Il; Cheong, Jae-Ho; Hyung, Woo Jin; Noh, Sung Hoon] Yonsei Univ, Coll Med, Dept Surg, Yonsei Univ Hlth Syst, Seoul, South Korea; [Noh, Sung Hoon] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Yonsei Univ Hlth Syst, Seoul, South Korea; [Kim, Dong Wook] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Yonsei Univ Hlth Syst, Seoul, South Korea; [Katai, Hitoshi; Fukagawa, Takeo] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan; [Seto, Yasuyuki; Okumura, Yasuhiro] Univ Tokyo, Dept Gastrointestinal Surg, Tokyo, Japan; [An, Ji Yeong] Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 06351, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Cancer Center - Japan; University of Tokyo; Sungkyunkwan University (SKKU); Samsung Medical Center	Noh, SH (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Yonsei Univ Hlth Syst, Seoul, South Korea.; Noh, SH (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Yonsei Univ Hlth Syst, Seoul, South Korea.	sunghoonn@yuhs.ac	Kim, Hyoungil/M-7288-2019	Kim, Hyoungil/0000-0002-6134-4523; Choi, Yoon Young/0000-0002-2179-7851; Noh, Sung Hoon/0000-0003-4386-6886; Cheong, Jae-Ho/0000-0002-1703-1781; Hyung, Woo Jin/0000-0002-8593-9214				Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Alatengbaolide, 2013, AM J CLIN ONCOL-CANC, V36, P325, DOI 10.1097/COC.0b013e318246b4e9; [Anonymous], 2010, AJCC CANC STAGING MA; [Anonymous], 1997, J CLIN PATHOL; Biondi A, 2011, J CLIN ONCOL, V29, P4338, DOI 10.1200/JCO.2011.36.9900; Cheong JH, 2006, ANN SURG ONCOL, V13, P377, DOI 10.1245/ASO.2006.04.018; Coburn NG, 2006, CANCER-AM CANCER SOC, V107, P2143, DOI 10.1002/cncr.22229; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujii K, 1999, BRIT J SURG, V86, P685, DOI 10.1046/j.1365-2168.1999.01115.x; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hayashi H, 2000, SURGERY, V127, P129, DOI 10.1067/msy.2000.102171; Ichikura T, 1999, CANCER-AM CANCER SOC, V86, P553, DOI 10.1002/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO;2-D; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; Jung KW, 2015, CANCER RES TREAT, V47, P142, DOI 10.4143/crt.2015.066; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim CY, 2009, ANN SURG ONCOL, V16, P1868, DOI 10.1245/s10434-009-0430-8; Kwee RM, 2009, GASTRIC CANCER, V12, P6, DOI 10.1007/s10120-008-0492-5; Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1; Memon MA, 2011, ANN SURG, V253, P900, DOI 10.1097/SLA.0b013e318212bff6; Nakagawa M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1940-3; Naylor GM, 2006, GUT, V55, P1545, DOI 10.1136/gut.2005.080358; Okines A, 2010, ANN ONCOL, V21, pv50, DOI 10.1093/annonc/mdq164; Reim D, 2013, J CLIN ONCOL, V31, P263, DOI 10.1200/JCO.2012.44.4315; ROBERTSON CS, 1994, ANN SURG, V220, P176, DOI 10.1097/00000658-199408000-00009; Sayegh Mazin E, 2004, Gastric Cancer, V7, P140; Seevaratnam R, 2012, GASTRIC CANCER, V15, pS3, DOI 10.1007/s10120-011-0069-6; Seevaratnam R, 2012, GASTRIC CANCER, V15, pS60, DOI 10.1007/s10120-011-0110-9; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Theuer CP, 2002, ARCH SURG-CHICAGO, V137, P960, DOI 10.1001/archsurg.137.8.960; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wittekind C, 2010, TNM CLASSIFICATION M; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yoon HM, 2012, J AM COLL SURGEONS, V214, P88, DOI 10.1016/j.jamcollsurg.2011.09.018; Yu W, 1997, BRIT J SURG, V84, P1305; Zhang JZ, 2013, ANN SURG, V257, P81, DOI 10.1097/SLA.0b013e31825eff3f	40	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149555	10.1371/journal.pone.0149555	http://dx.doi.org/10.1371/journal.pone.0149555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967161	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200004
J	Li, CX; Li, P; Tan, YM; Lam, SH; Chan, ECY; Gong, ZY				Li, Caixia; Li, Ping; Tan, Yee Min; Lam, Siew Hong; Chan, Eric C. Y.; Gong, Zhiyuan			Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; OXIDATIVE STRESS; METAL INTERACTIONS; DANIO-RERIO; EXPOSURE; DISEASE; CELLS; APOPTOSIS; BIOMARKER; RESPONSES	Arsenic is one of the most common metalloid contaminants in groundwater and it has both acute and chronic toxicity affecting multiple organs. Details of the mechanism of arsenic toxicity are still lacking and profile studies at metabolic level are very limited. Using gas chromatography coupled with mass spectroscopy (GC/MS), we first generated metabolomic profiles from the livers of arsenic-treated zebrafish and identified 34 significantly altered metabolite peaks as potential markers, including four prominent ones: cholic acid, glycylglycine, glycine and hypotaurine. Combined results from GC/MS, histological examination and pathway analyses suggested a series of alterations, including apoptosis, glycogenolysis, changes in amino acid metabolism and fatty acid composition, accumulation of bile acids and fats, and disturbance in glycolysis related energy metabolism. The alterations in glycolysis partially resemble Warburg effect commonly observed in many cancer cells. However, cellular damages were not reflected in two conventional liver function tests performed, Bilirubin assay and alanine aminotransferase (ALT) assay, probably because the short arsenate exposure was insufficient to induce detectable damage. This study demonstrated that metabolic changes could reflect mild liver impairments induced by arsenic exposure, which underscored their potential in reporting early liver injury.	[Li, Caixia; Li, Ping; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore; [Tan, Yee Min; Chan, Eric C. Y.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.; Gong, ZY (corresponding author), Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Chan, Eric Chun Yong/E-7101-2013; Gong, Zhiyuan/H-8794-2012; Lam, Siew Hong/H-8483-2012	Gong, Zhiyuan/0000-0002-9660-5260; Chan, Eric Chun Yong/0000-0001-6107-9072; Li, Caixia/0000-0003-2190-655X	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment & Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment & Water Industry Programme Office (EWI) of the PUB	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2000, LEUKEMIA LYMPHOMA, V37, P53, DOI 10.3109/10428190009057628; Allen T, 2004, BIOL TRACE ELEM RES, V98, P63, DOI 10.1385/BTER:98:1:63; Garcia-Sevillano MA, 2014, J PROTEOMICS, V104, P66, DOI 10.1016/j.jprot.2014.02.011; Aoki M, 2011, RAPID COMMUN MASS SP, V25, P1847, DOI 10.1002/rcm.5072; Banerjee N, 2008, TOXICOLOGY, V246, P101, DOI 10.1016/j.tox.2007.12.029; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166; Bears H, 2006, AQUAT TOXICOL, V77, P257, DOI 10.1016/j.aquatox.2005.12.008; Bolt HM, 2012, ARCH TOXICOL, V86, P825, DOI 10.1007/s00204-012-0866-7; Carlson P, 2014, AQUAT TOXICOL, V153, P66, DOI 10.1016/j.aquatox.2013.10.006; Chakraborti D., 2011, ENCY ENV HLTH, P165; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Correia Nuno, 2009, Cases J, V2, P7768, DOI 10.4076/1757-1626-2-7768; Das N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-639; de Wit NJW, 2012, J HEPATOL, V57, P1370, DOI 10.1016/j.jhep.2012.07.003; Dudka I, 2014, ENVIRON INT, V68, P71, DOI 10.1016/j.envint.2014.03.015; Garcia-Sevillano MA, 2013, METALLOMICS, V5, P1644, DOI 10.1039/c3mt00186e; Garcia-Sevillano MA, 2013, BIOMETALS, V26, P651, DOI 10.1007/s10534-013-9642-2; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Guha Mazumder D N, 2001, J Indian Med Assoc, V99, P314; Guha Mazumder DN., 2001, J INDIAN MED ASSOC, V99, P8; Guha Mazumder DN., 2001, J INDIAN MED ASSOC, V99, P4; Hamdi M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-104; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Islam K, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-64; Kharroubi W, 2014, ENVIRON SCI POLLUT R, V21, P1648, DOI 10.1007/s11356-013-2057-3; Kim JH, 2015, ENVIRON TOXICOL PHAR, V39, P668, DOI 10.1016/j.etap.2015.01.012; Koppenol WH, 2011, NAT REV CANCER, V11, P618, DOI 10.1038/nrc3108; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Lage CR, 2006, INTEGR COMP BIOL, V46, P1040, DOI 10.1093/icb/icl048; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lee JJ, 2004, J KOREAN MED SCI, V19, P127, DOI 10.3346/jkms.2004.19.1.127; Lee J, 2012, ANAL SCI, V28, P801, DOI 10.2116/analsci.28.801; Lefkowitch JH, 2006, ZAKIM BOYERS HEPATOL, P205; Levitt DG, 2014, CLIN EXP GASTROENTER, V7, P307, DOI 10.2147/CEG.S64283; Li D, 2009, AQUAT TOXICOL, V91, P229, DOI 10.1016/j.aquatox.2008.11.007; Li YY, 2013, BIOCHEM PHARMACOL, V86, P1517, DOI 10.1016/j.bcp.2013.08.015; Li Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132319; Liu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083954; Liu ZT, 2014, INT J MED SCI, V11, P925, DOI 10.7150/ijms.8951; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; Ma Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16093; Marchiset-Ferlay N, 2012, ENVIRON INT, V39, P150, DOI 10.1016/j.envint.2011.07.015; Mattingly CJ, 2009, ENVIRON HEALTH PERSP, V117, P981, DOI 10.1289/ehp.0900555; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; McCollum CW, 2014, AQUAT TOXICOL, V152, P152, DOI 10.1016/j.aquatox.2014.04.006; McIntyre D. O., 2011, FISH PHYSIOL, V31, P297; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Mikawa T, 2015, CELL MOL LIFE SCI, V72, P1881, DOI 10.1007/s00018-015-1840-3; Moore LE, 2013, ENVIRON MOL MUTAGEN, V54, P589, DOI 10.1002/em.21792; Nagato EG, 2013, CHEMOSPHERE, V93, P331, DOI 10.1016/j.chemosphere.2013.04.085; Nain S, 2012, ENVIRON TOXICOL, V27, P244, DOI 10.1002/tox.20635; Nayak AS, 2007, TOXICOL SCI, V98, P118, DOI 10.1093/toxsci/kfm072; Nemeti B, 2007, TOXICOL SCI, V100, P36, DOI 10.1093/toxsci/kfm211; PATEL DK, 1990, HUM EXP TOXICOL, V9, P389, DOI 10.1177/096032719000900606; Patel HV, 2013, J ENVIRON BIOL, V34, P231; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; REICHL FX, 1988, ARCH TOXICOL, V62, P473, DOI 10.1007/BF00288353; Shi X, 2014, J PROTEOME RES, V13, P547, DOI 10.1021/pr400719u; Sjovall J, 2010, STEROID ANALYSIS: SECOND EDITION, P837, DOI 10.1023/b135931_10; Stegeman JJ, 2010, FISH PHYSIOL, V29, P367, DOI 10.1016/S1546-5098(10)02910-9; Torres DM, 2010, GI LIVER SECRETS, P201; Vaitheesvaran B, 2015, METABOLOMICS, V11, P787, DOI 10.1007/s11306-014-0760-9; Vutukuru Sesha Srinivas, 2007, Int J Environ Res Public Health, V4, P224, DOI 10.3390/ijerph2007030005; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wang Y, 2011, EXP THER MED, V2, P481, DOI 10.3892/etm.2011.224; Wang YM, 2014, MOL PHARMACOL, V86, P62, DOI 10.1124/mol.113.091462; Watanabe T, 2013, ARCH TOXICOL, V87, P969, DOI 10.1007/s00204-012-0904-5; Wei L, 2009, TOXICOL APPL PHARM, V234, P314, DOI 10.1016/j.taap.2008.11.010; Woo SH, 2002, INT J ONCOL, V21, P57; Wu HF, 2013, AQUAT TOXICOL, V136, P91, DOI 10.1016/j.aquatox.2013.03.020; Xu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068737; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Yoshimura Y, 2011, J OCCUP HEALTH, V53, P45, DOI 10.1539/joh.L10108; Zhao F, 2013, TOXICOL APPL PHARM, V271, P72, DOI 10.1016/j.taap.2013.04.020	76	32	36	9	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151225	10.1371/journal.pone.0151225	http://dx.doi.org/10.1371/journal.pone.0151225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967897	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200036
J	Sabet, JA; Park, LK; Iyer, LK; Tai, AK; Koh, GY; Pfalzer, AC; Parnell, LD; Mason, JB; Liu, ZH; Byun, AJ; Crott, JW				Sabet, Julia A.; Park, Lara K.; Iyer, Lakshmanan K.; Tai, Albert K.; Koh, Gar Yee; Pfalzer, Anna C.; Parnell, Laurence D.; Mason, Joel B.; Liu, Zhenhua; Byun, Alexander J.; Crott, Jimmy W.			Paternal B Vitamin Intake Is a Determinant of Growth, Hepatic Lipid Metabolism and Intestinal Tumor Volume in Female Apc(1638N) Mouse Offspring	PLOS ONE			English	Article							MATERNAL METHYL SUPPLEMENTS; HIGH-FAT DIET; DNA METHYLATION; GENE-EXPRESSION; FOLIC-ACID; RNA; FOLATE; EPIGENETICS; PREGNANCY; OBESITY	Background The importance of maternal nutrition to offspring health and risk of disease is well established. Emerging evidence suggests paternal diet may affect offspring health as well. Objective In the current study we sought to determine whether modulating pre-conception paternal B vitamin intake alters intestinal tumor formation in offspring. Additionally, we sought to identify potential mechanisms for the observed weight differential among offspring by profiling hepatic gene expression and lipid content. Methods Male Apc(1638N) mice (prone to intestinal tumor formation) were fed diets containing replete (control, CTRL), mildly deficient (DEF), or supplemental (SUPP) quantities of vitamins B-2, B-6, B-12, and folate for 8 weeks before mating with control-fed wild type females. Wild type offspring were euthanized at weaning and hepatic gene expression profiled. Apc(1638N) offspring were fed a replete diet and euthanized at 28 weeks of age to assess tumor burden. Results No differences in intestinal tumor incidence or burden were found between male Apc(1638N) offspring of different paternal diet groups. Although in female Apc(1638N) offspring there were no differences in tumor incidence or multiplicity, a stepwise increase in tumor volume with increasing paternal B vitamin intake was observed. Interestingly, female offspring of SUPP and DEF fathers had a significantly lower body weight than those of CTRL fed fathers. Moreover, hepatic trigylcerides and cholesterol were elevated 3-fold in adult female offspring of SUPP fathers. Weanling offspring of the same fathers displayed altered expression of several key lipid-metabolism genes. Hundreds of differentially methylated regions were identified in the paternal sperm in response to DEF and SUPP diets. Aside from a few genes including Igf2, there was a striking lack of overlap between these genes differentially methylated in sperm and differentially expressed in offspring. Conclusions In this animal model, modulation of paternal B vitamin intake prior to mating alters offspring weight gain, lipid metabolism and tumor growth in a sex-specific fashion. These results highlight the need to better define how paternal nutrition affects the health of offspring.	[Sabet, Julia A.; Park, Lara K.; Koh, Gar Yee; Pfalzer, Anna C.; Parnell, Laurence D.; Mason, Joel B.; Liu, Zhenhua; Byun, Alexander J.; Crott, Jimmy W.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Sabet, Julia A.; Park, Lara K.; Pfalzer, Anna C.; Mason, Joel B.; Crott, Jimmy W.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Iyer, Lakshmanan K.] Tufts Univ, Sch Med, Tufts Ctr Neurosci Res, Neurosci Dept, Boston, MA 02111 USA; [Iyer, Lakshmanan K.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Tai, Albert K.] Tufts Univ, Sch Med, Tufts Univ Core Facil, Boston, MA 02111 USA; [Liu, Zhenhua] UMass Amherst, Sch Publ Hlth & Hlth Sci, Amherst, MA USA	Tufts University; United States Department of Agriculture (USDA); Tufts University; Tufts University; Tufts Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Crott, JW (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.; Crott, JW (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	jimmy.crott@tufts.edu	Sabet, Julia/AAE-1225-2021	Koh, Gar Yee/0000-0002-2783-1723	NCI (National Cancer Institute) [1 R03CA162505-1]; USDA-ARS [58-1950-0-014, 58-1950-4-003]; NATIONAL CANCER INSTITUTE [R03CA162505] Funding Source: NIH RePORTER	NCI (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by NCI (National Cancer Institute) 1 R03CA162505-1 and USDA-ARS #58-1950-0-014 and ##58-1950-4-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RJ, 1998, DIGEST DIS SCI, V43, P2652, DOI 10.1023/A:1026699126899; Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Bailey RL, 2010, AM J CLIN NUTR, V91, P231, DOI 10.3945/ajcn.2009.28427; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; CAMP VM, 1983, CLIN CHEM, V29, P642; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cerrato F, 2003, HUM MOL GENET, V12, P3123, DOI 10.1093/hmg/ddg338; Ciappio ED, 2011, GUT, V60, P1695, DOI 10.1136/gut.2011.240291; Cooney CA, 2002, J NUTR, V132, p2393S; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dolinoy DC, 2007, PEDIATR RES, V61, p30R, DOI 10.1203/pdr.0b013e31804575f7; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Ehara T, 2012, DIABETES, V61, P2442, DOI 10.2337/db11-1834; [范林峰 Fan Linfeng], 2012, [地理与地理信息科学, Geography and Geo-information Science], V28, P28; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gong Y, 2014, EUR REV MED PHARMACO, V18, P2808; Haggarty P, 2013, AM J CLIN NUTR, V97, P94, DOI 10.3945/ajcn.112.042572; Huffman DM, 2013, CANCER PREV RES, V6, P177, DOI 10.1158/1940-6207.CAPR-12-0414; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kim HW, 2013, MOL NUTR FOOD RES, V57, P671, DOI 10.1002/mnfr.201200558; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Levene AP, 2012, HISTOPATHOLOGY, V60, P971, DOI 10.1111/j.1365-2559.2012.04193.x; Levin BE, 2009, INT J OBESITY, V33, pS53, DOI 10.1038/ijo.2009.18; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu L, 2009, J AM ASSOC LAB ANIM, V48, P39; Liu ZH, 2007, J NUTR, V137, P2701, DOI 10.1093/jn/137.12.2701; Liu ZH, 2011, FASEB J, V25, P3136, DOI 10.1096/fj.11-184143; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Metayer C, 2014, EPIDEMIOLOGY, V25, P811, DOI 10.1097/EDE.0000000000000141; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; NICHOALDS GE, 1974, CLIN CHEM, V20, P624; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Rand E, 2003, J CELL BIOCHEM, V88, P400, DOI 10.1002/jcb.10352; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Sable PS, 2012, NEUROSCIENCE, V217, P46, DOI 10.1016/j.neuroscience.2012.05.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi LJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-59; Sie K, 2008, AM ASS CANC RES ANN; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Targher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949	57	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151579	10.1371/journal.pone.0151579	http://dx.doi.org/10.1371/journal.pone.0151579			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968002	Green Submitted, gold, Green Published			2022-12-26	WOS:000371989200064
J	Vila-Casadesus, M; Gironella, M; Lozano, JJ				Vila-Casadesus, Maria; Gironella, Meritxell; Jose Lozano, Juan			MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers	PLOS ONE			English	Article							MICRORNA TARGETS; PREDICTION; IDENTIFICATION; BIOCONDUCTOR; DISEASE; GENES; TOOLS	MicroRNAs (miRNAs) are small RNAs that regulate the expression of target mRNAs by specific binding on the mRNA 3'UTR and promoting mRNA degradation in the majority of cases. It is often of interest to know the specific targets of a miRNA in order to study them in a particular disease context. In that sense, some databases have been designed to predict potential miRNA-mRNA interactions based on hybridization sequences. However, one of the main limitations is that these databases have too many false positives and do not take into account disease-specific interactions. We have developed an R package (miRComb) able to combine miRNA and mRNA expression data with hybridization information, in order to find potential miRNA-mRNA targets that are more reliable to occur in a specific physiological or disease context. This article summarizes the pipeline and the main outputs of this package by using as example TCGA data from five gastrointestinal cancers (colon cancer, rectal cancer, liver cancer, stomach cancer and esophageal cancer). The obtained results can be used to develop a huge number of testable hypotheses by other authors. Globally, we show that the miRComb package is a useful tool to deal with miRNA and mRNA expression data, that helps to filter the high amount of miRNA-mRNA interactions obtained from the pre-existing miRNA target prediction databases and it presents the results in a standardised way (pdf report). Moreover, an integrative analysis of the miRComb miRNA-mRNA interactions from the five digestive cancers is presented. Therefore, miRComb is a very useful tool to start understanding miRNA gene regulation in a specific context. The package can be downloaded in http://mircomb.sourceforge.net.	[Vila-Casadesus, Maria; Jose Lozano, Juan] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Bioinformat Platform, Barcelona, Catalonia, Spain; [Vila-Casadesus, Maria; Gironella, Meritxell; Jose Lozano, Juan] Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer IDIBAP, Gastrointestinal & Pancreat Oncol Grp, Barcelona, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Lozano, JJ (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Bioinformat Platform, Barcelona, Catalonia, Spain.; Gironella, M; Lozano, JJ (corresponding author), Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer IDIBAP, Gastrointestinal & Pancreat Oncol Grp, Barcelona, Catalonia, Spain.	meritxell.gironella@ciberehd.org; juanjo.lozano@ciberehd.org	Vila Casadesús, Maria/J-8207-2016	Vila Casadesús, Maria/0000-0001-6597-7953; Gironella, Meritxell/0000-0003-4437-5181; Lozano, Juan Jose/0000-0001-7613-3908	Instituto de Salud Carlos III (FEDER-European Union) [PI13/02192]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer [GCB13131592CAST]; Instituto de Salud Carlos III; Ministerio de Educacion Cultura y Deporte [FPU12/05138]	Instituto de Salud Carlos III (FEDER-European Union); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Educacion Cultura y Deporte(Spanish Government)	The present work was supported by grants from Instituto de Salud Carlos III (PI13/02192; co-funded by FEDER-European Union) and from Fundacion Cientifica de la Asociacion Espanola contra el Cancer (GCB13131592CAST) to MG. CIBEREHD is funded by the Instituto de Salud Carlos III. MVC is funded by Ministerio de Educacion Cultura y Deporte (FPU12/05138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gade S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-488; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023; R Core Team, 2013, R LANG ENV STAT COMP; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ru YB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku631; Schroder MS, 2013, BIOINFORMATICS, V29, P666, DOI 10.1093/bioinformatics/bts708; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303	23	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151127	10.1371/journal.pone.0151127	http://dx.doi.org/10.1371/journal.pone.0151127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967326	Green Submitted, Green Published, gold			2022-12-26	WOS:000371989200032
J	Ioannou, MS; Girard, M; McPherson, PS				Ioannou, Maria S.; Girard, Martine; McPherson, Peter S.			Rab13 Traffics on Vesicles Independent of Prenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP DISSOCIATION INHIBITOR; SMALL GTPASE RAB13; C-TERMINAL DOMAIN; MEMBRANE COMPARTMENTS; NEURITE OUTGROWTH; EPITHELIAL-CELLS; PROTEIN; PATHWAY; RAB35; TRANSFERRIN	Rab GTPases are critical regulators of membrane trafficking. The canonical view is that Rabs are soluble in their inactive GDP-bound form, and only upon activation and conversion to their GTP-bound state are they anchored to membranes through membrane insertion of a C-terminal prenyl group. Here we demonstrate that C-terminal prenylation is not required for Rab13 to associate with and traffic on vesicles. Instead, inactive Rab13 appears to associate with vesicles via protein-protein interactions. Only following activation does Rab13 associate with the plasma membrane, presumably with insertion of the C-terminal prenyl group into the membrane.	[Ioannou, Maria S.; Girard, Martine; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca			Canadian Institutes of Health Research [MOP-62684]; Jeanne Timmins Costello fellowship; Anne and Richard Sievers Award in Neuroscience	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Jeanne Timmins Costello fellowship; Anne and Richard Sievers Award in Neuroscience	This work was supported by Canadian Institutes of Health Research Grant MOP-62684 (to P. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Jeanne Timmins Costello fellowship and an Anne and Richard Sievers Award in Neuroscience.	Abou-Zeid N, 2011, MOL BIOL CELL, V22, P3431, DOI 10.1091/mbc.E11-01-0030; Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Cherry S, 2013, ELIFE, V2, DOI 10.7554/eLife.01064; Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Ioannou MS, 2015, J CELL BIOL, V208, P629, DOI 10.1083/jcb.201407068; JOBERTY G, 1993, FEBS LETT, V330, P323, DOI 10.1016/0014-5793(93)80897-4; Kohler K, 2004, J CELL BIOL, V165, P175, DOI 10.1083/jcb.200312118; Kumari R, 2011, METHODS MOL BIOL, V746, P411, DOI 10.1007/978-1-61779-126-0_24; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Li F, 2014, P NATL ACAD SCI USA, V111, P2572, DOI 10.1073/pnas.1313655111; Marat AL, 2012, MOL BIOL CELL, V23, P163, DOI 10.1091/mbc.E11-05-0474; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Marzesco AM, 1998, J BIOL CHEM, V273, P22340, DOI 10.1074/jbc.273.35.22340; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Militello RD, 2013, TRAFFIC, V14, P502, DOI 10.1111/tra.12057; Mochizuki Y, 2013, J BIOL CHEM, V288, P1009, DOI 10.1074/jbc.M112.395087; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; Savina A, 2002, J CELL SCI, V115, P2505; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wu CS, 2011, J BIOL CHEM, V286, P23511, DOI 10.1074/jbc.M111.245209; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yang PS, 2011, CANCER SCI, V102, P2172, DOI 10.1111/j.1349-7006.2011.02089.x	47	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10726	10735		10.1074/jbc.M116.722298	http://dx.doi.org/10.1074/jbc.M116.722298			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26969162	Green Published, hybrid			2022-12-26	WOS:000377042600024
J	Cunningham, KE; Vincent, G; Sodhi, CP; Novak, EA; Ranganathan, S; Egan, CE; Stolz, DB; Rogers, MB; Firek, B; Morowitz, MJ; Gittes, GK; Zuckerbraun, BS; Hackam, DJ; Mollen, KP				Cunningham, Kellie E.; Vincent, Garret; Sodhi, Chhinder P.; Novak, Elizabeth A.; Ranganathan, Sarangarajan; Egan, Charlotte E.; Stolz, Donna Beer; Rogers, Matthew B.; Firek, Brian; Morowitz, Michael J.; Gittes, George K.; Zuckerbraun, Brian S.; Hackam, David J.; Mollen, Kevin P.			Peroxisome Proliferator-activated Receptor-gamma Coactivator 1-alpha (PGC1 alpha) Protects against Experimental Murine Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; EPITHELIAL BARRIER FUNCTION; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; MITOCHONDRIAL BIOGENESIS; OXIDATIVE STRESS; SKELETAL-MUSCLE; CROHNS-DISEASE; INTESTINAL INFLAMMATION; METABOLIC REGULATOR	Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PG CM) is the primary regulator of mitochondrial biogenesis and was recently found to be highly expressed within the intestinal epithelium. PGC1 alpha is decreased in the intestinal epithelium of patients with inflammatory bowel disease, but its role in pathogenesis is uncertain. We now hypothesize that PGC1 alpha protects against the development of colitis and helps to maintain the integrity of the intestinal barrier. We selectively deleted PGC1 alpha from the intestinal epithelium of mice by breeding a PGC1 alpha(loxP/loxP) mouse with a villin-cre mouse. Their progeny (pGC1 alpha(Delta IEC) mice) were subjected to 2% dextran sodium sulfate (DSS) colitis for 7 days. The SIRT1 agonist SRT1720 was used to enhance PGC1 alpha activation in wild-type mice during DSS exposure. Mice lacking PGC1 alpha within the intestinal epithelium were more susceptible to DSS colitis than their wild-type littermates. Pharmacologic activation of PGC1 alpha successfully ameliorated disease and restored mitochondrial integrity. These findings suggest that a depletion of PGC1 alpha in the intestinal epithelium contributes to inflammatory changes through a failure of mitochondrial structure and function as well as a breakdown of the intestinal barrier, which leads to increased bacterial translocation. PGC1 alpha induction helps to maintain mitochondrial integrity, enhance intestinal barrier function, and decrease inflammation.	[Vincent, Garret; Novak, Elizabeth A.; Egan, Charlotte E.; Rogers, Matthew B.; Firek, Brian; Morowitz, Michael J.; Gittes, George K.; Mollen, Kevin P.] UPMC, Div Pediat Surg, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Cunningham, Kellie E.; Vincent, Garret; Novak, Elizabeth A.; Egan, Charlotte E.; Rogers, Matthew B.; Firek, Brian; Morowitz, Michael J.; Gittes, George K.; Zuckerbraun, Brian S.; Mollen, Kevin P.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA; [Sodhi, Chhinder P.; Hackam, David J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA; [Ranganathan, Sarangarajan] UPMC, Dept Pathol, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Stolz, Donna Beer] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mollen, KP (corresponding author), UPMC, Childrens Hosp Pittsburgh, 4401 Penn Ave,Fac Pavil Ste 7000, Pittsburgh, PA 15224 USA.	kevin.mollen@chp.edu		Mollen, Kevin/0000-0001-7629-2722; Ranganathan, Sarangarajan/0000-0001-6214-9167; Hackam, David/0000-0001-5195-8807	National Institutes of Health [DK101753, GM078238, DK083752]; Association for Academic Surgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752, P30DK057521, K08DK101753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association for Academic Surgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK101753 (to K. P. M.), GM078238 (to D. J. H.), and DK083752 (to D. J. H.) and the Association for Academic Surgery (to K. P. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Aquilano K, 2013, CURR MOL MED, V13, P140, DOI 10.2174/156652413804486241; Bar F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015; Baldelli S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.458; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2015, J BIOL CHEM, V290, P20580, DOI 10.1074/jbc.M115.653584; D'Errico I, 2011, P NATL ACAD SCI USA, V108, P6603, DOI 10.1073/pnas.1016354108; Damiani C. R., 2007, J GASTROEN HEPATOL, V22, P1846; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Glover LE, 2013, P NATL ACAD SCI USA, V110, P19820, DOI 10.1073/pnas.1302840110; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Isman CA, 2003, J ENDOCRINOL, V177, P471, DOI 10.1677/joe.0.1770471; Jian BX, 2012, MOL MED, V18, P209, DOI 10.2119/molmed.2011.00365; KAMEYAMA J, 1984, TOHOKU J EXP MED, V143, P253, DOI 10.1620/tjem.143.253; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; Lewis K, 2009, ANN NY ACAD SCI, V1165, P327, DOI 10.1111/j.1749-6632.2009.04036.x; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu D, 2014, INT J BIOCHEM CELL B, V57, P7, DOI 10.1016/j.biocel.2014.09.018; Long MD, 2014, INFLAMM BOWEL DIS, V20, P398, DOI 10.1097/01.MIB.0000435441.30107.8b; Ma CX, 2006, CELL MICROBIOL, V8, P1669, DOI 10.1111/j.1462-5822.2006.00741.x; Mehlem A., 2016, DIABETES, V2016; Merga Y, 2014, DIGEST DIS, V32, P475, DOI 10.1159/000358156; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Nazli A, 2004, AM J PATHOL, V164, P947, DOI 10.1016/S0002-9440(10)63182-3; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Novak EA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00062; Oku T, 2006, INFLAMM BOWEL DIS, V12, P630, DOI 10.1097/01.MIB.0000225335.68614.73; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pallas M, 2009, CURR NEUROVASC RES, V6, P70, DOI 10.2174/156720209787466019; Pavlick KP, 2002, FREE RADICAL BIO MED, V33, P311, DOI 10.1016/S0891-5849(02)00853-5; Rodenburg W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-144; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROEDIGER WEW, 1980, LANCET, V2, P712; Santhanam S, 2012, INFLAMM BOWEL DIS, V18, P2158, DOI 10.1002/ibd.22926; Schurmann G, 1999, INT J COLORECTAL DIS, V14, P41, DOI 10.1007/s003840050181; Segui J, 2004, J LEUKOCYTE BIOL, V76, P537, DOI 10.1189/jlb.0304196; Shikhare G, 2010, J GASTROENTEROL, V45, P673, DOI 10.1007/s00535-010-0241-5; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sifroni KG, 2010, MOL CELL BIOCHEM, V342, P111, DOI 10.1007/s11010-010-0474-x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628; Ussakli CH, 2013, JNCI-J NATL CANCER I, V105, P1239, DOI 10.1093/jnci/djt167; Wang A, 2014, AM J PATHOL, V184, P2516, DOI 10.1016/j.ajpath.2014.05.019; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhu H, 2012, EXP BIOL MED, V237, P474, DOI 10.1258/ebm.2011.011358	73	43	43	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10184	10200		10.1074/jbc.M115.688812	http://dx.doi.org/10.1074/jbc.M115.688812			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26969166	Green Published, hybrid			2022-12-26	WOS:000375602800028
J	Kim-Muller, JY; Kim, YJR; Fan, JS; Zhao, SG; Banks, AS; Prentki, M; Accili, D				Kim-Muller, Ja Young; Kim, Young Jung R.; Fan, Jason; Zhao, Shangang; Banks, Alexander S.; Prentki, Marc; Accili, Domenico			FoxO1 Deacetylation Decreases Fatty Acid Oxidation in beta-Cells and Sustains Insulin Secretion in Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD PROTEIN FOXO1; TRANSCRIPTION FACTORS; REGULATES FOXO1; GLUCOSE; MICE; METABOLISM; RECEPTOR; FAILURE; MASS; DIFFERENTIATION	Pancreatic beta-cell dysfunction contributes to onset and progression of type 2 diabetes. In this state beta-cells become metabolically inflexible, losing the ability to select between carbohydrates and lipids as substrates for mitochondrial oxidation. These changes lead to beta-cell dedifferentiation. We have proposed that FoxO proteins are activated through deacetylation-dependent nuclear translocation to forestall the progression of these abnormalities. However, how deacetylated FoxO exert their actions remains unclear. To address this question, we analyzed islet function in mice homozygous for knock-in alleles encoding deacetylated FoxO1 (6KR). Islets expressing 6KR mutant FoxO1 have enhanced insulin secretion in vivo and ex vivo and decreased fatty acid oxidation ex vivo. Remarkably, the gene expression signature associated with FoxO1 deacetylation differs from wild type by only similar to 2% of the > 4000 genes regulated in response to re-feeding. But this narrow swath includes key genes required for beta-cell identity, lipid metabolism, and mitochondrial fatty acid and solute transport. The data support the notion that deacetylated FoxO1 protects beta-cell function by limiting mitochondrial lipid utilization and raise the possibility that inhibition of fatty acid oxidation in beta-cells is beneficial to diabetes treatment.	[Kim-Muller, Ja Young; Kim, Young Jung R.; Fan, Jason; Accili, Domenico] Columbia Univ, Naomi Berrie Diabet Ctr, Dept Med, New York, NY 10032 USA; [Kim-Muller, Ja Young] Merck Res Labs, Boston, MA USA; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Mol Nutr Unit, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Montreal Diabet Res Ctr, CRCHUM, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Dept Biochem, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Prentki, Marc] Univ Montreal, Dept Mol Med, Montreal, PQ H2X 0A9, Canada; [Banks, Alexander S.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Columbia University; Merck & Company; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Harvard University; Brigham & Women's Hospital	Accili, D (corresponding author), Dept Med, 1150 St Nicholas Ave,Room238, New York, NY 10032 USA.; Accili, D (corresponding author), Naomi Berrie Diabet Ctr, 1150 St Nicholas Ave,Room238, New York, NY 10032 USA.	da230@columbia.edu	ZHao, Shangang/H-5730-2019; Kim, Youngjung/F-6176-2017; Banks, Alexander/B-4832-2012	Zhao, Shangang/0000-0002-9209-8206; Fan, Jason/0000-0003-3481-1728; Kim, Youngjung/0000-0002-6345-1138; Banks, Alexander/0000-0003-1787-6925	National Institutes Grants [DK057539, DK64819, DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, R01DK058282, P30DK063608, P30DK026687, R01DK064819] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	National Institutes Grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes Grants DK057539, DK64819, and DK63608 (to the Columbia University Diabetes Research Center). The authors declare that they have no conflict of interest that relates to this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Brun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082364; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Chu RY, 2004, MOL CELL BIOL, V24, P6288, DOI 10.1128/MCB.24.14.6288-6297.2004; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Gosmain Y, 2011, DIABETES OBES METAB, V13, P31, DOI 10.1111/j.1463-1326.2011.01445.x; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Pajvani UB, 2015, DIABETOLOGIA, V58, P2459, DOI 10.1007/s00125-015-3722-5; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Qiang L, 2012, J BIOL CHEM, V287, P13944, DOI 10.1074/jbc.M111.332767; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Ren P, 2015, J PATHOL, V235, P90, DOI 10.1002/path.4429; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Soni MS, 2014, DIABETES, V63, P3805, DOI 10.2337/db13-1677; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talchai SC, 2015, DIABETES, V64, P2868, DOI 10.2337/db14-1696; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790	39	30	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10162	10172		10.1074/jbc.M115.705608	http://dx.doi.org/10.1074/jbc.M115.705608			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26984405	Green Published, hybrid			2022-12-26	WOS:000375602800026
J	Aziz, MH; Fakhar-e-Alam, M; Fatima, M; Shaheen, F; Iqbal, S; Atif, M; Talha, M; Ali, SM; Afzal, M; Majid, A; Al Harbi, TS; Ismail, M; Wang, ZMM; AlSalhi, MS; Alahmed, ZA				Aziz, Muhammad Hammad; Fakhar-e-Alam, M.; Fatima, Mahvish; Shaheen, Fozia; Iqbal, Seemab; Atif, M.; Talha, Muhammad; Ali, Syed Mansoor; Afzal, Muhammad; Majid, Abdul; Al Harbi, Thamir Shelih; Ismail, Muhammad; Wang, Zhiming M.; AlSalhi, M. S.; Alahmed, Z. A.			Photodynamic Effect of Ni Nanotubes on an HeLa Cell Line	PLOS ONE			English	Article							OXIDATIVE STRESS; NANOPARTICLES	Nickel nanomaterials are promising in the biomedical field, especially in cancer diagnostics and targeted therapy, due to their distinctive chemical and physical properties. In this experiment, the toxicity of nickel nanotubes (Ni NTs) were tested in an in vitro cervical cancer model (HeLa cell line) to optimize the parameters of photodynamic therapy (PDT) for their greatest effectiveness. Ni NTs were synthesized by electrodeposition. Morphological analysis and magnetic behavior were examined using a Scanning electron microscope (SEM), an energy dispersive X-ray analysis (EDAX) and a vibrating sample magnetometer (VSM) analysis. Phototoxic and cytotoxic effects of nanomaterials were studied using the Ni NTs alone as well as in conjugation with aminolevulinic acid (5-ALA); this was performed both in the dark and under laser exposure. Toxic effects on the HeLa cell model were evaluated by a neutral red assay (NRA) and by detection of intracellular reactive oxygen species (ROS) production. Furthermore, 10-200 nM of Ni NTs was prepared in solution form and applied to HeLa cells in 96-well plates. Maximum toxicity of Ni NTs complexed with 5-ALA was observed at 100 J/cm(2) and 200 nM. Up to 65-68% loss in cell viability was observed. Statistical analysis was performed on the experimental results to confirm the worth and clarity of results, with p-values = 0.003 and 0.000, respectively. Current results pave the way for a more rational strategy to overcome the problem of drug bioavailability in nanoparticulate targeted cancer therapy, which plays a dynamic role in clinical practice.	[Aziz, Muhammad Hammad; Majid, Abdul; Al Harbi, Thamir Shelih] Majmaah Univ, Coll Sci Zulfi, Dept Phys, Zulfi, Saudi Arabia; [Aziz, Muhammad Hammad] COMSATS Inst Informat & Technol, Dept Phys, Lahore, Pakistan; [Fakhar-e-Alam, M.; Wang, Zhiming M.] Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, Chengdu 610054, Peoples R China; [Fakhar-e-Alam, M.; Iqbal, Seemab] GC Univ Faisalabad, Dept Phys, Faisalabad, Pakistan; [Fatima, Mahvish; Afzal, Muhammad] Islamia Univ Bahawalpur, Dept Phys, Bahawalpur, Pakistan; [Shaheen, Fozia] GC Univ Lahore, Dept Phys, Lahore, Pakistan; [Atif, M.; Ali, Syed Mansoor; AlSalhi, M. S.; Alahmed, Z. A.] King Saud Univ, Coll Sci, Dept Phys & Astron, Riyadh 11451, Saudi Arabia; [Atif, M.] Natl Inst Laser & Optron, Islamabad, Pakistan; [Talha, Muhammad] King Saud Univ, Sci Res, Riyadh 11421, Saudi Arabia; [Ismail, Muhammad] IBGE, 24 Mauve Area,G-9-1, Islamabad, Pakistan	Majmaah University; COMSATS University Islamabad (CUI); University of Electronic Science & Technology of China; Government College University Faisalabad; Islamia University of Bahawalpur; Government College University Lahore; University of Lahore; King Saud University; King Saud University	Aziz, MH (corresponding author), Majmaah Univ, Coll Sci Zulfi, Dept Phys, Zulfi, Saudi Arabia.; Aziz, MH (corresponding author), COMSATS Inst Informat & Technol, Dept Phys, Lahore, Pakistan.; Atif, M (corresponding author), King Saud Univ, Coll Sci, Dept Phys & Astron, Riyadh 11451, Saudi Arabia.; Atif, M (corresponding author), Natl Inst Laser & Optron, Islamabad, Pakistan.	m.hammad@mu.edu.sa; atifhull@gmail.com	Atif, Muhammad/Z-5682-2019; AlSalhi, Mohamad S/F-2217-2019; Alahmed, Zeyad A/F-1683-2013; alsalhi, mohamad/M-5013-2019; Majid, Abdul/G-5584-2016; Atif, Muhammad/C-4789-2013	Atif, Muhammad/0000-0002-7356-4275; AlSalhi, Mohamad S/0000-0002-4557-8821; Alahmed, Zeyad A/0000-0001-7304-8118; Majid, Abdul/0000-0001-8861-4354; Atif, Muhammad/0000-0002-7356-4275	Deanship of Scientific Research, Majmaah University [37-1-3]	Deanship of Scientific Research, Majmaah University	The authors acknowledge the support from Deanship of Scientific Research, Majmaah University under project No. 37-1-3.	Ahamed M, 2013, CHEMOSPHERE, V93, P2514, DOI 10.1016/j.chemosphere.2013.09.047; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Ali SMU, 2012, INT J MED MED SCI, V2; Atif M, 2011, LASER PHYS, V21, P1235, DOI 10.1134/S1054660X11130020; Atif M, 2010, LASER PHYS LETT, V7, P757, DOI 10.1002/lapl.201010061; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Chikazumi S., 1964, PHYSICS MAGNETISM, P130; Fakhar-e-Alam M, 2014, LASER PHYS LETT, V11, DOI 10.1088/1612-2011/11/2/025601; Fakhar-e-Alam M, 2011, LASER PHYS, V21, P1978, DOI 10.1134/S1054660X1119011X; Fakhar-e-Alam M., 2012, REV NANOSCI NANOTECH, V1, P40, DOI [10.1166/rnn.2012.1004, DOI 10.1166/RNN.2012.1004]; Fatima M, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/12/125602; Garland SM, 2012, CANCER EPIDEM BIOMAR, V21, P1414, DOI 10.1158/1055-9965.EPI-12-0164; Hossain MZ, 2011, INT J NANOMED, V6, P1475, DOI 10.2147/IJN.S21697; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; Lahiria D, 2010, ACTA BIOMATER; Li X, 2012, J NANOMATER, V2012, P9; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Panchompoo J, 2010, ELECTROANAL, V22, P912, DOI 10.1002/elan.200900547; Patil SS, 2016, ENVIRON TECHNOL INNO, V5, P10, DOI 10.1016/j.eti.2015.11.001; Prina-Mello Adriele, 2006, J Nanobiotechnology, V4, P9, DOI 10.1186/1477-3155-4-9; Tao FF, 2006, ADV MATER, V18, P2161, DOI 10.1002/adma.200600275; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Yu IJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/789312	25	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150295	10.1371/journal.pone.0150295	http://dx.doi.org/10.1371/journal.pone.0150295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990435	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800026
J	He, XJ; Ma, HX; Zhao, XW; Nie, SJ; Li, YH; Zhang, ZM; Shen, YO; Chen, Q; Lu, YL; Lan, H; Zhou, SF; Gao, SB; Pan, GT; Lin, HJ				He, Xiujing; Ma, Haixia; Zhao, Xiongwei; Nie, Shujun; Li, Yuhua; Zhang, Zhiming; Shen, Yaou; Chen, Qi; Lu, Yanli; Lan, Hai; Zhou, Shufeng; Gao, Shibin; Pan, Guangtang; Lin, Haijian			Comparative RNA-Seq Analysis Reveals That Regulatory Network of Maize Root Development Controls the Expression of Genes in Response to N Stress	PLOS ONE			English	Article							ENHANCES NITROGEN ACQUISITION; BINDING TRANSCRIPTION FACTORS; NITRATE TRANSPORT; FACTOR FAMILY; ARABIDOPSIS; PROTEIN; GROWTH; CELL; ALLOCATION; MEMBERS	Nitrogen (N) is an essential nutrient for plants, and it directly affects grain yield and protein content in cereal crops. Plant root systems are not only critical for anchorage in the soil, but also for N acquisition. Therefore, genes controlling root development might also affect N uptake by plants. In this study, the responses of nitrogen on root architecture of mutant rtcs and wild-type of maize were investigated by morphological and physiological analysis. Subsequently, we performed a comparative RNA-Seq analysis to compare gene expression profiles between mutant rtcs roots and wild-type roots under different N conditions. We identified 786 co-modulated differentially expressed genes (DEGs) related to root development. These genes participated in various metabolic processes. A co-expression cluster analysis and a cis-regulatory motifs analysis revealed the importance of the AP2-EREBP transcription factor family in the rtcs-dependent regulatory network. Some genotype-specific DEGs contained at least one LBD motif in their promoter region. Further analyses of the differences in gene transcript levels between rtcs and wild-type under different N conditions revealed 403 co-modulated DEGs with distinct functions. A comparative analysis revealed that the regulatory network controlling root development also controlled gene expression in response to N-deficiency. Several AP2-EREBP family members involved in multiple hormone signaling pathways were among the DEGs. These transcription factors might play important roles in the rtcs-dependent regulatory network related to root development and the N-deficiency response. Genes encoding the nitrate transporters NRT2-1, NAR2.1, NAR2.2, and NAR2.3 showed much higher transcript levels in rtcs than in wildtype under normal-N conditions. This result indicated that the LBD gene family mainly functions as transcriptional repressors, as noted in other studies. In summary, using a comparative RNA-Seq-based approach, we identified DEGs related to root development that also participated in the N-deficiency response in maize. These findings will increase our understanding of the molecular regulatory networks controlling root development and N-stress responses.	[He, Xiujing; Ma, Haixia; Zhao, Xiongwei; Nie, Shujun; Li, Yuhua; Zhang, Zhiming; Shen, Yaou; Chen, Qi; Lu, Yanli; Lan, Hai; Zhou, Shufeng; Gao, Shibin; Pan, Guangtang; Lin, Haijian] Sichuan Agr Univ, Maize Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Wenjiang, Sichuan, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Lin, HJ (corresponding author), Sichuan Agr Univ, Maize Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Wenjiang, Sichuan, Peoples R China.	hilin0528@gmail.com	Nie, Shujun/GSD-4799-2022; Li, yu/HHZ-5236-2022; Ma, Haixia/ABC-4707-2021	Ma, Haixia/0000-0001-9080-2004	National Natural Science Foundation of China [31201221]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	HJL was supported by Grants from the National Natural Science Foundation of China (No. 31201221). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the anonymous referees and the editor for their comments and suggestions that helped improve the manuscript. The work was supported by grants from the National Natural Science Foundation of China (31201221).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Cheng Q., 2015, 2015 Optical Fiber Communications Conference and Exhibition (OFC). Proceedings; Chun L, 2005, PLANT SOIL, V276, P369, DOI 10.1007/s11104-005-5876-2; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feng HM, 2011, PLANT SIGNAL BEHAV, V6, P1286, DOI 10.4161/psb.6.9.16377; Feng ZH, 2012, PLANTA, V236, P1227, DOI 10.1007/s00425-012-1673-3; Gao K, 2015, PLANT CELL ENVIRON, V38, P740, DOI 10.1111/pce.12439; Gelli M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-179; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hetz W, 1996, PLANT J, V10, P845, DOI 10.1046/j.1365-313X.1996.10050845.x; Hirota A, 2007, PLANT CELL, V19, P2156, DOI 10.1105/tpc.107.050674; Hochholdinger F, 2004, TRENDS PLANT SCI, V9, P42, DOI 10.1016/j.tplants.2003.11.003; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Iwakawa H, 2002, PLANT CELL PHYSIOL, V43, P467, DOI 10.1093/pcp/pcf077; Jiang Y, 2012, J INTEGR PLANT BIOL, V54, P616, DOI 10.1111/j.1744-7909.2012.01149.x; Kang NY, 2013, PLANT CELL PHYSIOL, V54, P1326, DOI 10.1093/pcp/pct081; Kiba T, 2011, J EXP BOT, V62, P1399, DOI 10.1093/jxb/erq410; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krapp A, 2014, J EXP BOT, V65, P789, DOI 10.1093/jxb/eru001; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee HW, 2009, PLANT PHYSIOL, V151, P1377, DOI 10.1104/pp.109.143685; Lee SY, 2015, PLANT CELL REP, V34, P223, DOI 10.1007/s00299-014-1701-9; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Li YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-153; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu JC, 2008, PLANT SOIL, V305, P253, DOI 10.1007/s11104-008-9562-z; Liu XF, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/950262; Liu YJ, 2012, J PLANT PHYSIOL, V169, P183, DOI 10.1016/j.jplph.2011.08.018; Lu CM, 2001, J PLANT PHYSIOL, V158, P1423, DOI 10.1078/0176-1617-00501; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; Mathelier A, 2013, NUCLEIC ACIDS RES; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Muthreich N, 2013, PLANT PHYSIOL, V163, P419, DOI 10.1104/pp.113.221481; Okamoto M, 2006, PLANT PHYSIOL, V140, P1036, DOI 10.1104/pp.105.074385; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; PAGES L, 1994, PLANT SOIL, V164, P169, DOI 10.1007/BF00010068; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Saengwilai P, 2014, PLANT PHYSIOL, V166, P726, DOI 10.1104/pp.114.241711; Saengwilai P, 2014, PLANT PHYSIOL, V166, P581, DOI 10.1104/pp.113.232603; Saiz-Fernandez I, 2015, J PLANT PHYSIOL, V173, P120, DOI 10.1016/j.jplph.2014.06.018; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Takehisa H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24409; Taramino G, 2007, PLANT J, V50, P649, DOI 10.1111/j.1365-313X.2007.03075.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Tian QY, 2008, J PLANT PHYSIOL, V165, P942, DOI 10.1016/j.jplph.2007.02.011; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xin MM, 2013, PLANT CELL, V25, P3212, DOI 10.1105/tpc.113.115592; Xu C, 2015, TRENDS PLANT SCI; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Yan HF, 2011, J PLANT PHYSIOL, V168, P1067, DOI 10.1016/j.jplph.2010.12.018; Zhang HY, 2011, PLANT J, V65, P346, DOI 10.1111/j.1365-313X.2010.04426.x; Zhang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121222; Zhao DL, 2005, EUR J AGRON, V22, P391, DOI 10.1016/j.eja.2004.06.005; Zhao WC, 2015, PLANT CELL PHYSIOL, V56, P455, DOI 10.1093/pcp/pcu172; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078635	69	21	23	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151697	10.1371/journal.pone.0151697	http://dx.doi.org/10.1371/journal.pone.0151697			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990640	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800088
J	Nishizawa, A; Inoue, T; Ohira, S; Takahashi, E; Saruwatari, J; Iwao, K; Tanihara, H				Nishizawa, Asaho; Inoue, Toshihiro; Ohira, Saori; Takahashi, Eri; Saruwatari, Junji; Iwao, Keiichiro; Tanihara, Hidenobu			The Influence of Phacoemulsification on Surgical Outcomes of Trabeculectomy with Mitomycin-C for Uveitic Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AQUEOUS-HUMOR; PROINFLAMMATORY CYTOKINES; PSEUDOPHAKIC EYES; DISTINCT CYTOKINE; PROFILES; FAILURE; COHORT	Purpose To evaluate the influence of phacoemulsification after trabeculectomy on the postoperative intraocular pressure (IOP) in eyes with uveitic glaucoma (UG). Setting Kumamoto University Hospital, Kumamoto, Japan. Design A retrospective cohort study. Methods The medical records of patients with UG who had trabeculectomy with mitomycin-C (MMC) were reviewed. Complete and qualified surgical failures were defined by an IOP of >= 21 mmHg (condition A), >= 18 mmHg (condition B), or >= 15 mmHg (condition C) without and with glaucoma eye drops, respectively. Kaplan-Meier survival analysis, generalized by the Wilcoxon test, and the Cox proportional hazards model analysis were conducted. Post-trabeculectomy phacoemulsification was treated as a time-dependent variable. In 24 (30%) of the included 80 eyes, phacoemulsification was included, and they were divided into two groups: groups I (8 eyes with phacoemulsification within 1 year after trabeculectomy) and group II (16 eyes after 1 year following trabeculectomy). Results Multivariable Cox proportional hazards model analysis showed post-trabeculectomy phacoemulsification was a significant factor in both complete success and qualified success based upon condition C (P = 0.0432 and P = 0.0488, respectively), but not for the other conditions. Kaplan-Meier survival analyses indicated significant differences in success probabilities between groups I and group II for complete success and qualified success based upon condition C (P = 0.020 and P = 0.013, respectively). There was also a significant difference for qualified success based upon condition B (P = 0.034), while there was no significant difference for the other conditions. Conclusion Post-trabeculectomy phacoemulsification, especially within 1 year, can cause poor prognosis of IOP control of UG eyes after trabeculectomy with MMC.	[Nishizawa, Asaho; Inoue, Toshihiro; Ohira, Saori; Takahashi, Eri; Iwao, Keiichiro; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan; [Saruwatari, Junji] Kumamoto Univ, Dept Pharmacol & Therapeut, Fac Life Sci, Kumamoto, Japan	Kumamoto University; Kumamoto University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp	Saruwatari, Junji/Q-7748-2019	Saruwatari, Junji/0000-0001-6266-1347; Inoue, Toshihiro/0000-0003-3769-7609; Iwao, Keiichiro/0000-0002-4102-9374				Abu El-Asrar AM, 2011, IMMUNOBIOLOGY, V216, P1004, DOI 10.1016/j.imbio.2011.03.007; Awai-Kasaoka N, 2012, J CATARACT REFR SURG, V38, P419, DOI 10.1016/j.jcrs.2011.09.035; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; Carreno E, 2011, J OPHTHALMIC INFLAMM, V1, P43, DOI 10.1007/s12348-010-0012-8; COSTA VP, 1993, BRIT J OPHTHALMOL, V77, P693, DOI 10.1136/bjo.77.11.693; Curnow SJ, 2005, INVEST OPHTH VIS SCI, V46, P4251, DOI 10.1167/iovs.05-0444; DERMO F, 1979, AM J OPHTHALMOL, V88, P829, DOI 10.1016/0002-9394(79)90559-2; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Iwao K, 2014, J GLAUCOMA, V23, P88, DOI 10.1097/IJG.0b013e3182685167; Kaburaki T, 2009, EYE, V23, P1509, DOI [10.1038/eye.2009.117, 10.1038/eye.2009.117-cme]; Kojima S, 2015, JAMA OPHTHALMOL, V133, P148, DOI 10.1001/jamaophthalmol.2014.4489; Kuiper JJW, 2011, AM J OPHTHALMOL, V152, P177, DOI 10.1016/j.ajo.2011.01.031; Ooi KGJ, 2006, INVEST OPHTH VIS SCI, V47, P272, DOI 10.1167/iovs.05-0790; Shaarawy T., 2009, GUIDELINES DESIGN RE; Shimizu A, 2014, CLIN OPHTHALMOL, V8, P2383, DOI 10.2147/OPTH.S72383; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI 10.1001/jamaophthalmol.2013.5605; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; Valentincic NV, 2011, MOL VIS, V17, P2003; van Kooij B, 2006, AM J OPHTHALMOL, V142, P192, DOI 10.1016/j.ajo.2006.02.052; VESTI E, 1993, ACTA OPHTHALMOL, V71, P777	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151947	10.1371/journal.pone.0151947	http://dx.doi.org/10.1371/journal.pone.0151947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989899	Green Submitted, gold, Green Published			2022-12-26	WOS:000372582800122
J	Chang, CH; Lee, CY; Feng, SW; Miao, NF; Lin, PH; Lin, CT; Tsai, SH; Huang, YK				Chang, Chia-Huang; Lee, Chang-Yu; Feng, Sheng-Wei; Miao, Nae-Fang; Lin, Pei-Huan; Lin, Che-Tong; Tsai, Shin-Han; Huang, Yung-Kai			Effects of Salivary Oxidative Markers on Edentulous Patients' Satisfaction with Prosthetic Denture Treatments: A Pilot Study	PLOS ONE			English	Article							REMOVABLE PARTIAL DENTURES; ORAL-HEALTH; TOOTH LOSS; NUTRITIONAL-STATUS; SUPEROXIDE-DISMUTASE; OLDER-ADULTS; IMPACT; ASSOCIATION; NUTRIENT; PROFILE	Objectives The purpose of this study was to assess relationships among periodontal conditions, salivary antioxidant levels, and patients' satisfaction with their prostheses. Methods This study was conducted at the Division of Prosthodontics, Department of Dentistry, Taipei Medical University Hospital. The periodontal condition of patients was based on an assessment of the plaque index (PI) and gingival index (GI). The pH value, flow rate, and buffer capacity of the saliva were estimated. The salivary total antioxidant status (TAS) and superoxide dismutase (SOD) level were also determined. Patients' satisfaction with prosthetic treatments was evaluated using the Chinese version of the short-form Oral Health Impact Profile (OHIP-14C). A multivariate regression model was used to determine whether patients' satisfaction with prosthetic treatment was affected by their oral health status. Results In total, 35 edentulous patients were recruited. In the Spearman correlation analysis, salivary pH (r = -0.36, p = 0.03) and the buffer ability (r = -0.48, p<0.01) were associated with OHIP-14C scores. In the multivariate analysis, patients who had a higher GI also had a higher score of physical disabilities (beta = 1.38, p = 0.04). Levels of SOD increased with the scores of psychological discomfort (beta = 0.33 U/g protein, p = 0.04). Conclusions This study suggested that both the GI and SOD levels were associated with patients' satisfaction with prosthetic treatments. To the best of our knowledge, this is the first study to elucidate the relationship between OHIP scores and salivary oxidative markers in edentulous patients.	[Chang, Chia-Huang; Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Lee, Chang-Yu; Huang, Yung-Kai] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei 110, Taiwan; [Lee, Chang-Yu] Taipei Med Univ, Taipei Med Univ Hosp, Dept Dent, Div Periodont, Taipei 110, Taiwan; [Feng, Sheng-Wei; Lin, Pei-Huan; Lin, Che-Tong] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 110, Taiwan; [Miao, Nae-Fang] Taipei Med Univ, Sch Nursing, Taipei 110, Taiwan; [Lin, Che-Tong] Taipei Med Univ Hosp, Div Prosthodont, Dept Dent, Taipei 110, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Huang, YK (corresponding author), Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei 110, Taiwan.	ykhuang@tmu.edu.tw	Huang, Yung-Kai/C-7868-2012	Huang, Yung-Kai/0000-0002-4467-0300	National Science Council, Taiwan [NSC100-2314-B-038-042, NSC 102-2314-B-038-019]; Taipei Medical University Hospital, Taiwan [102TMU-TMUH-02]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University Hospital, Taiwan	This study was supported by a research grant from the National Science Council, Taiwan (NSC100-2314-B-038-042; NSC 102-2314-B-038-019) and Taipei Medical University Hospital, Taiwan (102TMU-TMUH-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin FA, 2005, J CLIN PERIODONTOL, V32, P238, DOI 10.1111/j.1600-051X.2005.00669.x; Allen Patrick Finbarr, 2003, J Can Dent Assoc, V69, P662; Allen PF, 1999, COMMUNITY DENT HLTH, V16, P176; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Arredondo M, 2014, J TRACE ELEM MED BIO, V28, P23, DOI 10.1016/j.jtemb.2013.10.004; Beck JD, 2014, J AM DENT ASSOC, V145, P531, DOI 10.14219/jada.2014.25; CARLSSON GE, 1970, DENT CLIN N AM, V14, P553; De Marchi RJ, 2008, NUTRITION, V24, P546, DOI 10.1016/j.nut.2008.01.054; Department of Household Registration Ministry of the Interior, 2015, HOUS REG STAT DAT AN, V8, P10; Divaris K, 2012, GERODONTOLOGY, V29, pE192, DOI 10.1111/j.1741-2358.2010.00440.x; Doundoulakis JH, 2003, J AM DENT ASSOC, V134, P1455, DOI 10.14219/jada.archive.2003.0073; EICHNER K, 1990, Stomatologie der DDR, V40, P321; Emami E, 2013, INT J DENT, V2013, DOI 10.1155/2013/498305; Gift H C, 1995, Med Care, V33, pNS57, DOI 10.1097/00005650-199511001-00008; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Hanioka T, 2007, GERODONTOLOGY, V24, P87, DOI 10.1111/j.1741-2358.2007.00166.x; Hershkovich O, 2007, J GERONTOL A-BIOL, V62, P361, DOI 10.1093/gerona/62.4.361; Hofstede TM, 1999, J PROSTHET DENT, V82, P94, DOI 10.1016/S0022-3913(99)70133-2; Joshipura KJ, 1996, J AM DENT ASSOC, V127, P459, DOI 10.14219/jada.archive.1996.0237; Kim Sang-Chul, 2010, J Periodontal Implant Sci, V40, P164, DOI 10.5051/jpis.2010.40.4.164; Kuo HC, 2011, QUAL LIFE RES, V20, P1707, DOI 10.1007/s11136-011-9901-z; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; Martinez-Gonzalez JM, 2013, ACTA ODONTOL SCAND, V71, P1303, DOI 10.3109/00016357.2012.762989; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; Nam Hyun-seok, 2012, General Dentistry, V60, P503; Novakovic N, 2014, J PERIODONTAL RES, V49, P129, DOI 10.1111/jre.12088; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123, DOI 10.1177/154405910308200209; Oh SH, 2014, CLIN ORAL IMPLANTS R; Peltzer K, 2014, INT J ENV RES PUB HE, V11, P11308, DOI 10.3390/ijerph111111308; Petersen PE, 2010, COMMUNITY DENT HLTH, V27, P257, DOI 10.1922/CDH_2711Petersen11; Precheur I, 2015, GERIATR PSYCHOL NEUR, V13, P22, DOI 10.1684/pnv.2015.0515; Quirynen M, 2011, J CLIN PERIODONTOL, V38, P581, DOI 10.1111/j.1600-051X.2011.01728.x; Ryu M, 2010, J ORAL REHABIL, V37, P194, DOI 10.1111/j.1365-2842.2009.02042.x; Sculley DV, 2003, CLIN SCI, V105, P167, DOI 10.1042/CS20030031; Sheiham A, 2001, PUBLIC HEALTH NUTR, V4, P797, DOI 10.1079/PHN2000116; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Sischo L, 2011, J DENT RES, V90, P1264, DOI 10.1177/0022034511399918; Slade GD, 1994, COMMUNITY DENT HLTH, P3; Urden Linda D, 2002, Lippincotts Case Manag, V7, P194, DOI 10.1097/00129234-200209000-00006; van der Weijden F, 2011, PERIODONTOL 2000, V55, P104, DOI 10.1111/j.1600-0757.2009.00337.x; Vanzeveren C, 2002, J ORAL REHABIL, V29, P232, DOI 10.1046/j.1365-2842.2002.00854.x; Veyrune J L, 2005, Gerodontology, V22, P3, DOI 10.1111/j.1741-2358.2004.00048.x; Wang TF, 2014, ARCH GERONTOL GERIAT, V58, P446, DOI 10.1016/j.archger.2014.01.002; Wong AHH, 2007, COMMUNITY DENT ORAL, V35, P64, DOI 10.1111/j.1600-0528.2007.00330.x; Wong MCM, 2002, COMMUNITY DENT ORAL, V30, P423, DOI 10.1034/j.1600-0528.2002.00013.x; Yang Po-Sheng, 2014, ScientificWorldJournal, V2014, P814671, DOI 10.1155/2014/814671; Zitzmann NU, 1999, INT J PROSTHODONT, V12, P307; Zlataric DK, 2003, J ORAL REHABIL, V30, P847, DOI 10.1046/j.1365-2842.2003.01039.x; Zlataric DK, 2002, J PERIODONTOL, V73, P137	50	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151605	10.1371/journal.pone.0151605	http://dx.doi.org/10.1371/journal.pone.0151605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986841	Green Published, gold			2022-12-26	WOS:000372580300094
J	Weeks, RJ; Ludgate, JL; LeMee, G; Morison, IM				Weeks, Robert J.; Ludgate, Jackie L.; LeMee, Gwenn; Morison, Ian M.			TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DOWN-REGULATION; LIM-DOMAIN; PROMOTER METHYLATION; EXTENSIVE ANALYSIS; GENE-EXPRESSION; SQUAMOUS-CELL; HYPERMETHYLATION; HETEROZYGOSITY; REGION	Background Childhood acute lymphoblastic leukaemia (ALL) is the most common malignancy in children. Despite high cure rates, side effects and late consequences of the intensive treatments are common. Unquestionably, the identification of new therapeutic targets will lead to safer, more effective treatments. We identified TES promoter methylation and transcriptional silencing as a very common molecular abnormality in childhood ALL, irrespective of molecular subtype. The aims of the present study were to demonstrate that TES promoter methylation is aberrant, to determine the effects of TES re-expression in ALL, and to determine if those effects are mediated via TP53 activity. Methods Normal fetal and adult tissue DNA was isolated and TES promoter methylation determined by Sequenom MassARRAY. Quantitative RT-PCR and immunoblot were used to confirm re-expression of TES in ALL cell lines after 5'-aza-2'-deoxycytidine (decitabine) exposure or transfection with TES expression plasmids. The effects of TES re-expression on ALL cells were investigated using standard cell proliferation, cell death and cell cycle assays. Results In this study, we confirm that the TES promoter is unmethylated in normal adult and fetal tissues. We report that decitabine treatment of ALL cell lines results in demethylation of the TES promoter and attendant expression of TES mRNA. Re-expression of TESTIN protein in ALL cells using expression plasmid transfection results in rapid cell death or cell cycle arrest independent of TP53 activity. Conclusions These results suggest that TES is aberrantly methylated in ALL and that re-expression of TESTIN has anti-leukaemia effects which point to novel therapeutic opportunities for childhood ALL.	[Weeks, Robert J.; Ludgate, Jackie L.; LeMee, Gwenn; Morison, Ian M.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand	University of Otago	Weeks, RJ (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand.	rob.weeks@otago.ac.nz	Weeks, Robert J/A-6876-2012; Morison, Ian M/A-1236-2008	Weeks, Robert J/0000-0003-0474-9089; Morison, Ian M/0000-0003-3616-0025	Cancer Society of New Zealand Inc.; CureKids NZ; Genesis Oncology Trust; Lottery Health Research	Cancer Society of New Zealand Inc.; CureKids NZ; Genesis Oncology Trust; Lottery Health Research	This work was funded in part by grants awarded by Cancer Society of New Zealand Inc. (www.cancernz.org.nz; IMM & RJW), CureKids NZ (http://www.curekids.org.nz; IMM & RJW), Genesis Oncology Trust (http://www.genesisoncology.org.nz; IMM & RJW) and Lottery Health Research (http://www.communitymatters.govt.nz/Funding-and-grants; IMM & RJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Arumemi F, 2013, ADV BIOSCIENCE BIOTE, V4; Bai Y, 2014, EUR J MED RES, V19, DOI 10.1186/s40001-014-0066-4; BIERNAUX C, 1995, BLOOD, V86, P3118; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Boeda B, 2011, J BIOL CHEM, V286, P11543, DOI 10.1074/jbc.M110.171264; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Chene L, 2004, INT J CANCER, V111, P798, DOI 10.1002/ijc.20337; Cigognini D, 2007, LEUKEMIA RES, V31, P477, DOI 10.1016/j.leukres.2006.09.007; Crone J, 2011, CANCER RES, V71, P2350, DOI 10.1158/0008-5472.CAN-10-3486; Dockerty JD, 2009, BLOOD CELL MOL DIS, V42, P113, DOI 10.1016/j.bcmd.2008.10.008; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fujiwara T, 2010, P NATL ACAD SCI USA, V107, P20429, DOI 10.1073/pnas.1007804107; Garvalov BK, 2003, J CELL BIOL, V161, P33, DOI 10.1083/jcb.200211015; Greaves Mel, 2003, Rev Clin Exp Hematol, V7, P233; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Griffith E, 2004, CELL MOTIL CYTOSKEL, V57, P133, DOI 10.1002/cm.10162; Gu ZP, 2014, MED SCI MONITOR, V20, P980, DOI 10.12659/MSM.890544; Gunduz E, 2009, ARCH OTOLARYNGOL, V135, P254, DOI 10.1001/archoto.2008.560; Hussain FTN, 2012, AM J HEMATOL, V87, P684, DOI 10.1002/ajh.23230; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; Krawchuk D, 2008, DEV DYNAM, V237, P1183, DOI 10.1002/dvdy.21514; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; Ma HQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-190; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; Mirebeau D, 2006, HAEMATOL-HEMATOL J, V91, P881; Mody R, 2008, BLOOD, V111, P5515, DOI 10.1182/blood-2007-10-117150; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Mullighan CG, 2012, J CLIN INVEST, V122, P3407, DOI 10.1172/JCI61203; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; PROKOCIMER M, 1986, BLOOD, V68, P113; Pui CH, 2014, LEUKEMIA, V28, P2336, DOI 10.1038/leu.2014.142; Qiu HF, 2010, CANCER SCI, V101, P1255, DOI 10.1111/j.1349-7006.2010.01497.x; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Sarti M, 2005, CLIN CANCER RES, V11, P806; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Skiriute D, 2013, J NEURO-ONCOL, V113, P441, DOI 10.1007/s11060-013-1133-3; Sproul D, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R84, 10.1186/gb-2012-13-10-r84]; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Tatarelli C, 2000, GENOMICS, V68, P1, DOI 10.1006/geno.2000.6272; Weeks RJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-163; Wiederschain D, 2003, MOL CELL BIOL, V23, P4230, DOI 10.1128/MCB.23.12.4230-4246.2003; Xia JC, 2006, CANCER GENET CYTOGEN, V166, P166, DOI 10.1016/j.cancergencyto.2005.11.005; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zhong YL, 2009, MOL CELL BIOCHEM, V320, P85, DOI 10.1007/s11010-008-9901-7; Zhu J, 2012, CANCER SCI, V103, P2092, DOI 10.1111/cas.12020	50	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151341	10.1371/journal.pone.0151341	http://dx.doi.org/10.1371/journal.pone.0151341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985820	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300063
J	Calabrese, G; Giuffrida, R; Fabbi, C; Figallo, E; Lo Furno, D; Gulino, R; Colarossi, C; Fullone, F; Giuffrida, R; Parenti, R; Memeo, L; Forte, S				Calabrese, Giovanna; Giuffrida, Raffaella; Fabbi, Claudia; Figallo, Elisa; Lo Furno, Debora; Gulino, Rosario; Colarossi, Cristina; Fullone, Francesco; Giuffrida, Rosario; Parenti, Rosalba; Memeo, Lorenzo; Forte, Stefano			Collagen-Hydroxyapatite Scaffolds Induce Human Adipose Derived Stem Cells Osteogenic Differentiation In Vitro	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; TRANSPLANTATION; MINERALIZATION; PHOSPHATASE; THERAPY; INSULIN; DESIGN	Mesenchymal stem cells (MSCs) play a crucial role in regulating normal skeletal homeostasis and, in case of injury, in bone healing and reestablishment of skeletal integrity. Recent scientific literature is focused on the development of bone regeneration models where MSCs are combined with biomimetic three-dimensional scaffolds able to direct MSC osteogenesis. In this work the osteogenic potential of human MSCs isolated from adipose tissue (hADSCs) has been evaluated in vitro in combination with collagen/Mg doped hydroxyapatite scaffolds. Results demonstrate the high osteogenic potential of hADSCs when cultured in specific differentiation induction medium, as revealed by the Alizarin Red S staining and gene expression profile analysis. In combination with collagen/hydroxyapatite scaffold, hADSCs differentiate into mature osteoblasts even in the absence of specific inducing factors; nevertheless, the supplement of the factors markedly accelerates the osteogenic process, as confirmed by the expression of specific markers of pre-osteoblast and mature osteoblast stages, such as osterix, osteopontin (also known as bone sialoprotein I), osteocalcin and specific markers of extracellular matrix maturation and mineralization stages, such as ALPL and osteonectin. Hence, the present work demonstrates that the scaffold per se is able to induce hADSCs differentiation, while the addition of osteo-inductive factors produces a significant acceleration of the osteogenic process. This observation makes the use of our model potentially interesting in the field of regenerative medicine for the treatment of bone defects.	[Calabrese, Giovanna; Giuffrida, Raffaella; Gulino, Rosario; Memeo, Lorenzo; Forte, Stefano] IOM Ric, Viagrande, Italy; [Fabbi, Claudia; Figallo, Elisa] Finceramica, Faenza, Italy; [Lo Furno, Debora; Gulino, Rosario; Giuffrida, Rosario; Parenti, Rosalba] Univ Catania, Dept Biomed & Biotechnol Sci, Physiol Sect, Catania, Italy; [Colarossi, Cristina; Fullone, Francesco; Memeo, Lorenzo] Mediterranean Inst Oncol, Dept Expt Oncol, Viagrande, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Catania; Mediterranean Institute of Oncology	Forte, S (corresponding author), IOM Ric, Viagrande, Italy.	stefano.forte@grupposamed.com	Furno, Debora Lo/P-1667-2019; Parenti, Rosalba/AAS-5489-2020; Giuffrida, Rosario/AFP-2975-2022; Parenti, Rosalba/ABC-5780-2020; Forte, Stefano/D-3645-2013	Furno, Debora Lo/0000-0002-1971-8990; Giuffrida, Rosario/0000-0001-7494-3675; Parenti, Rosalba/0000-0002-1614-4696; Forte, Stefano/0000-0001-5746-7451; Calabrese, Giovanna/0000-0003-1937-5403; Colarossi, Cristina/0000-0001-5395-8608; Memeo, Lorenzo/0000-0003-4251-7203	Italian "PON Ricerca e Competitivita" [ASSE I 829]; Finceramica	Italian "PON Ricerca e Competitivita"; Finceramica	The present research was funded by the Italian "PON Ricerca e Competitivita 2007-2013, ASSE I 829" grant programme entitled "Piattaforme tecnologiche innovative per l'ingegneria tissutale". Finceramica provided support in the form of salaries for authors CF and EF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. There was no additional external funding received for this study.; The present research was funded by the Italian "PON Ricerca e Competitivita 2007-2013, ASSE I 829" grant programme entitled "Piattaforme tecnologiche innovative per l'ingegneria tissutale". There was no additional external funding received for this study. The authors gratefully acknowledge Gabriele Anastasi for technical assistance.	Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Arinzeh Treena Livingston, 2005, Foot Ankle Clin, V10, P651, DOI 10.1016/j.fcl.2005.06.004; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Calabrese G, 2015, INT J MOL SCI, V16, P15609, DOI 10.3390/ijms160715609; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chim H, 2006, INT J ORAL MAX SURG, V35, P928, DOI 10.1016/j.ijom.2006.03.024; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]; Grigolo B, 2011, J Biol Regul Homeost Agents, V25, pS3; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; Karsenty G, 2000, MATRIX BIOL, V19, P85, DOI 10.1016/S0945-053X(00)00053-6; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014; Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Manferdini C, 2016, J TISSUE ENG REGEN M, V10, P374, DOI 10.1002/term.1723; Meyer U., 2009, FUNDAMENTALS TISSUE; Minuto F, 2005, J ENDOCRINOL INVEST, V28, P1; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nicoletti A, 2013, J MATER SCI-MATER M, V24, P17, DOI 10.1007/s10856-012-4782-4; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Pasqui D, 2014, J BIOMED MATER RES A, V102, P1568, DOI 10.1002/jbm.a.34810; Pham L, 2011, J CELL BIOCHEM, V112, P793, DOI 10.1002/jcb.23003; Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Sugawara Y, 2002, JPN J PHARMACOL, V88, P262, DOI 10.1254/jjp.88.262; Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008; Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Vicari L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5282185; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032364; Yu G, 2011, METHODS MOL BIOL, V702, P17, DOI 10.1007/978-1-61737-960-4_2; Zanetti AS, 2013, J BIOMED MATER RES B, V101B, P187, DOI 10.1002/jbm.b.32817; Zhu FC, 2012, J CELL PHYSIOL, V227, P2677, DOI 10.1002/jcp.23010; Zhu XS, 2012, CELL TISSUE RES, V350, P277, DOI 10.1007/s00441-012-1453-1; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	54	77	79	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151181	10.1371/journal.pone.0151181	http://dx.doi.org/10.1371/journal.pone.0151181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982592	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900067
J	Zeng, XZ; Wang, HL; Xing, XC; Wang, Q; Li, WZ				Zeng, Xianzhang; Wang, Honglei; Xing, Xichun; Wang, Qi; Li, Wenzhi			Dexmedetomidine Protects against Transient Global Cerebral Ischemia/Reperfusion Induced Oxidative Stress and Inflammation in Diabetic Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NADPH OXIDASE; BRAIN-INJURY; ALPHA(2)-AGONIST DEXMEDETOMIDINE; GLUCOSE DEPRIVATION; RISK-FACTORS; CELL-DEATH; DAMAGE; RECEPTORS; STROKE	Background Transient global cerebral ischemia/reperfusion (I/R) is a major perioperative complication, and diabetes increases the response of oxidative stress and inflammation induced by I/R. The objective of this study was to determine the protective effect of dexmedetomidine against transient global cerebral ischemia/reperfusion induced oxidative stress and inflammation in diabetic rats. Methods Sixty-four rats were assigned into four experimental groups: normoglycemia, normoglycemia + dexmedetomidine, hyperglycemia, and hyperglycemia + dexmedetomidine and all subsequent neurological examinations were evaluated by a blinded observer. Damage to the brain was histologically assessed using the TUNEL staining method while western blotting was used to investigate changes in the expression levels of apoptosis-related proteins as well as the microglia marker, ionized calcium-binding adapter molecule 1 (Iba1). Water content in the brain was also analyzed. In addition, hippocampal concentrations of malondialdehyde (MDA) and Nox2 (a member of the Nox family of NADPH oxidases), and the activity of superoxide dismutase and catalase were analyzed. Finally, changes in serum concentrations of tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 were detected. Results Results showed that diabetes increased brain water content, the number of apoptotic neurons, early neurological deficit scores, oxidative stress (MDA and Nox2) and inflammation (pro-inflammatory cytokines including TNF-alpha and IL-6) levels following transient global I/R injury, but that these symptoms were attenuated following administration of dexmedetomidine. Conclusions These findings suggest that dexmedetomidine can significantly alleviate damage resulting from I/R, and this mechanism may be related to a reduction in both oxidative stress and inflammation which is normally associated with I/R.	[Zeng, Xianzhang; Wang, Honglei; Xing, Xichun; Wang, Qi; Li, Wenzhi] Harbin Med Univ, Dept Anaesthesiol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Li, WZ (corresponding author), Harbin Med Univ, Dept Anaesthesiol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China.	wenzhili9@126.com			National Natural Science Foundation of China [81171076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by the National Natural Science Foundation of China (NO. 81171076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Arslan M, 2014, BRATISL MED J, V115, P494, DOI 10.4149/BLL_2014_096; Bitar MS, 1997, PHARMACOL BIOCHEM BE, V56, P15, DOI 10.1016/S0091-3057(96)00129-3; Bosca L, 1999, CELL SIGNAL, V11, P239, DOI 10.1016/S0898-6568(98)00064-3; Brambrink AM, 2006, ANESTHESIOLOGY, V104, P1208, DOI 10.1097/00000542-200606000-00016; Brambrink AM, 2000, J CEREBR BLOOD F MET, V20, P1425, DOI 10.1097/00004647-200010000-00004; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dahmani S, 2005, ANESTHESIOLOGY, V103, P969, DOI 10.1097/00000542-200511000-00011; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Dahmani S, 2010, ANESTHESIOLOGY, V112, P373, DOI 10.1097/ALN.0b013e3181ca6982; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Engelhard K, 2002, ANESTHESIOLOGY, V96, P450, DOI 10.1097/00000542-200202000-00034; Engelhard K, 2003, ANESTH ANALG, V96, P524, DOI 10.1097/00000539-200302000-00041; Eser O, 2008, BRAIN RES, V1218, P250, DOI 10.1016/j.brainres.2008.04.045; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; Figiel I, 2007, BRAIN RES, V1131, P17, DOI 10.1016/j.brainres.2006.10.095; Flaherty JH, 2007, J AM GERIATR SOC, V55, P1295, DOI 10.1111/j.1532-5415.2007.01273.x; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; GUO TZ, 1991, PHARMACOL BIOCHEM BE, V39, P383; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Han Z, 2009, NEUROL RES, V31, P390, DOI 10.1179/174313209X444116; Hanci V, 2010, UROL INT, V84, P105, DOI 10.1159/000273476; HOFFMAN WE, 1991, ANESTHESIOLOGY, V75, P328, DOI 10.1097/00000542-199108000-00022; Huang R, 2000, J CEREBR BLOOD F MET, V20, P895, DOI 10.1097/00004647-200006000-00001; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kip G, 2015, LIBYAN J MED, V10, DOI 10.3402/ljm.v10.27828; Kocoglu H, 2009, RENAL FAILURE, V31, P70, DOI 10.1080/08860220802546487; Kosenko E, 1999, FREE RADICAL BIO MED, V26, P1369, DOI 10.1016/S0891-5849(98)00339-6; Kowluru A, 2014, BIOCHEM PHARMACOL, V88, P275, DOI 10.1016/j.bcp.2014.01.017; Li LX, 2011, BRAIN RES BULL, V86, P390, DOI 10.1016/j.brainresbull.2011.09.005; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LI PA, 1995, NEUROBIOL DIS, V2, P97, DOI 10.1006/nbdi.1995.0010; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MAIER C, 1993, ANESTHESIOLOGY, V79, P306, DOI 10.1097/00000542-199308000-00016; MCCALL AL, 1992, DIABETES, V41, P557, DOI 10.2337/diabetes.41.5.557; Milhaud D, 2000, NEUROPHARMACOLOGY, V39, P2244, DOI 10.1016/S0028-3908(00)00085-X; MOORADIAN AD, 1988, ENDOCR REV, V9, P346, DOI 10.1210/edrv-9-3-346; Moreira PI, 2004, J NEUROENDOCRINOL, V16, P32, DOI 10.1111/j.1365-2826.2004.01107.x; Muranyi M, 2006, DIABETES, V55, P349, DOI 10.2337/diabetes.55.02.06.db05-0654; Muranyi M, 2003, DIABETES, V52, P481, DOI 10.2337/diabetes.52.2.481; Okada H, 2007, RESUSCITATION, V74, P538, DOI 10.1016/j.resuscitation.2007.01.032; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; RYAN CM, 1988, DIABETES CARE, V11, P86, DOI 10.2337/diacare.11.1.86; Shi HL, 2007, FRONT BIOSCI-LANDMRK, V12, P1318, DOI 10.2741/2150; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Straub RH, 1997, J NEUROCHEM, V68, P1633; Suzuki T, 2008, J SURG RES, V149, P69, DOI 10.1016/j.jss.2008.01.020; Tsuruta R, 2010, BRAIN RES, V1309, P155, DOI 10.1016/j.brainres.2009.10.065; Wong CHY, 2008, CURR MED CHEM, V15, P1; Xiang FL, 2010, DIABETES, V59, P2603, DOI 10.2337/db09-1562; Zhang FJ, 2012, J PHARM PHARMACOL, V64, P120, DOI 10.1111/j.2042-7158.2011.01382.x; ZHANG PL, 1991, DIABETES, V40, P338, DOI 10.2337/diabetes.40.3.338; Zhang XY, 2012, ANESTHESIOLOGY, V116, P1035, DOI 10.1097/ALN.0b013e3182503964; Zhu YY, 2006, NEUROSCI LETT, V393, P122, DOI 10.1016/j.neulet.2005.08.072	59	71	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151620	10.1371/journal.pone.0151620	http://dx.doi.org/10.1371/journal.pone.0151620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982373	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900105
J	Zhang, BZ; Zhang, L; Cui, RK; Zeng, XN; Gao, XW				Zhang, Baizhong; Zhang, Lei; Cui, Rukun; Zeng, Xinnian; Gao, Xiwu			Cloning and Expression of Multiple Cytochrome P450 Genes: Induction by Fipronil in Workers of the Red Imported Fire Ant (Solenopsis invicta Buren)	PLOS ONE			English	Article							CHIRONOMUS-TENTANS DIPTERA; DROSOPHILA-MELANOGASTER; HOUSE-FLY; INSECTICIDE RESISTANCE; MUSCA-DOMESTICA; APIS-MELLIFERA; P450 GENES; STRAIN; HYMENOPTERA; FORMICIDAE	Both exogenous and endogenous compounds can induce the expression of cytochrome P450 genes. The insect cytochrome P450 genes related to insecticide resistance are likely to be expressed as the "first line of defense" when challenged with insecticides. In this study, four cytochrome P450 genes, SinvCYP6B1, SinvCYP6A1, SinvCYP4C1, and SinvCYP4G15, were firstly isolated from workers of the red imported fire ant (Solenopsis invicta) through rapid amplification of cDNA ends (RACE) and sequenced. The fipronil induction profiles of the four cytochrome P450 genes and the two previously isolated CYP4AB1 and CYP4AB2 were characterized in workers. The results revealed that the expression of SinvCYP6B1, SinvCYP6A1, CYP4AB2, and SinvCYP4G15, increased 1.4-fold and 1.3-fold more than those of acetone control, respectively, after 24 h exposure to fipronil at concentrations of 0.25 mu g mL(-1) (median lethal dose) and 0.56 mu g mL(-1) (90% lethal dose), while no significant induction of the expression of CYP4AB1 and SinvCYP4C1 was detected. Among these genes, SinvCYP6B1 was the most significantly induced, and its maximum expression was 3.6-fold higher than that in acetone control. These results might suggest that multiple cytochrome P450 genes are co-up-regulated in workers of the fire ant through induction mechanism when challenged with fipronil. These findings indicated that cytochrome P450 genes play an important role in the detoxification of insecticides and provide a theoretical basis for the mechanisms of insecticide metabolism in the fire ant.	[Zhang, Baizhong; Cui, Rukun; Zeng, Xinnian] South China Agr Univ, Minist Educ, Key Lab Nat Pesticide & Chem Biol, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Lei; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China; [Zhang, Baizhong] Henan Inst Sci & Technol, Coll Nat Resources & Environm, Xinxiang 453003, Peoples R China	South China Agricultural University; China Agricultural University; Henan Institute of Science & Technology	Zeng, XN (corresponding author), South China Agr Univ, Minist Educ, Key Lab Nat Pesticide & Chem Biol, Guangzhou 510642, Guangdong, Peoples R China.; Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China.	zengxn@scau.edu.cn; gaoxiwu@263.net.cn			National Science Foundation of China [31071712]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are highly obliged to the National Science Foundation of China (31071712) for the financial support given to the present research work.; The authors are highly grateful to the National Science Foundation of China (31071712) for the financial support provided for the present research.	Abbas N, 2014, PARASITOL RES, V113, P1343, DOI 10.1007/s00436-014-3773-4; Ay R, 2010, J PEST SCI, V83, P85, DOI 10.1007/s10340-009-0274-9; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Cornette R, 2006, INSECT MOL BIOL, V15, P235, DOI 10.1111/j.1365-2583.2006.00632.x; Drummond AJ, 2012, GENEIOUSV 4 8; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Feyereisen R, 2005, COMPREHENSIVE MOL IN, V4, P1; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Gondhalekar AD, 2012, J MED ENTOMOL, V49, P122, DOI 10.1603/ME11106; Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.R07-02; Harrison TL, 2001, ARCH INSECT BIOCHEM, V48, P179, DOI 10.1002/arch.1070; Hu XP, 2005, PEST MANAG SCI, V61, P1209, DOI 10.1002/ps.1124; Huang Cheng-hua, 2006, Chinese Journal of Rice Science, V20, P447; JIANG Dongrong, 2008, GUANGXI PLANT PROTEC, V21, P20; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kuriachan I, 2000, ENVIRON ENTOMOL, V29, P943, DOI 10.1603/0046-225X-29.5.943; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Liu NN, 2004, GENE, V327, P81, DOI 10.1016/j.gene.2003.11.002; Liu XN, 2006, PESTIC BIOCHEM PHYS, V84, P127, DOI 10.1016/j.pestbp.2005.06.002; Londono DK, 2007, PESTIC BIOCHEM PHYS, V89, P104, DOI 10.1016/j.pestbp.2007.04.001; Londono DK, 2004, CHEMOSPHERE, V56, P701, DOI 10.1016/j.chemosphere.2003.12.001; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992; Marr R.M., 2003, ASSESSMENT NONTARGET; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nikou D, 2003, GENE, V318, P91, DOI 10.1016/S0378-1119(03)00763-7; OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Scott J.G, 2008, RECENT ADV INSECT PH, V1, P17; Sutherland TD, 2000, J INSECT PHYSIOL, V46, P1219, DOI 10.1016/S0022-1910(00)00042-1; Tarver MR, 2012, ARCH INSECT BIOCHEM, V80, P92, DOI 10.1002/arch.21030; Tufts DM, 2014, FLA ENTOMOL, V97, P1251, DOI 10.1653/024.097.0336; Vinson S. Bradleigh, 1997, American Entomologist, V43, P23; Wang L., 2013, COMPLEMENTARY ALTERN, V2013, P1; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Zhang B, 2015, J INTEGR AG IN PRESS, V15, P1; Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	46	19	22	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150915	10.1371/journal.pone.0150915	http://dx.doi.org/10.1371/journal.pone.0150915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982576	Green Published, gold			2022-12-26	WOS:000372574900057
J	Chu, C; Nielsen, R; Wu, YF				Chu, Chong; Nielsen, Rasmus; Wu, Yufeng			REPdenovo: Inferring De Novo Repeat Motifs from Short Sequence Reads	PLOS ONE			English	Article							RETROTRANSPOSONS; DATABASE; IMPACT	Repeat elements are important components of eukaryotic genomes. One limitation in our understanding of repeat elements is that most analyses rely on reference genomes that are incomplete and often contain missing data in highly repetitive regions that are difficult to assemble. To overcome this problem we develop a new method, REPdenovo, which assembles repeat sequences directly from raw shotgun sequencing data. REPdenovo can construct various types of repeats that are highly repetitive and have low sequence divergence within copies. We show that REPdenovo is substantially better than existing methods both in terms of the number and the completeness of the repeat sequences that it recovers. The key advantage of REPdenovo is that it can reconstruct long repeats from sequence reads. We apply the method to human data and discover a number of potentially new repeats sequences that have been missed by previous repeat annotations. Many of these sequences are incorporated into various parasite genomes, possibly because the filtering process for host DNA involved in the sequencing of the parasite genomes failed to exclude the host derived repeat sequences. REPdenovo is a new powerful computational tool for annotating genomes and for addressing questions regarding the evolution of repeat families. The software tool, REPdenovo, is available for download at https://github.com/Reedwarbler/REPdenovo.	[Chu, Chong; Wu, Yufeng] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Connecticut; University of California System; University of California Berkeley	Wu, YF (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.; Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rasmus_nielsen@berkeley.edu; ywu@engr.uconn.edu	Nielsen, Rasmus/D-4405-2009; Chu, Chong/AAA-4613-2022	Nielsen, Rasmus/0000-0003-0513-6591; Chu, Chong/0000-0002-0796-2339	US National Science Foundation [IIS-0953563, IIS-1447711, IIS-1526415]; Div Of Information & Intelligent Systems [1526415, 0953563, 1447711] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by grants IIS-0953563 and IIS-1447711 from US National Science Foundation (http://www.nsf.gov/) to YW and grant IIS-1526415 from US National Science Foundation to YW and RN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cormen T. H., 1992, INTRO ALGORITHMS; Durbin R., 1999, BIOL SEQUENCE ANAL P; Fiston-Lavier AS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1291; Hubley R., 2013, REPEATMASKER OPEN 40; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Keane TM, 2013, BIOINFORMATICS, V29, P389, DOI 10.1093/bioinformatics/bts697; Koch P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku210; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Nakagome M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-71; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; Witherspoon DJ, 2013, GENOME RES, V23, P1170, DOI 10.1101/gr.148973.112; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhuang JL, 2014, NUCLEIC ACIDS RES, V42, P6826, DOI 10.1093/nar/gku323	25	32	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150719	10.1371/journal.pone.0150719	http://dx.doi.org/10.1371/journal.pone.0150719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977803	gold, Green Submitted, Green Published			2022-12-26	WOS:000372572800033
J	Ding, T; Melcher, U				Ding, Tao; Melcher, Ulrich			Influences of Plant Species, Season and Location on Leaf Endophytic Bacterial Communities of Non-Cultivated Plants	PLOS ONE			English	Article							GROWTH PROMOTION; HUMAN MICROBIOME; DIVERSITY; PHYTOREMEDIATION; PHYLLOSPHERE; COLONIZATION; SUGARCANE; PATHOGENS; LETTUCE; GINSENG	Bacteria are known to be associated endophytically with plants. Research on endophytic bacteria has identified their importance in food safety, agricultural production and phytoremediation. However, the diversity of endophytic bacterial communities and the forces that shape their compositions in non-cultivated plants are largely uncharacterized. In this study, we explored the diversity, community structure, and dynamics of endophytic bacteria in different plant species in the Tallgrass Prairie Preserve of northern Oklahoma, USA. High throughput sequencing of amplified segments of bacterial rDNA from 81 samples collected at four sampling times from five plant species at four locations identified 335 distinct OTUs at 97% sequence similarity, representing 16 phyla. Proteobacteria was the dominant phylum in the communities, followed by the phyla Bacteriodetes and Actinobacteria. Bacteria from four classes of Proteobacteria were detected with Alphaproteobacteria as the dominant class. Analysis of molecular variance revealed that host plant species and collecting date had significant influences on the compositions of the leaf endophytic bacterial communities. The proportion of Alphaproteobacteria was much higher in the communities from Asclepias viridis than from other plant species and differed from month to month. The most dominant bacterial groups identified in LDA Effect Size analysis showed host-specific patterns, indicating mutual selection between host plants and endophytic bacteria and that leaf endophytic bacterial compositions were dynamic, varying with the host plant's growing season in three distinct patterns. In summary, next generation sequencing has revealed variations in the taxonomic compositions of leaf endophytic bacterial communities dependent primarily on the nature of the plant host species.	[Ding, Tao; Melcher, Ulrich] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Ding, Tao] NYU, Dept Biol, New York, NY 10003 USA	Oklahoma State University System; Oklahoma State University - Stillwater; New York University	Melcher, U (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	u-melcher-4@alumni.uchicago.edu			Oklahoma Agricultural Experiment Station; R. J. Sirny Professorship at Oklahoma State University; National Science Foundation [EPS-0447262]	Oklahoma Agricultural Experiment Station; R. J. Sirny Professorship at Oklahoma State University; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Oklahoma Agricultural Experiment Station, whose Director has approved this publication, the R. J. Sirny Professorship at Oklahoma State University and the National Science Foundation through EPS-0447262. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Bent E, 1998, CAN J MICROBIOL, V44, P980, DOI 10.1139/cjm-44-10-980; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Chanway CP, 1997, FOREST SCI, V43, P99; Chelius MK, DIVERSITY ARCHAEA BA; Cho KM, 2007, MICROB ECOL, V54, P341, DOI 10.1007/s00248-007-9208-3; Cole JR, 2013, NUCLEIC ACIDS RES, DOI [10.1093/nar/gkt1244, DOI 10.1093/NAR/GKT1244]; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Ding T, COMMUNITY TERMINAL R; Ding T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-1; Duijff BJ, 1997, NEW PHYTOL, V135, P325, DOI 10.1046/j.1469-8137.1997.00646.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EXCOFFIER L, 1992, GENETICS, V131, P479; Fletcher J, 2013, PHYTOPATHOLOGY, V103, P306, DOI 10.1094/PHYTO-09-12-0236-IA; Germaine KJ, 2006, FEMS MICROBIOL ECOL, V57, P302, DOI 10.1111/j.1574-6941.2006.00121.x; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Guo XA, 2002, APPL ENVIRON MICROB, V68, P3639, DOI 10.1128/AEM.68.7.3639-3643.2002; Hamady M, ERROR CORRECTING BAR; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ingham SC, 2005, J FOOD PROTECT, V68, P1134, DOI 10.4315/0362-028X-68.6.1134; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Lee S, 2004, J BACTERIOL, V186, P5384, DOI 10.1128/JB.186.16.5384-5391.2004; Lindow SE, 2003, APPL ENV MICROBIOL; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Magnani GS, 2010, GENET MOL RES, V9, P250, DOI 10.4238/vol9-1gmr703; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Methe B. A., 2012, NATURE, V486, P215, DOI DOI 10.1038/NATURE11209; Moore FP, 2006, SYST APPL MICROBIOL, V29, P539, DOI 10.1016/j.syapm.2005.11.012; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Newman LA, 2005, TRENDS BIOTECHNOL, V23, P6, DOI 10.1016/j.tibtech.2004.11.010; Pavlo A, 2011, BIOL CONTROL, V56, P43, DOI 10.1016/j.biocontrol.2010.09.014; Petrosino JF, METAGENOMIC PYROSEQU; QuadtHallmann A, 1997, CAN J MICROBIOL, V43, P577, DOI 10.1139/m97-081; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quecine MC, 2012, APPL ENVIRON MICROB, V78, P7511, DOI 10.1128/AEM.00836-12; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon C. E., 1949, MATH THEORY COMMUNIC; Vendan RT, 2010, J MICROBIOL, V48, P559, DOI 10.1007/s12275-010-0082-1; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898	47	61	64	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150895	10.1371/journal.pone.0150895	http://dx.doi.org/10.1371/journal.pone.0150895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974817	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600037
J	Huang, XY; He, ZY; Jiang, XW; Hou, MJ; Tang, ZH; Zhen, XZ; Liang, YM; Ma, J				Huang, Xiaoyan; He, Zhiying; Jiang, Xinwei; Hou, Mengjun; Tang, Zhihong; Zhen, Xiaozhou; Liang, Yuming; Ma, Jing			Folic Acid Represses Hypoxia-Induced Inflammation in THP-1 Cells through Inhibition of the PI3K/Akt/HIF-1 alpha Pathway	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FACTOR-I HIF-1; INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL FUNCTION; OXYGEN-TENSION; EXPRESSION; ACTIVATION; INTERLEUKIN-1; RECEPTOR; DISEASE	Though hypoxia has been implicated as a cause of inflammation, the underlying mechanism is not well understood. Folic acid has been shown to provide protection against oxidative stress and inflammation in patients with cardiovascular disease and various models approximating insult to tissue via inflammation. It has been reported that hypoxia-induced inflammation is associated with oxidative stress, upregulation of hypoxia-inducible factor 1-alpha (HIF-1 alpha), and production of pro-inflammatory molecules. Whether folic acid protects human monocytic cells (THP-1 cells) against hypoxia-induced damage, however, remains unknown. We used THP-1 cells to establish a hypoxia-induced cellular injury model. Pre-treating THP-1 cells with folic acid attenuated hypoxia-induced inflammatory responses, including a decrease in protein and mRNA levels of interleukin (IL)-1 beta and tumor necrosis factor-alpha (TNF-alpha), coupled with increased levels of IL-10. Folic acid also reduced hypoxia-induced Akt phosphorylation and decreased nuclear accumulation of HIF-1 alpha protein. Both LY294002 (a selective inhibitor of phosphatidyl inositol-3 kinase, PI3K) and KC7F2 (a HIF-1 alpha inhibitor) reduced levels of hypoxia-induced inflammatory cytokines. We also found that insulin (an Akt activator) and dimethyloxallyl glycine (DMOG, a HIF-1 alpha activator) induced over-expression of inflammatory cytokines, which could be blocked by folic acid. Taken together, these findings demonstrate how folic acid attenuates the hypoxia-induced inflammatory responses of THP-1 cells through inhibition of the PI3K/Akt/HIF-1 alpha pathway.	[Huang, Xiaoyan; He, Zhiying; Jiang, Xinwei; Zhen, Xiaozhou; Liang, Yuming; Ma, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Hou, Mengjun; Tang, Zhihong] Sun Yat Sen Univ, Sch Publ Hlth, Expt & Teaching Ctr Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China.	majing@mail.sysu.edu.cn			National Science Foundation of China [81372977]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by General Project of National Science Foundation of China (81372977) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA JE, 1995, J IMMUNOL, V155, P4391; Angele MK, 1999, AM J PHYSIOL-CELL PH, V276, pC285, DOI 10.1152/ajpcell.1999.276.2.C285; BEUTLER B, 1995, J INVEST MED, V43, P227; BLAKE DR, 1994, ANN NY ACAD SCI, V723, P308, DOI 10.1111/j.1749-6632.1994.tb36736.x; Bosco MC, 2008, IMMUNOBIOLOGY, V213, P733, DOI 10.1016/j.imbio.2008.07.031; Chachami G, 2009, BIOCHEM BIOPH RES CO, V390, P235, DOI 10.1016/j.bbrc.2009.09.093; Chiarello PG, 2009, DIGEST DIS SCI, V54, P627, DOI 10.1007/s10620-008-0398-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Depping R, 2015, J MOL MED, V93, P599, DOI 10.1007/s00109-015-1276-0; DINARELLO CA, 1991, BLOOD, V77, P1627; Doshi SN, 2002, CIRCULATION, V105, P22, DOI 10.1161/hc0102.101388; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Feng D, 2011, INFLAMM RES, V60, P817, DOI 10.1007/s00011-011-0337-2; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Galindo M, 2001, CLIN EXP IMMUNOL, V123, P36, DOI 10.1046/j.1365-2249.2001.01412.x; GHEZZI P, 1991, CYTOKINE, V3, P189, DOI 10.1016/1043-4666(91)90015-6; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Hoffbrand AV, 2001, BRIT J HAEMATOL, V113, P579, DOI 10.1046/j.1365-2141.2001.02822.x; Hong Soon-Sun, 2004, Cancer Res Treat, V36, P343, DOI 10.4143/crt.2004.36.6.343; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer R, 2009, J FOOD SCI, V74, pR114, DOI 10.1111/j.1750-3841.2009.01359.x; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Joshi S, 2014, J BIOL CHEM, V289, P22785, DOI 10.1074/jbc.M114.587493; Kaluz S, 2002, CANCER RES, V62, P4469; KARAKURUM M, 1994, J CLIN INVEST, V93, P1564, DOI 10.1172/JCI117135; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu YN, 2009, SHOCK, V32, P263, DOI 10.1097/SHK.0b013e31819940cb; Mandl M, 2014, MOL MED, V20, P215, DOI 10.2119/molmed.2014.00032; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Peyssonnaux C, 2004, CELL CYCLE, V3, P168; Royle C, 2009, CYTOKINE, V47, P56, DOI 10.1016/j.cyto.2009.04.006; Scannell G, 1996, New Horiz, V4, P179; Scott J M, 1998, J Cardiovasc Risk, V5, P223, DOI 10.1097/00043798-199808000-00003; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shafee N, 2009, CANCER LETT, V282, P109, DOI 10.1016/j.canlet.2009.03.004; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Solini A, 2006, INT J OBESITY, V30, P1197, DOI 10.1038/sj.ijo.0803265; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wani NA, 2008, IUBMB LIFE, V60, P834, DOI 10.1002/iub.133; Whayne TF, 2014, CURR OPIN CARDIOL, V29, P396, DOI 10.1097/HCO.0000000000000064; Woo KS, 1999, J AM COLL CARDIOL, V34, P2002, DOI 10.1016/S0735-1097(99)00469-6; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yu F, 2001, CANCER RES, V61, P4136; Zhang WD, 2006, J NEUROIMMUNOL, V174, P63, DOI 10.1016/j.jneuroim.2006.01.014	51	28	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151553	10.1371/journal.pone.0151553	http://dx.doi.org/10.1371/journal.pone.0151553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974319	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600089
J	Zhang, FG; Meng, XH; Feng, CL; Ran, W; Yu, GH; Zhang, YJ; Shen, QR				Zhang, Fengge; Meng, Xiaohui; Feng, Chenglong; Ran, Wei; Yu, Guanghui; Zhang, Yingjun; Shen, Qirong			Hydrolytic Amino Acids Employed as a Novel Organic Nitrogen Source for the Preparation of PGPF-Containing Bio-Organic Fertilizer for Plant Growth Promotion and Characterization of Substance Transformation during BOF Production	PLOS ONE			English	Article							TRICHODERMA-HARZIANUM; FLUORESCENCE EXCITATION; MATTER; WATER; OPTIMIZATION; COMPOST; SLUDGE; FORMULATIONS; SPECTROSCOPY; BIOCONTROL	Opportunity costs seriously limit the large-scale production of bio-organic fertilizers (BOFs) both in China and internationally. This study addresses the utilization of amino acids resulting from the acidic hydrolysis of pig corpses as organic nitrogen sources to increase the density of TrichodermaharzianumT-E5 (a typical plant growth-promoting fungi, PGPF). This results in a novel, economical, highly efficient and environmentally friendly BOF product. Fluorescence excitation-emission matrix (EEM) spectroscopy combined with fluorescence regional integration (FRI) was employed to monitor compost maturity levels, while pot experiments were utilized to test the effects of this novel BOF on plant growth. An optimization experiment, based on response surface methodologies (RSMs), showed that a maximum T-E5 population (3.72 x 10(8) ITS copies g(-1)) was obtained from a mixture of 65.17% cattle manure compost (W/W), 19.33% maggot manure (W/W), 15.50% (V/W) hydrolytic amino acid solution and 4.69%(V/W) inoculum at 28.7 degrees C after a 14 day secondary solid fermentation. Spectroscopy analysis revealed that the compost transformation process involved the degradation of protein-like substances and the formation of fulvic-like and humic-like substances. FRI parameters (P-I,P- n, P-II,P- n, P-III,P- n and P-V,P- n) were used to characterize the degree of compost maturity. The BOF resulted in significantly higher increased chlorophyll content, shoot length, and shoot and root dry weights of three vegetables (cucumber, tomato and pepper) by 9.9%similar to 22.4%, 22.9%similar to 58.5%, 31.0%similar to 84.9%, and 24.2%similar to 34.1%, respectively. In summary, this study presents an operational means of increasing PGPF T-E5 populations in BOF to promote plant growth with a concomitant reduction in production cost. In addition, a BOF compost maturity assessment using fluorescence EEM spectroscopy and FRI ensured its safe field application.	[Zhang, Fengge; Meng, Xiaohui; Feng, Chenglong; Ran, Wei; Yu, Guanghui; Shen, Qirong] Nanjing Agr Univ, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing 210095, Jiangsu, Peoples R China; [Zhang, Fengge] Nanjing Agr Univ, Grassland & Environm Engn Lab, Nanjing 210095, Jiangsu, Peoples R China; [Ran, Wei; Yu, Guanghui; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Shen, QR (corresponding author), Nanjing Agr Univ, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing 210095, Jiangsu, Peoples R China.; Shen, QR (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing 210095, Jiangsu, Peoples R China.	shenqirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Yu, Guanghui/H-4968-2013	Yu, Guanghui/0000-0002-5699-779X; Zhang, Yingjun/0000-0001-5776-4392	973 project [2015CB150506]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	973 project(National Basic Research Program of China); Innovative Research Team Development Plan of the Ministry of Education of China; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was financially supported by 973 project (2015CB150506), Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256), and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.	Abid N, 2006, WASTE MANAGE, V26, P1099, DOI 10.1016/j.wasman.2005.06.015; Ahmed Mushtaq, 2011, Journal of Mycology and Plant Pathology, V41, P77; [Anonymous], 1983, WASTE MANAGE RES, DOI [DOI 10.1177/0734242X8300100118, DOI 10.1016/0734-242X(83)90055-1]; Antizar-Ladislao B, 2006, CHEMOSPHERE, V64, P839, DOI 10.1016/j.chemosphere.2005.10.036; Baddi GA, 2004, BIORESOURCE TECHNOL, V93, P285, DOI 10.1016/j.biortech.2003.10.026; Benitez C, 1998, BIORESOURCE TECHNOL, V63, P147, DOI 10.1016/S0960-8524(97)00072-2; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Chen LH, 2011, BIORESOURCE TECHNOL, V102, P3900, DOI 10.1016/j.biortech.2010.11.126; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; De Souza JT, 2008, BIOL CONTROL, V46, P36, DOI 10.1016/j.biocontrol.2008.01.010; Doni F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-532; FRAVEL DR, 1995, PHYTOPATHOLOGY, V85, P165, DOI 10.1094/Phyto-85-165; Gone DL, 2009, J HAZARD MATER, V172, P693, DOI 10.1016/j.jhazmat.2009.07.052; Guo WQ, 2009, BIORESOURCE TECHNOL, V100, P1192, DOI 10.1016/j.biortech.2008.07.070; Halim SFA, 2009, BIORESOURCE TECHNOL, V100, P710, DOI 10.1016/j.biortech.2008.07.031; Henderson RK, 2009, WATER RES, V43, P863, DOI 10.1016/j.watres.2008.11.027; Huang XQ, 2011, APPL MICROBIOL BIOT, V91, P741, DOI 10.1007/s00253-011-3259-6; Huang Y, 2014, ENVIRON TECHNOL, V35, P1658, DOI 10.1080/09593330.2013.878397; Lugtenberg BJJ, 1999, ENVIRON MICROBIOL, V1, P439, DOI 10.1046/j.1462-2920.1999.00054.x; Marhuenda-Egea FC, 2007, CHEMOSPHERE, V68, P301, DOI 10.1016/j.chemosphere.2006.12.075; Masunaka A, 2011, MICROBES ENVIRON, V26, P128, DOI 10.1264/jsme2.ME10176; MATHUR SP, 1993, BIOL AGRIC HORTIC, V10, P65, DOI 10.1080/01448765.1993.9754655; Mirhosseini H, 2009, CARBOHYD POLYM, V75, P512, DOI 10.1016/j.carbpol.2008.08.022; Provenzano MR, 2001, J AGR FOOD CHEM, V49, P5874, DOI 10.1021/jf0106796; Said-Pullicino D, 2007, BIORESOURCE TECHNOL, V98, P1822, DOI 10.1016/j.biortech.2006.06.018; Santamaria RS, 2001, AGROCIENCIA, V35, P377; Shao ZH, 2009, J HAZARD MATER, V164, P1191, DOI 10.1016/j.jhazmat.2008.09.035; Tan JY, 2012, J FOOD AGRIC ENVIRON, V10, P1205; Tang Z, 2011, CHEMOSPHERE, V82, P1202, DOI 10.1016/j.chemosphere.2010.11.032; Tiquia SM, 2000, BIORESOURCE TECHNOL, V72, P1, DOI 10.1016/S0960-8524(99)90092-5; Wong JWC, 2001, BIORESOURCE TECHNOL, V76, P99, DOI 10.1016/S0960-8524(00)00103-6; Wu MJ, 2012, J RESIDUALS SCI TECH, V9, P65; Xu HC, 2010, WATER SCI TECHNOL, V61, P2931, DOI 10.2166/wst.2010.197; Yu GH, 2010, WATER RES, V44, P797, DOI 10.1016/j.watres.2009.10.021; Zhang FG, 2014, FEMS MICROBIOL LETT, V359, P116, DOI 10.1111/1574-6968.12582; Zhang FG, 2013, APPL SOIL ECOL, V72, P41, DOI 10.1016/j.apsoil.2013.05.016; Zhang FG, 2013, IND CROP PROD, V49, P619, DOI 10.1016/j.indcrop.2013.05.037; Zhang FG, 2013, PLANT SOIL, V368, P433, DOI 10.1007/s11104-012-1519-6	38	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149447	10.1371/journal.pone.0149447	http://dx.doi.org/10.1371/journal.pone.0149447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974549	Green Submitted, gold, Green Published			2022-12-26	WOS:000372570600011
J	Demers-Lamarche, J; Guillebaud, G; Tlili, M; Todkar, K; Belanger, N; Grondin, M; Nguyen, AP; Michel, J; Germain, M				Demers-Lamarche, Julie; Guillebaud, Gerald; Tlili, Mouna; Todkar, Kiran; Belanger, Noemie; Grondin, Martine; Nguyen, Angela P.; Michel, Jennifer; Germain, Marc			Loss of Mitochondrial Function Impairs Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; PARKINSONS-DISEASE; COMPLEX-I; HUNTINGTONS-DISEASE; MOUSE MODEL; AUTOPHAGY; PINK1; DYSFUNCTION; DEGRADATION; PATHOLOGY	Alterations in mitochondrial function, as observed in neurodegenerative diseases, lead to disrupted energy metabolism and production of damaging reactive oxygen species. Here, we demonstrate that mitochondrial dysfunction also disrupts the structure and function of lysosomes, the main degradation and recycling organelle. Specifically, inhibition of mitochondrial function, following deletion of the mitochondrial protein AIF, OPA1, or PINK1, as well as chemical inhibition of the electron transport chain, impaired lysosomal activity and caused the appearance of large lysosomal vacuoles. Importantly, our results show that lysosomal impairment is dependent on reactive oxygen species. Given that alterations in both mitochondrial function and lysosomal activity are key features of neurodegenerative diseases, this work provides important insights into the etiology of neurodegenerative diseases.	[Michel, Jennifer; Germain, Marc] Univ Quebec Trois Rivieres, Grp Rech Signalisat Cellulaire, Dept Med Biol, Trois Rivieres, PQ G9A 5H7, Canada; [Demers-Lamarche, Julie; Guillebaud, Gerald; Todkar, Kiran; Germain, Marc] Univ Quebec Trois Rivieres, Ctr Rech Biomed, Trois Rivieres, PQ G9A 5H7, Canada; [Nguyen, Angela P.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Ottawa	Germain, M (corresponding author), Univ Quebec Trois Rivieres, Dept Med Biol, 3351 Blvd Forges, Trois Rivieres, PQ G9A 5H7, Canada.	marc.germain1@uqtr.ca			Natural Sciences and Engineering Research Council of Canada; Fonds de Recherche du Quebec-Sante	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of graduate scholarships from the Fonds de Recherche du Quebec-Sante and the Natural Sciences and Engineering Research Council of Canada.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amo T, 2011, NEUROBIOL DIS, V41, P111, DOI 10.1016/j.nbd.2010.08.027; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Arduino DM, 2012, HUM MOL GENET, V21, P4680, DOI 10.1093/hmg/dds309; Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Ben-Gedalya T, 2012, TRAFFIC, V13, P635, DOI 10.1111/j.1600-0854.2012.01330.x; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Dairaku T, 2014, MOL GENET METAB, V111, P193, DOI 10.1016/j.ymgme.2013.11.003; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI [10.1089/ars.2008.2247, 10.1089/ARS.2008.2247]; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Germain M, 2013, HUM MOL GENET, V22, P952, DOI 10.1093/hmg/dds500; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Gustaw-Rothenburg K, 2010, BIOMARK MED, V4, P15, DOI 10.2217/BMM.09.86; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Karuppagounder SS, 2009, NEUROBIOL AGING, V30, P1587, DOI 10.1016/j.neurobiolaging.2007.12.013; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pagano G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/541230; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Patten DA, 2010, J ALZHEIMERS DIS, V20, pS357, DOI 10.3233/JAD-2010-100498; Perzov N, 2002, J EXP BIOL, V205, P1209; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Raimundo N, 2014, TRENDS MOL MED, V20, P282, DOI 10.1016/j.molmed.2014.01.005; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Schultheis PJ, 2013, HUM MOL GENET, V22, P2067, DOI 10.1093/hmg/ddt057; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; TURK B, 1994, BIOCHEMISTRY-US, V33, P14800, DOI 10.1021/bi00253a019; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Xie YX, 2015, NEURON, V87, P355, DOI 10.1016/j.neuron.2015.06.026; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	68	127	127	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10263	10276		10.1074/jbc.M115.695825	http://dx.doi.org/10.1074/jbc.M115.695825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26987902	Green Published, hybrid			2022-12-26	WOS:000375602800034
J	Du, ZQ; Xu, XM; Zhang, H; Wu, ZT; Liu, Y				Du, Ziqiang; Xu, Xiaoming; Zhang, Hong; Wu, Zhitao; Liu, Yong			Geographical Detector-Based Identification of the Impact of Major Determinants on Aeolian Desertification Risk	PLOS ONE			English	Article							NORTH CHINA; CLIMATE-CHANGE; RELATIVE ROLE; VEGETATION; COVER; DEGRADATION; DYNAMICS; PROVINCE; REGION; AREAS	Arid and semi-arid areas in North China are facing the challenge of a rising aeolian desertification risk (ADR) due to the intertwined effects of complex natural processes and intensified anthropogenic activities. An accurate quantitative assessment of the relationship between ADR and its determinants is beneficial for understanding the driving mechanisms of aeolian desertification and for controlling future desertification. Previous studies have failed to quantify the relative role of determinants driving ADR and have been limited in assessing their interactive impacts. In this study, a spatial variance analysis-based geographical detector methodology is used to quantify the effects of geological, physical, and human factors on the occurrence of ADR in an area characterized by mountains and hills in northern China. It is found that soil type, precipitation, and wind velocity are the major determinants of ADR, which implies that geological and physical elements (e.g., soil attribute) and climatic factors (e.g., precipitation and wind velocity) rather than human activities have played a greater role in the incidence of ADR. Particularly, the results show that the interaction of various determinants causes significant non-linearly enhanced impacts on the ADR. The findings of our study will assist local inhabitants and policy makers in developing measures for wind prevention and sand control to mitigate the effects of desertification in the region.	[Du, Ziqiang; Xu, Xiaoming; Wu, Zhitao; Liu, Yong] Shanxi Univ, Inst Loess Plateau, Taiyuan 030006, Shanxi, Peoples R China; [Zhang, Hong] Shanxi Univ, Coll Environm & Resource Sci, Taiyuan 030006, Peoples R China	Shanxi University; Shanxi University	Du, ZQ (corresponding author), Shanxi Univ, Inst Loess Plateau, Taiyuan 030006, Shanxi, Peoples R China.; Zhang, H (corresponding author), Shanxi Univ, Coll Environm & Resource Sci, Taiyuan 030006, Peoples R China.	duzq@sxu.edu.cn; zhanghong@sxu.edu.cn	Xu, Xiaoming/R-2155-2018	Xu, Xiaoming/0000-0003-1405-8089	Important Specialized Science and Technology Item of Shanxi Province [20121101011]; National Natural Science Foundation of China [41161066, 41401053, 41301609]; Foundation for Young Scientists of Shanxi Province [2015021172]	Important Specialized Science and Technology Item of Shanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Young Scientists of Shanxi Province	The work was supported by the Important Specialized Science and Technology Item of Shanxi Province (grant no. 20121101011), the National Natural Science Foundation of China (grant nos. 41161066, 41401053 and 41301609) and the Foundation for Young Scientists of Shanxi Province (grant no. 2015021172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Belushi A.S., 2003, THESIS JORDANIAN U J; Albalawi EK, 2013, J FOOD AGRIC ENVIRON, V11, P791; Asner GP, 2005, GLOBAL CHANGE BIOL, V11, P182, DOI 10.1111/j.1529-8817.2003.00880.x; Becerril-Pina R, 2015, J ARID ENVIRON, V120, P4, DOI 10.1016/j.jaridenv.2015.04.006; Bo T-L, 2013, AEOLIAN RES; Canora F., 2014, J MAPS, P1, DOI DOI 10.1080/17445647; Cao F, 2013, GISCI REMOTE SENS; Chen Y, 2005, LAND DEGRAD DEV, V16, P367, DOI 10.1002/ldr.667; D'Odorico P, 2013, ADV WATER RESOUR, V51, P326, DOI 10.1016/j.advwatres.2012.01.013; Gutman G, 1998, INT J REMOTE SENS, V19, P1533, DOI 10.1080/014311698215333; Hein L, 2011, J ARID ENVIRON, V75, P1164, DOI 10.1016/j.jaridenv.2011.05.002; Hellden U, 2008, GLOBAL PLANET CHANGE, V64, P169, DOI 10.1016/j.gloplacha.2008.10.006; Higginbottom TP, 2014, REMOTE SENS-BASEL, V6, P9552, DOI 10.3390/rs6109552; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021427; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Huang S, 2006, J ARID ENVIRON, V67, P308, DOI 10.1016/j.jaridenv.2006.02.016; Ibanez J, 2008, ECOL MODEL, V213, P180, DOI 10.1016/j.ecolmodel.2007.11.017; Li JC, 2015, J ARID LAND, V7, P755, DOI 10.1007/s40333-015-0050-z; Li S, 2007, LAND DEGRAD DEV, V18, P473, DOI 10.1002/ldr.787; Li SG, 2000, AGR FOREST METEOROL, V102, P125, DOI 10.1016/S0168-1923(00)00101-5; [李振山 LI Zhenshan], 2006, [中国沙漠, Journal of Desert Research], V26, P687; Liu SL, 2015, ENVIRON EARTH SCI, V73, P7561, DOI 10.1007/s12665-014-3926-x; Liu Y, 2004, INT J REMOTE SENS, V25, P4177, DOI 10.1080/01431160410001680419; Ma YH, 2007, ENVIRON GEOL, V51, P999, DOI 10.1007/s00254-006-0369-z; Millington JDA, 2007, ECOSYSTEMS, V10, P562, DOI 10.1007/s10021-007-9020-4; Piao SL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021764; Veron SR, 2006, J ARID ENVIRON, V66, P751, DOI 10.1016/j.jaridenv.2006.01.021; Vieira RMSP, 2015, SOLID EARTH, V6, P347, DOI 10.5194/se-6-347-2015; Wang JF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002112; Wang JF, 2012, ENVIRON MODELL SOFTW, V33, P114, DOI 10.1016/j.envsoft.2012.01.015; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang XM, 2006, GLOBAL ENVIRON CHANG, V16, P48, DOI 10.1016/j.gloenvcha.2005.06.006; Wang XM, 2008, EARTH-SCI REV, V88, P188, DOI 10.1016/j.earscirev.2008.02.001; Wang XM, 2009, GLOBAL PLANET CHANGE, V67, P167, DOI 10.1016/j.gloplacha.2009.02.004; Xu DY, 2014, CATENA, V123, P11, DOI 10.1016/j.catena.2014.07.004; Xu DY, 2011, J GEOGR SCI, V21, P926, DOI 10.1007/s11442-011-0890-1; Xu EQ, 2014, SOLID EARTH, V5, P1329, DOI 10.5194/se-5-1329-2014; Xue ZJ, 2013, GLOBAL PLANET CHANGE, V107, P102, DOI 10.1016/j.gloplacha.2013.05.001; Yue YM, 2012, PROCEDIA ENVIRON SCI, V13, P847, DOI 10.1016/j.proenv.2012.01.078; Zhang J, 2014, J ARID ENVIRON, V108, P19, DOI 10.1016/j.jaridenv.2014.04.006; Zhou W, 2015, ECOL INDIC, V48, P560, DOI 10.1016/j.ecolind.2014.08.043	42	28	35	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151331	10.1371/journal.pone.0151331	http://dx.doi.org/10.1371/journal.pone.0151331			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987114	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300061
J	Han, XT; Niu, Y; Guo, XX; Hu, Y; Yan, W; He, MG				Han, Xiaotong; Niu, Yong; Guo, Xinxing; Hu, Yin; Yan, William; He, Mingguang			Age-Related Changes of Intraocular Pressure in Elderly People in Southern China: Lingtou Eye Cohort Study	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; LONGITUDINAL ANALYSIS; JAPANESE POPULATION; BARBADOS EYE; ASSOCIATIONS; GLAUCOMA; ADULTS; YOUNG	Purpose To study age-related changes of intraocular pressure (IOP) and assess the cohort effect in both cross-sectional and longitudinal settings among elderly Chinese adults. Methods Participants were enrolled from the Lingtou Eye Cohort Study with Chinese government officials aged 40 years and older at baseline and received physical check-up and ocular examinations from 2010 to 2012. IOP was measured using a non-contact tonometer according to standardized protocols, as well as systolic blood pressure (SBP), diastolic blood pressure (DBP) and body mass index (BMI). Participants who had attended IOP measurements in both 2010 and 2012 were included in this study. Cross-sectional association of IOP with age was assessed using multivariate liner regression analyses and based on the data of 2010. Longitudinal changes in IOP were assessed by paired t-test. Results A total of 3372 subjects were enrolled in the current analysis (2010 mean [SD] age, 61.9 [7.1] years; 60.2% men). The mean IOP in 2010 was 15.4 +/- 2.3 mmHg for women and 15.2 +/- 2.3 mmHg for men with an intersex difference (P = 0.029). Cross-sectional analysis showed that IOP was negatively associated with age (P = 0.003, beta = -0.033 for women and P<0.001, beta = -0.061 for men) adjusted for baseline SBP, DBP and BMI. Paired t-test suggested that IOP was higher in the year 2012 than 2010 in women (P = 0.006) but did not change significantly in men within 2 years (P = 0.345). In addition, the 2-year changes of IOP were not associated with age adjusted for baseline IOP in 2010 (P = 0.249). Conclusion Cross-sectional data suggests that IOP is lower in people with older age. Longitudinal data does not support such findings and thus the identified decreasing pattern with age in cross-sectional analysis is likely caused by cohort effects.	[Han, Xiaotong; Guo, Xinxing; Hu, Yin; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Niu, Yong] Guangzhou 11 Peoples Hosp, Guangzhou, Guangdong, Peoples R China; [Yan, William; He, Mingguang] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Sun Yat Sen University; Centre for Eye Research Australia; University of Melbourne	He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.; He, MG (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia.	mingguang_he@yahoo.com	Guo, Xinxing/AAT-1652-2020; He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810; Han, Xiaotong/0000-0001-6836-3447	Fundamental Research Funds of the State Key Laboratory in Ophthalmology; National Natural Science Foundation of China [81125007]; Brien Holden Vision Institute	Fundamental Research Funds of the State Key Laboratory in Ophthalmology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Brien Holden Vision Institute	The study was supported by the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, and the National Natural Science Foundation of China (81125007) and a research grant from the Brien Holden Vision Institute. The sponsors had no role in study design, data collection, analysis or decision to publish or prepare of the manuscript.; This study was supported by the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, National Natural Science Foundation of China (81125007) and a research grant from the Brien Holden Vision Institute. The authors alone are responsible for the content writing of the paper.	AlMubrad TM, 2008, CLIN EXP OPTOM, V91, P524, DOI 10.1111/j.1444-0938.2008.00298.x; Astrom S, 2014, ACTA OPHTHALMOL, V92, P417, DOI 10.1111/aos.12232; Baek SU, 2015, EYE, V29, P625, DOI 10.1038/eye.2015.11; Carbonaro F, 2010, EYE, V24, P1165, DOI 10.1038/eye.2010.11; Elena Rochtchina, 2002, CLIN EXPT OPHTHALMOL, V2002, P173; Fogagnolo P, 2010, J GLAUCOMA, V19, P418, DOI 10.1097/IJG.0b013e3181aff432; Fogagnolo P, 2009, INVEST OPHTH VIS SCI, V50, P2209, DOI 10.1167/iovs.08-2889; Foster PJ, 2011, INVEST OPHTH VIS SCI, V52, P8179, DOI 10.1167/iovs.11-7853; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Fukuoka S, 2008, ACTA OPHTHALMOL, V86, P434, DOI 10.1111/j.1600-0420.2007.01068.x; Guedes Guilherme, 2011, Curr Aging Sci, V4, P110; Hennis A, 2003, OPHTHALMOLOGY, V110, P908, DOI 10.1016/S0161-6420(03)00075-7; Hu Y, 2015, INVEST OPHTH VIS SCI, V56, P842, DOI 10.1167/iovs.14-15943; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Lee MK, 2012, OPHTHALMOLOGY, V119, P450, DOI 10.1016/j.ophtha.2011.09.016; Lin HY, 2005, ARCH OPHTHALMOL-CHIC, V123, P381, DOI 10.1001/archopht.123.3.381; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Nemesure B, 2003, ARCH OPHTHALMOL-CHIC, V121, P856, DOI 10.1001/archopht.121.6.856; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Ozel AB, 2014, HUM GENET, V133, P41, DOI 10.1007/s00439-013-1349-5; Preussner PR, 2009, GRAEF ARCH CLIN EXP, V247, P1671, DOI 10.1007/s00417-009-1166-7; Qureshi IA, 1997, CLIN PHYSIOL, V17, P247, DOI 10.1111/j.1365-2281.1997.tb00004.x; Smedowski A, 2014, INVEST OPHTH VIS SCI, V55, P666, DOI 10.1167/iovs.13-13172; Wang DD, 2011, AM J OPHTHALMOL, V152, P454, DOI 10.1016/j.ajo.2011.03.005; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; Yoshida M, 2014, ENVIRON HEALTH PREV, V19, P100, DOI 10.1007/s12199-013-0359-1; Yoshida M, 2014, ACTA MED OKAYAMA, V68, P27; Zhao D, 2014, INVEST OPHTH VIS SCI, V55, P6244, DOI 10.1167/iovs.14-14151; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	31	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151766	10.1371/journal.pone.0151766	http://dx.doi.org/10.1371/journal.pone.0151766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986222	Green Published, gold			2022-12-26	WOS:000372580300126
J	Hwang, Y; Lee, KE; Weiderpass, E; Park, YJ; Chai, YJ; Kwon, H; Park, DJ; Cho, B; Choi, HC; Kang, D; Park, SK				Hwang, Yunji; Lee, Kyu Eun; Weiderpass, Elisabete; Park, Young Joo; Chai, Young Jun; Kwon, Hyungju; Park, Do Joon; Cho, BeLong; Choi, Ho-Chun; Kang, Daehee; Park, Sue K.			Acute High-Dose and Chronic Lifetime Exposure to Alcohol Consumption and Differentiated Thyroid Cancer: T-CALOS Korea	PLOS ONE			English	Article							RISK-FACTORS; CIGARETTE-SMOKING; POOLED ANALYSIS; PHARMACOKINETICS; CARCINOMA; MORTALITY; DRINKING; GENDER	Background This study evaluated the effects of acute high-dose and chronic lifetime exposure to alcohol and exposure patterns on the development of differentiated thyroid cancer (DTC). Methods The Thyroid Cancer Longitudinal Study (T-CALOS) included 2,258 DTC patients (449 men and 1,809 women) and 22,580 healthy participants (4,490 men and 18,090 women) who were individually matched by age, gender, and enrollment year. In-person interviews were conducted with a structured questionnaire to obtain epidemiologic data. Clinicopathologic features of the patients were obtained by chart reviews. Odds ratios (ORs) and 95% confidence intervals (95%CI) were estimated using conditional regression models. Results While light or moderate drinking behavior was related to a reduced risk of DTC, acute heavy alcohol consumption (151 g or more per event or on a single occasion) was associated with increased risks in men (OR = 2.22, 95% CI = 1.27-3.87) and women (OR = 3.61, 95% CI = 1.52-8.58) compared with never-drinkers. The consumption of alcohol for 31 or more years was a significant risk factor for DTC for both men (31-40 years: OR = 1.58, 95% CI = 1.10-2.28; 41 + years: OR = 3.46, 95% CI = 2.06-5.80) and women (31-40 years: OR = 2.18, 95% CI = 1.62-2.92; 41 + years: OR = 2.71, 95% CI = 1.36-5.05) compared with never-drinkers. The consumption of a large amount of alcohol on a single occasion was also a significant risk factor, even after restricting DTC outcomes to tumor size, lymph node metastasis, extrathyroidal extension and TNM stage. Conclusion The findings of this study suggest that the threshold effects of acute high-dose alcohol consumption and long-term alcohol consumption are linked to an increased risk of DTC.	[Hwang, Yunji; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hwang, Yunji; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Hwang, Yunji; Lee, Kyu Eun; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Kyu Eun; Kwon, Hyungju] Seoul Natl Univ Hosp & Coll Med, Dept Surg, Seoul, South Korea; [Lee, Kyu Eun] Seoul Natl Univ, Canc Hosp, Div Surg, Thyroid Ctr, Seoul, South Korea; [Weiderpass, Elisabete] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Dept Genet Epidemiol, Helsinki, Finland; [Park, Young Joo; Park, Do Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Chai, Young Jun] Seoul Natl Univ, Boramae Med Ctr, Dept Surg, Seoul, South Korea; [Kwon, Hyungju] Ewha Womans Univ, Coll Med, Breast & Thyroid Canc Ctr, Seoul, South Korea; [Cho, BeLong] Seoul Natl Univ Hosp, Dept Family Med, Hlth Promot Ctr Canc Survivor, Seoul 110744, South Korea; [Cho, BeLong] Seoul Natl Univ, Adv Inst Convergence Technol, 145 Gwanggyo Ro, Suwon, Gyeonggi Do, South Korea; [Choi, Ho-Chun] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Folkhalsan Research Center; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Park, SK (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.; Park, SK (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	suepark@snu.ac.kr	Weiderpass, Elisabete/AAP-2747-2021; Park, Young Joo/J-4161-2012; Cho, Belong/GLU-3443-2022; Chai, Young/AAW-6684-2021; Weiderpass, Elisabete/M-4029-2016	Weiderpass, Elisabete/0000-0003-2237-0128; Park, Young Joo/0000-0002-3671-6364; Cho, Belong/0000-0001-9558-689X; Weiderpass, Elisabete/0000-0003-2237-0128; Kwon, Hyungju/0000-0003-4979-8749; Kang, Daehee/0000-0003-4031-5878; Chai, Young Jun/0000-0001-8830-3433	Korean Foundation for Cancer Research [CB-2011-03-01]; Basic Research Laboratory Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2011-0001564]; Education and Research Encouragement Fund of Seoul National University Hospital; Brain Korea 21 PLUS Program	Korean Foundation for Cancer Research; Basic Research Laboratory Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Education and Research Encouragement Fund of Seoul National University Hospital; Brain Korea 21 PLUS Program	This study was conducted with research grants from the Korean Foundation for Cancer Research (Grant Number: CB-2011-03-01) and the Basic Research Laboratory Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant Number: 2011-0001564). This study was also supported by the Education and Research Encouragement Fund of Seoul National University Hospital and the Brain Korea 21 PLUS Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; BAUMGARTNER A, 1994, ALCOHOL CLIN EXP RES, V18, P284, DOI 10.1111/j.1530-0277.1994.tb00016.x; Chai YJ, 2014, CLIN ENDOCRINOL, V81, P432, DOI 10.1111/cen.12433; Franceschi S, 2015, INT J CANCER, V136, P2738, DOI 10.1002/ijc.29311; Guignard R, 2007, AM J EPIDEMIOL, V166, P1140, DOI 10.1093/aje/kwm204; Im HJ, 2014, KOREAN J FAM MED, V35, P173, DOI 10.4082/kjfm.2014.35.4.173; Jang SN, 2010, J AM GERIATR SOC, V58, P592, DOI 10.1111/j.1532-5415.2010.02744.x; Jung KW, 2015, CANCER RES TREAT, V47, P142, DOI 10.4143/crt.2015.066; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Jung SH, 2014, ASIAN PAC J CANCER P, V15, P3675, DOI 10.7314/APJCP.2014.15.8.3675; Kabat GC, 2012, CANCER EPIDEMIOL, V36, P335, DOI 10.1016/j.canep.2012.03.013; Kim SJ, 2012, WORLD J SURG, V36, P310, DOI 10.1007/s00268-011-1383-1; Kitahara CM, 2012, CANCER CAUSE CONTROL, V23, P1615, DOI 10.1007/s10552-012-0039-2; Lee KE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007234; Li TK, 2000, ALCOHOL CLIN EXP RES, V24, P415, DOI 10.1097/00000374-200004000-00009; Mack WJ, 2003, CANCER CAUSE CONTROL, V14, P773, DOI 10.1023/A:1026349702909; Mack WJ, 2002, ANN EPIDEMIOL, V12, P395, DOI 10.1016/S1047-2797(01)00281-2; Meinhold CL, 2009, BRIT J CANCER, V101, P1630, DOI 10.1038/sj.bjc.6605337; Mezey E, 2000, ALCOHOL CLIN EXP RES, V24, P421, DOI 10.1097/00000374-200004000-00012; Nagano J, 2007, J EPIDEMIOL, V17, P76, DOI 10.2188/jea.17.76; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Razzak AA, 2011, CANCER PREV RES, V4, P2035, DOI 10.1158/1940-6207.CAPR-11-0276; Roswall Nina, 2015, J Prev Med Public Health, V48, P1, DOI 10.3961/jpmph.14.052; Ryu M, 2010, EPIDEMIOL HEALTH, V32, DOI 10.4178/epih/e2010007; Sato N, 2001, ALCOHOL CLIN EXP RES, V25, p40S, DOI 10.1111/j.1530-0277.2001.tb02371.x; Schernhammer ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021102; Sobin L, 2009, TNM CLASSIFICATION M; Tufano RP, 2015, JAMA OTOLARYNGOL, V141, P566, DOI 10.1001/jamaoto.2015.0647; WILLIAMS RR, 1976, LANCET, V1, P996; Xhaard C, 2014, ASIAN PAC J CANCER P, V15, P2675, DOI 10.7314/APJCP.2014.15.6.2675	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151562	10.1371/journal.pone.0151562	http://dx.doi.org/10.1371/journal.pone.0151562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985827	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300087
J	Li, J; Yim, S; Pacheck, A; Sanchez, B; Rutkove, SB				Li, Jia; Yim, Sung; Pacheck, Adam; Sanchez, Benjamin; Rutkove, Seward B.			Electrical Impedance Myography to Detect the Effects of Electrical Muscle Stimulation in Wild Type and Mdx Mice	PLOS ONE			English	Article							ELECTROMYOSTIMULATION; STRENGTH; DUCHENNE; RELAXATION; CHILDREN	Objective Tools to better evaluate the impact of therapy on nerve and muscle disease are needed. Electrical impedance myography (EIM) is sensitive to neuromuscular disease progression as well as to therapeutic interventions including myostatin inhibition and antisense oligonucleotide-based treatments. Whether the technique identifies the impact of electrical muscle stimulation (EMS) is unknown. Methods Ten wild-type (wt) C57B6 mice and 10 dystrophin-deficient (mdx) mice underwent 2 weeks of 20 min/day EMS on left gastrocnemius and sham stimulation on the right gastrocnemius. Multifrequency EIM data and limb girth were obtained before and at the conclusion of the protocol. Muscle weight, in situ force measurements, and muscle fiber histology were also assessed at the conclusion of the study. Results At the time of sacrifice, muscle weight was greater on the EMS-treated side than on the sham-stimulated side (p = 0.018 for wt and p = 0.007 for mdx). Similarly, in wt animals, EIM parameters changed significantly compared to baseline (resistance (p = 0.009), reactance (p = 0.0003) and phase (p = 0.002); these changes were due in part to reductions in the EIM values on the EMS-treated side and elevations on the sham-simulated side. Mdx animals showed analogous but non-significant changes (p = 0.083, p = 0.064, and p = 0.57 for resistance, reactance and phase, respectively). Maximal isometric force trended higher on the stimulated side in wt animals only (p = 0.06). Myofiber sizes in wt animals were also larger on the stimulated side than on the sham-stimulated side (p = 0.034); no significant difference was found in the mdx mice (p = 0.79). Conclusion EIM is sensitive to stimulation-induced muscle alterations in wt animals; similar trends are also present in mdx mice. The mechanisms by which these EIM changes develop, however, remains uncertain. Possible explanations include longer-term trophic effects and shorter-term osmotic effects.	[Li, Jia; Yim, Sung; Pacheck, Adam; Sanchez, Benjamin; Rutkove, Seward B.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Rutkove, SB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	srutkove@bidmc.harvard.edu		Rutkove, Seward/0000-0002-6375-3312	National Institutes of Health [R01 NS055099]; Spinal Muscular Atrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spinal Muscular Atrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded entirely by National Institutes of Health R01 NS055099 and the Spinal Muscular Atrophy Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahad MA, 2009, CLIN NEUROPHYSIOL, V120, P1534, DOI 10.1016/j.clinph.2009.05.017; Bartok C, 2004, J APPL PHYSIOL, V96, P161, DOI 10.1152/japplphysiol.00686.2002; Bezerra P, 2009, MUSCLE NERVE, V40, P430, DOI 10.1002/mus.21329; CABRIC M, 1987, INT J SPORTS MED, V8, P323, DOI 10.1055/s-2008-1025677; Carroll TJ, 2006, J APPL PHYSIOL, V101, P1514, DOI 10.1152/japplphysiol.00531.2006; Crameri RM, 2002, SCAND J MED SCI SPOR, V12, P316, DOI 10.1034/j.1600-0838.2002.20106.x; DANGAIN J, 1989, J NEUROL NEUROSUR PS, V52, P1382, DOI 10.1136/jnnp.52.12.1382; Doupe J, 1943, J NEUROL PSYCHIATRY, V6, P136, DOI 10.1136/jnnp.6.3-4.136; FISHER MJ, 1990, INVEST RADIOL, V25, P480, DOI 10.1097/00004424-199005000-00003; FLECKENSTEIN JL, 1993, J APPL PHYSIOL, V74, P2855, DOI 10.1152/jappl.1993.74.6.2855; Gruther W, 2010, J REHABIL MED, V42, P593, DOI 10.2340/16501977-0564; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; Herrero JA, 2006, INT J SPORTS MED, V27, P533, DOI 10.1055/s-2005-865845; Hortobagyi T, 1999, MOTOR CONTROL, V3, P205, DOI 10.1123/mcj.3.2.205; Kern H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00189; Langley JN, 1918, J PHYSIOL-LONDON, V52, P15; Li J, INT C EL IMP GAIN FL; Li John Zenghong, 2012, ISRN Otolaryngol, V2012, P708974, DOI 10.5402/2012/708974; LUTHERT P, 1980, J NEUROL NEUROSUR PS, V43, P803, DOI 10.1136/jnnp.43.9.803; Maffiuletti NA, 2000, INT J SPORTS MED, V21, P437, DOI 10.1055/s-2000-3837; Malatesta D, 2003, J STRENGTH COND RES, V17, P573; Munn J, 2004, J APPL PHYSIOL, V96, P1861, DOI 10.1152/japplphysiol.00541.2003; Narayanaswami P, 2012, MUSCLE NERVE, V46, P257, DOI 10.1002/mus.23307; Ogino M, 2002, AM J PHYS MED REHAB, V81, P446, DOI 10.1097/00002060-200206000-00009; Pacheck A, 2016, CLIN NEUROPHYSIOL, V127, P1886, DOI 10.1016/j.clinph.2015.11.046; PloutzSnyder LL, 1997, MAGNET RESON MED, V37, P676, DOI 10.1002/mrm.1910370509; Pool D, 2016, DEV MED CHILD NEUROL, V58, P492, DOI 10.1111/dmcn.12955; Pratt SJP, 2013, J PHYSIOL-LONDON, V591, P559, DOI 10.1113/jphysiol.2012.241679; Routsi C, 2010, CRIT CARE, V14, DOI 10.1186/cc8987; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Sanchez B, 2014, PHYS MED BIOL, V59, P2369, DOI 10.1088/0031-9155/59/10/2369; Sanchez B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140521; SCOTT OM, 1990, J NEUROL SCI, V95, P171, DOI 10.1016/0022-510X(90)90240-N; SCOTT OM, 1986, J NEUROL NEUROSUR PS, V49, P1427, DOI 10.1136/jnnp.49.12.1427; Singer K P, 1986, Aust J Physiother, V32, P31, DOI 10.1016/S0004-9514(14)60641-3; Song YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052230; VEBER B, 1989, ANESTHESIOLOGY, V70, P684, DOI 10.1097/00000542-198904000-00024; VRBOVA G, 1981, J NEUROL NEUROSUR PS, V44, P1002, DOI 10.1136/jnnp.44.11.1002; Wan Q, 2015, AM J PHYS MED REHABI, P1, DOI 10.1097/PHM; Zhou S, 2000, Exerc Sport Sci Rev, V28, P177; ZUPAN A, 1992, MUSCLE NERVE, V15, P362, DOI 10.1002/mus.880150316	41	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151415	10.1371/journal.pone.0151415	http://dx.doi.org/10.1371/journal.pone.0151415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986564	Green Published, gold			2022-12-26	WOS:000372580300068
J	Miler, K				Miler, Krzysztof			Moribund Ants Do Not Call for Help	PLOS ONE			English	Article							PRECISION RESCUE BEHAVIOR; DIVISION-OF-LABOR; LIFE EXPECTANCY; WORKERS; HYMENOPTERA	When an antlion captures a foraging ant, the victim's nestmates may display rescue behaviour. This study tested the hypothesis that the expression of rescue behaviour depends on the life expectancy of the captured ant. This hypothesis predicts that the expression of rescue behaviour will be less frequent when the captured ant has a lower life expectancy than when it has a higher life expectancy because such a response would be adaptive at the colony level. Indeed, significant differences were found in the frequency of rescue behaviours in response to antlion victims with differing life expectancies. In agreement with prediction, victims with lower life expectancies were rescued less frequently, and those rescues had a longer latency and shorter duration. There was also a qualitative difference in the behaviour of rescuers to victims from the low and high life expectancy groups. Several explanations for these findings are proposed.	[Miler, Krzysztof] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Jagiellonian University	Miler, K (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	krzysztof.miler@uj.edu.pl	Miler, Krzysztof/CAJ-5113-2022	Miler, Krzysztof/0000-0001-7684-0629	Jagiellonian University [DS/BiNoZ/INoS/761/15]	Jagiellonian University	This research was funded by the Jagiellonian University (grant DS/BiNoZ/INoS/761/15). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beponis LM, 2014, ETHOLOGY, V120, P873, DOI 10.1111/eth.12257; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Czechowski W, 2002, ANN ZOOL, V52, P423; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Hollis KL, 2015, LEARN MOTIV, V50, P68, DOI 10.1016/j.lmot.2014.11.003; Hollis KL, 2013, ANIM BEHAV, V85, P537, DOI 10.1016/j.anbehav.2012.12.005; Koto A, 2015, BEHAV ECOL SOCIOBIOL, V69, P583, DOI 10.1007/s00265-014-1869-6; Moron D, 2008, ANIM BEHAV, V75, P345, DOI 10.1016/j.anbehav.2007.06.005; Moron D, 2012, AM NAT, V180, P744, DOI 10.1086/668009; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Nowbahari E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048516; Nowbahari Elise, 2010, Communicative & Integrative Biology, V3, P77; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Robinson EJH, 2009, INSECT SOC, V56, P1, DOI 10.1007/s00040-008-1035-0; SCHMIDHEMPEL P, 1984, INSECT SOC, V31, P345, DOI 10.1007/BF02223652; Taylor K, 2013, EVOL PSYCHOL-US, V11, P665, DOI 10.1177/147470491301100312; Tofilski A, 2002, BEHAV ECOL SOCIOBIOL, V51, P234, DOI [10.1007/s00265-001-0429-z, 10.1007/S00265-001-0429-Z]; Tofilski A, 2009, INSECT SOC, V56, P359, DOI 10.1007/s00040-009-0031-3; Tofilski A, 2008, AM NAT, V172, pE239, DOI 10.1086/591688; Woyciechowski M, 1998, APIDOLOGIE, V29, P191, DOI 10.1051/apido:19980111; Woyciechowski M, 2009, INSECT SOC, V56, P193, DOI 10.1007/s00040-009-0012-6	22	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151925	10.1371/journal.pone.0151925	http://dx.doi.org/10.1371/journal.pone.0151925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986741	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300153
J	Tjernlund, A; Burgener, A; Lindvall, JM; Peng, T; Zhu, J; Ohrmalm, L; Picker, LJ; Broliden, K; McElrath, MJ; Corey, L				Tjernlund, Annelie; Burgener, Adam; Lindvall, Jessica M.; Peng, Tao; Zhu, Jia; Oehrmalm, Lars; Picker, Louis J.; Broliden, Kristina; McElrath, M. Juliana; Corey, Lawrence			In Situ Staining and Laser Capture Microdissection of Lymph Node Residing SIV Gag-Specific CD8(+) T cells-A Tool to Interrogate a Functional Immune Response Ex Vivo	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-EXPRESSION; TRANSCRIPTIONAL PROFILES; ANTIRETROVIRAL THERAPY; INFECTED MACAQUES; SYSTEMS BIOLOGY; PLASMA VIREMIA; HIV-INFECTION; LYMPHOCYTES; REVEALS	While a plethora of data describes the essential role of systemic CD8(+) T cells in the control of SIV replication little is known about the local in situ CD8(+) T cell immune responses against SIV at the intact tissue level, due to technical limitations. In situ staining, using GagCM9 Qdot 655 multimers, were here combined with laser capture microdissection to detect and collect SIV Gag CM9 specific CD8(+) T cells in lymph node tissue from SIV infected rhesus macaques. CD8(+) T cells from SIV infected and uninfected rhesus macaques were also collected and compared to the SIV GagCM9 specific CD8(+) T cells. Illumina bead array and transcriptional analyses were used to assess the transcriptional profiles and the three different CD8(+) T cell populations displayed unique transcriptional patterns. This pilot study demonstrates that rapid and specific immunostaining combined with laser capture microdissection in concert with transcriptional profiling may be used to elucidate phenotypic differences between CD8(+) T cells in SIV infection. Such technologies may be useful to determine differences in functional activities of HIV/SIV specific T cells.	[Tjernlund, Annelie; Burgener, Adam; Oehrmalm, Lars; Broliden, Kristina] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med Solna,Unit Infect Dis, L8-01, S-17176 Stockholm, Sweden; [Burgener, Adam] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada; [Burgener, Adam] Univ Manitoba, Dept Med Microbiol, 730 William Ave, Winnipeg, MB, Canada; [Lindvall, Jessica M.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Biosci & Nutr, Stockholm, Sweden; [Peng, Tao; Zhu, Jia; McElrath, M. Juliana; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Peng, Tao; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Zhu, Jia; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Pathol, Beaverton, OR USA; [Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Karolinska Institutet; Karolinska University Hospital; Public Health Agency of Canada; University of Manitoba; Karolinska Institutet; Karolinska University Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Tjernlund, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med Solna,Unit Infect Dis, L8-01, S-17176 Stockholm, Sweden.	Annelie.Tjernlund@ki.se	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436; Lindvall, Jessica/0000-0002-5042-8481; Zhu, Jia/0000-0002-8676-5105	Swedish Research Council; Swedish Society for Medical Research; Swedish Society of Medicine; Swedish Physicians Against AIDS Research Foundation; Bill & Melinda Gates Foundation "Immune Correlates of Protection Against HIV and SIV Infection" [41185]; National Institutes of Health grant [R01 AI-42528, PO1 AI-30731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, R01AI111780, R01AI042528] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Swedish Society of Medicine; Swedish Physicians Against AIDS Research Foundation; Bill & Melinda Gates Foundation "Immune Correlates of Protection Against HIV and SIV Infection"; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Swedish Research Council, http://www.vr.se/(A.T.), the Swedish Society for Medical Research, http://www.ssmf.se/(A.T.), the Swedish Society of Medicine, http://www.sls.se/(A.T.), the Swedish Physicians Against AIDS Research Foundation http://www.aidsfond.se/(A.T.), the Bill & Melinda Gates Foundation #41185 "Immune Correlates of Protection Against HIV and SIV Infection", http://www.gatesfoundation.org/(M.J.M.) and National Institutes of Health grant R01 AI-42528 and PO1 AI-30731, http://www.nih.gov/(L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 1998, J IMMUNOL, V160, P6062; Belisle SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019681; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Bosinger SE, 2012, CURR OPIN HIV AIDS, V7, P71, DOI 10.1097/COH.0b013e32834dde01; Burgener A, 2013, J VIROL, V87, P5141, DOI 10.1128/JVI.03347-12; Chowdhury A, 2015, J VIROL, V89, P8677, DOI 10.1128/JVI.00869-15; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; George MD, 2006, J MED PRIMATOL, V35, P261, DOI 10.1111/j.1600-0684.2006.00180.x; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; George MD, 2014, VIROLOGY, V468, P581, DOI 10.1016/j.virol.2014.09.013; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gupta B, 2012, J IMMUNOTHER, V35, P488, DOI 10.1097/CJI.0b013e31826183a7; Horiike M, 2012, VIROLOGY, V423, P107, DOI 10.1016/j.virol.2011.11.024; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Iancu EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/452606; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 2000, BLOOD, V96, P1474, DOI 10.1182/blood.V96.4.1474.h8001474_1474_1479; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; Lederer S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000296; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Loffredo JT, 2006, MAMU A 01 INDIAN RHE; Mao HW, 2005, J VIROL, V79, P14887, DOI 10.1128/JVI.79.23.14887-14898.2005; Martinez-Marino B, 2007, VIROLOGY, V362, P217, DOI 10.1016/j.virol.2006.12.007; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Palermo RE, 2011, J VIROL, V85, P1099, DOI 10.1128/JVI.01522-10; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Pereyra F, 2014, J VIROL, V88, P12937, DOI 10.1128/JVI.01004-14; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Sasikala-Appukuttan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081623; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Smith AJ, 2010, J IMMUNOL, V185, P5417, DOI 10.4049/jimmunol.1002197; TENNERRACZ K, 1986, AM J PATHOL, V123, P9; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Tjernlund A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-12; Tsukamoto T, 2007, J VIROL, V81, P11640, DOI 10.1128/JVI.01475-07; Vojnov L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023515; Wu JQ, 2008, VIROLOGY, V380, P124, DOI 10.1016/j.virol.2008.06.039; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	57	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0149907	10.1371/journal.pone.0149907	http://dx.doi.org/10.1371/journal.pone.0149907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986062	Green Published, gold			2022-12-26	WOS:000372580300017
J	Wong, CM; Poulin, KL; Tong, G; Christou, C; Kennedy, MA; Falls, T; Bell, JC; Parks, RJ				Wong, Carmen M.; Poulin, Kathy L.; Tong, Grace; Christou, Carin; Kennedy, Michael A.; Falls, Theresa; Bell, John C.; Parks, Robin J.			Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer	PLOS ONE			English	Article							FUSOGENIC MEMBRANE GLYCOPROTEIN; VESICULAR STOMATITIS-VIRUS; SYNCYTIUM FORMATION; PORE EXPANSION; GENE-THERAPY; REOVIRUS; VECTORS; RECOMBINATION; REPLICATION; GENERATION	Adenoviruses (Ads) are used in numerous preclinical and clinical studies for delivery of anticancer therapeutic genes. Unfortunately, Ad has a poor ability to distribute throughout a tumor mass after intratumoral injection, and infects cells primarily within the immediate area of the injection tract. Thus, Ad-encoded transgene expression is typically limited to only a small percentage of cells within the tumor. One method to increase the proportion of the tumor impacted by Ad is through expression of fusogenic proteins. Infection of a single cell with an Ad vector encoding a fusogenic protein should lead to syncytium formation with adjacent cells, effectively spreading the effect of Ad and Ad-encoded therapeutic transgenes to a greater percentage of the tumor mass. Moreover, syncytium formation can be cytotoxic, suggesting that such proteins may be effective sole therapeutics. We show that an early region 1 (E1)-deleted Ad expressing reptilian reovirus p14 fusion-associated small transmembrane (FAST) protein caused extensive cell fusion in the replication-permissive 293 cell line and at high multiplicity of infection in non-permissive human lung adenocarcinoma A549 cells in vitro. FAST protein expression in the A549 cancer cell line led to a loss of cellular metabolic activity and membrane integrity, which correlated with induction of apoptosis. However, in an A549 xenograft CD-1 nude mouse cancer model, Ad-mediated FAST gene delivery did not induce detectable cell fusion, reduce tumor burden nor enhance mouse survival compared to controls. Taken together, our results show that, although AdFAST can enhance cancer cell killing in vitro, it is not effective as a sole therapeutic in the A549 tumor model in vivo.	[Wong, Carmen M.; Poulin, Kathy L.; Tong, Grace; Christou, Carin; Kennedy, Michael A.; Parks, Robin J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Wong, Carmen M.; Bell, John C.; Parks, Robin J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Parks, Robin J.] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Falls, Theresa; Bell, John C.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [Bell, John C.; Parks, Robin J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Parks, RJ (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	rparks@ohri.ca	Falls, Theresa/GWZ-9829-2022; Kennedy, Michael/M-2578-2019; Kennedy, Michael/ABE-6002-2021	Falls, Theresa/0000-0001-5995-9118; 	Canadian Institutes of Health Research (CIHR); Cancer Research Society (Canada); National Sciences and Engineering Research Council (NSERC); Queen Elizabeth II Graduate Scholarship in Science and Technology	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society (Canada); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology	Research in the Parks laboratory is supported by grants from the Canadian Institutes of Health Research (CIHR), the Cancer Research Society (Canada), and the National Sciences and Engineering Research Council (NSERC). C.M.W. holds the Queen Elizabeth II Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman AR, 2002, CANCER RES, V62, P6566; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Bodelon G, 2002, J BIOL CHEM, V277, P17789, DOI 10.1074/jbc.M202018200; Brown CW, 2009, J VIROL, V83, P552, DOI 10.1128/JVI.01921-08; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Ciechonska M, 2014, J VIROL, V88, P6528, DOI 10.1128/JVI.00314-14; Ciechonska M, 2014, J VIROL, V88, P6137, DOI 10.1128/JVI.00121-14; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Corcoran JA, 2011, J GEN VIROL, V92, P162, DOI 10.1099/vir.0.026013-0; Ebert O, 2004, CANCER RES, V64, P3265, DOI 10.1158/0008-5472.CAN-03-3753; Errington F, 2006, GENE THER, V13, P138, DOI 10.1038/sj.gt.3302609; Fu XP, 2003, MOL THER, V7, P748, DOI 10.1016/S1525-0016(03)00092-3; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Goulet BB, 2013, BIOCHEM CELL BIOL, V91, P252, DOI 10.1139/bcb-2012-0094; GRAHAM FL, 1987, J GEN VIROL, V68, P937, DOI 10.1099/0022-1317-68-3-937; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guedan S, 2012, GENE THER, V19, P1048, DOI 10.1038/gt.2011.184; Heise CC, 1999, CANCER GENE THER, V6, P499, DOI 10.1038/sj.cgt.7700071; Higuchi H, 2000, CANCER RES, V60, P6396; Hoffmann D, 2007, MOL CANCER THER, V6, P1942, DOI 10.1158/1535-7163.MCT-06-0790; Ilkow CS, 2015, NAT MED, V21, P530, DOI 10.1038/nm.3848; Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.21.13.2508; Le Boeuf F, 2010, MOL THER, V18, P888, DOI 10.1038/mt.2010.44; Li H, 2001, HUM GENE THER, V12, P2155, DOI 10.1089/10430340152710504; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; McCart JA, 2001, CANCER RES, V61, P8751; PARKS RJ, 1994, VIRUS RES, V32, P283, DOI 10.1016/0168-1702(94)90078-7; Poulin KL, 2010, J VIROL, V84, P10074, DOI 10.1128/JVI.02665-09; Ross PJ, 2009, COLD SPRING HARB PRO, V2009; Saha B, 2014, VIRUSES-BASEL, V6, P3563, DOI 10.3390/v6093563; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000016; Sargent KL, 2004, J VIROL, V78, P5032, DOI 10.1128/JVI.78.10.5032-5037.2004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Smith E, 2011, HUM GENE THER, V22, P1053, DOI 10.1089/hum.2010.227; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Sugimoto J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01462; Top D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000331	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151516	10.1371/journal.pone.0151516	http://dx.doi.org/10.1371/journal.pone.0151516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986751	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300081
J	McKay, CP; Rask, JC; Detweiler, AM; Bebout, BM; Everroad, RC; Lee, JZ; Chanton, JP; Mayer, MH; Caraballo, AAL; Kapili, B; Al-Awar, M; Al-Farraj, A				McKay, Christopher P.; Rask, Jon C.; Detweiler, Angela M.; Bebout, Brad M.; Everroad, R. Craig; Lee, Jackson Z.; Chanton, Jeffrey P.; Mayer, Marisa H.; Caraballo, Adrian A. L.; Kapili, Bennett; Al-Awar, Meshgan; Al-Farraj, Asma			An Unusual Inverted Saline Microbial Mat Community in an Interdune Sabkha in the Rub' al Khali (the Empty Quarter), United Arab Emirates	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DEATH-VALLEY; HALOPHILIC BACTERIUM; SUBSTRATE LIMITATION; EVAPORITE DEPOSITS; GENOME SEQUENCE; METHANE; BIOSIGNATURES; CLIMATE; LIFE	Salt flats (sabkha) are a recognized habitat for microbial life in desert environments and as analogs of habitats for possible life on Mars. Here we report on the physical setting and microbiology of interdune sabkhas among the large dunes in the Rub' al Khali (the Empty Quarter) in Liwa Oasis, United Arab Emirates. The salt flats, composed of gypsum and halite, are moistened by relatively fresh ground water. The result is a salinity gradient that is inverted compared to most salt flat communities with the hypersaline layer at the top and freshwater layers below. We describe and characterize a rich photosynthetically-based microbial ecosystem that is protected from the arid outside environment by a translucent salt crust. Gases collected from sediments under shallow ponds in the sabkha contain methane in concentrations as high as 3400 ppm. The salt crust could preserve biomarkers and other evidence for life in the salt after it dries out. Chloride-filled depressions have been identified on Mars and although surface flow of water is unlikely on Mars today, ground water is possible. Such a near surface system with modern groundwater flowing under ancient salt deposits could be present on Mars and could be accessed by surface rovers.	[McKay, Christopher P.; Rask, Jon C.; Detweiler, Angela M.; Bebout, Brad M.; Everroad, R. Craig; Lee, Jackson Z.; Mayer, Marisa H.; Caraballo, Adrian A. L.; Kapili, Bennett] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Detweiler, Angela M.; Everroad, R. Craig; Lee, Jackson Z.] Bay Area Environm Res Inst, Petaluma, CA USA; [Chanton, Jeffrey P.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Al-Awar, Meshgan] Dubai Police Acad, Res & Studies Ctr, Dubai, U Arab Emirates; [Al-Farraj, Asma] United Arab Emirates Univ, Dept Geog, Al Ain, U Arab Emirates	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; State University System of Florida; Florida State University; United Arab Emirates University	McKay, CP (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	Chris.McKay@NASA.gov			NASA; NASA ASTEP Program; Arab Youth Venture Foundation	NASA(National Aeronautics & Space Administration (NASA)); NASA ASTEP Program(National Aeronautics & Space Administration (NASA)); Arab Youth Venture Foundation	NASA funded this work.; This work was supported by the NASA ASTEP Program. Field work in the UAE was part of a NASA Spaceward Bound program and was supported by the Arab Youth Venture Foundation. We thank Lisa LaBonte, Hussain Al Ansari, and Annie Ortiz of the AYV Foundation and Michael Wing, Matt Reyes, and Lucinda Land for assistance in the field activities. We also thank Claire Langford for running the gas samples on the GC-IRMS. We thank the reviewers for the detailed and comprehensive reviews that greatly improved the paper.	Al-Farraj A, 2005, J ARID ENVIRON, V63, P740, DOI 10.1016/j.jaridenv.2005.01.025; Al-Katheeri ES, 2009, ENVIRON EARTH SCI, V59, P581, DOI 10.1007/s12665-009-0056-y; [Anonymous], 1970, P GEOLOGIST ASSOC, DOI DOI 10.1016/S0016-7878(70)80010-4; Antony CP, 2012, FEMS MICROBIOL ECOL, V81, P43, DOI 10.1111/j.1574-6941.2011.01274.x; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Barbieri R, 2006, PLANET SPACE SCI, V54, P726, DOI 10.1016/j.pss.2006.04.003; Bebout BM, 2004, GEOBIOLOGY, V2, P87, DOI 10.1111/j.1472-4677.2004.00024.x; Boer B, 1997, J ARID ENVIRON, V35, P3, DOI 10.1006/jare.1996.0162; CONRAD R, 1995, FEMS MICROBIOL ECOL, V16, P297, DOI 10.1111/j.1574-6941.1995.tb00294.x; Davila AF, 2011, ICARUS, V212, P579, DOI 10.1016/j.icarus.2010.12.023; Davila AF, 2010, ASTROBIOLOGY, V10, P617, DOI 10.1089/ast.2009.0421; Douglas S, 2004, PLANET SPACE SCI, V52, P223, DOI 10.1016/j.pss.2003.08.005; Douglas S, 2002, GEOLOGY, V30, P1075, DOI 10.1130/0091-7613(2002)030<1075:MBIEPO>2.0.CO;2; Douglas S, 2008, ICARUS, V193, P620, DOI 10.1016/j.icarus.2007.08.019; Edwards HGM, 2006, ANAL BIOANAL CHEM, V385, P46, DOI 10.1007/s00216-006-0396-3; El-Sayed MI, 1999, SEDIMENT GEOL, V123, P219, DOI 10.1016/S0037-0738(98)00116-X; El-Sayed MI, 2000, SEDIMENT GEOL, V134, P305, DOI 10.1016/S0037-0738(00)00052-X; Garcia-Maldonado JQ, 2015, MICROB ECOL, V69, P106, DOI 10.1007/s00248-014-0473-7; Glennie KW, 1998, QUATERNARY DESERTS AND CLIMATIC CHANGE, P279; Kelley CA, 2014, APPL ENVIRON MICROB, V80, P7316, DOI 10.1128/AEM.02641-14; Kelley CA, 2012, ASTROBIOLOGY, V12, P89, DOI 10.1089/ast.2011.0703; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lollar BS, 2006, CHEM GEOL, V226, P328, DOI 10.1016/j.chemgeo.2005.09.027; Lorenz RD, 2015, 4 INT PLAN DUN WORKS; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Ojha L, 2015, NAT GEOSCI, V8, P829, DOI [10.1038/ngeo2546, 10.1038/NGEO2546]; OREN A, 1988, A VAN LEEUW J MICROB, V54, P267, DOI 10.1007/BF00443585; Oren A, 2013, FEMS MICROBIOL LETT, V342, P1, DOI 10.1111/1574-6968.12094; Osterloo MM, 2008, SCIENCE, V319, P1651, DOI 10.1126/science.1150690; Osterloo MM, 2010, J GEOPHYS RES; Pagani I, 2011, STAND GENOMIC SCI, V4, P154, DOI 10.4056/sigs.1623941; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rice AL, 2001, ANAL CHEM, V73, P4104, DOI 10.1021/ac0155106; Riedel T, 2012, STAND GENOMIC SCI, V7, P120, DOI 10.4056/sigs.3296896; ROTHSCHILD LJ, 1994, J PHYCOL, V30, P431, DOI 10.1111/j.0022-3646.1994.00431.x; ROTHSCHILD LJ, 1990, ICARUS, V88, P246, DOI 10.1016/0019-1035(90)90188-F; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHINN EA, 1983, J SEDIMENT PETROL, V53, P595; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tazaz AM, 2013, ICARUS, V224, P268, DOI 10.1016/j.icarus.2012.06.008; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wang YX, 2013, INT J SYST EVOL MICR, V63, P3989, DOI 10.1099/ijs.0.052043-0; Webster CR, 2015, SCIENCE, V347, P415, DOI 10.1126/science.1261713; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Wierzchos J, 2006, ASTROBIOLOGY, V6, P415, DOI 10.1089/ast.2006.6.415; WILHARM T, 1991, INT J SYST BACTERIOL, V41, P558, DOI 10.1099/00207713-41-4-558; Wood WW, 2011, HYDROGEOL J, V19, P155, DOI 10.1007/s10040-010-0626-9; WOOD WW, 1995, J HYDROL, V164, P263, DOI 10.1016/0022-1694(94)02551-L; Wood WW, 2003, DEV WATER SCI, V50, P379; Wood WW, 2003, DEV WATER SCI, V50, P295; Wood WW, 2002, GEOL SOC AM BULL, V114, P259, DOI 10.1130/0016-7606(2002)114<0259:SOSTTC>2.0.CO;2; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; ZHILINA TN, 1990, FEMS MICROBIOL LETT, V87, P315, DOI 10.1111/j.1574-6968.1990.tb04930.x	56	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150342	10.1371/journal.pone.0150342	http://dx.doi.org/10.1371/journal.pone.0150342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982497	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900036
J	Bogamuwa, S; Jang, JC				Bogamuwa, Srimathi; Jang, Jyan-Chyun			Plant Tandem CCCH Zinc Finger Proteins Interact with ABA, Drought, and Stress Response Regulators in Processing-Bodies and Stress Granules	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MESSENGER-RNA; ARABIDOPSIS; TTP; EXPRESSION; BINDING; FAMILY; PHOSPHORYLATION; RECRUITMENT; ACTIVATION	Although multiple lines of evidence have indicated that Arabidopsis thaliana Tandem CCCH Zinc Finger proteins, AtTZF4, 5 and 6 are involved in ABA, GA and phytochrome mediated seed germination responses, the interacting proteins involved in these processes are unknown. Using yeast two-hybrid screens, we have identified 35 putative AtTZF5 interacting protein partners. Among them, Mediator of ABA-Regulated Dormancy 1 (MARD1) is highly expressed in seeds and involved in ABA signal transduction, while Responsive to Dehydration 21A (RD21A) is a well-documented stress responsive protein. Co-immunoprecipitation (Co-IP) and bimolecular fluorescence complementation (BiFC) assays were used to confirm that AtTZF5 can interact with MARD1 and RD21A in plant cells, and the interaction is mediated through TZF motif. In addition, AtTZF4 and 6 could also interact with MARD1 and RD21A in Y-2-H and BiFC assay, respectively. The protein-protein interactions apparently take place in processing bodies (PBs) and stress granules (SGs), because AtTZF5, MARD1 and RD21A could interact and co-localize with each other and they all can co-localize with the same PB and SG markers in plant cells.	[Bogamuwa, Srimathi; Jang, Jyan-Chyun] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Jang, Jyan-Chyun] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Jang, Jyan-Chyun] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Jang, Jyan-Chyun] Ohio State Univ, Ohio Agr Res & Dev Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Jang, JC (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.; Jang, JC (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.; Jang, JC (corresponding author), Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA.; Jang, JC (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Columbus, OH 43210 USA.	jang.40@osu.edu			National Science Foundation [IOB-0543751]; Ohio Plant Biotech Consortium [OHOA0794]; Ohio Agricultural Research and Development Center [OHOA1387, OHOA1006]	National Science Foundation(National Science Foundation (NSF)); Ohio Plant Biotech Consortium; Ohio Agricultural Research and Development Center	This work was supported by grants from National Science Foundation (IOB-0543751), Ohio Plant Biotech Consortium (OHOA0794), and Ohio Agricultural Research and Development Center (OHOA1387) to J.-C.J. and Ohio Agricultural Research and Development Center (OHOA1006) to S.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Belostotsky DA, 2003, GENETICS, V163, P311; Bogamuwa S, 2013, PLANT CELL ENVIRON, V36, P1507, DOI 10.1111/pce.12084; Bogamuwa SP, 2014, PLANT CELL PHYSIOL, V55, P1367, DOI 10.1093/pcp/pcu074; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chai G., 2012, BMC GENOMICS, V13, P1471; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fujiwara S, 2008, J BIOL CHEM, V283, P23073, DOI 10.1074/jbc.M803471200; Gu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032422; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; He YH, 2004, PLANT MOL BIOL, V54, P1, DOI 10.1023/B:PLAN.0000028730.10834.e3; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; Jackman MR, 1997, CANCER SURV, V29, P47; James P, 1996, GENETICS, V144, P1425; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jang JC, 2000, GENE DEV, V14, P1485; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; John PCL, 2001, PROTOPLASMA, V216, P119, DOI 10.1007/BF02673865; Kang SG, 2010, MOL PLANT, V3, P361, DOI 10.1093/mp/ssp115; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Kedar VP, 2010, PLOS ONE, V5, pA213, DOI 10.1371/journal.pone.0009588; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Maldonado-Bonilla LD, 2014, PLANT CELL PHYSIOL, V55, P412, DOI 10.1093/pcp/pct175; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pawson T, 2000, GENE DEV, V14, P1027; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Qu J, 2014, PLANT J, V78, P452, DOI 10.1111/tpj.12485; Shindo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029317; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Stoecklin G, 2007, GENE DEV, V21, P627, DOI 10.1101/gad.1538807; Su YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034250; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang L, 2010, EMBO J, V29, P1903, DOI 10.1038/emboj.2010.76; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xu J, 2012, IET RADAR SONAR NAV, V6, P2, DOI 10.1049/iet-rsn.2010.0375; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang CQ, 2013, PLANT CELL REP, V32, P1543, DOI 10.1007/s00299-013-1466-6; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	53	33	35	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151574	10.1371/journal.pone.0151574	http://dx.doi.org/10.1371/journal.pone.0151574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978070	Green Submitted, Green Published, gold			2022-12-26	WOS:000372572800091
J	Harris, LG; Murray, S; Pascoe, B; Bray, J; Meric, G; Magerios, L; Wilkinson, TS; Jeeves, R; Rohde, H; Schwarz, S; de Lencastre, H; Miragaia, M; Rolo, J; Bowden, R; Jolley, KA; Maiden, MCJ; Mack, D; Sheppard, SK				Harris, Llinos G.; Murray, Susan; Pascoe, Ben; Bray, James; Meric, Guillaume; Magerios, Leonardos; Wilkinson, Thomas S.; Jeeves, Rose; Rohde, Holger; Schwarz, Stefan; de Lencastre, Herminia; Miragaia, Maria; Rolo, Joana; Bowden, Rory; Jolley, Keith A.; Maiden, Martin C. J.; Mack, Dietrich; Sheppard, Samuel K.			Biofilm Morphotypes and Population Structure among Staphylococcus epidermidis from Commensal and Clinical Samples	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI; ACCUMULATION-ASSOCIATED PROTEIN; PHENOTYPIC VARIATION; VIRULENCE; STRAINS; AUREUS; IDENTIFICATION; EVOLUTION; GENES	Bacterial species comprise related genotypes that can display divergent phenotypes with important clinical implications. Staphylococcus epidermidis is a common cause of nosocomial infections and, critical to its pathogenesis, is its ability to adhere and form biofilms on surfaces, thereby moderating the effect of the host's immune response and antibiotics. Commensal S. epidermidis populations are thought to differ from those associated with disease in factors involved in adhesion and biofilm accumulation. We quantified the differences in biofilm formation in 98 S. epidermidis isolates from various sources, and investigated population structure based on ribosomal multilocus typing (rMLST) and the presence/absence of genes involved in adhesion and biofilm formation. All isolates were able to adhere and form biofilms in in vitro growth assays and confocal microscopy allowed classification into 5 biofilm morphotypes based on their thickness, biovolume and roughness. Phylogenetic reconstruction grouped isolates into three separate clades, with the isolates in the main disease associated clade displaying diversity in morphotype. Of the biofilm morphology characteristics, only biofilm thickness had a significant association with clade distribution. The distribution of some known adhesion-associated genes (aap and sesE) among isolates showed a significant association with the species clonal frame. These data challenge the assumption that biofilm-associated genes, such as those on the ica operon, are genetic markers for less invasive S. epidermidis isolates, and suggest that phenotypic characteristics, such as adhesion and biofilm formation, are not fixed by clonal descent but are influenced by the presence of various genes that are mobile among lineages.	[Harris, Llinos G.; Murray, Susan; Pascoe, Ben; Meric, Guillaume; Magerios, Leonardos; Wilkinson, Thomas S.; Jeeves, Rose; Mack, Dietrich; Sheppard, Samuel K.] Swansea Univ, Sch Med, Inst Life Sci, Med Microbiol & Infect Dis, Swansea, W Glam, Wales; [Pascoe, Ben; Sheppard, Samuel K.] Swansea Univ, Inst Life Sci, MRC CLIMB Consortium, Swansea, W Glam, Wales; [Bray, James; Jolley, Keith A.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Rohde, Holger] Univ Hamburg, Univ Klinikum Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hyg, Hamburg, Germany; [Schwarz, Stefan] Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany; [de Lencastre, Herminia; Miragaia, Maria; Rolo, Joana] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Miragaia, Maria; Rolo, Joana] Inst Tecnol Quim & Biol Antonio Xavier, Lab Bacterial Evolut & Mol Epidemiol, Oeiras, Portugal; [Bowden, Rory] Wellcome Trust Ctr Human Genet, Oxford Genom Ctr, Oxford, England; [Mack, Dietrich] Inst Med Diagnost GmbH, Mikrobiol Infektiol, Ingelheim, Germany; [Jeeves, Rose] Publ Hlth England, Microbiol Serv, Salisbury SP4 0JG, Wilts, England	Swansea University; Swansea University; University of Oxford; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Loeffler Institute; Universidade Nova de Lisboa; Rockefeller University; University of Oxford; Wellcome Centre for Human Genetics; Public Health England	Sheppard, SK (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Med Microbiol & Infect Dis, Swansea, W Glam, Wales.; Sheppard, SK (corresponding author), Swansea Univ, Inst Life Sci, MRC CLIMB Consortium, Swansea, W Glam, Wales.	s.k.sheppard@swansea.ac.uk	Pascoe, Ben/AAD-2728-2019; Jolley, Keith/ABE-8587-2020; Harris, Llinos/AAQ-9477-2021; Maiden, Martin/N-6805-2019; Wilkinson, Thomas S/C-5237-2013; Pascoe, Ben/C-2253-2009; Harris, Llinos G/AAR-5927-2021; Méric, Guillaume/R-3947-2017; Méric, Guillaume/AAD-2364-2019; Maiden, Martin C J/C-5055-2014; Rolo, Joana/G-4447-2011; Miragaia, Maria/J-2704-2015	Jolley, Keith/0000-0002-0751-0287; Maiden, Martin/0000-0001-6321-5138; Wilkinson, Thomas S/0000-0003-0397-6079; Pascoe, Ben/0000-0001-6376-5121; Harris, Llinos G/0000-0002-0295-3038; Méric, Guillaume/0000-0001-6288-9958; Méric, Guillaume/0000-0001-6288-9958; Maiden, Martin C J/0000-0001-6321-5138; Rolo, Joana/0000-0002-5291-212X; Murray, Susan/0000-0002-3310-651X; Rohde, Holger/0000-0001-8587-4433; Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; BRAY, JAMES/0000-0003-3554-4254; Bowden, Rory/0000-0001-8596-0366	Medical Research Council [MR/M501608/1, MR/L015080/1, G0801929]; Wellcome Trust [088786/C/09/Z, 090532/Z/09/Z]; MRC [G0801929, MR/L015080/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council grant numbers MR/M501608/1 and MR/L015080/1 awarded to SKS, and G0801929 awarded to LGH and DM (www.mrc.ac.uk); Wellcome Trust grant number 088786/C/09/Z awarded to SKS, and grant number 090532/Z/09/Z awarded to RB and KAJ (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrecubieta C, 2007, J BIOL CHEM, V282, P18767, DOI 10.1074/jbc.M610940200; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0; Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200; Chokr A, 2007, MICROB PATHOGENESIS, V42, P94, DOI 10.1016/j.micpath.2006.09.001; CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870, DOI 10.1128/IAI.55.12.2870-2877.1987; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Conlon BP, 2014, J BACTERIOL, V196, P4268, DOI 10.1128/JB.01946-14; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Galdbart JO, 1999, J CLIN MICROBIOL, V37, P1306, DOI 10.1128/JCM.37.5.1306-1312.1999; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gomes AR, 2005, ANTIMICROB AGENTS CH, V49, P366, DOI 10.1128/AAC.49.1.366-379.2005; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Handke LD, 2004, J MED MICROBIOL, V53, P367, DOI 10.1099/jmm.0.05372-0; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Klingenberg C, 2007, CLIN MICROBIOL INFEC, V13, P1100, DOI 10.1111/j.1469-0691.2007.01818.x; Kozitskaya S, 2005, J CLIN MICROBIOL, V43, P4751, DOI 10.1128/JCM.43.9.4751-4757.2005; LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991; Los R, 2010, FEMS MICROBIOL LETT, V310, P97, DOI 10.1111/j.1574-6968.2010.02050.x; Mack D, 2006, INT J ARTIF ORGANS, V29, P343, DOI 10.1177/039139880602900404; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Mack D, 2005, BIOFILMS, INFECTION, AND ANTIMICROBIAL THERAPY, P109; Meric G, 2015, GENOME BIOL EVOL, V7, P1313, DOI 10.1093/gbe/evv066; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; MURGA R, 1995, BIOTECHNOL BIOENG, V45, P503, DOI 10.1002/bit.260450607; Nilsson M, 1998, INFECT IMMUN, V66, P2666, DOI 10.1128/IAI.66.6.2666-2673.1998; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Piette A, 2009, VET MICROBIOL, V134, P45, DOI 10.1016/j.vetmic.2008.09.009; Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Rolo J, 2012, J ANTIMICROB CHEMOTH, V67, P1333, DOI 10.1093/jac/dks068; Schommer NN, 2011, INFECT IMMUN, V79, P2267, DOI 10.1128/IAI.01142-10; Scott RD, 2009, DIRECT MED COSTS HEA; Sheppard SK, 2012, GENES-BASEL, V3, P261, DOI 10.3390/genes3020261; Sheppard SK, 2011, MOL ECOL, V20, P3484, DOI 10.1111/j.1365-294X.2011.05179.x; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Weiss S, 2013, VET MICROBIOL, V167, P680, DOI 10.1016/j.vetmic.2013.07.036; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x	56	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151240	10.1371/journal.pone.0151240	http://dx.doi.org/10.1371/journal.pone.0151240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978068	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800051
J	Isetta, V; Montserrat, JM; Santano, R; Wimms, AJ; Ramanan, D; Woehrle, H; Navajas, D; Farre, R				Isetta, Valentina; Montserrat, Josep M.; Santano, Raquel; Wimms, Alison J.; Ramanan, Dinesh; Woehrle, Holger; Navajas, Daniel; Farre, Ramon			Novel Approach to Simulate Sleep Apnea Patients for Evaluating Positive Pressure Therapy Devices	PLOS ONE			English	Article							AIRWAY PRESSURE; GENDER-DIFFERENCES; CONSTANT; EFFICACY; EVENTS; ADULTS; BENCH; TRIAL; STAGE; CPAP	Bench testing is a useful method to characterize the response of different automatic positive airway pressure (APAP) devices under well-controlled conditions. However, previous models did not consider the diversity of obstructive sleep apnea (OSA) patients' characteristics and phenotypes. The objective of this proof-of-concept study was to design a new bench test for realistically simulating an OSA patient's night, and to implement a one-night example of a typical female phenotype for comparing responses to several currently-available APAP devices. We developed a novel approach aimed at replicating a typical night of sleep which includes different disturbed breathing events, disease severities, sleep/wake phases, body postures and respiratory artefacts. The simulated female OSA patient example that we implemented included periods of wake, light sleep and deep sleep with positional changes and was connected to ten different APAP devices. Flow and pressure readings were recorded; each device was tested twice. The new approach for simulating female OSA patients effectively combined a wide variety of disturbed breathing patterns to mimic the response of a predefined patient type. There were marked differences in response between devices; only three were able to overcome flow limitation to normalize breathing, and only five devices were associated with a residual apnea-hypopnea index of <5/h. In conclusion, bench tests can be designed to simulate specific patient characteristics, and typical stages of sleep, body position, and wake. Each APAP device behaved differently when exposed to this controlled model of a female OSA patient, and should lead to further understanding of OSA treatment.	[Isetta, Valentina; Santano, Raquel; Farre, Ramon] Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain; [Isetta, Valentina; Navajas, Daniel; Farre, Ramon] CIBERES, Madrid, Spain; [Montserrat, Josep M.] Hosp Clin Barcelona, Dept Pneumol, Sleep Lab, Barcelona, Spain; [Montserrat, Josep M.; Farre, Ramon] IDIBAPS, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Wimms, Alison J.; Ramanan, Dinesh; Woehrle, Holger] ResMed Sci Ctr, Munich, Germany; [Navajas, Daniel] IBEC, Inst Bioengn Catalonia, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ResMed; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Farre, R (corresponding author), Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain.; Farre, R (corresponding author), CIBERES, Madrid, Spain.; Farre, R (corresponding author), IDIBAPS, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	rfarre@ub.edu	Farre, Ramon/L-2664-2017; Navajas, Daniel/E-4233-2010	Farre, Ramon/0000-0002-9084-7824; Navajas, Daniel/0000-0001-7150-9363; MONTSERRAT, Josep Maria/0000-0003-3098-4605	ResMed Science Centre [307990]; Universitat de Barcelona [307990]; Ministerio de Economia y Competitividad [PI14/0004]; ResMed	ResMed Science Centre; Universitat de Barcelona; Ministerio de Economia y Competitividad(Spanish Government); ResMed	The work presented here has been partially supported by a research agreement (number 307990) between ResMed Science Centre and Universitat de Barcelona (PI: Ramon Farre). The work has been also partially funded by Ministerio de Economia y Competitividad (PI14/0004). There was no additional funding received for this study. ResMed Science Centre provided support in the form of salaries for authors AJW, DR, and HW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Authors wish to thank Mr. Miguel Angel Rodriguez for his technical support. English language medical writing assistance was provided by Nicola Ryan, independent medical writer, funded by ResMed.	Ayas NT, 2004, SLEEP, V27, P249, DOI 10.1093/sleep/27.2.249; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Behbehani K, 1998, SLEEP; Brown LK, 2006, CHEST, V130, P312, DOI 10.1016/S0012-3692(15)51841-2; d'Ortho MP, 2000, CHEST, V118, P1010, DOI 10.1378/chest.118.4.1010; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Eiseman NA, 2012, J CLIN SLEEP MED, V8, P655, DOI 10.5664/jcsm.2258; Farre R, 1999, LANCET, V353, P1154, DOI 10.1016/S0140-6736(99)01056-9; Farre R, 2002, AM J RESP CRIT CARE, V166, P469, DOI 10.1164/rccm.2111050; Gibson GJ, 2005, BRIT MED BULL, V72, P49, DOI 10.1093/bmb/ldh044; Gozal D, 2015, CHEST; Isetta Valentina, 2015, ERJ Open Res, V1; Jayaraman G, 2011, SLEEP BREATH, V15, P781, DOI 10.1007/s11325-010-0436-2; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Levy P, 2015, NAT REV DIS PRI 0625, P15015; Marrone O, 2002, CHEST, V121, P759, DOI 10.1378/chest.121.3.759; Massie CA, 2003, AM J RESP CRIT CARE, V167, P20, DOI 10.1164/rccm.200201-022OC; Nolan GM, 2006, EUR RESPIR J, V28, P159, DOI 10.1183/09031936.06.00127205; Noseda A, 2004, CHEST, V126, P31, DOI 10.1378/chest.126.1.31; O'Connor C, 2000, AM J RESP CRIT CARE, V161, P1465, DOI 10.1164/ajrccm.161.5.9904121; Oksenberg A, 1999, CHEST, V116, P1000, DOI 10.1378/chest.116.4.1000; Penzel T, 2001, SLEEP, V24, P90, DOI 10.1093/sleep/24.1.90; Pevernagie DA, 2004, CHEST, V126, P25, DOI 10.1378/chest.126.1.25; Randerath Winfried J, 2003, Med Sci Monit, V9, pCR353; Rigau J, 2006, CHEST, V130, P350, DOI 10.1378/chest.130.2.350; Russell T, 2011, AM J MED, V124, P1123, DOI 10.1016/j.amjmed.2011.04.017; Series F, 2001, EUR RESPIR J, V18, P170, DOI 10.1183/09031936.01.98103501; Tan HL, 2013, NAT SCI SLEEP, V5, P109, DOI 10.2147/NSS.S51907; Teschler H, 2000, EUR RESPIR J, V15, P990, DOI 10.1034/j.1399-3003.2000.01503.x; Teschler H, 1996, AM J RESP CRIT CARE, V154, P734, DOI 10.1164/ajrccm.154.3.8810613; Valencia-Flores, 1992, J Sleep Res, V1, P51; Ware JC, 2000, SLEEP, V23, P165; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151530	10.1371/journal.pone.0151530	http://dx.doi.org/10.1371/journal.pone.0151530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978077	gold, Green Published, Green Submitted			2022-12-26	WOS:000372572800083
J	Wu, XL; He, XX; Li, S; Xu, XQ; Chen, XJ; Zhu, H				Wu, Xiaoli; He, Xixi; Li, Shi; Xu, Xiaoqun; Chen, Xiangjian; Zhu, Hua			Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; CD44; EXPRESSION; INVASIVENESS; CARCINOMA; DNA	In addition to protein-coding genes, the human genome makes a large amount of noncoding RNAs. Long non-coding RNAs (lncRNAs) have been described as the largest subclass of the non-coding transcriptome in human noncoding RNAs. In recent years, lncRNAs have been considered to be the key regulators of tumor behavior. In this study, based on previous research, we investigated the expression and biological role of a newly identified cancerrelated lncRNA, lncRNA-uc002kmd.1. We analyzed the relationship between lncRNAuc002kmd.1 and colorectal cancer (CRC) in a total 45 CRC and paired adjacent, non-tumor tissue samples. We found that lncRNA-uc002kmd. 1 expression was usually highly expressed in carcinoma compared with the tissue adjacent to the carcinoma. Through a series of experiments, the results showed that lncRNA-uc002kmd. 1 regulates CD44 as a molecular decoy for miR211-3p. Our data indicated that the overexpression of lncRNAuc002kmd.1 enhanced cell proliferation in CRC.	[Wu, Xiaoli; He, Xixi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China; [Li, Shi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Urol, Wenzhou, Zhejiang, Peoples R China; [Xu, Xiaoqun] Wenzhou Med Univ, Affiliated Hosp 1, Operating Room, Wenzhou, Zhejiang, Peoples R China; [Chen, Xiangjian] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endoscop Surg, Wenzhou, Zhejiang, Peoples R China; [Zhu, Hua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Chen, XJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Endoscop Surg, Wenzhou, Zhejiang, Peoples R China.; Zhu, H (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China.	wz1370666@126.com; zhuhua06@sohu.com			Natural Science Foundation of Zhejiang Province of China [LY16H160048]; Wenzhou Public Welfare Science and Technology Project [Y20140707]; Incubation Project of The First Affiliated Hospital of Wenzhou Medical University [FHY2014009]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Wenzhou Public Welfare Science and Technology Project; Incubation Project of The First Affiliated Hospital of Wenzhou Medical University	The Project was supported by a grant from Natural Science Foundation of Zhejiang Province of China (LY16H160048). Also this work was supported by a grant from Wenzhou Public Welfare Science and Technology Project (Y20140707), also was supported by a grant from Incubation Project of The First Affiliated Hospital of Wenzhou Medical University (FHY2014009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cao WJ, 2013, WORLD J GASTROENTERO, V19, P3658, DOI 10.3748/wjg.v19.i23.3658; Chen S, 2013, J SURG ONCOL, V107, P799, DOI 10.1002/jso.23337; Fang XY, 2015, CANCER LETT, V356, P357, DOI 10.1016/j.canlet.2014.11.005; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Hu Y, 2014, CANCER RES, V74, P6890, DOI 10.1158/0008-5472.CAN-14-0686; Huang GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131225; Kozovska Z, 2014, BIOMED PHARMACOTHER, V68, P911, DOI 10.1016/j.biopha.2014.10.019; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Li N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098251; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Ma MZ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-156; Ma YL, 2016, GUT, V65, P1494, DOI 10.1136/gutjnl-2014-308392; Mattheolabakis G, 2015, J DRUG TARGET, V23, P605, DOI 10.3109/1061186X.2015.1052072; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Shang ZQ, 2015, ONCOTARGET, V6, P1202, DOI 10.18632/oncotarget.2841; STEELE G, 1991, ARCH SURG-CHICAGO, V126, P696; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Vinson KE, 2016, INT J CANCER, V138, P1835, DOI 10.1002/ijc.29800; Wu H, 2015, ONCOGENE, V34, P4723, DOI 10.1038/onc.2014.400; Wu HC, 2015, MOL CARCINOGEN, V54, P102, DOI 10.1002/mc.22078; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252; Wu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127557; Wu Y, 2015, INT J CLIN EXP MED, V8, P3595; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yin DD, 2015, TUMOR BIOL, V36, P4851, DOI 10.1007/s13277-015-3139-2; Yu FJ, 2015, J BIOL CHEM, V290, P28286, DOI 10.1074/jbc.M115.683813	30	53	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151287	10.1371/journal.pone.0151287	http://dx.doi.org/10.1371/journal.pone.0151287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974151	Green Submitted, gold, Green Published			2022-12-26	WOS:000372570600064
J	Wolf, P; Winhofer, Y; Smajis, S; Jankovic, D; Anderwald, CH; Trattnig, S; Luger, A; Krebs, M; Krssak, M				Wolf, Peter; Winhofer, Yvonne; Smajis, Sabina; Jankovic, Drazenka; Anderwald, Christian-Heinz; Trattnig, Siegfried; Luger, Anton; Krebs, Michael; Krssak, Martin			Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans	PLOS ONE			English	Article							MYOCARDIAL TRIGLYCERIDE CONTENT; EPICARDIAL ADIPOSE-TISSUE; INSULIN-RESISTANCE; LIPID-ACCUMULATION; DIASTOLIC FUNCTION; DIABETES-MELLITUS; STEATOSIS; VELOCITY; SHIFT	Background Obesity is a major risk factor to develop heart failure, in part due to possible lipotoxic effects of increased intramyocardial (MYCL) and/or local or paracrine effects of pericardial (PERI) lipid accumulation. Recent evidence suggests that MYCL is highly dynamic and might rather be a surrogate marker for disturbed energy metabolism than the underlying cause of cardiac dysfunction. On the other hand, PERI might contribute directly by mechanic and paracrine effects. Therefore, we hypothesized that PERI rather than MYCL is associated with myocardial function. Methods To avoid potential confounding of metabolic disease 31 metabolically healthy subjects (age: 29 +/- 10yrs; BMI: 23 +/- 3kg/m(2)) were investigated using H-1-magnetic resonance spectroscopy and imaging. MYCL and PERI, as well as systolic and diastolic left ventricular heart function were assessed. Additionally, anthropometric data and parameters of glucose and lipid metabolism were analyzed. Correlation analysis was performed using Pearson's correlation coefficient. Linear regression model was used to show individual effects of PERI and MYCL on myocardial functional parameters. Results Correlation analysis with parameters of systolic heart function revealed significant associations for PERI (Stroke Volume (SV): R = -0.513 p = 0.001; CardiacIndex (CI): R = -0.442 p = 0.014), but not for MYCL (SV: R = -0.233; p = 0.207; CI: R = -0.130; p = 0.484). No significant correlations were found for E/A ratio as a parameter of diastolic heart function. In multiple regression analysis CI was negatively predicted by PERI, whereas no impact of MYCL was observed in direct comparison. Conclusions Cardiac fat depots impact left ventricular heart function in a metabolically healthy population. Direct comparison of different lipid stores revealed that PERI is a more important predictor than MYCL for altered myocardial function.	[Wolf, Peter; Winhofer, Yvonne; Smajis, Sabina; Jankovic, Drazenka; Anderwald, Christian-Heinz; Luger, Anton; Krebs, Michael; Krssak, Martin] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria; [Jankovic, Drazenka] Wilhelminenspital Stadt Wien, Div Oncol Hematol & Palliat Care, Dept Internal Med 1, Vienna, Austria; [Trattnig, Siegfried; Krssak, Martin] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Ctr Excellence High Field MR, Vienna, Austria; [Anderwald, Christian-Heinz] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy; [Anderwald, Christian-Heinz] Specialized Hosp Complex Agathenhof, Med Direct, A-9322 Micheldorf, Carinthia, Austria	Medical University of Vienna; Wilhelminenspital; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR)	Krebs, M (corresponding author), Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria.	michael.krebs@meduniwien.ac.at	Krssak, Martin/AAU-8183-2020; Anderwald, Christian Heinz/AAG-2271-2021	Krssak, Martin/0000-0001-9717-803X; Anderwald, Christian Heinz/0000-0001-7485-0815; Wolf, Peter/0000-0001-6779-734X; Winhofer, Yvonne/0000-0002-0555-9044; Krebs, Michael/0000-0002-9265-7274; Trattnig, Siegfried/0000-0003-1623-3303	Austrian Association of Endocrinology and Metabolism (OGES); Austrian Heart Foundation; Medical Scientific Fund of the Mayor of the City of Vienna [12023]; Austrian National Bank [13249, 15363]	Austrian Association of Endocrinology and Metabolism (OGES); Austrian Heart Foundation; Medical Scientific Fund of the Mayor of the City of Vienna; Austrian National Bank	This study was in part funded by grants from the Austrian Association of Endocrinology and Metabolism (OGES) to PW as well as the Austrian Heart Foundation and the Medical Scientific Fund of the Mayor of the City of Vienna (Grant 12023), both to MKre and by the Austrian National Bank (Nr. 13249 and 15363) to MKrs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAER FM, 1994, HERZ, V19, P51; Barkhausen J, 2001, RADIOLOGY, V219, P264, DOI 10.1148/radiology.219.1.r01ap12264; Bayeva M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000433; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; Gaborit B, 2013, HORM METAB RES, V45, P991, DOI 10.1055/s-0033-1358669; Gaborit B, 2012, J AM COLL CARDIOL, V60, P1381, DOI 10.1016/j.jacc.2012.06.016; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Graner M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001979; Greulich S, 2012, CIRCULATION, V126, P2324, DOI 10.1161/CIRCULATIONAHA.111.039586; Guzzardi MA, 2014, DIABETOLOGIA, V57, P1937, DOI 10.1007/s00125-014-3307-8; Hammer S, 2008, AM J PHYSIOL-ENDOC M, V295, pE714, DOI 10.1152/ajpendo.90413.2008; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Hua N, 2014, J CARDIOVASCULAR MAG, V16, P1; Iacobellis G, 2005, J CLIN ENDOCR METAB, V90, P6300, DOI 10.1210/jc.2005-1087; Iacobellis G, 2014, OBESITY, V22, P332, DOI 10.1002/oby.20624; Iozzo P, 2009, J CLIN ENDOCR METAB, V94, P4472, DOI 10.1210/jc.2009-0436; Jankovic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050077; Kankaanpaa M, 2006, J CLIN ENDOCR METAB, V91, P4689, DOI 10.1210/jc.2006-0584; Krssak M, 2004, MAGN RESON MATER PHY, V16, P155, DOI 10.1007/s10334-003-0029-1; Krssak M, 2011, DIABETOLOGIA, V54, P1871, DOI 10.1007/s00125-011-2146-0; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; MOHIADDIN RH, 1991, J COMPUT ASSIST TOMO, V15, P237, DOI 10.1097/00004728-199103000-00009; Nyman K, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-103; Perseghin G, 2008, HEPATOLOGY, V47, P51, DOI 10.1002/hep.21983; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rijzewijk LJ, 2010, J AM COLL CARDIOL, V56, P225, DOI 10.1016/j.jacc.2010.02.049; Scherer T, 2014, J CLIN ENDOCR METAB, V99, pE2341, DOI 10.1210/jc.2014-2112; SHEHADEH A, 1995, CLIN CARDIOL, V18, P301, DOI 10.1002/clc.4960180604; van der Meer RW, 2007, J CARDIOVASC MAGN R, V9, P645, DOI 10.1080/10976640601093703; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Winhofer Y, 2015, AM J PHYSIOL-ENDOC M, V308, pE631, DOI 10.1152/ajpendo.00371.2014; Winhofer Y, 2014, J CLIN ENDOCR METAB, V99, P4299, DOI 10.1210/jc.2014-2242; Winhofer Y, 2012, DIABETES, V61, P1210, DOI 10.2337/db11-1275; Wolf P, 2014, WIEN MED WOCHENSCHR, V164, P320, DOI 10.1007/s10354-014-0292-y; Wolf P, 2014, J CLIN ENDOCR METAB, V99, pE1721, DOI 10.1210/jc.2014-1541	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151301	10.1371/journal.pone.0151301	http://dx.doi.org/10.1371/journal.pone.0151301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967641	Green Submitted, Green Published, gold			2022-12-26	WOS:000371989200043
J	Han, SX; Kwong, S; Ge, RW; Kolatkar, PR; Woods, AE; Blanchet, G; Kini, RM				Han, Summer Xia; Kwong, Shiyang; Ge, Ruowen; Kolatkar, Prasanna R.; Woods, Anthony E.; Blanchet, Guillaume; Kini, R. Manjunatha			Regulation of expression of venom toxins: silencing of prothrombin activator trocarin D by AG-rich motifs	FASEB JOURNAL			English	Article						purine repeat sequences; transcriptional repression; toxin gene evolution	PHOSPHOLIPASE A(2) GENES; COAGULATION-FACTOR-XA; POLYCOMB GROUP PROTEINS; SNAKE-VENOM; MOLECULAR EVOLUTION; ACCELERATED EVOLUTION; TRANSCRIPTIONAL ACTIVATION; PHYLOGENETIC ANALYSIS; RESPONSE ELEMENT; 3-FINGER TOXINS	Trocarin D (TroD), a venom prothrombin activator from Tropidechis carinatus, shares similar structure and function with blood coagulation factor Xa [Tropidechis carinatus FX (TrFX) a]. Their distinct physiologic roles are due to their distinct expression patterns. The genes of TroD and TrFX are highly similar, except for promoter and intron 1, indicating that TroD has probably evolved by duplication of FX, the plasma counterpart. The promoter insertion in TroD accounts for the elevated but not venom gland-specific expression. Here we examined the roles of 3 insertions and 2 deletions in intron 1 of TroD in the regulation of expression using luciferase as a reporter. By systematic deletions, we showed that a 209 bp region within the second insertion silences expression in mammalian and unmilked venom gland cells. Through bioinformatics analysis, we identified 5 AG-rich motifs in this region. All except the 5th motif are important for silencing function. YY1, Sp3 and HMGB2 were identified to bind these AG-rich motifs and silence gene expression in mammalian cells. Similar AG-rich motif clusters are also found in other toxin genes but not in their physiologic counterparts. Thus, AG-rich motifs contribute to regulation of expression of TroD, and probably other toxin genes.Han, S. X., Kwong, S., Ge, R., Kolatkar, P. R., Woods, A. E., Blanchet, G., Kini, R. M. Regulation of expression of venom toxins: silencing of prothrombin activator trocarin D by AG-rich motifs.	[Han, Summer Xia; Kwong, Shiyang; Ge, Ruowen; Blanchet, Guillaume; Kini, R. Manjunatha] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Kolatkar, Prasanna R.] Hamad Bin Khalifa Univ, Qatar Fdn Educ Sci & Community Dev, Qatar Biomed Res Inst, Doha, Qatar; [Woods, Anthony E.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	National University of Singapore; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); University of South Australia	Kini, RM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Prot Sci Lab, Sci Dr 4, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Ge, Ruowen/D-8352-2012	Ge, Ruowen/0000-0002-0750-7336; Woods, Anthony/0000-0002-8208-4054; Kini, Manjunatha/0000-0002-6100-3251	National University of Singapore	National University of Singapore(National University of Singapore)	The authors thank anonymous referees for their constructive comments on this manuscript. The authors appreciate the help from Jessica Logan and Andrew Beck ( University of South Australia) and Nathan Dunstan and Luke Allen ( Venom Supplies Pty. Ltd., Tanunda, SA, Australia) for successful culture of primary venom gland cells. The authors also appreciate Sizun Jiang and Dr. Calista Ng (former members of P.R.K's group, Genome Institute of Singapore), and Dr. Li Chenyu (Department of Biological Sciences, National University of Singapore) for their insightful discussions. The authors are also thankful to Harald Kerkkamp (Leiden University, Leiden, The Netherlands) for providing necessary sequences of Ophiophagus hannah genes. Additionally, the authors thank Quan-zhi Ye (Department of Physics and Astronomy, The University of Western Ontario, London, ON, Canada) for kind help with time management and paper writing. This study was supported by an academic research grant from the National University of Singapore. The authors declare no conflicts of interest.	Abu Reza M, 2005, THROMB HAEMOSTASIS, V93, P40, DOI 10.1160/TH04-07-0435; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Casewell NR, 2013, TRENDS ECOL EVOL, V28, P219, DOI 10.1016/j.tree.2012.10.020; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Chang LS, 1997, BIOCHEM BIOPH RES CO, V239, P756, DOI 10.1006/bbrc.1997.7549; Debrauwere H, 1997, BIOCHIMIE, V79, P577, DOI 10.1016/S0300-9084(97)82006-8; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Fujimi TJ, 2004, GENE, V332, P179, DOI 10.1016/j.gene.2004.02.050; Fujimi TJ, 2002, GENE, V292, P225, DOI 10.1016/S0378-1119(02)00682-0; Fujimi TJ, 2002, TOXICON, V40, P873, DOI 10.1016/S0041-0101(01)00272-0; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hargreaves AD, 2014, GENOME BIOL EVOL, V6, P2088, DOI 10.1093/gbe/evu166; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Joseph JS, 1999, BLOOD, V94, P621, DOI 10.1182/blood.V94.2.621.414k25_621_631; Junqueira-de-Azevedo ILM, 2015, MOL BIOL EVOL, V32, P754, DOI 10.1093/molbev/msu337; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; Kini RM, 2011, J THROMB HAEMOST, V9, P195, DOI 10.1111/j.1538-7836.2011.04279.x; Kini R. M., 1999, VENOM PHOSPHOLIPASE; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kordis D, 1997, EUR J BIOCHEM, V246, P772, DOI 10.1111/j.1432-1033.1997.00772.x; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kwong S, 2009, THROMB HAEMOSTASIS, V102, P469, DOI 10.1160/TH09-03-0162; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Laresgoiti U, 2013, NUCLEIC ACIDS RES, V41, P10185, DOI 10.1093/nar/gkt821; Le TNM, 2005, THROMB HAEMOSTASIS, V93, P420, DOI 10.1160/TH040-11-0707; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Ma DH, 2002, ARCH BIOCHEM BIOPHYS, V404, P98, DOI 10.1016/S0003-9861(02)00245-X; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; MouradaSilva AM, 1996, J MOL EVOL, V43, P263, DOI 10.1007/PL00006085; NAKASHIMA K, 1993, P NATL ACAD SCI USA, V90, P5964, DOI 10.1073/pnas.90.13.5964; Ogawa T, 1995, J MOL EVOL, V41, P867; Ogbourne S, 1998, BIOCHEM J, V331, P1; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; PAINE MJI, 1992, TOXICON, V30, P379, DOI 10.1016/0041-0101(92)90534-C; Pawlak J, 2008, BIOCHIMIE, V90, P868, DOI 10.1016/j.biochi.2008.02.016; Petrykowska HM, 2008, GENOME RES, V18, P1238, DOI 10.1101/gr.073817.107; Qi HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124588; Rao VS, 2003, BIOCHEM J, V369, P635, DOI 10.1042/BJ20020889; Rao VS, 2002, THROMB HAEMOSTASIS, V88, P611, DOI 10.1055/s-0037-1613264; Reza MA, 2007, J THROMB HAEMOST, V5, P117, DOI 10.1111/j.1538-7836.2006.02266.x; Reza MA, 2006, J THROMB HAEMOST, V4, P1346, DOI 10.1111/j.1538-7836.2006.01969.x; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Sipos L, 2007, P NATL ACAD SCI USA, V104, P12416, DOI 10.1073/pnas.0703144104; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Weill L, 2003, J VIROL, V77, P2903, DOI 10.1128/JVI.77.5.2903-2914.2003; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022	64	4	4	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2411	2425		10.1096/fj.201600213R	http://dx.doi.org/10.1096/fj.201600213R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26985007				2022-12-26	WOS:000376878300029
J	Thiyagarajan, K; Vitali, F; Tolaini, V; Galeffi, P; Cantale, C; Vikram, P; Singh, S; De Rossi, P; Nobili, C; Procacci, S; Del Fiore, A; Antonini, A; Presenti, O; Brunori, A				Thiyagarajan, Karthikeyan; Vitali, Fabio; Tolaini, Valentina; Galeffi, Patrizia; Cantale, Cristina; Vikram, Prashant; Singh, Sukhwinder; De Rossi, Patrizia; Nobili, Chiara; Procacci, Silvia; Del Fiore, Antonella; Antonini, Alessandro; Presenti, Ombretta; Brunori, Andrea			Genomic Characterization of Phenylalanine Ammonia Lyase Gene in Buckwheat	PLOS ONE			English	Article							CANDIDATE GENES; FAGOPYRUM; EXPRESSION; DIVERSITY; SOFTWARE; PATHWAY; RUTIN	Phenylalanine Ammonia Lyase (PAL) gene which plays a key role in bio-synthesis of medicinally important compounds, Rutin/quercetin was sequence characterized for its efficient genomics application. These compounds possessing anti-diabetic and anti-cancer properties and are predominantly produced by Fagopyrum spp. In the present study, PAL gene was sequenced from three Fagopyrum spp. (F. tataricum, F. esculentum and F. dibotrys) and showed the presence of three SNPs and four insertion/deletions at intra and inter specific level. Among them, the potential SNP (position 949th bp G>C) with Parsimony Informative Site was selected and successfully utilised to individuate the zygosity/allelic variation of 16 F. tataricum varieties. Insertion mutations were identified in coding region, which resulted the change of a stretch of 39 amino acids on the putative protein. Our Study revealed that autogamous species (F. tataricum) has lower frequency of observed SNPs as compared to allogamous species (F. dibotrys and F. esculentum). The identified SNPs in F. tataricum didn't result to amino acid change, while in other two species it caused both conservative and non-conservative variations. Consistent pattern of SNPs across the species revealed their phylogenetic importance. We found two groups of F. tataricum and one of them was closely related with F. dibotrys. Sequence characterization information of PAL gene reported in present investigation can be utilized in genetic improvement of buckwheat in reference to its medicinal value.	[Thiyagarajan, Karthikeyan; Vitali, Fabio; Tolaini, Valentina; Galeffi, Patrizia; Cantale, Cristina; De Rossi, Patrizia; Nobili, Chiara; Procacci, Silvia; Del Fiore, Antonella; Antonini, Alessandro; Presenti, Ombretta; Brunori, Andrea] UTAGRI INN, Italian Natl Agcy New Technol Energy & Sustainabl, Via Anguillarese 301, I-00123 Rome, Italy; [Thiyagarajan, Karthikeyan] Biovers Int, I-00054 Maccarese, Fiumicino, Italy; [Vikram, Prashant; Singh, Sukhwinder] Int Ctr Maize & Wheat Improvement, Genet Resource Program, El Batan, Texcoco, Mexico	Italian National Agency New Technical Energy & Sustainable Economics Development; Alliance; Bioversity International; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Thiyagarajan, K; Brunori, A (corresponding author), UTAGRI INN, Italian Natl Agcy New Technol Energy & Sustainabl, Via Anguillarese 301, I-00123 Rome, Italy.; Thiyagarajan, K (corresponding author), Biovers Int, I-00054 Maccarese, Fiumicino, Italy.	pltbiotech_tkarthi@outlook.com; andrea.brunori@enea.it	Karthikeyan, Thiyagarajan/AAI-4439-2020	Vikram, Prashant/0000-0002-3740-6608; Del Fiore, Antonella/0000-0003-3728-8864; nobili, chiara/0000-0003-4784-8351; Galeffi, Patrizia/0000-0002-0101-1751; Presenti, Ombretta/0000-0001-6404-1598; Thiyagarajan, Karthikeyan/0000-0003-2864-9373	ENEA International Fellowship; ENEA International Fellowship, Italy	ENEA International Fellowship; ENEA International Fellowship, Italy	Funding for this work came from an ENEA International Fellowship (2012-14), http://www.enea.it/en/job-study/international-fellowship.; Authors duly acknowledge the financial support of ENEA International Fellowship, Italy. We also extend our sincere thanks to all researchers of Biotechnology and Agroindustry Division (formerly called UTAGRI), ENEA, Italy, for their time to time support and encouragement. Authors also wishes to express their sincere gratitude to Prof. Enrico Porceddu and Prof. Mario Enrico Pe for their constant encouragement and support.	Bagal UR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S3-S1; Beaty TH, 2005, GENETICS, V171, P259, DOI 10.1534/genetics.105.043075; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Cho KS, 2015, PLOS ONE, V10; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; de Jong F, 2015, PHYTOCHEMISTRY, V117, P90, DOI 10.1016/j.phytochem.2015.06.005; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Durendic-Brenesel M, 2013, BOSNIAN J BASIC MED, V13, P100; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HUDSON RR, 1992, GENETICS, V132, P583; Kowalska I, 2007, J AGR FOOD CHEM, V55, P2645, DOI 10.1021/jf063635b; Kreft I., 2003, Fagopyrum, V20, P7; Kreft S, 1999, J AGR FOOD CHEM, V47, P4649, DOI 10.1021/jf990186p; Kumar S, 2001, GENETICS, V158, P1321; Kumar S, 2007, BIOINFORMATICS, V23, P1713, DOI 10.1093/bioinformatics/btm239; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CC, 2012, EXP DIABETES RES, DOI 10.1155/2012/375673; Li CL, 2012, PLANT MOL BIOL REP, V30, P1172, DOI 10.1007/s11105-012-0431-9; Li SQ, 2001, CRIT REV FOOD SCI, V41, P451, DOI 10.1080/20014091091887; Li XH, 2010, J AGR FOOD CHEM, V58, P12176, DOI 10.1021/jf103310g; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Z, 2001, J NUTR, V131, P1850, DOI 10.1093/jn/131.6.1850; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Ohnishi O, 1996, GENES GENET SYST, V71, P383, DOI 10.1266/ggs.71.383; Ohnishi O., 1998, Fagopyrum, V15, P18; Ohnishi O., 1995, P 6 INT S BUCKWHEAT, P175; Ohsawa R, 1995, EUPHYTICA, V86, P183; Peukert M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-97; R Core Team, 2018, R LANG ENV STAT COMP; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Steward A. N., 1930, CONTRIB GRAY HERB HA, V88, P1; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Vakhrusheva AA, 2011, J MOL EVOL, V72, P138, DOI 10.1007/s00239-010-9408-1; Verdu CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107103; Williams LE, 2013, GENOME BIOL EVOL, V5, P599, DOI 10.1093/gbe/evt033; Yamane K, 2003, AM J BOT, V90, P339, DOI 10.3732/ajb.90.3.339; Yasuda T, 2001, ADV BUCKWHEAT RES, P499; Yasui Y, 1998, GENES GENET SYST, V73, P201, DOI 10.1266/ggs.73.201; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	47	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151187	10.1371/journal.pone.0151187	http://dx.doi.org/10.1371/journal.pone.0151187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990297	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800045
J	Dietze, KK; Schimmer, S; Kretzmer, F; Wang, JZ; Lin, Y; Huang, X; Wu, WM; Wang, BJ; Lu, MJ; Dittmer, U; Yang, DL; Liu, J				Dietze, Kirsten K.; Schimmer, Simone; Kretzmer, Freya; Wang, Junzhong; Lin, Yong; Huang, Xuan; Wu, Weimin; Wang, Baoju; Lu, Mengji; Dittmer, Ulf; Yang, Dongliang; Liu, Jia			Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSE; VIRAL CLEARANCE; INFECTION; EXPANSION; EXPRESSION; DEPLETION; LIVER; MICE; HBV	Regulatory T cells (Tregs) play an important role in counter-regulating effector T cell responses in many infectious diseases. However, they can also contribute to the development of T cell dysfunction and pathogen persistence in chronic infections. Tregs have been reported to suppress virus-specific T cell responses in hepatitis B virus (HBV) infection of human patients as well as in HBV animal models. However, the phenotype and expansion of Tregs has so far only been investigated in other infections, but not in HBV. We therefore performed hydrodynamic injections of HBV plasmids into mice and analyzed the Treg response in the spleen and liver. Absolute Treg numbers significantly increased in the liver but not the spleen after HBV injection. The cells were natural Tregs that surprisingly did not show any activation or proliferation in response to the infection. However, they were able to suppress effector T cell responses, as selective depletion of Tregs significantly increased HBV-specific CD8+ T cell responses and accelerated viral antigen clearance. The data implies that natural Tregs infiltrate the liver in HBV infection without further activation or expansion but are still able to interfere with T cell mediated viral clearance.	[Dietze, Kirsten K.; Schimmer, Simone; Kretzmer, Freya; Lin, Yong; Huang, Xuan; Wu, Weimin; Lu, Mengji; Dittmer, Ulf] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Wang, Junzhong; Wang, Baoju; Yang, Dongliang; Liu, Jia] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	University of Duisburg Essen; Huazhong University of Science & Technology	Liu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China.	jialiu77@hotmail.com	Lu, Mengji/ABF-9410-2020; Wang, Junzhong/AAS-9767-2021		Deutsche Forschungsgemeinschaft [TRR60, GK 1045]; National Nature Science Foundation of China (SG-JIRP) [81461130019]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Nature Science Foundation of China (SG-JIRP)(National Natural Science Foundation of China (NSFC))	This work was supported by the Deutsche Forschungsgemeinschaft (TRR60 and GK 1045, www.dfg.de/) and the National Nature Science Foundation of China (SG-JIRP, 81461130019, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; Belkaid Y, 2008, EUR J IMMUNOL, V38, P918, DOI 10.1002/eji.200738120; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2011, IMMUNOLOGY, V133, P426, DOI 10.1111/j.1365-2567.2011.03460.x; Chen X, 2010, J IMMUNOL, V185, P174, DOI 10.4049/jimmunol.0903548; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Chuai X, 2014, ANTIVIR RES, V101, P68, DOI 10.1016/j.antiviral.2013.10.019; Crispe I Nicholas, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0321s22; Dai K, 2015, IMMUNOLOGY, V144, P506, DOI 10.1111/imm.12400; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dietze KK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003798; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Dong XJ, 2013, LIVER INT, V33, P1517, DOI 10.1111/liv.12248; Frank I, 2007, J VIROL, V81, P7156, DOI 10.1128/JVI.02711-06; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Furuichi Y, 2005, WORLD J GASTROENTERO, V11, P3772, DOI 10.3748/wjg.v11.i24.3772; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Joedicke JJ, 2014, J IMMUNOL, V193, P2952, DOI 10.4049/jimmunol.1400649; Joedicke Jara J., 2014, Virologica Sinica, V29, P48, DOI 10.1007/s12250-014-3396-z; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; JUNG MC, 1991, J HEPATOL, V13, P310, DOI 10.1016/0168-8278(91)90074-L; Kondo Y, 2006, WORLD J GASTROENTERO, V12, P4310, DOI 10.3748/wjg.v12.i27.4310; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Liu J., 2014, FRONT ENV SCI ENG, P1, DOI DOI 10.1371/J0URNAL.PPAT.1003856; Liu Jia, 2014, Virologica Sinica, V29, P10, DOI 10.1007/s12250-014-3410-5; Liu J, 2013, J IMMUNOL, V191, P6178, DOI 10.4049/jimmunol.1301262; Liu YM, 2015, INT J CLIN EXP MED, V8, P6735; Lu MJ, 1999, J VIROL, V73, P281, DOI 10.1128/JVI.73.1.281-289.1999; Manigold T, 2007, LANCET INFECT DIS, V7, P804, DOI 10.1016/S1473-3099(07)70289-X; Myers L, 2013, J IMMUNOL, V190, P5485, DOI 10.4049/jimmunol.1202951; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rowe JH, 2012, IMMUNOLOGY, V136, P1, DOI 10.1111/j.1365-2567.2011.03551.x; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Sugita K, 2015, EXP DERMATOL, V24, P554, DOI 10.1111/exd.12711; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; von Freyend MJ, 2011, J VIRAL HEPATITIS, V18, P216, DOI 10.1111/j.1365-2893.2010.01302.x; Wu J, 2014, J VIROL, V88, P10421, DOI 10.1128/JVI.00996-14; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yang GL, 2007, INT IMMUNOL, V19, P133, DOI 10.1093/intimm/dxl130; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547; Zelinskyy G, 2006, EUR J IMMUNOL, V36, P2658, DOI 10.1002/eji.200636059; Zelinskyy G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000406; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	59	19	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151717	10.1371/journal.pone.0151717	http://dx.doi.org/10.1371/journal.pone.0151717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986976	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300119
J	Benko, Z; Elder, RT; Li, G; Liang, D; Zhao, RY				Benko, Zsigmond; Elder, Robert T.; Li, Ge; Liang, Dong; Zhao, Richard Y.			HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-DAMAGE CHECKPOINT; CELL-DEATH; G(2) ARREST; TYPE-1 VPR; IN-VIVO; R VPR; APOPTOSIS; EXPRESSION; THIAMINE	Background HIV-1 protease (PR) is an essential viral enzyme. Its primary function is to proteolyze the viral Gag-Pol polyprotein for production of viral enzymes and structural proteins and for maturation of infectious viral particles. Increasing evidence suggests that PR cleaves host cellular proteins. However, the nature of PR-host cellular protein interactions is elusive. This study aimed to develop a fission yeast (Schizosaccharomyces pombe) model system and to examine the possible interaction of HIV-1 PR with cellular proteins and its potential impact on cell proliferation and viability. Results A fission yeast strain RE294 was created that carried a single integrated copy of the PR gene in its chromosome. The PR gene was expressed using an inducible nmt1 promoter so that PR-specific effects could be measured. HIV-1 PR from this system cleaved the same indigenous viral p6/MA protein substrate as it does in natural HIV-1 infections. HIV-1 PR expression in fission yeast cells prevented cell proliferation and induced cellular oxidative stress and changes in mitochondrial morphology that led to cell death. Both these PR activities can be prevented by a PR-specific enzymatic inhibitor, indinavir, suggesting that PR-mediated proteolytic activities and cytotoxic effects resulted from enzymatic activities of HIV-1 PR. Through genome-wide screening, a serine/threonine kinase, Hhp2, was identified that suppresses HIV-1 PR-induced protease cleavage and cell death in fission yeast and in mammalian cells, where it prevented PR-induced apoptosis and cleavage of caspase-3 and caspase-8. Conclusions This is the first report to show that HIV-1 protease is functional as an enzyme in fission yeast, and that it behaves in a similar manner as it does in HIV-1 infection. HIV-1 PR-induced cell death in fission yeast could potentially be used as an endpoint for mechanistic studies, and this system could be used for developing a high-throughput system for drug screenings.	[Benko, Zsigmond; Li, Ge; Liang, Dong; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Immunol Microbiol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Elder, Robert T.] Northwestern Univ, Feinberg Sch Med, Chicago Mem Inst Educ & Res, Chicago, IL 60611 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine	Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Immunol Microbiol, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	rzhao@som.umaryland.edu		Zhao, Richard Y./0000-0003-3424-2852	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH-NINDS) [NS063880]; University of Maryland Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063880] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH-NINDS); University of Maryland Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH-NINDS; NS063880) and a research fund from the University of Maryland Medical Center (to RYZ).; This study was supported in part by a research grant from the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH-NINDS; NS063880), and a research fund from the University of Maryland Medical Center (to RYZ).	[Anonymous], 2008, PE ANN V AP DET KIT; BARBET N, 1992, GENE, V114, P59, DOI 10.1016/0378-1119(92)90707-V; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Benko Z, 2004, J VIROL, V78, P11016, DOI 10.1128/JVI.78.20.11016-11029.2004; Benko Z., 2010, INT J HIGH THROUGHPU, V1, P151; Blanco R, 2003, J BIOL CHEM, V278, P1086, DOI 10.1074/jbc.M205636200; Bren GD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002112; BTX, 2011, EL MAN ECM600 PROT 0; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; Coffin JM, 1996, SCIENCE, V271, P671, DOI 10.1126/science.271.5249.671; Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996; Cummings RT, 2002, P NATL ACAD SCI USA, V99, P6603, DOI 10.1073/pnas.062171599; Devroe E, 2005, VIROLOGY, V331, P181, DOI 10.1016/j.virol.2004.10.023; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; Dunn BM, 2002, GENOME BIOL, V3; Elder RT, 2000, VIRUS RES, V68, P161, DOI 10.1016/S0168-1702(00)00167-2; Foucher AL, 2013, ANTIMICROB AGENTS CH, V57, P1252, DOI 10.1128/AAC.01983-12; Frei M., 2011, CENTRIFUGATION, V6; Gatlin J, 1998, VIROLOGY, V244, P87, DOI 10.1006/viro.1998.9083; Gianotti N, 2007, NEW MICROBIOL, V30, P79; Haneda E, 2000, BIOCHEM BIOPH RES CO, V275, P434, DOI 10.1006/bbrc.2000.3319; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Huard S, 2008, CELL RES, V18, P961, DOI 10.1038/cr.2008.272; Huard S, 2008, J VIROL, V82, P2904, DOI 10.1128/JVI.01098-07; Invitrogen, 2001, PROB YEAST VIAB; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; KAPLAN AH, 1994, P NATL ACAD SCI USA, V91, P5597, DOI 10.1073/pnas.91.12.5597; KEARNEY PH, 1994, BIOCHEM BIOPH RES CO, V203, P231, DOI 10.1006/bbrc.1994.2172; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Korant BD, 1998, ADV EXP MED BIOL, V436, P27; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Li G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011371; LILLEHOJ EP, 1988, J VIROL, V62, P3053, DOI 10.1128/JVI.62.8.3053-3058.1988; Madeo F, 2002, CURR GENET, V41, P208, DOI 10.1007/s00294-002-0310-2; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Masuda M, 2000, J VIROL, V74, P2636, DOI 10.1128/JVI.74.6.2636-2646.2000; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MIYAKAWA I, 1984, J CELL SCI, V66, P21; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nie Z, 2002, CELL DEATH DIFFER, V9, P1172, DOI 10.1038/sj.cdd.4401094; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Nkeze J, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0037-7; Nurse PM, 2002, BIOSCIENCE REP, V22, P487, DOI 10.1023/A:1022017701871; Olsson I, 2011, CURR GENET, V57, P1, DOI 10.1007/s00294-010-0327-x; Perez MAS, 2010, J PHYS CHEM B, V114, P2525, DOI 10.1021/jp910958u; Ravaux I, 2014, J VIROL METHODS, V195, P180, DOI 10.1016/j.jviromet.2013.08.019; Rumlova M, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-37; Ventoso L, 2005, ANTIVIR RES, V66, P47, DOI 10.1016/j.antiviral.2004.12.008; Wagner RN, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0200-6; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664; Yang HL, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-32; Zelenak C, 2012, CELL PHYSIOL BIOCHEM, V29, P171, DOI 10.1159/000337598; Zelivianski S, 2006, APOPTOSIS, V11, P377, DOI 10.1007/s10495-006-4030-9; Zhang CS, 1997, VIROLOGY, V230, P103, DOI 10.1006/viro.1997.8459; Zhao Y, 2000, FRONT BIOSCI, P905; ZHAO YQ, 1995, DNA CELL BIOL, V14, P359, DOI 10.1089/dna.1995.14.359; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996; Zhao YQ, 1998, VIROLOGY, V246, P266, DOI 10.1006/viro.1998.9208; Zhao YQ, 1998, BIOTECHNIQUES, V25, P438, DOI 10.2144/98253st06	62	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151286	10.1371/journal.pone.0151286	http://dx.doi.org/10.1371/journal.pone.0151286			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982200	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900074
J	Lihoreau, M; Chittka, L; Raine, NE				Lihoreau, Mathieu; Chittka, Lars; Raine, Nigel E.			Monitoring Flower Visitation Networks and Interactions between Pairs of Bumble Bees in a Large Outdoor Flight Cage	PLOS ONE			English	Article							FORAGING BUMBLEBEES; NECTAR; OPTIMIZATION; COMPETITION; CONSPECIFICS; POLLINATORS; HYMENOPTERA; RESPONSES; ECOLOGY; APIDAE	Pollinators, such as bees, often develop multi-location routes (traplines) to exploit subsets of flower patches within larger plant populations. How individuals establish such foraging areas in the presence of other foragers is poorly explored. Here we investigated the foraging patterns of pairs of bumble bees (Bombus terrestris) released sequentially into an 880m(2) outdoor flight cage containing 10 feeding stations (artificial flowers). Using motion-sensitive video cameras mounted on flowers, we mapped the flower visitation networks of both foragers, quantified their interactions and compared their foraging success over an entire day. Overall, bees that were released first (residents) travelled 37% faster and collected 77% more nectar, thereby reaching a net energy intake rate 64% higher than bees released second (newcomers). However, this prior-experience advantage decreased as newcomers became familiar with the spatial configuration of the flower array. When both bees visited the same flower simultaneously, the most frequent outcome was for the resident to evict the newcomer. On the rare occasions when newcomers evicted residents, the two bees increased their frequency of return visits to that flower. These competitive interactions led to a significant (if only partial) spatial overlap between the foraging patterns of pairs of bees. While newcomers may initially use social cues (such as olfactory footprints) to exploit flowers used by residents, either because such cues indicate higher rewards and/or safety from predation, residents may attempt to preserve their monopoly over familiar resources through exploitation and interference. We discuss how these interactions may favour spatial partitioning, thereby maximising the foraging efficiency of individuals and colonies.	[Lihoreau, Mathieu; Chittka, Lars; Raine, Nigel E.] Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, Mile End Rd, London E1 4NS, England; [Raine, Nigel E.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Lihoreau, Mathieu] Toulouse Univ, Res Ctr Anim Cognit CRCA, Ctr Integrat Biol CBI, CNRS,UPS, Toulouse, France; [Raine, Nigel E.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	University of London; Queen Mary University London; University of London; Royal Holloway University London; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Guelph	Lihoreau, M (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, Mile End Rd, London E1 4NS, England.; Lihoreau, M (corresponding author), Toulouse Univ, Res Ctr Anim Cognit CRCA, Ctr Integrat Biol CBI, CNRS,UPS, Toulouse, France.	mathieu.lihoreau@univ-tlse3.fr	Chittka, Lars/C-3110-2012; Raine, Nigel/AAK-6425-2020	Chittka, Lars/0000-0001-8153-1732; Raine, Nigel/0000-0001-6343-2829; Lihoreau, Mathieu/0000-0002-2463-2040	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council [BB/F52765X/1]; IDEX of the Federal University of Toulouse; Fyssen foundation; CNRS; W. Garfield Weston Foundation; ERC Advanced Grant SpaceRadarPollinator; Royal Society Wolfson Research Merit Award; BBSRC [BB/F52765X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F52765X/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); IDEX of the Federal University of Toulouse; Fyssen foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); W. Garfield Weston Foundation; ERC Advanced Grant SpaceRadarPollinator; Royal Society Wolfson Research Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a combined grant from the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, and the Engineering and Physical Sciences Research Council (BB/F52765X/1). While writing, ML was supported by the IDEX of the Federal University of Toulouse (Starting and Emergence grants), the Fyssen foundation and the CNRS. NER was supported as the Rebanks Family Chair in Pollinator Conservation by The W. Garfield Weston Foundation. LC was supported by ERC Advanced Grant SpaceRadarPollinator and by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Balfour NJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1731, DOI 10.1007/s00265-015-1985-y; Bergman M, 2010, P ROY SOC B-BIOL SCI, V277, P3027, DOI 10.1098/rspb.2010.0646; CARTAR RV, 1990, BEHAV ECOL SOCIOBIOL, V26, P121, DOI 10.1007/BF00171581; Charlton NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012186; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DREISIG H, 1995, OIKOS, V72, P161, DOI 10.2307/3546218; DUCHATEAU MJ, 1989, J ETHOL, V7, P141, DOI 10.1007/BF02350036; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gilbert L.E., 1980, COEVOLUTION ANIMALS, P210; GILL FB, 1988, ECOLOGY, V69, P1933, DOI 10.2307/1941170; Giraldeau L.A., 2000, MG BEH ECOL; Giurfa M, 2013, TRENDS NEUROSCI, V36, P285, DOI 10.1016/j.tins.2012.12.011; Goulson D, 1998, ANIM BEHAV, V55, P199, DOI 10.1006/anbe.1997.0570; HARDER LD, 1986, OECOLOGIA, V69, P309, DOI 10.1007/BF00377639; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Kapustjansky A, 2010, NATURWISSENSCHAFTEN, V97, P229, DOI 10.1007/s00114-009-0627-5; Kawaguchi LG, 2007, P ROY SOC B-BIOL SCI, V274, P2661, DOI 10.1098/rspb.2007.0860; Leadbeater E, 2005, CURR BIOL, V15, pR447, DOI 10.1016/j.cub.2005.06.011; Leadbeater E, 2011, ANIM COGN, V14, P915, DOI 10.1007/s10071-011-0423-4; LEMKE TO, 1984, ECOLOGY, V65, P538, DOI 10.2307/1941416; Lichtenberg EM, 2010, INSECT SOC, V57, P105, DOI 10.1007/s00040-009-0055-8; Lihoreau M, 2015, ECOL LETT, V18, P273, DOI 10.1111/ele.12406; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Lihoreau M, 2012, BIOL LETTERS, V8, P13, DOI 10.1098/rsbl.2011.0661; Lihoreau M, 2011, FUNCT ECOL, V25, P1284, DOI 10.1111/j.1365-2435.2011.01881.x; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Makino TT, 2005, BEHAV ECOL SOCIOBIOL, V57, P617, DOI 10.1007/s00265-004-0877-3; Morrell LJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P385, DOI 10.1007/s00265-003-0663-7; MORSE DH, 1977, SCIENCE, V197, P678, DOI 10.1126/science.197.4304.678; Muller H, 2012, ENTOMOL GEN, V34, P1; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Ohashi K, 2008, BEHAV ECOL, V19, P936, DOI 10.1093/beheco/arn048; Ohashi K, 2007, BEHAV ECOL, V18, P1, DOI [10.1093/beheco/ar1053, 10.1093/beheco/arl053]; Ohashi K, 2013, BEHAV ECOL, V24, P182, DOI 10.1093/beheco/ars152; Ohashi K, 2009, ANN BOT-LONDON, V103, P1365, DOI 10.1093/aob/mcp088; Opler P.A., 1983, P30; POSSINGHAM HP, 1989, AM NAT, V133, P42, DOI 10.1086/284900; PYKE GH, 1980, THEOR POPUL BIOL, V17, P232, DOI 10.1016/0040-5809(80)90008-8; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, ENTOMOL GEN, V30, P191; Raine NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045096; ROUBIK DW, 1980, ECOLOGY, V61, P836, DOI 10.2307/1936754; Simpson SJ, 2012, NATURE NUTR UNIYING; Stamps JA, 2001, AM NAT, V157, P154, DOI 10.1086/318634; Stephens D., 2007, FORAGING BEHAV ECOLO; Stout JC, 2002, BEHAV ECOL SOCIOBIOL, V52, P239, DOI 10.1007/s00265-002-0510-2; THOMSON JD, 1987, OECOLOGIA, V71, P295, DOI 10.1007/BF00377298; Thomson JD, 1997, BEHAV ECOL, V8, P199, DOI 10.1093/beheco/8.2.199; Thomson JD, 1996, BEHAV ECOL, V7, P158, DOI 10.1093/beheco/7.2.158; Venables WN., 2002, MODERN APPL STAT S 4; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368	59	21	21	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150844	10.1371/journal.pone.0150844	http://dx.doi.org/10.1371/journal.pone.0150844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982030	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900053
J	O'Neill, KE; Bredenkamp, N; Tischner, C; Vaidya, HJ; Stenhouse, FH; Peddie, CD; Nowell, CS; Gaskell, T; Blackburn, CC				O'Neill, Kathy E.; Bredenkamp, Nicholas; Tischner, Christin; Vaidya, Harsh J.; Stenhouse, Frances H.; Peddie, C. Diana; Nowell, Craig S.; Gaskell, Terri; Blackburn, C. Clare			Foxn1 Is Dynamically Regulated in Thymic Epithelial Cells during Embryogenesis and at the Onset of Thymic Involution	PLOS ONE			English	Article							FUNCTIONAL THYMUS; PROGENITOR-CELL; ADULT THYMUS; STEM-CELLS; MOUSE; NUDE; EXPRESSION; MICROENVIRONMENT; DIFFERENTIATION; THYMOPOIESIS	Thymus function requires extensive cross-talk between developing T-cells and the thymic epithelium, which consists of cortical and medullary TEC. The transcription factor FOXN1 is the master regulator of TEC differentiation and function, and declining Foxn1 expression with age results in stereotypical thymic involution. Understanding of the dynamics of Foxn1 expression is, however, limited by a lack of single cell resolution data. We have generated a novel reporter of Foxn1 expression, Foxn1(G), to monitor changes in Foxn1 expression during embryogenesis and involution. Our data reveal that early differentiation and maturation of cortical and medullary TEC coincides with precise sub-lineage-specific regulation of Foxn1 expression levels. We further show that initiation of thymic involution is associated with reduced cTEC functionality, and proportional expansion of FOXN1-negative TEC in both cortical and medullary sub-lineages. Cortex-specific down-regulation of Foxn1 between 1 and 3 months of age may therefore be a key driver of the early stages of age-related thymic involution.	[O'Neill, Kathy E.; Bredenkamp, Nicholas; Tischner, Christin; Vaidya, Harsh J.; Stenhouse, Frances H.; Peddie, C. Diana; Nowell, Craig S.; Gaskell, Terri; Blackburn, C. Clare] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland; [Bredenkamp, Nicholas] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England; [Tischner, Christin] Univ Cologne, Inst Genet, Cologne, Germany; [Nowell, Craig S.] UKNSCB, S Mimms EN6 3QG, Herts, England; [Gaskell, Terri] Guys Hosp, Cell Therapy Catapult, London SE1 9RT, England	University of Edinburgh; University of Cambridge; University of Cologne; Guy's & St Thomas' NHS Foundation Trust	Blackburn, CC (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	c.blackburn@ed.ac.uk	Vaidya, Harsh/L-4903-2019; Blackburn, Clare/AAM-7954-2020; Blackburn, Clare/B-2847-2009	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X	Biotechnology and Biological Sciences Research Council [BB/H021183/1BBSRC]; Leukaemia and Lymphoma Research grant [12012]; School of Biological Sciences, University of Edinburgh; Medical Research Council [71380]; European Union; EuroSyStem; ThymiStem [223098, 200720, 602587]; BBSRC [BB/H021183/1] Funding Source: UKRI; MRC [MR/L012766/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021183/1] Funding Source: researchfish; Medical Research Council [MR/L012766/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia and Lymphoma Research grant; School of Biological Sciences, University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); EuroSyStem(European Commission); ThymiStem; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results received funding from the Biotechnology and Biological Sciences Research Council grant number BB/H021183/1BBSRC (CCB, KO'N), Leukaemia and Lymphoma Research grant number 12012 (CCB, NB, KO'N), the School of Biological Sciences, University of Edinburgh (HV), the Medical Research Council grant number 71380 (CCB, FHS, TG), and the European Union Seventh Framework Programme (FP7/2007-2013) collaborative projects OptiStem (CCB), EuroSyStem (CCB and NB) and ThymiStem (CCB, KO'N) under grant agreement numbers (223098, 200720 and 602587 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Jenkinson WE, 2008, J IMMUNOL, V181, P6101, DOI 10.4049/jimmunol.181.9.6101; JONES B, 1995, TRENDS GENET, V11, P257, DOI 10.1016/S0168-9525(00)89068-X; Ki S, 2014, CELL REP, V9, P402, DOI 10.1016/j.celrep.2014.08.070; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; Metzger TC, 2013, CELL REP, V5, P166, DOI 10.1016/j.celrep.2013.08.038; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Rode I, 2015, J IMMUNOL, V195, P5678, DOI 10.4049/jimmunol.1502010; Sekai M, 2014, IMMUNITY, V41, P753, DOI 10.1016/j.immuni.2014.10.011; Ucar A, 2014, IMMUNITY, V41, P257, DOI 10.1016/j.immuni.2014.07.005; Velardi E, 2014, J EXP MED, V211, P2341, DOI 10.1084/jem.20131289; Wang XP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00019; Wong K, 2014, CELL REP, V8, P1198, DOI 10.1016/j.celrep.2014.07.029; Zook EC, 2011, BLOOD, V118, P5723, DOI 10.1182/blood-2011-03-342097	29	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151666	10.1371/journal.pone.0151666	http://dx.doi.org/10.1371/journal.pone.0151666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983083	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900110
J	Lee, J; Han, K; Song, JJ; Im, GJ; Chae, SW				Lee, Jieun; Han, Kyungdo; Song, Jae Jun; Im, Gi Jung; Chae, Sung Won			Sarcopenia and Hearing Loss in Older Koreans: Findings from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; COCHLEAR BLOOD-FLOW; NEUROTROPHIC FACTOR; BODY-COMPOSITION; IMPAIRMENT; BRAIN; ASSOCIATION; EXERCISE; ADULTS; THRESHOLDS	Age-related hearing impairment (ARHI) is becoming a more significant issue as geriatric population increases. Sarcopenia in older people is known to have a diverse health problem in various circumstances in recent studies. We assessed whether the decrease in muscle mass is related to ARHI. We used the 2010 data of the Korea National Health and Nutrition Examination Survey (KNHANES) to examine the associations between sarcopenia and ARHI. A total number of participants was 1,622 including 746 males and 876 females aged 60 years or older. Muscle mass was assessed as an appendicular skeletal muscle mass, and hearing loss was defined as the pure-tone averages (PTA) of test frequencies 0.5, 1, 2, 4 kHz at a threshold of 40 dB or higher in worse hearing side of the ear. Among 1,622 participants, 298 men and 256 women had hearing loss. Appendicular muscle mass (ASM), expressed as kg, was categorized in tertiles. In female population, after adjusting for age, smoking, drinking, amount of exercise, total body fat, education level, income level, and tinnitus, the odds ratio (OR) for hearing loss was 1.57 (95% confidence interval (CI) = 0.922.68) in the middle tertile and 1.79 (1.03-3.08) in the lowest tertile, compared with the highest tertile. P for trend in this model was 0.036. Controlling further for hypertension, diabetes mellitus, chronic kidney disease, and three types of noise exposure did not change the association. Larger muscle mass is associated with lower prevalence of hearing loss in elderly Korean females.	[Lee, Jieun] Korea Univ, Sch Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Sch Med, Dept Biostat, Seoul, South Korea; [Song, Jae Jun; Im, Gi Jung; Chae, Sung Won] Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine)	Chae, SW (corresponding author), Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	schae@kumc.or.kr	IM, GI JUNG/AAI-9755-2020	IM, GI JUNG/0000-0002-9457-4253				Brink P, 2007, GERONTOLOGIST, V47, P633, DOI 10.1093/geront/47.5.633; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Choi KM, 2013, ENDOCRINOL METAB, V28, P86, DOI 10.3803/EnM.2013.28.2.86; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Han K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086902; Hegarty JL, 1997, J NEUROSCI, V17, P1959; Helzner EP, 2005, J AM GERIATR SOC, V53, P2119, DOI 10.1111/j.1532-5415.2005.00525.x; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Hwang JH, 2009, OBESITY, V17, P1796, DOI 10.1038/oby.2009.66; Iolascon G, 2014, CLIN CASES MINER BON, V11, P215, DOI 10.11138/ccmbm/2014.11.3.215; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kim JH, 2013, J KOREAN MED SCI, V28, P1041, DOI 10.3346/jkms.2013.28.7.1041; Kim TS, 2014, CLIN ENDOCRINOL, V80, P368, DOI 10.1111/cen.12184; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Malgrange B, 1996, NEUROREPORT, V7, P913, DOI 10.1097/00001756-199603220-00016; Mom T, 1999, HEARING RES, V133, P40, DOI 10.1016/S0378-5955(99)00056-8; Mom T, 1997, BRAIN RES, V751, P20, DOI 10.1016/S0006-8993(96)01388-1; Morley JE, 2012, FAM PRACT, V29, pi44, DOI 10.1093/fampra/cmr063; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Pratesi A, 2013, CLIN CASES MINER BON, V10, P11, DOI 10.11138/ccmbm/2013.10.1.011; Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Snijder MB, 2004, J HYPERTENS, V22, P2339, DOI 10.1097/00004872-200412000-00016; Telischi FF, 1998, LARYNGOSCOPE, V108, P837, DOI 10.1097/00005537-199806000-00011; Torre P, 2005, J SPEECH LANG HEAR R, V48, P473, DOI 10.1044/1092-4388(2005/032); Tseng LA, 2014, J GERONTOL A-BIOL, V69, P93, DOI 10.1093/gerona/glt027; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2; Woo KJ, 2012, 11124000000012513 KR, P38; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008	34	10	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150281	10.1371/journal.pone.0150281	http://dx.doi.org/10.1371/journal.pone.0150281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978776	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800023
J	Lee, JH; Kang, MS; Mahapatra, C; Kim, HW				Lee, Jung-Hwan; Kang, Min-Sil; Mahapatra, Chinmaya; Kim, Hae-Won			Effect of Aminated Mesoporous Bioactive Glass Nanoparticles on the Differentiation of Dental Pulp Stem Cells	PLOS ONE			English	Article							IN-VITRO; MECHANICAL-PROPERTIES; ODONTOGENIC DIFFERENTIATION; FIBROUS SCAFFOLDS; 45S5 BIOGLASS(R); DRUG-DELIVERY; BONE-MARROW; COMPOSITES; NANOCARRIERS; PARTICLES	Mesoporous bioactive nanoparticles (MBNs) have been developed as promising additives to various types of bone or dentin regenerative material. However, biofunctionality of MBNs as dentin regenerative additive to dental materials have rarely been studied. We investigated the uptake efficiency of MBNs-NH2 with their endocytosis pathway and the role of MBNs-NH2 in odontogenic differentiation to clarify inherent biofunctionality. MBNs were fabricated by sol-gel synthesis, and 3% APTES was used to aminate these nanoparticles (MBNs-NH2) to reverse their charge from negative to positive. To characterize the MBNs-NH2, TEM, XRD, FTIR, zeta(xi)-potential measurements, and Brunauer-Emmett-Teller analysis were performed. After primary cultured rat dental pulp stem cells (rDPSCs) were incubated with various concentrations of MBNs-NH2, stem cell viability (24 hours) with or without differentiated media, internalization of MBNs-NH2 in rDPSCs (similar to 4 hours) via specific endocytosis pathway, intra or extracellular ion concentration and odontoblastic differentiation (similar to 28 days) were investigated. Incubation with up to 50 mu g/mL of MBNs-NH2 had no effect on rDPSCs viability with differentiated media (p>0.05). The internalization of MBNs-NH2 in rDPSCs was determined about 92% after 4 hours of incubation. Uptake was significantly decreased with ATP depletion and after 1 hour of pre-treatment with the inhibitor of macropinocytosis (p<0.05). There was significant increase of intracellular Ca and Si ion concentration in MBNs-NH2 treated cells compared to no-treated counterpart (p<0.05). The expression of odontogenic-related genes (BSP, COL1A, DMP-1, DSPP, and OCN) and the capacity for biomineralization (based on alkaline phosphatase activity and alizarin red staining) were significantly upregulated with MBNs-NH2. These results indicate that MBNs-NH2 induce odontogenic differentiation of rDPSCs and may serve as a potential dentin regenerative additive to dental material for promoting odontoblast differentiation.	[Lee, Jung-Hwan; Kang, Min-Sil; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 31116, South Korea; [Kang, Min-Sil; Mahapatra, Chinmaya; Kim, Hae-Won] Dankook Univ, Ctr Regenerat Med, Dept Nanobiomed Sci, Cheonan 31116, South Korea; [Kang, Min-Sil; Mahapatra, Chinmaya; Kim, Hae-Won] Dankook Univ, Ctr Regenerat Med, PLUS NBM Global Res BK21, Cheonan 31116, South Korea; [Kim, Hae-Won] Dankook Univ, Dept Biomat Sci, Coll Dent, Cheonan 31116, South Korea	Dankook University; Dankook University; Dankook University; Dankook University	Lee, JH; Kim, HW (corresponding author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 31116, South Korea.; Kim, HW (corresponding author), Dankook Univ, Ctr Regenerat Med, Dept Nanobiomed Sci, Cheonan 31116, South Korea.; Kim, HW (corresponding author), Dankook Univ, Ctr Regenerat Med, PLUS NBM Global Res BK21, Cheonan 31116, South Korea.; Kim, HW (corresponding author), Dankook Univ, Dept Biomat Sci, Coll Dent, Cheonan 31116, South Korea.	ducious@gmail.com; kimhw@dku.edu	Lee, Jung-Hwan/AFK-0831-2022; mahapatra, chinmaya/N-5911-2018	Lee, Jung-Hwan/0000-0001-8678-5459; mahapatra, chinmaya/0000-0001-8819-6682	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2009-0093829]; Ministry of Science, ICT & Future Planning [NRF-2015R1C1A1A01052127]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2009-0093829) and by the Ministry of Science, ICT & Future Planning (NRF-2015R1C1A1A01052127).	About I, 2000, EXP CELL RES, V258, P33, DOI 10.1006/excr.2000.4909; Bae WJ, 2012, DENT MATER, V28, P1271, DOI 10.1016/j.dental.2012.09.011; Banga AK, 2005, THERAPEUTIC PEPTIDES; Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059; Cao Y, 2015, J DENT RES, V94, P1544, DOI 10.1177/0022034515601658; Carvalho S.M., 2011, DENT MAT S1, V27, pe42; Chang CC, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/367157; Chang SJ, 1999, ARTIF CELL BLOOD SUB, V27, P229, DOI 10.3109/10731199909117696; Chiari MDS, 2015, DENT MATER, V31, P726, DOI 10.1016/j.dental.2015.03.015; Ding Y, 2015, J NONLINEAR FUNCT AN; Doostmohammadi A, 2011, CERAM INT, V37, P2311, DOI 10.1016/j.ceramint.2011.03.026; Eidi H, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0388-2; El-Fiqi A, 2015, J MATER CHEM B, V3, P1321, DOI 10.1039/c4tb01634c; El-Fiqi A, 2015, ACS APPL MATER INTER, V7, P1140, DOI 10.1021/am5077759; El-Fiqi A, 2014, RSC ADV, V4, P4444, DOI 10.1039/c3ra45858j; El-Fiqi A, 2013, ACTA BIOMATER, V9, P9508, DOI 10.1016/j.actbio.2013.07.036; El-Fiqi A, 2012, NANOSCALE, V4, P7475, DOI 10.1039/c2nr31775c; Epple M, 2010, J MATER CHEM, V20, P18, DOI 10.1039/b910885h; Faraji AH, 2009, BIOORGAN MED CHEM, V17, P2950, DOI 10.1016/j.bmc.2009.02.043; Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74; Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3; Gong WY, 2014, J ENDODONT, V40, P83, DOI 10.1016/j.joen.2013.08.018; Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010; Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45; Jo JH, 2009, J BIOMED MATER RES B, V91B, P213, DOI 10.1002/jbm.b.31392; Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023; Kang J, 2001, AM J PHYSIOL-ENDOC M, V280, pE428, DOI 10.1152/ajpendo.2001.280.3.E428; Kang MS, 2015, ACTA BIOMATER, V16, P103, DOI 10.1016/j.actbio.2014.12.028; Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kwon S, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413503357; Landgraf L, 2015, BEILSTEIN J NANOTECH, V6, P300, DOI 10.3762/bjnano.6.28; Li ST, 2015, J CELL PHYSIOL, V230, P2164, DOI 10.1002/jcp.24945; Lim SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9210; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Meiszterics A., 2011, 5B EUR C INT FEB MED; Mitchell JC, 2011, DENT MATER, V27, P386, DOI 10.1016/j.dental.2010.11.019; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Noh KT, 2010, MATER LETT, V64, P802, DOI 10.1016/j.matlet.2010.01.014; Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592; Oral O, 2014, DENT MATER, V30, P570, DOI 10.1016/j.dental.2014.02.017; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; ROUQUEROL J, 1994, STUD SURF SCI CATAL, V87, P1; Salehi S, 2015, DENT MATER, V31, P195, DOI 10.1016/j.dental.2014.12.004; Samberg M, 2012, NANOMEDICINE-UK, V7, P1197, DOI [10.2217/nnm.12.18, 10.2217/NNM.12.18]; Serigano K, 2010, J ORTHOP RES, V28, P1267, DOI 10.1002/jor.21147; Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3; Sing KSW, 2008, HDB HETEROGENEOUS CA; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Tao ZM, 2009, CHEM RES TOXICOL, V22, P1869, DOI 10.1021/tx900276u; Torii I, 2001, IMMUNOLOGY, V103, P70, DOI 10.1046/j.1365-2567.2001.01218.x; Tousi NS, 2013, MAT SCI ENG C-MATER, V33, P2757, DOI 10.1016/j.msec.2013.02.044; Tsigkou O, 2014, ADV HEALTHC MATER, V3, P115, DOI 10.1002/adhm.201300126; Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019; TSUKAMOTO Y, 1992, ARCH ORAL BIOL, V37, P1045, DOI 10.1016/0003-9969(92)90037-9; Vallittu PK, 2015, DENT MATER, V31, P371, DOI 10.1016/j.dental.2015.01.003; Varanasi VG, 2012, J ORAL IMPLANTOL, V38, P325, DOI 10.1563/AAID-JOI-D-11-00108; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wang HY, 2012, ADV MATER, V24, P3315, DOI 10.1002/adma.201104967; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034; Wang SN, 2014, ACTA BIOMATER, V10, P2792, DOI 10.1016/j.actbio.2014.02.013; Wei W, 2012, J ENDODONT, V38, P936, DOI 10.1016/j.joen.2012.03.020; Won JE, 2015, BIOTECHNOL LETT, V37, P935, DOI 10.1007/s10529-014-1745-5; Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101; Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002; Xia W, 2008, J NON-CRYST SOLIDS, V354, P1338, DOI 10.1016/j.jnoncrysol.2006.10.084; Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598; Yang SY, 2013, DENT MATER, V29, P1228, DOI 10.1016/j.dental.2013.09.007; Yang XC, 2007, J TISSUE ENG REGEN M, V1, P66, DOI 10.1002/term.16; Zaborina O, 1999, INFECT IMMUN, V67, P5231, DOI 10.1128/IAI.67.10.5231-5242.1999; Zhang HY, 2011, ACS NANO, V5, P2756, DOI 10.1021/nn200328m; Zhang J, 2009, J TISSUE ENG REGEN M, V3, P63, DOI 10.1002/term.135; Zhang YY, 2010, BIOMATERIALS, V31, P8465, DOI 10.1016/j.biomaterials.2010.07.060	80	46	50	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150727	10.1371/journal.pone.0150727	http://dx.doi.org/10.1371/journal.pone.0150727			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974668	gold, Green Submitted, Green Published			2022-12-26	WOS:000372570600028
J	Lindstrom, R; Lindholm, P; Kallijarvi, J; Palgi, M; Saarma, M; Heino, TI				Lindstrom, Riitta; Lindholm, Paivi; Kallijarvi, Jukka; Palgi, Mari; Saarma, Mart; Heino, Tapio I.			Exploring the Conserved Role of MANF in the Unfolded Protein Response in Drosophila melanogaster	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROTROPHIC FACTOR MANF; DOPAMINERGIC-NEURONS; GENE-EXPRESSION; CDNF PROTECTS; ERSE-II; CELLS; MODEL; BRAIN; YEAST	Disturbances in the homeostasis of endoplasmic reticulum (ER) referred to as ER stress is involved in a variety of human diseases. ER stress activates unfolded protein response (UPR), a cellular mechanism the purpose of which is to restore ER homeostasis. Previous studies show that Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) is an important novel component in the regulation of UPR. In vertebrates, MANF is upregulated by ER stress and protects cells against ER stress-induced cell death. Biochemical studies have revealed an interaction between mammalian MANF and GRP78, the major ER chaperone promoting protein folding. In this study we discovered that the upregulation of MANF expression in response to drug-induced ER stress is conserved between Drosophila and mammals. Additionally, by using a genetic in vivo approach we found genetic interactions between Drosophila Manf and genes encoding for Drosophila homologues of GRP78, PERK and XBP1, the key components of UPR. Our data suggest a role for Manf in the regulation of Drosophila UPR.	[Lindstrom, Riitta; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Lindstrom, Riitta; Lindholm, Paivi; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Kallijarvi, Jukka] Univ Helsinki, Folkhalsan Res Ctr, Helsinki, Finland; [Palgi, Mari] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Tallinn University of Technology	Lindstrom, R; Heino, TI (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.; Lindstrom, R (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	riitta.lindstrom@helsinki.fi; tapio.heino@helsinki.fi	Kallijarvi, Jukka/AAV-5091-2021; Lindstrom, Riitta/K-4448-2015	Kallijarvi, Jukka/0000-0003-3773-7025; Palgi, Mari/0000-0001-6142-6142; Lindstrom, Riitta/0000-0001-5177-0564; Pulkkila, Paivi/0000-0003-3022-5035	Viikki Doctoral Programme in Molecular Biosciences; Finnish Parkinson Foundation; Ella and Georg Ehrnrooth Foundation; University of Helsinki Funds; Alfred Kordelin Foundation; Academy of Finland [139910]; Estonian Research Council [IUT19-18]	Viikki Doctoral Programme in Molecular Biosciences; Finnish Parkinson Foundation; Ella and Georg Ehrnrooth Foundation; University of Helsinki Funds; Alfred Kordelin Foundation; Academy of Finland(Academy of Finland); Estonian Research Council(Estonian Research Council)	RL was supported by Viikki Doctoral Programme in Molecular Biosciences (http://www.helsinki.fi/vgsb/), The Finnish Parkinson Foundation (http://www.parkinsonsaatio.fi/), The Ella and Georg Ehrnrooth Foundation (http://www.ellageorg.fi/), and The University of Helsinki Funds, and Alfred Kordelin Foundation (http://www.kordelin.fi/). PL was supported by The Academy of Finland (grant No. 139910; http://www.aka.fi/en-GB/A/). MP was supported by Estonian Research Council (grant No. IUT19-18, http://www.etag.ee/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Airavaara M, 2010, EXP NEUROL, V225, P104, DOI 10.1016/j.expneurol.2010.05.020; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Benosman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064256; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dufey E, 2014, AM J PHYSIOL-CELL PH, V307, pC582, DOI 10.1152/ajpcell.00258.2014; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Kim AY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1518-0; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; Loewen CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013084; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Maor G, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-140; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nundlall S, 2010, CELL STRESS CHAPERON, V15, P835, DOI 10.1007/s12192-010-0193-y; Oh-hashi K, 2015, BIOL PHARM BULL, V38, P722, DOI 10.1248/bpb.b14-00825; Oh-Hashi K, 2013, CELL MOL BIOL LETT, V18, P398, DOI 10.2478/s11658-013-0096-x; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Plongthongkum N, 2007, BIOCHEM BIOPH RES CO, V354, P789, DOI 10.1016/j.bbrc.2007.01.056; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Ryoo HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075774; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sekine SU, 2013, NAT NEUROSCI, V16, P683, DOI 10.1038/nn.3389; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Stratoulias V, 2015, GENE EXPR PATTERNS, V18, P8, DOI 10.1016/j.gep.2015.04.002; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002	61	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151550	10.1371/journal.pone.0151550	http://dx.doi.org/10.1371/journal.pone.0151550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975047	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600087
J	Meunier, SM; Todorovic, B; Dare, EV; Begum, A; Guillemette, S; Wenger, A; Saxena, P; Campbell, JL; Sasges, M; Aucoin, MG				Meunier, Sarah M.; Todorovic, Biljana; Dare, Emma V.; Begum, Afroza; Guillemette, Simon; Wenger, Andrew; Saxena, Priyanka; Campbell, J. Larry; Sasges, Michael; Aucoin, Marc G.			Impact of Dissolved Oxygen during UV-Irradiation on the Chemical Composition and Function of CHO Cell Culture Media	PLOS ONE			English	Article							FELINE CALICIVIRUS; INACTIVATION; RIBOFLAVIN; VIRUSES; TRYPTOPHAN; RADIATION; BACTERIA; LIGHT; WATER	Ultraviolet (UV) irradiation is advantageous as a sterilization technique in the biopharmaceutical industry since it is capable of targeting non-enveloped viruses that are typically challenging to destroy, as well as smaller viruses that can be difficult to remove via conventional separation techniques. In this work, we investigated the influence of oxygen in the media during UV irradiation and characterized the effect on chemical composition using NMR and LC-MS, as well as the ability of the irradiated media to support cell culture. Chemically defined Chinese hamster ovary cell growth media was irradiated at high fluences in a continuous-flow UV reactor. UV-irradiation caused the depletion of pyridoxamine, pyridoxine, pyruvate, riboflavin, tryptophan, and tyrosine; and accumulation of acetate, formate, kynurenine, lumichrome, and sarcosine. Pyridoxamine was the only compound to undergo complete degradation within the fluences considered; complete depletion of pyridoxamine was observed at 200 mJ/cm(2). Although in both oxygen-and nitrogen-saturated media, the cell culture performance was affected at fluences above 200 mJ/cm(2), there was less of an impact on cell culture performance in the nitrogen-saturated media. Based on these results, minimization of oxygen in cell culture media prior to UV treatment is recommended to minimize the negative impact on sensitive media.	[Meunier, Sarah M.; Todorovic, Biljana; Dare, Emma V.; Guillemette, Simon; Wenger, Andrew; Aucoin, Marc G.] Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada; [Meunier, Sarah M.; Begum, Afroza; Saxena, Priyanka; Sasges, Michael] Trojan Technol, London, ON, Canada; [Campbell, J. Larry] SCIEX Ltd, Concord, ON, Canada	University of Waterloo; SCIEX	Aucoin, MG (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada.	maucoin@uwaterloo.ca	Aucoin, Marc/AAA-8450-2019	Aucoin, Marc/0000-0001-9393-5558	Natural Sciences and Engineering Research Council of Canada [NSERC] ENGAGE Plus [EGP2 460753-13]; NSERC Strategic Network (MabNet) [NETGP 380070-08]; Natural Sciences and Engineering Research Council of Canada [NSERC]; MITACS Accelerate Post-Doctoral Fellowships; Undergraduate Student Research Assistantships; Trojan Technologies; Chenomx Inc.; SCIEX	Natural Sciences and Engineering Research Council of Canada [NSERC] ENGAGE Plus; NSERC Strategic Network (MabNet); Natural Sciences and Engineering Research Council of Canada [NSERC](Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS Accelerate Post-Doctoral Fellowships; Undergraduate Student Research Assistantships; Trojan Technologies; Chenomx Inc.; SCIEX	This work was supported by the Natural Sciences and Engineering Research Council of Canada [NSERC, (www.nserccrsng.gc.ca)] ENGAGE Plus (EGP2 460753-13), and NSERC Strategic Network (MabNet, NETGP 380070-08) Grants to MGA. This work was also supported by the Natural Sciences and Engineering Research Council of Canada [NSERC, (www.nserc-crsng.gc.ca)] MITACS (www.mitacs.ca) Accelerate Post-Doctoral Fellowships to SMM, BT, EVD, AB and PS. This work was also supported by the Natural Sciences and Engineering Research Council of Canada [NSERC, (www.nserc-crsng.gc.ca), Undergraduate Student Research Assistantships to SG and AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also partially funded by Trojan Technologies, which also provided UV reactors and other in-kind support. This work was also supported in part by the generous contribution of Chenomx Inc. in the form of Chenomx NMR Suite 7.0-7.7 software to the Aucoin Lab. Trojan Technologies and SCIEX provided support in the form of salaries for authors MS and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad I, 2004, INT J PHARMACEUT, V280, P199, DOI 10.1016/j.ijpharm.2004.05.020; ANG CYW, 1979, J ASSOC OFF ANA CHEM, V62, P1170; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aranha H., 2011, CONTRACT PHARM, P82; Baylis SA, 2011, VACCINE, V29, P690, DOI 10.1016/j.vaccine.2010.11.028; Berting A, 2010, BIOTECHNOL BIOENG, V106, P598, DOI 10.1002/bit.22723; Cabaj A, 1996, WATER RES, V30, P1003, DOI 10.1016/0043-1354(95)00256-1; Chen Joseph, 2012, PDA J Pharm Sci Technol, V66, P580, DOI 10.5731/pdajpst.2012.00892; Chevrefils G., 2006, IUVA NEWS, V8, P38; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; FURNESS G, 1969, APPL MICROBIOL, V18, P360, DOI 10.1128/AEM.18.3.360-364.1969; Grzelak A, 2001, FREE RADICAL BIO MED, V30, P1418, DOI 10.1016/S0891-5849(01)00545-7; Hamdy MS, 2012, CATAL LETT, V142, P338, DOI 10.1007/s10562-012-0775-7; Hart R, 2012, US Pat Application, Patent No. [20,120,214,204, 20120214204, 2012/0214204]; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Holt LA, 1997, BIOCHIM BIOPHYS ACTA, V1, P131; Insinska-Rak M, 2012, J PHYS CHEM A, V116, P1199, DOI 10.1021/jp2094593; Moody Mark, 2011, PDA J Pharm Sci Technol, V65, P580, DOI 10.5731/pdajpst.2011.00824; Natera J, 2012, PHOTOCH PHOTOBIO SCI, V11, P938, DOI 10.1039/c2pp05318g; Nuanualsuwan S, 2002, PHOTOCHEM PHOTOBIOL, V76, P406, DOI 10.1562/0031-8655(2002)076&lt;0406:UIOFCH&gt;2.0.CO;2; Pirnie M., 2006, ENV PROT, V2, P1; Schmidt S, 2007, CHEM ENG TECHNOL, V30, P945, DOI 10.1002/ceat.200700056; Sokolenko S, 2014, ANAL CHEM, V86, P3330, DOI 10.1021/ac4033966; Thurston-Enriquez JA, 2013, APPL ENVIRON MICROB, V69, P577; Yen S, 2014, BIOTECHNOL PROGR, V30, P1190, DOI 10.1002/btpr.1942; YU LZ, 1982, INT J RADIAT BIOL, V41, P119, DOI 10.1080/09553008214550131; Zang L, 2011, ANAL CHEM, V83, P5422, DOI 10.1021/ac2009492	27	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150957	10.1371/journal.pone.0150957	http://dx.doi.org/10.1371/journal.pone.0150957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975046	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600039
J	Gatidis, S; Schmidt, H; Pfannenberg, CA; Nikolaou, K; Schick, F; Schwenzer, NF				Gatidis, Sergios; Schmidt, Holger; Pfannenberg, Christina A.; Nikolaou, Konstantin; Schick, Fritz; Schwenzer, Nina F.			Is It Possible to Detect Activated Brown Adipose Tissue in Humans Using Single-Time-Point Infrared Thermography under Thermoneutral Conditions? Impact of BMI and Subcutaneous Adipose Tissue Thickness	PLOS ONE			English	Article							FAT; MICE	Purpose To evaluate the feasibility to detect activated brown adipose tissue (BAT) using single-time-point infrared thermography of the supraclavicular skin region under thermoneutral conditions. To this end, infrared thermography was compared with 18-F-FDG PET, the current reference standard for the detection of activated BAT. Methods 120 patients were enrolled in this study. After exclusion of 18 patients, 102 patients (44 female, 58 male, mean age 58 +/- 17 years) were included for final analysis. All patients underwent a clinically indicated 18F-FDG-PET/CT examination. Immediately prior to tracer injection skin temperatures of the supraclavicular, presternal and jugular regions were measured using spatially resolved infrared thermography at room temperature. The presence of activated BAT was determined in PET by typical FDG uptake within the supraclavicular adipose tissue compartments. Local thickness of supraclavicular subcutaneous adipose tissue (SCAT) was measured on CT. Measured skin temperatures were statistically correlated with the presence of activated BAT and anthropometric data. Results Activated BAT was detected in 9 of 102 patients (8.8%). Local skin temperature of the supraclavicular region was significantly higher in individuals with active BAT compared to individuals without active BAT. However, after statistical correction for the influence of BMI, no predictive value of activated BAT on skin temperature of the supraclavicular region could be observed. Supraclavicular skin temperature was significantly negatively correlated with supraclavicular SCAT thickness. Conclusion We conclude that supraclavicular SCAT thickness influences supraclavicular skin temperature and thus makes a specific detection of activated BAT using single-time-point thermography difficult. Further studies are necessary to evaluate the possibility of BAT detection using alternative thermographic methods, e.g. dynamic thermography or MR-based thermometry taking into account BMI as a confounding factor.	[Gatidis, Sergios; Schmidt, Holger; Pfannenberg, Christina A.; Nikolaou, Konstantin; Schwenzer, Nina F.] Univ Tubingen, Dept Radiol Diagnost & Intervent Radiol, Tubingen, Germany; [Schick, Fritz] Univ Tubingen, Dept Radiol, Sect Expt Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Gatidis, S (corresponding author), Univ Tubingen, Dept Radiol Diagnost & Intervent Radiol, Tubingen, Germany.	sergios.gatidis@med.uni-tuebingen.de	Gatidis, Sergios/AAF-4858-2020	Gatidis, Sergios/0000-0002-6928-4967; Schick, Fritz/0000-0002-4231-3406	intramural grant of the Medical Faculty of the University of Tubingen (FORTuNE Grant ) [2147-0-0]	intramural grant of the Medical Faculty of the University of Tubingen (FORTuNE Grant )	This study was funded by an intramural grant of the Medical Faculty of the University of Tubingen supporting junior researchers (FORTuNE Grant 2147-0-0;http://www.med.uni-tuebingen.de/). The position of S.G. was funded for a period of 8 months. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branca RT, 2014, P NATL ACAD SCI USA, V111, P18001, DOI 10.1073/pnas.1403697111; Crane JD, 2014, MOL METAB, V3, P490, DOI 10.1016/j.molmet.2014.04.007; Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gifford A, ISMRM2012 MELB; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Jang C, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12167; Kim MS, 2014, J CLIN ENDOCR METAB, V99, pE1686, DOI 10.1210/jc.2014-1343; Lahesmaa M, 2014, J CLIN ENDOCR METAB, V99, pE28, DOI 10.1210/jc.2013-2312; Lee P, 2011, DIABETES OBES METAB, V13, P92, DOI 10.1111/j.1463-1326.2010.01318.x; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nirengi S, 2015, OBESITY, V23, P973, DOI 10.1002/oby.21012; Perkins AC, 2013, NUCL MED COMMUN, V34, P168, DOI 10.1097/MNM.0b013e32835bbbf0; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Robinson LJ, 2016, EXPT PHYSL; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Symonds ME, 2012, J PEDIAT; van der Lans AAJJ, 2016, J PHYSIOL SCI, V66, P77, DOI 10.1007/s12576-015-0398-z; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123795	24	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151152	10.1371/journal.pone.0151152	http://dx.doi.org/10.1371/journal.pone.0151152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967519	gold, Green Published, Green Submitted			2022-12-26	WOS:000371989200033
J	Najumudeen, AK; Jaiswal, A; Lectez, B; Oetken-Lindholm, C; Guzman, C; Siljamaki, E; Posada, IMD; Lacey, E; Aittokallio, T; Abankwa, D				Najumudeen, A. K.; Jaiswal, A.; Lectez, B.; Oetken-Lindholm, C.; Guzman, C.; Siljamaki, E.; Posada, I. M. D.; Lacey, E.; Aittokallio, T.; Abankwa, D.			Cancer stem cell drugs target K-ras signaling in a stemness context	ONCOGENE			English	Article							GENE-EXPRESSION; MEMBRANE ORIENTATION; PLASMA-MEMBRANE; SALINOMYCIN; CAVEOLIN-1; IDENTIFICATION; NANOCLUSTERS; RESISTANCE; CALMODULIN; PROTEINS	Cancer stem cells (CSCs) are considered to be responsible for treatment relapse and have therefore become a major target in cancer research. Salinomycin is the most established CSC inhibitor. However, its primary mechanistic target is still unclear, impeding the discovery of compounds with similar anti-CSC activity. Here, we show that salinomycin very specifically interferes with the activity of K-ras4B, but not H-ras, by disrupting its nanoscale membrane organization. We found that caveolae negatively regulate the sensitivity to this drug. On the basis of this novel mechanistic insight, we defined a K-ras-associated and stem cell-derived gene expression signature that predicts the drug response of cancer cells to salinomycin. Consistent with therapy resistance of CSC, 8% of tumor samples in the TCGA-database displayed our signature and were associated with a significantly higher mortality. Using our K-ras-specific screening platform, we identified several new candidate CSC drugs. Two of these, ophiobolin A and conglobatin A, possessed a similar or higher potency than salinomycin. Finally, we established that the most potent compound, ophiobolin A, exerts its K-ras4B-specific activity through inactivation of calmodulin. Our data suggest that specific interference with the K-ras4B/calmodulin interaction selectively inhibits CSC.	[Najumudeen, A. K.; Lectez, B.; Oetken-Lindholm, C.; Guzman, C.; Siljamaki, E.; Posada, I. M. D.; Abankwa, D.] Abo Akad Univ, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland; [Jaiswal, A.; Aittokallio, T.] Univ Helsinki, FIMM, Inst Mol Med Finland, Helsinki, Finland; [Lacey, E.] Microbial Screening Technol Pty Ltd, Bldg C, Smithfield, NSW, Australia	Abo Akademi University; University of Helsinki	Abankwa, D (corresponding author), Abo Akad Univ, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland.	daniel.abankwa@btk.fi	Najumudeen, Arafath/AAH-2250-2020; Aittokallio, Tero/B-6583-2009	Najumudeen, Arafath/0000-0002-3764-5721; Aittokallio, Tero/0000-0002-0886-9769; Jaiswal, Alok/0000-0002-1910-4681; Abankwa, Daniel/0000-0003-2769-0745; Siljamaki, Elina/0000-0003-1709-8633; Lectez, Benoit/0000-0001-9796-1606	Academy of Finland fellowship grant; Sigrid Juselius Foundation; Cancer Society of Finland; Marie-Curie Reintegration Grant; Jane and Aatos Erkko Foundation; Academy of Finland [272437, 269862, 279163]; ISB graduate school; Integrative Life Science Doctoral Program (ILS); Cancer Foundation Finland sr [150062] Funding Source: researchfish	Academy of Finland fellowship grant; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Marie-Curie Reintegration Grant(European Commission); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); ISB graduate school; Integrative Life Science Doctoral Program (ILS); Cancer Foundation Finland sr	Plasmids encoding tagged LactC2 and MDCK cells stably expressing either mGFP-K- or H-rasG12V were kindly provided by Prof John Hancock. Plasmids encoding PTRF and Cav-1 were kindly provided by Prof Rob Parton. We thank Lingjia Kong for help with the ESTOOLS database. We thank Jasmin Varjonen for experimental support. This work was supported by the Academy of Finland fellowship grant, the Sigrid Juselius Foundation, the Cancer Society of Finland, the Marie-Curie Reintegration Grant and the Jane and Aatos Erkko Foundation grants to DA, as well as Academy of Finland (grants 272437, 269862, 279163) and the Cancer Society of Finland grants to TA. AKN was supported by the ISB graduate school and AJ by the Integrative Life Science Doctoral Program (ILS).	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ansieau S, 2013, CANCER LETT, V338, P63, DOI 10.1016/j.canlet.2012.05.014; Ariotti N, 2014, J CELL BIOL, V204, P777, DOI 10.1083/jcb.201307055; Au TK, 1998, PLANT PHYSIOL, V118, P965, DOI 10.1104/pp.118.3.965; Baker N, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt276; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Blair K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002019; Boehmerle W, 2014, J MOL MED, V92, P889, DOI 10.1007/s00109-014-1155-0; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; Coxon FP, 2014, EUR J MED CHEM, V84, P77, DOI 10.1016/j.ejmech.2014.06.062; Crouthamel M, 2010, MOL PHARMACOL, V78, P767, DOI 10.1124/mol.110.066340; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman C, 2016, JALA-J LAB AUTOM, V21, P238, DOI 10.1177/2211068215606048; Guzman C, 2014, J BIOL CHEM, V289, P9519, DOI 10.1074/jbc.M113.537001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Huczynski A, 2012, BIOORG MED CHEM LETT, V22, P7002, DOI 10.1016/j.bmcl.2012.09.046; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Kong LJ, 2013, NAT METHODS, V10, P814, DOI 10.1038/nmeth.2576; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lemieux E, 2015, ONCOGENE, V34, P4914, DOI 10.1038/onc.2014.416; Li Q, 2013, NATURE, V504, P143, DOI 10.1038/nature12830; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Meissner P, 2001, BIOTECHNOL BIOENG, V75, P197, DOI 10.1002/bit.1179; Najumudeen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066425; Najurnudeen AK, 2015, BIOCHEMISTRY-US, V54, P7212, DOI 10.1021/acs.biochem.5b00724; Nassar ZD, 2013, NAT REV UROL, V10, P529, DOI 10.1038/nrurol.2013.168; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Nussinov R, 2016, CANCER RES, V76, P18, DOI 10.1158/0008-5472.CAN-15-1536; Nussinov R, 2015, MOL CANCER RES, V13, P1265, DOI 10.1158/1541-7786.MCR-15-0165; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Riccioni R, 2010, BLOOD CELL MOL DIS, V45, P86, DOI 10.1016/j.bcmd.2010.03.008; Rotblat B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011991; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Solman M, 2015, ELIFE, V4, DOI 10.7554/eLife.08905; Sotgia F, 2005, CELL CYCLE, V4, P1808, DOI 10.4161/cc.4.12.2198; Spiegel J, 2014, NAT CHEM BIOL, V10, P613, DOI 10.1038/nchembio.1560; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Zhou S, 2013, CURR MED CHEM, V20, P4095; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zhou Y, 2014, MOL CELL BIOL, V34, P862, DOI 10.1128/MCB.01227-13; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	68	59	60	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5248	5262		10.1038/onc.2016.59	http://dx.doi.org/10.1038/onc.2016.59			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	26973241	hybrid, Green Published			2022-12-26	WOS:000386053000004
J	Raynaud, S; Ragel, P; Rojas, T; Merida, A				Raynaud, Sandy; Ragel, Paula; Rojas, Tomas; Merida, Angel			The N-terminal Part of Arabidopsis thaliana Starch Synthase 4 Determines the Localization and Activity of the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-GLYCOGEN-SYNTHASE; CLASS IV; PURIFICATION; GRANULE; PLANTS; BIOSYNTHESIS; PROTEINS; GLUCOSE; BINDING	Starch synthase 4 (SS4) plays a specific role in starch synthesis because it controls the number of starch granules synthesized in the chloroplast and is involved in the initiation of the starch granule. We showed previously that SS4 interacts with fibrillins 1 and is associated with plastoglobules, suborganelle compartments physically attached to the thylakoid membrane in chloroplasts. Both SS4 localization and its interaction with fibrillins 1 were mediated by the N-terminal part of SS4. Here we show that the coiled-coil region within the N-terminal portion of SS4 is involved in both processes. Elimination of this region prevents SS4 from binding to fibrillins 1 and alters SS4 localization in the chloroplast. We also show that SS4 forms dimers, which depends on a region located between the coiled-coil region and the glycosyltransferase domain of SS4. This region is highly conserved between all SS4 enzymes sequenced to date. We show that the dimerization seems to be necessary for the activity of the enzyme. Both dimerization and the functionality of the coiled-coil region are conserved among SS4 proteins from phylogenetically distant species, such as Arabidopsis and Brachypodium. This finding suggests that the mechanism of action of SS4 is conserved among different plant species.	[Raynaud, Sandy; Ragel, Paula; Rojas, Tomas; Merida, Angel] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Ave Amer Vespucio 49, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Merida, A (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Ave Amer Vespucio 49, Seville 41092, Spain.	angel.merida@csic.es	Berlanga, Ángel Mérida/E-7623-2013; Ragel, Paula/AAA-3374-2021	Berlanga, Ángel Mérida/0000-0002-0880-2329; Ragel, Paula/0000-0002-8698-0833	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BIO2012-35043]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [BIO1180]; European Union-FEDER	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia); European Union-FEDER(European Commission)	This work was funded by grants BIO2012-35043 from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion and BIO1180 from the Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia and the European Union-FEDER. The authors declare that they have no conflicts of interest with the contents of this article.	Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cuesta-Seijo JA, 2013, ACTA CRYSTALLOGR D, V69, P1013, DOI 10.1107/S090744491300440X; D'Hulst C., 2012, SEB ESSENTIAL REV EX, P55; D'Hulst C, 2010, NEW PHYTOL, V188, P13, DOI 10.1111/j.1469-8137.2010.03361.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gamez-Arjona FM, 2014, PLANT J, V80, P305, DOI 10.1111/tpj.12633; Gamez-Arjona FM, 2011, PLANT BIOTECHNOL J, V9, P1049, DOI 10.1111/j.1467-7652.2011.00626.x; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Imparl-Radosevich JM, 1999, FEBS LETT, V457, P357, DOI 10.1016/S0014-5793(99)01066-2; Imparl-Radosevich JM, 1998, ARCH BIOCHEM BIOPHYS, V353, P64, DOI 10.1006/abbi.1998.0613; JETT MF, 1979, J BIOL CHEM, V254, P6739; Leterrier M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-98; Momma M, 2012, BIOSCI BIOTECH BIOCH, V76, P1591, DOI 10.1271/bbb.120305; Moran-Zorzano MT, 2007, FEBS LETT, V581, P4423, DOI 10.1016/j.febslet.2007.08.017; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Santelia D, 2011, CURR OPIN BIOTECH, V22, P271, DOI 10.1016/j.copbio.2010.11.014; Seung D, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002080; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; TAKAHARA H, 1978, BIOCHIM BIOPHYS ACTA, V522, P363, DOI 10.1016/0005-2744(78)90070-0; TAKEDA Y, 1975, J BIOL CHEM, V250, P8943; WITITSUWANNAKUL D, 1977, J BIOL CHEM, V252, P7812; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Yuan LX, 2013, PLANT CELL, V25, P974, DOI 10.1105/tpc.112.108027; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	28	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10759	10771		10.1074/jbc.M115.698332	http://dx.doi.org/10.1074/jbc.M115.698332			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26969163	Green Published, hybrid			2022-12-26	WOS:000377042600027
J	Aribam, SD; Harada, T; Elsheimer-Matulova, M; Iwata, T; Kanehira, K; Hikono, H; Matsui, H; Ogawa, Y; Shimoji, Y; Eguchi, M				Aribam, Swarmistha Devi; Harada, Tomoyuki; Elsheimer-Matulova, Marta; Iwata, Taketoshi; Kanehira, Katsushi; Hikono, Hirokazu; Matsui, Hidenori; Ogawa, Yohsuke; Shimoji, Yoshihiro; Eguchi, Masahiro			Specific Monoclonal Antibody Overcomes the Salmonella enterica Serovar Typhimurium's Adaptive Mechanisms of Intramacrophage Survival and Replication	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; PROTECTIVE IMMUNITY; MEDIATED IMMUNITY; CUTTING EDGE; NONTYPHOIDAL SALMONELLA; POLYACRYLAMIDE-GELS; DENDRITIC CELLS; ORAL CHALLENGE; MOUSE MODEL; IN-VIVO	Salmonella-specific antibodies play an important role in host immunity; however, the mechanisms of Salmonella clearance by pathogen-specific antibodies remain to be completely elucidated since previous studies on antibody-mediated protection have yielded inconsistent results. These inconsistencies are at least partially attributable to the use of polyclonal antibodies against Salmonella antigens. Here, we developed a new monoclonal antibody (mAb)-449 and identified its related immunogen that protected BALB/c mice from infection with Salmonella enterica serovar Typhimurium. In addition, these data indicate that the mAb-449 immunogen is likely a major protective antigen. Using in vitro infection studies, we also analyzed the mechanism by which mAb-449 conferred host protection. Notably, macrophages infected with mAb-449-treated S. Typhimurium showed enhanced pathogen uptake compared to counterparts infected with control IgG-treated bacteria. Moreover, these macrophages produced elevated levels of pro-inflammatory cytokine TNF alpha and nitric oxide, indicating that mAb-449 enhanced macrophage activation. Finally, the number of intracellular bacteria in mAb-449-activated macrophages decreased considerably, while the opposite was found in IgG-treated controls. Based on these findings, we suggest that, although S. Typhimurium has the potential to survive and replicate within macrophages, host production of a specific antibody can effectively mediate macrophage activation for clearance of intracellular bacteria.	[Aribam, Swarmistha Devi; Harada, Tomoyuki; Elsheimer-Matulova, Marta; Iwata, Taketoshi; Kanehira, Katsushi; Hikono, Hirokazu; Ogawa, Yohsuke; Shimoji, Yoshihiro; Eguchi, Masahiro] NARO, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan; [Matsui, Hidenori] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan; [Matsui, Hidenori] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kitasato University; Kitasato University	Eguchi, M (corresponding author), NARO, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	egumaro@affrc.go.jp			Japan Society for the Promotion of Science (JSPS) [25-03213, 15F15099]; JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research to ME (25-03213 and 15F15099) from the Japan Society for the Promotion of Science (JSPS). This work was supported by a postdoctoral fellowship for foreign researchers (to SD Aribam and M Elsheimer-Matulova) provided by the JSPS.; We thank K. Shiraiwa (National Institute of Animal Health) for technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research to ME (25-03213 and 15F15099) from the Japan Society for the Promotion of Science (JSPS). This work was supported by a postdoctoral fellowship for foreign researchers (to SD Aribam and M Elsheimer-Matulova) provided by the JSPS.	Aribam SD, 2014, J MICROBIOL METH, V98, P64, DOI 10.1016/j.mimet.2013.11.012; Barat S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002966; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; Casadevall A, 2004, INFECT IMMUN, V72, P6191, DOI 10.1128/IAI.72.11.6191-6196.2004; Casadevall A, 2003, INFECT IMMUN, V71, P4225, DOI 10.1128/IAI.71.8.4225-4228.2003; DING HF, 1990, J MED MICROBIOL, V31, P95, DOI 10.1099/00222615-31-2-95; Edelson BT, 1999, J IMMUNOL, V163, P4087; Eguchi M, 2007, FEMS IMMUNOL MED MIC, V50, P411, DOI 10.1111/j.1574-695X.2007.00275.x; Eguchi M, 2010, J INFECT DIS, V201, P62, DOI 10.1086/648615; FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627, DOI 10.1128/JCM.28.12.2627-2631.1990; GAHRING LC, 1990, INFECT IMMUN, V58, P443, DOI 10.1128/IAI.58.2.443-448.1990; Goh YS, 2011, IMMUNOLOGY, V133, P74, DOI 10.1111/j.1365-2567.2011.03411.x; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Grant AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003070; Iankov ID, 2004, MICROBES INFECT, V6, P901, DOI 10.1016/j.micinf.2004.05.007; Killion J W, 1988, FEMS Microbiol Immunol, V1, P41; Ko HJ, 2009, J IMMUNOL, V182, P2305, DOI 10.4049/jimmunol.0801980; Lalmanach AC, 1999, MICROBES INFECT, V1, P719, DOI 10.1016/S1286-4579(99)80073-2; Lee SJ, 2012, P NATL ACAD SCI USA, V109, P4998, DOI 10.1073/pnas.1111413109; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; MASTROENI P, 1993, MICROB PATHOGENESIS, V14, P473, DOI 10.1006/mpat.1993.1046; MASTROENI P, 1993, INFECT IMMUN, V61, P3981, DOI 10.1128/IAI.61.9.3981-3984.1993; McSorley SJ, 2000, INFECT IMMUN, V68, P3344, DOI 10.1128/IAI.68.6.3344-3348.2000; Menager N, 2007, IMMUNOLOGY, V120, P424, DOI 10.1111/j.1365-2567.2006.02527.x; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; NIWA M, 1969, J BACTERIOL, V97, P1069, DOI 10.1128/JB.97.3.1069-1077.1969; OBRIEN AD, 1979, J IMMUNOL, V123, P720; Pontes MH, 2015, P NATL ACAD SCI USA, V112, P5183, DOI 10.1073/pnas.1500989112; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rondini S, 2013, MICROB PATHOGENESIS, V63, P19, DOI 10.1016/j.micpath.2013.05.014; Siggins MK, 2011, J IMMUNOL, V186, P2365, DOI 10.4049/jimmunol.1000284; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Svensson M, 2000, INFECT IMMUN, V68, P6311, DOI 10.1128/IAI.68.11.6311-6320.2000; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Trebicka E, 2013, CLIN VACCINE IMMUNOL, V20, P1491, DOI 10.1128/CVI.00289-13; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Uppington H, 2006, IMMUNOLOGY, V119, P147, DOI 10.1111/j.1365-2567.2006.02416.x; Vassiloyanakopoulos AP, 1998, P NATL ACAD SCI USA, V95, P7676, DOI 10.1073/pnas.95.13.7676; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Yamamoto T, 2001, INFECT IMMUN, V69, P3164, DOI 10.1128/IAI.69.5.3164-3174.2001	49	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151352	10.1371/journal.pone.0151352	http://dx.doi.org/10.1371/journal.pone.0151352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986057	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300065
J	Diaz-Balzac, CA; Lazaro-Pena, MI; Vazquez-Figueroa, LD; Diaz-Balzac, RJ; Garcia-Arraras, JE				Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.; Vazquez-Figueroa, Lionel D.; Diaz-Balzac, Roberto J.; Garcia-Arraras, Jose E.			Holothurian Nervous System Diversity Revealed by Neuroanatomical Analysis	PLOS ONE			English	Article							URCHIN TUBE FEET; STARFISH ASTERIAS-RUBENS; STRONGYLOCENTROTUS-PURPURATUS; HEPTAPEPTIDE GFSKLYFAMIDE; SALMFAMIDE NEUROPEPTIDES; GLABERRIMA ECHINODERMATA; SMOOTH-MUSCLE; IMMUNOREACTIVITY; LOCALIZATION; CELLS	The Echinodermata comprise an interesting branch in the phylogenetic tree of deuterostomes. Their radial symmetry which is reflected in their nervous system anatomy makes them a target of interest in the study of nervous system evolution. Until recently, the study of the echinoderm nervous system has been hindered by a shortage of neuronal markers. However, in recent years several markers of neuronal and fiber subpopulations have been described. These have been used to identify subpopulations of neurons and fibers, but an integrative study of the anatomical relationship of these subpopulations is wanting. We have now used eight commercial antibodies, together with three antibodies produced by our group to provide a comprehensive and integrated description and new details of the echinoderm neuroanatomy using the holothurian Holothuria glaberrima (Selenka, 1867) as our model system. Immunoreactivity of the markers used showed: (1) specific labeling patterns by markers in the radial nerve cords, which suggest the presence of specific nerve tracts in holothurians. (2) Nerves directly innervate most muscle fibers in the longitudinal muscles. (3) Similar to other deuterostomes (mainly vertebrates), their enteric nervous system is composed of a large and diverse repertoire of neurons and fiber phenotypes. Our results provide a first blueprint of the anatomical organization of cells and fibers that form the holothurian neural circuitry, and highlight the fact that the echinoderm nervous system shows unexpected diversity in cell and fiber types and their distribution in both central and peripheral nervous components.	[Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave,Ullmann Room 709, Bronx, NY 10461 USA; [Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.; Vazquez-Figueroa, Lionel D.; Diaz-Balzac, Roberto J.; Garcia-Arraras, Jose E.] Univ Puerto Rico, Dept Biol, Univ Puerto Rico Rio Piedras Campus,POB 23360, San Juan, PR 00931 USA	Yeshiva University; Albert Einstein College of Medicine; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras	Garcia-Arraras, JE (corresponding author), Univ Puerto Rico, Dept Biol, Univ Puerto Rico Rio Piedras Campus,POB 23360, San Juan, PR 00931 USA.	jegarcia@hpcf.upr.edu		Lazaro-Pena, Maria I./0000-0002-3061-8835; Diaz-Balzac, Carlos A./0000-0002-4723-1282	NSF [IOS-1252679, IOS-0842870]; NIH [1R15NS081686-01, 1SC1GM084770-01, 1R03NS065275-01]; University of Puerto Rico-Rio Piedras (UPR-RP) MARC Program [5T34GM007821]; Albert Einstein College of Medicine MSTP training grant [T32GM007288]; National Institute of Child Health and Human Development (NICHD) [F31HD066967, 2R25GM061151, R25GM097635-01]; NIH-RCMI [RRO-3641-01]; University of Puerto Rico; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD066967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151, T32GM007288, T34GM007821, SC1GM084770, R25GM097635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS081686, R03NS065275] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico-Rio Piedras (UPR-RP) MARC Program; Albert Einstein College of Medicine MSTP training grant; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH-RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NSF (IOS-1252679 and IOS-0842870) and NIH (1R15NS081686-01, 1SC1GM084770-01 and 1R03NS065275-01). CADB was funded by the University of Puerto Rico-Rio Piedras (UPR-RP) MARC Program (5T34GM007821), the Albert Einstein College of Medicine MSTP training grant (T32GM007288) and the National Institute of Child Health and Human Development (NICHD) predoctoral fellowship (F31HD066967), MILP by the UPR-RP RISE Program (2R25GM061151) and LDVF by the NIH ENDURE Program (R25GM097635-01). We also acknowledge partial support from NIH-RCMI (RRO-3641-01) and the University of Puerto Rico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2011, J COMP NEUROL, V519, P3566, DOI 10.1002/cne.22724; Bullock T., 1965, STRUCTURE FUNCTION N; Burke RD, 2006, J COMP NEUROL, V496, P244, DOI 10.1002/cne.20939; COBB JLS, 1985, BIOL BULL, V168, P432, DOI 10.2307/1541523; COBB JLS, 1969, COMP BIOCHEM PHYSIOL, V28, P967, DOI 10.1016/0010-406X(69)92132-X; COBB JLS, 1966, PROC R SOC SER B-BIO, V164, P641, DOI 10.1098/rspb.1966.0053; COTTRELL G A, 1970, Comparative and General Pharmacology, V1, P73, DOI 10.1016/0010-4035(70)90011-X; Devlin C. Leah, 1999, Invertebrate Neuroscience, V4, P1, DOI 10.1007/s101580050001; DEVLIN CL, 1993, COMP BIOCHEM PHYS C, V106, P573, DOI 10.1016/0742-8413(93)90181-J; Diaz-Balzac CA, 2007, BIOL BULL-US, V213, P28, DOI 10.2307/25066616; Diaz-Balzac CA, 2014, INVERTEBR NEUROSCI, V14, P113, DOI 10.1007/s10158-014-0169-1; Diaz-Balzac CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032689; Diaz-Balzac CA, 2010, ZOOMORPHOLOGY, V129, P99, DOI 10.1007/s00435-010-0103-y; Diaz-Balzac CA, 2010, ZOOMORPHOLOGY, V129, P33, DOI 10.1007/s00435-009-0098-4; DIAZMIRANDA L, 1995, J COMP NEUROL, V352, P626, DOI 10.1002/cne.903520410; DiazMiranda L, 1996, CELL TISSUE RES, V286, P385, DOI 10.1007/s004410050708; DIAZMIRANDA L, 1995, COMP BIOCHEM PHYS C, V110, P171, DOI 10.1016/0742-8413(94)00094-Q; ELPHICK MR, 1995, J EXP BIOL, V198, P2519; ELPHICK MR, 1991, PEPTIDES, V12, P455, DOI 10.1016/0196-9781(91)90083-2; Elphick MR, 1991, NEUROPEPTIDE STRUCTU; FAUQUET M, 1989, J HISTOCHEM CYTOCHEM, V37, P1197, DOI 10.1177/37.8.2569003; Flament-Durand J, 1980, Acta Psychiatr Belg, V80, P364; FLOREY E, 1959, J PHYSIOL-LONDON, V145, P66, DOI 10.1113/jphysiol.1959.sp006127; FLOREY E, 1975, COMP BIOCHEM PHYS C, V51, P5, DOI 10.1016/0306-4492(75)90031-3; Garcia-Arraras J.E., 1993, HDB ENDOCRINE RES TR, P207; Garcia-Arraras JE, 2001, J EXP BIOL, V204, P865; GARCIAARRARAS JE, 1991, NEUROSCI LETT, V132, P199, DOI 10.1016/0304-3940(91)90301-9; Hoekstra LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044220; Hyman LH, 1955, INVERTEBRATES ECHINO; Inoue M, 2002, ZOOL SCI, V19, P1217, DOI 10.2108/zsj.19.1217; Lesser MP, 2011, P ROY SOC B-BIOL SCI, V278, P3371, DOI 10.1098/rspb.2011.0336; Mashanov V.S, 2016, STRUCTURE EVOLUTION, P665; Mashanov VS, 2007, EVOL DEV, V9, P244, DOI 10.1111/j.1525-142X.2007.00157.x; Mashanov VS, 2010, GLIA, V58, P1581, DOI 10.1002/glia.21031; Mashanov VS, 2006, ZOOMORPHOLOGY, V125, P27, DOI 10.1007/s00435-005-0010-9; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P139, DOI 10.1098/rspb.1995.0128; NEWMAN SJ, 1994, CELL TISSUE RES, V278, P177, DOI 10.1007/s004410050205; PENTREATH VW, 1972, BIOL REV, V47, P363, DOI 10.1111/j.1469-185X.1972.tb00977.x; PROTAS LL, 1980, GEN PHARMACOL, V11, P113, DOI 10.1016/0306-3623(80)90019-1; STUBBS TR, 1981, CELL TISSUE RES, V220, P373; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Ullrich-Luter EM, 2011, P NATL ACAD SCI USA, V108, P8367, DOI 10.1073/pnas.1018495108	42	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151129	10.1371/journal.pone.0151129	http://dx.doi.org/10.1371/journal.pone.0151129			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987052	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300048
J	Estrada, J; Ruiz-Herrero, T; Scholes, C; Wunderlich, Z; DePace, AH				Estrada, Javier; Ruiz-Herrero, Teresa; Scholes, Clarissa; Wunderlich, Zeba; DePace, Angela H.			SiteOut: An Online Tool to Design Binding Site-Free DNA Sequences	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ENHANCER; COMPLEX; SPECIFICITY; EXPRESSION; SHAPE	DNA-binding proteins control many fundamental biological processes such as transcription, recombination and replication. A major goal is to decipher the role that DNA sequence plays in orchestrating the binding and activity of such regulatory proteins. To address this goal, it is useful to rationally design DNA sequences with desired numbers, affinities and arrangements of protein binding sites. However, removing binding sites from DNA is computationally non-trivial since one risks creating new sites in the process of deleting or moving others. Here we present an online binding site removal tool, SiteOut, that enables users to design arbitrary DNA sequences that entirely lack binding sites for factors of interest. SiteOut can also be used to delete sites from a specific sequence, or to introduce site-free spacers between functional sequences without creating new sites at the junctions. In combination with commercial DNA synthesis services, SiteOut provides a powerful and flexible platform for synthetic projects that interrogate regulatory DNA.	[Estrada, Javier; Scholes, Clarissa; Wunderlich, Zeba; DePace, Angela H.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Ruiz-Herrero, Teresa] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wunderlich, Zeba] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA	Harvard University; Harvard Medical School; Harvard University; University of California System; University of California Irvine	DePace, AH (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.	angela_depace@hms.harvard.edu	Wunderlich, Zeba/I-9530-2019	Wunderlich, Zeba/0000-0003-4491-5715; Estrada Diez, Francisco Javier/0000-0001-8918-2573; Estrada, Javier/0000-0003-3646-204X	NIH [U01GM103804-01A1, R00HD073191]; NSF CAREER Award [1452557]; Grinnell Fund for Biomedical Research; Department of Systems Biology at HMS; Ramon Areces Foundation; Harvard Graduate Society Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD073191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM103804, T32GM007598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Grinnell Fund for Biomedical Research; Department of Systems Biology at HMS; Ramon Areces Foundation; Harvard Graduate Society Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the DePace lab is generously supported by NIH U01GM103804-01A1, NSF CAREER Award 1452557 and the Grinnell Fund for Biomedical Research. JE was supported by the Department of Systems Biology at HMS, TRH by the Ramon Areces Foundation, ZW by NIH grant R00HD073191, and CS by a Harvard Graduate Society Research Fellowship.	Akbari OS, 2008, DEVELOPMENT, V135, P123, DOI 10.1242/dev.010744; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Crocker J, 2015, LOW AFFINITY BINDING; Erceg J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004060; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Weingarten-Gabbay S, 2014, HUM GENET, V133, P701, DOI 10.1007/s00439-013-1413-1; Wolanski M, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00735; Wunderlich Z, 2015, CELL REP, V12, P1740, DOI 10.1016/j.celrep.2015.08.021; Zhou TY, 2015, P NATL ACAD SCI USA, V112, P4654, DOI 10.1073/pnas.1422023112	16	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151740	10.1371/journal.pone.0151740	http://dx.doi.org/10.1371/journal.pone.0151740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987123	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300121
J	Holldobler, B				Hoelldobler, Bert			Queen Specific Exocrine Glands in Legionary Ants and Their Possible Function in Sexual Selection	PLOS ONE			English	Article							ARMY ANTS; HYMENOPTERA; REPRODUCTION; FORMICIDAE; PHYLOGENY	The colonies of army ants and some other legionary ant species have single, permanently wingless queens with massive post petioles and large gasters. Such highly modified queens are called dichthadiigynes. This paper presents the unusually rich exocrine gland endowment of dichthadiigynes, which is not found in queens of other ant species. It has been suggested these kinds of glands produce secretions that attract and maintain worker retinues around queens, especially during migration. However, large worker retinues also occur in non-legionary species whose queens do not have such an exuberance of exocrine glands. We argue and present evidence in support of our previously proposed hypothesis that the enormous outfit of exocrine glands found in dichthadiigynes is due to sexual selection mediated by workers as the main selecting agents.	[Hoelldobler, Bert] Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ USA; [Hoelldobler, Bert] Univ Wurzburg, Biozentrum, Zool 2, D-97070 Wurzburg, Germany	Arizona State University; Arizona State University-Tempe; University of Wurzburg	Holldobler, B (corresponding author), Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ USA.; Holldobler, B (corresponding author), Univ Wurzburg, Biozentrum, Zool 2, D-97070 Wurzburg, Germany.	Bert.Hoelldobler@asu.edu						[Anonymous], 1971, INSECT SOC; Berghoff SM, 2003, INSECT SOC, V50, P139, DOI 10.1007/s00040-003-0642-z; Berghoff SM, 2002, INSECT SOC, V49, P133, DOI 10.1007/s00040-002-8292-0; BOLTON B, 1990, J NAT HIST, V24, P1339, DOI 10.1080/00222939000770811; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Brady SG, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-93; Brady SG, 2005, SYST ENTOMOL, V30, P593, DOI 10.1111/j.1365-3113.2005.00290.x; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; Brown W. L. jr., 1960, Bulletin of the Museum of Comparative Zoology Harvard, V122, P145; FLETCHER DJC, 1985, ANNU REV ENTOMOL, V30, P319, DOI 10.1146/annurev.en.30.010185.001535; FRANKS NR, 1987, BIOL J LINN SOC, V30, P229, DOI 10.1111/j.1095-8312.1987.tb00298.x; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; HOLLDOBLER B, 1994, INSECT SOC, V41, P63, DOI 10.1007/BF01240573; Holldobler B., 1982, Psyche (Cambridge), V89, P113, DOI 10.1155/1982/40397; HOLLDOBLER B, 1983, ANN ENTOMOL SOC AM, V76, P235, DOI 10.1093/aesa/76.2.235; HOLLDOBLER B, 1989, ZOOMORPHOLOGY, V108, P255, DOI 10.1007/BF00312158; Holldobler B., 1978, Psyche (Cambridge), V85, P285, DOI 10.1155/1978/23867; Holldobler B., 1990, pi; HOLLDOBLER B, 1982, NATURWISSENSCHAFTEN, V69, P90, DOI 10.1007/BF00441231; HOLLDOBLER B, 1985, FORTS ZOOL, V31, P237; Holldobler B., 2011, LEAFCUTTER ANTS CIVI; Holldobler B., 2009, THE SUPERORGANISM; Kronauer DJC, 2006, NATURWISSENSCHAFTEN, V93, P402, DOI 10.1007/s00114-006-0121-2; MASUKO K, 1990, INSECT SOC, V37, P31, DOI 10.1007/BF02223813; Nakata K, 1998, J INSECT BEHAV, V11, P869, DOI 10.1023/A:1020816227912; Passera Luc, 1984, ORGANISATION SOCIAL; PEETERS C, 1985, BEHAV ECOL SOCIOBIOL, V18, P29; Peeters C, 1991, QUEEN NUMBER SOCIALI, P235; RATHMAYER W, 1962, EXPERIENTIA, V18, P47, DOI 10.1007/BF02136658; Rettenmeyer C. W., 1963, Kansas University Science Bulletin, V44, P281; RETTENMEYER CW, 1978, ANN ENTOMOL SOC AM, V71, P519, DOI 10.1093/aesa/71.4.519; SCHNEIRL.TC, 1969, ANIM BEHAV, V17, P87, DOI 10.1016/0003-3472(69)90116-X; Schneirla T. C., 1971, ARMY ANTS STUDY SOCI; Whelden RM, 1963, J NY ENTOMOL SOC, V71, P246; WHELDEN ROY M., 1963, JOUR NEW YORK ENTOMOL SOC, V71, P158; WHELDEN ROY M., 1963, JOUR NEW YORK ENTOMOL SOC, V71, P14; WHELDEN ROY M., 1963, JOUR NEW YORK ENTOMOL SOC, V71, P90; Witte V, 2000, INSECT SOC, V47, P76, DOI 10.1007/s000400050012	38	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151604	10.1371/journal.pone.0151604	http://dx.doi.org/10.1371/journal.pone.0151604			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986740	Green Submitted, gold, Green Published			2022-12-26	WOS:000372580300093
J	Palermo, GD; Neri, QV; Cozzubbo, T; Cheung, S; Pereira, N; Rosenwaks, Z				Palermo, Gianpiero D.; Neri, Queenie V.; Cozzubbo, Tyler; Cheung, Stephanie; Pereira, Nigel; Rosenwaks, Zev			Shedding Light on the Nature of Seminal Round Cells	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; PREGNANCY RATES; GOOD-SAMARITANS; SEMEN ANALYSIS; INFERTILE MEN; LEUKOCYTOSPERMIA; LEUKOCYTES; FERTILIZATION; QUALITY; SPERMATOZOA	Introduction In this investigation we assess the incidence of round cells (RCs) in semen samples in our infertile patient population and their significance on intracytoplasmic sperm injection (ICSI) cycle outcomes. We also evaluate the usefulness of RCs as indicators of bacterial infection and highlight the origin of this cell-type, as well as its role in the human ejaculate. Patients and Methods In a prospective fashion, a total of 4,810 ejaculated samples were included in the study during a period of 24 months. RCs were characterized for white blood cell (WBC) components versus exfoliated germ cells by testing for multiple markers of ploidy as well as protamine assays. Cases displaying >= 2 x 10(6)/ml RCs were screened for bacteria. Raw specimens containing RC were processed by peroxidase and other leukocyte assays, specific stains for protamines were used to identify spermiogenic stage, aneuploidy (FISH) assessment was carried out, and the presence of various Sertoli-cell cytoplasmic remnants was analyzed to identify and characterize immature germ cells. The effect of RC on clinical outcome was assessed in specimens used for ICSI. Results The average age of the men involved was 39.2 +/- 7 years. Semen samples had a mean concentration of 40.7 +/- 31 x 10(6)/ml, motility of 42.6 +/- 35%, and morphology of 2.3 +/- 2%. RCs were identified in 261 specimens, representing a proportion of 5.4%. Men with RCs had comparable age but lower sperm concentration and morphology than the control group (P<0.001). The aneuploidy rate of 4.3% in RCs group was remarkably higher than the control group (2.3%; P<0.001). Sperm aneuploidy rate positively correlated with the number of RCs (P<0.001). Of 44 men, 17 of them in 18 cycles had up to 1.9 x 10(6)/ml RCs without affecting fertilization and clinical pregnancy rates when compared to controls (n = 365 cycles). In 27 men undergoing 33 ICSI cycles with >= 2 x 10(6)/ml RCs, the fertilization rate trended lower and the miscarriage rate was significantly increased (P = 0.05). There was lack of correlation between RC and bacteriological growth. Specific markers indicated that seminal RCs are mostly immature germ cells encased in the remnants of Sertoli cell cytoplasm. Moreover, their modest protamine content and their haploid status confirm that they are post-meiotic. Sequential observation in the same man showed that RC episodes were followed by an amelioration of semen parameters, and interestingly, the episodic occurrence of RCs often coincides with flu season peaks. Conclusions Seminal RCs are not a marker of infectiousness but rather a transient indicator of spermatogenic insult that possibly occurs in most men following a mild and transient ailment such as the flu.	[Palermo, Gianpiero D.; Neri, Queenie V.; Cozzubbo, Tyler; Cheung, Stephanie; Pereira, Nigel; Rosenwaks, Zev] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA	Cornell University	Palermo, GD (corresponding author), Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA.	gdpalerm@med.cornell.edu		Cheung, Stephanie/0000-0002-2092-7001				Agarwal A, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-126; Agarwal A, 2014, WORLD J MENS HEALTH, V32, P1, DOI 10.5534/wjmh.2014.32.1.1; AITKEN RJ, 1992, J REPROD FERTIL, V94, P451; AITKEN RJ, 1995, HUM REPROD, V10, P1736, DOI 10.1093/oxfordjournals.humrep.a136165; [Anonymous], 2010, WHO LAB MAN EX PROC; Aziz N, 2004, FERTIL STERIL, V81, P349, DOI 10.1016/j.fertnstert.2003.06.026; Bachir BG, 2014, UROL CLIN N AM, V41, P67, DOI 10.1016/j.ucl.2013.08.008; Barraud-Lange V, 2011, FERTIL STERIL, V96, P1315, DOI 10.1016/j.fertnstert.2011.09.035; BERGMANN M, 1994, ANAT EMBRYOL, V190, P515; Bugge M, 2007, HUM MOL GENET, V16, P2004, DOI 10.1093/hmg/ddm148; Cavagna M, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-44; Colombero LT, 1999, FERTIL STERIL, V72, P90, DOI 10.1016/S0015-0282(99)00158-2; Domes T, 2012, FERTIL STERIL, V97, P1050, DOI 10.1016/j.fertnstert.2012.01.124; Duan YG, 2014, FERTIL STERIL, V101, P70, DOI 10.1016/j.fertnstert.2013.09.006; Elder K, 2004, INFECT FERTILITY ASS; Focacci M, 1997, HUM REPROD, V12, P39, DOI 10.1093/humrep/12.1.39; Gambera L, 2007, HUM REPROD, V22, P1047, DOI 10.1093/humrep/del490; Gosden LV, 2014, METHODS MOL BIOL, V1154, P343, DOI 10.1007/978-1-4939-0659-8_16; Huang JYJ, 2012, BEST PRACT RES CL OB, V26, P777, DOI 10.1016/j.bpobgyn.2012.08.017; Irving C, 2011, J MATERN-FETAL NEO M, V24, P137, DOI 10.3109/14767051003758879; Johanisson E, 2000, HUM REPROD UPDATE, V6, P404, DOI 10.1093/humupd/6.4.404; KIESSLING AA, 1995, FERTIL STERIL, V64, P196, DOI 10.1016/S0015-0282(16)57681-X; Lackner JE, 2008, FERTIL STERIL, V90, P869, DOI 10.1016/j.fertnstert.2007.07.1310; Lackner JE, 2006, FERTIL STERIL, V86, P601, DOI 10.1016/j.fertnstert.2006.01.032; Ludwig M, 2003, WORLD J UROL, V21, P82, DOI 10.1007/s00345-003-0330-7; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Neri QV, 2014, CELL CALCIUM, V55, P24, DOI 10.1016/j.ceca.2013.10.006; Nicolaidis P, 1998, HUM REPROD, V13, P313, DOI 10.1093/humrep/13.2.313; Nistal M, 2011, HISTOPATHOLOGY, V58, P1019, DOI 10.1111/j.1365-2559.2011.03858.x; Palermo GD, 1996, HUM REPROD, V11, P1023; Palermo GD, 2002, HUM REPROD, V17, P570, DOI 10.1093/humrep/17.3.570; PALERMO GD, 1995, FERTIL STERIL, V63, P1231, DOI 10.1016/S0015-0282(16)57603-1; Palermo GD, 2014, FERTIL STERIL, V102, P1508, DOI 10.1016/j.fertnstert.2014.10.008; Palermo GD, 2008, REPROD BIOMED ONLINE, V17, P820, DOI 10.1016/S1472-6483(10)60411-7; Patil PS, 2013, J CYTOL, V30, P185, DOI 10.4103/0970-9371.117682; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; POLITCH JA, 1993, FERTIL STERIL, V60, P372; Ramesh KH, 1996, ANN GENET-PARIS, V39, P110; Rodin DM, 2003, FERTIL STERIL, V79, P1555, DOI 10.1016/S0015-0282(03)00340-6; Rosenwaks Z, 2014, METHODS MOL BIOL, V1154, P1, DOI 10.1007/978-1-4939-0659-8; Saleh RA, 2002, FERTIL STERIL, V78, P491, DOI 10.1016/S0015-0282(02)03294-6; Thomas J, 1997, HUM REPROD, V12, P2418, DOI 10.1093/humrep/12.11.2418; Trum JW, 1998, FERTIL STERIL, V70, P315, DOI 10.1016/S0015-0282(98)00163-0; Wolff H, 1998, ANDROLOGIA, V30, P35; Yanushpolsky EH, 1996, FERTIL STERIL, V66, P822, DOI 10.1016/S0015-0282(16)58643-9	45	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151640	10.1371/journal.pone.0151640	http://dx.doi.org/10.1371/journal.pone.0151640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982590	gold, Green Submitted, Green Published			2022-12-26	WOS:000372574900107
J	Avilov, S; Magnus, J; Cusack, S; Naffakh, N				Avilov, Sergiy; Magnus, Julie; Cusack, Stephen; Naffakh, Nadia			Time-Resolved Visualisation of Nearly-Native Influenza A Virus Progeny Ribonucleoproteins and Their Individual Components in Live Infected Cells	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; H5N1 NUCLEOPROTEIN; VIRAL POLYMERASE; RNA-POLYMERASE; AMINO-ACID; PROTEIN; OLIGOMERIZATION; REPLICATION; COMPLEXES; TRANSPORT	Influenza viruses are a global health concern because of the permanent threat of novel emerging strains potentially capable of causing pandemics. Viral ribonucleoproteins (vRNPs) containing genomic RNA segments, nucleoprotein oligomers, and the viral polymerase, play a central role in the viral replication cycle. Our knowledge about critical events such as vRNP assembly and interactions with other viral and cellular proteins is poor and could be substantially improved by time lapse imaging of the infected cells. However, such studies are limited by the difficulty to achieve live-cell compatible labeling of active vRNPs. Previously we designed the first unimpaired recombinant influenza WSN-PB2-GFP11 virus allowing fluorescent labeling of the PB2 subunit of the viral polymerase (Avilov et al., J. Virol. 2012). Here, we simultaneously labeled the viral PB2 protein using the above-mentioned strategy, and virus-encoded progeny RNPs through spontaneous incorporation of transiently expressed NP-mCherry fusion proteins during RNP assembly in live infected cells. This dual labeling enabled us to visualize progeny vRNPs throughout the infection cycle and to characterize independently the mobility, oligomerization status and interactions of vRNP components in the nuclei of live infected cells.	[Avilov, Sergiy; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France; [Avilov, Sergiy; Cusack, Stephen] Univ Grenoble Alpes, CNRS, UMI 3265, EMBL Int Unit Virus Host Cell Interact, Grenoble, France; [Magnus, Julie; Naffakh, Nadia] Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, Paris, France; [Magnus, Julie; Naffakh, Nadia] CNRS, UMR 3569, Paris, France; [Magnus, Julie; Naffakh, Nadia] Univ Paris Diderot, Sorbonne Paris Cite, Unite Genet Mol Virus ARN, Paris, France; [Avilov, Sergiy] Max Planck Inst Immunobiol & Epigenet, Stuebeweg 51, Freiburg, Germany	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society	Avilov, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France.; Avilov, S (corresponding author), Univ Grenoble Alpes, CNRS, UMI 3265, EMBL Int Unit Virus Host Cell Interact, Grenoble, France.; Naffakh, N (corresponding author), Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, Paris, France.; Naffakh, N (corresponding author), CNRS, UMR 3569, Paris, France.; Naffakh, N (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Unite Genet Mol Virus ARN, Paris, France.; Avilov, S (corresponding author), Max Planck Inst Immunobiol & Epigenet, Stuebeweg 51, Freiburg, Germany.	avilov@ie-freiburg.mpg.de; nadia.naffakh@pasteur.fr		Cusack, Stephen/0000-0002-9324-0796; Naffakh, Nadia/0000-0002-0424-0277	European Community [PIEF-GA-2009-236959]; EIPOD fellowship (EMBL); EU [259751]	European Community(European Commission); EIPOD fellowship (EMBL); EU(European Commission)	S.A. was supported by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (Grant Agreement PIEF-GA-2009-236959), and by an EIPOD fellowship (EMBL). This work was supported in part by the EU FP7 funded FLUPHARM project (FP7-INFLUENZA-2010 grant 259751, http://flupharm.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Amorim MJ, 2013, J VIROL, V87, P4694, DOI 10.1128/JVI.03123-12; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Avilov SV, 2012, VACCINE, V30, P7411, DOI 10.1016/j.vaccine.2012.09.077; Avilov SV, 2012, J VIROL, V86, P1433, DOI 10.1128/JVI.05820-11; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cauldwell AV, 2013, J VIROL, V87, P1278, DOI 10.1128/JVI.02597-12; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Chase GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002187; Chenavas S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003275; Chou YY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003358; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; Goldman R. D., 2010, LIVE CELL IMAGING; Gui X, 2014, VIROLOGY, V464, P11, DOI 10.1016/j.virol.2014.06.033; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Hutchinson EC, 2013, VIRUSES-BASEL, V5, P2424, DOI 10.3390/v5102424; Keppler A, 2009, ACS CHEM BIOL, V4, P127, DOI 10.1021/cb800298u; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lakdawala SS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003971; Loucaides EM, 2009, VIROLOGY, V394, P154, DOI 10.1016/j.virol.2009.08.015; Marklund JK, 2012, J VIROL, V86, P7292, DOI 10.1128/JVI.00014-12; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Moisy D, 2012, J VIROL, V86, P9122, DOI 10.1128/JVI.00789-12; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Mondal A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004826; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036415; Noda T, 2010, REV MED VIROL, V20, P380, DOI 10.1002/rmv.666; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Paterson D, 2014, J VIROL, V88, P339, DOI 10.1128/JVI.02022-13; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takizawa N, 2006, MICROBES INFECT, V8, P823, DOI 10.1016/j.micinf.2005.10.005; Tarus B, 2012, BIOCHIMIE, V94, P776, DOI 10.1016/j.biochi.2011.11.009; Turrell L, 2015, J VIROL, V89, P1452, DOI 10.1128/JVI.02332-14; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Vreede FT, 2010, VIROLOGY, V396, P125, DOI 10.1016/j.virol.2009.10.003; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396	52	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149986	10.1371/journal.pone.0149986	http://dx.doi.org/10.1371/journal.pone.0149986			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978069	Green Submitted, Green Published, gold			2022-12-26	WOS:000372572800019
J	Tong, HY; Davila-Fajardo, CL; Borobia, AM; Martinez-Gonzalez, LJ; Lubomirov, R; Leon, LMP; Banares, MJB; Diaz-Villamarin, X; Fernandez-Capitan, C; Barrera, JC; Carcas, AJ				Tong, Hoi Y.; Lucia Davila-Fajardo, Cristina; Borobia, Alberto M.; Javier Martinez-Gonzalez, Luis; Lubomirov, Rubin; Perea Leon, Laura Maria; Blanco Banares, Maria J.; Diaz-Villamarin, Xando; Fernandez-Capitan, Carmen; Cabeza Barrera, Jose; Carcas, Antonio J.		PGX-ACE Investigators Grp	A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population	PLOS ONE			English	Article							WARFARIN DOSE REQUIREMENTS; ACUTE PULMONARY-EMBOLISM; ATRIAL-FIBRILLATION; RANDOMIZED-TRIAL; DOSING ALGORITHM; THERAPY; VKORC1; CYP2C9; POLYMORPHISMS; ASSOCIATION	There is a strong association between genetic polymorphisms and the acenocoumarol dosage requirements. Genotyping the polymorphisms involved in the pharmacokinetics and pharmacodynamics of acenocoumarol before starting anticoagulant therapy would result in a better quality of life and a more efficient use of healthcare resources. The objective of this study is to develop a new algorithm that includes clinical and genetic variables to predict the most appropriate acenocoumarol dosage for stable anticoagulation in a wide range of patients. We recruited 685 patients from 2 Spanish hospitals and 1 primary healthcare center. We randomly chose 80% of the patients (n = 556), considering an equitable distribution of genotypes to form the generation cohort. The remaining 20% (n = 129) formed the validation cohort. Multiple linear regression was used to generate the algorithm using the acenocoumarol stable dosage as the dependent variable and the clinical and genotypic variables as the independent variables. The variables included in the algorithm were age, weight, amiodarone use, enzyme inducer status, international normalized ratio target range and the presence of CYP2C9*2 (rs1799853), CYP2C9*3 (rs1057910), VKORC1 (rs9923231) and CYP4F2 (rs2108622). The coefficient of determination (R-2) explained by the algorithm was 52.8% in the generation cohort and 64% in the validation cohort. The following R-2 values were evaluated by pathology: atrial fibrillation, 57.4%; valve replacement, 56.3%; and venous thromboembolic disease, 51.5%. When the patients were classified into 3 dosage groups according to the stable dosage (<11 mg/week, 11-21 mg/week, >21 mg/week), the percentage of correctly classified patients was higher in the intermediate group, whereas differences between pharmacogenetic and clinical algorithms increased in the extreme dosage groups. Our algorithm could improve acenocoumarol dosage selection for patients who will begin treatment with this drug, especially in extreme-dosage patients. The predictability of the pharmacogenetic algorithm did not vary significantly between diseases.	[Tong, Hoi Y.; Borobia, Alberto M.; Carcas, Antonio J.] IdiPAZ, La Paz Univ Hosp, Dept Clin Pharmacol, Madrid, Spain; [Lucia Davila-Fajardo, Cristina; Perea Leon, Laura Maria; Diaz-Villamarin, Xando; Cabeza Barrera, Jose] San Cecilio Univ Hosp, Dept Clin Pharm, Inst Biomed Res, Granada, Spain; [Javier Martinez-Gonzalez, Luis] Pfizer Univ Granada Andalusian Reg Govt, Ctr Genom & Oncol Res GENYO, Genom Unit, Hlth Sci Technol Pk, Granada, Spain; [Borobia, Alberto M.; Lubomirov, Rubin; Carcas, Antonio J.] Autonomous Univ Madrid, IdiPAZ, Sch Med, Dept Pharmacol, E-28049 Madrid, Spain; [Blanco Banares, Maria J.] La Paz Univ Hosp, Dept Hematol, Madrid, Spain; [Fernandez-Capitan, Carmen] La Paz Univ Hosp, IdiPAZ, Dept Internal Med, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario San Cecilio; Pfizer; University of Granada; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz	Borobia, AM; Carcas, AJ (corresponding author), IdiPAZ, La Paz Univ Hosp, Dept Clin Pharmacol, Madrid, Spain.; Borobia, AM; Carcas, AJ (corresponding author), Autonomous Univ Madrid, IdiPAZ, Sch Med, Dept Pharmacol, E-28049 Madrid, Spain.	a.borobia@gmail.com; antonio.carcas@uam.es	Martinez-Gonzalez, Luis Javier/L-6136-2014; Carcas, Antonio J/E-1149-2012; diaz-villamarin, xando/AAA-7223-2020; Borobia, Alberto M./H-6887-2013	Martinez-Gonzalez, Luis Javier/0000-0003-2202-0662; Carcas, Antonio J/0000-0003-1823-4174; diaz-villamarin, xando/0000-0003-0849-9902; DAVILA-FAJARDO, CRISTINA LUCIA/0000-0003-3339-239X; Borobia, Alberto M./0000-0002-8584-3263	Spanish Ministry of Health and Social Policy (Instituto de Salud Carlos III) [PI07/0710]; Andalusian Regional Ministry of Health (Progress and Health Foundation) [PI-0717-2013]	Spanish Ministry of Health and Social Policy (Instituto de Salud Carlos III); Andalusian Regional Ministry of Health (Progress and Health Foundation)	This study was funded by a grant from the Spanish Ministry of Health and Social Policy (Instituto de Salud Carlos III, PI07/0710) and the Andalusian Regional Ministry of Health (Progress and Health Foundation, PI-0717-2013). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Borobia AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041360; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Cerezo-Manchado JJ, 2013, THROMB HAEMOSTASIS, V109, P146, DOI 10.1160/TH12-08-0631; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Go AS, 2000, CIRCULATION, V102, P11, DOI 10.1161/01.CIR.102.1.11; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Gomez-Martin A, 2015, CHEMOSPHERE, V139, P534, DOI 10.1016/j.chemosphere.2015.07.079; HERMANS JJR, 1993, BRIT J PHARMACOL, V110, P482, DOI 10.1111/j.1476-5381.1993.tb13836.x; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Jimenez-Varo E, 2015, VASC PHARMACOL, V74, P151, DOI 10.1016/j.vph.2015.06.010; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kumar DK, 2015, EUR J CLIN PHARMACOL, V71, P173, DOI 10.1007/s00228-014-1791-x; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Michaud V, 2008, CLIN PHARMACOL THER, V83, P740, DOI 10.1038/sj.clpt.6100434; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Moreau C, 2011, J THROMB HAEMOST, V9, P711, DOI 10.1111/j.1538-7836.2011.04213.x; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Rathore SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037844; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; Thijssen HH, 2000, DRUG METAB DISPOS, V28, P1284; van Schie RMF, 2011, EUR HEART J, V32, P1909, DOI 10.1093/eurheartj/ehr116; Verde Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011210; Verhoef TI, 2013, NEW ENGL J MED, V369, P2304, DOI 10.1056/NEJMoa1311388; Zambon CF, 2011, PHARMACOGENOMICS, V12, P15, DOI [10.2217/pgs.10.162, 10.2217/PGS.10.162]	35	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150456	10.1371/journal.pone.0150456	http://dx.doi.org/10.1371/journal.pone.0150456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977927	Green Submitted, gold, Green Published			2022-12-26	WOS:000372572800026
J	van Mourik, PM; de Jong, J; Agpalo, D; Claussin, C; Rothstein, R; Chang, M				van Mourik, Paula M.; de Jong, Jannie; Agpalo, Danielle; Claussin, Clemence; Rothstein, Rodney; Chang, Michael			Recombination-Mediated Telomere Maintenance in Saccharomyces cerevisiae Is Not Dependent on the Shu Complex	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; RAD51 PARALOGUES; YEAST TELOMERES; DNTP POOLS; ABSENCE; GENES; SENESCENCE; PATHWAYS; DNA; ELONGATION	In cells lacking telomerase, telomeres shorten progressively during each cell division due to incomplete end-replication. When the telomeres become very short, cells enter a state that blocks cell division, termed senescence. A subset of these cells can overcome senescence and maintain their telomeres using telomerase-independent mechanisms. In Saccharomyces cerevisiae, these cells are called 'survivors' and are dependent on Rad52-dependent homologous recombination and Pol32-dependent break-induced replication. There are two main types of survivors: type I and type II. The type I survivors require Rad51 and maintain telomeres by amplification of subtelomeric elements, while the type II survivors are Rad51-independent, but require the MRX complex and Sgs1 to amplify the C(1-3)A/TG(1-3) telomeric sequences. Rad52, Pol32, Rad51, and Sgs1 are also important to prevent accelerated senescence, indicating that recombination processes are important at telomeres even before the formation of survivors. The Shu complex, which consists of Shu1, Shu2, Psy3, and Csm2, promotes Rad51-dependent homologous recombination and has been suggested to be important for break-induced replication. It also promotes the formation of recombination intermediates that are processed by the Sgs1-Top3-Rmi1 complex, as mutations in the SHU genes can suppress various sgs1, top3, and rmi1 mutant phenotypes. Given the importance of recombination processes during senescence and survivor formation, and the involvement of the Shu complex in many of the same processes during DNA repair, we hypothesized that the Shu complex may also have functions at telomeres. Surprisingly, we find that this is not the case: the Shu complex does not affect the rate of senescence, does not influence survivor formation, and deletion of SHU1 does not suppress the rapid senescence and type II survivor formation defect of a telomerase-negative sgs1 mutant. Altogether, our data suggest that the Shu complex is not important for recombination processes at telomeres.	[van Mourik, Paula M.; de Jong, Jannie; Claussin, Clemence; Chang, Michael] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Agpalo, Danielle; Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY USA	University of Groningen; Columbia University	Chang, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands.	m.chang@umcg.nl	Chang, Michael/B-9279-2012	Chang, Michael/0000-0002-1706-3337; Rothstein, Rodney/0000-0002-4107-9654	National Institutes of Health [GM50237]; Netherlands Organisation for Scientific Research Vidi grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050237, R01GM050237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research Vidi grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM50237 (RR) and a Netherlands Organisation for Scientific Research Vidi grant (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010397; Bernstein KA, 2011, MOL BIOL CELL, V22, P1599, DOI 10.1091/mbc.E10-08-0691; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Chang M, 2011, CELL CYCLE, V10, P3798, DOI 10.4161/cc.10.21.18095; Chang M, 2011, NAT STRUCT MOL BIOL, V18, P451, DOI 10.1038/nsmb.2034; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Claussin C, 2015, MICROB CELL, V2, P308, DOI 10.15698/mic2015.09.224; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Fallet E, 2014, NUCLEIC ACIDS RES, V42, P3648, DOI 10.1093/nar/gkt1328; Gaines WA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8834; Godin S, 2013, NUCLEIC ACIDS RES, V41, P4525, DOI 10.1093/nar/gkt138; Gupta A, 2013, GENETICS, V193, P1095, DOI 10.1534/genetics.112.149120; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Le S, 1999, GENETICS, V152, P143; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Poschke H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002960; Sasanuma H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2678; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Treco D A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1301s23; Vasianovich Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004679; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151314	10.1371/journal.pone.0151314	http://dx.doi.org/10.1371/journal.pone.0151314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974669	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600068
J	Liu, W; Li, H; Hong, SH; Piszczek, GP; Chen, W; Rodgers, GP				Liu, W.; Li, H.; Hong, S-H; Piszczek, G. P.; Chen, W.; Rodgers, G. P.			Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin/+ mice	ONCOGENE			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; BETA-CATENIN EXPRESSION; STAPHYLOCOCCUS-AUREUS; COLORECTAL-CANCER; HGC-1; ACTIVATION; OLFM4; DIFFERENTIATION; SUSCEPTIBILITY	Colon carcinogenesis is a multiple-step process involving the accumulation of a series of genetic and epigenetic alterations. The most commonly initiating event of intestinal carcinogenesis is mutation of the adenomatous polyposis coli (APC) gene, which leads to activation of the Wnt/beta-catenin pathway. Olfactomedin 4 (OLFM4) has emerged as an intestinal stem-cell marker, but its biological function in the intestine remains to be determined. Here we show that Olfm4 deletion induced colon adenocarcinoma in the distal colon of Apc(Min/+) mice. Mechanistically, we found that OLFM4 is a target gene of the Wnt/beta-catenin pathway and can downregulate beta-catenin signaling by competing with Wnt ligands for binding to Frizzled receptors, as well as by inhibition of the Akt-GSK-3 beta (Akt-glycogen synthase kinase-3 beta) pathway. We have shown that both Wnt and nuclear factor-kappa B (NF-kappa B) signaling were boosted in tumor tissues of Apc Olfm4 double-mutant mice. These data establish OLFM4 as a critical negative regulator of the Wnt/beta-catenin and NF-kappa B pathways that inhibits colon-cancer development initiated by APC mutation. In addition, Olfm4 deletion significantly enhanced intestinal-crypt proliferation and inflammation induced by azoxymethane/dextran sodium sulfate. Thus, OLFM4 has an important role in the regulation of intestinal inflammation and tumorigenesis, and could be a potential therapeutic target for intestinal malignant tumors. Unlike the human colonic epithelium, the mouse colonic epithelium does not express OLFM4, but nevertheless, systemic OLFM4 deletion promotes colon tumorigenesis and that loss from mucosal neutrophils may have a role to play.	[Liu, W.; Li, H.; Hong, S-H; Rodgers, G. P.] NHLBI, Mol & Clin Hematol Branch, NIH, Bldg 10,Room 9N119,9000 Rockville Pike, Bethesda, MD 20892 USA; [Hong, S-H] Natl Canc Ctr, Canc Genom Branch, Goyang Si, Gyeonggi Do, South Korea; [Piszczek, G. P.] NHLBI, Biochem & Biophys Ctr, Bldg 10, Bethesda, MD 20892 USA; [Chen, W.] NIDDK, Genom Core Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Cancer Center - Korea (NCC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rodgers, GP (corresponding author), NHLBI, Mol & Clin Hematol Branch, NIH, Bldg 10,Room 9N119,9000 Rockville Pike, Bethesda, MD 20892 USA.	gr5n@nih.gov	Piszczek, Grzegorz/GYU-2029-2022		intramural research fund of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338, ZIGHL006020, ZIAHL006004] Funding Source: NIH RePORTER	intramural research fund of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Michael A Eckhaus, National Institutes of Health, for the pathology assistance and Dr Ivan Ding, National Institutes of Health, for helpful suggestions and review of our manuscript. This study was supported by the intramural research fund of the National Institutes of Health.	Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Besson D, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009712-1, 10.1074/mcp.M111.009712]; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chin KL, 2008, BRIT J HAEMATOL, V143, P421, DOI 10.1111/j.1365-2141.2008.07368.x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Gersemann M, 2012, J CROHNS COLITIS, V6, P425, DOI 10.1016/j.crohns.2011.09.013; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inomata M, 1996, CANCER RES, V56, P2213; Kaler P, 2009, CANCER MICROENVIRON, V2, P69, DOI 10.1007/s12307-009-0030-y; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kavandi L, 2012, J CELL BIOCHEM, V113, P3143, DOI 10.1002/jcb.24191; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Liu WL, 2008, CLIN CANCER RES, V14, P1041, DOI 10.1158/1078-0432.CCR-07-4125; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Liu WL, 2013, J CLIN INVEST, V123, P3751, DOI 10.1172/JCI68453; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Liu WL, 2010, BLOOD, V116, P4938, DOI 10.1182/blood-2009-10-246439; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakaya N, 2008, J NEUROSCI, V28, P7900, DOI 10.1523/JNEUROSCI.0617-08.2008; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rosenbauer F, 2004, BLOOD, V103, P4294, DOI 10.1182/blood-2003-08-2688; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seko N, 2010, EXP THER MED, V1, P73, DOI 10.3892/etm_00000013; Shinozaki S, 2001, GUT, V48, P623, DOI 10.1136/gut.48.5.623; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6	42	48	48	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5237	5247		10.1038/onc.2016.58	http://dx.doi.org/10.1038/onc.2016.58			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	26973250	Green Published, hybrid			2022-12-26	WOS:000386053000003
J	Kordjazi, Z; Frusher, S; Buxton, C; Gardner, C; Bird, T				Kordjazi, Ziya; Frusher, Stewart; Buxton, Colin; Gardner, Caleb; Bird, Tomas			The Influence of Mark-Recapture Sampling Effort on Estimates of Rock Lobster Survival	PLOS ONE			English	Article							JASUS-EDWARDSII; WATER TEMPERATURE; SIZE; DENSITY; CATCHABILITY; CATCHES; AREA	Five annual capture-mark-recapture surveys on Jasus edwardsii were used to evaluate the effect of sample size and fishing effort on the precision of estimated survival probability. Datasets of different numbers of individual lobsters (ranging from 200 to 1,000 lobsters) were created by random subsampling from each annual survey. This process of random subsampling was also used to create 12 datasets of different levels of effort based on three levels of the number of traps (15, 30 and 50 traps per day) and four levels of the number of sampling-days (2, 4, 6 and 7 days). The most parsimonious Cormack-Jolly-Seber (CJS) model for estimating survival probability shifted from a constant model towards sex-dependent models with increasing sample size and effort. A sample of 500 lobsters or 50 traps used on four consecutive sampling-days was required for obtaining precise survival estimations for males and females, separately. Reduced sampling effort of 30 traps over four sampling days was sufficient if a survival estimate for both sexes combined was sufficient for management of the fishery.	[Kordjazi, Ziya; Frusher, Stewart; Buxton, Colin; Gardner, Caleb] Univ Tasmania, IMAS, Hobart, Tas, Australia; [Bird, Tomas] Univ Melbourne, ARC Ctr Excellence Environm Decis, Melbourne, Vic, Australia	University of Tasmania; University of Melbourne	Kordjazi, Z (corresponding author), Univ Tasmania, IMAS, Hobart, Tas, Australia.	ziya.kordjazi@utas.edu.au	Kordjazi, Ziya/AAA-6936-2022; Buxton, Colin/AAV-3489-2021; Gardner, Caleb/I-7086-2013	Kordjazi, Ziya/0000-0003-0734-946X; Buxton, Colin/0000-0002-3256-5220; Gardner, Caleb/0000-0003-0324-4337	Iranian Government scholarship from the Ministry of Science and Technology	Iranian Government scholarship from the Ministry of Science and Technology	ZK was supported by an Iranian Government scholarship from the Ministry of Science and Technology. This scholarship provided ZK with tuition fees and living costs and played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CA, 2000, CRUSTACEANA, V73, P425, DOI 10.1163/156854000504516; Barrett N, 2009, MAR FRESHWATER RES, V60, P417, DOI 10.1071/MF07154; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Burke VJ, 1995, HERPETOLOGICA, V51, P451; Burnham K. P., 1998, MODEL SELECTION INFE; Cilimburg AB, 2002, AUK, V119, P778, DOI 10.1642/0004-8038(2002)119[0778:EODOSP]2.0.CO;2; Comeau M, 2009, NEW ZEAL J MAR FRESH, V43, P401, DOI 10.1080/00288330909510009; Conner MM, 2015, T AM FISH SOC, V144, P34, DOI 10.1080/00028487.2014.963254; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Fiske IJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003080; Green BS, 2009, ICES J MAR SCI, V66, P656, DOI 10.1093/icesjms/fsp030; Howe EJ, 2013, POPUL ECOL, V55, P595, DOI 10.1007/s10144-013-0389-y; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kelly S, 1999, MAR FRESHWATER RES, V50, P409, DOI 10.1071/MF98126; Kordjazi Z, 2015, ICES J MAR SCI, V72, P244, DOI 10.1093/icesjms/fsv005; Laake J., 2012, PROGRAM MARK GENTLE; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lindberg MS, 2007, J WILDLIFE MANAGE, V71, P1002, DOI 10.2193/2005-696; McKelvey KS, 2001, CAN J ZOOL, V79, P1754, DOI 10.1139/cjz-79-10-1754; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; PENNINGTON M, 1991, BIOMETRICS, V47, P717, DOI 10.2307/2532157; PENNINGTON M, 1994, BIOMETRICS, V50, P725, DOI 10.2307/2532786; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; ROBSON D. S., 1964, TRANS AMER FISH SOC, V93, P215, DOI 10.1577/1548-8659(1964)93[215:SSIPME]2.0.CO;2; Schorr RA, 2014, ACTA CHIROPTEROL, V16, P231, DOI 10.3161/150811014X683426; SEBER GAF, 1965, BIOMETRIKA, V52, P249; SOMERS KM, 1986, AM MIDL NAT, V116, P36, DOI 10.2307/2425935; Srisurichan S, 2005, NEW ZEAL J MAR FRESH, V39, P749, DOI 10.1080/00288330.2005.9517350; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS MJ, 1982, MAR BIOL, V71, P187, DOI 10.1007/BF00394628; Ziegler PE, 2004, MAR BIOL, V145, P179, DOI 10.1007/s00227-004-1298-6; Ziegler PE, 2003, FISH RES, V61, P107, DOI 10.1016/S0165-7836(02)00240-0; Zimmerman JKM, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011016	33	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151683	10.1371/journal.pone.0151683	http://dx.doi.org/10.1371/journal.pone.0151683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990561	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800087
J	Park, JH; Kim, HJ; Kwon, GY; Gwack, J; Park, YJ; Youn, SK; Kwon, JW; Yang, BG; Lee, MS; Jung, M; Lee, H; Jun, BY; Lim, HS				Park, Ji-Hyuk; Kim, Hwa Jung; Kwon, Geun-Yong; Gwack, Jin; Park, Young-Joon; Youn, Seung-Ki; Kwon, Jun-Wook; Yang, Byung-Guk; Lee, Moo-Song; Jung, Miran; Lee, Hanyi; Jun, Byung-Yool; Lim, Hyun-Sul			Humidifier Disinfectants Are a Cause of Lung Injury among Adults in South Korea: A Community-Based Case-Control Study	PLOS ONE			English	Article							CLUSTER	Backgrounds An outbreak of lung injury among South Korean adults was examined in a hospital-based case-control study, and the suspected cause was exposure to humidifier disinfectant (HD). However, a case-control study with community-dwelling controls was needed to validate the previous study's findings, and to confirm the exposure-response relationship between HD and lung injury. Methods Each case of lung injury was matched with four community-dwelling controls, according to age (+/- 3 years), sex, residence, and history of childbirth since 2006 (for women). Environmental risk factors, which included type and use of humidifier and HD, were investigated using a structured questionnaire during August 2011. The exposure to HD was calculated for both cases and controls, and the corresponding risks of lung injury were compared. Results Among 28 eligible cases, 16 patients agreed to participate, and 60 matched controls were considered eligible for this study. The cases were more likely to have been exposed to HD (odds ratio: 116.1, 95% confidence interval: 6.5-2,063.7). All cases were exposed to HDs containing polyhexamethyleneguanidine phosphate, and the risk of lung injury increased with the cumulative exposure, duration of exposure, and exposure per day. Conclusions This study revealed a statistically significant exposure-response relationship between HD and lung injury. Therefore, continuous monitoring and stricter evaluation of environmental chemicals' safety should be conducted.	[Park, Ji-Hyuk; Lim, Hyun-Sul] Dongguk Univ, Coll Med, Dept Prevent Med, Gyeongju Si, Gyeongsangbuk D, South Korea; [Park, Ji-Hyuk; Kwon, Geun-Yong; Gwack, Jin; Park, Young-Joon; Youn, Seung-Ki] Korea Ctr Dis Control & Prevent, Div Epidem Intelligence Serv, Cheongju, Chungcheongbuk, South Korea; [Kim, Hwa Jung; Lee, Moo-Song] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Kwon, Jun-Wook] Korea Ctr Dis Control & Prevent, Ctr Infect Dis Control, Cheongju, Chungcheongbuk, South Korea; [Yang, Byung-Guk] Minist Hlth & Welf, Bur Publ Hlth Policy, Sejong, South Korea; [Lee, Moo-Song] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Prevent Med, Seoul, South Korea; [Jung, Miran] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nursing, Seoul, South Korea; [Lee, Hanyi] Hanyang Univ, Dept Nursing, Seoul 133791, South Korea; [Jun, Byung-Yool] Korea Ctr Dis Control & Prevent, Cheongju, Chungcheongbuk, South Korea	Dongguk University; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control; University of Ulsan; Asan Medical Center; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Hanyang University; Korea Centers for Disease Control & Prevention (KCDC)	Lim, HS (corresponding author), Dongguk Univ, Coll Med, Dept Prevent Med, Gyeongju Si, Gyeongsangbuk D, South Korea.; Jun, BY (corresponding author), Korea Ctr Dis Control & Prevent, Cheongju, Chungcheongbuk, South Korea.	drmdjun@hanmail.net; wisewine@dongguk.ac.kr	Lee, Hanyi/Z-5408-2019					Dassonville C, 2008, INDOOR AIR, V18, P480, DOI 10.1111/j.1600-0668.2008.00549.x; Gilliland FD, 2001, AM J RESP CRIT CARE, V163, P429, DOI 10.1164/ajrccm.163.2.2006009; Hong SB, 2014, THORAX, V69, P694, DOI 10.1136/thoraxjnl-2013-204135; 전종근, 2008, Clinical and Experimental Pediatrics, V51, P383; Jeon B.H., 2012, ENV HLTH TOXICOL, V27, DOI DOI 10.5620/EHT.2012.27.E2012002; Kim HJ, 2014, THORAX, V69, P703, DOI 10.1136/thoraxjnl-2013-204132; Lee JH, 2012, ENVIRON SCI TECHNOL, V46, P2498, DOI 10.1021/es300567j; The Korea Centers for Disease Control and Prevention, 2011, REC 6 PROD HUM DIS; The Korea Centers for Disease Control and Prevention, 2011, HUM DIS POSS CAUS LU; The Korean Society of Critical Care Medicine, 2012, PROSP SURV AD LUNG I; Yang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064430	11	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151849	10.1371/journal.pone.0151849	http://dx.doi.org/10.1371/journal.pone.0151849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990641	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800108
J	Vescovini, R; Telera, AR; Pedrazzoni, M; Abbate, B; Rossetti, P; Verzicco, I; Arcangeletti, MC; Medici, MC; Calderaro, A; Volpi, R; Sansoni, P; Fagnoni, FF				Vescovini, Rosanna; Telera, Anna Rita; Pedrazzoni, Mario; Abbate, Barbara; Rossetti, Pietro; Verzicco, Ignazio; Arcangeletti, Maria Cristina; Medici, Maria Cristina; Calderaro, Adriana; Volpi, Riccardo; Sansoni, Paolo; Fagnoni, Francesco Fausto			Impact of Persistent Cytomegalovirus Infection on Dynamic Changes in Human Immune System Profile	PLOS ONE			English	Article							CD8(+) T-CELLS; SEROPOSITIVITY; SUBSETS; CD4(+); ACCUMULATION; COMPARTMENTS; RESPONSES; PATHOGEN; AGE	Human cytomegalovirus (HCMV) imprints the immune system after primary infection, however its effect during chronic infection still needs to be deciphered. In this study we report the variation of blood cell count along with anti-HCMV IgG and T cell responses to pp-65 and IE-1 antigens, that occurred after an interval of five years in a cohort of 25 seropositive healthy adults. We found increased anti-viral IgG antibody responses and intracellular ninterferon-gamma secreting CD8+ T cell responses to pp-65: a result consistent with memory inflation. With the only exception of shortage in naive CD8+ T cells most memory T cell subsets as well as total CD8+ T cells, T cells, lymphocytes, monocytes and leukocytes had increased. By contrast, none of the cell types tested were found to have increased in 14 subjects stably seronegative. Rather, in addition to a shortage in naive CD8+ T cells, also memory T cell subsets and most other cell types decreased, either in a statistically significant or non-significant manner. The trend of T cell pool representation with regard to CD4/CD8 ratio was in the opposing directions depending on HCMV serology. Globally, this study demonstrates different dynamic changes of most blood cell types depending on presence or absence of HCMV infection. Therefore, HCMV plays a continual role in modulating homeostasis of blood T cells and a broader expanding effect on other cell populations of lymphoid and myeloid origin.	[Vescovini, Rosanna; Telera, Anna Rita; Pedrazzoni, Mario; Abbate, Barbara; Rossetti, Pietro; Verzicco, Ignazio; Arcangeletti, Maria Cristina; Medici, Maria Cristina; Calderaro, Adriana; Volpi, Riccardo; Sansoni, Paolo] Univ Parma, Dept Clin & Expt Med, Via Gramsci 14, I-43126 Parma, Italy; [Fagnoni, Francesco Fausto] Hosp Parma, Immunohematol & Transfus Ctr, Via Gramsci 14, I-43126 Parma, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma	Vescovini, R (corresponding author), Univ Parma, Dept Clin & Expt Med, Via Gramsci 14, I-43126 Parma, Italy.; Fagnoni, FF (corresponding author), Hosp Parma, Immunohematol & Transfus Ctr, Via Gramsci 14, I-43126 Parma, Italy.	rosanna.vescovini@unipr.it; ffagnoni@ao.pr.it	Volpi, Riccardo/J-3405-2018; Fagnoni, Francesco F/A-1642-2008	Volpi, Riccardo/0000-0001-8653-6217; rossetti, pietro/0000-0003-4539-1546	Fondazione Cassa di Risparmio di Parma e Piacenza; Regione Emilia Romagna, Programma di Ricerca Regione Universita, Area 1, Strategic Programmes	Fondazione Cassa di Risparmio di Parma e Piacenza; Regione Emilia Romagna, Programma di Ricerca Regione Universita, Area 1, Strategic Programmes	This work was supported by the Fondazione Cassa di Risparmio di Parma e Piacenza and in part by a grant from Regione Emilia Romagna, Programma di Ricerca Regione Universita 2010-2012, Area 1, Strategic Programmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; CHAKRAVARTI A, 1995, NAT MED, V1, P1240, DOI 10.1038/nm1295-1240; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Crough T, 2005, EUR J IMMUNOL, V35, P139, DOI 10.1002/eji.200425548; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Fagnoni FF, 2002, IMMUNOLOGY, V106, P27, DOI 10.1046/j.1365-2567.2002.01400.x; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Jackson SE, 2014, J VIROL, V88, P10894, DOI 10.1128/JVI.01477-14; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Li HF, 2014, EXP GERONTOL, V54, P84, DOI 10.1016/j.exger.2014.01.010; Libri V, 2011, IMMUNOLOGY, V132, P326, DOI 10.1111/j.1365-2567.2010.03386.x; LIFSON JD, 1985, CLIN IMMUNOL IMMUNOP, V36, P151, DOI 10.1016/0090-1229(85)90116-3; Litjens NHR, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-2; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Lugli E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00390; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; Miles DJC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002905; Muntasell A, 2013, EUR J IMMUNOL, V43, P1133, DOI 10.1002/eji.201243117; O'Hara GA, 2012, TRENDS IMMUNOL, V33, P84, DOI 10.1016/j.it.2011.11.005; Roederer M, 1997, Semin Immunol, V9, P389, DOI 10.1006/smim.1997.0097; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; van Leeuwen EMM, 2004, J IMMUNOL, V173, P1834, DOI 10.4049/jimmunol.173.3.1834; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Vescovini R, 2014, AGE, V36, P625, DOI 10.1007/s11357-013-9594-z; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wallace DL, 2011, IMMUNOLOGY, V132, P27, DOI 10.1111/j.1365-2567.2010.03334.x; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721	34	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151965	10.1371/journal.pone.0151965	http://dx.doi.org/10.1371/journal.pone.0151965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990192	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800124
J	Jiang, YL; Li, B; Chen, J				Jiang, Yulin; Li, Bin; Chen, Jie			Analysis of the Velocity Distribution in Partially-Filled Circular Pipe Employing the Principle of Maximum Entropy	PLOS ONE			English	Article							INFORMATION-THEORY; BOUNDARY SHEAR; CULVERTS	The flow velocity distribution in partially-filled circular pipe was investigated in this paper. The velocity profile is different from full-filled pipe flow, since the flow is driven by gravity, not by pressure. The research findings show that the position of maximum flow is below the water surface, and varies with the water depth. In the region of near tube wall, the fluid velocity is mainly influenced by the friction of the wall and the pipe bottom slope, and the variation of velocity is similar to full-filled pipe. But near the free water surface, the velocity distribution is mainly affected by the contractive tube wall and the secondary flow, and the variation of the velocity is relatively small. Literature retrieval results show relatively less research has been shown on the practical expression to describe the velocity distribution of partially-filled circular pipe. An expression of two-dimensional (2D) velocity distribution in partially-filled circular pipe flow was derived based on the principle of maximum entropy (POME). Different entropies were compared according to fluid knowledge, and non-extensive entropy was chosen. A new cumulative distribution function (CDF) of partially-filled circular pipe velocity in terms of flow depth was hypothesized. Combined with the CDF hypothesis, the 2D velocity distribution was derived, and the position of maximum velocity distribution was analyzed. The experimental results show that the estimated velocity values based on the principle of maximum Tsallis wavelet entropy are in good agreement with measured values.	[Jiang, Yulin; Li, Bin; Chen, Jie] Shanghai Univ, Coll Mechatron Engn & Automat, Shanghai, Peoples R China; [Jiang, Yulin] Jiujiang Univ, Coll Elect Engn, Jiujiang, Peoples R China	Shanghai University; Jiujiang University	Jiang, YL (corresponding author), Shanghai Univ, Coll Mechatron Engn & Automat, Shanghai, Peoples R China.; Jiang, YL (corresponding author), Jiujiang Univ, Coll Elect Engn, Jiujiang, Peoples R China.	ghostjiang@sina.com	Jiang, Yulin/AAI-7111-2020					Adrove A, 2013, PHYS FLUIDS, V25, P708; BARBE DE, 1991, J HYDRAUL ENG-ASCE, V117, P1389, DOI 10.1061/(ASCE)0733-9429(1991)117:10(1389); Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; CHEN NH, 1979, IND ENG CHEM FUND, V18, P296, DOI 10.1021/i160071a019; Chen ZQ, 2015, ENTROPY-SWITZ, V17, P3710, DOI 10.3390/e17063710; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Chen ZQ, 2014, APPL MATH COMPUT, V242, P462, DOI 10.1016/j.amc.2014.05.105; Chiu CL, 2006, J HYDROL, V316, P28, DOI 10.1016/j.jhydrol.2005.04.011; Chiu CL, 2005, HYDROL PROCESS, V19, P3935, DOI 10.1002/hyp.5857; CHIU CL, 1991, J HYDRAUL ENG-ASCE, V117, P615, DOI 10.1061/(ASCE)0733-9429(1991)117:5(615); Chiu CL, 2003, J HYDRAUL RES, V41, P589, DOI 10.1080/00221680309506891; CHIU CL, 1989, J HYDRAUL ENG-ASCE, V115, P576, DOI 10.1061/(ASCE)0733-9429(1989)115:5(576); CHIU CL, 1995, J HYDRAUL ENG-ASCE, V121, P26, DOI 10.1061/(ASCE)0733-9429(1995)121:1(26); CHIU CL, 1992, J HYDRAUL ENG-ASCE, V118, P989; CHIU CL, 1988, J HYDRAUL ENG-ASCE, V114, P738, DOI 10.1061/(ASCE)0733-9429(1988)114:7(738); Clark SP, 2011, J HYDRAUL RES, V49, P676, DOI 10.1080/00221686.2011.596399; Cui HJ, 2013, J HYDROL ENG, V18, P331, DOI 10.1061/(ASCE)HE.1943-5584.0000610; Furuichi S, 2004, J MATH PHYS, V45, P4868, DOI 10.1063/1.1805729; Guo JK, 2013, J HYDRAUL RES, V51, P408, DOI 10.1080/00221686.2013.784881; Hager WH, 2010, WASTEWATER HYDRAULICS: THEORY AND PRACTICE, SECOND EDITION, P1, DOI 10.1007/978-3-642-11383-3; House MR, 2005, J AM WATER RESOUR AS, V41, P209, DOI 10.1111/j.1752-1688.2005.tb03729.x; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Knight DW, 2000, J HYDRAUL ENG-ASCE, V126, P263, DOI 10.1061/(ASCE)0733-9429(2000)126:4(263); Luo H, 2011, J HYDROL ENG, V16, P303, DOI 10.1061/(ASCE)HE.1943-5584.0000319; Marini G, 2011, J HYDRAUL RES, V49, P784, DOI 10.1080/00221686.2011.635889; Nezu I., 1993, IAHR MONOGRAPH SERIE; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sterling M, 2000, P I CIVIL ENG-WATER, V142, P229, DOI 10.1680/wame.2000.142.4.229; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C, 1998, PHYSICA A, V261, P534, DOI 10.1016/S0378-4371(98)00437-3; Yang SQ, 2004, J HYDRAUL ENG-ASCE, V130, P1179, DOI 10.1061/(ASCE)0733-9429(2004)130:12(1179); Yoon JI, 2012, J HYDRAUL RES, V50, P304, DOI 10.1080/00221686.2012.673745	33	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151578	10.1371/journal.pone.0151578	http://dx.doi.org/10.1371/journal.pone.0151578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986064	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300089
J	Pasquier, D; de la Combe-Chossiere, LB; Carlier, D; Darloy, F; Degrendel-Courtecuisse, AC; Dufour, C; Fares, M; Gilbeau, L; Liem, X; Martin, P; Meyer, P; Minne, JF; Olszyk, O; Rhliouch, H; Tokarski, M; Viot, C; Castelain, B; Lartigau, E				Pasquier, David; de la Combe-Chossiere, Laurence Boutaud; Carlier, Damien; Darloy, Franck; Degrendel-Courtecuisse, Anne Catherine; Dufour, Chantal; Fares, Mustapha; Gilbeau, Laurent; Liem, Xavier; Martin, Philippe; Meyer, Pascal; Minne, Jean Francois; Olszyk, Olimpia; Rhliouch, Hassan; Tokarski, Marc; Viot, Chloe; Castelain, Bernard; Lartigau, Eric			Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of France	PLOS ONE			English	Article							CONFORMAL RADIATION-THERAPY; MAGNETIC-RESONANCE IMAGES; INTEROBSERVER VARIABILITY; CONSENSUS GUIDELINES; PROSTATE-CANCER; TARGET VOLUME; HEAD; SEGMENTATION; INTERVENTION; METHODOLOGY	Background Inter-observer delineation variation has been detailed for many years in almost every tumor location. Inadequate delineation can impair the chance of cure and/or increase toxicity. The aim of our original work was to prospectively improve the homogeneity of delineation among all of the senior radiation oncologists in the Nord-Pas de Calais region, irrespective of the conditions of practice. Methods All 11 centers were involved. The first studied cancer was prostate cancer. Three clinical cases were studied: a low-risk prostate cancer case (case 1), a high-risk prostate cancer case (pelvic nodes, case 2) and a case of post-operative biochemical elevated PSA (case 3). All of the involved physicians delineated characteristically the clinical target volume (CTV) and organs at risk. The volumes were compared using validated indexes: the volume ratio (VR), common and additional volumes (CV and AV), volume overlap (VO) and Dice similarity coefficient (DSC). A second delineation of the same three cases was performed after discussion of the slice results and the choice of shared guidelines to evaluate homogenization. A comparative analysis of the indexes before and after discussion was conducted using the Wilcoxon test for paired samples. A p-value less than 0.05 was considered to indicate statistical significance. Results The indexes were not improved in case 1, for which the inter-observer agreement was considered good after the first comparison (DSC = 0.83 +/- 0.06). In case 2, the second comparison showed homogenization of the CTV delineation with a significant improvement in CV (81.4 +/- 11.7 vs. 88.6 +/- 10.26, respectively, p = 0.048), VO (0.41 +/- 0.09 vs. 0.47 +/- 0.07, respectively; p = 0.009) and DSC (0.58 +/- 0.09 vs. 0.63 +/- 0.07, respectively; p = 0.0098). In case 3, VR and AV were significantly improved: VR: 1.71(+/- 0.6) vs. 1.34(+/- 0.46), respectively, p = 0.0034; AV: 46.58(+/- 14.50) vs. 38.08(+/- 15.10), respectively, p = 0.0024. DSC was not improved, but it was already superior to 0.6 in the first comparison. Conclusion Our prospective work showed that a collaborative discussion about clinical cases and the choice of shared guidelines within an established framework improved the homogeneity of CTV delineation among the senior radiation oncologists in our region.	[Pasquier, David; Liem, Xavier; Castelain, Bernard; Lartigau, Eric] Univ Lille, Ctr Oscar Lambret, Acad Radiat Oncol Dept, Lille, France; [Pasquier, David; Lartigau, Eric] UMR CNRS 9189, CRISTAL, Lille, France; [de la Combe-Chossiere, Laurence Boutaud] Inst Andree Dutreix, Dunkerque, France; [Carlier, Damien; Darloy, Franck] Ctr Leonard Vinci, Dechy, France; [Degrendel-Courtecuisse, Anne Catherine] Ctr Joliot Curie, Boulogne Sur Mer, France; [Dufour, Chantal; Minne, Jean Francois] Ctr Cancerol Dentellieres, Valenciennes, France; [Fares, Mustapha] Ctr Pierre Curie, Bethune, France; [Gilbeau, Laurent; Meyer, Pascal] Ctr Gray, Maubeuge, France; [Martin, Philippe] Ctr Bourgogne Clin Bois, Lille, France; [Olszyk, Olimpia] Ctr Galilee, Lille, France; [Rhliouch, Hassan] Ctr Marie Curie, Arras, France; [Tokarski, Marc] Ctr Cancerol Artois, Lens, France; [Viot, Chloe] Reseau Onco Nord Pas de Calais, Loos, France	UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Centrale Lille; Universite de Lille	Pasquier, D (corresponding author), Univ Lille, Ctr Oscar Lambret, Acad Radiat Oncol Dept, Lille, France.; Pasquier, D (corresponding author), UMR CNRS 9189, CRISTAL, Lille, France.	pasquier@o-lambret.fr	lartigau, eric/GSI-5327-2022; Pasquier, David/O-8004-2014	Pasquier, David/0000-0001-6019-7309	Ligue Contre le Cancer, Reseau Regional de Cancerologie [04]; Region Nord Pas de Calais, Reseau Regional de Cancerologie [1200 1826]; Fonds europeen de developpement regional FEDER, Reseau Regional de Cancerologie [38420]; Agence Regionale de Sante, Reseau Regional de Cancerologie [03]	Ligue Contre le Cancer, Reseau Regional de Cancerologie; Region Nord Pas de Calais, Reseau Regional de Cancerologie(Region Hauts-de-France); Fonds europeen de developpement regional FEDER, Reseau Regional de Cancerologie; Agence Regionale de Sante, Reseau Regional de Cancerologie	This work was supported by Ligue Contre le Cancer (http://www.ligue-cancer.net/), Grant number 04, Reseau Regional de Cancerologie; Region Nord Pas de Calais (http://www. nordpasdecalais.fr/jcms/c_5001/accueil), Grant number 1200 1826, Reseau Regional de Cancerologie; Fonds europeen de developpement regional FEDER (http://www.europe-en-france.gouv.fr/Configuration-Generale-Pages-secondaires/FEDER), Grant number 38420, Reseau Regional de Cancerologie; and Agence Regionale de Sante (http://www.ars.nordpasdecalais.sante.fr/Internet.nordpasdecalais.0.html), Grant number 03, Reseau Regional de Cancerologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allozi R, 2010, RADIOTHER ONCOL, V97, P572, DOI 10.1016/j.radonc.2010.06.009; Bekelman JE, 2009, INT J RADIAT ONCOL, V73, P416, DOI 10.1016/j.ijrobp.2008.04.028; Boehmer D, 2006, RADIOTHER ONCOL, V79, P259, DOI 10.1016/j.radonc.2006.05.012; Brouwer CL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-32; BUENO G, 2001, P MED IM UND AN MIUA, P73; Cazzaniga LF, 1998, RADIOTHER ONCOL, V47, P293, DOI 10.1016/S0167-8140(98)00028-0; Chalana V, 1997, IEEE T MED IMAGING, V16, P642, DOI 10.1109/42.640755; Dawant BM, 1999, IEEE T MED IMAGING, V18, P909, DOI 10.1109/42.811271; Debois M, 1999, INT J RADIAT ONCOL, V45, P857, DOI 10.1016/S0360-3016(99)00288-6; Dewas S, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-118; Fiorino C, 1998, RADIOTHER ONCOL, V47, P285, DOI 10.1016/S0167-8140(98)00021-8; Giraud P, 2002, RADIOTHER ONCOL, V62, P27, DOI 10.1016/S0167-8140(01)00444-3; Guo B, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0370-3; Guo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112187; Jager EA, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-014-0321-4; Kelemen A, 1999, IEEE T MED IMAGING, V18, P828, DOI 10.1109/42.811260; Lawton CAF, 2009, INT J RADIAT ONCOL, V74, P383, DOI 10.1016/j.ijrobp.2008.08.002; Lawton CAF, 2009, INT J RADIAT ONCOL, V74, P377, DOI 10.1016/j.ijrobp.2008.08.003; Ligier K, 2012, REV EPIDEMIOL SANTE, V60, P131, DOI 10.1016/j.respe.2011.10.006; Malone S, 2012, INT J RADIAT ONCOL, V84, P725, DOI 10.1016/j.ijrobp.2011.12.081; Michalski JM, 2010, INT J RADIAT ONCOL, V76, P361, DOI 10.1016/j.ijrobp.2009.02.006; Nyholm T, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-126; Ohri N, 2013, JNCI-J NATL CANCER I, V105, P387, DOI 10.1093/jnci/djt001; Pasquier D, 2007, INT J RADIAT ONCOL, V68, P592, DOI 10.1016/j.ijrobp.2007.02.005; Peters LJ, 2010, J CLIN ONCOL, V28, P2996, DOI 10.1200/JCO.2009.27.4498; Szumacher E, 2010, INT J RADIAT ONCOL, V76, P379, DOI 10.1016/j.ijrobp.2009.02.008	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150917	10.1371/journal.pone.0150917	http://dx.doi.org/10.1371/journal.pone.0150917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987121	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300037
J	Van Der Gucht, A; Zehou, O; Djelbani-Ahmed, S; Valeyrie-Allanore, L; Ortonne, N; Brugieres, P; Wolkenstein, P; Luciani, A; Rahmouni, A; Sbidian, E; Itti, E				Van Der Gucht, Axel; Zehou, Ouidad; Djelbani-Ahmed, Soraya; Valeyrie-Allanore, Laurence; Ortonne, Nicolas; Brugieres, Pierre; Wolkenstein, Pierre; Luciani, Alain; Rahmouni, Alain; Sbidian, Emilie; Itti, Emmanuel			Metabolic Tumour Burden Measured by F-18-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1	PLOS ONE			English	Article							NERVE SHEATH TUMORS; FDG PET; VOLUME; TOMOGRAPHY; GUIDELINES; MANAGEMENT; PHENOTYPE; MORTALITY; DIAGNOSIS; DEATH	Background To investigate the diagnostic and prognostic performances of F-18-FDG PET/CT measures of metabolic tumour burden in patients with neurofibromatosis type-1 (NF1), suspect of malignant transformation. Methods This retrospective study included 49 patients (15-60 years old, 30 women) with a diagnosis of NF1, followed in our Reference Centre for Rare Neuromuscular Diseases, who presented clinical signs of tumour progression (pain, neurological deficit, tumour growth). Quantitative metabolic parameters were measured on 149 tumoral targets, using semi-automatic software and the best cut off values to predict transformation was assessed by Receiver Operating Characteristics (ROC) analysis. Prognostic value of PET/CT metabolic parameters was assessed by Kaplan-Meier estimates of overall survival. Results Lesions were histologically documented in 40 patients: a sarcomatous transformation was found in 16, a dysplastic neurofibroma (NF) in 7, and a benign NF in 17; in the remaining 9 patients, a minimal follow-up of 12 mo (median 59 mo) confirmed the absence of transformation. The optimal cut off values for detection of malignant transformation were, in decreasing order of area under the ROC curves, a tumour-to-liver (T/L) ratio >2.5, SUVmax > 4.5, total lesion glycolysis (TLG) > 377, total metabolic tumour volume (TMTV) > 88 cm(3), and heterogeneity index (HIsuv) > 1.69. The best prognostic marker was the TLG: the 4-y estimates of survival were 97% [95% CI, 90% - 100%] in patients with TLG <= 377 vs. 27% [95% CI, 5% - 49%] in patients with TLG > 377 (P < 0.0001; chi(2) 27.85; hazard ratio 13.27 [95% CI, 3.72-47.35]). T/L ratio, SUVmax and TMTV demonstrated slightly lower performance to predict survival, with. 2 ranging 14.41-19.12. The HIsuv index was not predictive of survival. Conclusion Our study demonstrates that TLG and TMTV, as PET/CT measures of metabolic tumour burden, may be used clinically to identify sarcomatous transformation in patients with NF1 and predict overall survival, with a higher specificity for the TLG. Conventional measures such as the SUVmax, and T/L ratio also demonstrate high prognostic value.	[Van Der Gucht, Axel; Djelbani-Ahmed, Soraya; Itti, Emmanuel] Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, F-94010 Creteil, France; [Zehou, Ouidad; Valeyrie-Allanore, Laurence; Wolkenstein, Pierre; Sbidian, Emilie] Paris Est Univ, H Mondor Hosp, AP HP, Dept Dermatol, F-94010 Creteil, France; [Ortonne, Nicolas] Paris Est Univ, H Mondor Hosp, AP HP, Dept Pathol, F-94010 Creteil, France; [Brugieres, Pierre] Paris Est Univ, H Mondor Hosp, AP HP, Dept Neuroradiol, F-94010 Creteil, France; [Luciani, Alain; Rahmouni, Alain] Paris Est Univ, H Mondor Hosp, AP HP, Dept Med Imaging, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Van Der Gucht, A (corresponding author), Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, F-94010 Creteil, France.	axel.vandergucht@gmail.com	Sbidian, Emilie/ABH-5714-2020; Luciani, Alain/U-1429-2018	Itti, Emmanuel/0000-0003-1578-4058; Van Der Gucht, Axel/0000-0002-2060-4210; Ortonne, Nicolas/0000-0003-0111-7422				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Benz MR, 2010, J NUCL MED, V51, P1174, DOI 10.2967/jnumed.109.074229; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Biehl KJ, 2006, J NUCL MED, V47, P1808; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Brenner W, 2006, EUR J NUCL MED MOL I, V33, P428, DOI 10.1007/s00259-005-0030-1; Chirindel A, 2015, J NUCL MED, V56, P379, DOI 10.2967/jnumed.114.142372; Choi ES, 2013, EUR J NUCL MED MOL I, V40, P1836, DOI 10.1007/s00259-013-2511-y; Chung HH, 2012, ANN SURG ONCOL, V19, P1966, DOI 10.1245/s10434-011-2153-x; Combemale P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085954; Derlin T, 2013, CLIN NUCL MED, V38, pE19, DOI 10.1097/RLU.0b013e318266ce84; Doorn P F, 1995, Eur J Surg Oncol, V21, P78, DOI 10.1016/S0748-7983(05)80073-3; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2008, ANN ONCOL, V19, P390, DOI 10.1093/annonc/mdm450; Ferner RE, 2002, CANCER RES, V62, P1573; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Im HJ, 2012, EUR J NUCL MED MOL I, V39, P39, DOI 10.1007/s00259-011-1936-4; Kanoun S, 2014, EUR J NUCL MED MOL I, V41, P1735, DOI 10.1007/s00259-014-2783-x; Karabatsou K, 2009, NEUROSURGERY, V65, pA160, DOI 10.1227/01.NEU.0000337597.18599.D3; Khiewvan B, 2014, EUR J NUCL MED MOL I, V41, P1756, DOI 10.1007/s00259-014-2756-0; La TH, 2009, INT J RADIAT ONCOL, V74, P1335, DOI 10.1016/j.ijrobp.2008.10.060; Larson Steven M., 1999, Clin Positron Imaging, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Matsumine A, 2009, J CANCER RES CLIN, V135, P891, DOI 10.1007/s00432-008-0523-y; Meignan M, 2014, EUR J NUCL MED MOL I, V41, P1113, DOI 10.1007/s00259-014-2705-y; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Salamon J, 2014, EUR RADIOL, V24, P405, DOI 10.1007/s00330-013-3020-x; Salamon J, 2013, EUR J NUCL MED MOL I, V40, P685, DOI 10.1007/s00259-012-2314-6; Sasanelli M, 2014, EUR J NUCL MED MOL I, V41, P2017, DOI 10.1007/s00259-014-2822-7; Sbidian E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-51; Sbidian E, 2010, J INVEST DERMATOL, V130, P2173, DOI 10.1038/jid.2010.100; Duong TA, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-18; Tubiana M, 2009, RADIOLOGY, V251, P13, DOI 10.1148/radiol.2511080671; Valeyrie-Allanore L, 2008, BRIT J DERMATOL, V158, P1008, DOI 10.1111/j.1365-2133.2008.08494.x; Warbey VS, 2009, EUR J NUCL MED MOL I, V36, P751, DOI 10.1007/s00259-008-1038-0; Wasa J, 2010, AM J ROENTGENOL, V194, P1568, DOI 10.2214/AJR.09.2724; Zhang H, 2013, ACAD RADIOL, V20, P32, DOI 10.1016/j.acra.2012.07.002	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151809	10.1371/journal.pone.0151809	http://dx.doi.org/10.1371/journal.pone.0151809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987124	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300133
J	Wu, XX; Ebine, K; Ueda, T; Qiu, QS				Wu, Xuexia; Ebine, Kazuo; Ueda, Takashi; Qiu, Quan-Sheng			AtNHX5 and AtNHX6 Are Required for the Subcellular Localization of the SNARE Complex That Mediates the Trafficking of Seed Storage Proteins in Arabidopsis	PLOS ONE			English	Article							VACUOLAR SORTING RECEPTOR; GOLGI-APPARATUS; CATION/H+ ANTIPORTERS; NA+/H+ ANTIPORTERS; MEMBRANE-PROTEIN; EMERGING ROLES; ACID-RESIDUES; PLANT-GROWTH; H+-ATPASE; PH	The SNARE complex composed of VAMP727, SYP22, VTI11 and SYP51 is critical for protein trafficking and PSV biogenesis in Arabidopsis. This SNARE complex directs the fusion between the prevacuolar compartment (PVC) and the vacuole, and thus mediates protein trafficking to the vacuole. In this study, we examined the role of AtNHX5 and AtNHX6 in regulating this SNARE complex and its function in protein trafficking. We found that AtNHX5 and AtNHX6 were required for seed production, protein trafficking and PSV biogenesis. We further found that the nhx5 nhx6 syp22 triple mutant showed severe defects in seedling growth and seed development. The triple mutant had short siliques and reduced seed sets, but larger seeds. In addition, the triple mutant had numerous smaller protein storage vacuoles (PSVs) and accumulated precursors of the seed storage proteins in seeds. The PVC localization of SYP22 and VAMP727 was repressed in nhx5 nhx6, while a significant amount of SYP22 and VAMP727 was trapped in the Golgi or TGN in nhx5 nhx6. AtNHX5 and AtNHX6 were co-localized with SYP22 and VAMP727. Three conserved acidic residues, D164, E188, and D193 in AtNHX5 and D165, E189, and D194 in AtNHX6, were essential for the transport of the storage proteins, indicating the importance of exchange activity in protein transport. AtNHX5 or AtNHX6 did not interact physically with the SNARE complex. Taken together, AtNHX5 and AtNHX6 are required for the PVC localization of the SNARE complex and hence its function in protein transport. AtNHX5 and AtNHX6 may regulate the subcellular localization of the SNARE complex by their transport activity.	[Wu, Xuexia; Qiu, Quan-Sheng] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 73000, Gansu, Peoples R China; [Ebine, Kazuo; Ueda, Takashi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Ueda, Takashi] Japan Sci & Technol Agcy JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Lanzhou University; University of Tokyo; Japan Science & Technology Agency (JST)	Qiu, QS (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 73000, Gansu, Peoples R China.	qiuqsh@lzu.edu.cn	Ueda, Takashi/G-6984-2011	Ueda, Takashi/0000-0002-5190-892X; ebine, kazuo/0000-0003-3020-7208	National Basic Research Program of China (973 project) [2013CB429904]; National Natural Science Foundation of China (NSFC) [31070222, 31371438, 31571464]; Doctoral Fund of Ministry of Education of China (RFDP) [20130211110001]; Fundamental Research Funds for the Central Universities [lzujbky-2013-k10]	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China (RFDP); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program of China (973 project, 2013CB429904 to QSQ), National Natural Science Foundation of China (NSFC, 31070222 to QSQ), National Natural Science Foundation of China (NSFC, 31371438 to QSQ), National Natural Science Foundation of China (NSFC, 31571464 to QSQ), Doctoral Fund of Ministry of Education of China (RFDP, 20130211110001 to QSQ), Fundamental Research Funds for the Central Universities (lzujbky-2013-k10 to QSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashnest JR, 2015, PLANT CELL PHYSIOL, V56, P2220, DOI 10.1093/pcp/pcv138; Bassham DC, 2000, CURR OPIN CELL BIOL, V12, P491, DOI 10.1016/S0955-0674(00)00121-6; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; BOSS WF, 1984, EUR J CELL BIOL, V34, P1; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chanroj S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00025; CHRISPEELS MJ, 1983, PLANTA, V158, P140, DOI 10.1007/BF00397707; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Dibrov P, 1998, BIOCHEMISTRY-US, V37, P8282, DOI 10.1021/bi9801457; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Fuji K, 2007, PLANT CELL, V19, P597, DOI 10.1105/tpc.106.045997; Hara-Nishimura I, 1998, PLANT CELL, V10, P825, DOI 10.1105/tpc.10.5.825; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Herman EM, 1999, PLANT CELL, V11, P601, DOI 10.1105/tpc.11.4.601; Hillmer S, 2001, J CELL BIOL, V152, P41, DOI 10.1083/jcb.152.1.41; Hinz G, 1999, PLANT CELL, V11, P1509, DOI 10.1105/tpc.11.8.1509; Hohl I, 1996, J CELL SCI, V109, P2539; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jiang LW, 2000, J CELL BIOL, V150, P755, DOI 10.1083/jcb.150.4.755; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Kang H, 2012, PLANT CELL, V24, P5058, DOI 10.1105/tpc.112.103481; KIRSCH T, 1994, P NATL ACAD SCI USA, V91, P3403, DOI 10.1073/pnas.91.8.3403; Lee Y, 2013, PLANT PHYSIOL, V161, P121, DOI 10.1104/pp.112.210914; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Martiniere A, 2013, PLANT CELL, V25, P4028, DOI 10.1105/tpc.113.116897; Matsuoka K, 1997, PLANT CELL, V9, P533; MATSUOKA K, 1990, J BIOL CHEM, V265, P19750; Nishizawa K, 2003, PLANT J, V34, P647, DOI 10.1046/j.1365-313X.2003.01754.x; Ohtomo I, 2005, PLANT CELL PHYSIOL, V46, P1358, DOI 10.1093/pcp/pci146; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Otegui MS, 2008, TRAFFIC, V9, P1589, DOI 10.1111/j.1600-0854.2008.00787.x; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Park M, 2005, J CELL BIOL, V170, P757, DOI 10.1083/jcb.200504112; Park M, 2004, PLANT PHYSIOL, V134, P625, DOI 10.1104/pp.103.030635; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Qiu QS, 2012, J INTEGR PLANT BIOL, V54, P66, DOI 10.1111/j.1744-7909.2012.01097.x; Reguera M, 2015, PLANT CELL, V27, P1200, DOI 10.1105/tpc.114.135699; Reguera M, 2014, MOL PLANT, V7, P261, DOI 10.1093/mp/sst091; Richter S, 2009, TRAFFIC, V10, P819, DOI 10.1111/j.1600-0854.2009.00916.x; Robinson DG, 2005, TRAFFIC, V6, P615, DOI 10.1111/j.1600-0854.2005.00303.x; Schumacher K, 2014, CURR OPIN PLANT BIOL, V22, P71, DOI 10.1016/j.pbi.2014.09.005; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shimada T, 1997, PLANT CELL PHYSIOL, V38, P1414, DOI 10.1093/oxfordjournals.pcp.a029138; Shimada T, 2003, P NATL ACAD SCI USA, V100, P16095, DOI 10.1073/pnas.2530568100; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Sohn EJ, 2007, P NATL ACAD SCI USA, V104, P18801, DOI 10.1073/pnas.0708236104; Toyooka K, 2000, J CELL BIOL, V148, P453, DOI 10.1083/jcb.148.3.453; Uemura T, 2010, PLANT J, V64, P864, DOI 10.1111/j.1365-313X.2010.04372.x; Vitale A, 2005, TRENDS PLANT SCI, V10, P316, DOI 10.1016/j.tplants.2005.05.001; Wang LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118553; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zouhar J, 2010, PLANT J, V64, P577, DOI 10.1111/j.1365-313X.2010.04349.x	62	29	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151658	10.1371/journal.pone.0151658	http://dx.doi.org/10.1371/journal.pone.0151658			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986836	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300106
J	Zhao, YY; Wang, N; Liu, WH; Tao, WJ; Liu, LL; Shen, ZD				Zhao, Yan-Yan; Wang, Ning; Liu, Wan-Hui; Tao, Wen-Jie; Liu, Li-Li; Shen, Zhen-Duo			Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; BEVACIZUMAB; HETEROGENEITY; COMBINATION; BIODISTRIBUTION; ELECTROPHORESIS; SEPARATION; THERAPY; ASSAY	The similarity between a proposed biosimilar product and the reference product can be affected by many factors. This study is designed to examine whether any subtle difference in the distribution of the charge variants of an Avastin biosimilar can affect its in vitro potency and in vivo PK. Here, the acidic, basic and main peak fractions of a biosimilar product were isolated using high-performance cation-exchange chromatography and were subjected to various studies to compare their in vitro properties and in vivo PK profile. A serial of analytical methods, including size exclusion chromatography (SEC), imaged capillary isoelectric focusing (icIEF) capillary zone electrophoresis (CZE) and cation-exchange chromatography (CEX-HPLC) were also used to characterize the isolated charge variants. The kinetics constant was measured using a Biacore X100 system. The study indicates the biosimilar product has a high similarity with avastin in physicochemical properties. The potency in vitro and PK profile in rat of charge variants and biosimilar product are consistent with avastin.	[Zhao, Yan-Yan; Wang, Ning; Liu, Wan-Hui] Yantai Univ, Key Lab Mol Pharmacol & Drug Evaluat, Minist Educ,Sch Pharm, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Yantai 264005, Peoples R China; [Zhao, Yan-Yan; Liu, Wan-Hui; Tao, Wen-Jie; Liu, Li-Li; Shen, Zhen-Duo] Luye Pharma Grp Ltd, State Key Lab Long Acting & Targeting Drug Delive, Yantai 264005, Peoples R China	Yantai University	Liu, WH (corresponding author), Yantai Univ, Key Lab Mol Pharmacol & Drug Evaluat, Minist Educ,Sch Pharm, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Yantai 264005, Peoples R China.; Liu, WH (corresponding author), Luye Pharma Grp Ltd, State Key Lab Long Acting & Targeting Drug Delive, Yantai 264005, Peoples R China.	wanhuiliu@ytu.edu.cn	zhao, yan/GWC-9174-2022					Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Breen ED, 2001, PHARMACEUT RES, V18, P1345, DOI 10.1023/A:1013054431517; Christiansen J, 2004, MOL CANCER THER, V3, P1493; Dhillon S, 2013, BIODRUGS, V27, P375, DOI 10.1007/s40259-013-0043-4; Dou P, 2008, J CHROMATOGR A, V1190, P372, DOI 10.1016/j.chroma.2008.03.001; Espinosa-de la Garza CE, 2013, ELECTROPHORESIS, V34, P1133, DOI 10.1002/elps.201200575; Falcao M, 2007, ACTA OPHTHALMOLOGICA, V85; Fekete S, 2013, TRAC-TREND ANAL CHEM, V42, P74, DOI 10.1016/j.trac.2012.09.012; Gangopadhyay A, 1996, NUCL MED BIOL, V23, P257, DOI 10.1016/0969-8051(95)02057-8; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Guelat B, 2012, J CHROMATOGR A, V1253, P32, DOI 10.1016/j.chroma.2012.06.081; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Heng S, 2015, ANAL BIOCHEM, V475, P14, DOI 10.1016/j.ab.2014.12.012; Hong G, 1999, J PHARM SCI, V88, P147, DOI 10.1021/js970335n; Inoue S, 2007, MOL THER, V15, P287, DOI 10.1038/sj.mt.6300035; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kaschak T, 2011, MABS-AUSTIN, V3, P577, DOI 10.4161/mabs.3.6.17959; Khawli LA, 2002, CANCER BIOTHER RADIO, V17, P359, DOI 10.1089/108497802760363150; Khawli LA, 2010, MABS-AUSTIN, V2, P613, DOI 10.4161/mabs.2.6.13333; Kiyoshi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087099; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lau H, 2010, J CHROMATOGR B, V878, P868, DOI 10.1016/j.jchromb.2010.02.003; Linke T, 2012, J CHROMATOGR A, V1260, P120, DOI 10.1016/j.chroma.2012.08.061; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Liu YM, 2014, INVEST NEW DRUG, V32, P851, DOI 10.1007/s10637-014-0129-y; Mabry R, 2005, INFECT IMMUN, V73, P8362, DOI 10.1128/IAI.73.12.8362-8368.2005; Michels D., 2011, BIOPROCESS INT, V9, P48; Moorhouse KG, 1997, J PHARMACEUT BIOMED, V16, P593, DOI 10.1016/S0731-7085(97)00178-7; Presta LG, 1997, CANCER RES, V57, P4593; Putnam WS, 2010, TRENDS BIOTECHNOL, V28, P509, DOI 10.1016/j.tibtech.2010.07.001; RODWELL JD, 1986, P NATL ACAD SCI USA, V83, P2632, DOI 10.1073/pnas.83.8.2632; Rustandi RR, 2014, ELECTROPHORESIS, V35, P1072, DOI 10.1002/elps.201300422; Sosic Z, 2008, ELECTROPHORESIS, V29, P4368, DOI 10.1002/elps.200800157; Suzuki H, 2013, MOL CLIN ONCOL, V1, P480, DOI 10.3892/mco.2013.82; Tangarone B, 2008, IBC 12 WELL CHAR BIO; Teshima G, 2011, J CHROMATOGR A, V1218, P2091, DOI 10.1016/j.chroma.2010.10.107; Tinsley J, 2015, J CLIN PHARMACOL, V55, P698, DOI 10.1002/jcph.468; Tsimberidou AM, 2014, J NATL COMPR CANC NE, V12, P194, DOI 10.6004/jnccn.2014.0020; Vlasak J, 2008, CURR PHARM BIOTECHNO, V9, P468, DOI 10.2174/138920108786786402; Wacker C, 2011, EUR J PHARM BIOPHARM, V79, P503, DOI 10.1016/j.ejpb.2011.06.010; Wang Yaning, 2004, Angiogenesis, V7, P335, DOI 10.1007/s10456-004-8272-2; Warnke C, 2013, MULT SCLER J, V19, P1137, DOI 10.1177/1352458513475489; Zhang T, 2011, J CHROMATOGR A, V1218, P5079, DOI 10.1016/j.chroma.2011.05.061; Zhao SS, 2014, ELECTROPHORESIS, V35, P96, DOI 10.1002/elps.201300372	45	20	25	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151874	10.1371/journal.pone.0151874	http://dx.doi.org/10.1371/journal.pone.0151874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987122	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300145
J	Kabilova, TO; Sen'kova, AV; Nikolin, VP; Popova, NA; Zenkova, MA; Vlassov, VV; Chernolovskaya, EL				Kabilova, Tatyana O.; Sen'kova, Aleksandra V.; Nikolin, Valeriy P.; Popova, Nelly A.; Zenkova, Marina A.; Vlassov, Valentin V.; Chernolovskaya, Elena L.			Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INTERFERON-PRODUCTION; ADAPTIVE IMMUNITY; REFRACTORY STATE; SIRNA DELIVERY; IFN-ALPHA; IN-VIVO; CELLS; INNATE; 5'-TRIPHOSPHATE-SIRNA	Small interfering RNAs, depending on their structure, delivery system and sequence, can stimulate innate and adaptive immunity. The aim of this study was to investigate the antitumor and antimetastatic effects of immunostimulatory 19-bp dsRNA with 3'-trinucleotide overhangs (isRNA) on melanoma B16 in C57Bl/6 mice. Recently developed novel cationic lipo-somes 2X3-DOPE were used for the in vivo delivery of isRNA. Administration of isRNA/2X3-DOPE complexes significantly inhibits melanoma tumor growth and metastasis. Histopathological analysis of spleen cross sections showed hyperplasia of the lymphoid white pulp and formation of large germinal centers after isRNA/2X3-DOPE administration, indicating activation of the immune system. The treatment of melanoma-bearing mice with isRNA/2X3-DOPE decreases the destructive changes in the liver parenchyma. Thus, the developed isRNA displays pronounced immunostimulatory, antitumor and antimetastatic properties against melanoma B16 and may be considered a potential agent in the immunotherapy of melanoma.	[Kabilova, Tatyana O.; Sen'kova, Aleksandra V.; Zenkova, Marina A.; Vlassov, Valentin V.; Chernolovskaya, Elena L.] Inst Chem Biol & Fundamental Med SB RAS, 8 Lavrentiev Ave, Novosibirsk 630090, Russia; [Nikolin, Valeriy P.; Popova, Nelly A.] Inst Cytol & Genet SB RAS, 10 Lavrentiev Ave, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Chernolovskaya, EL (corresponding author), Inst Chem Biol & Fundamental Med SB RAS, 8 Lavrentiev Ave, Novosibirsk 630090, Russia.	elena_ch@niboch.nsc.ru	Zenkova, Marina A/G-5088-2013; Zenkova, Marina A./H-4666-2014; Kabilova, Tatyana/G-3494-2013; Vlassov, Valentin/F-4720-2013	Vlassov, Valentin/0000-0003-2845-2992; Zenkova, Marina/0000-0003-4044-1049	Russian Academy of Science [22-1, 44]; Russian Foundation for Basic Research [13-04-40181-H]; grant of Scientific Schools [1350.2014.4]	Russian Academy of Science(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); grant of Scientific Schools	This research was supported by the Russian Academy of Science under the programs "Molecular and Cellular Biology" (no. 22-1), "Science to Medicine" (no. 44) and "Nanostructures: Physics, Chemistry, Biology, Technology"; by the Russian Foundation for Basic Research (no. 13-04-40181-H); by the grant of Scientific Schools (no. 1350.2014.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Russian Academy of Science under the programs "Molecular and Cellular Biology" (no. 22-1), "Science to Medicine" (no. 44) and "Nanostructures: Physics, Chemistry, Biology, Technology"; by the Russian Foundation for Basic Research (no. 13-04-40181-H); by the grant of Scientific Schools (no. 1350.2014.4).	Adams S, 2009, IMMUNOTHERAPY-UK, V1, P949, DOI [10.2217/imt.09.70, 10.2217/IMT.09.70]; Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; BORDEN EC, 1971, J IMMUNOL, V106, P134; Braun FCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135444; Brown L, 2006, SURGERY, V140, P297, DOI 10.1016/j.surg.2006.05.005; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chang CI, 2011, NUCLEIC ACID THER, V21, P149, DOI 10.1089/nat.2011.0296; Chen XJ, 2013, EUR J PHARMACOL, V721, P86, DOI 10.1016/j.ejphar.2013.09.050; Currie AJ, 2008, J IMMUNOL, V180, P1535, DOI 10.4049/jimmunol.180.3.1535; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Du HY, 2012, ACTA PHARMACOL SIN, V33, P1047, DOI 10.1038/aps.2012.54; Eggert T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112717; Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117; Gantier MP, 2010, MOL THER, V18, P785, DOI 10.1038/mt.2010.4; Gantier MP, 2009, NAT BIOTECHNOL, V27, P911, DOI 10.1038/nbt1009-911; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111920; Jiang G, 2011, BIOCHEM BIOPH RES CO, V406, P311, DOI 10.1016/j.bbrc.2011.02.042; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kabilova TO, 2011, DOKL BIOCHEM BIOPHYS, V436, P8, DOI 10.1134/S1607672911010042; Kabilova TO, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-338; Kabilova TO, 2012, NUCLEIC ACID THER, V22, P196, DOI 10.1089/nat.2011.0328; Kariko K, 2004, CELLS TISSUES ORGANS, V177, P132, DOI 10.1159/000079987; Khairuddin N, 2012, IMMUNOL CELL BIOL, V90, P187, DOI 10.1038/icb.2011.19; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Latifynia A, 2010, J MICROBIOL IMMUNOL, V43, P138, DOI 10.1016/S1684-1182(10)60022-9; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Markov OO, 2012, J CONTROL RELEASE, V160, P200, DOI 10.1016/j.jconrel.2011.11.034; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Maslov MA, 2012, J CONTROL RELEASE, V160, P182, DOI 10.1016/j.jconrel.2011.11.023; McBride S, 2006, J IMMUNOL, V177, P6122, DOI 10.4049/jimmunol.177.9.6122; Mitchell MS, 2003, INT IMMUNOPHARMACOL, V3, P1051, DOI 10.1016/S1567-5769(03)00019-5; Najar HM, 2008, J INVEST DERMATOL, V128, P2204, DOI 10.1038/jid.2008.59; Olejniczak M, 2012, RNA, V18, P930, DOI 10.1261/rna.025627.110; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Prins RM, 2006, J IMMUNOL, V176, P157, DOI 10.4049/jimmunol.176.1.157; Puthenveetil S, 2006, NUCLEIC ACIDS RES, V34, P4900, DOI 10.1093/nar/gkl464; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; ROUSSET S, 1974, J GEN VIROL, V22, P9, DOI 10.1099/0022-1317-22-1-9; Sajeesh S, 2014, MOL PHARMACEUT, V11, P872, DOI 10.1021/mp400541z; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sasse AD, 2007, COCHRANE DB SYST REV, V1, P1; Sen'kova AV, 2014, BIOCHIMIE, V101, P256, DOI 10.1016/j.biochi.2014.02.006; Sharma S, 2003, BIOTECHNOL LETT, V25, P149, DOI 10.1023/A:1021927621813; Shin D, 2007, BIOCHEM BIOPH RES CO, V364, P436, DOI 10.1016/j.bbrc.2007.10.012; Stewart CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021552; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Wang K, 2013, J IMMUNOTHER, V36, P294, DOI 10.1097/CJI.0b013e318294183b; Zhang QF, 2013, BLOOD, V121, P1304, DOI 10.1182/blood-2012-07-442590; Zhang ZR, 2006, J CELL BIOCHEM, V97, P1217, DOI 10.1002/jcb.20716	55	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150751	10.1371/journal.pone.0150751	http://dx.doi.org/10.1371/journal.pone.0150751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981617	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900051
J	Mugge, W; Kuling, IA; Brenner, E; Smeets, JBJ				Mugge, Winfred; Kuling, Irene A.; Brenner, Eli; Smeets, Jeroen B. J.			Haptic Guidance Needs to Be Intuitive Not Just Informative to Improve Human Motor Accuracy	PLOS ONE			English	Article							SHARED CONTROL; PERFORMANCE; MOVEMENTS; SHOULDER; FEEDBACK; INTEGRATION; TORQUES	Humans make both random and systematic errors when reproducing learned movements. Intuitive haptic guidance that assists one to make the movements reduces such errors. Our study examined whether any additional haptic information about the location of the target reduces errors in a position reproduction task, or whether the haptic guidance needs to be assistive to do so. Holding a haptic device, subjects made reaches to visible targets without time constraints. They did so in a no-guidance condition, and in guidance conditions in which the direction of the force with respect to the target differed, but the force scaled with the distance to the target in the same way. We examined whether guidance forces directed towards the target would reduce subjects' errors in reproducing a prior position to the same extent as do forces rotated by 90 degrees or 180 degrees, as it might because the forces provide the same information in all three cases. Without vision of the arm, both the accuracy and precision were significantly better with guidance directed towards the target than in all other conditions. The errors with rotated guidance did not differ from those without guidance. Not surprisingly, the movements tended to be faster when guidance forces directed the reaches to the target. This study shows that haptic guidance significantly improved motor performance when using it was intuitive, while non-intuitively presented information did not lead to any improvements and seemed to be ignored even in our simple paradigm with static targets and no time constraints.	[Mugge, Winfred; Kuling, Irene A.; Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Mugge, W (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	w.mugge@vu.nl	Kuling, Irene/ABC-4022-2021; Smeets, Jeroen/B-4198-2008	Kuling, Irene/0000-0003-3556-0393; Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO): STW grant [12160]	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO): STW grant	This research is part of the H-Haptics perspective program supported by the Dutch Technology Foundation STW (www.stw.nl), which is part of the Netherlands Organization for Scientific Research (NWO): STW grant 12160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank MotekForce Link for support using D-Flow and for developing the driver for interfacing the control software suite with the Phantom haptic device. This research is part of the H-Haptics perspective program supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO): STW grant 12160.	Abbink DA, 2012, COGN TECHNOL WORK, V14, P19, DOI 10.1007/s10111-011-0192-5; Aisen ML, 1997, ARCH NEUROL-CHICAGO, V54, P443, DOI 10.1001/archneur.1997.00550160075019; Boessenkool H, 2013, IEEE T HAPTICS, V6, P2, DOI [10.1109/ToH.2012.22, 10.1109/TOH.2012.22]; CORDO PJ, 1989, TRENDS NEUROSCI, V12, P110, DOI 10.1016/0166-2236(89)90167-7; Draper JV, 1987, P INT TOP M REM SYST; Dvorkin AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-92; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Griffiths PG, 2005, HUM FACTORS, V47, P574, DOI 10.1518/001872005774859944; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; HANNAFORD B, 1991, IEEE T SYST MAN CYB, V21, P620, DOI 10.1109/21.97455; Hesse S, 2003, ARCH PHYS MED REHAB, V84, P915, DOI 10.1016/S0003-9993(02)04954-7; Heuer H, 2014, EXP BRAIN RES, V232, P2229, DOI 10.1007/s00221-014-3914-0; Heuer H, 2014, EXP BRAIN RES, V232, P675, DOI 10.1007/s00221-013-3775-y; Heuer H, 2011, EXP BRAIN RES, V211, P97, DOI 10.1007/s00221-011-2656-5; Kuling IA, 2015, EXP BRAIN RES, V233, P61, DOI 10.1007/s00221-014-4086-7; Kuling IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074236; Kurtzer I, 2009, J NEUROPHYSIOL, V102, P3004, DOI 10.1152/jn.00453.2009; Lynch D, 2005, CLIN REHABIL, V19, P594, DOI 10.1191/0269215505cr901oa; Mars F, 2014, IEEE T HAPTICS, V7, P324, DOI 10.1109/TOH.2013.2295095; Massimino M. J., 1989, P NASA C SPAC ROB, P89; Mulder M, 2012, HUMAN FACTORS J HUMA, V54, P681; Mulder M, 2008, IEEE SYS MAN CYBERN, P804, DOI 10.1109/ICSMC.2008.4811377; Novakovic V, 2011, EXP BRAIN RES, V209, P425, DOI 10.1007/s00221-011-2573-7; O'Malley MK, 2006, J DYN SYST-T ASME, V128, P75, DOI 10.1115/1.2168160; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Rosenberg LB, 1993, P VIRT REAL ANN INT; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; SHERIDAN TB, 2002, HUMANS AUTOMATION SY; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Asseldonk EHF, 2009, J PHYSIOL-PARIS, V103, P276, DOI 10.1016/j.jphysparis.2009.08.010; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Vitense HS, 2003, ERGONOMICS, V46, P68, DOI 10.1080/00140130303534; Wildenbeest JGW, 2013, IEEE T HAPTICS, V6, P242, DOI [10.1109/ToH.2012.19, 10.1109/TOH.2012.19]; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; Wu HG, 2013, J NEUROSCI, V33, P10772, DOI 10.1523/JNEUROSCI.3761-12.2013	37	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150912	10.1371/journal.pone.0150912	http://dx.doi.org/10.1371/journal.pone.0150912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982481	Green Published, gold			2022-12-26	WOS:000372574900056
J	Bokkasam, H; Ott, A				Bokkasam, Harish; Ott, Albrecht			Information Limited Oligonucleotide Amplification Assay for Affinity-Based, Parallel Detection Studies	PLOS ONE			English	Article							NONSPECIFIC HYBRIDIZATION; MICROARRAY; DNA; POSITION; NUMBER; SIZE	Molecular communication systems encounter similar constraints as telecommunications. In either case, channel crosstalk at the receiver end will result in information loss that statistical analysis cannot compensate. This is because in any communication channel there is a physical limit to the amount of information that can be transmitted. We present a novel and simple modified end amplification (MEA) technique to generate reduced and defined amounts of specific information in form of short fragments from an oligonucleotide source that also contains unrelated and redundant information. Our method can be a valuable tool to investigate information overflow and channel capacity in biomolecular recognition systems.	[Bokkasam, Harish; Ott, Albrecht] Univ Saarland, Inst Biol Expt Phys, D-66123 Saarbrucken, Germany	Saarland University	Ott, A (corresponding author), Univ Saarland, Inst Biol Expt Phys, D-66123 Saarbrucken, Germany.	albrecht.ott@uni-saarland.de			Deutsche Forschungsgemeinschaft (DFG) graduate college [GRK 1276]; collaborative research center "Physical Modeling of non-Equilibrium Processes in Biological Systems" [SFB 1027]	Deutsche Forschungsgemeinschaft (DFG) graduate college(German Research Foundation (DFG)); collaborative research center "Physical Modeling of non-Equilibrium Processes in Biological Systems"	The authors gratefully acknowledge the financial support provided by Deutsche Forschungsgemeinschaft (DFG) graduate college (GRK 1276) "Structure Formation and Transport in Complex Systems" and the collaborative research center (SFB 1027) "Physical Modeling of non-Equilibrium Processes in Biological Systems". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhanot G, 2003, BIOPHYS J, V84, P124, DOI 10.1016/S0006-3495(03)74837-1; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Greiner O, 2004, ANAL BIOCHEM, V324, P197, DOI 10.1016/j.ab.2003.10.030; Harrison A, 2013, NUCLEIC ACIDS RES, V41, P2779, DOI 10.1093/nar/gks1358; Huang XZ, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0037-5; Itzkovitz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-239; Klur S, 2004, GENOMICS, V83, P508, DOI 10.1016/j.ygeno.2003.09.005; Letowski J, 2004, J MICROBIOL METH, V57, P269, DOI 10.1016/j.mimet.2004.02.002; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Mehlmann M, 2005, ANAL BIOCHEM, V347, P316, DOI 10.1016/j.ab.2005.09.036; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Naiser T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-509; Pierce KE, 2007, METHODS MOL MED, P65, DOI [10.1007/978-1-59745-298-4_7, DOI 10.1007/978-1-59745-298-4_7]; Pozhitkov AE, 2008, J MICROBIOL METH, V75, P92, DOI 10.1016/j.mimet.2008.05.013; Riva A, 2005, COMPUT BIOL CHEM, V29, P319, DOI 10.1016/j.compbiolchem.2005.08.006; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schneider TD, 2000, NUCLEIC ACIDS RES, V28, P2794, DOI 10.1093/nar/28.14.2794; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Tarca AL, 2006, AM J OBSTET GYNECOL, V195, P373, DOI 10.1016/j.ajog.2006.07.001; Trapp C, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-20	20	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151072	10.1371/journal.pone.0151072	http://dx.doi.org/10.1371/journal.pone.0151072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978653	gold, Green Published, Green Submitted			2022-12-26	WOS:000372572800046
J	Nierat, MC; Demiri, S; Dupuis-Lozeron, E; Allali, G; Morelot-Panzini, C; Similowski, T; Adler, D				Nierat, Marie-Cecile; Demiri, Suela; Dupuis-Lozeron, Elise; Allali, Gilles; Morelot-Panzini, Capucine; Similowski, Thomas; Adler, Dan			When Breathing Interferes with Cognition: Experimental Inspiratory Loading Alters Timed Up-and-Go Test in Normal Humans	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; WALKING-WHILE-TALKING; MOTOR IMAGERY; ELECTROENCEPHALOGRAPHIC EVIDENCE; PREMOTOR POTENTIALS; SELF-CONSCIOUSNESS; CORTEX ACTIVATION; GAIT VARIABILITY; DISORDERS; FMRI	Human breathing stems from automatic brainstem neural processes. It can also be operated by cortico-subcortical networks, especially when breathing becomes uncomfortable because of external or internal inspiratory loads. How the "irruption of breathing into consciousness" interacts with cognition remains unclear, but a case report in a patient with defective automatic breathing (Ondine's curse syndrome) has shown that there was a cognitive cost of breathing when the respiratory cortical networks were engaged. In a pilot study of putative breathing-cognition interactions, the present study relied on a randomized design to test the hypothesis that experimentally loaded breathing in 28 young healthy subjects would have a negative impact on cognition as tested by "timed up-and-go" test (TUG) and its imagery version (iTUG). Progressive inspiratory threshold loading resulted in slower TUG and iTUG performance. Participants consistently imagined themselves faster than they actually were. However, progressive inspiratory loading slowed iTUG more than TUG, a finding that is unexpected with regard to the known effects of dual tasking on TUG and iTUG (slower TUG but stable iTUG). Insofar as the cortical networks engaged in response to inspiratory loading are also activated during complex locomotor tasks requiring cognitive inputs, we infer that competition for cortical resources may account for the breathing-cognition interference that is evidenced here.	[Nierat, Marie-Cecile; Demiri, Suela; Morelot-Panzini, Capucine; Similowski, Thomas] UPMC Univ Paris 06, Univ Sorbonne, INSERM, Neurophysiol Resp Expt & Clin UMRS1158, Paris, France; [Dupuis-Lozeron, Elise; Adler, Dan] Univ Hosp Geneva, Div Pulm Dis, Geneva, Switzerland; [Dupuis-Lozeron, Elise; Allali, Gilles; Adler, Dan] Univ Geneva, Geneva, Switzerland; [Dupuis-Lozeron, Elise] Univ Geneva, Geneva Sch Econ & Management, Res Ctr Stat, Geneva, Switzerland; [Allali, Gilles] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Allali, Gilles] Albert Einstein Coll Med, Div Cognit & Motor Aging, Dept Neurol, Bronx, NY 10467 USA; [Morelot-Panzini, Capucine; Similowski, Thomas] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Dept R3S, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Geneva; University of Geneva; University of Geneva; University of Geneva; Yeshiva University; Albert Einstein College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Similowski, T (corresponding author), UPMC Univ Paris 06, Univ Sorbonne, INSERM, Neurophysiol Resp Expt & Clin UMRS1158, Paris, France.; Similowski, T (corresponding author), Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Dept R3S, F-75013 Paris, France.	thomas.similowski@psl.aphp.fr	Allali, Gilles/D-1500-2009	Allali, Gilles/0000-0002-4455-6719; Dupuis Lozeron, Elise/0000-0002-3300-1363	program "Investissement d'Avenir" of the French Government [ANR-10-AIHU 06]; Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil (ADOREPS), Paris, France; Centre d'Assistance Respiratoire a Domicile d'Ile-de-France (CARDIF), Fontenay-aux-Roses, France	program "Investissement d'Avenir" of the French Government; Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil (ADOREPS), Paris, France; Centre d'Assistance Respiratoire a Domicile d'Ile-de-France (CARDIF), Fontenay-aux-Roses, France	This work was supported by the program "Investissement d'Avenir ANR-10-AIHU 06" of the French Government, and the Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil (ADOREPS), Paris, France. Suela Demiri was the recipient of a research scholarship granted by the Centre d'Assistance Respiratoire a Domicile d'Ile-de-France (CARDIF), Fontenay-aux-Roses, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2014, RESP PHYSIOL NEUROBI, V203, P68, DOI 10.1016/j.resp.2014.08.003; Allali G, 2014, RESP PHYSIOL NEUROBI, V201, P31, DOI 10.1016/j.resp.2014.06.012; Allali G, 2012, EUR NEUROL, V67, P116, DOI 10.1159/000334394; Allali G, 2014, J GERONTOL A-BIOL, V69, P1389, DOI 10.1093/gerona/glt207; [Anonymous], 2002, AM J RESP CRIT CARE, V166, P518; Beauchet O, 2015, EXP GERONTOL, V61, P98, DOI 10.1016/j.exger.2014.11.002; Beauchet O, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-66; Beauchet O, 2014, DRUG AGING, V31, P363, DOI 10.1007/s40266-014-0175-3; Beauchet O, 2010, J NEUROL SCI, V294, P102, DOI 10.1016/j.jns.2010.03.021; Blumen HM, 2014, HUM BRAIN MAPP, V35, P4090, DOI 10.1002/hbm.22461; Bridenbaugh SA, 2013, AGING CLIN EXP RES, V25, P283, DOI 10.1007/s40520-013-0046-5; Celle S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-140; De Sanctis P, 2014, NEUROIMAGE, V94, P55, DOI 10.1016/j.neuroimage.2014.03.016; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Georges M, 2016, EUR RESP J IN PRESS, DOI [10.1183/13993003.01686-201, DOI 10.1183/13993003.01686-201]; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Kannape OA, 2012, INT J PSYCHOPHYSIOL, V83, P191, DOI 10.1016/j.ijpsycho.2011.12.006; Lahousse L, 2015, EUR RESPIR J, V46, P88, DOI 10.1183/09031936.00213214; Lallart E, 2012, PSYCHIAT RES, V198, P366, DOI 10.1016/j.psychres.2011.12.013; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Launois C, 2015, SLEEP, V38, P1743, DOI 10.5665/sleep.5156; Morawiec E, 2015, J APPL PHYSIOL, V118, P1023, DOI 10.1152/japplphysiol.00201.2014; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Peiffer C, 2001, AM J RESP CRIT CARE, V163, P951, DOI 10.1164/ajrccm.163.4.2005057; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raux M, 2007, ANESTHESIOLOGY, V107, P746, DOI 10.1097/01.anes.0000287005.58761.e8; Raux M, 2007, J PHYSIOL-LONDON, V578, P569, DOI 10.1113/jphysiol.2006.120246; Raux M, 2013, RESP PHYSIOL NEUROBI, V189, P571, DOI 10.1016/j.resp.2013.08.005; Raux M, 2010, RESP PHYSIOL NEUROBI, V171, P67, DOI 10.1016/j.resp.2010.01.002; Sharman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107850; Snijders AH, 2007, LANCET NEUROL, V6, P63, DOI 10.1016/S1474-4422(06)70678-0; Tremoureux L, 2014, RESP PHYSIOL NEUROBI, V204, P64, DOI 10.1016/j.resp.2014.06.018; Tremoureux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084534; Tremoureux L, 2010, J APPL PHYSIOL, V108, P1127, DOI 10.1152/japplphysiol.91449.2008; Vallabhajosula S, 2015, J BIOMECH, V48, P921, DOI 10.1016/j.jbiomech.2015.02.024; Wang CH, 2008, J NEURAL TRANSM, V115, P1149, DOI 10.1007/s00702-008-0058-z; Yuan J, 2015, HUM BRAIN MAPP, V36, P1484, DOI 10.1002/hbm.22717	37	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151625	10.1371/journal.pone.0151625	http://dx.doi.org/10.1371/journal.pone.0151625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978782	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800095
J	Reinisova, M; Plachy, J; Kucerova, D; Senigl, F; Vinkler, M; Hejnar, J				Reinisova, Marketa; Plachy, Jiri; Kucerova, Dana; Senigl, Filip; Vinkler, Michal; Hejnar, Jiri			Genetic Diversity of NHE1, Receptor for Subgroup J Avian Leukosis Virus, in Domestic Chicken and Wild Anseriform Species	PLOS ONE			English	Article							BROILER BREEDER CHICKENS; ROUS-SARCOMA VIRUS; DECREASED SUSCEPTIBILITY; HOST-RANGE; INFECTION; TVA; RETROVIRUSES; TRANSMISSION; GLYCOPROTEIN; BINDING	J subgroup avian leukosis virus (ALV-J) infects domestic chicken, jungle fowl, and turkey and enters the host cell through a receptor encoded by tvj locus and identified as Na+/H+ exchanger 1 (NHE1). The resistance to ALV-J in a great majority of examined galliform species was explained by deletions or substitutions of the critical tryptophan 38 in the first extracellular loop of NHE1, and genetic polymorphisms around this site predict the susceptibility or resistance of a given species or individual. In this study, we examined the NHE1 polymorphism in domestic chicken breeds and documented quantitative differences in their susceptibility to ALV-J in vitro. In a panel of chicken breeds assembled with the aim to cover the maximum variability encountered in domestic chickens, we found a completely uniform sequence of NHE1 extracellular loop 1 (ECL1) without any source of genetic variation for the selection of ALV-J-resistant poultry. In parallel, we studied the natural polymorphisms of NHE1 in wild ducks and geese because of recent reports on ALV-J positivity in feral Asian species. In anseriform species, we demonstrate a specific and highly conserved critical ECL1 sequence without any homologue of tryptophan 38 in accordance with the resistance of duck cells to prototype ALV-J. Last, we demonstrated that the new Asian strains of ALV-J have not evolved their envelope glycoprotein to the entry the duck cells. Our results contribute substantially to the current discussion of possible heterotransmission of ALV-J and its spill-over into the wild ducks and geese.	[Reinisova, Marketa; Plachy, Jiri; Kucerova, Dana; Senigl, Filip; Hejnar, Jiri] Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CZ-14220 Prague 4, Czech Republic; [Vinkler, Michal] Charles Univ Prague, Fac Sci, Dept Zool, CZ-12844 Vinicna 7 2, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague	Hejnar, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	hejnar@img.cas.cz	Vinkler, Michal/G-2072-2011	Vinkler, Michal/0000-0003-3572-9494	Czech Science Foundation [13-309835-P502, P502/12/P179]; NPU [I: LO1419];  [RVO: 68378050]	Czech Science Foundation(Grant Agency of the Czech Republic); NPU; 	This research was supported by the Czech Science Foundation, project No. 13-309835-P502. M. V. was supported by the Czech Science Foundation grant No. P502/12/P179. The work was also institutionally supported by RVO: 68378050 and NPU I: LO1419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI J, 1995, J VIROL, V69, P779, DOI 10.1128/JVI.69.2.779-784.1995; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Benson SJ, 1998, J VIROL, V72, P10157, DOI 10.1128/JVI.72.12.10157-10164.1998; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; Chai N, 2006, P NATL ACAD SCI USA, V103, P5531, DOI 10.1073/pnas.0509785103; Chesters PM, 2001, J VIROL, V75, P4219, DOI 10.1128/JVI.75.9.4219-4225.2001; Elleder D, 2005, J VIROL, V79, P10408, DOI 10.1128/JVI.79.16.10408-10419.2005; Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110; Gingerich E, 2002, AVIAN DIS, V46, P745, DOI 10.1637/0005-2086(2002)046[0745:DOMLIB]2.0.CO;2; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Jiang LL, 2014, ARCH VIROL, V159, P1821, DOI 10.1007/s00705-014-2004-8; Kucerova D, 2013, J VIROL, V87, P8399, DOI 10.1128/JVI.03180-12; Liu CN, 2011, AVIAN PATHOL, V40, P269, DOI 10.1080/03079457.2011.560932; Lupiani B, 2006, AVIAN DIS, V50, P572, DOI 10.1637/7656-053006R.1; Malhotra S., 2015, Genome Announcements, V3, pe01586; NEHYBA J, 1990, J GEN VIROL, V71, P1937, DOI 10.1099/0022-1317-71-9-1937; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995; Plachy J, 2000, FOLIA BIOL-PRAGUE, V46, P17; Reinisova M, 2008, J VIROL, V82, P2097, DOI 10.1128/JVI.02206-07; Reinisova M, 2012, J VIROL, V86, P2021, DOI 10.1128/JVI.05771-11; Rong LJ, 1998, J VIROL, V72, P4552, DOI 10.1128/JVI.72.6.4552-4559.1998; Shen YW, 2014, J GEN VIROL, V95, P691, DOI 10.1099/vir.0.059915-0; Silva RF, 2000, VIROLOGY, V272, P106, DOI 10.1006/viro.2000.0352; Stepanets V, 2001, AVIAN PATHOL, V30, P33, DOI 10.1080/03079450020023177; Venugopal K, 2000, AVIAN PATHOL, V29, P497, DOI 10.1080/030794500750047252; Venugopal K, 1999, RES VET SCI, V67, P113, DOI 10.1053/rvsc.1998.0283; Witter RL, 2001, AVIAN PATHOL, V30, P641, DOI 10.1080/03079450120092134; Witter RL, 2000, AVIAN DIS, V44, P913, DOI 10.2307/1593066; Zeng XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094980; Zingler K, 1996, J VIROL, V70, P7510, DOI 10.1128/JVI.70.11.7510-7516.1996	32	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150589	10.1371/journal.pone.0150589	http://dx.doi.org/10.1371/journal.pone.0150589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978658	gold, Green Submitted, Green Published			2022-12-26	WOS:000372572800030
J	Schrutka, L; Goliasch, G; Meyer, B; Wurm, R; Koller, L; Kriechbaumer, L; Heinz, G; Pacher, R; Lang, IM; Distelmaier, K; Hulsmann, M				Schrutka, Lore; Goliasch, Georg; Meyer, Brigitte; Wurm, Raphael; Koller, Lorenz; Kriechbaumer, Lukas; Heinz, Gottfried; Pacher, Richard; Lang, Irene M.; Distelmaier, Klaus; Huelsmann, Martin			Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill Patients	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; APOLIPOPROTEIN-A-I; LONG-TERM SURVIVAL; OXIDATIVE STRESS; CARDIAC-SURGERY; HDL; SUPPLEMENTATION; METABOLISM; ACTIVATION; CAPACITY	Introduction Oxidative stress affects clinical outcome in critically ill patients. Although high-density lipoprotein (HDL) particles generally possess anti-oxidant capacities, deleterious properties of HDL have been described in acutely ill patients. The impact of anti-oxidant HDL capacities on clinical outcome in critically ill patients is unknown. We therefore analyzed the predictive value of anti-oxidant HDL function on mortality in an unselected cohort of critically ill patients. Method We prospectively enrolled 270 consecutive patients admitted to a university-affiliated intensive care unit (ICU) and determined anti-oxidant HDL function using the HDL oxidant index (HOI). Based on their HOI, the study population was stratified into patients with impaired anti-oxidant HDL function and the residual study population. Results During a median follow-up time of 9.8 years (IQR: 9.2 to 10.0), 69% of patients died. Cox regression analysis revealed a significant and independent association between impaired antioxidant HDL function and short-term mortality with an adjusted HR of 1.65 (95% CI 1.22-2.24; p = 0.001) as well as 10-year mortality with an adj. HR of 1.19 (95% CI 1.02-1.40; p = 0.032) when compared to the residual study population. Anti-oxidant HDL function correlated with the amount of oxidative stress as determined by Cu/Zn superoxide dismutase (r = 0.38; p < 0.001). Conclusion Impaired anti-oxidant HDL function represents a strong and independent predictor of 30-day mortality as well as long-term mortality in critically ill patients.	[Schrutka, Lore; Goliasch, Georg; Wurm, Raphael; Koller, Lorenz; Heinz, Gottfried; Pacher, Richard; Lang, Irene M.; Distelmaier, Klaus; Huelsmann, Martin] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Meyer, Brigitte] Kaiser Franz Josef Hosp Vienna, Dept Internal Med 4, Vienna, Austria; [Kriechbaumer, Lukas] Paracelsus Med Univ Salzburg, Univ Clin Orthoped, Salzburg, Austria	Medical University of Vienna; Paracelsus Private Medical University	Distelmaier, K (corresponding author), Med Univ Vienna, Dept Internal Med 2, Vienna, Austria.	klaus.distelmaier@meduniwien.ac.at	Wurm, Raphael/X-9952-2019	Wurm, Raphael/0000-0003-3027-7775; Schrutka, Lore/0000-0002-2731-2667; Goliasch, Georg/0000-0002-6219-6104; Lang, Irene/0000-0003-0485-2692	Medical Scientific Fund of the Mayor of the City of Vienna; Hans and Blanca Moser Stiftung	Medical Scientific Fund of the Mayor of the City of Vienna; Hans and Blanca Moser Stiftung	This project has been funded by the Medical Scientific Fund of the Mayor of the City of Vienna (2015; to KD) and by the Hans and Blanca Moser Stiftung (2014; to KD).	Adabag AS, 2009, EUR HEART J, V30, P1910, DOI 10.1093/eurheartj/ehp053; Adams V, 2013, CIRC RES, V113, P1345, DOI 10.1161/CIRCRESAHA.113.301684; Badimon JJ, 2015, J AM COLL CARDIOL, V66, P1486, DOI 10.1016/j.jacc.2015.08.008; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Crimi E, 2006, FREE RADICAL RES, V40, P665, DOI 10.1080/10715760600669612; Cuesta JM, 2012, CRIT CARE MED, V40, P3283, DOI 10.1097/CCM.0b013e31826567eb; Damuth E, 2015, LANCET RESP MED, V3, P544, DOI 10.1016/S2213-2600(15)00150-2; de Vega JMA, 2002, CRIT CARE MED, V30, P1782, DOI 10.1097/00003246-200208000-00018; Distelmaier K, 2015, THROMB HAEMOSTASIS, V114, P133, DOI 10.1160/TH14-10-0834; Distelmaier K, 2015, EUR J CLIN INVEST, V45, P731, DOI 10.1111/eci.12466; Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015; Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543, DOI 10.4037/ajcc2002.11.6.543; Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011; Graf J, 2008, CRIT CARE, V12, DOI 10.1186/cc6963; Griendling KK, 1998, J LAB CLIN MED, V132, P9, DOI 10.1016/S0022-2143(98)90019-1; Hardy G, 2012, NUTR CLIN PRACT, V27, P21, DOI 10.1177/0884533611434116; Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044; Himmelfarb J, 2004, J AM SOC NEPHROL, V15, P2449, DOI 10.1097/01.ASN.0000138232.68452.3B; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Kelesidis T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-87; Kelesidis T, 2011, J LIPID RES, V52, P2341, DOI 10.1194/jlr.D018937; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Lassnigg A, 2003, BRIT J ANAESTH, V90, P148, DOI 10.1093/bja/aeg042; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; McDonald CI, 2012, ASAIO J, V58, P217, DOI 10.1097/MAT.0b013e31824cc856; Metnitz PGH, 1999, INTENS CARE MED, V25, P180, DOI 10.1007/s001340050813; Meyer B, 2007, CRIT CARE MED, V35, P2268, DOI 10.1097/01.CCM.0000284509.23439.5B; Navab M, 2001, J LIPID RES, V42, P1308; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nobecourt E, 2005, DIABETOLOGIA, V48, P529, DOI 10.1007/s00125-004-1655-5; Oldham KM, 1998, J AM DIET ASSOC, V98, P1001, DOI 10.1016/S0002-8223(98)00230-2; Patel PJ, 2011, J AM COLL CARDIOL, V58, P2068, DOI 10.1016/j.jacc.2011.08.030; Pawlak K, 2005, CLIN BIOCHEM, V38, P700, DOI 10.1016/j.clinbiochem.2005.02.009; Riwanto M, 2013, CIRCULATION, V127, P891, DOI 10.1161/CIRCULATIONAHA.112.108753; Rohatgi A., 2014, N ENGL J MED; Santos-Gallego CG, 2016, CIRCULATION, V134; Sattler K, 2015, J AM COLL CARDIOL, V66, P1470, DOI 10.1016/j.jacc.2015.07.057; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shekar K, 2012, CRIT CARE, V16, DOI 10.1186/cc11679; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Watt DG, 2015, SURGERY, V157, P362, DOI 10.1016/j.surg.2014.09.009; Weichhart T, 2012, J AM SOC NEPHROL, V23, P934, DOI 10.1681/ASN.2011070668; Wraith KS, 2013, BLOOD, V122, P580, DOI 10.1182/blood-2013-04-491688; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	49	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151706	10.1371/journal.pone.0151706	http://dx.doi.org/10.1371/journal.pone.0151706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978526	gold, Green Published, Green Submitted			2022-12-26	WOS:000372572800101
J	Trovero, F; David, S; Bernard, P; Puech, A; Bizot, JC; Tassin, JP				Trovero, Fabrice; David, Sabrina; Bernard, Philippe; Puech, Alain; Bizot, Jean-Charles; Tassin, Jean-Pol			The Combination of Marketed Antagonists of alpha 1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence	PLOS ONE			English	Article							SEROTONERGIC NEURONS; ETHANOL; PRAZOSIN; DRINKING; DRUGS; AMPHETAMINE; NALTREXONE; BLOCKADE; C57BL/6J; COCAINE	Alcohol-dependence is a chronic disease with a dramatic and expensive social impact. Previous studies have indicated that the blockade of two monoaminergic receptors, alpha 1b-adrenergic and 5-HT2A, could inhibit the development of behavioral sensitization to drugs of abuse, a hallmark of drug-seeking and drug-taking behaviors in rodents. Here, in order to develop a potential therapeutic treatment of alcohol dependence in humans, we have blocked these two monoaminergic receptors by a combination of antagonists already approved by Health Agencies. We show that the association of ifenprodil (1 mg/kg) and cyproheptadine (1 mg/kg) (alpha 1-adrenergic and 5-HT2 receptor antagonists marketed as Vadilex (R) and Periactine (R) in France, respectively) blocks behavioral sensitization to amphetamine in C57Bl6 mice and to alcohol in DBA2 mice. Moreover, this combination of antagonists inhibits alcohol intake in mice habituated to alcohol (10% v/v) and reverses their alcohol preference. Finally, in order to verify that the effect of ifenprodil was not due to its anti-NMDA receptors property, we have shown that a combination of prazosin (0.5 mg/kg, an alpha 1b-adrenergic antagonist, Mini-Press (R) in France) and cyproheptadine (1 mg/kg) could also reverse alcohol preference. Altogether these findings strongly suggest that combined prazosin and cyproheptadine could be efficient as a therapy to treat alcoholismin humans. Finally, because alpha 1b-adrenergic and 5-HT2A receptors blockade also inhibits behavioral sensitization to psychostimulants, opioids and tobacco, it cannot be excluded that this combination will exhibit some efficacy in the treatment of addiction to other abused drugs.	[Trovero, Fabrice; David, Sabrina; Bizot, Jean-Charles] Key Obs SAS, Orleans, France; [Bernard, Philippe] Greenpharma SAS, Orleans, France; [Puech, Alain] Grp Hosp Pitie Salpetriere, Serv pharmacol, F-75634 Paris, France; [Tassin, Jean-Pol] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, Neurosci Paris Seine UM119, Paris, France; [Tassin, Jean-Pol] INSERM, Neurosci Paris Seine, UMR S 1130, Paris, France; [Tassin, Jean-Pol] CNRS, Neurosci Paris Seine, UMR 8246, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Trovero, F (corresponding author), Key Obs SAS, Orleans, France.	fabrice.trovero@key-obs.com		Tassin, Jean-Pol/0000-0001-6658-9581; BERNARD, Philippe/0000-0002-4420-617X	Agence Nationale de la Recherche (ANR-SENSIBALCO); Association pour la Recherche sur les Nicotianees (ARN); Key-Obs; Greenpharma	Agence Nationale de la Recherche (ANR-SENSIBALCO)(French National Research Agency (ANR)); Association pour la Recherche sur les Nicotianees (ARN); Key-Obs; Greenpharma	JPT wishes to thank Agence Nationale de la Recherche (ANR-SENSIBALCO) and Association pour la Recherche sur les Nicotianees (ARN) for their financial support. The funders (Key-Obs and Greenpharma) provided support in the form of salaries for authors FT, SD, JCB and PB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r JPT wishes to thank Agence Nationale de la Recherche (ANR-SENSIBALCO) and Association pour la Recherche sur les Nicotianees (ARN) for their support.	Auclair A, 2004, EUR J NEUROSCI, V20, P3073, DOI 10.1111/j.1460-9568.2004.03805.x; Bellot RG, 1996, EUR J PHARMACOL, V313, P175, DOI 10.1016/0014-2999(96)00641-3; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Broadbent J, 1999, PSYCHOPHARMACOLOGY, V141, P197, DOI 10.1007/s002130050825; CHENARD BL, 1991, J MED CHEM, V34, P3085, DOI 10.1021/jm00114a018; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Finn DA, 2005, PSYCHOPHARMACOLOGY, V178, P471, DOI 10.1007/s00213-004-2039-8; Fish EW, 2002, PSYCHOPHARMACOLOGY, V160, P39, DOI 10.1007/s00213-001-0934-9; Franck J, 2013, CURR OPIN NEUROBIOL, V23, P692, DOI 10.1016/j.conb.2013.05.005; Froehlich JC, 2015, ALCOHOL CLIN EXP RES, V39, P1538, DOI 10.1111/acer.12789; Froehlich JC, 2013, ALCOHOL CLIN EXP RES, V37, P1763, DOI 10.1111/acer.12148; Grahame NJ, 2000, PHARMACOL BIOCHEM BE, V67, P759, DOI 10.1016/S0091-3057(00)00411-1; Honrubia MA, 1997, CHEM PHARM BULL, V45, P842; Itzhak Y, 2000, BRAIN RES, V858, P402, DOI 10.1016/S0006-8993(00)01940-5; KARLER R, 1989, LIFE SCI, V45, P599, DOI 10.1016/0024-3205(89)90045-3; Lanteri C, 2014, MOL PSYCHIATR, V19, P823, DOI 10.1038/mp.2013.97; Lanteri C, 2008, NEUROPSYCHOPHARMACOL, V33, P1724, DOI 10.1038/sj.npp.1301548; Lanteri C, 2009, J NEUROSCI, V29, P987, DOI 10.1523/JNEUROSCI.3315-08.2009; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Moore EM, 2010, ALCOHOL CLIN EXP RES, V34, P734, DOI 10.1111/j.1530-0277.2009.01143.x; NESTOROS JN, 1980, SCIENCE, V209, P708, DOI 10.1126/science.7394531; Rasmussen DD, 2014, ALCOHOL CLIN EXP RES, V38, P1532, DOI 10.1111/acer.12441; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Salomon L, 2006, P NATL ACAD SCI USA, V103, P7476, DOI 10.1073/pnas.0600839103; Simpson TL, 2009, ALCOHOL CLIN EXP RES, V33, P255, DOI 10.1111/j.1530-0277.2008.00807.x; Tassin JP, 2008, BIOCHEM PHARMACOL, V75, P85, DOI 10.1016/j.bcp.2007.06.038; WALLACH M B, 1971, Psychopharmacology Bulletin, V7, P30; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7	30	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151242	10.1371/journal.pone.0151242	http://dx.doi.org/10.1371/journal.pone.0151242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968030	gold, Green Published, Green Submitted			2022-12-26	WOS:000371989200038
J	Baranovskiy, AG; Babayeva, ND; Zhang, YB; Gu, JY; Suwa, Y; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Babayeva, Nigar D.; Zhang, Yinbo; Gu, Jianyou; Suwa, Yoshiaki; Pavlov, Youri I.; Tahirov, Tahir H.			Mechanism of Concerted RNA-DNA Primer Synthesis by the Human Primosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE ALPHA-PRIMASE; C-TERMINAL DOMAIN; STRUCTURAL BASIS; POL ALPHA; EUKARYOTIC REPLISOME; CRYSTAL-STRUCTURE; P58 SUBUNIT; TRANSCRIPTION INITIATION; CATALYTIC SUBUNIT; REPLICATION	The human primosome, a 340-kilodalton complex of primase and DNA polymerase alpha (Pol alpha), synthesizes chimeric RNA-DNA primers to be extended by replicative DNA polymerases delta and epsilon. The intricate mechanism of concerted primer synthesis by two catalytic centers was an enigma for over three decades. Here we report the crystal structures of two key complexes, the human primosome and the C-terminal domain of the primase large subunit (p58(C)) with bound DNA/RNA duplex. These structures, along with analysis of primase/polymerase activities, provide a plausible mechanism for all transactions of the primosome including initiation, elongation, accurate counting of RNA primer length, primer transfer to Pol alpha, and concerted autoregulation of alternate activation/inhibition of the catalytic centers. Our findings reveal a central role of p58(C) in the coordinated actions of two catalytic domains in the primosome and ultimately could impact the design of anticancer drugs.	[Baranovskiy, Andrey G.; Babayeva, Nigar D.; Zhang, Yinbo; Gu, Jianyou; Suwa, Yoshiaki; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo; Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Gu, Jianyou] Zhejiang Prov Hosp Tradit Chinese Med, Inst Hematol, Hangzhou 310006, Zhejiang, Peoples R China; [Suwa, Yoshiaki] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, Sanda, Hyogo 6691337, Japan	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Zhejiang Chinese Medical University; Kwansei Gakuin University	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796; Tahirov, Tahir/0000-0002-1238-0069; Gu, Jianyou/0000-0003-0285-8919	NIGMS National Institutes of Health [P41 GM103403]; National Institutes of Health-ORIP HEI Grant [S10 RR029205]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM101167] Funding Source: NIH RePORTER	NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-ORIP HEI Grant; U.S. DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Temiakov (Rowan University) for kindly providing the expression vector for T7 RNA polymerase and A. Rizzino, D. Price, and K. Jordan for critical reading and editing of this manuscript. This work is also based upon research conducted at the APS on the NECAT beamlines, which are supported by NIGMS National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on 24-ID-C beamline is funded by National Institutes of Health-ORIP HEI Grant S10 RR029205. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract DE-AC02-06CH11357.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2016, J BIOL CHEM, V291, P4793, DOI 10.1074/jbc.M115.704064; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Baranovskiy AG, 2014, NUCLEIC ACIDS RES, V42, P14013, DOI 10.1093/nar/gku1209; Baranovskiy AG, 2014, ACTA CRYSTALLOGR F, V70, P206, DOI 10.1107/S2053230X13034432; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Beck K, 2010, NUCLEIC ACIDS RES, V38, P6707, DOI 10.1093/nar/gkq447; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1995, J BIOL CHEM, V270, P3905, DOI 10.1074/jbc.270.8.3905; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Geibel S, 2009, P NATL ACAD SCI USA, V106, P7810, DOI 10.1073/pnas.0902910106; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Jozwiakowski SK, 2015, P NATL ACAD SCI USA, V112, pE633, DOI 10.1073/pnas.1412982112; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; KUCHTA RD, 1990, J BIOL CHEM, V265, P16158; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Matsui E, 2003, BIOCHEMISTRY-US, V42, P14968, DOI 10.1021/bi035556o; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Suwa Y, 2015, J BIOL CHEM, V290, P14328, DOI 10.1074/jbc.M115.649954; Urban M, 2010, BIOCHEMISTRY-US, V49, P727, DOI 10.1021/bi9019516; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Xie P, 2011, EUR BIOPHYS J BIOPHY, V40, P1157, DOI 10.1007/s00249-011-0746-8; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhou B, 2012, J BIOL CHEM, V287, P26854, DOI 10.1074/jbc.M112.363655	58	59	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10006	10020		10.1074/jbc.M116.717405	http://dx.doi.org/10.1074/jbc.M116.717405			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26975377	Green Published, hybrid			2022-12-26	WOS:000375602800014
J	Manera, V; Chapoulie, E; Bourgeois, J; Guerchouche, R; David, R; Ondrej, J; Drettakis, G; Robert, P				Manera, Valeria; Chapoulie, Emmanuelle; Bourgeois, Jeremy; Guerchouche, Rachid; David, Renaud; Ondrej, Jan; Drettakis, George; Robert, Philippe			A Feasibility Study with Image-Based Rendered Virtual Reality in Patients with Mild Cognitive Impairment and Dementia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; APATHY; ATTENTION; REHABILITATION; STIMULI; IMPACT	Virtual Reality (VR) has emerged as a promising tool in many domains of therapy and rehabilitation, and has recently attracted the attention of researchers and clinicians working with elderly people with MCI, Alzheimer's disease and related disorders. Here we present a study testing the feasibility of using highly realistic image-based rendered VR with patients with MCI and dementia. We designed an attentional task to train selective and sustained attention, and we tested a VR and a paper version of this task in a single-session within-subjects design. Results showed that participants with MCI and dementia reported to be highly satisfied and interested in the task, and they reported high feelings of security, low discomfort, anxiety and fatigue. In addition, participants reported a preference for the VR condition compared to the paper condition, even if the task was more difficult. Interestingly, apathetic participants showed a preference for the VR condition stronger than that of non-apathetic participants. These findings suggest that VR-based training can be considered as an interesting tool to improve adherence to cognitive training in elderly people with cognitive impairment.	[Manera, Valeria; Chapoulie, Emmanuelle; Bourgeois, Jeremy; David, Renaud; Robert, Philippe] Univ Nice Sophia Antipolis, IA, EA CoBTeK, F-06189 Nice, France; [Guerchouche, Rachid; Drettakis, George] Inst Natl Rech Informat & Automat, Sophia Antipolis, France; [David, Renaud; Robert, Philippe] CHU Nice, Ctr Mem Ressources & Rech, F-06202 Nice, France; [Ondrej, Jan] Disney Res Los Angeles, Los Angeles, CA USA; [Ondrej, Jan] Univ Dublin Trinity Coll, Dublin 2, Ireland	UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Trinity College Dublin	Manera, V (corresponding author), Univ Nice Sophia Antipolis, IA, EA CoBTeK, F-06189 Nice, France.	valeria.manera@unice.fr	Manera, Valeria/O-3498-2016; David, Renaud/ABG-4662-2020; Ondrej, Jan/N-1947-2016	Manera, Valeria/0000-0003-4490-4485; Ondrej, Jan/0000-0002-5409-1521	FP7 European Commission Seventh Framework Programme VERVE project; Innovation Alzheimer Association; Lions district Provence-Alpes Cote d'azur; Disney Research Los Angeles	FP7 European Commission Seventh Framework Programme VERVE project; Innovation Alzheimer Association; Lions district Provence-Alpes Cote d'azur; Disney Research Los Angeles	This study was supported by a grant from the FP7 European Commission Seventh Framework Programme VERVE project (Vanquishing fear and apathy through e-inclusion: http://www.verveconsortium.com/), by the Innovation Alzheimer Association, and by the Lions district Provence-Alpes Cote d'azur. The study has been realized in the ecological room of the Edmond et Lily Safra center at the Institut Claude Pompidou. Disney Research Los Angeles provided support in the form of salaries for authors [JO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aalten P, 2003, DEMENT GERIATR COGN, V15, P99, DOI 10.1159/000067972; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Benoit M, 2008, INT J GERIATR PSYCH, V23, P409, DOI 10.1002/gps.1895; Benoit M, 2015, NEUROPSYCH DIS TREAT, V11, P557, DOI 10.2147/NDT.S73179; Brickenkamp R, 1981, TEST DZ AINFUREKSANK; Chapoulie E, 2014, REMINISCENCE THERAPY; Chaurasia G, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2487228.2487238; Cohen-Mansfield J, 2011, J CLIN PSYCHIAT, V72, P480, DOI 10.4088/JCP.09m05694oli; Cohen-Mansfield J, 2010, PSYCHIAT RES, V177, P216, DOI 10.1016/j.psychres.2009.02.010; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galante E, 2007, G Ital Med Lav Ergon, V29, pB26; Garcia-Betances RI, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00080; Gates N, 2011, BMC GERIATR, V11; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; Halter C, 1973, MANUEL TEST ATTENTIO; Leone E., 2012, ADV AGING RES, V1, P13, DOI [https://doi.org/10.4236/aar.2012.12002, DOI 10.4236/AAR.2012.12002, 10.4236/aar.2012.12002]; Levinoff Elise J, 2005, Brain Cogn, V57, P127, DOI 10.1016/j.bandc.2004.08.058; Manera V, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00024; McCallum Simon, 2013, Serious Games Development and Applications. 4th International Conference, SGDA 2013. Proceedings: LNCS 8101, P15, DOI 10.1007/978-3-642-40790-1_2; Morgan DG, 1997, WESTERN J NURS RES, V19, P740, DOI 10.1177/019394599701900604; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Sullivan C, 2011, GLASGOW MATH J, V53, P501, DOI 10.1017/S0017089511000097; ONeil M.E., 2011, SYSTEMATIC EVIDENCE; Optale G, 2010, NEUROREHAB NEURAL RE, V24, P348, DOI 10.1177/1545968309353328; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pettre J., 2009, SCA 09 P 2009 ACM SI, P189, DOI [10.1145/1599470.1599495, DOI 10.1145/1599470.1599495]; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2008, AM J GERIAT PSYCHIAT, V16, P770, DOI 10.1097/JGP.0b013e31817e73db; Robert PH, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00054; Robert PH, 2010, CNS NEUROSCI THER, V16, P263, DOI 10.1111/j.1755-5949.2009.00132.x; Rosen AC, 2011, J ALZHEIMERS DIS, V26, P349, DOI 10.3233/JAD-2011-0009; Shih-Ching Yeh, 2012, 2012 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2012), P23, DOI 10.1109/IECBES.2012.6498023; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Stavros Z, P 3 INT C PERV TECHN, P1, DOI [10.1145/18392941839319;2010, DOI 10.1145/18392941839319;2010]; Valenzuela MJ, 2006, PSYCHOL MED, V36, P1065, DOI 10.1017/S0033291706007744; van Zomeren AH, 1994, CLIN NEUROPSYCHOLOGY, P95; Weybright EH, 2010, THER RECREAT J, V44, P271; Yamaguchi H, 2011, INT PSYCHOGERIATR, V23, P674, DOI 10.1017/S1041610210001912; Zakzanis KK, 2009, MED SCI MONITOR, V15, pCR140; Zazzo R., 1972, MANUEL EXAMEN PSYCHO	46	86	89	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151487	10.1371/journal.pone.0151487	http://dx.doi.org/10.1371/journal.pone.0151487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26990298	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800065
J	Venancio, C; Ribeiro, R; Soares, A; Lopes, I				Venancio, Catia; Ribeiro, Rui; Soares, Amadeu; Lopes, Isabel			Multiple Stressor Differential Tolerances: Possible Implications at the Population Level	PLOS ONE			English	Article							DRIVEN GENETIC EROSION; DAPHNIA-LONGISPINA; CO-TOLERANCE; COPPER TOLERANCE; METALS; NICKEL; MINE; RESISTANCE; POLLUTION; ZINC	The probability of the most sensitive genotypes being eliminated from a population due to a contaminant pulse-genetic erosion-is negatively associated to the within-genotype variation. A sensitive genotype with a small phenotypic variation would be more prone to be lost-a critically sensitive genotype. Furthermore, natural populations inhabiting contaminated sites are usually exposed to several pollutants. Such co- or sequential exposure can have severe effects if at least some tolerant clonal lineages surviving one contaminant are sensitive to the others. Such an inverse relationship coupled with a low within-genotype variation potentially enhances genetic erosion. Accordingly, this study evaluated co-tolerance and the occurrence of clonal lineages critically sensitive to 48-hours lethal exposures of copper, zinc, cobalt, and chromium among eight clonal lineages of the cladocerans Daphnia longispina. Median lethal concentrations (LC50) of each metal were found to have the potential to provoke genetic erosion. Pairwise comparisons of LC50, from the eight clonal lineages, revealed neither negative nor positive correlations (r <= vertical bar 0.56 vertical bar; p >= 0.18), but inversely sensitive clonal lineages were found for all pairs of metals. Therefore, besides having the potential to eliminate critically sensitive clonal lineages in a first intermediately lethal pulse, all tested metals may provoke further losses of clonal lineages in an already genetically eroded population.	[Venancio, Catia; Soares, Amadeu; Lopes, Isabel] Univ Aveiro, Dept Biol, Campus Santiago, P-3810193 Aveiro, Portugal; [Venancio, Catia; Soares, Amadeu; Lopes, Isabel] Univ Aveiro, CESAM, Campus Santiago, P-3810193 Aveiro, Portugal; [Ribeiro, Rui] Univ Coimbra, Dept Life Sci, CFE, P-3000456 Coimbra, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra	Venancio, C (corresponding author), Univ Aveiro, Dept Biol, Campus Santiago, P-3810193 Aveiro, Portugal.; Venancio, C (corresponding author), Univ Aveiro, CESAM, Campus Santiago, P-3810193 Aveiro, Portugal.	catiavenancio@gmail.com	Soares, Amadeu/A-8304-2008; Ribeiro, Rui/C-7788-2012; Venâncio, Cátia/AAJ-1445-2020; Venâncio, Cátia/AAF-6779-2021; Lopes, Isabel/C-2858-2009	Soares, Amadeu/0000-0003-0879-9470; Ribeiro, Rui/0000-0002-0883-1939; Venâncio, Cátia/0000-0002-6232-4081; Lopes, Isabel/0000-0002-9325-0329	Fundo Social Europeu - FSE; Programa Operacional Potencial Humano - POPH; national funds (OE) through Foundation for Science and Technology (FCT); Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) within the CESAM's strategic program [UID/AMB/50017/2013, PTDC/BIA-BIC/3488/2012]; FCT [SFRH/BD/81717/2011]	Fundo Social Europeu - FSE(European Social Fund (ESF)); Programa Operacional Potencial Humano - POPH; national funds (OE) through Foundation for Science and Technology (FCT); Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) within the CESAM's strategic program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was partially funded by Fundo Social Europeu - FSE and Programa Operacional Potencial Humano - POPH, and by national funds (OE) through Foundation for Science and Technology (FCT) and Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) (http://alfa.fct.mctes.pt), within the CESAM's strategic program (UID/AMB/50017/2013) and Generosi (PTDC/BIA-BIC/3488/2012). C. Venancio is grant holder from FCT (ref. SFRH/BD/81717/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by Fundo Social Europeu-FSE and Programa Operacional Potencial Humano-POPH, and by national funds (OE) through Foundation for Science and Technology (FCT) and Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) (http://alfa.fct.mctes.pt), within the CESAM's strategic program (UID/AMB/50017/2013) and Generosi (PTDC/BIA-BIC/3488/2012). C. Venancio is grant holder from FCT (ref. SFRH/BD/81717/2011).	Adriaensen K, 2005, APPL ENVIRON MICROB, V71, P7279, DOI 10.1128/AEM.71.11.7279-7284.2005; Agra AR, 2010, ENVIRON TOXICOL CHEM, V29, P939, DOI 10.1002/etc.97; American Society for Testing and Materials, 2002, ANN BOOK ASTM STAND; [Anonymous], 2004, DAPHN SP AC IMM TEST; Asselman J, 2015, ENVIRON TOXICOL CHEM, V34, P1056, DOI 10.1002/etc.2887; Baird DJ, 1989, P 1 EUR C EC LYNGB D, P144; BARIAUD A, 1984, B ENVIRON CONTAM TOX, V32, P597, DOI 10.1007/BF01607543; Belfiore NM, 2001, MUTAT RES-REV MUTAT, V489, P97, DOI 10.1016/S1383-5742(01)00065-5; Bourret V, 2008, AQUAT TOXICOL, V86, P76, DOI 10.1016/j.aquatox.2007.10.003; El-Deeb Bahig, 2009, American Journal of Biochemistry and Biotechnology, V5, P47, DOI 10.3844/ajbb.2009.47.53; GARNHAM GW, 1992, APPL MICROBIOL BIOT, V37, P270, DOI 10.1007/BF00178183; Gonnelli C, 2001, PHYSIOL PLANTARUM, V113, P507, DOI 10.1034/j.1399-3054.2001.1130409.x; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; HALL A, 1980, NEW PHYTOL, V85, P73, DOI 10.1111/j.1469-8137.1980.tb04449.x; Harris KD, 2012, GENETICS RES INT, DOI DOI 10.1155/2012/147892; Hoffman A.A., 1997, EXTREME ENV CHANGE E; Lopes I, 2005, ENVIRON TOXICOL CHEM, V24, P1414, DOI 10.1897/04-132R.1; Lopes I, 2004, ARCH ENVIRON CON TOX, V46, P43, DOI 10.1007/s00244-003-2143-5; Lopes I, 2009, ENVIRON TOXICOL CHEM, V28, P1912, DOI 10.1897/08-359.1; Martins N, 2007, ENVIRON TOXICOL CHEM, V26, P1904, DOI 10.1897/06-111R.1; Medina MH, 2007, CHEMOSPHERE, V67, P2105, DOI 10.1016/j.chemosphere.2006.12.024; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; Morgan AJ, 2007, ENVIRON SCI TECHNOL, V41, P1085, DOI 10.1021/es061992x; MUNZINGER A, 1992, AQUAT TOXICOL, V23, P203, DOI 10.1016/0166-445X(92)90053-P; Nowak C, 2009, ENVIRON POLLUT, V157, P881, DOI 10.1016/j.envpol.2008.11.005; Ribeiro R, 2013, ECOTOXICOLOGY, V22, P889, DOI 10.1007/s10646-013-1070-0; Ribeiro R, 2012, ENVIRON TOXICOL CHEM, V31, P977, DOI 10.1002/etc.1802; Rogalski MA, 2015, ECOLOGY, V96, P1166, DOI 10.1890/14-1663.1; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Saro L, 2012, ENVIRON TOXICOL CHEM, V31, P909, DOI 10.1002/etc.1762; Silva R.M., 2010, INTERDISCIPLINARY ST, P213; SIMKISS K, 1989, Reviews in Aquatic Sciences, V1, P173; Soldo D, 2000, AQUAT TOXICOL, V47, P181, DOI 10.1016/S0166-445X(99)00020-X; Tessier Andre, 1994, P197; Tilstone GH, 1997, PLANT SOIL, V191, P173, DOI 10.1023/A:1004234604143; Tilstone GH, 1997, HEREDITY, V79, P445, DOI 10.1038/hdy.1997.183; TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821, DOI 10.1128/AEM.47.4.821-824.1984; Ungherese G, 2010, ENVIRON POLLUT, V158, P1638, DOI 10.1016/j.envpol.2009.12.007; van Straalen NM, 2002, HUM ECOL RISK ASSESS, V8, P983, DOI 10.1080/1080-700291905783; Vandegehuchte MB, 2009, COMP BIOCHEM PHYS C, V150, P343, DOI 10.1016/j.cbpc.2009.05.014; Vandegehuchte MB, 2010, ENVIRON POLLUT, V158, P3323, DOI 10.1016/j.envpol.2010.07.023; Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; VONFRENCKELLINSAM BAK, 1993, NEW PHYTOL, V125, P547, DOI 10.1111/j.1469-8137.1993.tb03902.x; Weider LJ, 1997, P ROY SOC B-BIOL SCI, V264, P1613, DOI 10.1098/rspb.1997.0225	45	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151847	10.1371/journal.pone.0151847	http://dx.doi.org/10.1371/journal.pone.0151847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990542	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800107
J	Cariveau, DP; Nayak, GK; Bartomeus, I; Zientek, J; Ascher, JS; Gibbs, J; Winfree, R				Cariveau, Daniel P.; Nayak, Geetha K.; Bartomeus, Ignasi; Zientek, Joseph; Ascher, John S.; Gibbs, Jason; Winfree, Rachael			The Allometry of Bee Proboscis Length and Its Uses in Ecology	PLOS ONE			English	Article							BUMBLE BEES; BODY-SIZE; EVOLUTION; HYMENOPTERA; PHYLOGENY; CONSTRAINTS; EFFICIENCY; BOMBUS; PLANTS; LIFE	Allometric relationships among morphological traits underlie important patterns in ecology. These relationships are often phylogenetically shared; thus quantifying allometric relationships may allow for estimating difficult-to-measure traits across species. One such trait, proboscis length in bees, is assumed to be important in structuring bee communities and plant-pollinator networks. However, it is difficult to measure and thus rarely included in ecological analyses. We measured intertegular distance (as a measure of body size) and proboscis length (glossa and prementum, both individually and combined) of 786 individual bees of 100 species across 5 of the 7 extant bee families (Hymenoptera: Apoidea: Anthophila). Using linear models and model selection, we determined which parameters provided the best estimate of proboscis length. We then used coefficients to estimate the relationship between intertegular distance and proboscis length, while also considering family. Using allometric equations with an estimation for a scaling coefficient between intertegular distance and proboscis length and coefficients for each family, we explain 91% of the variance in species-level means for bee proboscis length among bee species. However, within species, individual-level intertegular distance was a poor predictor of individual proboscis length. To make our findings easy to use, we created an R package that allows estimation of proboscis length for individual bee species by inputting only family and intertegular distance. The R package also calculates foraging distance and body mass based on previously published equations. Thus by considering both taxonomy and intertegular distance we enable accurate estimation of an ecologically and evolutionarily important trait.	[Cariveau, Daniel P.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Cariveau, Daniel P.; Nayak, Geetha K.; Zientek, Joseph; Winfree, Rachael] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Bartomeus, Ignasi] Estac Biol Donana EDB CSIC, Dept Ecol Integrat, Avda Americo Vespucio S-N, Seville 41092, Spain; [Ascher, John S.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Gibbs, Jason] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); National University of Singapore; Michigan State University	Cariveau, DP (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN USA.; Cariveau, DP (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	dcarivea@umn.edu	Cariveau, Daniel/AAB-9336-2020; Gibbs, Jason/H-6963-2012	Gibbs, Jason/0000-0002-4945-5423; Bartomeus, Ignasi/0000-0001-7893-4389	United States Department of Agriculture, Natural Resources Conservation Service Conservation Innovation Grant, NRCS [69-3A75-10-163]; Fulbright-Nehru Postdoctoral Fellowship; Rutgers University Aresty Undergraduate Research Award	United States Department of Agriculture, Natural Resources Conservation Service Conservation Innovation Grant, NRCS; Fulbright-Nehru Postdoctoral Fellowship; Rutgers University Aresty Undergraduate Research Award	This work was supported by the United States Department of Agriculture, Natural Resources Conservation Service Conservation Innovation Grant, NRCS Agreement #69-3A75-10-163 (to RW) (URL: nrcs.usda.gov/wps/portal/nrcs/main/national/programs/financial/cig/); a Fulbright-Nehru Postdoctoral Fellowship (to GN) (URL: cies.org/grantee/geetha-nayak); and a Rutgers University Aresty Undergraduate Research Award (to JZ) (URL: https://aresty.rutgers.edu/our-programs/funding/undergraduate-research-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maglianesi MA, 2014, ECOLOGY, V95, P3325, DOI 10.1890/13-2261.1; Benjamin FE, 2014, J APPL ECOL, V51, P440, DOI 10.1111/1365-2664.12198; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Borrell BJ, 2005, BIOTROPICA, V37, P664, DOI 10.1111/j.1744-7429.2005.00084.x; Borrell BJ, 2007, AM NAT, V169, P569, DOI 10.1086/512689; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Carvell C, 2011, ECOL APPL, V21, P1760, DOI 10.1890/10-0677.1; Clough Y, 2014, ECOL LETT, V17, P1168, DOI 10.1111/ele.12325; Corbet SA, 2000, ENTOMOL EXP APPL, V96, P289, DOI 10.1023/A:1004096432758; DANFORTH BN, 1989, J ZOOL, V218, P247, DOI 10.1111/j.1469-7998.1989.tb02536.x; Danforth BN, 1999, INSECT SOC, V46, P18, DOI 10.1007/s000400050107; Danforth BN, 2013, ANNU REV ENTOMOL, V58, P57, DOI 10.1146/annurev-ento-120811-153633; Dorchin A, 2013, APIDOLOGIE, V44, P90, DOI 10.1007/s13592-012-0159-4; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; GIBSON RL, 1989, INSECT SOC, V36, P28, DOI 10.1007/BF02225878; Goulson D, 2008, BIODIVERS CONSERV, V17, P3269, DOI 10.1007/s10531-008-9428-y; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; HARDER LD, 1983, CAN J ZOOL, V61, P1580, DOI 10.1139/z83-212; HARDER LD, 1982, CAN J ZOOL, V60, P1073, DOI 10.1139/z82-148; Harmon-Threatt AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060446; Hedtke SM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-138; Huxley J., 1932, PROBLEMS RELATIVE GR; Inouye D., 1977, The role of arthropods in forest ecosystems, P35; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Kawakita A, 2004, MOL PHYLOGENET EVOL, V31, P799, DOI 10.1016/j.ympev.2003.12.003; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Krenn HW, 2005, ARTHROPOD STRUCT DEV, V34, P1, DOI 10.1016/j.asd.2004.10.002; Kunte K, 2007, FUNCT ECOL, V21, P982, DOI 10.1111/j.1365-2435.2007.01299.x; MEDLER JOHN T., 1962, ANN ENTOMOL SOC AMER, V55, P212; Michener C. D., 2000, The bees of the world; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; MORSE DH, 1977, ANN ENTOMOL SOC AM, V70, P311, DOI 10.1093/aesa/70.3.311; Owen RE, 1995, J EVOLUTION BIOL, V8, P725, DOI 10.1046/j.1420-9101.1995.8060725.x; Peat J, 2005, ECOL ENTOMOL, V30, P176, DOI 10.1111/j.0307-6946.2005.00676.x; Rodriguez-Girones MA, 2007, AM NAT, V170, P455, DOI 10.1086/520121; Sacchi R, 2013, ZOOMORPHOLOGY, V132, P23, DOI 10.1007/s00435-012-0172-1; Shimizu A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03988; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Sommer S, 2012, ARTHROPOD STRUCT DEV, V41, P71, DOI 10.1016/j.asd.2011.08.002; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Taskinen S, 2013, J THEOR BIOL, V333, P38, DOI 10.1016/j.jtbi.2013.05.010; Vizentin-Bugoni J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2397; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x	52	62	62	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151482	10.1371/journal.pone.0151482	http://dx.doi.org/10.1371/journal.pone.0151482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986000	Green Published, gold			2022-12-26	WOS:000372580300076
J	Tan, C; Poggio, T				Tan, Cheston; Poggio, Tomaso			Neural Tuning Size in a Model of Primate Visual Processing Accounts for Three Key Markers of Holistic Face Processing	PLOS ONE			English	Article							OBJECT RECOGNITION; PERCEPTION; INFORMATION; MECHANISMS; FEATURES; NEURONS; MACAQUE; CORTEX; SHAPE	Faces are an important and unique class of visual stimuli, and have been of interest to neuroscientists for many years. Faces are known to elicit certain characteristic behavioral markers, collectively labeled "holistic processing", while non-face objects are not processed holistically. However, little is known about the underlying neural mechanisms. The main aim of this computational simulation work is to investigate the neural mechanisms that make face processing holistic. Using a model of primate visual processing, we show that a single key factor, "neural tuning size", is able to account for three important markers of holistic face processing: the Composite Face Effect (CFE), Face Inversion Effect (FIE) and Whole-Part Effect (WPE). Our proof-of-principle specifies the precise neurophysiological property that corresponds to the poorly-understood notion of holism, and shows that this one neural property controls three classic behavioral markers of holism. Our work is consistent with neurophysiological evidence, and makes further testable predictions. Overall, we provide a parsimonious account of holistic face processing, connecting computation, behavior and neurophysiology.	[Tan, Cheston; Poggio, Tomaso] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Tan, Cheston; Poggio, Tomaso] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Tan, Cheston] Inst Infocomm Res, Visual Comp Dept, Singapore, Singapore	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Tan, C; Poggio, T (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tan, C; Poggio, T (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tan, C (corresponding author), Inst Infocomm Res, Visual Comp Dept, Singapore, Singapore.	cheston-tan@i2r.a-star.edu.sg; tp@ai.mit.edu		Tan, Cheston/0000-0003-1248-4906	A*STAR (Agency for Science, Technology and Research) [1335h00098]; National Science Foundation STC award [CCF-1231216]	A*STAR (Agency for Science, Technology and Research)(Agency for Science Technology & Research (A*STAR)); National Science Foundation STC award(National Science Foundation (NSF))	This work was funded by A*STAR (Agency for Science, Technology and Research), Joint Council Office grant #1335h00098, and National Science Foundation STC award CCF-1231216. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; Cottrell GW, 2002, P 24 ANN C COGN SCI, P238; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Farzmahdi A, 2015, PREPRINT; Freiwald WA, 2009, NAT NEUROSCI, V12, P1187, DOI 10.1038/nn.2363; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gauthier I, 2000, COGN NEUROPSYCHOL, V17, P125, DOI 10.1080/026432900380535; Gauthier I, 2007, COGNITION, V103, P322, DOI 10.1016/j.cognition.2006.05.003; Mangini MC, 2004, COGNITIVE SCI, V28, P209, DOI 10.1016/j.cogsci.2003.11.004; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2011, OXFORD HDB FACE PERC, P149, DOI [DOI 10.1093/OXFORDHB/9780199559053.013.0009, 10.1093/oxfordhb/9780199559053.013.0009]; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; PERRETT DI, 1993, IMAGE VISION COMPUT, V11, P317, DOI 10.1016/0262-8856(93)90011-5; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Richler JJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00553; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Riesenhuber M, 2009, ACTA PSYCHOL, V132, P286, DOI 10.1016/j.actpsy.2009.07.004; Robbins R, 2007, COGNITION, V103, P34, DOI 10.1016/j.cognition.2006.02.008; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Tanaka J.W., 2011, OXFORD HDB FACE PERC, P177, DOI [DOI 10.1093/OXFORDHB/9780199559053.013.0010, 10.1093/oxfordhb/9780199559053.013.0010]; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Xu X, 2014, NEUROCOMPUTATIONAL A, V14, P1; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150980	10.1371/journal.pone.0150980	http://dx.doi.org/10.1371/journal.pone.0150980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985989	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300040
J	Kwon, YJ; Baek, HS; Ye, DJ; Shin, S; Kim, D; Chun, YJ				Kwon, Yeo-Jung; Baek, Hyoung-Seok; Ye, Dong-Jin; Shin, Sangyun; Kim, Donghak; Chun, Young-Jin			CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/beta-Catenin Signaling via Sp1 Upregulation	PLOS ONE			English	Article							PRIMARY CONGENITAL GLAUCOMA; BREAST-CANCER CELLS; ESTROGEN METABOLISM; E-CADHERIN; MESENCHYMAL TRANSITION; CYTOCHROME-P450 CYP1B1; GENE-EXPRESSION; TUMOR-CELLS; TRANSCRIPTION; INVASION	Cytochrome P450 1B1 (CYP1B1) is a major E2 hydroxylase involved in the metabolism of potential carcinogens. CYP1B1 expression has been reported to be higher in tumors compared to normal tissues, especially in hormone-related cancers including breast, ovary, and prostate tumors. To explore the role of CYP1B1 in cancer progression, we investigated the action of CYP1B1 in cells with increased CYP1B1 via the inducer 7,12-dimethylbenz[alpha] anthracene (DMBA) or an overexpression vector, in addition to decreased CYP1B1 via the inhibitor tetramethoxystilbene (TMS) or siRNA knockdown. We observed that CYP1B1 promoted cell proliferation, migration, and invasion in MCF-7 and MCF-10A cells. To understand its molecular mechanism, we measured key oncogenic proteins including beta-catenin, c-Myc, ZEB2, and matrix metalloproteinases following CYP1B1 modulation. CYP1B1 induced epithelial-mesenchymal transition (EMT) and activated Wnt/beta-catenin signaling via upregulation of CTNNB1, ZEB2, SNAI1, and TWIST1. Sp1, a transcription factor involved in cell growth and metastasis, was positively regulated by CYP1B1, and suppression of Sp1 expression by siRNA or DNA binding activity using mithramycin A blocked oncogenic transformation by CYP1B1. Therefore, we suggest that Sp1 acts as a key mediator for CYP1B1 action. Treatment with 4-hydroxyestradiol (4-OHE2), a major metabolite generated by CYP1B1, showed similar effects as CYP1B1 overexpression, indicating that CYP1B1 activity mediated various oncogenic events in cells. In conclusion, our data suggests that CYP1B1 promotes cell proliferation and metastasis by inducing EMT and Wnt/beta-catenin signaling via Sp1 induction.	[Kwon, Yeo-Jung; Baek, Hyoung-Seok; Ye, Dong-Jin; Shin, Sangyun; Chun, Young-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Kim, Donghak] Konkuk Univ, Dept Biol Sci, Seoul, South Korea	Chung Ang University; Konkuk University	Chun, YJ (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	yjchun@cau.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Korean government [NRF-2012R1A1A2041536, NRF-2015R1A5A1008958]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2012R1A1A2041536, NRF-2015R1A5A1008958]	Basic Science Research Program through the National Research Foundation of Korea - Korean government; National Research Foundation of Korea (NRF) - Korean government (MSIP)	This research was supported by the Basic Science Research Program (NRF-2012R1A1A2041536 and NRF-2015R1A5A1008958) through the National Research Foundation of Korea funded by the Korean government to YJC (http://www.nrf.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (NRF-2012R1A1A2041536 and NRF-2015R1A5A1008958).	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Belous AR, 2007, CANCER RES, V67, P812, DOI 10.1158/0008-5472.CAN-06-2133; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Campos-Mollo E, 2009, MOL VIS, V15, P417; Carvell MJ, 2007, CELL PHYSIOL BIOCHEM, V20, P617, DOI 10.1159/000107545; Chavarria-Soley G, 2008, HUM MUTAT, V29, P1147, DOI 10.1002/humu.20786; Chen B, 2010, LUNG CANCER, V70, P247, DOI 10.1016/j.lungcan.2010.03.011; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Vivo I, 2002, CANCER EPIDEM BIOMAR, V11, P489; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098651; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hachey DL, 2003, CANCER RES, V63, P8492; Hernandez-Perez M, 2012, AM J DERMATOPATH, V34, P723, DOI 10.1097/DAD.0b013e31824b1ddf; Hong M, 2014, BIOMOL THER, V22, P519, DOI 10.4062/biomolther.2014.112; Jiang WF, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-113; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Le Marchand L, 2005, CANCER EPIDEM BIOMAR, V14, P1998, DOI 10.1158/1055-9965.EPI-05-0076; Li DN, 2000, PHARMACOGENETICS, V10, P343, DOI 10.1097/00008571-200006000-00008; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; McFadyen MCE, 2001, BRIT J CANCER, V85, P242, DOI 10.1054/bjoc.2001.1907; MCKAY JA, 1995, FEBS LETT, V374, P270, DOI 10.1016/0014-5793(95)01126-Y; Murray GI, 1997, CANCER RES, V57, P3026; Nam EH, 2014, CARCINOGENESIS, V35, P302, DOI 10.1093/carcin/bgt340; Ohkuma M, 2007, BIOCHEM BIOPH RES CO, V352, P925, DOI 10.1016/j.bbrc.2006.11.114; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park JH, 2009, J GENE MED, V11, P824, DOI 10.1002/jgm.1355; Patel SAA, 2015, TOXICOL RES-UK, V4, P858, DOI 10.1039/c5tx00068h; Polakis P, 2000, GENE DEV, V14, P1837; Poplineau M, 2015, MOL CARCINOGEN, V54, P24, DOI 10.1002/mc.22071; Ragavan N, 2004, CANCER LETT, V215, P69, DOI 10.1016/j.canlet.2004.06.051; Saini S, 2009, CANCER RES, V69, P7038, DOI 10.1158/0008-5472.CAN-09-1691; Shimada T, 1996, CANCER RES, V56, P2979; Singh PB, 2010, ASIAN J ANDROL, V12, P203, DOI 10.1038/aja.2009.71; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; SPINK DC, 1994, J STEROID BIOCHEM, V51, P251, DOI 10.1016/0960-0760(94)90037-X; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Tang WM, 1996, J BIOL CHEM, V271, P28324, DOI 10.1074/jbc.271.45.28324; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Tokizane T, 2005, CLIN CANCER RES, V11, P5793, DOI 10.1158/1078-0432.CCR-04-2545; Turner NA, 2012, IUBMB LIFE, V64, P143, DOI 10.1002/iub.594; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Yuan JH, 2011, HEPATOLOGY, V54, P2025, DOI 10.1002/hep.24606; Zhang JP, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0222-1	52	62	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151598	10.1371/journal.pone.0151598	http://dx.doi.org/10.1371/journal.pone.0151598			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981862	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900102
J	Tidball, AM; Neely, MD; Chamberlin, R; Aboud, AA; Kumar, KK; Han, BY; Bryan, MR; Aschner, M; Ess, KC; Bowman, AB				Tidball, Andrew M.; Neely, M. Diana; Chamberlin, Reed; Aboud, Asad A.; Kumar, Kevin K.; Han, Bingying; Bryan, Miles R.; Aschner, Michael; Ess, Kevin C.; Bowman, Aaron B.			Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; INCREASED OXIDATIVE DAMAGE; SUPPRESSION; DYSFUNCTION; APOPTOSIS; PROTEINS; MUTATION; PATHWAY	Alterations in DNA damage response and repair have been observed in Huntington's disease (HD). We generated induced pluripotent stem cells (iPSC) from primary dermal fibroblasts of 5 patients with HD and 5 control subjects. A significant fraction of the HD iPSC lines had genomic abnormalities as assessed by karyotype analysis, while none of our control lines had detectable genomic abnormalities. We demonstrate a statistically significant increase in genomic instability in HD cells during reprogramming. We also report a significant association with repeat length and severity of this instability. Our karyotypically normal HD iPSCs also have elevated ATM-p53 signaling as shown by elevated levels of phosphorylated p53 and H2AX, indicating either elevated DNA damage or hypersensitive DNA damage signaling in HD iPSCs. Thus, increased DNA damage responses in the HD genotype is coincidental with the observed chromosomal aberrations. We conclude that the disease causing mutation in HD increases the propensity of chromosomal instability relative to control fibroblasts specifically during reprogramming to a pluripotent state by a commonly used episomal-based method that includes p53 knockdown.	[Tidball, Andrew M.; Neely, M. Diana; Aboud, Asad A.; Kumar, Kevin K.; Han, Bingying; Bryan, Miles R.; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37240 USA; [Tidball, Andrew M.; Neely, M. Diana; Kumar, Kevin K.; Bryan, Miles R.; Ess, Kevin C.; Bowman, Aaron B.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Chamberlin, Reed] Genet Associates Inc, Nashville, TN 37203 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Ess, Kevin C.] Vanderbilt Univ, Dept Pediat, Med Ctr, Nashville, TN 37240 USA; [Bowman, Aaron B.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University; Vanderbilt University	Bowman, AB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37240 USA.; Bowman, AB (corresponding author), Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA.; Bowman, AB (corresponding author), Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37232 USA.	aaron.bowman@vanderbilt.edu		Kumar, Kevin/0000-0002-0704-1492; Tidball, Andrew/0000-0002-1666-4106	National Institute of Environmental Health Sciences [ES016931, ES010563]; National Institute of Neurological Disorders and Stroke [F31 NS077632]; Vanderbilt Medical Scientist Training Program - National Institute of General Medical Sciences [T32 GM07347]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016931, R01ES010563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077632, R01NS078289] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Vanderbilt Medical Scientist Training Program - National Institute of General Medical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Environmental Health Sciences: ES016931 (ABB) and ES010563 (ABB/MA); the National Institute of Neurological Disorders and Stroke: F31 NS077632 (AMT) as well as additional support from the Vanderbilt Medical Scientist Training Program funded by the National Institute of General Medical Sciences: T32 GM07347 (KKK).	Alam ZI, 2000, J NEUROCHEM, V75, P840, DOI 10.1046/j.1471-4159.2000.0750840.x; An MC, 2012, CELL STEM CELL; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Chae JI, 2012, BIOCHEM J, V446, P359, DOI 10.1042/BJ20111495; Chattopadhyay B, 2005, NEUROSCI LETT, V374, P81, DOI 10.1016/j.neulet.2004.10.018; De Luca G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000266; Ehrnhoefer DE, 2014, HUM MOL GENET, V23, P717, DOI 10.1093/hmg/ddt458; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Ferlazzo ML, 2013, MOL NEUROBIOL, P1; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Illuzzi J, 2009, J NEUROSCI RES, V87, P733, DOI 10.1002/jnr.21881; Illuzzi JL, 2011, J MOL NEUROSCI, V45, P256, DOI 10.1007/s12031-011-9516-4; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Lu XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010523; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; MOSHELL AN, 1980, LANCET, V1, P9; Neely MD, 2011, NEUROMETHODS, V56, P27, DOI 10.1007/978-1-61779-077-5_2; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Raskin S, 2000, ARQ NEURO-PSIQUIAT, V58, P977, DOI 10.1590/S0004-282X2000000600001; Rasmussen MA, 2014, STEM CELL REP, V3, P404, DOI 10.1016/j.stemcr.2014.07.006; Ruiz S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9036; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tidball AM, 2015, HUM MOL GENET, V24, P1929, DOI 10.1093/hmg/ddu609; Tomasevic G, 1999, MOL BRAIN RES, V70, P304, DOI 10.1016/S0169-328X(99)00146-1; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799	40	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150372	10.1371/journal.pone.0150372	http://dx.doi.org/10.1371/journal.pone.0150372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982737	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900038
J	Warren, RJ				Warren, Robert J., II			Ghosts of Cultivation Past - Native American Dispersal Legacy Persists in Tree Distribution	PLOS ONE			English	Article							PLANT-POPULATIONS; SEED DISPERSAL; GENETIC-STRUCTURE; NICHE; CHEROKEE; VEGETATION; MIGRATION	A long-term assumption in ecology is that species distributions correspond with their niche requirements, but evidence that species can persist in unsuitable habitat for centuries undermines the link between species and habitat. Moreover, species may be more dependent on mutualist partners than specific habitats. Most evidence connecting indigenous cultures with plant dispersal is anecdotal, but historical records suggest that Native Americans transported and cultivated many species, including Gleditsia triacanthos ("Honey locust"). Gleditsia triacanthos was an important medicinal/culinary (e.g., sugar), cultural (e.g., game sticks) and spiritual tree for the Cherokee (southeastern U.S. Native Americans). This study tests the hypothesis that a Cherokee cultivation legacy drives current regional G. triacanthos distribution patterns. Gleditsia triacanthos occurs in rocky uplands and xeric fields, but inexplicably also occurs in mesic riverine corridors and floodplains where Cherokee once settled and farmed. I combined field experiments and surveys in the Southern Appalachian Mountain region (U.S.) to investigate G. triacanthos recruitment requirements and distribution patterns to determine whether there is a quantifiable G. triacanthos association with former Cherokee settlements. Moreover, I also investigated alternate dispersal mechanisms, such as stream transport and domestic cattle. The results indicate that a centuries-old legacy of Native American cultivation remains intact as G. triacanthos' current southern Appalachian distribution appears better explained Cherokee settlement patterns than habitat. The data indicate that the tree is severely dispersal limited in the region, only moving appreciable distances from former Cherokee settlements where cattle grazing is prevalent. Human land use legacy may play a long-term role in shaping species distributions, and pre-European settlement activity appears underrated as a factor influencing modern tree species distributions.	[Warren, Robert J., II] SUNY Coll Buffalo, Dept Biol, 1300 Elmwood Ave, Buffalo, NY 14222 USA	State University of New York (SUNY) System; Buffalo State College	Warren, RJ (corresponding author), SUNY Coll Buffalo, Dept Biol, 1300 Elmwood Ave, Buffalo, NY 14222 USA.	hexastylis@gmail.com			National Science Foundation [DEB-0823293]; Division Of Environmental Biology [1440485] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Science Foundation award DEB-0823293 to the Coweeta LTER Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2008, HOLOCENE, V18, P1123, DOI 10.1177/0959683608095581; [Anonymous], 2007, TECHNICAL NOTE NO 2; Ashe SA, 1904, N CAROLINA BOOKLET, V4, P3; Barlow C, 2000, GHOSTS EVOLUATION NO; Bartram W., 1794, TRAVELS N S CAROLINA; Bass II Q R, 1977, PREHISTORIC SETTLEME; Beck R, 2013, CHIEFDOMS, COLLAPSE, AND COALESCENCE IN THE EARLY AMERICAN SOUTH, P1, DOI 10.1017/CBO9781139135429; Blair RM, 1990, SILVICS N AM, V654, P358; Blitz JH, 2004, AM ANTIQUITY, V69, P291, DOI 10.2307/4128421; Boulanger MT, 2014, QUATERNARY SCI REV, V85, P35, DOI 10.1016/j.quascirev.2013.11.024; BRONSTEIN JL, 1989, EXPERIENTIA, V45, P622, DOI 10.1007/BF01975679; Campbell Lyle, 2000, AM INDIAN LANGUAGES, P396; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Crosby A.W., 1986, ECOLOGICAL IMPERIALI, DOI DOI 10.1017/CBO9780511805554; Davis R. P. S, 1998, ABBREVIATED NAGPRA I; DELCOURT PA, 1986, QUATERNARY RES, V25, P330, DOI 10.1016/0033-5894(86)90005-0; Delcourt PA, 2004, PREHISTORIC NATIVE A; Dickens Roy S., 1976, CHEROKEE PREHISTORY; Dickens RS, 1967, SO INDIANA STUDIES, V14, P25; Diez JM, 2007, J ECOL, V95, P159, DOI 10.1111/j.1365-2745.2006.01194.x; Ehrlen J, 2000, ECOLOGY, V81, P1667, DOI 10.1890/0012-9658(2000)081[1667:DLAPOI]2.0.CO;2; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Evans R, 1977, J CHEROKEE STUDIES, P2; Fogelson Raymond D, 2004, HDB N AM INDIANS, V14; Gilmore M.R., 1930, MICHIGAN ACAD SCI AR, V13, P89; Gordon D, 1966, REVISION GENUS GLEDI; Gragson TL, 2007, SOC SCI HIST, V31, P435, DOI 10.1215/01455532-2007-005; Graham EH, 1941, LEGUMES EROSION CONT, P412; Guiden Peter W., 2013, Ecological Restoration, V31, P356, DOI 10.3368/er.31.4.356; Hamel PB, 1975, CHEOKEE PLANTS THEIR; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Janzen DH, 1982, GARDEN, V6, P12; Keener C, 1997, N AM ARCHAEOL, V18, P326; King DH, 2005, CHEROKEE INDIAN NATI; King Duane H., 1979, CHEROKEE INDIAN NATI, P3; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lawson J, 1709, NEW VOYAGE CAROLINA; Lindbladh M, 1998, J BIOGEOGR, V25, P463, DOI 10.1046/j.1365-2699.1998.2530463.x; LIU NY, 1981, J AM SOC HORTIC SCI, V106, P691; Loeb RE, 1998, J TORREY BOT SOC, V125, P74, DOI 10.2307/2997233; Lounsbury FD, 1961, BUREAU AM ETHNOLOGY, V180; MacDougall A, 2003, J BIOGEOGR, V30, P633, DOI 10.1046/j.1365-2699.2003.00842.x; Martin PS, 1974, ARCTIC ALPINE ENV; McLauchlan K, 2003, HOLOCENE, V13, P557, DOI 10.1191/0959683603hl646rp; Mooney J., 1900, 19 ANN REP BUR AM ET; Mooney J., 1932, SWIMMER UNPUB; Mooney J., 1890, CHEROKEE BALL PLAY A, V3; Murphy HT, 2007, OIKOS, V116, P99, DOI 10.1111/j.2006.0030-1299.15050.x; Murphy JL, 2001, N AM ARCHAEOL, V22, P93, DOI 10.2190/TT5Y-YAXJ-0KAU-GUFK; Myers JA, 2004, OECOLOGIA, V139, P35, DOI 10.1007/s00442-003-1474-2; Pearson SM, 1999, ECOL APPL, V9, P1288, DOI 10.1890/1051-0761(1999)009[1288:LCAHAI]2.0.CO;2; Perry MJ, 1975, FOOD USE WILD PLANTS; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Prasad A.M., 2003, LITTLES RANGE FIA IM; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Rodning Christopher, 2008, N CAROLINA ARCHAEOLO, V57, P1; Rodning CB, 2011, N AM ARCHAEOL, V32, P131, DOI 10.2190/NA.32.2.b; Rodning Christopher B., 2002, SE ARCHAEOLOGY, V21, P10; Schnabel A, 1998, MOL ECOL, V7, P819, DOI 10.1046/j.1365-294x.1998.00397.x; SCHNABEL A, 1990, AM J BOT, V77, P1060, DOI 10.2307/2444577; SCHNABEL A, 1991, HEREDITY, V67, P357, DOI 10.1038/hdy.1991.99; SCWDS, 1980, SE COOP WILDL DIS ST; SINGH D P, 1991, New Forests, V5, P139, DOI 10.1007/BF00029304; Smith BA., 1979, CHEROKEE INDIAN NATI; Smith H.H., 1928, B PUBLIC MUSEUM CITY, P175; Speck FG, 1942, P DELAWARE COUNTY IN, V10, P175; Swanton JR, 1928, 42 BUR AM ETHN ANN R, P473; Swanton JR., 1946, INDIANS SE US; Tantaquidgeon G, 1972, FOLK MED DELEWARE RE; Taylor LA., 1940, PLANTS USED CURATIVE; Tulowiecki SJ, 2015, ECOL MONOGR, V85, P557, DOI 10.1890/14-2259.1; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; VanDerwarker AM, 2000, N CAROLINA ARCHAEOLO, V49, P59; VanDerwarker AM, 2006, ENCY APPALACHIA, P944; VanDerwarker AM, 2013, AM ANTIQUITY, V78, P68, DOI 10.7183/0002-7316.78.1.68; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Warren RJ, 2011, P ROY SOC B-BIOL SCI, V278, P1390, DOI 10.1098/rspb.2010.1886; Warren RJ, 2010, J ECOL, V98, P1178, DOI 10.1111/j.1365-2745.2010.01694.x	81	16	16	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150707	10.1371/journal.pone.0150707	http://dx.doi.org/10.1371/journal.pone.0150707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982877	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900049
J	Palucci, I; Camassa, S; Cascioferro, A; Sali, M; Anoosheh, S; Zumbo, A; Minerva, M; Iantomasi, R; De Maio, F; Di Sante, G; Ria, F; Sanguinetti, M; Palu, G; Brennan, MJ; Manganelli, R; Delogu, G				Palucci, Ivana; Camassa, Serena; Cascioferro, Alessandro; Sali, Michela; Anoosheh, Saber; Zumbo, Antonella; Minerva, Mariachiara; Iantomasi, Raffaella; De Maio, Flavio; Di Sante, Gabriele; Ria, Francesco; Sanguinetti, Maurizio; Palu, Giorgio; Brennan, Michael J.; Manganelli, Riccardo; Delogu, Giovanni			PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2	PLOS ONE			English	Article							PE-PGRS PROTEINS; PORPHYROMONAS-GINGIVALIS; LIPOARABINOMANNAN; EXPRESSION; VIRULENCE; NECROSIS; BINDING; GENE; CD14; INTERNALIZATION	PE_PGRS represent a large family of proteins typical of pathogenic mycobacteria whose members are characterized by an N-terminal PE domain followed by a large Gly-Ala repeatrich C-terminal domain. Despite the abundance of PE_PGRS-coding genes in the Mycobacterium tuberculosis (Mtb) genome their role and function in the biology and pathogenesis still remains elusive. In this study, we generated and characterized an Mtb H37Rv mutant (Mtb Delta 33) in which the structural gene of PE_PGRS33, a prototypical member of the protein family, was inactivated. We showed that this mutant entered macrophages with an efficiency up to ten times lower than parental or complemented strains, while its efficiency in infecting pneumocytes remained unaffected. Interestingly, the lack of PE_PGRS33 did not affect the intracellular growth of this mutant in macrophages. Using a series of functional deletion mutants of the PE_PGRS33 gene to complement the Mtb Delta 33 strain, we demonstrated that the PGRS domain is required to mediate cell entry into macrophages, with the key domain encompassing position 140-260 amino acids of PE_PGRS33. PE_PGRS33-mediated entry into macrophages was abolished in TLR2-deficient mice, as well as following treatment with wortmannin or an antibody against the complement receptor 3 (CR3), indicating that PE_PGRS33-mediated entry of Mtb in macrophages occurs through interaction with TLR2.	[Palucci, Ivana; Camassa, Serena; Sali, Michela; Zumbo, Antonella; Minerva, Mariachiara; Iantomasi, Raffaella; De Maio, Flavio; Sanguinetti, Maurizio; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, L Go A Gemelli 8, I-00168 Rome, Italy; [Di Sante, Gabriele; Ria, Francesco] Univ Cattolica Sacro Cuore, Inst Gen Pathol, L Go A Gemelli 8, I-00168 Rome, Italy; [Cascioferro, Alessandro; Anoosheh, Saber; Palu, Giorgio; Manganelli, Riccardo] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy; [Brennan, Michael J.] Aeras, Rockville, MD USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua	Delogu, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Microbiol, L Go A Gemelli 8, I-00168 Rome, Italy.	giovanni.delogu@unicatt.it	Di Sante, Gabriele/K-8629-2016; De Maio, Flavio/J-9452-2018; Manganelli, Riccardo/A-7361-2009; De Maio, Flavio/AAL-7355-2021; De Maio, Flavio/AAD-1076-2022; Cascioferro, Alessandro/E-3445-2017; Di Sante, Gabriele/N-5294-2018; Di Sante, Gabriele/N-5280-2018; Ria, Francesco/AAD-1174-2022; anoosheh, saber/D-1891-2011; Sanguinetti, Maurizio/A-1453-2019; Anoosheh, Saber/AAK-3400-2021; Di Sante, Gabriele/AHD-9850-2022; palucci, ivana/J-8542-2018	Di Sante, Gabriele/0000-0001-6608-3388; De Maio, Flavio/0000-0002-4744-9820; Manganelli, Riccardo/0000-0003-0940-7336; De Maio, Flavio/0000-0002-4744-9820; Cascioferro, Alessandro/0000-0001-7751-7348; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Ria, Francesco/0000-0001-7455-4290; anoosheh, saber/0000-0003-4614-0757; Sanguinetti, Maurizio/0000-0002-9780-7059; Di Sante, Gabriele/0000-0001-6608-3388; Minerva, Mariachiara/0000-0003-1518-7050; palucci, ivana/0000-0003-2106-1761	EU [201762]; MIUR PRIN [2008 Y8RZTF]	EU(European Commission); MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	Funded by EU (FP7/2007-2013) under grant agreement no201762 awarded to GD and RM and by MIUR PRIN (project number 2008 Y8RZTF) awarded to GD and RM.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Borrello S, 2011, INT J IMMUNOPATH PH, V24, P549, DOI 10.1177/039463201102400301; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dai SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003114; De Maio F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112482; Delogu G, 2014, CLIN MICROBIOL INFEC, V20, P59, DOI 10.1111/1469-0691.12460; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2008, HDB TUBERCULOSIS, P131; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dheenadhayalan V, 2006, J BACTERIOL, V188, P3721, DOI 10.1128/JB.188.10.3721-3725.2006; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Fenton MJ, 2008, BS TUBERCLE BACILLUS, P405; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Greco E, 2010, IMMUNOLOGY, V129, P125, DOI 10.1111/j.1365-2567.2009.03145.x; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Hajishengallis G, 2006, INFECT IMMUN, V74, P5658, DOI 10.1128/IAI.00784-06; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Harokopakis E, 2005, EUR J IMMUNOL, V35, P1201, DOI 10.1002/eji.200425883; Harokopakis E, 2006, J IMMUNOL, V176, P7645, DOI 10.4049/jimmunol.176.12.7645; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Klink M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073333; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; Means TK, 1999, J IMMUNOL, V163, P6748; Oliva C, 2009, P NATL ACAD SCI USA, V106, P13957, DOI 10.1073/pnas.0902392106; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Sendide K, 2005, J IMMUNOL, V174, P4210, DOI 10.4049/jimmunol.174.7.4210; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Talarico S, 2005, J CLIN MICROBIOL, V43, P4954, DOI 10.1128/JCM.43.10.4954-4960.2005; Talarico S, 2008, TUBERCULOSIS, V88, P283, DOI 10.1016/j.tube.2008.01.001; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Wang J, 2011, TUBERCULOSIS, V91, P287, DOI 10.1016/j.tube.2011.05.001; *WHO, 2004, GLOB TUB CONTR SURV; ZHANG YH, 1993, J CLIN INVEST, V91, P2076, DOI 10.1172/JCI116430; Zumbo A, 2013, PATHOG DIS, V69, P232, DOI 10.1111/2049-632X.12096	56	44	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150800	10.1371/journal.pone.0150800	http://dx.doi.org/10.1371/journal.pone.0150800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978522	gold, Green Submitted, Green Published			2022-12-26	WOS:000372572800037
J	Alves, AV; Sanjinez-Argandona, EJ; Linzmeier, AM; Cardoso, CAL; Macedo, MLR				Alves, Ariana Vieira; Sanjinez-Argandona, Eliana Janet; Linzmeier, Adelita Maria; Lima Cardoso, Claudia Andrea; Rodrigues Macedo, Maria Ligia			Food Value of Mealworm Grown on Acrocomia aculeata Pulp Flour	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ANTIOXIDANT CAPACITY; TENEBRIO-MOLITOR; FATTY-ACIDS; SUPPLEMENTATION; INSECTS; FEED; OIL	Insects have played an important role as human food throughout history, especially in Africa, Asia and Latin America. A good example of edible insects is the mealworm, Tenebrio molitor Linnaeus, 1758 (Coleoptera, Tenebrionidae), which are eaten in Africa, Asia, the Americas and Australia. This species is easily bred in captivity, requiring simple management. The bocaiuva (Acrocomia aculeata (Jacq.) Lodd) is an abundant palm tree found in the Brazilian Cerrado, providing fruits with high nutritional value. The aim of this work was to determine the chemical composition of T. molitor grown in different artificial diets with bocaiuva pulp flour. The nutritional composition, fatty acid composition, antioxidant activity, trypsin activity and anti-nutritional factors of larvae were analyzed. The results showed that mealworms grown on artificial diet with bocaiuva are a good source of protein (44.83%) and lipid (40.45%), with significant levels of unsaturated fatty acids (65.99%), antioxidant activity (4.5 mu M Trolox/g of oil extracted from larvae) and absence of anti-nutritional factors. This study indicates a new source of biomass for growing mealworms and shows that it is possible to breed mealworms in artificial diet with bocaiuva flour without compromising the nutritional quality of the larvae.	[Alves, Ariana Vieira; Sanjinez-Argandona, Eliana Janet] Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dourados, MS, Brazil; [Linzmeier, Adelita Maria] Fed Univ Fronteira Sul, Realeza, Parana, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Course Chem, Dourados, MS, Brazil; [Rodrigues Macedo, Maria Ligia] Univ Fed Mato Grosso do Sul, Dept Nat Sci, Lab Prot Purificat & Biol Funct, Campo Grande, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Fronteira Sul; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Alves, AV (corresponding author), Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dourados, MS, Brazil.	arianavieiralves@gmail.com	Cardoso, Claudia Andrea Lima/AAK-5578-2020; Linzmeier, Adelita/A-9239-2013; Argandoña, Eliana Janet EJSA Sanjinez/J-6524-2012	Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Argandoña, Eliana Janet EJSA Sanjinez/0000-0001-9377-8839; Macedo, Maria Ligia/0000-0001-6969-6307; Linzmeier, Adelita Maria/0000-0002-2979-8728	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Masters scholarship (Benefitted: AVA): Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) [http://fundect.ledes.net/]. Additional financial support was provided for equipments (Benefitted: EJSA): Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [http://www.capes.gov.br/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Miranda ED, 2002, J AGR FOOD CHEM, V50, P192, DOI 10.1021/jf010691y; [Anonymous], 2010, FAO Food Nutr Pap, V91, P1; [Anonymous], 2010, ESTUDO POTENCIAL ANT; [Anonymous], 2011, TAB BRAS COMP AL; [Anonymous], 2003, OFFICIAL METHODS ANA, P17; AOAC Association of Official Analytical Chemists, 2005, OFFICIAL METHODS ANA, P18; Araujo J.M.A., 2011, QUIMICA ALIMENTOS TE, V5; Atwater WO, 1896, FARMERS B, P28; Bednarova M, 2013, ACTA U AGR SILVICULT, V16; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bovera F, 2015, BRIT POULTRY SCI, V56, P569, DOI 10.1080/00071668.2015.1080815; Costa Neto Eraldo M., 2006, Boletin de la SEA, V38, P423; Costa-Neto EM, 2002, THESIS SOC ENTOMOLOG; Decker E.A., 2000, ANTIOXIDANTS MUSCLE; DeFoliart GR, 2012, HUMAN USE INSECTS FO; Dessimoni-Pinto N. A. V., 2010, Alimentos e Nutricao, V21, P79; Durst P. B., 2010, Forest insects as food: humans bite back. Proceedings of a workshop on Asia-Pacific resources and their potential for development, Chiang Mai, Thailand, 19-21 February, 2008, P1; Dutra-De-Oliveira JED, 2008, CIENCIAS NUTR APREND; FAO, 2010, FOR INS FOOD HUM BIT; FAO, 2009, ETUDES TRAVAUX LASDE; GraphPad, 1999, GRAPHPAD PRISM VERS; 유정미, 2013, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V42, P249; Ingram J, 2011, FOOD SECUR, V3, P417, DOI 10.1007/s12571-011-0149-9; Johnson V. D., 2010, FOREST INSECTS FOOD, P5; Jongema Y, 2012, LIST EDIBLE INSECTS; Karasov WH., 1997, HDB COMP PHYSL, P409, DOI 10.1002/cphy.cp130107; Kralik G, 2010, ACTA VET BRNO, V79, P363, DOI 10.2754/avb201079030363; Lescano CH, 2014, J MED FOOD, V00, P1; Ramos MIL, 2008, CIENCIA TECNOL ALIME, V28, P90, DOI 10.1590/S0101-20612008000500015; Longvah T, 2011, FOOD CHEM, V128, P400, DOI 10.1016/j.foodchem.2011.03.041; Marineli RD, 2012, FOOD RES INT, V49, P487, DOI 10.1016/j.foodres.2012.07.022; Marono S., 2015, Italian Journal of Animal Science, V14, P338; Mitsuhashi J., 2010, Forest insects as food: humans bite back. Proceedings of a workshop on Asia-Pacific resources and their potential for development, Chiang Mai, Thailand, 19-21 February, 2008, P115; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Premalatha M, 2011, RENEW SUST ENERG REV, V15, P4357, DOI 10.1016/j.rser.2011.07.115; de Oliveira CFR, 2011, PROCESS BIOCHEM, V46, P498, DOI 10.1016/j.procbio.2010.09.025; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Rumpold BA, 2013, INNOV FOOD SCI EMERG, V17, P1, DOI 10.1016/j.ifset.2012.11.005; Ruppert EE., 2005, ZOOLOGIA INVERTEBRAD; Sanjinez-Argandona EJ, 2011, REV BRAS FRUTIC, V33, P1023, DOI 10.1590/S0100-29452011000300040; Schiefenhovel W., 2009, Consuming the inedible: neglected dimensions of food choice, P163; Shockley M, 2013, MASS PRODUCTION BENE, P764; Siemianowska E., 2013, Agricultural Sciences, V4, P287; StatSoft, 2008, STAT DAT AN SOFTW SY; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Willhelm F. F., 2014, Nutrire - Revista da Sociedade Brasileira de Alimentacao e Nutricao, V39, P179, DOI 10.4322/nutrire.2014.016; Worldwatch Institute, 2010, EST MUND 2010 TRANSF; Yehuda S, 2002, NEUROBIOL AGING, V23, P843, DOI 10.1016/S0197-4580(02)00074-X; Zuo RT, 2013, BRIT J NUTR, V110, P1220, DOI 10.1017/S0007114513000378	51	35	36	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151275	10.1371/journal.pone.0151275	http://dx.doi.org/10.1371/journal.pone.0151275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974840	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600061
J	Adebiyi, OA; Adebiyi, OO; Owira, PMO				Adebiyi, Olubunmi A.; Adebiyi, Oluwafeyisetan O.; Owira, Peter M. O.			Naringin Reduces Hyperglycemia-Induced Cardiac Fibrosis by Relieving Oxidative Stress	PLOS ONE			English	Article							ISOPROTERENOL-INDUCED CARDIOTOXICITY; DIABETIC CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; HIGH GLUCOSE; REGULATING ENZYMES; COLLAGEN-SYNTHESIS; NADPH OXIDASE; WISTAR RATS; DYSFUNCTION; ANTIOXIDANTS	Introduction Hyperglycemia promotes myocardial fibrotic lesions through upregulation of PKC and p38 in response to redox changes. The effects of naringin on hyperglycemia-induced myocardial fibrotic changes and its putative effects on PKC-beta and p38 protein expression in type 1 rat model of diabetes are hereby investigated. Methods Male Sprague-Dawley rats were divided into six groups I-VI. Groups I and II, were orally treated with distilled water {3.0 ml/kg body weight (BW)} and naringin (50 mg/kg BW), respectively. Groups III, IV, V and VI were rendered diabetic by a single intraperitoneal injection of streptozotocin (60 mg/kg, BW) and were similarly treated with subcutaneous insulin (8.0 I. U/kg BW, twice daily), naringin (50 mg/kg BW), distilled water (3.0 ml/Kg BW) and ramipril (3.0 mg/kg/BW), respectively. The animals were sacrificed after 56 days by halothane overdose; blood and heart samples removed for further analysis. Results The untreated diabetic rats exhibited significantly increased oxidative stress, NADPH oxidase activity, increased cardiac fibrosis, PKC-beta and p38 mitogen activated protein kinase expression compared to controls. Naringin treatment significantly ameliorated these changes in diabetic rats compared to the untreated diabetic controls. Conclusions Naringin's amelioration of myocardial fibrosis by modulating p38 and PKC-beta protein expression possibly through its known antioxidant actions and may therefore be useful in retarding the progression of fibrosis in a diabetic heart.	[Adebiyi, Olubunmi A.; Adebiyi, Oluwafeyisetan O.; Owira, Peter M. O.] Univ KwaZulu Natal, Sch Hlth Sci, Dept Pharmacol, Mol & Clin Pharmacol Res Lab,Discipline Pharmaceu, POB X5401, Durban, South Africa	University of Kwazulu Natal	Owira, PMO (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Dept Pharmacol, Mol & Clin Pharmacol Res Lab,Discipline Pharmaceu, POB X5401, Durban, South Africa.	owirap@ukzn.ac.za			Grants and Scholarships Administration of the Medical Research Council of South Africa; College of Health Sciences, University of KwaZulu-Natal; office of Grants and Scholarships Administration of the Medical Research Council of South Africa	Grants and Scholarships Administration of the Medical Research Council of South Africa; College of Health Sciences, University of KwaZulu-Natal; office of Grants and Scholarships Administration of the Medical Research Council of South Africa	This study was supported partially by funding from the Grants and Scholarships Administration of the Medical Research Council of South Africa through Career Development award and the College of Health Sciences, University of KwaZulu-Natal. There was no additional external funding received for this work. The funders did not participate in the study, nor did they have any influence on the conduct or reporting of this study.; Special thanks to the technical staff of the biomedical resource unit of the University of KwaZulu-Natal, for their kind technical assistance in carrying out the animal experiments. We are indebted to the office of Grants and Scholarships Administration of the Medical Research Council of South Africa for the Career Development award that partially funded this project.	Adel AM, 2011, NAT SCI, V7, P134; Ahmed OM, 2011, LIFE SCI J, V8, P91; Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Baker KM, 2004, REGUL PEPTIDES, V120, P5, DOI 10.1016/j.regpep.2004.04.004; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959; Chen JF, 2014, BASIC CLIN PHARMACOL, V114, P293, DOI 10.1111/bcpt.12153; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Huang HL, 2013, INT J MOL MED, V32, P396, DOI 10.3892/ijmm.2013.1403; Huynh K, 2014, PHARMACOL THERAPEUT, V142, P375, DOI 10.1016/j.pharmthera.2014.01.003; Huynh K, 2013, FREE RADICAL BIO MED, V60, P307, DOI 10.1016/j.freeradbiomed.2013.02.021; Jagetia G. C., 2002, MUTAT RES, V19, P37; Jellis C, 2010, J AM COLL CARDIOL, V56, P89, DOI 10.1016/j.jacc.2010.02.047; Jeon SM, 2004, CLIN NUTR, V23, P1025, DOI 10.1016/j.clnu.2004.01.006; Jeon SM, 2002, CLIN CHIM ACTA, V317, P181, DOI 10.1016/S0009-8981(01)00778-1; Johar S, 2004, CIRCULATION, V110, P188; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Jung UJ, 2004, J NUTR, V134, P2499, DOI 10.1093/jn/134.10.2499; Kanno S, 2003, J PHARMACOL SCI, V92, P166, DOI 10.1254/jphs.92.166; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Ogata T, 2004, J AM COLL CARDIOL, V43, P1481, DOI 10.1016/j.jacc.2003.11.043; Pari L, 2010, INT J BIOL MED RES, V1, P206; Pitt B, 2012, CIRC-CARDIOVASC IMAG, V5, P9, DOI 10.1161/CIRCIMAGING.111.971143; Punithavathi VR, 2008, J APPL TOXICOL, V28, P806, DOI 10.1002/jat.1343; Qin FZ, 2007, FREE RADICAL BIO MED, V43, P271, DOI 10.1016/j.freeradbiomed.2007.04.021; Rajadurai M, 2007, TOXICOLOGY, V232, P216, DOI 10.1016/j.tox.2007.01.006; Rajadurai M, 2006, TOXICOLOGY, V228, P259, DOI 10.1016/j.tox.2006.09.005; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; Spinale FG, 2002, CIRC RES, V91, P1082, DOI 10.1161/01.RES.0000047874.80576.5A; Tokudome T, 2004, METABOLISM, V53, P710, DOI 10.1016/j.metabol.2004.01.006; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Xulu S, 2012, J CARDIOVASC PHARM, V59, P133, DOI 10.1097/FJC.0b013e31823827a4; Zhao WY, 2008, MOL CELL BIOCHEM, V317, P43, DOI 10.1007/s11010-008-9803-8	38	35	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149890	10.1371/journal.pone.0149890	http://dx.doi.org/10.1371/journal.pone.0149890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967518	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200006
J	Morales, ME; Derbes, RS; Ade, CM; Ortego, JC; Stark, J; Deininger, PL; Roy-Engel, AM				Morales, Maria E.; Derbes, Rebecca S.; Ade, Catherine M.; Ortego, Jonathan C.; Stark, Jeremy; Deininger, Prescott L.; Roy-Engel, Astrid M.			Heavy Metal Exposure Influences Double Strand Break DNA Repair Outcomes	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; MAMMALIAN-CELLS; GENE-EXPRESSION; PATHWAY CHOICE; ALU ELEMENTS; CADMIUM; INHIBITION; PROTEINS; LEUKEMIA; GENOME	Heavy metals such as cadmium, arsenic and nickel are classified as carcinogens. Although the precise mechanism of carcinogenesis is undefined, heavy metal exposure can contribute to genetic damage by inducing double strand breaks (DSBs) as well as inhibiting critical proteins from different DNA repair pathways. Here we take advantage of two previously published culture assay systems developed to address mechanistic aspects of DNA repair to evaluate the effects of heavy metal exposures on competing DNA repair outcomes. Our results demonstrate that exposure to heavy metals significantly alters how cells repair double strand breaks. The effects observed are both specific to the particular metal and dose dependent. Low doses of NiCl2 favored resolution of DSBs through homologous recombination (HR) and single strand annealing (SSA), which were inhibited by higher NiCl2 doses. In contrast, cells exposed to arsenic trioxide preferentially repaired using the "error prone" non-homologous end joining (alt-NHEJ) while inhibiting repair by HR. In addition, we determined that low doses of nickel and cadmium contributed to an increase in mutagenic recombination-mediated by Alu elements, the most numerous family of repetitive elements in humans. Sequence verification confirmed that the majority of the genetic deletions were the result of Alu-mediated non-allelic recombination events that predominantly arose from repair by SSA. All heavy metals showed a shift in the outcomes of alt-NHEJ repair with a significant increase of non-templated sequence insertions at the DSB repair site. Our data suggest that exposure to heavy metals will alter the choice of DNA repair pathway changing the genetic outcome of DSBs repair.	[Morales, Maria E.; Derbes, Rebecca S.; Ortego, Jonathan C.; Deininger, Prescott L.; Roy-Engel, Astrid M.] Dept Epidemiol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Morales, Maria E.; Derbes, Rebecca S.; Ortego, Jonathan C.; Deininger, Prescott L.; Roy-Engel, Astrid M.] Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Morales, Maria E.; Derbes, Rebecca S.; Ortego, Jonathan C.; Deininger, Prescott L.; Roy-Engel, Astrid M.] Tulane Univ, Hlth Sci Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Ade, Catherine M.] Tulane Univ, Dept Cellular & Mol Biol, 6400 Freret St, New Orleans, LA 70118 USA; [Stark, Jeremy] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA	Tulane University; Tulane University; Tulane University; Tulane University; City of Hope; Beckman Research Institute of City of Hope	Roy-Engel, AM (corresponding author), Dept Epidemiol, 1430 Tulane Ave, New Orleans, LA 70112 USA.; Roy-Engel, AM (corresponding author), Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.; Roy-Engel, AM (corresponding author), Tulane Univ, Hlth Sci Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.	aengel@tulane.edu			National Institutes of Health (NIH) [R01GM079709A, R01GM045668, P20GM103518/P20RR020152, R01CA120954]; Office of Research of Tulane University; NATIONAL CANCER INSTITUTE [R01CA120954] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045668, P20GM103518, R01GM079709] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research of Tulane University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) R01GM079709A (AMR-E), R01GM045668 (PLD), P20GM103518/P20RR020152 (AMR-E and PLD) and R01CA120954 to JMS. Bridge funds from the Office of Research of Tulane University were also awarded to AMR-E. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or Tulane University.	Ade C, 2013, CURR OPIN VIROL, V3, P639, DOI 10.1016/j.coviro.2013.09.002; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Andrew AS, 2003, INT J CANCER, V104, P263, DOI 10.1002/ijc.10968; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Arita A, 2013, CANCER EPIDEM BIOMAR, V22, P261, DOI 10.1158/1055-9965.EPI-12-1011; Asara Y, 2013, INT J MOL SCI, V14, P16600, DOI 10.3390/ijms140816600; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; de Smith AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003104; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Ding J, 2009, CANCER EPIDEM BIOMAR, V18, P1720, DOI 10.1158/1055-9965.EPI-09-0115; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; HARTWIG A, 1994, CANCER RES, V54, P4045; Hartwig A, 2002, FOOD CHEM TOXICOL, V40, P1179, DOI 10.1016/S0278-6915(02)00043-1; Hartwig A, 2001, ANTIOXID REDOX SIGN, V3, P625, DOI 10.1089/15230860152542970; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kitada K, 2013, CYTOGENET GENOME RES, V139, P1, DOI 10.1159/000342885; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee PC, 2010, NEOPLASIA, V12, P376, DOI 10.1593/neo.10110; Martinez VD, 2013, J THORAC ONCOL, V8, P1451, DOI 10.1097/JTO.0b013e3182a4dd8e; McNeill DR, 2004, ENVIRON HEALTH PERSP, V112, P799, DOI 10.1289/ehp.7038; Morales ME, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005016; NISHIOKA H, 1975, MUTAT RES, V31, P185, DOI 10.1016/0165-1161(75)90088-6; NORDBERG GF, 1981, ENVIRON HEALTH PERSP, V40, P65, DOI 10.2307/3429221; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Sakai C, 2014, ANTICANCER RES, V34, P6489; Schwerdtle T, 2010, CHEM RES TOXICOL, V23, P432, DOI 10.1021/tx900444w; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; VAINIO H, 1993, SCAND J WORK ENV HEA, V19, P360; Vargas-Poussou R, 2011, J AM SOC NEPHROL, V22, P693, DOI 10.1681/ASN.2010090907; Viau M, 2008, MUTAT RES-GEN TOX EN, V654, P13, DOI 10.1016/j.mrgentox.2008.04.009; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; White TB, 2015, MOB GENET ELEMENTS, V5; Witherspoon DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-530; Zhou ZH, 2012, TOXICOL SCI, V125, P412, DOI 10.1093/toxsci/kfr320	47	92	94	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151367	10.1371/journal.pone.0151367	http://dx.doi.org/10.1371/journal.pone.0151367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966913	Green Submitted, gold, Green Published			2022-12-26	WOS:000371989200048
J	Radchenko, M; Nie, RX; Lu, M				Radchenko, Martha; Nie, Rongxin; Lu, Min			Disulfide Cross-linking of a Multidrug and Toxic Compound Extrusion Transporter Impacts Multidrug Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE TRANSPORTER; STRUCTURAL BASIS; MATE; PROXIMITY; ANTIPORTER; MECHANISM; FAMILY; LOOPS; NORM	Multidrug and toxic compound extrusion (MATE) transporters contribute to multidrug resistance by extruding different drugs across cell membranes. The MATE transporters alternate between their extracellular and intracellular facing conformations to propel drug export, but how these structural changes occur is unclear. Here we combine site-specific cross-linking and functional studies to probe the movement of transmembrane helices in NorM from Neiserria gonorrheae (NorM-NG), a MATE transporter with known extracellular facing structure. We generated an active, cysteine-less NorM-NG and conducted pairwise cysteine mutagenesis on this variant. We found that copper phenanthroline catalyzed disulfide bond formation within five cysteine pairs and increased the electrophoretic mobility of the corresponding mutants. Furthermore, copper phenanthroline abolished the activity of the five paired cysteine mutants, suggesting that these substituted amino acids come in spatial proximity during transport, and the proximity changes are functionally indispensable. Our data also implied that the substrate-binding transmembrane helices move up to 10 angstrom in NorM-NG during transport and afforded distance restraints for modeling the intracellular facing transporter, thereby casting new light on the underlying mechanism.	[Radchenko, Martha; Nie, Rongxin; Lu, Min] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science	Lu, M (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	min.lu@rosalindfranklin.edu	NIE, RONGXIN/ABI-3206-2020		National Institutes of Health [R01-GM094195]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01-GM094195 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kubo Y, 2000, J BIOL CHEM, V275, P5270, DOI 10.1074/jbc.275.8.5270; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lu M, 2016, CHANNELS, V10, P88, DOI 10.1080/19336950.2015.1106654; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Radchenko M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8995; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Steed PR, 2013, BIOCHEMISTRY-US, V52, P5790, DOI 10.1021/bi4008935; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Valdes R, 2012, J BIOL CHEM, V287, P44036, DOI 10.1074/jbc.M112.414433	23	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9818	9826		10.1074/jbc.M116.715227	http://dx.doi.org/10.1074/jbc.M116.715227			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26975373	Green Published, hybrid			2022-12-26	WOS:000375602300038
J	Oxlade, O; Sugarman, J; Alvarez, GG; Pai, M; Schwartzman, K				Oxlade, Olivia; Sugarman, Jordan; Alvarez, Gonzalo G.; Pai, Madhukar; Schwartzman, Kevin			Xpert (R) MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation	PLOS ONE			English	Article							HYPOTHETICAL TRIAL; GENEXPERT MTB/RIF; XPERT MTB/RIF; SPUTUM	Background Tuberculosis (TB) remains a significant health problem in the Canadian Arctic. Substantial health system delays in TB diagnosis can occur, in part due to the lack of capacity for onsite microbiologic testing. A study recently evaluated the yield and impact of a rapid automated PCR test (Xpert (R) MTB/RIF) for the diagnosis of TB in Iqaluit (Nunavut). We conducted an economic analysis to evaluate the expected cost relative to the expected reduction in time to treatment initiation, with the addition of Xpert (R) MTB/RIF to the current diagnostic and treatment algorithms used in this setting. Methods A decision analysis model compared current microbiologic testing to a scenario where Xpert (R) MTB/RIF was added to the current diagnostic algorithm for active TB, and incorporated costs and clinical endpoints from the Iqaluit study. Several sensitivity analyses that considered alternative use were also considered. We estimated days to TB diagnosis and treatment initiation, health system costs, and the incremental cost per treatment day gained for each individual evaluated for possible TB. Results With the addition of Xpert (R) MTB/RIF, costs increased while days to TB treatment initiation were reduced. The incremental cost per treatment day gained (per individual investigated for TB) was $164 (95% uncertainty range $85, $452). In a sensitivity analysis that considered hospital discharge after a single negative Xpert (R) MTB/RIF, the Xpert (R) MTB/RIF scenario was cost saving. Interpretation Adding Xpert (R) MTB/RIF to the current diagnostic algorithm for TB in Nunavut appears to reduce time to diagnosis and treatment at reasonable cost. It may be especially well suited to overcome some of the other logistical barriers that are unique to this and other remote communities.	[Oxlade, Olivia; Sugarman, Jordan; Pai, Madhukar; Schwartzman, Kevin] McGill Univ, Dept Epidemiol, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Oxlade, Olivia; Pai, Madhukar; Schwartzman, Kevin] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Alvarez, Gonzalo G.] Ottawa Hosp Res Inst, Clin Epidemiol, Ottawa, ON, Canada; [Alvarez, Gonzalo G.] Univ Ottawa, Dept Med, Div Respirol, Ottawa, ON, Canada	McGill University; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Schwartzman, K (corresponding author), McGill Univ, Dept Epidemiol, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.; Schwartzman, K (corresponding author), McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada.	kevin.schwartzman@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Alvarez, Gonzalo G/0000-0003-1562-5305	Canadian Institutes of Health Research [MOP 89918, AOH 126659]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Support was provided by the Canadian Institutes of Health Research MOP 89918 to MP GA & AOH 126659 to KS OO JS [www.cihr.irsc.gc.ca]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GG, 2015, CHEST, V148, P767, DOI 10.1378/chest.14-2948; [Anonymous], 2013, PAT COST EST; [Anonymous], 2008, NUNAVUT NURSES SALAR; Bank of Canada, INFL CALC; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chaisson LH, 2014, CLIN INFECT DIS, V59, P1353, DOI 10.1093/cid/ciu620; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; Davis JL, 2014, AM J RESP CRIT CARE, V189, P1551, DOI 10.1164/rccm.201311-1974OC; Goverment of Canada, 2011, CAN CENS; Koppaka R, 2004, TOMANS TUBERCULOSIS, P51; Langley I, 2014, LANCET GLOB HEALTH, V2, pE581, DOI 10.1016/S2214-109X(14)70291-8; McGuire M, 2015, Can Commun Dis Rep, V41, P8, DOI 10.14745/ccdr.v41is2a02; Menzies D., 2014, CANADIAN TUBERCULOSI, V7th; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Public Health Agency of Canada, 2002, 2002 2010 TUB CAN RE; References Public Health Agency of Canada, 2012, TUB CAN 2012 PRER; Schoch OD, 2007, AM J RESP CRIT CARE, V175, P80, DOI 10.1164/rccm.200608-1092OC; Sohn H, 2014, CLIN INFECT DIS; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Sugarman J, 2014, INT J TUBERC LUNG D, V18, P1223, DOI 10.5588/ijtld.14.0163; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; World Health Organization, 2013, TUB DIAGN XPERT MTB	24	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150119	10.1371/journal.pone.0150119	http://dx.doi.org/10.1371/journal.pone.0150119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990299	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800025
J	Liu, JP; Tang, ZH; Zhang, J; Chen, Q; Xu, PF; Liu, WZ				Liu, Jinping; Tang, Zhaohui; Zhang, Jin; Chen, Qing; Xu, Pengfei; Liu, Wenzhong			Visual Perception-Based Statistical Modeling of Complex Grain Image for Product Quality Monitoring and Supervision on Assembly Production Line	PLOS ONE			English	Article							COMPUTER-VISION; MACHINE VISION; TEXTURAL FEATURES; CLASSIFICATION; INSPECTION; WAVELET; RECOGNITION; ALGORITHM; DESIGN; SYSTEM	Computer vision as a fast, low-cost, noncontact, and online monitoring technology has been an important tool to inspect product quality, particularly on a large-scale assembly production line. However, the current industrial vision system is far from satisfactory in the intelligent perception of complex grain images, comprising a large number of local homogeneous fragmentations or patches without distinct foreground and background. We attempt to solve this problem based on the statistical modeling of spatial structures of grain images. We present a physical explanation in advance to indicate that the spatial structures of the complex grain images are subject to a representative Weibull distribution according to the theory of sequential fragmentation, which is well known in the continued comminution of ore grinding. To delineate the spatial structure of the grain image, we present a method of multi-scale and omnidirectional Gaussian derivative filtering. Then, a product quality classifier based on sparse multikernel-least squares support vector machine is proposed to solve the low-confidence classification problem of imbalanced data distribution. The proposed method is applied on the assembly line of a food-processing enterprise to classify (or identify) automatically the production quality of rice. The experiments on the real application case, compared with the commonly used methods, illustrate the validity of our method.	[Liu, Jinping; Xu, Pengfei] Hunan Normal Univ, Coll Math & Comp Sci, Changsha, Hunan, Peoples R China; [Liu, Jinping; Xu, Pengfei] Minist Educ China, Key Lab High Performance Comp & Stochast Informat, Changsha, Hunan, Peoples R China; [Liu, Jinping; Tang, Zhaohui; Zhang, Jin; Chen, Qing] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Liu, Wenzhong] Huazhong Univ Sci & Technol, Sch Automat, Wuhan 430074, Peoples R China	Hunan Normal University; Ministry of Education, China; Central South University; Huazhong University of Science & Technology	Tang, ZH (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	ljp202518@163.com	Liu, Jinping/AAM-7723-2021; Chen, QH/GXH-3158-2022	Liu, Jinping/0000-0002-8669-882X; 	National Natural Science Foundation of China [61501183, 61571199, 61472134, 61272337]; Young Teacher Foundation of Hunan Normal University [11405]; Science and Technology Planning Project of Hunan Province of China [2013FJ4051]; Scientific Research Foundation of Educational Commission of Hunan Province of China [13B065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teacher Foundation of Hunan Normal University; Science and Technology Planning Project of Hunan Province of China; Scientific Research Foundation of Educational Commission of Hunan Province of China	This work is supported by the National Natural Science Foundation of China (Nos. 61501183, 61571199, 61472134, and 61272337), http://www.nsfc.gov.cn, and is partly supported by the Young Teacher Foundation of Hunan Normal University under Grant Number 11405, Science and Technology Planning Project of Hunan Province of China under Grant Number 2013FJ4051, and Scientific Research Foundation of Educational Commission of Hunan Province of China under Grant Number 13B065.	Arce SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02266; Aujol JF, 2006, INT J COMPUT VISION, V67, P111, DOI 10.1007/s11263-006-4331-z; Brosnan T, 2002, COMPUT ELECTRON AGR, V36, P193, DOI 10.1016/S0168-1699(02)00101-1; Brosnan T, 2004, J FOOD ENG, V61, P3, DOI 10.1016/S0260-8774(03)00183-3; BROWN WK, 1989, J ASTROPHYS ASTRON, V10, P89, DOI 10.1007/BF02714980; BROWN WK, 1995, J APPL PHYS, V78, P2758, DOI 10.1063/1.360073; Cho CS, 2005, IEEE T IND ELECTRON, V52, P1073, DOI 10.1109/TIE.2005.851648; Choudhary R, 2008, BIOSYST ENG, V99, P330, DOI 10.1016/j.biosystemseng.2007.11.013; Cocchi M, 2005, ANAL CHIM ACTA, V544, P100, DOI 10.1016/j.aca.2005.02.075; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Fujii K, 2003, PSYCHOL RES-PSYCH FO, V67, P197, DOI 10.1007/s00426-002-0113-6; Gao LX, 2010, SENSORS-BASEL, V10, P4602, DOI 10.3390/s100504602; Geusebroek JM, 2005, INT J COMPUT VISION, V62, P7, DOI 10.1007/s11263-005-4632-7; Ghahramani Z, 2015, NATURE, V521, P452, DOI 10.1038/nature14541; Golnabi H, 2007, ROBOT CIM-INT MANUF, V23, P630, DOI 10.1016/j.rcim.2007.02.005; Guo ZH, 2010, PATTERN RECOGN, V43, P706, DOI 10.1016/j.patcog.2009.08.017; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He MF, 2013, MINER ENG, V53, P203, DOI 10.1016/j.mineng.2013.08.011; Huang W, 2011, SENSORS-BASEL, V11, P506, DOI 10.3390/s110100506; Jackman P, 2013, TRENDS FOOD SCI TECH, V29, P35, DOI 10.1016/j.tifs.2012.08.008; Kassim AA, 2007, IMAGE VISION COMPUT, V25, P1080, DOI 10.1016/j.imavis.2006.05.024; KOHONEN T, 1990, INT JOINT C NEUR NET, V1, P545; Kumar A, 2008, IEEE T IND ELECTRON, V55, P348, DOI 10.1109/TIE.1930.896476; Kurtulmus F, 2015, EXPERT SYST APPL, V42, P1880, DOI 10.1016/j.eswa.2014.10.003; Liu JP, 2013, INT J COMPUT INT SYS, V6, P969, DOI 10.1080/18756891.2013.809938; Liu JP, 2013, MINER ENG, V45, P128, DOI 10.1016/j.mineng.2013.02.003; Liu Jinping, 2010, Chinese Journal of Scientific Instrument, V31, P1769; Majumdar S, 2000, T ASAE, V43, P1681, DOI 10.13031/2013.3068; Maropoulos PG, 2014, INT J ADV MANUF TECH, V70, P621, DOI 10.1007/s00170-013-5283-4; Materka A, 1998, TEXTURE ANAL METHODS, P9; Molleda J, 2014, IEEE IND APPL MAG, V20, P35, DOI 10.1109/MIAS.2013.2288385; Povlow BR, 1993, TEXTURE CLASSIFICATI, P642; Rahman A., 2012, INT J COMPUTATIONAL, V2, P27; Simi M, 2013, IEEE-ASME T MECH, V18, P1140, DOI 10.1109/TMECH.2012.2198830; Srivastava A, 2003, J MATH IMAGING VIS, V18, P17, DOI 10.1023/A:1021889010444; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; TAMURA H, 1978, IEEE T SYST MAN CYB, V8, P460, DOI 10.1109/TSMC.1978.4309999; TSUGAWA S, 1994, IEEE T IND ELECTRON, V41, P398, DOI 10.1109/41.303790; Wilde M, 2014, IEEE T HUM-MACH SYST, V44, P200, DOI 10.1109/THMS.2013.2295298; Xian GM, 2010, EXPERT SYST APPL, V37, P6737, DOI 10.1016/j.eswa.2010.02.067; Xie Y, 2014, OPT LASER ENG, V52, P218, DOI 10.1016/j.optlaseng.2013.06.006; Yadav BK, 2001, COMPUT ELECTRON AGR, V33, P19, DOI 10.1016/S0168-1699(01)00169-7; Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059; Zeng XY, 2005, IEEE T NEURAL NETWOR, V16, P1541, DOI 10.1109/TNN.2005.852239; Zhang BH, 2014, FOOD RES INT, V62, P326, DOI 10.1016/j.foodres.2014.03.012; Zhang Y, 2010, PATTERN RECOGN LETT, V31, P2033, DOI 10.1016/j.patrec.2010.05.030	47	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0146484	10.1371/journal.pone.0146484	http://dx.doi.org/10.1371/journal.pone.0146484			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986726	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300009
J	Molnar, J; Szakacs, G; Tusnady, GE				Molnar, Janos; Szakacs, Gergely; Tusnady, Gabor E.			Characterization of Disease-Associated Mutations in Human Transmembrane Proteins	PLOS ONE			English	Article							MEMBRANE-PROTEINS; DATA-BANK; TOPOLOGY; PREDICTION; TRANSPORTER; DISCOVERY; VARIANTS; DOMAIN; GENES	Transmembrane protein coding genes are commonly associated with human diseases. We characterized disease causing mutations and natural polymorphisms in transmembrane proteins by mapping missense genetic variations from the UniProt database on the transmembrane protein topology listed in the Human Transmembrane Proteome database. We found characteristic differences in the spectrum of amino acid changes within transmembrane regions: in the case of disease associated mutations the non-polar to non-polar and non-polar to charged amino acid changes are equally frequent. In contrast, in the case of natural polymorphisms non-polar to charged amino acid changes are rare while non-polar to non-polar changes are common. The majority of disease associated mutations result in glycine to arginine and leucine to proline substitutions. Mutations to positively charged amino acids are more common in the center of the lipid bilayer, where they cause more severe structural and functional anomalies. Our analysis contributes to the better understanding of the effect of disease associated mutations in transmembrane proteins, which can help prioritize genetic variations in personal genomic investigations.	[Molnar, Janos; Szakacs, Gergely; Tusnady, Gabor E.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Tusnady, GE (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary.	tusnady.gabor@ttk.mta.hu	Szakacs, Gergely/A-2580-2009; Tusnády, Gábor E./AAI-1136-2021; Tusnády, Gábor E/A-3207-2009	Szakacs, Gergely/0000-0002-9311-7827; Tusnády, Gábor E./0000-0001-8105-0285; Tusnády, Gábor E/0000-0001-8105-0285	Hungarian Scientific Research Fund (OTKA) [K104586]; "Momentum" Program of the Hungarian Academy of Sciences [LP2015-35]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "Momentum" Program of the Hungarian Academy of Sciences; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian Scientific Research Fund (OTKA, K104586), and the "Momentum" Program of the Hungarian Academy of Sciences to GET (LP2015-35). Funding for open access charge: Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bamshad MJ, 2012, AM J MED GENET A, V158A, P1523, DOI 10.1002/ajmg.a.35470; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007; Dobson L, 2015, BIOL DIRECT UNPUB; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pD283, DOI 10.1093/nar/gku1119; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Fromme P, 2011, CURR OPIN STRUC BIOL, V21, P509, DOI 10.1016/j.sbi.2011.06.001; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Hristova K, 2011, J MEMBRANE BIOL, V239, P49, DOI 10.1007/s00232-010-9323-9; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P1049, DOI 10.3324/haematol.2008.002873; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kitterman JA, 2005, PEDIATRICS, V116, pE654, DOI 10.1542/peds.2005-0469; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; Liu H, 2015, AM J MED GENET A, V167, P1337, DOI 10.1002/ajmg.a.36969; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Newstead S, 2008, PROTEIN SCI, V17, P466, DOI 10.1110/ps.073263108; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; PRUSINER SB, 1994, WESTERN J MED, V161, P264; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Shu Y, 2003, P NATL ACAD SCI USA, V100, P5902, DOI 10.1073/pnas.0730858100; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Tompa P, 2001, P NATL ACAD SCI USA, V98, P4431, DOI 10.1073/pnas.071308398; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Vihinen M, 2015, NATURE, V521, P261, DOI 10.1038/521261a; Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	44	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151760	10.1371/journal.pone.0151760	http://dx.doi.org/10.1371/journal.pone.0151760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986070	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000372580300125
J	Vedel-Krogh, S; Nielsen, SF; Schnohr, P; Nordestgaard, BG				Vedel-Krogh, Signe; Nielsen, Sune F.; Schnohr, Peter; Nordestgaard, Borge G.			Morbidity and Mortality in 7,684 Women According to Personal Hair Dye Use: The Copenhagen City Heart Study followed for 37 Years	PLOS ONE			English	Article							NONFASTING TRIGLYCERIDES; INFLAMMATORY BIOMARKERS; RISK; CANCER; CARCINOGENICITY; HAIRDRESSERS; EXPOSURE; MELANOMA; ALCOHOL; DISEASE	Background Permanent hair dye contains aromatic amines which are carcinogenic, and can cause allergic skin reactions. In the long term personal use of hair dye might therefore influence both morbidity and mortality. Objectives We tested the hypothesis that personal use of hair dye in women is associated with increased morbidity and mortality in the general population. Methods We included 7,684 women from the Copenhagen City Heart Study with information on the use of personal hair dye. We assessed the risk of cancer, skin diseases, other morbidities, and mortality during a median follow-up of 27 years (range 0-37). Results The multivariable adjusted hazard ratio for malignant melanoma in women with versus without personal use of hair dye was 2.07 (95% confidence interval 1.25-3.42). There was no increased risk of other cancer types. For other skin diseases and other major causes of morbidity we found no differences between the two groups, except for a minor excess of digestive diseases and increased risk of Parkinson's disease among women using hair dye. Finally, we found no difference in all-cause mortality comparing women using personal hair dye or not. After correction for multiple comparisons, none of the results remained significant. However, in sensitivity analysis the excess risk of malignant melanoma remained increased with a hazard ratio of 2.58 (95% CI 1.33-5.03) among users of personal hair dye. Conclusions Personal use of hair dye does not have major influences on morbidity and mortality. Our finding of a 2-fold risk of malignant melanoma in women using hair dye is hypothesis generating.	[Vedel-Krogh, Signe; Nielsen, Sune F.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Vedel-Krogh, Signe; Nielsen, Sune F.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Vedel-Krogh, Signe; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Schnohr, Peter; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark.; Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark.; Nordestgaard, BG (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.; Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark.	Boerge.Nordestgaard@regionh.dk	Vedel-Krogh, Signe/AAH-5195-2019; Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220; Vedel-Krogh, Signe/0000-0002-0435-1110	Lundbeck Foundation, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen	Lundbeck Foundation, Denmark(Lundbeckfonden); Faculty of Health and Medical Sciences, University of Copenhagen	The study was funded by the Lundbeck Foundation, Denmark (www.lundbeckfonden.com) and the Faculty of Health and Medical Sciences, University of Copenhagen (www.sund.ku.dk). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the paper.	AMES BN, 1975, P NATL ACAD SCI USA, V72, P2423, DOI 10.1073/pnas.72.6.2423; APPLEYARD M, 1989, SCAND J SOC MED S, V41, P1; Axmon A, 2006, SCAND J WORK ENV HEA, V32, P51, DOI 10.5271/sjweh.976; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; Bolt HM, 2007, CRIT REV TOXICOL, V37, P521, DOI 10.1080/10408440701385671; Corbett JF, 1999, DYES PIGMENTS, V41, P127, DOI 10.1016/S0143-7208(98)00075-8; Corpechot C, 2010, J HEPATOL, V53, P162, DOI 10.1016/j.jhep.2010.02.019; Czene K, 2003, INT J CANCER, V105, P108, DOI 10.1002/ijc.11040; Dahl M, 1998, LANCET, V351, P1911, DOI 10.1016/S0140-6736(97)11419-2; Feizy V, 2009, J AM ACAD DERMATOL, V61, P532, DOI 10.1016/j.jaad.2009.01.040; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; Gao X, 2009, ANN NEUROL, V65, P76, DOI 10.1002/ana.21535; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Harling M, 2010, OCCUP ENVIRON MED, V67, P351, DOI 10.1136/oem.2009.050195; HOLMAN CDJ, 1983, BRIT J CANCER, V48, P599, DOI 10.1038/bjc.1983.234; IARC Monographs Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V99, P1; International Agency for Research on Cancer, 2004, IARC MONOGR EVAL CAR, V83, P1; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; McFadden JP, 2007, BRIT MED J, V334, P220, DOI 10.1136/bmj.39042.643206.BE; Moscato G, 2005, CHEST, V128, P3590, DOI 10.1378/chest.128.5.3590; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nielsen SF, 2012, CAN MED ASSOC J, V184, pE57, DOI 10.1503/cmaj.110167; Nikolaou V, 2014, BRIT J DERMATOL, V170, P11, DOI 10.1111/bjd.12492; Nohynek GJ, 2010, TOXICOL APPL PHARM, V243, P239, DOI 10.1016/j.taap.2009.12.001; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Olsson AR, 2001, ANN RHEUM DIS, V60, P934, DOI 10.1136/ard.60.10.934; OSTERLIND A, 1988, INT J CANCER, V42, P825, DOI 10.1002/ijc.2910420604; Pan TH, 2011, INT J CANCER, V128, P2251, DOI 10.1002/ijc.25912; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; SanchezGuerrero J, 1996, ARTHRITIS RHEUM, V39, P657, DOI 10.1002/art.1780390418; Schmidt JD, 2014, BRIT J DERMATOL, V170, P352, DOI 10.1111/bjd.12676; SONTAG JM, 1981, JNCI-J NATL CANCER I, V66, P591; Sosted H, 2004, CONTACT DERMATITIS, V50, P344, DOI 10.1111/j.0105-1873.2004.00362.x; Takkouche B, 2005, JAMA-J AM MED ASSOC, V293, P2516, DOI 10.1001/jama.293.20.2516; Takkouche B, 2009, INT J EPIDEMIOL, V38, P1512, DOI 10.1093/ije/dyp283; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Tokumoto Y, 2003, INTERNAL MED, V42, P1104, DOI 10.2169/internalmedicine.42.1104; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Varbo A, 2011, ANN NEUROL, V69, P628, DOI 10.1002/ana.22384; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Whiteman DC, 2006, J CLIN ONCOL, V24, P3172, DOI 10.1200/JCO.2006.06.1325; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang Y, 2008, AM J EPIDEMIOL, V167, P1321, DOI 10.1093/aje/kwn058	46	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151636	10.1371/journal.pone.0151636	http://dx.doi.org/10.1371/journal.pone.0151636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986063	Green Published, gold			2022-12-26	WOS:000372580300101
J	Werbrouck, E; Van Gansbeke, D; Vanreusel, A; De Troch, M				Werbrouck, Eva; Van Gansbeke, Dirk; Vanreusel, Ann; De Troch, Marleen			Temperature Affects the Use of Storage Fatty Acids as Energy Source in a Benthic Copepod (Platychelipus littoralis, Harpacticoida)	PLOS ONE			English	Article							BIOCHEMICAL-COMPOSITION; SELECTIVE MOBILIZATION; MICROBIAL BIOMASS; STARVATION; LIPIDS; METABOLISM; ZOOPLANKTON; DYNAMICS; RESERVES; DAPHNIA	The utilization of storage lipids and their associated fatty acids (FA) is an important means for organisms to cope with periods of food shortage, however, little is known about the dynamics and FA mobilization in benthic copepods (order Harpacticoida). Furthermore, lipid depletion and FA mobilization may depend on the ambient temperature. Therefore, we subjected the temperate copepod Platychelipus littoralis to several intervals (3, 6 and 14 days) of food deprivation, under two temperatures in the range of the normal habitat temperature (4, 15 degrees C) and under an elevated temperature (24 degrees C), and studied the changes in FA composition of storage and membrane lipids. Although bulk depletion of storage FA occurred after a few days of food deprivation under 4 degrees C and 15 degrees C, copepod survival remained high during the experiment, suggesting the catabolization of other energy sources. Ambient temperature affected both the degree of FA depletion and the FA mobilization. In particular, storage FA were more exhausted and FA mobilization was more selective under 15 degrees C compared with 4 degrees C. In contrast, depletion of storage FA was limited under an elevated temperature, potentially due to a switch to partial anaerobiosis. Food deprivation induced selective DHA retention in the copepod's membrane, under all temperatures. However, prolonged exposure to heat and nutritional stress eventually depleted DHA in the membranes, and potentially induced high copepod mortality. Storage lipids clearly played an important role in the short-term response of the copepod P. littoralis to food deprivation. However, under elevated temperature, the use of storage FA as an energy source is compromised.	[Werbrouck, Eva; Van Gansbeke, Dirk; Vanreusel, Ann; De Troch, Marleen] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium	Ghent University	Werbrouck, E (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium.	eva.werbrouck@ugent.be	De Troch, Marleen/AAB-9809-2019	De Troch, Marleen/0000-0002-6800-0299	Ghent University [BOF-GOA 01GA1911W]; Research Foundation of Flanders [31523814, FWO12/ASP/319]	Ghent University(Ghent University); Research Foundation of Flanders(FWO)	EW is a fellow with the Research Foundation of Flanders (no. FWO12/ASP/319; http://www.fwo.be/en/). This research was further financed by Ghent University (BOF-GOA 01GA1911W). The FA analyses were supported by the Research Foundation of Flanders in the form of a research grant (31523814 - Fatty acids as dietary tracers in benthic food webs) awarded to MDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir S, 2008, J EXP MAR BIOL ECOL, V354, P1, DOI 10.1016/j.jembe.2007.08.024; Abele D, 2002, J EXP BIOL, V205, P1831; Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P237, DOI 10.1007/978-0-387-89366-2_10; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Arts MT, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P71; Azovsky AI, 2005, MAR BIOL, V148, P327, DOI 10.1007/s00227-005-0086-2; BAMSTEDT U, 1978, SARSIA, V63, P225, DOI 10.1080/00364827.1978.10411344; BLANCHARD GF, 1990, MAR ECOL PROG SER, V68, P101, DOI 10.3354/meps068101; Boschker HTS, 1999, LIMNOL OCEANOGR, V44, P309, DOI 10.4319/lo.1999.44.2.0309; Brett MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P115, DOI 10.1007/978-0-387-89366-2_6; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CASTELLINI MA, 1992, EXPERIENTIA, V48, P575, DOI 10.1007/BF01920242; Chapkin RS, 2002, LIPIDS, V37, P193, DOI 10.1007/s11745-002-0880-8; Christie W., 1989, GAS CHROMATOGRAPHY L; Clarke KR, 2006, PRIMER V6 USER MANUA; Cnudde C., 2013, TROPHIC ECOLOGY INTE; Cnudde C, 2015, MAR ECOL PROG SER, V524, P225, DOI 10.3354/meps11161; Combe JP, 2005, REMOTE SENS ENVIRON, V98, P371, DOI 10.1016/j.rse.2005.07.010; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; De Troch M, 2012, MAR ECOL PROG SER, V465, P53, DOI 10.3354/meps09920; EDER K, 1995, J CHROMATOGR B, V671, P113, DOI 10.1016/0378-4347(95)00142-6; ELENDT BP, 1990, J CRUSTACEAN BIOL, V10, P79, DOI 10.2307/1548671; Evjemo JO, 2001, AQUACULTURE, V193, P65, DOI 10.1016/S0044-8486(00)00470-1; FINDLAY RH, 1989, APPL ENVIRON MICROB, V55, P2888, DOI 10.1128/AEM.55.11.2888-2893.1989; Garcia-Esquivel Z, 2002, COMP BIOCHEM PHYS A, V133, P63, DOI 10.1016/S1095-6433(02)00112-5; GIERE O, 1993, MEIOBENTHOLOGY MICRO; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; Hagen W, 2001, ZOOL-ANAL COMPLEX SY, V104, P313, DOI 10.1078/0944-2006-00037; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Helland S, 2003, MAR BIOL, V143, P297, DOI 10.1007/s00227-003-1092-x; Hervant F, 1999, J EXP BIOL, V202, P3587; HICKS GRF, 1983, OCEANOGR MAR BIOL, V21, P67; Hulbert AJ, 2014, J COMP PHYSIOL B, V184, P149, DOI 10.1007/s00360-013-0786-8; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Jesus B, 2005, ESTUAR COAST SHELF S, V65, P30, DOI 10.1016/j.ecss.2005.05.005; Johnston DJ, 2004, COMP BIOCHEM PHYS B, V138, P137, DOI 10.1016/j.cbpc.2004.02.013; Kattner G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P257, DOI 10.1007/978-0-387-89366-2_11; Koussoroplis AM, 2014, LIMNOL OCEANOGR, V59, P947, DOI 10.4319/lo.2014.59.3.0947; Lang K, 1948, MONOGRPAHIE HARPACTI, V2; LEE RF, 1970, J LIPID RES, V11, P237; LEE RF, 1975, COMP BIOCHEM PHYS B, V52, P265, DOI 10.1016/0305-0491(75)90063-2; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; MAYZAUD P, 1976, MAR BIOL, V37, P47, DOI 10.1007/BF00386778; Mezek T, 2010, AQUAT ECOL, V44, P397, DOI 10.1007/s10452-009-9299-7; NILSSON P, 1987, MAR ECOL PROG SER, V39, P267, DOI 10.3354/meps039267; Olsen Y, 2014, AQUACULTURE, V428, P203, DOI 10.1016/j.aquaculture.2014.03.002; Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; Persson J, 2006, FRESHWATER BIOL, V51, P887, DOI 10.1111/j.1365-2427.2006.01540.x; Portner HO, 2012, MAR ECOL PROG SER, V470, P273, DOI 10.3354/meps10123; Pond DW, 2012, J PLANKTON RES, V34, P443, DOI 10.1093/plankt/fbs027; RACLOT T, 1995, J LIPID RES, V36, P2164; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; Ritar AJ, 2003, COMP BIOCHEM PHYS A, V136, P353, DOI 10.1016/S1095-6433(03)00167-3; Rychek EA, 2005, LIPIDS, V40, P599, DOI 10.1007/s11745-005-1421-1; Sahan E, 2007, AQUAT MICROB ECOL, V47, P253, DOI 10.3354/ame047253; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; Schlechtriem C, 2008, J GREAT LAKES RES, V34, P143, DOI 10.3394/0380-1330(2008)34[143:EOLFOT]2.0.CO;2; Schlechtriem C, 2006, LIPIDS, V41, P397, DOI 10.1007/s11745-006-5111-9; Schulte PM, 2015, J EXP BIOL, V218, P1856, DOI 10.1242/jeb.118851; Shields RJ, 1999, J NUTR, V129, P1186, DOI 10.1093/jn/129.6.1186; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Stuart JA, 1998, AM J PHYSIOL-REG I, V275, pR1977, DOI 10.1152/ajpregu.1998.275.6.R1977; Suderman K, 1998, MAR ECOL PROG SER, V164, P245, DOI 10.3354/meps164245; TESSIER AJ, 1983, LIMNOL OCEANOGR, V28, P667, DOI 10.4319/lo.1983.28.4.0667; TYLER S, 1984, J EXP ZOOL, V232, P1, DOI 10.1002/jez.1402320102; van Dooremalen C, 2010, J INSECT PHYSIOL, V56, P178, DOI 10.1016/j.jinsphys.2009.10.002; VANDENBERGHE W, 1981, MAR ECOL PROG SER, V4, P213, DOI 10.3354/meps004213; Veit-Kohler G, 2010, MAR BIOL, V157, P1819, DOI 10.1007/s00227-010-1454-0; VIRTUE P, 1993, MAR BIOL, V117, P441; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Williams JL, 2004, MAR BIOL, V144, P335, DOI 10.1007/s00227-003-1189-2; Wyckmans M, 2007, J EXP MAR BIOL ECOL, V345, P119, DOI 10.1016/j.jembe.2007.02.002	75	21	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151779	10.1371/journal.pone.0151779	http://dx.doi.org/10.1371/journal.pone.0151779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986852	Green Published, gold			2022-12-26	WOS:000372580300130
J	Yu, WY; Wardrop, NA; Bain, RES; Lin, YZ; Zhang, C; Wright, JA				Yu, Weiyu; Wardrop, Nicola A.; Bain, Robert E. S.; Lin, Yanzhao; Zhang, Ce; Wright, Jim A.			A Global Perspective on Drinking-Water and Sanitation Classification: An Evaluation of Census Content	PLOS ONE			English	Article								Following the recent expiry of the United Nations' 2015 Millennium Development Goals (MDGs), new international development agenda covering 2030 water, sanitation and hygiene (WASH) targets have been proposed, which imply new demands on data sources for monitoring relevant progress. This study evaluates drinking-water and sanitation classification systems from national census questionnaire content, based upon the most recent international policy changes, to examine national population census's ability to capture drinking-water and sanitation availability, safety, accessibility, and sustainability. In total, 247 censuses from 83 low income and lower-middle income countries were assessed using a scoring system, intended to assess harmonised water supply and sanitation classification systems for each census relative to the typology needed to monitor the proposed post-2015 indicators of WASH targets. The results signal a lack of international harmonisation and standardisation in census categorisation systems, especially concerning safety, accessibility, and sustainability of services in current census content. This suggests further refinements and harmonisation of future census content may be necessary to reflect ambitions for post-2015 monitoring.	[Yu, Weiyu; Wardrop, Nicola A.; Zhang, Ce; Wright, Jim A.] Univ Southampton, Geog & Environm, Southampton, Hants, England; [Bain, Robert E. S.] United Nations Childrens Fund, New York, NY USA; [Lin, Yanzhao] Yunnan Univ, Resource Environm & Earth Sci, Kunming City, Yunnan Province, Peoples R China	University of Southampton; UNICEF; Yunnan University	Yu, WY; Wright, JA (corresponding author), Univ Southampton, Geog & Environm, Southampton, Hants, England.	yurhcp@126.com; J.A.Wright@soton.ac.uk	Yu, Weiyu/AAV-4385-2020; Zhang, Ce/J-4906-2019; Wright, Jim/C-7881-2013	Zhang, Ce/0000-0001-5100-3584; Wright, Jim/0000-0002-8842-2181	Medical Research Council, UK [MR/J012343/1]; MRC [MR/J012343/1] Funding Source: UKRI; Medical Research Council [MR/J012343/1] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NAW was funded by the Medical Research Council, UK (project MR/J012343/1), web address: http://www.mrc.ac.uk/. No other individuals employed or contracted by the funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, INT PUBL US MICR SER; [Anonymous], 2015, JMP GREEN PAP GLOB M; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Esteve A, 2003, HIST METHOD, V36, P66, DOI 10.1080/01615440309601216; Flores O B, 2015, SOC INDIC RES, V2, P1; Gunther I, 2010, POLICY RES WORKING P, V5275; Kayser GL, 2013, INT J ENV RES PUB HE, V10, P4812, DOI 10.3390/ijerph10104812; Morning A, 2008, POPUL RES POLICY REV, V27, P239, DOI 10.1007/s11113-007-9062-5; Romilly G, 2015, FINANCING FUTURE INT; Stoler J, 2012, J WATER SANIT HYG DE, V2, P223, DOI 10.2166/washdev.2012.104; United Nations Department of Economic and Social Affairs, 2010, HDB POP HOUS CENS ED; United Nations General Assembly, 2010, HUM RIGHT WAT SAN A, P3; United Nations General Assembly, 2014, REP OP WORK GROUP GE; Van Koppen B, 2006, MULTIPLE USE WATERS; WHO Regional Office for Europe, 2014, WHO EXP M METH TOOLS, P12; WHO UNICEF, 2011, REP 1 CONS POST 2015; WHO/UNICEF, 2006, COR QUEST DRINK WAT; WHO UNICEF, 2014, WHO UNICEF JMP TASK; WHO UNICEF, 2012, JMP WORK GROUP EQ NO; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; WHO UNICEF, 2015, PROGR WAT SAN 2015 U; WHO UNICEF, 2012, REP 2 CONS POST 2015; World Bank, 2014, ANN REP REG; World Bank, 2014, UPD INC CLASS; World Health Organization United Nations Children's Fund, IMPR UN WAT SAN FAC; Yu WY, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0113-3	26	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151645	10.1371/journal.pone.0151645	http://dx.doi.org/10.1371/journal.pone.0151645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986472	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000372580300103
J	Di Bartolo, N; Compton, ELR; Warne, T; Edwards, PC; Tate, CG; Schertler, GFX; Booth, PJ				Di Bartolo, Natalie; Compton, Emma L. R.; Warne, Tony; Edwards, Patricia C.; Tate, Christopher G.; Schertler, Gebhard F. X.; Booth, Paula J.			Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support	PLOS ONE			English	Article							POTASSIUM CHANNEL KCSA; MEMBRANE-PROTEIN; IN-VITRO; TRANSPORT PROTEIN; LIGAND-BINDING; STABILITY; CRYSTALLIZATION; PURIFICATION; PROTEOLYSIS; EXPRESSION	The factors defining the correct folding and stability of integral membrane proteins are poorly understood. Folding of only a few select membrane proteins has been scrutinised, leaving considerable deficiencies in knowledge for large protein families, such as G protein coupled receptors (GPCRs). Complete reversible folding, which is problematic for any membrane protein, has eluded this dominant receptor family. Moreover, attempts to recover receptors from denatured states are inefficient, yielding at best 40-70% functional protein. We present a method for the reversible unfolding of an archetypal family member, the beta(1)-adrenergic receptor, and attain 100% recovery of the folded, functional state, in terms of ligand binding, compared to receptor which has not been subject to any unfolding and retains its original, folded structure. We exploit refolding on a solid support, which could avoid unwanted interactions and aggregation that occur in bulk solution. We determine the changes in structure and function upon unfolding and refolding. Additionally, we employ a method that is relatively new to membrane protein folding; pulse proteolysis. Complete refolding of beta(1)-adrenergic receptor occurs in n-decyl-beta-D-maltoside (DM) micelles from a urea-denatured state, as shown by regain of its original helical structure, ligand binding and protein fluorescence. The successful refolding strategy on a solid support offers a defined method for the controlled refolding and recovery of functional GPCRs and other membrane proteins that suffer from instability and irreversible denaturation once isolated from their native membranes.	[Di Bartolo, Natalie; Booth, Paula J.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Compton, Emma L. R.] Univ Strathclyde, Org & Staff Dev Unit, Glasgow, Lanark, Scotland; [Warne, Tony; Edwards, Patricia C.; Tate, Christopher G.] MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England; [Schertler, Gebhard F. X.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland	University of Bristol; University of Strathclyde; MRC Laboratory Molecular Biology; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Di Bartolo, N (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	natalie.dibartolo@bristol.ac.uk		Booth, Paula Jane/0000-0003-3893-360X; Warne, Tony/0000-0001-9646-6080; Schertler, Gebhard F.X./0000-0002-5846-6810; Compton-Daw, Emma/0000-0002-3832-7194	BBSRC [BB/G002037/1]; Wellcome Trust [72075]; Royal Society; Leverhulme Trust; Medical Research Council [MRC U10519215]; BBSRC [BB/G003653/1] Funding Source: UKRI; MRC [MC_U105197215] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003653/1, BB/G002037/1] Funding Source: researchfish; Medical Research Council [MC_U105197215] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge funding from BBSRC grant BB/G002037/1. PJB also thanks the Wellcome Trust (grant 72075) as well as the Royal Society for a Woflson Research Merit Award and Leverhulme Trust for a Research Fellowship. Research in CGT's laboratory was funded by a core grant from the Medical Research Council [MRC U10519215].	Baneres JL, 2011, TRENDS BIOTECHNOL, V29, P314, DOI 10.1016/j.tibtech.2011.03.002; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Barrera FN, 2005, BIOCHEMISTRY-US, V44, P14344, DOI 10.1021/bi050845t; Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Curnow P, 2011, P NATL ACAD SCI USA, V108, P14133, DOI 10.1073/pnas.1012594108; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Dahmane T, 2009, BIOCHEMISTRY-US, V48, P6516, DOI 10.1021/bi801729z; Ezure T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112874; Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107; Harris NJ, 2014, J MOL BIOL, V426, P1812, DOI 10.1016/j.jmb.2014.01.012; Hwa J, 2001, P NATL ACAD SCI USA, V98, P4872, DOI 10.1073/pnas.061632798; Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Miller D, 2009, J MOL BIOL, V393, P815, DOI 10.1016/j.jmb.2009.08.039; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Park Chiwook, 2006, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2011s46; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4; Sachse R, 2014, FEBS LETT, V588, P2774, DOI 10.1016/j.febslet.2014.06.007; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Skach WR, 2007, J CELL BIOL, V179, P1333, DOI 10.1083/jcb.200711107; vanKlompenburg W, 1997, FEBS LETT, V413, P109, DOI 10.1016/S0014-5793(97)00888-0; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014	32	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151582	10.1371/journal.pone.0151582	http://dx.doi.org/10.1371/journal.pone.0151582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982879	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000372574900099
J	Eckert, NR; Poston, B; Riley, ZA				Eckert, Nathanial R.; Poston, Brach; Riley, Zachary A.			Modulation of the Cutaneous Silent Period in the Upper-Limb with Whole-Body Instability	PLOS ONE			English	Article							NOCICEPTIVE WITHDRAWAL REFLEXES; OPTIMAL FEEDBACK-CONTROL; FUNCTIONAL-ORGANIZATION; UPPER EXTREMITY; MOTOR CONTROL; SPINAL-CORD; STIMULATION; HUMANS; RESPONSES; MOVEMENT	The silent period induced by cutaneous electrical stimulation of the digits has been shown to be task-dependent, at least in the grasping muscles of the hand. However, it is unknown if the cutaneous silent period is adaptable throughout muscles of the entire upper limb, in particular when the task requirements are substantially altered. The purpose of the present study was to examine the characteristics of the cutaneous silent period in several upper limb muscles when introducing increased whole-body instability. The cutaneous silent period was evoked in 10 healthy individuals with electrical stimulation of digit II of the right hand when the subjects were seated, standing, or standing on a wobble board while maintaining a background elbow extension contraction with the triceps brachii of similar to 5% of maximal voluntary contraction (MVC) strength. The first excitatory response (E1), first inhibitory response (CSP), and second excitatory response (E2) were quantified as the percent change from baseline and by their individual durations. The results showed that the level of CSP suppression was lessened (47.7 +/- 7.7% to 33.8 +/- 13.2% of baseline, p = 0.019) and the duration of the CSP inhibition decreased (p = 0.021) in the triceps brachii when comparing the seated and wobble board tasks. For the wobble board task the amount of cutaneous afferent inhibition of EMG activity in the triceps brachii decreased; which is proposed to be due to differential weighting of cutaneous feedback relative to the corticospinal drive, most likely due to presynaptic inhibition, to meet the demands of the unstable task.	[Eckert, Nathanial R.] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Poston, Brach] Univ Nevada, Dept Kinesiol & Nutr Sci, Las Vegas, NV 89154 USA; [Riley, Zachary A.] Indiana Univ Purdue Univ, Dept Kinesiol, Indianapolis, IN 46202 USA; [Eckert, Nathanial R.] Univ Florida, Dept Dent, Gainesville, FL USA	Indiana University System; Indiana University Bloomington; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of Florida	Riley, ZA (corresponding author), Indiana Univ Purdue Univ, Dept Kinesiol, Indianapolis, IN 46202 USA.	zariley@iupui.edu	Eckert, Nathanial/AGI-4504-2022	Eckert, Nathanial/0000-0002-0236-1809				Brinkworth RSA, 2003, J NEUROSCI METH, V122, P179, DOI 10.1016/S0165-0270(02)00321-7; CACCIA G, 1974, MINERVA MED, V64, P4884; Don R, 2008, EUR J NEUROSCI, V28, P559, DOI 10.1111/j.1460-9568.2008.06330.x; Floeter MK, 1998, MUSCLE NERVE, V21, P591, DOI 10.1002/(SICI)1097-4598(199805)21:5<591::AID-MUS5>3.0.CO;2-3; GARNETT R, 1980, J PHYSIOL-LONDON, V303, P351, DOI 10.1113/jphysiol.1980.sp013290; Inghilleri M, 1997, ELECTROMYOGR MOTOR C, V105, P109, DOI 10.1016/S0924-980X(97)96579-6; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Kofler M, 2004, CLIN NEUROPHYSIOL, V115, P1052, DOI 10.1016/j.clinph.2003.12.005; Kofler M, 2004, NEUROSCI LETT, V360, P69, DOI 10.1016/j.neulet.2004.02.035; Kofler M, 2003, J NEUROL SCI, V216, P67, DOI 10.1016/S0022-510X(03)00211-9; Kofler M, 2003, CLIN NEUROPHYSIOL, V114, P973, DOI 10.1016/S1388-2457(03)00060-9; Kofler M, 2001, CLIN NEUROPHYSIOL, V112, P1053, DOI 10.1016/S1388-2457(01)00540-5; Kofler M, 2008, EXP BRAIN RES, V188, P399, DOI 10.1007/s00221-008-1372-2; LEIS AA, 1992, MUSCLE NERVE, V15, P1345, DOI 10.1002/mus.880151209; Rose PK, 2003, NAT NEUROSCI, V6, P1243, DOI 10.1038/nn1203-1243; Schomburg E D, 2001, Acta Physiol Pharmacol Bulg, V26, P193; SCHOUENBORG J, 1990, EXP BRAIN RES, V83, P67; SCHOUENBORG J, 1992, EXP BRAIN RES, V90, P469; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Serrao M, 2006, J NEUROSCI, V26, P3505, DOI 10.1523/JNEUROSCI.5160-05.2006; Serrao M, 2001, CLIN NEUROPHYSIOL, V112, P2007, DOI 10.1016/S1388-2457(01)00675-7; SHEFNER JM, 1993, MUSCLE NERVE, V16, P278, DOI 10.1002/mus.880160306; Staude G, 1999, MED ENG PHYS, V21, P449, DOI 10.1016/S1350-4533(99)00067-3; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNCINI A, 1991, ELECTROEN CLIN NEURO, V81, P344, DOI 10.1016/0168-5597(91)90023-Q	26	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151520	10.1371/journal.pone.0151520	http://dx.doi.org/10.1371/journal.pone.0151520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981863	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900092
J	Hromadnikova, I; Li, S; Kotlabova, K; Dickinson, AM				Hromadnikova, Ilona; Li, Shuang; Kotlabova, Katerina; Dickinson, Anne M.			Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; TUMOR-CELLS; MEMBRANE EXPRESSION; CANCER-PATIENTS; IMMUNE-SYSTEM; CUTTING EDGE; STIMULATION; LYMPHOCYTES; NKG2D; HSP70	Previous studies from Multhoff and colleagues reported that plasma membrane Hsp70 acts as a tumour-specific recognition structure for activated NK cells, and that the incubation of NK cells with Hsp70 and/or a 14-mer peptide derived from the N-terminal sequence of Hsp70 (TKDNNLLGRFELSG, TKD, aa 450-463) plus a low dose of IL-2 triggers NK cell proliferation and migration, and their capacity to kill cancer cells expressing membrane Hsp70. Herein, we have used flow cytometry to determine the influence of in vitro stimulation of peripheral blood mononuclear cells from healthy individuals with IL-2 or IL-15, either alone or in combination with TKD peptide on the cell surface expression of CD94, NK cell activatory receptors (CD16, NK2D, NKG2C, NKp30, NKp44, NKp46, NKp80, KIR2DL4, DNAM-1 and LAMP1) and NK cell inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2 and NKR-P1A) by CD3+CD56+ (NKT), CD3+CD4+, CD3+CD8+ and CD19+ populations. NKG2D, DNAM-1, LAMP1 and NKR-P1A expression was upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD in NKT, CD8+ T cells and B cells. CD94 was upregulated in NKT and CD8+ T cells. Concurrently, an increase in a number of CD8+ T cells expressing LIR1/ILT-2 and CD4+ T cells positive for NKR-P1A was observed. The proportion of CD8+ T cells that expressed NKG2D was higher after IL-2/TKD treatment, when compared with IL-2 treatment alone. In comparison with IL-15 alone, IL-15/TKD treatment increased the proportion of NKT cells that were positive for CD94, LAMP1 and NKRP-1A. The more potent effect of IL-15/TKD on cell surface expression of NKG2D, LIR1/ILT-2 and NKRP-1A was observed in B cells compared with IL-15 alone. However, this increase was not of statistical significance. IL-2/TKD induced significant upregulation of LAMP1 in CD8+ T cells compared with IL-2 alone. Besides NK cells, other immunocompetent cells present within the fraction of peripheral blood mononuclear cells were influenced by the treatment with low-dose interleukins themselves or in combination with hsp70 derived (TKD) peptide.	[Hromadnikova, Ilona; Li, Shuang; Kotlabova, Katerina] Charles Univ Prague, Dept Mol Biol & Cell Pathol, Fac Med 3, Ruska 87, Prague 10000, Czech Republic; [Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Haematol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Charles University Prague; Newcastle University - UK	Hromadnikova, I (corresponding author), Charles Univ Prague, Dept Mol Biol & Cell Pathol, Fac Med 3, Ruska 87, Prague 10000, Czech Republic.	ilona.hromadnikova@lf3.cuni.cz	Hromadnikova, Ilona/E-1957-2017	Hromadnikova, Ilona/0000-0002-4396-3304; Dickinson, Anne/0000-0002-7356-7636; Kotlabova, Katerina/0000-0002-8824-4653	CellEurope project (FP7-People-ITN) [315963]	CellEurope project (FP7-People-ITN)	Work was supported by CellEurope project (FP7-People-2012-ITN, No. 315963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was done under the framework of CellEurope project (FP7-People-2012-ITN, No. 315963) coordinated by Professor Anne Dickinson from University of Newcastle upon Tyne, UK.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Bai YY, 2014, CLIN LAB, V60, P717, DOI 10.7754/Clin.Lab.2013.130435; Bjorkstrom NK, 2008, J IMMUNOL, V181, P4219, DOI 10.4049/jimmunol.181.6.4219; Bonanno G, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-129; Botzler C, 1999, EXP HEMATOL, V27, P470, DOI 10.1016/S0301-472X(98)00055-1; Brehm C, 2014, CANCER IMMUNOL IMMUN, V63, P821, DOI 10.1007/s00262-014-1556-5; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Dhanji S, 2003, J IMMUNOL, V171, P3442, DOI 10.4049/jimmunol.171.7.3442; Dunne J, 2001, J IMMUNOL, V167, P3129, DOI 10.4049/jimmunol.167.6.3129; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fouchaq B, 1999, EUR J BIOCHEM, V259, P379, DOI 10.1046/j.1432-1327.1999.00053.x; Franceschetti M, 2009, EXP HEMATOL, V37, P616, DOI 10.1016/j.exphem.2009.01.010; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Hantschel M, 2000, CELL STRESS CHAPERON, V5, P438, DOI 10.1379/1466-1268(2000)005<0438:HPMEOP>2.0.CO;2; Hodge G, 2013, RESPIROLOGY, V18, P369, DOI 10.1111/j.1440-1843.2012.02287.x; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/405295; Huenecke S, 2010, J IMMUNOTHER, V33, P200, DOI 10.1097/CJI.0b013e3181bb46f7; Iliopoulou EG, 2006, CLIN CANCER RES, V12, P6901, DOI 10.1158/1078-0432.CCR-06-0977; Jabri B, 2002, IMMUNITY, V17, P487, DOI 10.1016/S1074-7613(02)00427-2; Joshi SK, 2013, INT IMMUNOPHARMACOL, V17, P260, DOI 10.1016/j.intimp.2013.05.022; Kang N, 2005, TRANSPL P, V37, P782, DOI 10.1016/j.transproceed.2004.12.196; Kawamura T, 2009, J IMMUNOL, V182, P250, DOI 10.4049/jimmunol.182.1.250; Krause SW, 2004, CLIN CANCER RES, V10, P3699, DOI 10.1158/1078-0432.CCR-03-0683; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Kuylenstierna C, 2011, EUR J IMMUNOL, V41, P1913, DOI 10.1002/eji.200940278; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lin H, 2006, J LEUKOCYTE BIOL, V80, P164, DOI 10.1189/jlb.0705421; Malhotra A, 2011, IMMUNOTHERAPY-UK, V3, P1143, DOI [10.2217/IMT.11.102, 10.2217/imt.11.102]; Milani V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-50; Mingari MC, 1998, P NATL ACAD SCI USA, V95, P1172, DOI 10.1073/pnas.95.3.1172; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; Multhoff G, 1997, J IMMUNOL, V158, P4341; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Ota T, 2005, BLOOD, V106, P184, DOI 10.1182/blood-2004-11-4257; Payne KK, 2013, BREAST CANCER RES TR, V142, P45, DOI 10.1007/s10549-013-2733-5; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Rausch A, 2006, EUR J IMMUNOL, V36, P1156, DOI 10.1002/eji.200535290; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Romero P, 2001, J LEUKOCYTE BIOL, V70, P219; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sivori S, 2000, HUM IMMUNOL, V61, P1055, DOI 10.1016/S0198-8859(00)00201-9; Stangl S, 2006, J IMMUNOL, V176, P6270, DOI 10.4049/jimmunol.176.10.6270; Stangl S, 2011, P NATL ACAD SCI USA, V108, P733, DOI 10.1073/pnas.1016065108; Strauss-Albee DM, 2014, J IMMUNOL, V193, P4871, DOI 10.4049/jimmunol.1401821; Sugita J, 2010, ANN HEMATOL, V89, P115, DOI 10.1007/s00277-009-0780-0; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; TOPALIAN SL, 1987, ACTA HAEMATOL-BASEL, V78, P75, DOI 10.1159/000205907; Uldrich AP, 2005, J IMMUNOL, V175, P3092, DOI 10.4049/jimmunol.175.5.3092; Wang Jing, 2012, Zhonghua Er Ke Za Zhi, V50, P386; Wu MR, 2015, CANCER IMMUNOL IMMUN, V64, P409, DOI 10.1007/s00262-014-1648-2; Yang D, 2009, MOL IMMUNOL, V46, P1432, DOI 10.1016/j.molimm.2008.12.010; Zhou JJ, 2013, J REPROD IMMUNOL, V97, P197, DOI 10.1016/j.jri.2012.12.006	56	21	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151535	10.1371/journal.pone.0151535	http://dx.doi.org/10.1371/journal.pone.0151535			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982331	Green Published, gold			2022-12-26	WOS:000372574900095
J	Leighton, GM; Vander Meiden, L				Leighton, Gavin M.; Vander Meiden, Laura			Sociable Weavers Increase Cooperative Nest Construction after Suffering Aggression	PLOS ONE			English	Article							PHILETAIRUS-SOCIUS; PRACTICAL GUIDE; HELPERS PAY; EVOLUTION; BEHAVIOR; SEX; REPRODUCTION; PUNISHMENT; TRAGEDY; RELATEDNESS	The major transitions in evolution rely on the formation of stable groups that are composed of previously independent units, and the stability of these groups requires both cooperation and reduced conflict. Conflict over group resources may be common, as suggested by work in both cichlids and humans that has investigated how societies resolve conflict regarding investment in group resources, i.e. public goods. We investigated whether sociable weavers (Philetairus socius) use aggressive behaviors to modulate the cooperative behavior of group mates. We find that the individuals that build the communal thatch of the nest, i.e. the individuals most at risk of exploitation, are the most aggressive individuals. We show that individuals that invest in interior chamber maintenance, possibly a more selfish behavior, suffer relatively more aggression. After suffering aggression individuals significantly increase cooperative construction of the communal nest thatch. We show that cooperative individuals target aggression towards selfish individuals, and the individuals suffering aggression perform cooperative behaviors subsequent to suffering aggression. In addition to other evolutionary mechanisms, these results suggest that aggression, possibly via the pay-to-stay mechanism, is possibly being used to maintain a public good.	[Leighton, Gavin M.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Vander Meiden, Laura] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	Cornell University; University of Miami	Leighton, GM (corresponding author), Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA.	gml86@cornell.edu			National Science Foundation (IOS) [121500]; National Geographic [9274-13]; Robert E. Maytag Endowment	National Science Foundation (IOS)(National Science Foundation (NSF)); National Geographic(National Geographic Society); Robert E. Maytag Endowment	This work was funded by a National Science Foundation (http://www.nsf.gov/) grant to GML (IOS #121500), a National Geographic (www.nationalgeographic.com) Young Explorer's grant (#9274-13) awarded to GML, and the Robert E. Maytag Endowment.; The research performed here was approved by the University of Miami IACUC under protocol 12-098. We thank the Kuzikus property who housed us while we collected the data. This manuscript was improved by comments from J. David Van Dyken, M. Taborsky, and several anonymous referees. This work was funded by a National Science Foundation grant to GML (IOS #121500), a National Geographic Young Explorer's grant (#9274-13) awarded to GML, and the Robert E. Maytag Endowment.	[Anonymous], 2014, R LANG ENV STAT COMP; Bates D, LME4 LINEAR MIXED EF; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell MBV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5499; Bell MBV, 2012, P ROY SOC B-BIOL SCI, V279, P619, DOI 10.1098/rspb.2011.1093; Bergmuller R, 2005, ANIM BEHAV, V69, P19, DOI 10.1016/j.anbehav.2004.05.009; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Bush KL, 2005, CONSERV GENET, V6, P867, DOI 10.1007/s10592-005-9040-6; Cant MA, 2014, P NATL ACAD SCI USA, V111, P326, DOI 10.1073/pnas.1312626111; Cant MA, 2011, P ROY SOC B-BIOL SCI, V278, P170, DOI 10.1098/rspb.2010.1241; Clutton-Brock TH, 2002, SCIENCE, V297, P253, DOI 10.1126/science.1071412; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; COLLIAS EC, 1978, IBIS, V120, P1, DOI 10.1111/j.1474-919X.1978.tb04994.x; Cordero OX, 2012, P NATL ACAD SCI USA, V109, P20059, DOI 10.1073/pnas.1213344109; Covas R, 2008, BEHAV ECOL SOCIOBIOL, V63, P103, DOI 10.1007/s00265-008-0640-2; EMLEN ST, 1992, NATURE, V356, P331, DOI 10.1038/356331a0; FISCHER S, 2014, P BIOL SCI, V281, P1; Fisher RM, 2013, CURR BIOL, V23, P1120, DOI 10.1016/j.cub.2013.05.004; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Han JI, 2009, AUK, V126, P779, DOI 10.1525/auk.2009.08203; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Jackson DE, 2007, CURR BIOL, V17, pR650, DOI 10.1016/j.cub.2007.06.003; Johnson BR, 2013, CURR BIOL, V23, P2058, DOI 10.1016/j.cub.2013.08.050; Johnstone RA, 1999, P ROY SOC B-BIOL SCI, V266, P275, DOI 10.1098/rspb.1999.0633; Lacey E.A., 1991, P275; Leighton GM, 2015, BEHAV ECOL SOCIOBIOL, V69, P1835, DOI 10.1007/s00265-015-1996-8; Leighton GM, 2015, AVIAN BIOL RES, V8, P104, DOI 10.3184/175815515X14289391219157; Leighton GM, 2014, AVIAN BIOL RES, V7, P255, DOI 10.3184/175815514X14151918723245; Leighton GM, 2014, J ORNITHOL, V155, P927, DOI 10.1007/s10336-014-1075-3; Leighton GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091725; Leighton GM, 2015, J ORNITHOL, P1; MACLEAN G L, 1973, Ostrich, V44, P176, DOI 10.1080/00306525.1973.9639158; Monnin T, 2002, NATURE, V419, P61, DOI 10.1038/nature00932; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Quinones AE, 2016, P ROYAL SOC B, V371, P1; Raihani NJ, 2012, TRENDS ECOL EVOL, V27, P288, DOI 10.1016/j.tree.2011.12.004; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rat M, 2015, BEHAV ECOL SOCIOBIOL, V69, P437, DOI 10.1007/s00265-014-1856-y; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; REEVE HK, 1992, NATURE, V358, P147, DOI 10.1038/358147a0; REEVE HK, 1992, NATURE, V359, P823, DOI 10.1038/359823a0; Reeve HK, 1997, BEHAV ECOL, V8, P75, DOI 10.1093/beheco/8.1.75; Riehl C, 2010, CURR BIOL, V20, P1830, DOI 10.1016/j.cub.2010.09.005; SMITH JM, MAJOR TRANSITIONS EV; Stankowich T, 2002, ETHOLOGY, V108, P975, DOI 10.1046/j.1439-0310.2002.00830.x; Strassmann JE, 2011, P NATL ACAD SCI USA, V108, P10855, DOI 10.1073/pnas.1102451108; Taborsky M., 2016, COOPERATIVE BREEDING; Thompson FJ, 2014, BEHAV ECOL, V25, P706, DOI 10.1093/beheco/aru063; van Dijk RE, 2014, ECOL LETT, V17, P1141, DOI 10.1111/ele.12320; van Dijk RE, 2013, J AVIAN BIOL, V44, P102, DOI 10.1111/j.1600-048X.2012.05797.x; WHITE FN, 1975, IBIS, V117, P171, DOI 10.1111/j.1474-919X.1975.tb04205.x; Zottl M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2344; Zuur Alain F., 2009, P1	60	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150953	10.1371/journal.pone.0150953	http://dx.doi.org/10.1371/journal.pone.0150953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982704	Green Published, gold			2022-12-26	WOS:000372574900058
J	Qi, ZY; Wang, XL; Hao, S; Zhu, CL; He, WQ; Luo, WB				Qi, Zhengyang; Wang, Xiaolong; Hao, Shuang; Zhu, Chuanlin; He, Weiqi; Luo, Wenbo			Correlations of Electrophysiological Measurements with Identification Levels of Ancient Chinese Characters	PLOS ONE			English	Article							EXPERT OBJECT RECOGNITION; COGNITIVE-PROCESSES; FACE RECOGNITION; THETA; ALPHA; DELTA; COMPETITION; PERCEPTION; WORD; EEG	Studies of event-related potential (ERP) in the human brain have shown that the N170 component can reliably distinguish among different object categories. However, it is unclear whether this is true for different identifiable levels within a single category. In the present study, we used ERP recording to examine the neural response to different identification levels and orientations (upright vs. inverted) of Chinese characters. The results showed that P1, N170, and P250 were modulated by different identification levels of Chinese characters. Moreover, time frequency analysis showed similar results, indicating that identification levels were associated with object recognition, particularly during processing of a single categorical stimulus.	[Qi, Zhengyang; Wang, Xiaolong; Hao, Shuang; Zhu, Chuanlin; He, Weiqi; Luo, Wenbo] Liaoning Normal Univ, Res Ctr Brain & Cognit Neurosci, Dalian, Peoples R China; [Luo, Wenbo] Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China	Liaoning Normal University; Chongqing University of Arts & Sciences	He, WQ; Luo, WB (corresponding author), Liaoning Normal Univ, Res Ctr Brain & Cognit Neurosci, Dalian, Peoples R China.; Luo, WB (corresponding author), Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China.	weiqi79920686@sina.com; wenbo9390@sina.com			National Natural Science Foundation of China [31371033, 31170984]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	WL received the funding of the National Natural Science Foundation of China (31371033 and 31170984, http://www.nsfc.gov.cn/) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Campbell R, 2001, COGNITIVE BRAIN RES, V12, P233, DOI 10.1016/S0926-6410(01)00054-4; Cao XH, 2011, NEUROSCI LETT, V492, P165, DOI 10.1016/j.neulet.2011.02.002; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fan C, 2015, NEUROIMAGE, V110, P32, DOI 10.1016/j.neuroimage.2015.01.047; FARAH MJ, 1995, VISION RES, V35, P2089, DOI 10.1016/0042-6989(94)00273-O; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Hu L, 2014, J NEUROSCI, V34, P11439, DOI 10.1523/JNEUROSCI.1355-14.2014; Hu L, 2014, NEUROIMAGE, V84, P876, DOI 10.1016/j.neuroimage.2013.09.055; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kim KH, 2004, NEUROREPORT, V15, P1099, DOI 10.1097/00001756-200405190-00003; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Koyama S, 1998, NEUROPSYCHOLOGIA, V36, P83, DOI 10.1016/S0028-3932(97)00097-3; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rossion B, 2004, P NATL ACAD SCI USA, V101, P14521, DOI 10.1073/pnas.0405613101; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Rossion B, 2007, J COGNITIVE NEUROSCI, V19, P543, DOI 10.1162/jocn.2007.19.3.543; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Wang MY, 2011, BRAIN COGNITION, V77, P419, DOI 10.1016/j.bandc.2011.08.016; Wong ACN, 2005, COGN AFFECT BEHAV NE, V5, P306, DOI 10.3758/CABN.5.3.306; Wong ACN, 2007, VIS COGN, V15, P854, DOI 10.1080/13506280600948350; Yi SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118924; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zhang MX, 2011, PSYCHOPHYSIOLOGY, V48, P950, DOI 10.1111/j.1469-8986.2010.01153.x	35	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151133	10.1371/journal.pone.0151133	http://dx.doi.org/10.1371/journal.pone.0151133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982215	Green Submitted, gold, Green Published			2022-12-26	WOS:000372574900064
J	Rio-Rodriguez, D; Iglesias-Soler, E; del Olmo, MF				Rio-Rodriguez, Dan; Iglesias-Soler, Eliseo; Fernandez del Olmo, Miguel			Set Configuration in Resistance Exercise: Muscle Fatigue and Cardiovascular Effects	PLOS ONE			English	Article							K+-ATPASE ACTIVITY; BAROREFLEX SENSITIVITY; BLOOD-PRESSURE; PERCEIVED EXERTION; MOTOR CORTEX; STRENGTH; INHIBITION; INTENSITY; RESPONSES; RATINGS	Purpose Cardiovascular responses of traditional resistance (TS) training have been extensively explored. However, the fatigue mechanisms associated with an intra-set rest configuration (ISR) have not been investigated. This study compares two modalities of set configurations for resistance exercise that equates work to rest ratios and measures the central and peripheral fatigue in combination with cortical, hemodynamic and cardiovascular measures. Methods 11 subjects performed two isometric knee extension training sessions using TS and ISR configurations. Voluntary activation (VA), single twitch amplitude, low frequency fatigue (LFF), Mwave, motor evoked potential (MEP), short intracortical inhibition (SICI), intracortical facilitation (ICF) and heart rate variability were evaluated before and after each training session. During each session beat to beat heart rate, blood pressure and rate pressure product (RPP) were also evaluated. Results After exercise VA decreased significantly for TS but not for ISR (P < 0.001), single twitch amplitude and LFF values were lower for TS than ISR (P < 0.004), and SICI was reduced only for the TS configuration (P = 0.049). During exercise RPP values were significantly higher for the TS than for ISR (P = 0.001). RPP correlated with VA for TS (r = -.85 P < 0.001) suggesting a relationship between central fatigue and cardiovascular stress. Conclusions We conclude that ISR induced lower central and peripheral fatigue as well as lower cardiovascular stress in comparison with TS configuration. Our study suggests that set configuration is a key factor in the regulation of the neuromuscular and cardiovascular responses of resistance training.	[Rio-Rodriguez, Dan; Fernandez del Olmo, Miguel] Univ A Coruna, Fac Sports Sci & Phys Educ, Dept Phys Educ & Sport, Learning & Human Movement Control Grp, La Coruna, Spain; [Iglesias-Soler, Eliseo] Univ A Coruna, Fac Sports Sci & Phys Educ, Dept Phys Educ & Sport, Performance & Hlth Grp, La Coruna, Spain	Universidade da Coruna; Universidade da Coruna	del Olmo, MF (corresponding author), Univ A Coruna, Fac Sports Sci & Phys Educ, Dept Phys Educ & Sport, Learning & Human Movement Control Grp, La Coruna, Spain.	mafo@udc.es	Iglesias-Soler, Eliseo/G-5144-2010; Rio-Rodriguez, Dan/C-6775-2014	Iglesias-Soler, Eliseo/0000-0002-1212-4188; Fernandez del Olmo, Miguel/0000-0001-5325-503X; Rio-Rodriguez, Dan/0000-0002-1790-9013				Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Aughey RJ, 2007, J APPL PHYSIOL, V103, P39, DOI 10.1152/japplphysiol.00236.2006; Baum K, 2003, INT J SPORTS MED, V24, P441; Baumer T, 2002, EXP BRAIN RES, V146, P467, DOI 10.1007/s00221-002-1202-x; Bianchi AM, 1997, IEEE ENG MED BIOL, V16, P64, DOI 10.1109/51.620497; Bolgar MR, 2010, J SPORT SCI MED, V9, P557; Buchheit M, 2006, AM J PHYSIOL-HEART C, V291, pH451, DOI 10.1152/ajpheart.00008.2006; Buharin VE, 2014, J NEUROPHYSIOL, V111, P2656, DOI 10.1152/jn.00778.2013; Camm AJ, 1996, CIRCULATION, V93, P1043; Chin ER, 2006, CONTRIBUTION PH DEPE, P831; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Fisher JP, 2004, EXP PHYSIOL, V89, P639, DOI 10.1113/expphysiol.2004.028639; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gruet M, 2013, NEUROSCIENCE, V231, P384, DOI 10.1016/j.neuroscience.2012.10.058; Hardee JP, 2012, EUR J APPL PHYSIOL, V112, P3141, DOI 10.1007/s00421-011-2300-x; Heffernan KS, 2008, INT J SPORTS MED, V29, P289, DOI 10.1055/s-2007-965363; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Iglesias-Soler E, 2012, INT J SPORTS MED, V33, P351, DOI 10.1055/s-0031-1299699; Iglesias-Soler E, 2016, J SPORT SCI, V34, P1473, DOI 10.1080/02640414.2015.1119299; Iglesias-Soler E, 2015, CLIN PHYSIOL FUNCT I, V35, P250, DOI 10.1111/cpf.12158; Izquierdo M, 2006, J APPL PHYSIOL, V100, P1647, DOI 10.1152/japplphysiol.01400.2005; Kardos A, 2001, HYPERTENSION, V37, P911, DOI 10.1161/01.HYP.37.3.911; Keller-Ross ML, 2014, J APPL PHYSIOL, V116, P767, DOI 10.1152/japplphysiol.01129.2013; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Lagally KM, 2006, J STRENGTH COND RES, V20, P252, DOI 10.1519/00124278-200605000-00003; Leppik JA, 2004, J APPL PHYSIOL, V97, P1414, DOI 10.1152/japplphysiol.00964.2003; Maruyama A, 2006, CLIN NEUROPHYSIOL, V117, P864, DOI 10.1016/j.clinph.2005.12.019; Mayo X, 2014, PERCEPT MOTOR SKILL, V119, P825, DOI 10.2466/25.29.PMS.119c30z3; McCartney N, 1999, MED SCI SPORT EXER, V31, P31, DOI 10.1097/00005768-199901000-00007; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Millar PJ, 2014, SPORTS MED, V44, P345, DOI 10.1007/s40279-013-0118-x; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Mitchell JH, 2013, EXP PHYSIOL, V98, P867, DOI 10.1113/expphysiol.2012.071001; Morris MG, 2012, EUR J APPL PHYSIOL, V112, P337, DOI 10.1007/s00421-011-1970-8; Niemela TH, 2008, MED SCI SPORT EXER, V40, P864, DOI 10.1249/MSS.0b013e3181666f08; Ridding MC, 1999, EXP BRAIN RES, V126, P536, DOI 10.1007/s002210050762; SCHOTT J, 1995, EUR J APPL PHYSIOL O, V71, P337, DOI 10.1007/BF00240414; Stanley J, 2013, SPORTS MED, V43, P1259, DOI 10.1007/s40279-013-0083-4; Taylor AC, 2003, MED SCI SPORT EXER, V35, P251, DOI 10.1249/01.MSS.0000048725.15026.B5; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Tergau F, 2000, MED SCI SPORT EXER, V32, P1942, DOI 10.1097/00005768-200011000-00019; WESTERBLAD H, 1993, J APPL PHYSIOL, V75, P382, DOI 10.1152/jappl.1993.75.1.382	44	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151163	10.1371/journal.pone.0151163	http://dx.doi.org/10.1371/journal.pone.0151163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982500	gold, Green Submitted, Green Published			2022-12-26	WOS:000372574900066
J	Shaeib, F; Khan, SN; Thakur, M; Kohan-Ghadr, HR; Drewlo, S; Saed, GM; Pennathur, S; Abu-Soud, HM				Shaeib, Faten; Khan, Sana N.; Thakur, Mili; Kohan-Ghadr, Hamid-Reza; Drewlo, Sascha; Saed, Ghassan M.; Pennathur, Subramaniam; Abu-Soud, Husam M.			The Impact of Myeloperoxidase and Activated Macrophages on Metaphase II Mouse Oocyte Quality	PLOS ONE			English	Article							OXIDATIVE STRESS; HYDROGEN-PEROXIDE; NITRIC-OXIDE; PERITONEAL-FLUID; INFLAMMATORY MARKERS; FEMALE REPRODUCTION; MELATONIN; ENDOMETRIOSIS; INFERTILITY; IRON	Myeloperoxidase (MPO), an abundant heme-containing enzyme present in neutrophils, monocytes, and macrophages, is produced in high levels during inflammation, and associated with poor reproductive outcomes. MPO is known to generate hypochlorous acid (HOCl), a damaging reactive oxygen species (ROS) utilizing hydrogen peroxide (H2O2) and chloride (Cl-). Here we investigate the effect of activated immune cells and MPO on oocyte quality. Mouse metaphase II oocytes were divided into the following groups: 1) Incubation with a catalytic amount of MPO (40 nM) for different incubation periods in the presence of 100 mM Cl- with and without H2O2 and with and without melatonin (100 mu M), at 37 degrees C (n = 648/648 total number of oocytes in each group for oocytes with and without cumulus cells); 2) Co-cultured with activated mouse peritoneal macrophage and neutrophils cells (1.0 x 10(6) cells/ml) in the absence and presence ofmelatonin (200 mu M), an MPO inhibitor/ROS scavenger, for different incubation periods in HTF media, at 37 degrees C (n = 200/200); 3) Untreated oocytes incubated for 4 hrs as controls (n = 73/64). Oocytes were then fixed, stained and scored based on the microtubule morphology and chromosomal alignment. All treatments were found to negatively affect oocyte quality in a time dependent fashion as compared to controls. In all cases the presence of cumulus cells offered no protection; however significant protection was offered by melatonin. Similar results were obtained with oocytes treated with neutrophils. This work provides a direct link between MPO and decreased oocyte quality. Therefore, strategies to decrease MPO mediated inflammation may influence reproductive outcomes.	[Shaeib, Faten; Khan, Sana N.; Thakur, Mili; Kohan-Ghadr, Hamid-Reza; Drewlo, Sascha; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Shaeib, Faten; Khan, Sana N.; Thakur, Mili; Kohan-Ghadr, Hamid-Reza; Drewlo, Sascha; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA; [Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; University of Michigan System; University of Michigan; Wayne State University	Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA.; Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA.; Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	habusoud@med.wayne.edu	Kohan-Ghadr, Hamid-Reza/ABB-4848-2020; Drewlo, Sascha/AAS-9890-2020		National Institutes of Health [RO1HL066367, R01HL094230]; Children's Hospital of Michigan; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center [DK089503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094230, R01HL066367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant RO1HL066367 and R01HL094230, the Children's Hospital of Michigan, and the Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center (DK089503).	Agarwal A, 2004, REPROD BIOMED ONLINE, V9, P338, DOI 10.1016/S1472-6483(10)62151-7; Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Alvarez C, 2013, INDIAN J MED RES, V137, P331; Amjadi Fatemehsadat, 2014, Adv Biomed Res, V3, P1, DOI 10.4103/2277-9175.124626; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; [Anonymous], 1989, NEW ENGL J MED, V321, P327, DOI [10.1056/NEJM198908033210513, DOI 10.1056/NEJM198908033210513]; Arain F, 2015, PAK J MED SCI, V31, P694, DOI 10.12669/pjms.313.8003; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Banerjee J, 2013, FERTIL STERIL, V100, P578, DOI 10.1016/j.fertnstert.2013.04.030; Banerjee J, 2012, J PINEAL RES, V53, P122, DOI 10.1111/j.1600-079X.2012.00977.x; Banerjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035535; BEERS RF, 1952, J BIOL CHEM, V195, P133; Blair SA, 2013, J REPROD MED, V58, P107; Buyalos RP, 2000, CURR OPIN OBSTET GYN, V12, P377, DOI 10.1097/00001703-200010000-00006; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067; Cohen J, 2015, J ASSIST REPROD GEN, V32, P263, DOI 10.1007/s10815-014-0390-1; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; D'Angiolella V, 2007, CELL CYCLE, V6, P576, DOI 10.4161/cc.6.5.3934; da Silva CM, 2014, BIOMED PHARMACOTHER, V68, P899, DOI 10.1016/j.biopha.2014.08.005; Dalla Sega FV, 2014, BBA-MOL CELL RES, V1843, P806, DOI 10.1016/j.bbamcr.2014.01.011; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; DXTaRJR Annia Galano, 2013, AMFK AMK J PINEAL RE, V54, P245, DOI [10.1111/jpi.12010, DOI 10.1111/JPI.12010]; Edelstam G, 1998, INFLAMMATION, V22, P341, DOI 10.1023/A:1022322814288; EDELSTAM GAB, 1994, INFLAMMATION, V18, P141, DOI 10.1007/BF01534555; Eroglu A, 1998, FERTIL STERIL, V69, P944, DOI 10.1016/S0015-0282(98)00030-2; Eryilmaz OG, 2011, J ASSIST REPROD GEN, V28, P815, DOI 10.1007/s10815-011-9604-y; Fenton P J.., 2007, PURE APPL CHEM, V79, P2325; Findlay JK, 1994, MOL BIOL FEMALE REPR; Galijasevic S, 2008, BIOCHEMISTRY-US, V47, P2668, DOI 10.1021/bi702016q; Gazvani R, 2002, REPRODUCTION, V123, P217, DOI 10.1530/rep.0.1230217; Gorudko I. V., 2012, Biomeditsinskaya Khimiya, V58, P475; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Goud AP, 2006, BIOCHEMISTRY-US, V45, P11366, DOI 10.1021/bi060910e; Goud AP, 2005, BIOCHEMISTRY-US, V44, P11361, DOI 10.1021/bi050711f; Goud PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098720; Goud PT, 2014, FERTIL STERIL, V102, P151, DOI 10.1016/j.fertnstert.2014.03.053; Grulke S, 2008, CAN J VET RES, V72, P37; Gulcin I, 2003, J PINEAL RES, V34, P278; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HANEY AF, 1983, FERTIL STERIL, V39, P310; HONDA R, 1994, HUM REPROD, V9, P692, DOI 10.1093/oxfordjournals.humrep.a138573; Hugentobler SA, 2007, THERIOGENOLOGY, V68, P538, DOI 10.1016/j.theriogenology.2007.04.049; Imirzalioglu P, 2005, J PERIODONTOL, V76, P737, DOI 10.1902/jop.2005.76.5.737; Janeway A. A., 2001, IMMUNOBIOLOGY IMMUNE; Johnson JL, 2011, INFECT IMMUN, V79, P3607, DOI 10.1128/IAI.05043-11; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Khan SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132388; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kurdoglu Z, 2012, GYNECOL ENDOCRINOL, V28, P115, DOI 10.3109/09513590.2011.583959; Lamaita RM, 2012, REPROD SCI, V19, P704, DOI 10.1177/1933719111428518; Lamaita RM, 2012, J OBSTET GYNAECOL RE, V38, P810, DOI 10.1111/j.1447-0756.2011.01805.x; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lee SA, 2010, FERTIL STERIL, V93, P1260, DOI 10.1016/j.fertnstert.2008.11.024; Lindley EM, 2001, J ASSIST REPROD GEN, V18, P534, DOI 10.1023/A:1011991806423; LONDON SN, 1985, FERTIL STERIL, V43, P274; Lord T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106450; Lu T, 2008, BRIT J PHARMACOL, V154, P1308, DOI 10.1038/bjp.2008.173; Machado JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/350195; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Malpaux B, 2002, REPRODUCTION, P167; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Miyake Y, 2006, BIOL REPROD, V74, P501, DOI 10.1095/biolreprod.105.045641; MOTTA PM, 1995, HUM REPROD, V10, P2361; Ogino T, 2009, ADV EXP MED BIOL, V643, P451, DOI 10.1007/978-0-387-75681-3_47; OLIVE DL, 1985, FERTIL STERIL, V44, P772; Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Proteasa G, 2007, BIOCHEMISTRY-US, V46, P398, DOI 10.1021/bi0609725; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; Rambow J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00199; Rees MD, 2014, FREE RADICAL BIO MED, V72, P91, DOI 10.1016/j.freeradbiomed.2014.03.037; Reiter R J, 1980, Endocr Rev, V1, P109; Reiter RJ, 2012, MUTAT RES-REV MUTAT, V751, P7, DOI 10.1016/j.mrrev.2011.12.002; Riley CF, 2007, ACTA OBSTET GYN SCAN, V86, P877, DOI 10.1080/00016340701417398; Ruder EH, 2009, CURR OPIN OBSTET GYN, V21, P219, DOI 10.1097/GCO.0b013e32832924ba; Shaeib F, 2016, REPROD SCI, V23, P498, DOI 10.1177/1933719115607993; Shaeib F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120737; Shaeib F, 2013, FREE RADICAL BIO MED, V58, P154, DOI 10.1016/j.freeradbiomed.2012.12.007; Sliskovic I, 2009, FREE RADICAL BIO MED, V47, P1005, DOI 10.1016/j.freeradbiomed.2009.07.007; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Surrey ES, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/482959; Szaboova R, 2015, LONDON J PRIM CARE, V7, P55, DOI 10.1080/17571472.2015.11494378; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Talwar, MANUAL ASSISTED REPR, P280; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Tamura H, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-5; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Trinder D, 2002, GUT, V51, P290, DOI 10.1136/gut.51.2.290; Tripathi A, 2009, FREE RADICAL RES, V43, P287, DOI 10.1080/10715760802695985; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Valavanidis A, 2013, INT J ENV RES PUB HE, V10, P3886, DOI 10.3390/ijerph10093886; Gomez FJV, 2012, J PINEAL RES, V52, P349, DOI 10.1111/j.1600-079X.2011.00949.x; Wiersma JJ, 2008, MED SCI MONITOR, V14, pCR406; Wu RJ, 2004, HUM REPROD UPDATE, V10, P119, DOI 10.1093/humupd/dmh011; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200; ZELLER JM, 1987, AM J REPROD IMMUNOL, V13, P78	101	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151160	10.1371/journal.pone.0151160	http://dx.doi.org/10.1371/journal.pone.0151160			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982351	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900065
J	Hellmund, A; Berg, C; Geipel, A; Bludau, M; Heydweiller, A; Bachour, H; Muller, A; Muller, A; Gembruch, U				Hellmund, Astrid; Berg, Christoph; Geipel, Annegret; Bludau, Meike; Heydweiller, Andreas; Bachour, Haitham; Mueller, Andreas; Mueller, Annette; Gembruch, Ulrich			Prenatal Diagnosis and Evaluation of Sonographic Predictors for Intervention and Adverse Outcome in Congenital Pulmonary Airway Malformation	PLOS ONE			English	Article							CYSTIC ADENOMATOID MALFORMATION; FETAL LUNG LESIONS; EXTRACORPOREAL MEMBRANE-OXYGENATION; HEAD CIRCUMFERENCE RATIO; DIAPHRAGMATIC-HERNIA; BRONCHIOLOALVEOLAR CARCINOMA; PLEUROPULMONARY BLASTOMA; MANAGEMENT; HYDROPS; EXPERIENCE	Objective To describe antenatal findings and evaluate prenatal risk parameters for adverse outcome or need for intervention in fetuses with congenital pulmonary airway malformation (CPAM). Methods In our retrospective study all fetuses with a prenatal diagnosis of CPAM detected in our tertiary referral center between 2002 and 2013 were analyzed. Sonographic findings were noted and measurements of mass-to-thorax-ratio (MTR), congenital pulmonary airway malformation volume-ratio (CVR) and observed to expected lung-to head-ratio (o/e LHR) were conducted and correlated to fetal or neonatal morbidity and mortality and/or need for prenatal intervention. Results 67 fetuses with CPAM were included in the study. Hydropic fetuses were observed in 16.4% (11/67) of cases, prenatal intervention was undertaken in 9 cases; 7 pregnancies were terminated. The survival rate of non-hydropic fetuses with conservatively managed CPAM was 98.0%(50/51), the survival rate for hydropic fetuses with intention to treat was 42.9% (3/7). 10 (18.2%) children needed respiratory assistance. Fetuses with a CVR of <0.91 were significantly less likely to experience adverse outcome or need for prenatal intervention with sensitivity, specificity and positive/negative predictive value of 0.89, 0.71, 0.62 and 0.93, respectively. A MTR (mass-to-thorax-ratio) of <0.51 had a positive predictive value of 0.54 and a negative predictive value of 0.96 of adverse events with a sensitivity of 0.95 and a specificity of 0.63. The negative predictive value for o/e LHR of 45% was 0.84 with sensitivity, specificity and positive predictive value of 0.73, 0.68 and 0.52, respectively. Conclusions The majority of cases with CPAM have a favorable outcome. MTR and CVR are able to identify fetuses at risk, the o/e LHR is less sensitive.	[Hellmund, Astrid; Berg, Christoph; Geipel, Annegret; Bludau, Meike; Gembruch, Ulrich] Univ Bonn, Dept Obstet & Prenatal Med, Bonn, Germany; [Berg, Christoph] Univ Cologne, Div Prenatal Med & Gynecol Sonog, Dept Obstet & Gynecol, D-50931 Cologne, Germany; [Heydweiller, Andreas; Bachour, Haitham] Univ Bonn, Div Pediat Surg, Bonn, Germany; [Mueller, Andreas] Univ Bonn, Dept Neonatol, Bonn, Germany; [Mueller, Annette] Univ Bonn, Dept Pathol, Bonn, Germany	University of Bonn; University of Cologne; University of Bonn; University of Bonn; University of Bonn	Hellmund, A (corresponding author), Univ Bonn, Dept Obstet & Prenatal Med, Bonn, Germany.	Astrid.Hellmund@ukb.uni-bonn.de	Gembruch, Ulrich/Q-8228-2017	Gembruch, Ulrich/0000-0001-8284-4669				Achiron R, 2004, ULTRASOUND OBST GYN, V24, P107, DOI 10.1002/uog.1110; Adzick N Scott, 2003, Semin Pediatr Surg, V12, P10, DOI 10.1016/S1055-8586(03)70003-1; Adzick NS, 2010, SEMIN FETAL NEONAT M, V15, P1, DOI 10.1016/j.siny.2009.05.003; Adzick NS, 2009, CLIN PERINATOL, V36, P363, DOI 10.1016/j.clp.2009.03.001; Adzick NS, 1998, AM J OBSTET GYNECOL, V179, P884, DOI 10.1016/S0002-9378(98)70183-8; ADZICK NS, 1993, WORLD J SURG, V17, P342, DOI 10.1007/BF01658702; Aziz D, 2004, J PEDIATR SURG, V39, P329, DOI 10.1016/j.jpedsurg.2003.11.021; Baird R, 2014, SEMIN PEDIATR SURG, V23, P270, DOI 10.1053/j.sempedsurg.2014.09.007; Bebbington M, 2014, ULTRASOUND OBST GYN, V43, P670, DOI 10.1002/uog.13271; Bunduki V, 2000, PRENATAL DIAG, V20, P459, DOI 10.1002/1097-0223(200006)20:6<459::AID-PD851>3.0.CO;2-F; Cavoretto P, 2008, ULTRASOUND OBST GYN, V32, P769, DOI 10.1002/uog.6218; Crombleholme TM, 2002, J PEDIATR SURG, V37, P331, DOI 10.1053/jpsu.2002.30832; Cruz-Martinez R, 2015, ULTRASOUND OBST GYN, V46, P627, DOI 10.1002/uog.14921; Cruz-Martinez R, 2010, ULTRASOUND OBST GYN, V36, P32, DOI 10.1002/uog.7577; Cruz-Martinez R, 2015, FETAL DIAGN THER, V37, P75, DOI 10.1159/000361015; Curran PF, 2010, J PEDIATR SURG, V45, P145, DOI 10.1016/j.jpedsurg.2009.10.025; Davenport M, 2004, J PEDIATR SURG, V39, P549, DOI 10.1016/j.jpedsurg.2003.12.021; Dommergues M, 1997, AM J OBSTET GYNECOL, V177, P953, DOI 10.1016/S0002-9378(97)70300-4; Durell J, 2014, EARLY HUM DEV, V90, P935, DOI 10.1016/j.earlhumdev.2014.09.014; Ehrenberg-Buchner S, 2013, AM J OBSTET GYNECOL, V208, pe151; Grabowska K, 2013, FETAL THERAPY SCI BA; Granata C, 1998, PEDIATR PULM, V25, P62, DOI 10.1002/(SICI)1099-0496(199801)25:1<62::AID-PPUL8>3.0.CO;2-Q; Grethel EJ, 2007, J PEDIATR SURG, V42, P117, DOI 10.1016/j.jpedsurg.2006.09.060; Hadchouel A, 2011, ULTRASOUND OBST GYN, V38, P88, DOI 10.1002/uog.8909; Heling KS, 2005, ULTRASOUND OBST GYN, V25, P112, DOI 10.1002/uog.1837; Ierullo AM, 2005, ULTRASOUND OBST GYN, V26, P150, DOI 10.1002/uog.1920; Jani J, 2007, ULTRASOUND OBST GYN, V30, P67, DOI 10.1002/uog.4052; Kilian AK, 2009, KLIN PADIATR, V221, P295, DOI 10.1055/s-0029-1192022; Kunisaki SM, 2007, J PEDIATR SURG, V42, P404, DOI 10.1016/j.jpedsurg.2006.10.014; Kunisaki SM, 2015, J PEDIATR SURG, V50, P978, DOI 10.1016/j.jpedsurg.2015.03.025; Laberge Jean-Martin, 2005, Semin Pediatr Surg, V14, P16, DOI 10.1053/j.sempedsurg.2004.10.022; Laberge JM, 2001, FETAL DIAGN THER, V16, P178, DOI 10.1159/000053905; Li J, 2014, FETAL PEDIATR PATHOL, V33, P29, DOI 10.3109/15513815.2013.842272; Lima JS, 2014, J MATERN-FETAL NEO M, V27, P228, DOI 10.3109/14767058.2013.807236; Loh KC, 2012, J PEDIATR SURG, V47, P36, DOI 10.1016/j.jpedsurg.2011.10.015; Miniati DN, 2006, J PEDIATR SURG, V41, P66, DOI 10.1016/j.jpedsurg.2005.10.074; Miyoshi T, 2013, FETAL DIAGN THER, V34, P19, DOI 10.1159/000348776; Morris LM, 2009, J PEDIATR SURG, V44, P60, DOI 10.1016/j.jpedsurg.2008.10.012; Nasr A, 2010, J PEDIATR SURG, V45, P1086, DOI 10.1016/j.jpedsurg.2010.02.067; Ng C, 2014, ARCH DIS CHILD, V99, P432, DOI 10.1136/archdischild-2013-304048; Odibo AO, 2010, PRENATAL DIAG, V30, P518, DOI 10.1002/pd.2508; Ozcan C, 2001, J PEDIATR SURG, V36, P1062, DOI 10.1053/jpsu.2001.24747; Papagiannopoulos K, 2002, ANN THORAC SURG, V73, P1594, DOI 10.1016/S0003-4975(02)03469-0; Priest JR, 2009, PEDIATR PULM, V44, P14, DOI 10.1002/ppul.20917; RICE HE, 1994, J PEDIATR SURG, V29, P692, DOI 10.1016/0022-3468(94)90743-9; Ruano R, 2012, PRENATAL DIAG, V32, P1127, DOI 10.1002/pd.3969; Sauvat F, 2003, J PEDIATR SURG, V38, P548, DOI 10.1053/jpsu.2003.50119; Schrey S, 2012, ULTRASOUND OBST GYN, V39, P515, DOI 10.1002/uog.11084; Stanton M, 2009, J PEDIATR SURG, V44, P1027, DOI 10.1016/j.jpedsurg.2008.10.118; STOCKER JT, 1977, HUM PATHOL, V8, P155, DOI 10.1016/S0046-8177(77)80078-6; Stoiber B, 2015, ULTRASCHALL MED; THORPEBEESTON JG, 1994, PRENATAL DIAG, V14, P677, DOI 10.1002/pd.1970140807; Vu L, 2007, J PEDIATR SURG, V42, P1351, DOI 10.1016/j.jpedsurg.2007.03.039; Wall J, 2014, CURR OPIN PEDIATR, V26, P315, DOI 10.1097/MOP.0000000000000091; Wilson RD, 2006, AM J MED GENET A, V140A, P151, DOI 10.1002/ajmg.a.31031; Witlox RS, 2011, PRENATAL DIAG, V31, P628, DOI 10.1002/pd.2778; Yamashita A, 2015, J CLIN ULTRASOUND, V43, P451, DOI 10.1002/jcu.22214; Yinon Y, 2010, ULTRASOUND OBST GYN, V36, P58, DOI 10.1002/uog.7507; Yong PJ, 2012, FETAL DIAGN THER, V31, P94, DOI 10.1159/000331936	59	36	43	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150474	10.1371/journal.pone.0150474	http://dx.doi.org/10.1371/journal.pone.0150474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978067	Green Submitted, Green Published, gold			2022-12-26	WOS:000372572800027
J	Kwak, J; Strasser, E; Luzynski, K; Thoss, M; Penn, DJ				Kwak, Jae; Strasser, Eva; Luzynski, Ken; Thoss, Michaela; Penn, Dustin J.			Are MUPs a Toxic Waste Disposal System?	PLOS ONE			English	Article							MAJOR URINARY PROTEINS; PHEROMONE BINDING; VOLATILE LIGANDS; MULTIPLE ROLES; HOUSE MOUSE; LIPOCALINS; 2,4-DI-TERT-BUTYLPHENOL; TOXICOKINETICS; MICE; RAT	Male house mice produce large quantities of major urinary proteins (MUPs), which function to bind and transport volatile pheromones, though they may also function as scavengers that bind and excrete toxic compounds ('toxic waste hypothesis'). In this study, we demonstrate the presence of an industrial chemical, 2,4-di-tert-butylphenol (DTBP), in the urine of wild-derived house mice (Mus musculus musculus). Addition of guanidine hydrochloride to male and female urine resulted in an increased release of DTBP. This increase was only observed in the high molecular weight fractions (HMWF; > 3 kDa) separated from male or female urine, suggesting that the increased release of DTBP was likely due to the denaturation of MUPs and the subsequent release of MUP-bound DTBP. Furthermore, when DTBP was added to a HMWF isolated from male urine, an increase in 2-sec-butyl-4,5-dihydrothiazole (SBT), the major ligand of MUPs and a male-specific pheromone, was observed, indicating that DTBP was bound to MUPs and displaced SBT. These results suggest that DTBP is a MUP ligand. Moreover, we found evidence for competitive ligand binding between DTBP and SBT, suggesting that males potentially face a tradeoff between eliminating toxic wastes versus transporting pheromones. Our findings support the hypothesis that MUPs bind and eliminate toxic wastes, which may provide the most important fitness benefits of excreting large quantities of these proteins.	[Kwak, Jae] Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria; [Strasser, Eva; Luzynski, Ken; Thoss, Michaela; Penn, Dustin J.] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Kwak, J (corresponding author), Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria.	jaekwak@hotmail.com	Kwak, Jae/E-5781-2011	Kwak, Jae/0000-0003-4216-2019	Austrian Science Fund [FWF: P24711-B21]; Austrian Science Fund (FWF) [P 24711] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by a grant from the Austrian Science Fund https://www.fwf.ac.at (FWF: P24711-B21) to D.J. Penn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Choi SJ, 2013, J MED FOOD, V16, P977, DOI 10.1089/jmf.2012.2739; Flower DR, 1996, BIOCHEM J, V318, P1; Hagemeyer P, 2011, J CHEM ECOL, V37, P687, DOI 10.1007/s10886-011-9971-y; Hakk H, 2009, TOXICOL APPL PHARM, V241, P119, DOI 10.1016/j.taap.2009.08.009; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Kwak J, 2013, PHYSIOL BEHAV, V120, P211, DOI 10.1016/j.physbeh.2013.08.011; Kwak J, 2012, PHYSIOL BEHAV, V107, P112, DOI 10.1016/j.physbeh.2012.06.008; Kwak J, 2011, CHEM SENSES, V36, P443, DOI 10.1093/chemse/bjr015; LARSEN GL, 1990, XENOBIOTICA, V20, P1343, DOI 10.3109/00498259009046632; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Phelan MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108415; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Robertson D, 1998, J CHEM ECOL, V24, P1127, DOI 10.1023/A:1022434300449; Sharrow SD, 2002, PROTEIN SCI, V11, P2247, DOI 10.1110/ps.0204202; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Staskal DF, 2006, TOXICOL SCI, V94, P28, DOI 10.1093/toxsci/kfl091; Staskal DF, 2005, TOXICOL SCI, V83, P215, DOI 10.1093/toxsci/kfi018; Stopkova R, 2014, BIOCHEM SOC T, V42, P893, DOI 10.1042/BST20140053; Stopkova R, 2009, FOLIA ZOOL, V58, P29; TELFORD IR, 1962, AM J ANAT, V110, P29, DOI 10.1002/aja.1001100104; Thoss M, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00071; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; Yoon MA, 2006, BIOL PHARM BULL, V29, P735, DOI 10.1248/bpb.29.735	27	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151474	10.1371/journal.pone.0151474	http://dx.doi.org/10.1371/journal.pone.0151474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966901	Green Submitted, gold, Green Published			2022-12-26	WOS:000371989200057
J	Bokori-Brown, M; Petrov, PG; Khafaji, MA; Mughal, MK; Naylor, CE; Shore, AC; Gooding, KM; Casanova, F; Mitchell, TJ; Titball, RW; Winlove, CP				Bokori-Brown, Monika; Petrov, Peter G.; Khafaji, Mawya A.; Mughal, Muhammad K.; Naylor, Claire E.; Shore, Angela C.; Gooding, Kim M.; Casanova, Francesco; Mitchell, Tim J.; Titball, Richard W.; Winlove, C. Peter			Red Blood Cell Susceptibility to Pneumolysin CORRELATION WITH MEMBRANE BIOCHEMICAL AND PHYSICAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; SPHINGOMYELIN-SPECIFIC TOXIN; STREPTOCOCCUS-PNEUMONIAE; PERFRINGOLYSIN-O; ERYTHROCYTE DEFORMABILITY; SENESCENT ERYTHROCYTES; LIPID-PEROXIDATION; DISTRIBUTION WIDTH; CRYSTAL-STRUCTURE; OXIDATIVE STRESS	This study investigated the effect of the biochemical and biophysical properties of the plasma membrane as well as membrane morphology on the susceptibility of human red blood cells to the cholesterol-dependent cytolysin pneumolysin, a key virulence factor of Streptococcus pneumoniae, using single cell studies. We show a correlation between the physical properties of the membrane (bending rigidity and surface and dipole electrostatic potentials) and the susceptibility of red blood cells to pneumolysin-induced hemolysis. We demonstrate that biochemical modifications of the membrane induced by oxidative stress, lipid scrambling, and artificial cell aging modulate the cell response to the toxin. We provide evidence that the diversity of response to pneumolysin in diabetic red blood cells correlates with levels of glycated hemoglobin and that the mechanical properties of the red blood cell plasma membrane are altered in diabetes. Finally, we show that diabetic red blood cells are more resistant to pneumolysin and the related toxin perfringolysin O relative to healthy red blood cells. Taken together, these studies indicate that the diversity of cell response to pneumolysin within a population of human red blood cells is influenced by the biophysical and biochemical status of the plasma membrane and the chemical and/or oxidative stress pre-history of the cell.	[Bokori-Brown, Monika; Titball, Richard W.] Univ Exeter, Sch Biosci, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England; [Petrov, Peter G.; Khafaji, Mawya A.; Winlove, C. Peter] Univ Exeter, Sch Phys, Coll Engn Math & Phys Sci, Exeter EX4 4QL, Devon, England; [Khafaji, Mawya A.; Mitchell, Tim J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Shore, Angela C.; Gooding, Kim M.; Casanova, Francesco] Univ Exeter, Sch Med, Dept Diabet & Vasc Med, Barrack Rd, Exeter EX2 5AX, Devon, England; [Shore, Angela C.; Gooding, Kim M.; Casanova, Francesco] Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res Exeter Clin Res Facil, Exeter EX2 5DW, Devon, England; [Naylor, Claire E.] Birkbeck Coll, Dept Biol Sci, Malet St, London WC1E 7HX, England; [Khafaji, Mawya A.] King Abdulaziz Univ, Sch Med, Dept Radiol, POB 80215, Jeddah 21589, Saudi Arabia	University of Exeter; University of Exeter; University of Birmingham; University of Exeter; University of London; Birkbeck University London; King Abdulaziz University	Bokori-Brown, M (corresponding author), Univ Exeter, Sch Biosci, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	m.bokori-brown@exeter.ac.uk	Bokori-Brown, Monika/Y-2302-2019; Mughal, M. Kashif/O-1018-2019; khafaji, mawya/AAK-1221-2020	Mughal, M. Kashif/0000-0002-1321-0619; Casanova, Francesco/0000-0003-0275-4765; Shore, Angela/0000-0003-3039-308X; Mitchell, Timothy/0000-0002-8309-5556	Defence Science and Technology Laboratory, Porton Down, UK [DSTLx1000075949]	Defence Science and Technology Laboratory, Porton Down, UK	This work was supported by the Defence Science and Technology Laboratory Grant DSTLx1000075949, Porton Down, UK. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research (NIHR), or the Department of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Amer J, 2006, BBA-GEN SUBJECTS, V1760, P793, DOI 10.1016/j.bbagen.2006.01.012; Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrera FN, 2012, P NATL ACAD SCI USA, V109, P14422, DOI 10.1073/pnas.1212665109; BECHINGER B, 1991, BIOCHEMISTRY-US, V30, P3923, DOI 10.1021/bi00230a017; Beisswenger P, 2003, DIABETES METAB, V29, pS95; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Bokori-Brown M, 2013, PROTEIN SCI, V22, P650, DOI 10.1002/pro.2250; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; BROCKMAN H, 1994, CHEM PHYS LIPIDS, V73, P57, DOI 10.1016/0009-3084(94)90174-0; Buys AV, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-25; Callan-Jones A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004648; Celedon G, 2008, TOXICON, V51, P1383, DOI 10.1016/j.toxicon.2008.03.006; CHIEN S, 1978, BIOPHYS J, V24, P463, DOI 10.1016/S0006-3495(78)85395-8; Ciccoli L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/432616; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Cluitmans JCA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/764268; Davis S, 2015, J LIPID RES, V56, P1543, DOI 10.1194/jlr.M059519; deJong K, 1997, BIOCHEMISTRY-US, V36, P6768, DOI 10.1021/bi962973a; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deuticke B., 2003, RED CELL MEMBRANE TR, P27; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duggan J, 2008, EUR BIOPHYS J BIOPHY, V37, P1279, DOI 10.1007/s00249-008-0349-1; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; EVANS T C, 1991, Journal of Emergency Medicine, V9, P71, DOI 10.1016/0736-4679(91)90592-4; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Faure P, 1999, DIABETES, V48, P353, DOI 10.2337/diabetes.48.2.353; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Fitchen N, 2003, MOL IMMUNOL, V40, P407, DOI 10.1016/S0161-5890(03)00153-6; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Foller M, 2008, IUBMB LIFE, V60, P661, DOI 10.1002/iub.106; FORTIER N, 1988, BLOOD, V71, P1427; Fortin CF, 2006, J LEUKOCYTE BIOL, V79, P1061, DOI 10.1189/jlb.0805481; Gallo A, 2005, DIABETES, V54, P1123, DOI 10.2337/diabetes.54.4.1123; GAWRISCH K, 1992, BIOPHYS J, V61, P1213, DOI 10.1016/S0006-3495(92)81931-8; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gifford SC, 2006, BRIT J HAEMATOL, V135, P395, DOI 10.1111/j.1365-2141.2006.06279.x; Giovannetti A, 2012, CELL PHYSIOL BIOCHEM, V30, P418, DOI 10.1159/000339035; Gologan P., 2013, THESIS U EXETER EXET; Gurbuz N, 2004, CLIN HEMORHEOL MICRO, V31, P235; Hale JP, 2011, BIOPHYS J, V101, P1921, DOI 10.1016/j.bpj.2011.08.053; Hale JP, 2009, SOFT MATTER, V5, P3603, DOI 10.1039/b910422d; Hamilton NM, 2012, J MED CHEM, V55, P4431, DOI 10.1021/jm300317k; Harris FM, 2001, J BIOL CHEM, V276, P22722, DOI 10.1074/jbc.M010879200; Harvey RM, 2011, INFECT IMMUN, V79, P4122, DOI 10.1128/IAI.05418-11; HEBBEL RP, 1990, BLOOD, V76, P1015; Henriksen J, 2004, EUR BIOPHYS J BIOPHY, V33, P732, DOI 10.1007/s00249-004-0420-5; HENSELEIT U, 1990, BIOCHIM BIOPHYS ACTA, V1029, P127, DOI 10.1016/0005-2736(90)90445-T; Hess JR, 2009, TRANSFUSION, V49, P2599, DOI 10.1111/j.1537-2995.2009.02275.x; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Jewell SA, 2013, BBA-BIOMEMBRANES, V1828, P1250, DOI 10.1016/j.bbamem.2012.12.019; JOHNSON GJ, 1979, NEW ENGL J MED, V301, P522, DOI 10.1056/NEJM197909063011004; JOHNSON RM, 1994, BLOOD, V83, P1117; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KANTOR L, 1994, GERONTOLOGY, V40, P1; Kantor L, 1998, GERONTOLOGY, V44, P26, DOI 10.1159/000021979; Kaul K, 2013, ADV EXP MED BIOL, V771, P1; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; Kennedy AL, 1997, METABOLISM, V46, P14, DOI 10.1016/S0026-0495(97)90311-5; Kirkham LAS, 2006, INFECT IMMUN, V74, P586, DOI 10.1128/IAI.74.1.586-593.2006; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lawrence SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14352; Lim H. W., 2008, REB BLOOD CELL SHAPE, V4, DOI [10.1002/9783527623372.ch2a, DOI 10.1002/9783527623372.CH2A]; Lim JE, 2013, BIOCHEM BIOPH RES CO, V430, P659, DOI 10.1016/j.bbrc.2012.11.095; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; LITTLE C, 1980, BIOCHEM J, V188, P39, DOI 10.1042/bj1880039; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Marshall JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13293; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; MCPHERSON RA, 1992, BIOCHEMISTRY-US, V31, P512, DOI 10.1021/bi00117a030; Meleard P, 1997, BIOPHYS J, V72, P2616, DOI 10.1016/S0006-3495(97)78905-7; Mishra R, 2015, CLIN HEMORHEOL MICRO, V59, P287, DOI 10.3233/CH-131726; Mitchell Tim J, 2014, Subcell Biochem, V80, P145, DOI 10.1007/978-94-017-8881-6_8; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; MOKKEN FC, 1992, ANN HEMATOL, V64, P113, DOI 10.1007/BF01697397; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Mughal M. K., 2014, THESIS U GLASGOW GLA; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; O'Callaghan RJ, 2007, INVEST OPHTH VIS SCI, V48, P5125, DOI 10.1167/iovs.07-0320; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Ortqvist A, 2005, SEMIN RESP CRIT CARE, V26, P563, DOI 10.1055/s-2005-925523; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Pretorius E, 2014, AGING-US, V6, P788, DOI 10.18632/aging.100695; Rahbar S, 2000, CLIN CHIM ACTA, V301, P65, DOI 10.1016/S0009-8981(00)00327-2; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rasband W. S, 2015, IMAGEJ; ROONEY M, 1986, CHEM PHYS LIPIDS, V41, P81, DOI 10.1016/0009-3084(86)90126-X; Rossjohn J, 1998, J MOL BIOL, V284, P449, DOI 10.1006/jmbi.1998.2167; ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030; SAITO M, 1982, MECH AGEING DEV, V20, P53, DOI 10.1016/0047-6374(82)90074-4; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shewell LK, 2014, P NATL ACAD SCI USA, V111, pE5312, DOI 10.1073/pnas.1412703111; SHIGA T, 1990, CRIT REV ONCOL HEMAT, V10, P9, DOI 10.1016/1040-8428(90)90020-S; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; SHUKLA SD, 1978, BIOCHIM BIOPHYS ACTA, V512, P341, DOI 10.1016/0005-2736(78)90258-4; Siegl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076715; SNYDER LM, 1985, J CLIN INVEST, V76, P1971, DOI 10.1172/JCI112196; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; SONG JB, 1993, BIOPHYS J, V64, P1967, DOI 10.1016/S0006-3495(93)81566-2; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; Taylor SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061300; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tomaiuolo G, 2012, CYTOM PART A, V81A, P1040, DOI 10.1002/cyto.a.22215; Turchetti V, 1997, CLIN HEMORHEOL MICRO, V17, P209; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; Tziakas D, 2012, CLIN HEMORHEOL MICRO, V51, P243, DOI 10.3233/CH-2012-1530; Tziakas DN, 2007, J AM COLL CARDIOL, V49, P2081, DOI 10.1016/j.jacc.2006.08.069; VANDENBERG JJM, 1992, FREE RADICAL BIO MED, V12, P487, DOI 10.1016/0891-5849(92)90102-M; Wade KR, 2015, P NATL ACAD SCI USA, V112, P2204, DOI 10.1073/pnas.1423754112; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; Watanabe I, 2006, J MED MICROBIOL, V55, P505, DOI 10.1099/jmm.0.46333-0; WAUGH R, 1979, BIOPHYS J, V26, P115, DOI 10.1016/S0006-3495(79)85239-X; WAUGH RE, 1992, BLOOD, V79, P1351; Wippel C, 2011, J INFECT DIS, V204, P930, DOI 10.1093/infdis/jir434; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200; Yasin Z, 2003, BLOOD, V102, P365, DOI 10.1182/blood-2002-11-3416; Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023; Yilmaz N, 2013, BIOPHYS J, V105, P1397, DOI 10.1016/j.bpj.2013.07.052	127	15	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10210	10227		10.1074/jbc.M115.691899	http://dx.doi.org/10.1074/jbc.M115.691899			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26984406	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000375602800030
J	Liu, K; Li, FZ; Han, HC; Chen, Y; Mao, ZB; Luo, JY; Zhao, YM; Zheng, B; Gu, W; Zhao, WH				Liu, Kun; Li, Fanzhou; Han, Haichao; Chen, Yue; Mao, Zebin; Luo, Jianyuan; Zhao, Yingming; Zheng, Bin; Gu, Wei; Zhao, Wenhui			Parkin Regulates the Activity of Pyruvate Kinase M2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; GLUCOSE-METABOLISM; CANCER METABOLISM; PROMOTES; UBIQUITIN; ISOFORM; PKM2; P53; MONOUBIQUITINATION; PHOSPHORYLATION	Parkin, a ubiquitin E3 ligase, is mutated in most cases of autosomal recessive early onset Parkinson disease. It was discovered that Parkin is also mutated in glioblastoma and other human malignancies and that it inhibits tumor cell growth. Here, we identified pyruvate kinase M2 (PKM2) as a unique substrate for parkin through biochemical purification. We found that parkin interacts with PKM2 both in vitro and in vivo, and this interaction dramatically increases during glucose starvation. Ubiquitylation of PKM2 by parkin does not affect its stability but decreases its enzymatic activity. Parkin regulates the glycolysis pathway and affects the cell metabolism. Our studies revealed the novel important roles of parkin in tumor cell metabolism and provided new insight for therapy of Parkinson disease.	[Zhao, Wenhui] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Zhao, Wenhui] Beijing Key Lab Prot Posttranslat Modificat & Cel, Beijing 100191, Peoples R China; [Chen, Yue; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Dept Genet, Beijing 100191, Peoples R China; [Zheng, Bin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Peking University; University of Chicago; Peking University; Harvard University; Massachusetts General Hospital; Columbia University; Columbia University	Zhao, WH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.; Zhao, WH (corresponding author), Beijing Key Lab Prot Posttranslat Modificat & Cel, Beijing 100191, Peoples R China.	zhao6025729@bjmu.edu.cn	Li, Fangzhou/R-8789-2019; Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zheng, Bin/0000-0002-0998-7177; ZHAO, WENHUI/0000-0002-7703-7106	Peking University Health Science Center [BMU20140379]; NATIONAL CANCER INSTITUTE [R01CA166717] Funding Source: NIH RePORTER	Peking University Health Science Center(Peking University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Peking University Health Science Center Initial Aid Grant BMU20140379. To whom correspondence should be addressed. Tel.: 86-010-82805552; Fax: 86-010-82802416; E-mail: zhao6025729@bjmu.edu.cn.	Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Bettaieb A, 2013, J BIOL CHEM, V288, P17360, DOI 10.1074/jbc.M112.441469; Brooks CL, 2004, CELL CYCLE, V3, P436; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; McDonnell SRP, 2013, BLOOD, V122, P958, DOI 10.1182/blood-2013-01-482026; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	51	61	65	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10307	10317		10.1074/jbc.M115.703066	http://dx.doi.org/10.1074/jbc.M115.703066			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26975375	Green Published, hybrid			2022-12-26	WOS:000375602800037
J	Mader, L; Rueegg, CS; Vetsch, J; Rischewski, J; Ansari, M; Kuehni, CE; Michel, G				Mader, Luzius; Rueegg, Corina S.; Vetsch, Janine; Rischewski, Johannes; Ansari, Marc; Kuehni, Claudia E.; Michel, Gisela		SPOG	Employment Situation of Parents of Long-Term Childhood Cancer Survivors	PLOS ONE			English	Article							GENERAL-POPULATION; ECONOMIC-IMPACT; FAMILIES; SIBLINGS; REGISTRY; CHILDREN; HEALTH; INCOME; COSTS	Background Taking care of children diagnosed with cancer affects parents' professional life. The impact in the long-term however, is not clear. We aimed to compare the employment situation of parents of long-term childhood cancer survivors with control parents of the general population, and to identify clinical and socio-demographic factors associated with parental employment. Methods As part of the Swiss Childhood Cancer Survivor Study, we sent a questionnaire to parents of survivors aged 5-15 years, who survived >= 5 years after diagnosis. Information on control parents of the general population came from the Swiss Health Survey (restricted to men and women with >= 1 child aged 5-15 years). Employment was categorized as not employed, part-time, and full-time employed. We used generalized ordered logistic regression to determine associations with clinical and socio-demographic factors. Clinical data was available from the Swiss Childhood Cancer Registry. Results We included 394 parent-couples of survivors and 3'341 control parents (1'731 mothers; 1'610 fathers). Mothers of survivors were more often not employed (29% versus 22%; p(trend) = 0.007). However, no differences between mothers were found in multivariable analysis. Fathers of survivors were more often employed full-time (93% versus 87%; p(trend) = 0.002), which remained significant in multivariable analysis. Among parents of survivors, mothers with tertiary education (OR = 2.40, CI: 1.14-5.07) were more likely to be employed. Having a migration background (OR = 3.63, CI: 1.71-7.71) increased the likelihood of being full-time employed in mothers of survivors. Less likely to be employed were mothers of survivors diagnosed with lymphoma (OR = 0.31, CI: 0.13-0.73) and >2 children (OR = 0.48, CI: 0.30-0.75); and fathers of survivors who had had a relapse (OR = 0.13, CI: 0.04-0.36). Conclusion Employment situation of parents of long-term survivors reflected the more traditional parenting roles. Specific support for parents with low education, additional children, and whose child had a more severe cancer disease could improve their long-term employment situation.	[Mader, Luzius; Rueegg, Corina S.; Vetsch, Janine; Michel, Gisela] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland; [Rischewski, Johannes] Cantonal Hosp Lucerne, Childrens Hosp, Dept Oncol Hematol, Luzern, Switzerland; [Ansari, Marc] Univ Hosp Geneva, Dept Pediat, Unit Oncol Hematol, Geneva, Switzerland; [Kuehni, Claudia E.; Michel, Gisela] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Lucerne; Lucerne Cantonal Hospital; University of Geneva; University of Bern	Michel, G (corresponding author), Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland.	gisela.michel@unilu.ch	Michel, Gisela/G-1081-2018; Rueegg, Corina Silvia/H-7128-2019; ANSARI, Marc/V-3334-2017	Michel, Gisela/0000-0002-9589-0928; Rueegg, Corina Silvia/0000-0003-3720-4659; ansari, marc/0000-0002-9649-6498; Kuehni, Claudia E./0000-0001-8957-2002; Leibundgut, Kurt/0000-0003-2514-6041; Tinner, Eva Maria/0000-0001-5843-8097	Swiss National Science Foundation [100019_153268/1]; Ambizione Grant [PZ00P3121682/1, PZ00P3-141722]; Swiss Cancer League [KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ambizione Grant; Swiss Cancer League	This study was supported by the Swiss National Science Foundation (www.snf.ch): Grant No. 100019_153268/1; Ambizione Grant to GM: PZ00P3121682/1 and PZ00P3-141722. The Swiss Childhood Cancer Survivor Study was funded by the Swiss Cancer League (www.krebsliga.ch): KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011. The University of Lucerne research committee (FoKo) supports the open access publication (www.unilu.ch/en/research/university-of-lucerne-funding/research-committee/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderfer MA, 2010, PSYCHO-ONCOLOGY, V19, P789, DOI 10.1002/pon.1638; Bona K, 2014, J PAIN SYMPTOM MANAG, V47, P594, DOI 10.1016/j.jpainsymman.2013.04.003; Bundesamt fuar Statistik, 2013, SCHWEIZ GES 2012 KUR; Bundesamt fur Statistik, 2013, SCHWEIZ GES 2012 UB; Bundesamt fur Statistik, 2015, ARB 2015; Dussel V, 2011, J CLIN ONCOL, V29, P1007, DOI 10.1200/JCO.2009.27.8960; Eiser C, 2007, CHILD CARE HLTH DEV, V33, P455, DOI 10.1111/j.1365-2214.2006.00710.x; Germann U., 2005, EIDGENOSSISCHE VOLKS; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Heath JA, 2006, PEDIATR HEMAT ONCOL, V23, P439, DOI 10.1080/08880010600692526; Hoven E, 2013, ACTA ONCOL, V52, P1076, DOI 10.3109/0284186X.2012.760846; Kuehni CE, 2012, INT J EPIDEMIOL, V41, P1553, DOI 10.1093/ije/dyr142; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Lau S, 2014, PEDIATR BLOOD CANCER, V61, P2277, DOI 10.1002/pbc.25195; Lieberherr R., 2010, GESUNDHEIT GESUNDHEI; Limburg H, 2008, PEDIATR BLOOD CANCER, V51, P93, DOI 10.1002/pbc.21448; Michel G, 2008, PEDIATR BLOOD CANCER, V50, P46, DOI 10.1002/pbc.21129; Michel G, 2007, SWISS MED WKLY, V137, P502; Miedema B, 2008, CURR ONCOL, V15, P173; Mostert S, 2008, J PEDIAT HEMATOL ONC, V30, P738, DOI 10.1097/MPH.0b013e31817e4aad; Okada H, 2014, CANC NURS, P1; Robison LL, 2009, J CLIN ONCOL; Rueegg CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034930; Schindler M, 2014, BETREUUNGSAUFWAND EL; StataCorp, 2017, STAT SURV DAT REF MA; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Syse A, 2011, CANCER EPIDEMIOL, V35, P298, DOI 10.1016/j.canep.2010.08.002; Volken T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-167; Wakefield CE, 2014, J PSYCHOSOC ONCOL, V32, P602, DOI 10.1080/07347332.2014.936653; Wengenroth L, 2014, PEDIATR BLOOD CANCER, V61, P538, DOI 10.1002/pbc.24821	30	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151966	10.1371/journal.pone.0151966	http://dx.doi.org/10.1371/journal.pone.0151966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990301	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000372582800125
J	Felton, AM; Felton, A; Raubenheimer, D; Simpson, SJ; Krizsan, SJ; Hedwall, PO; Stolter, C				Felton, Annika M.; Felton, Adam; Raubenheimer, David; Simpson, Stephen J.; Krizsan, Sophie J.; Hedwall, Per-Ola; Stolter, Caroline			The Nutritional Balancing Act of a Large Herbivore: An Experiment with Captive Moose (Alces alces L)	PLOS ONE			English	Article							GENERALIST HERBIVORE; MAMMALIAN HERBIVORES; GEOMETRIC ANALYSIS; FOOD SELECTION; ENERGY-INTAKE; MACRONUTRIENT SELECTION; DIET SELECTION; SIZE SELECTION; PROTEIN; WINTER	The nutrient balancing hypothesis proposes that, when sufficient food is available, the primary goal of animal diet selection is to obtain a nutritionally balanced diet. This hypothesis can be tested using the Geometric Framework for nutrition (GF). The GF enables researchers to study patterns of nutrient intake (e.g. macronutrients; protein, carbohydrates, fat), interactions between the different nutrients, and how an animal resolves the potential conflict between over-eating one or more nutrients and under-eating others during periods of dietary imbalance. Using the moose (Alces alces L.), a model species in the development of herbivore foraging theory, we conducted a feeding experiment guided by the GF, combining continuous observations of six captive moose with analysis of the macronutritional composition of foods. We identified the moose's self-selected macronutrient target by allowing them to compose a diet by mixing two nutritionally complementary pellet types plus limited access to Salix browse. Such periods of free choice were intermixed with periods when they were restricted to one of the two pellet types plus Salix browse. Our observations of food intake by moose given free choice lend support to the nutrient balancing hypothesis, as the moose combined the foods in specific proportions that provided a particular ratio and amount of macronutrients. When restricted to either of two diets comprising a single pellet type, the moose i) maintained a relatively stable intake of non-protein energy while allowing protein intakes to vary with food composition, and ii) increased their intake of the food item that most closely resembled the self-selected macronutrient intake from the free choice periods, namely Salix browse. We place our results in the context of the nutritional strategy of the moose, ruminant physiology and the categorization of food quality.	[Felton, Annika M.; Felton, Adam; Hedwall, Per-Ola] Swedish Univ Agr Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden; [Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Krizsan, Sophie J.] Swedish Univ Agr Sci, Dept Agr Res Northern Sweden, S-90183 Umea, Sweden; [Stolter, Caroline] Univ Hamburg, Dept Anim Ecol & Conservat, Bioctr Grindel, Hamburg, Germany	Swedish University of Agricultural Sciences; University of Sydney; University of Sydney; University of Sydney; Swedish University of Agricultural Sciences; University of Hamburg	Felton, AM (corresponding author), Swedish Univ Agr Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden.	annika.felton@slu.se	Hedwall, Per-Ola/ABG-2195-2020	Hedwall, Per-Ola/0000-0002-0120-7420; Simpson, Stephen J./0000-0003-0256-7687; , Sophie/0000-0002-9424-3884; Raubenheimer, David/0000-0001-9050-1447	Stiftelsen Skogssallskapet [1011-79/150-7 HJHIL]; Magnus Bergwalls Stiftelse; Fonden for Skogsvetenskaplig Forskning - Swedish University of Agricultural Sciences	Stiftelsen Skogssallskapet; Magnus Bergwalls Stiftelse; Fonden for Skogsvetenskaplig Forskning - Swedish University of Agricultural Sciences	The work was supported by grants from Stiftelsen Skogssallskapet, nb 1011-79/150-7 HJHIL (https://www.skogssallskapet.se/om-oss/organisation/stiftelsen.html), Magnus Bergwalls Stiftelse (http://www.magnbergvallsstiftelse.nu/), and Fonden for Skogsvetenskaplig Forskning - Swedish University of Agricultural Sciences (https://internt.slu.se/Documents/internwebben/s-fak/Stipendier_medarbetare/Lilla-fonden-sv-en_2015.pdf). All were granted to AMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen MS, 1997, J DAIRY SCI, V80, P1447, DOI 10.3168/jds.S0022-0302(97)76074-0; [Anonymous], 1989, REC DIET ALL; Asher GW, 2011, LIVEST SCI, V140, P8, DOI 10.1016/j.livsci.2011.02.002; Ball JP, 2000, J APPL ECOL, V37, P247, DOI 10.1046/j.1365-2664.2000.00487.x; Beck JL, 2005, WEST N AM NATURALIST, V65, P516; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P76, DOI 10.1016/0040-5809(78)90006-0; BELOVSKY GE, 1986, OECOLOGIA, V70, P35, DOI 10.1007/BF00377109; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; Bengtsson S., 1983, 22 SLL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom R., 1987, Swedish Wildlife Research Supplement, V1, P213; Berteaux D, 1998, OECOLOGIA, V115, P84, DOI 10.1007/s004420050494; BRYANT JP, 1980, ANNU REV ECOL SYST, V11, P261, DOI 10.1146/annurev.es.11.110180.001401; Cederlund G., 1980, SWEDISH WILDLIFE RES, V11, P171; Chai WH, 1998, ANIM FEED SCI TECH, V74, P281, DOI 10.1016/S0377-8401(98)00187-4; Clauss M, 2002, ZOO BIOL, V21, P499, DOI 10.1002/zoo.10059; Clauss M., 2003, ZOO ANIMAL NUTR, VII, P27; Clauss M, 2009, J MORPHOL, V270, P929, DOI 10.1002/jmor.10729; Cone JW, 1996, ANIM FEED SCI TECH, V61, P113, DOI 10.1016/0377-8401(96)00950-9; DANELL K, 1991, ECOLOGY, V72, P1624, DOI 10.2307/1940962; Development Core Team R, 2013, R LANG ENV STAT COMP; Dussutour A, 2010, P NATL ACAD SCI USA, V107, P4607, DOI 10.1073/pnas.0912198107; Ellsworth E, 2013, WILDLIFE RES, V40, P349, DOI 10.1071/WR13106; Erlenbach JA, 2014, J MAMMAL, V95, P160, DOI 10.1644/13-MAMM-A-161; Felton AM, 2008, INT J PRIMATOL, V29, P379, DOI 10.1007/s10764-008-9241-1; Felton AM, 2009, INT J PRIMATOL, V30, P675, DOI 10.1007/s10764-009-9367-9; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; GROSS JE, 1993, OIKOS, V68, P75, DOI 10.2307/3545311; Hewson-Hughes AK, 2013, BEHAV ECOL, V24, P293, DOI 10.1093/beheco/ars168; Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429; HJELJORD O, 1982, J WILDLIFE MANAGE, V46, P333, DOI 10.2307/3808644; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Irwin MT, 2014, AM J PHYS ANTHROPOL, V153, P78, DOI 10.1002/ajpa.22412; Johnson CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070383; Keunen JE, 2002, J DAIRY SCI, V85, P3304, DOI 10.3168/jds.S0022-0302(02)74419-6; Krizsan S. J., 2013, Proceedings of the 4th Nordic Feed Science Conference, Uppsala, Sweden, 12-13 June 2013, P118; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; LUNDBERG P, 1990, HOLARCTIC ECOL, V13, P177; Mansson J, 2007, SCAND J FOREST RES, V22, P407, DOI 10.1080/02827580701515023; Mansson J, 2009, FOREST ECOL MANAG, V258, P2450, DOI 10.1016/j.foreco.2009.08.025; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; *MERCK CO INC, 2005, MERCK VET MAN; Milner JM, 2014, J WILDLIFE MANAGE, V78, P1322, DOI 10.1002/jwmg.798; Moen R, 1998, ECOSYSTEMS, V1, P52, DOI 10.1007/s100219900005; Moen R, 1997, ECOLOGY, V78, P505; Muller DWH, 2011, P ROY SOC B-BIOL SCI, V278, P2076, DOI 10.1098/rspb.2010.2275; NCFA, 1976, DET FOOD FEED ACC KJ, V6; Ohlson M, 2001, OIKOS, V94, P442, DOI 10.1034/j.1600-0706.2001.940307.x; OLDEMEYER JL, 1977, J WILDLIFE MANAGE, V41, P533, DOI 10.2307/3800528; PALO RT, 1992, OIKOS, V65, P450, DOI 10.2307/3545562; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; PARSONS AJ, 1994, J ANIM ECOL, V63, P465, DOI 10.2307/5563; Persson IL, 2000, ANN ZOOL FENN, V37, P251; Plantinga EA, 2011, BRIT J NUTR, V106, pS35, DOI 10.1017/S0007114511002285; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; Raubenheimer David, 2006, Notornis, V53, P100; Raubenheimer D, 2012, PHILOS T R SOC B, V367, P1628, DOI 10.1098/rstb.2012.0007; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; REGELIN WL, 1985, J WILDLIFE MANAGE, V49, P388, DOI 10.2307/3801539; Robbins CT, 2007, OIKOS, V116, P1675, DOI 10.1111/j.0030-1299.2007.16140.x; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Schwartz C. C., 1988, Alces, V24, P178; SCHWARTZ CC, 1987, J WILDLIFE MANAGE, V51, P352, DOI 10.2307/3801015; SCHWARTZ CC, 1988, J WILDLIFE MANAGE, V52, P26, DOI 10.2307/3801052; SHAHIDI F, 1992, J AM OIL CHEM SOC, V69, P917, DOI 10.1007/BF02636344; Shipley LA, 1999, OIKOS, V84, P55, DOI 10.2307/3546866; Shipley LA, 1998, CAN J ZOOL, V76, P1722, DOI 10.1139/cjz-76-9-1722; Shochat E, 1997, ZOO BIOL, V16, P479, DOI 10.1002/(SICI)1098-2361(1997)16:6<479::AID-ZOO2>3.0.CO;2-7; Simpson R. J., 2012, NATURE NUTR UNIFYING; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2003, APPETITE, V41, P123, DOI 10.1016/S0195-6663(03)00049-7; SMHI, 2013, KLIM ARS MAN; SOPPELA P, 1992, ACTA PHYSIOL SCAND, V145, P65, DOI 10.1111/j.1748-1716.1992.tb09337.x; SPALINGER DE, 1992, AM NAT, V140, P325, DOI 10.1086/285415; Stolter C, 2005, CAN J ZOOL, V83, P807, DOI [10.1139/z05-077, 10.1139/Z05-077]; THONNEY ML, 1976, J ANIM SCI, V43, P692, DOI 10.2527/jas1976.433692x; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; vanWieren SE, 1996, FOREST ECOL MANAG, V88, P149, DOI 10.1016/S0378-1127(96)03877-7; Villalba JJ, 2005, J CHEM ECOL, V31, P123, DOI 10.1007/s10886-005-0979-z; VIVAS HJ, 1991, J ANIM ECOL, V60, P395, DOI 10.2307/5286; Wam HK, 2010, EUR J WILDLIFE RES, V56, P745, DOI 10.1007/s10344-010-0370-4; Wam HK, 2010, RANGELAND ECOL MANAG, V63, P387, DOI 10.2111/REM-D-09-00039.1; Weber ML, 1998, CAN J ZOOL, V76, P1141, DOI 10.1139/cjz-76-6-1141; Webster JR, 2000, ANIM SCI, V70, P547, DOI 10.1017/S1357729800051894; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908	91	30	32	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150870	10.1371/journal.pone.0150870	http://dx.doi.org/10.1371/journal.pone.0150870			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986618	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300032
J	de Moura-Tonello, SCG; Porta, A; Marchi, A; Fagundes, AD; Francisco, CD; Rehder-Santos, P; Milan-Mattos, JC; Simoes, RP; Gois, MD; Catai, AM				Garcia de Moura-Tonello, Silvia Cristina; Porta, Alberto; Marchi, Andrea; Fagundes, Alessandra de Almeida; Francisco, Cristina de Oliveira; Rehder-Santos, Patricia; Milan-Mattos, Juliana Cristina; Simoes, Rodrigo Polaquini; Gois, Mariana de Oliveira; Catai, Aparecida Maria			Cardiovascular Variability Analysis and Baroreflex Estimation in Patients with Type 2 Diabetes in Absence of Any Manifest Neuropathy	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ARTERIAL-PRESSURE; SPECTRAL-ANALYSIS; SENSITIVITY; SYSTEM; DOMAIN; PERIOD; TIME	Introduction Indexes derived from spontaneous heart period (HP) and systolic arterial pressure (SAP) fluctuations can detect autonomic dysfunction in individuals with type 2 diabetes mellitus (DM) associated to cardiovascular autonomic neuropathy (CAN) or other neuropathies. It is unknown whether HP and SAP variability indexes are sensitive enough to detect the autonomic dysfunction in DM patients without CAN and other neuropathies. Methods We evaluated 68 males aged between 40 and 65 years. The group was composed by DM type 2 DM with no manifest neuropathy (n = 34) and healthy (H) subjects (n = 34). The protocol consisted of 15 minutes of recording of HP and SAP variabilities at rest in supine position (REST) and after active standing (STAND). The HP power in the high frequency band (HF, from 0.15 to 0.5 Hz), the SAP power in the low frequency band (LF, from 0.04 to 0.15 Hz) and BRS estimated via spectral approach and sequence method were computed. Results The HF power of HP was lower in DM patients than in H subjects, while the two groups exhibited comparable HF power of HP during STAND. The LF power of SAP was similar in DM and H groups at REST and increased during STAND in both groups. BRSs estimated in the HF band and via baroreflex sequence method were lower in DM than in H and they decreased further during STAND in both populations. Conclusion Results suggest that vagal control of heart rate and cardiac baroreflex control was impaired in type 2 DM, while sympathetic control directed to vessels, sympathetic and baroreflex response to STAND were preserved. Cardiovascular variability indexes are sensitive enough to typify the early, peculiar signs of autonomic dysfunction in type-2 DM patients well before CAN becomes manifest.	[Garcia de Moura-Tonello, Silvia Cristina; Fagundes, Alessandra de Almeida; Francisco, Cristina de Oliveira; Rehder-Santos, Patricia; Milan-Mattos, Juliana Cristina; Simoes, Rodrigo Polaquini; Gois, Mariana de Oliveira; Catai, Aparecida Maria] Univ Fed Sao Carlos, Dept Phys Therapy, BR-13560 Sao Carlos, Brazil; [Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy; [Marchi, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy	Universidade Federal de Sao Carlos; University of Milan; IRCCS Policlinico San Donato; Polytechnic University of Milan	Catai, AM (corresponding author), Univ Fed Sao Carlos, Dept Phys Therapy, BR-13560 Sao Carlos, Brazil.	mcatai@ufscar.br	Catai, Aparecida Maria/G-4612-2012; Rehder-Santos, Patricia/M-8642-2019; Simões, Rodrigo/B-7133-2013; Marchi, Andrea/J-7205-2016	Rehder-Santos, Patricia/0000-0001-5838-6936; Marchi, Andrea/0000-0001-5846-4164	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, AUXPE-CSF-PVE) [23038.007721/2013-4]; CAPES [99999.007781/2014-08]; Sao Paulo Foundation for Research Support/ Brasil (FAPESP) [2010/52070-4, 2013/07953-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, AUXPE-CSF-PVE)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Foundation for Research Support/ Brasil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	The research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, AUXPE-CSF-PVE, #23038.007721/2013-4) to Aparecida M. Catai and Alberto Porta, CAPES (#99999.007781/2014-08) to Silvia Cristina Garcia Moura-Tonello and Sao Paulo Foundation for Research Support/ Brasil (FAPESP, #2010/52070-4 and #2013/07953-3) to Aparecida M. Catai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Camm AJ, 1996, CIRCULATION, V93, P1043; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P352, DOI 10.1007/BF02441589; Ducher M, 1999, DIABETES CARE, V22, P388, DOI 10.2337/diacare.22.3.388; EWING DJ, 1981, LANCET, V1, P183; Frattola A, 1997, DIABETOLOGIA, V40, P1470, DOI 10.1007/s001250050851; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Javorka M, 2005, CLIN PHYSIOL FUNCT I, V25, P270, DOI 10.1111/j.1475-097X.2005.00623.x; Kaminska Anna, 2008, Endokrynol Pol, V59, P398; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Matsushima R, 2004, CLIN AUTON RES, V14, P376, DOI 10.1007/s10286-004-0182-2; Middlekauff HR, 2014, J AM COLL CARDIOL, V64, P1740, DOI 10.1016/j.jacc.2014.06.1201; Moura-Tonello SCG, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-13; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nollo G, 2005, AM J PHYSIOL-HEART C, V288, pH1777, DOI 10.1152/ajpheart.00594.2004; PAGANI M, 1988, HYPERTENSION, V12, P600, DOI 10.1161/01.HYP.12.6.600; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pereira JG, 2008, REV ESPACO SAUDE, V10, P7; Perseguini NM, 2011, BRAZ J MED BIOL RES, V44, P29, DOI 10.1590/S0100-879X2011000100005; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 1998, MED BIOL ENG COMPUT, V36, P35, DOI 10.1007/BF02522855; Porta A, 2002, BIOL CYBERN, V86, P241, DOI 10.1007/s00422-001-0292-z; Porta A, 2013, J APPL PHYSIOL, V115, P1032, DOI 10.1152/japplphysiol.00537.2013; Porta A, 2011, AM J PHYSIOL-REG I, V300, pR378, DOI 10.1152/ajpregu.00553.2010; Robertson D, 2012, AUTON NEUROSCI-BASIC, V172, P1, DOI 10.1016/j.autneu.2012.10.010; Rowaiye OO, 2013, CARDIOL J, V20, P453, DOI 10.5603/CJ.2013.0130; Ruiz J, 2005, HYPERTENSION, V46, P162, DOI 10.1161/01.HYP.0000169053.14440.7d; Sanya EO, 2003, EUR J CLIN INVEST, V33, P582, DOI 10.1046/j.1365-2362.2003.01170.x; Svacinova J, 2013, PHYSIOL RES, V62, P605, DOI 10.33549/physiolres.932510; Tank J, 2001, AM J MED SCI, V322, P24, DOI 10.1097/00000441-200107000-00005; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vinik AI, 2013, ENDOCRIN METAB CLIN, V42, P747, DOI 10.1016/j.ecl.2013.06.001; Vinik AI, 2001, CLEV CLIN J MED, V68, P928, DOI 10.3949/ccjm.68.11.928; Ziegler D, 2001, CLIN AUTON RES, V11, P369, DOI 10.1007/BF02292769	38	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0148903	10.1371/journal.pone.0148903	http://dx.doi.org/10.1371/journal.pone.0148903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987126	Green Published, gold			2022-12-26	WOS:000372580300013
J	Miller, ME; Rosten, P; Lemieux, ME; Lai, C; Humphries, RK				Miller, Michelle Erin; Rosten, Patty; Lemieux, Madeleine E.; Lai, Courteney; Humphries, R. Keith			Meis1 Is Required for Adult Mouse Erythropoiesis, Megakaryopoiesis and Hematopoietic Stem Cell Expansion	PLOS ONE			English	Article							DEFINITIVE HEMATOPOIESIS; EXPRESSION; LEUKEMIA; RENEWAL; GENES; ROLES; MSI2; HOX	Meis1 is recognized as an important transcriptional regulator in hematopoietic development and is strongly implicated in the pathogenesis of leukemia, both as a Hox transcription factor co-factor and independently. Despite the emerging recognition of Meis1's importance in the context of both normal and leukemic hematopoiesis, there is not yet a full understanding of Meis1's functions and the relevant pathways and genes mediating its functions. Recently, several conditional mouse models for Meis1 have been established. These models highlight a critical role for Meis1 in adult mouse hematopoietic stemcells (HSCs) and implicate reactive oxygen species (ROS) as a mediator of Meis1 function in this compartment. There are, however, several reported differences between these studies in terms of downstream progenitor populations impacted and effectors of function. In this study, we describe further characterization of a conditional knockout model based on mice carrying a loxP-flanked exon 8 of Meis1 which we crossed onto the inducible Cre localization/expression strains, B6; 129-Gt(ROSA) 26Sortm1(Cre/ERT) Nat/J or B6. Cg-Tg(Mx1-Cre) 1Cgn/J. Findings obtained from these two inducible Meis1 knockout models confirm and extend previous reports of the essential role of Meis1 in adult HSC maintenance and expansion and provide new evidence that highlights key roles of Meis1 in both megakaryopoiesis and erythropoiesis. Gene expression analyses point to a number of candidate genes involved in Meis1's role in hematopoiesis. Our data additionally support recent evidence of a role of Meis1 in ROS regulation.	[Miller, Michelle Erin; Rosten, Patty; Lai, Courteney; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Lemieux, Madeleine E.] Bioinfo, Plantagenet, ON, Canada; [Humphries, R. Keith] Univ British Columbia, Dept Med, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia	Humphries, RK (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.; Humphries, RK (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	khumphri@bccrc.ca		Humphries, Richard/0000-0003-0540-7005	Michael Smith Foundation of Health Research [ST-JGS-747(06-1)BM]; Terry Fox Foundation [18006, 122869]	Michael Smith Foundation of Health Research(Michael Smith Foundation for Health Research); Terry Fox Foundation	MEM received a Trainee Award (ST-JGS-747(06-1)BM) from the Michael Smith Foundation of Health Research, http://www.msfhr.org/.KH received Terry Fox New Frontiers Program Project Grants (18006 & 122869) from the Terry Fox Foundation, http://www.terryfox.org/. Funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bioinfo provided support in the form of salaries for author MEL, and MEL and Bioinfo provided microarray analysis information processing and statistical analysis pro bono and were not remunerated for the service. Bioinfo did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Argiropoulos B, 2008, EXP HEMATOL, V36, P845, DOI 10.1016/j.exphem.2008.02.011; Argiropoulos B, 2010, BLOOD, V115, P4071, DOI 10.1182/blood-2009-06-225573; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOCKAMP EO, 1995, BLOOD, V86, P1502, DOI 10.1182/blood.V86.4.1502.bloodjournal8641502; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Cai M, 2012, BLOOD; Capron C, 2011, EXP HEMATOL, V39, P629, DOI 10.1016/j.exphem.2011.02.014; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.253; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Cvejic A, 2011, HAEMATOL-HEMATOL J, V96, P190, DOI 10.3324/haematol.2010.027698; de Andres-Aguayo L, 2012, CURR OPIN HEMATOL, V19, P268, DOI 10.1097/MOH.0b013e328353c778; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; KRYSTAL G, 1994, J EXP MED, V180, P851, DOI 10.1084/jem.180.3.851; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Lieu YK, 2009, P NATL ACAD SCI USA, V106, P21689, DOI 10.1073/pnas.0907623106; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; PAWLIUK R, 1994, BLOOD, V84, P2868, DOI 10.1182/blood.V84.9.2868.bloodjournal8492868; Roychoudhury J, 2015, BLOOD, V125, P2544, DOI 10.1182/blood-2014-09-599258; Sardina JL, 2012, CRIT REV ONCOL HEMAT, V81, P257, DOI 10.1016/j.critrevonc.2011.03.005; Shinnick KM, 2010, J CLIN INVEST, V120, P4303, DOI 10.1172/JCI43556; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Zhang FJ, 2011, TOXICOL SCI, V120, P87, DOI 10.1093/toxsci/kfq364	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151584	10.1371/journal.pone.0151584	http://dx.doi.org/10.1371/journal.pone.0151584			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986211	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300090
J	Naveda-Rodriguez, A; Vargas, FH; Kohn, S; Zapata-Rios, G				Naveda-Rodriguez, Adrian; Hernan Vargas, Felix; Kohn, Sebastian; Zapata-Rios, Galo			Andean Condor (Vultur gryphus) in Ecuador: Geographic Distribution, Population Size and Extinction Risk	PLOS ONE			English	Article							CONSERVATION; AREAS; BOLIVIA; CHILE	The Andean Condor (Vultur gryphus) in Ecuador is classified as Critically Endangered. Before 2015, standardized and systematic estimates of geographic distribution, population size and structure were not available for this species, hampering the assessment of its current status and hindering the design and implementation of effective conservation actions. In this study, we performed the first quantitative assessment of geographic distribution, population size and population viability of Andean Condor in Ecuador. We used a methodological approach that included an ecological niche model to study geographic distribution, a simultaneous survey of 70 roosting sites to estimate population size and a population viability analysis (PVA) for the next 100 years. Geographic distribution in the form of extent of occurrence was 49 725 km(2). During a two-day census, 93 Andean Condors were recorded and a population of 94 to 102 individuals was estimated. In this population, adult-to-immature ratio was 1:0.5. In the modeled PVA scenarios, the probability of extinction, mean time to extinction and minimum population size varied from zero to 100%, 63 years and 193 individuals, respectively. Habitat loss is the greatest threat to the conservation of Andean Condor populations in Ecuador. Population size reduction in scenarios that included habitat loss began within the first 15 years of this threat. Population reinforcement had no effects on the recovery of Andean Condor populations given the current status of the species in Ecuador. The population size estimate presented in this study is the lower than those reported previously in other countries where the species occur. The inferences derived from the population viability analysis have implications for Condor management in Ecuador. This study highlights the need to redirect efforts from captive breeding and population reinforcement to habitat conservation.	[Naveda-Rodriguez, Adrian; Zapata-Rios, Galo] Wildlife Conservat Soc, Ecuador Program, Quito, Pichincha, Ecuador; [Hernan Vargas, Felix] Peregrine Fund, Boise, ID USA; [Kohn, Sebastian] Ctr Rescate Ilitio, Quito, Pichincha, Ecuador; [Naveda-Rodriguez, Adrian; Hernan Vargas, Felix; Kohn, Sebastian; Zapata-Rios, Galo] Grp Nacl Trabajo Condor Andino Ecuador, Quito, Pichincha, Ecuador		Naveda-Rodriguez, A (corresponding author), Wildlife Conservat Soc, Ecuador Program, Quito, Pichincha, Ecuador.; Naveda-Rodriguez, A (corresponding author), Grp Nacl Trabajo Condor Andino Ecuador, Quito, Pichincha, Ecuador.	anaveda@wcs.org	Naveda-Rodríguez, Adrián/AAD-7163-2020; Zapata-Ríos, Galo/H-8722-2019	Naveda-Rodríguez, Adrián/0000-0002-7557-2893; Zapata-Ríos, Galo/0000-0003-3508-5078; Vargas, Felix Hernan/0000-0002-0035-7670	Peregrine Fund; Wolf Creek Charitable Foundation; Butler Foundation; Centro de Rescate Ilitio; Ministry of Environment of Ecuador; Global Environmental Facility; United Nations Development Programme; Wildlife Conservation Society [00086648]	Peregrine Fund; Wolf Creek Charitable Foundation; Butler Foundation; Centro de Rescate Ilitio; Ministry of Environment of Ecuador; Global Environmental Facility; United Nations Development Programme; Wildlife Conservation Society	This work received financial support by The Peregrine Fund, Wolf Creek Charitable Foundation, The Butler Foundation, Centro de Rescate Ilitio, Barbara Butler (private donor), and Project: "Advancing Landscape Approaches in Ecuador's National Protected Area System to Improve Conservation of Globally Endangered Wildlife" of the Ministry of Environment of Ecuador, Global Environmental Facility, United Nations Development Programme and Wildlife Conservation Society (Project ID 00086648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; [Anonymous], [No title captured]; Astudillo PX, 2011, ORNITOL NEOTROP, V22, P257; BirdLife International, IUCN RED LIST THREAT; Douglass LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023843; Escobar-Gimpel V, 2014, CHIRICOCA, V18, P14; Escobar-Gimpel V, 2015, CHIRICOCA, V16, P38; Escobar-Gimpel V, 2015, ORNITOL NEOTROP, V26, P157; ESRI, 2011, ARCGIS DESKT REL 10; Ferguson-Lees J, 2001, RAPTORS WORLD; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Granizo T, 2002, LIBRO ROJO AVES ECUA; Hendrickson SL, 2003, CONDOR, V105, P1, DOI 10.1650/0010-5422(2003)105[1:LGVITG]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, IUCN RED LIST THREAT; IUCN/SSC, 2014, GUID US EXS MAN SPEC; Jarvis A, 2008, HOLE FILLED SEAMLESS; Koenen TM, 2000, J RAPTOR RES, V34, P933; Lacy R.C., 2014, VORTEX STOCHASTIC SI; Lambertucci SA, 2014, BIOL CONSERV, V170, P145, DOI 10.1016/j.biocon.2013.12.041; Lambertucci SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075821; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; McDonald J.H., 2014, HDB BIOL STAT; Mena-Vasconez P., 2006, BOT EC ANDES CENTRAL, P91; Mendez DR, 2015, J FIELD ORNITHOL, V86, P205, DOI 10.1111/jofo.12114; Meza-Saltos P, 2009, MEM 1 C INT AV RAP C; Ministerio del Ambiente del Ecuador, 1990, MAP COB US TIERR EC; Ministerio del Ambiente del Ecuador, 2014, MAP COB US TIERR EC; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Narvaez F., 2012, INFORME CENSO CONDOR; NASA, 2013, MODIS MCD12QQ; Naveda-Rodriguez A, 2015, J RAPTOR RES, V49, P441, DOI 10.3356/rapt-49-04-441-449.1; Panchi T., 2012, THESIS U GUAYAQUIL; Pearce JL, 2008, BIOL CONSERV, V141, P908, DOI 10.1016/j.biocon.2007.12.033; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIANA RP, 2015, B UNOP, V10, P9; Renjifo LM, 2002, LIBRO ROJO AVES COLO; Rios-Uzeda B, 2007, J FIELD ORNITHOL, V78, P170, DOI 10.1111/j.1557-9263.2007.00100.x; Rodriguez J, 2008, LIBRO ROJO FAUNA VEN; Sarno RJ, 2000, REV CHIL HIST NAT, V73, P3; SCOTT JM, 1993, WILDLIFE MONOGR, P1; SERFOR, 2015, PLAN NAC CONS COND A; Vargas FH, 2013, COMMUNICATION   1021; Vargas FH, MOVEBANK STUDY ANDEA; WALLACE MP, 1988, BIOTROPICA, V20, P144, DOI 10.2307/2388187; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Yanez M, 2002, CONSERVACION CONDOR	47	21	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151827	10.1371/journal.pone.0151827	http://dx.doi.org/10.1371/journal.pone.0151827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986004	Green Published, gold			2022-12-26	WOS:000372580300136
J	Stucchi, N; Scocchia, L; Carlini, A				Stucchi, Natale; Scocchia, Lisa; Carlini, Alessandro			When Geometry Constrains Vision: Systematic Misperceptions within Geometrical Configurations	PLOS ONE			English	Article							SACCADIC LOCALIZATION; VISUAL-PERCEPTION; SPATIAL-RESOLUTION; GESTALT PSYCHOLOGY; EYE-MOVEMENTS; VECTOR-FIELD; SHAPE; TARGETS; ATTENTION; ACCURACY	How accurate are we in reproducing a point within a simple shape? This is the empirical question we addressed in this work. Participants were presented with a tiny disk embedded in an empty circle (Experiment 1 and 3) or in a square (Experiment 2). Shortly afterwards the disk vanished and they had to reproduce the previously seen disk position within the empty shape by means of the mouse cursor, as accurately as possible. Several loci inside each shape were tested. We found that the space delimited by a circle and by a square is not homogeneous and the observed distortion appears to be consistent across observers and specific for the two tested shapes. However, a common pattern can be identified when reproducing geometrical loci enclosed in a shape: errors are shifted toward the periphery in the region around the center and toward the center in the region nearby the edges. The error absolute value declines progressively as we approach an equilibrium contour line between the center and the outline of the shape where the error is null. These results suggest that enclosing an empty space within a shape imposes an organization to it and warps its metrics: not only the perceived loci inside a shape are not the same as the geometrical loci, but they are misperceived in a systematic way that is functional to the correct identification of the center of the shape. Eye movements recordings (Experiment 3) are consistent with this interpretation of the data.	[Stucchi, Natale; Scocchia, Lisa] Univ Milano Bicocca, Dept Psychol, Piazza Ateneo Nuovo 1, I-20126 Milan, Italy; [Stucchi, Natale; Scocchia, Lisa] NeuroMi Milan Ctr Neurosci, Milan, Italy; [Carlini, Alessandro] Univ Burgundy, CNRS, Lab Res Learning & Dev LEAD, UMR 5022, Dijon, France	University of Milano-Bicocca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bourgogne	Scocchia, L (corresponding author), Univ Milano Bicocca, Dept Psychol, Piazza Ateneo Nuovo 1, I-20126 Milan, Italy.; Scocchia, L (corresponding author), NeuroMi Milan Ctr Neurosci, Milan, Italy.	lisa.scocchia@unimib.it	Carlini, Alessandro/GXF-8404-2022	Stucchi, Natale/0000-0002-7695-4068				Arnheim R., 1982, POWER CTR; Arnheim R, 1988, POWER CTR STUDY COMP, P239; Arnheim R., 1969, VISUAL THINKING, P345; Arnheim R, 1974, ART VISUAL PERCEPTIO, P508; ATTNEAVE F, 1955, Am J Psychol, V68, P209, DOI 10.2307/1418892; ATTNEAVE F, 1955, Am J Psychol, V68, P69, DOI 10.2307/1418390; BENJAFIELD J, 1980, CAN J PSYCHOL, V34, P253, DOI 10.1037/h0081053; BLUM H, 1973, J THEOR BIOL, V38, P205, DOI 10.1016/0022-5193(73)90175-6; BLUM H, 1974, ANN NY ACAD SCI, V231, P19, DOI 10.1111/j.1749-6632.1974.tb20549.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JF, 1937, AM J PSYCHOL, V49, P543, DOI 10.2307/1416380; Chalupa LM, 2004, VISUAL NEUROSCIENCES, V2; Chalupa LM, 2004, VISUAL NEUROSCIENCES, V1; Findlay J. M., 2003, ACTIVE VISION PSYCHO; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; FINDLAY JM, 2003, ACTIVE VISION PSYCHO, P220; HATFIELD G, 1985, PSYCHOL BULL, V97, P155, DOI 10.1037/0033-2909.97.2.155; HE P, 1991, J OPT SOC AM A, V8, P440, DOI 10.1364/JOSAA.8.000440; Kanizsa G., 1979, ORG VISION; Kleiner M, 2014, PSYCHTOOLBOX 3; Kohler W., 1920, SOURCE BOOK GESTALT; Kohler W, 1940, DYNAMICS PSYCHOL LIV; Kohler W, 1930, YALE REV, V19, P560; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; LASHLEY KS, 1951, PSYCHOL REV, V58, P123, DOI 10.1037/h0056603; McGowan JW, 1998, VISION RES, V38, P895, DOI 10.1016/S0042-6989(97)00232-0; Melcher D, 1999, VISION RES, V39, P2929, DOI 10.1016/S0042-6989(99)00029-2; Orbison WD, 1939, AM J PSYCHOL, V52, P31, DOI 10.2307/1416658; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PSOTKA J, 1978, J EXP PSYCHOL HUMAN, V4, P101, DOI 10.1037/0096-1523.4.1.101; Sickles WR, 1942, J EXP PSYCHOL, V30, P84, DOI 10.1037/h0057731; SPERRY RW, 1955, J COMP PHYSIOL PSYCH, V48, P463, DOI 10.1037/h0046231; STADLER M, 1991, PSYCHOL RES-PSYCH FO, V53, P102, DOI 10.1007/BF01371818; Stucchi N, 2010, PERCEPTION, V39, P1026, DOI 10.1068/p6665; Vishwanath D, 2003, VISION RES, V43, P1637, DOI 10.1016/S0042-6989(03)00168-8; Vishwanath D, 2004, J VISION, V4, P445, DOI 10.1167/4.6.4; Vishwanath D, 2000, VISION RES, V40, P2797, DOI 10.1016/S0042-6989(00)00118-8; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Wagemans J, 2012, PSYCHOL BULL, V138, P1218, DOI 10.1037/a0029334; Wardak C, 2011, NEUROPSYCHOLOGIA, V49, P535, DOI 10.1016/j.neuropsychologia.2010.12.008; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI [10.1037/11496-005, DOI 10.1037/11496-005]; Wertheimer M, 1938, LAWS ORG PERCEPTUAL; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wertheimer Max, 1925, PHILOS Z FORSCHUNG A, V1, P39; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Yeshurun Y, 2008, PERCEPT PSYCHOPHYS, V70, P104, DOI 10.3758/PP.70.1.104; YOKOSE Z, 1965, JPN PSYCHOL RES, V7, P101, DOI 10.4992/psycholres1954.7.101; Yokose Z, 1957, PSYCHOLOGIA, V1, P17	48	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151488	10.1371/journal.pone.0151488	http://dx.doi.org/10.1371/journal.pone.0151488			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986214	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300078
J	Barbone, D; Van Dam, L; Follo, C; Jithesh, PV; Zhang, SD; Richards, WG; Bueno, R; Fennell, DA; Broaddus, VC				Barbone, Dario; Van Dam, Loes; Follo, Carlo; Jithesh, Puthen V.; Zhang, Shu-Dong; Richards, William G.; Bueno, Raphael; Fennell, Dean A.; Broaddus, V. Courtney			Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; ARGININOSUCCINATE SYNTHETASE; ARGININE DEPRIVATION; CELL-LINES; PROMOTER METHYLATION; RESISTANCE; APOPTOSIS; IDENTIFICATION; CANCER; OVEREXPRESSION	To investigate the underlying causes of chemoresistance in malignant pleural mesothelioma, we have studied mesothelioma cell lines as 3D spheroids, which acquire increased chemoresistance compared to 2D monolayers. We asked whether the gene expression of 3D spheroids would reveal mechanisms of resistance. To address this, we measured gene expression of three mesothelioma cell lines, M28, REN and VAMT, grown as 2D monolayers and 3D spheroids. A total of 209 genes were differentially expressed in common by the three cell lines in 3D (138 upregulated and 71 downregulated), although a clear resistance pathway was not apparent. We then compared the list of 3D genes with two publicly available datasets of gene expression of 56 pleural mesotheliomas compared to normal tissues. Interestingly, only three genes were increased in both 3D spheroids and human tumors: argininosuccinate synthase 1 (ASS1), annexin A4 (ANXA4) and major vault protein (MVP); of these, ASS1 was the only consistently upregulated of the three genes by qRT-PCR. To measure ASS1 protein expression, we stained 2 sets of tissue microarrays (TMA): one with 88 pleural mesothelioma samples and the other with additional 88 pleural mesotheliomas paired with matched normal tissues. Of the 176 tumors represented on the two TMAs, ASS1 was expressed in 87 (50%; staining greater than 1 up to 3+). For the paired samples, ASS1 expression in mesothelioma was significantly greater than in the normal tissues. Reduction of ASS1 expression by siRNA significantly sensitized mesothelioma spheroids to the pro-apoptotic effects of bortezomib and of cisplatin plus pemetrexed. Although mesothelioma is considered by many to be an ASS1-deficient tumor, our results show that ASS1 is elevated at the mRNA and protein levels in mesothelioma 3D spheroids and in human pleural mesotheliomas. We also have uncovered a survival role for ASS1, which may be amenable to targeting to undermine mesothelioma multicellular resistance.	[Barbone, Dario; Follo, Carlo; Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Pulm, San Francisco, CA USA; [Van Dam, Loes] Univ Med Ctr Utrecht, Dept Mol Canc Res, Ctr Mol Med, Utrecht, Netherlands; [Jithesh, Puthen V.] Sidra Med & Res Ctr, Doha, Qatar; [Zhang, Shu-Dong] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Richards, William G.; Bueno, Raphael] Brigham & Womens Hosp, Div Thorac Surg, 75 Francis St, Boston, MA 02115 USA; [Fennell, Dean A.] Univ Leicester, Dept Canc Studies, Canc Res UK Leicester Ctr, Leicester, Leics, England	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Sidra Medical & Research Center; Queens University Belfast; Harvard University; Brigham & Women's Hospital; Cancer Research UK; University of Leicester	Barbone, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Pulm, San Francisco, CA USA.	dario.barbone@ucsf.edu	Zhang, Shu-Dong/G-1269-2010; Jithesh, Puthen Veettil/O-6262-2019	Zhang, Shu-Dong/0000-0002-7721-0167; Jithesh, Puthen Veettil/0000-0001-7747-0930; van Dam, Loes/0000-0002-5724-7632; Follo, Carlo/0000-0001-9711-2655	Mesothelioma Applied Research Foundation (MARF) [A121342]; Simmons Mesothelioma Foundation; Simmons Fellowship in Mesothelioma Research	Mesothelioma Applied Research Foundation (MARF); Simmons Mesothelioma Foundation; Simmons Fellowship in Mesothelioma Research	The work was supported by the following: Mesothelioma Applied Research Foundation (MARF) grant to DB (A121342) [http://www.curemeso.org/]; Simmons Mesothelioma Foundation gift to VCB [http://www.simmonsmesotheliomafoundation.org/]; and Simmons Fellowship in Mesothelioma Research to CF [http://www.simmonsmesotheliomafoundation.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Agnes Paquet (CNRS and University Nice Sophia Antipolis, IPMC, Valbonne, France) for helping with the gene expression microarray and Ingenuity analysis, and Rebecca A. Barbeau and the Sandler Asthma Basic Research (SABRE) Center Functional Genomics Core Facility, University of California San Francisco, Mission Bay for performing the gene expression microarrays. This work was supported by a Mesothelioma Applied Research Foundation (MARF) grant to DB (A121342) and by the Simmons Mesothelioma Foundation. CF was supported by a Simmons Fellowship in Mesothelioma Research.	Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Barbone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052753; Barczak A, 2003, GENOME RES, V13, P1775, DOI 10.1101/gr.1048803; Battisti S, 2012, AM J RESP CELL MOL, V46, P498, DOI 10.1165/rcmb.2011-0195OC; Broaddus VC, 2005, J BIOL CHEM, V280, P12486, DOI 10.1074/jbc.M408190200; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; Daubriac J, 2009, CELL DEATH DIFFER, V16, P1146, DOI 10.1038/cdd.2009.32; De Rienzo A, 2011, CLIN CANCER RES, V17, P310, DOI 10.1158/1078-0432.CCR-10-0806; Delage B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.83; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Fennell DA, 2004, LANCET ONCOL, V5, P354, DOI 10.1016/S1470-2045(04)01492-5; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gordon GJ, 2009, JNCI-J NATL CANCER I, V101, P678, DOI 10.1093/jnci/djp061; Gordon GJ, 2005, CLIN CANCER RES, V11, P4406, DOI 10.1158/1078-0432.CCR-04-2181; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Gordon GJ, 2003, J NATL CANCER I, V95, P598, DOI 10.1093/jnci/95.8.598; Guo GW, 2015, CANCER RES, V75, P264, DOI 10.1158/0008-5472.CAN-14-1008; HARASAWA R, 1993, RES MICROBIOL, V144, P489, DOI 10.1016/0923-2508(93)90057-9; Huang HY, 2013, CLIN CANCER RES, V19, P2861, DOI 10.1158/1078-0432.CCR-12-2641; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039556; Lind DS, 2004, J NUTR, V134, p2837S, DOI 10.1093/jn/134.10.2837S; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Melaiu O, 2015, MUTAT RES-FUND MOL M, V771, P6, DOI 10.1016/j.mrfmmm.2014.11.002; Melaiu O, 2012, MUTAT RES-REV MUTAT, V750, P132, DOI 10.1016/j.mrrev.2011.12.003; METCALF RA, 1992, CANCER RES, V52, P2610; NAGY JA, 1993, CANCER RES, V53, P2631; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Nicholson LJ, 2009, INT J CANCER, V125, P1454, DOI 10.1002/ijc.24546; Pinton G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036856; POPESCU NC, 1988, CANCER RES, V48, P142; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Sakai Y, 2010, CELLS TISSUES ORGANS, V191, P281, DOI 10.1159/000272316; Shan YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09783; Singhal S, 2003, CLIN CANCER RES, V9, P3080; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Syed N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.197; Szlosarek PW, 2006, CLIN CANCER RES, V12, P7126, DOI 10.1158/1078-0432.CCR-06-1101; Szlosarek PW, 2013, J CLIN ONCOL, V31, pE111, DOI 10.1200/JCO.2012.42.1784; Wangpaichitr M, 2014, ANTICANCER RES, V34, P6991; Watson PM, 2008, AM J RESP CELL MOL, V38, P671, DOI 10.1165/rcmb.2007-0205OC; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	47	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150044	10.1371/journal.pone.0150044	http://dx.doi.org/10.1371/journal.pone.0150044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982031	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900023
J	Blair, JA; Wang, C; Hernandez, D; Siedlak, SL; Rodgers, MS; Achar, RK; Fahmy, LM; Torres, SL; Petersen, RB; Zhu, XW; Casadesus, G; Lee, HG				Blair, Jeffrey A.; Wang, Chunyu; Hernandez, Damarys; Siedlak, Sandra L.; Rodgers, Mark S.; Achar, Rojan K.; Fahmy, Lara M.; Torres, Sandy L.; Petersen, Robert B.; Zhu, Xiongwei; Casadesus, Gemma; Lee, Hyoung-gon			Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation	PLOS ONE			English	Article							GENE-EXPRESSION; QUALITY-CONTROL; PROTEINS; DISEASE; PHOSPHORYLATION; MOUSE; TAU	At autopsy, the time that has elapsed since the time of death is routinely documented and noted as the postmortem interval (PMI). The PMI of human tissue samples is a parameter often reported in research studies and comparable PMI is preferred when comparing different populations, i.e., disease versus control patients. In theory, a short PMI may alleviate non-experimental protein denaturation, enzyme activity, and other chemical changes such as the pH, which could affect protein and nucleic acid integrity. Previous studies have compared PMI en masse by looking at many different individual cases each with one unique PMI, which may be affected by individual variance. To overcome this obstacle, in this study human hippocampal segments from the same individuals were sampled at different time points after autopsy creating a series of PMIs for each case. Frozen and fixed tissue was then examined by Western blot, RT-PCR, and immunohistochemistry to evaluate the effect of extended PMI on proteins, nucleic acids, and tissue morphology. In our results, immunostaining profiles for most proteins remained unchanged even after PMI of over 50 h, yet by Western blot distinctive degradation patterns were observed in different protein species. Finally, RNA integrity was lower after extended PMI; however, RNA preservation was variable among cases suggesting antemortem factors may play a larger role than PMI in protein and nucleic acid integrity.	[Blair, Jeffrey A.; Casadesus, Gemma] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Blair, Jeffrey A.; Casadesus, Gemma] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Wang, Chunyu; Hernandez, Damarys; Siedlak, Sandra L.; Rodgers, Mark S.; Achar, Rojan K.; Fahmy, Lara M.; Torres, Sandy L.; Petersen, Robert B.; Zhu, Xiongwei; Lee, Hyoung-gon] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Wang, Chunyu] Cent S Univ, Dept Neurol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Central South University	Casadesus, G (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.; Casadesus, G (corresponding author), Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA.; Zhu, XW; Lee, HG (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	xiongwei.zhu@case.edu; gcasades@kent.edu; hyoung-gon.lee@case.edu	Zhu, Xiongwei/A-9629-2009	Zhu, Xiongwei/0000-0003-2092-6508; Casadesus, Gemma/0000-0002-5206-5637	Alzheimer's Association [IIRG-11-205527]	Alzheimer's Association(Alzheimer's Association)	This study was supported by the Alzheimer's Association (IIRG-11-205527 to HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barksdale KA, 2010, FASEB J, V24, P3590, DOI 10.1096/fj.09-152108; Chandana R, 2009, INDIAN J MED RES, V129, P189; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; Halim ND, 2003, MOL PSYCHIATR, V8, P797, DOI 10.1038/sj.mp.4001319; Hynd MR, 2003, J NEUROCHEM, V85, P543, DOI 10.1046/j.1471-4159.2003.01747.x; Kim TH, 2009, ANAT REC, V292, P234, DOI 10.1002/ar.20823; Kolasinski J, 2012, BRAIN, V135, P2938, DOI 10.1093/brain/aws242; KOSIK KS, 1982, J NEUROCHEM, V39, P1529, DOI 10.1111/j.1471-4159.1982.tb07985.x; Li JL, 2003, NEUROPSYCHOPHARMACOL, V28, P1017, DOI 10.1038/sj.npp.1300112; Li XH, 2005, J NEUROCHEM, V92, P701, DOI 10.1111/j.1471-4159.2004.02898.x; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Monoranu CM, 2009, NEUROPATH APPL NEURO, V35, P329, DOI 10.1111/j.1365-2990.2008.01003a.x; PERRY RH, 1977, LANCET, V1, P38; Popova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-91; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Soltys DT, 2015, MUTAT RES-FUND MOL M, V776, P48, DOI 10.1016/j.mrfmmm.2015.01.003; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15709; Williams WM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-127; Zhang F, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0030-4	22	53	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151615	10.1371/journal.pone.0151615	http://dx.doi.org/10.1371/journal.pone.0151615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982086	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900103
J	Dhanyalakshmi, KH; Naika, MBN; Sajeevan, RS; Mathew, OK; Shafi, KM; Sowdhamini, R; Nataraja, KN				Dhanyalakshmi, K. H.; Naika, Mahantesha B. N.; Sajeevan, R. S.; Mathew, Oommen K.; Shafi, K. Mohamed; Sowdhamini, Ramanathan; Nataraja, Karaba N.			An Approach to Function Annotation for Proteins of Unknown Function (PUFs) in the Transcriptome of Indian Mulberry	PLOS ONE			English	Article							UNIVERSAL STRESS-PROTEIN; FOLD RECOGNITION; GENES; TOLERANCE; NETWORKS; DATABASE; DROUGHT; DOMAINS	The modern sequencing technologies are generating large volumes of information at the transcriptome and genome level. Translation of this information into a biological meaning is far behind the race due to which a significant portion of proteins discovered remain as proteins of unknown function (PUFs). Attempts to uncover the functional significance of PUFs are limited due to lack of easy and high throughput functional annotation tools. Here, we report an approach to assign putative functions to PUFs, identified in the transcriptome of mulberry, a perennial tree commonly cultivated as host of silkworm. We utilized the mulberry PUFs generated from leaf tissues exposed to drought stress at whole plant level. A sequence and structure based computational analysis predicted the probable function of the PUFs. For rapid and easy annotation of PUFs, we developed an automated pipeline by integrating diverse bioinformatics tools, designated as PUFs Annotation Server (PUFAS), which also provides a web service API (Application Programming Interface) for a large-scale analysis up to a genome. The expression analysis of three selected PUFs annotated by the pipeline revealed abiotic stress responsiveness of the genes, and hence their potential role in stress acclimation pathways. The automated pipeline developed here could be extended to assign functions to PUFs from any organism in general. PUFAS web server is available at http://caps.ncbs.res.in/pufas/ and the web service is accessible at http://capservices.ncbs.res.in/help/pufas.	[Dhanyalakshmi, K. H.; Sajeevan, R. S.; Nataraja, Karaba N.] Univ Agr Sci, Dept Crop Physiol, GKVK, Bengaluru 560065, India; [Naika, Mahantesha B. N.; Mathew, Oommen K.; Shafi, K. Mohamed; Sowdhamini, Ramanathan] TIFR, Natl Ctr Biol Sci, GKVK Campus, Bengaluru 560065, India; [Naika, Mahantesha B. N.] Univ Hort Sci, KRCCH Arabhavi 591218, Dept Biotechnol & Crop Improvement, Bagalkot, Karnataka, India	University of Agricultural Sciences Bangalore; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Nataraja, KN (corresponding author), Univ Agr Sci, Dept Crop Physiol, GKVK, Bengaluru 560065, India.; Sowdhamini, R (corresponding author), TIFR, Natl Ctr Biol Sci, GKVK Campus, Bengaluru 560065, India.	mini@ncbs.res.in; nataraja_karaba@yahoo.com	RADHA SIVARAJAN, SAJEEVAN/AAA-2479-2021; Naika, Mahantesha BN/AAI-5724-2020; Kaleeckal Mathew, Oommen/AAC-4217-2022	RADHA SIVARAJAN, SAJEEVAN/0000-0002-8671-4981; Kaleeckal Mathew, Oommen/0000-0002-6312-3118; B N Naika, Mahantesha/0000-0003-0753-792X; Nataraja, Karaba N./0000-0002-9766-3622; Shafi, Mohamed/0000-0002-2029-5016; K H, Dhanyalakshmi/0000-0002-6521-3774	Department of Biotechnology, Government of India [BT/PR13457/PBD/19/214/2010]; Department of Science and Technology (DST), Government of India; Department of Science and Technology, (DST), Government of India; NCBS	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Department of Science and Technology, (DST), Government of India(Department of Science & Technology (India)); NCBS	The research is supported by the Department of Biotechnology, Government of India grant no. BT/PR13457/PBD/19/214/2010 to KNN. KHD would like to thank Department of Science and Technology (DST), Government of India for DST-INSPIRE Fellowship.; The research is supported by the Department of Biotechnology, Government of India grant No. BT/PR13457/PBD/19/214/2010 to KNN. KHD would like to thank Department of Science and Technology, (DST), Government of India for DST-INSPIRE Fellowship. MBNN and RS thank the National Center for Biological Sciences (NCBS), Bengaluru for infrastructure, MBNN also thank NCBS for Bridge Postdoctoral Fellowship. KNN would like to thank Department of Science and Technology-Fund for Improvement of Science and Technology (DST-FIST) for the infrastructure facilities. KHD, MBNN, OKM, KMS, RSS and KNN thank NCBS and University of Agricultural Sciences (UAS), Bengaluru for the general facilities.	Aguilera F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-96; Ambrosone A, 2012, PLANT SCI, V182, P12, DOI 10.1016/j.plantsci.2011.02.004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Chang C, 2010, J BACTERIOL, V192, P1156, DOI 10.1128/JB.01508-09; de Vega-Bartol JJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-123; Diaz-Riquelme J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092339; Doerks T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034302; Ellison CE, 2014, MBIO, V5, DOI 10.1128/mBio.01046-13; Gollery M, 2007, TRENDS PLANT SCI, V12, P492, DOI 10.1016/j.tplants.2007.08.018; Gollery M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r57; Guengerich FP, 2010, MOL INTERV, V10, P153, DOI 10.1124/mi.10.3.6; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Jiang JF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003625; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kelly WP, 2008, CURR OPIN BIOTECH, V19, P396, DOI 10.1016/j.copbio.2008.06.010; Kerk D, 2003, PLANT PHYSIOL, V131, P1209, DOI 10.1104/pp.102.016006; Kitsios G, 2011, PLANT SIGNAL BEHAV, V6, P204, DOI 10.4161/psb.6.2.14835; Kumar K, 2014, GENE, V543, P93, DOI 10.1016/j.gene.2014.03.060; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Loukehaich R, 2012, J EXP BOT, V63, P5593, DOI 10.1093/jxb/ers220; Luhua S, 2008, PLANT PHYSIOL, V148, P280, DOI 10.1104/pp.108.124875; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mayer ML, 2000, NAT BIOTECHNOL, V18, P1242, DOI 10.1038/82342; Mckay T, 2015, ANNOTATION PROTEINS, P43; Meier M, 2013, P NATL ACAD SCI USA, V110, P477, DOI 10.1073/pnas.1210634110; Nagano Y, 2011, NUCLEIC ACIDS RES, V29, P4097; Naika M, 2013, MOL BIOSYST, V9, P1888, DOI 10.1039/c3mb70072k; Nokso-koivisto J, 2015, PANNZER HIGH THROUGH, V31, P1544; Pandey SP, 2011, NUCLEIC ACIDS RES, V39, P4691, DOI 10.1093/nar/gkr060; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Sajeevan R. S., 2014, American Journal of Plant Sciences, V5, P2057; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuller A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/103132; Schuppler U, 1998, PLANT PHYSIOL, V117, P667, DOI 10.1104/pp.117.2.667; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Ye YZ, 2004, PROTEIN SCI, V13, P1841, DOI 10.1110/ps.03602304	49	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151323	10.1371/journal.pone.0151323	http://dx.doi.org/10.1371/journal.pone.0151323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982336	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900075
J	Altadill, T; Campoy, I; Lanau, L; Gill, K; Rigau, M; Gil-Moreno, A; Reventos, J; Byers, S; Colas, E; Cheema, AK				Altadill, Tatiana; Campoy, Irene; Lanau, Lucia; Gill, Kirandeep; Rigau, Marina; Gil-Moreno, Antonio; Reventos, Jaume; Byers, Stephen; Colas, Eva; Cheema, Amrita K.			Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR; IN-VITRO; ACID; FUTURE; COENZYME-Q10; MARKERS; SERINE; BRAIN	Identification of sensitive and specific biomarkers with clinical and translational utility will require smart experimental strategies that would augment expanding the breadth and depth of molecular measurements within the constraints of currently available technologies. Exosomes represent an information rich matrix to discern novel disease mechanisms that are thought to contribute to pathologies such as dementia and cancer. Although proteomics and transcriptomic studies have been reported using Exosomes-Like Vesicles (ELVs) from different sources, exosomal metabolome characterization and its modulation in health and disease remains to be elucidated. Here we describe methodologies for UPLC-ESI-MS based small molecule profiling of ELVs from human plasma and cell culture media. In this study, we present evidence that indeed ELVs carry a rich metabolome that could not only augment the discovery of low abundance biomarkers but may also help explain the molecular basis of disease progression. This approach could be easily translated to other studies seeking to develop predictive biomarkers that can subsequently be used with simplified targeted approaches.	[Altadill, Tatiana; Campoy, Irene; Lanau, Lucia; Colas, Eva] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, Biomed Res Grp Ginecol, E-08193 Barcelona, Spain; [Gill, Kirandeep; Byers, Stephen; Cheema, Amrita K.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Gill, Kirandeep; Byers, Stephen; Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Biochem Mol & Cellular Biol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Rigau, Marina; Reventos, Jaume] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Gil-Moreno, Antonio] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Dept Gynecol, E-08193 Barcelona, Spain; [Colas, Eva] Univ Lleida, IRBLleida, Hosp Univ Arnau de Vilanova, Dept Pathol & Mol Genet,Oncol Pathol Grp, Lleida, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Georgetown University; Georgetown University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Universitat de Lleida; University Hospital Arnau de Vilanova	Cheema, AK (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA.; Cheema, AK (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem Mol & Cellular Biol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	akc27@georgetown.edu	Gil-Moreno, Antonio/C-1122-2016	Gil-Moreno, Antonio/0000-0003-1106-5590; Cheema, Amrita/0000-0003-4877-7583	Spanish Ministry of Health [RD12/0036/0035]; Spanish Ministry of Economy and Competitivy [PI14/02043]; AECC (Grupos Estables de Investi-gacion) [2011 - AECC- GCB 110333 REVE]; Fundacio La Marato TV3 [2/C/2013]; CIRIT Generalitat de Catalunya [2014 SGR 1330]; European Commission, 7th Framework Programe, IRSES - Belgium [PROTBIOFLUID -269285]; NIH/NCI [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Economy and Competitivy; AECC (Grupos Estables de Investi-gacion); Fundacio La Marato TV3; CIRIT Generalitat de Catalunya(Generalitat de Catalunya); European Commission, 7th Framework Programe, IRSES - Belgium; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Spanish Ministry of Health (RD12/0036/0035), the Spanish Ministry of Economy and Competitivy (PI14/02043), the AECC (Grupos Estables de Investi-gacion 2011 - AECC- GCB 110333 REVE), the Fundacio La Marato TV3 (2/C/2013), the CIRIT Generalitat de Catalunya (2014 SGR 1330) and the European Commission, 7th Framework Programe, IRSES (PROTBIOFLUID -269285) - Belgium. The authors would like to acknowledge the Proteomics and Metabolomics Shared Resource partially supported by Cancer Center Support Grant NIH/NCI grant P30-CA051008.	Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Colas E, 2011, INT J CANCER, V129, P2435, DOI 10.1002/ijc.25901; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Diamandis EP, 2014, CLIN CHEM LAB MED, V52, P791, DOI 10.1515/cclm-2014-0317; Franquesa M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00525; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Guidetti P, 2003, MOL BRAIN RES, V118, P132, DOI 10.1016/j.molbrainres.2003.08.004; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Healy ZR, 2011, CANCER EPIDEM BIOMAR, V20, P1516, DOI 10.1158/1055-9965.EPI-11-0279; Ho WSV, 2010, BRIT J PHARMACOL, V160, P1580, DOI 10.1111/j.1476-5381.2010.00788.x; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Krantz Seth B, 2010, Cancers (Basel), V2, P2084, DOI 10.3390/cancers2042084; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Mabert K, 2014, INT J RADIAT BIOL, V90, P659, DOI 10.3109/09553002.2014.892229; Makabi-Panzu B, 1998, VACCINE, V16, P1504, DOI 10.1016/S0264-410X(98)00018-8; Mazzeo C, 2015, J ALLERGY CLIN IMMUN; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Mizutani K, 2014, ANTICANCER RES, V34, P3419; Omri A, 2000, J DRUG TARGET, V7, P383; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pfeifer P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/161393; Pham H, 2004, INT J CANCER, V111, P192, DOI 10.1002/ijc.20245; Pocsfalvi G, 2016, MASS SPECTROM REV, V35, P3, DOI 10.1002/mas.21457; Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63; Sheikh Kathryn D, 2011, J Biomol Tech, V22, P1; Stahl W, 1996, ADV EXP MED BIOL, V387, P121; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Szajnik Marta, 2013, Gynecol Obstet (Sunnyvale), VSuppl 4, P3; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wei Ru, 2014, Methods Mol Biol, V1198, P171, DOI 10.1007/978-1-4939-1258-2_12; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yang Y, 2015, CURRENT MED CHEM; Zeczycki TN, 2014, BIOCHEM BIOPH RES CO, V450, P366, DOI 10.1016/j.bbrc.2014.05.133	42	58	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151339	10.1371/journal.pone.0151339	http://dx.doi.org/10.1371/journal.pone.0151339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974972	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600070
J	Fang, H; Dong, H; Cai, T; Zheng, P; Li, HX; Zhang, DW; Sun, JB				Fang, Huan; Dong, Huina; Cai, Tao; Zheng, Ping; Li, Haixing; Zhang, Dawei; Sun, Jibin			In Vitro Optimization of Enzymes Involved in Precorrin-2 Synthesis Using Response Surface Methodology	PLOS ONE			English	Article							UROPORPHYRINOGEN-III METHYLTRANSFERASE; ADENOSYL-L-METHIONINE; HEME D(1) BIOSYNTHESIS; ESCHERICHIA-COLI; BACILLUS-MEGATERIUM; FATTY-ACID; EXPRESSION; PATHWAY; GENE; OVERPRODUCTION	In order to maximize the production of biologically-derived chemicals, kinetic analyses are first necessary for predicting the role of enzyme components and coordinating enzymes in the same reaction system. Precorrin-2 is a key precursor of cobalamin and siroheme synthesis. In this study, we sought to optimize the concentrations of several molecules involved in precorrin-2 synthesis in vitro: porphobilinogen synthase (PBGS), porphobilinogen deaminase (PBGD), uroporphyrinogen III synthase (UROS), and S-adenosyl-l-methionine-dependent urogen III methyltransferase (SUMT). Response surface methodology was applied to develop a kinetic model designed to maximize precorrin-2 productivity. The optimal molar ratios of PBGS, PBGD, UROS, and SUMT were found to be approximately 1: 7: 7: 34, respectively. Maximum precorrin-2 production was achieved at 0.1966 +/- 0.0028 mu M/min, agreeing with the kinetic model's predicted value of 0.1950 mu M/min. The optimal concentrations of the cofactor S-adenosyl-L-methionine (SAM) and substrate 5-aminolevulinic acid (ALA) were also determined to be 200 mu M and 5 mM, respectively, in a tandem-enzyme assay. By optimizing the relative concentrations of these enzymes, we were able to minimize the effects of substrate inhibition and feedback inhibition by S-adenosylhomocysteine on SUMT and thereby increase the production of precorrin-2 by approximately five-fold. These results demonstrate the effectiveness of kinetic modeling via response surface methodology for maximizing the production of biologically-derived chemicals.	[Fang, Huan; Dong, Huina; Cai, Tao; Zheng, Ping; Zhang, Dawei; Sun, Jibin] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Fang, Huan; Dong, Huina; Zheng, Ping; Zhang, Dawei; Sun, Jibin] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Fang, Huan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Haixing] Nanchang Univ, Sinogerman Joint Res Inst, Nanchang, Jiangxi, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanchang University	Zhang, DW (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China.; Zhang, DW (corresponding author), Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China.	zhang_dw@tib.cas.cn		Sun, Jibin/0000-0002-0208-504X	State Key Development Program for Basic Research of China (973 Program) [2013CB733600]; National Nature Science Foundation of China [31370089]; Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences	State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences	This work was supported by the State Key Development Program for Basic Research of China (973 Program, 2013CB733600) (http://www.most.gov.cn/), the National Nature Science Foundation of China (31370089) (http://www.nsfc.gov.cn/), and the Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences (http://www.sysbio.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha N, 2015, J IND MICROBIOL BIOT, V42, P21, DOI 10.1007/s10295-014-1542-0; Alper H, 2006, P NATL ACAD SCI USA, V103, P3006, DOI 10.1073/pnas.0511314103; BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989; Box GE., 1978, STAT EXPT; Comba S, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0172-0; Gadhe A, 2011, J CHEM TECHNOL BIOT, V86, P1535, DOI 10.1002/jctb.2671; Guo DY, 2014, METAB ENG, V22, P69, DOI 10.1016/j.ymben.2014.01.003; He J, 2009, BIORESOURCE TECHNOL, V100, P5922, DOI 10.1016/j.biortech.2009.06.087; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Juminaga D, 2012, APPL ENVIRON MICROB, V78, P89, DOI 10.1128/AEM.06017-11; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Larentis AL, 2012, J IND MICROBIOL BIOT, V39, P897, DOI 10.1007/s10295-012-1099-8; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; Liu Q, 2015, METAB ENG, V28, P82, DOI 10.1016/j.ymben.2014.12.004; Liu R, 2014, METAB ENG, V22, P10, DOI 10.1016/j.ymben.2013.12.004; Liu TG, 2010, METAB ENG, V12, P378, DOI 10.1016/j.ymben.2010.02.003; Lobo SAL, 2009, BIOCHEM J, V420, P317, DOI 10.1042/BJ20090151; Lopez-Gallego F, 2010, CURR OPIN CHEM BIOL, V14, P174, DOI 10.1016/j.cbpa.2009.11.023; Na D, 2010, CURR OPIN MICROBIOL, V13, P363, DOI 10.1016/j.mib.2010.02.004; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; ROBIN C, 1991, J BACTERIOL, V173, P4893, DOI 10.1128/jb.173.15.4893-4896.1991; Rodrigues RCLB, 2012, BIORESOURCE TECHNOL, V108, P134, DOI 10.1016/j.biortech.2011.09.026; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SATTLER I, 1995, J BACTERIOL, V177, P1564, DOI 10.1128/jb.177.6.1564-1569.1995; Schubert HL, 2008, BIOCHEM J, V415, P257, DOI 10.1042/BJ20080785; Storbeck S, 2011, J BIOL CHEM, V286, P26754, DOI 10.1074/jbc.M111.239855; Storbeck S, 2009, FEBS J, V276, P5973, DOI 10.1111/j.1742-4658.2009.07306.x; Yin L, 2013, BIOL SCI, V368, DOI [10.1098/rstb.2012.0262, DOI 10.1098/RSTB.2012.0262]; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Zajicek RS, 2009, FEBS J, V276, P6399, DOI 10.1111/j.1742-4658.2009.07354.x; Zhu FY, 2014, BIOTECHNOL BIOENG, V111, P1396, DOI 10.1002/bit.25198	32	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151149	10.1371/journal.pone.0151149	http://dx.doi.org/10.1371/journal.pone.0151149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974652	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600052
J	Kent, IA; Rane, PS; Dickinson, RB; Ladd, AJC; Lele, TP				Kent, Ian A.; Rane, Parag S.; Dickinson, Richard B.; Ladd, Anthony J. C.; Lele, Tanmay P.			Transient Pinning and Pulling: A Mechanism for Bending Microtubules	PLOS ONE			English	Article							LIVING CELLS; TRANSITION FREQUENCIES; DYNAMIC INSTABILITY; CYTOPLASMIC DYNEIN; EPITHELIAL-CELLS; MIGRATING CELLS; MINUS END; IN-VIVO; TENSEGRITY; DYNACTIN	Microtubules have a persistence length of the order of millimeters in vitro, but inside cells they bend over length scales of microns. It has been proposed that polymerization forces bend microtubules in the vicinity of the cell boundary or other obstacles, yet bends develop even when microtubules are polymerizing freely, unaffected by obstacles and cell boundaries. How these bends are formed remains unclear. By tracking the motions of microtubules marked by photobleaching, we found that in LLC-PK1 epithelial cells local bends develop primarily by plus-end directed transport of portions of the microtubule contour towards stationary locations (termed pinning points) along the length of the microtubule. The pinning points were transient in nature, and their eventual release allowed the bends to relax. The directionality of the transport as well as the overall incidence of local bends decreased when dynein was inhibited, while myosin inhibition had no observable effect. This suggests that dynein generates a tangential force that bends microtubules against stationary pinning points. Simulations of microtubule motion and polymerization accounting for filament mechanics and dynein forces predict the development of bends of size and shape similar to those observed in cells. Furthermore, simulations show that dynein-generated bends at a pinning point near the plus end can cause a persistent rotation of the tip consistent with the observation that bend formation near the tip can change the direction of microtubule growth. Collectively, these results suggest a simple physical mechanism for the bending of growing microtubules by dynein forces accumulating at pinning points.	[Kent, Ian A.; Rane, Parag S.; Dickinson, Richard B.; Ladd, Anthony J. C.; Lele, Tanmay P.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lele, TP (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	tlele@che.ufl.edu	Dickinson, Richard B/A-4435-2012; Ladd, Anthony/AAC-8602-2019	Dickinson, Richard B/0000-0002-7415-2889; 	National Institutes of Health [RO1 GM102486]; National Science Foundation [1236616]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health RO1 GM102486 (T.P.L. and R.B. D.) and National Science Foundation 1236616.	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Brangwynne CP, 2007, P NATL ACAD SCI USA, V104, P16128, DOI 10.1073/pnas.0703094104; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; Howard J., 2001, MECH MOTOR PROTEINS; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ingber DE, 2000, J APPL PHYSIOL, V89, P1663, DOI 10.1152/jappl.2000.89.4.1663; Jolly Amber L, 2010, Commun Integr Biol, V3, P589, DOI 10.4161/cib.3.6.13212; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Komarova YA, 2002, J CELL SCI, V115, P3527; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Llopis I, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061901; Odde DJ, 1999, J CELL SCI, V112, P3283; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; Shekhar N, 2013, CELL MOL BIOENG, V6, P120, DOI 10.1007/s12195-013-0281-z; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; Stamenovic D, 2002, AM J PHYSIOL-CELL PH, V282, pC617, DOI 10.1152/ajpcell.00271.2001; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wu J, 2011, MOL BIOL CELL, V22, P4834, DOI 10.1091/mbc.E11-07-0611; Wu J, 2011, J CELL PHYSIOL, V226, P2666, DOI 10.1002/jcp.22616; Yvon AMC, 1997, J CELL SCI, V110, P2391	38	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151322	10.1371/journal.pone.0151322	http://dx.doi.org/10.1371/journal.pone.0151322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974838	Green Published, gold			2022-12-26	WOS:000372570600069
J	Reudink, MW; Kyle, CJ; McKellar, AE; Somers, CM; Reudink, RLF; Kyser, TK; Franks, SE; Nocera, JJ				Reudink, Matthew W.; Kyle, Christopher J.; McKellar, Ann E.; Somers, Christopher M.; Reudink, Robyn L. F.; Kyser, T. Kurt; Franks, Samantha E.; Nocera, Joseph J.			Linking Isotopes and Panmixia: High WithinColony Variation in Feather delta 2H, delta 13C, and delta 15N across the Range of the American White Pelican	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENE FLOW; MICROSATELLITE LOCI; NITROGEN ISOTOPES; LAKE; ASSIGNMENT; MIGRATION; PATTERNS; HYDROGEN; ECOLOGY	Complete panmixia across the entire range of a species is a relatively rare phenomenon; however, this pattern may be found in species that have limited philopatry and frequent dispersal. American white pelicans (Pelecanus erythrorhyncos) provide a unique opportunity to examine the role of long-distance dispersal in facilitating gene flow in a species recently reported as panmictic across its broad breeding range. This species is also undergoing a range expansion, with new colonies arising hundreds of kilometers outside previous range boundaries. In this study, we use a multiple stable isotope (delta H-2, delta C-13, delta N-15) approach to examine feather isotopic structuring at 19 pelican colonies across North America, with the goal of establishing an isotopic basemap that could be used for assigning individuals at newly established breeding sites to source colonies. Within-colony isotopic variation was extremely high, exceeding 100% in delta H-2 within some colonies (with relatively high variation also observed for delta C-13 and delta N-15). The high degree of within-site variation greatly limited the utility of assignment-based approaches (42% cross-validation success rate; range: 0-90% success). Furthermore, clustering algorithms identified four likely isotopic clusters; however, those clusters were generally unrelated to geographic location. Taken together, the high degree of within-site isotopic variation and lack of geographically-defined isotopic clusters preclude the establishment of an isotopic basemap for American white pelicans, but may indicate that a high incidence of long-distance dispersal is facilitating gene flow, leading to genetic panmixia.	[Reudink, Matthew W.; Kyle, Christopher J.] Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada; [McKellar, Ann E.] Environm Canada, Saskatoon, SK, Canada; [Somers, Christopher M.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Reudink, Robyn L. F.] British Columbia Minist Forests Lands & Nat Resou, Kamloops, BC, Canada; [Kyser, T. Kurt] Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON, Canada; [Franks, Samantha E.] British Trust Ornithol, Thetford, Norfolk, England; [Reudink, Matthew W.; Nocera, Joseph J.] Trent Univ, Ontario Minist Nat Resources & Forestry, Peterborough, ON K9J 7B8, Canada; [Reudink, Matthew W.] Thompson Rivers Univ, Dept Biol Sci, Kamloops, BC, Canada	Trent University; Environment & Climate Change Canada; University of Regina; Queens University - Canada; British Trust for Ornithology; Ministry of Natural Resources & Forestry; Trent University	Reudink, MW (corresponding author), Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada.; Reudink, MW (corresponding author), Trent Univ, Ontario Minist Nat Resources & Forestry, Peterborough, ON K9J 7B8, Canada.; Reudink, MW (corresponding author), Thompson Rivers Univ, Dept Biol Sci, Kamloops, BC, Canada.	mreudink@tru.ca	Somers, Christopher/AAE-6390-2019	McKellar, Ann/0000-0002-7032-3759; Nocera, Joseph/0000-0002-5913-8851; Reudink, Matthew/0000-0001-8956-5849	Climate Change Fund for Ontario; Explorer's Club; MITACS; Canada Research Chairs Program; Natural Sciences and Engineering Research Council of Canada; Saskatchewan Ministry of the Environment's Fish and Wildlife Development Fund	Climate Change Fund for Ontario; Explorer's Club; MITACS; Canada Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Ministry of the Environment's Fish and Wildlife Development Fund	Funding for this project was provided by the Climate Change Fund for Ontario (JJN), the Explorer's Club (MWR; https://explorers.org/expeditions/funding/expedition_grants), MITACS (https://www.mitacs.ca/en/programs/accelerate), the Canada Research Chairs Program (CMS; http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx), the Natural Sciences and Engineering Research Council of Canada (CMS; http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp), and the Saskatchewan Ministry of the Environment's Fish and Wildlife Development Fund (CMS; http://www.environment.gov.sk.ca/fwdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DW, 2005, WATERBIRDS, V28, P1, DOI 10.1675/1524-4695(2005)28[1:IBACOT]2.0.CO;2; Bergek S, 2012, J FISH BIOL, V80, P2302, DOI 10.1111/j.1095-8649.2012.03286.x; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Beveridge M, 2006, MOL ECOL, V15, P951, DOI 10.1111/j.1365-294X.2006.02846.x; BOELLSTORFF DE, 1988, COLON WATERBIRD, V11, P215, DOI 10.2307/1521002; Bond AL, 2012, WATERBIRDS, V35, P324, DOI 10.1675/063.035.0213; Bugajski A, 2012, CANADIAN J FISHERIES, V91, P589; Bunnell F.L., 1981, Colonial Waterbirds, V4, P2, DOI 10.2307/1521105; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; CHAPMAN BR, 1988, COLON WATERBIRD, V11, P275, DOI 10.2307/1521009; Chessel D., 2004, R NEWS, V4, P5; Coltman DW, 2007, MOL ECOL, V16, P1639, DOI 10.1111/j.1365-294X.2007.03229.x; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Franks SE, 2012, J AVIAN BIOL, V43, P155, DOI 10.1111/j.1600-048X.2012.05573.x; FreemanGallant GR, 1996, EVOLUTION, V50, P1631, DOI 10.1111/j.1558-5646.1996.tb03935.x; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Genz A., 2009, COMPUTATION MULTIVAR, V195; Genz A., 2021, MVTNORM MULTIVARIATE; Gomez-Diaz E, 2007, ECOL APPL, V17, P1484, DOI 10.1890/06-1232.1; Hickman CR, 2008, MOL ECOL RESOUR, V8, P1439, DOI 10.1111/j.1755-0998.2008.02191.x; Hoarau G, 2002, MOL ECOL, V11, P1165, DOI 10.1046/j.1365-294X.2002.01515.x; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Keith JO, 2005, WATERBIRDS, V28, P9, DOI 10.1675/1524-4695(2005)28[9:AOOTAW]2.0.CO;2; Knopf F. L., 2004, BIRDS N AM; Lajtha K, 1994, STABLE ISOTOPES ECOL, P1; Lake JL, 2001, CAN J FISH AQUAT SCI, V58, P870, DOI 10.1139/cjfas-58-5-870; Machado MD, 2009, CONSERV GENET, V10, P1033, DOI 10.1007/s10592-008-9681-3; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Miller NG, 2011, BIOL LETTERS, V7, P43, DOI 10.1098/rsbl.2010.0525; Morat F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086585; Murphy EC, 2005, WATERBIRDS, V28, P61, DOI 10.1675/1524-4695(2005)28[61:CIOIHW]2.0.CO;2; Neethling M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-325; Oomen RA, 2011, J HERED, V102, P584, DOI 10.1093/jhered/esr055; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pekarik Cynthia, 2009, Ontario Birds, V27, P42; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poupin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028046; Pyle P, 2008, IDENTIFICATION GUIDE; R Development Core Team, 2012, R LANG ENV STAT COMP; Reudink MW, 2011, BIOL J LINN SOC, V102, P583, DOI 10.1111/j.1095-8312.2010.01608.x; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Royle JA, 2004, ECOL APPL, V14, P1780; Ruegg KC, 2014, MOL ECOL, V23, P5726, DOI 10.1111/mec.12977; Rundel CW, 2013, MOL ECOL, V22, P4163, DOI 10.1111/mec.12393; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Sellick MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004735; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Somers Christopher M., 2010, Blue Jay, V68, P75; Sovada MA, 2005, WATERBIRDS, V28, P27, DOI 10.1675/1524-4695(2005)28[27:HACSOT]2.0.CO;2; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; Todorov V, 2009, J STAT SOFTW, V32, P1; WARD RD, 1992, EVOL BIOL, V26, P73; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Welch AJ, 2012, HEREDITY, V109, P19, DOI 10.1038/hdy.2012.7; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1; Wunder MB, 2012, J ANIM ECOL, V81, P1223, DOI 10.1111/j.1365-2656.2012.01998.x; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135	62	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150810	10.1371/journal.pone.0150810	http://dx.doi.org/10.1371/journal.pone.0150810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974163	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600032
J	Gao, ZY; Huo, LJ; Cui, DM; Yang, X; Zeng, JW				Gao, Zhenya; Huo, Lijun; Cui, Dongmei; Yang, Xiao; Zeng, Junwen			The Expression of Bone Morphogenetic Protein 2 and Matrix Metalloproteinase 2 through Retinoic Acid Receptor Beta Induced by All-Trans Retinoic Acid in Cultured ARPE-19 Cells	PLOS ONE			English	Article							HUMAN SCLERAL FIBROBLASTS; FORM-DEPRIVATION MYOPIA; PIGMENT EPITHELIUM; GUINEA-PIG; EYE GROWTH; IN-VITRO; DIFFERENTIATION; CHICK; PREVALENCE; ACTIVATION	Purpose All-trans retinoic acid (ATRA) plays an important role in ocular development. Previous studies found that retinoic acid could influence the metabolism of scleral remodeling by promoting retinal pigment epithelium (RPE) cells to secrete secondary signaling factors. The purpose of this study was to investigate whether retinoic acid affected secretion of bone morphogenetic protein 2 (BMP-2) and matrix metalloproteinase 2 (MMP-2) and to explore the signaling pathway of retinoic acid in cultured acute retinal pigment epithelial 19 (ARPE-19) cells. Methods The effects of ATRA (concentrations from 10(-9) to 10(-5) mol/l) on the expression of retinoic acid receptors (RARs) in ARPE-19 cells were examined at the mRNA and protein levels using reverse transcription-polymerase chain reaction (RT-PCR) and western blot assay, respectively. The effects of treating ARPE-19 cells with ATRA concentrations ranging from 10(-9) to 10(-5) mol/l for 24 h and 48 h or with 10(-6) mol/l ATRA at different times ranging from 6h to 72h were assessed using real-time quantitative PCR (qPCR) and enzyme-linked immunosorbent assay (ELISA). The contribution of RAR beta-induced activation of ARPE-19 cells was confirmed using LE135, an antagonist of RAR beta. Results RAR beta mRNA levels significantly increased in the ARPE-19 cells treated with ATRA for 24h and 48h. These increases in RAR beta mRNA levels were dose dependent (at concentrations of 10(-9) to 10(-5) mol/l) with a maximum effect observed at 10(-6) mol/l. There were no significant changes in the mRNA levels of RAR alpha and RAR gamma. Western blot assay revealed that RAR beta protein levels were increased significantly in a time-dependent manner in ARPE-19 cells treated with 10(-6) mol/l ATRA from 12 h to 72 h, with a marked increase observed at 24 h and 48 h. The upregulation of RAR beta and the ATRA-induced secretion in ARPE-19 cells could be inhibited by the RAR beta antagonist LE135. Conclusion ATRA induced upregulation of RAR beta in ARPE-19 cells and stimulated these cells to secrete BMP-2 and MMP-2.	[Gao, Zhenya; Cui, Dongmei; Yang, Xiao; Zeng, Junwen] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China; [Huo, Lijun] Sun Yat Sen Univ, Affiliated Hosp 1, 58 Zhong Shan Er Rd, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zeng, JW (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China.	cier72@163.com	gao, zhenya/AAP-5080-2021		National Natural Science Foundation of China [81170872, 81200716]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81170872 and 81200716), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China (81170872 and 81200716)	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Bitzer M, 2000, EXP EYE RES, V70, P97, DOI 10.1006/exer.1999.0762; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cheung B, 1998, ONCOGENE, V17, P751, DOI 10.1038/sj.onc.1201982; Gao ZY, 2012, INT J OPHTHALMOL-CHI, V5, P661, DOI 10.3980/j.issn.2222-3959.2012.06.02; Geisen C, 1997, CANCER RES, V57, P1460; Guggenheim JA, 1996, INVEST OPHTH VIS SCI, V37, P1380; HEBERLEIN U, 1995, CELL, V81, P987, DOI 10.1016/S0092-8674(05)80003-0; Hu JM, 2008, MOL VIS, V14, P2373; Hu XT, 2014, CELL PROLIFERAT, V47, P200, DOI 10.1111/cpr.12100; Huang Jia, 2011, Zhonghua Yan Ke Za Zhi, V47, P938; Huo LJ, 2013, MOL VIS, V19, P1795; Ju J, 2015, AM J TRANSL RES, V7, P856; Li CX, 2010, MOL VIS, V16, P689; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mao JF, 2012, INT J OPHTHALMOL-CHI, V5, P670, DOI 10.3980/j.issn.2222-3959.2012.06.04; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; McFadden SA, 2006, EXP EYE RES, V83, P949, DOI 10.1016/j.exer.2006.05.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pavan B, 2006, CURR MED CHEM, V13, P3553, DOI 10.2174/092986706779026183; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; RADA JA, 1995, INVEST OPHTH VIS SCI, V36, P1555; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Seko Y, 1996, EXP EYE RES, V63, P443, DOI 10.1006/exer.1996.0134; Shelton L, 2007, EXP EYE RES, V84, P314, DOI 10.1016/j.exer.2006.10.004; Shirakami Y, 2012, CARCINOGENESIS, V33, P268, DOI 10.1093/carcin/bgr275; SI SP, 1995, EXP CELL RES, V219, P243, DOI 10.1006/excr.1995.1224; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI DOI 10.1001/ARCH0PHTHALM0L.2009.303; Wang Q, 2011, MOL VIS, V17, P647; Xu XC, 1999, CANCER RES, V59, P2477	36	3	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150831	10.1371/journal.pone.0150831	http://dx.doi.org/10.1371/journal.pone.0150831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967733	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200017
J	Hossain, ME; Jassim, WA; Zilany, MSA				Hossain, Mohammad E.; Jassim, Wissam A.; Zilany, Muhammad S. A.			Reference-Free Assessment of Speech Intelligibility Using Bispectrum of an Auditory Neurogram	PLOS ONE			English	Article							HIGHER-ORDER SPECTRA; NERVE-FIBERS; COCHLEAR NEUROPATHY; IMPAIRED LISTENERS; WORD RECOGNITION; ACOUSTIC TRAUMA; HAIR CELL; HEARING; NOISE; MODEL	Sensorineural hearing loss occurs due to damage to the inner and outer hair cells of the peripheral auditory system. Hearing loss can cause decreases in audibility, dynamic range, frequency and temporal resolution of the auditory system, and all of these effects are known to affect speech intelligibility. In this study, a new reference-free speech intelligibility metric is proposed using 2-D neurograms constructed from the output of a computational model of the auditory periphery. The responses of the auditory-nerve fibers with a wide range of characteristic frequencies were simulated to construct neurograms. The features of the neurograms were extracted using third-order statistics referred to as bispectrum. The phase coupling of neurogram bispectrum provides a unique insight for the presence (or deficit) of supra-threshold nonlinearities beyond audibility for listeners with normal hearing (or hearing loss). The speech intelligibility scores predicted by the proposed method were compared to the behavioral scores for listeners with normal hearing and hearing loss both in quiet and under noisy background conditions. The results were also compared to the performance of some existing methods. The predicted results showed a good fit with a small error suggesting that the subjective scores can be estimated reliably using the proposed neural-response-based metric. The proposed metric also had a wide dynamic range, and the predicted scores were well-separated as a function of hearing loss. The proposed metric successfully captures the effects of hearing loss and supra-threshold nonlinearities on speech intelligibility. This metric could be applied to evaluate the performance of various speech-processing algorithms designed for hearing aids and cochlear implants.	[Hossain, Mohammad E.; Jassim, Wissam A.; Zilany, Muhammad S. A.] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Zilany, MSA (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	zilany@um.edu.my	Zilany, Muhammad S/C-1541-2012	Zilany, Muhammad S/0000-0003-0181-0737; Jassim, Wissam/0000-0001-5998-142X; Hossain, Md Ekramul/0000-0001-6913-8313	 [UM.C/625/1/HIR/152];  [RP016B-13AET]	; 	This study was supported by the grants UM.C/625/1/HIR/152 and RP016B-13AET. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILGER RC, 1976, J SPEECH HEAR RES, V19, P718, DOI 10.1044/jshr.1904.718; BRADLEY JS, 1986, J ACOUST SOC AM, V80, P837, DOI 10.1121/1.393907; Bruce IC, 2004, PHYSIOL MEAS, V25, P945, DOI 10.1088/0967-3334/25/4/013; Bruce IC, 2003, J ACOUST SOC AM, V113, P369, DOI 10.1121/1.1519544; CHANDRAN V, 1991, IEEE T SIGNAL PROCES, V39, P2640, DOI 10.1109/78.107414; Chandran V, 1997, IEEE T IMAGE PROCESS, V6, P703, DOI 10.1109/83.568927; Chandran V, 1993, INT J BIFURCAT CHAOS, V3, P551, DOI 10.1142/S021812749300043X; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; CHIANG HH, 1990, IEEE T AUTOMAT CONTR, V35, P36, DOI 10.1109/9.45141; Chow TWS, 1997, SIGNAL PROCESS, V61, P23, DOI 10.1016/S0165-1684(97)00089-3; Chua K. C., 2008, Journal of Medical Engineering & Technology, V32, P145, DOI 10.1080/03091900601050862; Chua KC, 2010, MED ENG PHYS, V32, P679, DOI 10.1016/j.medengphy.2010.04.009; Davies-Venn E, 2009, EAR HEARING, V30, P494, DOI 10.1097/AUD.0b013e3181aec5bc; Donohue K., 2009, AUDIO SYSTEMS ARRAY; Dubno JR, 2005, J ACOUST SOC AM, V118, P914, DOI 10.1121/1.1953107; DUBNO JR, 1982, J SPEECH HEAR RES, V25, P141, DOI 10.1044/jshr.2501.141; DURLACH NI, 1981, AUDIOLOGY, V20, P181; El-Khamy SE, 1995, COMP COMM 1995 P IEE; Falk TH, 2010, IEEE T AUDIO SPEECH, V18, P1766, DOI 10.1109/TASL.2010.2052247; FRENCH NR, 1947, J ACOUST SOC AM, V19, P90, DOI 10.1121/1.1916407; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; GABRIEL KJ, 1992, J ACOUST SOC AM, V91, P336, DOI 10.1121/1.402776; Garofolo JS, 1993, TIMIT ACOUSTIC PHONE; Heinz MG, 2009, JARO-J ASSOC RES OTO, V10, P407, DOI 10.1007/s10162-009-0169-8; HELME BI, 1985, IEEE T ACOUST SPEECH, V33, P903, DOI 10.1109/TASSP.1985.1164635; Hines A, 2012, SPEECH COMMUN, V54, P306, DOI 10.1016/j.specom.2011.09.004; Hines A, 2010, SPEECH COMMUN, V52, P736, DOI 10.1016/j.specom.2010.04.006; Hornsby BWY, 2005, J ACOUST SOC AM, V118, P1719, DOI 10.1121/1.1993128; Ibrahim RA, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P429, DOI 10.1007/978-1-4419-5686-6_40; Institute ANS, 1997, AM NAT STAND METH CA; Jorgensen S, 2013, J ACOUST SOC AM, V134, P436, DOI 10.1121/1.4807563; Khadra L, 2005, IEEE T BIO-MED ENG, V52, P1840, DOI 10.1109/TBME.2005.856281; KIANG NYS, 1976, ANN OTO RHINOL LARYN, V85, P752, DOI 10.1177/000348947608500605; KIANG NYS, 1990, HEARING RES, V49, P1, DOI 10.1016/0378-5955(90)90091-3; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; LIBERMAN MC, 1982, J ACOUST SOC AM, V72, P1441, DOI 10.1121/1.388677; Maison SF, 2013, J NEUROSCI, V33, P5542, DOI 10.1523/JNEUROSCI.5027-12.2013; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Muthuswamy J, 1999, IEEE T BIO-MED ENG, V46, P92, DOI 10.1109/10.736762; Ng T-T, 2004, CIRC SYST 2004 ISCAS; NIKIAS CL, 1987, P IEEE, V75, P869, DOI 10.1109/PROC.1987.13824; Oxenham AJ, 2003, JARO-J ASSOC RES OTO, V4, P541, DOI 10.1007/s10162-002-3058-y; Plack CJ, 2004, J ACOUST SOC AM, V115, P1684, DOI 10.1121/1.1675812; RAGHUVEER MR, 1985, IEEE T ACOUST SPEECH, V33, P1213, DOI 10.1109/TASSP.1985.1164679; Rhode W, 1973, INVESTIGATION POST M, P49; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; SCHMIEDT RA, 1980, J NEUROPHYSIOL, V43, P1367, DOI 10.1152/jn.1980.43.5.1367; Shen C, 1997, SIGNAL PROCESS, V61, P39, DOI 10.1016/S0165-1684(97)00090-X; Shera CA, 2010, JARO-J ASSOC RES OTO, V11, P343, DOI 10.1007/s10162-010-0217-4; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; STEENEKEN HJM, 1980, J ACOUST SOC AM, V67, P318, DOI 10.1121/1.384464; Studebaker GA, 1999, J ACOUST SOC AM, V105, P2431, DOI 10.1121/1.426848; Studebaker GA, 2002, J ACOUST SOC AM, V111, P1422, DOI 10.1121/1.1445788; Swami A, 2000, HIGHER ORDER SPECTRA, V2, P3; Taal CH, 2011, IEEE T AUDIO SPEECH, V19, P2125, DOI 10.1109/TASL.2011.2114881; THORNTON AR, 1978, J SPEECH HEAR RES, V21, P507, DOI 10.1044/jshr.2103.507; Tillman TW, 1966, 1966 DTIC NW U; Yang L, 2008, AUD LANG IM PROC 200; Zhang JW, 2000, IEEE T BIO-MED ENG, V47, P352, DOI 10.1109/10.827296; Zhou SM, 2008, INFORM SCIENCES, V178, P1629, DOI 10.1016/j.ins.2007.11.012; Zilany MSA, 2007, J ACOUST SOC AM, V122, P402, DOI 10.1121/1.2735117; Zilany MSA, 2006, J ACOUST SOC AM, V120, P1446, DOI 10.1121/1.2225512; Zilany MSA, 2014, J ACOUST SOC AM, V135, P283, DOI 10.1121/1.4837815; Zilany MSA, 2009, J ACOUST SOC AM, V126, P2390, DOI 10.1121/1.3238250	67	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150415	10.1371/journal.pone.0150415	http://dx.doi.org/10.1371/journal.pone.0150415			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967160	gold, Green Submitted, Green Published			2022-12-26	WOS:000371989200013
J	Mahdy, MAK; Al-Mekhlafi, AM; Abdul-Ghani, R; Saif-Ali, R; Al-Mekhlafi, HM; Al-Eryani, SM; Lim, YAL; Mahmud, R				Mahdy, Mohammed A. K.; Al-Mekhlafi, Abdulsalam M.; Abdul-Ghani, Rashad; Saif-Ali, Reyadh; Al-Mekhlafi, Hesham M.; Al-Eryani, Samira M.; Lim, Yvonne A. L.; Mahmud, Rohela			First Molecular Characterization of Leishmania Species Causing Visceral Leishmaniasis among Children in Yemen	PLOS ONE			English	Article							DONOVANI COMPLEX; CUTANEOUS LEISHMANIASIS; KALA-AZAR; INFANTUM; DIAGNOSIS; EPIDEMIOLOGY; HETEROGENEITY; EVOLUTIONARY; SENSITIVITY; REGION	Visceral leishmaniasis (VL) is a debilitating, often fatal disease caused by Leishmania donovani complex; however, it is a neglected tropical disease. L. donovani complex comprises two closely related species, L. donovani that is mostly anthroponotic and L. infantum that is zoonotic. Differentiation between these two species is critical due to the differences in their epidemiology and pathology. However, they cannot be differentiated morphologically, and their speciation using isoenzyme-based methods poses a difficult task and may be unreliable. Molecular characterization is now the most reliable method to differentiate between them and to determine their phylogenetic relationships. The present study aims to characterize Leishmania species isolated from bone marrows of Yemeni pediatric patients using sequence analysis of the ribosomal internal transcribed spacer-1 (ITS1) gene. Out of 41 isolates from Giemsa-stained bone marrow smears, 25 isolates were successfully amplified by nested polymerase chain reaction and sequenced in both directions. Phylogenetic analysis using neighbor joining method placed all study isolates in one cluster with L. donovani complex (99% bootstrap). The analysis of ITS1 for microsatellite repeat numbers identified L. infantum in 11 isolates and L. donovani in 14 isolates. These data suggest the possibility of both anthroponotic and zoonotic transmission of VL-causing Leishmania species in Yemen. Exploring the possible animal reservoir hosts is therefore needed for effective control to be achieved.	[Mahdy, Mohammed A. K.; Abdul-Ghani, Rashad] Univ Sci & Technol, Trop Dis Res Ctr, Fac Med, Sanaa, Yemen; [Mahdy, Mohammed A. K.; Abdul-Ghani, Rashad; Saif-Ali, Reyadh; Al-Mekhlafi, Hesham M.; Al-Eryani, Samira M.] Sanaa Univ, Fac Med & Hlth Sci, Dept Parasitol, Sanaa, Yemen; [Saif-Ali, Reyadh] Sanaa Univ, Fac Med & Hlth Sci, Dept Biochem, Sanaa, Yemen; [Al-Mekhlafi, Hesham M.; Lim, Yvonne A. L.; Mahmud, Rohela] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Mahdy, MAK (corresponding author), Univ Sci & Technol, Trop Dis Res Ctr, Fac Med, Sanaa, Yemen.	alsharaby9@yahoo.com	Mahdy, Mohammed A.K./C-1187-2010; LIM, YVONNE AL/B-5276-2010; Abdul-Ghani, Rashad/N-3289-2013; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016	Mahdy, Mohammed A.K./0000-0002-8340-5219; LIM, YVONNE AL/0000-0003-4050-6332; Abdul-Ghani, Rashad/0000-0001-7181-1108; Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410; kamal, amera/0000-0002-9154-9415; Saif-Ali, Riyadh/0000-0002-0246-3856	University of Malaya [RG302/11HTM]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya (RG302/11HTM).; The authors thank the management and personnel of Al-Sabeen Hospital for their cooperation and for giving the permission to use the archived samples. This work was supported by University of Malaya (RG302/11HTM).	Al-Kamel MA, 2015, INT J DERMA IN PRESS; Al-Shamahy HA, 1998, ANN SAUDI MED, V18, P66, DOI 10.5144/0256-4947.1998.66; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Cao DP, 2011, PARASITOL RES, V109, P163, DOI 10.1007/s00436-010-2239-6; Chance ML, 1982, P WORKSH HELD PAN AM; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Haidar NA, 2001, SAUDI MED J, V22, P516; Hamid GA, 2009, TURK J HEMATOL, V26, P25; Hide M, 2001, PARASITOLOGY, V123, P425, DOI 10.1017/S003118200100871X; Hide M, 2006, ACTA TROP, V100, P241, DOI 10.1016/j.actatropica.2006.10.012; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; Jamjoom MB, 2004, PARASITOLOGY, V129, P399, DOI 10.1017/S0031182004005955; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kolaczinski JH, 2008, EMERG INFECT DIS, V14, P664, DOI 10.3201/eid1404.071099; Kuhls K, 2005, MICROBES INFECT, V7, P1224, DOI 10.1016/j.micinf.2005.04.009; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Mahdy MAK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012879; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; Mauricio IL, 2001, PARASITOLOGY, V122, P393, DOI 10.1017/S0031182001007466; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Oskam L, 1998, T ROY SOC TROP MED H, V92, P120, DOI 10.1016/S0035-9203(98)90982-8; Palumbo E, 2010, MINERVA PEDIATR, V62, P389; Postigo JAR, 2010, INT J ANTIMICROB AG, V36, pS62, DOI 10.1016/j.ijantimicag.2010.06.023; PRATLONG F, 1995, T ROY SOC TROP MED H, V89, P398, DOI 10.1016/0035-9203(95)90025-X; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Raguenaud ME, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000085; Ramirez JR, 2000, J CLIN MICROBIOL, V38, P3768; RIOUX JA, 1989, B SOC PATHOL EXOT, V82, P658; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMAZSOCCOL V, 1993, ANN PARASIT HUM COMP, V68, P107; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toz SO, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002205; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang BB, 2010, PARASITOL RES, V107, P1049, DOI 10.1007/s00436-010-1969-9; Zemanova E, 2004, AM J TROP MED HYG, V70, P613, DOI 10.4269/ajtmh.2004.70.613	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151265	10.1371/journal.pone.0151265	http://dx.doi.org/10.1371/journal.pone.0151265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966902	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200039
J	Laugier, F; Delyon, J; Andre, J; Bensussan, A; Dumaz, N				Laugier, F.; Delyon, J.; Andre, J.; Bensussan, A.; Dumaz, N.			Hypoxia and MITF regulate KIT oncogenic properties in melanocytes	ONCOGENE			English	Article							STEM-CELL FACTOR; HUMAN-MELANOMA CELLS; METASTATIC MELANOMA; SIGNAL-TRANSDUCTION; OXYGEN; SKIN; ACTIVATION; EXPRESSION; SURVIVAL; IMATINIB	KIT mutations are frequent in acral, mucosal and chronic sun-damage (CSD) melanoma, but little is known about the mechanisms driving the transformation of KIT-mutated melanocytes into melanoma cells. We showed that exposition of melanocytes harboring the L576PKIT mutation to a hypoxic environment induced their transformation into malignant cells. Transformed L576PKIT melanocytes showed downregulation of MITF expression characteristic of melanoma initiating cells (MICs). In agreement, these cells were able to form spheres in neural crest cell medium and low-adherence conditions, also a characteristic of MICs. Downregulation of MITF by RNA interference induced transformation of KIT-mutated melanocytes in normoxia and acquisition of a MIC phenotype by these cells. Hence, low level of MITF cooperates with oncogenic KIT to transform melanocytes. Activation of the cAMP pathway in transformed L576PKIT melanocytes stimulated MITF expression, and reduced cellular proliferation and sphere formation. These findings highlight the essential role of MITF in revealing the oncogenic activity of KIT in melanocytes and suggest that the cAMP pathway is a therapeutic target in KIT-mutated melanoma.	[Laugier, F.; Delyon, J.; Andre, J.; Bensussan, A.; Dumaz, N.] Hop St Louis, Ctr Rech Peau, INSERM, U976, Paris, France; [Laugier, F.; Delyon, J.; Andre, J.; Bensussan, A.; Dumaz, N.] Univ Paris Diderot, Sorbonne Paris Cite, UMRS976, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Dumaz, N (corresponding author), Hop St Louis, U976, INSERM, Pavillon Bazin,1 Ave Claude Vellefaux, F-75010 Paris, France.	nicolas.dumaz@inserm.fr	Bensussan, Armand/E-5434-2017; Delyon, Julie/O-5147-2019; Dumaz, Nicolas/B-5907-2008	Delyon, Julie/0000-0002-4557-3377; Dumaz, Nicolas/0000-0003-3511-2160; Bensussan, Armand/0000-0002-0409-2497	L'Oreal Research Innovation; INSERM; Universite Paris Diderot; Fondation ARC pour la Recherche sur le Cancer	L'Oreal Research Innovation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	We thank Pr Antoni Ribas for the M230 melanoma cell line. This work was funded by L'Oreal Research & Innovation, INSERM, Universite Paris Diderot and Fondation ARC pour la Recherche sur le Cancer. FL was supported by L'Oreal Research & Innovation.	Bastian BC, 2013, J CLIN ONCOL, V31, P3288, DOI 10.1200/JCO.2013.50.3227; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Bedogni B, 2009, PIGM CELL MELANOMA R, V22, P166, DOI 10.1111/j.1755-148X.2009.00553.x; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bourillon A, 2013, PIGM CELL MELANOMA R, V26, P88, DOI 10.1111/pcmr.12032; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Cheli Y, 2012, ONCOGENE, V31, P2461, DOI 10.1038/onc.2011.425; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dumaz N, 2015, MELANOMA RES, V25, P88, DOI 10.1097/CMR.0000000000000116; Evans SM, 2006, J INVEST DERMATOL, V126, P2596, DOI 10.1038/sj.jid.5700451; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Feige E, 2011, P NATL ACAD SCI USA, V108, pE924, DOI 10.1073/pnas.1106351108; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garrido MC, 2010, J INVEST DERMATOL, V130, P20, DOI 10.1038/jid.2009.334; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; Guo J, 2011, J CLIN ONCOL, V29, P2904, DOI 10.1200/JCO.2010.33.9275; Hamai A, 2006, ONCOGENE, V25, P7618, DOI 10.1038/sj.onc.1209738; Hodi FS, 2013, J CLIN ONCOL, V31, P3182, DOI 10.1200/JCO.2012.47.7836; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; HORIKOSHI T, 1991, J INVEST DERMATOL, V96, P841, DOI 10.1111/1523-1747.ep12474550; Huang SY, 1996, ONCOGENE, V13, P2339; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; LASSAM N, 1992, ONCOGENE, V7, P51; Liang RX, 2011, PIGM CELL MELANOMA R, V24, P714, DOI 10.1111/j.1755-148X.2011.00870.x; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Monsel G, 2010, ONCOGENE, V29, P227, DOI 10.1038/onc.2009.320; Ohanna M, 2013, ONCOTARGET, V4, P2212, DOI 10.18632/oncotarget.1143; Park E, 2012, AM J DERMATOPATH, V34, P41, DOI 10.1097/DAD.0b013e31821ec0ef; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Rezvani HR, 2011, J INVEST DERMATOL, V131, P1793, DOI 10.1038/jid.2011.141; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Todd JR, 2014, ONCOGENE, V33, P236, DOI 10.1038/onc.2012.562; von Euw E, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-22; Young SM, 2007, CELL SIGNAL, V19, P2572, DOI 10.1016/j.cellsig.2007.08.004	39	6	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 22	2016	35	38					5070	5077		10.1038/onc.2016.39	http://dx.doi.org/10.1038/onc.2016.39			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW9GT	26973244				2022-12-26	WOS:000383965300010
J	Reigstad, I; Smeland, HYH; Skogstrand, T; Sortland, K; Schmid, MC; Reed, RK; Stuhr, L				Reigstad, Inga; Smeland, Hilde Y. H.; Skogstrand, Trude; Sortland, Kristina; Schmid, Marei Caroline; Reed, Rolf K.; Stuhr, Linda			Stromal Integrin alpha 11 beta 1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; EXTRACELLULAR-MATRIX; COLLAGEN RECEPTOR; CELL; FIBROBLASTS; EXPRESSION; BINDING	Purpose It has been implied that the collagen binding integrin alpha 11 beta 1 plays a role in carcinogenesis. As still relatively little is known about how the stromal integrin alpha 11 beta 1 affects different aspects of tumor development, we wanted to examine the direct effects on primary tumor growth, fibrosis, tumor interstitial fluid pressure (PIF) and metastasis in murine 4T1 mammary and RM11 prostate tumors, using an in vivo SCID integrin alpha 11-deficient mouse model. Methods Tumor growth was measured using a caliper, PIF by the wick-in-needle technique, activated fibroblasts by alpha-SMA immunofluorescence staining and fibrosis by transmission electron microscopy and picrosirius-red staining. Metastases were evaluated using hematoxylin and eosin stained sections. Results RM11 tumor growth was significantly reduced in the SCID integrin alpha 11-deficient (alpha 11-KO) compared to in SCID integrin alpha 11 wild type (WT) mice, whereas there was no similar effect in the 4T1 tumor model. The 4T1 model demonstrated an alteration in collagen fibril diameter in the integrin alpha 11-KO mice compared to WT, which was not found in the RM11 model. There were no significant differences in the amount of activated fibroblasts, total collagen content, collagen organization or PIF in the tumors in integrin alpha 11-deficient mice compared to WT mice. There was also no difference in lung metastases between the two groups. Conclusion Deficiency of stromal integrin alpha 11 beta 1 showed different effects on tumor growth and collagen fibril diameter depending on tumor type, but no effect on tumor PIF or development of lung metastasis.	[Reigstad, Inga; Smeland, Hilde Y. H.; Skogstrand, Trude; Sortland, Kristina; Schmid, Marei Caroline; Reed, Rolf K.; Stuhr, Linda] Univ Bergen, Dept Biomed, Bergen, Norway; [Reigstad, Inga; Skogstrand, Trude; Sortland, Kristina] Haukeland Hosp, Matrix Biol Grp, N-5021 Bergen, Norway; [Smeland, Hilde Y. H.; Schmid, Marei Caroline; Reed, Rolf K.] Univ Bergen, Ctr Canc Biomarkers, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Reigstad, I (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.; Reigstad, I (corresponding author), Haukeland Hosp, Matrix Biol Grp, N-5021 Bergen, Norway.	inga.reigstad@uib.no	Reed, Rolf K./B-9422-2017	Reed, Rolf K./0000-0002-2633-6595	Research Council of Norway [223250/F50]; Helse-Vest, NO [911708, 911966]	Research Council of Norway(Research Council of Norway); Helse-Vest, NO	This work was supported by The Research Council of Norway, grants 223250/F50 to Center of Cancer Biomarkers, University of Bergen; Helse-Vest, NO, grant number 911708-Inga Reigstad; and Helse-Vest, NO, grant number 911966-Rolf K. Reed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Friman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034082; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Ishii G, 2016, ADV DRUG DELIVER REV, V99, P186, DOI 10.1016/j.addr.2015.07.007; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; Lu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103173; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Navab R, 2016, ONCOGENE, V35, P1899, DOI 10.1038/onc.2015.254; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Schulz JN, 2015, J INVEST DERMATOL, V135, P1435, DOI 10.1038/jid.2015.24; Svendsen OS, 2009, ARTERIOSCL THROM VAS, V29, P1864, DOI 10.1161/ATVBAHA.109.194308; Talior-Volodarsky I, 2012, CARDIOVASC RES, V96, P265, DOI 10.1093/cvr/cvs259; THOMPSON TC, 1993, MOL CARCINOGEN, V7, P165, DOI 10.1002/mc.2940070307; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; van Dijk M, 2013, EXP CELL RES, V319, P1663, DOI 10.1016/j.yexcr.2013.02.006; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Vuoristo M, 2007, MELANOMA RES, V17, P215, DOI 10.1097/CMR.0b013e328270b935; Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953; Westcott JM, 2015, J CLIN INVEST, V125, P1927, DOI 10.1172/JCI77767; WIIG H, 1986, ANN BIOMED ENG, V14, P139, DOI 10.1007/BF02584264; Zeltz C, 2014, ADV EXP MED BIOL, V819, P73, DOI 10.1007/978-94-017-9153-3_5; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	37	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151663	10.1371/journal.pone.0151663	http://dx.doi.org/10.1371/journal.pone.0151663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990302	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800085
J	Jang, ES; Jeong, SH; Kim, JW; Choi, YS; Leissner, P; Brechot, C				Jang, Eun Sun; Jeong, Sook-Hyang; Kim, Jin-Wook; Choi, Yun Suk; Leissner, Philippe; Brechot, Christian			Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma	PLOS ONE			English	Article							DES-GAMMA-CARBOXYPROTHROMBIN; CHRONIC HEPATITIS; BIOMARKERS; SERUM; CANCER; MARKER; AFP; RECOMMENDATIONS; METAANALYSIS; CIRRHOSIS	Background & Aims Alpha-fetoprotein (AFP) is the most widely used serum biomarker for hepatocellular carcinoma (HCC), despite its limitations. As complementary biomarkers, protein induced by vitamin K absence (PIVKA-II), osteopontin (OPN), and Dickkopf-1 (DKK-1) have been proposed. This study aimed to perform a head-to-head comparison of the diagnostic performance of AFP, PIVKA-II, OPN and DKK-1 as single or in combination to seek the best biomarker or panel, and to investigate the clinical factors affecting their performance. Methods Using 401 stored plasma samples obtained from 208 HCC patients and 193 liver cirrhosis control patients, plasma AFP, PIVKA-II, OPN and DKK-1 levels were measured by ELISA, and receiver operating characteristic curve analyses were performed for each biomarker and for every combination of two to four markers. Results Of the four biomarkers, AFP showed the highest area under the curve (0.786). The sensitivity and specificity for each single biomarker was 62% and 90.2% (AFP>20 ng/mL), 51.0% and 91.2% (PIVKA-II>10 ng/mL), 46.2% and 80.3% (OPN>100 ng/mL), and 50.0% and 80.8% (DKK-1>500 pg/mL), respectively. Among the combinations of two biomarkers, AFP>20 ng/mL or DKK-1>500 pg/mL showed the best diagnostic performance (sensitivity 78.4%, specificity 72.5%). Triple or quadruple combination did not improve the diagnostic performance further. The patient's age, etiology and tumor invasiveness of HCC affected the performance of each marker. Conclusions AFP was the most useful single biomarker for HCC diagnosis, and the combined measurement of AFP and DKK-1 could maximize the diagnostic yield. Clinical decision should be based on the consideration of various factors affecting the diagnostic performance of each biomarker. Efforts to seek novel HCC biomarkers should be continued.	[Jang, Eun Sun; Jeong, Sook-Hyang; Kim, Jin-Wook; Choi, Yun Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seoul 151, South Korea; [Leissner, Philippe] bioMerieux, Med Diagnost Discovery Dept, Marcy Letoile, France; [Brechot, Christian] Merieux Inst, Lyon, France	Seoul National University (SNU); Seoul National University Hospital; bioMerieux	Jeong, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seoul 151, South Korea.	jsh@snubh.org	BRECHOT, Christian/S-2011-2018	Kim, Jin-Wook/0000-0003-0934-3344	bioMerieux	bioMerieux	This study was supported by grant from bioMerieux. The funder provided support in the form of salaries for authors [PL and CB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2003, ONCOLOGY-BASEL, V65, P95, DOI 10.1159/000072332; Beale G, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-200; BOYKO EJ, 1994, MED DECIS MAKING, V14, P175, DOI 10.1177/0272989X9401400210; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chaiteerakij R, 2015, CLIN GASTROENTEROL H, V13, P237, DOI 10.1016/j.cgh.2013.10.038; Chung MY, 2003, CLIN MOL HEPATOL, V9, P116; Durazo FA, 2008, J GASTROEN HEPATOL, V23, P1541, DOI 10.1111/j.1440-1746.2008.05395.x; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Ge TX, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0367-z; Keselman HJ, 1999, PSYCHOL METHODS, V4, P58, DOI 10.1037/1082-989X.4.1.58; Kim GA, 2015, LIVER INT, V35, P232, DOI 10.1111/liv.12516; Kim J, 2006, AM J GASTROENTEROL, V101, P2051, DOI 10.1111/j.1572-0241.2006.00679.x; Lee JM, 2014, DIGEST DIS, V32, P764, DOI 10.1159/000368020; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Putz-Bankuti C, 2010, Z GASTROENTEROL, V48, pP20; SATO Y, 1994, J SURG ONCOL, V55, P265, DOI 10.1002/jso.2930550414; Shang SF, 2012, HEPATOLOGY, V55, P483, DOI 10.1002/hep.24703; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Shim JJ, 2014, J GASTROEN HEPATOL, V29, P1699, DOI 10.1111/jgh.12612; Volk Michael L., 2007, Cancer Biomarkers, V3, P79; Wang MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S3-S9; Yang H, 2013, INT J BIOL MARKER, V28, P286, DOI [10.5301/JBM.5000015, 10.5301/jbm.5000015]; Zhang CH, 2012, INT J CANCER, V130, P2685, DOI 10.1002/ijc.26301; Zhang J, 2014, INT J BIOL MARKER, V29, pE403, DOI 10.5301/jbm.5000101; Zhao L, 2008, INT J CLIN PRACT, V62, P1056, DOI 10.1111/j.1742-1241.2007.01368.x	30	59	61	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151069	10.1371/journal.pone.0151069	http://dx.doi.org/10.1371/journal.pone.0151069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986465	Green Submitted, gold, Green Published			2022-12-26	WOS:000372580300043
J	Nie, ZY; Kang, GJ; Duan, CF; Li, Y; Dai, LJ; Zeng, RZ				Nie, Zhiyi; Kang, Guijuan; Duan, Cuifang; Li, Yu; Dai, Longjun; Zeng, Rizhong			Profiling Ethylene-Responsive Genes Expressed in the Latex of the Mature Virgin Rubber Trees Using cDNA Microarray	PLOS ONE			English	Article							HEVEA-BRASILIENSIS LATEX; NATURAL-RUBBER; ISOPRENOID BIOSYNTHESIS; DIPHOSPHATE SYNTHASE; ACTIN CYTOSKELETON; STRESS RESPONSES; ARABIDOPSIS; STIMULATION; CELLS; YIELD	Ethylene is commonly used as a latex stimulant of Hevea brasiliensis by application of ethephon (chloro-2-ethylphosphonic acid); however, the molecular mechanism by which ethylene increases latex production is not clear. To better understand the effects of ethylene stimulation on the laticiferous cells of rubber trees, a latex expressed sequence tag (EST)based complementary DNA microarray containing 2,973 unique genes (probes) was first developed and used to analyze the gene expression changes in the latex of the mature virgin rubber trees after ethephon treatment at three different time-points: 8, 24 and 48 h. Transcript levels of 163 genes were significantly altered with fold-change values >= 2 or <=-2 (q-value < 0.05) in ethephon-treated rubber trees compared with control trees. Of the 163 genes, 92 were up-regulated and 71 down-regulated. The microarray results were further confirmed using real-time quantitative reverse transcript-PCR for 20 selected genes. The 163 ethylene-responsive genes were involved in several biological processes including organic substance metabolism, cellular metabolism, primary metabolism, biosynthetic process, cellular response to stimulus and stress. The presented data suggest that the laticifer water circulation, production and scavenging of reactive oxygen species, sugar metabolism, and assembly and depolymerization of the latex actin cytoskeleton might play important roles in ethylene-induced increase of latex production. The results may provide useful insights into understanding the molecular mechanism underlying the effect of ethylene on latex metabolism of H. brasiliensis.	[Nie, Zhiyi; Kang, Guijuan; Duan, Cuifang; Li, Yu; Dai, Longjun; Zeng, Rizhong] CATAS, Key Lab Biol & Genet Resources Rubber Tree, Minist Agr, Rubber Res Inst, Danzhou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Zeng, RZ (corresponding author), CATAS, Key Lab Biol & Genet Resources Rubber Tree, Minist Agr, Rubber Res Inst, Danzhou, Hainan, Peoples R China.	hnzrz@aliyun.com			 [31201143];  [1630022011023];  [1630022012008]	; ; 	The work was supported by the following: http://www.nsfc.gov.cn/, No. 31201143, Guijuan Kang; http://rri.catas.cn/, No. 1630022011023, Guijuan Kang; and http://rri.catas.cn/, No. 1630022012008, Cuifang Duan.	Adiwilaga K, 1996, PLANT MOL BIOL, V30, P935, DOI 10.1007/BF00020805; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; AMALOU Z, 1992, PLANT PHYSIOL, V98, P1270, DOI 10.1104/pp.98.4.1270; An F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125595; APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Chrestin H., 1989, PHYSL RUBBER TREE LA, P431; CHYE ML, 1992, PLANT MOL BIOL, V19, P473, DOI 10.1007/BF00023395; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; Coupe M., 1989, PHYSL RUBBER TREE LA, P295; D'Auzac J., 1997, Recent Research Developments in Plant Physiology, V1, P273; D'Auzac J., 1989, PHYSL RUBBER TREE LA, P257, DOI [10.1590/S0104-14282006000300015, DOI 10.1590/S0104-14282006000300015]; Dai LJ, 2013, PLANT MOL BIOL, V82, P155, DOI 10.1007/s11103-013-0047-y; Dat JF, 2003, PLANT J, V33, P621, DOI 10.1046/j.1365-313X.2003.01655.x; DAUZAC J, 1989, PHYSL RUBBER TREE LA, P221; De Paepe A, 2004, PLANT J, V39, P537, DOI 10.1111/j.1365-313X.2004.02156.x; DENNIS MS, 1989, J BIOL CHEM, V264, P18608; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066; [段翠芳 Duan Cuifang], 2007, [热带作物学报, Chinese Journal of Tropical Crops], V28, P46; Dusotoit-Coucaud A, 2010, TREE PHYSIOL, V30, P1586, DOI 10.1093/treephys/tpq088; Dusotoit-Coucaud A, 2009, ANN BOT-LONDON, V104, P635, DOI 10.1093/aob/mcp150; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ESCHBACH JM, 1984, PHYSIOL VEG, V22, P295; Faridah Y, 1996, J RUBBER RES, V10, P182; Gao ZQ, 2008, PESQUI AGROPECU BRAS, V43, P275, DOI 10.1590/S0100-204X2008000200018; GIDROL X, 1988, PLANT PHYSIOL, V86, P899, DOI 10.1104/pp.86.3.899; GOMEZ JB, 1979, ULTRACYTOLOGY LATEX; GOODING EGB, 1952, NEW PHYTOL, V51, P11, DOI 10.1111/j.1469-8137.1952.tb06112.x; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo Y, 2005, J VIROL, V79, P14392, DOI 10.1128/JVI.79.22.14392-14403.2005; Hao BingZhong, 2004, Journal of Rubber Research, V7, P281; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacob JL, 1989, PHYSL RUBBER TREE LA, P345; KEKWICK RGO, 1989, PHYSL RUBBER TREE LA, P146; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Krishnakumar R., 2008, Journal of Plantation Crops, V36, P315; KRISHNAKUMAR R, 2006, TAPPING PANEL DRYNES, P116; KUSH A, 1994, PLANT PHYSIOL BIOCH, V32, P761; Lacote R, 2010, FIELD CROP RES, V115, P94, DOI 10.1016/j.fcr.2009.10.007; Li DJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-140; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; LIEBERMAN M, 1979, ANNU REV PLANT PHYS, V30, P533, DOI 10.1146/annurev.pp.30.060179.002533; Liu Y, 2005, J INTEGR PLANT BIOL, V47, P769, DOI 10.1111/j.1744-7909.2005.00111.x; LUSTINEC J, 1968, BIOL PLANTARUM, V10, P284, DOI 10.1007/BF02921011; Martinez-Godoy MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-318; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Mesquita Alessandro Carlos, 2006, Braz. J. Plant Physiol., V18, P263, DOI 10.1590/S1677-04202006000200002; MILFORD G F J, 1969, Journal of the Rubber Research Institute of Malaysia, V21, P274; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nie ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116857; Oh SK, 1999, J BIOL CHEM, V274, P17132, DOI 10.1074/jbc.274.24.17132; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Privat I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-5; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sakdapipanich JT, 2007, J BIOSCI BIOENG, V103, P287, DOI 10.1263/jbb.103.287; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Silpi U, 2007, TREE PHYSIOL, V27, P881, DOI 10.1093/treephys/27.6.881; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Takaya A, 2003, BBA-GENE STRUCT EXPR, V1625, P214, DOI 10.1016/S0167-4781(02)00602-4; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Tungngoen K, 2011, J PLANT PHYSIOL, V168, P253, DOI 10.1016/j.jplph.2010.06.009; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; TUPY J, 1976, BIOL PLANTARUM, V18, P373, DOI 10.1007/BF02922474; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valster AH, 1997, PLANT CELL, V9, P1815; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Van Zhong G, 2003, PLANT MOL BIOL, V53, P117, DOI 10.1023/B:PLAN.0000009270.81977.ef; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Zeng RZ, 2009, PLANT SCI, V176, P602, DOI 10.1016/j.plantsci.2009.01.009; Zhu JH, 2009, PLANT SIGNAL BEHAV, V4, P1072, DOI 10.4161/psb.4.11.9738	88	8	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0152039	10.1371/journal.pone.0152039	http://dx.doi.org/10.1371/journal.pone.0152039			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985821	Green Submitted, gold, Green Published			2022-12-26	WOS:000372580300159
J	Chomel, BB; Molia, S; Kasten, RW; Borgo, GM; Stuckey, MJ; Maruyama, S; Chang, CC; Haddad, N; Koehler, JE				Chomel, Bruno B.; Molia, Sophie; Kasten, Rickie W.; Borgo, Gina M.; Stuckey, Matthew J.; Maruyama, Soichi; Chang, Chao-chin; Haddad, Nadia; Koehler, Jane E.			Isolation of Bartonella henselae and Two New Bartonella Subspecies, Bartonella koehlerae Subspecies boulouisii subsp nov and Bartonella koehlerae Subspecies bothieri subsp nov from Free-Ranging Californian Mountain Lions and Bobcats	PLOS ONE			English	Article							DOMESTIC CATS; ROCHALIMAEA-HENSELAE; PCR AMPLIFICATION; FELIS-CONCOLOR; GRAY FOXES; INFECTION; PREVALENCE; IDENTIFICATION; PATHOGENS; ANTIBODY	Domestic cats are the natural reservoir of Bartonella henselae, B. clarridgeiae and B. koehlerae. To determine the role of wild felids in the epidemiology of Bartonella infections, blood was collected from 14 free-ranging California mountain lions (Puma concolor) and 19 bobcats (Lynx rufus). Bartonella spp. were isolated from four (29%) mountain lions and seven (37%) bobcats. These isolates were characterized using growth characteristics, biochemical reactions, molecular techniques, including PCR-RFLP of selected genes or interspacer region, pulsed-field gel electrophoresis (PFGE), partial sequencing of several genes, and DNA-DNA hybridization. Two isolates were identical to B. henselae genotype II. All other isolates were distinguished from B. henselae and B. koehlerae by PCR-RFLP of the gltA gene using endonucleases HhaI, TaqI and AciI, with the latter two discriminating between the mountain lion and the bobcat isolates. These two novel isolates displayed specific PFGE profiles distinct from B. henselae, B. koehlerae and B. clarridgeiae. Sequences of amplified gene fragments from the three mountain lion and six bobcat isolates were closely related to, but distinct from, B. henselae and B. koehlerae. Finally, DNA-DNA hybridization studies demonstrated that the mountain lion and bobcat strains are most closely related to B. koehlerae. We propose naming the mountain lion isolates B. koehlerae subsp. boulouisii subsp. nov. (type strain: L-42-94), and the bobcat isolates B. koehlerae subsp. bothieri subsp. nov. (type strain: L-17-96), and to emend B. koehlerae as B. koehlerae subsp.koehlerae. The mode of transmission and the zoonotic potential of these new Bartonella subspecies remain to be determined.	[Chomel, Bruno B.; Molia, Sophie; Kasten, Rickie W.; Stuckey, Matthew J.] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA; [Molia, Sophie] Ctr Cooperat Int Rech Agron Dev, Campus Int Baillarguet,TA C-22-E, Montpellier, France; [Borgo, Gina M.; Koehler, Jane E.] Univ Calif San Francisco, Microbial Pathogenesis & Host Def Program, San Francisco, CA 94143 USA; [Borgo, Gina M.; Koehler, Jane E.] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA; [Maruyama, Soichi] Nihon Univ, Lab Vet Publ Hlth, Dept Vet Med, Coll Bioresource Sci, Tokyo, Japan; [Chang, Chao-chin] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Sch Vet Med, Taichung 40227, Taiwan; [Haddad, Nadia] LERPAZ, UPE, Ecole Natl Vet Alfort, UMR BIPAR,ENVA,ANSES,UPEC,USC INRA, Maisons Alfort, France	University of California System; University of California Davis; CIRAD; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nihon University; National Chung Hsing University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Chomel, BB (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA.	bbchomel@ucdavis.edu		Molia, Sophie/0000-0002-5695-7464; Borgo, Gina/0000-0002-5583-1675	George and Phyllis Miller Feline Research Fund; Center for Companion Animal Health, University of California, Davis; Master of Preventive Veterinary Medicine Research Project Fund (University of California, Davis); Merial Inc., Athens, GA; Lavoisier grant (French Ministry of Foreign Affairs); Barron fellowship (University of California, Davis); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; California HIV Research Program Award; NIH from the NIAID [U54AI065359, R01AI103299]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, R01AI103299] Funding Source: NIH RePORTER	George and Phyllis Miller Feline Research Fund; Center for Companion Animal Health, University of California, Davis(University of California System); Master of Preventive Veterinary Medicine Research Project Fund (University of California, Davis); Merial Inc., Athens, GA; Lavoisier grant (French Ministry of Foreign Affairs); Barron fellowship (University of California, Davis); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); California HIV Research Program Award; NIH from the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part by the George and Phyllis Miller Feline Research Fund, Center for Companion Animal Health, University of California, Davis, the Master of Preventive Veterinary Medicine Research Project Fund (University of California, Davis) and Merial Inc., Athens, GA. Sophie Molia was a recipient of a Lavoisier grant (French Ministry of Foreign Affairs) and a Barron fellowship (University of California, Davis). Jane E. Koehler received funding support from a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, a California HIV Research Program Award, and NIH grants U54AI065359 and R01AI103299 from the NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Darren Simpson for trapping the mountain lions and bobcats in central California and Dr. Pamela Swift for allowing access to the animals kept at the Wildlife Investigations Laboratory, California Department of Fish and Wildlife, Rancho Cordova, CA, as well as Walter Boyce and Grace Lee for providing the blood of the mountain lions from the San Diego Mountains. The authors also thank K.R. Jones, California Department of Fish and Wildlife, and K.A. Floyd-Hawkins, Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, for their technical assistance. The authors thank Arnold G. Steigerwalt for performing the DNA-DNA hybridization, and Don J. Brenner for his thoughtful comments on the manuscript. This project was funded in part by the George and Phyllis Miller Feline Research Fund, Center for Companion Animal Health, University of California, Davis, the Master of Preventive Veterinary Medicine Research Project Fund (University of California, Davis) and Merial Inc., Athens, GA. Sophie Molia was a recipient of a Lavoisier grant (French Ministry of Foreign Affairs) and a Barron fellowship (University of California, Davis). Jane E. Koehler received funding support from a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, a California HIV Research Program Award, and NIH grants U54AI065359 and R01AI103299 from the NIAID.	Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2; Avidor B, 2004, J CLIN MICROBIOL, V42, P3462, DOI 10.1128/JCM.42.8.3462-3468.2004; Bevins SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031403; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Breitschwerdt EB, 2007, J CLIN MICROBIOL, V45, P270, DOI 10.1128/JCM.01451-06; Breitschwerdt EB, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-76; BRENNER DJ, 1993, INT J SYST BACTERIOL, V43, P777, DOI 10.1099/00207713-43-4-777; BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982; Chang CC, 2000, J CLIN MICROBIOL, V38, P4193, DOI 10.1128/JCM.38.11.4193-4200.2000; Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931; Chomel BB, 2004, VET RES, V35, P233, DOI 10.1051/vetres:2004001; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Chomel BB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001843; Droz S, 1999, J CLIN MICROBIOL, V37, P1117, DOI 10.1128/JCM.37.4.1117-1122.1999; Girard YA, 2012, VECTOR-BORNE ZOONOT, V12, P913, DOI 10.1089/vbz.2011.0858; Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2; Henn JB, 2007, J CLIN MICROBIOL, V45, P2411, DOI 10.1128/JCM.02539-06; Henn JB, 2009, EMERG INFECT DIS, V15, P1984, DOI 10.3201/eid1512.081692; Johnson G, 2003, J CLIN MICROBIOL, V41, P1069, DOI 10.1128/JCM.41.3.1069-1072.2003; Kadesky KM, 1998, J PEDIATR SURG, V33, P863, DOI 10.1016/S0022-3468(98)90661-3; Kelly PJ, 1998, LANCET, V351, P1706, DOI 10.1016/S0140-6736(05)77744-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIZER KW, 1989, WESTERN J MED, V150, P87; KOEHLER JE, 1994, JAMA-J AM MED ASSOC, V271, P531, DOI 10.1001/jama.271.7.531; La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4; MacFadding JF, 1980, BIOCH TESTS IDENTIFI; Marston EL, 1999, INT J SYST BACTERIOL, V49, P1015, DOI 10.1099/00207713-49-3-1015; Molia S, 2004, VET MICROBIOL, V100, P31, DOI 10.1016/j.vetmic.2004.01.007; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; PAULMURPHY J, 1994, J WILDLIFE DIS, V30, P205, DOI 10.7589/0090-3558-30.2.205; Pretorius AM, 2004, EMERG INFECT DIS, V10, P2257, DOI 10.3201/eid1012.031054; REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; Riley SPD, 2004, J WILDLIFE DIS, V40, P11, DOI 10.7589/0090-3558-40.1.11; Rolain JM, 2003, CLIN DIAGN LAB IMMUN, V10, P686, DOI 10.1128/CDLI.10.4.686-691.2003; Rotstein DS, 2000, J WILDLIFE DIS, V36, P157, DOI 10.7589/0090-3558-36.1.157; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; WELCH DF, 1993, J CLIN MICROBIOL, V31, P2381, DOI 10.1128/JCM.31.9.2381-2386.1993; Yamamoto K, 2002, J CLIN MICROBIOL, V40, P466, DOI 10.1128/JCM.40.2.466-474.2002; Yamamoto K, 1998, J WILDLIFE DIS, V34, P56, DOI 10.7589/0090-3558-34.1.56; Yamamoto K, 1998, VET IMMUNOL IMMUNOP, V65, P191, DOI 10.1016/S0165-2427(98)00154-8; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P3641, DOI 10.1128/JCM.40.10.3641-3647.2002	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0148299	10.1371/journal.pone.0148299	http://dx.doi.org/10.1371/journal.pone.0148299			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981874	Green Published, gold, Green Submitted			2022-12-26	WOS:000372574900012
J	Manjili, HK; Ma'mani, L; Tavaddod, S; Mashhadikhan, M; Shafiee, A; Naderi-Manesh, H				Manjili, Hamidreza Kheiri; Ma'mani, Leila; Tavaddod, Sharareh; Mashhadikhan, Maedeh; Shafiee, Abbas; Naderi-Manesh, Hossein			D, L-Sulforaphane Loaded Fe3O4@ Gold Core Shell Nanoparticles: A Potential Sulforaphane Delivery System	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; SILICA NANOPARTICLE; CYCLE ARREST; IRON-OXIDE; THERAPY; IMMOBILIZATION; ACTIVATION; PREVENTION	A novel design of gold-coated iron oxide nanoparticles was fabricated as a potential delivery system to improve the efficiency and stability of d, l-sulforaphane as an anticancer drug. To this purpose, the surface of gold-coated iron oxide nanoparticles was modified for sulforaphane delivery via furnishing its surface with thiolated polyethylene glycol-folic acid and thiolated polyethylene glycol-FITC. The synthesized nanoparticles were characterized by different techniques such as FTIR, energy dispersive X-ray spectroscopy, UV-visible spectroscopy, scanning and transmission electron microscopy. The average diameters of the synthesized nanoparticles before and after sulforaphane loading were obtained similar to 33 nm and similar to 38 nm, respectively, when similar to 2.8 mmol/g of sulforaphane was loaded. The result of cell viability assay which was confirmed by apoptosis assay on the human breast cancer cells (MCF-7 line) as a model of in vitro-cancerous cells, proved that the bare nanoparticles showed little inherent cytotoxicity, whereas the sulforaphane-loaded nanoparticles were cytotoxic. The expression rate of the anti-apoptotic genes (bcl-2 and bcl-x(L)), and the proapoptotic genes (bax and bak) were quantified, and it was found that the expression rate of bcl-2 and bcl-x(L) genes significantly were decreased when MCF-7 cells were incubated by sulforaphane-loaded nanoparticles. The sulforaphane-loaded into the designed gold-coated iron oxide nanoparticles, acceptably induced apoptosis in MCF-7 cells.	[Manjili, Hamidreza Kheiri; Tavaddod, Sharareh; Naderi-Manesh, Hossein] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran; [Ma'mani, Leila] AREEO, ABRII, Dept Nanotechnol, Karaj, Iran; [Mashhadikhan, Maedeh] Islamic Azad Univ, Fac Sci, Sci & Res Branch, Dept Biol, Tehran, Iran; [Shafiee, Abbas] Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran 14176, Iran; [Shafiee, Abbas] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran 14176, Iran	Tarbiat Modares University; Islamic Azad University; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Naderi-Manesh, H (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran.; Shafiee, A (corresponding author), Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran 14176, Iran.	ashafiee@ams.ac.ir; naderman@modares.ac.ir	Tavaddod, Sharareh/H-1384-2016; manjili, hamidreza kheiri/J-9876-2016; Ma'mani, Leila/J-5069-2017	Tavaddod, Sharareh/0000-0001-6871-1595; manjili, hamidreza kheiri/0000-0001-7981-4629; 				Almeida AJ, 2007, ADV DRUG DELIVER REV, V59, P478, DOI 10.1016/j.addr.2007.04.007; Bao CC, 2014, NANOMEDICINE-UK, V9, P2353, DOI [10.2217/nnm.14.155, 10.2217/NNM.14.155]; Chacko RT, 2012, ADV DRUG DELIVER REV, V64, P836, DOI 10.1016/j.addr.2012.02.002; Chen M, 2003, J APPL PHYS, V93, P7551, DOI 10.1063/1.1555312; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Cui YL, 2005, BIOMED MICRODEVICES, V7, P153, DOI 10.1007/s10544-005-1596-x; Falahati M, 2011, BBA-PROTEINS PROTEOM, V1814, P1195, DOI 10.1016/j.bbapap.2011.04.005; Fallah-Bagheri A, 2012, INT J BIOL MACROMOL, V51, P933, DOI 10.1016/j.ijbiomac.2012.07.023; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Hahm ER, 2010, CANCER PREV RES, V3, P484, DOI 10.1158/1940-6207.CAPR-09-0250; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jin Y, 1999, J AGR FOOD CHEM, V47, P3121, DOI 10.1021/jf990082e; Johansson NL, 2008, PLANTA MED, V74, P747, DOI 10.1055/s-2008-1074520; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; Mahmoud WE, 2013, LANGMUIR, V29, P13095, DOI 10.1021/la403158d; Mahou R, 2012, POLYMERS-BASEL, V4, P561, DOI 10.3390/polym4010561; Mi P, 2014, J CONTROL RELEASE, V174, P63, DOI 10.1016/j.jconrel.2013.10.038; Pan Xiaogang, 2004, Expert Opin Drug Deliv, V1, P7, DOI 10.1517/17425247.1.1.7; Parnaud G, 2004, NUTR CANCER, V48, P198, DOI 10.1207/s15327914nc4802_10; Pedrosa P, 2015, NANOMATERIALS-BASEL, V5, P1853, DOI 10.3390/nano5041853; Rausch V, 2010, CANCER RES, V70, P5004, DOI 10.1158/0008-5472.CAN-10-0066; Rudolf E, 2009, FOOD CHEM TOXICOL, V47, P2366, DOI 10.1016/j.fct.2009.06.034; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Smolensky ED, 2011, CHEM COMMUN, V47, P2149, DOI 10.1039/c0cc03746j; Subramani K, 2009, CURR NANOSCI, V5, P135, DOI 10.2174/157341309788185406; Tanner P, 2011, ACCOUNTS CHEM RES, V44, P1039, DOI 10.1021/ar200036k; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Wu W., 2009, CHEMINFORM, V40, pi; Xiao Q., 2007, EFFECT TEMPERATURE P; Xu ZC, 2007, J AM CHEM SOC, V129, P8698, DOI 10.1021/ja073057v; Yang CS, 2013, CANCER PREV RES, V6, P1011, DOI 10.1158/1940-6207.CAPR-13-0312; Yang J, 2006, INT J PHARMACEUT, V324, P185, DOI 10.1016/j.ijpharm.2006.06.029; Zeng LY, 2013, NANOSCALE, V5, P2107, DOI 10.1039/c3nr33978e; Zhang L, 2013, INT J NANOMED, V8, P1517, DOI 10.2147/IJN.S43263; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhou T, 2012, J MATER CHEM, V22, P470, DOI 10.1039/c1jm13692e; Zhu YF, 2010, J PHYS CHEM C, V114, P16382, DOI 10.1021/jp106685q	39	34	34	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151344	10.1371/journal.pone.0151344	http://dx.doi.org/10.1371/journal.pone.0151344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982588	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000372574900077
J	Zhao, FX; Sun, HJ; Wu, JJ; Gao, ZY; Liu, RH				Zhao, Fangxia; Sun, Huijun; Wu, Jianjun; Gao, Ziyou; Liu, Ronghui			Analysis of Road Network Pattern Considering Population Distribution and Central Business District	PLOS ONE			English	Article							RELATIVE NEIGHBORHOOD GRAPH; DESIGN PROBLEM; TRANSPORTATION; MODELS; EQUILIBRIUM; DENSITY	This paper proposes a road network growing model with the consideration of population distribution and central business district (CBD) attraction. In the model, the relative neighborhood graph (RNG) is introduced as the connection mechanism to capture the characteristics of road network topology. The simulation experiment is set up to illustrate the effects of population distribution and CBD attraction on the characteristics of road network. Moreover, several topological attributes of road network is evaluated by using coverage, circuitness, treeness and total length in the experiment. Finally, the suggested model is verified in the simulation of China and Beijing Highway networks.	[Zhao, Fangxia; Sun, Huijun; Wu, Jianjun] Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China; [Zhao, Fangxia; Gao, Ziyou] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Liu, Ronghui] Univ Leeds, Inst Transport Studies, Leeds LS2 9JT, W Yorkshire, England	Beijing Jiaotong University; Beijing Jiaotong University; University of Leeds	Sun, HJ (corresponding author), Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China.	hjsun1@bjtu.edu.cn		Liu, Ronghui/0000-0003-0627-3184	China National Funds for Distinguished Young Scientists [71525002]; National Science Foundation of China [71271024]; Research Foundation of State Key Laboratory of Rail Traffic Control and Safety [RCS2016ZT002]; National Basic Research Program of China [2012CB725401]; UK Rail Safety and Standards Board [T1071]	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of State Key Laboratory of Rail Traffic Control and Safety; National Basic Research Program of China(National Basic Research Program of China); UK Rail Safety and Standards Board	J. Wu was supported by the China National Funds for Distinguished Young Scientists under Grant No. 71525002, the National Science Foundation of China under Grant No. 71271024, Research Foundation of State Key Laboratory of Rail Traffic Control and Safety under Grant No. RCS2016ZT002. Z. Gao was supported by National Basic Research Program of China under Grant No. 2012CB725401. R. Liu was supported by UK Rail Safety and Standards Board under Grant No. T1071.	Barthelemy M, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/07/L07002; Barthelemy M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.138702; Barthelemy M, 2009, NETW SPAT ECON, V9, P401, DOI 10.1007/s11067-008-9068-5; BOYCE DE, 1984, ENVIRON PLANN A, V16, P1445, DOI 10.1068/a161445; Buckwalter DW, 2013, APPL GEOGR, V41, P158, DOI 10.1016/j.apgeog.2013.04.008; Chen AT, 2011, TRANSPORT REV, V31, P743, DOI 10.1080/01441647.2011.589539; Combinido JSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048151; Ding Y, 1998, J SHANGHAI MARITIME, V19, P7; Farahani RZ, 2013, EUR J OPER RES, V229, P281, DOI 10.1016/j.ejor.2013.01.001; FRIESZ TL, 1985, TRANSPORT RES A-POL, V19, P413, DOI 10.1016/0191-2607(85)90041-X; Garcia-Lopez MA, 2012, J URBAN ECON, V72, P176, DOI 10.1016/j.jue.2012.05.003; Huang H, 2014, APPL GEOGR, V47, P78, DOI 10.1016/j.apgeog.2013.11.012; HWANG FK, 1992, NETWORKS, V22, P55, DOI 10.1002/net.3230220105; JAROMCZYK JW, 1992, P IEEE, V80, P1502, DOI 10.1109/5.163414; Lee M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140152; Levinson D, 2007, ISTTT17, p[111, 839]; Levinson D, 2008, J ECON GEOGR, V8, P55, DOI 10.1093/jeg/lbm038; Levinson D, 2006, TRANSPORT SCI, V40, P179, DOI 10.1287/trsc.1050.0132; Levinson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029721; Lin D, 2013, PROCD SOC BEHV, V96, P461, DOI 10.1016/j.sbspro.2013.08.054; LINGAS A, 1994, COMP GEOM-THEOR APPL, V4, P199, DOI 10.1016/0925-7721(94)90018-3; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; MAGNANTI TL, 1984, TRANSPORT SCI, V18, P1, DOI 10.1287/trsc.18.1.1; Migdalas A, 1995, J GLOBAL OPTIM, V7, P381, DOI 10.1007/BF01099649; Parthasarathi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077718; Rui YK, 2009, EUR PHYS J B, V71, P259; Shao FJ, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114400014; SUPOWIT KJ, 1983, J ACM, V30, P428, DOI 10.1145/2402.322386; Szeto WY, 2015, NETW SPAT ECON, V15, P791, DOI 10.1007/s11067-013-9191-9; TOUSSAINT GT, 1980, PATTERN RECOGN, V12, P261, DOI 10.1016/0031-3203(80)90066-7; Wang DZW, 2015, TRANSPORT RES E-LOG, V79, P213, DOI 10.1016/j.tre.2015.04.005; Xie F, 2007, GEOGR ANAL, V39, P336, DOI 10.1111/j.1538-4632.2007.00707.x; Xie F, 2009, COMPUT ENVIRON URBAN, V33, P211, DOI 10.1016/j.compenvurbsys.2008.09.009; Xie YB, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036106; Yamins D, 2003, NETW SPAT ECON, V3, P69, DOI 10.1023/A:1022001117715; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016; Yang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116551; Zhao FX, 2016, NETW SPAT ECON, V16, P997, DOI 10.1007/s11067-015-9308-4	38	11	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151676	10.1371/journal.pone.0151676	http://dx.doi.org/10.1371/journal.pone.0151676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26981857	Green Published, gold			2022-12-26	WOS:000372574900112
J	Jiang, ZD; Zhang, K; Huang, WX; Yuan, QX				Jiang, Zidong; Zhang, Kai; Huang, Wanxia; Yuan, Qingxi			A Preliminary Study on Sinus Fungus Ball with MicroCT and X-Ray Fluorescence Technique	PLOS ONE			English	Article							PARANASAL SINUSES; MAXILLARY SINUS; ASPERGILLOSIS; DIAGNOSIS; CRITERIA; RISK	Background Sinus fungus ball, an accumulation of fungal dense concretions, is a common disease in practice, and might cause fatal complications or lead to death once converted into invasive type. Early preoperative diagnosis of this disease can lead to appropriate treatment for patients and prevent multiple surgical procedures. Up to now, the diagnostic criteria of sinus fungus ball have been defined and computed tomography (CT) scan was considered as a valuable preoperative diagnostic tool. However, the sensitivity of clinical CT is only about 62%. Thus, investigating the factors which influence sensitivity is necessary for clinical CT to be a more valuable preoperative diagnosis tool. Furthermore, CT scan usually presents micro-calcifications or spots with metallic density in sinus fungus ball. Previous literatures show that there are some metallic elements such as calciumand zinc in fungus ball, and they concluded that endodontic treatment has a strong correlation with the development of maxillary sinus fungus ball and zinc ion was an exogenous risk factor. But the pathogenesis of sinus fungus ball still remains unclear because fungus ball can also develop in other non-maxillary sinuses or the maxillary sinus without root canal treatment. Is zinc ion the endogenous factor? Study on this point might be also helpful for investigating the pathogenesis of sinus fungus ball. In this paper, we tried to investigate the factors which influence the sensitivity of clinical CT by imaging sinus fungus ball with microCT. The origin of zinc ion was also studied through elements test for different fungal ball samples using x-ray fluorescence technique. Methods Specimens including fungal ball material and sinus mucosa from patients confirmed by pathological findings were extracted after surgery. All fungal ball specimens came from sphenoid sinus, ethmoidal sinus and maxillary sinus with or without previous endodontic treatment respectively. All of them were imaged by microCT with spatial resolution up to 5 mu m to acquire three-dimensional structure, and then the heavy metal elements were detected with x-ray fluorescence spectrometer analysis. Result High concentration of zinc and calcium were detected in all fungal ball specimens compared to sinus mucosa membrane. Particles with different size varied from disperse to density, which have similar shape to the result of clinical CT but with different size, were found in three-dimensional reconstruction results of microCT. Conclusions Spatial resolution is an influent factor of clinical CT sensitivity for sinus fungus ball. Improving the resolution of clinical CT will help to improve its sensitivity. Besides iatrogenic endodontic materials, endogenous metal elements of zinc and calcium might associate with the growth of fungal ball and the micro-calcifications or spots with metallic density of CT imaging.	[Jiang, Zidong] Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Zhang, Kai; Huang, Wanxia; Yuan, Qingxi] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Jiang, ZD (corresponding author), Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing, Peoples R China.; Yuan, QX (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China.	zidongjiangcn@aliyun.com; yuanqx@ihep.ac.cn	huang, wanxia/AAE-6861-2020	Yuan, Qingxi/0000-0002-2997-7654; Zhang, Kai/0000-0001-5058-9077	National Natural Science Foundation of China [81441032, 11205189, U1332109, 81271574]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Numbers 81441032(ZJ), 11205189(KZ), U1332109 (QY), and 81271574, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-341; BECKMANNAGETTA J, 1983, LANCET, V2, P1260; Bosi GR, 2012, INT ARCH OTORHINOLAR, V16, P286, DOI 10.7162/S1809-97772012000200020; Broglie MA, 2009, RHINOLOGY, V47, P379, DOI 10.4193/Rhin09.026; Chakrabarti A, 2009, LARYNGOSCOPE, V119, P1809, DOI 10.1002/lary.20520; Chobillon MAJ, 2004, RHINOLOGY, V42, P230; Costa F, 2007, ORAL SURG ORAL MED O, V103, pE23, DOI 10.1016/j.tripleo.2006.12.015; deShazo RD, 1997, ARCH OTOLARYNGOL, V123, P1181, DOI 10.1001/archotol.1997.01900110031005; deShazo RD, 1997, J ALLERGY CLIN IMMUN, V99, P475, DOI 10.1016/S0091-6749(97)70073-3; DeShazo RD, 1997, NEW ENGL J MED, V337, P254, DOI 10.1056/NEJM199707243370407; Dhong HJ, 2000, AM J RHINOL, V14, P227, DOI 10.2500/105065800779954446; Douglas G, 1994, BMJ-BRIT MED J, V308, P1552; Falworth MS, 1996, ORAL SURG ORAL MED O, V81, P255, DOI 10.1016/S1079-2104(96)80426-4; Fanucci E, 2013, Oral Implantol (Rome), V6, P63; Grosjean P, 2007, EUR ARCH OTO-RHINO-L, V264, P461, DOI 10.1007/s00405-007-0281-5; JAKSE R, 1982, HNO, V30, P45; Mackenzie J. J., 1893, J HOPKINS HOSP B, V4, P9; McComb JQ, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2169-5; Mensi M, 2004, ORAL SURG ORAL MED O, V98, P119, DOI 10.1016/j.tripleo.2003.12.035; Mensi M, 2007, ORAL SURG ORAL MED O, V103, P433, DOI 10.1016/j.tripleo.2006.08.014; Nicolai P, 2015, ACTA OTORHINOLARYNGO, V35, P93; Nicolai P, 2009, LARYNGOSCOPE, V119, P2275, DOI 10.1002/lary.20578; Nomura Kazuhiro, 2013, Int J Otolaryngol, V2013, P731640, DOI 10.1155/2013/731640; Pagella F, 2007, MYCOSES, V50, P451, DOI 10.1111/j.1439-0507.2007.01416.x; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Seo YJ, 2011, ACTA RADIOL, V52, P790, DOI 10.1258/ar.2011.110021; STAMMBERGER H, 1984, ANN OTO RHINOL LARYN, V93, P251, DOI 10.1177/000348948409300313; Tsai TL, 2006, OTOLARYNG HEAD NECK, V134, P494, DOI 10.1016/j.otohns.2005.10.009	28	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0148515	10.1371/journal.pone.0148515	http://dx.doi.org/10.1371/journal.pone.0148515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978273	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800012
J	Velusamy, SK; Sampathkumar, V; Godboley, D; Fine, DH				Velusamy, Senthil Kumar; Sampathkumar, Vandana; Godboley, Dipti; Fine, Daniel H.			Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments	PLOS ONE			English	Article							LOCALIZED AGGRESSIVE PERIODONTITIS; BUCCAL EPITHELIAL-CELLS; OLD-WORLD PRIMATES; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; EXHIBITS SPECIFICITY; BIOFILM FORMATION; ENDOCARDITIS; DISEASE; GENE; POLYSACCHARIDE	Leukotoxin (Ltx) is a prominent virulence factor produced by Aggregatibacter actinomycetemcomitans, an oral microorganism highly associated with aggressive periodontitis. Ltx compromises host responsiveness by altering the viability of neutrophils, lymphocytes, and macrophages. Previously, we developed a Rhesus (Rh) monkey colonization model designed to determine the effect of virulence gene mutations on colonization of A. actinomycetemcomitans. Unexpectedly, an A. actinomycetemcomitans leukotoxin (ltxA) mutant (RhAa-VS2) failed to colonize in the Rh model. No previous literature suggested that Ltx was associated with A. actinomycetemcomitans binding to tooth surfaces. These results led us to explore the broad effects of the ltxA mutation in vitro. Results indicated that LtxA activity was completely abolished in RhAa-VS2 strain, while complementation significantly (P<0.0001) restored leukotoxicity compared to RhAa-VS2 strain. RT-PCR analysis of ltx gene expression ruled out polar effects. Furthermore, binding of RhAa-VS2 to salivary-coated hydroxyapatite (SHA) was significantly decreased (P<0.0001) compared to wild type RhAa3 strain. Real time RT-PCR analysis of the genes related to SHA binding in RhAa-VS2 showed that genes related to binding were downregulated [rcpA (P = 0.018), rcpB (P = 0.02), tadA (P = 0.002)] as compared to wild type RhAa3. RhAa-VS2 also exhibited decreased biofilm depth (P = 0.008) and exo-polysaccharide production (P<0.0001). Buccal epithelial cell (BEC) binding of RhAa-VS2 was unaffected. Complementation with ltxA restored binding to SHA (P<0.002) but had no effect on biofilm formation when compared to RhAa3. In conclusion, mutation of ltxA diminished hard tissue binding in vitro, which helps explain the previous in vivo failure of a ltxA knockout to colonize the Rh oral cavity. These results suggest that; 1) one specific gene knockout (in this case ltxA) could affect other seemingly unrelated genes (such as rcpA, rcpB tadA etc), and 2) some caution should be used when interpreting the effect attributed to targeted gene mutations when seen in a competitive in vivo environment.	[Velusamy, Senthil Kumar; Sampathkumar, Vandana; Godboley, Dipti; Fine, Daniel H.] Rutgers Sch Dent Med, Dept Oral Biol, 185 S Orange Ave, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Fine, DH (corresponding author), Rutgers Sch Dent Med, Dept Oral Biol, 185 S Orange Ave, Newark, NJ USA.	finedh@sdm.rutgers.edu			National Institute of Dental and Craniofacial Research (NIDCR) [1R21DE021172-01A1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021172] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	DHF would like to acknowledge support derived from grant 1R21DE021172-01A1 from the National Institute of Dental and Craniofacial Research (NIDCR) to support the work performed in this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashova NV, 2006, INFECT IMMUN, V74, P2015, DOI 10.1128/IAI.74.4.2015-2021.2006; Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07; Cortelli SC, 2009, J CLIN MICROBIOL, V47, P2018, DOI 10.1128/JCM.00338-09; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Das M, 1997, ANNU REV MED, V48, P25, DOI 10.1146/annurev.med.48.1.25; DiFranco KM, 2012, J BIOL CHEM, V287, P17618, DOI 10.1074/jbc.M111.314674; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; ELLNER JJ, 1979, MEDICINE, V58, P145, DOI 10.1097/00005792-197903000-00003; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Fine DH, 2013, J CLIN MICROBIOL, V51, P2850, DOI 10.1128/JCM.00729-13; Fine DH, 2010, J CLIN MICROBIOL, V48, P4464, DOI 10.1128/JCM.00964-10; Fine DH, 2005, INFECT IMMUN, V73, P1947, DOI 10.1128/IAI.73.4.1947-1953.2005; Fine DH, 2015, J ORAL BIOL NORTHBOR, V2; Fives-Taylor PM, 1999, PERIODONTOL 2000, V20, P136, DOI 10.1111/j.1600-0757.1999.tb00161.x; Haubek D, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23980; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Inoue T, 2003, MICROBIOL IMMUNOL, V47, P877, DOI 10.1111/j.1348-0421.2003.tb03454.x; Izano EA, 2007, J DENT RES, V86, P618, DOI 10.1177/154405910708600707; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Johansson A, 2000, EUR J ORAL SCI, V108, P136, DOI 10.1034/j.1600-0722.2000.00790.x; Juarez-Rodriguez MD, 2013, PLASMID, V69, P211, DOI 10.1016/j.plasmid.2013.01.002; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Karched M, 2012, J BACTERIOL, V194, P1275, DOI 10.1128/JB.06710-11; KOLODRUBETZ D, 1989, INFECT IMMUN, V57, P1465, DOI 10.1128/IAI.57.5.1465-1469.1989; LALLY ET, 1989, J BIOL CHEM, V264, P15451; LEAR JD, 1995, BBA-BIOMEMBRANES, V1238, P34, DOI 10.1016/0005-2736(95)00086-I; Lim YM, 2008, INFECT IMMUN, V76, P5110, DOI 10.1128/IAI.00445-08; Muller HP, 1996, J PERIODONTAL RES, V31, P373, DOI 10.1111/j.1600-0765.1996.tb00506.x; Paturel L, 2004, CLIN MICROBIOL INFEC, V10, P98, DOI 10.1111/j.1469-0691.2004.00794.x; Planet PJ, 2003, NAT GENET, V34, P193, DOI 10.1038/ng1154; Sambrook J., 2001, MOL CLONING LAB MANU; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Shanmugam M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134285; Shanmugam M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117487; SLOTS J, 1976, SCAND J DENT RES, V84, P1; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Thomson VJ, 1999, J BACTERIOL, V181, P7298, DOI 10.1128/JB.181.23.7298-7307.1999; Venketaraman V, 2008, MICROB PATHOGENESIS, V45, P173, DOI 10.1016/j.micpath.2008.05.007; Xu K, 2012, FEMS MICROBIOL LETT, V337, P97, DOI 10.1111/1574-6968.12016; Yue G, 2007, INFECT IMMUN, V75, P4440, DOI 10.1128/IAI.02020-06; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x	43	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151361	10.1371/journal.pone.0151361	http://dx.doi.org/10.1371/journal.pone.0151361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977924	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800066
J	Canal, F; Charawi, S; Grimber, G; Houbron, C; Drouet, V; Colnot, S; Terris, B; Cavard, C; Perret, C				Canal, Frederic; Charawi, Sara; Grimber, Gisele; Houbron, Christophe; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine			Generation of Mice with Hepatocyte-Specific Conditional Deletion of Notum	PLOS ONE			English	Article							HEPATOCELLULAR CARCINOMAS; SOMATIC MUTATIONS; SIGNALING PATHWAY; LIVER; GENE; METABOLISM; HOMOLOG; TCF7L2; WINGLESS; ZONATION	Background Fine tuning of the Wnt/beta-catenin signaling pathway is essential for the proper development and function of the liver. Aberrant activation of this pathway is observed in 20%-40% of hepatocellular carcinomas (HCC). Notum encodes a secreted Wnt deacylase that inhibits Wnt activity and thereby restricts the zone of activation of Wnt/beta-catenin signaling. An important role of NOTUM has been described in development in drosophila, planaria and zebrafish, but its role in the mammalian liver is unknown. Notum is required for spatial control of the Wnt/beta-catenin signaling in several animal models and the Wnt/beta-catenin pathway contributes to liver patterning involved in metabolic zonation. Therefore, Notum may be involved in the liver patterning induced by the Wnt/beta-catenin signaling during the adult stage. Methodology/principal findings We generated a conditional Notum knockout mouse mutant to study the effect of the deletion of Notum in the liver. We show that Notum is a direct target of the Wnt/beta-catenin signaling in the liver. Liver-specific deletion of Notum did not modify liver zonation, but Notum deletion had a long-term effect on mouse physiology. In particular, male mutant mice developed metabolic disorders. Conclusion We show that Notum is not a key actor of Wnt/beta-catenin-dependent liver patterning of adult mice, but has role in liver glucose homeostasis. Male mice deficient in Notum specifically in the liver develop metabolic dysfunctions implicating Notum in the development of Type 2 diabetes.	[Canal, Frederic; Charawi, Sara; Grimber, Gisele; Houbron, Christophe; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Canal, Frederic; Charawi, Sara; Grimber, Gisele; Houbron, Christophe; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine] CNRS, UMR8104, F-75014 Paris, France; [Canal, Frederic; Charawi, Sara; Grimber, Gisele; Houbron, Christophe; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine] Univ Paris 05, F-75014 Paris, France; [Canal, Frederic; Charawi, Sara; Grimber, Gisele; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine] Equipe Labellisee LNCC, Paris, France; [Terris, Benoit] Hop Cochin, Pathol Unit, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Perret, C (corresponding author), Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France.; Perret, C (corresponding author), CNRS, UMR8104, F-75014 Paris, France.; Perret, C (corresponding author), Univ Paris 05, F-75014 Paris, France.; Perret, C (corresponding author), Equipe Labellisee LNCC, Paris, France.	christine.perret@inserm.fr	Terris, Benoit/P-1497-2017; Perret-Mayeux, Christine/L-3297-2017; Colnot, Sabine/A-9169-2008	Colnot, Sabine/0000-0002-3949-9107; perret, christine/0000-0003-4710-7051	INSERM; CNRS; Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer"; INCA; LABEX Who am I ?	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer"; INCA(Institut National du Cancer (INCA) France); LABEX Who am I ?	Core fundings came from INSERM, CNRS, grants from Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer", INCA grants and LABEX Who am I ?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audard V, 2007, J PATHOL, V212, P345, DOI 10.1002/path.2169; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Cantu JA, 2013, J NEUROSCI, V33, P2177, DOI 10.1523/JNEUROSCI.3694-12.2013; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Ip W, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-28; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Nobrega MA, 2013, DIABETES, V62, P706, DOI 10.2337/db12-1418; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Torisu Y, 2008, CANCER SCI, V99, P1139, DOI 10.1111/j.1349-7006.2008.00814.x; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Zhang XJ, 2015, DEV CELL, V32, P719, DOI 10.1016/j.devcel.2015.02.014	23	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150997	10.1371/journal.pone.0150997	http://dx.doi.org/10.1371/journal.pone.0150997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974334	Green Submitted, Green Published, gold			2022-12-26	WOS:000372570600041
J	Carroll, CS; Amankwa, LN; Pinto, LJ; Fuller, JD; Moore, MM				Carroll, Cassandra S.; Amankwa, Lawrence N.; Pinto, Linda J.; Fuller, Jeffrey D.; Moore, Margo M.			Detection of a Serum Siderophore by LC-MS/MS as a Potential Biomarker of Invasive Aspergillosis	PLOS ONE			English	Article							LATERAL-FLOW DEVICE; BRONCHOALVEOLAR LAVAGE FLUID; REAL-TIME PCR; BETA-D-GLUCAN; PULMONARY ASPERGILLOSIS; FUNGAL-INFECTIONS; TRANSPLANT RECIPIENTS; CLINICAL-PERFORMANCE; TESTING SERUM; DIAGNOSIS	Invasive aspergillosis (IA) is a life-threatening systemic mycosis caused primarily by Aspergillus fumigatus. Early diagnosis of IA is based, in part, on an immunoassay for circulating fungal cell wall carbohydrate, galactomannan (GM). However, a wide range of sensitivity and specificity rates have been reported for the GM test across various patient populations. To obtain iron in vivo, A. fumigatus secretes the siderophore, N, N', N ''-triacetylfusarinine C (TAFC) and we hypothesize that TAFC may represent a possible biomarker for early detection of IA. We developed an ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method for TAFC analysis from serum, and measured TAFC in serum samples collected from patients at risk for IA. The method showed lower and upper limits of quantitation (LOQ) of 5 ng/ml and 750 ng/ml, respectively, and complete TAFC recovery from spiked serum. As proof of concept, we evaluated 76 serum samples from 58 patients with suspected IA that were investigated for the presence of GM. Fourteen serum samples obtained from 11 patients diagnosed with probable or proven IA were also analyzed for the presence of TAFC. Control sera (n = 16) were analyzed to establish a TAFC cut-off value (>= 6 ng/ml). Of the 36 GM-positive samples (>= 0.5 GM index) from suspected IA patients, TAFC was considered positive in 25 (69%). TAFC was also found in 28 additional GM-negative samples. TAFC was detected in 4 of the 14 samples (28%) from patients with proven/probable aspergillosis. Log-transformed TAFC and GM values from patients with proven/probable IA, healthy individuals and SLE patients showed a significant correlation with a Pearson r value of 0.77. In summary, we have developed a method for the detection of TAFC in serum that revealed this fungal product in the sera of patients at risk for invasive aspergillosis. A prospective study is warranted to determine whether this method provides improved early detection of IA.	[Carroll, Cassandra S.; Pinto, Linda J.; Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Amankwa, Lawrence N.] Ctr Drug Res & Dev, Vancouver, BC V6T 1Z3, Canada; [Fuller, Jeffrey D.] Alberta Hlth Serv, Prov Lab Publ Hlth & Microbiol, Edmonton, AB T6G 2R7, Canada	Simon Fraser University; Alberta Health Services (AHS)	Moore, MM (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	mmoore@sfu.ca			Natural Sciences and Engineering Research Council of Canada [105704]; Merck Canada Inc. [569192]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Merck Canada Inc.	This work was supported by (1) Natural Sciences and Engineering Research Council of Canada (105704), http://www.nserc.ca, to MM and (2) Merck Canada Inc. (569192) (formerly Schering-Plough Canada Inc.), http://www.merck.ca, to MM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta J, 2011, CLIN MICROBIOL INFEC, V17, P1053, DOI 10.1111/j.1469-0691.2010.03357.x; Alothman AF, 2014, J INFECT PUBLIC HEAL, V7, P6, DOI 10.1016/j.jiph.2013.08.002; Ashbee HR, 2014, J ANTIMICROB CHEMOTH, V69, P1162, DOI 10.1093/jac/dkt508; Bertrand S, 2010, MED MYCOL, V48, pS98, DOI 10.3109/13693786.2010.503972; Bio-Rad, PLAT ASP EIA; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brasier AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143165; Buess M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-237; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerqueira LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092851; CHARLANG G, 1981, MOL CELL BIOL, V1, P94, DOI 10.1128/MCB.1.2.94; Dannaoui E, 2010, J CLIN MICROBIOL, V48, P2043, DOI 10.1128/JCM.02319-09; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; De Vlieger G, 2011, J CLIN MICROBIOL, V49, P3783, DOI 10.1128/JCM.00879-11; Doyle J, 2012, METHOD DETECTING INF; Dufresne SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042736; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Hinckson EA, 2005, MED SCI SPORT EXER, V37, P696, DOI 10.1249/01.MSS.0000159023.06934.53; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; Hoenigl M, 2014, J CLIN MICROBIOL, V52, P2039, DOI 10.1128/JCM.00467-14; Hoenigl M, 2012, J INFECTION, V65, P588, DOI 10.1016/j.jinf.2012.10.003; Husain S, 2003, CLIN INFECT DIS, V37, P221, DOI 10.1086/375822; Khan ZU, 2008, J MED MICROBIOL, V57, P36, DOI 10.1099/jmm.0.47301-0; Lass-Florl C, 2009, CLIN MICROBIOL INFEC, V15, P60, DOI 10.1111/j.1469-0691.2009.02999.x; Lass-Florl C, 2007, CLIN INFECT DIS, V45, pE101, DOI 10.1086/521245; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; da Silva TVM, 2014, MYCOPATHOLOGIA, V177, P111, DOI 10.1007/s11046-013-9718-0; MIYAZAKI T, 1995, J CLIN MICROBIOL, V33, P3115, DOI 10.1128/JCM.33.12.3115-3118.1995; Morgan J, 2005, MED MYCOL, V43, pS49, DOI 10.1080/13693780400020113; Neofytos D, 2013, TRANSPL INFECT DIS, V15, P233, DOI 10.1111/tid.12060; Nguyen MH, 2011, BIOL BLOOD MARROW TR, V17, P1043, DOI 10.1016/j.bbmt.2010.11.013; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Panda NK, 2008, AM J OTOLARYNG, V29, P24, DOI 10.1016/j.amjoto.2006.12.004; Petrik M, 2010, J NUCL MED, V51, P639, DOI 10.2967/jnumed.109.072462; Racil Z, 2011, INT J INFECT DIS, V15, pE874, DOI 10.1016/j.ijid.2011.09.011; Raymond-Bouchard I, 2012, EUKARYOT CELL, V11, P1333, DOI 10.1128/EC.00159-12; Rogers TR, 2007, J ANTIMICROB CHEMOTH, V61, pI35, DOI 10.1093/jac/dkm429; Rogers TR, 2013, BRIT J HAEMATOL, V161, P517, DOI 10.1111/bjh.12285; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Singh N, 2005, CLIN MICROBIOL REV, V18, P44, DOI 10.1128/CMR.18.1.44-69.2005; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; Sulahian A, 2014, J CLIN MICROBIOL, V52, P2328, DOI 10.1128/JCM.03567-13; Thornton CR, 2008, CLIN VACCINE IMMUNOL, V15, P1095, DOI 10.1128/CVI.00068-08; Tucholska M, 2009, J PROTEOME RES, V8, P1143, DOI 10.1021/pr8005217; White PL, 2015, J CLIN MICROBIOL, V53, P2832, DOI 10.1128/JCM.00905-15; White PL, 2013, J CLIN MICROBIOL, V51, P1510, DOI 10.1128/JCM.03189-12; White PL, 2011, J CLIN MICROBIOL, V49, P2169, DOI 10.1128/JCM.00101-11; White PL, 2010, J CLIN MICROBIOL, V48, P3753, DOI 10.1128/JCM.01466-10; Yasuoka A, 1996, CLIN VACCINE IMMUNOL, V3, P3	53	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151260	10.1371/journal.pone.0151260	http://dx.doi.org/10.1371/journal.pone.0151260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974544	Green Published, Green Submitted, gold			2022-12-26	WOS:000372570600059
J	Chang, J; Choi, J; Rah, YC; Yoo, MH; Oh, KH; Im, GJ; Lee, SH; Kwon, SY; Park, HC; Chae, SW; Jung, HH				Chang, Jiwon; Choi, June; Rah, Yoon Chan; Yoo, Myung Hoon; Oh, Kyoung Ho; Im, Gi Jung; Lee, Seung Hoon; Kwon, Soon Young; Park, Hae-Chul; Chae, Sung Won; Jung, Hak Hyun			Sodium Selenite Acts as an Otoprotectant against Neomycin-Induced Hair Cell Damage in a Zebrafish Model	PLOS ONE			English	Article							AMINOGLYCOSIDE-INDUCED OTOTOXICITY; SYSTEMIC INFLAMMATORY RESPONSE; RERIO LATERAL-LINE; DANIO-RERIO; THIOREDOXIN REDUCTASE; PROTECTIVE ROLE; DEATH; REGENERATION; REVEALS; SCREEN	Sodium selenite is a trace element essential for many physiological functions in the body. It is involved in various biological processes; it acts as a cofactor for antioxidant enzymes that protect against free radicals and is reported to limit metal-mediated oxidative DNA damage. In the present study, we investigated the effect of sodium selenite on neomycin ototoxicity in wild-type and transgenic zebrafish (Brn3C: EGFP). Five or six days post-fertilization, zebrafish larvae were co-exposed to 125 mu M neomycin and various concentrations (10 mu M, 100 mu M, 250 mu M, and 500 mu M) of sodium selenite for 1 h. Hair cells within neuromasts of the supraorbital (SO1 and SO2), otic (O1), and occipital (OC1) lateral lines were analyzed by fluorescence microscopy (n = 10 fish per treatment). Hair cell survival was estimated as the ratio of the hair cell numbers in each group compared to those of the control group that were not exposed to neomycin. Apoptosis and hair cell damage of neuromasts were evaluated using the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) assay and 2-[4-(dimethylamino)styryl]-N-ethylpyridinium iodide (DASPEI) assay, respectively. Ultrastructural changes were evaluated using scanning electron microscopy and transmission electron microscopy. Neuromast hair cells were preserved in zebrafish exposed to 125 mu M neomycin and 500 mu M sodium selenite for 1 h. Sodium selenite protected against neomycin-induced hair cell loss of neuromasts, reduced apoptosis, and prevented zebrafish ultrastructural changes. We propose that sodium selenite protects against neomycin-induced hair cell damage by inhibiting apoptosis, decreasing the disarray of stereocilia, and preventing ultrastructural changes in the neuromast hair cells of the zebrafish.	[Chang, Jiwon] Hallym Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Choi, June; Rah, Yoon Chan; Yoo, Myung Hoon; Oh, Kyoung Ho; Im, Gi Jung; Lee, Seung Hoon; Kwon, Soon Young; Chae, Sung Won; Jung, Hak Hyun] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea; [Park, Hae-Chul] Korea Univ, Grad Sch Med, Lab Neurodev Genet, Seoul, South Korea	Hallym University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Choi, J (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea.	mednlaw@korea.ac.kr	ho, oh kyoung/AAZ-3407-2020; IM, GI JUNG/AAI-9755-2020	Yoo, Myung Hoon/0000-0002-9158-8924; IM, GI JUNG/0000-0002-9457-4253; CHOI, JUNE/0000-0002-6330-279X	Department Foundation of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine; Soo ENT Clinic	Department Foundation of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine; Soo ENT Clinic	This research was supported by a Grant-in-Aid from the Department Foundation of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, and the Soo ENT Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Battin EE, 2011, METALLOMICS, V3, P503, DOI 10.1039/c0mt00063a; Battin EE, 2009, CELL BIOCHEM BIOPHYS, V55, P1, DOI 10.1007/s12013-009-9054-7; Berger MM, 2006, CRIT CARE, V10, DOI 10.1186/cc5084; Broome CS, 2004, AM J CLIN NUTR, V80, P154; Buck LMJ, 2012, HEARING RES, V284, P67, DOI 10.1016/j.heares.2011.12.001; Chiu LL, 2008, JARO-J ASSOC RES OTO, V9, P178, DOI 10.1007/s10162-008-0118-y; Choi J, 2014, J APPL TOXICOL, V34, P554, DOI 10.1002/jat.2964; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; GOVAERTS PJ, 1990, TOXICOL LETT, V52, P227, DOI 10.1016/0378-4274(90)90033-I; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Huth M E, 2011, Int J Otolaryngol, V2011, P937861, DOI 10.1155/2011/937861; Kim TY, 2002, KOREAN J ELECT MICRO, V32, P57; Kohrle J, 2009, BEST PRACT RES CL EN, V23, P815, DOI 10.1016/j.beem.2009.08.002; Lee S, 2015, HUM EXP TOXICOL; LENOIR M, 1987, HEARING RES, V26, P199, DOI 10.1016/0378-5955(87)90112-2; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Ma Y, 2012, FOOD CHEM TOXICOL, V50, P2854, DOI 10.1016/j.fct.2012.04.037; Naik HRP, 2009, EUR J MED CHEM, V44, P981, DOI 10.1016/j.ejmech.2008.07.006; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; Ou H, 2012, HEARING RES, V288, P58, DOI 10.1016/j.heares.2012.01.009; Ou HC, 2007, HEARING RES, V233, P46, DOI 10.1016/j.heares.2007.07.003; Ou HC, 2012, JARO-J ASSOC RES OTO, V13, P759, DOI 10.1007/s10162-012-0353-0; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Owens KN, 2007, J COMP NEUROL, V502, P522, DOI 10.1002/cne.21345; Park C.B.C.H., 1999, KOREAN J ELECT MICRO, V29, P437; Park MK, 2014, INT J PEDIATR OTORHI, V78, P1311, DOI 10.1016/j.ijporl.2014.05.018; Phillips JS, 2007, CLIN OTOLARYNGOL, V32, P330, DOI 10.1111/j.1749-4486.2007.01532.x; Priuska EM, 1995, BIOCHEM PHARMACOL, V50, P1749, DOI 10.1016/0006-2952(95)02160-4; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Roland Peter S, 2004, Ear Nose Throat J, V83, P15; Roland Peter S, 2003, Ear Nose Throat J, V82 Suppl 1, P3; Rotstein C, 2004, OTOXICITY, P81; Rybak Leonard P, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P328, DOI 10.1097/00020840-200310000-00004; Rybak LP, 2005, OTOLARYNGOLOGY HEAD, P2933; Sakr Y, 2007, BRIT J ANAESTH, V98, P775, DOI 10.1093/bja/aem091; Selimoglu E, 2003, YONSEI MED J, V44, P517, DOI 10.3349/ymj.2003.44.3.517; Selimoglu E, 2007, CURR PHARM DESIGN, V13, P119, DOI 10.2174/138161207779313731; Staecker H, 2007, OTOL NEUROTOL, V28, P223, DOI 10.1097/MAO.0b013e31802b3225; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Sugahara K, 2006, HEARING RES, V221, P128, DOI 10.1016/j.heares.2006.08.009; Vlasits AL, 2012, HEARING RES, V294, P153, DOI 10.1016/j.heares.2012.08.002; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whanger PD, 2004, BRIT J NUTR, V91, P11, DOI 10.1079/BJN20031015; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Winterstein AG, 2013, OTOLARYNG HEAD NECK, V148, P277, DOI 10.1177/0194599812471499; Wu CY, 2015, J APPL TOXICOL, V35, P273, DOI 10.1002/jat.3043; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861	53	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151557	10.1371/journal.pone.0151557	http://dx.doi.org/10.1371/journal.pone.0151557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974429	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600090
J	Hess, MK; Hess, AS; Garrick, DJ				Hess, Melanie K.; Hess, Andrew S.; Garrick, Dorian J.			The Effect of Calf Gender on Milk Production in Seasonal Calving Cows and Its Impact on Genetic Evaluations	PLOS ONE			English	Article							BIRTH-WEIGHT; SEXED SEMEN; DAIRY-COWS; CATTLE; LACTATION; YIELD; HOLSTEINS; ECONOMICS; HISTORY; RECORDS	Gender of the calf whose birth initiates lactation could influence whole lactation milk yield of the dam due to hormonal influences on mammary gland development, or through calf gender effects on gestation length. Fetal gender could influence late lactation yields because cows become pregnant at peak lactation. The effects of calf gender sequences in parities 1-3 were assessed by separately fitting animal models to datasets from New Zealand comprising 274 000 Holstein Friesian and 85 000 Jersey cows, decreasing to 12 000 and 4 000 cows by parity 3. The lactation initiated by the birth of a female rather than a male calf was associated with a 0.33-1.1% (p <= 0.05) higher milk yield. Female calf gender had carryover effects associated with higher milk yield in second lactations for Holstein Friesians (0.24%; p = 0.01) and third lactations for Jerseys (1.1%; p = 0.01). Cows giving birth to bull calves have 2 day longer gestations, which reduces lactation length in seasonal calving herds. Adding a covariate for lactation length to the animal model eroded some of these calf gender effects, such that calving a female led to higher milk yield only for second lactation Holstein Friesians (1.6%; p = 0.002). The interval centering method generates lower estimates of whole lactation yield when Wood's lactation curves are shifted to the right by 2 days for male calves and this explained the higher yield in female calves when differences in lactation length were considered. Correlations of estimated breeding values between models including or excluding calf gender sequence were 1.00 for bulls or cows. Calf gender primarily influences milk yield through increased gestation length of male calves, and bias associated with the interval centering method used to estimate whole lactation milk yields. Including information on calf gender is unlikely to have an effect on selection response in New Zealand dairy cattle.	[Hess, Melanie K.; Hess, Andrew S.; Garrick, Dorian J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Hess, Melanie K.] Livestock Improvement Corp, Hamilton, New Zealand; [Garrick, Dorian J.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	Iowa State University; Livestock Improvement Corporation; Massey University	Hess, MK (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA USA.; Hess, MK (corresponding author), Livestock Improvement Corp, Hamilton, New Zealand.	mhayr@lic.co.nz	Garrick, Dorian/P-9628-2019; Garrick, Dorian/Q-3239-2019	Garrick, Dorian/0000-0001-8640-5372; Hess, Melanie/0000-0002-7502-0036; Hess, Andrew/0000-0001-6738-3817	Iowa State University Foundation through the Jay L. Lush Chair in Animal Breeding and Genetics	Iowa State University Foundation through the Jay L. Lush Chair in Animal Breeding and Genetics	The project received no direct funding but authors were supported by the Iowa State University Foundation through the Jay L. Lush Chair in Animal Breeding and Genetics. Livestock Improvement Corporation (LIC) did not fund this project nor have any role in the study design, analysis, decision to publish or preparation of the manuscript. LIC undertakes artificial insemination, progeny testing and herd testing so most of the milk record data was collected by that organization. The specific roles of the authors arearticulated in the 'author contributions' section.	Adham IM, 2002, MOL ENDOCRINOL, V16, P244, DOI 10.1210/me.16.2.244; Alberghina D, 2015, ARCH TIERZUCHT, V58, P73, DOI 10.5194/aab-58-73-2015; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; [Anonymous], 2014, REPLICATION STUDY FR; Beavers L, 2014, IS SEX BIASED MILK P; Borchersen S, 2009, THERIOGENOLOGY, V71, P59, DOI 10.1016/j.theriogenology.2008.09.026; Bradford BJ, 2014, RE REPLICATION STUDY; Butler ST, 2014, ANIMAL, V8, P165, DOI 10.1017/S1751731114000664; Chegini A, 2015, SPAN J AGRIC RES, V13, DOI 10.5424/sjar/2015132-6320; CHEW BP, 1981, J DAIRY SCI, V64, P2401, DOI 10.3168/jds.S0022-0302(81)82863-9; Daly S E, 1995, J Hum Lact, V11, P21, DOI 10.1177/089033449501100119; DeJarnette JM, 2009, THERIOGENOLOGY, V71, P49, DOI 10.1016/j.theriogenology.2008.09.042; Dematawewa CMB, 1997, J DAIRY SCI, V80, P754, DOI 10.3168/jds.S0022-0302(97)75995-2; Elzhov TV, MINPACK LM R INTERFA; ERB RE, 1980, J ANIM SCI, V51, P143, DOI 10.2527/jas1980.511143x; Ettema JF, 2015, J DAIRY SCI, V98, P1078, DOI 10.3168/jds.2014-8774; Fitch J.B., 1924, J DAIRY SCI, V7, P222, DOI DOI 10.3168/JDS.S0022-0302(24)94016-1; Garner DL, 2008, THERIOGENOLOGY, V69, P886, DOI 10.1016/j.theriogenology.2008.01.006; GIANOLA D, 1974, J DAIRY SCI, V57, P235, DOI 10.3168/jds.S0022-0302(74)84864-2; Gilmour A. R., ASREML USER GUIDE RE; Graesboll K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124051; Guo Z, 2002, J DAIRY SCI, V85, P1596, DOI 10.3168/jds.S0022-0302(02)74230-6; Hadsell DL, 2004, ADV EXP MED BIOL, V554, P229; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Hinde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086169; Ivell R, 2002, BIOL REPROD, V67, P699, DOI 10.1095/biolreprod.102.005199; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Landete-Castillejos T, 2005, BEHAV ECOL SOCIOBIOL, V57, P267, DOI 10.1007/s00265-004-0848-8; PTAK E, 1993, LIVEST PROD SCI, V34, P23, DOI 10.1016/0301-6226(93)90033-E; Robert-Granie C, 1999, LIVEST PROD SCI, V60, P343, DOI 10.1016/S0301-6226(99)00105-0; SARGENT FD, 1968, J DAIRY SCI, V51, P170, DOI 10.3168/jds.S0022-0302(68)86943-7; Searle S.R., 1971, LINEAR MODELS; Seidel GE, 2007, THERIOGENOLOGY, V68, P443, DOI 10.1016/j.theriogenology.2007.04.005; Seidel GE, 2003, THERIOGENOLOGY, V59, P585, DOI 10.1016/S0093-691X(02)01242-6; Twigger AJ, 2015, SCI REPORTS, V5, P14; Weigel K. A., 2004, J DAIRY SCI, V87, pE120, DOI DOI 10.3168/JDS.S0022-0302(04)70067-3; WOOD PDP, 1967, NATURE, V216, P164, DOI 10.1038/216164a0	37	18	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151236	10.1371/journal.pone.0151236	http://dx.doi.org/10.1371/journal.pone.0151236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974166	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600056
J	Ma, GM; He, TP; Yu, Y; Duan, HF; Yang, CB				Ma, Guangming; He, Taiping; Yu, Yong; Duan, Haifeng; Yang, Chuangbo			Improving Image Quality of Bronchial Arteries with Virtual Monochromatic Spectral CT Images	PLOS ONE			English	Article							NONBRONCHIAL SYSTEMIC ARTERIES; ROW CT; ANGIOGRAPHY; EXPERIENCE; DIAGNOSIS	Objective To evaluate the clinical value of using monochromatic images in spectral CT pulmonary angiography to improve image quality of bronchial arteries. Methods We retrospectively analyzed the chest CT images of 38 patients who underwent contrast-enhanced spectral CT. These images included a set of 140kVp polychromatic images and the default 70keV monochromatic images. Using the standard Gemstone Spectral Imaging (GSI) viewer on an advanced workstation (AW4.6, GE Healthcare), an optimal energy level (in keV) for obtaining the best contrast-to-noise ratio (CNR) for the artery could be automatically obtained. The signal-to-noise ratio (SNR), CNR and objective image quality score (15) for these 3 image sets (140kVp, 70keV and optimal energy level) were obtained and, statistically compared. The image quality score consistency between the two observers was also evaluated using Kappa test. Results The optimal energy levels for obtaining the best CNR were 62.58 +/- 2.74keV. SNR and CNR from the 140kVp polychromatic, 70keV and optimal keV monochromatic images were (16.44 +/- 5.85, 13.24 +/- 5.52), (20.79 +/- 7.45, 16.69 +/- 6.27) and (24.9 +/- 9.91, 20.53 +/- 8.46), respectively. The corresponding subjective image quality scores were 1.97 +/- 0.82, 3.24 +/- 0.75, and 4.47 +/- 0.60. SNR, CNR and subjective scores had significant difference among groups (all p<0.001). The optimal keV monochromatic images were superior to the 70keV monochromatic and 140kVp polychromatic images, and there was high agreement between the two observers on image quality score (kappa>0.80). Conclusions Virtual monochromatic images at approximately 63keV in dual-energy spectral CT pulmonary angiography yielded the best CNR and highest diagnostic confidence for imaging bronchial arteries.	[Ma, Guangming; He, Taiping; Yu, Yong; Duan, Haifeng; Yang, Chuangbo] Shannxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Radiol, Xianyang City, Shaanxi, Peoples R China		He, TP (corresponding author), Shannxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Radiol, Xianyang City, Shaanxi, Peoples R China.	513119536@qq.com						Boe K, 2012, WATER SCI TECHNOL, V66, P2146, DOI 10.2166/wst.2012.438; Chenuel B, 2002, EUR RESPIR J, V20, P710, DOI 10.1183/09031936.02.00892001; Cui Y, 2012, BRIT J RADIOL, V85, pE887, DOI 10.1259/bjr/27844842; Fuchs TA, 2013, J CARDIOVASC COMPUT, V7, P25, DOI 10.1016/j.jcct.2013.01.004; Lin XZ, 2012, EUR J RADIOL, V81, P2487, DOI 10.1016/j.ejrad.2011.10.028; McCrum-Gardner E, 2008, BRIT J ORAL MAX SURG, V46, P38, DOI 10.1016/j.bjoms.2007.09.002; Murthy N, 2007, J BIOL CHEM, V282, P18254, DOI 10.1074/jbc.M701428200; Pinho DF, 2013, EUR RADIOL, V23, P351, DOI 10.1007/s00330-012-2624-x; Potretzke TA, 2015, RADIOLOGY, V275, P119, DOI 10.1148/radiol.14140875; Raju R, 2014, J CARDIOVASC COMPUT, V8, P282, DOI 10.1016/j.jcct.2014.06.003; Remy-Jardin M, 2004, RADIOLOGY, V233, P741, DOI 10.1148/radiol.2333040031; Tanaka Osamu, 2006, Diagn Interv Radiol, V12, P201; Yoon YC, 2005, RADIOLOGY, V234, P292, DOI 10.1148/radiol.2341032079; Zhao LQ, 2012, EUR J RADIOL, V81, P1677, DOI 10.1016/j.ejrad.2011.02.063	14	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150985	10.1371/journal.pone.0150985	http://dx.doi.org/10.1371/journal.pone.0150985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967737	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200026
J	McNarry, MA; Mackintosh, KA				McNarry, Melitta A.; Mackintosh, Kelly A.			Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis	PLOS ONE			English	Article							LONG-TERM REPRODUCIBILITY; FREQUENCY-DOMAIN; RELIABILITY; MORTALITY; EXERCISE; ADULTS; REST	Fundamental to the potential utilisation of heart rate variability (HRV) indices as a prognostic tool is the reproducibility of these measures. The purpose of the present study was therefore to investigate the reproducibility of 24-hour derived HRV indices in a clinical paediatric population. Eighteen children (10 boys; 12.4 +/- 2.8 years) with mild to moderate Cystic Fibrosis (CF; FVC: 83 +/- 12% predicted; FEV1: 80 +/- 9% predicted) and eighteen age-and sex-matched controls (10 boys; 12.5 +/- 2.7 years) wore a combined ECG and accelerometer for two consecutive days. Standard time and frequency domain indices of HRV were subsequently derived. Reproducibility was assessed by Bland-Altman plots, 95% limits of agreement and intra-class correlation coefficients (ICC). In both groups, there was no systematic difference between days, with the variables demonstrating a symmetrical, homoscedastic distribution around the zero line. The time domain parameters demonstrated a good to excellent reproducibility irrespective of the population considered (ICC: 0.56 to 0.86). In contrast, whilst the frequency domain parameters similarly showed excellent reproducibility in the healthy children (ICC: 0.70 to 0.96), the majority of the frequency domain parameters illustrated a poor to moderate reproducibility in those with CF (ICC: 0.22 to 0.43). The exceptions to this trend were the normalised LF and HF components which were associated with a good to excellent reproducibility. These findings thereby support the utilisation of time and relative frequency domain HRV indices as a prognostic tool in children with CF. Furthermore, the present results highlight the excellent reproducibility of HRV in healthy children, indicating that this may be a useful tool to assess intervention effectiveness in this population.	[McNarry, Melitta A.; Mackintosh, Kelly A.] Swansea Univ, Coll Engn, Swansea SA2 8PP, W Glam, Wales	Swansea University	McNarry, MA (corresponding author), Swansea Univ, Coll Engn, Swansea SA2 8PP, W Glam, Wales.	m.mcnarry@swansea.ac.uk	McNarry, Melitta/G-9032-2016; McNarry, Melitta/AAC-6899-2020	McNarry, Melitta/0000-0003-0813-7477; McNarry, Melitta/0000-0003-0813-7477; Mackintosh, Kelly/0000-0003-0355-6357				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ASMUSSEN E, 1968, ACTA PHYSIOL SCAND, V73, P527, DOI 10.1111/j.1365-201X.1968.tb10892.x; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Burger AJ, 1997, AM J CARDIOL, V80, P1198, DOI 10.1016/S0002-9149(97)00639-5; Camm AJ, 1996, CIRCULATION, V93, P1043; CASOLO G, 1989, AM J CARDIOL, V64, P1162, DOI 10.1016/0002-9149(89)90871-0; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; DAVIS PB, 1983, J CHRON DIS, V36, P269, DOI 10.1016/0021-9681(83)90062-0; DAVIS PB, 1978, PEDIATR RES, V12, P703, DOI 10.1203/00006450-197806000-00005; Department of Health PAHIaP, 2011, START ACT STAY ACT R; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Florencio R, 2013, BRAZ J PHYS THER, V17, P419, DOI 10.1590/S1413-35552012005000109; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Konrady A O, 2001, Med Sci Monit, V7, P58; Leicht AS, 2008, BRAZ J MED BIOL RES, V41, P627, DOI 10.1590/S0100-879X2008000700013; Lord SW, 2001, CLIN SCI, V100, P43, DOI 10.1042/CS20000111; MALIK M, 1990, CLIN CARDIOL, V13, P570, DOI 10.1002/clc.4960130811; McNarry MA, 2012, PHYSIOL MEAS, V33, P1123, DOI 10.1088/0967-3334/33/7/1123; Nolan J, 1996, AM J CARDIOL, V77, P154, DOI 10.1016/S0002-9149(96)90587-1; PAGANI M, 1988, J AUTONOM NERV SYST, V23, P143, DOI 10.1016/0165-1838(88)90078-1; Perandini LA, 2009, REV BRAS CIN DES HUM, V12, P8; Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055; Pitzalis MV, 1996, CARDIOVASC RES, V32, P226, DOI 10.1016/0008-6363(96)00086-7; Rich C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067206; Sandercock GRH, 2004, CLIN PHYSIOL FUNCT I, V24, P359, DOI 10.1111/j.1475-097X.2004.00584.x; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; Stanojevic S, 2009, AM J RESP CRIT CARE, V180, P547, DOI 10.1164/rccm.200903-0323OC; STEIN PK, 1995, AM HEART J, V129, P975, DOI 10.1016/0002-8703(95)90119-1; Szollosi I, 2011, INTERN MED J, V41, P455, DOI 10.1111/j.1445-5994.2009.02039.x; WATKINS PJ, 1980, ANN INTERN MED, V92, P304, DOI 10.7326/0003-4819-92-2-304; Winsley R, 2002, PEDIATR EXERC SCI, V14, P328, DOI 10.1123/pes.14.4.328; Ziegler D, 1999, HORM METAB RES, V31, P672, DOI 10.1055/s-2007-978819; ZUANETTI G, 1991, J AM COLL CARDIOL, V17, P604, DOI 10.1016/S0735-1097(10)80172-X	34	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151464	10.1371/journal.pone.0151464	http://dx.doi.org/10.1371/journal.pone.0151464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968039	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200056
J	Zhang, L; Ma, T; Brozick, J; Babalola, K; Budiu, R; Tseng, G; Vlad, AM				Zhang, L.; Ma, T.; Brozick, J.; Babalola, K.; Budiu, R.; Tseng, G.; Vlad, A. M.			Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer	ONCOGENE			English	Article							K-RAS; DISTANT METASTASES; MOUSE MODEL; CELL-LINES; EXPRESSION; CARCINOMA; IMMUNOBIOLOGY; INHIBITION; MUTATIONS; ONCOGENE	Mucin1 (MUC1) is an epithelial glycoprotein overexpressed in ovarian cancer and actively involved in tumor cell migration and metastasis. Using novel in vitro and in vivo MUC1-expressing conditional (Cre-loxP) ovarian tumor models, we focus here on MUC1 biology and the roles of Kras activation and Pten deletion during cell transformation and epithelial-to-mesenchymal transition (EMT). We generated several novel murine ovarian cancer cell lines derived from the ovarian surface epithelia (OSE) of mice with conditional mutations in Kras, Pten or both. In addition, we also generated several tumor-derived new cell lines that reproduce the original tumor phenotype in vivo and mirror late stage metastatic disease. Our results demonstrate that de novo activation of oncogenic Kras does not trigger increased proliferation, cellular transformation or EMT, and prevents MUC1 upregulation. In contrast, Pten deletion accelerates cell proliferation, triggers cellular transformation in vitro and in vivo, and stimulates MUC1 expression. Ovarian tumor-derived cell lines MKP-Liver and MKP-Lung cells reproduce in vivo EMT and represent the first immune competent mouse model for distant hematogenous spread. Whole genome microarray expression analysis using tumor and OSE-derived cell lines reveal a 121 gene signature associated with EMT and metastasis. When applied to n = 542 cases from The Cancer Genome Atlas (TCGA) ovarian cancer dataset, the gene signature identifies a patient subset with decreased survival (P = 0.04). Using an extensive collection of novel murine cell lines we have identified distinct roles for Kras and Pten on MUC1 and EMT in vivo and in vitro. The data has implications for future design of combination therapies targeting Kras mutations, Pten deletions and MUC1 vaccines.	[Zhang, L.; Babalola, K.; Budiu, R.; Vlad, A. M.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, B403,204 Craft Ave, Pittsburgh, PA 15213 USA; [Zhang, L.; Brozick, J.; Budiu, R.; Vlad, A. M.] Magee Womens Res Inst, B403,204 Craft Ave, Pittsburgh, PA 15213 USA; [Ma, T.; Tseng, G.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vlad, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, B403,204 Craft Ave, Pittsburgh, PA 15213 USA.; Vlad, AM (corresponding author), Magee Womens Res Inst, B403,204 Craft Ave, Pittsburgh, PA 15213 USA.	vladam@upmc.edu	Brozick, Joan/AAA-5785-2019; Ma, Tianzhou/AAC-8221-2021	Ma, Tianzhou/0000-0003-3605-0811	Department of Defense (DOD) Ovarian Cancer Academy Award [W81XWH-10-1-0525]; NIH/NCI [R01 CA163462]; NIH; NATIONAL CANCER INSTITUTE [R01CA163462] Funding Source: NIH RePORTER	Department of Defense (DOD) Ovarian Cancer Academy Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partly supported by the Department of Defense (DOD) Ovarian Cancer Academy Award W81XWH-10-1-0525 and NIH/NCI R01 CA163462 (to AMV). Dr Vlad's work has been funded by the NIH.	Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Budiu RA, 2013, ONCOGENE, V32, P3664, DOI 10.1038/onc.2012.397; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carson DD, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127pe35; Cormio G, 2003, INT J GYNECOL CANCER, V13, P125, DOI 10.1046/j.1525-1438.2003.13054.x; DAUPLAT J, 1987, CANCER-AM CANCER SOC, V60, P1561, DOI 10.1002/1097-0142(19871001)60:7<1561::AID-CNCR2820600725>3.0.CO;2-V; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; Deng JL, 2013, CANCER METAST REV, V32, P535, DOI 10.1007/s10555-013-9423-y; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dong Y, 1997, J PATHOL, V183, P311, DOI 10.1002/(SICI)1096-9896(199711)183:3<311::AID-PATH917>3.0.CO;2-2; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Hasan N, 2015, TRANSL CANCER RES, V4, P14, DOI 10.3978/j.issn.2218-676X.2015.01.02; Horlings HM, 2015, J PATHOL, V236, P397, DOI 10.1002/path.4542; Horlings HM, 2015, JAMA ONCOL, V1, P275, DOI 10.1001/jamaoncol.2015.35; Huang J, 2011, GENE CHROMOSOME CANC, V50, P606, DOI 10.1002/gcc.20883; Ince TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8419; Iwanaga K, 2008, CANCER RES, V68, P1119, DOI 10.1158/0008-5472.CAN-07-3117; Jain N, 2014, CLIN CANCER RES, V20, P490, DOI 10.1158/1078-0432.CCR-13-1311; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kandil E, 2013, J SURG RES, V184, P898, DOI 10.1016/j.jss.2013.03.052; KERR VE, 1985, CANCER, V56, P1209, DOI 10.1002/1097-0142(19850901)56:5<1209::AID-CNCR2820560542>3.0.CO;2-Y; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Maione P, 2013, REV RECENT CLIN TRIA, V8, P93, DOI 10.2174/15748871113089990047; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; MIZUUCHI H, 1995, CANCER, V76, P86, DOI 10.1002/1097-0142(19950701)76:1<86::AID-CNCR2820760112>3.0.CO;2-L; Nick AM, 2015, NAT REV CLIN ONCOL, V12, P239, DOI 10.1038/nrclinonc.2015.26; Obata K, 1998, CANCER RES, V58, P2095; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Roh MH, 2010, MODERN PATHOL, V23, P1316, DOI 10.1038/modpathol.2010.119; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Vlad AM, 2004, ADV IMMUNOL, V82, P249, DOI 10.1016/S0065-2776(04)82006-6; Wang L, 2007, GYNECOL ONCOL, V105, P695, DOI 10.1016/j.ygyno.2007.02.004; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Zhang LX, 2013, CANCER IMMUNOL IMMUN, V62, P423, DOI 10.1007/s00262-012-1325-2	45	15	15	0	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 22	2016	35	38					5010	5020		10.1038/onc.2016.53	http://dx.doi.org/10.1038/onc.2016.53			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW9GT	26973247	Green Accepted			2022-12-26	WOS:000383965300005
J	Morioka, S; Sai, K; Omori, E; Ikeda, Y; Matsumoto, K; Ninomiya-Tsuji, J				Morioka, S.; Sai, K.; Omori, E.; Ikeda, Y.; Matsumoto, K.; Ninomiya-Tsuji, J.			TAK1 regulates hepatic lipid homeostasis through SREBP	ONCOGENE			English	Article							ELEMENT-BINDING PROTEINS; IL-1 SIGNALING PATHWAY; MTOR COMPLEX 1; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; DEPENDENT DEGRADATION; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; CANCER DEVELOPMENT; ADIPOSE-TISSUE	Sterol-regulatory element-binding proteins (SREBPs) are key transcription factors regulating cholesterol and fatty acid biosynthesis. SREBP activity is tightly regulated to maintain lipid homeostasis, and is modulated upon extracellular stimuli such as growth factors. While the homeostatic SREBP regulation is well studied, stimuli-dependent regulatory mechanisms are still elusive. Here we demonstrate that SREBPs are regulated by a previously uncharacterized mechanism through transforming growth factor-beta activated kinase 1 (TAK1), a signaling molecule of inflammation. We found that TAK1 binds to and inhibits mature forms of SREBPs. In an in vivo setting, hepatocyte-specific Tak1 deletion upregulates liver lipid deposition and lipogenic enzymes in the mouse model. Furthermore, hepatic Tak1 deficiency causes steatosis pathologies including elevated blood triglyceride and cholesterol levels, which are established risk factors for the development of hepatocellular carcinoma (HCC) and are indeed correlated with Tak1-deficiency-induced HCC development. Pharmacological inhibition of SREBPs alleviated the steatosis and reduced the expression level of the HCC marker gene in the Tak1-deficient liver. Thus, TAK1 regulation of SREBP critically contributes to the maintenance of liver homeostasis to prevent steatosis, which is a potentially important mechanism to prevent HCC development.	[Morioka, S.; Sai, K.; Omori, E.; Ikeda, Y.; Ninomiya-Tsuji, J.] North Carolina State Univ, Dept Biol Sci, Campus Box 7633,850 Main Campus Dr, Raleigh, NC 27695 USA; [Sai, K.; Matsumoto, K.] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi, Japan; [Morioka, S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	University of North Carolina; North Carolina State University; Nagoya University; University of Virginia	Morioka, S; Ninomiya-Tsuji, J (corresponding author), North Carolina State Univ, Dept Biol Sci, Campus Box 7633,850 Main Campus Dr, Raleigh, NC 27695 USA.; Morioka, S (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	sm9ss@virginia.edu; Jun_Tsuji@ncsu.edu	Morioka, Sho/I-2074-2019	Morioka, Sho/0000-0002-1153-4919; Ninomiya-Tsuji, Jun/0000-0002-5584-0176; Ikeda-Iwabu, Yuka/0000-0003-3550-7891	National Institutes of Health [GM068812]; Grants-in-Aid for Scientific Research [26112706] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112986, R01GM068812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NC State biological animal facility for technical support, Dr Akira for Tak1-loxed mice and Simmons, A. for critical reading. This work was supported by National Institutes of Health Grant GM068812 (to JNT).	Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Braeuning A, 2006, TOXICOLOGY, V227, P127, DOI 10.1016/j.tox.2006.07.024; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Ikeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088037; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Inokuchi-Shimizu S, 2014, J CLIN INVEST, V124, P3566, DOI 10.1172/JCI74068; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mihaly SR, 2014, CELL DEATH DIFFER, V21, P1667, DOI 10.1038/cdd.2014.123; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Morioka S, 2009, ONCOGENE, V28, P2257, DOI 10.1038/onc.2009.110; Morioka S, 2014, J CELL BIOL, V204, P607, DOI 10.1083/jcb.201305070; Morioka S, 2012, BLOOD, V120, P3846, DOI 10.1182/blood-2012-03-416198; Nakayama H, 2007, METABOLISM, V56, P470, DOI 10.1016/j.metabol.2006.11.004; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ringseis R, 2013, MOL ENDOCRINOL, V27, P781, DOI 10.1210/me.2012-1269; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Sohda T, 1998, J HUM GENET, V43, P49, DOI 10.1007/s100380050036; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Sundqvist A, 2003, P NATL ACAD SCI USA, V100, P13833, DOI 10.1073/pnas.2335135100; Tacer KF, 2007, PHYSIOL GENOMICS, V31, P216, DOI 10.1152/physiolgenomics.00264.2006; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhang L, 2013, CARCINOGENESIS, V34, P577, DOI 10.1093/carcin/bgs381	70	19	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3829	3838		10.1038/onc.2015.453	http://dx.doi.org/10.1038/onc.2015.453			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26973245	Green Accepted			2022-12-26	WOS:000380753200008
J	Pang, QX; Gao, LL; Hu, WJ; An, Y; Deng, HK; Zhang, YC; Sun, XW; Zhu, GZ; Liu, BH; Zhao, BS				Pang, Qiuxiang; Gao, Lili; Hu, Wenjing; An, Yang; Deng, Hongkuan; Zhang, Yichao; Sun, Xiaowen; Zhu, Guangzhong; Liu, Baohua; Zhao, Bosheng			De Novo Transcriptome Analysis Provides Insights into Immune Related Genes and the RIG-I-Like Receptor Signaling Pathway in the Freshwater Planarian (Dugesia japonica)	PLOS ONE			English	Article							NF-KAPPA-B; MOLECULAR CHARACTERIZATION; FUNCTIONAL GENOMICS; ADAPTER PROTEIN; INNATE IMMUNITY; CDNA CLONING; SYSTEM; REGENERATION; HOMOLOG; BETA	Background The freshwater planarian Dugesia japonica (D. japonica) possesses extraordinary ability to regenerate lost organs or body parts. Interestingly, in the process of regeneration, there is little wound infection, suggesting that D. japonica has a formidable innate immune system. The importance of immune system prompted us to search for immune-related genes and RIG-I-like receptor signaling pathways. Results Transcriptome sequencing of D. japonica was performed on an IlluminaHiSeq2000 platform. A total of 27,180 transcripts were obtained by Trinity assembler. CEGMA analysis and mapping of all trimmed reads back to the assembly result showed that our transcriptome assembly covered most of the whole transcriptome. 23,888 out of 27,180 transcripts contained ORF (open reading fragment), and were highly similar to those in Schistosoma mansoni using BLASTX analysis. 8,079 transcripts (29.7%) and 8,668 (31.9%) were annotated by Blast2GO and KEGG respectively. A DYNLRB-like gene was cloned to verify its roles in the immune response. Finally, the expression patterns of 4 genes (RIG-I, TRAF3, TRAF6, P38) in the RIG-I-like receptor signaling pathway were detected, and the results showed they are very likely to be involved in planarian immune response. Conclusion RNA-Seq analysis based on the next-generation sequencing technology was an efficient approach to discover critical genes and to understand their corresponding biological functions. Through GO and KEGG analysis, several critical and conserved signaling pathways and genes related to RIG-I-like receptor signaling pathway were identified. Four candidate genes were selected to identify their expression dynamics in the process of pathogen stimulation. These annotated transcripts of D. japonica provide a useful resource for subsequent investigation of other important pathways.	[Pang, Qiuxiang; Gao, Lili; Hu, Wenjing; Deng, Hongkuan; Zhang, Yichao; Sun, Xiaowen; Zhu, Guangzhong; Zhao, Bosheng] Shandong Univ Technol, Sch Life Sci, Lab Dev & Evolutionary Biol, Zibo 255049, Peoples R China; [Pang, Qiuxiang; Gao, Lili; Hu, Wenjing; Deng, Hongkuan; Liu, Baohua] Shandong Univ Technol, Sch Life Sci, Antiaging & Regenerat Med Res Inst, Zibo 255049, Peoples R China; [An, Yang] Immolife Biotech Co Ltd, Nanjing 210000, Jiangsu, Peoples R China; [Liu, Baohua] Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China	Shandong University of Technology; Shandong University of Technology; Shenzhen University	Zhao, BS (corresponding author), Shandong Univ Technol, Sch Life Sci, Lab Dev & Evolutionary Biol, Zibo 255049, Peoples R China.; Liu, BH (corresponding author), Shandong Univ Technol, Sch Life Sci, Antiaging & Regenerat Med Res Inst, Zibo 255049, Peoples R China.; Liu, BH (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China.	ppliew@szu.edu.cn; zhaobosheng@sdut.edu.cn	Liu, Baohua/AAH-3685-2020	Liu, Baohua/0000-0002-1599-8059	National Natural Science Foundation of China [31172074, 30700071, 31572263]; Shandong Provincial Natural Science Foundation [ZR2010CL002]; Educational Commission of Shandong Province for University Excellent Teacher of International Cooperation Training Project, Young Teacher Support Program in Shandong University of Technology; Immolife-biotech Co. Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Educational Commission of Shandong Province for University Excellent Teacher of International Cooperation Training Project, Young Teacher Support Program in Shandong University of Technology; Immolife-biotech Co. Ltd.	This work was supported by the National Natural Science Foundation of China (Grant Numbers 31172074, 30700071, 31572263), the Shandong Provincial Natural Science Foundation (Grant Number ZR2010CL002), the Educational Commission of Shandong Province for University Excellent Teacher of International Cooperation Training Project, Young Teacher Support Program in Shandong University of Technology and the Immolife-biotech Co. Ltd. The funder from Immolife-biotech Co. Ltd. only provided support in the form of salaries for Yang An, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abnave P, 2014, CELL HOST MICROBE, V16, P338, DOI 10.1016/j.chom.2014.08.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Baguna J., 1988, Progress in Zoology, V36, P65; Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P205, DOI 10.1016/S0145-305X(00)00057-4; Bowman AB, 1999, J CELL BIOL, V146, P165; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Feng H, 2011, FISH SHELLFISH IMMUN, V30, P1159, DOI 10.1016/j.fsi.2011.03.002; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Forsthoefel DJ, 2009, CURR OPIN GENET DEV, V19, P412, DOI 10.1016/j.gde.2009.05.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Handberg-Thorsager M, 2008, FRONT BIOSCI-LANDMRK, V13, P6374, DOI 10.2741/3160; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang BY, 2014, MOL BIOL REP, V41, P6481, DOI 10.1007/s11033-014-3531-9; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Jin QY, 2012, MOL CELL ENDOCRINOL, V348, P233, DOI 10.1016/j.mce.2011.08.029; Johansson MW, 1999, DEV COMP IMMUNOL, V23, P303, DOI 10.1016/S0145-305X(99)00013-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kwon ES, 2010, NATURE, V466, P498, DOI 10.1038/nature09184; Lan JF, 2013, DEV COMP IMMUNOL, V41, P608, DOI 10.1016/j.dci.2013.07.004; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Li YW, 2014, DEV COMP IMMUNOL, V44, P217, DOI 10.1016/j.dci.2013.12.011; Liang YJ, 2011, FISH SHELLFISH IMMUN, V31, P963, DOI 10.1016/j.fsi.2011.08.014; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo T, 2006, DEV COMP IMMUNOL, V30, P607, DOI 10.1016/j.dci.2005.10.004; Mao M, 1996, P NATL ACAD SCI USA, V93, P5910, DOI 10.1073/pnas.93.12.5910; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mialhe E, 1995, MOL MAR BIOL BIOTECH, V4, P275; Mikkelsen SS, 2009, J BIOL CHEM, V284, P10774, DOI 10.1074/jbc.M807272200; Morita K, 2002, EMBO J, V21, P1063, DOI 10.1093/emboj/21.5.1063; Nie L, 2015, DEV COMP IMMUNOL, V48, P95, DOI 10.1016/j.dci.2014.09.008; Pang QX, 2010, COMP BIOCHEM PHYS B, V157, P54, DOI 10.1016/j.cbpb.2010.05.002; Peiris TH, 2014, SEMIN IMMUNOL, V26, P295, DOI 10.1016/j.smim.2014.06.005; Petersen CP, 2014, CELL HOST MICROBE, V16, P271, DOI 10.1016/j.chom.2014.08.016; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Salo E, 2006, BIOESSAYS, V28, P546, DOI 10.1002/bies.20416; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SODERHALL K, 1994, ANN NY ACAD SCI, V712, P155, DOI 10.1111/j.1749-6632.1994.tb33570.x; Su ZQ, 2011, EXPERT REV MOL DIAGN, V11, P333, DOI [10.1586/ERM.11.3, 10.1586/erm.11.3]; Tseng IT, 2004, FISH SHELLFISH IMMUN, V17, P325, DOI 10.1016/j.fsi.2004.04.010; Wang H, 2007, MOL IMMUNOL, V44, P722, DOI 10.1016/j.molimm.2006.04.015; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang JL, 2011, NAT PRODUCT BIOPROSP, V1, P1, DOI 10.1007/s13659-011-0003-y; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Young JAT, 2004, P NATL ACAD SCI USA, V101, P12781, DOI 10.1073/pnas.0404890101; Zeng A, 2013, J CELL BIOL, V201, P409, DOI 10.1083/jcb.201207172; Zhai YJ, 2015, DEV COMP IMMUNOL, V49, P1, DOI 10.1016/j.dci.2014.11.006; Zhang Y, 2014, FISH SHELLFISH IMMUN, V40, P466, DOI 10.1016/j.fsi.2014.07.029	63	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151597	10.1371/journal.pone.0151597	http://dx.doi.org/10.1371/journal.pone.0151597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986572	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300092
J	Roy, HE; Baxter, E; Saunders, A; Pocock, MJO				Roy, Helen E.; Baxter, Elizabeth; Saunders, Aoine; Pocock, Michael J. O.			Focal Plant Observations as a Standardised Method for Pollinator Monitoring: Opportunities and Limitations for Mass Participation Citizen Science	PLOS ONE			English	Article							BIOLOGICAL RECORDS CENTER; EMERGING TECHNOLOGIES; ECOLOGICAL RESEARCH; DECLINES; GARDENS; SCALE; TOOL; CONSERVATION; COMMUNITIES; BUMBLEBEES	Background Recently there has been increasing focus on monitoring pollinating insects, due to concerns about their declines, and interest in the role of volunteers in monitoring pollinators, particularly bumblebees, via citizen science. Methodology / Principal Findings The Big Bumblebee Discovery was a one-year citizen science project run by a partnership of EDF Energy, the British Science Association and the Centre for Ecology & Hydrology which sought to assess the influence of the landscape at multiple scales on the diversity and abundance of bumblebees. Timed counts of bumblebees (Bombus spp.; identified to six colour groups) visiting focal plants of lavender (Lavendula spp.) were carried out by about 13 000 primary school children (7-11 years old) from over 4000 schools across the UK. 3948 reports were received totalling 26 868 bumblebees. We found that while the wider landscape type had no significant effect on reported bumblebee abundance, the local proximity to flowers had a significant effect (fewer bumblebees where other flowers were reported to be >5m away from the focal plant). However, the rate of mis-identifcation, revealed by photographs uploaded by participants and a photo-based quiz, was high. Conclusions / Significance Our citizen science results support recent research on the importance of local flocal resources on pollinator abundance. Timed counts of insects visiting a lure plant is potentially an effective approach for standardised pollinator monitoring, engaging a large number of participants with a simple protocol. However, the relatively high rate of mis-identifications (compared to reports from previous pollinator citizen science projects) highlights the importance of investing in resources to train volunteers. Also, to be a scientifically valid method for enquiry, citizen science data needs to be sufficiently high quality, so receiving supporting evidence (such as photographs) would allow this to be tested and for records to be verified.	[Roy, Helen E.; Pocock, Michael J. O.] Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England; [Baxter, Elizabeth; Saunders, Aoine] British Sci Assoc, Wellcome Wolfson Bldg,165 Queens Gate, London SW7 5HD, England	UK Centre for Ecology & Hydrology (UKCEH)	Roy, HE (corresponding author), Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	hele@ceh.ac.uk	Pocock, Michael/A-5632-2012; Roy, Helen/A-1488-2010	Pocock, Michael/0000-0003-4375-0445; 	EDF Energy; Joint Nature Conservation Committee; Natural Environment Research Council; NERC [ceh020002, ceh020009] Funding Source: UKRI; Natural Environment Research Council [ceh020009, ceh020002] Funding Source: researchfish	EDF Energy; Joint Nature Conservation Committee; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	EDF Energy provided financial support to the British Science Association who subcontracted the Centre for Ecology & Hydrology. The Centre for Ecology & Hydrology led the study design, data collection and analysis, decision to publish and preparation of the manuscript. EDF Energy and the British Science Association played a major role in recruiting participants through their web portals and networks. Additionally educational resources were developed by EDF Energy in consultation with the authors. The authors reviewed all the resources prior to publication. Inclusion of additional insect flower visitors beyond bumblebees, such as the honeybee, Apis mellifera, and stripey hoverflies, was considered but the design of the log book constrained the number of fields. The infrastructure of the EDF Energy web portal "The Pod" was used to disseminate the educational resources and for on-line data collection. The British Science Association are represented within the authorship in recognition of their contributions throughout the study. One of the aims of the study was to submit a manuscript for peer-review and this was disclosed within the subcontract to the Centre for Ecology & Hydrology. HER and MJOP through the Biological Records Centre receive support from the Joint Nature Conservation Committee and the Natural Environment Research Council.	August T, 2015, BIOL J LINN SOC, V115, P731, DOI 10.1111/bij.12534; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Ball S.G., 2011, ATLAS HOVERFLIES GRE; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Birkin L, 2015, ECOL ENTOMOL, V40, P3, DOI 10.1111/een.12227; Bonney R, 2009, PUBLIC PARTICIPATION; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Crall AW, 2010, BIOL INVASIONS, V12, P3419, DOI 10.1007/s10530-010-9740-9; Defra, 2014, NAT POLL STRAT BEES; Defra, 2015, UK BIOD IND; DEFRA, 2011, NAT CHOIC SEC VAL NA; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; FUSSELL M, 1992, J APPL ECOL, V29, P451, DOI 10.2307/2404513; Garbuzov M, 2015, ACTA OECOL, V62, P53, DOI 10.1016/j.actao.2014.12.002; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Goulson Dave, 2001, British Journal of Entomology and Natural History, V14, P129; Goulson D, 2011, J APPL ECOL, V48, P3, DOI 10.1111/j.1365-2664.2010.01929.x; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Levrel H, 2010, ECOL ECON, V69, P1580, DOI 10.1016/j.ecolecon.2010.03.001; Losey JE, 2007, J INSECT CONSERV, V11, P415, DOI 10.1007/s10841-007-9077-6; Lye GC, 2012, J INSECT CONSERV, V16, P697, DOI 10.1007/s10841-011-9450-3; Mackechnie C, 2011, J ENVIRON MONITOR, V13, P2687, DOI 10.1039/c1em10615e; MARDEN JH, 1981, PHYSIOL ENTOMOL, V6, P431, DOI 10.1111/j.1365-3032.1981.tb00658.x; Mason SC, 2015, BIOL J LINN SOC, V115, P586, DOI 10.1111/bij.12574; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Nov O, 2011, ICONFERENCE SEATTLE2; Oberhauser K, 2012, FRONT ECOL ENVIRON, V10, P318, DOI 10.1890/110274; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Pescott OL, 2015, BIOL J LINN SOC, V115, P611, DOI 10.1111/bij.12541; Phillips AL, 2008, AM SCI, V96, P375, DOI 10.1511/2008.74.375; Pocock MJO, 2015, BIOL J LINN SOC, V115, P475, DOI 10.1111/bij.12548; Pocock MJO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086226; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Powney GD, 2015, BIOL J LINN SOC, V115, P532, DOI 10.1111/bij.12517; Pywell RF, 2012, BIOL LETTERS, V8, P772, DOI 10.1098/rsbl.2012.0367; Roy D. B., 2014, CELEBRATING 50 YEARS; Roy H., 2011, LADYBIRDS COCCINELLI; Roy HE, UNDERSTANDING CITIZE; Roy HE, 2015, ECOL ENTOMOL, V40, P336, DOI 10.1111/een.12203; Roy HE, 2015, BIOL J LINN SOC, V115, P678, DOI 10.1111/bij.12518; Roy HE, 2015, BIOL J LINN SOC, V115, P469, DOI 10.1111/bij.12575; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Scheper J, 2015, J APPL ECOL, V52, P1165, DOI 10.1111/1365-2664.12479; Silvertown J, 2015, ZOOKEYS, P125, DOI 10.3897/zookeys.480.8803; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Stewart AJA, 2015, BIOL J LINN SOC, V115, P647, DOI 10.1111/bij.12543; Thomas JA, 2015, BIOL J LINN SOC, V115, P636, DOI 10.1111/bij.12527; UK Environmental Observation Framework, 2011, CIT SCI OBS MON SCOP; Woodcock BA, 2013, AGR ECOSYST ENVIRON, V171, P1, DOI 10.1016/j.agee.2013.03.005; Worthington JP, 2012, METHODS ECOL EVOL, V3, P303, DOI 10.1111/j.2041-210X.2011.00164.x	59	28	29	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150794	10.1371/journal.pone.0150794	http://dx.doi.org/10.1371/journal.pone.0150794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985824	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300027
J	Sergeant, ES; Grewar, JD; Weyer, CT; Guthrie, AJ				Sergeant, Evan S.; Grewar, John D.; Weyer, Camilla T.; Guthrie, Alan J.			Quantitative Risk Assessment for African Horse Sickness in Live Horses Exported from South Africa	PLOS ONE			English	Article							VIRUS; ASSAY	5 African horse sickness (AHS) is a severe, often fatal, arbovirus infection of horses, transmitted by Culicoides spp. midges. AHS occurs in most of sub-Saharan Africa and is a significant impediment to export of live horses from infected countries, such as South Africa. A stochastic risk model was developed to estimate the probability of exporting an undetected AHS-infected horse through a vector protected pre-export quarantine facility, in accordance with OIE recommendations for trade from an infected country. The model also allows for additional risk management measures, including multiple PCR tests prior to and during pre-export quarantine and optionally during post-arrival quarantine, as well as for comparison of risk associated with exports from a demonstrated low-risk area for AHS and an area where AHS is endemic. If 1 million horses were exported from the low-risk area with no post-arrival quarantine we estimate the median number of infected horses to be 5.4 (95% prediction interval 0.5 to 41). This equates to an annual probability of 0.0016 (95% PI: 0.00015 to 0.012) assuming 300 horses exported per year. An additional PCR test while in vector-protected post-arrival quarantine reduced these probabilities by approximately 12-fold. Probabilities for horses exported from an area where AHS is endemic were approximately 15 to 17 times higher than for horses exported from the low-risk area under comparable scenarios. The probability of undetected AHS infection in horses exported from an infected country can be minimised by appropriate risk management measures. The final choice of risk management measures depends on the level of risk acceptable to the importing country.	[Sergeant, Evan S.] AusVet Anim Hlth Serv, Canberra, ACT, Australia; [Grewar, John D.] Western Cape Dept Agr, Vet Serv, Elsenburg, South Africa; [Weyer, Camilla T.; Guthrie, Alan J.] Univ Pretoria, Equine Res Ctr, Fac Vet Sci, ZA-0002 Pretoria, South Africa	University of Pretoria	Sergeant, ES (corresponding author), AusVet Anim Hlth Serv, Canberra, ACT, Australia.	evan@ausvet.com.au	Guthrie, Alan/J-6375-2013	Guthrie, Alan/0000-0001-7729-9918; Grewar, John/0000-0002-4496-8051	Equine Health Fund of South Africa, a division of Wits Health Consortium (Pty) Ltd; South African horse industry through the Equine Equine Health Fund; AusVet Animal Health Services	Equine Health Fund of South Africa, a division of Wits Health Consortium (Pty) Ltd; South African horse industry through the Equine Equine Health Fund; AusVet Animal Health Services	The participation of ES in this research was funded by private donors through the Equine Health Fund of South Africa, a division of Wits Health Consortium (Pty) Ltd (http://www.equinehealthfund.co.za/Home.aspx). The Equine Research Centre is supported by South African horse industry funding, through the Equine Health Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ES is employed by AusVet Animal Health Services. AusVet Animal Health Services provided support in the form of salary for author ES, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aguero M, 2008, J VET DIAGN INVEST, V20, P325, DOI 10.1177/104063870802000310; Alexander J, 2008, EFSA J, V6; [Anonymous], 2014, R LANG ENV STAT COMP; Coetzer J., 2004, INFECT DIS LIVESTOCK; de Vos CJ, 2012, PREV VET MED, V106, P108, DOI 10.1016/j.prevetmed.2012.01.019; Faverjon C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0435-4; Grewar J. D., 2013, J S AFR VET ASSOC, V84, DOI DOI 10.4102/jsava.v84i1.973; Guthrie AJ, 2013, J VIROL METHODS, V189, P30, DOI 10.1016/j.jviromet.2012.12.014; Guthrie AJ, 2009, VACCINE, V27, P4434, DOI 10.1016/j.vaccine.2009.05.044; Lee CCD, 2014, J VIROL, V88, P5677, DOI 10.1128/JVI.00139-14; Maja M, 2014, STANDARD REGISTRATIO; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; Nomikou K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005056; OIE, 2012, MANUAL DIAGNOSTIC TE; OiE, 2015, OIE LIST DIS INF INF; OIE, 2013, OIE TECHNICAL DIS CA; OIE World Organisation for Animal Health, 2014, TERR AN HLTH COD; OIE (World Organization for Animal Health), 2014, MAN DIAGN TESTS VACC; Page PC, 2015, VET PARASITOL, V210, P84, DOI 10.1016/j.vetpar.2015.02.007; Sergeant E, 2013, EPITOOLS EPIDEMIOLOG; Sinclair M, 2006, J S AFR VET ASSOC, V77, P191; Weyer CT, 2013, EQUINE VET J, V45, P117, DOI 10.1111/j.2042-3306.2012.00590.x	22	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151757	10.1371/journal.pone.0151757	http://dx.doi.org/10.1371/journal.pone.0151757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986002	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300124
J	Di Sanzo, M; Aversa, I; Santamaria, G; Gagliardi, M; Panebianco, M; Biamonte, F; Zolea, F; Faniello, MC; Cuda, G; Costanzo, F				Di Sanzo, Maddalena; Aversa, Ilenia; Santamaria, Gianluca; Gagliardi, Monica; Panebianco, Mariafranca; Biamonte, Flavia; Zolea, Fabiana; Faniello, Maria Concetta; Cuda, Giovanni; Costanzo, Francesco			FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation	PLOS ONE			English	Article							GENE; CLONING; CHAIN	Ferritin, the major iron storage protein, performs its essential functions in the cytoplasm, nucleus and mitochondria. The variable assembly of 24 subunits of the Heavy (H) and Light (L) type composes the cytoplasmic molecule. In humans, two distinct genes code these subunits, both belonging to complex multigene families. Until now, one H gene has been identified with the coding sequence interrupted by three introns and more than 20 intronless copies widely dispersed on different chromosomes. Two of the intronless genes are actively transcribed in a tissue-specific manner. Herein, we report that FTH1P3, another intronless pseudogene, is transcribed. FTH1P3 transcript was detected in several cell lines and tissues, suggesting that its transcription is ubiquitary, as it happens for the parental ferritin H gene. Moreover, FTH1P3 expression is positively regulated during the cell differentiation process.	[Di Sanzo, Maddalena; Aversa, Ilenia; Santamaria, Gianluca; Panebianco, Mariafranca; Biamonte, Flavia; Zolea, Fabiana; Faniello, Maria Concetta; Cuda, Giovanni; Costanzo, Francesco] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Res Ctr Adv Biochem & Mol Biol, Salvatore Venuta Campus, Catanzaro, Italy; [Gagliardi, Monica] Magna Graecia Univ Catanzaro, IBFM CNR, Catanzaro, Italy	Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Magna Graecia University of Catanzaro	Costanzo, F (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Res Ctr Adv Biochem & Mol Biol, Salvatore Venuta Campus, Catanzaro, Italy.	fsc@unicz.it	Biamonte, Flavia/AAC-4934-2019; Costanzo, Francesco Saverio/K-3168-2018; Aversa, Ilenia/AAK-5501-2020; Cuda, Giovanni/AAC-2821-2019; Cuda, Giovanni/F-5359-2012; Biamonte, Flavia/AAF-2092-2020	Biamonte, Flavia/0000-0003-3248-3863; Costanzo, Francesco Saverio/0000-0002-3096-9416; Aversa, Ilenia/0000-0003-4721-6792; Cuda, Giovanni/0000-0001-6313-1866; Cuda, Giovanni/0000-0001-6313-1866; FANIELLO, Concetta Maria/0000-0001-6938-2754; SANTAMARIA, Gianluca/0000-0001-9284-7492	PROMETEO (Design and development of innovative technological Platforms for tissue Regeneration in the Oral-Maxillo facial, haematopoietic, neuronal and cardiac system) [PON01_02834]; ICaRe - Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biobanche per la criopreservazione di cellule staminali umane e di tessuto osseo per uso clinico e design e sviluppo di bioscaffold innovative [PON03PE_00009_2]	PROMETEO (Design and development of innovative technological Platforms for tissue Regeneration in the Oral-Maxillo facial, haematopoietic, neuronal and cardiac system); ICaRe - Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biobanche per la criopreservazione di cellule staminali umane e di tessuto osseo per uso clinico e design e sviluppo di bioscaffold innovative	This research was supported by PON01_02834 PROMETEO (Design and development of innovative technological Platforms for tissue Regeneration in the Oral-Maxillo facial, haematopoietic, neuronal and cardiac system), and Progetto PON03PE_00009_2 ICaRe - Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biobanche per la criopreservazione di cellule staminali umane e di tessuto osseo per uso clinico e design e sviluppo di bioscaffold innovative.; This research was supported by: PON01_02834 PROMETEO (Design and development of innovative technological Platforms for tissue Regeneration in the Oral-Maxillo facial, haematopoietic, neuronal and cardiac system). Progetto PON03PE_00009_2 ICaRe-Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biobanche per la criopreservazione di cellule staminali umane e di tessuto osseo per uso clinico e design e sviluppo di bioscaffold innovative.	Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bevilacqua MA, 1997, BIOCHEM BIOPH RES CO, V240, P179, DOI 10.1006/bbrc.1997.7632; BEVILACQUA MA, 1995, BIOCHEM J, V311, P769, DOI 10.1042/bj3110769; Biamonte F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122105; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Chwalisz Marina, 2014, BMC Res Notes, V7, P378, DOI 10.1186/1756-0500-7-378; COSTANZO F, 1984, EMBO J, V3, P23, DOI 10.1002/j.1460-2075.1984.tb01756.x; COSTANZO F, 1986, NUCLEIC ACIDS RES, V14, P721, DOI 10.1093/nar/14.2.721; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; De Maria S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-264; Di Sanzo M, 2011, J PROTEOME RES, V10, P5444, DOI 10.1021/pr200705z; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esposito F, 2015, CELL CYCLE, V14, P1471, DOI 10.1080/15384101.2015.1021520; Faniello MC, 2008, INT J BIOCHEM CELL B, V40, P2110, DOI 10.1016/j.biocel.2008.02.010; Faniello MC, 2009, CLIN BIOCHEM, V42, P911, DOI 10.1016/j.clinbiochem.2009.02.013; GATTI RA, 1987, AM J HUM GENET, V41, P654; HENTZE MW, 1986, P NATL ACAD SCI USA, V83, P7226, DOI 10.1073/pnas.83.19.7226; Jez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089546; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; Li W, 2013, J GENET GENOMICS, V40, P171, DOI 10.1016/j.jgg.2013.03.003; Misaggi R, 2014, GENE, V535, P327, DOI 10.1016/j.gene.2013.10.067; MURRAY MT, 1987, P NATL ACAD SCI USA, V84, P7438, DOI 10.1073/pnas.84.21.7438; Palazzo AF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004351; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Quaresima B, 1994, PCR Methods Appl, V4, P85; Quaresima B, 2008, CLIN CANCER RES, V14, P6797, DOI 10.1158/1078-0432.CCR-07-5208; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rutnam ZJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3914; Ruzzenenti P, 2015, BBA-GEN SUBJECTS, V1850, P1267, DOI 10.1016/j.bbagen.2015.02.016; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; SANTORO C, 1986, NUCLEIC ACIDS RES, V14, P2863, DOI 10.1093/nar/14.7.2863; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; STEVENS PW, 1987, MOL CELL BIOL, V7, P1751, DOI 10.1128/MCB.7.5.1751; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wen YZ, 2012, RNA BIOL, V9, P27, DOI 10.4161/rna.9.1.18277; WORWOOD M, 1985, HUM GENET, V69, P371, DOI 10.1007/BF00291657; Zhang SC, 2015, ARCH ORAL BIOL, V60, P1581, DOI 10.1016/j.archoralbio.2015.08.003; Zheng H, 1997, BBA-GENE STRUCT EXPR, V1351, P150, DOI 10.1016/S0167-4781(96)00188-1	42	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151359	10.1371/journal.pone.0151359	http://dx.doi.org/10.1371/journal.pone.0151359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982978	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900079
J	Karlsson, OE; Larsson, J; Hayer, J; Berg, M; Jacobson, M				Karlsson, Oskar E.; Larsson, Jenny; Hayer, Juliette; Berg, Mikael; Jacobson, Magdalena			The Intestinal Eukaryotic Virome in Healthy and Diarrhoeic Neonatal Piglets	PLOS ONE			English	Article							VIRAL METAGENOMICS; MOLECULAR CHARACTERIZATION; PORCINE KOBUVIRUSES; VIRUSES; PIGS; DIVERSITY; SWINE; ASTROVIRUS; INFECTION; SEQUENCE	Neonatal porcine diarrhoea of uncertain aetiology has been reported from a number of European countries. The aim of the present study was to use viral metagenomics to examine a potential viral involvement in this diarrhoea and to describe the intestinal virome with focus on eukaryotic viruses. Samples from the distal jejunum of 50 diarrhoeic and 19 healthy piglets from 10 affected herds were analysed. The viral fraction of the samples was isolated and nucleic acids (RNA and DNA fractions) were subjected to sequence independent amplification. Samples from diarrhoeic piglets from the same herds were pooled whereas samples from healthy piglets were analysed individually. In total, 29 clinical samples, plus two negative controls and one positive control consisting of a mock metagenome were sequenced using the Ion Torrent platform. The resulting sequence data was subjected to taxonomic classification using Kraken, Diamond and HMMER. In the healthy specimens, eight different mammalian virus families were detected (Adenoviridae, Anelloviridae, Astroviridae, Caliciviridae, Circoviridae, Parvoviridae, Picornaviridae, and Reoviridae) compared to four in the pooled diarrhoeic samples (Anelloviridae, Circoviridae, Picornaviridae, and Reoviridae). It was not possible to associate a particular virus family with the investigated diarrhoea. In conclusion, this study does not support the hypothesis that the investigated diarrhoea was caused by known mammalian viruses. The results do, however, indicate that known mammalian viruses were present in the intestine as early as 24-48 hours after birth, indicating immediate infection post-partum or possibly transplacental infection.	[Karlsson, Oskar E.; Berg, Mikael] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden; [Karlsson, Oskar E.; Hayer, Juliette] SLU, Dept Anim Breeding & Genet HGEN, SLU Global Bioinformat Ctr, Uppsala, Sweden; [Karlsson, Oskar E.; Berg, Mikael] OIE Collaborating Ctr Biotechnol Based Diag Infec, Uppsala, Sweden; [Larsson, Jenny; Jacobson, Magdalena] Swedish Univ Agr Sci SLU, Dept Clin Sci KV, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Karlsson, OE (corresponding author), Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden.; Karlsson, OE (corresponding author), SLU, Dept Anim Breeding & Genet HGEN, SLU Global Bioinformat Ctr, Uppsala, Sweden.; Karlsson, OE (corresponding author), OIE Collaborating Ctr Biotechnol Based Diag Infec, Uppsala, Sweden.	oskar.e.karlsson@slu.se	Hayer, Juliette/ABG-5814-2021	Hayer, Juliette/0000-0003-4899-9637; Berg, Mikael/0000-0001-5779-3345; Karlsson Lindsjo, Oskar/0000-0003-1068-981X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas [221-2012-586]; EU project AniBioThreat [Home/2009/ISEC/AG/191]; Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs; Swedish Farmers' Foundation for Agricultural Research [H1050154]; RFI/VR; Science for Life Laboratory, Sweden; SLU Global Bioinformatics Centre, part of the infrastructure at faculty Veterinary Medicine and Animal Science, SLU, Uppsala, Sweden	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas(Swedish Research Council Formas); EU project AniBioThreat; Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs; Swedish Farmers' Foundation for Agricultural Research; RFI/VR; Science for Life Laboratory, Sweden; SLU Global Bioinformatics Centre, part of the infrastructure at faculty Veterinary Medicine and Animal Science, SLU, Uppsala, Sweden	Financial support was obtained from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas (221-2012-586) awarded to MB, http://www.formas.se/. This work has been supported by grants from the framework of the EU project AniBioThreat (grant agreement: Home/2009/ISEC/AG/191) with financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs. This publication reflects views only of the authors, and the European Commission cannot be held responsible for any use that may be made of the information contained therein (awarded to MB, http://ec.europa.eu/dgs/home-affairs/index_en.htm); Swedish Farmers' Foundation for Agricultural Research, grant H1050154, Neonatal diarrhoea in piglets-an emergent problem in modern pig production, awarded to MJ, http://www.lantbruksforskning.se/. The authors would like to acknowledge support of the National Genomics Infrastructure (NGI) / Uppsala Genome Center and UPPMAX for providing assistance in massive parallel sequencing and computational infrastructure. Work performed at NGI / Uppsala Genome Center has been funded by RFI/VR and Science for Life Laboratory, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for the analyses of this project was provided by the SLU Global Bioinformatics Centre, part of the infrastructure at faculty Veterinary Medicine and Animal Science, SLU, Uppsala, Sweden.	An DJ, 2011, VIRUS GENES, V42, P208, DOI 10.1007/s11262-010-0561-9; Barry AF, 2011, INFECT GENET EVOL, V11, P1811, DOI 10.1016/j.meegid.2011.06.020; Belak S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/j.vetmic.2013.01.022; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879; Delwart E, 2012, VIRUS RES, V164, P114, DOI 10.1016/j.virusres.2011.11.021; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Di Bartolo I, 2015, ARCH VIROL, V160, P1533, DOI 10.1007/s00705-015-2397-z; Dumarest M, 2015, BIOLOGICALS, V43, P31, DOI 10.1016/j.biologicals.2014.10.004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ganesh B, 2012, INDIAN J VIROL, V23, P387, DOI 10.1007/s13337-012-0106-z; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Gin T, 2010, P 21 IPVS C, P758; Granberg F, 2015, METHODS MOL BIOL, V1247, P491, DOI 10.1007/978-1-4939-2004-4_33; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Karlsson OE, 2013, BIOSECUR BIOTERROR, V11, pS227, DOI 10.1089/bsp.2013.0008; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khamrin P, 2009, EMERG INFECT DIS, V15, P2075, DOI 10.3201/eid1512.090724; Kongsted H, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-206; Kraberger S, 2015, INFECT GENET EVOL, V31, P73, DOI 10.1016/j.meegid.2015.01.001; Lager KM, 2012, J VET DIAGN INVEST, V24, P1177, DOI 10.1177/1040638712463212; Lan DL, 2011, ARCH VIROL, V156, P1567, DOI 10.1007/s00705-011-1035-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsson J, 2014, J COMP PATHOL, V151, P137, DOI 10.1016/j.jcpa.2014.04.003; Larsson J, 2015, J MED MICROBIOL, V64, P916, DOI 10.1099/jmm.0.000108; Li B, 2012, J VIROL, V86, P1286, DOI 10.1128/JVI.06589-11; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Martinez LC, 2010, INFECT GENET EVOL, V10, P984, DOI 10.1016/j.meegid.2010.06.004; Mor SK, 2012, J VET DIAGN INVEST, V24, P1064, DOI 10.1177/1040638712458781; MORIN M, 1990, CAN J VET RES, V54, P385; Munnink BBO, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-22; Park SJ, 2010, ARCH VIROL, V155, P1803, DOI 10.1007/s00705-010-0774-1; Pruitt K., 2002, NCBI HDB, P307; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rosario K, 2012, J GEN VIROL, V93, P2668, DOI 10.1099/vir.0.045948-0; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Rosseel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076144; Sachsenroder J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088888; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; SHIMIZU M, 1990, J CLIN MICROBIOL, V28, P201, DOI 10.1128/JCM.28.2.201-206.1990; Sjolund M, 2014, P 6 EUR S PORC HLTH, P111; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; SVENSMARK B, 1989, ACTA VET SCAND, V30, P43; Thomson JR., 2012, DIS SWINE, P216; Phan TG, 2015, VIROLOGY, V482, P98, DOI 10.1016/j.virol.2015.03.011; Verma H, 2013, VIRUS GENES, V46, P551, DOI 10.1007/s11262-013-0879-1; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wallgren P, 2012, P 22 IPVS C JEJ KOR, P76; WILL LA, 1994, J VET DIAGN INVEST, V6, P416, DOI 10.1177/104063879400600403; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang B, 2014, J GEN VIROL, V95, P1603, DOI 10.1099/vir.0.063743-0; Zhang W, 2008, J VIROL, V82, P8239, DOI 10.1128/JVI.01020-08	57	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151481	10.1371/journal.pone.0151481	http://dx.doi.org/10.1371/journal.pone.0151481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982708	Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900088
J	Song, YJ; Li, JS; Meng, S; Yin, L; Xue, YF; Ma, YH				Song, Yajian; Li, Jinshan; Meng, Shan; Yin, Liang; Xue, Yanfen; Ma, Yanhe			A Novel Manno-Oligosaccharide Binding Protein Identified in Alkaliphilic Bacillus sp N16-5 Is Involved in Mannan Utilization	PLOS ONE			English	Article							ABC TRANSPORT-SYSTEMS; GEOBACILLUS-STEAROTHERMOPHILUS; CASSETTE TRANSPORTERS; SUBTILIS; ETHANOL; BIOMASS; ENERGY	ManH, a novel substrate-binding protein of an ABC transporter, was identified from the mannan utilization gene cluster of Bacillus sp. N16-5. We cloned, overexpressed, and purified ManH and measured its binding affinity to different substrates by isothermal titration calorimetry. ManH binds to mannotriose, mannotetraose, mannopentose, and galactosylmannotriose with dissociation constants in the micromolar range. Deletion of manH led to decreased growth ability of the strain when cultivated in medium with manno-oligosaccharides or mannan as the carbon source. ManH belongs to a manno-oligosaccharide transporter and plays an important role in mannan utilization by Bacillus sp. N16-5.	[Song, Yajian; Meng, Shan; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China; [Song, Yajian] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Tianjin Key Lab Ind Microbiol,Coll Biotechnol, Tianjin 300457, Peoples R China; [Li, Jinshan; Yin, Liang; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China; [Ma, Yanhe] Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Tianjin University Science & Technology; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Ma, YH (corresponding author), Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China.; Ma, YH (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.; Ma, YH (corresponding author), Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.	mayanhe@im.ac.cn	MA, YAN/HHN-2912-2022		National Natural Science Foundation of China [31400031]; Ministry of Sciences and Technology of China [2011CBA00800, 2013CBA733900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (No. 31400031) and the Ministry of Sciences and Technology of China (Nos. 2011CBA00800 and 2013CBA733900). YS received the funding from the National Natural Science Foundation of China (No. 31400031), YM received the funding from the Ministry of Sciences and Technology of China (No. 2011CBA00800), and YX received the funding from the Ministry of Sciences and Technology of China (No. 2013CBA733900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Chekan JR, 2014, J BIOL CHEM, V289, P34965, DOI 10.1074/jbc.M114.579904; Connelly MB, 2004, J BACTERIOL, V186, P4159, DOI 10.1128/JB.186.13.4159-4167.2004; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Ferreira MJ, 2010, J BACTERIOL, V192, P5312, DOI 10.1128/JB.00832-10; Gao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028148; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; HORIKOSHI K, 1971, AGR BIOL CHEM TOKYO, V35, P1407, DOI 10.1080/00021369.1971.10860094; Ito M, 2001, BIOSCI BIOTECH BIOCH, V65, P2773, DOI 10.1271/bbb.65.2773; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nataf Y, 2009, J BACTERIOL, V191, P203, DOI 10.1128/JB.01190-08; Ouyang Jia, 2006, Biotechnol J, V1, P1266, DOI 10.1002/biot.200600103; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; Song YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054090; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Tsujibo H, 2004, J BACTERIOL, V186, P1029, DOI 10.1128/JB.186.4.1029-1037.2004; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8	27	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150059	10.1371/journal.pone.0150059	http://dx.doi.org/10.1371/journal.pone.0150059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978267	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800020
J	Wieten, RW; Jonker, EFF; van Leeuwen, EMM; Remmerswaal, EBM; ten Berge, IJM; de Visser, AW; van Genderen, PJJ; Goorhuis, A; Visser, LG; Grobusch, MP; de Bree, GJ				Wieten, Rosanne W.; Jonker, Emile F. F.; van Leeuwen, Ester M. M.; Remmerswaal, Ester B. M.; ten Berge, Ineke J. M.; de Visser, Adriette W.; van Genderen, Perry J. J.; Goorhuis, Abraham; Visser, Leo G.; Grobusch, Martin P.; de Bree, Godelieve J.			A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ELDERLY PERSONS; VIRUS 17D; MEMORY; EFFECTOR; INFECTION; BET; DIFFERENTIATION; EXPRESSION; INFLUENZA	Introduction Prompted by recent amendments of Yellow Fever (YF) vaccination guidelines from boost to single vaccination strategy and the paucity of clinical data to support this adjustment, we used the profile of the YF-specific CD8(+) T-cell subset profiles after primary vaccination and neutralizing antibodies as a proxy for potentially longer lasting immunity. Methods and Findings PBMCs and serum were collected in six individuals on days 0, 3, 5, 12, 28 and 180, and in 99 individuals >10 years after YF-vaccination. Phenotypic characteristics of YF-tetramer(+) CD8(+) T-cells were determined using class I tetramers. Antibody responses were measured using a standardized plaque reduction neutralization test (PRNT). Also, characteristics of YF-tetramer positive CD8(+) T-cells were compared between individuals who had received a primary-and a booster vaccination. YF-tetramer(+) CD8(+) T-cells were detectable on day 12 (median tetramer(+) cells as percentage of CD8(+) T-cells 0.2%, range 0.07-3.1%). On day 180, these cells were still present (median 0.06%, range 0.02-0.78%). The phenotype of YF-tetramer positive CD8(+) T-cells shifted from acute phase effector cells on day 12, to late differentiated or effector memory phenotype (CD45RA(-/+) CD27(-)) on day 28. Two subsets of YF-tetramer positive T-cells (CD45RA(+)CD27(-) and CD45RA(+)CD27(+)) persisted until day 180. Within all phenotypic subsets, the T-bet: Eomes ratio tended to be high on day 28 after vaccination and shifted towards predominant Eomes expression on day 180 (median 6.0 (day 28) vs. 2.2 (day 180) p = 0.0625), suggestive of imprinting compatible with long-lived memory properties. YF-tetramer positive CD8(+) T-cells were detectable up to 18 years post vaccination, YF-specific antibodies were detectable up to 40 years after single vaccination. Booster vaccination did not increase titers of YF-specific antibodies (mean 12.5 vs. 13.1, p = 0.583), nor induce frequencies or alter phenotypes of YF-tetramer(+) CD8(+) T-cells. Conclusion The presence of a functionally competent YF-specific memory T-cell pool 18 years and sufficient titers of neutralizing antibodies 35-40 years after first vaccination suggest that single vaccination may be sufficient to provide long-term immunity.	[Wieten, Rosanne W.; Goorhuis, Abraham; Grobusch, Martin P.; de Bree, Godelieve J.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [de Bree, Godelieve J.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Jonker, Emile F. F.; de Visser, Adriette W.; Visser, Leo G.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [van Leeuwen, Ester M. M.; Remmerswaal, Ester B. M.; ten Berge, Ineke J. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Remmerswaal, Ester B. M.; ten Berge, Ineke J. M.] Univ Amsterdam, Acad Med Ctr, Renal Transplant Unit, Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van Genderen, Perry J. J.] Travel Clin Havenziekenhuis, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Visser, LG (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	l.g.visser@lumc.nl	Kuijper, ed/AAB-7853-2022; Remmerswaal, Ester/ABF-3596-2020; Visser, Leo/AAH-5755-2021	Kuijper, ed/0000-0001-5726-2405; Remmerswaal, Ester/0000-0003-4694-6048; Jonker, Emile/0000-0001-6104-0688; Goorhuis, Abraham/0000-0001-7423-6217				Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay van Lier, 2008, CYTOM PART A, V73, P975; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605; Blom K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004622; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021; Co MDT, 2009, IMMUNOLOGY, V128, pe718, DOI 10.1111/j.1365-2567.2009.03070.x; Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; Coulange Bodilis H, 2011, Bull Soc Pathol Exot, V104, P260, DOI 10.1007/s13149-011-0135-7; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; de Bree GJ, 2005, J INFECT DIS, V191, P1710, DOI 10.1086/429695; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dolfi DV, 2013, J LEUKOCYTE BIOL, V93, P825, DOI 10.1189/jlb.0912438; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Gómez Sergio Y, 2008, Rev. salud pública, V10, P796; Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264; Grobusch MP, 2013, CLIN MICROBIOL INFEC, V19, P885, DOI 10.1111/1469-0691.12332; Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Hoji A, 2005, IMMUNOLOGY, V115, P239, DOI 10.1111/j.1365-2567.2005.02135.x; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Knox JJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00217; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Monath T. P., 2008, VACCINES, P959; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nabeshima S, 2002, CLIN EXP IMMUNOL, V128, P339, DOI 10.1046/j.1365-2249.2002.01819.x; Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Patel D, 2013, TRAVEL MED INFECT DI, V11, P266, DOI 10.1016/j.tmaid.2013.08.007; Plotkin S., 2008, VACCINES, V6th ed., P17; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; Popescu I, 2014, J IMMUNOL, V193, P5709, DOI 10.4049/jimmunol.1401436; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Strategic Advisory Group of Experts, 2013, BACKGR PAP YELL FEV; van Aalderen MC, 2015, J VIROL, V89, P5110, DOI 10.1128/JVI.03478-14; van Aalderen MC, 2014, EUR J IMMUNOL, V44, P934, DOI 10.1002/eji.201344269; Wherry EJ, 1999, J IMMUNOL, V163, P3735; Wieten RW, 17D YELLOW FEV UNPUB; Wirth TC, 2010, EUR J IMMUNOL, V40, P1916, DOI 10.1002/eji.201040310; Wrammert J, 2009, J CLIN IMMUNOL, V29, P151, DOI 10.1007/s10875-008-9267-3	63	56	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149871	10.1371/journal.pone.0149871	http://dx.doi.org/10.1371/journal.pone.0149871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977808	Green Published, gold, Green Submitted			2022-12-26	WOS:000372572800017
J	Lucchi, NW; Ljolje, D; Silva-Flannery, L; Udhayakumar, V				Lucchi, Naomi W.; Ljolje, Dragan; Silva-Flannery, Luciana; Udhayakumar, Venkatachalam			Use of Malachite Green-Loop Mediated Isothermal Amplification for Detection of Plasmodium spp. Parasites	PLOS ONE			English	Article							MALARIA ELIMINATION; FALCIPARUM-MALARIA; DIAGNOSIS; LAMP; ZANZIBAR; ASSAY	Malaria elimination efforts are hampered by the lack of sensitive tools to detect infections with low-level parasitemia, usually below the threshold of standard diagnostic methods, microscopy and rapid diagnostic tests. Isothermal nucleic acid amplification assays such as the loop-mediated isothermal amplification (LAMP), are well suited for field use as they do not require thermal cyclers to run the test. However, the use of specialized equipment, as described by many groups, reduces the versatility of the LAMP technique as a simple tool for use in endemic countries. In this study, the use of the malachite green (MG) dye, as a visual endpoint readout, together with a simple mini heat block was evaluated for the detection of malaria parasites. The assay was performed for 1 hour at 63 degrees C and the results scored by 3 independent human readers. The limit of detection of the assay was determined using well-quantified Plasmodium spp. infected reference samples and its utility in testing clinical samples was determined using 190 pre-treatment specimens submitted for reference diagnosis of imported malaria in the United States. Use of a simplified boil and spin methods of DNA extraction from whole blood and filter paper was also investigated. We demonstrate the accurate and sensitive detection of malaria parasites using this assay with a detection limit ranging between 1-8 parasites/mu L, supporting its applicability for the detection of infections with low parasite burden. This assay is compatible with the use of a simple boil and spin sample preparation method from both whole blood and filter papers without a loss of sensitivity. The MG-LAMP assay described here has great potential to extend the reach of molecular tools to settings where they are needed.	[Lucchi, Naomi W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Ctr Global Hlth, Atlanta, GA USA; [Ljolje, Dragan; Silva-Flannery, Luciana] Atlanta Res & Educ Fdn, Vet Affairs Med Ctr, Decatur, GA USA	Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lucchi, NW (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Ctr Global Hlth, Atlanta, GA USA.	NLucchi@cdc.gov		Lucchi, Naomi/0000-0001-8789-8041	Malaria Branch at the Centers for Disease Control and Prevention; Atlanta Research and Education Foundation	Malaria Branch at the Centers for Disease Control and Prevention; Atlanta Research and Education Foundation	This report was made possible through support provided by the Malaria Branch at the Centers for Disease Control and Prevention and the Atlanta Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This report was made possible through support provided by the Malaria Branch at the Centers for Disease Control and Prevention and the Atlanta Research and Education Foundation. We would like to thank Dr. John Barnwell for providing the quantified Plasmodium samples for the study and technical support of the project. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Abdul-Ghani R, 2012, ACTA TROP, V122, P233, DOI 10.1016/j.actatropica.2012.02.004; Britton S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0848-3; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Jothikumar P, 2014, J MICROBIOL METH, V98, P122, DOI 10.1016/j.mimet.2014.01.002; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Mohon A, 2014, ACTA TROP, V134, P52, DOI 10.1016/j.actatropica.2014.02.016; Morris U, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0731-2; Notomi Tsugunori, 2007, Nihon Rinsho, V65, P957; Nzelu CO, 2014, ACTA TROP, V132, P1, DOI 10.1016/j.actatropica.2013.12.016; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Patel JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054986; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Poon LLM, 2006, CLIN CHEM, V52, P303; Proux S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-323; Roth JM, 2016, CRIT REV CL LAB SCI, V53, P87, DOI 10.3109/10408363.2015.1084991; Sema M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0559-9; Yamamura M, 2009, JPN J INFECT DIS, V62, P20	22	52	54	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151437	10.1371/journal.pone.0151437	http://dx.doi.org/10.1371/journal.pone.0151437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967908	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200054
J	McGovern, G; Martin, S; Jeffrey, M; Dexter, G; Hawkins, SAC; Bellworthy, SJ; Thurston, L; Algar, L; Gonzalez, L				McGovern, Gillian; Martin, Stuart; Jeffrey, Martin; Dexter, Glenda; Hawkins, Steve A. C.; Bellworthy, Sue J.; Thurston, Lisa; Algar, Lynne; Gonzalez, Lorenzo			Minimum Effective Dose of Cattle and Sheep BSE for Oral Sheep Infection	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRION PROTEIN; TRANSGENIC MICE; SCRAPIE; DISEASE; PATHOGENESIS; PHENOTYPE; VARIANT; AGENT; SUSCEPTIBILITY	The minimum dose required to cause infection of Romney and Suffolk sheep of the ARQ/ARQ or ARQ/ARR prion protein gene genotypes following oral inoculation with Romney or Suffolk a sheep Bovine spongiform encephalopathy (BSE)-derived or cattle BSE-derived agent was investigated using doses ranging from 0.0005g to 5g. ARQ/ARQ sheep which were methionine (M) / threonine (T) heterozygous or T/T homozygous at codon 112 of the Prnp gene, dosed ARQ/ARR sheep and undosed controls did not show any evidence of infection. Within groups of susceptible sheep, the minimum effective oral dose of BSE was found to be 0.05g, with higher attack rates following inoculation with the 5g dose. Surprisingly, this study found no effect of dose on survival time suggesting a possible lack of homogeneity within the inoculum. All clinical BSE cases showed PrPd accumulation in brain; however, following cattle BSE inoculation, LRS involvement within Romney recipients was found to be significantly lower than within the Suffolk sheep inoculated group which is in agreement with previous reports.	[McGovern, Gillian; Martin, Stuart; Jeffrey, Martin; Algar, Lynne; Gonzalez, Lorenzo] Anim & Plant Hlth Agcy APHA Lasswade, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Dexter, Glenda; Hawkins, Steve A. C.; Bellworthy, Sue J.; Thurston, Lisa] APHA Weybridge, Addlestone KT15 3NB, Surrey, England		Gonzalez, L (corresponding author), Anim & Plant Hlth Agcy APHA Lasswade, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland.	Lorenzo.Gonzalez@apha.gsi.gov.uk	González, Lorenzo/A-5325-2010	González, Lorenzo/0000-0003-4199-4526	Department for Environment, Food and Rural affairs [SE1945, SE1846]; Defra [SE1945, SE1846]	Department for Environment, Food and Rural affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural affairs, grant numbers: SE1945, SE1846, received by SM and LG, respectively.; These experiments were funded by Defra projects SE1846 and SE1945. The authors are indebted to Hugh Simmons (APHA, Weybridge) for the provision of TSE-free sheep, to the staff at ARSU (APHA, Weybridge) for husbandry, Janey Witz for assistance with statistical analyses and to Ann Dunachie and Maria Oliva for immunohistochemistry work. Critical appraisal of the manuscript by Jim Hope (APHA) is also acknowledged.	Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Espinosa JC, 2007, J VIROL, V81, P835, DOI 10.1128/JVI.01356-06; Espinosa JC, 2007, J GEN VIROL, V88, P1379, DOI 10.1099/vir.0.82647-0; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2014, J COMP PATHOL, V150, P57, DOI 10.1016/j.jcpa.2013.10.001; Gonzalez L, 2007, J GEN VIROL, V88, P714, DOI 10.1099/vir.0.82426-0; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Houston F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143251; Hunter N, 2012, J VIROL, V86, P11856, DOI 10.1128/JVI.01573-12; Jeffrey M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0269-x; Jeffrey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091026; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; McGovern G, 2015, J COMP PATHOL, V152, P28, DOI 10.1016/j.jcpa.2014.09.004; McGovern G, 2009, VET PATHOL, V46, P233, DOI 10.1354/vp.46-2-233; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saunders GC, 2009, J GEN VIROL, V90, P2569, DOI 10.1099/vir.0.012724-0; Stack M, 2009, J GEN VIROL, V90, P764, DOI 10.1099/vir.0.005983-0; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103; Wilesmith J W, 1991, Curr Top Microbiol Immunol, V172, P21; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	29	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151440	10.1371/journal.pone.0151440	http://dx.doi.org/10.1371/journal.pone.0151440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968011	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200055
J	Kostantin, E; Hardy, S; Valinsky, WC; Kompatscher, A; de Baaij, JHF; Zolotarov, Y; Landry, M; Uetani, N; Martinez-Cruz, LA; Hoenderop, JGJ; Shrier, A; Tremblay, ML				Kostantin, Elie; Hardy, Serge; Valinsky, William C.; Kompatscher, Andreas; de Baaij, Jeroen H. F.; Zolotarov, Yevgen; Landry, Melissa; Uetani, Noriko; Alfonso Martinez-Cruz, Luis; Hoenderop, Joost G. J.; Shrier, Alvin; Tremblay, Michel L.			Inhibition of PRL-2.CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; CYCLIN M2 CNNM2; MAGNESIUM TRANSPORTER; MOLECULAR-MECHANISMS; REGENERATING LIVER; CELL-MIGRATION; CBS DOMAINS; PHOSPHATASE; METASTASIS; PRL-3	The oncogenic phosphatase of regenerating liver 2 (PRL-2) has been shown to regulate intracellular magnesium levels by forming a complex through an extended amino acid loop present in the Bateman module of the CNNM3 magnesium transporter. Here we identified highly conserved residues located on this amino acid loop critical for the binding with PRL-2. A single point mutation (D426A) of one of those critical amino acids was found to completely disrupt PRL-2.human Cyclin M 3 (CNNM3) complex formation. Whole-cell voltage clamping revealed that expression of CNNM3 influenced the surface current, whereas overexpression of the binding mutant had no effect, indicating that the binding of PRL-2 to CNNM3 is important for the activity of the complex. Interestingly, overexpression of the CNNM3 D426A-binding mutant in cancer cells decreased their ability to proliferate under magnesium-deprived situations and under anchorage independent growth conditions, demonstrating a PRL2.CNNM3 complex-dependent oncogenic advantage in a more stringent environment. We further confirmed the importance of this complex in vivo using an orthotopic xenograft breast cancer model. Finally, because molecular modeling showed that the Asp-426 side chain in CNNM3 buries into the catalytic cavity of PRL-2, we showed that a PRI, inhibitor could abrogate complex formation, resulting in a decrease in proliferation of human breast cancer cells. In summary, we provide evidence that this fundamental regulatory aspect of PRL-2 in cancer cells could potentially lead to broadly applicable and innovative therapeutic avenues.	[Kostantin, Elie; Hardy, Serge; Zolotarov, Yevgen; Landry, Melissa; Uetani, Noriko; Tremblay, Michel L.] Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kostantin, Elie; Zolotarov, Yevgen; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 0G4, Canada; [Valinsky, William C.; Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ H3A 0G4, Canada; [Kompatscher, Andreas; de Baaij, Jeroen H. F.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Alfonso Martinez-Cruz, Luis] Ctr Cooperat Res Biosci CIC BioGUNE, Struct Biol Unit, Technol Pk Bizkaia, Derio 48160, Bizkaia, Spain	McGill University; McGill University; Radboud University Nijmegen; CIC bioGUNE	Tremblay, ML (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, 1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca	de Baaij, Jeroen/P-5704-2015; Zolotarov, Yevgen/AAK-6125-2021; Hoenderop, Joost G.J./H-8047-2014	de Baaij, Jeroen/0000-0003-2372-8486; Zolotarov, Yevgen/0000-0001-5445-1219; Hoenderop, Joost G.J./0000-0002-1816-8544; Valinsky, Corey/0000-0001-7736-9146	Canadian Institutes of Health Research [CIHR MOP 142497]; Merck, Sharp AMP; Dohme Corp./McGill Faculty of Medicine [PT 66481]; Quebec Breast Cancer Foundation; Canadian Breast Cancer Research Alliance [020303]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Merck, Sharp AMP; Dohme Corp./McGill Faculty of Medicine; Quebec Breast Cancer Foundation; Canadian Breast Cancer Research Alliance	This work was supported by an operating grant from the Canadian Institutes of Health Research (The PRL-CNNM-Magnesium Cascade, a New Paradigm in Oncogenesis: CIHR MOP 142497). This work was also supported by a Merck, Sharp & Dohme Corp./McGill Faculty of Medicine Grant for Translational Research Program: Characterization of the PTP4A2/CNNM3 Complex as a Novel Target for Cancer Therapy (Grant PT 66481) and by the Quebec Breast Cancer Foundation and the Canadian Breast Cancer Research Alliance (Grant 020303). The authors declare that they have no conflicts of interest with the contents of this article.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Corral-Rodriguez MA, 2014, BIOCHEM J, V464, P23, DOI 10.1042/BJ20140409; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Castiglioni S, 2011, MAGNESIUM RES, V24, pS92, DOI 10.1684/mrh.2011.0285; Daouti S, 2008, CANCER RES, V68, P1162, DOI 10.1158/0008-5472.CAN-07-2349; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2012, J BIOL CHEM, V287, P13644, DOI 10.1074/jbc.M112.342204; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Gavenonis J, 2014, NAT CHEM BIOL, V10, P716, DOI [10.1038/NCHEMBIO.1580, 10.1038/nchembio.1580]; Gomez-Garcia I, 2012, ACTA CRYSTALLOGR F, V68, P1198, DOI 10.1107/S1744309112035348; Gopinath P, 2015, P NATL ACAD SCI USA, V112, P12011, DOI 10.1073/pnas.1516239112; Guzinska-Ustymowicz K, 2011, ANTI-CANCER AGENT ME, V11, P99, DOI 10.2174/187152011794941145; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; HERSCHMAN HR, 1987, CARCINOGENESIS, V8, P993, DOI 10.1093/carcin/8.7.993; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; Hoeger B, 2014, EUR J MED CHEM, V88, P89, DOI 10.1016/j.ejmech.2014.08.060; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Jeong DG, 2005, J MOL BIOL, V345, P401, DOI 10.1016/j.jmb.2004.10.061; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kobayashi M, 2014, STEM CELLS, V32, P1956, DOI 10.1002/stem.1672; Labbe DP, 2012, PROG MOL BIOL TRANSL, V106, P253, DOI 10.1016/B978-0-12-396456-4.00009-2; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; Meng XJ, 2013, CANCER LETT, V333, P96, DOI 10.1016/j.canlet.2013.01.031; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Nelson CA, 1996, J IMMUNOL, V157, P755; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Rao VR, 2015, CANCERS, V7, P849, DOI 10.3390/cancers7020813; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Tan ZJ, 2011, METAL IONS LIFE SCI, V9, P101, DOI 10.1039/978184973251200101; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Wang Y, 2012, ONCOGENE, V31, P818, DOI 10.1038/onc.2011.281; Wolf FI, 2012, CLIN SCI, V123, P417, DOI 10.1042/CS20120086; Wolf FI, 2004, FRONT BIOSCI-LANDMRK, V9, P2056, DOI 10.2741/1389; Ye Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep17046; Zhao N, 2011, PROTEIN SCI, V20, P1275, DOI 10.1002/pro.655; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	50	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10716	10725		10.1074/jbc.M115.705863	http://dx.doi.org/10.1074/jbc.M115.705863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26969161	hybrid, Green Published			2022-12-26	WOS:000377042600023
J	Giddens, JP; Lomino, JV; Amin, MN; Wang, LX				Giddens, John P.; Lomino, Joseph V.; Amin, Mohammed N.; Wang, Lai-Xi			Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; ASPARAGINE-LINKED OLIGOSACCHARIDES; ANION-EXCHANGE CHROMATOGRAPHY; FLAVOBACTERIUM-MENINGOSEPTICUM; TRANSGLYCOSYLATION ACTIVITY; BISECTING GLCNAC; GLYCOSYLATION; GLYCANS; SEPARATION; BINDING	Chemoenzymatic synthesis is emerging as a promising approach to the synthesis of homogeneous glycopeptides and glycoproteins highly demanded for functional glycomics studies, but its generality relies on the availability of a range of enzymes with high catalytic efficiency and well defined substrate specificity. We describe in this paper the discovery of glycosynthase mutants derived from Elizabethkingia meningoseptica endoglycosidase F3 (Endo-F3) of the GH18 family, which are devoid of the inherent hydrolytic activity but are able to take glycan oxazolines for transglycosylation. Notably, the Endo-F3 D165A and D165Q mutants demonstrated high acceptor substrate specificity toward alpha 1,6-fucosyl-GlcNAc-Asn or alpha 1, 6-fucosyl-GlcNAc-polypeptide in transglycosylation, enabling a highly convergent synthesis of core-fucosylated, complex CD52 glycopeptide antigen. The Endo-F3 mutants were able to use both bi- and triantennary glycan oxazolines as substrates for transglycosylation, in contrast to previously reported endogly-cosidases derived from Endo-S, Endo-M, Endo-D, and Endo-A mutants that could not recognize triantennary N-glycans. Using rituximab as a model system, we have further demonstrated that the Endo-F3 mutants are highly efficient for glycosylation remodeling of monoclonal antibodies to produce homogeneous intact antibody glycoforms. Interestingly, the new triantennary glycan glycoform of antibody showed much higher affinity for galectin-3 than that of the commercial antibody. The Endo-F3 mutants represent the first endoglycosidase-based glycosynthases capable of transferring triantennary complex N-glycans, which would be very useful for glycoprotein synthesis and glycosylation remodeling of antibodies.	[Giddens, John P.; Lomino, Joseph V.; Amin, Mohammed N.; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Giddens, John P.; Amin, Mohammed N.; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Wang, LX (corresponding author), Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA.	wang518@umd.edu	wang, xl/Y-8251-2019; Wang, Lai-Xi/E-8790-2019; Wang, Xin/GYU-1129-2022; Wang, Lai-Xi/E-8755-2019; wang, xiao/HGB-7081-2022; Wang, Xin/AAN-8435-2021	Wang, Lai-Xi/0000-0003-4293-5819; wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Giddens, John/0000-0001-8123-8704	National Institutes of Health [R01 GM080374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM080374 (to L. X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288; Amin MN, 2011, J AM CHEM SOC, V133, P14404, DOI 10.1021/ja204831z; Andre S, 2007, BIOCHEMISTRY-US, V46, P6984, DOI 10.1021/bi7000467; Andre S, 2009, BIOL CHEM, V390, P557, DOI 10.1515/BC.2009.072; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barrabes S, 2007, GLYCOBIOLOGY, V17, P388, DOI 10.1093/glycob/cwm002; BENDIAK B, 1989, BIOCHEMISTRY-US, V28, P6491, DOI 10.1021/bi00441a050; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Castilho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054836; Castilho A, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200032; Chalker JM, 2011, ACCOUNTS CHEM RES, V44, P730, DOI 10.1021/ar200056q; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Eller S, 2007, ANGEW CHEM INT EDIT, V46, P4173, DOI 10.1002/anie.200604788; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Funasaka T, 2014, GLYCOBIOLOGY, V24, P886, DOI 10.1093/glycob/cwu086; Gaidzik N, 2013, CHEM SOC REV, V42, P4421, DOI 10.1039/c3cs35470a; Gamblin DP, 2009, CHEM REV, V109, P131, DOI 10.1021/cr078291i; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hang HC, 2001, ACCOUNTS CHEM RES, V34, P727, DOI 10.1021/ar9901570; HARDY MR, 1988, P NATL ACAD SCI USA, V85, P3289, DOI 10.1073/pnas.85.10.3289; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hojo H, 2012, J ORG CHEM, V77, P9437, DOI 10.1021/jo3010155; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2011, CHEMBIOCHEM, V12, P932, DOI 10.1002/cbic.201000763; Huang W, 2010, ORG BIOMOL CHEM, V8, P5224, DOI 10.1039/c0ob00341g; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kim KK, 2005, INT J SYST EVOL MICR, V55, P1287, DOI 10.1099/ijs.0.63541-0; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Li L, 2015, CHEM SCI, V6, P5652, DOI 10.1039/c5sc02025e; Lin CW, 2015, P NATL ACAD SCI USA, V112, P10611, DOI 10.1073/pnas.1513456112; Lomino JV, 2011, J BACTERIOL, V193, P2089, DOI 10.1128/JB.01231-10; MOSESSON MW, 1966, BIOCHEMISTRY-US, V5, P2829, DOI 10.1021/bi00873a008; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Plummer TH, 1996, ANAL BIOCHEM, V235, P98; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Rose RJ, 2013, MABS-AUSTIN, V5, P219, DOI 10.4161/mabs.23532; Sato H, 2008, CARBOHYD RES, V343, P1333, DOI 10.1016/j.carres.2008.03.008; Schmaltz RM, 2011, CHEM REV, V111, P4259, DOI 10.1021/cr200113w; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; Sun B, 2008, CHEM-EUR J, V14, P7072, DOI 10.1002/chem.200800757; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Tarentino A, 1999, GLYCOBIOLOGY, V9, pIII; TARENTINO AL, 1995, GLYCOBIOLOGY, V5, P599, DOI 10.1093/glycob/5.6.599; TARENTINO AL, 1993, J BIOL CHEM, V268, P9702; TOWNSEND RR, 1989, ANAL BIOCHEM, V182, P1; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Unverzagt C, 2002, J MED CHEM, V45, P478, DOI 10.1021/jm0110237; Unverzagt C, 1994, Bioorg Med Chem, V2, P1189, DOI 10.1016/S0968-0896(00)82070-2; Unverzagt C, 2013, CHEM SOC REV, V42, P4408, DOI 10.1039/c3cs35485g; Verostek MF, 2000, ANAL BIOCHEM, V278, P111, DOI 10.1006/abio.1999.4433; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Walczak MA, 2012, J AM CHEM SOC, V134, P16430, DOI 10.1021/ja307628w; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang H, 2013, BIOORGAN MED CHEM, V21, P2037, DOI 10.1016/j.bmc.2013.01.028; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wang P, 2009, J AM CHEM SOC, V131, P16669, DOI 10.1021/ja907136d; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Yuan Y, 2010, BIOPOLYMERS, V94, P373, DOI 10.1002/bip.21374	79	65	69	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9356	9370		10.1074/jbc.M116.721597	http://dx.doi.org/10.1074/jbc.M116.721597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26966183	hybrid, Green Published			2022-12-26	WOS:000374849000043
J	Chen, WD; Zhu, YL; Cui, FC; Liu, LY; Sun, ZY; Chen, JZ; Li, YQ				Chen, Wenduo; Zhu, Youliang; Cui, Fengchao; Liu, Lunyang; Sun, Zhaoyan; Chen, Jizhong; Li, Yunqi			GPU-Accelerated Molecular Dynamics Simulation to Study Liquid Crystal Phase Transition Using Coarse-Grained Gay-Berne Anisotropic Potential	PLOS ONE			English	Article							GRAPHICS PROCESSING UNITS; SURFACE-INITIATED POLYMERIZATION; MAIN-CHAIN; COMPUTER-SIMULATION; FLEXIBLE MOLECULES; MONTE-CARLO; MODEL; POLYMERS; SPACERS; POLYDISPERSITY	Gay-Berne (GB) potential is regarded as an accurate model in the simulation of anisotropic particles, especially for liquid crystal (LC) mesogens. However, its computational complexity leads to an extremely time-consuming process for large systems. Here, we developed a GPU-accelerated molecular dynamics (MD) simulation with coarse-grained GB potential implemented in GALAMOST package to investigate the LC phase transitions for mesogens in small molecules, main-chain or side-chain polymers. For identical mesogens in three different molecules, on cooling from fully isotropic melts, the small molecules form a single-domain smectic-B phase, while the main-chain LC polymers prefer a single-domain nematic phase as a result of connective restraints in neighboring mesogens. The phase transition of side-chain LC polymers undergoes a two-step process: nucleation of nematic islands and formation of multi-domain nematic texture. The particular behavior originates in the fact that the rotational orientation of the mesogenes is hindered by the polymer backbones. Both the global distribution and the local orientation of mesogens are critical for the phase transition of anisotropic particles. Furthermore, compared with the MD simulation in LAMMPS, our GPU-accelerated code is about 4 times faster than the GPU version of LAMMPS and at least 200 times faster than the CPU version of LAMMPS. This study clearly shows that GPU-accelerated MD simulation with GB potential in GALAMOST can efficiently handle systems with anisotropic particles and interactions, and accurately explore phase differences originated from molecular structures.	[Chen, Wenduo; Cui, Fengchao; Liu, Lunyang; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, 5625 Renmin St, Changchun 130022, Peoples R China; [Chen, Wenduo; Cui, Fengchao; Liu, Lunyang; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, 5625 Renmin St, Changchun 130022, Peoples R China; [Zhu, Youliang; Sun, Zhaoyan; Chen, Jizhong] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, 5625 Renmin St, Changchun 130022, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, 5625 Renmin St, Changchun 130022, Peoples R China.; Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, 5625 Renmin St, Changchun 130022, Peoples R China.; Chen, JZ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, 5625 Renmin St, Changchun 130022, Peoples R China.	jzchen@ciac.ac.cn; yunqi@ciac.ac.cn	Zhu, You-Liang/AAS-2299-2020; Li, Yunqi/C-8372-2016	Zhu, You-Liang/0000-0002-9561-0770; Li, Yunqi/0000-0002-5190-3037; liu, lunyang/0000-0003-2506-883X; Chen, Wenduo/0000-0002-4828-4706	National Natural Science Foundation of China [21404105, 21374117, 21404102, 21474111]; One Hundred Talents Program of Chinese Academy of Sciences; National Program on Key Basic Research Project (973 Program) [2015CB655302]; China Postdoctoral Science Foundation [2014M551200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	WC was supported by National Natural Science Foundation of China (21404105, http://www.nsfc.gov.cn/). YL was supported by National Natural Science Foundation of China (21374117), One Hundred Talents Program of Chinese Academy of Sciences (http://www.cas.cn/) and National Program on Key Basic Research Project (973 Program 2015CB655302 http://www.most.gov.cn/). YZ was supported by National Natural Science Foundation of China (21404102) and China Postdoctoral Science Foundation (2014M551200, http://jj.chinapostdoctor.org.cn/V1/Program1). ZS was supported by National Natural Science Foundation of China (21474111).	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Allen MP, 1996, J PHYS-CONDENS MAT, V8, P9433, DOI 10.1088/0953-8984/8/47/041; Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Berardi R, 2004, J CHEM PHYS, V121, P9123, DOI 10.1063/1.1790453; BLUMSTEIN A, 1982, J POLYM SCI POL PHYS, V20, P877, DOI 10.1002/pol.1982.180200510; Boamfa MI, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.025501; Boamfa MI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.050701; Bose TK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265701; Brown WM, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3058435; Busselez R, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4896052; Care CM, 2005, REP PROG PHYS, V68, P2665, DOI 10.1088/0034-4885/68/11/R04; Chen XF, 2010, CHEM SOC REV, V39, P3072, DOI 10.1039/b814540g; Cuetos A, 2002, J CHEM PHYS, V117, P2934, DOI 10.1063/1.1491872; de Miguel E, 2002, J CHEM PHYS, V117, P6313, DOI 10.1063/1.1504430; DEMIGUEL E, 1991, MOL PHYS, V74, P405, DOI 10.1080/00268979100102321; Dewar A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011704; DICKE HR, 1985, ANGEW MAKROMOL CHEM, V131, P95, DOI 10.1002/apmc.1985.051310107; Ebrahimi D, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4870932; Friedrichs MS, 2009, J COMPUT CHEM, V30, P864, DOI 10.1002/jcc.21209; GAY JG, 1981, J CHEM PHYS, V74, P3316, DOI 10.1063/1.441483; Gemunden P, 2015, SOFT MATTER, V11, P532, DOI 10.1039/c4sm02075h; Gopinadhan M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.078301; Heinemann T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4902824; Ilnytskyi J, 2001, COMPUT PHYS COMMUN, V134, P23, DOI 10.1016/S0010-4655(00)00187-9; Ilnytskyi JM, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2712438; Ilnytskyi JM, 2002, COMPUT PHYS COMMUN, V148, P43, DOI 10.1016/S0010-4655(02)00467-8; Juszynska-Galazka E, 2014, J PHYS CHEM B, V118, P14982, DOI 10.1021/jp510584w; Karimi-Varzaneh HA, 2011, J COMPUT CHEM, V32, P1475, DOI 10.1002/jcc.21717; Koga M, 2013, MACROMOL CHEM PHYS, V214, P2295, DOI 10.1002/macp.201300353; Li YQ, 2004, J CHEM PHYS, V121, P1133, DOI 10.1063/1.1758938; Li YQ, 2013, J PHYS CHEM B, V117, P2615, DOI 10.1021/jp309135m; Li ZW, 2013, RSC ADV, V3, P813, DOI 10.1039/c2ra22108j; Liu AJ, 2015, SOFT MATTER, V11, P2326, DOI 10.1039/c4sm02344g; Liu H, 2012, ACS MACRO LETT, V1, P1249, DOI 10.1021/mz3003374; Liu YJ, 2014, J AM CHEM SOC, V136, P2602, DOI 10.1021/ja412172f; LUCKHURST GR, 1993, MOL PHYS, V80, P233, DOI 10.1080/00268979300102241; Lyulin AV, 1998, MACROMOLECULES, V31, P4626, DOI 10.1021/ma971105y; Martinez-Felipe A, 2013, IND ENG CHEM RES, V52, P8714, DOI 10.1021/ie303130e; McBride C, 1999, MOL PHYS, V97, P511, DOI 10.1080/00268979909482851; Milano G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3142103; Nielsen SO, 2004, J PHYS-CONDENS MAT, V16, pR481, DOI 10.1088/0953-8984/16/15/R03; Peroukidis SD, 2015, SOFT MATTER, V11, P5999, DOI 10.1039/c5sm00903k; Persson RAX, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4729745; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pujolle-Robic C, 2001, NATURE, V409, P167, DOI 10.1038/35051537; Qi WK, 2012, POLYMER, V53, P634, DOI 10.1016/j.polymer.2011.11.049; Rovigatti L, 2015, SOFT MATTER, V11, P692, DOI 10.1039/c4sm02218a; Sasaki H, 2015, J PHYS CHEM B, V119, P4531, DOI 10.1021/jp512710r; Satoh K, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818418; Shen HJ, 2014, J CHEM THEORY COMPUT, V10, P731, DOI 10.1021/ct400974z; Shibaev VP, 2014, POLYM SCI SER A+, V56, P727, DOI 10.1134/S0965545X14060091; SHILOV S, 1993, MAKROMOL CHEM-THEOR, V2, P21; Skacej G, 2011, SOFT MATTER, V7, P9983, DOI 10.1039/c1sm05709j; Stimson LM, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1948376; Stone JE, 2010, J MOL GRAPH MODEL, V29, P116, DOI 10.1016/j.jmgm.2010.06.010; Sunarso A, 2010, J COMPUT PHYS, V229, P5486, DOI 10.1016/j.jcp.2010.03.047; Nguyen TD, 2014, NANOSCALE, V6, P3083, DOI 10.1039/c3nr05413f; Nguyen TD, 2011, COMPUT PHYS COMMUN, V182, P2307, DOI 10.1016/j.cpc.2011.06.005; van Meel JA, 2008, MOL SIMULAT, V34, P259, DOI 10.1080/08927020701744295; Vanzo D, 2012, SOFT MATTER, V8, P11790, DOI 10.1039/c2sm27114a; Vita F, 2014, ACS MACRO LETT, V3, P91, DOI 10.1021/mz400518x; Ware TH, 2015, SCIENCE, V347, P982, DOI 10.1126/science.1261019; Wilson MR, 2007, CHEM SOC REV, V36, P1881, DOI 10.1039/b612799c; Wilson MR, 1997, J CHEM PHYS, V107, P8654, DOI 10.1063/1.475017; Withers IM, 2003, J CHEM PHYS, V119, P10209, DOI 10.1063/1.1615768; Workineh ZG, 2014, POLYMERS-BASEL, V6, P2082, DOI 10.3390/polym6082082; Wu Z. N., 2014, ANGEW CHEM, V126, P12392, DOI DOI 10.1002/ange.201407390; Xie SJ, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4908047; Xie SJ, 2014, J CHEM PHYS, V140; Xue YH, 2013, PHYS CHEM CHEM PHYS, V15, P15356, DOI 10.1039/c3cp51960k; Yang G, 2012, MACROMOLECULES, V45, P3590, DOI 10.1021/ma2027879; Yang KD, 2014, SOFT MATER, V12, P185, DOI 10.1080/1539445X.2013.858359; Zhou ZX, 2015, J AM CHEM SOC, V137, P2179, DOI 10.1021/ja512179x; Zhu YL, 2013, J COMPUT CHEM, V34, P2197, DOI 10.1002/jcc.23365	74	7	7	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151704	10.1371/journal.pone.0151704	http://dx.doi.org/10.1371/journal.pone.0151704			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986851	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300118
J	Chevalier, J; Chamoux, C; Hammes, F; Chicoye, A				Chevalier, Julie; Chamoux, Catherine; Hammes, Florence; Chicoye, Annie			Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; PLACEBO-CONTROLLED PHASE-3; NATURAL-HISTORY; ORAL BG-12; FRANCE	Objectives The paper aimed to estimate the incremental cost-effectiveness ratio (ICER) at the public published price for delayed-release dimethyl fumarate versus relevant Multiple Sclerosis disease-modifying therapies available in France in June 2015. Methods The economic model was adapted to the French setting in accordance with the Haute Autorite de Sante guidelines using a model previously developed for NICE. A cohort of Relapsing Remitting Multiple Sclerosis patients was simulated over a 30-year time horizon. Twenty one health states were taken into account: Kurtzke Expanded Disability Status Scale (EDSS) 0-9 for Relapsing Remitting Multiple Sclerosis patients, EDSS 0-9 for Secondary Progressive Multiple Sclerosis patients, and death. Estimates of relative treatment efficacy were determined using a mixed-treatment comparison. Probabilities of events were derived from the dimethyl fumarate pivotal clinical trials and the London Ontario Dataset. Costs and utilities were extracted from the published literature from both the payer and societal perspectives. Univariate and probabilistic sensitivity analyses were performed to assess the robustness of the model results. Results From both perspectives, dimethyl fumarate and interferon beta-1a (IFN beta-1a) 44mcg were the two optimal treatments, as the other treatments (IFN beta-1a 30mcg, IFN beta-1b 250mcg, teriflunomide, glatiramer acetate, fingolimod) were dominated on the efficiency frontier. From the societal perspective, dimethyl fumarate versus IFN beta-1a 44mcg incurred an incremental cost of (sic)3,684 and an incremental quality-adjusted life year (QALY) of 0.281, corresponding to an ICER of (sic)13,110/QALY. Conclusions Despite reference threshold for France, dimethyl fumarate can be considered as a cost-effective option as it is on the efficiency frontier.	[Chevalier, Julie; Chicoye, Annie] Mapi Grp, Real World Strategy & Analyt, Paris, France; [Chamoux, Catherine; Hammes, Florence] Biogen France SAS, Econ Sante & Affaires Gouvernement, Nanterre, France; [Chicoye, Annie] ESSEC Business Sch, Inst Hlth Econ & Management, Cergy Pontoise, France	ESSEC Business School	Chevalier, J (corresponding author), Mapi Grp, Real World Strategy & Analyt, Paris, France.	jchevalier@mapigroup.com			Biogen France SAS	Biogen France SAS	Biogen France SAS financed the study, no other current funding sources were received for this study. Julie Chevalier and Annie Chicoye are employed by Mapi Group. Mapi Group provided support in the form of salaries for authors JC and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Catherine Chamoux and Florence Hammes are employed by Biogen France SAS. Biogen France SAS provided support in the form of salaries for authors CC and FH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, ENDORSE ETUDE 109MS3; [Anonymous], 2012, DEFINE ETUDE 109MS30; [Anonymous], 2012, CONFIRM ETUDE 109MS3; [Anonymous], 2014, NICE TECHNOLOGY APPR; Biogen, 2015, UPD SYST REV MIX TRE; Briggs A, 2006, DECISION MODELING HL; Chevalier J, 2013, EUR J HEALTH ECON, V14, P57, DOI 10.1007/s10198-011-0351-x; Confavreux Christian, 2006, Rev Prat, V56, P1313; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; [H. A. d. S HAS], 2012, METH GUID CHOIC METH; Hutchinson M, 2014, CURR MED RES OPIN, V30, P613, DOI 10.1185/03007995.2013.863755; INED [Internet], TABL DE MORT; Kobelt G, 2009, MULT SCLER J, V15, P741, DOI 10.1177/1352458509102771; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leroy E, 2007, MULT SCLER J, V13, P865, DOI 10.1177/1352458507077410; Phillips JT, 2013, 65 AM AC NEUR ANN M; TYSEDMUS, 2012, TYSEDMUS OBSERVATION; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; Zuvich RL, 2009, SEMIN IMMUNOL, V21, P328, DOI 10.1016/j.smim.2009.08.003	23	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150703	10.1371/journal.pone.0150703	http://dx.doi.org/10.1371/journal.pone.0150703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987055	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300024
J	Downing, J; Karter, A; Rodriguez, H; Dow, WH; Adler, N; Schillinger, D; Warton, M; Laraia, B				Downing, Janelle; Karter, Andrew; Rodriguez, Hector; Dow, William H.; Adler, Nancy; Schillinger, Dean; Warton, Margaret; Laraia, Barbara			No Spillover Effect of the Foreclosure Crisis on Weight Change: The Diabetes Study of Northern California (DISTANCE)	PLOS ONE			English	Article							HOME FORECLOSURE; HEALTH; MORBIDITY; STRESS; IMPACT; RISK	The emerging body of research suggests the unprecedented increase in housing foreclosures and unemployment between 2007 and 2009 had detrimental effects on health. Using data from electronic health records of 105,919 patients with diabetes in Northern California, this study examined how increases in foreclosure rates from 2006 to 2010 affected weight change. We anticipated that two of the pathways that explain how the spike in foreclosure rates affects weight gain-increasing stress and declining salutary health behaviors- would be acute in a population with diabetes because of metabolic sensitivity to stressors and health behaviors. Controlling for unemployment, housing prices, temporal trends, and time-invariant confounders with individual fixed effects, we found no evidence of an association between the foreclosure rate in each patient's census block of residence and body mass index. Our results suggest, although more than half of the population was exposed to at least one foreclosure within their census block, the foreclosure crisis did not independently impact weight change.	[Downing, Janelle; Rodriguez, Hector; Dow, William H.; Laraia, Barbara] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Karter, Andrew; Warton, Margaret] Kaiser Permanente, Div Res, Oakland, CA USA; [Adler, Nancy] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Schillinger, Dean] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California Berkeley; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Downing, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	jdowning@berkeley.edu	RODRIGUEZ, HECTOR/Q-7996-2019; Laraia, Barbara/GXG-1829-2022	RODRIGUEZ, HECTOR/0000-0002-6564-2229; Downing, Jae/0000-0002-2382-5537; Dow, William/0000-0002-4080-1668	Neighborhood Effects on Weight Change and Diabetes Risk Factors grant from the NIDDK [R01DK080744]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080744] Funding Source: NIH RePORTER	Neighborhood Effects on Weight Change and Diabetes Risk Factors grant from the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Neighborhood Effects on Weight Change and Diabetes Risk Factors grant R01DK080744 from the NIDDK at www.niddk.nih.gov. These authors have no support or funding to report.	Arcaya M, 2014, CIRCULATION; Arcaya M, 2013, AM J PUBLIC HEALTH, V103, pE50, DOI 10.2105/AJPH.2013.301460; Arnio AN, 2012, SOC SCI RES, V41, P1598, DOI 10.1016/j.ssresearch.2012.05.013; Baumer EP, 2012, SOC SCI QUART, V93, P577, DOI 10.1111/j.1540-6237.2012.00888.x; Bennett GG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000087; Bindman AB, 2008, ANN INTERN MED, V149, P854, DOI 10.7326/0003-4819-149-12-200812160-00004; Buiter W.H, 2008, HOUSING WEALTH ISNT; Burgard SA, 2012, SOC SCI MED, V75, P2215, DOI 10.1016/j.socscimed.2012.08.020; Cagney KA, 2014, J INFORM, V104; Campbell JY, 2009, FORCED SALES HOUSE P; Cannuscio CC, 2012, NURS OUTLOOK, V60, P134, DOI 10.1016/j.outlook.2011.08.004; Catalano R, 2011, ANNU REV PUBL HEALTH, V32, P431, DOI 10.1146/annurev-publhealth-031210-101146; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cui L, 2015, J URBAN EC; Currie J., 2011, IS THERE LINK FORECL; Ellen IG, 2013, J URBAN ECON, V74, P59, DOI 10.1016/j.jue.2012.09.003; Estevao MM, 2011, HAS GREAT RECESSION; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gerardi K., 2013, UNEMPLOYMENT NEGATIV, DOI 10.2139/ssrn.2293152; Goodstein R, 2010, DO FORECLOSURES INCR; Houle JN, 2014, SOC SCI MED, V118, P1, DOI 10.1016/j.socscimed.2014.07.054; Houle JN, 2014, AM J PUBLIC HEALTH, V104, P1073, DOI 10.2105/AJPH.2013.301774; Houle JN, 2014, J EPIDEMIOLOGY COMMU; Immergluck D, 2006, HOUSING STUD, V21, P851, DOI 10.1080/02673030600917743; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Karahan F, 2013, FRB NEW YORK STAFF R; Katz CM, 2011, J RES CRIME DELINQ; Kingsley G. Thomas, 2009, IMPACTS FORECLOSURES; Lacoe J, 2015, J RES CRIME DELINQ; Lin ZG, 2009, J REAL ESTATE FINANC, V38, P387, DOI 10.1007/s11146-007-9093-z; Lindblad MR, 2015, HOUSING STUDIES, P1; McLaughlin KA, 2012, PSYCHOL MED, V42, P1441, DOI 10.1017/S0033291711002613; Moffet HH, 2009, INT J EPIDEMIOL, V38, P38, DOI 10.1093/ije/dyn040; Oliver G, 1999, PHYSIOL BEHAV, V66, P511, DOI 10.1016/S0031-9384(98)00322-9; Pevalin DJ, 2009, J EPIDEMIOL COMMUN H, V63, P949, DOI 10.1136/jech.2008.083477; Pollack CE, 2011, J URBAN HEALTH, V88, P469, DOI 10.1007/s11524-011-9564-7; Pollack CE, 2009, AM J PUBLIC HEALTH, V99, P1833, DOI 10.2105/AJPH.2009.161380; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Ruhm CJ, 2005, J HEALTH ECON, V24, P341, DOI 10.1016/j.jhealeco.2004.09.007; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stucky T. D., 2012, SOCIAL SCI Q, V93, P602; Systems DI, 2006, ADDRESS LEVEL FORECL; Taylor MP, 2007, PSYCHOL MED, V37, P1027, DOI 10.1017/S0033291706009767; Wang SS, 2004, INT J OBESITY, V28, P1333, DOI 10.1038/sj.ijo.0802730; Winkler AE., 2013, MON LABOR REV, V136, P1; Wood JN, 2012, PEDIATRICS, V130, pE358, DOI 10.1542/peds.2011-3755; Yilmazer T, 2015, SOC SCI MED, V130, P234, DOI 10.1016/j.socscimed.2015.02.028	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151334	10.1371/journal.pone.0151334	http://dx.doi.org/10.1371/journal.pone.0151334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26985671	gold, Green Published			2022-12-26	WOS:000372580300062
J	Machisa, MT; Christofides, N; Jewkes, R				Machisa, Mercilene T.; Christofides, Nicola; Jewkes, Rachel			Structural Pathways between Child Abuse, Poor Mental Health Outcomes and Male-Perpetrated Intimate Partner Violence (IPV)	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SOUTH-AFRICAN STRESS; PHYSICAL VIOLENCE; EASTERN CAPE; ALCOHOL; TRAUMA; RISK; SYMPTOMS; BEHAVIOR; AUDIT	Background Violent trauma exposures, including child abuse, are risk factors for PTSD and comorbid mental health disorders. Child abuse experiences of men exacerbate adult male-perpetrated intimate partner violence (IPV). The relationship between child abuse, poor mental health and IPV perpetration is complex but research among the general population is lacking. This study describes the relationship and pathways between history of child abuse exposure and male-perpetrated IPV while exploring the potentially mediating effect of poor mental health. Methods We analysed data from a randomly selected, two-stage clustered, cross-sectional household survey conducted with 416 adult men in Gauteng Province of South Africa. We used multinomial regression modelling to identify associated factors and Structural Equation Modelling (SEM) to test the primary hypothesis that poor mental health (defined as abusing alcohol or having PTSD or depressive symptoms) mediates the relationship between child abuse and IPV perpetration. Results Eighty eight percent of men were physically abused, 55% were neglected, 63% were emotionally abused and 20% were sexually abused at least once in their childhood. Twenty four percent of men had PTSD symptoms, 24% had depressive symptoms and 36% binge drank. Fifty six percent of men physically abused and 31% sexually abused partners at least once in their lifetime. Twenty two percent of men had one episode and 40% had repeat episodes of IPV perpetration. PTSD symptomatology risk increased with severity of child trauma and other trauma. PTSD severity increased the risk for binge drinking. Child trauma, other trauma and PTSD symptomatology increased the severity of depressive symptoms. PTSD symptomatology was comorbid with alcohol abuse and depressive symptoms. Child trauma, having worked in the year before the survey, other trauma and PTSD increased the risk of repeat episodes of IPV perpetration. Highly equitable gender attitudes were protective against single and repeat episodes of IPV perpetration. There was a direct path between the history of child trauma and IPV perpetration and three other indirect paths showing the mediating effects of PTSD, other trauma and gender attitudes. Conclusions Child trauma is a risk factor for both poor mental health and male-perpetrated IPV among men in Gauteng. Male-perpetrated IPV in these settings should be explained through a combination of the Trauma, Feminist, and Intergenerational Transmission of Family Violence theories. Prevention interventions for male-perpetrated IPV in South Africa need to incorporate strategies and therapies to address poor mental health conditions.	[Machisa, Mercilene T.; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Machisa, Mercilene T.; Christofides, Nicola; Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Witwatersrand	Machisa, MT (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Machisa, MT (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	Mercilene.Machisa@mrc.ac.za	Machisa, Mercilene/ABD-2257-2020	Machisa, Mercilene/0000-0001-7275-1100; Jewkes, Rachel/0000-0002-4330-6267				Abrahams N, 2005, AM J PUBLIC HEALTH, V95, P1811, DOI 10.2105/AJPH.2003.035006; Abrahams Naeemah, 2006, Violence Vict, V21, P247; Anderson KL, 1997, J MARRIAGE FAM, V59, P655, DOI 10.2307/353952; Atwoli L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-182; Bell KM, 2009, JAMA-J AM MED ASSOC, V302, P562, DOI 10.1001/jama.2009.1126; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blanchet A, 2012, EUROPEAN J PSYCHOTRA, V3, DOI [10.3402/ejpt.v3403i3400.19225, DOI 10.3402/EJPT.V3403I3400.19225]; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Daigneault I, 2009, CHILD ABUSE NEGLECT, V33, P638, DOI 10.1016/j.chiabu.2009.04.003; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; DUTTON DG, 1995, J TRAUMA STRESS, V8, P299, DOI 10.1007/BF02109566; Edwards D. J. A., 2005, J PSYCHOL AFR, V15, P125; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Frank D, 2008, J GEN INTERN MED, V23, P781, DOI 10.1007/s11606-008-0594-0; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Gevers A, 2014, ROLE MENTAL HLTH PRI, V2014, P7, DOI [10.3402/gha.v7.24741, DOI 10.3402/GHA.V7.24741]; Gupta J, 2008, CAN MED ASSOC J, V179, P535, DOI 10.1503/cmaj.071655; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1007/BF00977235; Holmes WC, 2005, J URBAN HEALTH, V82, pI89, DOI 10.1093/jurban/jti028; Iverson KM, 2011, BEHAV THER, V42, P236, DOI 10.1016/j.beth.2010.06.003; Iverson KM, 2011, PSYCHOSOCIAL TREATME; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R., 2010, CHILD ABUSE NEGLECT; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; Machisa M. T. JR, 2011, WAR HOME GAUTENG GBV; Maneta E, 2012, VIOLENCE VICTIMS, V27, P315, DOI 10.1891/0886-6708.27.3.315; Maniglio R, 2009, CLIN PSYCHOL REV, V29, P647, DOI 10.1016/j.cpr.2009.08.003; Meneses-Gaya C, 2010, ALCOHOL CLIN EXP RES, V34, P1417, DOI 10.1111/j.1530-0277.2010.01225.x; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Orcutt HK, 2003, J TRAUMA STRESS, V16, P381, DOI 10.1023/A:1024470103325; Parry CDH, 2005, ADDICTION, V100, P426, DOI 10.1111/j.1360-0443.2005.01015.x; Peltzer K, 1999, PSYCHOL REP, V85, P646, DOI 10.2466/PR0.85.6.646-650; Peltzer K, 2011, AFRICAN J PSYCHIAT, P14; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Russell M, 2013, PREV SCI; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seedat S, 2000, S AFR J CHILD ADOLES, V12, P38, DOI DOI 10.1080/16826108.2000.9632366; Seedat Soraya, 2005, Violence Vict, V20, P87, DOI 10.1891/vivi.2005.20.1.87; Seth P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120850; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Suliman S., 2005, ANN GEN PSYCHIAT, V4; Taft CT, 2005, J CONSULT CLIN PSYCH, V73, P151, DOI 10.1037/0022-006X.73.1.151; Tomlinson M, 2009, SAMJ S AFR MED J, V99, P368; van der Kolk B. A, 2003, PSYCHOL TRAUMA; Vinck P, 2013, SOC SCI MED, V77, P41, DOI 10.1016/j.socscimed.2012.10.026; Walby Sylvia, 1990, THEORISING PATRIARCH; Watt MH, 2012, J STUD ALCOHOL DRUGS, V73, P549, DOI 10.15288/jsad.2012.73.549; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; Wolf EJ, 2013, J TRAUMA STRESS, V26, P329, DOI 10.1002/jts.21805; Women D. V. A., 2001, PUTTING WOMEN 1; World Health Organization, 2000, WHO MULTICOUNTRY STU	57	52	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150986	10.1371/journal.pone.0150986	http://dx.doi.org/10.1371/journal.pone.0150986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26986056	Green Published, gold			2022-12-26	WOS:000372580300041
J	Vivarelli, F; Canistro, D; Sapone, A; De Nicola, GR; Marquillas, CB; Iori, R; Antonazzo, IC; Gentilini, F; Paolini, M				Vivarelli, Fabio; Canistro, Donatella; Sapone, Andrea; De Nicola, Gina Rosalinda; Marquillas, Clara Babot; Iori, Renato; Antonazzo, Ippazio Cosimo; Gentilini, Fabio; Paolini, Moreno			Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders	PLOS ONE			English	Article							HIGH-FAT DIET; DRUG-METABOLIZING-ENZYMES; TUSCAN BLACK CABBAGE; OXIDATIVE STRESS; NUTRITIONAL ANTIOXIDANTS; ACYLATED ANTHOCYANINS; ENDOTHELIAL-CELLS; SENSITIVE ASSAY; DOWN-REGULATION; SHORT-TERM	Background Obesity is recognized as a leading global health problem, correlated with an increased risk for several chronic diseases. One strategy for weight control management includes the use of vegetables rich in bioactive compounds to counteract weight gain, improve the antioxidant status and stimulate lipid catabolism. Aim of the Study The aim of this study was to investigate the role of Raphanus sativus Sango sprout juice (SSJ), a Brassica extraordinarily rich in anthocyanins (AC) and isothiocyanates (ITCs), in a non-genetic model of obesity (high fat diet-HFD induced). Methods Control groups were fed with HFD or regular diet (RD). After a 10-week period, animals were assigned to experimental units and treated by gavage for 28 days as follows: HFD and RD control groups (rats fed HFD or RD and treated with vehicle only) and HFD-treated groups (rats fed HFD and treated with 15, 75 or 150 mg/kg b.w. of SSJ). Body weight and food consumption were recorded and serum lipid profile was measured (total cholesterol, triglycerides, and non-esterified fatty acids). Hepatic phase-I, phase-II as well as antioxidant enzymatic activities were assessed. Results SSJ lowered total cholesterol level, food intake and liver weight compared with HFD rodents. SSJ at medium dose proved effective in reducing body-weight (similar to 19 g reduction). SSJ was effective in up-regulating the antioxidant enzymes catalase, NAD(P)H:quinone reductase, oxidised glutathione reductase and superoxide dismutase, which reached or exceeded RD levels, as well as the phase II metabolic enzyme UDP-glucuronosyl transferase (up to about 43%). HFD up-regulated almost every cytochrome P450 isoform tested, and a mild down-regulation to baseline was observed after SSJ intervention. Conclusion This work reveals, for the first time, the antioxidant, hypolipidemic and antiobesity potential of SSJ, suggesting its use as an efficient new functional food/nutraceutical product.	[Vivarelli, Fabio; Canistro, Donatella; Sapone, Andrea; Marquillas, Clara Babot; Antonazzo, Ippazio Cosimo; Paolini, Moreno] Univ Bologna, Dept Pharm & Biotechnol, Alma Mater Studiorum, Bologna, Italy; [De Nicola, Gina Rosalinda; Iori, Renato] Ctr Ric Colture Ind CRA CIN, Consiglio Ric Agr Anal Econ Agr, Bologna, Italy; [Gentilini, Fabio] Univ Bologna, Dept Vet Med Sci, Alma Mater Studiorum, Bologna, Italy	University of Bologna; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Bologna	Vivarelli, F; Canistro, D (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Alma Mater Studiorum, Bologna, Italy.	fabio.vivarelli3@unibo.it; donatella.canistro@unibo.it	De Nicola, Gina Rosalinda/AAC-9218-2021; Stefanadis, Christodoulos/ABH-2232-2020	De Nicola, Gina Rosalinda/0000-0002-2916-8662; Stefanadis, Christodoulos/0000-0001-5974-6454; Vivarelli, Fabio/0000-0002-8734-0985; Antonazzo, Ippazio Cosimo/0000-0001-8046-4574; CANISTRO, DONATELLA/0000-0002-6378-1698	Italian Ministry of Education, University and Research	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	All sources of financial and material support were provided by a grant from the Italian Ministry of Education, University and Research.	Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; AITIO A, 1978, ANAL BIOCHEM, V85, P488, DOI 10.1016/0003-2697(78)90245-2; Anwar S, 2014, TOXICOL LETT, V226, P206, DOI 10.1016/j.toxlet.2014.01.048; Arima H, 2010, INTERNAL MED, V49, P2043, DOI 10.2169/internalmedicine.49.3918; Badshah H, 2013, NEUROPEPTIDES, V47, P347, DOI 10.1016/j.npep.2013.06.001; Bailey Y. L., 1967, TECHNIQUES PROTEIN C; Barillari J, 2007, J AGR FOOD CHEM, V55, P5505, DOI 10.1021/jf070558r; BAST A, 1986, TRENDS PHARMACOL SCI, V7, P266, DOI 10.1016/0165-6147(86)90349-4; BAUER C, 1994, TERATOGEN CARCIN MUT, V14, P13, DOI 10.1002/tcm.1770140103; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Box P, 1978, STAT EXPT; Bruce M., 1967, METHOD ENZYMOL, V10, P551; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625; Canistro D, 2004, MUTAT RES-FUND MOL M, V545, P23, DOI 10.1016/j.mrfmmm.2003.08.001; Canistro D, 2009, FOOD CHEM TOXICOL, V47, P454, DOI 10.1016/j.fct.2008.11.040; Canistro D, 2012, FOOD CHEM TOXICOL, V50, P2612, DOI 10.1016/j.fct.2012.05.030; Choi KM, 2012, OBESITY, V20, P1365, DOI 10.1038/oby.2011.388; Cimino F, 2013, GENES NUTR, V8, P391, DOI 10.1007/s12263-012-0324-4; Crujeiras AB, 2013, FREE RADICAL RES, V47, P243, DOI 10.3109/10715762.2013.772604; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; De Nicola GR, 2013, FOOD CHEM, V141, P297, DOI 10.1016/j.foodchem.2013.02.102; de Pascual-Teresa S, 2010, INT J MOL SCI, V11, P1679, DOI 10.3390/ijms11041679; Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; ERNSTER L, 1962, BIOCHIM BIOPHYS ACTA, V58, P171, DOI 10.1016/0006-3002(62)90997-6; Finer N, 2013, ENCY HUMAN NUTR, P404; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fisher CD, 2009, DRUG METAB DISPOS, V37, P2087, DOI 10.1124/dmd.109.027466; Fontaine KR, 2012, INT J OBESITY, V36, P1121, DOI 10.1038/ijo.2011.194; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Ghose R, 2011, LIFE SCI, V89, P57, DOI 10.1016/j.lfs.2011.05.005; Gonzalez-Castejon M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Gupta D, 2012, EXPERT REV CARDIOVAS, V10, P379, DOI [10.1586/ERC.12.4, 10.1586/erc.12.4]; HABIG WH, 1974, J BIOL CHEM, V249, P7130; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Ho JN, 2012, BIOSCI BIOTECH BIOCH, V76, P1068, DOI 10.1271/bbb.110666; Huang HL, 2007, OBES SURG, V17, P1457, DOI 10.1007/s11695-008-9423-0; Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kim KH, 2011, ANNU REV FOOD SCI T, V2, P237, DOI 10.1146/annurev-food-022510-133656; Kolotkin RL, 2012, OBESITY, V20, P2325, DOI 10.1038/oby.2012.104; Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539; Lee YM, 2006, NUTRITION, V22, P956, DOI 10.1016/j.nut.2005.12.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUBET RA, 1985, ARCH BIOCHEM BIOPHYS, V238, P43, DOI 10.1016/0003-9861(85)90138-9; Marinou K, 2010, INT J CARDIOL, V138, P3, DOI 10.1016/j.ijcard.2009.03.135; Matera R, 2015, FOOD CHEM, V166, P397, DOI 10.1016/j.foodchem.2014.06.056; Matera R, 2012, FOOD CHEM, V133, P563, DOI 10.1016/j.foodchem.2012.01.050; Matsuda M, 2014, HORM MOL BIOL CLIN I, V19, P75, DOI 10.1515/hmbci-2014-0001; MAZEL P, 1971, FUNDAMENTALS DRUG ME, P546; Melega S, 2013, BRIT J NUTR, V110, P988, DOI 10.1017/S0007114513000068; Melega S, 2013, MUTAT RES-GEN TOX EN, V751, P45, DOI 10.1016/j.mrgentox.2012.10.013; MISRA HP, 1972, J BIOL CHEM, V247, P3170; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; PAOLINI M, 1991, CARCINOGENESIS, V12, P759, DOI 10.1093/carcin/12.5.759; Paolini M, 1996, J INVEST MED, V44, P470; Puccinelli E, 2013, XENOBIOTICA, V43, P686, DOI 10.3109/00498254.2012.756558; Raunio H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00123; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.3862; Sankhari JM, 2012, J SCI FOOD AGR, V92, P1688, DOI 10.1002/jsfa.5532; Sapone A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/790987; Sheweita SA, 2000, CURR DRUG METAB, V1, P107, DOI 10.2174/1389200003339117; Singla P, 2010, WORLD J DIABETES, V1, P76, DOI 10.4239/wjd.v1.i3.76; Sancho RAS, 2012, FOOD RES INT, V46, P378, DOI 10.1016/j.foodres.2011.11.021; Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395; Tsai AG, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-191; Valgimigli L, 2009, ENVIRON MOL MUTAGEN, V50, P222, DOI 10.1002/em.20468; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; WHO, 1998, WHO OB PREV MAN GLOB; Wu T, 2014, INT J FOOD SCI NUTR, V65, P351, DOI 10.3109/09637486.2013.854749; Wu T, 2013, FOOD FUNCT, V4, P1654, DOI 10.1039/c3fo60251f; Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077585; Xiao Z, 2012, J NUTR, V142, p1377S, DOI 10.3945/jn.111.152041	77	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150913	10.1371/journal.pone.0150913	http://dx.doi.org/10.1371/journal.pone.0150913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987061	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300036
J	Assimes, TL; Lee, IT; Juang, JM; Guo, XQ; Wang, TD; Kim, ET; Lee, WJ; Absher, D; Chiu, YF; Hsu, CC; Chuang, LM; Quertermous, T; Hsiung, CA; Rotter, JI; Sheu, WHH; Chen, YDI; Taylor, KD				Assimes, Themistocles L.; Lee, I. -T.; Juang, Jyh-Ming; Guo, Xiuqing; Wang, Tzung-Dau; Kim, Eric T.; Lee, Wen-Jane; Absher, Devin; Chiu, Yen-Feng; Hsu, Chih-Cheng; Chuang, Lee-Ming; Quertermous, Thomas; Hsiung, Chao A.; Rotter, Jerome I.; Sheu, Wayne H. -H.; Chen, Yii-Der Ida; Taylor, Kent D.			Genetics of Coronary Artery Disease in Taiwan: A Cardiometabochip Study by the Taichi Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HAN CHINESE; VISUALIZATION; POPULATION; VARIANTS	By means of a combination of genome-wide and follow-up studies, recent large-scale association studies of populations of European descent have now identified over 46 loci associated with coronary artery disease (CAD). As part of the TAICHI Consortium, we have collected and genotyped 8556 subjects from Taiwan, comprising 5423 controls and 3133 cases with coronary artery disease, for 9087 CAD SNPs using the CardioMetaboChip. We applied penalized logistic regression to ascertain the top SNPs that contribute together to CAD susceptibility in Taiwan. We observed that the 9p21 locus contributes to CAD at the level of genome-wide significance (rs1537372, with the presence of C, the major allele, the effect estimate is -0.216, standard error 0.033, p value 5.8x10(-10)). In contrast to a previous report, we propose that the 9p21 locus is a single genetic contribution to CAD in Taiwan because: 1) the penalized logistic regression and the follow-up conditional analysis suggested that rs1537372 accounts for all of the CAD association in 9p21, and 2) the high linkage disequilibrium observed for all associated SNPs in 9p21. We also observed evidence for the following loci at a false discovery rate > 5%: SH2B3, ADAMTS7, PHACTR1, GGCX, HTRA1, COL4A1, and LARP6-LRRC49. We also took advantage of the fact that penalized methods are an efficient approach to search for gene-by-gene interactions, and observed that two-way interactions between the PHACTR1 and ADAMTS7 loci and between the SH2B3 and COL4A1 loci contribute to CAD risk. Both the similarities and differences between the significance of these loci when compared with significance of loci in studies of populations of European descent underscore the fact that further genetic association of studies in additional populations will provide clues to identify the genetic architecture of CAD across all populations worldwide.	[Assimes, Themistocles L.; Quertermous, Thomas] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Lee, I. -T.; Sheu, Wayne H. -H.] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrine & Metab, Taichung, Taiwan; [Juang, Jyh-Ming; Wang, Tzung-Dau] Natl Univ, Coll Med, Cardiovasc Ctr, Dept Internal Med,Natl Taiwan Univ Hosp, Taipei, Taiwan; [Juang, Jyh-Ming; Wang, Tzung-Dau] Natl Univ, Coll Med, Div Cardiol, Dept Internal Med,Natl Taiwan Univ Hosp, Taipei, Taiwan; [Guo, Xiuqing; Kim, Eric T.; Rotter, Jerome I.; Chen, Yii-Der Ida; Taylor, Kent D.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Guo, Xiuqing; Kim, Eric T.; Rotter, Jerome I.; Chen, Yii-Der Ida; Taylor, Kent D.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Lee, Wen-Jane] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Absher, Devin; Hsiung, Chao A.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Chiu, Yen-Feng; Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan Town, Miaoli County, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrine & Metab, Taipei 100, Taiwan	Stanford University; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; Taichung Veterans General Hospital; HudsonAlpha Institute for Biotechnology; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital	Taylor, KD (corresponding author), Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.; Taylor, KD (corresponding author), Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.	ktaylor@labiomed.org	Assimes, Themistocles Leonard/D-9696-2015; Rotter, Jerome/AAY-6598-2021; Chuang, Lee-Ming/AAF-3324-2019	Assimes, Themistocles Leonard/0000-0003-2349-0009; Quertermous, Thomas/0000-0002-7645-9067; Juang, Jyh-Ming Jimmy/0000-0003-4767-7636; Lee, I-Te/0000-0003-2665-3635; CHUANG, LEE-MING/0000-0003-0978-2662; WANG, TZUNG-DAU/0000-0002-7180-3607	NHLBI [HL087647]; NIH [K23DK088942]; National Science Council [NSC 98-2314-B-075A-002-MY3]; Taichung Veterans General Hospital, Taichung, Taiwan [TCVGH-1013001C, TCVGH-1013002D]; National Health Research Institutes [BS-094-PP-01, PH-100-PP-03, PH-100-SP-01]; National Center for Advancing Translational Sciences, CTSI grant [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) [DK063491]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109512, R33HL120757, R01HL087647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK088942, P30DK063491] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital, Taichung, Taiwan; National Health Research Institutes(National Health Research Institutes, Japan); National Center for Advancing Translational Sciences, CTSI grant; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The TAICHI study was supported by a grant from NHLBI grant HL087647. TLA is supported by an NIH career development award K23DK088942. The Taiwan Dragon was supported by grants from National Science Council (NSC 98-2314-B-075A-002-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan (TCVGH-1013001C; TCVGH-1013002D). The TCAD was supported by grants from National Science Council (NSC 98-2314-B-075A-002-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan (TCVGH-1013001C; TCVGH-1013002D). The SAPPHIRe was supported by grants from National Health Research Institutes (BS-094-PP-01 & PH-100-PP-03). HALST was supported by grants from National Health Research Institutes (PH-100-SP-01). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.; The TAICHI study was supported by a grant from NHLBI grant HL087647. TLA is support by an NIH career development award K23DK088942. The Taiwan Dragon was supported by grants from National Science Council (NSC 98-2314-B-075A-002-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan (TCVGH-1013001C; TCVGH-1013002D). The TCAD was supported by grants from National Science Council (NSC 98-2314-B-075A-002-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan (TCVGH-1013001C; TCVGH-1013002D). The SAPPHIRe was supported by grants from National Health Research Institutes (BS-094-PP-01 & PH-100-PP-03). HALST was supported by grants from National Health Research Institutes (PH-100-SP-01). The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chang YC, 2012, CLIN ENDOCRINOL, V76, P365, DOI 10.1111/j.1365-2265.2011.04175.x; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Chen HH, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0502-7; Crawley M.J., 2007, R BOOK; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erbilgin A, 2013, J LIPID RES, V54, P1894, DOI 10.1194/jlr.M037085; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Johnson AD, 2013, CIRCULATION, V127, P799, DOI 10.1161/CIRCULATIONAHA.112.111559; Kuo JZ, 2013, DIABETOLOGIA, V56, P2619, DOI 10.1007/s00125-013-3047-1; Lange K, 2014, ANNU REV STAT APPL, V1, P279, DOI 10.1146/annurev-statistics-022513-115638; Lange K, 2013, BIOINFORMATICS, V29, P1568, DOI 10.1093/bioinformatics/btt187; Lee IT, 2014, CHROMOSOME 9P21 VARI, V2014, DOI [10.1155/2014/626907, DOI 10.1155/2014/626907]; Lemmens R, 2013, HUM MOL GENET, V22, P391, DOI 10.1093/hmg/dds436; Liang KW, 2013, J CHIN MED ASSOC, V76, P312, DOI 10.1016/j.jcma.2013.03.005; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Makinen VP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004502; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sheu WHH, 2007, CLIN CHIM ACTA, V382, P117, DOI 10.1016/j.cca.2007.04.013; Sheu WHH, 2013, HUM MOL GENET, V22, P3165, DOI 10.1093/hmg/ddt161; Tsai HJ, 2010, CLIN CHIM ACTA, V411, P2009, DOI 10.1016/j.cca.2010.08.025; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Zhou H, 2011, BIOCOMPUT-PAC SYM, P106	37	19	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0138014	10.1371/journal.pone.0138014	http://dx.doi.org/10.1371/journal.pone.0138014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982883	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900009
J	Vaughan, D; Brogioli, M; Maier, T; White, A; Waldron, S; Rittweger, J; Toigo, M; Wettstein, J; Laczko, E; Fluck, M				Vaughan, David; Brogioli, Michael; Maier, Thomas; White, Andy; Waldron, Sarah; Rittweger, Joern; Toigo, Marco; Wettstein, Jessica; Laczko, Endre; Flueck, Martin			The Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Modifies Exercise-Induced Muscle Metabolism	PLOS ONE			English	Article							GENE I/D POLYMORPHISM; GLUCOSE-UPTAKE; ACE GENE; SERUM; INSULIN; CHROMATOGRAPHY; CARBOHYDRATE; INTENSITY; SYSTEM; FAT	Objective A silencer region (I-allele) within intron 16 of the gene for the regulator of vascular perfusion, angiotensin-converting enzyme (ACE), is implicated in phenotypic variation of aerobic fitness and the development of type II diabetes. We hypothesised that the reportedly lower aerobic performance in non-carriers compared to carriers of the ACE I-allele, i.e. ACE-DD vs. ACE-ID/ACE-II genotype, is associated with alterations in activity-induced glucose metabolism and capillarisation in exercise muscle. Methods Fifty-three, not-specifically trained Caucasian men carried out a one-legged bout of cycling exercise to exhaustion and/or participated in a marathon, the aim being to identify and validate genotype effects on exercise metabolism. Respiratory exchange ratio (RER), serum glucose and lipid concentration, glycogen, and metabolite content in vastus lateralis muscle based on ultra-performance lipid chromatography-mass spectrometry (UPLC-MS), were assessed before and after the cycling exercise in thirty-three participants. Serum metabolites were measured in forty subjects that completed the marathon. Genotype effects were assessed post-hoc. Results Cycling exercise reduced muscle glycogen concentration and this tended to be affected by the ACE I-allele (p = 0.09). The ACE-DD genotype showed a lower maximal RER and a selective increase in serum glucose concentration after exercise compared to ACE-ID and ACE-II genotypes (+24% vs. +2% and -3%, respectively). Major metabolites of mitochondrial metabolism (i.e. phosphoenol pyruvate, nicotinamide adenine dinucleotide phosphate, L-Aspartic acid, glutathione) were selectively affected in vastus lateralis muscle by exercise in the ACE-DD genotype. Capillary-to-fibre ratio was 24%-lower in the ACE-DD genotype. Individuals with the ACE-DD genotype demonstrated an abnormal increase in serum glucose to 7.7 mM after the marathon. Conclusion The observations imply a genetically modulated role for ACE in control of glucose import and oxidation in working skeletal muscle. ACE-DD genotypes thereby transit into a pre-diabetic state with exhaustive exercise, which relates to a lowered muscle capillarisation, and deregulation of mitochondria-associated metabolism.	[Vaughan, David; Brogioli, Michael; Maier, Thomas; Waldron, Sarah; Rittweger, Joern; Flueck, Martin] Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, Manchester M15 6BH, Lancs, England; [Brogioli, Michael; Maier, Thomas] ETH, Inst Human Movement Sci & Sport, Zurich, Switzerland; [White, Andy] Chester Marathon, Chester, Cheshire, England; [Toigo, Marco; Wettstein, Jessica; Flueck, Martin] Univ Zurich, Univ Hosp Balgrist, Zurich, Switzerland; [Laczko, Endre] UZH ETHZ, Funct Genom Ctr Zurich, Zurich, Switzerland; [Brogioli, Michael] Univ Zurich, Univ Hosp Balgrist, Spinal Cord Injury Ctr, Zurich, Switzerland; [Rittweger, Joern] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany	Manchester Metropolitan University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Helmholtz Association; German Aerospace Centre (DLR)	Fluck, M (corresponding author), Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, Manchester M15 6BH, Lancs, England.; Fluck, M (corresponding author), Univ Zurich, Univ Hosp Balgrist, Zurich, Switzerland.	mflueck@research.balgrist.ch	Rittweger, Jörn/A-4308-2009	Rittweger, Jörn/0000-0002-2223-8963; Laczko, Endre/0000-0003-0271-3971				Ahmed SK, 1997, EXP PHYSIOL, V82, P231, DOI 10.1113/expphysiol.1997.sp004012; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bergeron R, 2001, AM J PHYSIOL-REG I, V281, pR1854, DOI 10.1152/ajpregu.2001.281.6.R1854; Bird SR, 2012, MATURITAS, V72, P311, DOI 10.1016/j.maturitas.2012.05.015; Brothers RM, 2006, J PHYSIOL-LONDON, V577, P727, DOI 10.1113/jphysiol.2006.113977; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Carlson BE, 2008, AM J PHYSIOL-HEART C, V295, pH1572, DOI 10.1152/ajpheart.00262.2008; Clifford PS, 2004, J APPL PHYSIOL, V97, P393, DOI 10.1152/japplphysiol.00179.2004; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Essen-Gustavsson B, 2002, ACTA PHYSIOL SCAND, V174, P275, DOI 10.1046/j.1365-201x.2002.00942.x; Flueck M, 2010, EUR J APPL PHYSIOL, V110, P1095, DOI 10.1007/s00421-010-1662-9; Graham TE, 1998, ADV EXP MED BIOL, V441, P271; Halliwill J R, 2001, Exerc Sport Sci Rev, V29, P65, DOI 10.1097/00003677-200104000-00005; Harriss DJ, 2011, INT J SPORTS MED, V32, P819, DOI 10.1055/s-0031-1287829; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; Huang XH, 1998, HUM GENET, V102, P372, DOI 10.1007/s004390050707; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Jamerson KA, 1996, HYPERTENSION, V27, P854, DOI 10.1161/01.HYP.27.4.854; Li RW, 2013, J ANAT, V223, P525, DOI 10.1111/joa.12101; LITHELL H, 1981, DIABETES, V30, P19, DOI 10.2337/diabetes.30.1.19; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McPhee JS, 2009, EXP PHYSIOL, V94, P684, DOI 10.1113/expphysiol.2008.045658; Myerson S, 1999, J APPL PHYSIOL, V87, P1313, DOI 10.1152/jappl.1999.87.4.1313; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; PANAHLOO A, 1995, CIRCULATION, V92, P3390, DOI 10.1161/01.CIR.92.12.3390; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Puthucheary Z, 2011, SPORTS MED, V41, P433, DOI 10.2165/11588720-000000000-00000; Ramos-Jimenez Arnulfo, 2008, Clin Med Circ Respirat Pulm Med, V2, P1; Rieder MJ, 1997, CIRC RES, V80, P312, DOI 10.1161/01.RES.80.3.312; RIFAI N, 1992, CLIN CHEM, V38, P150; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Roberts TJ, 1996, J EXP BIOL, V199, P1651; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Salem Abdel Halim, 2009, BMC Res Notes, V2, P99, DOI 10.1186/1756-0500-2-99; SCHWIELER JH, 1991, N-S ARCH PHARMACOL, V343, P166, DOI 10.1007/BF00168605; Sowers JR, 1997, HYPERTENSION, V29, P691, DOI 10.1161/01.HYP.29.3.691; STAESSEN J, 1987, J APPL PHYSIOL, V63, P188, DOI 10.1152/jappl.1987.63.1.188; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Ginkel S, 2015, SCAND J MED SCI SPOR, V25, pe360, DOI 10.1111/sms.12324; van Ginkel S, 2014, 19 ANN ECSS C AMST N; van Ginkel S, 2015, APPL TRANSL GENOM, V4, P33, DOI 10.1016/j.atg.2015.03.002; Vaughan D, 2013, EUR J APPL PHYSIOL, V113, P1719, DOI 10.1007/s00421-012-2583-6; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; Yang M, 2006, BIOMED ENVIRON SCI, V19, P323	47	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149046	10.1371/journal.pone.0149046	http://dx.doi.org/10.1371/journal.pone.0149046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982073	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000372574900013
J	Kress-Bennett, JM; Hiller, NL; Eutsey, RA; Powell, E; Longwell, MJ; Hillman, T; Blackwell, T; Byers, B; Mell, JC; Post, JC; Hu, FZ; Ehrlich, GD; Janto, BA				Kress-Bennett, Jennifer M.; Hiller, N. Luisa; Eutsey, Rory A.; Powell, Evan; Longwell, Mark J.; Hillman, Todd; Blackwell, Tenisha; Byers, Barbara; Mell, Joshua C.; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.; Janto, Benjamin A.			Identification and Characterization of msf, a Novel Virulence Factor in Haemophilus influenzae	PLOS ONE			English	Article							RICH PROTEIN-A; ACUTE OTITIS-MEDIA; MIDDLE-EAR MUCOSA; UROPATHOGENIC ESCHERICHIA-COLI; LEGIONELLA-PNEUMOPHILA ENHC; BRONCHIAL EPITHELIAL-CELLS; HELICOBACTER-PYLORI; SINORHIZOBIUM-MELILOTI; BIOFILM FORMATION; GENE-EXPRESSION	Haemophilus influenzae is an opportunistic pathogen. The emergence of virulent, non-typeable strains (NTHi) emphasizes the importance of developing new interventional targets. We screened the NTHi supragenome for genes encoding surface-exposed proteins suggestive of immune evasion, identifying a large family containing Sel1-like repeats (SLRs). Clustering identified ten SLR-containing gene subfamilies, each with various numbers of SLRs per gene. Individual strains also had varying numbers of SLR-containing genes from one or more of the subfamilies. Statistical genetic analyses of gene possession among 210 NTHi strains typed as either disease or carriage found a significant association between possession of the SlrVA subfamily (which we have termed, macrophage survival factor, msf) and the disease isolates. The PittII strain contains four chromosomally contiguous msf genes. Deleting all four of these genes (msfA1-4) (KO) resulted in a highly significant decrease in phagocytosis and survival in macrophages; which was fully complemented by a single copy of the msfA1 gene. Using the chinchilla model of otitis media and invasive disease, the KO strain displayed a significant decrease in fitness compared to the WT in coinfections; and in single infections, the KO lost its ability to invade the brain. The singly complemented strain showed only a partial ability to compete with theWT suggesting gene dosage is important in vivo. The transcriptional profiles of the KO and WT in planktonic growth were compared using the NTHi supragenome array, which revealed highly significant changes in the expression of operons involved in virulence and anaerobiosis. These findings demonstrate that the msfA1-4 genes are virulence factors for phagocytosis, persistence, and trafficking to non-mucosal sites.	[Kress-Bennett, Jennifer M.; Hiller, N. Luisa; Eutsey, Rory A.; Powell, Evan; Longwell, Mark J.; Hillman, Todd; Blackwell, Tenisha; Byers, Barbara; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.; Janto, Benjamin A.] Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA; [Kress-Bennett, Jennifer M.; Mell, Joshua C.; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.; Janto, Benjamin A.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Mell, Joshua C.; Ehrlich, Garth D.; Janto, Benjamin A.] Drexel Univ, Coll Med, Ctr Genom Sci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA; [Hiller, N. Luisa] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Allegheny Campus, Pittsburgh, PA USA	Allegheny General Hospital; Drexel University; Drexel University; Carnegie Mellon University; Drexel University	Janto, BA (corresponding author), Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA.; Janto, BA (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.; Janto, BA (corresponding author), Drexel Univ, Coll Med, Ctr Genom Sci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA.	bjanto@drexelmed.edu	Janto, Benjamin/E-7459-2010; Hiller, N. Luisa/A-3739-2016	Janto, Benjamin/0000-0002-3841-4917; Hiller, N. Luisa/0000-0001-6572-1368; Ehrlich, Garth/0000-0003-1140-6594	Allegheny General Hospital, Allegheny-Singer Research Institute; Drexel University College of Medicine; National Institute on Deafness and Other Communication Disorders [DC002148, DC002148-16S1]; National Institute of Allergy and Infectious Diseases [AI080935]; National Institutes of Health [DC002148, AI080935, DC02148-16S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002148] Funding Source: NIH RePORTER	Allegheny General Hospital, Allegheny-Singer Research Institute; Drexel University College of Medicine; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Allegheny General Hospital, Allegheny-Singer Research Institute, Drexel University College of Medicine, National Institute on Deafness and Other Communication Disorders, http://www.nidcd.nih.gov, grant#DC002148 (GDE), National Institute on Deafness and Other Communication Disorders, http://www.nidcd.nih.gov, grant#DC002148-16S1 (GDE), and National Institute of Allergy and Infectious Diseases, http://www.niaid.nih.gov, grant#AI080935 (GDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Allegheny General Hospital, Allegheny-Singer Research Institute, Drexel University College of Medicine and National Institutes of Health grant numbers [DC002148, DC02148-16S1, AI080935 to GDE]. The authors thank Drs. Robert Munson and Lauren Bakaletz for the prsm2211 plasmid used for GFP expression; Dr. William Swords for rabbit anti-NTHi antiserum; Drs. Arnold Smith, Helena Zemlickova, Janet Gilsdorf, Michael Apicella, and Timothy Murphy for NTHi strains; Joshua Earl for bioinformatic assistance; Chandana Batchu for her analysis of the SlrV locus 1; Kortney Marszalek for her help analyzing data from the single infections; Suzanne Ezzo and Amy Cupps for their help caring for and monitoring chinchillas; and Mary O'Toole and Carol Hope for their help with the preparation of the manuscript.	Ahren IL, 2001, MICROB PATHOGENESIS, V31, P151, DOI 10.1006/mpat.2001.0456; Ahren IL, 2001, J INFECT DIS, V184, P150, DOI 10.1086/322016; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Baker M, 2012, NAT METHODS, V9, P23, DOI 10.1038/nmeth.1807; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bandi V, 2001, AM J RESP CRIT CARE, V164, P2114, DOI 10.1164/ajrccm.164.11.2104093; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Bayles KW, 2000, TRENDS MICROBIOL, V8, P274, DOI 10.1016/S0966-842X(00)01762-5; Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; Block SL, 2001, INT J PEDIATR OTORHI, V61, P47, DOI 10.1016/S0165-5876(01)00550-X; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; Brook I, 1998, ACTA OTO-LARYNGOL, V118, P206; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Buchinsky FJ, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-56; CAMMACK R, 1990, BIOCHEMISTRY-US, V29, P8410, DOI 10.1021/bi00488a030; Chen EJ, 2008, MOL MICROBIOL, V69, P1290, DOI 10.1111/j.1365-2958.2008.06362.x; Cheong JWS, 2015, EPIDEMIOL INFECT, V143, P2993, DOI 10.1017/S0950268815000345; Chong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067965; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001; COTTER PA, 1989, J BACTERIOL, V171, P3817, DOI 10.1128/jb.171.7.3817-3823.1989; Craig JE, 2001, FEMS MICROBIOL LETT, V203, P55, DOI 10.1016/S0378-1097(01)00328-7; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dagan R, 2001, J INFECT DIS, V183, P880, DOI 10.1086/319250; Deml L, 2005, INFECT IMMUN, V73, P4732, DOI 10.1128/IAI.73.8.4732-4742.2005; Dohar JE, 2005, LARYNGOSCOPE, V115, P1469, DOI 10.1097/01.mlg.0000172036.82897.d4; DUIM B, 1994, MOL MICROBIOL, V11, P1181, DOI 10.1111/j.1365-2958.1994.tb00394.x; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Erwin AL, 2005, INFECT IMMUN, V73, P5853, DOI 10.1128/IAI.73.9.5853-5863.2005; Eutsey RA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-484; Farjo RS, 2004, PEDIATR INFECT DIS J, V23, P41, DOI 10.1097/01.inf.0000106981.89572.d1; FARLEY MM, 1986, J INFECT DIS, V154, P752, DOI 10.1093/infdis/154.5.752; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FORSGREN J, 1994, INFECT IMMUN, V62, P673, DOI 10.1128/IAI.62.2.673-679.1994; Forsgren J, 1996, ACTA OTO-LARYNGOL, V116, P766, DOI 10.3109/00016489609137922; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004; Gilsdorf JR, 1998, INFECT IMMUN, V66, P5053, DOI 10.1128/IAI.66.11.5053-5059.1998; Gon S, 2000, J BACTERIOL, V182, P5779, DOI 10.1128/JB.182.20.5779-5786.2000; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P137, DOI 10.1016/j.anl.2009.03.012; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janto BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105493; Kelly L, 2011, J MED MICROBIOL, V60, P384, DOI 10.1099/jmm.0.026914-0; Ketterer MR, 1999, INFECT IMMUN, V67, P4161, DOI 10.1128/IAI.67.8.4161-4170.1999; Klein JO, 2000, J LAB CLIN MED, V135, P220, DOI 10.1067/mlc.2000.105614; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Liu MY, 2008, CELL MICROBIOL, V10, P1906, DOI 10.1111/j.1462-5822.2008.01180.x; Liu MY, 2012, CELL HOST MICROBE, V12, P166, DOI 10.1016/j.chom.2012.06.004; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Livorsi DJ, 2012, J INFECTION, V65, P496, DOI 10.1016/j.jinf.2012.08.005; Luthy L, 2002, J BIOL CHEM, V277, P10187, DOI 10.1074/jbc.M108993200; MacNeil JR, 2011, CLIN INFECT DIS, V53, P1230, DOI 10.1093/cid/cir735; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Mittl PRE, 2003, CLIN DIAGN LAB IMMUN, V10, P542, DOI 10.1128/CDLI.10.4.542-545.2003; Mittl PRE, 2000, J BIOL CHEM, V275, P17693, DOI 10.1074/jbc.M001869200; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Murphy TF, 2015, CLIN VACCINE IMMUNOL; MUSSER JM, 1986, INFECT IMMUN, V52, P183, DOI 10.1128/IAI.52.1.183-191.1986; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Newton HJ, 2006, INFECT IMMUN, V74, P1683, DOI 10.1128/IAI.74.3.1683-1691.2006; Nizet V, 1996, J INFECT DIS, V173, P180, DOI 10.1093/infdis/173.1.180; Norton PM, 1999, FEMS IMMUNOL MED MIC, V26, P25, DOI 10.1111/j.1574-695X.1999.tb01369.x; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pastorello I, 2013, MBIO, V4, DOI 10.1128/mBio.00206-13; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettigrew MM, 2002, INFECT IMMUN, V70, P3551, DOI 10.1128/IAI.70.7.3551-3556.2002; Pittman MS, 2005, BIOCHEM SOC T, V33, P190, DOI 10.1042/BST0330190; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Poock SR, 2002, J BIOL CHEM, V277, P23664, DOI 10.1074/jbc.M200731200; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Potter L, 2001, ADV MICROB PHYSIOL, V45, P51, DOI 10.1016/S0065-2911(01)45002-8; Ravcheev DA, 2005, MOL BIOL+, V39, P832; Ravcheev DA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-54; Read TD, 1998, INFECT IMMUN, V66, P1622, DOI 10.1128/IAI.66.4.1622-1631.1998; Resman F, 2011, CLIN MICROBIOL INFEC, V17, P1638, DOI 10.1111/j.1469-0691.2010.03417.x; Roschitzki B, 2011, CURR MICROBIOL, V63, P239, DOI 10.1007/s00284-011-9969-2; Saeed-Kothe A, 2004, APPL ENVIRON MICROB, V70, P4136, DOI 10.1128/AEM.70.7.4136-4143.2004; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shen K, 2005, INFECT IMMUN, V73, P3479, DOI 10.1128/IAI.73.6.3479-3491.2005; Shuel M, 2010, FEMS IMMUNOL MED MIC, V58, P277, DOI 10.1111/j.1574-695X.2009.00634.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIKKEMA DJ, 1992, INFECT IMMUN, V60, P5204, DOI 10.1128/IAI.60.12.5204-5211.1992; St Geme JW, 2002, CELL MICROBIOL, V4, P191; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STGEME JW, 1990, INFECT IMMUN, V58, P4036, DOI 10.1128/IAI.58.12.4036-4044.1990; Strouts FR, 2012, EMERG INFECT DIS, V18, P449, DOI 10.3201/eid1803.110728; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Swords WE, 2003, J ENDOTOXIN RES, V9, P131, DOI 10.1179/096805103125001531; Swords WE, 2001, CELL MICROBIOL, V3, P525, DOI 10.1046/j.1462-5822.2001.00132.x; Tanapongpipat S, 1998, BIOCHEM J, V334, P355, DOI 10.1042/bj3340355; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlich GA, 2002, INFECT IMMUN, V70, P395, DOI 10.1128/IAI.70.1.395-399.2002; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Urosev D, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-19; von Ohle C, 2010, APPL ENVIRON MICROB, V76, P2326, DOI 10.1128/AEM.02090-09; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; WEINER JH, 1988, J BACTERIOL, V170, P1505, DOI 10.1128/jb.170.4.1505-1510.1988; Wells DH, 2007, MOL MICROBIOL, V64, P647, DOI 10.1111/j.1365-2958.2007.05680.x; WILLIAMS AE, 1991, J INFECT DIS, V163, P1366, DOI 10.1093/infdis/163.6.1366; Yao SY, 2004, J BACTERIOL, V186, P6042, DOI [10.1128/JB.186.18.6042-6049.2004, 10.1128/jb.186.18.6042-6049.2004]; Zhang LX, 2000, INFECT IMMUN, V68, P2009, DOI 10.1128/IAI.68.4.2009-2015.2000	127	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149891	10.1371/journal.pone.0149891	http://dx.doi.org/10.1371/journal.pone.0149891			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977929	gold, Green Submitted, Green Published			2022-12-26	WOS:000372572800018
J	Liu, X; Li, JL; Tian, YP; Liao, MG; Zhang, ZW				Liu, Xu; Li, Jinlu; Tian, Yuping; Liao, Mingan; Zhang, Zhenwen			Influence of Berry Heterogeneity on Phenolics and Antioxidant Activity of Grapes and Wines: A Primary Study of the New Winegrape Cultivar Meili (Vitis vinifera L.)	PLOS ONE			English	Article							ANTHOCYANIN EXTRACTABILITY; VARIETAL DIFFERENCES; SUNLIGHT EXPOSURE; PINOT-NOIR; CAPACITY; SKIN; ACCUMULATION; PROFILES; TEMPERATURE; POLYPHENOLS	Wine grapes are usually harvested in vineyards when they ripen. However, not all of the berries in a vineyard ripen homogeneously because of different microclimates around the clusters and berries. In this study, the influence of berry heterogeneity on the phenolic content and antioxidant capacity of grapes and wines under a continental monsoon climate was evaluated for a new wine grape cultivar Meili (Vitis vinifera L.). The total phenolic, flavonoid, flavanol, and monomeric anthocyanin contents in the skin and wine significantly increased with grape density; however, there was no significant difference in the seeds between the two lower densities. The highest values of DPPH free radical-scavenging activity, cupric-reducing antioxidant capacity, and hydroxyl radical-scavenging activity in the skin, seed and wine were detected for the densest berries. The sum of individual phenolic compounds in skin, seed and wine increased with berry density, though no significant difference for skin was observed between the two higher density classes. Hence, the chemical components of Meili grapes and wines were positively associated with the berry density at harvest under the continental monsoon climate.	[Liu, Xu; Li, Jinlu; Tian, Yuping; Zhang, Zhenwen] Northwest A&F Univ, Coll Enol, Yangling, Shaanxi, Peoples R China; [Liu, Xu; Zhang, Zhenwen] Shaanxi Engn Res Ctr Vitiviniculture, Yangling, Shaanxi, Peoples R China; [Liao, Mingan] Sichuan Agr Univ, Dept Hort, Yaan, Sichuan, Peoples R China	Northwest A&F University - China; Sichuan Agricultural University	Zhang, ZW (corresponding author), Northwest A&F Univ, Coll Enol, Yangling, Shaanxi, Peoples R China.; Zhang, ZW (corresponding author), Shaanxi Engn Res Ctr Vitiviniculture, Yangling, Shaanxi, Peoples R China.	zhangzhenwenwine@126.com	Atak, Arif/J-2913-2018	Atak, Arif/0000-0001-7251-2417	National Natural Science Foundation of China [31401819]; National Technology System of Grape Industry [CARS-30-zp-9]; Key Science and Technology Program of Shaanxi Province, China [2014K01-08-01]; National Twelfth Five-Year Plan for Science & Technology Support [2012BAD31B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technology System of Grape Industry; Key Science and Technology Program of Shaanxi Province, China; National Twelfth Five-Year Plan for Science & Technology Support	This work was supported by the National Natural Science Foundation of China (31401819, http://www.nsfc.gov.cn), the National Technology System of Grape Industry (CARS-30-zp-9, http://www.qgqj.com.cn/), the Key Science and Technology Program of Shaanxi Province, China (2014K01-08-01, http://www.sninfo.gov.cn/), and the National Twelfth Five-Year Plan for Science & Technology Support (2012BAD31B07, http://program.most.gov.cn/).	Apak R, 2004, J AGR FOOD CHEM, V52, P7970, DOI 10.1021/jf048741x; Azuma A, 2012, PLANTA, V236, P1067, DOI 10.1007/s00425-012-1650-x; Baiano A, 2011, J AGR FOOD CHEM, V59, P9815, DOI 10.1021/jf203003c; Bavaresco L, 2012, MINI-REV MED CHEM, V12, P1366; Bergqvist J, 2001, AM J ENOL VITICULT, V52, P1; Bindon KA, 2014, J AGR FOOD CHEM, V62, P1130, DOI 10.1021/jf4050606; Boido E, 2011, AUST J GRAPE WINE R, V17, P383, DOI 10.1111/j.1755-0238.2011.00164.x; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Burns J, 2000, J AGR FOOD CHEM, V48, P220, DOI 10.1021/jf9909757; Cheng YF, 2008, THESIS NW A F U; Chorti E, 2010, AM J ENOL VITICULT, V61, P23; Cohen SD, 2012, J EXP BOT, V63, P2655, DOI 10.1093/jxb/err449; Cohen SD, 2010, CRIT REV FOOD SCI, V50, P620, DOI 10.1080/10408390802603441; Coombe B. G., 2004, VITICULTURE, V1, P210; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; Cortell JM, 2006, J AGR FOOD CHEM, V54, P8510, DOI 10.1021/jf0616560; Cortell JM, 2005, J AGR FOOD CHEM, V53, P5798, DOI 10.1021/jf0504770; Di Majo D, 2008, FOOD CHEM, V111, P45, DOI 10.1016/j.foodchem.2008.03.037; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Downey MO, 2004, AUST J GRAPE WINE R, V10, P55, DOI 10.1111/j.1755-0238.2004.tb00008.x; Fanzone M, 2011, J AGR FOOD CHEM, V59, P6120, DOI 10.1021/jf200073k; Casassa LF, 2014, ANNU REV FOOD SCI T, V5, P83, DOI 10.1146/annurev-food-030713-092438; Fournand D, 2006, J AGR FOOD CHEM, V54, P7331, DOI 10.1021/jf061467h; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hara M, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P235, DOI 10.1007/978-1-4614-0634-1_13; Haselgrove L., 2000, Australian Journal of Grape and Wine Research, V6, P141, DOI 10.1111/j.1755-0238.2000.tb00173.x; Jayaprakasha GK, 2001, FOOD CHEM, V73, P285, DOI 10.1016/S0308-8146(00)00298-3; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kontoudakis N, 2011, FOOD CHEM, V124, P767, DOI 10.1016/j.foodchem.2010.06.093; Kreft S, 2002, J EXP BOT, V53, P1801, DOI 10.1093/jxb/erf032; Letaief H, 2008, AM J ENOL VITICULT, V59, P323; Li H, 2008, J FOOD DRUG ANAL, V16, P67; Li YG, 1996, J SCI FOOD AGR, V70, P89, DOI 10.1002/(SICI)1097-0010(199601)70:1&lt;89::AID-JSFA470&gt;3.0.CO;2-N; Lo Scalzo R, 2007, ITAL J FOOD SCI, V19, P329; Lutz M, 2011, J FOOD SCI, V76, pC1088, DOI 10.1111/j.1750-3841.2011.02298.x; Mavi A, 2004, BIOL PHARM BULL, V27, P702, DOI 10.1248/bpb.27.702; Meng JF., 2011, THESIS NW A F U; Meng JF, 2012, FOOD CHEM, V134, P2049, DOI 10.1016/j.foodchem.2012.04.005; *OIV, 2005, REC METH INT AN VINS, V1; Poudel PR, 2008, J FOOD COMPOS ANAL, V21, P622, DOI 10.1016/j.jfca.2008.07.003; Segade SR, 2011, LWT-FOOD SCI TECHNOL, V44, P392, DOI 10.1016/j.lwt.2010.09.004; Rolle L, 2015, FOOD CHEM, V173, P105, DOI 10.1016/j.foodchem.2014.10.033; Rolle L, 2012, AM J ENOL VITICULT, V63, P195, DOI 10.5344/ajev.2012.11069; Rolle L, 2011, J AGR FOOD CHEM, V59, P8796, DOI 10.1021/jf201318x; Rolle L, 2011, J SCI FOOD AGR, V91, P505, DOI 10.1002/jsfa.4213; Rolle L, 2009, AM J ENOL VITICULT, V60, P93; Segade SR, 2013, INT J FOOD SCI TECH, V48, P103, DOI 10.1111/j.1365-2621.2012.03164.x; Song Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0078566, 10.1371/journal.pone.0088106]; Sroka Z, 2003, FOOD CHEM TOXICOL, V41, P753, DOI 10.1016/S0278-6915(02)00329-0; Stojanovic J, 2007, FOOD CHEM, V101, P898, DOI 10.1016/j.foodchem.2006.02.044; Tang K, 2015, J FOOD SCI, V80, pC20, DOI 10.1111/1750-3841.12691; Torchio F, 2010, ANAL CHIM ACTA, V660, P183, DOI 10.1016/j.aca.2009.10.017; Van Leeuw R, 2014, J FOOD COMPOS ANAL, V36, P40, DOI 10.1016/j.jfca.2014.07.001; Vidal S, 2004, ANAL CHIM ACTA, V513, P57, DOI 10.1016/j.aca.2003.10.017; vonGadow A, 1997, FOOD CHEM, V60, P73, DOI 10.1016/S0308-8146(96)00312-3; Wood LG, 2006, J SCI FOOD AGR, V86, P2057, DOI 10.1002/jsfa.2604; Xanthopoulou MN, 2010, FOOD CHEM, V120, P665, DOI 10.1016/j.foodchem.2009.10.058; Xu CM, 2010, FOOD CHEM, V119, P1557, DOI 10.1016/j.foodchem.2009.09.042; Yeh CW, 2003, PHARMACOGENOMICS J, V3, P267, DOI 10.1038/sj.tpj.6500192; Yilmaz Y, 2015, J FOOD PROCESS PRES, V39, P1682, DOI 10.1111/jfpp.12399; Zouid I, 2013, J TEXTURE STUD, V44, P95, DOI 10.1111/jtxs.12001	61	11	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151276	10.1371/journal.pone.0151276	http://dx.doi.org/10.1371/journal.pone.0151276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974974	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600062
J	Maier-Noth, A; Schaal, B; Leathwood, P; Issanchou, S				Maier-Noeth, Andrea; Schaal, Benoist; Leathwood, Peter; Issanchou, Sylvie			The Lasting Influences of Early Food-Related Variety Experience: A Longitudinal Study of Vegetable Acceptance from 5 Months to 6 Years in Two Populations	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; REPEATED EXPOSURE; FLAVOR-FLAVOR; PRESCHOOL-CHILDREN; INCREASE; INFANTS; LIFE; PREFERENCES; PATTERNS; CHILDHOOD	Children's vegetable consumption falls below current recommendations, highlighting the need to identify strategies that can successfully promote better acceptance of vegetables. Recently, experimental studies have reported promising interventions that increase acceptance of vegetables. The first, offering infants a high variety of vegetables at weaning, increased acceptance of new foods, including vegetables. The second, offering an initially disliked vegetable at 8 subsequent meals markedly increased acceptance for that vegetable. So far, these effects have been shown to persist for at least several weeks. We now present follow-up data at 15 months, 3 and 6 years obtained through questionnaire (15 mo, 3y) and experimental (6y) approaches. At 15 months, participants who had been breast-fed were reported as eating and liking more vegetables than those who had been formula-fed. The initially disliked vegetable that became accepted after repeated exposure was still liked and eaten by 79% of the children. At 3 years, the initially disliked vegetable was still liked and eaten by 73% of the children. At 6 years, observations in an experimental setting showed that children who had been breast-fed and children who had experienced high vegetable variety at the start of weaning ate more of new vegetables and liked them more. They were also more willing to taste vegetables than formula-fed children or the no or low variety groups. The initially disliked vegetable was still liked by 57% of children. This follow-up study suggests that experience with chemosensory variety in the context of breastfeeding or at the onset of complementary feeding can influence chemosensory preferences for vegetables into childhood.	[Maier-Noeth, Andrea; Leathwood, Peter] Nestle Res Ctr, POB 44, CH-1000 Lausanne 26, Switzerland; [Schaal, Benoist; Issanchou, Sylvie] CNRS, Ctr Sci Gout & Alimentat UMR6265, F-21000 Dijon, France; [Schaal, Benoist; Issanchou, Sylvie] INRA, Ctr Sci Gout & Alimentat UMR1324, F-21000 Dijon, France; [Schaal, Benoist; Issanchou, Sylvie] Univ Bourgogne Franche Comte, UMR Ctr Sci Gout & Alimentat, F-21000 Dijon, France; [Maier-Noeth, Andrea] Lebensmittelforschung GmbH, Dept Consumer LINK, Nestle Prod Technol Ctr, Singen, Germany	Nestle SA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Nestle SA	Issanchou, S (corresponding author), CNRS, Ctr Sci Gout & Alimentat UMR6265, F-21000 Dijon, France.; Issanchou, S (corresponding author), INRA, Ctr Sci Gout & Alimentat UMR1324, F-21000 Dijon, France.; Issanchou, S (corresponding author), Univ Bourgogne Franche Comte, UMR Ctr Sci Gout & Alimentat, F-21000 Dijon, France.	Sylvie.Issanchou@dijon.inra.fr			Nestle Nutrition	Nestle Nutrition(Nestle SA)	Nestle Nutrition provided funds to Inra to conduct the study. Authors AM and PL were employed by Nestle Research Center when the studies were designed and executed. Nestle provided support in the form of salaries for authors AM and PL. The specific roles of these authors are articulated in the 'author contributions' section. Nestle did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EC, 2012, PUBLIC HEALTH NUTR, V15, P1705, DOI 10.1017/S1368980012002686; Ahern SM, 2014, APPETITE, V80, P154, DOI 10.1016/j.appet.2014.04.016; Allam MDE, 2010, DEVELOPMENTAL SCI, V13, P849, DOI 10.1111/j.1467-7687.2009.00941.x; [Anonymous], 2004, YOUNG PEOPLES HLTH C; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Bouhlal S, 2014, APPETITE, V83, P209, DOI 10.1016/j.appet.2014.07.032; Burnier D, 2011, EUR J CLIN NUTR, V65, P196, DOI 10.1038/ejcn.2010.238; Carruth BR, 2004, J AM DIET ASSOC, V104, pS57, DOI 10.1016/j.jada.2003.10.024; CASHDAN E, 1994, HUM NATURE-INT BIOS, V5, P279, DOI 10.1007/BF02692155; Caton SJ, 2013, BRIT J NUTR, V109, P2089, DOI 10.1017/S0007114512004126; Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527; de Lauzon-Guillain B, 2013, AM J CLIN NUTR, V98, P804, DOI 10.3945/ajcn.112.057026; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Wild V, 2015, PEDIATR OBES, V10, P205, DOI 10.1111/ijpo.244; Gerrish CJ, 2001, AM J CLIN NUTR, V73, P1080; Grieger JA, 2011, PUBLIC HEALTH NUTR, V14, P1939, DOI 10.1017/S1368980011001030; Haller R, 1999, CHEM SENSES, V24, P465, DOI 10.1093/chemse/24.4.465; Hausner H, 2012, APPETITE, V58, P1152, DOI 10.1016/j.appet.2012.03.009; Hausner H, 2010, CLIN NUTR, V29, P141, DOI 10.1016/j.clnu.2009.11.007; Hepper PG, 2013, DEV PSYCHOBIOL, V55, P568, DOI 10.1002/dev.21059; KIMMEL SA, 1994, FOOD TECHNOL-CHICAGO, V48, P92; KUCZYNSKI L, 1990, DEV PSYCHOL, V26, P398, DOI 10.1037/0012-1649.26.3.398; Lin JiaRong, 2003, Nutritional Sciences Journal, V28, P104; Maier A, 2007, APPETITE, V49, P429, DOI 10.1016/j.appet.2007.02.007; Maier A, 2007, FOOD QUAL PREFER, V18, P1023, DOI 10.1016/j.foodqual.2007.04.005; Maier AS, 2008, CLIN NUTR, V27, P849, DOI 10.1016/j.clnu.2008.08.002; Mennella JA, 2002, EARLY HUM DEV, V68, P71, DOI 10.1016/S0378-3782(02)00008-7; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Nicklaus S, 2005, ACTA PAEDIATR, V94, P1023, DOI 10.1080/08035250510025761; Nicklaus S, 2004, FOOD QUAL PREFER, V15, P805, DOI 10.1016/j.foodqual.2004.02.010; Remy E, 2013, J NUTR, V143, P1194, DOI 10.3945/jn.113.175646; Schaal B, 2006, WOODHEAD PUBL FOOD S, P403, DOI 10.1533/9781845691400.3.403; SCHAAL B, 2005, PRENATAL DEV POSTNAT, V2, P51; Scott JA, 2012, NUTRIENTS, V4, P1464, DOI 10.3390/nu4101464; Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9; SULLIVAN SA, 1994, PEDIATRICS, V93, P271; Wardle J, 2003, APPETITE, V40, P155, DOI 10.1016/S0195-6663(02)00135-6; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	38	62	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151356	10.1371/journal.pone.0151356	http://dx.doi.org/10.1371/journal.pone.0151356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968029	Green Published, gold, Green Submitted			2022-12-26	WOS:000371989200047
J	German, P; Bai, S; Liu, XD; Sun, M; Zhou, L; Kalra, S; Zhang, X; Minelli, R; Scott, KL; Mills, GB; Jonasch, E; Ding, Z				German, P.; Bai, S.; Liu, X-D; Sun, M.; Zhou, L.; Kalra, S.; Zhang, X.; Minelli, R.; Scott, K. L.; Mills, G. B.; Jonasch, E.; Ding, Z.			Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function	ONCOGENE			English	Article							PROTEIN-KINASE CK2; TUMOR-SUPPRESSOR PROTEIN; GENE ALTERATIONS; IN-VIVO; MUTATIONS; PRODUCT; COMPLEX; BINDING; HIF; IDENTIFICATION	Loss of von Hippel Lindau (VHL) protein function is a key driver of VHL diseases, including sporadic and inherited clear cell renal cell carcinoma. Modulation of the proteostasis of VHL, especially missense point-mutated VHL, is a promising approach to augmenting VHL levels and function. VHL proteostasis is regulated by multiple mechanisms including folding, chaperone binding, complex formation and phosphorylation. Nevertheless, many details underlying the regulations of VHL proteostasis are unknown. VHL is expressed as two variants, VHL30 and VHL19. Furthermore, the long-form variant of VHL was often detected as multiple bands by western blotting. However, how these multiple species of VHL are generated and whether the process regulates VHL proteostasis and function are unknown. We hypothesized that the two major species are generated by VHL protein cleavage, and the cleavage regulates VHL proteostasis and subsequent function. We characterized VHL species using genetical and pharmacological approaches and showed that VHL was first cleaved at the N-terminus by chymotrypsin C before being directed for proteasomal degradation. Casein kinase 2-mediated phosphorylation at VHL N-terminus was required for the cleavage. Furthermore, inhibition of cleavage stabilized VHL protein and thereby promoted HIF downregulation. Our study reveals a novel mechanism regulating VHL proteostasis and function, which is significant for identifying new drug targets and developing new therapeutic approaches targeting VHL deficiency in VHL diseases.	[German, P.; Bai, S.; Liu, X-D; Sun, M.; Zhou, L.; Kalra, S.; Zhang, X.; Jonasch, E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Minelli, R.; Scott, K. L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mills, G. B.; Ding, Z.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Jonasch, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Unit 1374, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Ding, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ejonasch@mdanderson.org; zding@mdanderson.org		Liu, xiande/0000-0002-9639-0458	University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program; MD Anderson Cancer Center Institutional Research Grant; NIH grant [UO1CA168394, 5 PN2 EY016525-10]; NCI CCSG grant; NATIONAL CANCER INSTITUTE [P30CA016672, U01CA168394] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program; MD Anderson Cancer Center Institutional Research Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI CCSG grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr Kimryn Rathmell for providing renal proximal tubule epithelial cells. This work was supported by a grant from The University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program (ZD), an MD Anderson Cancer Center Institutional Research Grant (ZD), the NIH grant UO1CA168394 (KLS and GBM), the NIH grant 5 PN2 EY016525-10 (EJ) and NCI CCSG grant to MD Anderson Cancer Center.	Ampofo E, 2010, INT J BIOCHEM CELL B, V42, P1729, DOI 10.1016/j.biocel.2010.07.008; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Ding ZY, 2014, CANCER RES, V74, P3127, DOI 10.1158/0008-5472.CAN-13-3213; Ding ZY, 2012, J BIOMOL SCREEN, V17, P572, DOI 10.1177/1087057112436557; DUAN DR, 1995, P NATL ACAD SCI USA, V92, P6459, DOI 10.1073/pnas.92.14.6459; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Guerra B, 2015, CANCER LETT, V356, P751, DOI 10.1016/j.canlet.2014.10.026; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; Jonasch E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4797; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lee CM, 2009, ONCOGENE, V28, P1694, DOI 10.1038/onc.2009.12; Lolkema MP, 2005, J BIOL CHEM, V280, P22205, DOI 10.1074/jbc.M503220200; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Montenarh M, 2014, ADV CLIN EXP MED, V23, P153, DOI 10.17219/acem/37040; Mottet D, 2005, INT J CANCER, V117, P764, DOI 10.1002/ijc.21268; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Pizzi M, 2015, ONCOTARGET, V6, P6544, DOI 10.18632/oncotarget.3446; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rechsteiner MP, 2011, CANCER RES, V71, P5500, DOI 10.1158/0008-5472.CAN-11-0757; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Yang CZ, 2013, CELL REP, V3, P52, DOI 10.1016/j.celrep.2012.12.007	33	7	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 22	2016	35	38					4973	4980		10.1038/onc.2016.40	http://dx.doi.org/10.1038/onc.2016.40			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW9GT	26973240	Green Accepted			2022-12-26	WOS:000383965300002
J	De Gasperin, O; Kilner, RM				De Gasperin, Ornela; Kilner, Rebecca M.			Interspecific Interactions and the Scope for Parent-Offspring Conflict: High Mite Density Temporarily Changes the Trade-Off between Offspring Size and Number in the Burying Beetle, Nicrophorus vespilloides	PLOS ONE			English	Article							PHORETIC MITES; CLUTCH SIZE; EGG SIZE; TACTICS; SILPHIDAE; ASSOCIATIONS; NECROPHORUS; ENVIRONMENT; COMPETITION; COLEOPTERA	Parents have a limited amount of resources to invest in reproduction and commonly trade-off how much they invest in offspring size (or quality) versus brood size. A negative relationship between offspring size and number has been shown in numerous taxa and it underpins evolutionary conflicts of interest between parents and their young. For example, previous work on vertebrates shows that selection favours mothers that produce more offspring, at the expense of individual offspring size, yet favours offspring that have relatively few siblings and therefore attain a greater size at independence. Here we analyse how this trade-off is temporarily affected by stochastic variation in the intensity of interspecific interactions. We examined the effect of the mite Poecilochirus carabi on the relationship between offspring size and number in the burying beetle, Nicrophorus vespilloides. We manipulated the initial number of mites in the reproductive event (by introducing either no mites, 4 mites, 10 mites, or 16 mites), and assessed the effect on the brood. We found a similar trade-off between offspring size and number in all treatments, except in the '16 mite' treatment where the correlation between offspring number and size flattened considerably. This effect arose because larvae in small broods failed to attain a high mass by dispersal. Our results show that variation in the intensity of interspecific interactions can temporarily change the strength of the trade-off between offspring size and number. In this study, high densities of mites prevented individual offspring from attaining their optimal weight, thus potentially temporarily biasing the outcome of parent-offspring conflict in favour of parents.	[De Gasperin, Ornela; Kilner, Rebecca M.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England	University of Cambridge	De Gasperin, O (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	ornela.gasperin@gmail.com	Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758; De Gasperin, Ornela/0000-0003-3415-2072	Cambridge Trust; Mexican Council for Science and Technology (CONACyT); European Research Council (ERC) [310785]; Royal Society	Cambridge Trust; Mexican Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); European Research Council (ERC)(European Research Council (ERC)European Commission); Royal Society(Royal Society of London)	ODeG was supported by the Cambridge Trust and by the Mexican Council for Science and Technology (CONACyT). RMK was supported in part by the European Research Council (ERC) Consolidators grant 310785 BALDWINIAN_BEETLES and by a Wolfson Merit Award from the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BARTLETT J, 1987, BEHAV ECOL SOCIOBIOL, V21, P179, DOI 10.1007/BF00303208; Bates D., 2012, IME4 LINEAR MIXED EF; Boncoraglio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031713; BROWN JM, 1992, ECOLOGY, V73, P463, DOI 10.2307/1940753; De Gasperin O, 2015, ECOL EVOL, V5, P5552, DOI 10.1002/ece3.1795; De Gasperin O, 2015, ECOL ENTOMOL, V40, P787, DOI 10.1111/een.12259; De Gasperin O, 2015, ANIM BEHAV, V109, P199, DOI 10.1016/j.anbehav.2015.08.014; EBERT D, 1993, ARCH HYDROBIOL, P453; EGGERT AK, 1992, BEHAV ECOL SOCIOBIOL, V31, P237, DOI 10.1007/BF00171678; EGGERT AK, 1992, BEHAV ECOL, V3, P243, DOI 10.1093/beheco/3.3.243; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Fleming I. A., 1990, ECOLOGY, V71, P2, DOI DOI 10.2307/1940241; Fox J, 2015, CAR COMPANION APPL R; GLIWICZ ZM, 1992, OECOLOGIA, V91, P463, DOI 10.1007/BF00650317; Godfray HCJ, 1995, AM NAT, P1; Guisande C, 1996, MAR ECOL PROG SER, V143, P37, DOI 10.3354/meps143037; Hopwood PE, 2016, ECOL ENTOMOL, V41, P96, DOI 10.1111/een.12275; House CM, 2007, P ROY SOC B-BIOL SCI, V274, P1309, DOI 10.1098/rspb.2007.0054; Janzen FJ, 2009, J EVOLUTION BIOL, V22, P2222, DOI 10.1111/j.1420-9101.2009.01838.x; Kilner RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07340; Kilner RM, 2012, EVOLUTION OF PARENTAL CARE, P119; Kilner RM, 2012, ADV STUD BEHAV, V38, P283; Lyon BE, 1998, NATURE, V392, P380, DOI 10.1038/32878; MOCK DW, 1992, TRENDS ECOL EVOL, V7, P409, DOI 10.1016/0169-5347(92)90022-4; Muller JK, 2007, BEHAV ECOL, V18, P196, DOI 10.1093/beheco/arl073; Muller J.K., 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P23; Muller JK, 2003, BEHAV ECOL, V14, P212, DOI 10.1093/beheco/14.2.212; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; PUKOWSKI ERNA, 1933, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V27, P518, DOI 10.1007/BF00403155; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauter CM, 2010, BIOSCENE J COLL BIOL, V36, P6; Rozen DE, 2008, P NATL ACAD SCI USA, V105, P17890, DOI 10.1073/pnas.0805403105; Schrader M, 2015, EVOLUTION, V69, P1077, DOI 10.1111/evo.12615; SCHWARZ HH, 1992, OECOLOGIA, V89, P487, DOI 10.1007/BF00317154; Schwarz HH, 1998, J NAT HIST, V32, P159, DOI 10.1080/00222939800770101; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; Smiseth PT, 2005, ANIM BEHAV, V69, P551, DOI 10.1016/j.anbehav.2004.06.004; Smith HG, 1989, PARUS MAJOR J ANIM E, V58, P383, DOI [10.2307/ 4837), DOI 10.2307/4837)]; SPRINGETT BP, 1968, J ANIM ECOL, V37, P417, DOI 10.2307/2957; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; TRUMBO ST, 1990, J INSECT BEHAV, V3, P491, DOI 10.1007/BF01052013; Ward RJ, 2009, BEHAV ECOL; Wilson AJ, 2009, J ANIM ECOL, V78, P354, DOI 10.1111/j.1365-2656.2008.01489.x; Wilson AJ, 2005, J EVOLUTION BIOL, V18, P405, DOI 10.1111/j.1420-9101.2004.00824.x; Wilson DS, 1987, EVOL ECOL, V1, P139, DOI 10.1007/BF02067397	46	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150969	10.1371/journal.pone.0150969	http://dx.doi.org/10.1371/journal.pone.0150969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985819	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300039
J	DeGennaro, CM; Savir, Y; Springer, M				DeGennaro, Christine M.; Savir, Yonatan; Springer, Michael			Identifying Metabolic Subpopulations from Population Level Mass Spectrometry	PLOS ONE			English	Article							FLUX ANALYSIS; CELL METABOLISM; STEM-CELLS; EXPRESSION; MODEL; RATIO	Metabolism underlies many important cellular decisions, such as the decisions to proliferate and differentiate, and defects in metabolic signaling can lead to disease and aging. In addition, metabolic heterogeneity can have biological consequences, such as differences in outcomes and drug susceptibilities in cancer and antibiotic treatments. Many approaches exist for characterizing the metabolic state of a population of cells, but technologies for measuring metabolism at the single cell level are in the preliminary stages and are limited. Here, we describe novel analysis methodologies that can be applied to established experimental methods to measure metabolic variability within a population. We use mass spectrometry to analyze amino acid composition in cells grown in a mixture of C-12- and C-13-labeled sugars; these measurements allow us to quantify the variability in sugar usage and thereby infer information about the behavior of cells within the population. The methodologies described here can be applied to a large range of metabolites and macromolecules and therefore have the potential for broad applications.	[DeGennaro, Christine M.; Springer, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Savir, Yonatan] Technion Israel Inst Technol, Fac Med, Dept Physiol Biophys & Syst Biol, IL-31096 Haifa, Israel	Harvard University; Harvard Medical School; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Springer, M (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	michael_springer@hms.harvard.edu		DeGennaro, Christine/0000-0001-7318-9949	National Science Foundations Grant [1349248]; National Institutes of Health [P50 GM107618]; Milton Fellowship; Novartis Postdoctoral Fellowship; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107618] Funding Source: NIH RePORTER	National Science Foundations Grant(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milton Fellowship; Novartis Postdoctoral Fellowship; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Science Foundations Grant 1349248 and the National Institutes of Health P50 GM107618 (M.S.), the Milton Fellowship and Novartis Postdoctoral Fellowship (C.M.D.), and the Human Frontier Science Program (Y.S.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ahlqvist KJ, 2015, BBA-BIOENERGETICS, V1847, P1380, DOI 10.1016/j.bbabio.2015.05.014; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Canelas AB, 2008, BIOTECHNOL BIOENG, V100, P734, DOI 10.1002/bit.21813; Christensen B, 1999, METAB ENG, V1, P282, DOI 10.1006/mben.1999.0117; Escalante-Chong R, 2015, P NATL ACAD SCI USA, V112, P1636, DOI 10.1073/pnas.1418058112; Gebreselassie NA, 2015, METAB ENG, V31, P132, DOI 10.1016/j.ymben.2015.07.005; Ghosh A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003827; Heinemann M, 2011, CURR OPIN BIOTECH, V22, P26, DOI 10.1016/j.copbio.2010.09.008; Justus CR, 2015, INT J MOL SCI, V16, P11055, DOI 10.3390/ijms160511055; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kotte O, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20135022; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Nargund S, 2014, MOL BIOSYST, V10, P1496, DOI 10.1039/c3mb70348g; NURSE P, 1974, J BACTERIOL, V117, P1108, DOI 10.1128/JB.117.3.1108-1116.1974; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth EC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00350; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; SZYPERSKI T, 1995, EUR J BIOCHEM, V232, P433, DOI 10.1111/j.1432-1033.1995.433zz.x; van Dijk G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00173; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Vasdekis AE, 2015, METAB ENG, V27, P115, DOI 10.1016/j.ymben.2014.09.007; Venturelli OS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002042; Wang J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002041; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Zamboni N, 2011, CURR OPIN BIOTECH, V22, P103, DOI 10.1016/j.copbio.2010.08.009; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151659	10.1371/journal.pone.0151659	http://dx.doi.org/10.1371/journal.pone.0151659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986964	Green Published, gold			2022-12-26	WOS:000372580300107
J	Husseneder, C; Donaldson, JR; Foil, LD				Husseneder, Claudia; Donaldson, Jennifer R.; Foil, Lane D.			Genetically Engineered Yeast Expressing a Lytic Peptide from Bee Venom (Melittin) Kills Symbiotic Protozoa in the Gut of Formosan Subterranean Termites	PLOS ONE			English	Article							ISOPTERA; RHINOTERMITIDAE; BACTERIA	The Formosan subterranean termite, Coptotermes formosanus Shiraki, is a costly invasive urban pest in warm and humid regions around the world. Feeding workers of the Formosan subterranean termite genetically engineered yeast strains that express synthetic protozoacidal lytic peptides has been shown to kill the cellulose digesting termite gut protozoa, which results in death of the termite colony. In this study, we tested if Melittin, a natural lytic peptide from bee venom, could be delivered into the termite gut via genetically engineered yeast and if the expressed Melittin killed termites via lysis of symbiotic protozoa in the gut of termite workers and/or destruction of the gut tissue itself. Melittin expressing yeast did kill protozoa in the termite gut within 56 days of exposure. The expressed Melittin weakened the gut but did not add a synergistic effect to the protozoacidal action by gut necrosis. While Melittin could be applied for termite control via killing the cellulose-digesting protozoa in the termite gut, it is unlikely to be useful as a standalone product to control insects that do not rely on symbiotic protozoa for survival.	[Husseneder, Claudia; Donaldson, Jennifer R.; Foil, Lane D.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Husseneder, C (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	chusseneder@agcenter.lsu.edu		Husseneder, Claudia/0000-0001-5962-9354	Louisiana Agricultural Experiment Station	Louisiana Agricultural Experiment Station	This research was supported by funds from the Louisiana Agricultural Experiment Station to CH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechinger B, 1997, J MEMBRANE BIOL, V156, P197, DOI 10.1007/s002329900201; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; Culliney TW, 2000, B ENTOMOL RES, V90, P9, DOI 10.1017/S0007485300000031; Damianoglou A, 2010, PROTEIN PEPTIDE LETT, V17, P1351, DOI 10.2174/0929866511009011351; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; HIDER RC, 1988, ENDEAVOUR, V12, P60, DOI 10.1016/0160-9327(88)90082-8; Hurwitz I, 2011, INT J BIOL SCI, V7, P1334, DOI 10.7150/ijbs.7.1334; Husseneder C, 2005, APPL MICROBIOL BIOT, V68, P360, DOI 10.1007/s00253-005-1914-5; Husseneder C, 2005, CURR MICROBIOL, V50, P119, DOI 10.1007/s00284-004-4428-y; Husseneder C, 2009, INSECT SYMBIOSIS, V3, P361; Husseneder Claudia, 2010, J Vis Exp, DOI 10.3791/2190; IBM Corporation, 2014, IBM SPSS STAT WIND V; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; LAI P Y, 1983, Proceedings of the Hawaiian Entomological Society, V24, P271; Mutwiri GK, 2000, J PARASITOL, V86, P1355, DOI 10.1645/0022-3395(2000)086[1355:EOTAPD]2.0.CO;2; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Sethi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106199; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; Su N. Y., 1987, Research Extension Series, Hawaii Institute of Tropical Agriculture and Human Resources, P3; Valderrama MJ, 1999, J FOOD PROTECT, V62, P189, DOI 10.4315/0362-028X-62.2.189; YAMIN MA, 1979, SOCIOBIOLOGY, V4, P3; YOSHIMURA T, 1995, MOKUZAI GAKKAISHI, V41, P206; Yoshimura Tsuyoshi, 1995, Wood Research, V82, P68	25	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151675	10.1371/journal.pone.0151675	http://dx.doi.org/10.1371/journal.pone.0151675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985663	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300110
J	Matsubara, K; Yamamoto, E; Kobayashi, N; Ishii, T; Tanaka, J; Tsunematsu, H; Yoshinaga, S; Matsumura, O; Yonemaru, J; Mizobuchi, R; Yamamoto, T; Kato, H; Yano, M				Matsubara, Kazuki; Yamamoto, Eiji; Kobayashi, Nobuya; Ishii, Takuro; Tanaka, Junichi; Tsunematsu, Hiroshi; Yoshinaga, Satoshi; Matsumura, Osamu; Yonemaru, Jun-ichi; Mizobuchi, Ritsuko; Yamamoto, Toshio; Kato, Hiroshi; Yano, Masahiro			Improvement of Rice Biomass Yield through QTL-Based Selection	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; ORYZA-SATIVA L.; MARKER-ASSISTED SELECTION; COMPLEX TRAITS; ARABIDOPSIS-THALIANA; CULTIVARS; EPISTASIS; DISCOVERY; ALLELES	Biomass yield of rice (Oryza sativa L.) is an important breeding target, yet it is not easy to improve because the trait is complex and phenotyping is laborious. Using progeny derived from a cross between two high-yielding Japanese cultivars, we evaluated whether quantitative trait locus (QTL)-based selection can improve biomass yield. As a measure of biomass yield, we used plant weight (aboveground parts only), which included grain weight and stem and leaf weight. We measured these and related traits in recombinant inbred lines. Phenotypic values for these traits showed a continuous distribution with transgressive segregation, suggesting that selection can affect plant weight in the progeny. Four significant QTLs were mapped for plant weight, three for grain weight, and five for stem and leaf weight (at alpha = 0.05); some of them overlapped. Multiple regression analysis showed that about 43% of the phenotypic variance of plant weight was significantly explained (P < 0.0001) by six of the QTLs. From F-2 plants derived from the same parental cross as the recombinant inbred lines, we divergently selected lines that carried alleles with positive or negative additive effects at these QTLs, and performed successive selfing. In the resulting F-6 lines and parents, plant weight significantly differed among the genotypes (at alpha = 0.05). These results demonstrate that QTL-based selection is effective in improving rice biomass yield.	[Matsubara, Kazuki; Kobayashi, Nobuya; Ishii, Takuro; Tanaka, Junichi; Tsunematsu, Hiroshi; Kato, Hiroshi; Yano, Masahiro] NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Yamamoto, Eiji; Yonemaru, Jun-ichi; Mizobuchi, Ritsuko; Yamamoto, Toshio; Kato, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Yoshinaga, Satoshi; Matsumura, Osamu] NARO Agr Res Ctr, Niigata 9430154, Japan; [Yamamoto, Eiji] NARO Inst Vegetable & Tea Sci, Tsu, Mie 5142392, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Matsubara, K (corresponding author), NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan.	vague@affrc.go.jp	Matsubara, Kazuki/S-9378-2019; Yamamoto, Toshio/AAX-7146-2020; Yano, Masahiro/AAC-5441-2019	Matsubara, Kazuki/0000-0002-2084-8362; Yamamoto, Toshio/0000-0002-5209-7735; Yano, Masahiro/0000-0003-1510-4622	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan; Ministry of Agriculture, Forestry and Fisheries, Japan	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan; Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This project was supported by funding from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan, and Ministry of Agriculture, Forestry and Fisheries, Japan to Hiroshi KATO and Masahiro YANO.	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; CHURCHILL GA, 1994, GENETICS, V138, P963; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Goto A, 2009, JARQ-JPN AGR RES Q, V43, P13, DOI 10.6090/jarq.43.13; Grenier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136594; Hill WG, 2010, PHILOS T R SOC B, V365, P73, DOI 10.1098/rstb.2009.0203; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; JIANG CJ, 1995, GENETICS, V140, P1111; Juenger T, 2000, GENETICS, V156, P1379; LANDE R, 1990, GENETICS, V124, P743; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li ZK, 1997, GENETICS, V145, P453; Matsubara K, 2015, J HERED, V106, P113, DOI 10.1093/jhered/esu065; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Ohta H., 2010, B NATL I CROP SCI, V11, P67; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Poland J, 2015, CURR OPIN PLANT BIOL, V24, P119, DOI 10.1016/j.pbi.2015.02.009; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Wang S, 2012, WINDOWS QTL CARTOGRA; Xiao JH, 1998, GENETICS, V150, P899; Yamamoto E, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-50; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yamamoto T, 2009, DNA RES, V16, P141, DOI 10.1093/dnares/dsp006; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112; Yonemaru J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-346; Yonemaru J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032982; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151830	10.1371/journal.pone.0151830	http://dx.doi.org/10.1371/journal.pone.0151830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986071	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300137
J	O'Brien-Simpson, NM; Pantarat, N; Attard, TJ; Walsh, KA; Reynolds, EC				O'Brien-Simpson, Neil M.; Pantarat, Namfon; Attard, Troy J.; Walsh, Katrina A.; Reynolds, Eric C.			A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PEPTIDES; SUSCEPTIBILITY; METHICILLIN; MECHANISM; GROWTH; TIME; MRSA	We describe a microbial flow cytometry method that quantifies within 3 hours antimicrobial peptide (AMP) activity, termed Minimum Membrane Disruptive Concentration (MDC). Increasing peptide concentration positively correlates with the extent of bacterial membrane disruption and the calculated MDC is equivalent to its MBC. The activity of AMPs representing three different membranolytic modes of action could be determined for a range of Gram positive and negative bacteria, including the ESKAPE pathogens, E. coli and MRSA. By using the MDC50 concentration of the parent AMP, the method provides high-throughput, quantitative screening of AMP analogues. A unique feature of the MDC assay is that it directly measures peptide/bacteria interactions and lysed cell numbers rather than bacteria survival as with MIC and MBC assays. With the threat of multi-drug resistant bacteria, this high-throughput MDC assay has the potential to aid in the development of novel antimicrobials that target bacteria with improved efficacy.	[O'Brien-Simpson, Neil M.; Pantarat, Namfon; Attard, Troy J.; Walsh, Katrina A.; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu	O'Brien-Simpson, Neil/B-2901-2009	O'Brien-Simpson, Neil/0000-0001-8462-5603; FCCN, Bogus/0000-0001-6282-8004; Walsh, Katrina/0000-0002-0927-2008	Australian Government, Department of Industry, Innovation and Science; Australian National Health and Medical Research Council Project [1008106]	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science); Australian National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Government, Department of Industry, Innovation and Science and the Australian National Health and Medical Research Council Project (Grant 1008106).	Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x; Bartlett KH, 2004, INT J ANTIMICROB AG, V23, P606, DOI 10.1016/j.ijantimicag.2004.02.018; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Butler T, 2001, J ANTIMICROB CHEMOTH, V48, P903, DOI 10.1093/jac/48.6.903; Casey JT, 2004, J MICROBIOL METH, V58, P327, DOI 10.1016/j.mimet.2004.04.017; CDC, 2000, MMWR-MORBID MORTAL W, V49, P149; Chia CSB, 2011, BIOPOLYMERS, V96, P147, DOI 10.1002/bip.21438; Coombs G, 2007, ANTIMICROBIALS 2007; Fernandez DI, 2009, BBA-BIOMEMBRANES, V1788, P1630, DOI 10.1016/j.bbamem.2008.10.007; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Freire JM, 2015, BBA-BIOMEMBRANES, V1848, P554, DOI 10.1016/j.bbamem.2014.11.001; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Huang TH, 2015, ANAL CHEM, V87, P1941, DOI 10.1021/ac504241x; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kollef MH, 2006, CURR OPIN INFECT DIS, V19, P161, DOI 10.1097/01.qco.0000216627.13445.e2; Kredics L, 2013, CHEM BIODIVERS, V10, P744, DOI 10.1002/cbdv.201200390; Kusuma CM, 2005, ANTIMICROB AGENTS CH, V49, P3256, DOI 10.1128/AAC.49.8.3256-3263.2005; Lambert RJW, 2000, J APPL MICROBIOL, V88, P784, DOI 10.1046/j.1365-2672.2000.01017.x; Lee H, 2015, BBA-BIOMEMBRANES, V1848, P634, DOI 10.1016/j.bbamem.2014.11.016; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lozano-Chiu M, 1999, J CLIN MICROBIOL, V37, P2755, DOI 10.1128/JCM.37.9.2755-2759.1999; Maisetta G, 2013, FEBS J, V280, P2842, DOI 10.1111/febs.12288; Matsuzaki K., 2008, BIOCHIM BIOPHYS ACTA, V8, P8; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Motyl M, 2005, CURR PROTOC PHARM; Ohkushi D, 2013, J INFECT CHEMOTHER, V19, P871, DOI 10.1007/s10156-013-0584-y; Pan JJ, 2009, J MEMBRANE BIOL, V231, P11, DOI 10.1007/s00232-009-9199-8; Raventos D, 2005, COMB CHEM HIGH T SCR, V8, P219, DOI 10.2174/1386207053764549; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; ROZGONYI F, 1990, ACTA MICROBIOL HUNG, V37, P179; Sani MA, 2013, ANTIMICROB AGENTS CH, V57, P3593, DOI 10.1128/AAC.00195-13; Tieleman DP, 1999, BIOPHYS J, V76, P1757, DOI 10.1016/S0006-3495(99)77337-6; Tiwari V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00512; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Wayne PA., 2009, M07A7 CLSI; World Health Organization, 2014, ANT RES GLOB REP SUR; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	38	43	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151694	10.1371/journal.pone.0151694	http://dx.doi.org/10.1371/journal.pone.0151694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986223	Green Published, gold			2022-12-26	WOS:000372580300114
J	Shang, FQ; Zhang, J; Li, Z; Zhang, J; Yin, YJ; Wang, YQ; Marin, TL; Gongol, B; Xiao, H; Zhang, YY; Chen, Z; Shyy, JYJ; Lei, T				Shang, Fenqing; Zhang, Jiao; Li, Zhao; Zhang, Jin; Yin, Yanjun; Wang, Yaqiong; Marin, Traci L.; Gongol, Brendan; Xiao, Han; Zhang, You-yi; Chen, Zhen; Shyy, John Y-J; Lei, Ting			Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ANGIOTENSIN RECEPTOR ANTAGONIST; IMPROVES ENDOTHELIAL FUNCTION; POLY(ADP-RIBOSE) POLYMERASE; ESSENTIAL-HYPERTENSION; OXIDATIVE STRESS; CELL-DEATH; INHIBITION; DYSFUNCTION; EXPRESSION	Hyperglycemia and hypertension impair endothelial function in part through oxidative stress-activated poly (ADP-ribose) polymerase 1 (PARP1). Biguanides and angiotensin II receptor blockers (ARBs) such as metformin and telmisartan have a vascular protective effect. We used cultured vascular endothelial cells (ECs), diabetic and hypertensive rodent models, and AMPKa2-knockout mice to investigate whether metformin and telmisartan have a beneficial effect on the endothelium via AMP-activated protein kinase (AMPK) phosphorylation of PARP1 and thus inhibition of PARP1 activity. The results showed that metformin and telmisartan, but not glipizide and metoprolol, activated AMPK, which phosphorylated PARP1 Ser-177 in cultured ECs and the vascular wall of rodent models. Experiments using phosphorylated/de-phosphorylated PARP1 mutants show that AMPK phosphorylation of PARP1 leads to decreased PARP1 activity and attenuated protein poly (ADP-ribosyl)ation (PARylation), but increased endothelial nitric oxide synthase (eNOS) activity and silent mating type information regulation 2 homolog 1 (SIRT1) expression. Taken together, the data presented here suggest biguanides and ARBs have a beneficial effect on the vasculature by the cascade of AMPK phosphorylation of PARP1 to inhibit PARP1 activity and protein PARylation in ECs, thereby mitigating endothelial dysfunction.	[Shang, Fenqing; Zhang, Jiao; Li, Zhao; Zhang, Jin; Yin, Yanjun; Wang, Yaqiong; Shyy, John Y-J; Lei, Ting] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Cardiovasc Res Ctr, Xian 710049, Peoples R China; [Zhang, Jiao] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiol, Xian 710049, Peoples R China; [Marin, Traci L.; Gongol, Brendan] Loma Linda Univ, Sch Allied Hlth, Dept Cardiopulm Sci, Loma Linda, CA 92350 USA; [Marin, Traci L.; Gongol, Brendan] Loma Linda Univ, Sch Allied Hlth, Dept Anat, Loma Linda, CA 92350 USA; [Marin, Traci L.; Gongol, Brendan] Loma Linda Univ, Sch Med, Dept Cardiopulm Sci, Loma Linda, CA USA; [Marin, Traci L.; Gongol, Brendan] Loma Linda Univ, Sch Med, Dept Anat, Loma Linda, CA USA; [Xiao, Han; Zhang, You-yi] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [Chen, Zhen] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Lei, Ting] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Pathol, Sch Basic Med Sci, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University; Peking University; University of California System; University of California San Diego; Xi'an Jiaotong University	Lei, T (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Cardiovasc Res Ctr, Xian 710049, Peoples R China.; Lei, T (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Pathol, Sch Basic Med Sci, Xian 710049, Peoples R China.	leiting@mail.xjtu.edu.cn	Xiao, Han/T-5032-2019	Bouman-Chen, Zhen/0000-0002-3291-1090	NSFC [81270349, 81300067]; US National Institutes of Health [HL89940, HL108735, HL122368]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089940, R01HL108735, R00HL122368, K99HL122368] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NSFC 81270349, NSFC 81300067, US National Institutes of Health grants HL89940, HL108735, and US National Institutes of Health grant HL122368.	Ambrose HE, 2007, ONCOGENE, V26, P6244, DOI 10.1038/sj.onc.1210434; Andreone TL, 2003, J IMMUNOL, V170, P2113, DOI 10.4049/jimmunol.170.4.2113; Asmar R, 2002, J RENIN-ANGIO-ALDO S, V3, P176, DOI 10.3317/jraas.2002.038; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bellien J, 2007, CLIN SCI, V112, P393, DOI 10.1042/CS20060236; Benndorf RA, 2007, J CARDIOVASC PHARM, V50, P367, DOI 10.1097/FJC.0b013e31811dfbe7; Boyle JG, 2011, DIABETOLOGIA, V54, P1799, DOI 10.1007/s00125-011-2126-4; Cheang WS, 2014, ARTERIOSCL THROM VAS, V34, P830, DOI 10.1161/ATVBAHA.113.301938; Choi SK, 2012, HYPERTENSION, V59, P1060, DOI 10.1161/HYPERTENSIONAHA.111.190140; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; De Acular LGK, 2006, DIABETES CARE, V29, P1083, DOI 10.2337/dc05-2146; Deji N, 2012, BIOCHEM BIOPH RES CO, V418, P559, DOI 10.1016/j.bbrc.2012.01.070; Diamanti-Kandarakis E, 2012, NAT REV ENDOCRINOL, V8, P328, DOI 10.1038/nrendo.2012.69; Dorenkamp M, 2005, EUR J PHARMACOL, V520, P179, DOI 10.1016/j.ejphar.2005.07.020; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Gongol B, 2013, P NATL ACAD SCI USA, V110, P3161, DOI 10.1073/pnas.1222051110; Hans CP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007430; Higashi Y, 2000, J AM COLL CARDIOL, V35, P284, DOI 10.1016/S0735-1097(99)00561-6; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Hong J, 2013, DIABETES CARE, V36, P1304, DOI 10.2337/dc12-0719; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kishi T, 2012, J HYPERTENS, V30, P1646, DOI 10.1097/HJH.0b013e328355860e; Libby P, 2003, DIABETES METAB, V29, pS117, DOI 10.1016/S1262-3636(03)72796-7; Mather KJ, 2001, J AM COLL CARDIOL, V37, P1344, DOI 10.1016/S0735-1097(01)01129-9; Mathews MT, 2008, ARTERIOSCL THROM VAS, V28, P711, DOI 10.1161/ATVBAHA.107.156406; Matsumura T, 2011, ARTERIOSCL THROM VAS, V31, P1268, DOI 10.1161/ATVBAHA.110.222067; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Pacher P, 2002, DIABETES, V51, P514, DOI 10.2337/diabetes.51.2.514; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Paradisi G, 2001, CIRCULATION, V103, P1410, DOI 10.1161/01.CIR.103.10.1410; Qin WD, 2013, BBA-MOL CELL RES, V1833, P59, DOI 10.1016/j.bbamcr.2012.10.013; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Romualdi D, 2008, HUM REPROD, V23, P2127, DOI 10.1093/humrep/den230; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Satoh M, 2010, HYPERTENS RES, V33, P135, DOI 10.1038/hr.2009.190; Scalera F, 2008, HYPERTENSION, V51, P696, DOI 10.1161/HYPERTENSIONAHA.107.104570; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Schiffrin EL, 2002, J HYPERTENS, V20, P71, DOI 10.1097/00004872-200201000-00011; Sharma V, 2008, AM J PHYSIOL-HEART C, V294, pH1609, DOI 10.1152/ajpheart.00949.2007; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; von Lukowicz T, 2008, CARDIOVASC RES, V78, P158, DOI 10.1093/cvr/cvm110; Yuen CY, 2011, CARDIOVASC RES, V90, P122, DOI 10.1093/cvr/cvq392; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	49	33	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151845	10.1371/journal.pone.0151845	http://dx.doi.org/10.1371/journal.pone.0151845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986624	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300140
J	Takahashi, R; Mabuchi, S; Kawano, M; Sasano, T; Matsumoto, Y; Kuroda, H; Kozasa, K; Hashimoto, K; Sawada, K; Kimura, T				Takahashi, Ryoko; Mabuchi, Seiji; Kawano, Mahiru; Sasano, Tomoyuki; Matsumoto, Yuri; Kuroda, Hiromasa; Kozasa, Katsumi; Hashimoto, Kae; Sawada, Kenjiro; Kimura, Tadashi			Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary	PLOS ONE			English	Article							IRINOTECAN HYDROCHLORIDE CPT-11; NUCLEOTIDE-EXCISION-REPAIR; PHASE-I; THERAPEUTIC TARGET; SOLID TUMORS; CANCER; TRABECTEDIN; CISPLATIN; RESISTANT; TOPOTECAN	Objective The objective of this study was to evaluate the antitumor effects of lurbinectedin as a single agent or in combination with existing anticancer agents for clear cell carcinoma (CCC) of the ovary, which is regarded as an aggressive, chemoresistant, histological subtype. Methods Using human ovarian CCC cell lines, the antitumor effects of lurbinectedin, SN-38, doxorubicin, cisplatin, and paclitaxel as single agents were assessed using the MTS assay. Then, the antitumor effects of combination therapies involving lurbinectedin and 1 of the other 4 agents were evaluated using isobologram analysis to examine whether these combinations displayed synergistic effects. The antitumor activity of each treatment was also examined using cisplatin-resistant and paclitaxel-resistant CCC sublines. Finally, we determined the effects of mTORC1 inhibition on the antitumor activity of lurbinectedin-based chemotherapy. Results Lurbinectedin exhibited significant antitumor activity toward chemosensitive and chemoresistant CCC cells in vitro. An examination of mouse CCC cell xenografts revealed that lurbinectedin significantly inhibits tumor growth. Among the tested combinations, lurbinectedin plus SN-38 resulted in a significant synergistic effect. This combination also had strong synergistic effects on both the cisplatin-resistant and paclitaxel-resistant CCC cell lines. Everolimus significantly enhanced the antitumor activity of lurbinectedin-based chemotherapies. Conclusions Lurbinectedin, a new agent that targets active transcription, exhibits antitumor activity in CCC when used as a single agent and has synergistic antitumor effects when combined with irinotecan. Our results indicate that lurbinectedin is a promising agent for treating ovarian CCC, both as a first-line treatment and as a salvage treatment for recurrent lesions that develop after platinum-based or paclitaxel treatment.	[Takahashi, Ryoko; Mabuchi, Seiji; Kawano, Mahiru; Sasano, Tomoyuki; Matsumoto, Yuri; Kuroda, Hiromasa; Kozasa, Katsumi; Hashimoto, Kae; Sawada, Kenjiro; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Mabuchi, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	smabuchi@gyne.med.osaka-u.ac.jp	Mabuchi, Seiji/AAX-1986-2020	Sasano, Tomoyuki/0000-0003-3754-475X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23592446]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-aid for General Scientific Research no. 23592446 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias A, 2010, CANCER-AM CANCER SOC, V116, P1462, DOI 10.1002/cncr.24915; Carter NJ, 2007, DRUGS, V67, P2257, DOI 10.2165/00003495-200767150-00009; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Elez ME, 2014, CLIN CANCER RES, V20, P2205, DOI 10.1158/1078-0432.CCR-13-1880; Erba E, 2000, BRIT J CANCER, V82, P1732; Hisamatsu T, 2013, MOL CANCER THER, V12, P1367, DOI 10.1158/1535-7163.MCT-12-1185; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Itamochi H, 2002, JPN J CANCER RES, V93, P723, DOI 10.1111/j.1349-7006.2002.tb01312.x; Kawano M, 2014, INT J GYNECOL CANCER, V24, P829, DOI 10.1097/IGC.0000000000000143; Leal JFM, 2010, BRIT J PHARMACOL, V161, P1099, DOI 10.1111/j.1476-5381.2010.00945.x; Mabuchi S, 2011, CLIN CANCER RES, V17, P4462, DOI 10.1158/1078-0432.CCR-10-2987; Mabuchi S, 2009, CLIN CANCER RES, V15, P5404, DOI 10.1158/1078-0432.CCR-09-0365; Mathijssen RHJ, 2002, CURR CANCER DRUG TAR, V2, P103, DOI 10.2174/1568009023333890; Molina JR, 2008, CLIN CANCER RES, V14, P7900, DOI 10.1158/1078-0432.CCR-08-0415; Monk BJ, 2010, J CLIN ONCOL, V28, P3107, DOI 10.1200/JCO.2009.25.4037; NIIMI S, 1992, CANCER RES, V52, P328; Nozawa S, 1988, Hum Cell, V1, P426; NOZAWA S, 1991, JPN J CANCER RES, V82, P854, DOI 10.1111/j.1349-7006.1991.tb02713.x; Okamoto A, 2014, 2014 ASCO ANN M J S, V32, p5s; Palanisamy S., 2015, EXPERT OPIN DRUG DEL, V27, P1; Pitot HC, 2000, CLIN CANCER RES, V6, P2236; Poveda A, 2014, J CLIN ONCOL, V32, p5s; Romano M, 2013, INT J CANCER, V133, P2024, DOI 10.1002/ijc.28213; Sasano T, 2015, MOL CANCER RES, V13, P795, DOI 10.1158/1541-7786.MCR-14-0314; Soares DG, 2011, MOL CANCER THER, V10, P1481, DOI 10.1158/1535-7163.MCT-11-0252; Sugiyama T, 1998, CANCER LETT, V128, P211, DOI 10.1016/S0304-3835(98)00065-2; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Taamma A, 2001, J CLIN ONCOL, V19, P1256, DOI 10.1200/JCO.2001.19.5.1256; Takakura S, 2007, INT SURG, V92, P202; Takano M, 2015, 2015 ASCO ANN M J S, V33; Takebayashi Y, 2001, NAT MED, V7, P961, DOI 10.1038/91008; Tomioka Y., 1998, J KURUME MED ASS, V61, P323; Vidal A, 2012, CLIN CANCER RES, V18, P5399, DOI 10.1158/1078-0432.CCR-12-1513; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Zhang N, 2013, INT J ONCOL, V42, P2053, DOI 10.3892/ijo.2013.1906	35	20	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151050	10.1371/journal.pone.0151050	http://dx.doi.org/10.1371/journal.pone.0151050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986199	gold, Green Published			2022-12-26	WOS:000372580300042
J	Terragni, R; Morselli-Labate, AM; Vignoli, M; Bottero, E; Brunetti, B; Saunders, JH				Terragni, Rossella; Morselli-Labate, Antonio M.; Vignoli, Massimo; Bottero, Enrico; Brunetti, Barbara; Saunders, Jimmy H.			Is Serum Total LDH Evaluation Able to Differentiate between Alimentary Lymphoma and Inflammatory Bowel Disease in a Real World Clinical Setting?	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE ACTIVITY; GASTROINTESTINAL INFLAMMATION; MUSCULARIS PROPRIA; CELL LYMPHOMA; FELINE; CLASSIFICATION; CATS; DIAGNOSIS; BIOPSY; DOGS	Context An increase in enzyme lactate dehydrogenase (LDH) in serum is a negative prognostic factor for survival in cats affected by lymphoma. Measuring LDH at the time of diagnosis has been studied for differentiating neoplastic disease from non-neoplastic disease in dogs. Inflammatory bowel disease (IBD) and alimentary lymphoma are common diseases in cats. Objective The aim of this study was to determine whether elevation of total LDH occurred in cats with alimentary lymphoma and non-neoplastic gastrointestinal disease, such as IBD, and to evaluate whether this enzyme is useful in supporting the differential diagnosis of these specific diseases. Materials and Methods A prospective non-randomized controlled study was carried-out in a real world setting of three Italian private veterinary clinics. Seventy-one client-owned cats with a history of chronic gastrointestinal symptoms were enrolled; 33 cats were histologically diagnosed as having alimentary lymphoma and 38 cats as having IBD. Serum samples of total LDH analysis were measured. Results Gender (P = 0.016) and age (P = 0.046) were found to be significant factors influencing the differentiation of serum total LDH between cats with alimentary lymphoma and those with IBD. Despite low diagnostic accuracy in the overall population (63%), a cut-off value of serum total LDH ranging from 0.85- to 1.04-times the upper reference limit showed good capability (accuracy >80%) of differentiating these two conditions in neutered males and cats younger than 8 years of age (AUC: 0.805, 0.833; sensitivities: 76.9%, 83.3%; specificities: 80.0%, 76.5%; PPV: 76.9%, 55.6%; NPV: 80.0%, 92.9%; respectively). Conclusions Although our study showed that gender and age are significant factors in differentiating serum total LDH between cats with alimentary lymphoma and those with IBD, this test had poor diagnostic accuracy in differentiating between these two conditions in the overall population.	[Terragni, Rossella] Petcare Vet Assoc, Marzabotto, BO, Italy; [Morselli-Labate, Antonio M.] Univ Bologna, Alma Mater Studiorum, Dept Med & Surg Sci, Bologna, Italy; [Brunetti, Barbara] Univ Bologna, Alma Mater Studiorum, Dept Vet Med Sci, Bologna, Italy; [Vignoli, Massimo] Univ Teramo, Fac Vet Med, Piano Daccio, TE, Italy; [Bottero, Enrico] Argentina Polyclin, Arma Di Taggia, IM, Italy; [Saunders, Jimmy H.] Univ Ghent, Fac Vet Med, Med Imaging, B-9000 Ghent, Belgium	University of Bologna; University of Bologna; University of Teramo; Ghent University	Terragni, R (corresponding author), Petcare Vet Assoc, Marzabotto, BO, Italy.	terragni.rossella@gmail.com	Vignoli, Massimo/R-5134-2019; Brunetti, Barbara/AAK-1860-2021	Vignoli, Massimo/0000-0002-4981-4051; BRUNETTI, BARBARA/0000-0002-2694-905X				Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; Barrs V, 2012, J FELINE MED SURG, V14, P182, DOI 10.1177/1098612X12439265; Bilir C, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0497-y; Chino J, 2013, J VET MED SCI, V75, P701, DOI 10.1292/jvms.12-0246; Daniaux LA, 2014, J FELINE MED SURG, V16, P89, DOI 10.1177/1098612X13498596; Day MJ, 2008, J COMP PATHOL, V138, pS1, DOI 10.1016/j.jcpa.2008.01.001; Grover S, 2005, COMP CONT EDUC PRACT, V27, P741; Gustafson TL, 2014, J AM ANIM HOSP ASSOC, V50, P46, DOI 10.5326/JAAHA-MS-5989; Hadden AG, 2008, J VET INTERN MED, V22, P153, DOI 10.1111/j.1939-1676.2007.0031.x; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Guzman-de la Garza FJ, 2013, CLINICS, V68, P1034, DOI 10.6061/clinics/2013(07)23; Jergens AE, 2014, VET PATHOL, V51, P946, DOI 10.1177/0300985813511123; Jergens AE, 2012, J FELINE MED SURG, V14, P445, DOI 10.1177/1098612X12451548; Jung SH, 2015, ACTA HAEMATOL-BASEL, V133, P10, DOI 10.1159/000360068; Marconato L, 2009, VET COMP ONCOL, V7, P236, DOI 10.1111/j.1476-5829.2009.00196.x; Marconato L, 2010, JAVMA-J AM VET MED A, V236, P969, DOI 10.2460/javma.236.9.969; Patel S, 2015, J CANCER RES THER, V11, P119, DOI 10.4103/0973-1482.138193; PEZZILLI R, 1995, DIGEST DIS SCI, V40, P2341, DOI 10.1007/BF02063235; Rissetto K, 2011, J AM ANIM HOSP ASSOC, V47, P28, DOI 10.5326/JAAHA-MS-5554; Russell KJ, 2012, J FELINE MED SURG, V14, P910, DOI 10.1177/1098612X12454861; Santagostino SF, 2015, VET PATHOL, V52, P250, DOI 10.1177/0300985814537529; Scott KD, 2011, J VET INTERN MED, V25, P1253, DOI 10.1111/j.1939-1676.2011.00831.x; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Washabau RJ, 2010, J VET INTERN MED, V24, P10, DOI 10.1111/j.1939-1676.2009.0443.x; Washizu T, 2002, VET RES COMMUN, V26, P341, DOI 10.1023/A:1016278409138; Wu XZ, 2010, WORLD J GASTROENTERO, V16, P4084, DOI 10.3748/wjg.v16.i32.4084; Zhao Z, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/140913; Zwingenberger AL, 2010, J VET INTERN MED, V24, P289, DOI 10.1111/j.1939-1676.2009.0457.x	28	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151641	10.1371/journal.pone.0151641	http://dx.doi.org/10.1371/journal.pone.0151641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986208	Green Published, gold			2022-12-26	WOS:000372580300102
J	Shah, NS; Ridgway, JP; Pettit, N; Fahrenbach, J; Robicsek, A				Shah, Nirav S.; Ridgway, Jessica P.; Pettit, Natasha; Fahrenbach, John; Robicsek, Ari			Documenting Penicillin Allergy: The Impact of Inconsistency	PLOS ONE			English	Article							IMMEDIATE HYPERSENSITIVITY REACTIONS; HOSPITALIZED-PATIENTS; CARE; PREVALENCE; VARIABILITY	Background Allergy documentation is frequently inconsistent and incomplete. The impact of this variability on subsequent treatment is not well described. Objective To determine how allergy documentation affects subsequent antibiotic choice. Design Retrospective, cohort study. Participants 232,616 adult patients seen by 199 primary care providers (PCPs) between January 1, 2009 and January 1, 2014 at an academic medical system. Main Measures Inter-physician variation in beta-lactam allergy documentation; antibiotic treatment following beta-lactam allergy documentation. Key Results 15.6% of patients had a reported beta-lactam allergy. Of those patients, 39.8% had a specific allergen identified and 22.7% had allergic reaction characteristics documented. Variation between PCPs was greater than would be expected by chance (all p<0.001) in the percentage of their patients with a documented beta-lactam allergy (7.9% to 24.8%), identification of a specific allergen (e.g. amoxicillin as opposed to "penicillins") (24.0% to 58.2%) and documentation of the reaction characteristics (5.4% to 51.9%). After beta-lactam allergy documentation, patients were less likely to receive penicillins (Relative Risk [RR] 0.16 [95% Confidence Interval: 0.15-0.17]) and cephalosporins (RR 0.28 [95% CI 0.27-0.30]) and more likely to receive fluoroquinolones (RR 1.5 [95% CI 1.5-1.6]), clindamycin (RR 3.8 [95% CI 3.6-4.0]) and vancomycin (RR 5.0 [95% CI 4.3-5.8]). Among patients with beta-lactam allergy, rechallenge was more likely when a specific allergen was identified (RR 1.6 [95% CI 1.5-1.8]) and when reaction characteristics were documented (RR 2.0 [95% CI 1.8-2.2]). Conclusions Provider documentation of beta-lactam allergy is highly variable, and details of the allergy are infrequently documented. Classification of a patient as beta-lactam allergic and incomplete documentation regarding the details of the allergy lead to beta-lactam avoidance and use of other antimicrobial agents, behaviors that may adversely impact care quality and cost.	[Shah, Nirav S.; Ridgway, Jessica P.; Pettit, Natasha; Robicsek, Ari] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Fahrenbach, John; Robicsek, Ari] Northshore Univ HealthSyst, Dept Clin Analyt, Evanston, IL USA; [Robicsek, Ari] Northshore Univ HealthSyst, Dept Med, Evanston, IL USA	University of Chicago; NorthShore University Health System; NorthShore University Health System	Shah, NS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	Nss197@gmail.com		fahrenbach, john/0000-0001-6785-9707	NorthShore University HealthSystems	NorthShore University HealthSystems	AR received funding through NorthShore University HealthSystems, (http://www.northshore.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABSY M, 1994, SOUTHERN MED J, V87, P805, DOI 10.1097/00007611-199408000-00007; Albin S, 2014, ALLERGY ASTHMA PROC, V35, P489, DOI 10.2500/aap.2014.35.3791; Borch JE, 2006, BASIC CLIN PHARMACOL, V98, P357, DOI 10.1111/j.1742-7843.2006.pto_230.x; deShazo RD, 1997, JAMA-J AM MED ASSOC, V278, P1895, DOI 10.1001/jama.278.22.1895; Edelson DP, 2014, J HOSP MED, V9, P353, DOI 10.1002/jhm.2174; GADDE J, 1993, JAMA-J AM MED ASSOC, V270, P2456, DOI 10.1001/jama.270.20.2456; Hart JL, 2015, JAMA INTERN MED, V175, P1019, DOI 10.1001/jamainternmed.2015.0372; KERR JR, 1994, BRIT J CLIN PRACT, V48, P5; Lee CE, 2000, ARCH INTERN MED, V160, P2819, DOI 10.1001/archinte.160.18.2819; Likosky DS, 2014, J THORAC CARDIOV SUR, V148, P3084, DOI 10.1016/j.jtcvs.2014.07.106; LIN RY, 1992, ARCH INTERN MED, V152, P930, DOI 10.1001/archinte.152.5.930; MacLaughlin EJ, 2000, ARCH FAM MED, V9, P722, DOI 10.1001/archfami.9.8.722; Macy E, 2011, CLIN EXP ALLERGY, V41, P1498, DOI 10.1111/j.1365-2222.2011.03837.x; Macy E, 2009, PERM J, V13, P12; Macy E, 2014, J ALLERGY CLIN IMMUN, V133, P790, DOI 10.1016/j.jaci.2013.09.021; Macy E, 2013, J ALLER CL IMM-PRACT, V1, P258, DOI 10.1016/j.jaip.2013.02.002; Macy E, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.01.034; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; OSWALD NTA, 1983, BRIT MED J, V287, P265, DOI 10.1136/bmj.287.6387.265; PRESTON SL, 1994, AM J HOSP PHARM, V51, P79, DOI 10.1093/ajhp/51.1.79; Robinson JL, 2002, CLIN INFECT DIS, V35, P26, DOI 10.1086/340740; Sade K, 2003, CLIN EXP ALLERGY, V33, P501, DOI 10.1046/j.1365-2222.2003.01638.x; Salkind AR, 2001, JAMA-J AM MED ASSOC, V285, P2498, DOI 10.1001/jama.285.19.2498; SAXON A, 1987, ANN INTERN MED, V107, P204, DOI 10.7326/0003-4819-107-2-204; SOGN DD, 1992, ARCH INTERN MED, V152, P1025, DOI 10.1001/archinte.152.5.1025; Solensky R, 2000, ANN ALLERG ASTHMA IM, V84, P329, DOI 10.1016/S1081-1206(10)62782-2; Solensky R, 2003, CLIN REV ALLERG IMMU, V24, P201, DOI 10.1385/CRIAI:24:3:201; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Soto CM, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-22; SURTEES SJ, 1991, BRIT MED J, V302, P1051, DOI 10.1136/bmj.302.6784.1051; WEISS ME, 1988, CLIN ALLERGY, V18, P515, DOI 10.1111/j.1365-2222.1988.tb02904.x; WICKERN GM, 1994, J ALLERGY CLIN IMMUN, V94, P725, DOI 10.1016/0091-6749(94)90180-5; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; Wyatt JP, 1996, J ACCID EMERG MED, V13, P114	34	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150514	10.1371/journal.pone.0150514	http://dx.doi.org/10.1371/journal.pone.0150514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981866	gold, Green Published			2022-12-26	WOS:000372574900042
J	Barnard, S; Marshall-Pescini, S; Passalacqua, C; Beghelli, V; Capra, A; Normando, S; Pelosi, A; Valsecchi, P				Barnard, Shanis; Marshall-Pescini, Sarah; Passalacqua, Chiara; Beghelli, Valentina; Capra, Alexa; Normando, Simona; Pelosi, Annalisa; Valsecchi, Paola			Does Subjective Rating Reflect Behavioural Coding? Personality in 2 Month-Old Dog Puppies: An Open-Field Test and Adjective-Based Questionnaire	PLOS ONE			English	Article							CANIS-FAMILIARIS; DOMESTIC DOG; GUIDE DOGS; PREDICTIVE-VALIDITY; SERVICE DOGS; TEMPERAMENT; TRAITS; DIMENSIONS; BOLDNESS; METHODOLOGY	A number of studies have recently investigated personality traits in non-human species, with the dog gaining popularity as a subject species for research in this area. Recent research has shown the consistency of personality traits across both context and time for adult dogs, both when using questionnaire based methods of investigation and behavioural analyses of the dogs' behaviour. However, only a few studies have assessed the correspondence between these two methods, with results varying considerably across studies. Furthermore, most studies have focused on adult dogs, despite the fact that an understanding of personality traits in young puppies may be important for research focusing on the genetic basis of personality traits. In the current study, we sought to evaluate the correspondence between a questionnaire based method and the in depth analyses of the behaviour of 2-month old puppies in an open-field test in which a number of both social and non-social stimuli were presented to the subjects. We further evaluated consistency of traits over time by re-testing a subset of puppies. The correspondence between methods was high and test-retest consistency (for the main trait) was also good using both evaluation methods. Results showed clear factors referring to the two main personality traits 'extroversion,' (i.e. the enthusiastic, exuberant approach to the stimuli) and 'neuroticism,' (i.e. the more cautious and fearful approach to the stimuli), potentially similar to the shyness-boldness dimension found in previous studies. Furthermore, both methods identified an 'amicability' dimension, expressing the positive interactions the pups directed at the humans stranger, and a 'reservedness' dimension which identified pups who largely chose not to interact with the stimuli, and were defined as quiet and not nosey in the questionnaire.	[Barnard, Shanis; Pelosi, Annalisa; Valsecchi, Paola] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Marshall-Pescini, Sarah] Univ Vienna, Comparat Cognit, Messerli Res Inst, Univ Vet Med,Med Univ Vienna, Vienna, Austria; [Marshall-Pescini, Sarah] Wolf Sci Ctr, Ernstbrunn, Austria; [Passalacqua, Chiara] Univ Milan, Sez Neurosci, Dipartimento Fisiopatol Med Chirurg & Trapianti, Milan, Italy; [Beghelli, Valentina] Univ Bologna, Dipartimento Sci Med Vet, Bologna, Italy; [Capra, Alexa] Assoc Sport Dilettantist, Gentle Team, Asti, Italy; [Normando, Simona] Univ Padua, Dipartimento Biomed Comparata & Alimentaz, Padua, Italy; [Barnard, Shanis] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	University of Parma; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Milan; University of Bologna; University of Padua; Queens University Belfast	Marshall-Pescini, S (corresponding author), Univ Vienna, Comparat Cognit, Messerli Res Inst, Univ Vet Med,Med Univ Vienna, Vienna, Austria.; Marshall-Pescini, S (corresponding author), Wolf Sci Ctr, Ernstbrunn, Austria.	sarah.marshall@vetmeduni.ac.at	Barnard, Shanis/J-7151-2012	Valsecchi, Paola/0000-0002-0491-9845; Marshall-Pescini, Sarah/0000-0002-5944-4701	Universita di Parma; Universita di Milano; Universita di Bologna; Universita di Milan; European Research Council under the European Union [311870]	Universita di Parma; Universita di Milano; Universita di Bologna; Universita di Milan; European Research Council under the European Union(European Research Council (ERC))	Shanis Barnard, Chiara Passalacqua and Valentina Beghelli were supported by a doctoral grant from the Universita di Parma, Universita di Milano and Universita di Bologna respectively. Sarah Marshall-Pescini was supported by a postdoctoral grant from the Universita di Milan and funds from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. [311870]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrier LO, 2013, APPL ANIM BEHAV SCI, V146, P96, DOI 10.1016/j.applanim.2013.04.002; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; De Meester RH, 2008, J VET BEHAV, V3, P161, DOI 10.1016/j.jveb.2007.10.005; Diederich C, 2006, APPL ANIM BEHAV SCI, V97, P51, DOI 10.1016/j.applanim.2005.11.018; Dowling-Guyer S, 2011, APPL ANIM BEHAV SCI, V130, P107, DOI 10.1016/j.applanim.2010.12.004; Duffy D. L., 2008, J VET BEHAV, V3, P186, DOI DOI 10.1016/j.jveb.2007.12.010; Duffy DL, 2012, APPL ANIM BEHAV SCI, V138, P99, DOI 10.1016/j.applanim.2012.02.011; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; FUNDER DC, 1995, PSYCHOL REV, V102, P652, DOI 10.1037/0033-295X.102.4.652; Godbout M, 2011, EXCESSIVE MOUTHING P, V6, P93; Godbout M, 2007, J VET BEHAV, V2, P126, DOI 10.1016/j.jveb.2007.06.002; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; Goodmann P.A., 2002, WOLF ETHOGRAM; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Handelman B., 2012, CANINE BEHAV PHOTO I; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; JOHN OP, 1994, CHILD DEV, V65, P160, DOI 10.2307/1131373; John OP, 2007, IMPORTANCE BEING VAL, P461; Jolliffe IT, 1972, DISCARDING VARIABLES, P160; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kenny D. A, 1994, INTERPERSONAL PERCEP; Kline P., 2014, EASY GUIDE FACTOR AN; KOLER-MATZNICK J., 2005, ETHOGRAM NEW GUINEA; KRUGLANSKI AW, 1989, PSYCHOL BULL, V106, P395, DOI 10.1037/0033-2909.106.3.395; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kubinyi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030271; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2009, APPL ANIM BEHAV SCI, V119, P85, DOI 10.1016/j.applanim.2009.02.027; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; McDonald RP., 2014, FACTOR ANAL RELATED, DOI 10.4324/9781315802510; McGarrity ME, 2015, BEHAV PROCESS, V110, P117, DOI 10.1016/j.beproc.2014.09.029; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Mirko E, 2013, APPL ANIM BEHAV SCI, V149, P45, DOI 10.1016/j.applanim.2013.10.003; Mirko E, 2012, APPL ANIM BEHAV SCI, V138, P88, DOI 10.1016/j.applanim.2012.02.016; Netto WJ, 1997, APPL ANIM BEHAV SCI, V52, P243, DOI 10.1016/S0168-1591(96)01126-4; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Robins RW, 1997, QUEST SELF INSIGHT T; Saetre P, 2006, GENES BRAIN BEHAV, V5, P240, DOI 10.1111/j.1601-183X.2005.00155.x; Scott J.P., 2012, GENETICS SOCIAL BEHA; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Sokal RR, 1963, PRINCIPLES NUMERICAL; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Valsecchi P, 2011, J VET BEHAV, V6, P161, DOI 10.1016/j.jveb.2011.01.002; van den Berg L, 2003, BEHAV GENET, V33, P469, DOI 10.1023/A:1025714431089; VANDERBORG JAM, 1991, APPL ANIM BEHAV SCI, V32, P237, DOI 10.1016/S0168-1591(05)80047-4; Vazire S., 2007, MEASURING PERSONALIT, P190; Walker J, 2010, ANIM WELFARE, V19, P75; Wiggins J.S., 1973, PERSONALITY PREDICTI; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012; Zeigler-Hill V, 2010, APPL ANIM BEHAV SCI, V124, P104, DOI 10.1016/j.applanim.2010.02.012	64	13	13	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149831	10.1371/journal.pone.0149831	http://dx.doi.org/10.1371/journal.pone.0149831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977588	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800016
J	Huang, TM; Zhao, ZY; Yan, C; Lu, J; Li, XZ; Tang, CZ; Fan, MX; Luo, YL				Huang, Tianming; Zhao, Zhiyong; Yan, Chao; Lu, Jing; Li, Xuzhou; Tang, Chaozheng; Fan, Mingxia; Luo, Yanli			Altered Spontaneous Activity in Patients with Persistent Somatoform Pain Disorder Revealed by Regional Homogeneity	PLOS ONE			English	Article							RESTING-STATE; CEREBRAL ACTIVATION; NEURAL ACTIVITY; BRAIN ACTIVITY; FMRI; REPRESENTATION; PERCEPTION; CONNECTIVITY; HYPERALGESIA; EPILEPSY	Persistent somatoform pain disorder (PSPD) is a mental disorder un-associated with any somatic injury and can cause severe somatosensory and emotional impairments in patients. However, so far, the neuro-pathophysiological mechanism of the functional impairments in PSPD is still unclear. The present study assesses the difference in regional spontaneous activity between PSPD and healthy controls (HC) during a resting state, in order to elucidate the neural mechanisms underlying PSPD. Resting-state functional Magnetic Resonance Imaging data were obtained from 13 PSPD patients and 23 age-and gender-matched HC subjects in this study. Kendall's coefficient of concordance was used to measure regional homogeneity (ReHo), and a two-sample t-test was subsequently performed to investigate the ReHo difference between PSPD and HC. Additionally, the correlations between the mean ReHo of each survived area and the clinical assessments were further analyzed. Compared with the HC group, patients with PSPD exhibited decreased ReHo in the bilateral primary somatosensory cortex, posterior cerebellum, and occipital lobe, while increased ReHo in the prefrontal cortex (PFC) and default mode network (including the medial PFC, right inferior parietal lobe (IPL), and left supramarginal gyrus). In addition, significant positive correlations were found between the mean ReHo of both right IPL and left supramarginal gyrus and participants' Self-Rating Anxiety Scale (SAS) scores, and between the mean ReHo of the left middle frontal gyrus and Visual Analogue Scale (VAS) scores. Our results suggest that abnormal spontaneous brain activity in specific brain regions during a resting state may be associated with the dysfunctions in pain, memory and emotional processing commonly observed in patients with PSPD. These findings help us to understand the neural mechanisms underlying PSPD and suggest that the ReHo metric could be used as a clinical marker for PSPD.	[Huang, Tianming] Shanghai Changning Mental Hlth Ctr, Dept Psychiat, Shanghai, Peoples R China; [Zhao, Zhiyong; Fan, Mingxia] E China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Yan, Chao] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China; [Yan, Chao] E China Normal Univ, Sch Psychol & Cognit Sci, STCSM, Shanghai 200062, Peoples R China; [Lu, Jing] Tongji Univ, Tongji Hosp, Dept Tradit Chinese Med, Shanghai 200092, Peoples R China; [Li, Xuzhou] E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, Key Lab Brain Funct Genom,MOE, Shanghai 200062, Peoples R China; [Li, Xuzhou] E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, STCSM, Shanghai 200062, Peoples R China; [Tang, Chaozheng] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai 200433, Peoples R China; [Luo, Yanli] Tongji Univ, Dept Psychiat, Tongji Hosp, Shanghai 200092, Peoples R China	East China Normal University; East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM); Tongji University; East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM); Fudan University; Tongji University	Fan, MX (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.; Luo, YL (corresponding author), Tongji Univ, Dept Psychiat, Tongji Hosp, Shanghai 200092, Peoples R China.	mxfan@phy.ecnu.edu.cn; luoluoyanli@163.com			National Natural Science Foundation of China [81100821]; Shanghai Changning District Committee of Health and Family Planning [20144Y011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Changning District Committee of Health and Family Planning	This research was supported by the National Natural Science Foundation of China (Contract grant number: 81100821) and Shanghai Changning District Committee of Health and Family Planning (Contract grant number: 20144Y011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antognini JF, 1997, LIFE SCI, V61, pPL349, DOI 10.1016/S0024-3205(97)00960-0; Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Apkarian AV, 2001, NEUROSCI LETT, V311, P193, DOI 10.1016/S0304-3940(01)02122-X; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baron R, 1999, NEUROLOGY, V52, P923, DOI 10.1212/WNL.52.5.923; Burba B, 2006, CAN J PSYCHIAT, V51, P468, DOI 10.1177/070674370605100709; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Casey KL, 2003, EXP NEUROL, V184, pS80, DOI 10.1016/j.expneurol.2003.07.006; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Craig A, 1996, FUNCTIONAL IMAGING I; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; Egloff N, 2014, GEN HOSP PSYCHIAT, V36, P284, DOI 10.1016/j.genhosppsych.2014.01.011; GIBBONS JD, 1990, RANK CORRELATION MET; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Helmchen C, 2003, NEUROSCI LETT, V335, P202, DOI 10.1016/S0304-3940(02)01164-3; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang L., 2015, NEUROSCIENTIST; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Karibe H, 2010, PSYCHIAT CLIN NEUROS, V64, P476, DOI 10.1111/j.1440-1819.2010.02119.x; Li HJ, 2015, J CHILD PSYCHOL PSYC, V56, P432, DOI 10.1111/jcpp.12307; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Luo Youtian, 2014, 2014 17th International Symposium on Electromagnetic Launch Technology (EML), P1, DOI 10.1109/EML.2014.6920147; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nikendei C, 2009, J PSYCHOSOM RES, V67, P199, DOI 10.1016/j.jpsychores.2009.01.017; Oshiro Y, 1998, NEUROREPORT, V9, P2285, DOI 10.1097/00001756-199807130-00026; Otti A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-84; Petrak F, 2003, EUR J PAIN, V7, P463, DOI 10.1016/S1090-3801(03)00014-4; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Qiu EC, 2012, CHINESE MED J-PEKING, V125, P705, DOI 10.3760/cma.j.issn.0366-6999.2012.04.027; Quintero GC, 2013, J PAIN RES, V6, P713, DOI 10.2147/JPR.S45958; Reips UD, 2008, BEHAV RES METHODS, V40, P699, DOI 10.3758/BRM.40.3.699; Reis GM, 2010, J PAIN, V11, P1015, DOI 10.1016/j.jpain.2010.01.269; Schonenberg M, 2014, EUR J PAIN, V18, P949, DOI 10.1002/j.1532-2149.2013.00440.x; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Seifert F, 2011, CURR OPIN ANESTHESIO, V24, P515, DOI 10.1097/ACO.0b013e32834a1079; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Shi Y, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/210120; Shibasaki Hiroshi, 2004, Suppl Clin Neurophysiol, V57, P39; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sokolov AA, 2009, CEREB CORTEX; Stefanie K, 2011, EUR ARCH PSY CLIN N, V261, P267, DOI 10.1007/s00406-010-0148-4; Stoeter P, 2007, NEUROIMAGE, V36, P418, DOI 10.1016/j.neuroimage.2007.01.052; SVEINBJORNSDOTTIR S, 1993, EPILEPSIA, V34, P493, DOI 10.1111/j.1528-1157.1993.tb02590.x; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Wang YP, 2015, NEUROPSYCH DIS TREAT, V11, P2659, DOI 10.2147/NDT.S94877; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xie YF, 2009, ACTA PHARMACOL SIN, V30, P31, DOI 10.1038/aps.2008.14; Yang TH, 2014, J NEUROL SCI, V340, P58, DOI 10.1016/j.jns.2014.02.025; Yoshino A, 2014, PSYCHIAT RES-NEUROIM, V221, P246, DOI 10.1016/j.pscychresns.2013.12.006; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang SS, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-115; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhao L, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-85; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007; Zung W, 1973, MODERN PROBLEMS PHAR, V7, P170; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	70	16	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151360	10.1371/journal.pone.0151360	http://dx.doi.org/10.1371/journal.pone.0151360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977802	gold, Green Published			2022-12-26	WOS:000372572800065
J	Komiya, C; Tsuchiya, K; Shiba, K; Miyachi, Y; Furuke, S; Shimazu, N; Yamaguchi, S; Kanno, K; Ogawa, Y				Komiya, Chikara; Tsuchiya, Kyoichiro; Shiba, Kumiko; Miyachi, Yasutaka; Furuke, Shunsaku; Shimazu, Noriko; Yamaguchi, Shinobu; Kanno, Kazuo; Ogawa, Yoshihiro			Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITION; ELEMENT-BINDING PROTEIN-1; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ADIPOCYTE DEATH; DOUBLE-BLIND; GLUCOSE; DAPAGLIFLOZIN; DISEASE; HYPERGLYCEMIA	Type 2 diabetes mellitus (T2DM) is associated with a high incidence of non-alcoholic fatty liver disease (NAFLD) related to obesity and insulin resistance. Currently, medical interventions for NAFLD have focused on diet control and exercise to reduce body weight, and there is a requirement for effective pharmacological therapies. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are oral antidiabetic drugs that promote the urinary excretion of glucose by blocking its reabsorption in renal proximal tubules. SGLT2 inhibitors lower blood glucose independent of insulin action and are expected to reduce body weight because of urinary calorie loss. Here we show that an SGLT2 inhibitor ipragliflozin improves hepatic steatosis in high-fat diet-induced and leptin-deficient (ob/ob) obese mice irrespective of body weight reduction. In the obese mice, ipragliflozin-induced hyperphagia occurred to increase energy intake, attenuating body weight reduction with increased epididymal fat mass. There is an inverse correlation between weights of liver and epididymal fat in ipragliflozin-treated obese mice, suggesting that ipragliflozin treatment promotes normotopic fat accumulation in the epididymal fat and prevents ectopic fat accumulation in the liver. Despite increased adiposity, ipragliflozin ameliorates obesity-associated inflammation and insulin resistance in epididymal fat. Clinically, ipragliflozin improves liver dysfunction in patients with T2DM irrespective of body weight reduction. These findings provide new insight into the effects of SGLT2 inhibitors on energy homeostasis and fat accumulation and indicate their potential therapeutic efficacy in T2DM-associated hepatic steatosis.	[Komiya, Chikara; Tsuchiya, Kyoichiro; Shiba, Kumiko; Miyachi, Yasutaka; Furuke, Shunsaku; Shimazu, Noriko; Yamaguchi, Shinobu; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Dept Grad Sch Med & Dent Sci, Tokyo, Japan; [Kanno, Kazuo] Kanno Clin, Tokyo, Japan; [Ogawa, Yoshihiro] Japan Agcy Med Res & Dev, CREST, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Tsuchiya, K (corresponding author), Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Dept Grad Sch Med & Dent Sci, Tokyo, Japan.	ktsuchiya.mem@tmd.ac.jp		Ogawa, Yoshihiro/0000-0002-0834-2836	Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Pharma Inc.	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Pharma Inc.(Astellas Pharmaceuticals)	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Ipragliflozin was provided by Astellas Pharma Inc. The clinical study at Kanno clinic was financially supported by Astellas Pharma Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Del Prato S, 2015, DIABETES OBES METAB, V17, P581, DOI 10.1111/dom.12459; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Ferrannini G, 2015, DIABETES CARE, V38, P1730, DOI 10.2337/dc15-0355; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Iizuka Takashi, 2016, J Clin Med Res, V8, P116, DOI 10.14740/jocmr2417w; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Morley TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8906; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nakano S, 2015, J CLIN EXP HEPATOL, V5, P190, DOI 10.1016/j.jceh.2015.02.005; Obata A, 2015, ENDOCRINOLO IN PRESS; Qiang S, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0102-8; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stenlof K, 2013, DIABETES OBES METAB, V15, P372, DOI 10.1111/dom.12054; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Tanaka M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5982; Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093; Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010; Watanabe Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116851; Waterson MJ, 2015, CELL METAB, V22, P962, DOI 10.1016/j.cmet.2015.09.026; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	41	148	155	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151511	10.1371/journal.pone.0151511	http://dx.doi.org/10.1371/journal.pone.0151511			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977813	Green Submitted, Green Published, gold			2022-12-26	WOS:000372572800081
J	Zurek, M; Sladen, L; Johansson, E; Olsson, M; Jackson, S; Zhang, H; Mayer, G; Hockings, PD				Zurek, Magdalena; Sladen, Louise; Johansson, Edvin; Olsson, Marita; Jackson, Sonya; Zhang, Hui; Mayer, Gaell; Hockings, Paul D.			Assessing the Relationship between Lung Density and Function with Oxygen-Enhanced Magnetic Resonance Imaging in a Mouse Model of Emphysema	PLOS ONE			English	Article							ULTRA-SHORT; NONINVASIVE ASSESSMENT; MRI; COPD; VENTILATION; RATS; T-1	Purpose A magnetic resonance imaging method is presented that allows for the simultaneous assessment of oxygen delivery, oxygen uptake, and parenchymal density. The technique is applied to a mouse model of porcine pancreatic elastase (PPE) induced lung emphysema in order to investigate how structural changes affect lung function. Method Nine-week-old female C57BL6 mice were instilled with saline or PPE at days 0 and 7. At day 19, oxygen delivery, oxygen uptake, and lung density were quantified from T1 and proton-density measurements obtained via oxygen-enhanced magnetic resonance imaging (OE-MRI) using an ultrashort echo-time imaging sequence. Subsequently, the lungs were sectioned for histological observation. Blood-gas analyses and pulmonary functional tests via FlexiVent were performed in separate cohorts. Principal Findings PPE-challenged mice had reduced density when assessed via MRI, consistent with the parenchyma loss observed in the histology sections, and an increased lung compliance was detected via FlexiVent. The oxygenation levels, as assessed via the blood-gas analysis, showed no difference between PPE-challenged animals and control. This finding was mirrored in the global MRI assessments of oxygen delivery and uptake, where the changes in relaxation time indices were matched between the groups. The heterogeneity of the same parameters however, were increased in PPE-challenged animals. When the oxygenation status was investigated in regions of varying density, a reduced oxygen-uptake was found in low-density regions of PPE-challenged mice. In high-density regions the uptake was higher than that of regions of corresponding density in control animals. The oxygen delivery was proportional to the oxygen uptake in both groups. Conclusions The proposed method allowed for the regional assessment of the relationship between lung density and two aspects of lung function, the oxygen delivery and uptake. When compared to global indices of lung function, an increased sensitivity for detecting heterogeneous lung disorders was found. This indicated that the technique has potential for early detection of lung dysfunction-before global changes occur.	[Zurek, Magdalena; Johansson, Edvin; Hockings, Paul D.] AstraZeneca, Personalised Healthcare & Biomarkers, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden; [Sladen, Louise; Jackson, Sonya; Mayer, Gaell] AstraZeneca, Resp Inflammat & Autoimmun, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden; [Olsson, Marita] AstraZeneca, Discovery Sci, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden; [Zhang, Hui] AstraZeneca, Drug Safety & Metab, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden; [Hockings, Paul D.] Chalmers Univ Technol, MedTech West, S-41296 Gothenburg, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Chalmers University of Technology	Zurek, M (corresponding author), AstraZeneca, Personalised Healthcare & Biomarkers, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden.	magdalena.zurek@astrazeneca.com	Hockings, Paul D/AAM-7950-2020; Zurek, Magdalena/A-6064-2012	Hockings, Paul D/0000-0002-7154-9047; Johansson, Edvin/0000-0003-2515-2054	ITN Marie Curie, FP7-ITN PINET [PITN-GA-2010-264864]	ITN Marie Curie, FP7-ITN PINET	This work was supported by ITN Marie Curie, FP7-ITN PINET; Grant number: PITN-GA-2010-264864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PERMUTATION TESTS PR; Bianchi A, 2015, NMR BIOMED, V28, P1471, DOI 10.1002/nbm.3417; Cazzola M, 2008, REV PORT PNEUMOL, V14, P579, DOI 10.1016/S0873-2159(15)30266-X; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Efron B., 1994, INTRO BOOTSTRAP; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Inoue K, 2010, INT IMMUNOPHARMACOL, V10, P1380, DOI 10.1016/j.intimp.2010.07.016; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; Jacono FJ, 2013, RESP PHYSIOL NEUROBI, V189, P371, DOI 10.1016/j.resp.2013.07.010; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137282; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121520; Jogi J, 2015, INT J CHRONIC OBSTR, V10, P25, DOI 10.2147/COPD.S73423; Johnson KM, 2013, MAGN RESON MED, V70, P1241, DOI 10.1002/mrm.24570; Kruger SJ, 2016, J MAGN RESON IMAGING, V43, P295, DOI 10.1002/jmri.25002; Kruger SJ, 2014, NMR BIOMED, V27, P1535, DOI 10.1002/nbm.3158; Luthje L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-7; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Ma WJ, 2015, J MAGN RESON IMAGING, V41, P1465, DOI 10.1002/jmri.24680; Mahadeva R, 2002, THORAX, V57, P908, DOI 10.1136/thorax.57.10.908; Mills GH, 2003, BRIT J ANAESTH, V91, P16, DOI 10.1093/bja/aeg149; Milne S, 2014, J THORAC DIS, V6, P1570, DOI 10.3978/j.issn.2072-1439.2014.11.30; Morgan AR, 2014, EUR J RADIOL, V83, P2093, DOI 10.1016/j.ejrad.2014.08.004; Ohno Y, 2002, MAGN RESON MED, V47, P1139, DOI 10.1002/mrm.10168; Ohno Y, 2007, EUR J RADIOL, V64, P320, DOI 10.1016/j.ejrad.2007.08.006; Ohno Y, 2011, EUR J RADIOL, V77, P85, DOI 10.1016/j.ejrad.2009.06.027; Pracht ED, 2005, MAGNET RESON MED, V53, P1193, DOI 10.1002/mrm.20448; Quintana HK, 2006, MAGN RESON MED, V56, P1242, DOI 10.1002/mrm.21051; Sandek K, 2002, RESP MED, V96, P934, DOI 10.1053/rmed.2002.1371; SATO S, 1994, EUR RESPIR J, V7, P1294, DOI 10.1183/09031936.94.07071294; Stadler A, 2008, MAGN RESON MED, V59, P96, DOI 10.1002/mrm.21446; Stadler A, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/23624; Szabari MV, 2015, RESP PHYSIOL NEUROBI, V215, P13, DOI 10.1016/j.resp.2015.04.005; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Togao O, 2011, J MAGN RESON IMAGING, V34, P539, DOI 10.1002/jmri.22645; Triphan SMF, 2015, J MAGN RESON IMAGING, V41, P1708, DOI 10.1002/jmri.24692; Waterton JC, 2013, NEW DEV NMR, P333, DOI 10.1039/9781849737661-00333; Watt KN, 2008, MAGN RESON MED, V59, P1412, DOI 10.1002/mrm.21517; Weingartner S, 2014, MAGN RESON MED; West J.B., 2011, PULMONARY PATHOPHYSI; Zhang WJ, 2015, RADIOLOGY, V275, P579, DOI 10.1148/radiol.14132953; Zurek M, 2014, MAGN RESON MED, V71, P2180, DOI 10.1002/mrm.24876; Zurek M, 2012, MAGN RESON MED, V68, P898, DOI 10.1002/mrm.23281	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151211	10.1371/journal.pone.0151211	http://dx.doi.org/10.1371/journal.pone.0151211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977928	Green Submitted, gold, Green Published			2022-12-26	WOS:000372572800050
J	Chen, YG; Zhang, Y; Deng, LQ; Chen, H; Zhang, YJ; Zhou, NJ; Yuan, K; Yu, LZ; Xiong, ZH; Gui, XM; Yu, YR; Wu, XM; Min, WP				Chen, Yi-Guo; Zhang, Yong; Deng, Lin-Qiang; Chen, Hui; Zhang, Yu-Juan; Zhou, Nan-Jin; Yuan, Keng; Yu, Li-Zhi; Xiong, Zhang-Hua; Gui, Xiao-Mei; Yu, Yan-Rong; Wu, Xiao-Mu; Min, Wei-Ping			Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4	PLOS ONE			English	Article							IMPROVES BACTERIAL CLEARANCE; INNATE IMMUNE-RESPONSES; DECREASES INFLAMMATION; ECONOMIC OUTCOMES; ALPHA-HEMOLYSIN; MICE; EPIDEMIOLOGY; PRETREATMENT; NEUTROPHILS; MORTALITY	The spread of methicillin-resistant Staphylococcus aureus (MRSA) is a critical health issue that has drawn greater attention to the potential use of immunotherapy. Toll-like receptor 2 (TLR2), a pattern recognition receptor, is an essential component in host innate defense system against S. aureus infection. However, little is known about the innate immune response, specifically TLR2 activation, against MRSA infection. Here, we evaluate the protective effect and the mechanism of MRSA murine pneumonia after pretreatment with Pam3CSK4, a TLR2 agonist. We found that the MRSA-pneumonia mouse model, pre-treated with Pam3CSK4, had reduced bacteria and mortality in comparison to control mice. As well, lower protein and mRNA levels of TNF-alpha, IL-1 beta and IL-6 were observed in lungs and bronchus of the Pam3CSK4 pretreatment group. Conversely, expression of anti-inflammatory cytokine IL-10, but not TGF-beta, increased in Pam3CSK4-pretreated mice. Our additional studies showed that CXCL-2 and CXCL1, which are necessary for neutrophil recruitment, were less evident in the Pam3CSK4-pretreated group compared to control group, whereas the expression of Fc gamma receptors (Fc gamma I/II) and complement receptors (CR1/3) increased in murine lungs. Furthermore, we found that increased survival and improved bacterial clearance were not a result of higher levels of neutrophil infiltration, but rather a result of enhanced phagocytosis and bactericidal activity of neutrophils in vitro and in vivo as well as increased robust oxidative activity and release of lactoferrin. Our cumulative findings suggest that Pam3CSK4 could be a novel immunotherapeutic candidate against MRSA pneumonia.	[Chen, Yi-Guo; Deng, Lin-Qiang; Chen, Hui; Zhang, Yu-Juan; Yu, Li-Zhi; Xiong, Zhang-Hua; Gui, Xiao-Mei; Wu, Xiao-Mu; Min, Wei-Ping] Nanchang Univ, Jiangxi Prov Peoples Hosp, Med Lab, Nanchang 330008, Jiangxi, Peoples R China; [Chen, Yi-Guo; Deng, Lin-Qiang; Chen, Hui; Zhang, Yu-Juan; Yu, Li-Zhi; Xiong, Zhang-Hua; Gui, Xiao-Mei; Wu, Xiao-Mu; Min, Wei-Ping] Nanchang Univ, Inst Immunotherapy, Nanchang 330008, Jiangxi, Peoples R China; [Zhang, Yong; Zhang, Yu-Juan; Zhou, Nan-Jin; Yuan, Keng; Yu, Yan-Rong; Min, Wei-Ping] Jiangxi Acad Med Sci, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Yong; Zhang, Yu-Juan; Zhou, Nan-Jin; Yuan, Keng; Yu, Yan-Rong; Min, Wei-Ping] Jiangxi Prov Key Lab Immunotherapy, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Wu, XM; Min, WP (corresponding author), Nanchang Univ, Jiangxi Prov Peoples Hosp, Med Lab, Nanchang 330008, Jiangxi, Peoples R China.; Wu, XM; Min, WP (corresponding author), Nanchang Univ, Inst Immunotherapy, Nanchang 330008, Jiangxi, Peoples R China.; Min, WP (corresponding author), Jiangxi Acad Med Sci, Nanchang 330006, Jiangxi, Peoples R China.; Min, WP (corresponding author), Jiangxi Prov Key Lab Immunotherapy, Nanchang 330006, Jiangxi, Peoples R China.	wuxm79@163.com; weiping.min@gmail.com		Yu, Yanrong/0000-0002-0989-5432	National Nature Scientific Foundation of China [81360454]; Natural Science Foundation of Jiangxi Province [20132BAB205049]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was supported by the National Nature Scientific Foundation of China ( grant number 81360454) to YGC ( http://www.nsfc.gov.cn/) and The Natural Science Foundation of Jiangxi Province ( grant number 20132BAB205049) to YGC ( www.jxstc.gov.cn).	Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; [Anonymous], EURASIP J WIRELESS C, DOI DOI 10.11646/Z00TAXA.3989.1.1; Anstead GM, 2013, METHODS MOL BIOL, V185, P259, DOI 10.1007/978-1-62703-664-1_16; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Bal AM, 2005, EXPERT OPIN PHARMACO, V6, P2257, DOI 10.1517/14656566.6.13.2257; Bennett JW, 2008, DIAGN MICR INFEC DIS, V60, P437, DOI 10.1016/j.diagmicrobio.2007.11.002; Bommineni YR, 2014, MOL IMMUNOL, V59, P55, DOI 10.1016/j.molimm.2014.01.004; Brett M, 2015, CURR PHARM DESIGN, V21, P2131, DOI 10.2174/1381612821666150310101347; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen YH, 2014, EUR J CLIN MICROBIOL, V33, P233, DOI 10.1007/s10096-013-1949-y; Cheng CW, 2013, CLIN CHIM ACTA, V419, P19, DOI 10.1016/j.cca.2013.01.011; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Cremieux AC, 2014, J INFECT DIS, V209, P1773, DOI 10.1093/infdis/jit840; Delaloye J, 2013, CURR VASC PHARMACOL, V11, P123; Falugi F, 2013, MBIO, V4, DOI 10.1128/mBio.00575-13; Feterowski C, 2005, INT IMMUNOL, V17, P1035, DOI 10.1093/intimm/dxh282; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Haghighat Setareh, 2013, Avicenna Journal of Medical Biotechnology, V5, P204; Harrison C J, 2009, Minerva Pediatr, V61, P503; Joice R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068940; Joshi T, 2006, INT J HEMATOL, V84, P210, DOI 10.1532/IJH97.06140; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Lilius EM, 2012, SCI WORLD J, DOI 10.1100/2012/527347; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Loftspring MC, 2012, TRANSL STROKE RES, V3, pS147, DOI 10.1007/s12975-012-0184-7; Lu T, 2014, J INNATE IMMUN, V6, P639, DOI 10.1159/000360478; Luna CM, 2010, CURR OPIN INFECT DIS, V23, P178, DOI 10.1097/QCO.0b013e328336a23f; Mahfood Haddad Toufik, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-209003; Manda-Handzlik A, 2015, ADV EXP MED BIOL, V857, P51, DOI 10.1007/5584_2015_117; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McIntire CR, 2009, APOPTOSIS, V14, P522, DOI 10.1007/s10495-009-0312-3; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mocca CP, 2014, CLIN VACCINE IMMUNOL, V21, P622, DOI 10.1128/CVI.00051-14; Murphey ED, 2008, CRIT CARE MED, V36, P3067, DOI 10.1097/CCM.0b013e31818c6fb7; Murphey ED, 2008, MICROBES INFECT, V10, P1244, DOI 10.1016/j.micinf.2008.07.021; Nandi A, 2015, INFLAMMATION, V38, P224, DOI 10.1007/s10753-014-0026-8; O'Brien GC, 2005, J IMMUNOL, V174, P1020, DOI 10.4049/jimmunol.174.2.1020; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pier GB, 2013, HUM VACC IMMUNOTHER, V9, P1865, DOI 10.4161/hv.25182; Qiao YH, 2013, ACTA PAEDIATR, V102, P1081, DOI 10.1111/apa.12386; Ramirez P, 2011, CRIT CARE MED, V39, P2211, DOI 10.1097/CCM.0b013e3182257445; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Rodvold KA, 2014, CLIN INFECT DIS, V58, pS20, DOI 10.1093/cid/cit614; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Shorr AF, 2010, J CLIN MICROBIOL, V48, P3258, DOI 10.1128/JCM.02529-09; Sonego F, 2014, EXPERT REV CLIN IMMU, V10, P1019, DOI 10.1586/1744666X.2014.922876; Taneja C, 2010, J HOSP MED, V5, P528, DOI 10.1002/jhm.704; Tarai Bansidhar, 2013, J Lab Physicians, V5, P71, DOI 10.4103/0974-2727.119843; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Varrone JJ, 2014, J ORTHOP RES, V32, P1389, DOI 10.1002/jor.22672; Wang J, 2014, ANN NY ACAD SCI, V1319, P66, DOI 10.1111/nyas.12445; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Yimin, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074287	61	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149233	10.1371/journal.pone.0149233	http://dx.doi.org/10.1371/journal.pone.0149233			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974438	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600010
J	Furuya, M; Tanaka, R; Okudela, K; Nakamura, S; Yoshioka, H; Tsuzuki, T; Shibuya, R; Yatera, K; Shirasaki, H; Sudo, Y; Kimura, N; Yamada, K; Uematsu, S; Kunimura, T; Kato, I; Nakatani, Y				Furuya, Mitsuko; Tanaka, Reiko; Okudela, Koji; Nakamura, Satoko; Yoshioka, Hiromu; Tsuzuki, Toyonori; Shibuya, Ryo; Yatera, Kazuhiro; Shirasaki, Hiroki; Sudo, Yoshiko; Kimura, Naoko; Yamada, Kazuaki; Uematsu, Shugo; Kunimura, Toshiaki; Kato, Ikuma; Nakatani, Yukio			Pulmonary Neoplasms in Patients with Birt-Hogg-Dube Syndrome: Histopathological Features and Genetic and Somatic Events	PLOS ONE			English	Article							RENAL TUMORS; LUNG CANCERS; FOLLICULIN; CYSTS; MUTATIONS; PROTEIN; FAMILIES; DISEASE; FNIP2; FLCN	Birt-Hogg-Dube syndrome (BHD) is an inherited disorder caused by genetic mutations in the folliculin (FLCN) gene. Individuals with BHD have multiple pulmonary cysts and are at a high risk for developing renal cell carcinomas (RCCs). Currently, little information is available about whether pulmonary cysts are absolutely benign or if the lungs are at an increased risk for developing neoplasms. Herein, we describe 14 pulmonary neoplastic lesions in 7 patients with BHD. All patients were confirmed to have germline FLCN mutations. Neoplasm histologies included adenocarcinoma in situ (n = 2), minimally invasive adenocarcinoma (n = 1), papillary adenocarcinoma (n = 1), micropapillary adenocarcinoma (n = 1), atypical adenomatous hyperplasia (n = 8), and micronodular pneumocyte hyperplasia (MPH)-like lesion (n = 1). Five of the six adenocarcinoma/MPH-like lesions (83.3%) demonstrated a loss of heterozygosity (LOH) of FLCN. All of these lesions lacked mutant alleles and preserved wild-type alleles. Three invasive adenocarcinomas possessed additional somatic events: 2 had a somatic mutation in the epidermal growth factor receptor gene (EGFR) and another had a somatic mutation in KRAS. Immunohistochemical analysis revealed that most of the lesions were immunostained for phospho-mammalian target of rapamycin (p-mTOR) and phospho-S6. Collective data indicated that pulmonary neoplasms of peripheral adenocarcinomatous lineage in BHD patients frequently exhibit LOH of FLCN with mTOR pathway signaling. Additional driver gene mutations were detected only in invasive cases, suggesting that FLCN LOH may be an underlying abnormality that cooperates with major driver gene mutations in the progression of pulmonary adenocarcinomas in BHD patients.	[Furuya, Mitsuko; Kato, Ikuma] Yokohama City Univ, Dept Mol Pathol, Grad Sch Med, Yokohama, Kanagawa, Japan; [Tanaka, Reiko] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Okudela, Koji] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; [Nakamura, Satoko] Kagawa Prefectural Cent Hosp, Dept Pathol, Takamatsu, Kagawa, Japan; [Yoshioka, Hiromu] Japanese Red Cross Nagoya Daini Hosp, Dept Thorac Surg, Nagoya, Aichi, Japan; [Tsuzuki, Toyonori] Japanese Red Cross Nagoya Daini Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Yatera, Kazuhiro] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka, Japan; [Shibuya, Ryo] Univ Occupat & Environm Hlth, Pathol & Oncol, Kitakyushu, Fukuoka, Japan; [Shirasaki, Hiroki] Saiseikai Fukui Hosp, Dept Internal Med, Fukui, Japan; [Sudo, Yoshiko] Saiseikai Fukui Hosp, Dept Pathol, Fukui, Japan; [Kimura, Naoko] Natl Disaster Med Ctr, Dept Thorac Surg, Tokyo, Japan; [Yamada, Kazuaki] Natl Disaster Med Ctr, Dept Pathol, Tokyo, Japan; [Uematsu, Shugo] Showa Univ, Dept Thorac Surg, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan; [Kunimura, Toshiaki] Showa Univ, Dept Pathol, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan; [Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan	Yokohama City University; Chiba University; Yokohama City University; Japanese Red Cross Nagoya Daini Hospital; Japanese Red Cross Nagoya Daini Hospital; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Showa University; Showa University; Chiba University	Furuya, M (corresponding author), Yokohama City Univ, Dept Mol Pathol, Grad Sch Med, Yokohama, Kanagawa, Japan.	mfuruya@yokohama-cu.ac.jp	Tsuzuki, Toyonori/GRJ-7409-2022; Kato, Ikuma/AAF-5926-2020; Uematsu, Shugo/AAP-7856-2020	Tsuzuki, Toyonori/0000-0002-4855-4366; Kato, Ikuma/0000-0002-7731-9509; Shugo, Uematsu/0000-0002-3713-6986	JSPS KAKENHI [26460422, 15K08374]; Yokohama Foundation for Advancement of Medical Science; Yokohama Academic Foundation; Project Mirai Cancer Research Grants; Mitsubishi Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yokohama Foundation for Advancement of Medical Science; Yokohama Academic Foundation; Project Mirai Cancer Research Grants; Mitsubishi Foundation	This work is supported by JSPS KAKENHI Grant Number 26460422 (M.F.) and 15K08374 (Y.N.), Yokohama Foundation for Advancement of Medical Science (M.F.), Yokohama Academic Foundation (M.F.), Project Mirai Cancer Research Grants (M.F.), and the Mitsubishi Foundation (M.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayo DS, 2007, CHEST, V132, P679, DOI 10.1378/chest.07-0042; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Butnor KJ, 2006, AM J SURG PATHOL, V30, P395; Furuya M, 2012, J CLIN PATHOL; Furuya M, 2015, CANCER SCI, V106, P315, DOI 10.1111/cas.12601; Furuya M, 2013, J CLIN PATHOL, V66, P178, DOI 10.1136/jclinpath-2012-201200; Furuya M, 2012, AM J SURG PATHOL, V36, P589, DOI 10.1097/PAS.0b013e3182475240; Gunji Y, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049874; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi H, 2015, P NATL ACAD SCI USA, V112, pE1624, DOI 10.1073/pnas.1419502112; Hasumi H, 2012, JNCI-J NATL CANCER I, V104, P1750, DOI 10.1093/jnci/djs418; Hayashi T, 2010, MODERN PATHOL, V23, P1251, DOI 10.1038/modpathol.2010.114; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Iribe Y, 2016, AM J PATHOL, V186, P337, DOI 10.1016/j.ajpath.2015.10.013; Iribe Y, 2015, PATHOL INT, V65, P126, DOI 10.1111/pin.12254; Koga S, 2009, PATHOL INT, V59, P720, DOI 10.1111/j.1440-1827.2009.02434.x; Kumasaka T, 2014, HISTOPATHOLOGY, V65, P100, DOI 10.1111/his.12368; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nishida C, 2015, RESP MED, V109, P923, DOI 10.1016/j.rmed.2015.05.005; Nishii T, 2013, PATHOL INT, V63, P45, DOI 10.1111/pin.12028; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Vocke CD, 2005, J NATL CANCER I, V97, P931, DOI 10.1093/jnci/dji154; Yoshida A, 2014, MODERN PATHOL, V27, P711, DOI 10.1038/modpathol.2013.192	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151476	10.1371/journal.pone.0151476	http://dx.doi.org/10.1371/journal.pone.0151476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974543	Green Published, gold, Green Submitted			2022-12-26	WOS:000372570600083
J	O'Connell, S; Lillis, D; Cotter, A; O'Dea, S; Tuite, H; Fleming, C; Crowley, B; Fitzgerald, I; Dalby, L; Barry, H; Shields, D; Norris, S; Plunkett, PK; Bergin, C				O'Connell, Sarah; Lillis, Darren; Cotter, Aoife; O'Dea, Siobhan; Tuite, Helen; Fleming, Catherine; Crowley, Brendan; Fitzgerald, Ian; Dalby, Linda; Barry, Helen; Shields, Darragh; Norris, Suzanne; Plunkett, Patrick K.; Bergin, Colm			Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study	PLOS ONE			English	Article							BURDEN; VIRUS	Objectives Studies suggest 2 per 1000 people in Dublin are living with HIV, the level above which universal screening is advised. We aimed to assess the feasibility and acceptability of a universal opt-out HIV, Hepatitis B and Hepatitis C testing programme for Emergency Department patients and to describe the incidence and prevalence of blood-borne viruses in this population. Methods An opt-out ED blood borne virus screening programme was piloted from March 2014 to January 2015. Patients undergoing blood sampling during routine clinical care were offered HIV 1&2 antibody/antigen assay, HBV surface antigen and HCV antibody tests. Linkage to care where necessary was co-ordinated by the study team. New diagnosis and prevalence rates were defined as the new cases per 1000 tested and number of positive tests per 1000 tested respectively. Results Over 45 weeks of testing, of 10,000 patient visits, 8,839 individual patient samples were available for analysis following removal of duplicates. A sustained target uptake of >50% was obtained after week 3.97(1.09%), 44(0.49%) and 447(5.05%) HIV, Hepatitis B and Hepatitis C tests were positive respectively. Of these, 7(0.08%), 20(0.22%) and 58(0.66%) were new diagnoses of HIV, Hepatitis B and Hepatitis C respectively. The new diagnosis rate for HIV, Hepatitis B and Hepatitis C was 0.8, 2.26 and 6.5 per 1000 and study prevalence for HIV, Hepatitis B and Hepatitis C was 11.0, 5.0 and 50.5 per 1000 respectively. Conclusions Opt-out blood borne viral screening was feasible and acceptable in an inner-city ED. Blood borne viral infections were prevalent in this population and newly diagnosed cases were diagnosed and linked to care. These results suggest widespread blood borne viral testing in differing clinical locations with differing population demographic risks may be warranted.	[O'Connell, Sarah; Cotter, Aoife; O'Dea, Siobhan; Bergin, Colm] St James Hosp, Dept Genitourinary Med & Infect Dis, Dublin 8, Ireland; [Lillis, Darren; Shields, Darragh] St James Hosp, Dept Emergency Med, Dublin 8, Ireland; [Norris, Suzanne] St James Hosp, Hepatol Dept, Dublin 8, Ireland; [Tuite, Helen; Fleming, Catherine] Galway Univ Hosp, Dept Infect Dis, Dublin, Ireland; [Crowley, Brendan; Fitzgerald, Ian; Dalby, Linda; Barry, Helen] St James Hosp, Dept Microbiol, Dublin 8, Ireland; [Norris, Suzanne; Bergin, Colm] Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	O'Connell, S (corresponding author), St James Hosp, Dept Genitourinary Med & Infect Dis, Dublin 8, Ireland.	soconnell@stjames.ie		Plunkett, Patrick/0000-0003-0714-2717	MSD pharmaceuticals; Gilead; GlaxoSmithKline/Viiv; MSD pharmaceuticals; Gilead; GlaxoSmithKline/Viiv	MSD pharmaceuticals; Gilead(Gilead Sciences); GlaxoSmithKline/Viiv; MSD pharmaceuticals; Gilead(Gilead Sciences); GlaxoSmithKline/Viiv	An unrestricted grant was received by CB from MSD pharmaceuticals (http://www.msd-ireland.com/), Gilead (http://www.gilead.com/about/worldwide-operations/europe/Ireland) and GlaxoSmithKline/Viiv (http://ie.gsk.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHIVA, UK NAT GUID HIV TEST; Block TM, 2015, ANTIVIR RES, V121, P69, DOI 10.1016/j.antiviral.2015.06.014; Burns F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035212; CDC, 2006, REV REC HIV TEST AD; CDC, 2013, MMWR, V62; Centers for Disease Control and Prevention, 2015, HIV INF US GLANC; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, P9; El Khoury AC, 2012, J VIRAL HEPATITIS, V19, P153, DOI 10.1111/j.1365-2893.2011.01563.x; European Centre for Disease Prevention and Control, 2015, ANN EP REP 2014 SEX; HSE, 2015, HIV IR 2014; HSE. Health Protection Surveillance Centre, 2015, EP HEP C IR 2013; HSE. Health Protection Surveillance Centre, 2015, EP HEP B IR 2013; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Lambert J, 2013, Ir Med J, V106, P136; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Martyn F, 2011, Ir Med J, V104, P144; Nardone A, 2009, EPIDEMIOL INFECT, V137, P961, DOI 10.1017/S0950268808001672; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; The INSIGHT START Study Group, 2015, N ENGL J MED; Thornton L, 2012, EPIDEMIOL INFECT, V140, P1461, DOI 10.1017/S0950268811001920; Tuite H, 2015, Ir Med J, V108, P199; White DAE, 2011, ANN EMERG MED, V58, pS89, DOI 10.1016/j.annemergmed.2011.03.032	23	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150546	10.1371/journal.pone.0150546	http://dx.doi.org/10.1371/journal.pone.0150546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967517	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200015
J	Paik, KJ; Maan, ZN; Zielins, ER; Duscher, D; Whittam, AJ; Morrison, SD; Brett, EA; Ransom, RC; Hu, MS; Wu, JC; Gurtner, GC; Longaker, MT; Wan, DC				Paik, Kevin J.; Maan, Zeshaan N.; Zielins, Elizabeth R.; Duscher, Dominik; Whittam, Alexander J.; Morrison, Shane D.; Brett, Elizabeth A.; Ransom, Ryan C.; Hu, Michael S.; Wu, Joseph C.; Gurtner, Geoffrey C.; Longaker, Michael T.; Wan, Derrick C.			Short Hairpin RNA Silencing of PHD-2 Improves Neovascularization and Functional Outcomes in Diabetic Wounds and Ischemic Limbs	PLOS ONE			English	Article							PROLYL HYDROXYLASE; HIF-1-ALPHA; RESPONSES; VECTORS; THERAPY	The transcription factor hypoxia-inducible factor 1-alpha (HIF-1 alpha) is responsible for the downstream expression of over 60 genes that regulate cell survival and metabolism in hypoxic conditions as well as those that enhance angiogenesis to alleviate hypoxia. However, under normoxic conditions, HIF-1 alpha is hydroxylated by prolyl hydroxylase 2, and subsequently degraded, with a biological half-life of less than five minutes. Here we investigated the therapeutic potential of inhibiting HIF-1 alpha degradation through short hairpin RNA silencing of PHD-2 in the setting of diabetic wounds and limb ischemia. Treatment of diabetic mouse fibroblasts with shPHD-2 in vitro resulted in decreased levels of PHD-2 transcript demonstrated by qRT-PCR, higher levels of HIF-1 alpha as measured by western blot, and higher expression of the downstream angiogenic genes SDF-1 and VEGF alpha, as measured by qRT-PCR. In vivo, shPHD-2 accelerated healing of full thickness excisional wounds in diabetic mice compared to shScr control, (14.33 +/- 0.45 days vs. 19 +/- 0.33 days) and was associated with an increased vascular density. Delivery of shPHD-2 also resulted in improved perfusion of ischemic hind limbs compared to shScr, prevention of distal digit tip necrosis, and increased survival of muscle tissue. Knockdown of PHD-2 through shRNA treatment has the potential to stimulate angiogenesis through overexpression of HIF-1 alpha and upregulation of pro-angiogenic genes downstream of HIF-1 alpha, and may represent a viable, non-viral approach to gene therapy for ischemia related applications.	[Paik, Kevin J.; Maan, Zeshaan N.; Zielins, Elizabeth R.; Duscher, Dominik; Whittam, Alexander J.; Morrison, Shane D.; Brett, Elizabeth A.; Ransom, Ryan C.; Hu, Michael S.; Gurtner, Geoffrey C.; Longaker, Michael T.; Wan, Derrick C.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Plast & Reconstruct Surg Div, Dept Surg,Sch Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA; [Wu, Joseph C.; Longaker, Michael T.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wan, DC (corresponding author), Stanford Univ, Hagey Lab Pediat Regenerat Med, Plast & Reconstruct Surg Div, Dept Surg,Sch Med, Stanford, CA 94305 USA.	dwan@stanford.edu	Duscher, Dominik/AAH-5330-2020; Wu, Joseph/H-1067-2013	Morrison, Shane/0000-0003-3868-3532; Ransom, Ryan/0000-0001-6696-1793; Maan, Zeshaan/0000-0002-7683-1914; Wu, Joseph/0000-0002-6068-8041; Wan, Derrick/0000-0003-4666-1683	Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health [NIHR21DE019274, NIHR01DE019434, NIHR01DE021683, NIHU01HL099776]; American College of Surgeons Franklin H. Martin Faculty Research Fellowship; Stanford University Child Health Research Institute Faculty Scholar Award; Howard Hughes Medical Institute Medical Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019434, R01DE021683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019274] Funding Source: NIH RePORTER	Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Franklin H. Martin Faculty Research Fellowship; Stanford University Child Health Research Institute Faculty Scholar Award; Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Oak Foundation, the Hagey Laboratory for Pediatric Regenerative Medicine, and the National Institutes of Health, Grants NIHR21DE019274, NIHR01DE019434, NIHR01DE021683, and NIHU01HL099776 to M.T.L. and G.C.G. D.C.W. was supported by the American College of Surgeons Franklin H. Martin Faculty Research Fellowship, the Hagey Laboratory for Pediatric Regenerative Medicine, and the Stanford University Child Health Research Institute Faculty Scholar Award. S.D.M. was supported by the Howard Hughes Medical Institute Medical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bader HL, 2012, FEBS LETT, V586, P1562, DOI 10.1016/j.febslet.2012.04.032; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; El-Ftesi S, 2009, PLAST RECONSTR SURG, V123, P475, DOI 10.1097/PRS.0b013e3181954d08; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Huang M, 2011, CIRCULATION, V124, pS46, DOI 10.1161/CIRCULATIONAHA.110.014019; Huang NF, 2009, JOVE-J VIS EXP, DOI [10.3791/1034, DOI 10.3791/1034]; Lan F, 2012, CIRCULATION, V126, pS20, DOI 10.1161/CIRCULATIONAHA.111.084913; Lijkwan MA, 2014, HUM GENE THER, V25, P41, DOI 10.1089/hum.2013.110; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Nauta AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059167; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Rennert RC, 2013, EXPERT OPIN BIOL TH, V13, P1523, DOI 10.1517/14712598.2013.842972; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Stenler S, 2014, HUM VACCIN IMMUNOTHE, V10; Thangarajah H, 2010, CELL CYCLE, V9, P75, DOI 10.4161/cc.9.1.10371; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wu W, 2013, PLAST RECONSTR SURG, V131, P27, DOI 10.1097/PRS.0b013e3182729cfc; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084548; Zimmermann AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093373	29	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150927	10.1371/journal.pone.0150927	http://dx.doi.org/10.1371/journal.pone.0150927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967994	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200019
J	Zhai, W; Sun, Y; Jiang, M; Wang, M; Gasiewicz, TA; Zheng, J; Chang, C				Zhai, W.; Sun, Y.; Jiang, M.; Wang, M.; Gasiewicz, T. A.; Zheng, J.; Chang, C.			Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2 alpha/C-MYC axis under hypoxia	ONCOGENE			English	Article							CLEAR-CELL; NONCODING RNAS; BINDING; GENE; HIF; CARCINOMA; CANCER; EPIDEMIOLOGY; SPECIFICITY; PROGRESSION	It is well established that hypoxia contributes to tumor progression in a hypoxia inducible factor-2 alpha (HIF-2 alpha)-dependent manner in renal cell carcinoma (RCC), yet the role of long noncoding RNAs (LncRNAs) involved in hypoxia-mediated RCC progression remains unclear. Here we demonstrate that LncRNA-SARCC (Suppressing Androgen Receptor in Renal Cell Carcinoma) is differentially regulated by hypoxia in a von Hippel-Lindau (VHL)-dependent manner both in RCC cell culture and clinical specimens. LncRNA-SARCC can suppress hypoxic cell cycle progression in the VHL-mutant RCC cells while derepress it in the VHL-restored RCC cells. Mechanism dissection reveals that LncRNA-SARCC can post-transcriptionally regulate androgen receptor (AR) by physically binding and destablizing AR protein to suppress AR/HIF-2 alpha/C-MYC signals. In return, HIF-2 alpha can transcriptionally regulate the LncRNA-SARCC expression via binding to hypoxia-responsive elements on the promoter of LncRNA-SARCC. The negative feedback modulation between LncRNA-SARCC/AR complex and HIF-2 alpha signaling may then lead to differentially modulated RCC progression in a VHL-dependent manner. Together, these results may provide us a new therapeutic approach via targeting this newly identified signal from LncRNA-SARCC to AR-mediated HIF-2 alpha/C-MYC signals against RCC progression.	[Zhai, W.; Zheng, J.] Tongji Univ, Shanghai Peoples Hosp 10, Dept Urol, Shanghai, Peoples R China; [Zhai, W.; Sun, Y.; Wang, M.; Chang, C.] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA; [Zhai, W.; Sun, Y.; Wang, M.; Chang, C.] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA; [Zhai, W.; Sun, Y.; Wang, M.; Chang, C.] Univ Rochester, Med Ctr, Dept Radiat Oncol, George Whipple Lab Canc Res, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA; [Zhai, W.; Sun, Y.; Wang, M.; Chang, C.] Univ Rochester, Med Ctr, Wilmot Canc Ctr, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA; [Jiang, M.] Nantong Univ, Sch Med, Lab Nucl Receptors & Canc Res, Nantong, Jiangsu, Peoples R China; [Gasiewicz, T. A.] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Chang, C.] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Tongji University; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Nantong University; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zheng, J; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.; Zheng, J; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.; Zheng, J; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Radiat Oncol, George Whipple Lab Canc Res, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.; Zheng, J; Chang, C (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Ctr, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	zhengjh0471@sina.com.cn; chang@urmc.rochester.edu		Jiang, Ming/0000-0003-3361-9881	NIH [CA155477, CA156700]; George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial, Research Center of Excellence [DOH99-TD-B-111-004]; National Science Foundation of China [31570775]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial, Research Center of Excellence; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by NIH grants (CA155477 and CA156700), George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial, Research Center of Excellence (DOH99-TD-B-111-004 to China Medical University, Taichung, Taiwan) and the National Science Foundation of China (31570775). We also gratefully acknowledged the help from Mr Jason Walrath of Department of Environmental Medicine of URMC for hypoxia experiments using In ViVo<INF>2</INF> hypoxic workstation. We thank Karen Wolf for help preparing the manuscript.	Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen Y, 2015, ONCOTARGET, V6, P31203, DOI 10.18632/oncotarget.4522; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Claessens F, 1996, J BIOL CHEM, V271, P19013, DOI 10.1074/jbc.271.32.19013; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Harrison LRE, 2011, J CLIN INVEST, V121, P1075, DOI 10.1172/JCI43505; He DL, 2014, CANCER RES, V74, P4420, DOI 10.1158/0008-5472.CAN-13-2681; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kuo HP, 2009, BIOCHEM BIOPH RES CO, V389, P640, DOI 10.1016/j.bbrc.2009.09.042; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Lipworth L, 2006, J UROLOGY, V176, P2353, DOI 10.1016/j.juro.2006.07.130; Lu W, 2015, MOL BIOL CELL, V26, P1296, DOI 10.1091/mbc.E14-10-1423; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Moon EJ, 2007, ANTIOXID REDOX SIGN, V9, P1237, DOI 10.1089/ars.2007.1623; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Muller H, 2007, BIOORGAN MED CHEM, V15, P7470, DOI 10.1016/j.bmc.2007.07.024; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Parker AS, 2005, UROLOGY, V65, P1090, DOI 10.1016/j.urology.2004.12.040; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Stone Louise, 2015, Nat Rev Urol, V12, P125, DOI 10.1038/nrurol.2015.26; Takahashi K, 2014, J CELL SCI, V127, P1585, DOI 10.1242/jcs.141069; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298; Verrijdt G, 1999, MOL ENDOCRINOL, V13, P1558, DOI 10.1210/me.13.9.1558; Wang J, 2014, MOL ENDOCRINOL, V28, P239, DOI 10.1210/me.2013-1258; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yao M, 2002, JNCI-J NATL CANCER I, V94, P1569; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377	52	52	53	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4866	4880		10.1038/onc.2016.19	http://dx.doi.org/10.1038/onc.2016.19			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26973243				2022-12-26	WOS:000383330700005
J	Mohammad, GH; Damink, SWMO; Malago, M; Dhar, DK; Pereira, SP				Mohammad, Goran Hamid; Damink, S. W. M. Olde; Malago, Massimo; Dhar, Dipok Kumar; Pereira, Stephen P.			Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome	PLOS ONE			English	Article							TUMOR M2-PYRUVATE KINASE; INFILTRATING LYMPHOCYTES; NUCLEAR TRANSLOCATION; AEROBIC GLYCOLYSIS; PROGNOSTIC-FACTOR; CELL CARCINOMA; PKM2 PROMOTES; MARKER; PHOSPHORYLATION; PROGRESSION	Pancreatic cancer has a 5-year survival rate of less than 4%. Despite advances in diagnostic technology, pancreatic cancer continues to be diagnosed at a late and incurable stage. Accurate biomarkers for early diagnosis and to predict treatment response are urgently needed. Since alteration of glucose metabolism is one of the hallmarks of cancer cells, we proposed that pyruvate kinase type M2 (M2PK) and lactate dehydrogenase A (LDHA) enzymes could represent novel diagnostic markers and potential therapeutic targets in pancreatic cancer. In 266 tissue sections from normal pancreas, pancreatic cystic neoplasms, pancreatic intraepithelial neoplasia (PanIN) and cancer, we evaluated the expression of PKM2, LDHA, Ki-67 and CD8+ by immunohistochemistry and correlated these markers with clinicopathological characteristics and patient survival. PKM2 and LDHA expression was also assessed by Western blot in 10 human pancreatic cancer cell lines. PKM2 expression increased progressively from cyst through PanIN to cancer, whereas LDHA was overexpressed throughout the carcinogenic process. All but one cell line showed high expression of both proteins. Patients with strong PKM2 and LDHA expression had significantly worse survival than those with weak PKM2 and/or LDHA expression (7.0 months vs. 27.9 months, respectively, p = 0.003, log rank test). The expression of both PKM2 and LDHA correlated directly with Ki-67 expression, and inversely with intratumoral CD8+ cell count. PKM2 was significantly overexpressed in poorly differentiated tumours and both PKM2 and LDHA were overexpressed in larger tumours. Multivariable analysis showed that combined expression of PKM2 and LDHA was an independent poor prognostic marker for survival. In conclusion, our results demonstrate a high expression pattern of two major glycolytic enzymes during pancreatic carcinogenesis, with increased expression in aggressive tumours and a significant adverse effect on survival.	[Mohammad, Goran Hamid; Damink, S. W. M. Olde; Malago, Massimo; Dhar, Dipok Kumar; Pereira, Stephen P.] UCL, Royal Free Hosp Campus, UCL Inst Liver & Digest Hlth, London, England; [Mohammad, Goran Hamid] Univ Sulaimani, Sch Sci, Dept Chem, Sulaimanyah, Kurdistan Regio, Iraq; [Damink, S. W. M. Olde] Maastricht Univ, Med Ctr, Dept Surg, NL-6200 MD Maastricht, Netherlands; [Dhar, Dipok Kumar] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia	University of London; University College London; University of Sulimanyah; Maastricht University; King Faisal Specialist Hospital & Research Center	Pereira, SP (corresponding author), UCL, Royal Free Hosp Campus, UCL Inst Liver & Digest Hlth, London, England.	stephen.pereira@ucl.ac.uk	Pereira, Stephen P/C-5639-2009; Mohammad, Goran/C-6819-2019; Damink, Steven WM Olde/U-7919-2019	Pereira, Stephen P/0000-0003-0821-1809; Mohammad, Goran/0000-0003-4822-1497; Damink, Steven WM Olde/0000-0002-5202-9345	Pancreatic Cancer Research Fund; Jason Boas Foundation; NIH [P01 CA084203]; UCLH/UCL Comprehensive Biomedical Centre from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; NATIONAL CANCER INSTITUTE [P01CA084203] Funding Source: NIH RePORTER	Pancreatic Cancer Research Fund; Jason Boas Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLH/UCL Comprehensive Biomedical Centre from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Pancreatic Cancer Research Fund, The Jason Boas Foundation, NIH grant P01 CA084203 and the UCLH/UCL Comprehensive Biomedical Centre, which receives a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC FACT FIG 2014; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Ashida A, 2006, INT J ONCOL, V28, P1345; Azoitei N, Z GASTROENTEROL, V51, pK55; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Cancer Research UK, 2014, PANCR CANC STAT; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Crane CA, 2014, P NATL ACAD SCI USA, V111, P12823, DOI 10.1073/pnas.1413933111; Dhar DK, 2013, CANCER-AM CANCER SOC, V119, P575, DOI 10.1002/cncr.27611; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Feng JK, 2015, MOL MED REP, V11, P2111, DOI 10.3892/mmr.2014.2990; Fiume L, 2014, FUTURE MED CHEM, V6, P429, DOI [10.4155/FMC.13.206, 10.4155/fmc.13.206]; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goonetilleke KS, 2007, PANCREAS, V34, P318, DOI 10.1097/MPA.0b013e31802ee9c7; Gourgou-Bourgade S, 2013, J CLIN ONCOL, V31, P23, DOI 10.1200/JCO.2012.44.4869; Hardt PD, 2008, EXPERT REV MOL DIAGN, V8, P579, DOI 10.1586/14737159.8.5.579; He TL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0633-8; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Ikeguchi M, 2004, EJSO-EUR J SURG ONC, V30, P53, DOI 10.1016/j.ejso.2003.10.001; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Joergensen MT, 2010, PANCREAS, V39, P243, DOI 10.1097/MPA.0b013e3181bae8ab; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kachel P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1135-y; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Kumar Y, 2007, PANCREAS, V35, P114, DOI 10.1097/mpa.0b013e3180537237; Kumar Y, 2010, TUMOR BIOL, V31, P69, DOI 10.1007/s13277-009-0010-3; Le A, 2012, CLIN CANCER RES, V18, P4285, DOI 10.1158/1078-0432.CCR-12-0041; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Li J, 2014, CLIN TRANSL ONCOL, V16, P200, DOI 10.1007/s12094-013-1063-8; Li YG, 2009, DIGEST LIVER DIS, V41, P605, DOI 10.1016/j.dld.2008.11.010; Li ZW, 2014, BBA-REV CANCER, V1846, P285, DOI 10.1016/j.bbcan.2014.07.008; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Liu WR, 2015, ONCOTARGET, V6, P846, DOI 10.18632/oncotarget.2749; Lockney Natalie A, 2015, J Gastrointest Cancer, V46, P390, DOI 10.1007/s12029-015-9764-6; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Nakano O, 2001, CANCER RES, V61, P5132; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Parra-Bonilla G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075984; Rajeshkumar N V., 2015, CANCER RES, P713; Rong YF, 2013, TUMOR BIOL, V34, P1523, DOI 10.1007/s13277-013-0679-1; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shi M, 2014, CLIN CANCER RES, V20, P4370, DOI 10.1158/1078-0432.CCR-14-0186; Singh SR, 2015, CANCER LETT, V356, P147, DOI 10.1016/j.canlet.2014.06.002; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Sun X, 2015, TUMOR BIOL, P1; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wang Y, 2015, CANC BIOL T IN PRESS; Warner SL, 2014, FUTURE MED CHEM, V6, P1167, DOI [10.4155/FMC.14.70, 10.4155/fmc.14.70]; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Xue JJ, 2014, EUR J MED CHEM, V80, P1, DOI 10.1016/j.ejmech.2014.04.035; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yu Y, 2001, BIOCHEM PHARMACOL, V62, P81, DOI 10.1016/S0006-2952(01)00636-0; Yu YP, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-78; Zhang XL, 2013, PATHOL RES PRACT, V209, P510, DOI 10.1016/j.prp.2013.06.005; Zhao D, 2013, ONCOTARGET, V4, P802, DOI 10.18632/oncotarget.1007; Zhou CF, 2012, IUBMB LIFE, V64, P775, DOI 10.1002/iub.1066	66	57	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151635	10.1371/journal.pone.0151635	http://dx.doi.org/10.1371/journal.pone.0151635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989901	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800082
J	Deng, J; Sun, PS; Zhao, FX; Han, XH; Yang, GH; Feng, YZ; Ren, GX				Deng, Jian; Sun, Pingsheng; Zhao, Fazhu; Han, Xinhui; Yang, Gaihe; Feng, Yongzhong; Ren, Guangxin			Soil C, N, P and Its Stratification Ratio Affected by Artificial Vegetation in Subsoil, Loess Plateau China	PLOS ONE			English	Article							DRY COMBUSTION METHODS; ORGANIC-CARBON; LAND-USE; SAMPLING DEPTH; AFFORESTATION; DYNAMICS; MATTER; NITROGEN; FOREST; SEQUESTRATION	Artificial vegetation restoration can induce variations in accumulation and distribution of soil carbon (C), nitrogen (N) and phosphorus (P). However, little is known about variations in soil C, N and P nutrient fraction stratification following artificial vegetation in Loess Plateau China. Based on the hypothesis that re-vegetated can improve soil quality and stratification ratios (SR) can be used as an indicator to evaluate soil quality. This study measured contents and storages of soil organic carbon (SOC), total nitrogen (TN), total phosphorus (TP) and their SRs in topsoil (0-20 cm) and subsoil (20-60 cm) in three 30-year re-vegetated lands that had been converted from arable land (Robinia pseudoacacia L., Caragana Korshinskii Kom. and abandoned cropland with low interferences and few management measures) and one slope cropland (SC) as a control for three soil profiles(0-20 cm, 20-40 cm and 40-60 cm) from June 2009 to June 2013. The results showed that the contents and storages of SOC, TN and TP in re-vegetated land were significantly higher than those in the SC in both topsoil and subsoil. The storages of SOC, TN and TP in the topsoil (0-20 cm) of the re-vegetated lands increased by 16.2%-26.4%, 12.7%-28.4% and 16.5%-20.9%, respectively, and increased by smaller but significant amounts in subsoil from 2009 to 2013. The SRs for SOC, TN and TP in the re-vegetated lands were mostly >2 (either for 0-20: 2040 cm or 0-20: 40-60 cm) and greater than that in the SC. The SRs showed an increasing trend with increasing restoration age. The results also showed that the land use type and soil depth were the most influential factors for the SRs and storages, and the SRs of SOC and TN had significantly positive correlations with their storages. The SRs were concluded to be a good indicator for evaluating the soil quality, which can be significantly enhanced through vegetation restoration. Moreover, vegetation restoration can significantly enhance SOC, TN and TP accumulation in both topsoil and subsoil.	[Deng, Jian; Sun, Pingsheng; Zhao, Fazhu; Han, Xinhui; Yang, Gaihe; Feng, Yongzhong; Ren, Guangxin] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Deng, Jian; Sun, Pingsheng; Yang, Gaihe; Feng, Yongzhong; Ren, Guangxin] Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.; Yang, GH (corresponding author), Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn	Feng, Yongzhong/F-5090-2012; Deng, Jian/E-2988-2014	Feng, Yongzhong/0000-0002-5202-4368; Deng, Jian/0000-0002-0841-7084	Special Fund for forest-scientific Research in the Public Interest [201304312]; National Natural Science Foundation of China [41301601]; Science and Technology Coordinating Innovative Engineering project of Shaanxi province [2015KTCL02-07]	Special Fund for forest-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Coordinating Innovative Engineering project of Shaanxi province	The study was financially supported by Special Fund for forest-scientific Research in the Public Interest (No. 201304312) (http://www.forestry.gov.cn), National Natural Science Foundation of China (No. 41301601) (http://www.nsfc.gov.cn/) and the Science and Technology Coordinating Innovative Engineering project of Shaanxi province (No. 2015KTCL02-07)(http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; [Anonymous], 2015, PRIMER 7 USER MANUAL; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Binkley D, 2005, NATO SCI S SS IV EAR, V55, P155; Cannell MGR, 1999, FORESTRY, V72, P237, DOI 10.1093/forestry/72.3.237; Chang RY, 2012, CATENA, V95, P145, DOI 10.1016/j.catena.2012.02.012; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Sa JCDM, 2013, SOIL SCI SOC AM J, V77, P2094, DOI 10.2136/sssaj2013.01.0007; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Feng X, 2013, SCI REPORTS, V3; Francaviglia R, 2014, AGR ECOSYST ENVIRON, V183, P86, DOI 10.1016/j.agee.2013.10.026; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P95, DOI 10.1016/S0167-1987(02)00018-1; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Grieve IC, 2001, CATENA, V42, P361, DOI 10.1016/S0341-8162(00)00147-8; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hok L, 2015, AGR ECOSYST ENVIRON, V214, P54, DOI 10.1016/j.agee.2015.08.013; Jia GM, 2005, FOREST ECOL MANAG, V217, P117, DOI 10.1016/j.foreco.2005.05.055; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Klute A., 1986, METHODS SOIL ANAL 1; Korkanc SY, 2014, CATENA, V123, P62, DOI 10.1016/j.catena.2014.07.009; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lima AMN, 2006, FOREST ECOL MANAG, V235, P219, DOI 10.1016/j.foreco.2006.08.331; Liu GB, 1999, AMBIO, V28, P663; Macdonald CA, 2009, SOIL BIOL BIOCHEM, V41, P1642, DOI 10.1016/j.soilbio.2009.05.003; Mikhailova EA, 2003, COMMUN SOIL SCI PLAN, V34, P1853, DOI 10.1081/CSS-120023220; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Peregrina F, 2014, J PLANT NUTR SOIL SC, V177, P548, DOI 10.1002/jpln.201300371; Qiu LP, 2010, PLANT SOIL, V332, P207, DOI 10.1007/s11104-010-0286-5; Raiesi F, 2012, PLANT SOIL, V351, P161, DOI 10.1007/s11104-011-0941-5; Ruiz-Navarro A, 2009, GEODERMA, V153, P353, DOI 10.1016/j.geoderma.2009.08.024; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; SMECK NE, 1985, GEODERMA, V36, P185, DOI 10.1016/0016-7061(85)90001-1; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Tfaily MM, 2014, J GEOPHYS RES-BIOGEO, V119, P661, DOI 10.1002/2013JG002492; Tivet F, 2012, SOIL SCI SOC AM J, V76, P1048, DOI 10.2136/sssaj2011.0328; VandenBygaart AJ, 2011, SOIL SCI SOC AM J, V75, P226, DOI 10.2136/sssaj2010.0099; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Xue Sha, 2009, Scientia Agricultura Sinica, V42, P1458; Zhang CB, 2014, J ARID LAND, V6, P601, DOI 10.1007/s40333-014-0004-x; Zhang DJ, 2014, PLANT SOIL, V376, P307, DOI 10.1007/s11104-013-1954-z; Zhao FZ, 2015, ECOL ENG, V74, P415, DOI 10.1016/j.ecoleng.2014.11.010; Zhao FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099657; Zhao FZ, 2013, SOIL SCI, V178, P550, DOI 10.1097/SS.0000000000000018; Zheng ZC, 2012, WATER SCI ENG, V5, P191, DOI 10.3882/j.issn.1674-2370.2012.02.007	51	36	40	9	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151446	10.1371/journal.pone.0151446	http://dx.doi.org/10.1371/journal.pone.0151446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987057	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300072
J	Dewland, TA; Bibbins-Domingo, K; Lin, F; Vittinghoff, E; Foster, E; Ogunyankin, KO; Lima, JA; Jacobs, DR; Hu, DL; Burchard, EG; Marcus, GM				Dewland, Thomas A.; Bibbins-Domingo, Kirsten; Lin, Feng; Vittinghoff, Eric; Foster, Elyse; Ogunyankin, Kofo O.; Lima, Joao A.; Jacobs, David R.; Hu, Donglei; Burchard, Esteban G.; Marcus, Gregory M.			Racial Differences in Left Atrial Size: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) Study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; ALCOHOL-CONSUMPTION; FIBRILLATION; VOLUME; HEART; PREVALENCE; ANCESTRY; DESIGN; STROKE; MEN	Whites have an increased risk of atrial fibrillation (AF) compared to Blacks. The mechanism underlying this association is unknown. Left atrial (LA) size is an important AF risk factor, and studies in older adults suggest Whites have larger LA diameters. However, because AF itself causes LA dilation, LA size differences may be due to greater subclinical AF among older Whites. We therefore assessed for racial differences in LA size among young adults at low AF risk. The Coronary Artery Risk Development in Young Adults (CARDIA) study enrolled White and Black participants between 18 and 30 years of age. LA diameter was measured in a subset of participants using echocardiography at Year 5 (n = 4,201) and Year 25 (n = 3,373) of follow up. LA volume was also assessed at Year 5 (n = 2,489). Multivariate linear regression models were used to determine the adjusted association between race and LA size. In unadjusted analyses, mean LA diameter was significantly larger among Blacks compared to Whites both at Year 5 (35.5 +/- 4.8 mm versus 35.1 +/- 4.5 mm, p = 0.01) and Year 25 (37.4 +/- 5.1 mm versus 36.8 +/- 4.9 mm, p = 0.002). After adjusting for demographics, comorbidities, and echocardiographic parameters, Whites demonstrated an increased LA diameter (0.7 mm larger at Year 5, 95% CI 0.3-1.1, p<0.001; 0.6 mm larger at Year 25, 95% CI 0.3-1.0, p<0.001). There was no significant association between race and adjusted Year 5 LA volume. In conclusion, in a young, well-characterized cohort, the larger adjusted LA diameter among White participants suggests inherent differences in atrial structure may partially explain the higher risk of AF in Whites. The incongruent associations between race, LA diameter, and LA volume suggest that LA geometry, rather than size alone, may have implications for AF risk.	[Dewland, Thomas A.; Marcus, Gregory M.] Univ Calif San Francisco, Dept Med, Div Cardiol, Electrophysiol Sect, San Francisco, CA 94143 USA; [Dewland, Thomas A.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Bibbins-Domingo, Kirsten; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bibbins-Domingo, Kirsten; Lin, Feng; Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Foster, Elyse] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA USA; [Ogunyankin, Kofo O.] First Cardiol Consultants, Lagos, Nigeria; [Lima, Joao A.] Johns Hopkins Hosp & Sch Med, Dept Med, Div Cardiol, Baltimore, MD USA; [Jacobs, David R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Hu, Donglei] Univ Calif San Francisco, Dept Med, Inst Human Genet, San Francisco, CA USA	University of California System; University of California San Francisco; Oregon Health & Science University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, Electrophysiol Sect, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Ogunyankin, Kofo/AAZ-4013-2020; Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696; Jacobs, David/0000-0002-7232-0543	American Heart Association [12POST11810036, 12GRNT11780061]; Joseph Drown Foundation; National Heart, Lung, and Blood Institute (NHLBI); Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; Intramural Research Program of the National Institute on Aging (NIA); University of Alabama at Birmingham [HHSN268201300025C, HHSN268201300026C]; NIA [AG0005]; NHLBI [AG0005]	American Heart Association(American Heart Association); Joseph Drown Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); Intramural Research Program of the National Institute on Aging (NIA); University of Alabama at Birmingham; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was made possible by grant numbers 12POST11810036 (TAD) and 12GRNT11780061 (GMM) from the American Heart Association and by the Joseph Drown Foundation (GMM). The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201300025C & HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content. First Cardiology Consultants provided support in the form of salaries for authors KOO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Armstrong AC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004001; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Cioffi G, 2004, J HYPERTENS, V22, P1589, DOI 10.1097/01.hjh.0000125454.28861.76; Desai CS, 2013, AM J EPIDEMIOL, V177, P20, DOI 10.1093/aje/kws224; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GOTTDIENER JS, 1994, J AM COLL CARDIOL, V24, P1492, DOI 10.1016/0735-1097(94)90145-7; Gottdiener JS, 1998, CIRCULATION, V98, P140, DOI 10.1161/01.CIR.98.2.140; Kishi S, 2014, AM J CARDIOL, V113, P377, DOI 10.1016/j.amjcard.2013.08.052; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Manolio TA, 2002, AM J CARDIOL, V90, P983, DOI 10.1016/S0002-9149(02)02665-6; Marcus GM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.05.019; Marcus GM, 2010, CIRCULATION, V122, P2009, DOI 10.1161/CIRCULATIONAHA.110.958306; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Pletcher MJ, 2005, AM J EPIDEMIOL, V161, P423, DOI 10.1093/aje/kwi062; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; Psaty BM, 1997, CIRCULATION, V96, P2455; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Singh KJ, 2013, J CARD FAIL, V19, P183, DOI 10.1016/j.cardfail.2012.12.005; SUAREZ GS, 1991, CLIN CARDIOL, V14, P652, DOI 10.1002/clc.4960140806; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tsang TSM, 2001, MAYO CLIN PROC, V76, P467, DOI 10.4065/76.5.467; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wozakowska-Kaplon B, 2005, INT J CARDIOL, V101, P47, DOI 10.1016/j.ijcard.2004.03.010	30	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151559	10.1371/journal.pone.0151559	http://dx.doi.org/10.1371/journal.pone.0151559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985672	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300086
J	Severo, ETD; Calonego, FW; Sansigolo, CA; Bond, B				Durgante Severo, Elias Taylor; Calonego, Fred Willians; Sansigolo, Claudio Angeli; Bond, Brian			Changes in the Chemical Composition and Decay Resistance of Thermally-Modified Hevea brasiliensis Wood	PLOS ONE			English	Article							NATURAL DURABILITY; MATURE WOODS; JUVENILE; EUCALYPTUS; HEARTWOOD; BEECH	In this study the effect of thermal treatment on the equilibrium moisture content, chemical composition and biological resistance to decay fungi of juvenile and mature Hevea brasiliensis wood (rubber wood) was evaluated. Samples were taken from a 53-year-old rubber wood plantation located in Tabapua, Sao Paulo, Brazil. The samples were thermally-modified at 180 degrees C, 200 degrees C and 220 degrees C. Results indicate that the thermal modification caused: (1) a significant increase in the extractive content and proportional increase in the lignin content at 220 degrees C; (2) a significant decrease in the equilibrium moisture content, holocelluloses, arabinose, galactose and xylose content, but no change in glucose content; and (3) a significant increase in wood decay resistance against both Pycnoporus sanguineus (L.) Murrill and Gloeophyllum trabeum (Pers.) Murrill decay fungi. The greatest decay resistance was achieved from treatment at 220 degrees C which resulted in a change in wood decay resistance class from moderately resistant to resistant. Finally, this study also demonstrated that the influence of thermal treatment in mature wood was lower than in juvenile wood.	[Durgante Severo, Elias Taylor; Calonego, Fred Willians; Sansigolo, Claudio Angeli] Sao Paulo State Univ, UNESP, Fac Agr Sci, Dept Forest Sci, Sao Paulo, Brazil; [Durgante Severo, Elias Taylor; Bond, Brian] Virginia Tech, Brooks Forest Prod Ctr, Dept Sustainable Biomat, Blacksburg, VA USA; [Durgante Severo, Elias Taylor] Fazenda Expt Lageado, Fac Agr Sci, Dept Forest Sci, POB 237, BR-18603970 Botucatu, SP, Brazil; [Bond, Brian] Virginia Polytech Inst & State Univ, Brooks Forest Prod Ctr, 1650 Ramble Rd, Blacksburg, VA 24061 USA	Universidade Estadual Paulista; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Severo, ETD (corresponding author), Sao Paulo State Univ, UNESP, Fac Agr Sci, Dept Forest Sci, Sao Paulo, Brazil.; Severo, ETD (corresponding author), Virginia Tech, Brooks Forest Prod Ctr, Dept Sustainable Biomat, Blacksburg, VA USA.; Severo, ETD (corresponding author), Fazenda Expt Lageado, Fac Agr Sci, Dept Forest Sci, POB 237, BR-18603970 Botucatu, SP, Brazil.	severo@fca.unesp.br	Severo, Elias T. D./H-5210-2013	Bond, Brian/0000-0001-6712-8250; Calonego, Fred Willians/0000-0002-1597-5586	Research Assistance Foundation from Sao Paulo (FAPESP), Brazil [2013/15372-0]	Research Assistance Foundation from Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank the Research Assistance Foundation from Sao Paulo (FAPESP), Brazil, for financial support through grant numbers 2013/15372-0.; The authors thank the Research Assistance Foundation from Sao Paulo (FAPESP), Brazil, for financial support through grant numbers 2013/15372-0.	American Society for Testing and Materials, 2008, D2017 ASTM; [Anonymous], 1999, 222OM98 TAPPI; [Anonymous], 2007, D1413 ASTM, DOI 10.31520/D1413-073; [Anonymous], 1999, 264CM97 TAPPI; Bachle H, 2010, WOOD SCI TECHNOL, V44, P421, DOI 10.1007/s00226-010-0361-3; Bhuiyan MTR, 2000, J WOOD SCI, V46, P431, DOI 10.1007/BF00765800; Brito JO, 2008, BIORESOURCE TECHNOL, V99, P8545, DOI 10.1016/j.biortech.2008.03.069; Calonego FW, 2012, EUR J WOOD WOOD PROD, V70, P453, DOI 10.1007/s00107-011-0568-5; Calonego FW, 2010, BIORESOURCE TECHNOL, V101, P9391, DOI 10.1016/j.biortech.2010.06.119; Esteves B, 2008, HOLZFORSCHUNG, V62, P344, DOI 10.1515/HF.2008.057; Ferreira A, 2011, EUR J WOOD WOOD PROD, V69, P659, DOI 10.1007/s00107-010-0510-2; Goldschmid O., 1971, LIGNINS OCCURRENCE F, P241; Hakkou M, 2006, POLYM DEGRAD STABIL, V91, P393, DOI 10.1016/j.polymdegradstab.2005.04.042; Haupt M, 2003, HOLZ ROH WERKST, V61, P473, DOI 10.1007/s00107-003-0428-z; Homan W, 2000, P WORLD C TIMB ENG B; HONG LT, 1994, RUBBERWOOD PROCESSIN, P37; Hong LT, 1995, 20 INT UN FOR RES OR; KADIR AA, 1989, HOLZFORSCHUNG, V43, P173, DOI 10.1515/hfsg.1989.43.3.173; Kopitovic S., 1989, Drevarsky Vyskum, P13; Latorraca JVF, 2011, AN ACAD BRAS CIENC, V83, P1059, DOI 10.1590/S0001-37652011005000016; Lenth CA, 2001, WOOD FIBER SCI, V33, P104; Metsa-Kortelainen S, WATER; Severo ETD, 2013, EUR J WOOD WOOD PROD, V71, P815, DOI 10.1007/s00107-013-0731-2; Severo ETD, 2012, EUR J WOOD WOOD PROD, V70, P741, DOI 10.1007/s00107-012-0611-1; Severo ETD, 2009, PI0902388A2 INPI; Shanks RA, 2011, J THERM ANAL CALORIM, V106, P93, DOI 10.1007/s10973-011-1620-8; SULLIVAN J, 1994, J CHROMATOGR A, V671, P339, DOI 10.1016/0021-9673(94)80259-9; Teoh YP, 2011, J WOOD SCI, V57, P255, DOI 10.1007/s10086-011-1173-2; Vernois M, 2001, REV HEAT TREATMENTS; Waskett P, 2001, OPPORTUNITIES UK GRO, P83; Weiland JJ, 2003, HOLZ ROH WERKST, V61, P216, DOI 10.1007/s00107-003-0364-y; Wikberg H, 2004, CARBOHYD POLYM, V58, P461, DOI 10.1016/j.carbpol.2004.08.008	32	26	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151353	10.1371/journal.pone.0151353	http://dx.doi.org/10.1371/journal.pone.0151353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986200	gold, Green Published, Green Submitted			2022-12-26	WOS:000372580300066
J	Kessans, SA; Linhart, MD; Meador, LR; Kilbourne, J; Hogue, BG; Fromme, P; Matoba, N; Mor, TS				Kessans, Sarah A.; Linhart, Mark D.; Meador, Lydia R.; Kilbourne, Jacquelyn; Hogue, Brenda G.; Fromme, Petra; Matoba, Nobuyuki; Mor, Tsafrir S.			Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles	PLOS ONE			English	Article							PROXIMAL EXTERNAL REGION; NEUTRALIZING MONOCLONAL-ANTIBODIES; TRANSCYTOSIS-BLOCKING ABS; T-CELL RESPONSES; IMMUNE-RESPONSES; EPITHELIAL TRANSCYTOSIS; TRANSMEMBRANE DOMAIN; VACCINE CANDIDATE; ORAL IMMUNIZATION; GLYCOPROTEIN GP41	It is widely anticipated that a prophylactic vaccine may be needed to control the HIV/AIDS epidemic worldwide. Despite over two decades of research, a vaccine against HIV-1 remains elusive, although a recent clinical trial has shown promising results. Recent studies have focused on highly conserved domains within HIV-1 such as the membrane proximal external region (MPER) of the envelope glycoprotein, gp41. MPER has been shown to play critical roles in mucosal transmission of HIV-1, though this peptide is poorly immunogenic on its own. Here we provide evidence that plant-produced HIV-1 enveloped virus-like particles (VLPs) consisting of Gag and a deconstructed form of gp41 comprising the MPER, transmembrane, and cytoplasmic domains (Dgp41) provides an effective platform to display MPER for use as an HIV vaccine candidate. Prime-boost strategies combining systemic and mucosal priming with systemic boosting using two different vaccine candidates (VLPs and CTB-MPR-a fusion of MPER and the B-subunit of cholera toxin) were investigated in BALB/c mice. Serum antibody responses against both the Gag and gp41 antigens were elicited when systemically primed with VLPs. These responses could be recalled following systemic boosting with VLPs. In addition, mucosal priming with VLPs allowed for a boosting response against Gag and gp41 when boosted with either candidate. Importantly, the VLPs also induced Gag-specific CD4 and CD8 T-cell responses. This report on the immunogenicity of plant-based Gag/Dgp41 VLPs may represent an important milestone on the road towards a broadly efficacious and inexpensive subunit vaccine against HIV-1.	[Kessans, Sarah A.; Linhart, Mark D.; Meador, Lydia R.; Hogue, Brenda G.; Matoba, Nobuyuki; Mor, Tsafrir S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Kessans, Sarah A.; Linhart, Mark D.; Meador, Lydia R.; Kilbourne, Jacquelyn; Hogue, Brenda G.; Matoba, Nobuyuki; Mor, Tsafrir S.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Hogue, Brenda G.; Fromme, Petra] Arizona State Univ, Biodesign Inst, Ctr Appl Struct Discovery, Tempe, AZ USA; [Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Kessans, Sarah A.] Univ Canterbury, Dept Chem, Biomol Interact Ctr, Christchurch 1, New Zealand; [Matoba, Nobuyuki] Owensboro Canc Res Program, Owensboro, KY USA; [Matoba, Nobuyuki] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Matoba, Nobuyuki] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Louisville; University of Louisville	Mor, TS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ USA.; Mor, TS (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA.	tsafrir.mor@asu.edu		Hogue, Brenda/0000-0002-4545-9208; Matoba, Nobuyuki/0000-0001-7231-3004; Fromme, Petra/0000-0003-0953-4909	National Institutes of Health, National Institute of Allergy and Infectious diseases [U19 AI062150]; Center for Membrane Proteins in Infectious Diseases (MPID); Protein Structure Initiative (PSI: Biology) of the National Institute of General Medicine Science; National Institutes of Health [1U54 GM094625]; National Institutes of Health, the National Institute of Allergy and Infectious Diseases [R03 AI073157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062150, R03AI073157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094625] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Membrane Proteins in Infectious Diseases (MPID); Protein Structure Initiative (PSI: Biology) of the National Institute of General Medicine Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by the National Institutes of Health, National Institute of Allergy and Infectious diseases (U19 AI062150 to TM); by the Center for Membrane Proteins in Infectious Diseases (MPID), which is funded by the Protein Structure Initiative (PSI: Biology) of the National Institute of General Medicine Science, the National Institutes of Health (1U54 GM094625 to PF, BGH, and TSM); and the National Institutes of Health, the National Institute of Allergy and Infectious Diseases and R03 AI073157 to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Balasubramaniam M, 2011, PHYSIOLOGY, V26, P236, DOI 10.1152/physiol.00051.2010; Benjelloun F, 2013, AIDS, V27, P1992, DOI 10.1097/QAD.0b013e3283632ea1; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Bouvin-Pley M, 2014, J VIROL, V88, P13910, DOI 10.1128/JVI.02083-14; Broliden K, 2001, IMMUNOL LETT, V79, P29, DOI 10.1016/S0165-2478(01)00263-2; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Doan LX, 2005, REV MED VIROL, V15, P75, DOI 10.1002/rmv.449; Durrani Z, 1998, J IMMUNOL METHODS, V220, P93, DOI 10.1016/S0022-1759(98)00145-8; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gong Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136507; Gong Z, 2014, PROTEIN SCI, V23, P1607, DOI 10.1002/pro.2540; Gonzalez-Rabade N, 2011, PLANT BIOTECHNOL J, V9, P629, DOI 10.1111/j.1467-7652.2011.00609.x; Guetard D, 2008, VACCINE, V26, P4477, DOI 10.1016/j.vaccine.2008.06.059; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Ivankin A, 2012, BBA-BIOMEMBRANES, V1818, P2521, DOI 10.1016/j.bbamem.2012.06.002; Kaul R, 2001, AIDS, V15, P431, DOI 10.1097/00002030-200102160-00026; Kessans SA, 2013, PLANT BIOTECHNOL J, V11, P681, DOI 10.1111/pbi.12058; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Kuehn BM, 2015, JAMA-J AM MED ASSOC, V313, P1000, DOI 10.1001/jama.2015.0942; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Leary S, 2013, AVMA GUIDELINES EUTH; Leroux-Roels G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055438; Lindh I, 2008, APMIS, V116, P985, DOI 10.1111/j.1600-0463.2008.00900.x; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Magerus-Chatinet A, 2007, VIROLOGY, V362, P67, DOI 10.1016/j.virol.2006.11.035; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Matoba N, 2004, P NATL ACAD SCI USA, V101, P13584, DOI 10.1073/pnas.0405297101; Matoba N, 2009, PLANT BIOTECHNOL J, V7, P129, DOI 10.1111/j.1467-7652.2008.00381.x; Matoba N, 2008, CURR HIV RES, V6, P218, DOI 10.2174/157016208784324994; Matoba N, 2006, VACCINE, V24, P5047, DOI 10.1016/j.vaccine.2006.03.045; Matoba N, 2011, VACCINE, V29, P5584, DOI 10.1016/j.vaccine.2011.06.007; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5488; McInerney TL, 1999, VACCINE, V17, P1359, DOI 10.1016/S0264-410X(98)00388-0; McLain L, 1996, VACCINE, V14, P799, DOI 10.1016/0264-410X(95)00229-T; Meyers A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-53; Montefiori DC, 2001, J VIROL, V75, P5879, DOI 10.1128/JVI.75.13.5879-5890.2001; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Mor TS, 2001, BIOTECHNOL BIOENG, V75, P259, DOI 10.1002/bit.10012; Ofek G, 2014, J VIROL, V88, P2426, DOI 10.1128/JVI.02837-13; Pastori C, 2012, VIROLOGY, V431, P1, DOI 10.1016/j.virol.2012.05.005; Perez-Filgueira DM, 2004, J VIROL METHODS, V121, P201, DOI 10.1016/j.jviromet.2004.06.022; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Rybicki EP, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0205-0; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Sagar M, 2012, J INFECT DIS, V205, P1248, DOI 10.1093/infdis/jis183; Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053; Scotti N, 2009, PLANTA, V229, P1109, DOI 10.1007/s00425-009-0898-2; Shen RZ, 2010, J IMMUNOL, V184, P3648, DOI 10.4049/jimmunol.0903346; Thanavala Y, 2005, P NATL ACAD SCI USA, V102, P3378, DOI 10.1073/pnas.0409899102; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Tudor D, 2011, AIDS, V25, P751, DOI 10.1097/QAD.0b013e32834507bd; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052; Verkoczy L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004073; Verkoczy L, 2013, J IMMUNOL, V191, P2538, DOI 10.4049/jimmunol.1300971; Wang J, 2011, VACCINE, V29, P8542, DOI 10.1016/j.vaccine.2011.09.032; Williamson AL, 2016, EXPERT REV VACCINES, V15, P585, DOI 10.1586/14760584.2016.1129904; Zhang XR, 2006, PLANT BIOTECHNOL J, V4, P419, DOI 10.1111/j.1467-7652.2006.00191.x; Zhang YF, 2014, SCI CHINA LIFE SCI, V57, P987, DOI 10.1007/s11427-014-4746-7; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zimran A, 2015, BLOOD CELL MOL DIS, V54, P9, DOI 10.1016/j.bcmd.2014.10.002; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	75	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151842	10.1371/journal.pone.0151842	http://dx.doi.org/10.1371/journal.pone.0151842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986483	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300139
J	Kluge, M; Campos, FS; Tavares, M; de Amorim, DB; Valdez, FP; Giongo, A; Roehe, PM; Franco, AC				Kluge, Mariana; Campos, Fabricio Souza; Tavares, Mauricio; de Amorim, Derek Blaese; Valdez, Fernanda Pedone; Giongo, Adriana; Roehe, Paulo Michel; Franco, Ana Claudia			Metagenomic Survey of Viral Diversity Obtained from Feces of Subantarctic and South American Fur Seals	PLOS ONE			English	Article							GROUP-C ROTAVIRUS; CROSS-SPECIES TRANSMISSION; HEPATITIS-E VIRUS; VESICULAR EXANTHEMA; DIARRHEIC DOGS; FECAL VIROME; LION VIRUS; CHILDREN; PICOBIRNAVIRUS; PARVOVIRUS	The Brazilian South coast seasonally hosts numerous marine species, observed particularly during winter months. Some animals, including fur seals, are found dead or debilitated along the shore and may harbor potential pathogens within their microbiota. In the present study, a metagenomic approach was performed to evaluate the viral diversity in feces of fur seals found deceased along the coast of the state of Rio Grande do Sul. The fecal virome of two fur seal species was characterized: the South American fur seal (Arctocephalus australis) and the Subantarctic fur seal (Arctocephalus tropicalis). Fecal samples from 10 specimens (A. australis, n = 5; A. tropicalis, n = 5) were collected and viral particles were purified, extracted and amplified with a random PCR. The products were sequenced through Ion Torrent and Illumina platforms and assembled reads were submitted to BLASTx searches. Both viromes were dominated by bacteriophages and included a number of potentially novel virus genomes. Sequences of picobirnaviruses, picornaviruses and a hepevirus-like were identified in A. australis. A rotavirus related to group C, a novel member of the Sakobuvirus and a sapovirus very similar to California sea lion sapovirus 1 were found in A. tropicalis. Additionally, sequences of members of the Anelloviridae and Parvoviridae families were detected in both fur seal species. This is the first metagenomic study to screen the fecal virome of fur seals, contributing to a better understanding of the complexity of the viral community present in the intestinal microbiota of these animals.	[Kluge, Mariana; Campos, Fabricio Souza; Roehe, Paulo Michel; Franco, Ana Claudia] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Microbiol Immunol & Parasitol, Virol Lab, Porto Alegre, RS, Brazil; [Tavares, Mauricio; de Amorim, Derek Blaese] Univ Fed Rio Grande do Sul, CECLIMAR Ctr Coastal Limnol & Marine Studies, Imbe, RS, Brazil; [Valdez, Fernanda Pedone] PUCRS Pontif Catholic Univ Rio Grande do Sul, Genom & Mol Biol Lab, Porto Alegre, RS, Brazil; [Giongo, Adriana] PUCRS Pontif Catholic Univ Rio Grande do Sul, IPR Inst Petr & Nat Resources, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Franco, AC (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Microbiol Immunol & Parasitol, Virol Lab, Porto Alegre, RS, Brazil.	anafranco.ufrgs@gmail.com	ROEHE, PAULO MICHEL/K-1208-2012; Campos, Fabricio S/D-8819-2014; Tavares, Maurício/D-6801-2015; Giongo, Adriana/P-8718-2015; Franco, Ana Cláudia AC/N-4373-2015	ROEHE, PAULO MICHEL/0000-0002-2370-7661; Campos, Fabricio S/0000-0002-5948-472X; Tavares, Maurício/0000-0003-3618-9928; Giongo, Adriana/0000-0002-1412-7040; Kluge, Mariana/0000-0001-7500-2041; Franco, Ana/0000-0001-7747-5125	National Council for the Improvement of Higher Education (CAPES); National Council for Scientific and Technological Development (CNPq); Study and Project Funding Agency (FINEP)	National Council for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Study and Project Funding Agency (FINEP)	The research leading to these results has received funding from the National Council for the Improvement of Higher Education (CAPES-http://www.capes.gov.br/), the National Council for Scientific and Technological Development (CNPq-http://www.cnpq.br/), and the Study and Project Funding Agency (FINEP-http://www.finep.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2015, ARCH VIROL, V160, P1837, DOI 10.1007/s00705-015-2425-z; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allison AB, 2013, J VIROL, V87, P2342, DOI 10.1128/JVI.02428-12; Allison AB, 2012, J VIROL, V86, P865, DOI 10.1128/JVI.06187-11; Arbiza J., 2012, NEW APPROACHES STUDY, V2, P151, DOI DOI 10.5772/54214; Attoui H., 2011, VIRUS TAXONOMY, P541; Barry AF, 2011, INFECT GENET EVOL, V11, P1811, DOI 10.1016/j.meegid.2011.06.020; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Bester M.N., 1987, NOAA Technical Report NMFS, V51, P57; Bhattacharya R, 2007, INFECT GENET EVOL, V7, P229, DOI 10.1016/j.meegid.2006.09.005; Biagini P, 2011, VIRUS TAXONOMY CLASS, P326; Bihl F, 2010, J ANTIMICROB CHEMOTH, V65, P817, DOI 10.1093/jac/dkq085; Bodewes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079259; Burek KA, 2005, J WILDLIFE DIS, V41, P512, DOI 10.7589/0090-3558-41.3.512; Clarke I, 2011, VIRUS TAXONOMY CLASS, P977; Coria-Galindo E, 2009, J WILDLIFE DIS, V45, P722, DOI 10.7589/0090-3558-45.3.722; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; de Bruyn PJN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003757; de Oliveira Amanda, 2011, Latin American Journal of Aquatic Mammals, V9, P145; Delmas B., 2011, VIRUS TAXONOMY, P535; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Esona MD, 2008, J CLIN VIROL, V42, P221, DOI 10.1016/j.jcv.2008.02.002; Fahsbender E, 2015, SCI REP-UK, V5, DOI 10.1038/srep09637; Ferreira JM, 2008, POLAR BIOL, V31, P303, DOI 10.1007/s00300-007-0358-z; Gabbay YB, 1999, J DIARRHOEAL DIS RES, V17, P69; Ganesh Balasubramanian, 2014, VirusDisease, V25, P223, DOI 10.1007/s13337-014-0207-y; GELBERG HB, 1982, VET PATHOL, V19, P413, DOI 10.1177/030098588201900407; Geraci JR., 1993, MARINE MAMMALS ASHOR, P371; Giordano MO, 2008, J INFECTION, V56, P371, DOI 10.1016/j.jinf.2008.02.017; Gulland F. M. D., 2001, CRC HDB MARINE MAMMA; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Ikeda Y, 2002, EMERG INFECT DIS, V8, P341, DOI 10.3201/eid0804.010228; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Karlsson EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5791; Katz Helena, 2012, ISRN Zoology, P1; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Kerley G., 1987, STATUS BIOL ECOLOGY, P61; Kim YJ, 1999, J CLIN MICROBIOL, V37, P1484, DOI 10.1128/JCM.37.5.1484-1488.1999; Knowles N., 2011, VIRUS TAXONOMY CLASS, P855; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Malik YS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780752; Carruyo-Nunez GM, 2014, REV CIENT-FAC CIEN V, V24, P125; Marvil P, 1999, J GEN VIROL, V80, P653, DOI 10.1099/0022-1317-80-3-653; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Mawatari T, 2004, J VET MED SCI, V66, P887, DOI 10.1292/jvms.66.887; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Moura J.F., 2007, LATIN AM J AQUATIC M, V6, p103 , DOI DOI 10.5597/LAJAM00114; Ng TFF, 2014, VET MICROBIOL, V171, P102, DOI 10.1016/j.vetmic.2014.04.005; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; Ogden KM, 2012, VIROLOGY, V431, P50, DOI 10.1016/j.virol.2012.05.011; Pinedo MC, 1990, G ORLA SER ZOOL, V15, P37; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sikorski A, 2013, GENOME ANNOUNC, V1, DOI [10.1099/vir.0.052654-0.17, DOI 10.1099/VIR.0.052654-0.17]; Simoes-Lopes PC, 1995, BIOCIENCIAS, V3, P173; SMITH AW, 1973, NATURE, V244, P108, DOI 10.1038/244108a0; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Soma T, 2015, MICROBIOL IMMUNOL, V59, P123, DOI 10.1111/1348-0421.12223; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; Steinel A, 2001, J WILDLIFE DIS, V37, P594, DOI 10.7589/0090-3558-37.3.594; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; The Pirbright Institute, 2015, PIC PAG; Tijssen P., 2011, VIRUS TAXONOMY, P405; Phan TG, 2015, VIRUS GENES, V50, P134, DOI 10.1007/s11262-014-1123-3; Vaz-Ferreira R, 1982, FAO FISHERIES SERIES, V5, P497; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Waltzek TB, 2012, ZOONOSES PUBLIC HLTH, V59, P521, DOI 10.1111/j.1863-2378.2012.01492.x; Wang QH, 2006, J CLIN MICROBIOL, V44, P2057, DOI 10.1128/JCM.02634-05; Woo PCY, 2014, VIROLOGY, V471, P117, DOI 10.1016/j.virol.2014.09.020; Woo PCY, 2012, J VIROL, V86, P6377, DOI 10.1128/JVI.00686-12; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Zhang W, 2014, J GEN VIROL, V95, P2553, DOI 10.1099/vir.0.069674-0	77	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151921	10.1371/journal.pone.0151921	http://dx.doi.org/10.1371/journal.pone.0151921			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986573	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300152
J	Kobayashi, M; Yamato, E; Tanabe, K; Tashiro, F; Miyazaki, S; Miyazaki, J				Kobayashi, Masaki; Yamato, Eiji; Tanabe, Koji; Tashiro, Fumi; Miyazaki, Satsuki; Miyazaki, Jun-ichi			Functional Analysis of Novel Candidate Regulators of Insulin Secretion in the MIN6 Mouse Pancreatic beta Cell Line	PLOS ONE			English	Article							GENE-EXPRESSION; MEMBRANE DEPOLARIZATION; MOLECULAR DETERMINANTS; GUANYLATE-CYCLASE; LENTIVIRUS VECTOR; RAT ISLETS; PROTEIN; RELEASE; IDENTIFICATION; SECRETAGOGIN	Elucidating the regulation of glucose-stimulated insulin secretion (GSIS) in pancreatic beta cells is important for understanding and treating diabetes. The pancreatic beta cell line, MIN6, retains GSIS but gradually loses it in long-term culture. The MIN6 subclone, MIN6c4, exhibits well-regulated GSIS even after prolonged culture. We previously used DNA microarray analysis to compare gene expression in the parental MIN6 cells and MIN6c4 cells and identified several differentially regulated genes that may be involved in maintaining GSIS. Here we investigated the potential roles of six of these genes in GSIS: Tmem59l (Transmembrane protein 59 like), Scgn (Secretagogin), Gucy2c (Guanylate cyclase 2c), Slc29a4 (Solute carrier family 29, member 4), Cdhr1 (Cadherin-related family member 1), and Celsr2 (Cadherin EGF LAG seven-pass G-type receptor 2). These genes were knocked down in MIN6c4 cells using lentivirus vectors expressing gene-specific short hairpin RNAs (shRNAs), and the effects of the knockdown on insulin expression and secretion were analyzed. Suppression of Tmem59l, Scgn, and Gucy2c expression resulted in significantly decreased glucose- and/ or KCl-stimulated insulin secretion from MIN6c4 cells, while the suppression of Slc29a4 expression resulted in increased insulin secretion. Tmem59l overexpression rescued the phenotype of the Tmem59l knockdown MIN6c4 cells, and immunostaining analysis indicated that the TMEM59L protein colocalized with insulin and GM130, a Golgi complex marker, in MIN6 cells. Collectively, our findings suggested that the proteins encoded by Tmem59l, Scgn, Gucy2c, and Slc29a4 play important roles in regulating GSIS. Detailed studies of these proteins and their functions are expected to provide new insights into the molecular mechanisms involved in insulin secretion.	[Kobayashi, Masaki; Tanabe, Koji; Tashiro, Fumi; Miyazaki, Satsuki; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Dept Stem Cell Regulat Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Yamato, Eiji] Mukogawa Womens Univ, Dept Nutr & Food Sci, 6-46 Ikebiraki Cho, Nishinomiya, Hyogo 6638558, Japan	Osaka University; Mukogawa Women's University	Miyazaki, J (corresponding author), Osaka Univ, Grad Sch Med, Dept Stem Cell Regulat Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Miyazaki, Satsuki/0000-0003-1781-1590; Yamato, Eiji/0000-0002-9075-6869; masaki, kobayashi/0000-0002-0985-0322				Aoki M, 2014, BIOCHEM BIOPH RES CO, V445, P357, DOI 10.1016/j.bbrc.2014.01.193; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Belz M, 2014, AM J PHYSIOL-ENDOC M, V306, pE697, DOI 10.1152/ajpendo.00362.2013; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Bolz H, 2005, MOL VIS, V11, P929; Cortijo C, 2012, CELL REP, V2, P1593, DOI 10.1016/j.celrep.2012.10.016; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Elson GCA, 1999, BIOCHEM BIOPH RES CO, V264, P55, DOI 10.1006/bbrc.1999.1481; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; Eto K, 2002, DIABETES, V51, P87, DOI 10.2337/diabetes.51.1.87; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Green CD, 2011, AM J PHYSIOL-ENDOC M, V300, pE640, DOI 10.1152/ajpendo.00544.2010; GRODSKY GM, 1966, DIABETES, V15, P910, DOI 10.2337/diab.15.12.910; GYLFE E, 1978, J ENDOCRINOL, V78, P239, DOI 10.1677/joe.0.0780239; Hasegawa K, 2013, FASEB J, V27, P2301, DOI 10.1096/fj.12-226092; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HERCHUELZ A, 1980, ENDOCRINOLOGY, V107, P491, DOI 10.1210/endo-107-2-491; KITA T, 1994, AM J PHYSIOL, V266, pF342, DOI 10.1152/ajprenal.1994.266.2.F342; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagamatsu S, 1999, DIABETES, V48, P2367, DOI 10.2337/diabetes.48.12.2367; Nakajima D, 2001, MOL BRAIN RES, V94, P85; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Ohtani M, 2013, GEN COMP ENDOCR, V187, P86, DOI 10.1016/j.ygcen.2013.02.011; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; PFEIFER MA, 1981, AM J MED, V70, P579, DOI 10.1016/0002-9343(81)90579-9; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Russell MA, 2010, ISLETS, V2, P374, DOI 10.4161/isl.2.6.13917; Salehi A, 2009, LIFE SCI, V85, P470, DOI 10.1016/j.lfs.2009.08.001; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Suckalel J, 2010, TRENDS ENDOCRIN MET, V21, P599, DOI 10.1016/j.tem.2010.06.003; Ullrich S, 2010, J BIOL CHEM, V285, P20664, DOI 10.1074/jbc.M109.055608; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; YAMATO E, 1994, BIOCHEM BIOPH RES CO, V199, P327, DOI 10.1006/bbrc.1994.1232; Yamato E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061211; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhou MY, 2007, J BIOL CHEM, V282, P3188, DOI 10.1074/jbc.M609421200	44	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151927	10.1371/journal.pone.0151927	http://dx.doi.org/10.1371/journal.pone.0151927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986842	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300154
J	Mauro-Herrera, M; Doust, AN				Mauro-Herrera, Margarita; Doust, Andrew N.			Development and Genetic Control of Plant Architecture and Biomass in the Panicoid Grass, Setaria	PLOS ONE			English	Article							AXILLARY BUD OUTGROWTH; FOXTAIL MILLET; TILLER NUMBER; MULTIPLE LOCI; MAIZE; RICE; MUTANT; HEIGHT; MODEL; YIELD	The architecture of a plant affects its ability to compete for light and to respond to environmental stresses, thus affecting overall fitness and productivity. Two components of architecture, branching and height, were studied in 182 F-7 recombinant inbred lines (RILs) at the vegetative, flowering and mature developmental stages in the panicoid C-4 model grass system, Setaria. The RIL population was derived from a cross between domesticated S. italica (foxtail millet) and its wild relative S. viridis (green foxtail). In both field and greenhouse trials the wild parent was taller initially, started branching earlier, and flowered earlier, while the domesticated parent was shorter initially, but flowered later, producing a robust tall plant architecture with more nodes and leaves on the main culm and few or no branches. Biomass was highly correlated with height of the plant and number of nodes on the main culm, and generally showed a negative relationship with branch number. However, several of the RILs with the highest biomass in both trials were significantly more branched than the domesticated parent of the cross. Quantitative trait loci (QTL) analyses indicate that both height and branching are controlled by multiple genetic regions, often with QTL for both traits colocalizing in the same genomic regions. Genomic positions of several QTL colocalize with QTL in syntenic regions in other species and contain genes known to control branching and height in sorghum, maize, and switchgrass. Included in these is the ortholog of the rice SD-1 semi-dwarfing gene, which underlies one of the major Setaria height QTL. Understanding the relationships between height and branching patterns in Setaria, and their genetic control, is an important step to gaining a comprehensive knowledge of the development and genetic regulation of panicoid grass architecture.	[Mauro-Herrera, Margarita; Doust, Andrew N.] Oklahoma State Univ, Dept Plant Biol Ecol & Evolut, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Doust, AN (corresponding author), Oklahoma State Univ, Dept Plant Biol Ecol & Evolut, Stillwater, OK 74078 USA.	andrew.doust@okstate.edu			Oklahoma Center of the Advancement of Science [PSB09-7, PSB11-35]; NSF Plant Genome [IOS-1339332]; Division Of Integrative Organismal Systems [1339332] Funding Source: National Science Foundation	Oklahoma Center of the Advancement of Science; NSF Plant Genome(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Oklahoma Center of the Advancement of Science PSB09-7, PSB11-35 to AD; and NSF Plant Genome, IOS-1339332 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; BASTEN CJ, 1994, 5 WORLD C GEN APPL L; Basten CJ., 2002, QTL CARTOGRAPHER VER; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bhandari HS, 2011, CROP SCI, V51, P1525, DOI 10.2135/cropsci2010.10.0588; Bian YL, 2015, EUPHYTICA, V205, P85, DOI 10.1007/s10681-015-1397-0; Bonser SP, 1996, OIKOS, V77, P347, DOI 10.2307/3546076; Braun N, 2012, PLANT PHYSIOL, V158, P225, DOI 10.1104/pp.111.182725; Brutnell TP, 2015, ANNU REV PLANT BIOL, V66, P465, DOI 10.1146/annurev-arplant-042811-105528; Cassani E, 2009, MOL BREEDING, V24, P375, DOI 10.1007/s11032-009-9298-3; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chen YN, 2012, PLANT BIOTECHNOL J, V10, P139, DOI 10.1111/j.1467-7652.2011.00637.x; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Choi MS, 2012, PLANT CELL REP, V31, P57, DOI 10.1007/s00299-011-1139-2; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; CHURCHILL GA, 1994, GENETICS, V138, P963; COYNE DP, 1980, HORTSCIENCE, V15, P244; Dabbert T, 2010, THEOR APPL GENET, V121, P705, DOI 10.1007/s00122-010-1342-5; Daverdin G, 2015, BIOENERG RES, V8, P137, DOI 10.1007/s12155-014-9508-7; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doerge RW, 1996, GENETICS, V142, P285; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Doust AN, 2006, MOL ECOL, V15, P1335, DOI 10.1111/j.1365-294X.2005.02791.x; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Doust A, 2007, ANN BOT-LONDON, V100, P941, DOI 10.1093/aob/mcm040; Doust AN, 2007, CURR OPIN PLANT BIOL, V10, P21, DOI 10.1016/j.pbi.2006.11.015; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Finlayson SA, 2007, PLANT CELL PHYSIOL, V48, P667, DOI 10.1093/pcp/pcm044; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Garg AK, 2006, PLANTA, V223, P627, DOI 10.1007/s00425-005-0101-3; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo SL, 2013, J INEQUAL APPL, DOI 10.1186/1029-242X-2013-67; Holland JB, 1998, J HERED, V89, P374, DOI 10.1093/jhered/89.4.374; Hubbard L, 2002, GENETICS, V162, P1927; Hutchings M. J., 1990, CLONAL GROWTH PLANTS, V57, P76; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; JANSEN RC, 1994, GENETICS, V136, P1447; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jiang H, 2008, PROG NAT SCI-MATER, V18, P1539, DOI 10.1016/j.pnsc.2008.05.025; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Kebrom TH, 2013, TRENDS PLANT SCI, V18, P41, DOI 10.1016/j.tplants.2012.07.001; Kebrom TH, 2006, PLANT PHYSIOL, V140, P1109, DOI 10.1104/pp.105.074856; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; Kong WQ, 2014, THEOR APPL GENET, V127, P2387, DOI 10.1007/s00122-014-2384-x; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Lewis JM, 2008, PLANT CELL REP, V27, P1217, DOI 10.1007/s00299-008-0543-8; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu GF, 2010, GENETICA, V138, P885, DOI 10.1007/s10709-010-9471-y; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Lowry DB, 2015, BIOENERG RES, V8, P1856, DOI 10.1007/s12155-015-9629-7; Lukens LN, 1999, GENET RES, V74, P291, DOI 10.1017/S0016672399004073; Lynch M., 1998, GENETICS ANAL QUANTI; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Mauro-Herrera M, 2013, G3-GENES GENOM GENET, V3, P283, DOI 10.1534/g3.112.005207; McGarry RC, 2012, PLANT SCI, V188, P71, DOI 10.1016/j.plantsci.2012.03.002; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Morgan PW, 2002, CROP SCI, V42, P1791, DOI 10.2135/cropsci2002.1791; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Poncet V, 2000, THEOR APPL GENET, V100, P147, DOI 10.1007/s001220050020; Qie LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101868; Sakamoto T, 2003, NAT BIOTECHNOL, V21, P909, DOI 10.1038/nbt847; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Salvi S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-4; Schnable JC, 2011, MAYDICA, V56, P183; Serba DD, 2015, BIOENERG RES, V8, P307, DOI 10.1007/s12155-014-9523-8; Solbrig OT, 1994, BIODIVERSITY ECOSYST, V99, P97; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tong HN, 2009, PLANT J, V58, P803, DOI 10.1111/j.1365-313X.2009.03825.x; Wan CG, 1998, ENVIRON EXP BOT, V40, P247, DOI 10.1016/S0098-8472(98)00044-6; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wang Z, 2010, EUPHYTICA, V174, P447, DOI 10.1007/s10681-010-0166-3; WILK MB, 1968, BIOMETRIKA, V55, P1; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; Wu XS, 2010, J EXP BOT, V61, P2923, DOI 10.1093/jxb/erq117; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Yan JQ, 1998, THEOR APPL GENET, V97, P267, DOI 10.1007/s001220050895; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang D, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0477-6; Zou JH, 2005, PLANTA, V222, P604, DOI 10.1007/s00425-005-0007-0	100	36	38	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151346	10.1371/journal.pone.0151346	http://dx.doi.org/10.1371/journal.pone.0151346			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985990	Green Published, gold			2022-12-26	WOS:000372580300064
J	Sang, W; Yu, L; He, L; Ma, WH; Zhu, ZH; Zhu, F; Wang, XP; Lei, CL				Sang, Wen; Yu, Lin; He, Li; Ma, Wei-Hua; Zhu, Zhi-Hui; Zhu, Fen; Wang, Xiao-Ping; Lei, Chao-Liang			UVB Radiation Delays Tribolium castaneum Metamorphosis by Influencing Ecdysteroid Metabolism	PLOS ONE			English	Article							ULTRAVIOLET-B RADIATION; RED FLOUR BEETLE; MOLECULAR INSIGHTS; MOLTING HORMONE; MANDUCA-SEXTA; RANA-PIPIENS; BOMBYX-MORI; P450 ENZYME; DNA-REPAIR; DROSOPHILA	Ultraviolet B (UVB) radiation is an important environmental factor. It is generally known that UVB exhibits high genotoxicity due to causing DNA damage, potentially leading to skin carcinogenesis and aging in mammals. However, little is known about the effects of UVB on the development and metamorphosis of insects, which are the most abundant terrestrial animals. In the present study, we performed dose-response analyses of the effects UVB irradiation on Tribolium castaneum metamorphosis, assessed the function of the T. castaneum prothoracicotropic hormone gene (Trcptth), and analyzed ecdysteroid pathway gene expression profile and ecdysterone titers post-UVB irradiation. The results showed that UVB not only caused death of T. castaneum larvae, but also delayed larval-pupal metamorphosis and reduced the size and emergence rate of pupae. In addition, we verified the function of Trcptth, which is responsible for regulating metamorphosis. It was also found that the expression profiles of Trcptth as well as ecdysteroidogenesis and response genes were influenced by UVB radiation. Therefore, a disturbance pulse of ecdysteroid may be involved in delaying development under exposure to irradiation. To our knowledge, this is the first report indicating that UVB can influence the metamorphosis of insects. This study will contribute to a better understanding of the impact of UVB on signaling mechanisms in insect metamorphosis.	[Sang, Wen; He, Li; Ma, Wei-Hua; Zhu, Zhi-Hui; Zhu, Fen; Wang, Xiao-Ping; Lei, Chao-Liang] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Yu, Lin] Huazhong Agr Univ, Key Lab Plant Pathol Hubei Prov, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Lei, CL (corresponding author), Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	ioir@mail.hzau.edu.cn		MA, WEIHUA/0000-0001-9521-2038	National Natural Science Foundation of China [31171856]; China Scholarship Council; graduate student Science and Technology Project of HuaZhong Agriculture University [2012YB16]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation [2012YB16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); graduate student Science and Technology Project of HuaZhong Agriculture University; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation	This work was supported by the National Natural Science Foundation of China, (No. 31171856), http://www.nsfc.gov.cn/ and the China Scholarship Council and graduate student Science and Technology Project of HuaZhong Agriculture University, (2012YB16), http://yjs.hzau.edu.cn/.; This research was supported by the National Natural Science Foundation of China (No. 31171856), China Scholarship Council and Huazhong Agricultural University Scientific & Technological Self-innovation Foundation (2012YB16). We would like to thank Dr. Hong-yu Zhang for providing the Pub-nls-EGFP vector.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Amare A, 2007, PEPTIDES, V28, P1282, DOI 10.1016/j.peptides.2007.04.014; Bacher S, 2005, FUNCT ECOL, V19, P263, DOI 10.1111/j.1365-2435.2005.00954.x; Belden LK, 2002, OECOLOGIA, V130, P551, DOI 10.1007/s00442-001-0843-y; Broehan G, 2010, INSECT BIOCHEM MOLEC, V40, P274, DOI 10.1016/j.ibmb.2009.10.009; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Croteau MC, 2008, PHYSIOL BIOCHEM ZOOL, V81, P743, DOI 10.1086/591949; Croteau MC, 2008, J TOXICOL ENV HEAL A, V71, P134, DOI 10.1080/15287390701613330; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Emanuele E, 2014, J DRUGS DERMATOL, V13, P274; Gelman DB, 2002, J INSECT PHYSIOL, V48, P63, DOI 10.1016/S0022-1910(01)00146-9; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Grant KP, 1995, CAN J ZOOL, V73, P2292, DOI 10.1139/z95-271; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Hackney JF, 2012, PLOS ONE, P7; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Higgins GM, 1926, J EXP ZOOL, V46, P333, DOI 10.1002/jez.1400460305; Ilijin L, 2014, TURK J BIOL, V38, P157, DOI 10.3906/biy-1306-75; ISHIBASHI J, 1994, BIOCHEMISTRY-US, V33, P5912, DOI 10.1021/bi00185a031; Jackowska M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-24; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kingan TG, 2000, J EXP BIOL, V203, P3011; Kong Y, 2014, INSECT MOL BIOL, V23, P632, DOI 10.1111/imb.12115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchal E, 2010, PEPTIDES, V31, P506, DOI 10.1016/j.peptides.2009.08.020; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Niwa YS, 2014, GENES GENET SYST, V89, P27, DOI 10.1266/ggs.89.27; Nowotarski SL, 2015, CANCER GROWTH METAST, P17, DOI 10.4137/CGM.S21219; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Paul ND, 2003, TRENDS ECOL EVOL, V18, P48, DOI 10.1016/S0169-5347(02)00014-9; Peric-Mataruga Vesna, 2006, Archives of Biological Sciences, V58, P1; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Potter KA, 2013, PHYSIOL ENTOMOL, V38, P246, DOI 10.1111/phen.12030; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Sang W, 2015, ENVIRON ENTOMOL, V44, P418, DOI 10.1093/ee/nvv010; Sang W, 2012, J INSECT PHYSIOL, V58, P830, DOI 10.1016/j.jinsphys.2012.03.007; Shah P, 2015, PHOTOCHEM PHOTOBIOL, V91, P254, DOI 10.1111/php.12406; Tauchman SJ, 2007, INSECT BIOCHEM MOLEC, V37, P847, DOI 10.1016/j.ibmb.2007.05.015; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; TRUMAN JW, 1974, J EXP BIOL, V60, P371; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608	44	10	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151831	10.1371/journal.pone.0151831	http://dx.doi.org/10.1371/journal.pone.0151831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986217	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300138
J	Shinneman, DJ; Means, RE; Potter, KM; Hipkins, VD				Shinneman, Douglas J.; Means, Robert E.; Potter, Kevin M.; Hipkins, Valerie D.			Exploring Climate Niches of Ponderosa Pine (Pinus ponderosa Douglas ex Lawson) Haplotypes in the Western United States: Implications for Evolutionary History and Conservation	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; GENETIC-STRUCTURE; ICE-AGES; POPULATION; FOREST; CONSEQUENCES; POLLEN; SEED; SYSTEMATICS; PREDICTION	Ponderosa pine (Pinus ponderosa Douglas ex Lawson) occupies montane environments throughout western North America, where it is both an ecologically and economically important tree species. A recent study using mitochondrial DNA analysis demonstrated substantial genetic variation among ponderosa pine populations in the western U.S., identifying 10 haplotypes with unique evolutionary lineages that generally correspond spatially with distributions of the Pacific (P. p. var. ponderosa) and Rocky Mountain (P. p. var. scopulorum) varieties. To elucidate the role of climate in shaping the phylogeographic history of ponderosa pine, we used nonparametric multiplicative regression to develop predictive climate niche models for two varieties and 10 haplotypes and to hindcast potential distribution of the varieties during the last glacial maximum (LGM), similar to 22,000 yr BP. Our climate niche models performed well for the varieties, but haplotype models were constrained in some cases by small datasets and unmeasured microclimate influences. The models suggest strong relationships between genetic lineages and climate. Particularly evident was the role of seasonal precipitation balance in most models, with winter- and summer-dominated precipitation regimes strongly associated with P. p. vars. ponderosa and scopulorum, respectively. Indeed, where present-day climate niches overlap between the varieties, introgression of two haplotypes also occurs along a steep clinal divide in western Montana. Reconstructed climate niches for the LGM suggest potentially suitable climate existed for the Pacific variety in the California Floristic province, the Great Basin, and Arizona highlands, while suitable climate for the Rocky Mountain variety may have existed across the southwestern interior highlands. These findings underscore potentially unique phylogeographic origins of modern ponderosa pine evolutionary lineages, including potential adaptations to Pleistocene climates associated with discrete temporary glacial refugia. Our predictive climate niche models may inform strategies for further genetic research (e.g., sampling design) and conservation that promotes haplotype compatibility with projected changes in future climate.	[Shinneman, Douglas J.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA; [Means, Robert E.] Bur Land Management Wyoming, Cheyenne, WY USA; [Potter, Kevin M.] N Carolina State Univ, Dept Forestry & Environm Resources, Res Triangle Pk, NC USA; [Hipkins, Valerie D.] US Forest Serv, Natl Forest Genet Lab, USDA, Placerville, CA USA	United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Forest Service	Shinneman, DJ (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA.	dshinneman@usgs.gov	Potter, Kevin M./I-4455-2019	Potter, Kevin M./0000-0002-7330-5345	Southern Research Station of the USDA Forest Service [14-CS-11330110-042, 15-CS-11330110-067]; North Carolina State University [14-CS-11330110-042, 15-CS-11330110-067]; U.S. Bureau of Land Management [L12PG00219]; U.S. Geological Survey [L12PG00219]	Southern Research Station of the USDA Forest Service; North Carolina State University; U.S. Bureau of Land Management; U.S. Geological Survey(United States Geological Survey)	This work was supported in part through Cost Share Agreements 14-CS-11330110-042 and 15-CS-11330110-067 between the Southern Research Station of the USDA Forest Service and North Carolina State University (Kevin Potter). Funding for developing the climate niche models presented in this paper was provided through an Interagency Agreement (L12PG00219) between the U.S. Bureau of Land Management and the U.S. Geological Survey (Douglas Shinneman). Robert Means (BLM) helped to collect and analyze data, prepare the manuscript, and was involved in the decision to publish.	Anderson RS, 2000, PALAEOGEOGR PALAEOCL, V155, P31, DOI 10.1016/S0031-0182(99)00093-0; Anderson RS, 1989, MULTIRESOURCE MANAGE, P15; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Betancourt J.L., 1990, PACKRAT MIDDENS LAST; Brayshaw T. C., 1997, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V99, P673; Callaham RZ, 2013, PSWRP264 USDA FOR SE; Charlet David Alan, 2007, Aliso, V24, P31; COLE K, 1983, QUATERNARY RES, V19, P117, DOI 10.1016/0033-5894(83)90031-5; Conkle MT, 1998, P POND PIN SPEC MAN, P27; CRITCHFIELD W. B., 1965, MADRONO, V18, P63; Critchfield W. B., 1984, Madrono, V31, P144; Critchfield W. B., 1966, MISCELLANEOUS PUBLIC, V991; Crookston N. L, 2008, CLIMATE ESTIMATES PL; Dodson EK, 2013, FOREST ECOL MANAG, V302, P163, DOI 10.1016/j.foreco.2013.03.050; DONG JS, 1994, GENETICS, V136, P1187; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellenwood JR, 2015, FHTET1501 USDA FOR S; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Evans J.S., 2014, ARCGIS TOOLBOX SURFA; Gotelli NJ, 2015, J BIOGEOGR, V42, P1577, DOI 10.1111/jbi.12562; Gray LK, 2013, CLIMATIC CHANGE, V117, P289, DOI 10.1007/s10584-012-0548-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hibbs DE, 2002, NORTHWEST SCI, V76, P80; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Johansen AD, 2003, MOL ECOL, V12, P293, DOI 10.1046/j.1365-294X.2003.01723.x; Johnstone JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00102.1; Kaye MW, 2010, J BIOGEOGR, V37, P1668, DOI 10.1111/j.1365-2699.2010.02327.x; Lascoux M, 2004, PHILOS T ROY SOC B, V359, P197, DOI 10.1098/rstb.2003.1390; Latta RG, 1998, EVOLUTION, V52, P61, DOI [10.2307/2410920, 10.1111/j.1558-5646.1998.tb05138.x]; Latta RG, 1999, EVOLUTION, V53, P769, DOI 10.2307/2640717; Lauria F., 1997, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V99, P655; Lintz HE, 2011, ECOL MODEL, V222, P427, DOI 10.1016/j.ecolmodel.2010.10.017; Littell JS, 2010, CLIMATIC CHANGE, V102, P129, DOI 10.1007/s10584-010-9858-x; Little E., 1971, CONIFERS IMPORTANT H, V1; MacDonald Glen M., 1998, P122; McCune B, 2006, J VEG SCI, V17, P819, DOI 10.1111/j.1654-1103.2006.tb02505.x; MCKEE A, 1987, GREAT BASIN NAT, V47, P163; Minnich RA, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P43; Mitton JB, 2000, MOL ECOL, V9, P91, DOI 10.1046/j.1365-294x.2000.00840.x; Norris JR, 2016, J BIOGEOGR, V43, P778, DOI 10.1111/jbi.12670; Norris JR, 2006, J BIOGEOGR, V33, P342, DOI 10.1111/j.1365-2699.2005.01396.x; Norris JR, 2006, THESIS U WYOMING US; Oliver W.W., 1990, AGR HDB, P413; PELOQUIN RL, 1984, SOUTHWEST NAT, V29, P115, DOI 10.2307/3670776; Perry JP., 1991, PINES MEXICO CENTRAL; PETIT RJ, 1993, HEREDITY, V71, P630, DOI 10.1038/hdy.1993.188; Potter KM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0865-y; Potter KM, 2013, AM J BOT, V100, P1562, DOI 10.3732/ajb.1300039; Potter KM, 2014, GENETIC ASSESSMENT P; Rehfeldt GE, 1999, AM J BOT, V86, P741, DOI 10.2307/2656584; Rehfeldt GE, 1999, SILVAE GENET, V48, P167; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P126, DOI 10.1016/j.foreco.2014.02.035; Roberts DR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2903; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sinclair WT, 1999, MOL ECOL, V8, P83, DOI 10.1046/j.1365-294X.1999.00527.x; Spaulding W.G., 1983, LATE QUATERNARY ENV, V1, P259; Spaulding WG, 1984, P 8 N AM FOR BIOL WO, P42; Thomassen HA, 2010, MOL ECOL, V19, P3532, DOI 10.1111/j.1365-294X.2010.04737.x; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; Van Devender T. R., 1987, N AM ADJACENT OCEANS, P323; Van Devender T.R., 1990, PACKRAT MIDDENS LAST, P104; Wang C-W, 1977, WO34 USDA FOR SERV; Westfall RD, 2004, FOREST ECOL MANAG, V197, P159, DOI 10.1016/j.foreco.2004.05.011; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011	71	27	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151811	10.1371/journal.pone.0151811	http://dx.doi.org/10.1371/journal.pone.0151811			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985674	Green Published, gold			2022-12-26	WOS:000372580300134
J	Stanley, RJ; Thomas, GMH				Stanley, Rob J.; Thomas, Geraint M. H.			Activation of G Proteins by Guanine Nucleotide Exchange Factors Relies on GTPase Activity	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; LIVING CELLS; GAPS; KINETICS; CANCER; RCC1; GEFS; RAN	G proteins are an important family of signalling molecules controlled by guanine nucleotide exchange and GTPase activity in what is commonly called an 'activation/inactivation cycle'. The molecular mechanism by which guanine nucleotide exchange factors (GEFs) catalyse the activation of monomeric G proteins is well-established, however the complete reversibility of this mechanism is often overlooked. Here, we use a theoretical approach to prove that GEFs are unable to positively control G protein systems at steady-state in the absence of GTPase activity. Instead, positive regulation of G proteins must be seen as a product of the competition between guanine nucleotide exchange and GTPase activity-emphasising a central role for GTPase activity beyond merely signal termination. We conclude that a more accurate description of the regulation of G proteins via these processes is as a 'balance/imbalance' mechanism. This result has implications for the understanding of intracellular signalling processes, and for experimental strategies that rely on modulating G protein systems.	[Stanley, Rob J.; Thomas, Geraint M. H.] UCL, CoMPLEX, London, England; [Stanley, Rob J.; Thomas, Geraint M. H.] UCL, Dept Cell & Dev Biol, London, England	University of London; University College London; University of London; University College London	Thomas, GMH (corresponding author), UCL, CoMPLEX, London, England.; Thomas, GMH (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	g.thomas@ucl.ac.uk		Stanley, Rob/0000-0002-4396-1122	British Heart Foundation [SP/08/004]	British Heart Foundation(British Heart Foundation)	British Heart Foundation SP/08/004 (https://www.bhf.org.uk) funded RS's PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Alberts B, 2013, ESSENTIAL CELL BIOL; Barren B, 2007, J NEUROSCI RES, V85, P3505, DOI 10.1002/jnr.21414; Baynes J.W., 2014, MED BIOCH; Berg JM, 2010, BIOCHEMISTRY; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bolsover S. R., 2011, CELL BIOL SHORT COUR; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Chang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045651; Dong JH, 2007, GENE, V396, P116, DOI 10.1016/j.gene.2007.03.001; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Goody RS, 2014, FEBS J, V281, P593, DOI 10.1111/febs.12551; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; Gunawardena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036321; Hancock J., 2010, CELL SIGNALLING; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Loirand G, 2013, PHYSIOL REV, V93, P1659, DOI 10.1152/physrev.00021.2012; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Michaelis L, 1913, BIOCHEM Z, V49, P333; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Nelson D.L, 2013, LEHNINGER PRINCIPLES, V6th; Northup John K, 2012, Cell Logist, V2, P140; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oliveira AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052874; Peyker A, 2005, CHEMBIOCHEM, V6, P78, DOI 10.1002/cbic.200400280; Randazzo P. A., 2013, CELLULAR LOGISTICS, V3, pe27609, DOI [10.4161/cl.27609, DOI 10.4161/CL.27609]; Seixas E, 2013, TRAFFIC, V14, P871, DOI 10.1111/tra.12072; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Voet D., 2010, BIOCHEMISTRY; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	43	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151861	10.1371/journal.pone.0151861	http://dx.doi.org/10.1371/journal.pone.0151861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986850	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300142
J	Vreede, KS; Sunnerhagen, KS				Vreede, Katarina Skough; Sunnerhagen, Katharina S.			Characteristics of Patients at First Visit to a Polio Clinic in Sweden	PLOS ONE			English	Article							POSTPOLIO SYNDROME; MUSCLE-FIBERS; POLIOMYELITIS; STRENGTH; NETHERLANDS; PERFORMANCE; MANAGEMENT; SAMPLE; FORCE	Aim Describe polio patients visiting a polio clinic in Sweden, a country where vaccination was introduced in 1957. Design A consecutive cohort study. Patients Prior polio patients. Methods All patients (n = 865) visiting the polio clinic at Sahlgrenska University Hospital, Gothenburg Sweden, between 1994 and 2012 were included in this study. Data at first visit regarding patient characteristics, polio classification, data of electromyography, origin, assistive devices and gait speed as well as muscle strength were collected for these patients. Twenty-three patients were excluded because no polio diagnosis could be established. A total of 842 patients with confirmed polio remained in the study. Results More than twenty percent of the patients were from countries outside the Nordic region and considerably younger than those from the Nordic region. The majority of the emigrants were from Asia and Africa followed by Europe (outside the Nordic region). Of all patients included ninety-seven percent (n = 817) had polio in the lower extremity and almost 53% (n = 444) had polio in the upper extremity while 28% (n = 238) had polio in the trunk, according to clinical classification of polio. Compared with a sample of the normal population, the polio patients walked 61-71% slower, and were 53-77% weaker in muscle strength of the knee and foot as well as grip strength. Conclusion The younger patients with polio emigrating from countries with different cultures may lead to a challenge for the multi professional teams working with post-polio rehabilitation and are of importance when planning for the care of polio patients the coming years.	[Vreede, Katarina Skough; Sunnerhagen, Katharina S.] Univ Gothenburg, Dept Clin Neurosci, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Vreede, KS (corresponding author), Univ Gothenburg, Dept Clin Neurosci, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	katarina.skough@ki.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400				Andreasson CGG, 1999, LAKARTIDNINGEN, V41, P4446; [Anonymous], 1991, BIOMECHANICS MOTOR C; Bickerstaffe A, 2015, MUSCLE NERVE, V51, P24, DOI 10.1002/mus.24272; BORG K, 1989, J NEUROL NEUROSUR PS, V52, P1141, DOI 10.1136/jnnp.52.10.1141; BORG K, 1991, J NEUROL NEUROSUR PS, V54, P236, DOI 10.1136/jnnp.54.3.236; Farbu E, 2006, EUR J NEUROL, V13, P795, DOI 10.1111/j.1468-1331.2006.01385.x; Gonzalez H, 2010, LANCET NEUROL, V9, P634, DOI 10.1016/S1474-4422(10)70095-8; Grimby G, 1998, MUSCLE NERVE, V21, P1428, DOI 10.1002/(SICI)1097-4598(199811)21:11<1428::AID-MUS10>3.3.CO;2-D; Halstead LS, 1998, SCI AM, V278, P42, DOI 10.1038/scientificamerican0498-42; HALSTEAD LS, 1985, ORTHOPEDICS, V8, P845; Ivanyi B, 1999, ARCH PHYS MED REHAB, V80, P687, DOI 10.1016/S0003-9993(99)90173-9; Lagerstrom C, 1998, SCAND J REHABIL MED, V30, P113; Lehmann K, 2006, ACTA NEUROL SCAND, V113, P55, DOI 10.1111/j.1600-0404.2006.00443.x; LUNDGRENLINDQUIST B, 1983, SCAND J REHABIL MED, V15, P125; Nollet F, 2002, J NEUROL NEUROSUR PS, V73, P695, DOI 10.1136/jnnp.73.6.695; NORDENSKIOLD UM, 1993, SCAND J RHEUMATOL, V22, P14, DOI 10.3109/03009749309095105; Sandberg A, 2004, ARCH PHYS MED REHAB, V85, P1174, DOI 10.1016/j.apmr.2003.08.101; Sunnehagen KS, 2000, SCAND J REHABIL MED, V32, P159; WEINSTEIN L, 1957, NEW ENGL J MED, V257, P47, DOI 10.1056/NEJM195707112570201; Wekre LL, 1998, SPINAL CORD, V36, P280, DOI 10.1038/sj.sc.3100557; WINDEBANK AJ, 1991, NEUROLOGY, V41, P501, DOI 10.1212/WNL.41.4.501	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150286	10.1371/journal.pone.0150286	http://dx.doi.org/10.1371/journal.pone.0150286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981623	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900031
J	Xiao, M; Du, GK; Zhong, GB; Yan, DJ; Zeng, HZ; Cai, WW				Xiao, Man; Du, Guankui; Zhong, Guobing; Yan, Dongjing; Zeng, Huazong; Cai, Wangwei			Gas Chromatography/Mass Spectrometry-Based Metabolomic Profiling Reveals Alterations in Mouse Plasma and Liver in Response to Fava Beans	PLOS ONE			English	Article							LINOLEIC-ACID; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; COMPARATIVE TOXICITY; LIPID-PEROXIDATION; HUMAN ERYTHROCYTES; OXIDATIVE STRESS; FATTY-ACIDS; CELLS; DEFICIENCY; DIVICINE	Favism is a life-threatening hemolytic anemia resulting from the intake of fava beans by susceptible individuals with low erythrocytic glucose 6-phosphate dehydrogenase (G6PD) activity. However, little is known about the metabolomic changes in plasma and liver after the intake of fava beans in G6PD normal and deficient states. In this study, gas chromatography/mass spectrometry was used to analyze the plasma and liver metabolic alterations underlying the effects of fava beans in C3H- and G6PD-deficient (G6PDx) mice, and to find potential biomarkers and metabolic changes associated with favism. Our results showed that fava beans induced oxidative stress in both C3H and G6PDx mice. Significantly, metabolomic differences were observed in plasma and liver between the control and fava bean treated groups of both C3H and G6PDx mice. The levels of 7 and 21 metabolites in plasma showed significant differences between C3H-control (C3H-C)- and C3H fava beans-treated (C3H-FB) mice, and G6PDx-control (G6PDx-C)- and G6PDx fava beans-treated (G6PDx-FB) mice, respectively. Similarly, the levels of 7 and 25 metabolites in the liver showed significant differences between C3H and C3H-FB, and G6PDx and G6PDx-FB, respectively. The levels of oleic acid, linoleic acid, and creatinine were significantly increased in the plasma of both C3H-FB and G6PDx-FB mice. In the liver, more metabolic alterations were observed in G6PDx-FB mice than in C3H-FB mice, and were involved in a sugar, fatty acids, amino acids, cholesterol biosynthesis, the urea cycle, and the nucleotide metabolic pathway. These findings suggest that oleic acid, linoleic acid, and creatinine may be potential biomarkers of the response to fava beans in C3H and G6PDx mice and therefore that oleic acid and linoleic acid may be involved in oxidative stress induced by fava beans. This study demonstrates that G6PD activity in mice can affect their metabolic pathways in response to fava beans.	[Xiao, Man; Du, Guankui; Zhong, Guobing; Yan, Dongjing; Cai, Wangwei] Hainan Med Coll, Dept Biochem & Mol Biol, Haikou 571199, Peoples R China; [Zeng, Huazong] Shanghai Sensichip Infotech Co Ltd, Shanghai 200433, Peoples R China	Hainan Medical University	Cai, WW (corresponding author), Hainan Med Coll, Dept Biochem & Mol Biol, Haikou 571199, Peoples R China.	caiww591020@163.com	Du, Guankui/AAG-7628-2019	Du, Guankui/0000-0002-1117-8299	National Key Basic Research Program of China [2012CB526600]; National Natural Science Foundation of China [30960171, 81260092]; Natural Science Foundation of Hainan Province [812195]; Shanghai Sensichip Infotech Co., Ltd.	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province; Shanghai Sensichip Infotech Co., Ltd.	The National Key Basic Research Program of China (2012CB526600) (WWC), National Natural Science Foundation of China (No. 30960171, No. 81260092) (WWC) and Natural Science Foundation of Hainan Province (No. 812195) (MX) had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shanghai Sensichip Infotech Co., Ltd. provided support in the form of salaries for author HZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Astarita G, 2013, J NUTRIGENET NUTRIGE, V6, P181, DOI 10.1159/000354403; AYDROYD W R, 1964, FAO Nutr Stud, V19, P1; Beger RD, 2010, TOXICOL APPL PHARM, V243, P154, DOI 10.1016/j.taap.2009.11.019; BELSEY MA, 1973, B WORLD HEALTH ORGAN, V48, P1; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Birdsall T C, 1998, Altern Med Rev, V3, P128; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CHEVION M, 1982, EUR J BIOCHEM, V127, P405, DOI 10.1111/j.1432-1033.1982.tb06886.x; COPLEY SD, 1992, ANAL BIOCHEM, V201, P152, DOI 10.1016/0003-2697(92)90188-D; Cury-Boaventura MF, 2006, LIFE SCI, V78, P1448, DOI 10.1016/j.lfs.2005.07.038; Cury-Boaventura MF, 2005, NUTRITION, V21, P395, DOI 10.1016/j.nut.2004.07.007; Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014; Hatanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058626; Healy DA, 2003, CLIN SCI, V104, P171, DOI 10.1042/CS20020223; Ho HY, 2013, FREE RADICAL BIO MED, V54, P71, DOI 10.1016/j.freeradbiomed.2012.10.557; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Innis Sheila M, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P359, DOI 10.1097/MED.0b013e3282be90b9; Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; MAGER J, 1965, BIOCHEM BIOPH RES CO, V20, P235, DOI 10.1016/0006-291X(65)90352-9; McMillan DC, 1999, TOXICOL SCI, V51, P310, DOI 10.1093/toxsci/51.2.310; McMillan DC, 2001, TOXICOL SCI, V62, P353, DOI 10.1093/toxsci/62.2.353; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Putri SP, 2013, J BIOSCI BIOENG, V115, P579, DOI 10.1016/j.jbiosc.2012.12.007; Reiterer G, 2004, J NUTR, V134, P771, DOI 10.1093/jn/134.4.771; Richard D, 2008, PHARMACOL RES, V57, P451, DOI 10.1016/j.phrs.2008.05.002; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; SATOH H, 1994, ADV EXP MED BIOL, V359, P181; Spiteller G, 1998, CHEM PHYS LIPIDS, V95, P105, DOI 10.1016/S0009-3084(98)00091-7; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Takada E, 2008, CANCER CHEMOTH PHARM, V62, P569, DOI 10.1007/s00280-007-0638-x; Tang HY, 2015, ANTIOXID REDOX SIGN, V22, P744, DOI 10.1089/ars.2014.6142; Tavazzi B, 2000, EUR J BIOCHEM, V267, P684, DOI 10.1046/j.1432-1327.2000.01042.x; TOBOREK M, 1994, AM J CLIN NUTR, V59, P60, DOI 10.1093/ajcn/59.1.60; WINTERBOURN CC, 1989, BIOCHEM PHARMACOL, V38, P611, DOI 10.1016/0006-2952(89)90206-2; Wu H, 2009, J CHROMATOGR B, V877, P3111, DOI 10.1016/j.jchromb.2009.07.039; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xu EY, 2009, CURR OPIN DRUG DISC, V12, P40	39	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151103	10.1371/journal.pone.0151103	http://dx.doi.org/10.1371/journal.pone.0151103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981882	Green Submitted, Green Published, gold			2022-12-26	WOS:000372574900062
J	Kamei, K; Harada, R; Hamada, R; Sakai, T; Hamasaki, Y; Hataya, H; Ito, S; Ishikura, K; Honda, M				Kamei, Koichi; Harada, Ryoko; Hamada, Riku; Sakai, Tomoyuki; Hamasaki, Yuko; Hataya, Hiroshi; Ito, Shuichi; Ishikura, Kenji; Honda, Masataka			Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PROGNOSTIC INDICATORS; CONTROLLED-TRIAL; NATURAL-HISTORY; PREDICTING PROGRESSION; NEPHROTIC SYNDROME; CHILDREN; CHINESE; DISEASE; CREATININE	Background Proteinuria is the most important risk factor for IgA nephropathy progression. The purpose of this study is to evaluate the long-term outcome and risk factors for poor prognosis in childhood IgA nephropathy. Methods Patients who were diagnosed with IgA nephropathy between 1972 and 1992 at the Tokyo Metropolitan Kiyose Children's Hospital were included. We analyzed risk factors for progression to end-stage kidney disease (ESKD) and chronic renal insufficiency (CRI) using Kaplan-Meier method and multivariate analyses of Cox proportional hazard model. Results One hundred patients were included and the median observation period was 11.8 years. Twelve and 17 patients progressed to ESKD and CRI, respectively. The survival probabilities were 90.0% at 10 years and 79.8% at 20 years for ESKD, and 86.1% at 10 years and 72.3% at 20 years for CRI. Notably, patients with heavy proteinuria with hypoalbuminemia during follow-up period showed extremely poor prognosis. In this group, the survival rate at 10 years from ESKD and CRI was 40.6% and 20.8%, respectively. By multivariate analysis, proteinuria at diagnosis and proteinuria during follow-up period were risk factors for ESKD, whereas glomeruli showing mesangial proliferation >= 50% and proteinuria during follow-up period were risk factors for CRI. Patients without heavy proteinuria during follow-up period did not develop CRI and 63% of patients with mild proteinuria during follow-up period showed no proteinuria at the last observation. Conclusions The degree of proteinuria during follow-up period is the strongest risk factor for ESKD and CRI.	[Kamei, Koichi; Ishikura, Kenji] Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Tokyo, Japan; [Harada, Ryoko; Hamada, Riku; Hataya, Hiroshi; Ishikura, Kenji; Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Fuchu, Tokyo, Japan; [Sakai, Tomoyuki] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan; [Hamasaki, Yuko] Toho Univ, Fac Med, Dept Pediat Nephrol, Tokyo, Japan; [Ito, Shuichi] Yokohama City Univ, Dept Pediat, Yokohama, Kanagawa 232, Japan	National Center for Child Health & Development - Japan; Tokyo Metropolitan Children's Medical Center; Shiga University of Medical Science; Toho University; Yokohama City University	Kamei, K (corresponding author), Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Tokyo, Japan.	kamei-k@ncchd.go.jp	Ito, Shuichi/AAD-1962-2022					Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Coppo R, 2005, J NEPHROL, V18, P503; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Halling SE, 2012, NEPHROL DIAL TRANSPL, V27, P715, DOI 10.1093/ndt/gfr339; Han SH, 2011, NEPHROL DIAL TRANSPL, V26, P1570, DOI 10.1093/ndt/gfq559; HOGG RJ, 1994, PEDIATR NEPHROL, V8, P15, DOI 10.1007/BF00868251; Kamei K, 2011, CLIN J AM SOC NEPHRO, V6, P1301, DOI 10.2215/CJN.08630910; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Matsushita S, CLIN EXP NEPHROL; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Ronkainen J, 2006, PEDIATR NEPHROL, V21, P1266, DOI 10.1007/s00467-006-0163-x; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Shen PC, 2007, NEPHRON CLIN PRACT, V106, P157, DOI 10.1159/000104426; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; To KF, 2000, AM J KIDNEY DIS, V35, P392, DOI 10.1016/S0272-6386(00)70191-0; Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y; Wakai K, 2006, NEPHROL DIAL TRANSPL, V21, P2800, DOI 10.1093/ndt/gfl342; WYATT RJ, 1995, J PEDIATR-US, V127, P913, DOI 10.1016/S0022-3476(95)70027-7; YOSHIKAWA N, 1992, NEPHRON, V60, P60, DOI 10.1159/000186706; Yoshikawa N, 1999, J AM SOC NEPHROL, V10, P101; Yoshikawa N, 2001, PEDIATR NEPHROL, V16, P446, DOI 10.1007/s004670100582; Yoshikawa N, 2006, CLIN J AM SOC NEPHRO, V1, P511, DOI 10.2215/CJN.01120905	28	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150885	10.1371/journal.pone.0150885	http://dx.doi.org/10.1371/journal.pone.0150885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978656	Green Published, Green Submitted, gold			2022-12-26	WOS:000372572800038
J	Surmik, D; Boczarowski, A; Balin, K; Dulski, M; Szade, J; Kremer, B; Pawlicki, R				Surmik, Dawid; Boczarowski, Andrzej; Balin, Katarzyna; Dulski, Mateusz; Szade, Jacek; Kremer, Barbara; Pawlicki, Roman			Spectroscopic Studies on Organic Matter from Triassic Reptile Bones, Upper Silesia, Poland	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; INFRARED-SPECTROSCOPY; AMINO-ACID; ADSORBED PROTEINS; DINOSAUR BONES; SOFT-TISSUES; IRON; OSTEOCYTES; DIAGENESIS; COLLAGEN	Fossil biomolecules from an endogenous source were previously identified in Cretaceous to Pleistocene fossilized bones, the evidence coming from molecular analyses. These findings, however, were called into question and an alternative hypothesis of the invasion of the bone by bacterial biofilm was proposed. Herewith we report a new finding of morphologically preserved blood-vessel-like structures enclosing organic molecules preserved in iron-oxide-mineralized vessel walls from the cortical region of nothosaurid and tanystropheid (aquatic and terrestrial diapsid reptiles) bones. These findings are from the Early/Middle Triassic boundary (Upper Roetian/Lowermost Muschelkalk) strata of Upper Silesia, Poland. Multiple spectroscopic analyses (FTIR, ToF-SIMS, and XPS) of the extracted "blood vessels" showed the presence of organic compounds, including fragments of various amino acids such as hydroxyproline and hydroxylysine as well as amides, that may suggest the presence of collagen protein residues. Because these amino acids are absent from most proteins other than collagen, we infer that the proteinaceous molecules may originate from endogenous collagen. The preservation of molecular signals of proteins within the "blood vessels" was most likely made possible through the process of early diagenetic iron oxide mineralization. This discovery provides the oldest evidence of in situ preservation of complex organic molecules in vertebrate remains in a marine environment.	[Surmik, Dawid; Boczarowski, Andrzej] Univ Silesia, Fac Earth Sci, Bedzinska 60, Sosnowiec, Poland; [Surmik, Dawid; Boczarowski, Andrzej] Pk Sci & Human Evolut, 1 Maja 10, PL-46040 Krasiejow, Poland; [Balin, Katarzyna; Szade, Jacek] Univ Silesia, A Chelkowski Inst Phys, Uniwersytecka 4, PL-40007 Katowice, Poland; [Balin, Katarzyna; Dulski, Mateusz; Szade, Jacek] Silesian Ctr Educ & Interdisciplinary Res, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland; [Dulski, Mateusz] Univ Silesia, Inst Mat Sci, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland; [Kremer, Barbara] Polish Acad Sci, Inst Paleobiol, Twarda 51-55, PL-00818 Warsaw, Poland; [Pawlicki, Roman] Jagiellonian Univ, Coll Med, Dept Histol, Kopernika 7, PL-31034 Krakow, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University	Surmik, D (corresponding author), Univ Silesia, Fac Earth Sci, Bedzinska 60, Sosnowiec, Poland.; Surmik, D (corresponding author), Pk Sci & Human Evolut, 1 Maja 10, PL-46040 Krasiejow, Poland.	dawid@surmik.pl	Balin, Katarzyna/D-6225-2017; Kremer, Barbara/ABB-1201-2020; Szade, Jacek/W-6169-2018	Balin, Katarzyna/0000-0002-1811-3033; Kremer, Barbara/0000-0002-0464-1265; Surmik, Dawid/0000-0003-0121-9592; Dulski, Mateusz/0000-0001-8686-1853; Szade, Jacek/0000-0003-2083-4275	National Science Center [2011/01/N/ST10/06989]	National Science Center(National Science Centre, Poland)	This research project is supported by National Science Center (www.ncn.gov.pl) grant no. 2011/01/N/ST10/06989.	ADAMS E, 1978, SCIENCE, V202, P591, DOI 10.1126/science.212833; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Assmann P., 1944, STRATIGRAPHIE OBERSC; Atzei D, 2014, APPL SURF SCI, V307, P120, DOI 10.1016/j.apsusc.2014.03.178; Baltrusaitis J, 2007, PHYS CHEM CHEM PHYS, V9, P5542, DOI 10.1039/b709167b; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bell LS, 2008, AM J PHYS ANTHROPOL, V137, P449, DOI 10.1002/ajpa.20886; Bertazzo S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8352; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; CAMBIER P, 1986, CLAY MINER, V21, P191, DOI 10.1180/claymin.1986.021.2.08; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Cleland TP, 2015, J PROTEOME RES, V14, P5252, DOI 10.1021/acs.jproteome.5b00675; Cleland TP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0015; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; DELORENZO V, 1986, J BACTERIOL, V165, P570, DOI 10.1128/jb.165.2.570-578.1986; Diedrich CG, 2009, GLOBAL PLANET CHANGE, V65, P27, DOI 10.1016/j.gloplacha.2008.11.002; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; FYSH SA, 1983, CLAY CLAY MINER, V31, P377, DOI 10.1346/CCMN.1983.0310507; Graat P, 1998, SURF INTERFACE ANAL, V26, P773, DOI 10.1002/(SICI)1096-9918(199810)26:11<773::AID-SIA419>3.0.CO;2-#; Graham DJ, 2006, APPL SURF SCI, V252, P6860, DOI 10.1016/j.apsusc.2006.02.149; Greenwalt DE, 2013, P NATL ACAD SCI USA, V110, P18496, DOI 10.1073/pnas.1310885110; Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984; GURLEY LR, 1991, J PROTEIN CHEM, V10, P75, DOI 10.1007/BF01024658; Hagdorn H, 2007, PAN EUROPEAN CORRELA, P46; Henss A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0332; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; Ivarsson M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03487; JANSEN RJJ, 1995, CARBON, V33, P1021, DOI 10.1016/0008-6223(95)00030-H; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Kowal-Linka M., 2008, GEOLOGOS, V14, P125; Kowal-Linka Monika, 2012, Przeglad Geologiczny, V60, P646; Kowal-Linka M, 2014, CHEM GEOL, V363, P213, DOI 10.1016/j.chemgeo.2013.10.038; Kremer B, 2012, J RAMAN SPECTROSC, V43, P32, DOI 10.1002/jrs.2985; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lagant P, 1998, BIOSPECTROSCOPY, V4, P379, DOI 10.1002/(SICI)1520-6343(1998)4:6<379::AID-BSPY3>3.0.CO;2-2; Leefmann T, 2013, RAPID COMMUN MASS SP, V27, P565, DOI 10.1002/rcm.6483; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindgren J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0614; Lindgren J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1819; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Mansour A. N., 1996, Surface Science Spectra, V4, P357, DOI 10.1116/1.1247825; Muramoto S, 2011, J PHYS CHEM C, V115, P24247, DOI 10.1021/jp208035x; MUYZER G, 1992, GEOLOGY, V20, P871, DOI 10.1130/0091-7613(1992)020<0871:POTBPO>2.3.CO;2; NAKAJIMA T, 1970, BIOCHEM BIOPH RES CO, V39, P28, DOI 10.1016/0006-291X(70)90752-7; NAKAJIMA T, 1969, SCIENCE, V164, P1400, DOI 10.1126/science.164.3886.1400; National Academy of Science. Iron, 1979, IR REP SUBC IR; NAWROCKI J, 2000, PRZ GEOL, V48, P236; Oberg KA, 2004, EUR J BIOCHEM, V271, P2937, DOI 10.1111/j.1432-1033.2004.04220.x; PAWLICKI R, 1977, ACTA HISTOCHEM, V58, P75, DOI 10.1016/S0065-1281(77)80110-4; PAWLICKI R, 1995, FOLIA HISTOCHEM CYTO, V33, P183; PAWLICKI R, 1977, ACTA HISTOCHEM, V59, P40, DOI 10.1016/S0065-1281(77)80077-9; PAWLICKI R, 1966, NATURE, V211, P655, DOI 10.1038/211655a0; PAWLICKI R, 1983, FOL HISTOCH CYTOCHEM, V21, P253; Pfretzschner HU, 2006, PALAEONTOGR ABT A, V278, P135, DOI 10.1127/pala/278/2006/135; Piga G, 2011, PALAEOGEOGR PALAEOCL, V310, P92, DOI 10.1016/j.palaeo.2011.05.018; POVARENNYKH AS, 1978, AM MINERAL, V63, P956; Rahmelow K, 1998, ANAL BIOCHEM, V257, P1, DOI 10.1006/abio.1997.2502; Reisz RR, 2013, NATURE, V496, P210, DOI 10.1038/nature11978; Rieppel O, 1999, PALAEOGEOGR PALAEOCL, V153, P1, DOI 10.1016/S0031-0182(99)00067-X; Rieppel O, 2000, HDB PALAHERPETOLOGIE; Rieppel Olivier, 1997, P121, DOI 10.1016/B978-012155210-7/50009-0; Rieppel Olivier, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V197, P383; ROTHSCHILD KJ, 1986, P NATL ACAD SCI USA, V83, P347, DOI 10.1073/pnas.83.2.347; ROTHSCHILD KJ, 1989, P NATL ACAD SCI USA, V86, P9832, DOI 10.1073/pnas.86.24.9832; Ruiz-Herrera J., 2012, FUNGAL CELL WALL STR, Vsecond; Sanni OD, 2002, SURF INTERFACE ANAL, V33, P715, DOI 10.1002/sia.1438; Sawlowicz Z, 2006, MINERALOGIA POLONICA, V29, P184; Schweitzer MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2741; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2008, CR PALEVOL, V7, P159, DOI 10.1016/j.crpv.2008.02.005; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2013, BONE, V52, P414, DOI 10.1016/j.bone.2012.10.010; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Schweitzer MH, 1999, J VERTEBR PALEONTOL, V19, P712, DOI 10.1080/02724634.1999.10011183; Sommer-Knudsen J, 1998, PHYTOCHEMISTRY, V47, P483, DOI 10.1016/S0031-9422(97)00724-3; Stathopoulou ET, 2008, PALAEOGEOGR PALAEOCL, V266, P168, DOI 10.1016/j.palaeo.2008.03.022; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Stuart B. H., 1997, BIOL APPL INFRARED S; Surmik D., 2010, FOSSIL VERTEBRATES M, P110; Szulc Joachim, 2000, Annales Societatis Geologorum Poloniae, V70, P1; Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Thiel V, 2014, ORG GEOCHEM, V68, P71, DOI 10.1016/j.orggeochem.2013.12.006; Turner-Walker G., 1999, B GEOL SOC NORFOLK, V48, P3; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Wagner MS, 2004, APPL SURF SCI, V231, P366, DOI 10.1016/j.apsusc.2004.03.100; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; WELSH ID, 1989, PHYS REV B, V40, P6386, DOI 10.1103/PhysRevB.40.6386; Wu H, 2001, CELL MOL LIFE SCI, V58, P1418, DOI 10.1007/PL00000785; ZAWIDZKA K, 1975, Acta Geologica Polonica, V25, P217	93	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151143	10.1371/journal.pone.0151143	http://dx.doi.org/10.1371/journal.pone.0151143			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977600	Green Submitted, gold, Green Published			2022-12-26	WOS:000372572800048
J	Pai, CH; Yen, CT; Chen, CP; Yu, IS; Lin, SW; Lin, SR				Pai, Chen-Hsueh; Yen, Ching-Tzu; Chen, Chie-Pein; Yu, I-Shing; Lin, Shu-Wha; Lin, Shu-Rung			Lack of Thromboxane Synthase Prevents Hypertension and Fetal Growth Restriction after High Salt Treatment during Pregnancy	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; LINKING PLACENTAL ISCHEMIA; OXIDATIVE STRESS; PREECLAMPTIC PREGNANCIES; INFLAMMATORY CYTOKINES; VASCULAR EXPRESSION; PATHOPHYSIOLOGY; PROSTACYCLIN; A(2); ENDOTHELIUM	Preeclampsia (PE) is a potentially fatal pregnancy-related hypertensive disorder characterized by poor placenta development that can cause fetal growth restriction. PE-associated pathologies, including thrombosis, hypertension, and impaired placental development, may result from imbalances between thromboxane A(2) (TXA(2)) and prostacyclin. Low-dose aspirin, which selectively inhibits TXA(2) production, is used to prevent high-risk PE. However, the role of TXA(2) in aspirin-mediated protective effects in women with PE is not understood fully. In this study, we examined the role of prostanoids in PE using human samples and an induced PE mouse model. We demonstrated that the administration of salted drinking water (2.7% NaCl) to wild-type mice resulted in elevated placental TXA(2) synthase (TXAS) and plasma TXA(2), but not prostacyclin, levels, which was also found in our clinical PE placenta samples. The high salt-treated wild-type pregnant mice had shown unchanged maternal body weight, hypertension (MAP increase 15 mmHg), and decreased pup weight (similar to 50%) and size (similar to 24%), but these adverse effects were ameliorated in TXAS knockout (KO) mice. Moreover, increased expression of interleukin-1 beta and downstream phosphorylated-p38-mitogen-activated protein kinase were concordant with apoptosis induction in the placentas of salt water-treated wild-type mice. These alterations were not observed in TXAS KO mice. Together, our data suggest that TXA(2) depletion has anti-PE effects due to the prevention of hypertension and placental damage through downregulation of the interleukin-1 beta pathway.	[Pai, Chen-Hsueh; Yen, Ching-Tzu; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yen, Ching-Tzu] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Chen, Chie-Pein] Mackay Mem Hosp, Dept Obstet & Gynecol, Div High Risk Pregnancy, Taipei, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Coll Med, Lab Anim Ctr, Taipei 10764, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Coll Sci, Dept Biosci Technol, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Biomed Technol, Taoyuan, Taiwan	National Taiwan University; National Taiwan University; Mackay Memorial Hospital; National Taiwan University; Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University	Lin, SW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.; Lin, SR (corresponding author), Chung Yuan Christian Univ, Coll Sci, Dept Biosci Technol, Taoyuan, Taiwan.; Lin, SR (corresponding author), Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan.; Lin, SR (corresponding author), Chung Yuan Christian Univ, Ctr Biomed Technol, Taoyuan, Taiwan.	mtshuwha@ntu.edu.tw; shurung@cycu.edu.tw	CHEN, CHEN/HDM-6657-2022	LIN, SHU-WHA/0000-0001-6748-5581; Pai, Chen-Hsueh/0000-0001-5425-897X	National Science Council of Taiwan [NSC 100-2632-M-033-001-MY3, NSC 101-2632-M-033-001-MY2, NSC 102-2632-M-033-001-MY3, NSC 102-2320-B-033 -003, MOST 104-2319-B-002-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan, www.most.gov.tw/ (Grant No. No. NSC 100-2632-M-033-001-MY3, NSC 101-2632-M-033-001-MY2, NSC 102-2632-M-033-001-MY3 and NSC 102-2320-B-033 -003, MOST 104-2319-B-002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; ALLY AI, 1980, PROSTAG LEUKOTR ESS, V4, P431, DOI 10.1016/0161-4630(80)90051-8; Beausejour A, 2007, PLACENTA, V28, P52, DOI 10.1016/j.placenta.2005.12.003; Beausejour A, 2003, AM J PHYSIOL-HEART C, V285, pH375, DOI 10.1152/ajpheart.01132.2002; Benyo DF, 2001, J CLIN ENDOCR METAB, V86, P2505, DOI 10.1210/jc.86.6.2505; Bowen RS, 2005, PLACENTA, V26, P402, DOI 10.1016/j.placenta.2004.07.007; Briceno-Perez C, 2009, HYPERTENS PREGNANCY, V28, P138, DOI 10.1080/10641950802022384; Chen CP, 2013, PLACENTA, V34, P913, DOI 10.1016/j.placenta.2013.06.311; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Elmahashi Mohamed O, 2014, BMC Res Notes, V7, P23, DOI 10.1186/1756-0500-7-23; Fung C, 2011, J DEV ORIG HLTH DIS, V2, P291, DOI 10.1017/S2040174411000535; Furuya M, 2008, VASC HEALTH RISK MAN, V4, P1301, DOI 10.2147/VHRM.S4009; Gilbert JS, 2008, AM J PHYSIOL-HEART C, V294, pH541, DOI 10.1152/ajpheart.01113.2007; GOESCHEN K, 1993, J PERINAT MED, V21, P481, DOI 10.1515/jpme.1993.21.6.481; Granger JP, 2002, MICROCIRCULATION, V9, P147, DOI 10.1038/sj.mn.7800137; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Hayakawa M, 2006, J SOC GYNECOL INVEST, V13, P566, DOI 10.1016/j.jsgi.2006.09.007; Kalinderis M, 2011, AM J REPROD IMMUNOL, V66, P468, DOI 10.1111/j.1600-0897.2011.01019.x; Knight M, 2000, Cochrane Database Syst Rev, pCD000492; Kriston T, 1999, AM J PHYSIOL-REG I, V276, pR831, DOI 10.1152/ajpregu.1999.276.3.R831; LeFevre ML, 2014, ANN INTERN MED, V161, P819, DOI 10.7326/M14-1884; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Llinas MT, 2002, AM J HYPERTENS, V15, P793, DOI 10.1016/S0895-7061(02)02975-8; Lockwood CJ, 2008, AM J PATHOL, V172, P1571, DOI 10.2353/ajpath.2008.070629; LOSONCZY G, 1995, AM J PHYSIOL-REG I, V269, pR720, DOI 10.1152/ajpregu.1995.269.3.R720; Lyall F, 2002, PLACENTA, V23, pS142, DOI 10.1053/plac.2002.0803; Mccoy S, 2009, AM J HEALTH-SYST PH, V66, P337, DOI 10.2146/ajhp080104; Mousa AA, 2012, HYPERTENSION, V59, P1249, DOI 10.1161/HYPERTENSIONAHA.111.188730; Nilkaeo A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/79359; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Raghupathy R, 2013, MED PRIN PRACT, V22, P8, DOI 10.1159/000354200; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Reslan Ossama M., 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P204; Roberge S, 2012, AM J PERINAT, V29, P551, DOI 10.1055/s-0032-1310527; Rocca B, 2000, NAT MED, V6, P219, DOI 10.1038/72334; Schramm AM, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/920467; Schurigt Uta, 2005, Arthritis Res Ther, V7, pR174, DOI 10.1186/ar1466; Seki H, 1999, HYPERTENS PREGNANCY, V18, P157, DOI 10.3109/10641959909023075; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Shah DA, 2015, BIOCHEM PHARMACOL, V95, P211, DOI 10.1016/j.bcp.2015.04.012; Sibai BM, 2015, NAT REV ENDOCRINOL, V11, P6, DOI 10.1038/nrendo.2014.199; SIBAI BM, 1989, OBSTET GYNECOL, V74, P551; Sidaway Peter, 2014, Nat Rev Nephrol, V10, P613, DOI 10.1038/nrneph.2014.166; Trivedi NA, 2011, J POSTGRAD MED, V57, P91, DOI 10.4103/0022-3859.81858; Usha K, 2011, J OBSTET GYN INDIA, V61, P505, DOI 10.1007/s13224-011-0092-x; Vaughan JE, 2006, AM J OBSTET GYNECOL, V195, P1415, DOI 10.1016/j.ajog.2006.02.053; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Walsh SW, 2004, PROSTAG LEUKOTR ESS, V70, P223, DOI 10.1016/j.plefa.2003.04.010; WALSH SW, 1985, AM J OBSTET GYNECOL, V152, P335, DOI 10.1016/S0002-9378(85)80223-4; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; WEINER CP, 1992, AM J OBSTET GYNECOL, V166, P1171, DOI 10.1016/S0002-9378(11)90603-6; WOODWORTH SH, 1994, J CLIN ENDOCR METAB, V78, P1225, DOI 10.1210/jc.78.5.1225; Xu TT, 2015, J CLIN HYPERTENS, V17, P567, DOI 10.1111/jch.12541; Yang YL, 2010, LEUKEMIA RES, V34, P18, DOI 10.1016/j.leukres.2009.07.023; Yu IS, 2004, BLOOD, V104, P135, DOI 10.1182/blood-2003-10-3661; Yusuf K, 2001, PEDIATR RES, V50, P203, DOI 10.1203/00006450-200108000-00007; Zhao S, 2008, PLACENTA, V29, P81, DOI 10.1016/j.placenta.2007.08.007	58	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151617	10.1371/journal.pone.0151617	http://dx.doi.org/10.1371/journal.pone.0151617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974824	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600093
J	Song, MH; Godoy, RI				Song, Min-Ho; Godoy, Rolf Inge			How Fast Is Your Body Motion? Determining a Sufficient Frame Rate for an Optical Motion Tracking System Using Passive Markers	PLOS ONE			English	Article								This paper addresses how to determine a sufficient frame (sampling) rate for an optical motion tracking system using passive reflective markers. When using passive markers for the optical motion tracking, avoiding identity confusion between the markers becomes a problem as the speed of motion increases, necessitating a higher frame rate to avoid a failure of the motion tracking caused by marker confusions and/or dropouts. Initially, one might believe that the Nyquist-Shannon sampling rate estimated from the assumed maximal temporal variation of a motion (i.e. a sampling rate at least twice that of the maximum motion frequency) could be the complete solution to the problem. However, this paper shows that also the spatial distance between the markers should be taken into account in determining the suitable frame rate of an optical motion tracking with passive markers. In this paper, a frame rate criterion for the optical tracking using passive markers is theoretically derived and also experimentally verified using a high-quality optical motion tracking system. Both the theoretical and the experimental results showed that the minimum frame rate is proportional to the ratio between the maximum speed of the motion and the minimum spacing between markers, and may also be predicted precisely if the proportional constant is known in advance. The inverse of the proportional constant is here defined as the tracking efficiency constant and it can be easily determined with some test measurements. Moreover, this newly defined constant can provide a new way of evaluating the tracking algorithm performance of an optical tracking system.	[Song, Min-Ho; Godoy, Rolf Inge] Univ Oslo, Dept Musicol, fourMs Grp, Oslo, Norway	University of Oslo	Song, MH (corresponding author), Univ Oslo, Dept Musicol, fourMs Grp, Oslo, Norway.	minho.song@imv.uio.no		Song, Minho/0000-0003-0249-1723				Allen BD, 2005, VRST 05 P ACM S VIRT, P201, DOI DOI 10.1145/1101616.1101658; [Anonymous], 2015, QUAL TRACKMANAGER QT; Bishop, 2007, P TRENDS ISS TRACK V; Bishop G, 2001, SIGGRAPH COURSE PACK; BRUGGER W, 1978, MED BIOL ENG COMPUT, V16, P207, DOI 10.1007/BF02451923; Goebl W., 2014, EXPRESSIVENESS MUSIC, P221; Guerra-filho G. B., 2005, RITA, V12, P61; Herda L, 2001, HUM MOVEMENT SCI, V20, P313, DOI 10.1016/S0167-9457(01)00050-1; Jensenius A.R., 2010, MUSICAL GESTURES SOU, P12, DOI DOI 10.4324/9780203863411; Kolahi A, 2007, BIOMED SIGNAL PROCES, V2, P59, DOI 10.1016/j.bspc.2007.02.001; Lu TW, 2012, KAOHSIUNG J MED SCI, V28, pS13, DOI 10.1016/j.kjms.2011.08.004; MacRitchie J, 2015, MUSIC SCI, V19, P171, DOI 10.1177/1029864915572813; MacRitchie J, 2013, J NEW MUSIC RES, V42, P79, DOI 10.1080/09298215.2012.762529; MALIK NA, 1993, EXP FLUIDS, V15, P279; Menache A., 1999, UNDERSTANDING MOTION, P15; Moeslund TB, 2001, COMPUT VIS IMAGE UND, V81, P231, DOI 10.1006/cviu.2000.0897; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mulder A., 1994, 941 TR S FRAS U SCH; Muller M., 2007, INFORM RETRIEVAL MUS, P187; Nyquist H, 2002, P IEEE, V90, P280, DOI 10.1109/5.989875; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Wang LA, 2003, PATTERN RECOGN, V36, P585, DOI 10.1016/S0031-3203(02)00100-0; Zhou HY, 2008, BIOMED SIGNAL PROCES, V3, P1, DOI 10.1016/j.bspc.2007.09.001	23	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150993	10.1371/journal.pone.0150993	http://dx.doi.org/10.1371/journal.pone.0150993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967900	gold, Green Published, Green Submitted			2022-12-26	WOS:000371989200027
J	Asghar, MS; Becerra, L; Larsson, HBW; Borsook, D; Ashina, M				Asghar, Mohammad Sohail; Becerra, Lino; Larsson, Henrik B. W.; Borsook, David; Ashina, Messoud			Calcitonin Gene-Related Peptide Modulates Heat Nociception in the Human Brain - An fMRI Study in Healthy Volunteers	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CENTRAL-NERVOUS-SYSTEM; EVOKED DISCHARGE FREQUENCY; ANTERIOR CINGULATE CORTEX; HUMAN CEREBRAL-ARTERIES; DYNAMIC-RANGE NEURONS; STEM ACTIVATION; BINDING-SITES; DORSAL-HORN; SPINAL-CORD	Background Intravenous infusion of calcitonin-gene-related-peptide (CGRP) provokes headache and migraine in humans. Mechanisms underlying CGRP-induced headache are not fully clarified and it is unknown to what extent CGRP modulates nociceptive processing in the brain. To elucidate this we recorded blood-oxygenation-level-dependent (BOLD) signals in the brain by functional MRI after infusion of CGRP in a double-blind placebo-controlled crossover study of 27 healthy volunteers. BOLD-signals were recorded in response to noxious heat stimuli in the V1-area of the trigeminal nerve. In addition, we measured BOLD-signals after injection of sumatriptan (5-HT1B/1D antagonist). Results Brain activation to noxious heat stimuli following CGRP infusion compared to baseline resulted in increased BOLD-signal in insula and brainstem, and decreased BOLD-signal in the caudate nuclei, thalamus and cingulate cortex. Sumatriptan injection reversed these changes. Conclusion The changes in BOLD-signals in the brain after CGRP infusion suggests that systemic CGRP modulates nociceptive transmission in the trigeminal pain pathways in response to noxious heat stimuli.	[Asghar, Mohammad Sohail; Ashina, Messoud] Univ Copenhagen, Glostrup Hosp, Danish Headache Ctr, Fac Hlth & Med Sci, DK-2600 Glostrup, Denmark; [Asghar, Mohammad Sohail; Ashina, Messoud] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Fac Hlth & Med Sci, DK-2600 Glostrup, Denmark; [Becerra, Lino; Borsook, David] Boston Childrens Hosp, PAIN Grp, Boston, MA 02453 USA; [Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Ctr Pain & Brain, Boston, MA 02453 USA; [Larsson, Henrik B. W.] Univ Copenhagen, Glostrup Hosp, Fac Hlth & Med Sci, Funct Imaging Unit,Dept Diagnost, DK-2600 Glostrup, Denmark	University of Copenhagen; University of Copenhagen; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Copenhagen	Ashina, M (corresponding author), Univ Copenhagen, Glostrup Hosp, Danish Headache Ctr, Fac Hlth & Med Sci, DK-2600 Glostrup, Denmark.; Ashina, M (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Neurol, Fac Hlth & Med Sci, DK-2600 Glostrup, Denmark.	ashina@dadlnet.dk	Ashina, Messoud/AFU-1246-2022	Ashina, Messoud/0000-0003-0951-5804	University of Copenhagen; Lundbeck Foundation Center for Neurovascular Signaling (LUCENS); Research Foundation of the Capital Region of Denmark; Danish Council for Independent Research-Medical Sciences (FSS) [271-08-0446]; Novo Nordisk Foundation; Cool Sorption Foundation; Danish Headache Foundation; Alex Klees Smerteforskningslegat; Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat; Merck Co., Inc. [33936]; Else Torps and Flemming Jensens legat; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	University of Copenhagen; Lundbeck Foundation Center for Neurovascular Signaling (LUCENS)(Lundbeck Corporation); Research Foundation of the Capital Region of Denmark; Danish Council for Independent Research-Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Cool Sorption Foundation; Danish Headache Foundation; Alex Klees Smerteforskningslegat; Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat; Merck Co., Inc.(Merck & Company); Else Torps and Flemming Jensens legat; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors were independently responsible for the study design, data analysis and manuscript. The study was sponsored by University of Copenhagen, Lundbeck Foundation Center for Neurovascular Signaling (LUCENS), the Research Foundation of the Capital Region of Denmark, Danish Council for Independent Research-Medical Sciences (FSS; grant 271-08-0446), the Novo Nordisk Foundation, Cool Sorption Foundation, Danish Headache Foundation, Alex Klees Smerteforskningslegat, Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat and Else Torps and Flemming Jensens legat. The Investigator Initiated Studies Program of Merck & Co., Inc., provided funding towards this study (research grant 33936). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The corresponding author had full access to all the study data and had the final responsibility to submit for publication.	Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Allman JM, 2011, ANN NY ACAD SCI, V1225, P59, DOI 10.1111/j.1749-6632.2011.06011.x; Amin FM, 2013, CEPHALALGIA, V33, P1009, DOI 10.1177/0333102413483374; Amin FM, 2013, LANCET NEUROL, V12, P454, DOI 10.1016/S1474-4422(13)70067-X; Asghar MS, 2010, NEUROLOGY, V75, P1520, DOI 10.1212/WNL.0b013e3181f9626a; Asghar MS, 2012, J HEADACHE PAIN, V13, P159, DOI 10.1007/s10194-011-0415-4; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Ashina M, 2000, PAIN, V86, P133, DOI 10.1016/S0304-3959(00)00232-3; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Borsook D, 2004, J NEUROBIOL, V61, P107, DOI 10.1002/neu.20085; Brain SD, 1996, GEN PHARMACOL, V27, P607, DOI 10.1016/0306-3623(95)00125-5; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.3.CO;2-E; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chatchaisak D, 2013, J CHEM NEUROANAT, V47, P50, DOI 10.1016/j.jchemneu.2012.09.005; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; de Leeuw R, 2006, ORAL SURG ORAL MED O, V102, P750, DOI 10.1016/j.tripleo.2005.12.018; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; EDVINSSON L, 1987, ANN NEUROL, V21, P431, DOI 10.1002/ana.410210503; Eftekhari S, 2010, NEUROSCIENCE, V169, P683, DOI 10.1016/j.neuroscience.2010.05.016; Eftekhari S, 2013, J PAIN, V14, P1289, DOI 10.1016/j.jpain.2013.03.010; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Fan J, 2011, NEUROIMAGE, V54, P2539, DOI 10.1016/j.neuroimage.2010.10.007; FOWLER PA, 1991, EUR NEUROL, V31, P291, DOI 10.1159/000116756; GOADSBY PJ, 1988, ANN NEUROL, V23, P193, DOI 10.1002/ana.410230214; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; IADAROLA MJ, 1995, PAIN, V63, P55, DOI 10.1016/0304-3959(95)00015-K; INAGAKI S, 1986, BRAIN RES, V374, P287, DOI 10.1016/0006-8993(86)90423-3; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; JansenOlesen I, 1996, CEPHALALGIA, V16, P310, DOI 10.1046/j.1468-2982.1996.1605310.x; Klein TA, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00014, 10.3389/fnins.2013.00113]; Kramer HH, 2007, PAIN, V133, P72, DOI 10.1016/j.pain.2007.03.001; KRUGER L, 1988, BRAIN RES, V463, P223, DOI 10.1016/0006-8993(88)90395-2; LACEY LF, 1995, EUR J CLIN PHARMACOL, V47, P543; Lassen LH, 2008, J HEADACHE PAIN, V9, P151, DOI 10.1007/s10194-008-0036-8; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Levy D, 2005, ANN NEUROL, V58, P698, DOI 10.1002/ana.20619; Li DG, 2008, J PAIN, V9, P1155, DOI 10.1016/j.jpain.2008.06.011; LINEBERRY CG, 1975, BRAIN RES, V98, P110, DOI 10.1016/0006-8993(75)90513-2; MacLean P, 1990, TRIUNE BRAIN EVOLUTI; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; MAO JR, 1992, BRAIN RES, V574, P157, DOI 10.1016/0006-8993(92)90812-N; MASON RT, 1984, NATURE, V308, P653, DOI 10.1038/308653a0; May A, 1998, PAIN, V74, P61, DOI 10.1016/S0304-3959(97)00144-9; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; MCCULLOCH J, 1986, P NATL ACAD SCI USA, V83, P5731, DOI 10.1073/pnas.83.15.5731; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MORECRAFT RJ, 1992, J COMP NEUROL, V322, P471, DOI 10.1002/cne.903220403; Morelli N, 2013, CEPHALALGIA, V33, P416, DOI 10.1177/0333102412474505; Naliboff BD, 2001, PSYCHOSOM MED, V63, P365, DOI 10.1097/00006842-200105000-00006; Naliboff BD, 2006, GASTROENTEROLOGY, V131, P352, DOI 10.1053/j.gastro.2006.05.014; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; PEDERSENBJERGAARD U, 1991, PEPTIDES, V12, P333, DOI 10.1016/0196-9781(91)90022-H; Pendse G, 2009, NEUROIMAGE, V47, P231, DOI 10.1016/j.neuroimage.2009.02.035; Petersen KA, 2005, CLIN PHARMACOL THER, V77, P202, DOI 10.1016/j.clpt.2004.10.001; Petersen KA, 2005, CEPHALALGIA, V25, P139, DOI 10.1111/j.1468-2982.2004.00830.x; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploner M, 1999, PAIN, V81, P211, DOI 10.1016/S0304-3959(99)00012-3; Reinert A, 1998, EXP BRAIN RES, V121, P174, DOI 10.1007/s002210050449; ROSEN SD, 1994, LANCET, V344, P147, DOI 10.1016/S0140-6736(94)92755-3; SEXTON PM, 1991, MOL NEUROBIOL, V5, P251, DOI 10.1007/BF02935550; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Starr CJ, 2009, J NEUROSCI, V29, P2684, DOI 10.1523/JNEUROSCI.5173-08.2009; STOVER JD, 1992, SOMATOSENS MOT RES, V9, P107, DOI 10.3109/08990229209144766; Sun RQ, 2004, J NEUROPHYSIOL, V92, P320, DOI 10.1152/jn.00086.2004; Sun RQ, 2003, PAIN, V104, P201, DOI 10.1016/S0304-3959(03)00008-3; Thomsen LL, 1996, CEPHALALGIA, V16, P169, DOI 10.1046/j.1468-2982.1996.1603169.x; TSAI SH, 1988, J COMP NEUROL, V271, P435, DOI 10.1002/cne.902710310; TSCHOPP FA, 1985, P NATL ACAD SCI USA, V82, P248, DOI 10.1073/pnas.82.1.248; Upadhyay J, 2008, MAGN RESON MED, V60, P1037, DOI 10.1002/mrm.21682; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Visser WH, 1996, HEADACHE, V36, P471, DOI 10.1046/j.1526-4610.1996.3608471.x; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wang Y, 2013, EXP BRAIN RES, V226, P15, DOI 10.1007/s00221-013-3405-8; Weigelt A, 2010, PAIN, V149, P529, DOI 10.1016/j.pain.2010.03.027; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Wunderlich Arthur P, 2011, Open Neuroimag J, V5, P1, DOI 10.2174/1874440001105010001; YOSHIDA A, 1991, J COMP NEUROL, V307, P609, DOI 10.1002/cne.903070408; Yu LC, 1999, REGUL PEPTIDES, V83, P21, DOI 10.1016/S0167-0115(99)00046-4; Yu Y, 2002, REGUL PEPTIDES, V103, P23, DOI 10.1016/S0167-0115(01)00326-3; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005	93	26	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150334	10.1371/journal.pone.0150334	http://dx.doi.org/10.1371/journal.pone.0150334			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990646	gold, Green Submitted, Green Published			2022-12-26	WOS:000372582800028
J	Freeland-Riggert, BT; Cairns, SH; Poulton, BC; Riggert, CM				Freeland-Riggert, Brandye T.; Cairns, Stefan H.; Poulton, Barry C.; Riggert, Christopher M.			Differences Found in the Macroinvertebrate Community Composition in the Presence or Absence of the Invasive Alien Crayfish, Orconectes hylas	PLOS ONE			English	Article							RED SWAMP CRAYFISH; PROCAMBARUS-CLARKII; PACIFASTACUS-LENIUSCULUS; OMNIVOROUS CRAYFISH; FEEDING PREFERENCES; QUADRUNCUS CREASER; NONNATIVE CRAYFISH; IMPERILED CRAYFISH; PERUNCUS CREASER; LIFE-HISTORIES	Introductions of alien species into aquatic ecosystems have been well documented, including invasions of crayfish species; however, little is known about the effects of these introductions on macroinvertebrate communities. The woodland crayfish (Orconectes hylas (Faxon)) has been introduced into the St. Francis River watershed in southeast Missouri and has displaced populations of native crayfish. The effects of O. hylas on macroinvertebrate community composition were investigated in a fourth-order Ozark stream at two locations, one with the presence of O. hylas and one without. Significant differences between sites and across four sampling periods and two habitats were found in five categories of benthic macroinvertebrate metrics: species richness, percent/composition, dominance/diversity, functional feeding groups, and biotic indices. In most seasons and habitat combinations, the invaded site had significantly higher relative abundance of riffle beetles (Coleoptera: Elmidae), and significantly lower Missouri biotic index values, total taxa richness, and both richness and relative abundance of midges (Diptera: Chironomidae). Overall study results indicate that some macroinvertebrate community differences due to the O. hylas invasion were not consistent between seasons and habitats, suggesting that further research on spatial and temporal habitat use and feeding ecology of Ozark crayfish species is needed to improve our understanding of the effects of these invasions on aquatic communities.	[Freeland-Riggert, Brandye T.; Cairns, Stefan H.] Univ Cent Missouri, Dept Biol & Agr, Warrensburg, MO USA; [Poulton, Barry C.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA; [Riggert, Christopher M.] Missouri Dept Conservat, Jefferson City, MO USA; [Freeland-Riggert, Brandye T.] Missouri Dept Nat Resources, POB 176, Jefferson City, MO USA	University Central Missouri; United States Department of the Interior; United States Geological Survey	Freeland-Riggert, BT (corresponding author), Univ Cent Missouri, Dept Biol & Agr, Warrensburg, MO USA.; Freeland-Riggert, BT (corresponding author), Missouri Dept Nat Resources, POB 176, Jefferson City, MO USA.	Brandye.Freeland-Riggert@dnr.mo.gov			University of Central Missouri	University of Central Missouri	The authors received no specific funding for this work. At the time of the study Brandye T. Freeland-Riggert was currently not employed by USGS as a federal employee nor was the study funded though the University of Central Missouri where Brandye T. Freeland-Riggert was a biology graduate student.	ABRAHAMSSON SA, 1966, OIKOS, V17, P96, DOI 10.2307/3564784; Alcorlo P, 2004, CRUSTACEANA, V77, P435, DOI 10.1163/1568540041643283; Allan JD., 2021, STREAM ECOLOGY STRUC, DOI [DOI 10.1007/978-3-030-61286-3, 10.1007/978-3-030-61286-3]; ANDERSON NH, 1979, J FISH RES BOARD CAN, V36, P335, DOI 10.1139/f79-052; [Anonymous], 1960, INT C ENTOMOLOGY 2; [Anonymous], 1960, INT C ENTOMOLOGY 2; [Anonymous], 1960, INT C ENTOMOLOGY 2; [Anonymous], 1960, INT C ENTOMOLOGY 2; [Anonymous], 1960, INT C ENTOMOLOGY 2; Barbour M.T., 1999, RAPID BIOASSESSMENT, V339; Bondar GA, 2005, CANADIAN J FISHERIES, V62, P2632; BROWN HP, 1987, ANNU REV ENTOMOL, V32, P253, DOI 10.1146/annurev.ento.32.1.253; Chucholl C, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011082; Clements WH, 2004, ECOL APPL, V14, P954, DOI 10.1890/03-5009; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Crawford L, 2006, AQUAT CONSERV, V16, P611, DOI 10.1002/aqc.761; CUMMINS KW, 1974, BIOSCIENCE, V24, P631, DOI 10.2307/1296676; DeShon J. D., 1995, BIOL ASSESSMENT CRIT, P217, DOI DOI 10.1080/0964056022000013039; Distefano R.J., 2011, Freshwater Crayfish, V18, P37; DiStefano RJ, MANAGEMENT IN PRESS; DiStefano Robert, 2002, Freshwater Crayfish, V13, P439; DiStefano RJ, 2008, J CRUSTACEAN BIOL, V28, P417, DOI 10.1651/0278-0372(2008)028[0417:COICPQ]2.0.CO;2; DiStefano RJ, 2008, J CRUSTACEAN BIOL, V28, P189, DOI 10.1651/06-2822R.1; DiStefano RJ, 2009, FISHERIES, V34, P586, DOI 10.1577/1548-8446-34.12.586; Dorn NJ, 2004, OECOLOGIA, V140, P150, DOI 10.1007/s00442-004-1548-9; Edmunds G.F., 1976, MAYFLIES N CENTRAL A; Elliott JM, 2000, ECOL ENTOMOL, V25, P26, DOI 10.1046/j.1365-2311.2000.00229.x; Englund G, 2000, FRESHWATER BIOL, V43, P75, DOI 10.1046/j.1365-2427.2000.00524.x; France R, 1996, OECOLOGIA, V107, P239, DOI 10.1007/BF00327908; Freeland-Riggert BT, 2014, THESIS U CENTRAL MIS; Gamradt SC, 1997, CONSERV BIOL, V11, P793, DOI 10.1046/j.1523-1739.1997.96230.x; Gherardi F, 2000, AQUAT SCI, V62, P179, DOI 10.1007/PL00001330; Gherardi F, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P258; Gherardi F, 2007, BFPP-CONNAISS GEST P, P7, DOI 10.1051/kmae:2007014; Goddard J.S., 1988, P145; Guan RZ, 1998, AQUACULTURE, V169, P177, DOI 10.1016/S0044-8486(98)00377-9; HANSON JM, 1990, FRESHWATER BIOL, V24, P69, DOI 10.1111/j.1365-2427.1990.tb00308.x; Hayslip G, EPA910992013; HILL AM, 1994, ECOLOGY, V75, P2118, DOI 10.2307/1941615; HILSENHOFF W L, 1988, Journal of the North American Benthological Society, V7, P65, DOI 10.2307/1467832; Hobbs HH, 2001, CRUSTACEANA, V74, P635, DOI 10.1163/156854001750377911; Holdich DM, 1999, CRUSTACEAN ISS, V11, P31; Hollows JW, 2002, NEW ZEAL J MAR FRESH, V36, P129, DOI 10.1080/00288330.2002.9517076; Houghton DC, 1998, GREAT LAKES ENTOMOL, V31, P13; Huryn AD, 2000, ANNU REV ENTOMOL, V45, P83, DOI 10.1146/annurev.ento.45.1.83; Hynes H. B. N., 1970, ECOLOGY RUNNING WATE; Ilheu M., 1993, Freshwater Crayfish, V9, P359; JACKSON JK, 1995, J N AM BENTHOL SOC, V14, P115, DOI 10.2307/1467728; Jacobsen D, 2003, FRESHWATER BIOL, V48, P2025, DOI 10.1046/j.1365-2427.2003.01140.x; Jacobsen D, 2008, OECOLOGIA, V154, P795, DOI 10.1007/s00442-007-0877-x; Jacobson RB, 2004, DS94 USGS US DEP INT; Jones P.D., 1983, Freshwater Crayfish, V5, P192; KERANS BL, 1994, ECOL APPL, V4, P768, DOI 10.2307/1942007; KLEMM DJ, 1990, EPA600490030; Klose K, 2012, FRESHWATER BIOL, V57, P526, DOI 10.1111/j.1365-2427.2011.02721.x; Kreps TA, 2012, CAN J FISH AQUAT SCI, V69, P1164, DOI [10.1139/f2012-052, 10.1139/F2012-052]; Kuhlmann ML, 2007, NORTHEAST NAT, V14, P507, DOI 10.1656/1092-6194(2007)14[507:IOTUSR]2.0.CO;2; LODGE DM, 1994, ECOLOGY, V75, P1265, DOI 10.2307/1937452; Lodge DM, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:NCTNAF>2.0.CO;2; Lodge DM, 1998, AUST J ECOL, V23, P53, DOI 10.1111/j.1442-9993.1998.tb00705.x; McCarthy JM, 2006, FRESHWATER BIOL, V51, P224, DOI 10.1111/j.1365-2427.2005.01485.x; MCCLAIN WR, 1992, AQUACULTURE, V101, P251, DOI 10.1016/0044-8486(92)90029-K; MDC, 2015, MISS SPEC COMM CONS; MDNR, 2010, SEM MACR STREAM BIOA; MDNR, 2003, BIOL ASS STUD BIG CR; MDNR, 2010, FLOW MEAS OP CHANN S; MDNR, 2010, STREAM HAB ASS PROJ; MDNR, 2000, BIOL ASS REP BIG CRE; MDNR, 2010, TAX LEV MACR ID MDNR; Merritt R. W., 2008, INTRO AQUATIC INSECT; Momot Walter T., 1995, Reviews in Fisheries Science, V3, P33; Muck JA, 2002, AM MIDL NAT, V147, P338, DOI 10.1674/0003-0031(2002)147[0338:RBOTCO]2.0.CO;2; Muenz TK, 2004, THESIS U GEORGIA ATH; Nigh T.A., 2002, ATLAS MISSOURI ECORE; Nystrom P, 1996, FRESHWATER BIOL, V36, P631, DOI 10.1046/j.1365-2427.1996.d01-528.x; Nystrom P, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P192; Nystrom P, 1998, HYDROBIOLOGIA, V368, P201, DOI 10.1023/A:1003266603371; Occhipinti-Ambrogi A, 2004, MAR POLLUT BULL, V49, P688, DOI 10.1016/j.marpolbul.2004.08.011; Oliveira J, 1998, AQUAC RES, V29, P123, DOI 10.1046/j.1365-2109.1998.00936.x; OLSEN TM, 1991, CAN J FISH AQUAT SCI, V48, P1853, DOI 10.1139/f91-219; Parkyn SM, 2001, FRESHWATER BIOL, V46, P641, DOI 10.1046/j.1365-2427.2001.00702.x; Pennak RW, 1989, FRESHWATER INVERTEBR; Pflieger WL, 1996, CRAYFISHES MISSOURI; Poulton BC, 2010, ENVIRON MONIT ASSESS, V163, P619, DOI 10.1007/s10661-009-0864-2; Poulton BC, 2007, 20075108 US DEP INT; Rabalais MR, 2006, AM MIDL NAT, V155, P295, DOI 10.1674/0003-0031(2006)155[295:IOAICS]2.0.CO;2; Rahm EJ, 2005, CRUSTACEANA, V78, P437, DOI 10.1163/1568540054473585; Riggert CM, 1999, AM MIDL NAT, V142, P348, DOI 10.1674/0003-0031(1999)142[0348:DASAOT]2.0.CO;2; Rodriguez CF, 2005, BIOL INVASIONS, V7, P75, DOI 10.1007/s10530-004-9636-7; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schwiebert EG, 2007, NUMPHS, VI; Stark B.P, 2008, INTRO AQUATIC INSECT, V4th, P311; Stenroth P, 2003, FRESHWATER BIOL, V48, P466, DOI 10.1046/j.1365-2427.2003.01020.x; STEWART KW, 1973, ANN ENTOMOL SOC AM, V66, P959, DOI 10.1093/aesa/66.5.959; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Strecker AL, 2011, FISHERIES, V36, P74, DOI 10.1577/03632415.2011.10389070; Taugbol T, 1999, CRUSTACEAN ISS, V11, P271; Taylor CA, 2007, FISHERIES, V32, P372, DOI 10.1577/1548-8446(2007)32[372:AROTCS]2.0.CO;2; THORP JH, 2001, ECOLOGY CLASSIFICATI; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Westhoff JT, 2012, HYDROBIOLOGIA, V683, P43, DOI 10.1007/s10750-011-0939-2; Whitledge GW, 1996, FRESHW CRAYFISH, V11, P159; Zar JH, 1974, BIOSTATISTICAL ANAL	103	1	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150199	10.1371/journal.pone.0150199	http://dx.doi.org/10.1371/journal.pone.0150199			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986207	Green Published, gold			2022-12-26	WOS:000372580300018
J	Mombach, KD; Brito, CLD; Padoin, AV; Casagrande, DS; Mottin, CC				Mombach, Karin Daniele; de Souza Brito, Cesar Luis; Padoin, Alexandre Vontobel; Casagrande, Daniela Schaan; Mottin, Claudio Cora			Emotional and Affective Temperaments in Smoking Candidates for Bariatric Surgery	PLOS ONE			English	Article							NICOTINE DEPENDENCE; PERSONALITY-TRAITS; CIGARETTE-SMOKING; INTEGRATIVE MODEL; BIPOLAR SPECTRUM; ANGER TRAITS; RISK-FACTORS; TOBACCO USE; FOLLOW-UP; DISORDERS	Introduction The prevalence of smoking habits in severe obesity is higher than in the general population. There is some evidence that smokers have different temperaments compared to non-smokers. The aim of this study is to evaluate the associations between smoking status (smokers, ex-smokers and non-smokers) and temperament characteristics in bariatric surgery candidates. Methods We analyzed data on temperament of 420 bariatric surgery candidates, as assessed by the AFECTS scale, in an exploratory cross-sectional survey of bariatric surgery candidates who have been grouped into smokers, ex-smokers and non-smokers. Results We detected significant statistical differences in temperament related to the smoking status in this population after controlling the current use of psychiatric medication. Smokers had higher anxiety and lower control than non-smokers. Ex-smokers with BMI >50 kg/m(2) presented higher coping and control characteristics than smokers. Conclusions Smoking in bariatric surgery candidates was associated with lower control and higher anxious temperament, when controlled by current use of psychiatric medication. Smokers with BMI >50 kg/m(2) presented lower coping and control than ex-smokers. Assessment of temperament in bariatric surgery candidates may help in decisions about smoking cessation treatment and prevention of smoking relapse after surgery.	[Mombach, Karin Daniele; Padoin, Alexandre Vontobel; Mottin, Claudio Cora] Pontificia Univ Catolica Rio Grande do Sul, Fac Med, Postgrad Program Med & Hlth Sci, Clin Sugery, Porto Alegre, RS, Brazil; [Mombach, Karin Daniele; de Souza Brito, Cesar Luis; Padoin, Alexandre Vontobel; Casagrande, Daniela Schaan; Mottin, Claudio Cora] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Obes & Metab Syndrome Ctr, Porto Alegre, RS, Brazil; [de Souza Brito, Cesar Luis; Padoin, Alexandre Vontobel; Mottin, Claudio Cora] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Fac Med, Porto, Portugal	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade do Porto	Mombach, KD (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Med, Postgrad Program Med & Hlth Sci, Clin Sugery, Porto Alegre, RS, Brazil.; Mombach, KD (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Obes & Metab Syndrome Ctr, Porto Alegre, RS, Brazil.	karindm@gmail.com	Padoin, Alexandre V/M-7660-2013; de Souza Brito, Cesar Luis/AAG-9984-2019	Padoin, Alexandre V/0000-0002-9754-4818; de Souza Brito, Cesar Luis/0000-0002-2509-7270	Brazilian Government - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP)	Brazilian Government - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This study was supported by the Brazilian Government - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); and Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P45, DOI 10.1016/j.jad.2003.10.012; Alciati A, 2007, J AFFECT DISORDERS, V101, P131, DOI 10.1016/j.jad.2006.11.008; Amann B, 2009, J AFFECT DISORDERS, V118, P155, DOI 10.1016/j.jad.2009.01.020; Bisol LW, 2010, J AFFECT DISORDERS, V127, P89, DOI 10.1016/j.jad.2010.04.016; Blackburn GL, 2009, OBESITY, V17, P842, DOI 10.1038/oby.2008.578; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chatkin R, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-61; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cosci F, 2009, ADDICT BEHAV, V34, P28, DOI 10.1016/j.addbeh.2008.08.003; Etter JF, 2003, NICOTINE TOB RES, V5, P401, DOI 10.1080/1462220031000094240; Eysenck HJ, 1997, J PERS SOC PSYCHOL, V73, P1224, DOI 10.1037/0022-3514.73.6.1224; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Finks JF, 2011, ANN SURG, V254, P633, DOI 10.1097/SLA.0b013e318230058c; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Gurpegui M, 2007, PROG NEURO-PSYCHOPH, V31, P997, DOI 10.1016/j.pnpbp.2007.02.006; Hall W, 2002, TOB CONTROL, V11, P119, DOI 10.1136/tc.11.2.119; HEATH AC, 1995, BEHAV GENET, V25, P103, DOI 10.1007/BF02196921; Hintsanen M, 2012, J PSYCHOSOM RES, V73, P391, DOI 10.1016/j.jpsychores.2012.08.012; Kalarchian MA, 2007, AM J PSYCHIAT, V164, P328, DOI 10.1176/appi.ajp.164.2.328; Kang Eunjeong, 2010, J Prev Med Public Health, V43, P193, DOI 10.3961/jpmph.2010.43.3.193; Katzow JJ, 2003, BIPOLAR DISORD, V5, P436, DOI 10.1046/j.1399-5618.2003.00068.x; Koster A, 2008, AM J CLIN NUTR, V88, P1206, DOI 10.3945/ajcn.2008.26298; Lara DR, 2006, J AFFECT DISORDERS, V94, P89, DOI 10.1016/j.jad.2006.03.021; Lara DR, 2006, J AFFECT DISORDERS, V94, P67, DOI 10.1016/j.jad.2006.02.025; Lara DR, 2012, J AFFECT DISORDERS, V140, P14, DOI 10.1016/j.jad.2011.08.036; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Levine MD, 2007, ADDICT BEHAV, V32, P2365, DOI 10.1016/j.addbeh.2007.02.002; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Livingston EH, 2006, J AM COLL SURGEONS, V203, P625, DOI 10.1016/j.jamcollsurg.2006.07.006; Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; Nguyen NT, 2003, J AM COLL SURGEONS, V197, P548, DOI 10.1016/S1072-7515(03)00648-3; Osler M, 2001, GENET EPIDEMIOL, V21, P193, DOI 10.1002/gepi.1028; Pelissolo A, 2000, PSYCHIAT RES, V94, P67, DOI 10.1016/S0165-1781(00)00127-X; Pompili M, 2009, J ADDICT DIS, V28, P13, DOI 10.1080/10550880802544757; Rezvanfard M, 2010, ARCH IRAN MED, V13, P395, DOI 010135/AIM.006; Rihmer Z, 2010, CURR OPIN PSYCHIATR, V23, P12, DOI 10.1097/YCO.0b013e32833299d4; Ryden A, 2004, INT J OBESITY, V28, P1485, DOI 10.1038/sj.ijo.0802768; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sullivan S, 2007, INT J OBESITY, V31, P669, DOI 10.1038/sj.ijo.0803464; Tindle HA, 2010, AM J MED, V123, P1036, DOI 10.1016/j.amjmed.2010.06.016; Unseld M, 2012, J AFFECT DISORDERS, V141, P324, DOI 10.1016/j.jad.2012.03.028; von Zerssen D, 1998, J AFFECT DISORDERS, V51, P1; Zhang W, 2005, OBES SURG, V15, P43, DOI 10.1381/0960892052993422	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150722	10.1371/journal.pone.0150722	http://dx.doi.org/10.1371/journal.pone.0150722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26987115	Green Published, gold			2022-12-26	WOS:000372580300025
J	Nguyen, MU; Kwong, J; Chang, J; Gillet, VG; Lee, RM; Johnson, KG				Nguyen, Margaret U.; Kwong, Jereen; Chang, Julia; Gillet, Victoria G.; Lee, Rachel M.; Johnson, Karl Gregory			The Extracellular and Cytoplasmic Domains of Syndecan Cooperate Postsynaptically to Promote Synapse Growth at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CELL-SURFACE; DENDRITIC SPINES; MYOBLAST FUSION; RECEPTOR; PATHWAY; PROTEIN; PHOSPHATASE; EXPRESSION; NEUROFIBROMIN	The heparan sulfate proteoglycan (HSPG) Syndecan (Sdc) is a crucial regulator of synapse development and growth in both vertebrates and invertebrates. In Drosophila, Sdc binds via its extracellular heparan sulfate (HS) sidechains to the receptor protein tyrosine phosphatase LAR to promote the morphological growth of the neuromuscular junction (NMJ). To date, however, little else is known about the molecular mechanisms by which Sdc functions to promote synapse growth. Here we show that all detectable Sdc found at the NMJ is provided by the muscle, strongly suggesting a post-synaptic role for Sdc. We also show that both the cytoplasmic and extracellular domains of Sdc are required to promote synapse growth or to rescue Sdc loss of function. We report the results of a yeast two-hybrid screen using the cytoplasmic domains of Sdc as bait, and identify several novel candidate binding partners for the cytoplasmic domains of Sdc. Together, these studies provide new insight into the mechanism of Sdc function at the NMJ, and provide enticing future directions for further exploring how Sdc promotes synapse growth.	[Kwong, Jereen; Chang, Julia; Johnson, Karl Gregory] Pomona Coll, Program Mol Biol, Claremont, CA 91711 USA; [Nguyen, Margaret U.; Gillet, Victoria G.; Lee, Rachel M.; Johnson, Karl Gregory] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA	Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Johnson, KG (corresponding author), Pomona Coll, Program Mol Biol, Claremont, CA 91711 USA.; Johnson, KG (corresponding author), Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA.	karl.johnson@pomona.edu		Johnson, Karl/0000-0003-3931-5985	National Science Foundation - Research at Undergraduate Institutions [0841551]; Division of Integrative Organismal Systems - Neural Systems Cluster [0841551]; National Institutes of Health Academic Research Enhancement Award [1R15NS065433-01]; National Institute of Neurological Disorders and Stroke [1R15NS065433-01]; Pomona College Summer Undergraduate Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS065433] Funding Source: NIH RePORTER	National Science Foundation - Research at Undergraduate Institutions; Division of Integrative Organismal Systems - Neural Systems Cluster; National Institutes of Health Academic Research Enhancement Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pomona College Summer Undergraduate Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Science Foundation - Research at Undergraduate Institutions; Division of Integrative Organismal Systems - Neural Systems Cluster. The recipient was KGJ and the grant number was 0841551 (http://www.nsf.gov/div/index.jsp?div=IOS). This work was also funded by the National Institutes of Health Academic Research Enhancement Award; National Institute of Neurological Disorders and Stroke. The recipient was KGJ and the grant number was 1R15NS065433-01. Additional funding came from the Pomona College Summer Undergraduate Research Program. Recipients of these funds were MUN, JK, JC and VGG (http://www.pomona.edu/research).	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chanana B, 2009, P NATL ACAD SCI USA, V106, P11984, DOI 10.1073/pnas.0901148106; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; De Renzis S, 2006, DEV CELL, V10, P257, DOI 10.1016/j.devcel.2006.01.011; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; GRINBLAT Y, 1989, NUCLEIC ACIDS RES, V17, P7303, DOI 10.1093/nar/17.18.7303; Guo YQ, 2000, J CELL SCI, V113, P3499; Hernandez G, 2004, PROTEOMICS, V4, P316, DOI 10.1002/pmic.200300555; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kamimura K, 2013, J CELL BIOL, V200, P219, DOI 10.1083/jcb.201207036; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Klass CM, 2000, J CELL SCI, V113, P493; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martin PT, 2002, GLYCOBIOLOGY, V12, p1R, DOI 10.1093/glycob/12.1.1R; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Okina E, 2012, INT J BIOCHEM CELL B, V44, P2161, DOI 10.1016/j.biocel.2012.08.017; Schulz JG, 2011, EMBO REP, V12, P1039, DOI 10.1038/embor.2011.153; Siddiqui TJ, 2013, NEURON, V79, P680, DOI 10.1016/j.neuron.2013.06.029; Smart AD, 2011, DEV NEUROBIOL, V71, P608, DOI 10.1002/dneu.20854; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Swan LE, 2004, GENE DEV, V18, P223, DOI 10.1101/gad.287604; Volta M, 2010, BIOCHEM BIOPH RES CO, V391, P1216, DOI 10.1016/j.bbrc.2009.12.043; Zhang Y, 2000, J CELL SCI, V113, P3103	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151621	10.1371/journal.pone.0151621	http://dx.doi.org/10.1371/journal.pone.0151621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987116	Green Published, gold			2022-12-26	WOS:000372580300097
J	Roques, L; Bonnefon, O				Roques, Lionel; Bonnefon, Olivier			Modelling Population Dynamics in Realistic Landscapes with Linear Elements: A Mechanistic-Statistical Reaction-Diffusion Approach	PLOS ONE			English	Article							AEDES-ALBOPICTUS; ESTABLISHMENT; MOVEMENTS; MOSQUITO	We propose and develop a general approach based on reaction-diffusion equations for modelling a species dynamics in a realistic two-dimensional (2D) landscape crossed by linear one-dimensional (1D) corridors, such as roads, hedgerows or rivers. Our approach is based on a hybrid "2D/1D model", i.e, a system of 2D and 1D reaction-diffusion equations with homogeneous coefficients, in which each equation describes the population dynamics in a given 2D or 1D element of the landscape. Using the example of the range expansion of the tiger mosquito Aedes albopictus in France and its main highways as 1D corridors, we show that the model can be fitted to realistic observation data. We develop a mechanistic-statistical approach, based on the coupling between a model of population dynamics and a probabilistic model of the observation process. This allows us to bridge the gap between the data (3 levels of infestation, at the scale of a French department) and the output of the model (population densities at each point of the landscape), and to estimate the model parameter values using a maximum-likelihood approach. Using classical model comparison criteria, we obtain a better fit and a better predictive power with the 2D/1D model than with a standard homogeneous reaction-diffusion model. This shows the potential importance of taking into account the effect of the corridors (highways in the present case) on species dynamics. With regard to the particular case of A. albopictus, the conclusion that highways played an important role in species range expansion in mainland France is consistent with recent findings from the literature.	[Roques, Lionel; Bonnefon, Olivier] INRA, UR BioSP 546, F-84914 Avignon, France	INRAE	Roques, L (corresponding author), INRA, UR BioSP 546, F-84914 Avignon, France.	lionel.roques@avignon.inra.fr		olivier, bonnefon/0000-0002-0462-4836	French Agence Nationale pour la Recherche [ANR-12-AGRO-0006]; European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant [321186]	French Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant(European Research Council (ERC))	This work was supported by French Agence Nationale pour la Recherche, within the ANR-12-AGRO-0006 PEERLESS (http://www.agence-nationale-recherche.fr/?Projet=ANR-12-AGRO-0006) and European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 321186 - ReaDi (http://erc.europa.eu/projects-and-results/erc-funded-projects/readi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard D, 2012, MATH GEOSCI, V44, P545, DOI 10.1007/s11004-012-9396-3; Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Berestycki H, 2013, J MATH BIOL, V66, P743, DOI 10.1007/s00285-012-0604-z; Berliner LM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002865; Bertuzzo E, 2009, J ROYAL SOC INTERFAC; Bianchi FJJA, 2003, ENVIRON ENTOMOL, V32, P1290, DOI 10.1603/0046-225X-32.6.1290; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Caminade C, 2012, J R SOC INTERFACE; Cantrell R.S., 2003, SPATIAL ECOLOGY VIA; Flacio E., 2006, SOVE15TH EUROPEAN M, P57; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; FRIED I, 1972, AIAA J, V10, P219, DOI 10.2514/3.6561; Garcia AF, 2000, ANN APPL BIOL, V137, P89, DOI 10.1111/j.1744-7348.2000.tb00040.x; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Gneiting T, 2007, J R STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Grindrod P., 1996, THEORY APPL REACTION; Haddad NM, 2003, ECOLOGY, V84, P609, DOI 10.1890/0012-9658(2003)084[0609:CUBDT]2.0.CO;2; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Hecht F, 2012, J NUMER MATH, V20, P251, DOI 10.1515/jnum-2012-0013; Klaus F., 2015, J LANDSCAPE ECOLOGY, V8, P22, DOI [10.1515/jlecol-2015-0001, DOI 10.1515/JLECOL-2015-0001]; McKenzie HW, 2012, INTERFACE FOCUS, V2, P205, DOI 10.1098/rsfs.2011.0086; Murray J.D., 2002, INTERDISCIPLINARY AP, V17; Ovaskainen O, 2008, ECOLOGY, V89, P542, DOI 10.1890/07-0443.1; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Preisler HK, 2004, ENVIRONMETRICS, V15, P643, DOI 10.1002/env.636; Robinet C, 2012, BIOL INVASIONS, V14, P1557, DOI 10.1007/s10530-011-9979-9; Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600; Roques A, 2015, PROCESSIONARY MOTHS; Roques L., 2013, MODELES REACTION DIF; Roques L, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2014.0349; Roques L, 2011, J THEOR BIOL, V274, P43, DOI 10.1016/j.jtbi.2011.01.006; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shigesada N., 1997, OXFORD SERIES ECOLOG; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Soubeyrand S, 2014, POPUL ECOL, V56, P427, DOI 10.1007/s10144-013-0415-0; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1631, DOI 10.1007/s11071-012-0374-6; Takken W, 2007, ECOL CONT VECTOR-BOR, V1, P1; Turchin Peter, 1998; Wikle CK, 2003, INT STAT REV, V71, P181, DOI 10.1111/j.1751-5823.2003.tb00192.x; Wilks D. S, 2011, STAT METHODS ATMOSPH, V100	45	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151217	10.1371/journal.pone.0151217	http://dx.doi.org/10.1371/journal.pone.0151217			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986201	gold, Green Submitted, Green Published			2022-12-26	WOS:000372580300054
J	Porreca, I; Severino, LU; D'Angelo, F; Cuomo, D; Ceccarelli, M; Altucci, L; Amendola, E; Nebbioso, A; Mallardo, M; De Felice, M; Ambrosino, C				Porreca, Immacolata; Severino, Luisa Ulloa; D'Angelo, Fulvio; Cuomo, Danila; Ceccarelli, Michele; Altucci, Lucia; Amendola, Elena; Nebbioso, Angela; Mallardo, Massimo; De Felice, Mario; Ambrosino, Concetta			"Stockpile" of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells	PLOS ONE			English	Article							URINARY BISPHENOL-A; NUCLEOTIDE EXCISION-REPAIR; P53 PROMOTER; DNA-DAMAGE; PROLIFERATION; APOPTOSIS; EXPOSURE; BINDING; HEALTH; ALPHA	Epidemiological and experimental data highlighted the thyroid-disrupting activity of bisphenol A (BPA). Although pivotal to identify the mechanisms of toxicity, direct low-dose BPA effects on thyrocytes have not been assessed. Here, we report the results of microarray experiments revealing that the transcriptome reacts dynamically to low-dose BPA exposure, adapting the changes in gene expression to the exposure duration. The response involves many genes, enriching specific pathways and biological functions mainly cell death/proliferation or DNA repair. Their expression is only slightly altered but, since they enrich specific pathways, this results in major effects as shown here for transcripts involved in the DNA repair pathway. Indeed, even though no phenotypic changes are induced by the treatment, we show that the exposure to BPA impairs the cell response to further stressors. We experimentally verify that prolonged exposure to low doses of BPA results in a delayed response to UV-C-induced DNA damage, due to impairment of p21-Tp53 axis, with the BPA-treated cells more prone to cell death and DNA damage accumulation. The present findings shed light on a possible mechanism by which BPA, not able to directly cause genetic damage at environmental dose, may exert an indirect genotoxic activity.	[Porreca, Immacolata; D'Angelo, Fulvio; Ceccarelli, Michele; Ambrosino, Concetta] IRGS, Biogem, Via Camporeale, I-83031 Avellino, Italy; [Severino, Luisa Ulloa] Univ Trieste, PhD Sch Nanotechnol, I-34127 Trieste, Italy; [Cuomo, Danila; Ceccarelli, Michele; Ambrosino, Concetta] Univ Sannio, Dept Sci & Technol, Via Port Arsa 11, I-82100 Benevento, Italy; [Altucci, Lucia; Nebbioso, Angela] Univ Naples 2, Dept Biophys & Gen Pathol, Via L De Crecchio 7, I-80138 Naples, Italy; [Amendola, Elena; Mallardo, Massimo; De Felice, Mario] Univ Naples Federico II, Mol Med & Med Biotechnol, Via Pansini 6, I-80131 Naples, Italy; [De Felice, Mario] IEOS CNR, Via Pansini 6, I-80131 Naples, Italy	University of Trieste; University of Sannio; Universita della Campania Vanvitelli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Ambrosino, C (corresponding author), IRGS, Biogem, Via Camporeale, I-83031 Avellino, Italy.; Ambrosino, C (corresponding author), Univ Sannio, Dept Sci & Technol, Via Port Arsa 11, I-82100 Benevento, Italy.	coambros@unisannio.it	NEBBIOSO, ANGELA/GVS-1294-2022; ambrosino, concetta/AAB-3452-2019; Ulloa Severino, Luisa/GVR-8532-2022; Ceccarelli, Michele/AGP-1739-2022; Amendola, Elena/P-2434-2016; Altucci, Lucia/S-8031-2019; Cuomo, Danila/AAS-8567-2021; D'Angelo, Fulvio/AAG-9788-2020	D'Angelo, Fulvio/0000-0002-4940-4693; Ceccarelli, Michele/0000-0002-4702-6617; Cuomo, Danila/0000-0003-4752-5819; MALLARDO, Massimo/0000-0002-4001-3856; Porreca, Immacolata/0000-0003-2008-0477	Italian Workers' Compensation Authority [12010]; Italian Ministry of Health [RF 2010-2309484]; Sensor Regione Campania [23]	Italian Workers' Compensation Authority; Italian Ministry of Health(Ministry of Health, Italy); Sensor Regione Campania	This work was funded by the Italian Workers' Compensation Authority (grant no. 12010), the Italian Ministry of Health (grant no. RF 2010-2309484) and Sensor Regione Campania (grant no. 23).	Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; Ambrosino C, 2010, MOL CELL PROTEOMICS, V9, P1352, DOI 10.1074/mcp.M900519-MCP200; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Braun JM, 2011, CURR OPIN PEDIATR, V23, P233, DOI 10.1097/MOP.0b013e3283445675; Brucker-Davis F, 2011, THYROID, V21, P1133, DOI 10.1089/thy.2010.0459; Carchia E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.319; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chevrier J, 2013, ENVIRON HEALTH PERSP, V121, P138, DOI 10.1289/ehp.1205092; Choi M, 2002, IUBMB LIFE, V53, P309, DOI 10.1080/15216540213466; Dairkee SH, 2013, CARCINOGENESIS, V34, P703, DOI 10.1093/carcin/bgs379; Del Terra E, 2003, THYROID, V13, P747, DOI 10.1089/105072503768499635; Delclos KB, 2014, TOXICOL SCI, V139, P174, DOI 10.1093/toxsci/kfu022; Delfosse V, 2014, VITAM HORM, V94, P229, DOI 10.1016/B978-0-12-800095-3.00009-2; Dunkern TR, 2002, MOL BIOL CELL, V13, P348, DOI 10.1091/mbc.01-05-0225; Durando M, 2007, ENVIRON HEALTH PERSP, V115, P80, DOI 10.1289/ehp.9282; Gentilcore D, 2013, TOXICOLOGY, V304, P21, DOI 10.1016/j.tox.2012.12.001; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Ito Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050481; Jenkins S, 2009, ENVIRON HEALTH PERSP, V117, P910, DOI 10.1289/ehp.11751; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Meir M, 2015, NUCLEIC ACIDS RES, V43, P4517, DOI 10.1093/nar/gkv270; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Porreca I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1067; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; REISMAN D, 1993, CELL GROWTH DIFFER, V4, P57; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Romano ME, 2015, ENVIRON RES, V138, P453, DOI 10.1016/j.envres.2015.03.003; Sheng ZG, 2012, TOXICOL APPL PHARM, V259, P133, DOI 10.1016/j.taap.2011.12.018; Takagi H, 2002, CANCER LETT, V178, P1, DOI 10.1016/S0304-3835(01)00804-7; Takahashi S, 2001, MUTAT RES-GEN TOX EN, V490, P199, DOI 10.1016/S1383-5718(00)00161-3; Tarapore P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090332; Tiwari D, 2012, MUTAT RES-GEN TOX EN, V743, P83, DOI 10.1016/j.mrgentox.2011.12.023; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Wang F, 2012, OCCUP ENVIRON MED, V69, P679, DOI 10.1136/oemed-2011-100529; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Xin F, 2014, MUTAT RES-GEN TOX EN, V769, P29, DOI 10.1016/j.mrgentox.2014.04.019; Yin R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098635; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058; Zhang Yawei, 2008, Biosci Hypotheses, V1, P195, DOI 10.1016/j.bihy.2008.06.003	47	25	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151618	10.1371/journal.pone.0151618	http://dx.doi.org/10.1371/journal.pone.0151618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982218	Green Published, gold			2022-12-26	WOS:000372574900104
J	Pujades-Rodriguez, M; Duyx, B; Thomas, SL; Stogiannis, D; Rahman, A; Smeeth, L; Hemingway, H				Pujades-Rodriguez, Mar; Duyx, Bram; Thomas, Sara L.; Stogiannis, Dimitris; Rahman, Anisur; Smeeth, Liam; Hemingway, Harry			Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; LIFETIME RISKS; EVENTS; ASSOCIATIONS; STROKE; GLUCOCORTICOIDS; METAANALYSIS; MORTALITY; SMOKING	Introduction While rheumatoid arthritis is an established risk factor for cardiovascular disease (CVD), our knowledge of how the pattern of risk varies for different cardiovascular phenotypes is incomplete. The association between rheumatoid arthritis and the initial presentation of 12 types of CVDs were examined in a contemporary population of men and women of a wide age range. Methods CALIBER data, which links primary care, hospital and mortality data in England, was analysed. A cohort of people aged >= 18 years and without history of CVD was assembled and included all patients with prospectively recorded rheumatoid arthritis from January 1997, until March 2010, matched with up to ten people without rheumatoid arthritis by age, sex and general practice. The associations between rheumatoid arthritis and the initial presentation of 12 types of CVDs were estimated using multivariable random effects Poisson regression models. Results The analysis included 12,120 individuals with rheumatoid arthritis and 121,191 comparators. Of these, 2,525 patients with and 18,146 without rheumatoid arthritis developed CVDs during a median of 4.2 years of follow-up. Patients with rheumatoid arthritis had higher rates of myocardial infarction (adjusted incidence ratio [IRR] = 1.43, 95% CI 1.21-1.70), unheralded coronary death (IRR = 1.60, 95% CI 1.18-2.18), heart failure (IRR = 1.61, 95% CI 1.43-1.83), cardiac arrest (HR = 2.26, 95% CI 1.69-3.02) and peripheral arterial disease (HR = 1.36, 95% CI1.14- 1.62); and lower rates of stable angina (HR = 0.83, 95% CI 0.73-0.95). There was no evidence of association with cerebrovascular diseases, abdominal aortic aneurysm or unstable angina, or of interactions with sex or age. Conclusions The observed associations with some but not all types of CVDs inform both clinical practice and the selection of cardiovascular endpoints for trials and for the development of prognostic models for patients with rheumatoid arthritis.	[Pujades-Rodriguez, Mar; Duyx, Bram; Stogiannis, Dimitris; Smeeth, Liam; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, 222 Euston Rd, London NW1 2DA, England; [Pujades-Rodriguez, Mar] Univ Leeds, MRC Med Bioinformat Ctr, Leeds Inst Biomed & Clin Sci, Worsley Bldg, Leeds LS2 9JT, W Yorkshire, England; [Thomas, Sara L.; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England; [Rahman, Anisur] UCL, Fac Med Sci, Ctr Rheumatol Res, Div Med, London WC1E 6JF, England	University of London; University College London; University of Leeds; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Pujades-Rodriguez, M (corresponding author), UCL, Farr Inst Hlth Informat Res, 222 Euston Rd, London NW1 2DA, England.; Pujades-Rodriguez, M (corresponding author), Univ Leeds, MRC Med Bioinformat Ctr, Leeds Inst Biomed & Clin Sci, Worsley Bldg, Leeds LS2 9JT, W Yorkshire, England.	M.D.M.PujadesRodriguez@leeds.ac.uk	Duyx, Bram/W-8668-2019; Pujades-Rodriguez, Mar/T-1129-2018; Hemingway, Harry/C-1219-2009; Smeeth, Liam/X-5862-2018	Duyx, Bram/0000-0002-8879-5391; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Hemingway, Harry/0000-0003-2279-0624; Smeeth, Liam/0000-0002-9168-6022	Welcome Trust [WT 086091/Z/08/Z]; UK National Institute for Health Research [RP-PG-0407-10314]; Farr Institute of Health Informatics Research from the Medical Research Council [MR/K006584/1]; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust; Wellcome Trust [098504/Z/12/Z]; MRC [MR/L01629X/1] Funding Source: UKRI; Medical Research Council [MR/K006584/1, MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Welcome Trust(Wellcome Trust); UK National Institute for Health Research(National Institute for Health Research (NIHR)); Farr Institute of Health Informatics Research from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by grants from the Welcome Trust [WT 086091/Z/08/Z]; the UK National Institute for Health Research (RP-PG-0407-10314); and by awards establishing the Farr Institute of Health Informatics Research from the Medical Research Council (MR/K006584/1), in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientific Office (Scottish Government Health Directorates), and the Wellcome Trust. LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science [098504/Z/12/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the National Institute for Health Research Public Health Research Programme or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avina-Zubieta JA, 2011, ANN RHEUM DIS, V70, P990, DOI 10.1136/ard.2010.140210; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Bergstrom U, 2011, RHEUMATOLOGY, V50, P2005, DOI 10.1093/rheumatology/ker258; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Rodriguez LAG, 2009, SCAND J RHEUMATOL, V38, P173, DOI 10.1080/03009740802448825; Germano G, 2012, EUR HEART J, V33, P137; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gonzalez A, 2008, J RHEUMATOL, V35, P1009; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Holmqvist ME, 2010, J INTERN MED, V268, P578, DOI 10.1111/j.1365-2796.2010.02260.x; Holmqvist M, 2013, ANN RHEUM DIS, V72, P541, DOI 10.1136/annrheumdis-2012-201387; Kerola AM, 2012, ANN RHEUM DIS, V71, P1606, DOI 10.1136/annrheumdis-2012-201334; Kremers HM, 2008, ARTHRITIS RHEUM-US, V58, P2268, DOI 10.1002/art.23650; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Lindhardsen J, 2011, ANN RHEUM DIS, V70, P929, DOI 10.1136/ard.2010.143396; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; National Institute for Health and Clinical Excellence (NICE), 2009, RHEUMATOID ARTHRITIS; Nicola PJ, 2005, ARTHRITIS RHEUM-US, V52, P412, DOI 10.1002/art.20855; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Pujades-Rodriguez M, 2015, INT J EPIDEMIOL, V44, P129, DOI 10.1093/ije/dyu218; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rodriguez-Rodriguez L, 2011, ATHEROSCLEROSIS, V216, P125, DOI 10.1016/j.atherosclerosis.2010.10.052; Roifman I, 2011, CAN J CARDIOL, V27, P174, DOI 10.1016/j.cjca.2010.12.040; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Sparks JA, 2015, ARTHRITIS CARE RES H; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007	43	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151245	10.1371/journal.pone.0151245	http://dx.doi.org/10.1371/journal.pone.0151245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978266	Green Published, gold, Green Accepted			2022-12-26	WOS:000372572800052
J	Horner, PJ; Wills, GS; Righarts, A; Vieira, S; Kounali, D; Samuel, D; Winston, A; Muir, D; Dickson, NP; McClure, MO				Horner, Patrick J.; Wills, Gillian S.; Righarts, Antoinette; Vieira, Sueli; Kounali, Daphne; Samuel, Dhanraj; Winston, Alan; Muir, David; Dickson, Nigel P.; McClure, Myra O.			Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; GENERAL-POPULATION; ANTIGEN; IMMUNOASSAY; SPECIFICITY; SENSITIVITY; PREVALENCE; HEALTH; WOMEN; TIME	Chlamydia trachomatis (Ct) serological studies in populations could help monitor changes in lifetime cumulative risk of infection. We developed a double-antigen sandwich ELISA based on the Ct-specific Pgp3 antigen, then tested blind stored sera from over 800 participants in a New Zealand birth cohort from Dunedin at ages 26, 32 and 38. The double-antigen sandwich ELISA was more sensitive than our previously characterised indirect Pgp3 ELISA. Pgp3 antibody was detected more often in women compared to men and correlated with increasing numbers of sexual partners, self-reported Ct, and younger age at sexual debut in both women and men. At age 26, 24.1% (99/411) of women were Pgp3 seropositive, as were 79.5%(35/44) of those reporting Ct infection; Pgp3 antibody persisted to age 38 in 96.5%(83/86). In men at age 26, the figures were 10.7%(47/442) and 25.0% (6/24), respectively, with high (83.9%) antibody persistence to age 38. At age 38, among those Pgp3 seropositive, 63.3% of women and 83.1% of men had not reported Ct infection. Thus, Ct-specific Pgp3 antibody was detected in most women reporting Ct infection and correlated with risk of infection in those who did not, with most infections remaining undetected. As this antibody persisted for at least twelve years in 96% of these women, serology could be used to evaluate Ct prevention programmes among women.	[Horner, Patrick J.; Wills, Gillian S.; Vieira, Sueli; Winston, Alan; McClure, Myra O.] Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, Jefferiss Trust Labs, London, England; [Horner, Patrick J.; Kounali, Daphne] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Righarts, Antoinette; Dickson, Nigel P.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Kounali, Daphne] Univ Bristol, Natl Inst Hlth Res Hlth Protect Res Unit NIHR HPR, Bristol, Avon, England; [Samuel, Dhanraj] Publ Hlth England, London, England; [Muir, David] Imperial Coll Healthcare Trust, Dept Infect & Immun, London, England	Imperial College London; University of Bristol; University of Otago; University of Bristol; Public Health England	McClure, MO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, Jefferiss Trust Labs, London, England.	m.mcclure@imperial.ac.uk	Righarts, Antoinette/N-1889-2019; Kounali, Daphne/AAE-3630-2020; Winston, Alan/AGZ-3015-2022	Righarts, Antoinette/0000-0003-2822-4842; Kounali, Daphne/0000-0002-6392-6690; Winston, Alan/0000-0002-5847-8416; Horner, Paddy/0000-0003-0411-8332	Health Research Council of New Zealand [09/086]; NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol [HPRU-2012-10026]; Public Health England	Health Research Council of New Zealand(Health Research Council of New Zealand); NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol; Public Health England	This work was supported by The Health Research Council of New Zealand. 09/086, www.hrc.govt.nz/ (NPD); NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol, www.nihr.ac.uk/funding/health-protection-research-units.htm, HPRU-2012-10026 (PH and DK); Health Protection Agency (now Public Health England) funded the testing of stored sera (GW and SV). The funders played no part in the design, conduct, analysis or reporting of this study, nor in the decision to submit the manuscript for publication.	Black CM, 1997, CLIN MICROBIOL REV, V10, P160, DOI 10.1128/CMR.10.1.160; Brabin L, 2005, SEX TRANSM INFECT, V81, P128, DOI 10.1136/sti.2004.010223; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Brunham RC, 2008, SEX TRANSM DIS, V35, P53, DOI 10.1097/OLQ.0b013e31815e41a3; Burgisser P, 1996, J CLIN MICROBIOL, V34, P634, DOI 10.1128/JCM.34.3.634-637.1996; Castro AR, 2002, CLIN DIAGN LAB IMMUN, V9, P1376, DOI 10.1128/CDLI.9.6.1376-1378.2002; CDC, 2010, GUIDELINES TREATMENT; COMANDUCCI M, 1993, J GEN MICROBIOL, V139, P1083, DOI 10.1099/00221287-139-5-1083; Crowther John R., 2009, V516, P1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dickson N, 2014, SEX TRANSM INFECT, V90, P243, DOI 10.1136/sextrans-2013-051235; ECDC, 2009, CHLAM CONTR EUR; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Horner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072001; Horner PJ, 2013, SEX TRANSM INFECT, V89, P398, DOI 10.1136/sextrans-2011-050386; Hu WP, 2008, CLIN VACCINE IMMUNOL, V15, P1151, DOI 10.1128/CVI.00186-07; Johnson AM, 2008, SEX TRANSM INFECT, V84, P79, DOI 10.1136/sti.2007.028472; Li A, 2010, CLIN VACCINE IMMUNOL, V17, P464, DOI 10.1128/CVI.00457-09; Li Z, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-90; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lyytikainen E, 2007, SEX TRANSM INFECT, V84, P19, DOI 10.1136/sti.2007.027409; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; Milliken G.A., 2009, ANAL MESSY DATA, V1; Morre SA, 2002, J CLIN MICROBIOL, V40, P584, DOI 10.1128/JCM.40.2.584-587.2002; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Narvanen A, 1997, Infect Dis Obstet Gynecol, V5, P349; Nwokolo NC, 2015, 2015 UK NATL GUIDELI; Pimenta J, 2000, BRIT MED J, V321, P629, DOI 10.1136/bmj.321.7261.629; Poulton Richie, 2006, N Z Med J, V119, pU2002; Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Price MJ, 2013, STAT MED, V32, P1547, DOI 10.1002/sim.5603; Price MJ, 2012, SEX TRANSM DIS, V39, P608, DOI 10.1097/OLQ.0b013e3182572475; Price MJ, 2014, EPIDEMIOLOGY INFECT, V142, P15; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; van Aar F, 2014, SEX TRANSM INFECT, V90, P434, DOI 10.1136/sextrans-2013-051074; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09; Woodhall SC, 2015, PLOS ONE; Wu FB, 2008, J MED MICROBIOL, V57, P947, DOI 10.1099/jmm.0.47835-0	42	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151497	10.1371/journal.pone.0151497	http://dx.doi.org/10.1371/journal.pone.0151497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974653	gold, Green Published, Green Submitted			2022-12-26	WOS:000372570600084
J	Chruscinski, A; Huang, FYY; Nguyen, A; Lioe, J; Tumiati, LC; Kozuszko, S; Tinckam, KJ; Rao, V; Dunn, SE; Persinger, MA; Levy, GA; Ross, HJ				Chruscinski, Andrzej; Huang, Flora Y. Y.; Nguyen, Albert; Lioe, Jocelyn; Tumiati, Laura C.; Kozuszko, Stella; Tinckam, Kathryn J.; Rao, Vivek; Dunn, Shannon E.; Persinger, Michael A.; Levy, Gary A.; Ross, Heather J.			Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation	PLOS ONE			English	Article							ANTIBODY-MEDIATED REJECTION; DILATED CARDIOMYOPATHY; CARDIAC TRANSPLANTATION; IGM ANTIBODIES; MYOCARDITIS; PRETRANSPLANT; DYSFUNCTION; ALLOGRAFTS; RECIPIENTS; DIAGNOSIS	Autoantibodies directed against endogenous proteins including contractile proteins and endothelial antigens are frequently detected in patients with heart failure and after heart transplantation. There is evidence that these autoantibodies contribute to cardiac dysfunction and correlate with clinical outcomes. Currently, autoantibodies are detected in patient sera using individual ELISA assays (one for each antigen). Thus, screening for many individual autoantibodies is laborious and consumes a large amount of patient sample. To better capture the broad-scale antibody reactivities that occur in heart failure and post-transplant, we developed a custom antigen microarray technique that can simultaneously measure IgM and IgG reactivities against 64 unique antigens using just five microliters of patient serum. We first demonstrated that our antigen microarray technique displayed enhanced sensitivity to detect autoantibodies compared to the traditional ELISA method. We then piloted this technique using two sets of samples that were obtained at our institution. In the first retrospective study, we profiled pre-transplant sera from 24 heart failure patients who subsequently received heart transplants. We identified 8 antibody reactivities that were higher in patients who developed cellular rejection (2 or more episodes of grade 2R rejection in first year after transplant as defined by revised criteria from the International Society for Heart and Lung Transplantation) compared with those who did have not have rejection episodes. In a second retrospective study with 31 patients, we identified 7 IgM reactivities that were higher in heart transplant recipients who developed antibody-mediated rejection (AMR) compared with control recipients, and in time course studies, these reactivities appeared prior to overt graft dysfunction. In conclusion, we demonstrated that the autoantibody microarray technique outperforms traditional ELISAs as it uses less patient sample, has increased sensitivity, and can detect autoantibodies in a multiplex fashion. Furthermore, our results suggest that this autoantibody array technology may help to identify patients at risk of rejection following heart transplantation and identify heart transplant recipients with AMR.	[Chruscinski, Andrzej; Huang, Flora Y. Y.; Lioe, Jocelyn; Kozuszko, Stella; Tinckam, Kathryn J.; Rao, Vivek; Levy, Gary A.; Ross, Heather J.] Univ Hlth Network, Multiorgan Transplant Program, Toronto, ON, Canada; [Chruscinski, Andrzej; Ross, Heather J.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Nguyen, Albert; Dunn, Shannon E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Tumiati, Laura C.; Rao, Vivek] Univ Hlth Network, Div Cardiac Surg, Toronto, ON, Canada; [Dunn, Shannon E.] Toronto Gen Res Inst, Toronto, ON, Canada; [Dunn, Shannon E.] Res Inst, Womens Coll, Toronto, ON, Canada; [Persinger, Michael A.] Laurentian Univ, Behav Neurosci Program, Sudbury, ON P3E 2C6, Canada; [Persinger, Michael A.] Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada; [Persinger, Michael A.] Laurentian Univ, Human Studies Programs, Sudbury, ON P3E 2C6, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Women's College Research Institute; Laurentian University; Laurentian University; Laurentian University	Chruscinski, A (corresponding author), Univ Hlth Network, Multiorgan Transplant Program, Toronto, ON, Canada.; Chruscinski, A (corresponding author), Univ Hlth Network, Div Cardiol, Toronto, ON, Canada.	andrzej.chruscinski@uhn.ca		Nguyen, Albert An/0000-0001-8724-7476; Tinckam, Kathryn/0000-0002-6638-2887	Heart and Stroke Foundation of Canada; Training Program in Regenerative Medicine (Canadian Institutes of Health Research); Training Program in Regenerative Medicine; Astellas Pharma Canada Inc.	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Training Program in Regenerative Medicine (Canadian Institutes of Health Research); Training Program in Regenerative Medicine; Astellas Pharma Canada Inc.	AC was supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada and the Training Program in Regenerative Medicine (Canadian Institutes of Health Research). FH was supported by the Training Program in Regenerative Medicine. This work was funded by a grant from Astellas Pharma Canada Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboni I, 2008, PROTEOMICS, V8, P3443, DOI 10.1002/pmic.200800146; Caforio ALP, 2002, EUR J HEART FAIL, V4, P411, DOI 10.1016/S1388-9842(02)00010-7; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Chih S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/210210; Colvin MM, 2015, CIRCULATION, V131, P1608, DOI 10.1161/CIR.0000000000000093; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Doesch AO, 2010, J CLIN APHERESIS, V25, P315, DOI 10.1002/jca.20263; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ghayour-Mobarhan M, 2008, INT J EXP PATHOL, V89, P209, DOI 10.1111/j.1365-2613.2008.00586.x; Giannessi D, 2007, CELL STRESS CHAPERON, V12, P265, DOI 10.1379/CSC-272.1; Gronwall C, 2014, J CLIN IMMUNOL, V34, pS12, DOI 10.1007/s10875-014-0025-4; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Hagedorn PH, 2010, IMMUNOLOGY, V130, P427, DOI 10.1111/j.1365-2567.2010.03246.x; HAMMOND EH, 1989, J HEART TRANSPLANT, V8, P430; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; Kaya Z, 2012, CIRC RES, V110, P145, DOI 10.1161/CIRCRESAHA.111.243360; Kaya Z, 2010, CLIN IMMUNOL, V134, P80, DOI 10.1016/j.clim.2009.04.008; Kobashigawa J, 2011, J HEART LUNG TRANSPL, V30, P252, DOI 10.1016/j.healun.2010.11.003; KUBO SH, 1995, J HEART LUNG TRANSPL, V14, P409; Li L, 2009, P NATL ACAD SCI USA, V106, P4148, DOI 10.1073/pnas.0900563106; LIAO L, 1995, J EXP MED, V181, P1123, DOI 10.1084/jem.181.3.1123; Mahesh B, 2007, AM J PATHOL, V170, P1415, DOI 10.2353/ajpath.2007.060728; Morgun A, 2004, J HEART LUNG TRANSPL, V23, P204, DOI 10.1016/S1053-2498(03)00114-1; Nath DS, 2010, J HEART LUNG TRANSPL, V29, P1277, DOI 10.1016/j.healun.2010.05.025; NEU N, 1987, J IMMUNOL, V139, P3630; Nwakanma LU, 2007, ANN THORAC SURG, V84, P1556, DOI 10.1016/j.athoracsur.2007.05.095; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Patel PA, 2013, EUR J HEART FAIL, V15, P724, DOI 10.1093/eurjhf/hft065; Porcheray F, 2010, TRANSPLANTATION, V89, P1239, DOI 10.1097/TP.0b013e3181d72091; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Raichlin E, 2009, J HEART LUNG TRANSPL, V28, P320, DOI 10.1016/j.healun.2009.01.006; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veillette GR, 2011, TRANSPLANTATION, V91, P1187, DOI 10.1097/TP.0b013e318218415d; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Zhu JH, 2001, CIRCULATION, V103, P1071, DOI 10.1161/01.CIR.103.8.1071	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151224	10.1371/journal.pone.0151224	http://dx.doi.org/10.1371/journal.pone.0151224			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967734	gold, Green Published, Green Submitted			2022-12-26	WOS:000371989200035
J	Dorsch, M; Behmenburg, F; Raible, M; Blase, D; Grievink, H; Hollmann, MW; Heinen, A; Huhn, R				Dorsch, Marianne; Behmenburg, Friederike; Raible, Miriam; Blase, Dominic; Grievink, Hilbert; Hollmann, Markus W.; Heinen, Andre; Huhn, Ragnar			Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore	PLOS ONE			English	Article							K-ATP-CHANNELS; ISCHEMIA-REPERFUSION INJURY; GENERATING FREE-RADICALS; INFARCT SIZE; RAT-HEART; IN-VIVO; CARDIOPROTECTION; ACTIVATION; TRIGGERS; PATHWAY	Background Morphine induces myocardial preconditioning (M-PC) via activation of mitochondrial large conductance Ca2+-sensitive potassium (mK(Ca)) channels. An upstream regulator of mK(Ca) channels is protein kinase A (PKA). Furthermore, mK(Ca) channel activation regulates mitochondrial bioenergetics and thereby prevents opening of the mitochondrial permeability transition pore (mPTP). Here, we investigated in the rat heart in vivo whether 1) M-PC is mediated by activation of PKA, and 2) pharmacological opening of the mPTP abolishes the cardioprotective effect of M-PC and 3) M-PC is critically dependent on STAT3 activation, which is located upstream of mPTP within the signalling pathway. Methods Male Wistar rats were randomised to six groups (each n = 6). All animals underwent 25 minutes of regional myocardial ischemia and 120 minutes of reperfusion. Control animals (Con) were not further treated. Morphine preconditioning was initiated by intravenous administration of 0.3 mg/kg morphine (M-PC). The PKA blocker H-89 (10 mu g/kg) was investigated with and without morphine (H-89+M-PC, H-89). We determined the effect of mPTP opening with atractyloside (5 mg/kg) with and without morphine (Atr+M-PC, Atr). Furthermore, the effect of morphine on PKA activity was tested in isolated adult rat cardiomyocytes. In further experiments in isolated hearts we tested the protective properties of morphine in the presence of STAT3 inhibition, and whether pharmacological prevention of the mPTP-opening by cyclosporine A (CsA) is cardioprotective in the presence of STAT3 inhibition. Results Morphine reduced infarct size from 64 +/- 5% to 39 +/- 9% (P<0.05 vs. Con). H-89 completely blocked preconditioning by morphine (64 +/- 9%; P<0.05 vs. M-PC), but H-89 itself had not effect on infarct size (61 +/- 10%; P>0.05 vs. Con). Also, atractyloside abolished infarct size reduction of morphine completely (65 +/- 9%; P<0.05 vs. M-PC) but had no influence on infarct size itself (64 +/- 5%; P>0.05 vs. Con). In isolated hearts STAT3 inhibitor Stattic completely abolished morphine-induced preconditioning. Administration of Stattic and mPTP inhibitor cyclosporine A reduced infarct size to 31 +/- 6% (Stat+CsA, P<0.05 vs. Con). Cyclosporine A alone reduced infarct size to 26 +/- 7% (CsA P<0.05 vs. Con). In cardiomyocytes, PKA activity was increased by morphine. Conclusion Our data suggest that morphine-induced cardioprotection is mediated by STAT3-activation and inhibition of mPTP, with STA3 located upstream of mPTP. There is some evidence that protein kinase A is involved within the signalling pathway.	[Dorsch, Marianne; Behmenburg, Friederike; Raible, Miriam; Blase, Dominic; Grievink, Hilbert; Heinen, Andre; Huhn, Ragnar] Univ Hosp Duesseldorf, Dept Anesthesiol, Moorenstr 5, D-40225 Dusseldorf, Germany; [Hollmann, Markus W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Dept Anesthesiol, Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands; [Heinen, Andre] Univ Dusseldorf, Inst Cardiovasc Physiol, Univ Str 1, D-40225 Dusseldorf, Germany; [Grievink, Hilbert] Hadassah Univ Hosp, Dept Anesthesiol & Crit Care Med, IL-91120 Jerusalem, Israel; [Grievink, Hilbert] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Ein Kerem Campus, Jerusalem, Israel	University of Amsterdam; Academic Medical Center Amsterdam; Heinrich Heine University Dusseldorf; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Behmenburg, F (corresponding author), Univ Hosp Duesseldorf, Dept Anesthesiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	Friederike.Behmenburg@med.uni-duesseldorf.de	Huhn, Ragnar/X-6466-2018	Huhn, Ragnar/0000-0002-3114-7190	Heinrich-Heine-University Duesseldorf, Germany [SFF 701301765]	Heinrich-Heine-University Duesseldorf, Germany	This work was supported by a research fund (SFF 701301765) from the Heinrich-Heine-University Duesseldorf, Germany.	Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Cao CM, 2005, J PHARMACOL EXP THER, V312, P644, DOI 10.1124/jpet.104.074476; Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023; Cohen MV, 2001, CIRC RES, V89, P273, DOI 10.1161/hh1501.094266; Frassdorf J, 2010, CAN J ANESTH, V57, P767, DOI 10.1007/s12630-010-9325-1; Gross ER, 2006, AM J PHYSIOL-HEART C, V291, pH827, DOI 10.1152/ajpheart.00003.2006; Gross ER, 2006, CARDIOVASC RES, V70, P212, DOI 10.1016/j.cardiores.2005.12.019; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Heinen A, 2008, ANESTHESIOLOGY, V109, P830, DOI 10.1097/ALN.0b013e3181895aa0; Heinen A, 2014, EXP GERONTOL, V56, P99, DOI 10.1016/j.exger.2014.03.029; Huhn R, 2010, BRIT J ANAESTH, V105, P589, DOI 10.1093/bja/aeq213; Huhn R, 2012, EXP GERONTOL, V47, P116, DOI 10.1016/j.exger.2011.11.003; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Makaula S, 2005, J CARDIOVASC PHARM, V45, P341, DOI 10.1097/01.fjc.0000156825.80951.14; Mullenheim J, 2002, ANESTHESIOLOGY, V96, P934; MURAKI T, 1984, J PHARM PHARMACOL, V36, P490, DOI 10.1111/j.2042-7158.1984.tb04436.x; Murphy E, 2007, ANNU REV PHYSIOL, V69, P51, DOI 10.1146/annurev.physiol.69.031905.163645; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Obal D, 2005, ANESTH ANALG, V101, P1252, DOI 10.1213/01.ANE.0000181336.96511.32; Pain T, 2000, CIRC RES, V87, P460; Park SY, 2013, TOXICOL APPL PHARM, V268, P68, DOI 10.1016/j.taap.2013.01.017; Puana R, 2008, ANESTH ANALG, V106, P480, DOI 10.1213/ane.0b013e318160648b; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Sanada S, 2004, CIRCULATION, V110, P51, DOI 10.1161/01.CIR.0000133390.12306.C7; Sato T, 2005, CIRCULATION, V111, P198, DOI 10.1161/01.CIR.0000151099.15706.B1; Skyschally A, 2015, CIRC RES, V117, P279, DOI 10.1161/CIRCRESAHA.117.306878; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; Toma O, 2004, ANESTHESIOLOGY, V101, P1372; Zhang SZ, 2006, ANESTHESIOLOGY, V105, P550, DOI 10.1097/00000542-200609000-00019; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	32	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151025	10.1371/journal.pone.0151025	http://dx.doi.org/10.1371/journal.pone.0151025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968004	gold, Green Submitted, Green Published			2022-12-26	WOS:000371989200028
J	Sato, S; Jung, HM; Nakagawa, T; Pawlosky, R; Takeshima, T; Lee, WR; Sakiyama, H; Laxman, S; Wynn, RM; Tu, BP; MacMillan, JB; De Brabander, JK; Veech, RL; Uyeda, K				Sato, Shogo; Jung, Hunmin; Nakagawa, Tsutomu; Pawlosky, Robert; Takeshima, Tomomi; Lee, Wan-Ru; Sakiyama, Haruhiko; Laxman, Sunil; Wynn, R. Max; Tu, Benjamin P.; MacMillan, John B.; De Brabander, Jef K.; Veech, Richard L.; Uyeda, Kosaku			Metabolite Regulation of Nuclear Localization of Carbohydrate-response Element-binding Protein (ChREBP) ROLE OF AMP AS AN ALLOSTERIC INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYBUTYRATE; TRANSCRIPTION FACTOR; FATTY-ACID; FREE MG2+; GLUCOSE; PHOSPHORYLATION; LIPOGENESIS; DEFICIENCY; MECHANISM; MODEL	The carbohydrate-response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays an essential role in converting excess carbohydrate to fat storage in the liver. In response to glucose levels, ChREBP is regulated by nuclear/cytosol trafficking via interaction with 14-3-3 proteins, CRM-1 (exportin-1 or XPO-1), or importins. Nuclear localization of ChREBP was rapidly inhibited when incubated in branched-chain alpha-ketoacids, saturated and unsaturated fatty acids, or 5-aminoimidazole-4-carboxamide ribonucleotide. Here, we discovered that protein-free extracts of high fat-fed livers contained, in addition to ketone bodies, a new metabolite, identified as AMP, which specifically activates the interaction between ChREBP and 14-3-3. The crystal structure showed that AMP binds directly to the N terminus of ChREBP-alpha 2 helix. Our results suggest that AMP inhibits the nuclear localization of ChREBP through an allosteric activation of ChREBP/14-3-3 interactions and not by activation of AMPK. AMP and ketone bodies together can therefore inhibit lipogenesis by restricting localization of ChREBP to the cytoplasm during periods of ketosis.	[Sakiyama, Haruhiko; Laxman, Sunil; Wynn, R. Max; Tu, Benjamin P.; MacMillan, John B.; De Brabander, Jef K.; Uyeda, Kosaku] Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Pawlosky, Robert; Veech, Richard L.] NIAAA, Bethesda, MD 20892 USA; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Uyeda, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Uyeda, K (corresponding author), Vet Affairs Med Ctr, 4500 S Lancaster Rd, Dallas, TX USA.	kuyeda@utsouthwestern.edu	Jung, Hunmin/ABD-2108-2020; Laxman, Sunil/F-9886-2018	Laxman, Sunil/0000-0002-0861-5080; Wynn, Richard/0000-0002-1879-2136; Sato, Shogo/0000-0002-2874-7072; Jung, Hunmin/0000-0002-8171-0412; MacMillan, John/0000-0003-1430-1077	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000110] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16K01820] Funding Source: KAKEN	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Hong Zhang, the Biochemistry and Biophysics Department, University of Texas Southwestern Medical Center for use of the crystallization chamber, and Dr. Jay Horton, Internal Medicine, University of Texas Southwestern Medical Center, for acetylCoA carboxylase. We also thank Dr Martin Kemper, the National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, for assistance in calculation of phosphorylation potentials. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ge Q, 2012, J BIOL CHEM, V287, P41914, DOI 10.1074/jbc.M112.418855; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Gohda T, 2001, CLIN NEPHROL, V56, P475; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; GUYNN RW, 1973, J BIOL CHEM, V248, P6966; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nakagawa T, 2013, J BIOL CHEM, V288, P28358, DOI 10.1074/jbc.M113.498550; NEWTON RP, 1984, BIOCHEM J, V221, P665, DOI 10.1042/bj2210665; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Srivastava S, 2012, J NEUROCHEM, V123, P668, DOI 10.1111/jnc.12026; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VELOSO D, 1973, J BIOL CHEM, V248, P4811; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804	32	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10515	10527		10.1074/jbc.M115.708982	http://dx.doi.org/10.1074/jbc.M115.708982			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26984404	hybrid, Green Published			2022-12-26	WOS:000377042600007
J	Aprile-Garcia, F; Metzger, MW; Paez-Pereda, M; Stadler, H; Acuna, M; Liberman, AC; Senin, SA; Gerez, J; Hoijman, E; Refojo, D; Mitkovski, M; Panhuysen, M; Stuhmer, W; Holsboer, F; Deussing, JM; Arzt, E				Aprile-Garcia, Fernando; Metzger, Michael W.; Paez-Pereda, Marcelo; Stadler, Herbert; Acuna, Matias; Liberman, Ana C.; Senin, Sergio A.; Gerez, Juan; Hoijman, Esteban; Refojo, Damian; Mitkovski, Miso; Panhuysen, Markus; Stuehmer, Walter; Holsboer, Florian; Deussing, Jan M.; Arzt, Eduardo			Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MAJOR DEPRESSIVE DISORDER; RESONANCE ENERGY-TRANSFER; HUMAN P2X(7) RECEPTOR; PURINERGIC RECEPTOR; P2RX7 GENE; MICROGLIAL CELLS; IMMUNE-SYSTEM; OF-FUNCTION; TNF-ALPHA	The P2X7 receptor is a member of the P2X family of ligand-gated ion channels. A single-nucleotide polymorphism leading to a glutamine (Gln) by arginine (Arg) substitution at codon 460 of the purinergic P2X7 receptor (P2X7R) has been associated with mood disorders. No change in function (loss or gain) has been described for this SNP so far. Here we show that although the P2X7R-Gln460Arg variant per se is not compromised in its function, co-expression of wild-type P2X7R with P2X7R-Gln460Arg impairs receptor function with respect to calcium influx, channel currents and intracellular signaling in vitro. Moreover, co-immunoprecipitation and FRET studies show that the P2X7R-Gln460Arg variant physically interacts with P2X7R-WT. Specific silencing of either the normal or polymorphic variant rescues the heterozygous loss of function phenotype and restores normal function. The described loss of function due to co-expression, unique for mutations in the P2RX7 gene so far, explains the mechanism by which the P2X7R-Gln460Arg variant affects the normal function of the channel and may represent a mechanism of action for other mutations.	[Aprile-Garcia, Fernando; Acuna, Matias; Liberman, Ana C.; Senin, Sergio A.; Gerez, Juan; Arzt, Eduardo] Max Planck Gesell, CONICET, Inst Invest Biomed Buenos Aires IBioBA, Partner Inst, Buenos Aires, DF, Argentina; [Aprile-Garcia, Fernando; Arzt, Eduardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina; [Metzger, Michael W.; Paez-Pereda, Marcelo; Refojo, Damian; Holsboer, Florian; Deussing, Jan M.; Arzt, Eduardo] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Stadler, Herbert; Panhuysen, Markus] Affectis Pharmaceut, D-44227 Dortmund, Germany; [Hoijman, Esteban] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Ctr Microscopias Avanzadas, Buenos Aires, DF, Argentina; [Mitkovski, Miso; Stuehmer, Walter] Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany; [Holsboer, Florian] HMNC Brain Hlth, Munich, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; University of Buenos Aires; Max Planck Society; University of Buenos Aires; Max Planck Society	Arzt, E (corresponding author), Max Planck Gesell, CONICET, Inst Invest Biomed Buenos Aires IBioBA, Partner Inst, Buenos Aires, DF, Argentina.; Arzt, E (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina.; Arzt, E (corresponding author), Max Planck Inst Psychiat, D-80804 Munich, Germany.	earzt@ibioba-mpsp-conicet.gov.ar	Stuehmer, Walter/A-2176-2009; Hoijman, Esteban/AAI-8735-2020; Deussing, Jan M/ABB-5993-2021	Stuehmer, Walter/0000-0002-0642-7764; Hoijman, Esteban/0000-0003-1927-1989; Deussing, Jan/0000-0002-9329-5252; Aprile-Garcia, Fernando/0000-0002-5133-0857; Mitkovski, Miso/0000-0001-9195-2434; Refojo, Damian/0000-0002-9798-6413	Affectis Pharmaceuticals AG; University of Buenos Aires (UBA); CONICET; FOCEMMercosur [COF 03/11]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; German Federal Ministry of Education and Research [FKZ 01ZX1314H]; program for medical genome research within the framework of the NGFN-Plus [FKZ:01GS08151]; Volkswagen Stiftung	Affectis Pharmaceuticals AG; University of Buenos Aires (UBA)(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FOCEMMercosur; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); program for medical genome research within the framework of the NGFN-Plus; Volkswagen Stiftung(Volkswagen)	This work was partially supported by grants from Affectis Pharmaceuticals AG (http://www.affectis.com/), the University of Buenos Aires (UBA) (http://www.uba.ar/), the CONICET (http://www.conicet.gov.ar/), FOCEMMercosur (COF 03/11) (http://www.mercosur.int/innovaportal/v/385/2/innova.front/fondo_para_la_convergencia_estructural_del_mercosur_focem) and Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (http://www.agencia.mincyt.gob.ar/) (E.A); by the German Federal Ministry of Education and Research (https://www.bmbf.de/en), within the framework of the e:Med research and funding concept (IntegraMent: Integrated Understanding of Causes and Mechanisms in Mental Disorders; FKZ 01ZX1314H), by the program for medical genome research within the framework of the NGFN-Plus (FKZ:01GS08151) (http://www.ngfn.de/en) (J.D.) and by the Volkswagen Stiftung (D.R.) (https://www.volkswagenstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio LS, 2011, BRIT J PHARMACOL, V163, P1069, DOI 10.1111/j.1476-5381.2011.01303.x; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Bartlett R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271813; Bulanova E, 2005, J IMMUNOL, V174, P3880, DOI 10.4049/jimmunol.174.7.3880; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Gendron FP, 2003, J NEUROCHEM, V87, P344, DOI 10.1046/j.1471-4159.2003.01995.x; Gendron FP, 2003, AM J PHYSIOL-CELL PH, V284, pC571, DOI 10.1152/ajpcell.00286.2002; Green EK, 2009, AM J MED GENET B, V150B, P1063, DOI 10.1002/ajmg.b.30931; Grigoroiu-Serbanescu M, 2009, AM J MED GENET B, V150B, P1017, DOI 10.1002/ajmg.b.30952; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Halmai Z, 2013, J AFFECT DISORDERS, V150, P104, DOI 10.1016/j.jad.2013.02.033; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Jiang LH, 2003, J NEUROSCI, V23, P8903; Jones KA, 2013, MOL CELL NEUROSCI, V53, P52, DOI 10.1016/j.mcn.2012.10.002; Kataoka A, 2009, J NEUROCHEM, V108, P115, DOI 10.1111/j.1471-4159.2008.05744.x; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; Lodge NJ, 2008, CURR OPIN DRUG DISC, V11, P633; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Marquez-Klaka B, 2009, EUR BIOPHYS J BIOPHY, V38, P329, DOI 10.1007/s00249-008-0325-9; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Mingam R, 2008, BRAIN BEHAV IMMUN, V22, P234, DOI 10.1016/j.bbi.2007.08.007; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Murakami K, 2003, NEUROSCIENCE, V117, P37, DOI 10.1016/S0306-4522(02)00804-7; Nagy G, 2008, PROG NEURO-PSYCHOPH, V32, P1884, DOI 10.1016/j.pnpbp.2008.08.021; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; Ohlendorff SD, 2007, PHARMACOGENET GENOM, V17, P555, DOI 10.1097/FPC.0b013e3280951625; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Perez-Flores G, 2015, BIOCHEM BIOPH RES CO, V467, P484, DOI 10.1016/j.bbrc.2015.10.025; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shieh CH, 2014, GLIA, V62, P592, DOI 10.1002/glia.22628; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sluyter Ronald, 2011, Recent Pat DNA Gene Seq, V5, P41; Soronen P, 2011, AM J MED GENET B, V156B, P435, DOI 10.1002/ajmg.b.31179; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Sperlagh B, 2014, TRENDS PHARMACOL SCI, V35, P537, DOI 10.1016/j.tips.2014.08.002; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Viikki M, 2011, NEUROSCI LETT, V493, P127, DOI 10.1016/j.neulet.2011.02.023; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Young MT, 2008, J BIOL CHEM, V283, P26241, DOI 10.1074/jbc.M804458200	61	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151862	10.1371/journal.pone.0151862	http://dx.doi.org/10.1371/journal.pone.0151862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986975	Green Submitted, Green Published, gold			2022-12-26	WOS:000372580300143
J	Chowanadisai, W; Messerli, SM; Miller, DH; Medina, JE; Hamilton, JW; Messerli, MA; Brodsky, AS				Chowanadisai, Winyoo; Messerli, Shanta M.; Miller, Daniel H.; Medina, Jamie E.; Hamilton, Joshua W.; Messerli, Mark A.; Brodsky, Alexander S.			Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors	PLOS ONE			English	Article							CANCER CELL-LINES; MESENCHYMAL TRANSITION; GENE-EXPRESSION; DNA METHYLATION; YAP; CARBOPLATIN; EMT	The majority of ovarian tumors eventually recur in a drug resistant form. Using cisplatin sensitive and resistant cell lines assembled into 3D spheroids we profiled gene expression and identified candidate mechanisms and biological pathways associated with cisplatin resistance. OVCAR-8 human ovarian carcinoma cells were exposed to sub-lethal concentrations of cisplatin to create a matched cisplatin-resistant cell line, OVCAR-8R. Genome-wide gene expression profiling of sensitive and resistant ovarian cancer spheroids identified 3,331 significantly differentially expressed probesets coding for 3,139 distinct protein-coding genes (Fc > 2, FDR < 0.05) (S2 Table). Despite significant expression changes in some transporters including MDR1, cisplatin resistance was not associated with differences in intracellular cisplatin concentration. Cisplatin resistant cells were significantly enriched for a mesenchymal gene expression signature. OVCAR-8R resistance derived gene sets were significantly more biased to patients with shorter survival. From the most differentially expressed genes, we derived a 17-gene expression signature that identifies ovarian cancer patients with shorter overall survival in three independent datasets. We propose that the use of cisplatin resistant cell lines in 3D spheroid models is a viable approach to gain insight into resistance mechanisms relevant to ovarian tumors in patients. Our data support the emerging concept that ovarian cancers can acquire drug resistance through an epithelial-to-mesenchymal transition.	[Chowanadisai, Winyoo] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA; [Chowanadisai, Winyoo; Messerli, Shanta M.; Medina, Jamie E.; Hamilton, Joshua W.; Messerli, Mark A.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Miller, Daniel H.; Brodsky, Alexander S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Miller, Daniel H.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Medina, Jamie E.] Bridgewater State Univ, Dept Biol Sci, Bridgewater, MA 02325 USA; [Hamilton, Joshua W.] Univ Minnesota, Swenson Coll Sci & Engn, Duluth, MN 55804 USA; [Messerli, Mark A.] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Brodsky, Alexander S.] Brown Univ, Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02903 USA; [Brodsky, Alexander S.] Brown Univ, Alpert Med Sch, Providence, RI 02903 USA; [Brodsky, Alexander S.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Marine Biological Laboratory - Woods Hole; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts System of Public Higher Education; Bridgewater State College; University of Minnesota System; University of Minnesota Duluth; South Dakota State University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Messerli, MA (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.; Brodsky, AS (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Messerli, MA (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.; Brodsky, AS (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02903 USA.; Brodsky, AS (corresponding author), Brown Univ, Alpert Med Sch, Providence, RI 02903 USA.; Brodsky, AS (corresponding author), Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA.	mark.messerli@sdstate.edu; alex_brodsky@brown.edu		/0000-0002-4866-1145	National Institutes of Health (NIH) NCRR [P41 RR001395-27S1]; National Science Foundation (NSF) [DBI-1005378]; Office of Research at Oklahoma State University; Mary Kay Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Research at Oklahoma State University; Mary Kay Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by the National Institutes of Health (NIH) NCRR supplement grant P41 RR001395-27S1 (JWH), National Science Foundation (NSF) DBI-1005378 "REU Site: Biological Discovery in Woods Hole", faculty startup funds from the Office of Research at Oklahoma State University (WC), and the Mary Kay Foundation (ASB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Joel Commisso at the Interdisciplinary Center for Plasma Mass Spectrometry at the University of California, Davis, for his technical expertise. We thank Milton C. Gum for his advice regarding dataset analyses. This work was funded by the NIH NCRR supplement grant P41 RR001395-27S1 (J.W.H.), NSF DBI-1005378 "REU Site: Biological Discovery in Woods Hole", faculty startup funds from the Office of Research at Oklahoma State University (W.C.), and the Mary Kay Foundation (A.S.B.).	Baldwin LA, 2012, OBSTET GYNECOL, V120, P612, DOI 10.1097/AOG.0b013e318264f794; Beck A, 2013, DRYAD DIGITAL REPOSI; Beck AH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002875; Bentink S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030269; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Debernardis D, 1997, CANCER RES, V57, P870; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gupta N, 2013, GYNECOL ONCOL, V130, P200, DOI 10.1016/j.ygyno.2013.03.019; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamazawa S, 2000, ONCOLOGY-BASEL, V59, P329, DOI 10.1159/000012191; Kang J, 2012, JNCI-J NATL CANCER I, V104, P670, DOI 10.1093/jnci/djs177; Ke WF, 2011, MED ONCOL, V28, pS135, DOI 10.1007/s12032-010-9747-1; Lee KW, 2015, CLIN CANCER RES, V21, P357, DOI 10.1158/1078-0432.CCR-14-1374; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Ma L, 2010, ACTA BIOCH BIOPH SIN, V42, P593, DOI 10.1093/abbs/gmq067; Marchini S, 2013, EUR J CANCER, V49, P520, DOI 10.1016/j.ejca.2012.06.026; Mitra AK, 2015, GYNECOL ONCOL, V138, P372, DOI 10.1016/j.ygyno.2015.05.040; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Nevedomskaya E, 2016, J PROTEOME RES, V15, P280, DOI 10.1021/acs.jproteome.5b00793; Overbeck TR, 2013, ONCOLOGY-BASEL, V84, P362, DOI 10.1159/000348884; Rago AP, 2009, TISSUE ENG PT A, V15, P387, DOI 10.1089/ten.tea.2008.0107; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; SCHILDER RJ, 1990, INT J CANCER, V45, P416, DOI 10.1002/ijc.2910450306; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Song IS, 2004, MOL CANCER THER, V3, P1543; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Ween MP, 2015, CRIT REV ONCOL HEMAT, V96, P220, DOI 10.1016/j.critrevonc.2015.05.012; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205	48	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151089	10.1371/journal.pone.0151089	http://dx.doi.org/10.1371/journal.pone.0151089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986722	Green Published, gold			2022-12-26	WOS:000372580300045
J	He, J; Liu, W; Huang, YX				He, Jiang; Liu, Wei; Huang, Yao-Xiong			Simultaneous Determination of Glass Transition Temperatures of Several Polymers	PLOS ONE			English	Article							THERMAL LAG; MICROSPHERES; COEFFICIENTS; DEPENDENCE; DSC	Aims A simple and easy optical method is proposed for the determination of glass transition temperature (T-g) of polymers. Methods & Results T-g was determined using the technique of microsphere imaging to monitor the variation of the refractive index of polymer microsphere as a function of temperature. It was demonstrated that the method can eliminate most thermal lag and has sensitivity about six fold higher than the conventional method in T-g determination. So the determined T-g is more accurate and varies less with cooling/heating rate than that obtained by conventional methods. The most attractive character of the method is that it can simultaneously determine the T-g of several polymers in a single experiment, so it can greatly save experimental time and heating energy. Conclusion The method is not only applicable for polymer microspheres, but also for the materials with arbitrary shapes. Therefore, it is expected to be broadly applied to different fundamental researches and practical applications of polymers.	[Huang, Yao-Xiong] Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China; Ji Nan Univ, Key Lab Biomat, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Huang, YX (corresponding author), Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	tyxhuang@jnu.edu.cn			Chinese National Natural Science Foundation [30940019, 60377043]; Guang Dong Provincial and Guang Zhou City Science and Technology Foundations	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guang Dong Provincial and Guang Zhou City Science and Technology Foundations	This work was supported by the Chinese National Natural Science Foundation (Nos. 30940019 and 60377043) and Guang Dong Provincial and Guang Zhou City Science and Technology Foundations.	BEAUCAGE G, 1993, J POLYM SCI POL PHYS, V31, P319, DOI 10.1002/polb.1993.090310310; Ciosek P, 2007, ANALYST, V132, P963, DOI 10.1039/b705107g; Dobkowski Z, 2006, POLYM DEGRAD STABIL, V91, P488, DOI 10.1016/j.polymdegradstab.2005.01.051; Dupaix RB, 2005, POLYMER, V46, P4827, DOI 10.1016/j.polymer.2005.03.083; Efremov MY, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2901601; Efremov MY, 2004, MACROMOLECULES, V37, P4607, DOI 10.1021/ma035909r; Fiaz M, 1996, POLYMER, V37, P755, DOI 10.1016/0032-3861(96)87250-8; GUSEV AS, 1970, POLARIZABILITY GREAT; Haynes W. M., 2012, CRC HDB CHEM PHYS; HUTCHINSON JM, 1992, PHILOS MAG B, V66, P449, DOI 10.1080/13642819208220114; Hutchinson JM, 2009, J THERM ANAL CALORIM, V98, P579, DOI 10.1007/s10973-009-0268-0; Kang ES, 2003, J SOL-GEL SCI TECHN, V26, P981, DOI 10.1023/A:1020761430016; Kawaguchi S, 2005, ADV POLYM SCI, V175, P299, DOI 10.1007/b100118; Lacik I, 2000, POLYM TEST, V19, P755, DOI 10.1016/S0142-9418(99)00046-X; Moynihan CT, 1996, THERMOCHIM ACTA, V280, P153, DOI 10.1016/0040-6031(95)02781-5; MOYNIHAN CT, 1974, J PHYS CHEM-US, V78, P2673, DOI 10.1021/j100619a008; ODonnell PB, 1997, ADV DRUG DELIVER REV, V28, P25, DOI 10.1016/S0169-409X(97)00049-5; Okubo N, 1995, TA, V68, P1; Patsidis A, 2008, EXPRESS POLYM LETT, V2, P718, DOI 10.3144/expresspolymlett.2008.85; Priyadarshi A, 2005, J APPL POLYM SCI, V98, P950, DOI 10.1002/app.22003; Rieger J, 1996, J THERM ANAL, V46, P965, DOI 10.1007/BF01983614; Sun W, 2014, INT J ADHES ADHES, V52, P31, DOI 10.1016/j.ijadhadh.2014.03.009; Thomas LC, 2001, AM LAB, V33, P26; WALLACE WE, 1995, PHYS REV E, V52, pR3329, DOI 10.1103/PhysRevE.52.R3329; Yue LY, 2011, BIOSENS BIOELECTRON, V30, P216, DOI 10.1016/j.bios.2011.09.015	25	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151454	10.1371/journal.pone.0151454	http://dx.doi.org/10.1371/journal.pone.0151454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985670	Green Published, gold			2022-12-26	WOS:000372580300074
J	Khalid, O; Vera, MU; Gordts, PL; Ellinwood, NM; Schwartz, PH; Dickson, PI; Esko, JD; Wang, RY				Khalid, Omar; Vera, Moin U.; Gordts, Philip L.; Ellinwood, N. Matthew; Schwartz, Philip H.; Dickson, Patricia I.; Esko, Jeffrey D.; Wang, Raymond Y.			Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; EMBRYONIC STEM-CELLS; BONE-MARROW-TRANSPLANTATION; CORONARY-HEART-DISEASE; TOLL-LIKE RECEPTOR-4; HURLER-SYNDROME; APOLIPOPROTEIN-J; HEPARAN-SULFATE; MOUSE MODEL; MICROGLIAL ACTIVATION	Background Cardiovascular disease, a progressive manifestation of alpha-L-iduronidase deficiency or mucopolysaccharidosis type I, continues in patients both untreated and treated with hematopoietic stem cell transplantation or intravenous enzyme replacement. Few studies have examined the effects of alpha-L-iduronidase deficiency and subsequent glycosaminoglycan storage upon arterial gene expression to understand the pathogenesis of cardiovascular disease. Methods Gene expression in carotid artery, ascending, and descending aortas from four non-tolerized, non-enzyme treated 19 month-old mucopolysaccharidosis type I dogs was compared with expression in corresponding vascular segments from three normal, age-matched dogs. Data were analyzed using R and whole genome network correlation analysis, a bias-free method of categorizing expression level and significance into discrete modules. Genes were further categorized based on module-trait relationships. Expression of clusterin, a protein implicated in other etiologies of cardiovascular disease, was assessed in canine and murine mucopolysaccharidosis type I aortas via Western blot and in situ immunohistochemistry. Results Gene families with more than two-fold, significant increased expression involved lysosomal function, proteasome function, and immune regulation. Significantly downregulated genes were related to cellular adhesion, cytoskeletal elements, and calcium regulation. Clusterin gene overexpression (9-fold) and protein overexpression (1.3 to 1.62-fold) was confirmed and located specifically in arterial plaques of mucopolysaccharidosis-affected dogs and mice. Conclusions Overexpression of lysosomal and proteasomal-related genes are expected responses to cellular stress induced by lysosomal storage in mucopolysaccharidosis type I. Upregulation of immunity-related genes implicates the potential involvement of glycosaminoglycan-induced inflammation in the pathogenesis of mucopolysaccharidosis-related arterial disease, for which clusterin represents a potential biomarker.	[Khalid, Omar; Schwartz, Philip H.] CHOC Res Inst, Natl Human Neural Stem Cell Resource, Orange, CA USA; [Vera, Moin U.; Dickson, Patricia I.] Harbor UCLA, Los Angeles Biomed Res Inst, Div Med Genet, Torrance, CA USA; [Gordts, Philip L.; Esko, Jeffrey D.; Wang, Raymond Y.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ellinwood, N. Matthew] Iowa State Univ, Coll Agr & Life Sci, Ames, IA USA; [Schwartz, Philip H.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA; [Wang, Raymond Y.] CHOC Childrens Hosp, Div Metab Disorders, Orange, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California San Diego; Iowa State University; University of California System; University of California Irvine	Wang, RY (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.; Wang, RY (corresponding author), CHOC Childrens Hosp, Div Metab Disorders, Orange, CA USA.	rawang@choc.org	Wang, Raymond Yu Jeang/H-8870-2019; Wang, Raymond Yu Jeang/CAJ-3535-2022; Ellinwood, Norman/AAX-7005-2021; Ellinwood, Matthew/R-6419-2018	Wang, Raymond Yu Jeang/0000-0001-6494-7613; Gordts, Philip/0000-0001-7224-4328; Ellinwood, Matthew/0000-0002-1701-5052	National Institutes of Health (NIH) [T01NS05242-11]; Children's Hospital of Orange County Pediatric Subspecialty Faculty; MPSI Research Foundation; Children's Hospital of Orange County; European Community FP7 Award [PIOF-GA-2010-273994]; Lysosomal Disease Network [U54-NS065768]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085381, U54NS065768] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Orange County Pediatric Subspecialty Faculty; MPSI Research Foundation; Children's Hospital of Orange County; European Community FP7 Award; Lysosomal Disease Network; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant T01NS05242-11 (NME), Children's Hospital of Orange County Pediatric Subspecialty Faculty and the MPSI Research Foundation (RYW), Children's Hospital of Orange County (OK and PHS), European Community FP7 Award, PIOF-GA-2010-273994 (PG), and the Lysosomal Disease Network U54-NS065768 (MV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenhoven M, 2015, BLOOD, V125, P2164, DOI 10.1182/blood-2014-11-608075; Archer LD, 2014, J INHERIT METAB DIS, V37, P1, DOI 10.1007/s10545-013-9613-3; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Baldo G, 2011, MOL GENET METAB, V104, P608, DOI 10.1016/j.ymgme.2011.08.018; Braunlin E, 2006, PEDIATR RES, V59, P27, DOI 10.1203/01.pdr.0000190579.24054.39; Braunlin E, 2014, CARDIOVASC PATHOL, V23, P145, DOI 10.1016/j.carpath.2014.01.001; Braunlin EA, 2006, AM J CARDIOL, V98, P416, DOI 10.1016/j.amjcard.2006.02.047; BROSIUS FC, 1981, AM J CARDIOL, V47, P649, DOI 10.1016/0002-9149(81)90550-6; Bruyere J, 2015, J MOL BIOL, V427, P775, DOI 10.1016/j.jmb.2014.09.012; CHEITLIN MD, 1975, JAMA-J AM MED ASSOC, V231, P951, DOI 10.1001/jama.231.9.951; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; DIEMER V, 1992, J BIOL CHEM, V267, P5257; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Esko J, 2015, MOL GENET METAB, V114, pS42, DOI 10.1016/j.ymgme.2014.12.080; FACTOR SM, 1978, VIRCHOWS ARCH A, V379, P1, DOI 10.1007/BF00432778; Fesslova V, 2009, CARDIOL YOUNG, V19, P170, DOI 10.1017/S1047951109003576; Frohbergh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100882; GOMPF RE, 1990, AM J VET RES, V51, P2054; Hamada N, 2011, J ATHEROSCLER THROMB, V18, P209, DOI 10.5551/jat.5819; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Ishikawa Y, 1998, ARTERIOSCL THROM VAS, V18, P665, DOI 10.1161/01.ATV.18.4.665; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Jordan MC, 2005, MOL GENET METAB, V86, P233, DOI 10.1016/j.ymgme.2005.05.003; JORDANSTARCK TC, 1994, J LIPID RES, V35, P194; Kakkis ED, 1996, BIOCHEM MOL MED, V58, P156, DOI 10.1006/bmme.1996.0044; Kampmann C, 2014, J INHERIT METAB DIS, V37, P269, DOI 10.1007/s10545-013-9649-4; Kelly AS, 2013, J INHERIT METAB DIS, V36, P221, DOI 10.1007/s10545-011-9438-x; Khalid O, 2014, GENOM DATA, V2, P127, DOI 10.1016/j.gdata.2014.06.011; Khalid O, 2014, STEM CELL RES, V12, P791, DOI 10.1016/j.scr.2014.03.009; Killedar S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-39; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; Kim JJ, 2014, STEM CELLS, V32, P1468, DOI 10.1002/stem.1675; Kim JJ, 2012, J BIOL CHEM, V287, P41103, DOI 10.1074/jbc.M112.416545; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leal GN, 2010, CARDIOL YOUNG, V20, P254, DOI 10.1017/S104795110999062X; Lin HY, 2005, J INHERIT METAB DIS, V28, P1146, DOI 10.1007/s10545-005-0211-x; Liu YL, 2005, MOL THER, V11, P35, DOI 10.1016/j.ymthe.2004.08.027; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lyons JA, 2011, LAB INVEST, V91, P665, DOI 10.1038/labinvest.2011.7; Martins C, 2015, BRAIN, V138, P336, DOI 10.1093/brain/awu355; MENON KP, 1992, GENOMICS, V14, P763, DOI 10.1016/S0888-7543(05)80182-X; Metcalf JA, 2010, MOL GENET METAB, V99, P396, DOI 10.1016/j.ymgme.2009.12.003; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Nemes A, 2008, HEART VESSELS, V23, P108, DOI 10.1007/s00380-007-1013-x; Neufeld EF, 2013, ONLINE METABOLIC MOL; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Parente MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032419; Poulakou MV, 2008, IN VIVO, V22, P537; RENTERIA VG, 1976, AM J CARDIOL, V38, P487, DOI 10.1016/0002-9149(76)90468-9; Sandhoff K., 2011, COLD SPRING HARB PER, V3, P3; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Schwarz M, 2008, THROMB HAEMOSTASIS, V100, P110, DOI 10.1160/TH07-12-0737; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHULL RM, 1984, AM J PATHOL, V114, P487; Sifuentes M, 2007, MOL GENET METAB, V90, P171, DOI 10.1016/j.ymgme.2006.08.007; Simonaro CM, 2015, MOL GENET METAB, V114, pS106, DOI 10.1016/j.ymgme.2014.12.241; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Villani GRD, 2007, J NEUROSCI RES, V85, P612, DOI 10.1002/jnr.21134; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wang RY, 2015, MOL GENET METAB, V114, pS123, DOI 10.1016/j.ymgme.2014.12.284; Wang RY, 2014, MOL GENET METAB, V112, P286, DOI 10.1016/j.ymgme.2014.05.015; Wang RY, 2014, MOL GENET METAB, V111, P128, DOI 10.1016/j.ymgme.2013.11.001; Wang RY, 2011, MOL GENET METAB, V104, P592, DOI 10.1016/j.ymgme.2011.09.004; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Woloszynek JC, 2004, BIOCHEM J, V379, P461, DOI 10.1042/BJ20031048; Wraith JE, 2006, J INHERIT METAB DIS, V29, P442, DOI 10.1007/s10545-006-0239-6; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Yano S, 2009, J INHERIT METAB DIS, V32, pS53, DOI 10.1007/s10545-009-1057-4; Yasuda E, 2013, MOL GENET METAB, V109, P301, DOI 10.1016/j.ymgme.2013.04.009; YLAHERTTUALA S, 1987, ARTERIOSCLEROSIS, V7, P333, DOI 10.1161/01.ATV.7.4.333	76	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150850	10.1371/journal.pone.0150850	http://dx.doi.org/10.1371/journal.pone.0150850			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986213	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300030
J	Nair, SC; Jacobs, JWG; Bakker, MF; Jahangier, ZN; Bijlsma, JWJ; van Laar, JM; Lafeber, FPJG; Welsing, PMJ				Nair, Sandhya C.; Jacobs, Johannes W. G.; Bakker, Marije F.; Jahangier, Z. Nazira; Bijlsma, Johannes W. J.; van Laar, Jacobs M.; Lafeber, Floris P. J. G.; Welsing, Paco M. J.		Utrecht Arthritis Cohort Study Grp	Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; EARLY RHEUMATOID-ARTHRITIS; EULAR RECOMMENDATIONS; DISEASE; MANAGEMENT; THERAPY; VALIDATION; STRATEGIES; EFFICACY; PREDICT	Objective To determine the optimal methotrexate dose in individual patients and to explore whether this optimal dose and the level of disease activity at that dose could be predicted. Methods Data from CAMERA II trial comparing MTX and MTX with 10 mg of prednisone both in a tight control treatment strategy in early RA was used. For each patient a curve for disease activity over time was fitted and the MTX dose after which further step-up did not result in relevant improvement in disease activity anymore was determined the 'lowest optimally effective MTX dose (LOED)'. The association of demographic and clinical characteristics at baseline with this LOED and with the level of disease activity reached at LOED was studied. Results In 204 (100 MTX and 104 MTX with prednisone) out of 236 patients LOED could be defined. 10 mg/wk was the most prevalent LOED in patients treated with MTX and prednisone and 10 mg/wk, 20 mg/wk and 30 mg/wk in the MTX strategy. Although the specific LOED could not reliably be predicted, higher baseline disease activity, height and lower weight were associated with higher LOEDs (i.e at least 15 mg/wk). A score was presented to decide on a starting dose of 10 mg/wk or (at least) 15 mg/wk. The level of disease activity at LOED could not be reliably predicted. Conclusion A starting dose of 10 mg/wk might be a good choice for most patients and is frequently already the optimal dose. However, a subgroup of patient can be determined who would require higher MTX doses.	[Nair, Sandhya C.; Jacobs, Johannes W. G.; Bakker, Marije F.; Bijlsma, Johannes W. J.; van Laar, Jacobs M.; Lafeber, Floris P. J. G.; Welsing, Paco M. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Jahangier, Z. Nazira] Tergooi Hosp, Dept Rheumatol, Hilversum, Netherlands	Utrecht University; Utrecht University Medical Center	Nair, SC (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	sandyn26@gmail.com			ReumaFonds [LLP-9] Funding Source: researchfish	ReumaFonds		Bakker MF, 2007, ANN RHEUM DIS, V66, P56, DOI 10.1136/ard.2007.078360; Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Bijlsma JWJ, 2007, ANN RHEUM DIS, V66, P1409, DOI 10.1136/ard.2007.076463; Boers M, 2003, ARTHRITIS RHEUM, V48, P1771, DOI 10.1002/art.11156; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Gaujoux-Viala C, 2010, ANN RHEUM DIS, V69, P1004, DOI 10.1136/ard.2009.127225; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Hider SL, 2009, ANN RHEUM DIS, V68, P57, DOI 10.1136/ard.2008.088237; Jacobs JWG, 2012, RHEUMATOLOGY, V51, piv3, DOI 10.1093/rheumatology/kes083; Knevel R, 2010, ANN RHEUM DIS, V69, P987, DOI 10.1136/ard.2009.126748; Maradit-Kremers H, 2006, J RHEUMATOL, V33, P248; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rantalaiho V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3060; Saevarsdottir S, 2011, ANN RHEUM DIS, V70, P469, DOI 10.1136/ard.2010.139212; Schipper LG, 2010, RHEUMATOLOGY, V49, P2154, DOI 10.1093/rheumatology/keq195; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2013, ANN RHEUM DIS; Van der Goes MC, 2012, OSTEOPOROS INT; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Wessels JAM, 2007, ARTHRITIS RHEUM-US, V56, P1765, DOI 10.1002/art.22640	22	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0148791	10.1371/journal.pone.0148791	http://dx.doi.org/10.1371/journal.pone.0148791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987073	Green Published, gold, Green Submitted			2022-12-26	WOS:000372580300012
J	Estrada, M; Delgado, M; Blasco, D; Latasa, M; Cabello, AM; Benitez-Barrios, V; Fraile-Nuez, E; Mozetic, P; Vidal, M				Estrada, Marta; Delgado, Maximino; Blasco, Dolors; Latasa, Mikel; Mara Cabello, Ana; Benitez-Barrios, Veronica; Fraile-Nuez, Eugenio; Mozetic, Patricija; Vidal, Montserrat			Phytoplankton across Tropical and Subtropical Regions of the Atlantic, Indian and Pacific Oceans	PLOS ONE			English	Article							DIATOM LEPTOCYLINDRUS-MEDITERRANEUS; NORTH PACIFIC; SOLENICOLA-SETIGERA; SPECIES STRUCTURE; CHLOROPHYLL; DIVERSITY; ECOLOGY; BIOGEOGRAPHY; VARIABILITY; ABUNDANCE	We examine the large-scale distribution patterns of the nano-and microphytoplankton collected from 145 oceanic stations, at 3 m depth, the 20% light level and the depth of the subsurface chlorophyll maximum, during the Malaspina-2010 Expedition (December 2010-July 2011), which covered 15 biogeographical provinces across the Atlantic, Indian and Pacific oceans, between 35 degrees N and 40 degrees S. In general, the water column was stratified, the surface layers were nutrient-poor and the nano-and microplankton (hereafter phytoplankton, for simplicity, although it included also heterotrophic protists) community was dominated by dinoflagellates, other flagellates and coccolithophores, while the contribution of diatoms was only important in zones with shallow nutriclines such as the equatorial upwelling regions. We applied a principal component analysis to the correlation matrix among the abundances (after logarithmic transform) of the 76 most frequent taxa to synthesize the information contained in the phytoplankton data set. The main trends of variability identified consisted of: 1) A contrast between the community composition of the upper and the lower parts of the euphotic zone, expressed respectively by positive or negative scores of the first principal component, which was positively correlated with taxa such as the dinoflagellates Oxytoxum minutum and Scrippsiella spp., and the coccolithophores Discosphaera tubifera and Syracosphaera pulchra (HOL and HET), and negatively correlated with taxa like Ophiaster hydroideus (coccolithophore) and several diatoms, 2) a general abundance gradient between phytoplankton-rich regions with high abundances of dinoflagellate, coccolithophore and ciliate taxa, and phytoplankton-poor regions (second principal component), 3) differences in dominant phytoplankton and ciliate taxa among the Atlantic, the Indian and the Pacific oceans (third principal component) and 4) the occurrence of a diatom-dominated assemblage (the fourth principal component assemblage), including several pennate taxa, Planktoniella sol, Hemiaulus hauckii and Pseudo-nitzschia spp., in the divergence regions. Our findings indicate that consistent assemblages of co-occurring phytoplankton taxa can be identified and that their distribution is best explained by a combination in different degrees of both environmental and historical influences.	[Estrada, Marta; Delgado, Maximino; Blasco, Dolors; Mara Cabello, Ana] Inst Ciencies Mar CSIC, Barcelona, Catalunya, Spain; [Latasa, Mikel] Inst Espanol Oceanog, Ctr Oceanog Gijon Xixon, Gijon Xixon, Asturias, Spain; [Benitez-Barrios, Veronica; Fraile-Nuez, Eugenio] Inst Espanol Oceanog, Ctr Oceanog Canarias, Tenerife, Canarias, Spain; [Mozetic, Patricija] Natl Inst Biol, Marine Biol Stn, Piran, Slovenia; [Vidal, Montserrat] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Catalunya, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Spanish Institute of Oceanography; Spanish Institute of Oceanography; National Institute of Biology - Slovenia; University of Barcelona	Estrada, M (corresponding author), Inst Ciencies Mar CSIC, Barcelona, Catalunya, Spain.	marta@icm.csic.es	Fraile-Nuez, Eugenio/D-1521-2010; Nuez, Eugenio Fraile/R-2258-2019; Latasa, Mikel/D-2202-2011; Estrada, Marta/L-6207-2014; Vidal, Montserrat/L-6051-2014	Fraile-Nuez, Eugenio/0000-0003-4250-4445; Nuez, Eugenio Fraile/0000-0003-4250-4445; Latasa, Mikel/0000-0002-8202-0923; Estrada, Marta/0000-0001-5769-9498; Vidal, Montserrat/0000-0002-7878-3290; Mozetic, Patricija/0000-0002-4668-4511; Cabello Perez, Ana Maria/0000-0002-7165-5632	Consolider-Ingenio, Ministerio de Economia y Competitividad [CSD2008-00077]; Consejo Superior de Investigaciones Cientificas (CSIC)	Consolider-Ingenio, Ministerio de Economia y Competitividad; Consejo Superior de Investigaciones Cientificas (CSIC)	This work was supported by Consolider-Ingenio 2010, CSD2008-00077 of the former Spanish Ministerio de Ciencia e Innovacion (ES) (Now Ministerio de Economia y Competitividad, www.mineco.gob.es); Consejo Superior de Investigaciones Cientificas (CSIC) (ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvain S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003154; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Andersen RA, 1996, DEEP-SEA RES PT II, V43, P517, DOI 10.1016/0967-0645(95)00095-X; Balech E., 1988, DINOFLAGELADOS ATLAN; Balech E, 1995, GENUS ALEXANDRIUM HA; BEERS J R, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P607; BERARD-THERRIAULT L., 1999, PUBLICATION SPECIALE, V128, P1; BLASCO D, 1980, DEEP-SEA RES, V27, P799, DOI 10.1016/0198-0149(80)90045-X; Blasco D, 2012, EXPEDICION DE CIRCUNNAVEGACION MALASPINA 2010: CAMBIO GLOBAL Y EXPLORACION DE LA BIODIVERSIDAD DEL OCEANO: LIBRO BLANCO DE METODOS Y TECNICAS DE TRABAJO OCEANOGRAFICO, P107; Cermeno P, 2008, LIMNOL OCEANOGR, V53, P312, DOI 10.4319/lo.2008.53.1.0312; Chretiennot-Dinet M.-J., 1990, ATLAS PHYTOPLANCTON; Cortes MY, 2001, DEEP-SEA RES PT II, V48, P1957, DOI 10.1016/S0967-0645(00)00165-X; Cros L, 2002, SCI MAR, V66, P5; Cullen JJ, 2015, ANNU REV MAR SCI, V7, P207, DOI 10.1146/annurev-marine-010213-135111; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; DELGADO M, 1991, Scientia Marina, V55, P1; Duarte C.M., 2015, LIMNOL OCEANOGR B, V24, P11, DOI [10.1002/lob.10008, DOI 10.1002/L0B.10008]; Edwards M, 2002, MAR ECOL PROG SER, V239, P1, DOI 10.3354/meps239001; Estrada M, 2012, EXPEDICION DE CIRCUNNAVEGACION MALASPINA 2010: CAMBIO GLOBAL Y EXPLORACION DE LA BIODIVERSIDAD DEL OCEANO: LIBRO BLANCO DE METODOS Y TECNICAS DE TRABAJO OCEANOGRAFICO, P399; Estrada M., 1985, NATO Conference Series I Ecology, V8, P247; Estrada M., 1991, OECOLOGIA AQUATICA, V10, P157; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fernandez-Castro B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9002; Fiedler PC, 2002, DEEP-SEA RES PT I, V49, P321, DOI 10.1016/S0967-0637(01)00057-7; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fukuyo Y., 1990, RED TIDE ORGANISMS J; Gomez F, 2007, BIOGEOSCIENCES, V4, P1101, DOI 10.5194/bg-4-1101-2007; Gomez F., 2013, CICIMAR Oceanides, V28, P1; Gomez F, 2008, MAR POLLUT BULL, V56, P620, DOI 10.1016/j.marpolbul.2007.12.014; Gomez Fernando, 2006, Algae, V21, P445; Gomez F, 2007, ACTA PROTOZOOL, V46, P15; GOULD RW, 1988, J MAR RES, V46, P399; Grasshoff K, 1999, METHODS SEAWATER ANA; Gregg WW, 2007, DEEP-SEA RES PT II, V54, P447, DOI 10.1016/j.dsr2.2006.12.007; Guiry MD, 2012, J PHYCOL, V48, P1057, DOI 10.1111/j.1529-8817.2012.01222.x; Haidar AT, 2001, DEEP-SEA RES PT II, V48, P1925, DOI 10.1016/S0967-0645(00)00169-7; Hallegraeff GM, 2003, MANUAL HARMFUL MARIN; Herbland A., 1987, OCEANOL ACTA SP ISS, P115; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Jeffrey S.W., 2006, ALGAL CULTURES ANALO, P33, DOI [10.5860/choice.43-6522, DOI 10.5860/CHOICE.43-6522]; Jolicoeur P, 1960, GROWTH, V24, P359; Kaczmarska I, 2014, AM J BOT, V101, P267, DOI 10.3732/ajb.1300306; Kamykowski D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001640; Latasa M, 2005, LIMNOL OCEANOGR, V50, P1447, DOI 10.4319/lo.2005.50.5.1447; Legendre P., 2012, NUMERICAL ECOLOGY; Levandowsky M., 1987, BIOL DINOFLAGELLATES, P360; Li BL, 2013, DEEP-SEA RES PT II, V93, P84, DOI 10.1016/j.dsr2.2013.03.007; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Medlin LK, 2007, GENE, V406, P180, DOI 10.1016/j.gene.2007.09.011; Monterey G, 1997, SEASONAL VARIABILITY; Padmakumar KB, 2012, SYMBIOSIS, V56, P97, DOI 10.1007/s13199-012-0160-8; Percopo I, 2011, BOT MAR, V54, P243, DOI 10.1515/BOT.2011.033; Rampi L., 1980, CNEN RT BIO, V8, P1; Rousseaux CS, 2015, GLOBAL BIOGEOCHEM CY, V29, P1674, DOI 10.1002/2015GB005139; Saldarriaga JF, 2003, J PHYCOL, V39, P368, DOI 10.1046/j.1529-8817.2003.02113.x; Schlitzer R., 2013, OCEAN DATA VIEW; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Sournia A., 1986, ATLAS PHYTOPLANCTON, VI; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Tomas C., 1995, IDENTIFYING MARINE D; Tomas CR, 1993, MARINE PHYTOPLANKTON; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; VENRICK EL, 1990, ECOLOGY, V71, P1547, DOI 10.2307/1938291; Venrick EL, 1999, J PLANKTON RES, V21, P1029, DOI 10.1093/plankt/21.6.1029; VENRICK EL, 1988, J PLANKTON RES, V10, P987, DOI 10.1093/plankt/10.5.987; Young J.R., 2003, J NANNOPLANKTON RES, V1, P1	70	49	50	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151699	10.1371/journal.pone.0151699	http://dx.doi.org/10.1371/journal.pone.0151699			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982180	Green Published, gold			2022-12-26	WOS:000372574900114
J	Hutchison, ZL; Hendrick, VJ; Burrows, MT; Wilson, B; Last, KS				Hutchison, Zoe L.; Hendrick, Vicki J.; Burrows, Michael T.; Wilson, Ben; Last, Kim S.			Buried Alive: The Behavioural Response of the Mussels, Modiolus modiolus and Mytilus edulis to Sudden Burial by Sediment	PLOS ONE			English	Article							INDIGENOUS PERNA-PERNA; DREDGED MATERIAL; MECHANICAL-PROPERTIES; ENVIRONMENTAL-IMPACT; THERMAL TOLERANCE; MARINE BIVALVE; SAND; INVERTEBRATES; COASTAL; OXYGEN	Sedimentation in the sea occurs through natural processes, such as wave and tidal action, which can be exacerbated during storms and floods. Changes in terrestrial land use, marine aggregate extraction, dredging, drilling and mining are known to result in substantial sediment deposition. Research suggests that deposition will also occur due to the modern development of marine renewable energy. The response to individual burial under three depths of sediment, three sediment fractions and five burial durations was investigated in two mussel species, Modiolus modiolus and Mytilus edulis in specialist mesocosms. Both mussel species showed substantial mortality, which increased with duration of burial and burial by finer sediment fractions. M. modiolus was better able to survive short periods of burial than M. edulis, but at longer durations mortality was more pronounced. No mortality was observed in M. modiolus in burial durations of eight days or less but by 16 days of burial, over 50% cumulative mortality occurred. Under variable temperature regimes, M. edulis mortality increased from 20% at 8 degrees C to over 60% at 14.5 and 20 degrees C. Only M. edulis was able to emerge from burial, facilitated by increased byssus production, laid mostly on vertical surfaces but also on sediment particles. Emergence was higher from coarse sediment and shallow burials. Byssus production in M. edulis was not related to the condition index of the mussels. Results suggest that even marginal burial would result in mortality and be more pronounced in warm summer periods. Our results suggest that in the event of burial, adult M. modiolus would not be able to emerge from burial unless local hydrodynamics assist, whereas a small proportion of M. edulis may regain contact with the sediment water interface. The physiological stress resulting in mortality, contribution of local hydrodynamics to survival and other ecological pressures such as mussels existing in aggregations, are discussed.	[Hutchison, Zoe L.] Cranfield Univ, Ctr Offshore Renewable Energy Engn, Cranfield MK43 0AL, Beds, England; [Hendrick, Vicki J.; Burrows, Michael T.; Wilson, Ben; Last, Kim S.] Scottish Assoc Marine Sci SAMS, Dept Ecol, Oban PA37 1QA, Argyll, Scotland	Cranfield University	Last, KS (corresponding author), Scottish Assoc Marine Sci SAMS, Dept Ecol, Oban PA37 1QA, Argyll, Scotland.	kim.last@sams.ac.uk	Burrows, Michael/ABF-4844-2020	Burrows, Michael/0000-0003-4620-5899; Hutchison, Zoe/0000-0003-1866-7877	Marine Aggregate Levy Sustainability Fund (MALSF); research consortium Marine Renewable Energy and the Environment (MaREE) - European Regional Development Fund; FP7 Tidal Demonstration for Energy Scheme (TIDES) [322428]; Marine Aggregate Levy Sustainability Fund (MePF) [08/P76]; Marine Renewable Energy and the Environment (MaREE) [RE011]; Highlands and Island Enterprise; Scottish Funding Council; European Regional Development Fund; Natural Environment Research Council [NE/L003058/1] Funding Source: researchfish; NERC [NE/L003058/1] Funding Source: UKRI	Marine Aggregate Levy Sustainability Fund (MALSF); research consortium Marine Renewable Energy and the Environment (MaREE) - European Regional Development Fund; FP7 Tidal Demonstration for Energy Scheme (TIDES); Marine Aggregate Levy Sustainability Fund (MePF); Marine Renewable Energy and the Environment (MaREE); Highlands and Island Enterprise; Scottish Funding Council; European Regional Development Fund(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KSL recieved funding from the Marine Aggregate Levy Sustainability Fund (MePF; 08/P76) and the FP7 Tidal Demonstration for Energy Scheme (TIDES; 322428). BW recieved funding from a project called Marine Renewable Energy and the Environment (MaREE; RE011). This project was supported by funding from Highlands and Island Enterprise, the Scottish Funding Council and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge funding from the Marine Aggregate Levy Sustainability Fund (MALSF) and the research consortium Marine Renewable Energy and the Environment (MaREE) which was supported by the European Regional Development Fund. The work was also supported by the FP7 Tidal Demonstration for Energy Scheme (TIDES). The authors thank the MASTS Marine Energy Forum for their contribution to the writing retreat where part of this paper was written. We thank Jose Farinas-Franco for the provision of small M. modiolus. The authors are extremely grateful to aquarium manager, the late John Kershaw, for his assistance with the development and set-up of the pVoRT mesocosm facility. We would also like to thank the contributions of Harriet Condie, Christine Lockwood and Chris Beveridge (aquarium technician) for experimental assistance, and collaborator Andrew J. Davies for invaluable discussions in the experimental design.	Abanades J, 2015, RENEW ENERG, V75, P572, DOI 10.1016/j.renene.2014.10.048; [Anonymous], 2014, R LANG ENV STAT COMP; Babarro JMF, 2010, J COMP PHYSIOL B, V180, P95, DOI 10.1007/s00360-009-0392-y; BAYNE B, 1973, Netherlands Journal of Sea Research, V7, P399, DOI 10.1016/0077-7579(73)90061-6; BAYNE BL, 1978, OECOLOGIA, V37, P137, DOI 10.1007/BF00344987; Boyd SE, 2005, ICES J MAR SCI, V62, P145, DOI 10.1016/j.icesjms.2004.11.014; Boyd SE, 2003, ESTUAR COAST SHELF S, V57, P209, DOI 10.1016/S0272-7714(02)00346-3; Boyd SE, 2000, ESTUAR COAST SHELF S, V51, P805, DOI 10.1006/ecss.2000.0722; Brazee SL, 2006, BIOL BULL-US, V211, P263, DOI 10.2307/4134548; Burnham K. P., 2002, MODEL SELECTION MUTI; CASTILLA JC, 1978, MAR POLLUT BULL, V9, P67, DOI 10.1016/0025-326X(78)90451-4; Chapple JP, 1998, J EXP MAR BIOL ECOL, V229, P53, DOI 10.1016/S0022-0981(98)00040-9; Cottrell RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147534; CROSBY M P, 1990, Journal of Shellfish Research, V9, P233; DALY MA, 1977, MAR BIOL, V43, P45, DOI 10.1007/BF00392570; Davies AJ, 2009, J EXP MAR BIOL ECOL, V370, P35, DOI 10.1016/j.jembe.2008.11.015; DEVOOYS CGN, 1987, NETH J SEA RES, V21, P75, DOI 10.1016/0077-7579(87)90023-8; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dinesen GE, 2014, MAR BIOL RES, V10, P845, DOI 10.1080/17451000.2013.866250; Dolmer P, 1998, J EXP MAR BIOL ECOL, V228, P137, DOI 10.1016/S0022-0981(98)00024-0; Essink Karel, 1999, Journal of Coastal Conservation, V5, P69, DOI 10.1007/BF02802741; FAMME P, 1981, MAR BIOL LETT, V2, P345; FAO, 2014, FISH AQ INF STAT SER; Ginzburg LR, 2004, TRENDS ECOL EVOL, V19, P121, DOI 10.1016/j.tree.2003.11.004; Gormley KSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068263; Gosling E.M., 2003, CIRCULATION RESP EXC; HELCOM, 1999, MAR SED EXTR BALT SE; Hendrick VJ, 2011, BIOGENIC REEFS MARIN; Hendrick VJ, PLOS ONE IN PRESS; Hinchey EK, 2006, HYDROBIOLOGIA, V556, P85, DOI 10.1007/s10750-005-1029-0; Holt TJ, 1998, OVERVIEW DYNAMIC SEN; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jones C., 2014, WAVE ENERGY CONVERTE; JORGENSEN BB, 1980, OIKOS, V34, P68, DOI 10.2307/3544551; KRANZ PM, 1974, J GEOL, V82, P237, DOI 10.1086/627961; MAURER D, 1981, MAR ENVIRON RES, V4, P299, DOI 10.1016/0141-1136(81)90043-X; MEADOWS PS, 1989, MAR BIOL, V101, P219, DOI 10.1007/BF00391461; MILLER DC, 1992, J MAR RES, V50, P489, DOI 10.1357/002224092784797601; Miller RG, 2013, FRONT ECOL ENVIRON, V11, P433, DOI 10.1890/120089; Mytilus Tyler-Walters H., 2008, MARINE LIFE INFORM N; Neill SP, 2012, RENEW ENERG, V37, P387, DOI 10.1016/j.renene.2011.07.003; Neill SP, 2009, RENEW ENERG, V34, P2803, DOI 10.1016/j.renene.2009.06.015; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; Newell RC, 1999, MAR POLLUT BULL, V38, P809, DOI 10.1016/S0025-326X(99)00045-4; Newell RIE., 1989, 8211102; OKAMURA B, 1986, OECOLOGIA, V69, P341, DOI 10.1007/BF00377054; OLSGARD F, 1993, J EXP MAR BIOL ECOL, V172, P185, DOI 10.1016/0022-0981(93)90097-8; Owen SF, 2001, COMP BIOCHEM PHYS A, V128, P631, DOI 10.1016/S1095-6433(00)00340-8; Pearce T, 2009, J EXP BIOL, V212, P1449, DOI 10.1242/jeb.025551; Pearce T, 2009, J EXP BIOL, V212, P1442, DOI 10.1242/jeb.025544; PRICE HA, 1982, J MAR BIOL ASSOC UK, V62, P147, DOI 10.1017/S0025315400020178; READ KRH, 1967, COMP BIOCHEM PHYSIOL, V22, P149, DOI 10.1016/0010-406X(67)90176-4; Rees I., 2009, ASSESSMENT MODIOLUS; RIISGARD H. U., 2011, J MAR BIOL, DOI [DOI 10.1155/2011/312459, 10.1155/2011/312459]; Roberts D, 2011, MODIOLUS RESTORATION; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Strong JA, 2008, BIOL ENVIRON, V108B, P109, DOI 10.3318/BIOE.2008.108.2.109; Stronkhorst J, 2003, ENVIRON POLLUT, V124, P17, DOI 10.1016/S0269-7491(02)00430-X; Suchanek T.H., 1992, MUSSEL MYTILUS ECOLO, P87; THEEDE H, 1969, MAR BIOL, V2, P325, DOI 10.1007/BF00355712; THEEDE H, 1973, Netherlands Journal of Sea Research, V7, P244, DOI 10.1016/0077-7579(73)90048-3; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Trannum HC, 2010, J EXP MAR BIOL ECOL, V383, P111, DOI 10.1016/j.jembe.2009.12.004; Trembanis A, 2013, GEOCHEM GEOPHY GEOSY, V14, P4334, DOI 10.1002/ggge.20260; Trueman E. R., 1966, Proceedings of the Malacological Society of London, V37, P97; TRUEMAN ER, 1966, J EXP BIOL, V44, P469; Tyler-Walters H, 2007, HORSE MUSSEL MARINE; van Duren LA, 2006, J SEA RES, V55, P3, DOI 10.1016/j.seares.2005.08.001; van Leeuwen B, 2010, ECOL ENG, V36, P145, DOI 10.1016/j.ecoleng.2009.01.002; Walkington I, 2009, APPL OCEAN RES, V31, P239, DOI 10.1016/j.apor.2009.10.007; WANG WX, 1991, MAR ECOL PROG SER, V70, P223, DOI 10.3354/meps070223; Widdows J, 2002, HELGOLAND MAR RES, V56, P3, DOI 10.1007/s10152-001-0100-0; WIDDOWS J, 1989, PHYSIOL ZOOL, V62, P764, DOI 10.1086/physzool.62.3.30157926; Wilber DH, 2007, MAR POLLUT BULL, V54, P42, DOI 10.1016/j.marpolbul.2006.08.042; WITMAN JD, 1984, MAR ECOL PROG SER, V16, P259, DOI 10.3354/meps016259; YOUNG GA, 1985, MAR ECOL PROG SER, V24, P261, DOI 10.3354/meps024261; ZANDEE DI, 1986, NETH J ZOOL, V36, P322; Zardi GI, 2008, MAR BIOL, V153, P853, DOI 10.1007/s00227-007-0857-z; Zardi GI, 2006, MAR BIOL, V148, P1031, DOI 10.1007/s00227-005-0155-6; Zhang W, 2014, ENCY MARINE GEOSCIEN	82	16	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151471	10.1371/journal.pone.0151471	http://dx.doi.org/10.1371/journal.pone.0151471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982582	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900087
J	Ruggeri, P; Splendiani, A; Di Muri, C; Fioravanti, T; Santojanni, A; Leonori, I; De Felice, A; Biagiotti, I; Carpi, P; Arneri, E; Cerioni, PN; Giovannotti, M; Barucchi, VC				Ruggeri, Paolo; Splendiani, Andrea; Di Muri, Cristina; Fioravanti, Tatiana; Santojanni, Alberto; Leonori, Iole; De Felice, Andrea; Biagiotti, Ilaria; Carpi, Piera; Arneri, Enrico; Cerioni, Paola Nisi; Giovannotti, Massimo; Barucchi, Vincenzo Caputo			Coupling Demographic and Genetic Variability from Archived Collections of European Anchovy (Engraulis encrasicolus)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; POLYMORPHIC MICROSATELLITE LOCI; SMALL PELAGIC FISH; ALLELE FREQUENCY; SARDINA-PILCHARDUS; RE-IMPLEMENTATION; DNA ISOLATION; ADRIATIC SEA; BOTTLENECK; DIVERSITY	It is well known that temporal fluctuations in small populations deeply influence evolutionary potential. Less well known is whether fluctuations can influence the evolutionary potentials of species with large census sizes. Here, we estimated genetic population parameters from as survey of polymorphic microsatellite DNA loci in archived otoliths from Adriatic European anchovy (Engraulis encrasicolus), a fish with large census sizes that supports numerous local fisheries. Stocks have fluctuated greatly over the past few decades, and the Adriatic fishery collapsed in 1987. Our results show a significant reduction of mean genetic parameters as a consequence of the population collapse. In addition, estimates of effective population size (N-e) are much smaller than those expected in a fishes with large population census sizes (N-c). Estimates of N-e indicate low effective population sizes, even before the population collapse. The ratio N-e/N-e ranged between 10(-6) and 10(-8), indicating a large discrepancy between the anchovy gene pool and population census size. Therefore, anchovy populations may be more vulnerable to fishery effort and environmental change than previously thought.	[Ruggeri, Paolo; Splendiani, Andrea; Di Muri, Cristina; Fioravanti, Tatiana; Cerioni, Paola Nisi; Giovannotti, Massimo; Barucchi, Vincenzo Caputo] Univ Politecn Marche, Dipartimento Sci Vita Ambiente, Via Brecce Bianche, I-60131 Ancona, Italy; [Santojanni, Alberto; Leonori, Iole; De Felice, Andrea; Biagiotti, Ilaria; Carpi, Piera; Barucchi, Vincenzo Caputo] CNR, Ist Scienze Marine, Sez Pesca Marittima, Largo Fiera Pesca, I-60125 Ancona, Italy; [Arneri, Enrico] FAO FIRF, Dept Fisheries & Aquaculture, AdriaMed Project, Viale Terme Caracalla, I-00153 Rome, Italy	Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Barucchi, VC (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita Ambiente, Via Brecce Bianche, I-60131 Ancona, Italy.; Barucchi, VC (corresponding author), CNR, Ist Scienze Marine, Sez Pesca Marittima, Largo Fiera Pesca, I-60125 Ancona, Italy.	v.caputo@univpm.it	Giovannotti, Massimo/AAZ-3563-2020; De+Felice, Andrea/AHA-1500-2022; Leonori, Iole/AAF-6681-2020; De Felice, Andrea/L-9465-2014; Leonori, Iole/AAD-7901-2020; Di Muri, Cristina/ABF-5993-2021; Di Muri, Cristina/GSN-8197-2022; Biagiotti, Ilaria/C-8893-2014	De+Felice, Andrea/0000-0002-0051-2052; Leonori, Iole/0000-0001-7673-1684; De Felice, Andrea/0000-0002-0051-2052; Leonori, Iole/0000-0001-7673-1684; Di Muri, Cristina/0000-0003-4072-0662; Di Muri, Cristina/0000-0003-4072-0662; Biagiotti, Ilaria/0000-0002-5395-6896; Giovannotti, Massimo/0000-0001-7622-3583; NISI CERIONI, Paola/0000-0001-5074-9843; SANTOJANNI, ALBERTO/0000-0003-4947-3004; Ruggeri, Paolo/0000-0002-5433-508X; Carpi, Piera/0000-0002-9306-5385	RITMARE National Flagship Project (Italian Ministry for University and Research) [SP2_WP1_AZ4_UO02]; Universita Politecnica delle Marche (Ancona, Italy)	RITMARE National Flagship Project (Italian Ministry for University and Research); Universita Politecnica delle Marche (Ancona, Italy)	This work was supported by the RITMARE National Flagship Project (Italian Ministry for University and Research) SP2_WP1_AZ4_UO02. Annual funds are provided by Universita Politecnica delle Marche (Ancona, Italy) to Vincenzo Caputo Barucchi.; Special thanks are provided to Stewart Grant, Erik Sotka and two anonymous reviewers who greatly helped us to improve this manuscript and allowed us to tackle the major criticisms and a huge thank you to Tara Baris who helpfully edited an early draft of the manuscript to improve readability. This research was mainly supported by Universita Politecnica delle Marche (Ancona, Italy).	Alheit J, 2014, J MARINE SYST, V131, P21, DOI 10.1016/j.jmarsys.2013.11.002; Allendorf F, 2013, CONSERV GENET, V2nd; Allendorf FW, 2014, MOL ECOL, V23, P23, DOI 10.1111/mec.12574; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Azzali M, 2002, MAR ECOL-P S Z N I, V23, P78, DOI 10.1111/j.1439-0485.2002.tb00009.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Benbouza Halima, 2006, Biotechnologie Agronomie Societe et Environnement, V10, P77; Berthier P, 2002, GENETICS, V160, P741; Bonanomi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15395; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Carpi P, 2015, SCI MAR, V79, P57, DOI 10.3989/scimar.03903.29A; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cuveliers EL, 2011, MOL ECOL, V20, P3555, DOI 10.1111/j.1365-294X.2011.05196.x; Cuveliers EL, 2009, MOL ECOL RESOUR, V9, P725, DOI 10.1111/j.1755-0998.2009.02516.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Falush D, 2003, GENETICS, V164, P1567; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Gaggiotti OE, 1999, CAN J FISH AQUAT SCI, V56, P1376, DOI 10.1139/cjfas-56-8-1376; Ganias K, 2014, REPROD POTENTIAL BIO; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Habel JC, 2014, BIOL REV, V89, P484, DOI 10.1111/brv.12068; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Hoarau G, 2005, P ROY SOC B-BIOL SCI, V272, P497, DOI 10.1098/rspb.2004.2963; Hood G., 2009, POPTOOLS V 3 1 0; Hutchinson WF, 1999, MOL ECOL, V8, P893; Jasper JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081916; Kauer MO, 2003, GENETICS, V165, P1137; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Landi M, 2005, MOL ECOL NOTES, V5, P266, DOI 10.1111/j.1471-8286.2005.00892.x; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Laurent V, 2007, BIOL J LINN SOC, V90, P591, DOI 10.1111/j.1095-8312.2007.00747.x; Leonori I, 2011, DTA06 MAR RES CNR; Leonori I, 2012, ACTA ADRIAT, V53, P389; Lin L, 2011, GENET MOL RES, V10, P764, DOI 10.4238/vol10-2gmr1085; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Marty L, 2015, EVOL APPL, V8, P47, DOI 10.1111/eva.12220; Morello EB, 2009, OCEANOGR MAR BIOL, V47, P209; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nielsen EE, 2008, FISH FISH, V9, P450, DOI 10.1111/j.1467-2979.2008.00304.x; O'Leary SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066126; Pakaki V, 2009, MOL ECOL RESOUR, V9, P1406, DOI 10.1111/j.1755-0998.2009.02681.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; POLLAK E, 1983, GENETICS, V104, P531; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruggeri P, 2012, CAN J FISH AQUAT SCI, V69, P1698, DOI 10.1139/F2012-092; Santojanni A, 2003, SCI MAR, V67, P327, DOI 10.3989/scimar.2003.67n3327; Santojanni A., 2006, Biologia Marina Mediterranea, V13, P98; Santojanni A, 2006, CLIM RES, V31, P181, DOI 10.3354/cr031181; Schaerlaekens DG, 2011, J EXP MAR BIOL ECOL, V398, P56, DOI 10.1016/j.jembe.2010.12.010; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Speller CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051122; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; Van Beveren E, 2014, MAR BIOL, V161, P1809, DOI 10.1007/s00227-014-2463-1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Waples RS, 2007, GENETICS, V175, P219, DOI 10.1534/genetics.106.065300; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	70	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151507	10.1371/journal.pone.0151507	http://dx.doi.org/10.1371/journal.pone.0151507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982808	gold, Green Submitted, Green Published			2022-12-26	WOS:000372574900089
J	Tayao, M; Andrici, J; Farzin, M; Clarkson, A; Sioson, L; Watson, N; Chua, TC; Sztynda, T; Samra, JS; Gill, AJ				Tayao, Michael; Andrici, Juliana; Farzin, Mahtab; Clarkson, Adele; Sioson, Loretta; Watson, Nicole; Chua, Terence C.; Sztynda, Tamara; Samra, Jaswinder S.; Gill, Anthony J.			Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							EXTRAHEPATIC CHOLANGIOCARCINOMA; MUTATIONS PREDISPOSE; MESOTHELIOMA; IMMUNOHISTOCHEMISTRY; EPIDEMIOLOGY; PERITONEAL; PROTEIN-1; LANDSCAPE; DIAGNOSIS; TUMORS	Background Pancreatic cancer is both common and highly lethal and therefore new biomarkers or potential targets for treatment are needed. Loss of BRCA associated protein-1 (BAP1) expression has been found in up to a quarter of intrahepatic cholangiocarcinomas. Given the close anatomical relationship between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma, we therefore sought to investigate the frequency of loss of BAP1 expression in pancreatic ductal adenocarcinoma. Methods The records of the department of Anatomical Pathology Royal North Shore Hospital, Sydney, Australia, were searched for cases of pancreatic ductal adenocarcinoma diagnosed between 1992 and 2014 with material available in archived formalin fixed paraffin embedded tissue blocks. Immunohistochemistry for BAP1 was performed on tissue microarray sections and if staining was equivocal or negative it was confirmed on whole sections. Negative staining for BAP1 was defined as loss of expression in all neoplastic nuclei, with preserved expression in non-neoplastic cells which acted as an internal positive control. Results Loss of BAP1 expression was found in only 1 of 306 (0.33%) pancreatic ductal adenocarcinomas. This case was confirmed to demonstrate diffuse loss of expression throughout all neoplastic cells in multiple blocks, consistent with BAP1 loss being an early clonal event. All other cases demonstrated positive expression of BAP1. Conclusion We conclude that, in contrast to intrahepatic cholangiocarcinoma, loss of expression of BAP1 occurs very rarely in pancreatic ductal adenocarcinoma. Therefore BAP1 inactivation is unlikely to be a frequent driver abnormality in pancreatic adenocarcinoma.	[Tayao, Michael; Andrici, Juliana; Farzin, Mahtab; Clarkson, Adele; Sioson, Loretta; Watson, Nicole; Gill, Anthony J.] Royal N Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Res Grp, St Leonards, NSW 2065, Australia; [Tayao, Michael; Sztynda, Tamara] Univ Technol Sydney, Sch Life Sci, Ultimo, NSW 2007, Australia; [Andrici, Juliana; Samra, Jaswinder S.; Gill, Anthony J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Andrici, Juliana; Farzin, Mahtab; Clarkson, Adele; Sioson, Loretta; Gill, Anthony J.] Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW 2065, Australia; [Chua, Terence C.; Samra, Jaswinder S.] Royal N Shore Hosp, Dept Gastrointestinal Surg, St Leonards, NSW 2065, Australia; [Chua, Terence C.; Samra, Jaswinder S.] Univ Sydney, Discipline Surg, Sydney, NSW 2006, Australia; [Chua, Terence C.; Samra, Jaswinder S.] Macquarie Univ, Macquarie Univ Hosp, N Ryde, NSW, Australia; [Gill, Anthony J.] Royal N Shore Hosp, Sydney Vital Translat Res Ctr, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Technology Sydney; University of Sydney; Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Macquarie University; Royal North Shore Hospital	Andrici, J (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Res Grp, St Leonards, NSW 2065, Australia.; Andrici, J (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.; Andrici, J (corresponding author), Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW 2065, Australia.	iand7910@uni.sydney.edu.au	Gill, Anthony/D-4215-2015; Gill, Anthony J./M-5015-2019	Gill, Anthony/0000-0002-9447-1967; CHUA, TERENCE/0000-0002-4263-1017	Sydney Vital, Translational Cancer Research, through a Cancer Institute NSW competitive grant	Sydney Vital, Translational Cancer Research, through a Cancer Institute NSW competitive grant	This project was supported by the Sydney Vital, Translational Cancer Research, through a Cancer Institute NSW competitive grant to AJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Andrici J, 2015, LOSS EXPRESSION BAP1; Andrici J, 2016, HUM PATHOL, V51, P9, DOI 10.1016/j.humpath.2015.12.012; Andrici J, 2015, MODERN PATHOL, V28, P1360, DOI 10.1038/modpathol.2015.87; Arzt L, 2014, PATHOL ONCOL RES, V20, P145, DOI 10.1007/s12253-013-9677-2; Battaglia A, 2014, CLIN MED INSIGHTS-ON, V8, P37, DOI 10.4137/CMO.S15239; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Cardinale V, 2010, WORLD J GASTRO ONCOL, V2, P407, DOI 10.4251/wjgo.v2.i11.407; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chang DK, 2014, CURR OPIN GENET DEV, V24, P74, DOI 10.1016/j.gde.2013.12.001; Cigognetti M, 2015, MODERN PATHOL, V28, P1043, DOI 10.1038/modpathol.2015.65; de la Fouchardiere A, 2014, CLIN GENET, V1, P1; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Farzin M, 2015, PATHOLOGY, V47, P302, DOI 10.1097/PAT.0000000000000250; Frampton AE, 2013, FUTURE ONCOL, V9, P31, DOI [10.2217/FON.12.175, 10.2217/fon.12.175]; Giovinazzo F, 2012, SURG ONCOL, V21, pE171, DOI 10.1016/j.suronc.2012.07.004; Gonzalez-Perez A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r106; Graham JS, 2015, CLIN GENET, V88, P213, DOI 10.1111/cge.12536; Haugk B, 2010, HISTOPATHOLOGY, V57, P503, DOI 10.1111/j.1365-2559.2010.03610.x; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Ho TH, 2015, UROL ONCOL, V33, pe9, DOI DOI 10.1016/J.UR0L0NC.2014.10.014; Hwang HC, 2016, AM J SURG PATHOL, V40; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Joseph RW, 2016, J UROLOGY, V195, P180, DOI 10.1016/j.juro.2015.07.113; Khan SA, 2008, HPB, V10, P77, DOI 10.1080/13651820801992641; Koopmans AE, 2014, MODERN PATHOL, V27, P1321, DOI 10.1038/modpathol.2014.43; McGregor SM, 2015, HUM PATHOL, V46, P1670, DOI 10.1016/j.humpath.2015.06.024; Mochel MC, 2015, AM J CLIN PATHOL, V143, P901, DOI 10.1309/AJCPG8LFJC0DHDQT; Murali R, 2013, PATHOLOGY, V45, P116, DOI 10.1097/PAT.0b013e32835d0efb; Pins A, 2015, HUM PATHOL, V46, P239, DOI 10.1016/j.humpath.2014.10.015; Popova T, 2013, AM J HUM GENET, V92, P974, DOI 10.1016/j.ajhg.2013.04.012; Porpodis K, 2013, J THORAC DIS, V5, pS397, DOI 10.3978/j.issn.2072-1439.2013.08.08; Putra J, 2015, EXP MOL PATHOL, V99, P240, DOI 10.1016/j.yexmp.2015.07.005; Reid MD, 2014, AM J CLIN PATHOL, V141, P168, DOI 10.1309/AJCP0FKDP7ENVKEV; Rusch A, 2015, LUNG CANCER, V87, P77, DOI 10.1016/j.lungcan.2014.10.017; Shah AA, 2013, PATHOLOGY, V45, P651, DOI 10.1097/PAT.0000000000000002; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singhi AD, 2016, MODERN PATHOL, V29, P14, DOI 10.1038/modpathol.2015.121; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wiesner T, 2012, AM J SURG PATHOL, V36, P818, DOI 10.1097/PAS.0b013e3182498be5; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Yoshikawa Y, 2012, CANCER SCI, V103, P868, DOI 10.1111/j.1349-7006.2012.02223.x	44	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150338	10.1371/journal.pone.0150338	http://dx.doi.org/10.1371/journal.pone.0150338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982343	gold, Green Published, Green Submitted			2022-12-26	WOS:000372574900035
J	Tiainen, M; Tiippana, K; Vainio, M; Peromaa, T; Komeilipoor, N; Vainio, L				Tiainen, Mikko; Tiippana, Kaisa; Vainio, Martti; Peromaa, Tarja; Komeilipoor, Naeem; Vainio, Lari			Selective Influences of Precision and Power Grips on Speech Categorization	PLOS ONE			English	Article							PERCEPTION; GRASP; LANGUAGE; MOUTH	Recent studies have shown that articulatory gestures are systematically associated with specific manual grip actions. Here we show that executing such actions can influence performance on a speech-categorization task. Participants watched and/or listened to speech stimuli while executing either a power or a precision grip. Grip performance influenced the syllable categorization by increasing the proportion of responses of the syllable congruent with the executed grip (power grip-[ke] and precision grip-[te]). Two follow-up experiments indicated that the effect was based on action-induced bias in selecting the syllable.	[Tiainen, Mikko; Tiippana, Kaisa; Peromaa, Tarja; Komeilipoor, Naeem; Vainio, Lari] Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland; [Vainio, Martti] Univ Helsinki, Inst Behav Sci, Phonet & Speech Synth Res Grp, Helsinki, Finland	University of Helsinki; University of Helsinki	Tiainen, M (corresponding author), Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland.	mikko.o.tiainen@helsinki.fi	Tiippana, Kaisa/AFQ-7636-2022	Tiippana, Kaisa/0000-0002-2305-8104; Peromaa, Tarja/0000-0001-6290-111X; Vainio, Martti/0000-0003-2570-0196; Tiainen, Mikko/0000-0003-3245-9337; Vainio, Lari/0000-0001-7754-9745	Academy of Finland [1265610]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (http://www.aka.fi/) under Grant 1265610, reveived by MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; D'Ausilio A, 2012, CORTEX, V48, P882, DOI 10.1016/j.cortex.2011.05.017; Daar M, 2008, CORTEX, V44, P400, DOI 10.1016/j.cortex.2007.12.003; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Gentilucci M, 2004, EUR J NEUROSCI, V19, P190, DOI 10.1111/j.1460-9568.2004.03104.x; Gentilucci M, 2003, EUR J NEUROSCI, V17, P179, DOI 10.1046/j.1460-9568.2003.02438.x; Gentilucci M, 2001, J NEUROPHYSIOL, V86, P1685, DOI 10.1152/jn.2001.86.4.1685; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Green DM, 1966, SIGNAL DETECTION THE; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Loetscher T, 2010, CURR BIOL, V20, pR264, DOI 10.1016/j.cub.2010.01.015; Macmillan N. A., 1991, DETECTION THEORY USE; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Mochida T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068619; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Sams M, 2005, COGNITIVE BRAIN RES, V23, P429, DOI 10.1016/j.cogbrainres.2004.11.006; Sato M, 2013, EXP BRAIN RES, V227, P275, DOI 10.1007/s00221-013-3510-8; Smalle EHM, 2015, CEREB CORTEX, V25, P3690, DOI 10.1093/cercor/bhu218; Symes E, 2008, J EXP PSYCHOL HUMAN, V34, P854, DOI 10.1037/0096-1523.34.4.854; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Vainio L, 2014, EXP BRAIN RES, V232, P2359, DOI 10.1007/s00221-014-3932-y; Vainio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053061; Witt JK, 2015, PERCEPTION, V44, P289, DOI 10.1068/p7908	29	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151688	10.1371/journal.pone.0151688	http://dx.doi.org/10.1371/journal.pone.0151688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978074	Green Published, gold			2022-12-26	WOS:000372572800099
J	Turowski, V; Sperling, B; Hanczaruk, MA; Gobel, TW; Viertlboeck, BC				Turowski, Vanessa; Sperling, Beatrice; Hanczaruk, Matthias A.; Goebel, Thomas W.; Viertlboeck, Birgit C.			Chicken TREM-B1, an Inhibitory Ig-Like Receptor Expressed on Chicken Thrombocytes	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; IMMUNE-RESPONSES; MULTIGENE FAMILY; COMPLEX ENCODES; B-LYMPHOCYTES; CUTTING EDGE; FC-RECEPTOR; NK CELLS; T-CELLS; TRANSCRIPT-1	Triggering receptors expressed on myeloid cells (TREM) form a multigene family of immunoregulatory Ig-like receptors and play important roles in the regulation of innate and adaptive immunity. In chickens, three members of the TREM family have been identified on chromosome 26. One of them is TREM-B1 which possesses two V-set Ig-domains, an uncharged transmembrane region and a long cytoplasmic tail with one ITSM and two ITIMs indicating an inhibitory function. We generated specific monoclonal antibodies by immunizing a Balb/c mouse with a TREM-B1-FLAG transfected BWZ.36 cell line and tested the hybridoma supernatants on TREM-B1-FLAG transfected 2D8 cells. We obtained two different antibodies specific for TREM-B1, mab 7E8 (mouse IgG1) and mab 1E9 (mouse IgG2a) which were used for cell surface staining. Single and double staining of different tissues, including whole blood preparations, revealed expression on thrombocytes. Next we investigated the biochemical properties of TREM-B1 by using the specific mab 1E9 for immunoprecipitation of either lysates of surface biotinylated peripheral blood cells or stably transfected 2D8 cells. Staining with streptavidin coupled horse radish peroxidase revealed a glycosylated monomeric protein of about 50 kDa. Furthermore we used the stably transfected 2D8 cell line for analyzing the cytoplasmic tyrosine based signaling motifs. After pervanadate treatment, we detected phosphorylation of the tyrosine residues and subsequent recruitment of the tyrosine specific protein phosphatase SHP-2, indicating an inhibitory potential for TREM-B1. We also showed the inhibitory effect of TREM-B1 in chicken thrombocytes using a CD107 degranulation assay. Crosslinking of TREM-B1 on activated primary thrombocytes resulted in decreased CD107 surface expression of about 50-70%.	[Turowski, Vanessa; Sperling, Beatrice; Hanczaruk, Matthias A.; Goebel, Thomas W.; Viertlboeck, Birgit C.] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Hanczaruk, Matthias A.] Bundeswehr Inst Microbiol, Munich, Germany	University of Munich; Bundeswehr Institute of Microbiology (IMB)	Viertlboeck, BC (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	Birgit.Viertlboeck@lmu.de			Deutsche Forschungsgemeinschaft (DFG) [VI459/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grant VI459/2-2 www.dfg.de to BCV.	Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; Arnon TI, 2008, J MOL BIOL, V381, P1012, DOI 10.1016/j.jmb.2008.06.082; Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; CHEN CLH, 1986, J EXP MED, V164, P375, DOI 10.1084/jem.164.1.375; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Dennis G, 2000, P NATL ACAD SCI USA, V97, P13245, DOI 10.1073/pnas.230442897; Derive M, 2012, J IMMUNOL, V188, P5585, DOI 10.4049/jimmunol.1102674; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gattis JL, 2006, J BIOL CHEM, V281, P13396, DOI 10.1074/jbc.M600489200; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Jansen CA, 2010, DEV COMP IMMUNOL, V34, P759, DOI 10.1016/j.dci.2010.02.009; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KASPERS B, 1993, VET IMMUNOL IMMUNOP, V36, P333, DOI 10.1016/0165-2427(93)90029-4; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Laun K, 2006, PLOS GENET, V2, P707, DOI 10.1371/journal.pgen.0020073; Lu YT, 2006, HYBRIDOMA, V25, P20, DOI 10.1089/hyb.2006.25.20; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Neulen ML, 2015, DEV COMP IMMUNOL, V49, P72, DOI 10.1016/j.dci.2014.11.012; Neulen ML, 2012, IMMUNOGENETICS, V64, P389, DOI 10.1007/s00251-011-0591-z; PECK R, 1982, J IMMUNOL, V129, P4; Puehler F, 2003, J IMMUNOL METHODS, V274, P229, DOI 10.1016/S0022-1759(02)00515-X; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rothwell CJ, 1996, VET IMMUNOL IMMUNOP, V55, P225, DOI 10.1016/S0165-2427(96)05635-8; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Seliger C, 2012, VET IMMUNOL IMMUNOP, V145, P86, DOI 10.1016/j.vetimm.2011.10.010; Sperling B, 2015, DEV COMP IMMUNOL, V50, P121, DOI 10.1016/j.dci.2015.02.004; St Paul M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043381; Straub C, 2014, DEV COMP IMMUNOL, V42, P159, DOI 10.1016/j.dci.2013.09.007; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; Viertboeck BC, 2009, J IMMUNOL, V182, P1533, DOI 10.4049/jimmunol.182.3.1533; Viertlboeck BC, 2007, VET IMMUNOL IMMUNOP, V119, P137, DOI 10.1016/j.vetimm.2007.06.017; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Viertlboeck BC, 2004, J IMMUNOL, V173, P7385, DOI 10.4049/jimmunol.173.12.7385; Viertlboeck BC, 2006, IMMUNOGENETICS, V58, P180, DOI 10.1007/s00251-006-0091-8; Viertlboeck BC, 2008, MOL IMMUNOL, V45, P2097, DOI 10.1016/j.molimm.2007.10.012; Viertlboeck BC, 2008, MOL IMMUNOL, V45, P1398, DOI 10.1016/j.molimm.2007.08.024; Viertlboeck BC, 2007, P NATL ACAD SCI USA, V104, P11718, DOI 10.1073/pnas.0702011104; Viertlboeck BC, 2013, DEV COMP IMMUNOL, V41, P403, DOI 10.1016/j.dci.2013.04.017; Viertlboeck BC, 2011, VET IMMUNOL IMMUNOP, V144, P1, DOI 10.1016/j.vetimm.2011.07.001; Viertlboeck BC, 2010, DEV COMP IMMUNOL, V34, P866, DOI 10.1016/j.dci.2010.03.007; Viertlboeck BC, 2009, J IMMUNOL, V182, P6985, DOI 10.4049/jimmunol.0803060; Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175; Washington AV, 2004, BLOOD, V104, P1042, DOI 10.1182/blood-2004-01-0315; Washington AV, 2002, BLOOD, V100, P3822, DOI 10.1182/blood-2002-02-0523; YAMADA E, 2008, CURR PROTOC IMMUNOL, pCH1; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Zechmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081942; Zhu YW, 2011, IMMUNITY, V34, P466, DOI 10.1016/j.immuni.2011.04.008	56	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151513	10.1371/journal.pone.0151513	http://dx.doi.org/10.1371/journal.pone.0151513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967520	Green Published, Green Submitted, gold			2022-12-26	WOS:000371989200060
J	Wang, C; Lin, X; Li, L; Lin, SJ				Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie			Differential Growth Responses of Marine Phytoplankton to Herbicide Glyphosate	PLOS ONE			English	Article							DISSOLVED ORGANIC PHOSPHORUS; TRANSPORTER GENE PHND; FRESH-WATER POND; PSEUDOMONAS SP; ACUTE TOXICITY; ROUNDUP; LIMITATION; COMMUNITY; IMPACT; DEGRADATION	Glyphosate is a globally popular herbicide to kill weeds and its wide applications may lead to accumulation in coastal oceans as a source of phosphorus (P) nutrient or growth inhibitor of phytoplankton. We studied the physiological effects of glyphosate on fourteen species representing five major coastal phytoplankton phyla (haptophyta, bacillariophyta, dinoflagellata, raphidophyta, and chlorophyta). Based on growth responses to different concentrations of glyphosate under contrasting dissolved inorganic phosphorus (DIP) conditions, we found that phytoplankton species could be classified into five groups. Group I (Emiliania huxleyi, Skeletonema costatum, Phaeodactylum tricornutum) could utilize glyphosate as sole P-source to support growth in axenic culture, but in the presence of DIP, they were inhibited by both 36-mu M and 360-mu M glyphosate. Group II (Karenia mikimotoi, Prorocentrum minimum, Dunaliella tertiolecta, Symbiodinium sp., Heterosigma akashiwo and Alexandrium catenella) could not utilize glyphosate as sole P-source to support growth, and in the presence of DIP growth was not affected by 36-mu M but inhibited by 360-mu M glyphosate. Glyphosate consistently enhanced growth of Group III (Isochrysis galbana) and inhibited Group IV (Thalassiosira weissflogii, Thalassiosira pseudonana and Chattonella marina) regardless of DIP condition. Group V (Amphidinium carterae) exhibited no measurable response to glyphosate regardless of DIP condition. This grouping is not congruent with the phylogenetic relationships of the phytoplankton species suggesting functional differentiation driven by environmental pressure. We conclude that glyphosate could be used as P-source by some species while is toxic to some other species and yet has no effects on others. The observed differential effects suggest that the continued use of glyphosate and increasing concentration of this herbicide in the coastal waters will likely exert significant impact on coastal marine phytoplankton community structure.	[Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, Coll Ocean & Marine Biodivers, Xiamen, Fujian, Peoples R China; [Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, Global Change Res Ctr, Xiamen, Fujian, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Xiamen University; Xiamen University; Xiamen University; University of Connecticut	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Xiamen Univ, Coll Ocean & Marine Biodivers, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Xiamen Univ, Global Change Res Ctr, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016	CHEN, SHYR-CHYR/0000-0002-5858-3013; LIU, KAO-LANG/0000-0003-4100-8909; WANG, CHIH-HUNG/0000-0003-0802-7825; WU, YAO-MING/0000-0002-1720-7863; YANG, JUSTIN CHENG-TA/0000-0001-8256-2477; LIEN, WAN-CHING/0000-0001-9448-5093	National Natural Science Foundation of China (NSFC) [41176091, 41330959]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC), 41176091 and 41330959. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1978, CAN J BOT, V56, P2196, DOI 10.1139/b78-263; Annett R, 2014, J APPL TOXICOL, V34, P458, DOI 10.1002/jat.2997; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arunakumara K. K. I. U., 2013, African Journal of Microbiology Research, V7, P4084; Baylis AD, 2000, PEST MANAG SCI, V56, P299, DOI 10.1002/(SICI)1526-4998(200004)56:4<299::AID-PS144>3.0.CO;2-K; BERNER T, 1989, J PHYCOL, V25, P70, DOI 10.1111/j.0022-3646.1989.00070.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BOWMER KH, 1982, PESTIC SCI, V13, P623, DOI 10.1002/ps.2780130609; Busse MD, 2001, SOIL BIOL BIOCHEM, V33, P1777, DOI 10.1016/S0038-0717(01)00103-1; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; DICK RE, 1995, APPL MICROBIOL BIOT, V43, P545, DOI 10.1007/BF00218464; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Duke SO, 2011, J AGR FOOD CHEM, V59, P5835, DOI 10.1021/jf102704x; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Edge CB, 2013, SCI TOTAL ENVIRON, V444, P145, DOI 10.1016/j.scitotenv.2012.11.045; FENG JC, 1990, J AGR FOOD CHEM, V38, P1118, DOI 10.1021/jf00094a046; Fiori E, 2014, AQUAT TOXICOL, V147, P112, DOI 10.1016/j.aquatox.2013.12.014; FOLMAR LC, 1979, ARCH ENVIRON CON TOX, V8, P269, DOI 10.1007/BF01056243; Forlani G, 2008, PLANT CELL PHYSIOL, V49, P443, DOI 10.1093/pcp/pcn021; Forlani G, 2015, NEW PHYTOL, V205, P160, DOI 10.1111/nph.13022; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; Giesy JP, 2000, REV ENVIRON CONTAM T, V167, P35; Gimsing AL, 2004, APPL SOIL ECOL, V27, P233, DOI 10.1016/j.apsoil.2004.05.007; GOLDSBOROUGH LG, 1989, ARCH ENVIRON CON TOX, V18, P537, DOI 10.1007/BF01055020; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; HERNANDO F, 1989, J PLANT PHYSIOL, V134, P26, DOI 10.1016/S0176-1617(89)80197-X; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hove-Jensen B, 2014, MICROBIOL MOL BIOL R, V78, P176, DOI 10.1128/MMBR.00040-13; Ilikchyan IN, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00135; Ilikchyan IN, 2009, ENVIRON MICROBIOL, V11, P1314, DOI 10.1111/j.1462-2920.2009.01869.x; Kamlow M, 2013, THESIS NORWEGIAN U S; Karl DM, 2000, NATURE, V406, P31, DOI 10.1038/35017683; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; KREUTZWEISER DP, 1989, B ENVIRON CONTAM TOX, V42, P331, DOI 10.1007/BF01699957; Kryuchkova YV, 2014, MICROBIOL RES, V169, P99, DOI 10.1016/j.micres.2013.03.002; Krzysko-Lupicka T, 2008, CHEMOSPHERE, V71, P1386, DOI 10.1016/j.chemosphere.2007.11.006; Labry C, 2002, J PLANKTON RES, V24, P97, DOI 10.1093/plankt/24.2.97; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; LeGresley M, 2010, COUNTING CHAMBER MET; Lin X, 2011, J PHYCOL, V47, P1110, DOI 10.1111/j.1529-8817.2011.01038.x; Lipok J, 2010, ECOTOX ENVIRON SAFE, V73, P1681, DOI 10.1016/j.ecoenv.2010.08.017; LIU CM, 1991, APPL ENVIRON MICROB, V57, P1799, DOI 10.1128/AEM.57.6.1799-1804.1991; Ma J, 2003, B ENVIRON CONTAM TOX, V71, P594, DOI 10.1007/s00128-003-8521-x; MITCHELL DG, 1987, B ENVIRON CONTAM TOX, V39, P1028, DOI 10.1007/BF01689594; Modesto KA, 2010, CHEMOSPHERE, V81, P781, DOI 10.1016/j.chemosphere.2010.07.005; Mohr S, 2008, ENVIRON POLLUT, V152, P530, DOI 10.1016/j.envpol.2007.07.010; Mohr S, 2007, AQUAT TOXICOL, V82, P73, DOI 10.1016/j.aquatox.2007.02.001; MOORE JK, 1983, APPL ENVIRON MICROB, V46, P316, DOI 10.1128/AEM.46.2.316-320.1983; Nandula V. K., 2005, Outlooks on Pest Management, V16, P183, DOI 10.1564/16aug11; ORRETT K, 1987, LIMNOL OCEANOGR, V32, P383, DOI 10.4319/lo.1987.32.2.0383; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Perez GL, 2007, ECOL APPL, V17, P2310, DOI 10.1890/07-0499.1; Peruzzo PJ, 2008, ENVIRON POLLUT, V156, P61, DOI 10.1016/j.envpol.2008.01.015; PIPKE R, 1988, APPL ENVIRON MICROB, V54, P1293, DOI 10.1128/AEM.54.5.1293-1296.1988; PIPKE R, 1987, EUR J BIOCHEM, V165, P267, DOI 10.1111/j.1432-1033.1987.tb11437.x; QUINN JP, 1989, APPL MICROBIOL BIOT, V31, P283, DOI 10.1007/BF00258410; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Sandrini JZ, 2013, AQUAT TOXICOL, V130, P171, DOI 10.1016/j.aquatox.2013.01.006; Saxton MA, 2011, J GREAT LAKES RES, V37, P683, DOI 10.1016/j.jglr.2011.07.004; Schaffer JD, 2004, B ENVIRON CONTAM TOX, V72, P1032, DOI 10.1007/s00128-004-0347-7; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SCHULZ A, 1985, FEMS MICROBIOL LETT, V28, P297, DOI 10.1111/j.1574-6968.1985.tb00809.x; SERVIZI JA, 1987, B ENVIRON CONTAM TOX, V39, P15, DOI 10.1007/BF01691783; Shi XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071232; Stachowski-Haberkorn S, 2008, AQUAT TOXICOL, V89, P232, DOI 10.1016/j.aquatox.2008.07.004; Stalikas CD, 2001, J CHROMATOGR A, V907, P1, DOI 10.1016/S0021-9673(00)01009-8; Sun YY, 2009, BIOTECHNOL BIOPROC E, V14, P225, DOI 10.1007/s12257-008-0013-8; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Suzumura M, 1998, LIMNOL OCEANOGR, V43, P1553, DOI 10.4319/lo.1998.43.7.1553; TALBOT HW, 1984, CURR MICROBIOL, V10, P255, DOI 10.1007/BF01577137; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963; Vendrell E, 2009, B ENVIRON CONTAM TOX, V82, P538, DOI 10.1007/s00128-009-9674-z; Vera MS, 2010, ECOTOXICOLOGY, V19, P710, DOI 10.1007/s10646-009-0446-7; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; Webster TMU, 2014, ENVIRON SCI TECHNOL, V48, P1271, DOI 10.1021/es404258h; Winer BJ, 1971, STAT PRINCIPLES EXPT; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	84	118	126	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151633	10.1371/journal.pone.0151633	http://dx.doi.org/10.1371/journal.pone.0151633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985828	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300099
J	Wang, CH; Wu, CY; Yang, JCT; Lien, WC; Wang, HP; Liu, KL; Wu, YM; Chen, SC				Wang, Chih-Hung; Wu, Cheng-Yi; Yang, Justin Cheng-Ta; Lien, Wan-Ching; Wang, Hsiu-Po; Liu, Kao-Lang; Wu, Yao-Ming; Chen, Shyr-Chyr			Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center	PLOS ONE			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; SURGICAL-PATIENTS; MANAGEMENT; DIAGNOSIS; BRIDGE; TRIAL; BILE	Background Percutaneous cholecystostomy tube (PCT) has been effectively used for the treatment of acute cholecystitis (AC) for patients unsuitable for early cholecystectomy. This retrospective study investigated the recurrence rate after successful PCT treatment and factors associated with recurrence. Methods We reviewed patients treated with PCT for AC from October 2004 through December 2013. Patients with successful PCT treatment were those who were free from persistent PCT drainage. We used multivariable logistic regression analysis sequentially to identify factors associated with each outcome. Results The study included 184 patients (mean age: 70.1 years). The average duration for parenteral antibiotics was 14.4 days and 20.0 days for PCT drainage. The one-year recurrence rate was 9.2% (17/184) with most recurrences occurring within two months (6.5%, 12/184) of the procedure. Complicated cholecystitis (odds ratio [OR]: 4.67; 95% confidence interval [CI]: 1.44-15.70; P = 0.01) and PCT drainage duration >32 days (OR: 4.92; 95% CI: 1.03-23.53; P = 0.05) positively correlated with one-year recurrence; parenteral antibiotics duration > 10 days (OR: 0.21; 95% CI: 0.05-0.68; P = 0.01) was inversely associated with one-year recurrence. Conclusions The recurrence rate was low for patients after successful PCT treatment. Predictors for recurrence included the severity of initial AC and subsequently provided treatments.	[Wang, Chih-Hung; Wu, Cheng-Yi; Chen, Shyr-Chyr] Natl Taiwan Univ, Dept Emergency Med, Taipei 10764, Taiwan; [Wang, Chih-Hung; Wu, Cheng-Yi; Yang, Justin Cheng-Ta; Wang, Hsiu-Po; Liu, Kao-Lang; Wu, Yao-Ming; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, Justin Cheng-Ta; Liu, Kao-Lang] Natl Taiwan Univ, Dept Med Imaging, Taipei 10764, Taiwan; [Lien, Wan-Ching] Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsinchu, Taiwan; [Lien, Wan-Ching] Natl Taiwan Univ, Hsinchu, Taiwan; [Wang, Hsiu-Po] Natl Taiwan Univ, Dept Internal Med, Taipei 10764, Taiwan; [Wu, Yao-Ming] Natl Taiwan Univ, Dept Surg, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Lien, WC (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsinchu, Taiwan.; Lien, WC (corresponding author), Natl Taiwan Univ, Hsinchu, Taiwan.	wanchinglien@ntu.edu.tw	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016	CHEN, SHYR-CHYR/0000-0002-5858-3013; LIU, KAO-LANG/0000-0003-4100-8909; WANG, CHIH-HUNG/0000-0003-0802-7825; WU, YAO-MING/0000-0002-1720-7863; YANG, JUSTIN CHENG-TA/0000-0001-8256-2477; LIEN, WAN-CHING/0000-0001-9448-5093				Browning P D, 1993, J Vasc Interv Radiol, V4, P531, DOI 10.1016/S1051-0443(93)71915-6; Chang YR, 2014, SURGERY, V155, P615, DOI 10.1016/j.surg.2013.12.026; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chok KSH, 2010, ANZ J SURG, V80, P280, DOI 10.1111/j.1445-2197.2009.05105.x; Crnich CJ, 2012, INFECT DIS CLIN N AM, V26, P143, DOI 10.1016/j.idc.2011.09.007; Davis CA, 1999, ARCH SURG-CHICAGO, V134, P727, DOI 10.1001/archsurg.134.7.727; de Mestral C, 2013, J TRAUMA ACUTE CARE, V74, P175, DOI 10.1097/TA.0b013e31827890e1; Decker G, 2001, ACTA CHIR BELG, V101, P294; Gomi H, 2013, J HEPATO-BIL-PAN SCI, V20, P60, DOI 10.1007/s00534-012-0572-0; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Hatjidakis AA, 1998, CARDIOVASC INTER RAD, V21, P36, DOI 10.1007/s002709900208; HOUGHTON PWJ, 1985, BRIT J SURG, V72, P220, DOI 10.1002/bjs.1800720327; HUBER DF, 1983, AM J SURG, V146, P719, DOI 10.1016/0002-9610(83)90326-4; Kiviniemi H, 1998, INT SURG, V83, P299; Kortram K, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-7; Leveau P, 2008, SCAND J GASTROENTERO, V43, P593, DOI 10.1080/00365520701851673; Li M, 2013, AM SURGEON, V79, P524; MARGIOTTA SJ, 1988, AM SURGEON, V54, P34; McGillicuddy EA, 2012, BRIT J SURG, V99, P1254, DOI 10.1002/bjs.8836; Miura F, 2013, J HEPATO-BIL-PAN SCI, V20, P47, DOI 10.1007/s00534-012-0563-1; MORRIS CR, 1952, SURGERY, V32, P673; Okamoto K, 2013, J HEPATO-BIL-PAN SCI, V20, P55, DOI 10.1007/s00534-012-0562-2; Pessaux P, 2001, SURG LAPARO ENDO PER, V11, P252, DOI 10.1097/00129689-200108000-00005; RADDER RW, 1980, DIAGN IMAGING, V49, P330; ROSLYN JJ, 1980, AM J SURG, V140, P126, DOI 10.1016/0002-9610(80)90428-6; Sanjay P, 2013, HPB, V15, P511, DOI 10.1111/j.1477-2574.2012.00610.x; Smith TJ, 2013, ANN SURG, V257, P1112, DOI 10.1097/SLA.0b013e318274779c; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; VANDERLINDEN W, 1970, AM J SURG, V120, P7, DOI 10.1016/S0002-9610(70)80133-7; Venara A, 2014, J VISC SURG, V151, P435, DOI 10.1016/j.jviscsurg.2014.06.003; Wang CH, 2014, WORLD J SURG, V38, P347, DOI 10.1007/s00268-013-2311-3; WERBEL GB, 1989, ARCH SURG-CHICAGO, V124, P782; Winbladh A, 2009, HPB, V11, P183, DOI 10.1111/j.1477-2574.2009.00052.x; Wise JN, 2005, AM J ROENTGENOL, V184, P1647, DOI 10.2214/ajr.184.5.01841647; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Zerem E, 2014, SURG LAPARO ENDO PER, V24, P187, DOI 10.1097/SLE.0b013e31828fa45e	36	118	126	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148017	10.1371/journal.pone.0148017	http://dx.doi.org/10.1371/journal.pone.0148017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26985828	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528400058
